data_2m3g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m3g _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.589 0.233 . . . . 3.8199999999999998 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 2.46 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.9299999999999999 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.69 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 2.4100000000000001 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 2.2599999999999998 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 1.5800000000000001 111.166 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 1.54 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.89000000000000001 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.8200000000000001 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.8500000000000001 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 2.23 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.95999999999999996 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 1.4099999999999999 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.5699999999999998 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.8799999999999999 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.7999999999999998 110.442 179.542 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 4.0199999999999996 113.377 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 3.1600000000000001 112.139 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.3900000000000001 110.62 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.5 110.685 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 2.1099999999999999 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.8999999999999999 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.48 111.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.5299999999999998 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.74 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.68999999999999995 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 2.1699999999999999 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.594 ' HE1' HG23 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.47 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.9199999999999999 111.386 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.55000000000000004 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 1.6499999999999999 110.953 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 1.1399999999999999 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 2.4199999999999999 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.4099999999999999 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 1.0900000000000001 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 1.47 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 1.23 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.3399999999999999 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 2.3100000000000001 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 2.48 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 2.1200000000000001 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.54 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.2999999999999998 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 3.4199999999999999 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.8900000000000001 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 1.4299999999999999 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.1599999999999999 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.403 ' O ' HG13 ' A' ' 74' ' ' ILE . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.7999999999999998 110.992 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 1.29 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 3.3999999999999999 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.405 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.46 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 70' ' ' TYR . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 2.21 110.654 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.4199999999999999 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.73 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.9399999999999999 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.9099999999999999 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.8200000000000001 112.126 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 2.1099999999999999 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.26 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 2.1099999999999999 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.9099999999999999 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 109' ' ' GLN . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 2.2200000000000002 110.482 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 2.54 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.8600000000000001 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.9199999999999999 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 2.4700000000000002 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 3.0699999999999998 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 2.0099999999999998 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.7 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 3.0800000000000001 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.98 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 6.0499999999999998 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.4100000000000001 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.7000000000000002 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.9699999999999998 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.9399999999999999 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 6.96 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.7000000000000002 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 3.25 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 3.1099999999999999 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.5900000000000001 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 4.0300000000000002 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 2.4300000000000002 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.8100000000000001 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.4300000000000002 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.579 HG21 HD11 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.75 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 3.2200000000000002 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 2.3799999999999999 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 2.2200000000000002 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.6499999999999999 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 3.2599999999999998 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.416 HG22 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 1.28 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 1.0900000000000001 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 2.1299999999999999 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.6400000000000001 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.8799999999999999 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.6699999999999999 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.4900000000000002 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.6000000000000001 110.838 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 4.79 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.8600000000000001 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 3.23 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.4900000000000002 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 2.3700000000000001 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.96 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 2.6000000000000001 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.5699999999999998 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 2.2599999999999998 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.77000000000000002 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.6099999999999999 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 2.0699999999999998 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.72 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 4.0099999999999998 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 3.3999999999999999 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 3.0600000000000001 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.6699999999999999 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.46 111.091 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 4.3099999999999996 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.6200000000000001 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 3.1200000000000001 111.646 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 3.0499999999999998 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.619 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 3.0899999999999999 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo . . . . . 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.3599999999999999 112.684 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.878 0.371 . . . . 2.9399999999999999 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.3999999999999999 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 3.27 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 2.02 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.6400000000000001 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 2.0899999999999999 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.6400000000000001 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.1499999999999999 110.899 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.8399999999999999 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 165' ' ' TYR . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 2.3999999999999999 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.95 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.7 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 4.1100000000000003 110.719 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 2.4100000000000001 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 2.02 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 175' ' ' LEU . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 2.0299999999999998 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.4 HD13 HG11 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.9399999999999999 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.519 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 2.3300000000000001 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.73999999999999999 112.958 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 180' ' ' PRO . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 2.6499999999999999 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 1.1100000000000001 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 2.4500000000000002 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 179' ' ' TYR . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.9299999999999999 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.9399999999999999 111.618 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.6099999999999999 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.9100000000000001 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 2.1899999999999999 112.819 179.598 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.834 0.35 . . . . 2.6600000000000001 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 2.2200000000000002 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.96 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.6699999999999999 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.79 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 2.3900000000000001 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 2.2599999999999998 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.67 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.8799999999999999 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79000000000000004 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 2.2999999999999998 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 2.8100000000000001 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 2.0499999999999998 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.6800000000000002 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 3.4100000000000001 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.3799999999999999 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 3.5600000000000001 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.8399999999999999 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 4.1299999999999999 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.77 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.4399999999999999 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.9100000000000001 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.7599999999999998 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.5900000000000001 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 221' ' ' LEU . 3.3 mm? . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 4.0099999999999998 111.229 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 3.6000000000000001 110.993 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.8799999999999999 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.521 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG22 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1899999999999999 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 2.21 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.416 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 2.3500000000000001 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 1.48 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 1.51 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.82999999999999996 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.8 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.79 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 1.3700000000000001 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.7599999999999998 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.6899999999999999 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 5.1500000000000004 111.032 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.159 0 N-CA-C 112.011 0.375 . . . . 3.5899999999999999 112.011 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.5699999999999998 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.8799999999999999 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 2.5299999999999998 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.8999999999999999 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.432 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.6200000000000001 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 2.3199999999999998 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.434 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 1.3899999999999999 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.80000000000000004 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 2.2200000000000002 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.448 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 2.5600000000000001 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.74 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.57999999999999996 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.505 HD21 ' HG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 1.4299999999999999 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 1.23 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.435 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.6299999999999999 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 1.1699999999999999 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 1.45 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 1.3600000000000001 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.436 HG23 HG21 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.417 ' HB2' HG23 ' C' ' 127' ' ' VAL . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.71 110.886 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.8900000000000001 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 2.3500000000000001 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.1800000000000002 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.79 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.52 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.6899999999999999 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 2.25 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.3999999999999999 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.23 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.422 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.8999999999999999 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 1.3100000000000001 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.468 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.71 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 2.6699999999999999 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 2.0 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.462 ' O ' HG21 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.6099999999999999 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.8300000000000001 110.414 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.8899999999999999 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.462 HG21 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.6000000000000001 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.549 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 2.1200000000000001 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.3100000000000001 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 2.0800000000000001 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 2.21 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.444 HD13 ' N ' ' B' ' 85' ' ' LEU . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 2.3599999999999999 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.444 ' N ' HD13 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 2.5099999999999998 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.72 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.455 HD11 HD23 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.78 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.73 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.8799999999999999 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . 0.413 ' HB2' HD13 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.5 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 3.1499999999999999 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 5.0800000000000001 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 3.1899999999999999 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.9699999999999998 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.2400000000000002 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 6.25 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.472 ' HA ' HD23 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.6200000000000001 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 3.0600000000000001 111.063 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.6899999999999999 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.53 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.454 ' HB2' HD12 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 3.6099999999999999 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.6699999999999999 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.7999999999999998 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 2.3100000000000001 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.457 ' O ' HG22 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.5699999999999998 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 3.3799999999999999 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.594 HG23 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 2.6200000000000001 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 2.1699999999999999 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . 0.457 HG22 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.6499999999999999 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.9500000000000002 110.64 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 1.21 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 1.1100000000000001 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.59999999999999998 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.98 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 2.0800000000000001 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.3100000000000001 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 2.3300000000000001 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.685 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 3.0800000000000001 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.685 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.9699999999999998 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.0 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.0600000000000001 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 3.2200000000000002 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.6099999999999999 111.281 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.6699999999999999 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 2.5699999999999998 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 2.27 111.081 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 2.2999999999999998 110.971 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 2.0800000000000001 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 2.6499999999999999 110.709 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 1.51 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 2.3999999999999999 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.48 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . 0.427 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 2.4500000000000002 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.427 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 3.3500000000000001 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.9299999999999999 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 5.0800000000000001 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.6699999999999999 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 2.1099999999999999 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.79 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.3599999999999999 112.921 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.766 0.317 . . . . 2.46 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . 0.413 HD13 ' HB2' ' B' ' 91' ' ' ALA . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 3.02 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 2.1499999999999999 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 3.25 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.77 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.52 111.188 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.9399999999999999 110.91 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.7799999999999998 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.455 HD23 HD11 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 2.1499999999999999 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.2400000000000002 111.008 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.1299999999999999 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 2.4700000000000002 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.98 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 2.1000000000000001 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 2.5800000000000001 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.8700000000000001 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.494 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 2.0299999999999998 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67000000000000004 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.554 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 2.5600000000000001 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 1.1799999999999999 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.494 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 2.1000000000000001 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.6499999999999999 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 3.1699999999999999 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.507 HG21 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 2.4100000000000001 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.507 HG23 HG21 ' B' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.1200000000000001 111.252 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.815 0.341 . . . . 2.8300000000000001 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.4900000000000002 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.2799999999999998 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . 0.408 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.9199999999999999 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.3500000000000001 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 2.8300000000000001 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 2.27 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.78 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 2.0600000000000001 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77000000000000002 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 2.4300000000000002 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.425 ' HB3' HD21 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.9299999999999999 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.6499999999999999 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 3.1000000000000001 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.3899999999999999 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 3.0600000000000001 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.3500000000000001 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 4.3700000000000001 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 2.0 110.929 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.2200000000000002 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 3.0899999999999999 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 4.1600000000000001 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.6699999999999999 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.9700000000000002 111.319 -179.541 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.799 0.333 . . . . 3.2400000000000002 110.998 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.7599999999999998 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.585 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 2.3399999999999999 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.25 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.46 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 2.3799999999999999 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.5800000000000001 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 1.46 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.95 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 2.1400000000000001 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 1.02 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.51 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.5800000000000001 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.5699999999999998 110.306 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 p90 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.7799999999999998 111.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.7200000000000002 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.9800000000000004 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 2.4100000000000001 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 2.4300000000000002 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.6299999999999999 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 2.29 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 1.3799999999999999 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.90000000000000002 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 2.27 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 2.2400000000000002 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.71 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.57999999999999996 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.43 HD23 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.8200000000000001 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 1.28 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 2.46 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.7 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 1.2 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.4099999999999999 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.96 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 127' ' ' VAL . 18.6 tp60 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 2.25 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 3.4300000000000002 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 68' ' ' ALA . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 2.5499999999999998 111.248 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.27 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.8500000000000001 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.6200000000000001 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 3.2599999999999998 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 2.2599999999999998 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . 0.411 ' HB2' HG13 ' C' ' 61' ' ' VAL . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.544 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.467 ' HD1' ' HE ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.3999999999999999 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . 0.45 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.8199999999999998 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 1.3899999999999999 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.467 ' HE ' ' HD1' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 2.3599999999999999 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 2.7000000000000002 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.45 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.8200000000000001 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.3300000000000001 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 2.4100000000000001 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.9199999999999999 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.79 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.97 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.642 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 2.2000000000000002 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.25 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.8300000000000001 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 2.1400000000000001 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 2.2400000000000002 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.8 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 2.1200000000000001 110.481 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 4.0300000000000002 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 2.0699999999999998 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.47 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' MET . . . . . 0.486 ' HE2' HG12 ' C' ' 95' ' ' ILE . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.8599999999999999 110.689 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.6299999999999999 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 5.46 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . 0.486 HG12 ' HE2' ' C' ' 92' ' ' MET . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.8399999999999999 110.714 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.8399999999999999 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.8600000000000003 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 6.0700000000000003 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.79 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . 0.401 HD13 ' N ' ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 3.1499999999999999 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.8799999999999999 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.72 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 3.6200000000000001 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.476 HD11 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.8199999999999998 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.478 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.7000000000000002 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.54 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.8799999999999999 111.596 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.71 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.478 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 2.52 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 2.1699999999999999 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.5900000000000001 111.518 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.422 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 3.0299999999999998 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.422 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 1.3300000000000001 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 1.3100000000000001 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.65000000000000002 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 2.0299999999999998 110.582 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 2.23 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 1.4399999999999999 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.79 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.5499999999999998 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.3100000000000001 110.839 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.436 HG21 HG23 ' B' ' 56' ' ' ILE . 7.1 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.73 111.236 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 3.3799999999999999 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 3.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 2.48 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.74 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 2.5699999999999998 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . 0.505 ' HG ' HD21 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 2.2000000000000002 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.72999999999999998 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 2.1000000000000001 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.76 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.51 111.149 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.9399999999999999 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.54 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 2.4700000000000002 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 3.0699999999999998 111.33 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.9399999999999999 110.742 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 4.5199999999999996 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.9300000000000002 111.6 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.8599999999999999 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.7000000000000002 111.959 -179.429 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.831 0.348 . . . . 3.1800000000000002 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.1800000000000002 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.9900000000000002 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 2.2400000000000002 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.3900000000000001 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.6499999999999999 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.6299999999999999 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.2599999999999998 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . 0.527 ' HZ3' ' HH ' ' C' ' 171' ' ' TYR . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.9199999999999999 110.756 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.8 110.916 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 2.21 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 2.0299999999999998 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . 0.527 ' HH ' ' HZ3' ' C' ' 167' ' ' LYS . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.8799999999999999 110.63 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 2.3100000000000001 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 2.0 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 2.4199999999999999 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.7000000000000002 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.1100000000000001 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.474 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 2.3100000000000001 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.71999999999999997 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 2.71 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 1.0700000000000001 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.474 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 2.0800000000000001 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.71 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.8999999999999999 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.49 HG21 HG22 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 2.2000000000000002 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.49 HG22 HG21 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 3.23 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.9099999999999999 112.757 179.741 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.797 0.332 . . . . 2.8599999999999999 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6800000000000002 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.54 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.77 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 2.5299999999999998 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.8799999999999999 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 2.48 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.95 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.548 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.8700000000000001 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76000000000000001 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 2.3599999999999999 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 2.6200000000000001 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.9299999999999999 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.6600000000000001 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 3.1099999999999999 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.4099999999999999 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.77 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.8399999999999999 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 4.3399999999999999 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 2.25 110.771 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2000000000000002 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.54 111.259 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 4.0099999999999998 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.6400000000000001 111.19 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.642 0.258 . . . . 3.8199999999999998 111.255 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 2.46 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' MET . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.9299999999999999 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 1.0800000000000001 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 2.2599999999999998 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.5800000000000001 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 1.54 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.89000000000000001 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.573 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.8500000000000001 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 2.23 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.95999999999999996 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.4099999999999999 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.5699999999999998 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.8799999999999999 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.7999999999999998 110.637 179.447 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.4 0.519 . . . . 4.0199999999999996 112.4 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 3.1600000000000001 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.3900000000000001 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.5 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 2.1099999999999999 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.8999999999999999 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.48 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.407 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.5299999999999998 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 2.0499999999999998 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.74 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.68999999999999995 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 2.1699999999999999 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.47 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.9199999999999999 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.55000000000000004 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 1.6499999999999999 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 1.1399999999999999 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.401 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 2.4199999999999999 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.4099999999999999 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 1.0900000000000001 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 1.47 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 1.23 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.43 HD12 HD22 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.8700000000000001 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HA ' ' HZ2' ' A' ' 60' ' ' LYS . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.587 HE21 ' H ' ' A' ' 59' ' ' GLY . 22.6 tp60 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.3399999999999999 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' H ' HE21 ' A' ' 58' ' ' GLN . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.464 ' HZ2' ' HA ' ' A' ' 57' ' ' ASP . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 2.3100000000000001 110.884 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 2.1200000000000001 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.54 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.2999999999999998 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 3.4199999999999999 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.8900000000000001 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 1.4299999999999999 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.458 ' HD1' ' HE ' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.1599999999999999 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.7999999999999998 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.29 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HE ' ' HD1' ' A' ' 69' ' ' HIS . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 3.3999999999999999 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.46 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 2.21 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.73 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.9399999999999999 110.412 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.9099999999999999 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.8200000000000001 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 2.1099999999999999 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.26 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 2.1099999999999999 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.9099999999999999 110.618 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 2.2200000000000002 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.54 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.8600000000000001 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.9199999999999999 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 2.4700000000000002 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 3.0699999999999998 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 2.0099999999999998 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.7 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' MET . . . . . 0.47 ' HE3' HG12 ' A' ' 95' ' ' ILE . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 3.0800000000000001 110.993 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.413 ' HG2' ' HH ' ' A' ' 35' ' ' TYR . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.98 110.866 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 6.0499999999999998 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 92' ' ' MET . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.4100000000000001 111.464 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.7000000000000002 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.9699999999999998 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.9399999999999999 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 6.96 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.7000000000000002 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 3.25 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 3.1099999999999999 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.5900000000000001 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 4.0300000000000002 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 2.4300000000000002 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.8100000000000001 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.4300000000000002 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.75 111.837 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 3.2200000000000002 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 2.3799999999999999 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 2.2200000000000002 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.6499999999999999 111.216 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 3.2599999999999998 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 1.28 110.961 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 1.0900000000000001 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 2.1299999999999999 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.6400000000000001 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.3400000000000001 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.8799999999999999 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.6699999999999999 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.4900000000000002 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.6000000000000001 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 4.79 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.8600000000000001 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 3.23 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.4900000000000002 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 2.3700000000000001 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.96 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.562 ' HH ' ' HB2' ' A' ' 183' ' ' TRP . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 2.6000000000000001 110.878 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.5699999999999998 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 2.2599999999999998 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.6099999999999999 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 2.0699999999999998 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.72 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 4.0099999999999998 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 3.3999999999999999 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.433 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 3.0600000000000001 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.433 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.6699999999999999 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.46 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 4.3099999999999996 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.6200000000000001 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 3.1200000000000001 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 3.0499999999999998 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 3.0899999999999999 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.3599999999999999 112.384 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.873 0.368 . . . . 2.9399999999999999 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.3999999999999999 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.423 HD12 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 2.02 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.6400000000000001 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.423 HD12 HD12 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.6400000000000001 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.8399999999999999 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 2.3999999999999999 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.95 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.7 111.593 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 4.1100000000000003 110.206 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 2.4100000000000001 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.402 HG22 HD13 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 2.02 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 2.0299999999999998 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 2.5499999999999998 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.9399999999999999 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.73999999999999999 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 2.6499999999999999 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 1.1100000000000001 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 2.4500000000000002 111.524 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.467 HG22 ' CD2' ' A' ' 183' ' ' TRP . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.9299999999999999 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.562 ' HB2' ' HH ' ' A' ' 132' ' ' TYR . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.9399999999999999 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.6099999999999999 111.265 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.414 ' HB ' ' H ' ' A' ' 186' ' ' GLY . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.9100000000000001 110.676 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 185' ' ' ILE . . . . . . . . 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 2.1899999999999999 112.335 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.748 0.309 . . . . 2.6600000000000001 111.019 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 2.2200000000000002 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.96 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 201' ' ' LEU . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.6699999999999999 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.79 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 2.3900000000000001 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 2.2599999999999998 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.8799999999999999 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79000000000000004 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 2.2999999999999998 110.244 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 2.8100000000000001 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 2.0499999999999998 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.6800000000000002 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 3.4100000000000001 110.958 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.3799999999999999 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 3.5600000000000001 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.8399999999999999 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 4.1299999999999999 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.4399999999999999 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.9100000000000001 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.7599999999999998 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.5900000000000001 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 4.0099999999999998 111.259 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.76 0.314 . . . . 3.6000000000000001 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.8799999999999999 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 61.8 m-70 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 2.1699999999999999 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1899999999999999 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 2.21 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 2.3500000000000001 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 1.48 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.82999999999999996 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.9299999999999999 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.8 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.79 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 1.3700000000000001 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.7599999999999998 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.6899999999999999 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 5.1500000000000004 110.589 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.705 0.288 . . . . 3.5899999999999999 111.536 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.5699999999999998 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.8799999999999999 111.299 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 2.2200000000000002 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.432 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 2.5299999999999998 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.8999999999999999 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.409 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.6200000000000001 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 2.3199999999999998 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 1.3899999999999999 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.80000000000000004 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.409 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 2.2200000000000002 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.533 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 2.5600000000000001 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.74 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.57999999999999996 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 1.4299999999999999 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 1.23 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.6299999999999999 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 1.1699999999999999 110.891 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 1.45 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 1.3600000000000001 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 2.02 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' C' ' 122' ' ' SER . 17.3 mm100 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.71 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.8900000000000001 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.3500000000000001 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.1800000000000002 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.2599999999999998 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.79 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.52 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' B' ' 123' ' ' GLU . 10.0 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.6899999999999999 110.881 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 2.25 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.3999999999999999 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.586 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.23 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.405 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.8999999999999999 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 1.3100000000000001 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.71 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 2.6699999999999999 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 2.0 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.3100000000000001 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.6099999999999999 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.8300000000000001 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.409 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.8899999999999999 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.409 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.6000000000000001 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 2.1200000000000001 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.3100000000000001 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.498 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 2.0800000000000001 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 2.3599999999999999 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.498 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 2.5099999999999998 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.72 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.479 HD23 HD13 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.78 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.73 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.8799999999999999 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 2.1000000000000001 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.5 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 3.1499999999999999 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 3.1499999999999999 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 5.0800000000000001 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 3.1899999999999999 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.6500000000000004 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.9699999999999998 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 6.25 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.6200000000000001 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 3.0600000000000001 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.6899999999999999 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.53 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 3.6099999999999999 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.6699999999999999 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.7999999999999998 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 2.3100000000000001 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.468 ' HG1' HG13 ' B' ' 142' ' ' ILE . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.5699999999999998 111.528 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 3.3799999999999999 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 2.6200000000000001 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 2.1699999999999999 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.6499999999999999 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.9500000000000002 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.21 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 1.1100000000000001 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.59999999999999998 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.469 HD11 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.98 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.469 ' N ' HD11 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 2.0800000000000001 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.3100000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.71 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 2.3300000000000001 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . 0.503 ' HA ' HE22 ' B' ' 66' ' ' GLN . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.8900000000000001 110.691 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 3.0800000000000001 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.9699999999999998 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.0 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 3.0600000000000001 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 3.2200000000000002 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6099999999999999 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.6699999999999999 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 2.5699999999999998 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 2.27 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 2.2999999999999998 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.69999999999999996 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 2.0800000000000001 111.584 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 2.6499999999999999 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 1.51 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 2.3999999999999999 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.48 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . 0.432 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 2.4500000000000002 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.468 HG13 ' HG1' ' B' ' 108' ' ' THR . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 3.3500000000000001 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.9299999999999999 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 5.0800000000000001 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.5900000000000001 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.6699999999999999 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 2.1099999999999999 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.485 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.79 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.3599999999999999 112.868 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.889 0.376 . . . . 2.46 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 3.02 110.614 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 2.1499999999999999 111.257 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 3.25 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.52 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.9399999999999999 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.7799999999999998 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.479 HD13 HD23 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 2.2400000000000002 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.6699999999999999 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . 0.519 ' HH ' ' HA3' ' B' ' 212' ' ' GLY . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 4.1299999999999999 110.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 2.4700000000000002 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.98 111.524 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 2.1000000000000001 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 2.5800000000000001 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.8700000000000001 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 2.0299999999999998 110.565 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67000000000000004 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 2.5600000000000001 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 1.1799999999999999 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 2.1000000000000001 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.468 HG21 ' CD2' ' B' ' 183' ' ' TRP . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.6499999999999999 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . 0.468 ' CD2' HG21 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 3.1699999999999999 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.477 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 2.4100000000000001 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 3.1200000000000001 111.071 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 2.8300000000000001 111.247 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.4900000000000002 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 2.2799999999999998 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.9199999999999999 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . 0.443 ' N ' HD22 ' B' ' 201' ' ' LEU . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 2.3500000000000001 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 2.8300000000000001 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.421 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 2.27 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.78 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.413 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 2.0600000000000001 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.508 ' HA ' ' HH ' ' B' ' 179' ' ' TYR . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77000000000000002 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 2.4300000000000002 110.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 2.5899999999999999 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.438 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.9299999999999999 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.6499999999999999 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 3.1000000000000001 111.076 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . 0.519 ' HA3' ' HH ' ' B' ' 171' ' ' TYR . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.3899999999999999 112.468 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 3.0600000000000001 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.3500000000000001 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 4.3700000000000001 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.2200000000000002 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 3.0899999999999999 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 4.1600000000000001 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.6699999999999999 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.9700000000000002 111.566 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.75 0.309 . . . . 3.2400000000000002 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.7599999999999998 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.483 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 2.3399999999999999 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.432 ' O ' HG13 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.25 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.46 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.435 ' HH ' ' HB2' ' C' ' 207' ' ' PHE . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 2.3799999999999999 110.949 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.432 HG13 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.5800000000000001 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 1.46 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 1.04 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' C' ' 15' ' ' MET . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.95 110.575 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 2.1400000000000001 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.3399999999999999 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 1.02 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.51 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.5800000000000001 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.5699999999999998 110.425 179.716 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.7799999999999998 111.559 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.7200000000000002 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.9800000000000004 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 2.4100000000000001 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 2.4300000000000002 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.8500000000000001 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.431 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.6299999999999999 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 2.29 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.577 HG21 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 1.3799999999999999 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 2.27 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.443 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.71 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.57999999999999996 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.8200000000000001 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 1.28 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 2.46 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.431 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.7 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 1.2 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.4099999999999999 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.498 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 2.25 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 3.4300000000000002 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 2.5499999999999998 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.27 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.8500000000000001 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.6200000000000001 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 3.2599999999999998 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 2.2599999999999998 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.51 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.435 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.3999999999999999 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . 0.456 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.8199999999999998 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 1.3899999999999999 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.435 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 2.3599999999999999 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.406 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 2.7000000000000002 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.456 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.8200000000000001 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.3300000000000001 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 2.4100000000000001 110.733 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.9199999999999999 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.908 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.577 HG23 HG21 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.97 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.508 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 2.2000000000000002 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.25 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.8300000000000001 111.208 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 2.1400000000000001 111.286 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.483 HD13 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 2.2400000000000002 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD13 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.6699999999999999 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.8 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 2.1200000000000001 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 2.29 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 4.0300000000000002 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 2.0699999999999998 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.47 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.8599999999999999 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.6299999999999999 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 5.46 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.8399999999999999 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.8399999999999999 110.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.8600000000000003 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 6.0700000000000003 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.79 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 3.1499999999999999 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.8799999999999999 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.72 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 3.6200000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.8199999999999998 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.448 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.7000000000000002 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.54 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.517 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.71 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.533 HG23 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 2.52 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 2.1699999999999999 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.5900000000000001 111.158 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 3.0299999999999998 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 1.3100000000000001 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.65000000000000002 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 2.0299999999999998 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.425 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 2.23 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 1.4399999999999999 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.79 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' SER . . . . . 0.446 ' HA ' HE22 ' B' ' 58' ' ' GLN . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.5499999999999998 110.982 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.3100000000000001 110.848 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.862 0.363 . . . . 1.73 110.984 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 3.3799999999999999 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 3.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 2.48 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.74 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 2.5699999999999998 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.7000000000000002 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 2.2000000000000002 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.72999999999999998 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 2.1000000000000001 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.76 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.51 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.9399999999999999 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.54 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 2.4700000000000002 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.44 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 3.0699999999999998 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.9399999999999999 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 4.5199999999999996 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.6499999999999999 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.9300000000000002 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.8599999999999999 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.7000000000000002 112.019 -179.576 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.78 0.324 . . . . 3.1800000000000002 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.1800000000000002 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.9900000000000002 110.752 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 2.2400000000000002 111.165 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.3900000000000001 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.6499999999999999 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.6299999999999999 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.2599999999999998 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.9199999999999999 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.8 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 2.21 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 2.0299999999999998 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.8799999999999999 110.887 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 2.3100000000000001 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 2.4199999999999999 111.88 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.7000000000000002 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.1100000000000001 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.429 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 2.3100000000000001 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.666 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 2.71 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 1.0700000000000001 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.429 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 2.0800000000000001 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.445 HG23 ' CD2' ' C' ' 183' ' ' TRP . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.71 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . 0.445 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.8999999999999999 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.413 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 2.2000000000000002 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 3.23 110.943 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.9099999999999999 112.194 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 2.8599999999999999 111.385 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.6800000000000002 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 2.54 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.77 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 2.5299999999999998 111.651 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . 0.441 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.8799999999999999 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.48 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 2.48 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.95 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.8700000000000001 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76000000000000001 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . 0.435 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 2.3599999999999999 110.256 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 2.6200000000000001 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.9299999999999999 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.6600000000000001 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 3.1099999999999999 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.4099999999999999 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.77 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.8399999999999999 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 4.3399999999999999 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 2.25 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2000000000000002 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.54 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 4.0099999999999998 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.6400000000000001 111.759 -179.481 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.755 0.312 . . . . 3.8199999999999998 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 2.46 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.9299999999999999 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 2.4100000000000001 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.416 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 2.2599999999999998 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 1.5800000000000001 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.89000000000000001 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE2' ' HG2' ' A' ' 210' ' ' LYS . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.8200000000000001 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 2.23 110.622 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.95999999999999996 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 1.4099999999999999 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.5699999999999998 110.535 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.8799999999999999 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.7999999999999998 111.068 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 113.003 0.742 . . . . 4.0199999999999996 113.003 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 36' ' ' GLU . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 3.1600000000000001 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 35' ' ' TYR . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.3900000000000001 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.5 110.157 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 2.1099999999999999 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.8999999999999999 110.52 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.48 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.5299999999999998 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 2.0499999999999998 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.74 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.68999999999999995 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 2.1699999999999999 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.47 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.9199999999999999 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.55000000000000004 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 1.6499999999999999 110.7 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 1.1399999999999999 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 2.4199999999999999 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 1.0900000000000001 110.72 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 1.47 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 1.23 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.728 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.466 HE22 ' HA ' ' B' ' 122' ' ' SER . 15.9 mm100 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.3399999999999999 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 2.3100000000000001 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 2.48 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.6400000000000001 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.54 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.2999999999999998 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 3.4199999999999999 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.45 ' N ' HD11 ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.8900000000000001 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 1.4299999999999999 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.1599999999999999 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.7999999999999998 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 1.29 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 3.3999999999999999 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.46 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 2.21 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.4199999999999999 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.73 111.499 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.9399999999999999 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.9099999999999999 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.8200000000000001 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 2.1099999999999999 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.26 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 2.1099999999999999 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.9099999999999999 109.772 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 2.2200000000000002 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 2.54 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.8600000000000001 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 84' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.9199999999999999 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 3.0699999999999998 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 2.0099999999999998 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.7 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 3.0800000000000001 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.98 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 6.0499999999999998 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.4100000000000001 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.7000000000000002 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.9699999999999998 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.9399999999999999 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 6.96 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.7000000000000002 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 3.1099999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.5900000000000001 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 4.0300000000000002 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 2.4300000000000002 110.936 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.444 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.8100000000000001 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.4300000000000002 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.75 111.501 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.468 ' HG3' HD23 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 3.2200000000000002 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 2.3799999999999999 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 2.2200000000000002 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.6499999999999999 111.112 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 3.2599999999999998 110.507 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.28 110.47 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 1.0900000000000001 110.204 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 2.1299999999999999 112.268 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.6400000000000001 111.418 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.3400000000000001 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.8799999999999999 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 2.0099999999999998 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.6699999999999999 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.4900000000000002 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.6000000000000001 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 4.79 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.8600000000000001 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 3.23 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.4900000000000002 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 2.3700000000000001 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 2.6000000000000001 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.5699999999999998 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 2.2599999999999998 110.705 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.77000000000000002 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.6099999999999999 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.72 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 4.0099999999999998 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 3.3999999999999999 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 3.0600000000000001 111.346 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.6699999999999999 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.46 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 4.3099999999999996 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.6200000000000001 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 3.1200000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 3.0499999999999998 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.562 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 3.0899999999999999 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo . . . . . 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.3599999999999999 112.992 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.361 . . . . 2.9399999999999999 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.3999999999999999 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.3700000000000001 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 3.27 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.02 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.6400000000000001 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 2.0899999999999999 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.6400000000000001 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.1499999999999999 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.8399999999999999 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.431 HD12 HD23 ' A' ' 216' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.3999999999999999 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.95 111.31 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.7 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 4.1100000000000003 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 2.4100000000000001 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 2.02 111.53 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 2.0299999999999998 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 2.5499999999999998 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.9399999999999999 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.427 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 2.3300000000000001 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.73999999999999999 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.542 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 2.6499999999999999 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 1.1100000000000001 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 2.4500000000000002 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.9299999999999999 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.9399999999999999 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.6099999999999999 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.9100000000000001 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 2.1899999999999999 112.531 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 2.6600000000000001 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 2.2200000000000002 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.96 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.6699999999999999 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.79 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.483 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 2.3900000000000001 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 2.2599999999999998 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.8799999999999999 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79000000000000004 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 2.2999999999999998 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 2.8100000000000001 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 2.0499999999999998 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . 0.465 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.6800000000000002 110.754 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 3.4100000000000001 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.3799999999999999 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 3.5600000000000001 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.8399999999999999 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 4.1299999999999999 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.77 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.9100000000000001 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.7599999999999998 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.5900000000000001 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 4.0099999999999998 110.916 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.797 0.332 . . . . 3.6000000000000001 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.8799999999999999 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1899999999999999 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 2.21 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 2.3500000000000001 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 1.48 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 1.51 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.82999999999999996 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.9299999999999999 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.8 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.79 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 1.3700000000000001 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.7599999999999998 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.6899999999999999 111.049 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 5.1500000000000004 111.298 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.012 1.116 . . . . 3.5899999999999999 114.012 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.485 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.5699999999999998 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.8799999999999999 112.191 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . 0.45 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 2.2200000000000002 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 2.5299999999999998 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.8999999999999999 110.803 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.412 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.6200000000000001 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 2.3199999999999998 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.574 HG21 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 1.3899999999999999 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.80000000000000004 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.412 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 2.2200000000000002 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 2.5600000000000001 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.74 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.57999999999999996 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 1.4299999999999999 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 1.23 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.49 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.418 ' HB2' HG23 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.6299999999999999 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 1.1699999999999999 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 1.45 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 2.02 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.622 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.1 tp60 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.71 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . 0.622 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.8900000000000001 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 2.3500000000000001 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.1800000000000002 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.2599999999999998 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.79 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.52 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.6899999999999999 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 2.25 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.3999999999999999 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.23 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.8999999999999999 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 1.3100000000000001 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.71 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.471 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 2.6699999999999999 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 2.0 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.6099999999999999 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.8300000000000001 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.474 ' O ' HD22 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.8899999999999999 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.574 HG23 HG21 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.6000000000000001 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 2.1200000000000001 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.3100000000000001 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.474 HD22 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 2.0800000000000001 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 2.3599999999999999 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.425 ' N ' HD13 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 2.5099999999999998 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.405 ' O ' HG22 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.72 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.464 ' HA ' ' HG1' ' B' ' 90' ' ' THR . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.78 111.125 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.73 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.8799999999999999 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.464 ' HG1' ' HA ' ' B' ' 87' ' ' LEU . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 2.1000000000000001 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.5 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 3.1499999999999999 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.444 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 3.1499999999999999 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . 0.444 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 5.0800000000000001 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 3.1899999999999999 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HD3' ' HZ3' ' C' ' 96' ' ' LYS . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.6500000000000004 111.271 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.9699999999999998 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.2400000000000002 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 6.25 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.6200000000000001 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 3.0600000000000001 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.6899999999999999 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.53 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 3.6099999999999999 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.6699999999999999 111.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.411 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.7999999999999998 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 2.3100000000000001 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.5699999999999998 111.231 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' B' ' 84' ' ' LEU . 15.4 mm100 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 3.3799999999999999 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.526 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 2.6200000000000001 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.6499999999999999 111.504 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.9500000000000002 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 1.21 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 1.1100000000000001 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.59999999999999998 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.422 HD13 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.98 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.422 HG13 HD13 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 2.0800000000000001 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.3100000000000001 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.71 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' SER . . . . . 0.474 ' HG ' ' HB2' ' B' ' 128' ' ' ARG . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 2.3300000000000001 110.721 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.8900000000000001 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.613 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 3.0800000000000001 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . 0.613 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.9699999999999998 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.474 ' HB2' ' HG ' ' B' ' 122' ' ' SER . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 3.0600000000000001 110.664 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 3.2200000000000002 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.6099999999999999 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.6699999999999999 111.173 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.5699999999999998 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 2.27 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.69999999999999996 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 2.0800000000000001 111.27 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 2.6499999999999999 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 1.51 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 2.3999999999999999 111.313 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.48 111.444 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 2.4500000000000002 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 3.3500000000000001 111.71 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.9299999999999999 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 5.0800000000000001 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.5900000000000001 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.6699999999999999 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 2.1099999999999999 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.521 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 3.0 t-20 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.79 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo . . . . . 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.3599999999999999 113.087 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.968 0.413 . . . . 2.46 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 3.02 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 2.1499999999999999 111.691 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 3.25 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . 0.408 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.52 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.9399999999999999 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.7799999999999998 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.453 HD11 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 2.1499999999999999 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.453 ' N ' HD11 ' B' ' 168' ' ' LEU . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 2.2400000000000002 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 4.1299999999999999 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 2.4700000000000002 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.98 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 2.5800000000000001 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . 0.434 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.8700000000000001 110.545 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 2.0299999999999998 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.467 ' O ' HG23 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 2.5600000000000001 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.455 ' HG2' ' O ' ' B' ' 177' ' ' ILE . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 1.1799999999999999 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 177' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 2.1000000000000001 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.6499999999999999 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 3.1699999999999999 111.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.448 HG21 HG22 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 2.4100000000000001 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.448 HG22 HG21 ' B' ' 184' ' ' ILE . 34.8 pt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 3.1200000000000001 111.4 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.313 . . . . 2.8300000000000001 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.4900000000000002 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 2.2799999999999998 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.9199999999999999 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.3500000000000001 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 2.8300000000000001 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.421 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 2.27 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.78 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 2.0600000000000001 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77000000000000002 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 2.4300000000000002 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.5899999999999999 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.45 ' HB2' HD12 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.9299999999999999 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.6499999999999999 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 3.1000000000000001 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.3899999999999999 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 3.0600000000000001 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.3500000000000001 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 4.3700000000000001 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 2.0 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 3.0899999999999999 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 4.1600000000000001 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.6699999999999999 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . 0.412 HD23 ' N ' ' B' ' 221' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.9700000000000002 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.682 0.277 . . . . 3.2400000000000002 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.7599999999999998 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 2.3399999999999999 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.25 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.46 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.3799999999999999 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.5800000000000001 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 1.46 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 1.04 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.95 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 2.1400000000000001 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 2.3399999999999999 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 1.02 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.51 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.5800000000000001 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.5699999999999998 111.049 179.564 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' C' ' 36' ' ' GLU . 12.2 p90 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.7799999999999998 112.313 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' C' ' 35' ' ' TYR . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.7200000000000002 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.9800000000000004 110.109 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 2.4100000000000001 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 2.4300000000000002 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.8500000000000001 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.419 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.6299999999999999 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 2.29 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 1.3799999999999999 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.90000000000000002 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.434 HG21 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 2.27 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . 0.434 ' N ' HG21 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 2.2400000000000002 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.71 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.57999999999999996 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.8200000000000001 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 1.28 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 2.46 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.7 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 1.2 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.4099999999999999 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 1.3200000000000001 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.96 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.9399999999999999 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.511 HE21 ' H ' ' C' ' 59' ' ' GLY . 24.8 tp60 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.866 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.511 ' H ' HE21 ' C' ' 58' ' ' GLN . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 3.4300000000000002 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 2.5499999999999998 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.27 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.8500000000000001 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.6200000000000001 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 3.2599999999999998 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 2.2599999999999998 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.51 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 110.809 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.8199999999999998 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 1.3899999999999999 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 2.3599999999999999 111.132 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 2.7000000000000002 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.8200000000000001 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.3300000000000001 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . 0.483 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 2.4100000000000001 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.9199999999999999 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.451 ' O ' HD21 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.79 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.97 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.565 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 2.2000000000000002 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.25 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.451 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.8300000000000001 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 2.1400000000000001 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 2.2400000000000002 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.6699999999999999 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.627 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 2.1200000000000001 110.645 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 2.29 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 4.0300000000000002 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 2.0699999999999998 110.998 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.47 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.8599999999999999 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.6299999999999999 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 5.46 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.8399999999999999 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . 0.402 ' HZ3' ' HD3' ' B' ' 96' ' ' LYS . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.8399999999999999 111.311 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.8600000000000003 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 6.0700000000000003 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.79 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 3.1499999999999999 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.8799999999999999 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.72 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 3.6200000000000001 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.8199999999999998 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.7000000000000002 110.894 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.569 HG22 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.8799999999999999 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.71 110.287 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 2.52 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 2.1699999999999999 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.5900000000000001 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 3.0299999999999998 110.515 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 1.3300000000000001 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 1.3100000000000001 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.65000000000000002 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 2.0299999999999998 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 2.23 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 1.4399999999999999 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.79 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' SER . . . . . 0.564 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.5499999999999998 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.3100000000000001 110.965 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.873 0.368 . . . . 1.73 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 3.3799999999999999 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 3.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 2.48 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.74 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 2.5699999999999998 110.901 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.7000000000000002 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 2.2000000000000002 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.72999999999999998 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 2.1000000000000001 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.76 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.9399999999999999 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 2.4700000000000002 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.569 HD13 HG22 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 3.0699999999999998 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.9399999999999999 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 4.5199999999999996 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.6499999999999999 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.9300000000000002 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.8599999999999999 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.7000000000000002 112.402 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.82 0.343 . . . . 3.1800000000000002 111.112 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.1800000000000002 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.9900000000000002 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 2.2400000000000002 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.3900000000000001 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.6499999999999999 110.888 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . 0.441 ' HA ' ' HG1' ' C' ' 170' ' ' THR . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.9199999999999999 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.8 110.583 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . 0.462 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 170' ' ' THR . . . . . 0.441 ' HG1' ' HA ' ' C' ' 167' ' ' LYS . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 2.0299999999999998 111.031 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.8799999999999999 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 2.0 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 2.4199999999999999 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.7000000000000002 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.1100000000000001 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 2.3100000000000001 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.71999999999999997 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.583 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 2.71 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 1.0700000000000001 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.429 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 2.0800000000000001 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.71 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.8999999999999999 110.778 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 2.2000000000000002 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.23 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.9099999999999999 112.752 179.755 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.904 0.383 . . . . 2.8599999999999999 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.6800000000000002 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 2.54 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 2.5299999999999998 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.8799999999999999 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.486 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 2.48 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.95 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.637 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.8700000000000001 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76000000000000001 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 2.3599999999999999 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 2.6200000000000001 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.9299999999999999 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.6600000000000001 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 3.1099999999999999 110.439 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.4099999999999999 111.844 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.77 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.8399999999999999 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 4.3399999999999999 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 2.25 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.54 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 4.0099999999999998 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.6400000000000001 110.841 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.788 0.328 . . . . 3.8199999999999998 110.678 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 2.46 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.475 ' HE2' ' HG1' ' A' ' 199' ' ' THR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.9299999999999999 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 2.4100000000000001 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 2.2599999999999998 109.981 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 1.5800000000000001 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 1.54 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.89000000000000001 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.8200000000000001 110.904 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 2.23 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.95999999999999996 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 1.4099999999999999 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.5699999999999998 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.8799999999999999 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.7999999999999998 110.469 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 4.0199999999999996 112.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.459 ' HA ' HD21 ' A' ' 38' ' ' LEU . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.3900000000000001 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.5 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 2.1099999999999999 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.423 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.8999999999999999 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.48 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.5299999999999998 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 2.0499999999999998 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.472 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.74 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.68999999999999995 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 2.1699999999999999 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.47 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.9199999999999999 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.55000000000000004 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 1.6499999999999999 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.1399999999999999 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 2.4199999999999999 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.4099999999999999 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 1.0900000000000001 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.47 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 1.23 110.255 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.8700000000000001 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 127' ' ' VAL . 85.0 mm-40 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.3399999999999999 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 2.3100000000000001 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 2.48 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.6400000000000001 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 2.1200000000000001 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.54 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.2999999999999998 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 3.4199999999999999 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.8900000000000001 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 1.4299999999999999 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.1599999999999999 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.7999999999999998 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 1.29 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 3.3999999999999999 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.46 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 2.21 110.496 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.4199999999999999 109.515 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.73 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.9399999999999999 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' O ' HD22 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.9099999999999999 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.422 HG22 HG21 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.8200000000000001 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 2.1099999999999999 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.26 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 2.1099999999999999 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.9099999999999999 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 2.2200000000000002 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 2.54 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.8600000000000001 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.9199999999999999 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 2.4700000000000002 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 3.0699999999999998 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 2.0099999999999998 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.7 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 3.0800000000000001 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.98 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 6.0499999999999998 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.4100000000000001 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.7000000000000002 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.9699999999999998 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.9399999999999999 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 6.96 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.7000000000000002 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 3.25 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 3.1099999999999999 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.5900000000000001 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 4.0300000000000002 111.072 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 2.4300000000000002 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.8100000000000001 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.4300000000000002 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.505 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.75 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 3.2200000000000002 111.213 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 2.3799999999999999 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 2.2200000000000002 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 3.2599999999999998 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 1.28 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 1.0900000000000001 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 2.1299999999999999 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.488 ' N ' HD11 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.6400000000000001 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.3400000000000001 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.8799999999999999 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 2.0099999999999998 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.6699999999999999 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.4900000000000002 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.6000000000000001 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.607 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 4.79 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.531 HG23 HD13 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.8600000000000001 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.23 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.4900000000000002 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.531 HD13 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 2.3700000000000001 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.96 111.041 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 2.6000000000000001 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.5699999999999998 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 2.2599999999999998 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.77000000000000002 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.6099999999999999 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.72 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 4.0099999999999998 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 3.3999999999999999 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 3.0600000000000001 111.413 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.6699999999999999 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.46 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 4.3099999999999996 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.6200000000000001 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 3.1200000000000001 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 3.0499999999999998 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.3 t-20 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 3.0899999999999999 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo . . . . . 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.3599999999999999 112.994 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.862 0.363 . . . . 2.9399999999999999 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.3999999999999999 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 3.27 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 2.02 111.342 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.6400000000000001 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.6400000000000001 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.1499999999999999 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.8399999999999999 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 2.3999999999999999 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.95 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.7 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 110.357 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 2.4100000000000001 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 2.02 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 2.0299999999999998 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 2.5499999999999998 111.149 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.9399999999999999 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 2.3300000000000001 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.73999999999999999 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.521 ' N ' ' HD2' ' A' ' 180' ' ' PRO . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 2.6499999999999999 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 1.1100000000000001 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 2.4500000000000002 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 185' ' ' ILE . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.9299999999999999 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.9399999999999999 111.883 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.6099999999999999 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 182' ' ' VAL . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.9100000000000001 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 2.1899999999999999 112.37 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.869 0.366 . . . . 2.6600000000000001 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' THR . . . . . 0.475 ' HG1' ' HE2' ' A' ' 8' ' ' HIS . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 2.2200000000000002 111.217 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.6699999999999999 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.79 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.455 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 2.3900000000000001 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 2.2599999999999998 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.8799999999999999 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79000000000000004 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 2.2999999999999998 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 2.8100000000000001 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 2.0499999999999998 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.6800000000000002 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 3.4100000000000001 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.3799999999999999 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 3.5600000000000001 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.8399999999999999 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 4.1299999999999999 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.77 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.9100000000000001 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.7599999999999998 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.5900000000000001 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 4.0099999999999998 110.88 179.798 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.401 HD12 HD23 ' B' ' 7' ' ' LEU . 2.2 pp . . . . . 0 N--CA 1.46 0.055 0 CA-C-O 120.682 0.277 . . . . 3.6000000000000001 111.325 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.435 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.8799999999999999 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.53 ' HE2' HH22 ' B' ' 72' ' ' ARG . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 2.1699999999999999 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1899999999999999 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 2.21 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 2.3500000000000001 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 1.48 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 1.51 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.82999999999999996 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.9299999999999999 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.8 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.79 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 1.3700000000000001 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.7599999999999998 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.6899999999999999 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 5.1500000000000004 110.197 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.513 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 N-CA-C 113.185 0.809 . . . . 3.5899999999999999 113.185 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.513 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.5699999999999998 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.8799999999999999 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 2.2200000000000002 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.416 HG11 ' O ' ' B' ' 35' ' ' TYR . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 2.5299999999999998 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.8999999999999999 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.6200000000000001 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 2.3199999999999998 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 1.3899999999999999 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.80000000000000004 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 2.2200000000000002 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.55 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 2.5600000000000001 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.57999999999999996 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.467 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 1.4299999999999999 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 1.23 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.49 111.363 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.467 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.6299999999999999 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 1.1699999999999999 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 1.45 110.23 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 1.3600000000000001 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.434 ' NE2' HG13 ' C' ' 127' ' ' VAL . 84.3 mm-40 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.71 110.904 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.8900000000000001 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 2.3500000000000001 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.1800000000000002 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.2599999999999998 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.79 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.52 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.6899999999999999 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 2.25 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.3999999999999999 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.446 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.23 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.8999999999999999 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 1.3100000000000001 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.53 HH22 ' HE2' ' B' ' 8' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.71 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.409 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 2.6699999999999999 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 2.0 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.3100000000000001 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.6099999999999999 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.8300000000000001 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.8899999999999999 112.081 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.433 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.6000000000000001 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 2.1200000000000001 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.3100000000000001 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.545 ' HB3' HD13 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.0800000000000001 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 2.21 110.207 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 2.3599999999999999 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 2.5099999999999998 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.72 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.73 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.8799999999999999 111.324 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 2.1000000000000001 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.5 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 3.1499999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 3.1499999999999999 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 5.0800000000000001 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 3.1899999999999999 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.6500000000000004 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.9699999999999998 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.2400000000000002 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 6.25 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' THR . . . . . 0.415 ' HG1' ' HG ' ' A' ' 38' ' ' LEU . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.6200000000000001 111.624 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 3.0600000000000001 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.6899999999999999 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.53 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 3.6099999999999999 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.6699999999999999 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.7999999999999998 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.558 ' HB ' HD11 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.5699999999999998 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 3.3799999999999999 111.274 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 2.6200000000000001 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 2.1699999999999999 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.6499999999999999 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.463 HG21 HD23 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.9500000000000002 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 1.21 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 1.1100000000000001 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.59999999999999998 112.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.463 HD23 HG21 ' B' ' 113' ' ' ILE . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.98 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.547 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 2.0800000000000001 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.3100000000000001 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.71 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' SER . . . . . 0.516 ' HG ' ' HB2' ' B' ' 128' ' ' ARG . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 2.3300000000000001 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.8900000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.45 ' HB2' HG13 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 3.0800000000000001 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.9699999999999998 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 58' ' ' GLN . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 2.0 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.516 ' HB2' ' HG ' ' B' ' 122' ' ' SER . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 3.0600000000000001 110.729 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 3.2200000000000002 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.6099999999999999 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.6699999999999999 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 2.5699999999999998 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 2.27 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.2999999999999998 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.69999999999999996 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 2.0800000000000001 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 2.6499999999999999 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 1.51 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3999999999999999 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.48 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.4500000000000002 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.558 HD11 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 3.3500000000000001 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.9299999999999999 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 5.0800000000000001 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.5900000000000001 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.6699999999999999 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 2.1099999999999999 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.581 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.4 t-20 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.79 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo . . . . . 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.3599999999999999 112.711 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.848 0.356 . . . . 2.46 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 164' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 3.02 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 2.1499999999999999 111.255 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 3.25 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.77 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.52 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.7799999999999998 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 2.1499999999999999 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.6699999999999999 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 4.1299999999999999 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 2.4700000000000002 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.98 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 2.1000000000000001 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 2.5800000000000001 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.8700000000000001 111.315 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.0299999999999998 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67000000000000004 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 2.5600000000000001 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 1.1799999999999999 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.519 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 2.1000000000000001 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.474 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.6499999999999999 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 3.1699999999999999 111.755 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 2.4100000000000001 111.602 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 3.1200000000000001 111.421 -179.828 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.349 . . . . 2.8300000000000001 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.4900000000000002 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 2.2799999999999998 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.9199999999999999 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 2.3500000000000001 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 2.8300000000000001 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 2.27 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.78 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.567 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 2.0600000000000001 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77000000000000002 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG22 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 2.4300000000000002 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 2.5899999999999999 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.9299999999999999 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.6499999999999999 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . 0.423 HG22 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 3.1000000000000001 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.3899999999999999 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 3.0600000000000001 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.3500000000000001 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 4.3700000000000001 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.0 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.2200000000000002 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 3.0899999999999999 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 4.1600000000000001 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.9700000000000002 110.817 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.705 0.288 . . . . 3.2400000000000002 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.7599999999999998 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.55 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 73.5 m-70 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 2.3399999999999999 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.403 ' O ' HG11 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.25 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.46 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 2.3799999999999999 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.403 HG11 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 1.46 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 1.04 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' C' ' 47' ' ' SER . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.95 110.222 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 2.1400000000000001 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.419 HD12 ' O ' ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 2.3399999999999999 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 1.02 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.51 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.5800000000000001 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.5699999999999998 110.218 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.988 0.736 . . . . 3.7799999999999998 112.988 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.7200000000000002 112.679 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.9800000000000004 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 2.4100000000000001 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 2.4300000000000002 113.15 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.8500000000000001 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.6299999999999999 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 2.29 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.633 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 1.3799999999999999 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 2.27 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 2.2400000000000002 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' C' ' 15' ' ' MET . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.71 111.69 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.57999999999999996 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 138' ' ' ALA . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.8200000000000001 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 1.28 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 2.46 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.7 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.4099999999999999 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 1.3200000000000001 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . 0.422 HG23 ' O ' ' C' ' 56' ' ' ILE . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.81 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 2.25 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 3.4300000000000002 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 2.5499999999999998 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.27 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.8500000000000001 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.6200000000000001 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 3.2599999999999998 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.51 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.3999999999999999 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.8199999999999998 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.406 ' O ' HG21 ' C' ' 74' ' ' ILE . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 1.3899999999999999 112.121 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.571 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 2.3599999999999999 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 2.7000000000000002 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.406 HG21 ' O ' ' C' ' 71' ' ' ALA . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.8200000000000001 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.3300000000000001 109.38 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 2.4100000000000001 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.9199999999999999 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.79 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.97 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 2.2000000000000002 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.25 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.426 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.8300000000000001 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 2.1400000000000001 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 2.2400000000000002 110.767 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.6699999999999999 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.8 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.597 HD23 HD13 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 2.1200000000000001 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 2.29 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 4.0300000000000002 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 2.0699999999999998 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.47 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' MET . . . . . 0.471 ' HE3' HD13 ' C' ' 102' ' ' ILE . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.8599999999999999 110.907 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.6299999999999999 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 5.46 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.8399999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.8399999999999999 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.8600000000000003 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 6.0700000000000003 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.79 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 3.1499999999999999 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.471 HD13 ' HE3' ' C' ' 92' ' ' MET . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.8799999999999999 110.697 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.72 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 3.6200000000000001 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.8199999999999998 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.7000000000000002 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.54 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.431 ' HB ' HG22 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.8799999999999999 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.461 HE22 ' HE1' ' C' ' 176' ' ' TRP . 14.7 mm100 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.71 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.55 HG23 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 2.52 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 2.1699999999999999 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.5900000000000001 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 3.0299999999999998 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 1.3300000000000001 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 1.3100000000000001 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.65000000000000002 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 2.0299999999999998 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.436 HG12 HD13 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 2.23 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.4399999999999999 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.79 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.5499999999999998 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.3100000000000001 111.038 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.527 ' HA ' HD23 ' C' ' 130' ' ' LEU . 8.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.849 0.357 . . . . 1.73 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 3.3799999999999999 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 3.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 2.48 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.74 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 2.5699999999999998 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.7000000000000002 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 2.2000000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.72999999999999998 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 2.1000000000000001 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.76 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.51 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.9399999999999999 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.54 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 2.4700000000000002 111.568 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 3.0699999999999998 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.9399999999999999 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 4.5199999999999996 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.6499999999999999 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.9300000000000002 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.8599999999999999 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.7000000000000002 112.02 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.821 0.343 . . . . 3.1800000000000002 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.1800000000000002 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.9900000000000002 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 2.2400000000000002 111.193 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.3900000000000001 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.6499999999999999 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.6299999999999999 110.969 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.2599999999999998 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.9199999999999999 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.597 HD13 HD23 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.8 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 2.21 111.336 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 2.0299999999999998 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.8799999999999999 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 2.3100000000000001 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 2.0 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 2.4199999999999999 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.411 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.7000000000000002 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . 0.461 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.1100000000000001 111.457 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 2.3100000000000001 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 113.143 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.525 ' N ' ' HD2' ' C' ' 180' ' ' PRO . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 2.71 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 1.0700000000000001 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.421 ' O ' HG21 ' C' ' 185' ' ' ILE . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 2.0800000000000001 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' C' ' 185' ' ' ILE . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.71 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.8999999999999999 111.966 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 2.2000000000000002 112.751 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 3.23 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.9099999999999999 112.639 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . 0.411 ' H ' HD12 ' C' ' 197' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.757 0.313 . . . . 2.8599999999999999 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.6800000000000002 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 2.54 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.77 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 2.5299999999999998 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.8799999999999999 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 2.48 110.407 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.95 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.8700000000000001 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76000000000000001 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 2.3599999999999999 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 2.6200000000000001 110.148 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.411 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.9299999999999999 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.6600000000000001 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . 0.41 HG21 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 3.1099999999999999 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.41 ' N ' HG21 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.4099999999999999 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.77 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.8399999999999999 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 4.3399999999999999 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 2.25 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2000000000000002 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.54 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 4.0099999999999998 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.6400000000000001 111.247 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.824 0.345 . . . . 3.8199999999999998 111.011 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 2.46 110.778 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.3 m-70 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.9299999999999999 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 1.0800000000000001 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 2.4100000000000001 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 2.2599999999999998 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 1.5800000000000001 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 1.54 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.89000000000000001 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.8200000000000001 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.8500000000000001 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 2.23 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' HD13 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.95999999999999996 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 1.4099999999999999 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.5699999999999998 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.8799999999999999 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.7999999999999998 111.07 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.012 0.375 . . . . 4.0199999999999996 112.012 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 3.1600000000000001 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.3900000000000001 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.5 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' B' ' 104' ' ' PHE . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 2.1099999999999999 110.929 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.8999999999999999 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.48 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.5299999999999998 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 2.0499999999999998 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.74 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.68999999999999995 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 2.1699999999999999 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.47 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.9199999999999999 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.55000000000000004 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 1.6499999999999999 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.1399999999999999 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 2.4199999999999999 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.4099999999999999 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0900000000000001 110.868 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 1.47 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.8700000000000001 110.698 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.3399999999999999 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 2.3100000000000001 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 2.48 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.6400000000000001 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 2.1200000000000001 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.54 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.2999999999999998 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.615 HE21 ' H ' ' A' ' 67' ' ' ILE . 25.0 tp60 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 3.4199999999999999 110.996 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.615 ' H ' HE21 ' A' ' 66' ' ' GLN . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.8900000000000001 111.123 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 111.128 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.1599999999999999 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.7999999999999998 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 1.29 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 3.3999999999999999 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.46 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 2.21 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.4199999999999999 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.419 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.73 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.9399999999999999 111.007 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD21 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.9099999999999999 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.8200000000000001 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 2.1099999999999999 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.26 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 2.1099999999999999 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.9099999999999999 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 2.2200000000000002 110.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 2.54 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.9199999999999999 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 2.4700000000000002 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 3.0699999999999998 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 2.0099999999999998 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.7 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 3.0800000000000001 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.98 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 6.0499999999999998 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.4100000000000001 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.7000000000000002 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.9699999999999998 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.9399999999999999 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 6.96 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.7000000000000002 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 3.25 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 3.1099999999999999 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.5900000000000001 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 4.0300000000000002 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 2.4300000000000002 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.8100000000000001 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.4300000000000002 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.479 ' HG1' HG23 ' A' ' 142' ' ' ILE . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.75 111.828 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.509 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 3.8 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 3.2200000000000002 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 2.3799999999999999 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 2.2200000000000002 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.6499999999999999 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 3.2599999999999998 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 1.28 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' SER . . . . . 0.481 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 1.0900000000000001 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 2.1299999999999999 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.6400000000000001 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.3400000000000001 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.8799999999999999 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 2.0099999999999998 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.6699999999999999 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.4900000000000002 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.6000000000000001 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 4.79 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.8600000000000001 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 3.23 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4900000000000002 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 2.3700000000000001 110.598 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.545 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.96 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 2.6000000000000001 110.701 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.5699999999999998 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 2.2599999999999998 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.77000000000000002 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.6099999999999999 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD13 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 2.0699999999999998 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.72 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 4.0099999999999998 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 3.3999999999999999 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 3.0600000000000001 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.479 HG23 ' HG1' ' A' ' 108' ' ' THR . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.6699999999999999 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.46 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 4.3099999999999996 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.6200000000000001 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 3.1200000000000001 111.371 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 3.0499999999999998 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 3.0 t-20 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 3.0899999999999999 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.3599999999999999 113.327 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.895 0.379 . . . . 2.9399999999999999 111.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.3999999999999999 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.3700000000000001 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 3.27 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 2.02 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.6400000000000001 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 2.0899999999999999 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.493 ' N ' HD11 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.6400000000000001 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.8399999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.95 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 4.1100000000000003 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 2.4100000000000001 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 2.02 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 2.0299999999999998 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 2.5499999999999998 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.9399999999999999 111.538 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.73999999999999999 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.513 ' N ' ' HD2' ' A' ' 180' ' ' PRO . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 2.6499999999999999 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 1.1100000000000001 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 2.4500000000000002 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 178' ' ' GLY . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.9299999999999999 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.415 ' N ' HG22 ' A' ' 182' ' ' VAL . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.9399999999999999 112.76 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.6099999999999999 112.148 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.9100000000000001 112.468 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 2.1899999999999999 113.18 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.755 0.312 . . . . 2.6600000000000001 110.764 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 2.2200000000000002 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.96 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.6699999999999999 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.79 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 2.3900000000000001 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 2.2599999999999998 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.8799999999999999 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79000000000000004 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 2.2999999999999998 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 2.8100000000000001 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 2.0499999999999998 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.6800000000000002 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.4100000000000001 111.073 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.3799999999999999 112.196 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 3.5600000000000001 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.8399999999999999 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 4.1299999999999999 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.77 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.4399999999999999 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.9100000000000001 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.7599999999999998 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.5900000000000001 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 4.0099999999999998 111.135 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.698 0.259 . . . . 3.6000000000000001 111.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.95 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 2.1699999999999999 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 2.21 110.315 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.47 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 2.3500000000000001 110.688 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.48 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.51 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.82999999999999996 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' MET . . . . . 0.593 ' HA ' ' HE3' ' B' ' 15' ' ' MET . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.9299999999999999 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.8 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.418 HD11 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.418 ' N ' HD11 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 1.3700000000000001 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.7599999999999998 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.6899999999999999 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 5.1500000000000004 110.464 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.637 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 114.514 1.302 . . . . 3.5899999999999999 114.514 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.5699999999999998 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.8799999999999999 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 2.2200000000000002 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 2.5299999999999998 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.8999999999999999 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.6200000000000001 110.159 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 2.3199999999999998 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.434 HG21 HG22 ' B' ' 79' ' ' THR . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 1.3899999999999999 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.80000000000000004 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 2.2200000000000002 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 2.5600000000000001 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.74 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.57999999999999996 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.413 HD21 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 1.4299999999999999 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 1.23 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.49 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.6299999999999999 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 1.1699999999999999 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 1.45 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 1.3600000000000001 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.523 HG23 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 2.02 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.71 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.8900000000000001 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 2.3500000000000001 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.1800000000000002 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.2599999999999998 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.79 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.52 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.6899999999999999 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 2.25 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.3999999999999999 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.584 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.23 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.8999999999999999 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.454 ' O ' HG21 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 1.3100000000000001 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.71 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.455 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 2.6699999999999999 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.454 HG21 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 2.0 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.3100000000000001 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . 0.455 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.6099999999999999 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.467 ' HE3' HG22 ' B' ' 113' ' ' ILE . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.8300000000000001 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.428 ' O ' HD22 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.8899999999999999 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.434 HG22 HG21 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.6000000000000001 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 2.1200000000000001 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.3100000000000001 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.428 HD22 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 2.0800000000000001 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 2.21 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.507 HD11 HD13 ' B' ' 105' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 2.3599999999999999 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.425 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 2.5099999999999998 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.72 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.78 110.276 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.73 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . 0.637 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.8799999999999999 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 2.1000000000000001 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.5 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 3.1499999999999999 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 3.1499999999999999 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 5.0800000000000001 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 3.1899999999999999 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.6500000000000004 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.9699999999999998 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.2400000000000002 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 6.25 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.6200000000000001 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.0600000000000001 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.6899999999999999 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.53 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 3.6099999999999999 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.507 HD13 HD11 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.6699999999999999 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' MET . . . . . 0.42 ' N ' HD11 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.7999999999999998 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 2.3100000000000001 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.424 ' HB ' HD12 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.5699999999999998 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.564 HE21 HD12 ' B' ' 113' ' ' ILE . 57.7 tp60 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 3.3799999999999999 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 2.6200000000000001 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 2.1699999999999999 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.6499999999999999 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.564 HD12 HE21 ' B' ' 109' ' ' GLN . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.9500000000000002 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 1.21 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 1.1100000000000001 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.59999999999999998 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.49 HD23 HG22 ' B' ' 113' ' ' ILE . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.98 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.547 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 2.0800000000000001 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.3100000000000001 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.71 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 2.3300000000000001 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.8900000000000001 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.51 ' HB2' HG11 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 3.0800000000000001 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.9699999999999998 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 2.0 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 3.0600000000000001 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 3.2200000000000002 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.6099999999999999 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.6699999999999999 110.695 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 2.5699999999999998 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 2.27 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 2.2999999999999998 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.69999999999999996 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 2.0800000000000001 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 2.6499999999999999 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 1.51 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 2.3999999999999999 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.48 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 2.4500000000000002 111.739 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 3.3500000000000001 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.9299999999999999 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 5.0800000000000001 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.5900000000000001 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.42 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.6699999999999999 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 2.1099999999999999 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.79 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.3599999999999999 113.303 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 2.46 110.979 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 3.02 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 2.1499999999999999 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 3.25 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.77 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.52 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.9399999999999999 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.7799999999999998 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 2.2400000000000002 111.142 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.6699999999999999 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 4.1299999999999999 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 2.4700000000000002 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.98 111.442 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 2.1000000000000001 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 2.5800000000000001 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.8700000000000001 110.761 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.438 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 2.0299999999999998 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.464 ' O ' HG23 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 2.5600000000000001 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 1.1799999999999999 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.464 HG23 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 2.1000000000000001 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.6499999999999999 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . 0.487 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 3.1699999999999999 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 2.4100000000000001 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 26.8 pt . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 3.1200000000000001 111.279 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . 0.423 HD11 ' N ' ' B' ' 197' ' ' ILE . 3.0 mp . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.643 0.259 . . . . 2.8300000000000001 111.386 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.4900000000000002 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 2.2799999999999998 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.9199999999999999 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.3500000000000001 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 2.8300000000000001 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 2.27 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.78 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.525 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 2.0600000000000001 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77000000000000002 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 2.4300000000000002 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 2.5899999999999999 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.537 ' HG ' ' HD2' ' B' ' 210' ' ' LYS . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.9299999999999999 110.874 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . 0.537 ' HD2' ' HG ' ' B' ' 209' ' ' SER . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.6499999999999999 111.022 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 3.1000000000000001 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.3899999999999999 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 3.0600000000000001 110.796 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.3500000000000001 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 4.3700000000000001 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 2.0 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.2200000000000002 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 3.0899999999999999 111.369 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 4.1600000000000001 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.6699999999999999 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.9700000000000002 111.085 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.72 0.295 . . . . 3.2400000000000002 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.42 HD23 ' N ' ' C' ' 7' ' ' LEU . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.7599999999999998 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.604 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 2.3399999999999999 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.25 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.46 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 2.3799999999999999 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.5800000000000001 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 1.46 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 1.04 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.95 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 2.1400000000000001 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . 0.48 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 2.3399999999999999 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . 0.48 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 1.02 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.51 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.5699999999999998 111.372 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.7799999999999998 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.9800000000000004 110.533 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 2.4100000000000001 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 2.4300000000000002 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.8500000000000001 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.6299999999999999 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 2.29 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.475 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 1.3799999999999999 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.90000000000000002 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 2.27 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 2.2400000000000002 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.57999999999999996 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.8200000000000001 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 1.28 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.46 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.7 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 1.2 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.4099999999999999 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 1.3200000000000001 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.96 110.507 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.9399999999999999 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 2.25 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 3.4300000000000002 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 2.5499999999999998 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.27 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.8500000000000001 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.6200000000000001 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 3.2599999999999998 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 2.2599999999999998 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.3999999999999999 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . 0.511 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.8199999999999998 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD13 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.3899999999999999 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.544 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 2.3599999999999999 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 2.7000000000000002 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.8200000000000001 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.3300000000000001 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 2.4100000000000001 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.9199999999999999 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.79 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.97 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 2.2000000000000002 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.25 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.8300000000000001 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 2.1400000000000001 109.449 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 2.2400000000000002 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.6699999999999999 111.019 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.8 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.1200000000000001 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 2.29 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 4.0300000000000002 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 2.0699999999999998 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.47 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.8599999999999999 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.6299999999999999 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 5.46 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.8399999999999999 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.8399999999999999 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.8600000000000003 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 6.0700000000000003 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.79 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 3.1499999999999999 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.8799999999999999 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.72 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 3.6200000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.8199999999999998 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.7000000000000002 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.54 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.8799999999999999 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.71 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 2.52 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.5900000000000001 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 3.0299999999999998 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 1.3300000000000001 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 1.3100000000000001 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.65000000000000002 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 2.0299999999999998 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 2.23 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 1.4399999999999999 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.79 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.5499999999999998 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.3100000000000001 110.758 179.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.709 0.29 . . . . 1.73 111.107 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 3.3799999999999999 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . 0.42 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 3.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.523 HD23 HG23 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 2.48 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.74 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 2.5699999999999998 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . 0.42 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.7000000000000002 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . 0.413 ' SG ' HD21 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 2.2000000000000002 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.72999999999999998 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 2.1000000000000001 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.76 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.51 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.9399999999999999 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.54 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 2.4700000000000002 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.408 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 3.0699999999999998 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.9399999999999999 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 4.5199999999999996 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.6499999999999999 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . 0.408 HG13 ' O ' ' C' ' 142' ' ' ILE . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.9300000000000002 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.8599999999999999 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.7000000000000002 112.426 -178.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.762 0.315 . . . . 3.1800000000000002 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.1800000000000002 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.9900000000000002 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 2.2400000000000002 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.3900000000000001 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.6499999999999999 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.6299999999999999 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.2599999999999998 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.9199999999999999 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.8 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 2.21 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 2.0299999999999998 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . 0.504 ' HH ' ' HA ' ' C' ' 209' ' ' SER . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.8799999999999999 110.5 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 2.3100000000000001 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 2.0 111.506 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 2.4199999999999999 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.7000000000000002 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . 0.465 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.1100000000000001 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.526 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 2.3100000000000001 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.71999999999999997 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.598 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 2.71 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 1.0700000000000001 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.526 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 2.0800000000000001 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.544 HG21 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.8999999999999999 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.401 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 2.2000000000000002 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 3.23 111.77 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.9099999999999999 112.781 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.874 0.369 . . . . 2.8599999999999999 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.6800000000000002 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.77 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 2.5299999999999998 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.8799999999999999 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.47 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 2.48 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.95 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.8700000000000001 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76000000000000001 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 2.3599999999999999 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 2.6200000000000001 110.808 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.504 ' HA ' ' HH ' ' C' ' 171' ' ' TYR . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.9299999999999999 110.656 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.6600000000000001 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 3.1099999999999999 110.793 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.77 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.8399999999999999 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . 0.401 ' HA ' HD13 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 4.3399999999999999 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 2.25 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 214' ' ' SER . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.54 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 4.0099999999999998 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.6400000000000001 111.256 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 10' ' ' ILE . 70.2 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.976 0.417 . . . . 3.8199999999999998 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 2.46 111.135 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.9299999999999999 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.262 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 2.4100000000000001 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 2.2599999999999998 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 1.5800000000000001 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 1.54 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.89000000000000001 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.8200000000000001 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.8500000000000001 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 2.23 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 1.4099999999999999 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.5699999999999998 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.8799999999999999 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.7999999999999998 110.696 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 N--CA 1.461 0.1 0 N-CA-C 112.53 0.566 . . . . 4.0199999999999996 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 3.1600000000000001 111.998 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.3900000000000001 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.5 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 2.1099999999999999 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.8999999999999999 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.48 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.5299999999999998 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.411 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 2.0499999999999998 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.74 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.68999999999999995 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 2.1699999999999999 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.495 ' HE1' HG21 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.47 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.55000000000000004 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 1.6499999999999999 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 1.1399999999999999 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 2.4199999999999999 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.466 ' HG2' HG12 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.4099999999999999 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 1.0900000000000001 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 1.47 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 1.23 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.8700000000000001 110.745 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.3399999999999999 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 2.3100000000000001 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 2.48 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.6400000000000001 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 2.1200000000000001 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.54 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.2999999999999998 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 3.4199999999999999 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.8900000000000001 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 1.4299999999999999 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.1599999999999999 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.7999999999999998 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 1.29 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 3.3999999999999999 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.46 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 2.21 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG21 ' A' ' 74' ' ' ILE . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.4199999999999999 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.73 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.9399999999999999 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.9099999999999999 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.8200000000000001 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 2.1099999999999999 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.26 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 2.1099999999999999 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.9099999999999999 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 2.2200000000000002 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.482 ' N ' HD11 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 2.54 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.8600000000000001 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 2.4700000000000002 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 3.0699999999999998 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.7 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 3.0800000000000001 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.98 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 6.0499999999999998 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.4100000000000001 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HD3' ' N ' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.7000000000000002 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.9699999999999998 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.9399999999999999 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 6.96 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 3.25 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 3.1099999999999999 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.5900000000000001 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 4.0300000000000002 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 2.4300000000000002 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.8100000000000001 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.4300000000000002 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.518 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.75 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 3.2200000000000002 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 2.3799999999999999 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 2.2200000000000002 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.6499999999999999 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 3.2599999999999998 111.098 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 1.28 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 1.0900000000000001 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 2.1299999999999999 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.6400000000000001 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.3400000000000001 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 2.0099999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.6699999999999999 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.4900000000000002 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.6000000000000001 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 4.79 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.8600000000000001 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 3.23 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.4900000000000002 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 2.3700000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.96 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 2.6000000000000001 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.5699999999999998 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 2.2599999999999998 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.77000000000000002 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.6099999999999999 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 2.0699999999999998 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 4.0099999999999998 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 3.3999999999999999 110.842 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 3.0600000000000001 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.6699999999999999 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.46 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 4.3099999999999996 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.6200000000000001 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 3.1200000000000001 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 3.0499999999999998 111.568 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.584 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.2 t-20 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 3.0899999999999999 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.3599999999999999 112.861 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 2.9399999999999999 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.3700000000000001 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 3.27 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.6400000000000001 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 2.0899999999999999 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.6400000000000001 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.1499999999999999 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.8399999999999999 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 2.3999999999999999 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.95 111.201 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.7 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 4.1100000000000003 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 2.4100000000000001 111.501 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 2.02 111.628 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 2.0299999999999998 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 2.5499999999999998 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.9399999999999999 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 2.3300000000000001 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 112.876 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 2.6499999999999999 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 1.1100000000000001 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 2.4500000000000002 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.9299999999999999 111.045 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.9399999999999999 111.955 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.6099999999999999 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.9100000000000001 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 2.1899999999999999 112.854 179.681 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.8 0.334 . . . . 2.6600000000000001 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 2.2200000000000002 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.96 111.345 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.6699999999999999 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.79 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 2.3900000000000001 109.97 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 2.2599999999999998 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.8799999999999999 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79000000000000004 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 2.2999999999999998 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 2.8100000000000001 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 2.0499999999999998 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.6800000000000002 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 3.4100000000000001 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.3799999999999999 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 3.5600000000000001 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.8399999999999999 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 4.1299999999999999 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.77 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.4399999999999999 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.9100000000000001 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.7599999999999998 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.5900000000000001 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 4.0099999999999998 111.446 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.407 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.75 0.31 . . . . 3.6000000000000001 111.023 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.8799999999999999 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.545 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1899999999999999 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 2.21 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.469 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 2.3500000000000001 110.517 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 1.48 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 1.51 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.82999999999999996 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.9299999999999999 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.8 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.79 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.402 ' N ' HD13 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' B' ' 41' ' ' MET . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 1.3700000000000001 111.168 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.7599999999999998 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.6899999999999999 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 5.1500000000000004 110.664 179.662 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.5899999999999999 111.47 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.5699999999999998 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.8799999999999999 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 2.2200000000000002 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 2.5299999999999998 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' MET . . . . . 0.469 ' HE1' ' HB2' ' B' ' 19' ' ' ALA . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.6200000000000001 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 2.3199999999999998 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG22 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 1.3899999999999999 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.80000000000000004 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 2.2200000000000002 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 2.5600000000000001 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.475 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.74 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.57999999999999996 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 1.4299999999999999 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 1.23 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.49 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.6299999999999999 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 1.1699999999999999 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 1.45 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.545 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 1.3600000000000001 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 2.02 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.71 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.8900000000000001 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 2.3500000000000001 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.1800000000000002 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.2599999999999998 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.79 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.52 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.6899999999999999 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 2.25 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.23 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.8999999999999999 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.528 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.71 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 2.6699999999999999 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 2.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.3100000000000001 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.6099999999999999 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.8300000000000001 110.626 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.8899999999999999 111.844 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.529 HG22 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.6000000000000001 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 2.1200000000000001 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.3100000000000001 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 2.0800000000000001 111.102 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 2.21 110.712 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.405 HD13 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 2.3599999999999999 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.405 ' N ' HD13 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 2.5099999999999998 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.72 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.582 HD21 HD13 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.8799999999999999 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 2.1000000000000001 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.5 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 3.1499999999999999 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 3.1499999999999999 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 5.0800000000000001 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 3.1899999999999999 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.6500000000000004 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.9699999999999998 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.2400000000000002 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 6.25 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.6200000000000001 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 3.0600000000000001 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.6899999999999999 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.53 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 3.6099999999999999 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.6699999999999999 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.7999999999999998 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 2.3100000000000001 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.429 HG22 HG23 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.5699999999999998 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 3.3799999999999999 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . 0.495 HG21 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 2.6200000000000001 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 2.1699999999999999 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.6499999999999999 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.9500000000000002 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.21 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.59999999999999998 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.539 HD11 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.98 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.539 ' N ' HD11 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 2.0800000000000001 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.3100000000000001 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.71 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 2.3300000000000001 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.8900000000000001 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 3.0800000000000001 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.9699999999999998 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 2.0 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 3.0600000000000001 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 3.2200000000000002 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.6099999999999999 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.6699999999999999 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 2.5699999999999998 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 2.27 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 2.2999999999999998 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 2.0800000000000001 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 2.6499999999999999 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 1.51 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 2.3999999999999999 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.48 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 2.4500000000000002 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.429 HG23 HG22 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 3.3500000000000001 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.9299999999999999 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 5.0800000000000001 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.5900000000000001 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.6699999999999999 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 2.1099999999999999 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.79 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.3599999999999999 112.594 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 2.46 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.02 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 2.1499999999999999 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.25 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.77 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.52 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.9399999999999999 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.7799999999999998 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.582 HD13 HD21 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 2.1499999999999999 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.2400000000000002 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.6699999999999999 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . 0.413 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 4.1299999999999999 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.98 111.481 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 2.1000000000000001 111.705 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 2.5800000000000001 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.8700000000000001 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.448 ' O ' HG13 ' B' ' 181' ' ' ILE . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 2.0299999999999998 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67000000000000004 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 2.5600000000000001 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 1.1799999999999999 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 2.1000000000000001 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.463 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.6499999999999999 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 3.1699999999999999 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 2.4100000000000001 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 3.1200000000000001 111.377 -179.562 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.729 0.299 . . . . 2.8300000000000001 110.972 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.4900000000000002 110.728 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.2799999999999998 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.9199999999999999 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 2.3500000000000001 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 2.8300000000000001 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 2.27 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.78 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 2.0600000000000001 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77000000000000002 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 2.4300000000000002 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 2.5899999999999999 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.9299999999999999 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.6499999999999999 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 3.1000000000000001 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.3899999999999999 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 3.0600000000000001 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.3500000000000001 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 4.3700000000000001 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 2.0 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.2200000000000002 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 3.0899999999999999 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 4.1600000000000001 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.9700000000000002 110.957 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.61 0.243 . . . . 3.2400000000000002 111.492 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.7599999999999998 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.476 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 2.3399999999999999 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.25 110.8 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.46 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 2.3799999999999999 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.5800000000000001 111.375 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 1.46 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 1.04 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.95 110.831 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 2.1400000000000001 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 2.3399999999999999 110.865 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 1.02 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.51 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.5800000000000001 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.5699999999999998 110.35 179.621 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.747 0.308 . . . . 3.7799999999999998 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.7200000000000002 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.9800000000000004 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 2.4100000000000001 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 2.4300000000000002 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.8500000000000001 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.413 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.407 ' HA ' HD11 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.528 HG22 HG21 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 1.3799999999999999 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.90000000000000002 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 2.27 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 2.2400000000000002 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.71 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.57999999999999996 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.8200000000000001 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 1.28 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 2.46 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.7 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 1.3200000000000001 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.96 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.9399999999999999 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' C' ' 53' ' ' ALA . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 2.25 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 3.4300000000000002 110.933 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 2.5499999999999998 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.8500000000000001 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.6200000000000001 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 3.2599999999999998 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 2.2599999999999998 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.51 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.531 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.3999999999999999 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.8199999999999998 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 2.3599999999999999 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 2.7000000000000002 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.8200000000000001 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.3300000000000001 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 2.4100000000000001 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.9199999999999999 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.79 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.528 HG21 HG22 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.97 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 2.2000000000000002 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.25 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.8300000000000001 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 2.1400000000000001 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 85' ' ' LEU . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 2.2400000000000002 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.463 ' N ' HD13 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.6699999999999999 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.8 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.419 HD22 HD13 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 2.1200000000000001 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' SER . . . . . 0.434 ' HG ' HD13 ' C' ' 102' ' ' ILE . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 2.29 110.772 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 4.0300000000000002 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 2.0699999999999998 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.47 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.8599999999999999 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.6299999999999999 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 5.46 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.8399999999999999 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.8600000000000003 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 6.0700000000000003 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.79 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 3.1499999999999999 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . 0.434 HD13 ' HG ' ' C' ' 88' ' ' SER . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.8799999999999999 110.933 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.72 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 3.6200000000000001 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.8199999999999998 110.74 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HB3' ' C' ' 81' ' ' PRO . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.7000000000000002 111.193 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.54 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.411 HG23 HD11 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.8799999999999999 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . 0.529 HE22 ' HE1' ' C' ' 176' ' ' TRP . 6.6 tp-100 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.71 110.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 2.52 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 2.1699999999999999 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.5900000000000001 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 3.0299999999999998 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 1.3300000000000001 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.536 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 1.3100000000000001 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.65000000000000002 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.441 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 2.0299999999999998 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 2.23 111.207 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 1.4399999999999999 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' C' ' 122' ' ' SER . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.79 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.5499999999999998 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.3100000000000001 109.441 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' C' ' 129' ' ' TYR . 8.8 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.215 0.531 . . . . 1.73 110.811 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 3.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 2.48 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . 0.559 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 2.5699999999999998 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.7000000000000002 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 2.2000000000000002 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 2.1000000000000001 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.76 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.51 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.9399999999999999 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.414 HD11 ' O ' ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.54 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 2.4700000000000002 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.411 HD11 HG23 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 3.0699999999999998 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.9399999999999999 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 4.5199999999999996 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.6499999999999999 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.9300000000000002 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.8599999999999999 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.7000000000000002 111.341 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.857 0.361 . . . . 3.1800000000000002 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.1800000000000002 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.9900000000000002 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 2.2400000000000002 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.3900000000000001 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.6499999999999999 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.6299999999999999 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.2599999999999998 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.9199999999999999 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.419 HD13 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.8 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.21 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 2.0299999999999998 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.8799999999999999 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 2.3100000000000001 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 173' ' ' THR . . . . . 0.447 HG22 HD11 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 2.0 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 2.4199999999999999 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.7000000000000002 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . 0.529 ' HE1' HE22 ' C' ' 109' ' ' GLN . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.1100000000000001 110.796 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.447 HD11 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 2.3100000000000001 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.593 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 2.71 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 1.0700000000000001 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 2.0800000000000001 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.8999999999999999 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 2.2000000000000002 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 3.23 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.9099999999999999 112.547 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 2.8599999999999999 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.6800000000000002 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 2.54 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . 0.491 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.77 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 2.5299999999999998 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.8799999999999999 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 2.48 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.95 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.631 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.8700000000000001 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76000000000000001 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 2.3599999999999999 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 2.6200000000000001 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.9299999999999999 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.6600000000000001 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 3.1099999999999999 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.4099999999999999 112.451 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.77 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.8399999999999999 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 4.3399999999999999 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 2.25 110.7 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2000000000000002 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.54 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 4.0099999999999998 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 95.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.6400000000000001 110.856 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.639 0.257 . . . . 3.8199999999999998 110.821 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 2.46 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.9299999999999999 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 1.0800000000000001 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 2.4100000000000001 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 2.2599999999999998 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 1.5800000000000001 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 1.54 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.89000000000000001 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.527 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.8200000000000001 110.589 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.8500000000000001 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.427 HD13 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 2.23 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.427 ' N ' HD13 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.95999999999999996 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 1.4099999999999999 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.5699999999999998 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.8799999999999999 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.7999999999999998 111.0 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 4.0199999999999996 112.59 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 3.1600000000000001 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.3900000000000001 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.5 110.857 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 2.1099999999999999 110.982 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.8999999999999999 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD11 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.48 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.542 ' HE1' HD13 ' A' ' 45' ' ' ILE . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.5299999999999998 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 2.0499999999999998 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.429 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.74 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.68999999999999995 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.542 HD13 ' HE1' ' A' ' 41' ' ' MET . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 2.1699999999999999 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.489 ' HE1' ' HG1' ' B' ' 114' ' ' THR . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.47 110.918 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.9199999999999999 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.55000000000000004 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 1.6499999999999999 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 1.1399999999999999 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 2.4199999999999999 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.4099999999999999 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 1.0900000000000001 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 1.47 110.246 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 1.23 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.8700000000000001 110.583 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.3399999999999999 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 2.3100000000000001 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 2.48 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 2.1200000000000001 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.54 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.2999999999999998 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 3.4199999999999999 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.8900000000000001 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 1.4299999999999999 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.1599999999999999 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.7999999999999998 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.413 ' O ' HG21 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 1.29 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.447 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.46 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.413 HG21 ' O ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 2.21 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.4199999999999999 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.73 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.515 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.9399999999999999 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.9099999999999999 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.4 HG21 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.8200000000000001 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 2.1099999999999999 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.26 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.575 HD21 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 2.1099999999999999 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.9099999999999999 109.147 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 2.2200000000000002 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.575 HD12 HD21 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 2.54 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.8600000000000001 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB3' HD23 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 2.4700000000000002 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 3.0699999999999998 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 2.0099999999999998 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.7 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 3.0800000000000001 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.98 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 6.0499999999999998 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.4100000000000001 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.7000000000000002 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.9699999999999998 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 6.96 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.7000000000000002 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 3.25 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 3.1099999999999999 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.5900000000000001 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 4.0300000000000002 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HB3' HD22 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 2.4300000000000002 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.8100000000000001 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.4300000000000002 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 104' ' ' PHE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.75 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 3.2200000000000002 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 2.3799999999999999 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 2.2200000000000002 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.6499999999999999 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.468 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 3.2599999999999998 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 1.28 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 1.0900000000000001 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 2.1299999999999999 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.6400000000000001 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.3400000000000001 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 2.0099999999999998 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.6699999999999999 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.4900000000000002 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.6000000000000001 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 4.79 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.8600000000000001 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 3.23 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.4900000000000002 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 2.3700000000000001 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.96 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 2.6000000000000001 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.5699999999999998 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 2.2599999999999998 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.77000000000000002 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.6099999999999999 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 2.0699999999999998 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 4.0099999999999998 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 3.3999999999999999 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 3.0600000000000001 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.6699999999999999 111.473 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.46 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 4.3099999999999996 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.6200000000000001 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 3.1200000000000001 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 3.0499999999999998 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.551 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 3.0899999999999999 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo . . . . . 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.3599999999999999 113.177 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.873 0.368 . . . . 2.9399999999999999 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.3999999999999999 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.3700000000000001 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.6400000000000001 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 2.0899999999999999 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.6400000000000001 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.1499999999999999 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.8399999999999999 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 2.3999999999999999 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.95 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.7 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 4.1100000000000003 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 2.4100000000000001 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 2.02 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 2.0299999999999998 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 2.5499999999999998 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.9399999999999999 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 174' ' ' VAL . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 2.3300000000000001 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.73999999999999999 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.616 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 2.6499999999999999 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 1.1100000000000001 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 2.4500000000000002 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.9299999999999999 111.421 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.9399999999999999 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.6099999999999999 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.9100000000000001 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 2.1899999999999999 112.772 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 2.6600000000000001 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 2.2200000000000002 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.96 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.6699999999999999 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.79 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 2.3900000000000001 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 2.2599999999999998 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.8799999999999999 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79000000000000004 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 2.2999999999999998 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 2.8100000000000001 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.6800000000000002 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 3.4100000000000001 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.3799999999999999 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 3.5600000000000001 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.8399999999999999 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 4.1299999999999999 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.77 110.66 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.4399999999999999 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.7599999999999998 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.5900000000000001 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 4.0099999999999998 111.129 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.638 0.256 . . . . 3.6000000000000001 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.406 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.8799999999999999 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1899999999999999 110.599 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 2.21 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 2.3500000000000001 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.486 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 1.51 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.82999999999999996 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.9299999999999999 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.8 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.79 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 1.3700000000000001 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.7599999999999998 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.6899999999999999 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 5.1500000000000004 110.693 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 112.119 0.414 . . . . 3.5899999999999999 112.119 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.5699999999999998 112.103 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.8799999999999999 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 2.2200000000000002 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.436 HG11 ' HG ' ' B' ' 86' ' ' SER . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.5299999999999998 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.8999999999999999 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.6200000000000001 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 2.3199999999999998 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.571 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 1.3899999999999999 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.80000000000000004 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 2.2200000000000002 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 2.5600000000000001 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.74 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.57999999999999996 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 1.4299999999999999 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 1.23 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.49 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.6299999999999999 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 1.1699999999999999 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' MET . . . . . 0.426 ' HE3' HH21 ' B' ' 72' ' ' ARG . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.536 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 1.3600000000000001 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.458 HD12 HG22 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 2.02 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.71 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.8900000000000001 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 2.3500000000000001 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.1800000000000002 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.2599999999999998 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.79 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.52 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.6899999999999999 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.46 HD12 ' N ' ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 2.25 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.3999999999999999 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.562 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.23 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.8999999999999999 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.71 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.436 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 2.6699999999999999 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 2.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.6099999999999999 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.8300000000000001 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD21 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.8899999999999999 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.571 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.6000000000000001 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 2.1200000000000001 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.3100000000000001 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.403 HD21 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 2.0800000000000001 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 2.21 110.595 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 2.3599999999999999 110.474 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 110.444 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.436 ' HG ' HG11 ' B' ' 39' ' ' VAL . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.72 110.241 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.78 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.73 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.8799999999999999 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' THR . . . . . 0.592 HG22 HD23 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 2.1000000000000001 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.5 111.36 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 3.1499999999999999 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 5.0800000000000001 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 3.1899999999999999 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.6500000000000004 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.9699999999999998 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.2400000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 6.25 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.6200000000000001 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 3.0600000000000001 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.51 HD11 ' H ' ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.6899999999999999 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 3.6099999999999999 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.6699999999999999 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.7999999999999998 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 2.3100000000000001 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.491 ' HG1' HD12 ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.5699999999999998 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 3.3799999999999999 110.726 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 2.6200000000000001 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 2.1699999999999999 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.6499999999999999 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.9500000000000002 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.508 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 1.21 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 1.1100000000000001 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.59999999999999998 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.98 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 2.0800000000000001 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.71 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 2.3300000000000001 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.8900000000000001 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.9699999999999998 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 2.0 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 3.0600000000000001 110.836 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 3.2200000000000002 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.6099999999999999 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.6699999999999999 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 2.5699999999999998 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 2.27 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 2.2999999999999998 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.69999999999999996 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 2.6499999999999999 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 1.51 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 2.3999999999999999 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 2.4500000000000002 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.491 HD12 ' HG1' ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 3.3500000000000001 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.9299999999999999 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 5.0800000000000001 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.5900000000000001 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.6699999999999999 110.992 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 2.1099999999999999 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.79 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.3599999999999999 113.024 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.673 0.273 . . . . 2.46 110.736 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 3.02 110.715 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 2.1499999999999999 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.25 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.77 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.52 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.9399999999999999 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.7799999999999998 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.479 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 2.1499999999999999 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . 0.479 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 2.2400000000000002 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.6699999999999999 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 4.1299999999999999 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.4700000000000002 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.98 111.643 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 HD23 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 2.1000000000000001 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.447 HD23 HG22 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 2.5800000000000001 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.8700000000000001 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.464 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.0299999999999998 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 2.5600000000000001 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 1.1799999999999999 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.464 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 2.1000000000000001 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.6499999999999999 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 3.1699999999999999 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 2.4100000000000001 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 3.1200000000000001 111.337 -179.757 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.76 0.314 . . . . 2.8300000000000001 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.4900000000000002 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 199' ' ' THR . . . . . 0.483 HG22 ' HE2' ' B' ' 8' ' ' HIS . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.2799999999999998 111.02 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.9199999999999999 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 2.3500000000000001 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 2.8300000000000001 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 2.27 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.78 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 2.0600000000000001 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77000000000000002 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 2.4300000000000002 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 2.5899999999999999 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 209' ' ' SER . . . . . 0.412 ' HB2' HD11 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.9299999999999999 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.6499999999999999 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 3.1000000000000001 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.3899999999999999 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 3.0600000000000001 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.3500000000000001 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 4.3700000000000001 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 2.0 110.58 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.2200000000000002 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 3.0899999999999999 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 4.1600000000000001 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.6699999999999999 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . 0.592 HD23 HG22 ' B' ' 90' ' ' THR . 3.3 mm? . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.9700000000000002 111.043 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.31 . . . . 3.2400000000000002 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.7599999999999998 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.531 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 2.3399999999999999 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.25 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.46 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 2.3799999999999999 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.5800000000000001 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 1.46 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 1.04 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.512 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.95 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 2.3399999999999999 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 1.02 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.51 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.5800000000000001 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 7.9 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.5699999999999998 111.287 -179.923 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.427 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.7799999999999998 111.032 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.9800000000000004 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 2.4100000000000001 110.38 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.4300000000000002 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.8500000000000001 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.416 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.6299999999999999 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 2.29 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 1.3799999999999999 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.90000000000000002 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 2.27 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 2.2400000000000002 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.422 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.71 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.57999999999999996 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.8200000000000001 111.086 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.28 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 2.46 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.7 110.51 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 1.2 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.4099999999999999 110.26 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 1.3200000000000001 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.96 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.9399999999999999 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' C' ' 53' ' ' ALA . 14.8 mm100 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 2.25 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 3.4300000000000002 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 2.5499999999999998 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.27 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.8500000000000001 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.6200000000000001 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 3.2599999999999998 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 2.2599999999999998 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.3999999999999999 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . 0.425 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.8199999999999998 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 1.3899999999999999 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 2.3599999999999999 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 2.7000000000000002 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.425 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.8200000000000001 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' C' ' 47' ' ' SER . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 2.4100000000000001 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.482 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.9199999999999999 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.79 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.97 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 2.2000000000000002 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.25 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.8300000000000001 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 2.1400000000000001 110.046 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 2.2400000000000002 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.6699999999999999 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' SER . . . . . 0.431 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.8 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.474 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 2.1200000000000001 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 2.29 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . 0.431 ' HE3' ' HA ' ' C' ' 86' ' ' SER . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 4.0300000000000002 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 2.0699999999999998 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.47 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.8599999999999999 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.6299999999999999 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 5.46 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.8399999999999999 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.8399999999999999 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.8600000000000003 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.79 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 3.1499999999999999 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.8799999999999999 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.72 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 3.6200000000000001 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . 0.417 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.8199999999999998 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.7000000000000002 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.54 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.8799999999999999 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.71 111.065 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.52 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 2.1699999999999999 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.5900000000000001 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.482 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 3.0299999999999998 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 1.3300000000000001 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 110.456 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.298 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 2.0299999999999998 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 2.23 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.79 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.5499999999999998 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.3100000000000001 111.0 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.458 HG22 HD12 ' B' ' 56' ' ' ILE . 10.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.713 0.292 . . . . 1.73 111.374 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 3.3799999999999999 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 3.0 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 2.48 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.74 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 2.5699999999999998 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.7000000000000002 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 2.2000000000000002 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.72999999999999998 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.76 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.51 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.9399999999999999 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.54 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 2.4700000000000002 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 3.0699999999999998 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.9399999999999999 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 4.5199999999999996 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.6499999999999999 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.9300000000000002 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.8599999999999999 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.7000000000000002 112.342 -178.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.791 0.329 . . . . 3.1800000000000002 111.048 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.1800000000000002 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . 0.429 HD22 ' N ' ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.9900000000000002 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 2.2400000000000002 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.3900000000000001 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.6499999999999999 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . 0.427 ' O ' HG21 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.6299999999999999 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.2599999999999998 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.9199999999999999 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.8 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . 0.427 HG21 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 2.21 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 2.0299999999999998 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.8799999999999999 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 2.3100000000000001 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 2.0 111.959 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 2.4199999999999999 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.7000000000000002 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.1100000000000001 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.71999999999999997 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 2.71 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 1.0700000000000001 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.504 ' O ' HG23 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 2.0800000000000001 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.71 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.8999999999999999 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.504 HG23 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 2.2000000000000002 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 3.23 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.9099999999999999 112.438 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.822 0.344 . . . . 2.8599999999999999 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 2.54 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.77 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 2.5299999999999998 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.8799999999999999 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.497 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 2.48 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.95 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.8700000000000001 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76000000000000001 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 2.3599999999999999 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 2.6200000000000001 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.9299999999999999 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . 0.512 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.6600000000000001 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 3.1099999999999999 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.4099999999999999 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.77 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.8399999999999999 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 4.3399999999999999 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.784 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2000000000000002 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.54 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 4.0099999999999998 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.6400000000000001 111.161 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.695 0.283 . . . . 3.8199999999999998 110.811 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 2.46 110.952 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.9299999999999999 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 2.4100000000000001 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 2.2599999999999998 110.6 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 1.5800000000000001 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.54 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.89000000000000001 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.8200000000000001 110.49 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.8500000000000001 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 2.23 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 1.4099999999999999 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.5699999999999998 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.8799999999999999 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.7999999999999998 110.611 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.727 0.298 . . . . 4.0199999999999996 111.036 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 3.1600000000000001 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.3900000000000001 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.5 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 2.1099999999999999 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.8999999999999999 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.48 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.5299999999999998 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 2.0499999999999998 112.762 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.43 HG22 HG21 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.74 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.68999999999999995 114.136 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 2.1699999999999999 112.115 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.47 110.707 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.9199999999999999 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.55000000000000004 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 1.6499999999999999 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 1.1399999999999999 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 2.4199999999999999 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.4099999999999999 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 1.0900000000000001 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 1.47 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 1.23 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.8700000000000001 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.3399999999999999 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 2.3100000000000001 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 2.48 111.252 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 2.1200000000000001 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.54 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.2999999999999998 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 3.4199999999999999 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.8900000000000001 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 1.4299999999999999 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.1599999999999999 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.7999999999999998 110.68 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 1.29 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 3.3999999999999999 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.46 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 2.21 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.408 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.73 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.9399999999999999 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.9099999999999999 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG21 HG22 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.8200000000000001 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 2.1099999999999999 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.26 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 2.1099999999999999 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.9099999999999999 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 2.2200000000000002 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 2.54 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.8600000000000001 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.9199999999999999 110.788 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 3.0699999999999998 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 2.0099999999999998 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.7 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 3.0800000000000001 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.98 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 6.0499999999999998 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.4100000000000001 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.7000000000000002 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.9699999999999998 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.9399999999999999 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 6.96 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.471 ' HA ' HD21 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.7000000000000002 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 3.25 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 3.1099999999999999 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.5900000000000001 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 4.0300000000000002 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 2.4300000000000002 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.8100000000000001 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.4300000000000002 111.307 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.75 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.502 ' HG3' HD22 ' A' ' 84' ' ' LEU . 10.8 mm100 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 3.2200000000000002 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 2.3799999999999999 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 2.2200000000000002 110.671 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.6499999999999999 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 3.2599999999999998 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 1.28 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 1.0900000000000001 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 2.1299999999999999 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HD11 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.6400000000000001 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.3400000000000001 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.8799999999999999 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 2.0099999999999998 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.6699999999999999 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.4900000000000002 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HB2' HG11 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.6000000000000001 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 4.79 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.8600000000000001 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 3.23 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.4900000000000002 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 2.3700000000000001 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.96 111.187 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 2.6000000000000001 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.5699999999999998 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.404 ' SG ' HD21 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 2.2599999999999998 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.77000000000000002 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.6099999999999999 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 2.0699999999999998 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.72 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 4.0099999999999998 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 3.3999999999999999 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 3.0600000000000001 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.6699999999999999 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.46 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 4.3099999999999996 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 3.1200000000000001 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.0499999999999998 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.547 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 3.0899999999999999 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.3599999999999999 112.605 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.874 0.369 . . . . 2.9399999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.3999999999999999 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 3.27 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 2.02 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.6400000000000001 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 2.0899999999999999 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.6400000000000001 110.715 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.1499999999999999 110.597 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.8399999999999999 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 2.3999999999999999 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.95 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.7 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 4.1100000000000003 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 2.4100000000000001 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 2.02 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 2.0299999999999998 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 2.5499999999999998 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.9399999999999999 111.374 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 2.3300000000000001 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.73999999999999999 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 2.6499999999999999 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 1.1100000000000001 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 2.4500000000000002 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.9299999999999999 111.461 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.9399999999999999 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.6099999999999999 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.9100000000000001 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 2.1899999999999999 113.06 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.725 0.298 . . . . 2.6600000000000001 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 2.2200000000000002 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.96 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.6699999999999999 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.79 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 2.3900000000000001 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 2.2599999999999998 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.489 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.8799999999999999 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79000000000000004 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 2.2999999999999998 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 2.8100000000000001 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 2.0499999999999998 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.6800000000000002 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 3.4100000000000001 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.3799999999999999 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 3.5600000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.8399999999999999 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 4.1299999999999999 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.77 110.483 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.4399999999999999 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.9100000000000001 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.7599999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.5900000000000001 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 4.0099999999999998 110.972 -179.858 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 3.6000000000000001 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.8799999999999999 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1899999999999999 110.662 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 2.21 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.3500000000000001 110.615 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 1.48 111.075 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 1.51 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.82999999999999996 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.9299999999999999 110.837 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.8 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 1.3700000000000001 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.7599999999999998 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.6899999999999999 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 5.1500000000000004 110.49 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.471 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.5899999999999999 113.348 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.471 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.5699999999999998 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.8799999999999999 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 2.2200000000000002 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 2.5299999999999998 111.698 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.8999999999999999 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.6200000000000001 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 2.3199999999999998 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 1.3899999999999999 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.80000000000000004 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 2.2200000000000002 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 2.5600000000000001 111.294 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.74 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.57999999999999996 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 1.4299999999999999 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 1.23 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.49 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.6299999999999999 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 1.1699999999999999 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 1.45 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 1.3600000000000001 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 2.02 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.517 HE22 ' HA ' ' C' ' 122' ' ' SER . 13.0 mm100 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.71 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.8900000000000001 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 2.3500000000000001 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.1800000000000002 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.2599999999999998 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.79 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.52 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.6899999999999999 111.014 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.776 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.3999999999999999 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.23 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.8999999999999999 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 1.3100000000000001 112.115 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.71 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 2.6699999999999999 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 2.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.3100000000000001 109.389 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.6099999999999999 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.8300000000000001 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.6000000000000001 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 2.1200000000000001 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.3100000000000001 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 2.0800000000000001 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 2.21 110.659 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.528 HD22 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 2.3599999999999999 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.418 ' N ' HD11 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 2.5099999999999998 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.72 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.78 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.8799999999999999 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 2.1000000000000001 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.5 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 3.1499999999999999 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 3.1499999999999999 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 5.0800000000000001 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.6500000000000004 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.9699999999999998 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 6.25 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.6200000000000001 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 3.0600000000000001 110.917 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.6899999999999999 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.53 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 3.6099999999999999 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.6699999999999999 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.7999999999999998 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 2.3100000000000001 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.5699999999999998 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD22 ' B' ' 84' ' ' LEU . 8.4 tp-100 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 3.3799999999999999 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 2.1699999999999999 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.6499999999999999 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.9500000000000002 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 1.1100000000000001 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.59999999999999998 112.923 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.98 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 2.0800000000000001 111.111 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.3100000000000001 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.71 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 2.3300000000000001 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.8900000000000001 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 3.0800000000000001 110.925 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.9699999999999998 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 2.0 110.88 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . 0.522 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 3.0600000000000001 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 3.2200000000000002 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.6099999999999999 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.6699999999999999 111.165 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 2.5699999999999998 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 2.27 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 2.2999999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.69999999999999996 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 2.0800000000000001 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 2.6499999999999999 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 1.51 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 2.3999999999999999 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.48 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 2.4500000000000002 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 3.3500000000000001 111.09 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.9299999999999999 110.337 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 5.0800000000000001 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.5900000000000001 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.6699999999999999 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 2.1099999999999999 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.578 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.79 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo . . . . . 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.3599999999999999 112.643 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.701 0.286 . . . . 2.46 111.116 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 3.02 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 2.1499999999999999 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 3.25 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.77 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.52 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.9399999999999999 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.7799999999999998 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 2.1499999999999999 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 2.2400000000000002 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.6699999999999999 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 4.1299999999999999 110.36 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 2.4700000000000002 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' THR . . . . . 0.421 ' HG1' ' N ' ' B' ' 174' ' ' VAL . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.98 111.674 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . 0.421 ' N ' ' HG1' ' B' ' 173' ' ' THR . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 2.1000000000000001 111.462 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 2.5800000000000001 111.732 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . 0.47 ' HE1' HE22 ' B' ' 109' ' ' GLN . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 111.476 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.45 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 2.0299999999999998 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67000000000000004 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.618 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 2.5600000000000001 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 1.1799999999999999 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.45 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 2.1000000000000001 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.6499999999999999 111.373 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 3.1699999999999999 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 2.4100000000000001 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 3.1200000000000001 111.311 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.712 0.291 . . . . 2.8300000000000001 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.4900000000000002 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 2.2799999999999998 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.9199999999999999 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 201' ' ' LEU . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 2.3500000000000001 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 2.8300000000000001 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . 0.418 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 2.27 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.78 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.472 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 2.0600000000000001 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77000000000000002 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 2.4300000000000002 110.194 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 2.5899999999999999 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.9299999999999999 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.6499999999999999 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 3.1000000000000001 110.97 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.3899999999999999 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 3.0600000000000001 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.3500000000000001 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 4.3700000000000001 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 2.0 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.2200000000000002 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 3.0899999999999999 110.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 4.1600000000000001 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.9700000000000002 110.804 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . 0.412 ' N ' HD21 ' C' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.738 0.304 . . . . 3.2400000000000002 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.7599999999999998 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.546 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 2.3399999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.424 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.25 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.46 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 2.3799999999999999 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.424 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.5800000000000001 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 1.46 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 1.04 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.95 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 2.1400000000000001 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 2.3399999999999999 110.505 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 1.02 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.51 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.5800000000000001 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.5699999999999998 110.581 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.488 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.373 0.508 . . . . 3.7799999999999998 112.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.7200000000000002 111.803 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.9800000000000004 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 2.4100000000000001 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 2.4300000000000002 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.8500000000000001 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.6299999999999999 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 2.29 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.417 HG13 ' O ' ' C' ' 39' ' ' VAL . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 1.3799999999999999 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.90000000000000002 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 2.27 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 2.2400000000000002 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.71 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.57999999999999996 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . 0.404 HD21 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.8200000000000001 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 1.28 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 2.46 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.7 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 1.2 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' MET . . . . . 0.4 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.4099999999999999 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 1.3200000000000001 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.96 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.9399999999999999 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.402 ' HB3' ' HB1' ' C' ' 53' ' ' ALA . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 3.4300000000000002 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 2.5499999999999998 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.27 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.8500000000000001 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.6200000000000001 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 3.2599999999999998 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 2.2599999999999998 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.51 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.3999999999999999 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.8199999999999998 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . 0.421 ' HA ' ' CG2' ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.3899999999999999 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 2.3599999999999999 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 2.7000000000000002 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . 0.421 ' CG2' ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.8200000000000001 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.3300000000000001 109.652 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 2.4100000000000001 111.2 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.9199999999999999 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.79 112.423 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.97 112.166 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 2.2000000000000002 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.25 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.8300000000000001 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' C' ' 87' ' ' LEU . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 2.1400000000000001 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . 0.417 ' H ' HD21 ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 2.2400000000000002 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.6699999999999999 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.8 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 2.1200000000000001 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 2.29 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 4.0300000000000002 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.47 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.8599999999999999 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.6299999999999999 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 5.46 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.8399999999999999 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.8399999999999999 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.8600000000000003 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 6.0700000000000003 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.79 111.174 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 3.1499999999999999 110.875 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.72 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 3.6200000000000001 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.8199999999999998 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.7000000000000002 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.54 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.8799999999999999 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.71 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 2.52 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 2.1699999999999999 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.5900000000000001 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 3.0299999999999998 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 1.3300000000000001 110.735 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 1.3100000000000001 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.65000000000000002 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 2.0299999999999998 111.291 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 2.23 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 1.4399999999999999 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.79 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' SER . . . . . 0.517 ' HA ' HE22 ' B' ' 58' ' ' GLN . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.5499999999999998 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.3100000000000001 111.041 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.474 HG23 HD13 ' C' ' 130' ' ' LEU . 13.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.961 0.41 . . . . 1.73 110.862 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 3.3799999999999999 110.888 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 3.0 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.474 HD13 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 2.48 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.74 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 2.5699999999999998 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.7000000000000002 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 2.2000000000000002 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.72999999999999998 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 2.1000000000000001 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.76 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.9399999999999999 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.54 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 2.4700000000000002 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 3.0699999999999998 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.9399999999999999 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 4.5199999999999996 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.6499999999999999 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.9300000000000002 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.8599999999999999 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.7000000000000002 112.0 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.348 . . . . 3.1800000000000002 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.1800000000000002 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.9900000000000002 110.625 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 2.2400000000000002 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.3900000000000001 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.6499999999999999 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.2599999999999998 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.9199999999999999 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.8 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 2.21 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 2.0299999999999998 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.8799999999999999 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 2.3100000000000001 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 2.0 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 2.4199999999999999 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.7000000000000002 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.1100000000000001 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 2.3100000000000001 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . 0.471 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.71999999999999997 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.6 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 2.71 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.606 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 1.0700000000000001 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.471 HG22 ' O ' ' C' ' 178' ' ' GLY . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.444 HG23 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.71 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.8999999999999999 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.477 HG22 HG22 ' C' ' 185' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 2.2000000000000002 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.477 HG22 HG22 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 3.23 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.9099999999999999 112.494 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.782 0.325 . . . . 2.8599999999999999 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.6800000000000002 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 2.54 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.77 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 2.5299999999999998 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.8799999999999999 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' HH12 ' C' ' 72' ' ' ARG . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 2.48 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.95 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.8700000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76000000000000001 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 2.3599999999999999 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 2.6200000000000001 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.9299999999999999 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.6600000000000001 110.867 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 3.1099999999999999 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.4099999999999999 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.77 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.8399999999999999 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 4.3399999999999999 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 2.25 110.381 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.54 110.5 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 4.0099999999999998 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.6400000000000001 110.877 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.714 0.292 . . . . 3.8199999999999998 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 2.46 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.9299999999999999 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 1.0800000000000001 110.95 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 2.4100000000000001 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 2.2599999999999998 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.5800000000000001 110.949 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 1.54 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.89000000000000001 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.8200000000000001 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.8500000000000001 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 2.23 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.95999999999999996 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 1.4099999999999999 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.5699999999999998 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.8799999999999999 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.7999999999999998 110.466 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.133 -1.062 . . . . 4.0199999999999996 108.133 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 3.1600000000000001 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.3900000000000001 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.5 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 2.1099999999999999 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.8999999999999999 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.48 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.5299999999999998 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 2.0499999999999998 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.74 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.68999999999999995 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 2.1699999999999999 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.47 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.416 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.9199999999999999 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.55000000000000004 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.41 HD21 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 1.6499999999999999 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 1.1399999999999999 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 2.4199999999999999 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.4099999999999999 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 1.0900000000000001 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 1.47 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 1.23 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.8700000000000001 110.546 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.3399999999999999 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.3100000000000001 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 2.48 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.6400000000000001 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 2.1200000000000001 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.54 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.2999999999999998 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.8900000000000001 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 1.4299999999999999 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.1599999999999999 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.7999999999999998 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 1.29 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 3.3999999999999999 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.46 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 2.21 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4199999999999999 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . 0.416 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.73 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.9399999999999999 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.9099999999999999 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.8200000000000001 111.62 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 2.1099999999999999 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.26 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 2.1099999999999999 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.9099999999999999 110.689 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 2.2200000000000002 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 2.54 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.8600000000000001 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.9199999999999999 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 2.4700000000000002 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 3.0699999999999998 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 2.0099999999999998 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.7 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 3.0800000000000001 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.98 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 6.0499999999999998 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.4100000000000001 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.7000000000000002 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.9699999999999998 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.9399999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 6.96 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.7000000000000002 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 3.25 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 3.1099999999999999 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.5900000000000001 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 4.0300000000000002 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 2.4300000000000002 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.8100000000000001 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.4300000000000002 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.456 ' H ' ' HG ' ' A' ' 107' ' ' SER . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.75 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . 0.454 ' HG2' HD23 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 3.2200000000000002 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 2.3799999999999999 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 2.2200000000000002 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.6499999999999999 111.28 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 3.2599999999999998 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 1.28 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 1.0900000000000001 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 2.1299999999999999 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.6400000000000001 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.3400000000000001 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.8799999999999999 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.0099999999999998 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.6699999999999999 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.4900000000000002 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.448 ' HB2' HG13 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.6000000000000001 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 4.79 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.8600000000000001 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 3.23 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.4900000000000002 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.3700000000000001 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.45 ' HA ' ' HG ' ' A' ' 134' ' ' CYS . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.96 111.249 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 2.6000000000000001 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.5699999999999998 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.45 ' HG ' ' HA ' ' A' ' 131' ' ' TRP . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 2.2599999999999998 110.952 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.77000000000000002 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.6099999999999999 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 2.0699999999999998 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.72 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 4.0099999999999998 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 3.3999999999999999 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 3.0600000000000001 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.6699999999999999 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.46 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 4.3099999999999996 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.598 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.6200000000000001 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 3.1200000000000001 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 3.0499999999999998 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.61 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 3.0899999999999999 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.3599999999999999 112.843 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.849 0.357 . . . . 2.9399999999999999 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.3700000000000001 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 3.27 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.6400000000000001 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 2.0899999999999999 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.6400000000000001 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.1499999999999999 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.8399999999999999 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 2.3999999999999999 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.95 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.7 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 4.1100000000000003 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 2.4100000000000001 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 2.02 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 2.0299999999999998 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 2.5499999999999998 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.9399999999999999 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.48 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 2.3300000000000001 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.73999999999999999 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.537 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 2.6499999999999999 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 1.1100000000000001 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 2.4500000000000002 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.9299999999999999 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . 0.46 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.9399999999999999 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.6099999999999999 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.9100000000000001 111.331 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 2.1899999999999999 113.211 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.765 0.317 . . . . 2.6600000000000001 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 2.2200000000000002 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.96 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.6699999999999999 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.79 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 2.3900000000000001 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 2.2599999999999998 111.591 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.537 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.8799999999999999 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79000000000000004 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 2.2999999999999998 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 2.8100000000000001 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 3.4100000000000001 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.3799999999999999 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 3.5600000000000001 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.8399999999999999 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 4.1299999999999999 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.77 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.4399999999999999 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.7599999999999998 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.5900000000000001 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 4.0099999999999998 111.107 -179.771 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.761 0.315 . . . . 3.6000000000000001 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.8799999999999999 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 2.1699999999999999 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1899999999999999 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 2.21 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 2.3500000000000001 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 1.48 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 1.51 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.82999999999999996 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.9299999999999999 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.8 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . 0.4 HD13 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.79 110.567 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD13 ' B' ' 17' ' ' ILE . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 1.3700000000000001 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.7599999999999998 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.6899999999999999 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 5.1500000000000004 110.198 179.756 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.581 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.5899999999999999 113.767 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . 0.581 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.5699999999999998 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.8799999999999999 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 2.2200000000000002 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' B' ' 86' ' ' SER . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 2.5299999999999998 111.581 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.8999999999999999 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.6200000000000001 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 2.3199999999999998 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.43 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 1.3899999999999999 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.80000000000000004 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.424 HG22 HG12 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 2.2200000000000002 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . 0.484 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 2.5600000000000001 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.553 ' HG ' ' HG1' ' B' ' 79' ' ' THR . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.74 111.59 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.57999999999999996 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 1.4299999999999999 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.49 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.6299999999999999 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 1.1699999999999999 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 1.45 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 1.3600000000000001 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . 0.422 HG22 HD13 ' C' ' 130' ' ' LEU . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 2.02 110.268 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.71 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.8900000000000001 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 2.3500000000000001 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.1800000000000002 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.2599999999999998 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.79 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.52 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.6899999999999999 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 2.25 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.3999999999999999 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.414 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.8999999999999999 111.64 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 1.3100000000000001 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.453 ' NH2' HG22 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.71 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.467 ' HA ' ' HB2' ' B' ' 76' ' ' TRP . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 2.6699999999999999 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.465 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 2.0 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.3100000000000001 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.6099999999999999 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.421 ' SD ' HD23 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.8300000000000001 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.8899999999999999 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.553 ' HG1' ' HG ' ' B' ' 47' ' ' SER . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.6000000000000001 111.582 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 2.1200000000000001 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.607 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.3100000000000001 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 2.0800000000000001 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 2.21 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.461 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 2.5099999999999998 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' SER . . . . . 0.515 ' HG ' HG13 ' B' ' 39' ' ' VAL . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.72 111.053 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.78 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.73 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . 0.461 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.8799999999999999 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 2.1000000000000001 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.5 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 3.1499999999999999 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 3.1499999999999999 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 5.0800000000000001 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 3.1899999999999999 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.6500000000000004 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.9699999999999998 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.2400000000000002 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . 0.51 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 6.25 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.6200000000000001 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 3.0600000000000001 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.6899999999999999 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.53 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 3.6099999999999999 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.6699999999999999 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.7999999999999998 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 2.3100000000000001 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.546 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.5699999999999998 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.483 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 3.3799999999999999 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.6200000000000001 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 2.1699999999999999 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.6499999999999999 111.533 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . 0.483 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.9500000000000002 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.21 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 1.1100000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.59999999999999998 112.013 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.421 HD23 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.98 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 2.0800000000000001 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.3100000000000001 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.71 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 2.3300000000000001 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.8900000000000001 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . 0.511 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 3.0800000000000001 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.9699999999999998 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 2.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 3.0600000000000001 110.802 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 3.2200000000000002 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.6099999999999999 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.6699999999999999 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 2.5699999999999998 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 2.27 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . 0.41 ' SG ' HD21 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 2.2999999999999998 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.69999999999999996 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 2.0800000000000001 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 2.6499999999999999 110.979 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 1.51 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 2.3999999999999999 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.48 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 2.4500000000000002 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.546 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 3.3500000000000001 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . 0.47 HD12 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.9299999999999999 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 5.0800000000000001 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . 0.588 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.5900000000000001 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . 0.422 HG21 ' O ' ' B' ' 143' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.6699999999999999 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . 0.47 ' HE1' HD12 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 2.1099999999999999 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.639 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 14.6 m120 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.79 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.639 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo . . . . . 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.3599999999999999 112.979 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.654 0.264 . . . . 2.46 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 3.02 110.828 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.1499999999999999 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 3.25 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.77 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.52 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.9399999999999999 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.7799999999999998 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 2.1499999999999999 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 2.2400000000000002 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.6699999999999999 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 4.1299999999999999 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 2.4700000000000002 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.98 111.377 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.1000000000000001 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.8700000000000001 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.501 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 2.0299999999999998 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67000000000000004 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 2.5600000000000001 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 1.1799999999999999 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 2.1000000000000001 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.53 HG21 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.6499999999999999 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 3.1699999999999999 112.084 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 2.4100000000000001 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 3.1200000000000001 111.853 -179.183 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.873 0.368 . . . . 2.8300000000000001 110.833 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.4900000000000002 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 199' ' ' THR . . . . . 0.453 HG22 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 2.2799999999999998 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.9199999999999999 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 2.3500000000000001 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 2.8300000000000001 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 2.27 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.78 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 2.0600000000000001 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77000000000000002 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 2.4300000000000002 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 2.5899999999999999 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.9299999999999999 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.6499999999999999 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 3.1000000000000001 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.3899999999999999 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 3.0600000000000001 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.3500000000000001 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 4.3700000000000001 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 2.0 110.516 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.2200000000000002 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 3.0899999999999999 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 4.1600000000000001 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.6699999999999999 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.9700000000000002 110.796 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.747 0.308 . . . . 3.2400000000000002 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.7599999999999998 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 2.3399999999999999 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.25 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.46 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 2.3799999999999999 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.5800000000000001 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 1.46 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 1.04 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.95 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 2.1400000000000001 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 2.3399999999999999 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 1.02 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.51 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.5800000000000001 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.5699999999999998 110.993 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 112.343 0.498 . . . . 3.7799999999999998 112.343 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.7200000000000002 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.9800000000000004 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 2.4100000000000001 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 2.4300000000000002 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.8500000000000001 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.6299999999999999 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 2.29 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.45 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 1.3799999999999999 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.90000000000000002 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 2.27 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 2.2400000000000002 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' SER . . . . . 0.413 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.71 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.57999999999999996 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.8200000000000001 111.212 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 1.28 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 2.46 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.7 110.23 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 1.2 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.4099999999999999 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.449 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 1.3200000000000001 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.96 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . 0.546 ' HA ' ' HZ1' ' C' ' 60' ' ' LYS . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.9399999999999999 111.108 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 2.25 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . 0.546 ' HZ1' ' HA ' ' C' ' 57' ' ' ASP . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 3.4300000000000002 111.225 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 2.5499999999999998 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.27 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.8500000000000001 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.6200000000000001 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 3.2599999999999998 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.2599999999999998 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.51 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.3999999999999999 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.8199999999999998 111.254 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 1.3899999999999999 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 2.3599999999999999 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 2.7000000000000002 111.22 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.8200000000000001 110.175 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . 0.413 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.3300000000000001 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 2.4100000000000001 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.9199999999999999 110.486 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.79 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.97 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 2.2000000000000002 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.25 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.8300000000000001 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 2.1400000000000001 109.947 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 2.2400000000000002 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.6699999999999999 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.8 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 2.1200000000000001 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.29 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 4.0300000000000002 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 2.0699999999999998 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.47 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.8599999999999999 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.6299999999999999 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 5.46 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.8399999999999999 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.8399999999999999 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.8600000000000003 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 6.0700000000000003 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.79 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 3.1499999999999999 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.72 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 3.6200000000000001 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.8199999999999998 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.7000000000000002 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.54 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8799999999999999 111.511 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.71 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.484 HG23 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 2.52 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . 0.424 HG12 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 2.1699999999999999 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.5900000000000001 111.234 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.477 HG22 HD22 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 3.0299999999999998 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 1.3300000000000001 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' SER . . . . . 0.456 ' HG ' ' HA2' ' C' ' 135' ' ' GLY . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 1.3100000000000001 110.371 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.65000000000000002 112.594 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.477 HD22 HG22 ' C' ' 113' ' ' ILE . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 2.0299999999999998 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.525 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 2.23 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 1.4399999999999999 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.79 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.5499999999999998 110.907 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.3100000000000001 110.825 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' C' ' 130' ' ' LEU . 14.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.92 0.39 . . . . 1.73 111.061 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 3.3799999999999999 110.622 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 3.0 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . 0.475 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 2.48 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . 0.475 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.74 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 2.5699999999999998 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.7000000000000002 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 2.2000000000000002 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . 0.456 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.72999999999999998 112.924 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 2.1000000000000001 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.76 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.51 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.9399999999999999 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.54 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . 0.482 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 2.4700000000000002 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.482 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 3.0699999999999998 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.9399999999999999 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 4.5199999999999996 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.6499999999999999 113.155 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . 0.403 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.9300000000000002 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.8599999999999999 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.7000000000000002 112.46 -179.218 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.713 0.292 . . . . 3.1800000000000002 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.1800000000000002 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.9900000000000002 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 2.2400000000000002 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.3900000000000001 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.6499999999999999 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.6299999999999999 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.9199999999999999 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.8 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 2.21 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . 0.49 ' HH ' ' HA3' ' C' ' 212' ' ' GLY . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.8799999999999999 110.79 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 2.3100000000000001 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 2.0 111.956 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 2.4199999999999999 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.7000000000000002 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.517 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 2.3100000000000001 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.572 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 2.71 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.572 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 1.0700000000000001 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 2.0800000000000001 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.71 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.8999999999999999 112.147 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 2.2000000000000002 112.232 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' C' ' 182' ' ' VAL . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 3.23 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.9099999999999999 112.391 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.601 0.239 . . . . 2.8599999999999999 111.208 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 2.54 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.77 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 2.5299999999999998 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.8799999999999999 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 2.48 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.95 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.8700000000000001 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76000000000000001 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 2.3599999999999999 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 2.6200000000000001 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.9299999999999999 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.6600000000000001 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 3.1099999999999999 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . 0.49 ' HA3' ' HH ' ' C' ' 171' ' ' TYR . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.4099999999999999 112.376 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.77 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.8399999999999999 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 4.3399999999999999 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 2.25 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2000000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.54 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 4.0099999999999998 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.6400000000000001 111.082 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 6' ' ' LEU . 1.6 pt? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.742 0.305 . . . . 3.8199999999999998 111.162 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 2.46 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.477 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.9299999999999999 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 1.0800000000000001 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.4100000000000001 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 2.2599999999999998 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 1.5800000000000001 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 1.54 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.89000000000000001 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.8200000000000001 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.8500000000000001 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.507 ' HA ' HD13 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 2.23 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.95999999999999996 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 1.4099999999999999 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.8799999999999999 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.7999999999999998 110.522 179.787 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.079 0 N-CA-C 112.267 0.469 . . . . 4.0199999999999996 112.267 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 3.1600000000000001 111.209 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.3900000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.5 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.585 HD22 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 2.1099999999999999 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.8999999999999999 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.48 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.5299999999999998 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 2.0499999999999998 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 39' ' ' VAL . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.74 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.68999999999999995 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 2.1699999999999999 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TRP . . . . . 0.431 ' HE1' ' HG1' ' B' ' 114' ' ' THR . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.47 111.37 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.9199999999999999 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.55000000000000004 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 2.4199999999999999 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.4099999999999999 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 1.0900000000000001 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.407 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 1.23 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.8700000000000001 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.3399999999999999 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 2.3100000000000001 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 2.48 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.6400000000000001 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 2.1200000000000001 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.54 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.2999999999999998 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 3.4199999999999999 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 1.4299999999999999 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.1599999999999999 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.7999999999999998 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 1.29 111.997 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 3.3999999999999999 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.46 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 2.21 110.316 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.4199999999999999 109.296 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.73 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.9399999999999999 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.9099999999999999 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.405 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.8200000000000001 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 2.1099999999999999 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.26 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 2.1099999999999999 110.66 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.9099999999999999 109.5 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 2.2200000000000002 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 2.54 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.8600000000000001 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 3.0699999999999998 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 2.0099999999999998 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.7 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 3.0800000000000001 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.98 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 6.0499999999999998 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.4100000000000001 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.7000000000000002 111.027 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.9699999999999998 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.9399999999999999 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 6.96 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.7000000000000002 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 3.25 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 3.1099999999999999 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.5900000000000001 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 4.0300000000000002 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 2.4300000000000002 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.8100000000000001 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.4300000000000002 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.558 HG23 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.75 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 3.2200000000000002 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 2.3799999999999999 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 2.2200000000000002 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.6499999999999999 111.47 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 3.2599999999999998 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 1.28 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 1.0900000000000001 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 2.1299999999999999 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.6400000000000001 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.3400000000000001 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 2.0099999999999998 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.6699999999999999 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.4900000000000002 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.788 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.6000000000000001 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.788 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 4.79 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 129' ' ' TYR . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.8600000000000001 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 3.23 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.4900000000000002 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 2.3700000000000001 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' TRP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 2.6000000000000001 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.5699999999999998 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 2.2599999999999998 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.77000000000000002 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.6099999999999999 111.064 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.72 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 4.0099999999999998 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 3.3999999999999999 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 3.0600000000000001 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.558 HG12 HG23 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.6699999999999999 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.46 110.925 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 4.3099999999999996 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 3.1200000000000001 111.189 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 3.0499999999999998 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 3.0899999999999999 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.3599999999999999 112.556 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.718 0.294 . . . . 2.9399999999999999 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.3999999999999999 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.3700000000000001 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 3.27 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 2.02 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.6400000000000001 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 2.0899999999999999 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' TYR . . . . . 0.417 ' O ' HG21 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.6400000000000001 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.8399999999999999 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 2.3999999999999999 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.95 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.7 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 4.1100000000000003 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.4100000000000001 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 2.02 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 2.0299999999999998 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 2.5499999999999998 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.9399999999999999 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 2.3300000000000001 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.73999999999999999 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' TYR . . . . . 0.551 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 2.6499999999999999 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 1.1100000000000001 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 2.4500000000000002 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.9299999999999999 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.9399999999999999 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . 0.477 HG21 HG22 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.6099999999999999 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG21 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.9100000000000001 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 2.1899999999999999 112.518 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.8 0.333 . . . . 2.6600000000000001 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 2.2200000000000002 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.96 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.6699999999999999 110.685 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.79 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 2.3900000000000001 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 2.2599999999999998 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.8799999999999999 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79000000000000004 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 2.2999999999999998 110.296 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' PHE . . . . . 0.401 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 2.8100000000000001 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 2.0499999999999998 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.6800000000000002 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 208' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 3.4100000000000001 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.3799999999999999 112.149 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 3.5600000000000001 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.8399999999999999 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 4.1299999999999999 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.77 110.664 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.4399999999999999 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.9100000000000001 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.7599999999999998 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.5900000000000001 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 4.0099999999999998 110.953 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.701 0.286 . . . . 3.6000000000000001 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' LEU . . . . . 0.441 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.8799999999999999 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' HIS . . . . . 0.502 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 2.1699999999999999 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 2.21 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' TYR . . . . . 0.472 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 2.3500000000000001 110.485 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 1.48 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 1.51 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.82999999999999996 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.9299999999999999 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.8 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.79 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 1.3700000000000001 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.7599999999999998 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.6899999999999999 109.988 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 5.1500000000000004 110.202 179.538 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' TYR . . . . . 0.441 ' HB2' ' HE1' ' C' ' 99' ' ' TRP . 6.1 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.5899999999999999 111.951 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.5699999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.8799999999999999 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 2.2200000000000002 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 2.5299999999999998 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.8999999999999999 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.6200000000000001 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 2.3199999999999998 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.51 HG22 HG21 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 1.3899999999999999 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.80000000000000004 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 2.2200000000000002 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 2.5600000000000001 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.412 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.74 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.57999999999999996 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 1.4299999999999999 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.23 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.49 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' MET . . . . . 0.411 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.6299999999999999 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 1.1699999999999999 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 1.45 110.361 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 1.3600000000000001 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 2.02 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLN . . . . . 0.525 ' HG3' HD11 ' C' ' 118' ' ' ILE . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.71 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.8900000000000001 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 2.3500000000000001 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.1800000000000002 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.2599999999999998 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.79 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.52 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.6899999999999999 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 2.25 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' HIS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.23 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.8999999999999999 111.203 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 1.3100000000000001 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.71 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 2.6699999999999999 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 2.0 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' ASP . . . . . 0.462 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.3100000000000001 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.6099999999999999 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.8300000000000001 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.445 HG11 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.8899999999999999 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' THR . . . . . 0.51 HG21 HG22 ' B' ' 43' ' ' ILE . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.6000000000000001 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 2.1200000000000001 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' PRO . . . . . 0.607 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.3100000000000001 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' LEU . . . . . 0.496 HD21 HD13 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 2.0800000000000001 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 2.21 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 2.3599999999999999 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.496 HD13 HD21 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 2.5099999999999998 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.72 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.78 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.73 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.8799999999999999 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.1000000000000001 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.5 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 3.1499999999999999 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 3.1499999999999999 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 5.0800000000000001 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 3.1899999999999999 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.6500000000000004 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.9699999999999998 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 6.25 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.6200000000000001 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 3.0600000000000001 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.6899999999999999 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' GLY . . . . . 0.585 ' HA3' HD22 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.53 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 3.6099999999999999 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' LEU . . . . . 0.542 ' HB3' HD23 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.6699999999999999 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.7999999999999998 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 2.3100000000000001 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' THR . . . . . 0.563 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5699999999999998 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' GLN . . . . . 0.429 ' NE2' HG23 ' B' ' 80' ' ' THR . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 3.3799999999999999 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 2.6200000000000001 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 2.1699999999999999 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.6499999999999999 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.9500000000000002 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 1.21 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 1.1100000000000001 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.59999999999999998 112.745 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.98 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 2.0800000000000001 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.3100000000000001 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.71 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 2.3300000000000001 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.8900000000000001 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 3.0800000000000001 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.9699999999999998 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 2.0 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 3.0600000000000001 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 3.2200000000000002 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.6099999999999999 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.6699999999999999 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 2.5699999999999998 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 2.27 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 2.2999999999999998 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.69999999999999996 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 2.6499999999999999 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 1.51 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 2.3999999999999999 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.48 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 142' ' ' ILE . . . . . 0.563 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 3.3500000000000001 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.9299999999999999 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 5.0800000000000001 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.5900000000000001 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.6699999999999999 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 2.1099999999999999 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.79 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo . . . . . 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.3599999999999999 112.198 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 2.46 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 3.02 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 2.1499999999999999 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 3.25 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.77 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.52 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.9399999999999999 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.7799999999999998 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 2.1499999999999999 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 2.2400000000000002 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.6699999999999999 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 171' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 4.1299999999999999 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 2.4700000000000002 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.98 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 2.1000000000000001 111.905 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 2.5800000000000001 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' TRP . . . . . 0.408 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.8700000000000001 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67000000000000004 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' TYR . . . . . 0.479 ' N ' ' HD2' ' B' ' 180' ' ' PRO . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 2.5600000000000001 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 1.1799999999999999 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' ILE . . . . . 0.5 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 2.1000000000000001 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' VAL . . . . . 0.448 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.6499999999999999 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 3.1699999999999999 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' ILE . . . . . 0.45 HG21 HG21 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 2.4100000000000001 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' ILE . . . . . 0.45 HG21 HG21 ' B' ' 184' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 3.1200000000000001 112.219 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.689 0.28 . . . . 2.8300000000000001 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.4900000000000002 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 199' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' B' ' 200' ' ' PHE . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 2.2799999999999998 111.524 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 200' ' ' PHE . . . . . 0.44 ' H ' ' HG1' ' B' ' 199' ' ' THR . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.9199999999999999 111.248 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 2.3500000000000001 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 2.8300000000000001 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 2.27 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.78 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 205' ' ' LEU . . . . . 0.417 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 2.0600000000000001 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 206' ' ' PRO . . . . . 0.472 ' HB2' ' HH ' ' B' ' 11' ' ' TYR . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77000000000000002 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 2.4300000000000002 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 2.5899999999999999 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.9299999999999999 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.6499999999999999 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 3.1000000000000001 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.3899999999999999 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 3.0600000000000001 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.3500000000000001 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 4.3700000000000001 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 2.0 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.2200000000000002 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 3.0899999999999999 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 4.1600000000000001 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.6699999999999999 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.9700000000000002 110.864 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 3.2400000000000002 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 7' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.7599999999999998 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 8' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.3399999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' TRP . . . . . 0.478 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.25 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.46 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 2.3799999999999999 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.5800000000000001 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 1.04 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' MET . . . . . 0.49 ' HE1' ' HB3' ' C' ' 44' ' ' PRO . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.95 111.119 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 2.1400000000000001 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 2.3399999999999999 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 1.02 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.51 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.5800000000000001 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.5699999999999998 110.293 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.7799999999999998 111.484 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.7200000000000002 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.9800000000000004 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 2.4100000000000001 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 2.4300000000000002 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.8500000000000001 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' MET . . . . . 0.456 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.6299999999999999 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 2.29 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ILE . . . . . 0.599 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 1.3799999999999999 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.90000000000000002 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 2.27 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 2.2400000000000002 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.71 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.57999999999999996 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.8200000000000001 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 1.28 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 2.46 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' MET . . . . . 0.421 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.7 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 1.2 111.028 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.4099999999999999 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 1.3200000000000001 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.96 111.148 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.9399999999999999 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' GLN . . . . . 0.472 ' NE2' ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 2.25 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 3.4300000000000002 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 2.5499999999999998 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.27 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.8500000000000001 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.6200000000000001 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 3.2599999999999998 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 2.2599999999999998 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.51 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' HIS . . . . . 0.616 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.3999999999999999 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' TYR . . . . . 0.42 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.8199999999999998 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 1.3899999999999999 112.345 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 2.3599999999999999 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' TYR . . . . . 0.447 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 2.7000000000000002 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.8200000000000001 110.476 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 2.4100000000000001 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.9199999999999999 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD22 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.79 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' THR . . . . . 0.533 HG23 HG21 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.97 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 2.2000000000000002 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.25 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' LEU . . . . . 0.465 HD11 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.8300000000000001 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 2.1400000000000001 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' LEU . . . . . 0.465 HD12 HD11 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.6699999999999999 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.8 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 2.29 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 4.0300000000000002 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 2.0699999999999998 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.47 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.8599999999999999 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.6299999999999999 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 5.46 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.8399999999999999 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.8399999999999999 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.8600000000000003 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 6.0700000000000003 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.79 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 3.1499999999999999 111.521 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.8799999999999999 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.72 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 3.6200000000000001 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.8199999999999998 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' MET . . . . . 0.418 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.7000000000000002 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.54 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' THR . . . . . 0.41 HG21 HG23 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.8799999999999999 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.71 111.667 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 2.52 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 2.1699999999999999 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.5900000000000001 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 3.0299999999999998 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.65000000000000002 113.325 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' LEU . . . . . 0.495 HD13 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 2.0299999999999998 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' ILE . . . . . 0.525 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 2.23 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 1.4399999999999999 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.79 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' SER . . . . . 0.501 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.5499999999999998 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.3100000000000001 110.301 179.475 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.836 0.351 . . . . 1.73 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 3.3799999999999999 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 3.0 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 2.48 110.652 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.74 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 2.5699999999999998 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.7000000000000002 111.035 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 2.2000000000000002 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 2.1000000000000001 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.9399999999999999 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.54 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 2.4700000000000002 111.453 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 142' ' ' ILE . . . . . 0.41 HG23 HG21 ' C' ' 108' ' ' THR . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 3.0699999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.9399999999999999 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 4.5199999999999996 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.6499999999999999 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.9300000000000002 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.8599999999999999 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.7000000000000002 112.017 -179.443 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.823 0.344 . . . . 3.1800000000000002 110.771 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.1800000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 161' ' ' LEU . . . . . 0.448 HD12 HD13 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.9900000000000002 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 2.2400000000000002 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 164' ' ' LEU . . . . . 0.448 HD13 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.6499999999999999 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.6299999999999999 111.042 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.2599999999999998 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.9199999999999999 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.8 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 2.21 110.975 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 2.0299999999999998 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.8799999999999999 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 2.3100000000000001 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 2.0 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 2.4199999999999999 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 175' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.7000000000000002 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.1100000000000001 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 177' ' ' ILE . . . . . 0.412 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 2.3100000000000001 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 179' ' ' TYR . . . . . 0.528 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 2.71 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 180' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 1.0700000000000001 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 181' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 2.0800000000000001 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 182' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.71 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.8999999999999999 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 184' ' ' ILE . . . . . 0.544 HG21 HG22 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 2.2000000000000002 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 185' ' ' ILE . . . . . 0.544 HG22 HG21 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 3.23 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.9099999999999999 112.416 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.779 0.323 . . . . 2.8599999999999999 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.6800000000000002 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 2.54 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 200' ' ' PHE . . . . . 0.435 ' HB2' HD12 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.77 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 2.5299999999999998 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.8799999999999999 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 2.48 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.95 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.8700000000000001 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76000000000000001 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 2.3599999999999999 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 2.6200000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 209' ' ' SER . . . . . 0.488 ' HB2' HD21 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.9299999999999999 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.6600000000000001 111.606 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 3.1099999999999999 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.4099999999999999 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.77 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.8399999999999999 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 4.3399999999999999 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 2.25 110.596 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2000000000000002 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.54 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 4.0099999999999998 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.6400000000000001 111.389 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.851 0.358 . . . . 8.5199999999999996 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.29 -17.83 60.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 6.0999999999999996 110.919 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.47 117.28 17.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 6.6900000000000004 110.993 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -84.92 92.51 8.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 6.5199999999999996 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.5 t -127.85 -80.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 3.77 110.959 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt 63.42 2.56 1.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.337 -0.392 . . . . 3.8199999999999998 111.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 2.46 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.498 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.9299999999999999 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 1.0800000000000001 110.69 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 2.4100000000000001 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 2.2599999999999998 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 1.5800000000000001 111.166 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 1.54 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.89000000000000001 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.8200000000000001 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.8500000000000001 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 2.23 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.95999999999999996 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 1.4099999999999999 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.5699999999999998 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.8799999999999999 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.73 -33.14 62.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.7999999999999998 110.442 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -54.76 -36.03 64.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.978 -0.555 . . . . 4.7999999999999998 110.588 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.6 m -84.1 -27.52 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 2.7799999999999998 110.671 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 tp -83.25 -1.6 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 3.27 110.769 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -59.37 -20.88 58.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 2.52 111.021 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -46.77 -32.62 3.77 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.554 0.692 . . . . 6.0099999999999998 109.445 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.476 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.6 p-10 -172.31 131.36 0.68 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.746 -1.115 . . . . 4.79 109.309 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.4 Cg_endo -81.64 171.19 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.601 2.201 . . . . 3.3900000000000001 111.907 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' H ' ' HH ' ' A' ' 37' ' ' TYR . 76.0 ttt180 -146.52 125.68 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 7.4100000000000001 111.725 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.21 3.04 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.839 -0.619 . . . . 4.9800000000000004 113.193 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.54 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 34.5 m -136.32 149.78 68.84 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.615 0.245 . . . . 5.2199999999999998 111.659 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HG2' ' HE1' ' A' ' 35' ' ' TYR . 19.5 Cg_exo -67.41 166.41 23.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.996 2.464 . . . . 4.1299999999999999 112.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -44.33 -56.69 3.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 4.0199999999999996 113.377 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.413 ' HE1' ' HG2' ' A' ' 33' ' ' PRO . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 3.1600000000000001 112.139 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.54 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.3900000000000001 110.62 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.408 ' HH ' ' H ' ' A' ' 30' ' ' ARG . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.5 110.685 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.472 HD23 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 2.1099999999999999 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.8999999999999999 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.48 111.345 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.5299999999999998 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 2.0499999999999998 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.74 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.68999999999999995 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 2.1699999999999999 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.594 ' HE1' HG23 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.47 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.9199999999999999 111.386 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.55000000000000004 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 1.6499999999999999 110.953 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 1.1399999999999999 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 2.4199999999999999 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.4099999999999999 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.406 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 1.0900000000000001 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.419 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 1.47 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.498 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 1.23 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.8700000000000001 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.3399999999999999 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 2.3100000000000001 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 2.48 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 2.1200000000000001 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.54 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.2999999999999998 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 3.4199999999999999 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.8900000000000001 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 1.4299999999999999 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.1599999999999999 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.403 ' O ' HG13 ' A' ' 74' ' ' ILE . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.7999999999999998 110.992 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 1.29 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 3.3999999999999999 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.405 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.46 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 70' ' ' TYR . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 2.21 110.654 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.4199999999999999 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.405 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.73 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.9399999999999999 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.425 ' O ' HD21 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.9099999999999999 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.8200000000000001 112.126 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.489 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 2.1099999999999999 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.26 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 2.1099999999999999 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.9099999999999999 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.415 HD13 ' HB2' ' A' ' 109' ' ' GLN . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 2.2200000000000002 110.482 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 2.54 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.8600000000000001 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.9199999999999999 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 2.4700000000000002 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 3.0699999999999998 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 2.0099999999999998 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.7 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 3.0800000000000001 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.98 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 6.0499999999999998 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.4100000000000001 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.7000000000000002 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.9699999999999998 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.9399999999999999 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 6.96 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.7000000000000002 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 3.25 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 3.1099999999999999 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.5900000000000001 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 4.0300000000000002 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 2.4300000000000002 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.8100000000000001 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.4300000000000002 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.579 HG21 HD11 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.75 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.489 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 3.2200000000000002 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 2.3799999999999999 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 2.2200000000000002 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.6499999999999999 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 3.2599999999999998 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.416 HG22 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 1.28 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 1.0900000000000001 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 2.1299999999999999 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.6400000000000001 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.3400000000000001 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.8799999999999999 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.6699999999999999 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.4900000000000002 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.537 HH12 ' HG3' ' C' ' 1' ' ' MET . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.6000000000000001 110.838 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 4.79 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.8600000000000001 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 3.23 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.4900000000000002 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 2.3700000000000001 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.96 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 2.6000000000000001 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.5699999999999998 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.43 ' SG ' HD23 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 2.2599999999999998 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.77000000000000002 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.427 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.6099999999999999 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 2.0699999999999998 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.72 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 4.0099999999999998 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 3.3999999999999999 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 3.0600000000000001 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.579 HD11 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.6699999999999999 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.46 111.091 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 4.3099999999999996 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.6200000000000001 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 3.1200000000000001 111.646 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 3.0499999999999998 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.619 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 3.0899999999999999 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo -65.8 -2.06 5.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.3599999999999999 112.684 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 166' ' ' ASP . 55.5 tp -61.04 -31.82 71.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.312 -0.404 . . . . 3.7200000000000002 111.156 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -135.95 -4.61 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.504 -0.316 . . . . 9.25 111.108 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.77 -50.72 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.395 -0.366 . . . . 3.1000000000000001 111.439 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.583 ' HB3' ' HZ1' ' A' ' 153' ' ' LYS . 8.3 mtpm? -75.38 -30.97 60.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 4.8899999999999997 111.174 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.4 p -83.12 5.77 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 4.2599999999999998 111.312 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -69.73 -24.47 63.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 6.1100000000000003 110.861 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 39.5 m -110.75 -35.83 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 3.3300000000000001 111.135 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.48 -67.99 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 4.2699999999999996 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -156.09 115.05 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.9399999999999999 110.847 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.3999999999999999 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 3.27 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 2.02 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.6400000000000001 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.457 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 2.0899999999999999 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.458 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.6400000000000001 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.569 ' HA ' HD21 ' A' ' 150' ' ' LEU . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.1499999999999999 110.899 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.61 ' HZ3' ' HB2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.8399999999999999 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 165' ' ' TYR . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 2.3999999999999999 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.95 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.7 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 4.1100000000000003 110.719 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 2.4100000000000001 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 2.02 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.4 HG11 HD13 ' A' ' 175' ' ' LEU . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 2.0299999999999998 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.4 HD13 HG11 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 2.5499999999999998 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.9399999999999999 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.519 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 2.3300000000000001 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.73999999999999999 112.958 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.469 ' N ' ' HD2' ' A' ' 180' ' ' PRO . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 2.6499999999999999 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 1.1100000000000001 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.519 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 2.4500000000000002 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.573 ' HB ' ' HA2' ' A' ' 189' ' ' GLY . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.9299999999999999 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.404 ' CE3' ' HA ' ' A' ' 183' ' ' TRP . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.9399999999999999 111.618 -179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.5 HG23 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.6099999999999999 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.5 HG13 HG23 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.9100000000000001 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.444 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 64.56 173.01 3.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 2.1899999999999999 112.819 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.38 74.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.492 2.128 . . . . 3.46 111.541 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.1 m 62.25 53.13 2.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.53 . . . . 4.04 110.775 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.573 ' HA2' ' HB ' ' A' ' 182' ' ' VAL . . . -176.09 -143.96 4.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.502 -0.856 . . . . 4.4800000000000004 113.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -95.32 0.71 53.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.673 0.273 . . . . 8.6699999999999999 111.429 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.444 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . 89.17 170.38 45.0 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.578 -0.82 . . . . 3.4300000000000002 112.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 18.2 m-90 54.79 27.68 9.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 6.8099999999999996 110.813 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.408 HD13 ' HA3' ' A' ' 189' ' ' GLY . 5.6 pt -123.39 151.98 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 3.5899999999999999 111.05 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.03 -175.07 5.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 3.3900000000000001 111.228 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -79.44 -35.16 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 6.1100000000000003 110.916 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 36.6 m -61.2 -54.08 48.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 3.04 110.732 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 15.5 tt -64.95 -26.99 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 2.7999999999999998 110.972 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -56.3 -58.76 6.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.388 -0.369 . . . . 2.6600000000000001 110.741 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 2.2200000000000002 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.96 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.6699999999999999 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.79 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 2.3900000000000001 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 2.2599999999999998 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.67 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.8799999999999999 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79000000000000004 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 2.2999999999999998 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 2.8100000000000001 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 2.0499999999999998 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.6800000000000002 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 3.4100000000000001 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.3799999999999999 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 3.5600000000000001 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.8399999999999999 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 4.1299999999999999 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.77 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.4399999999999999 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.9100000000000001 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.7599999999999998 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.5900000000000001 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 221' ' ' LEU . 3.3 mm? -82.86 -58.94 2.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 4.0099999999999998 111.229 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 50.74 75.84 0.17 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.395 -0.366 . . . . 6.3799999999999999 110.653 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . 0.476 ' ND2' ' HB3' ' A' ' 225' ' ' ASN . 7.2 t30 -115.57 -54.89 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 6.0700000000000003 111.128 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.8 mt 59.86 80.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 6.6600000000000001 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . 0.476 ' HB3' ' ND2' ' A' ' 223' ' ' ASN . 3.3 p-10 -104.82 -168.34 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 6.9900000000000002 110.943 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -165.52 51.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 6.9400000000000004 110.744 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -125.53 136.11 52.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 6.8300000000000001 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.01 -26.47 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 11.49 110.787 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.313 -0.851 . . . . 9.4700000000000006 110.948 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.81 0.338 . . . . 9.0999999999999996 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -105.86 10.04 32.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 7.2000000000000002 110.981 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 59.22 -170.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.087 -0.506 . . . . 6.7300000000000004 111.084 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 58.61 34.65 24.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.159 -0.473 . . . . 5.4400000000000004 111.245 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 72.5 p -147.12 70.83 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 4.1299999999999999 110.96 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.1 38.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 3.6000000000000001 110.993 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.8799999999999999 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.521 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 2.1699999999999999 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG22 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1899999999999999 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 2.21 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.416 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 2.3500000000000001 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.413 HG22 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 1.48 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 1.51 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.82999999999999996 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.9299999999999999 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.8 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.79 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 1.3700000000000001 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.7599999999999998 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.6899999999999999 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.613 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 83.7 m-85 -73.91 -28.31 61.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 5.1500000000000004 111.032 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.473 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 t90 -56.08 -49.74 72.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.231 -0.44 . . . . 4.1799999999999997 110.448 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -81.48 -21.21 38.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 2.77 110.179 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.613 ' HB3' ' HA ' ' B' ' 22' ' ' PHE . 42.0 tp -77.85 0.1 25.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.492 -0.776 . . . . 3.4900000000000002 110.655 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.473 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 3.2 m -52.38 -22.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.915 -0.314 . . . . 3.0299999999999998 111.154 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -53.61 -19.73 4.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.04 0.924 . . . . 6.4500000000000002 108.906 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.741 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 0.4 OUTLIER -66.39 -154.18 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-N 113.835 -1.529 . . . . 5.3700000000000001 108.236 177.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.741 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 52.5 Cg_exo -0.35 87.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.433 2.755 . . . . 4.2999999999999998 115.998 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -120.24 69.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.781 -1.1 . . . . 8.5600000000000005 108.676 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 3.53 8.14 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.518 -1.033 . . . . 4.6100000000000003 110.518 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 28.7 m -130.89 160.69 65.48 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 114.905 -0.647 . . . . 5.4800000000000004 109.91 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' B' ' 32' ' ' VAL . 18.8 Cg_exo -35.56 116.99 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.369 2.046 . . . . 4.3899999999999997 114.871 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -36.88 22.59 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.09 -0.959 . . . . 4.2999999999999998 108.657 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' B' ' 33' ' ' PRO . 0.4 OUTLIER -51.07 -22.66 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.813 -1.54 . . . . 3.5899999999999999 112.011 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.5699999999999998 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.8799999999999999 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 2.2200000000000002 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 2.5299999999999998 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.8999999999999999 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.432 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.6200000000000001 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 2.3199999999999998 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.434 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 1.3899999999999999 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.80000000000000004 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.432 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 2.2200000000000002 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.448 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 2.5600000000000001 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.74 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.57999999999999996 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.505 HD21 ' HG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 1.4299999999999999 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 1.23 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.435 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.49 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.6299999999999999 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 1.1699999999999999 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 1.45 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 1.3600000000000001 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.436 HG23 HG21 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 2.02 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.417 ' HB2' HG23 ' C' ' 127' ' ' VAL . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.71 110.886 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.8900000000000001 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 2.3500000000000001 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.1800000000000002 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.2599999999999998 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.79 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.52 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.6899999999999999 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 2.25 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.3999999999999999 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.468 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.23 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.422 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.8999999999999999 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 1.3100000000000001 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.468 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.71 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 2.6699999999999999 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.422 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 2.0 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.462 ' O ' HG21 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.6099999999999999 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.8300000000000001 110.414 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.8899999999999999 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.462 HG21 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.6000000000000001 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.549 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 2.1200000000000001 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.3100000000000001 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 2.0800000000000001 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 2.21 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.444 HD13 ' N ' ' B' ' 85' ' ' LEU . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 2.3599999999999999 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.444 ' N ' HD13 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 2.5099999999999998 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.72 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.455 HD11 HD23 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.78 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.73 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.8799999999999999 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 2.1000000000000001 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . 0.413 ' HB2' HD13 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.5 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 3.1499999999999999 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 3.1499999999999999 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 5.0800000000000001 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 3.1899999999999999 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.6500000000000004 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.9699999999999998 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.2400000000000002 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 6.25 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.472 ' HA ' HD23 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.6200000000000001 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 3.0600000000000001 111.063 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.6899999999999999 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.53 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.454 ' HB2' HD12 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 3.6099999999999999 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.6699999999999999 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.7999999999999998 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 2.3100000000000001 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.457 ' O ' HG22 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.5699999999999998 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.419 ' HG3' HD22 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 3.3799999999999999 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.594 HG23 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 2.6200000000000001 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 2.1699999999999999 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . 0.457 HG22 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.6499999999999999 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.9500000000000002 110.64 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 1.21 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 1.1100000000000001 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.59999999999999998 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.98 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.429 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 2.0800000000000001 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.3100000000000001 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.4 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.429 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.71 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 2.3300000000000001 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.685 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 3.0800000000000001 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.685 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.9699999999999998 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.469 HG13 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 2.0 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 3.0600000000000001 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 3.2200000000000002 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.6099999999999999 111.281 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.6699999999999999 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 2.5699999999999998 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 2.27 111.081 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 2.2999999999999998 110.971 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 2.0800000000000001 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 2.6499999999999999 110.709 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 1.51 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 2.3999999999999999 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.48 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . 0.427 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 2.4500000000000002 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.427 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 3.3500000000000001 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.9299999999999999 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 5.0800000000000001 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.6699999999999999 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 2.1099999999999999 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.449 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.79 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo -70.14 -1.29 8.53 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.3599999999999999 112.921 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' B' ' 166' ' ' ASP . 57.3 tp -61.23 -21.91 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 3.29 110.988 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.16 -14.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 8.9000000000000004 110.835 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -38.47 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 2.8399999999999999 110.975 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.36 -41.99 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 4.96 110.742 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 73.4 p -79.4 6.49 10.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 4.1699999999999999 110.858 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -60.52 -25.35 66.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 5.71 110.686 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.0 p -115.5 -17.86 11.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 3.75 111.022 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.41 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 8.5 tt0 -80.89 -68.55 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 4.6299999999999999 110.94 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.504 ' HG ' ' H ' ' B' ' 161' ' ' LEU . 40.6 t -157.53 117.24 3.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 3.1099999999999999 111.122 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t -73.68 -39.31 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 2.46 111.236 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . 0.504 ' H ' ' HG ' ' B' ' 158' ' ' SER . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 3.02 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 2.1499999999999999 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 3.25 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.77 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.52 111.188 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . 0.413 ' HA ' HD21 ' B' ' 150' ' ' LEU . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.9399999999999999 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.7799999999999998 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.455 HD23 HD11 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 2.1499999999999999 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 2.2400000000000002 111.008 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.6699999999999999 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 4.1299999999999999 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 2.4700000000000002 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.98 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 2.1000000000000001 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.425 HD21 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 2.5800000000000001 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.8700000000000001 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.494 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 2.0299999999999998 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67000000000000004 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.554 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 2.5600000000000001 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 1.1799999999999999 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.494 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 2.1000000000000001 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.443 HG21 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.6499999999999999 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 3.1699999999999999 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.507 HG21 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 2.4100000000000001 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.507 HG23 HG21 ' B' ' 184' ' ' ILE . 2.8 pp -118.0 175.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 3.1200000000000001 111.252 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.63 23.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 2.0600000000000001 112.582 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.448 ' HD3' ' HB ' ' B' ' 193' ' ' ILE . 58.2 Cg_endo -72.05 164.23 36.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.642 2.228 . . . . 3.29 111.93 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t 56.71 14.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 4.5 110.336 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.28 -86.13 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.653 -0.703 . . . . 4.7000000000000002 112.155 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -159.39 84.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 8.4800000000000004 110.645 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.38 177.4 35.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.842 -0.694 . . . . 3.9300000000000002 112.321 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -110.58 24.14 13.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 7.3799999999999999 110.762 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.448 ' HB ' ' HD3' ' B' ' 187' ' ' PRO . 59.9 mt -88.56 139.89 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 3.6299999999999999 111.16 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.09 147.02 40.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.154 -0.476 . . . . 3.8599999999999999 110.8 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -62.94 -12.34 24.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.02 -0.536 . . . . 6.2300000000000004 111.65 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 89.4 m -68.73 -53.98 18.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 2.8799999999999999 110.796 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt -64.35 -26.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 2.8300000000000001 110.82 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.4900000000000002 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.2799999999999998 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . 0.408 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.9199999999999999 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 2.3500000000000001 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 2.8300000000000001 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 2.27 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.78 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 2.0600000000000001 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77000000000000002 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 2.4300000000000002 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 2.5899999999999999 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.425 ' HB3' HD21 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.9299999999999999 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.6499999999999999 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 3.1000000000000001 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.3899999999999999 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 3.0600000000000001 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.3500000000000001 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 4.3700000000000001 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 2.0 110.929 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.2200000000000002 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 3.0899999999999999 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 4.1600000000000001 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.6699999999999999 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp -84.7 -57.95 2.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.9700000000000002 111.319 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 53.93 68.41 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.904 0.383 . . . . 6.5700000000000003 110.918 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.49 143.78 19.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 5.9100000000000001 110.608 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.88 92.12 3.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 7.2599999999999998 110.889 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.44 159.49 14.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 7.5099999999999998 110.726 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -138.46 77.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 8.2100000000000009 110.867 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.3 m -154.22 128.9 9.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.0999999999999996 111.029 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -147.26 -21.04 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 14.06 110.583 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.279 -0.867 . . . . 10.4 110.89 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.537 ' HG3' HH12 ' A' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.716 0.293 . . . . 8.3499999999999996 111.029 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 56.89 82.72 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.115 -0.493 . . . . 6.8499999999999996 110.78 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . 0.492 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.7 pt? -72.62 149.2 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 6.6799999999999997 111.128 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.51 -38.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 4.8200000000000003 110.8 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 63.1 p -118.76 94.09 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 3.5299999999999998 110.939 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.453 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.0 mp -94.82 2.62 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 3.2400000000000002 110.998 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.7599999999999998 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.585 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 2.3399999999999999 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.25 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.46 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 2.3799999999999999 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.5800000000000001 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 1.46 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 1.04 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.95 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 2.1400000000000001 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 2.3399999999999999 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 1.02 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.51 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.5800000000000001 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -59.67 -33.46 71.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.5699999999999998 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.07 -17.48 43.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.596 . . . . 5.9299999999999997 110.725 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -64.74 -42.82 94.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 5.1600000000000001 110.118 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 37.0 t -81.07 -29.51 34.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 2.79 110.269 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 tp -77.71 -0.97 28.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 3.3700000000000001 110.534 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.3 m -56.62 -20.92 23.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 2.7400000000000002 111.064 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -52.88 -28.25 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.374 0.607 . . . . 6.2800000000000002 109.434 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -168.36 131.69 1.31 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.045 -0.98 . . . . 4.79 109.868 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 7.3 Cg_endo -87.81 -176.27 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.825 2.35 . . . . 3.9199999999999999 112.458 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . 0.426 ' HB2' HD22 ' C' ' 218' ' ' LEU . 41.1 mmt180 -89.82 28.75 1.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 9.3900000000000006 111.393 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.448 ' HA2' HD22 ' C' ' 224' ' ' LEU . . . 118.32 -46.2 1.17 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.776 . . . . 4.2699999999999996 113.008 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.536 HG11 HD11 ' C' ' 221' ' ' LEU . 20.7 m -73.41 142.62 81.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.51 0.195 . . . . 5.5 111.128 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.41 ' HG2' ' HE2' ' C' ' 35' ' ' TYR . 23.5 Cg_exo -65.57 166.33 20.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.723 2.282 . . . . 3.6000000000000001 112.653 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . 0.408 ' HG2' ' N ' ' C' ' 35' ' ' TYR . 0.0 OUTLIER -50.46 -44.37 55.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.669 0.618 . . . . 4.2699999999999996 112.669 -178.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.41 ' HE2' ' HG2' ' C' ' 33' ' ' PRO . 6.6 p90 -54.38 -41.37 69.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.7799999999999998 111.235 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.7200000000000002 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.9800000000000004 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 2.4100000000000001 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 2.4300000000000002 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.8500000000000001 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.6299999999999999 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 2.29 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 1.3799999999999999 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.90000000000000002 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 2.27 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 2.2400000000000002 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.71 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.57999999999999996 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.43 HD23 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.8200000000000001 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 1.28 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.458 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 2.46 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.7 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 1.2 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.4099999999999999 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.96 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.488 ' HB2' HG23 ' A' ' 127' ' ' VAL . 18.6 tp60 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 2.25 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 3.4300000000000002 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . 0.411 HG13 ' HB2' ' C' ' 68' ' ' ALA . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 2.5499999999999998 111.248 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.27 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.8500000000000001 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.6200000000000001 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 3.2599999999999998 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 2.2599999999999998 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . 0.411 ' HB2' HG13 ' C' ' 61' ' ' VAL . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.544 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.467 ' HD1' ' HE ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.3999999999999999 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . 0.45 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.8199999999999998 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 1.3899999999999999 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.467 ' HE ' ' HD1' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 2.3599999999999999 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.401 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 2.7000000000000002 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.45 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.8200000000000001 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.3300000000000001 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 2.4100000000000001 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.401 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.9199999999999999 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.426 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.79 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.97 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.642 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 2.2000000000000002 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.25 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.8300000000000001 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 2.1400000000000001 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 2.2400000000000002 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.8 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 2.1200000000000001 110.481 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 2.29 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 4.0300000000000002 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 2.0699999999999998 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.47 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' MET . . . . . 0.486 ' HE2' HG12 ' C' ' 95' ' ' ILE . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.8599999999999999 110.689 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.6299999999999999 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 5.46 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . 0.486 HG12 ' HE2' ' C' ' 92' ' ' MET . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.8399999999999999 110.714 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.8399999999999999 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.8600000000000003 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 6.0700000000000003 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.79 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . 0.401 HD13 ' N ' ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 3.1499999999999999 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.8799999999999999 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.72 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 3.6200000000000001 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.476 HD11 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.8199999999999998 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.478 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.7000000000000002 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.54 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.8799999999999999 111.596 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.71 111.342 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.478 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 2.52 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 2.1699999999999999 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.5900000000000001 111.518 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.422 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 3.0299999999999998 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.422 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 1.3300000000000001 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 1.3100000000000001 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.65000000000000002 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 2.0299999999999998 110.582 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 2.23 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 1.4399999999999999 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.79 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.5499999999999998 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.63 -18.75 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.3100000000000001 110.839 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.5 ' HB2' HG13 ' C' ' 127' ' ' VAL . 77.5 mtm180 -126.23 147.18 49.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 3.52 111.129 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.18 -11.09 59.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 4.2400000000000002 110.832 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -83.63 -48.25 10.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 5.4500000000000002 110.743 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.5 HG13 ' HB2' ' C' ' 124' ' ' ARG . 7.1 p -67.5 -34.38 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 1.73 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 3.3799999999999999 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 3.0 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 2.48 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.74 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 2.5699999999999998 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.7000000000000002 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . 0.505 ' HG ' HD21 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 2.2000000000000002 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.72999999999999998 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 2.1000000000000001 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.76 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.51 111.149 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.9399999999999999 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.54 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 2.4700000000000002 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 3.0699999999999998 111.33 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.9399999999999999 110.742 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 4.5199999999999996 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.9300000000000002 111.6 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.8599999999999999 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.434 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 54.9 t30 -60.45 -51.9 76.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.7000000000000002 111.959 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.434 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 64.5 Cg_endo -72.64 -7.25 20.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 2.46 112.737 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.67 -21.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 3.46 110.707 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -138.71 -22.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.55 . . . . 9.1199999999999992 110.929 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.97 -50.43 19.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 2.9700000000000002 111.353 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -71.28 -35.68 71.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 4.8899999999999997 110.966 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 54.8 p -82.83 2.51 33.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 4.1500000000000004 111.305 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -65.54 -28.89 69.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 5.5800000000000001 110.486 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.6 p -114.29 -20.62 10.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 3.5800000000000001 111.127 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.487 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 7.6 tt0 -73.12 -66.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 4.1799999999999997 110.721 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -156.66 113.47 3.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 2.6800000000000002 110.596 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p -72.7 -39.55 66.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 3.1800000000000002 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.1800000000000002 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.9900000000000002 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 2.2400000000000002 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.3900000000000001 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.6499999999999999 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.6299999999999999 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.2599999999999998 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . 0.527 ' HZ3' ' HH ' ' C' ' 171' ' ' TYR . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.9199999999999999 110.756 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.8 110.916 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 2.21 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 2.0299999999999998 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . 0.527 ' HH ' ' HZ3' ' C' ' 167' ' ' LYS . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.8799999999999999 110.63 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 2.3100000000000001 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 2.0 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 2.4199999999999999 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.7000000000000002 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.1100000000000001 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.474 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 2.3100000000000001 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.71999999999999997 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.599 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 2.71 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 1.0700000000000001 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.474 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 2.0800000000000001 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.451 HG23 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.71 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.8999999999999999 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.49 HG21 HG22 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 2.2000000000000002 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.49 HG22 HG21 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 3.23 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.15 -154.6 27.81 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.9099999999999999 112.757 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.477 ' HD3' ' HB ' ' C' ' 193' ' ' ILE . 59.3 Cg_endo -72.15 159.17 50.52 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.615 2.21 . . . . 3.46 112.116 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 31.8 m 55.56 20.34 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 4.2199999999999998 110.302 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.71 45.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.707 -0.679 . . . . 4.3499999999999996 112.427 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 48.8 t80 61.77 97.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.914 0.387 . . . . 8.2400000000000002 111.303 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.93 167.18 40.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.008 -0.615 . . . . 3.6699999999999999 112.192 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -106.12 22.36 15.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 6.4900000000000002 110.939 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.477 ' HB ' ' HD3' ' C' ' 187' ' ' PRO . 48.7 mt -90.47 144.53 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 3.1899999999999999 111.173 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.67 152.69 18.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 4.3399999999999999 111.19 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.6 -27.54 61.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 5.9900000000000002 110.995 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.2 t -65.77 -30.21 70.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 2.7999999999999998 111.177 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt -77.85 -32.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 2.8599999999999999 110.872 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6800000000000002 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 2.54 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.77 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 2.5299999999999998 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.8799999999999999 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 2.48 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.95 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.548 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.8700000000000001 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76000000000000001 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 2.3599999999999999 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 2.6200000000000001 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.9299999999999999 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.6600000000000001 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 3.1099999999999999 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.4099999999999999 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.77 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.8399999999999999 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 4.3399999999999999 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 2.25 110.771 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2000000000000002 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' C' ' 30' ' ' ARG . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.54 111.259 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 4.0099999999999998 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.536 HD11 HG11 ' C' ' 32' ' ' VAL . 76.7 mt -84.95 -59.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.6400000000000001 111.19 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 50.75 72.29 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 6.3799999999999999 110.751 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -164.66 148.3 9.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 6.0899999999999999 110.867 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.448 HD22 ' HA2' ' C' ' 31' ' ' GLY . 95.9 mt -123.74 131.21 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 7.0099999999999998 110.749 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -140.24 115.2 9.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.4 . . . . 6.7999999999999998 110.885 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -101.97 109.18 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 7.0499999999999998 110.974 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.1 t -155.2 87.04 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 6.8200000000000003 110.903 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -142.06 -45.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 10.17 110.737 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.154 -0.926 . . . . 9.4499999999999993 110.857 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.478 ' H15' H203 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.549 H163 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.485 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.767 0.317 . . . . 8.5199999999999996 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -95.42 12.91 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 6.0999999999999996 110.929 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.1 mt -97.5 111.29 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 6.6900000000000004 110.473 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.2 142.94 32.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 6.5199999999999996 111.086 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.44 ' HB2' ' HD1' ' A' ' 8' ' ' HIS . 73.9 p -173.22 145.01 1.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 3.77 110.913 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.3 pt? -136.63 -29.49 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.285 -0.416 . . . . 3.8199999999999998 111.255 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 2.46 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 54' ' ' MET . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.9299999999999999 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 1.0800000000000001 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 2.4100000000000001 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 2.2599999999999998 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.469 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.5800000000000001 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 1.54 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.89000000000000001 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.573 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.8200000000000001 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.8500000000000001 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 2.23 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.95999999999999996 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 1.4099999999999999 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.5699999999999998 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.8799999999999999 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 13.8 m-85 -72.98 -39.23 66.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.7999999999999998 110.637 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -53.11 -37.76 62.03 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.453 -0.573 . . . . 4.7999999999999998 109.453 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.9 p -85.36 -21.35 28.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.64 -0.709 . . . . 2.7799999999999998 110.105 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -77.28 0.36 22.39 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.853 -0.612 . . . . 3.27 110.555 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 28' ' ' ASN . 21.3 p -48.92 -21.84 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 2.52 111.105 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -51.33 -21.3 2.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.107 0.956 . . . . 6.0099999999999998 108.723 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.748 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 3.5 t-20 -66.47 -156.04 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 113.507 -1.678 . . . . 4.79 107.901 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 56.0 Cg_exo -1.79 70.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.599 2.866 . . . . 3.3900000000000001 115.76 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' ASN . 13.9 ptm180 -102.93 54.07 0.77 Allowed 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.342 -0.984 . . . . 7.4100000000000001 108.342 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.36 9.04 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.572 -1.411 . . . . 4.9800000000000004 109.572 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 29' ' ' PRO . 96.1 t -111.85 139.11 21.92 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 114.446 -0.877 . . . . 5.2199999999999998 110.023 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HB2' ' CZ ' ' A' ' 35' ' ' TYR . 61.0 Cg_exo -38.77 145.86 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.976 2.451 . . . . 4.1299999999999999 114.114 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.32 -16.2 57.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.044 -0.98 . . . . 4.0199999999999996 112.4 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.591 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 3.1600000000000001 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.591 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.3900000000000001 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.5 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 2.1099999999999999 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.8999999999999999 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.48 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.407 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.5299999999999998 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 2.0499999999999998 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.483 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.74 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.68999999999999995 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 2.1699999999999999 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.454 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.47 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.9199999999999999 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.573 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.55000000000000004 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 1.6499999999999999 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 1.1399999999999999 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.401 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 2.4199999999999999 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.469 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.4099999999999999 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.454 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 1.0900000000000001 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.448 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 1.47 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 1.23 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.43 HD12 HD22 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.8700000000000001 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HA ' ' HZ2' ' A' ' 60' ' ' LYS . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.587 HE21 ' H ' ' A' ' 59' ' ' GLY . 22.6 tp60 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.3399999999999999 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' H ' HE21 ' A' ' 58' ' ' GLN . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.464 ' HZ2' ' HA ' ' A' ' 57' ' ' ASP . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 2.3100000000000001 110.884 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 2.48 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 2.1200000000000001 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.54 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.2999999999999998 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 3.4199999999999999 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.8900000000000001 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 1.4299999999999999 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.458 ' HD1' ' HE ' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.1599999999999999 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.7999999999999998 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 1.29 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.458 ' HE ' ' HD1' ' A' ' 69' ' ' HIS . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 3.3999999999999999 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.46 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 2.21 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.73 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.9399999999999999 110.412 179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.9099999999999999 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.453 HG23 HG22 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.8200000000000001 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.584 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 2.1099999999999999 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.584 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.26 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.403 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 2.1099999999999999 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.9099999999999999 110.618 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.449 HD21 ' O ' ' A' ' 80' ' ' THR . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 2.2200000000000002 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 2.54 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.8600000000000001 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.9199999999999999 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 2.4700000000000002 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 3.0699999999999998 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 2.0099999999999998 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.7 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' MET . . . . . 0.47 ' HE3' HG12 ' A' ' 95' ' ' ILE . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 3.0800000000000001 110.993 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.413 ' HG2' ' HH ' ' A' ' 35' ' ' TYR . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.98 110.866 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 6.0499999999999998 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.47 HG12 ' HE3' ' A' ' 92' ' ' MET . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.4100000000000001 111.464 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.7000000000000002 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.9699999999999998 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.9399999999999999 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 6.96 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.7000000000000002 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 3.25 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 3.1099999999999999 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.5900000000000001 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 4.0300000000000002 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 2.4300000000000002 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.8100000000000001 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.4300000000000002 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.75 111.837 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 3.2200000000000002 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 2.3799999999999999 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 2.2200000000000002 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.6499999999999999 111.216 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 3.2599999999999998 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 1.28 110.961 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 1.0900000000000001 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 2.1299999999999999 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.492 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.6400000000000001 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.3400000000000001 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.8799999999999999 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 2.0099999999999998 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.6699999999999999 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.4900000000000002 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.6000000000000001 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 4.79 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.8600000000000001 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 3.23 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.4900000000000002 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 2.3700000000000001 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.96 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.562 ' HH ' ' HB2' ' A' ' 183' ' ' TRP . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 2.6000000000000001 110.878 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.5699999999999998 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 2.2599999999999998 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.77000000000000002 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.6099999999999999 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 2.0699999999999998 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.72 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.404 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 4.0099999999999998 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 3.3999999999999999 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.433 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 3.0600000000000001 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.433 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.6699999999999999 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.46 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 4.3099999999999996 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.6200000000000001 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.409 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 3.1200000000000001 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 3.0499999999999998 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.629 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 3.0899999999999999 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.629 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo -55.64 -27.78 62.38 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.3599999999999999 112.384 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.27 49.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 3.7200000000000002 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.44 -59.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.126 -0.488 . . . . 9.25 110.98 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.8 -36.25 28.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 3.1000000000000001 111.62 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.52 -17.41 41.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 4.8899999999999997 111.19 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.8 p -96.77 6.72 48.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 4.2599999999999998 111.011 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -79.27 -25.81 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 6.1100000000000003 111.252 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -105.14 -36.92 7.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.478 -0.328 . . . . 3.3300000000000001 111.491 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -57.29 -76.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.331 -0.395 . . . . 4.2699999999999996 111.263 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -158.75 118.04 3.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 2.9399999999999999 110.88 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.3999999999999999 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.423 HD12 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 3.27 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 2.02 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.6400000000000001 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.423 HD12 HD12 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 2.0899999999999999 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.6400000000000001 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.8399999999999999 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.439 HD22 ' HB3' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 2.3999999999999999 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.95 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.7 111.593 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 4.1100000000000003 110.206 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 2.4100000000000001 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.402 HG22 HD13 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 2.02 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 2.0299999999999998 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 2.5499999999999998 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.9399999999999999 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.402 HD13 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 2.3300000000000001 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.73999999999999999 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 2.6499999999999999 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 1.1100000000000001 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 2.4500000000000002 111.524 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.512 ' HB ' ' HA ' ' A' ' 188' ' ' SER . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.9299999999999999 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.562 ' HB2' ' HH ' ' A' ' 132' ' ' TYR . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.9399999999999999 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.6099999999999999 111.265 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.668 ' HB ' ' HA2' ' A' ' 189' ' ' GLY . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.9100000000000001 110.676 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.414 ' H ' ' HB ' ' A' ' 185' ' ' ILE . . . -155.54 -99.1 0.16 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 2.1899999999999999 112.335 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.05 78.62 2.17 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.435 2.09 . . . . 3.46 111.745 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.512 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 35.6 t 60.42 22.47 12.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.855 -0.611 . . . . 4.04 110.845 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.668 ' HA2' ' HB ' ' A' ' 185' ' ' ILE . . . 74.18 84.68 0.3 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.914 -0.66 . . . . 4.4800000000000004 112.882 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -175.39 -19.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.598 0.199 . . . . 8.6699999999999999 111.496 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -155.3 -172.24 22.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.118 -1.039 . . . . 3.4300000000000002 113.643 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -64.87 158.81 24.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 6.8099999999999996 110.725 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.2 mt -88.01 139.59 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.029 -0.532 . . . . 3.5899999999999999 111.519 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -117.53 -90.08 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.11 -0.496 . . . . 3.3900000000000001 110.807 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -177.49 -76.44 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.454 -0.339 . . . . 6.1100000000000003 110.864 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.9 p -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 3.04 111.261 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.56 -24.12 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 2.7999999999999998 110.848 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -57.81 -59.29 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 2.6600000000000001 111.019 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 2.2200000000000002 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.96 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 188' ' ' SER . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.6699999999999999 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.79 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.41 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 2.3900000000000001 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 2.2599999999999998 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.457 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.8799999999999999 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79000000000000004 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 2.2999999999999998 110.244 179.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 2.8100000000000001 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 2.0499999999999998 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.6800000000000002 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 3.4100000000000001 110.958 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.3799999999999999 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 3.5600000000000001 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.8399999999999999 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 4.1299999999999999 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.77 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.4399999999999999 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.9100000000000001 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.7599999999999998 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.5900000000000001 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -55.81 -33.81 64.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 4.0099999999999998 111.259 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -72.88 92.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 6.3799999999999999 110.723 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -142.96 163.62 32.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 6.0700000000000003 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.45 107.5 6.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 6.6600000000000001 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -165.29 144.39 6.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.307 -0.406 . . . . 6.9900000000000002 111.009 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.0 111.87 18.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 6.9400000000000004 110.976 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -80.83 149.33 29.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 6.8300000000000001 111.102 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -158.18 145.84 18.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 11.49 110.952 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.251 -0.88 . . . . 9.4700000000000006 110.904 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.809 0.338 . . . . 9.0999999999999996 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.73 50.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 7.2000000000000002 111.124 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.0 mt -115.52 124.05 50.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 6.7300000000000004 110.97 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.77 120.39 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 5.4400000000000004 110.753 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 59.7 m -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 4.1299999999999999 111.089 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -134.96 -20.12 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 3.6000000000000001 110.918 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.8799999999999999 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 61.8 m-70 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 2.1699999999999999 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1899999999999999 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 2.21 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 2.3500000000000001 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 1.48 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 1.51 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.82999999999999996 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.9299999999999999 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.8 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.79 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 1.3700000000000001 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.7599999999999998 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.6899999999999999 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.85 -30.35 61.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 5.1500000000000004 110.589 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -62.3 -42.56 99.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 4.1799999999999997 110.366 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.4 m -78.86 -19.64 51.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 2.77 110.755 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.4 tp -85.64 -1.47 57.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.526 . . . . 3.4900000000000002 110.901 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 24.5 t -56.59 -19.76 17.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.26 -0.427 . . . . 3.0299999999999998 111.243 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.425 ' HG2' HD21 ' B' ' 28' ' ' ASN . 59.2 ttp180 -50.4 -30.83 13.32 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.449 -0.574 . . . . 6.4500000000000002 109.449 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.425 HD21 ' HG2' ' B' ' 27' ' ' ARG . 7.6 p30 -177.21 132.6 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 5.3700000000000001 109.948 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -93.19 49.72 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.828 2.352 . . . . 4.2999999999999998 111.939 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.552 ' HG3' HD23 ' B' ' 221' ' ' LEU . 22.0 tpt180 58.92 24.95 13.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 8.5600000000000005 110.947 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.96 -45.44 3.03 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.821 -0.704 . . . . 4.6100000000000003 112.791 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.17 149.1 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.459 0.171 . . . . 5.4800000000000004 110.947 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.443 ' HB2' ' HD1' ' B' ' 35' ' ' TYR . 48.0 Cg_exo -54.68 165.7 2.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.572 2.182 . . . . 4.3899999999999997 112.549 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -61.7 -18.88 61.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 4.2999999999999998 112.224 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.443 ' HD1' ' HB2' ' B' ' 33' ' ' PRO . 2.1 p90 -52.35 -35.01 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.705 0.288 . . . . 3.5899999999999999 111.536 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.5699999999999998 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.507 ' HH ' ' HB2' ' B' ' 30' ' ' ARG . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.8799999999999999 111.299 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 2.2200000000000002 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.432 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 2.5299999999999998 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.8999999999999999 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.409 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.6200000000000001 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 2.3199999999999998 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.452 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 1.3899999999999999 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.452 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.80000000000000004 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.409 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 2.2200000000000002 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.533 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 2.5600000000000001 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.47 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.74 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.57999999999999996 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 1.4299999999999999 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 1.23 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.49 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.6299999999999999 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 1.1699999999999999 110.891 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 1.45 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 1.3600000000000001 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 2.02 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.446 HE22 ' HA ' ' C' ' 122' ' ' SER . 17.3 mm100 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.71 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.8900000000000001 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . 0.447 HG11 ' HB2' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 2.3500000000000001 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . 0.519 ' HB2' ' HB3' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.1800000000000002 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.2599999999999998 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.79 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.52 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' B' ' 123' ' ' GLU . 10.0 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.6899999999999999 110.881 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 2.25 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . 0.447 ' HB2' HG11 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.3999999999999999 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.586 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.23 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.405 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.8999999999999999 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 1.3100000000000001 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.71 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.409 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 2.6699999999999999 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.405 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 2.0 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.3100000000000001 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.6099999999999999 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.8300000000000001 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.409 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.8899999999999999 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.409 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.6000000000000001 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 2.1200000000000001 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.3100000000000001 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.498 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 2.0800000000000001 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 2.21 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 2.3599999999999999 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.498 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 2.5099999999999998 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.72 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.479 HD23 HD13 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.78 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.73 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.8799999999999999 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 2.1000000000000001 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.5 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 3.1499999999999999 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 3.1499999999999999 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 5.0800000000000001 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 3.1899999999999999 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.6500000000000004 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.9699999999999998 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 6.25 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.6200000000000001 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 3.0600000000000001 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.6899999999999999 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.53 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 3.6099999999999999 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.6699999999999999 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.7999999999999998 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 2.3100000000000001 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.468 ' HG1' HG13 ' B' ' 142' ' ' ILE . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.5699999999999998 111.528 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 3.3799999999999999 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.454 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 2.6200000000000001 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 2.1699999999999999 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.6499999999999999 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.9500000000000002 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.413 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 1.21 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 1.1100000000000001 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.59999999999999998 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.469 HD11 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.98 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.469 ' N ' HD11 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 2.0800000000000001 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.3100000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.71 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 2.3300000000000001 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . 0.503 ' HA ' HE22 ' B' ' 66' ' ' GLN . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.8900000000000001 110.691 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 3.0800000000000001 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.9699999999999998 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.0 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 3.0600000000000001 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 3.2200000000000002 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . 0.43 HD22 HD12 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6099999999999999 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.6699999999999999 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 2.5699999999999998 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 2.27 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 2.2999999999999998 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.69999999999999996 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 2.0800000000000001 111.584 -179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 2.6499999999999999 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 1.51 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 2.3999999999999999 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.48 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . 0.432 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 2.4500000000000002 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.468 HG13 ' HG1' ' B' ' 108' ' ' THR . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 3.3500000000000001 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.9299999999999999 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 5.0800000000000001 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.5900000000000001 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.6699999999999999 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 2.1099999999999999 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.485 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.79 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo -63.56 -7.23 12.08 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.3599999999999999 112.868 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.16 26.49 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.898 0.38 . . . . 3.29 111.005 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -145.62 -58.86 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 8.9000000000000004 111.031 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -47.56 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 2.8399999999999999 111.288 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.6 -13.17 61.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 4.96 111.355 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 42.2 p -105.69 5.69 31.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.301 -0.409 . . . . 4.1699999999999999 111.292 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -74.77 -35.34 62.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 5.71 110.791 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.6 p -94.85 -22.28 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.75 111.337 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.28 -71.9 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 4.6299999999999999 110.815 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.469 ' HG ' ' H ' ' B' ' 161' ' ' LEU . 48.4 t -163.31 114.32 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 3.1099999999999999 110.876 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 -29.15 66.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 2.46 110.908 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' B' ' 158' ' ' SER . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 3.02 110.614 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 2.1499999999999999 111.257 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 3.25 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.77 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.52 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.9399999999999999 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.7799999999999998 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.479 HD13 HD23 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 2.2400000000000002 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.6699999999999999 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . 0.519 ' HH ' ' HA3' ' B' ' 212' ' ' GLY . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 4.1299999999999999 110.289 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 2.4700000000000002 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.98 111.524 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 2.1000000000000001 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.438 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 2.5800000000000001 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.8700000000000001 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . . . . . . . . . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 2.0299999999999998 110.565 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67000000000000004 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.645 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 2.5600000000000001 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 1.1799999999999999 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 2.1000000000000001 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.483 ' HB ' ' HA ' ' B' ' 188' ' ' SER . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.6499999999999999 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . 0.468 ' CD2' HG21 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 3.1699999999999999 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.477 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 2.4100000000000001 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.42 -83.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 3.1200000000000001 111.071 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.22 -94.43 0.1 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.809 -0.71 . . . . 2.0600000000000001 112.266 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.14 79.86 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.596 2.197 . . . . 3.29 111.967 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' SER . . . . . 0.565 ' HB3' ' HB3' ' B' ' 201' ' ' LEU . 73.9 p 47.26 34.64 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.967 -0.56 . . . . 4.5 111.349 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 182' ' ' VAL . . . 93.31 137.65 8.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.773 -0.727 . . . . 4.7000000000000002 112.726 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 59.32 99.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.879 0.371 . . . . 8.4800000000000004 111.017 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.42 29.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.725 -0.75 . . . . 3.9300000000000002 112.718 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -94.05 145.08 24.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 7.3799999999999999 110.801 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 23.6 mt -88.2 140.21 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 3.6299999999999999 110.99 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -134.66 -87.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.379 . . . . 3.8599999999999999 111.073 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -173.63 -70.53 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.377 -0.374 . . . . 6.2300000000000004 111.029 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.2 m -70.2 -21.17 63.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.8799999999999999 111.427 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.65 -31.17 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 2.8300000000000001 111.247 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.4900000000000002 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 2.2799999999999998 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.9199999999999999 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' B' ' 188' ' ' SER . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 2.3500000000000001 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 2.8300000000000001 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.421 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 2.27 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.78 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.413 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 2.0600000000000001 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.508 ' HA ' ' HH ' ' B' ' 179' ' ' TYR . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77000000000000002 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 2.4300000000000002 110.437 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 2.5899999999999999 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.438 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.9299999999999999 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.6499999999999999 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 3.1000000000000001 111.076 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . 0.519 ' HA3' ' HH ' ' B' ' 171' ' ' TYR . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.3899999999999999 112.468 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 3.0600000000000001 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.3500000000000001 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 4.3700000000000001 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 2.0 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.2200000000000002 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 3.0899999999999999 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 4.1600000000000001 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.6699999999999999 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.552 HD23 ' HG3' ' B' ' 30' ' ' ARG . 58.8 tp -54.48 -29.5 50.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.9700000000000002 111.566 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.61 104.89 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 6.5700000000000003 111.233 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -140.88 -178.55 5.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.04 0.447 . . . . 5.9100000000000001 111.118 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tt -172.46 83.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.71 -0.677 . . . . 7.2599999999999998 110.097 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.5 154.62 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.511 . . . . 7.5099999999999998 111.163 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -112.22 147.03 37.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 8.2100000000000009 110.727 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.3 t -130.59 137.59 49.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.214 -0.448 . . . . 8.0999999999999996 111.201 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -155.69 162.15 40.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 14.06 110.762 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.185 -0.912 . . . . 10.4 110.905 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.788 0.328 . . . . 8.3499999999999996 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.8 63.66 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 6.8499999999999996 110.787 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -66.06 137.05 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 6.6799999999999997 110.833 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.45 179.92 4.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 4.8200000000000003 110.934 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 62.3 m -152.92 128.1 9.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 3.5299999999999998 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.0 -177.3 3.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 3.2400000000000002 110.891 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.7599999999999998 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.483 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 2.3399999999999999 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.432 ' O ' HG13 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.25 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.46 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.435 ' HH ' ' HB2' ' C' ' 207' ' ' PHE . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 2.3799999999999999 110.949 179.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.432 HG13 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.5800000000000001 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 1.46 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 1.04 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.536 ' HE2' ' HA ' ' C' ' 15' ' ' MET . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.95 110.575 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 2.1400000000000001 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 2.3399999999999999 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 1.02 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.51 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.5800000000000001 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -55.6 -26.82 45.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.5699999999999998 110.425 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -65.65 -41.88 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 5.9299999999999997 110.677 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -59.86 -36.72 77.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 5.1600000000000001 110.652 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -73.7 -21.22 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 2.79 110.928 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 95.5 mt -88.55 -0.88 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 3.3700000000000001 111.624 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 64.8 p -57.64 -19.08 23.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.625 0.232 . . . . 2.7400000000000002 111.625 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -51.3 -30.08 17.0 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.306 -0.627 . . . . 6.2800000000000002 109.306 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -176.68 133.0 0.39 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.75 -1.113 . . . . 4.79 109.43 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 35.8 Cg_endo -89.77 39.91 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.345 2.03 . . . . 3.9199999999999999 112.442 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 56.89 33.67 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 9.3900000000000006 111.496 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.87 3.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.756 -0.735 . . . . 4.2699999999999996 112.561 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.438 ' O ' ' HB2' ' C' ' 29' ' ' PRO . 77.0 t -70.86 133.1 86.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.638 -0.134 . . . . 5.5 110.638 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.463 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 50.2 Cg_exo -51.96 165.36 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.352 2.035 . . . . 3.6000000000000001 112.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -59.43 -18.39 38.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 4.2699999999999996 112.429 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.463 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -52.41 -39.46 60.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.7799999999999998 111.559 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.7200000000000002 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.9800000000000004 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 2.4100000000000001 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 2.4300000000000002 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.8500000000000001 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.431 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.6299999999999999 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 2.29 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.577 HG21 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 1.3799999999999999 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.90000000000000002 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 2.27 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 2.2400000000000002 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.443 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.71 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.57999999999999996 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.8200000000000001 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . 0.483 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 1.28 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 2.46 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.431 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.7 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 1.2 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' MET . . . . . 0.483 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.4099999999999999 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.483 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 1.3200000000000001 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.498 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.96 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.498 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 2.25 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 3.4300000000000002 110.957 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 2.5499999999999998 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.27 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . 0.519 ' HB3' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.8500000000000001 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.6200000000000001 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 3.2599999999999998 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 2.2599999999999998 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.51 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.435 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.3999999999999999 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . 0.456 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.8199999999999998 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 1.3899999999999999 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.435 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 2.3599999999999999 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.406 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 2.7000000000000002 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.456 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.8200000000000001 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.3300000000000001 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 2.4100000000000001 110.733 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.9199999999999999 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.79 111.908 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.577 HG23 HG21 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.97 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.508 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 2.2000000000000002 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.25 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.8300000000000001 111.208 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 2.1400000000000001 111.286 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.483 HD13 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 2.2400000000000002 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD13 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.6699999999999999 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.8 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 2.1200000000000001 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 2.29 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 4.0300000000000002 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 2.0699999999999998 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . 0.433 ' HB3' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.47 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.8599999999999999 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.6299999999999999 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 5.46 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.8399999999999999 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . 0.448 ' HD3' HE22 ' C' ' 229' ' ' GLN . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.8399999999999999 110.978 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.8600000000000003 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 6.0700000000000003 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.79 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 3.1499999999999999 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.8799999999999999 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.72 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 3.6200000000000001 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.8199999999999998 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.448 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.7000000000000002 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.54 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.8799999999999999 111.517 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.446 ' HG2' HD22 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.71 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.533 HG23 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 2.52 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 2.1699999999999999 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.5900000000000001 111.158 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 3.0299999999999998 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.446 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 1.3300000000000001 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 1.3100000000000001 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.65000000000000002 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 2.0299999999999998 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.425 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 2.23 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 1.4399999999999999 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.79 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' SER . . . . . 0.446 ' HA ' HE22 ' B' ' 58' ' ' GLN . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.5499999999999998 110.982 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.16 -28.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.3100000000000001 110.848 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.452 ' HB2' HG11 ' C' ' 127' ' ' VAL . 78.7 mtm180 -126.56 151.18 48.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 3.52 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.63 -15.03 55.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.15 -0.477 . . . . 4.2400000000000002 111.277 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -81.25 -40.73 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 5.4500000000000002 110.672 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.452 HG11 ' HB2' ' C' ' 124' ' ' ARG . 14.4 p -77.49 -23.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 1.73 110.984 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 3.3799999999999999 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 3.0 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 2.48 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.74 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 2.5699999999999998 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.7000000000000002 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 2.2000000000000002 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.72999999999999998 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . 0.411 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 2.1000000000000001 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.76 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.51 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.9399999999999999 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.54 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 2.4700000000000002 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.44 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 3.0699999999999998 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.9399999999999999 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 4.5199999999999996 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.6499999999999999 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.9300000000000002 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.8599999999999999 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.547 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 2.9 t-20 -66.72 -51.49 39.37 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.7000000000000002 112.019 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 19.4 Cg_endo -58.35 -20.77 49.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.123 1.882 . . . . 2.46 112.773 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.33 45.33 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 3.46 110.768 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' C' ' 151' ' ' ARG . 8.1 tpm_? -163.24 -58.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 9.1199999999999992 111.044 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -48.37 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.88 0.371 . . . . 2.9700000000000002 111.22 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 ttpp -67.24 -26.71 66.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 4.8899999999999997 110.875 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 71.7 p -91.0 5.44 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 4.1500000000000004 111.546 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -82.73 -23.42 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 5.5800000000000001 110.641 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 50.7 p -101.26 -35.69 9.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 3.5800000000000001 111.394 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.14 -76.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.459 -0.337 . . . . 4.1799999999999997 111.016 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -155.96 115.71 3.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 2.6800000000000002 110.875 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -68.62 -31.44 70.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 3.1800000000000002 111.107 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.1800000000000002 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.9900000000000002 110.752 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 2.2400000000000002 111.165 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.3900000000000001 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.6499999999999999 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.6299999999999999 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.2599999999999998 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.9199999999999999 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.8 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 2.21 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 2.0299999999999998 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.8799999999999999 110.887 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 2.3100000000000001 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 2.4199999999999999 111.88 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.7000000000000002 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.1100000000000001 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.429 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 2.3100000000000001 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.666 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 2.71 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 1.0700000000000001 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.429 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 2.0800000000000001 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' C' ' 188' ' ' SER . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.71 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.445 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.8999999999999999 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.413 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 2.2000000000000002 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.412 ' HB ' ' O ' ' C' ' 189' ' ' GLY . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 3.23 110.943 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . 0.43 ' HA3' ' HD3' ' C' ' 187' ' ' PRO . . . -172.88 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.9099999999999999 112.194 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.43 ' HD3' ' HA3' ' C' ' 186' ' ' GLY . 9.6 Cg_exo -71.39 79.21 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.523 2.149 . . . . 3.46 111.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 188' ' ' SER . . . . . 0.564 ' HA ' ' HB ' ' C' ' 182' ' ' VAL . 97.3 p 47.27 29.41 1.22 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.909 -0.587 . . . . 4.2199999999999998 111.146 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' C' ' 185' ' ' ILE . . . 132.86 -139.2 10.74 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.676 -0.773 . . . . 4.3499999999999996 112.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -49.24 128.57 16.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.362 . . . . 8.2400000000000002 111.442 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.92 157.22 7.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.847 -0.692 . . . . 3.6699999999999999 112.483 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -69.45 152.25 45.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 6.4900000000000002 110.867 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 15.1 mt -88.08 139.43 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 3.1899999999999999 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -131.01 -95.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 4.3399999999999999 110.811 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -177.63 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.845 0.355 . . . . 5.9900000000000002 111.204 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -65.17 -35.61 81.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 2.7999999999999998 111.454 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.91 -31.08 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 2.8599999999999999 111.385 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.6800000000000002 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 2.54 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.77 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . 0.442 HD21 ' HG ' ' C' ' 188' ' ' SER . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 2.5299999999999998 111.651 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . 0.441 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.8799999999999999 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.48 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 2.48 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.95 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.518 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.8700000000000001 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76000000000000001 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . 0.435 ' HB2' ' HH ' ' C' ' 11' ' ' TYR . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 2.3599999999999999 110.256 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 2.6200000000000001 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.9299999999999999 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.6600000000000001 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 3.1099999999999999 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.4099999999999999 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.77 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.8399999999999999 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 4.3399999999999999 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 2.25 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2000000000000002 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.54 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . 0.438 ' NE2' HH21 ' C' ' 222' ' ' ARG . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 4.0099999999999998 110.741 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt -44.75 -51.99 8.82 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.6400000000000001 111.759 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . 0.438 HH21 ' NE2' ' C' ' 219' ' ' HIS . 25.9 ptt180 -72.47 125.21 26.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 6.3799999999999999 110.987 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -173.71 143.39 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 6.0899999999999999 110.731 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 63.9 tp -109.7 131.55 54.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 7.0099999999999998 110.651 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.24 -179.96 8.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 6.7999999999999998 111.122 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -155.99 93.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 7.0499999999999998 110.636 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 77.1 p -102.5 116.81 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 6.8200000000000003 111.136 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -139.42 133.68 31.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 10.17 110.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . 0.448 HE22 ' HD3' ' C' ' 96' ' ' LYS . 6.6 tp-100 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 9.4499999999999993 110.87 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.438 ' H7 ' H193 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.435 H162 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.488 ' H8 ' H161 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.838 0.351 . . . . 8.5199999999999996 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.19 17.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 6.0999999999999996 111.078 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 tp -153.72 -61.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 6.6900000000000004 110.737 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.82 75.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 6.5199999999999996 111.043 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -155.5 81.34 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 3.77 110.806 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.94 175.05 5.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.254 -0.43 . . . . 3.8199999999999998 111.09 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 2.46 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.9299999999999999 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 1.0800000000000001 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 2.4100000000000001 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.416 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 2.2599999999999998 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 1.5800000000000001 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.54 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.89000000000000001 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.465 ' HE2' ' HG2' ' A' ' 210' ' ' LYS . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.8200000000000001 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.8500000000000001 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 2.23 110.622 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.95999999999999996 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 1.4099999999999999 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.5699999999999998 110.535 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.8799999999999999 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -55.47 -36.21 66.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.7999999999999998 111.068 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.485 ' O ' ' OG ' ' A' ' 26' ' ' SER . 49.4 t-105 -93.67 -24.91 17.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 4.7999999999999998 110.963 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 m -66.55 -46.76 75.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 2.7799999999999998 111.21 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.5 tp -83.61 -0.85 52.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 3.27 111.23 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 79.3 p -51.91 -22.95 4.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.353 -0.385 . . . . 2.52 111.362 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -46.99 -38.59 11.0 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.362 0.601 . . . . 6.0099999999999998 109.78 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.435 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 21.3 p-10 -170.12 132.3 1.01 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.061 -0.972 . . . . 4.79 109.698 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 52.7 Cg_endo -93.84 98.78 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.74 2.293 . . . . 3.3900000000000001 112.489 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -117.57 114.87 24.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.595 . . . . 7.4100000000000001 111.033 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.68 -46.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 4.9800000000000004 112.85 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.66 HG11 ' HB3' ' A' ' 36' ' ' GLU . 23.8 t -135.26 111.53 10.87 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.609 0.243 . . . . 5.2199999999999998 111.445 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 5.2 Cg_exo -78.63 166.54 23.69 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.275 2.65 . . . . 4.1299999999999999 112.279 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -41.63 -43.64 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.003 0.742 . . . . 4.0199999999999996 113.003 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.452 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 3.1600000000000001 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.66 ' HB3' HG11 ' A' ' 32' ' ' VAL . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.3900000000000001 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.461 ' HB2' HG12 ' A' ' 32' ' ' VAL . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.5 110.157 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 2.1099999999999999 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.8999999999999999 110.52 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.48 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.416 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.5299999999999998 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 2.0499999999999998 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.74 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.68999999999999995 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 2.1699999999999999 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.526 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.47 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.9199999999999999 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.55000000000000004 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 1.6499999999999999 110.7 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 1.1399999999999999 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 2.4199999999999999 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 1.0900000000000001 110.72 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 1.47 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.627 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 1.23 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.8700000000000001 111.728 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.466 HE22 ' HA ' ' B' ' 122' ' ' SER . 15.9 mm100 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.3399999999999999 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.641 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 2.3100000000000001 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 2.48 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.6400000000000001 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 2.1200000000000001 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.54 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.2999999999999998 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 3.4199999999999999 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.45 ' N ' HD11 ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.8900000000000001 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 1.4299999999999999 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.1599999999999999 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.7999999999999998 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.641 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 1.29 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 3.3999999999999999 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.46 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.572 HG23 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 2.21 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.4199999999999999 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.454 ' NE1' ' H10' ' A' ' 301' ' ' RET . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.73 111.499 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.439 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.9399999999999999 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.9099999999999999 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.8200000000000001 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 2.1099999999999999 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.26 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 2.1099999999999999 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.9099999999999999 109.772 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.468 HD23 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 2.2200000000000002 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 2.54 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.8600000000000001 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 84' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.9199999999999999 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 2.4700000000000002 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 3.0699999999999998 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 2.0099999999999998 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.7 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 3.0800000000000001 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.98 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 6.0499999999999998 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.4100000000000001 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.7000000000000002 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.9699999999999998 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.9399999999999999 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 6.96 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.7000000000000002 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 3.1099999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.5900000000000001 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 4.0300000000000002 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 2.4300000000000002 110.936 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.444 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.8100000000000001 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.4300000000000002 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.75 111.501 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.468 ' HG3' HD23 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 3.2200000000000002 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 2.3799999999999999 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 2.2200000000000002 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.6499999999999999 111.112 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 3.2599999999999998 110.507 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 1.28 110.47 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 1.0900000000000001 110.204 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 2.1299999999999999 112.268 -178.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.6400000000000001 111.418 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.3400000000000001 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.8799999999999999 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 2.0099999999999998 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.6699999999999999 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.4900000000000002 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.47 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.6000000000000001 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 4.79 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.47 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.8600000000000001 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 3.23 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.4900000000000002 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 2.3700000000000001 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.96 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 2.6000000000000001 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.5699999999999998 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 2.2599999999999998 110.705 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.77000000000000002 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.6099999999999999 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 2.0699999999999998 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.72 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 4.0099999999999998 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 3.3999999999999999 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 3.0600000000000001 111.346 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.6699999999999999 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.46 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 4.3099999999999996 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.6200000000000001 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 3.1200000000000001 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 3.0499999999999998 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.562 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 3.0899999999999999 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.562 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo -66.49 0.22 3.69 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.3599999999999999 112.992 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.439 HD12 HG12 ' A' ' 169' ' ' VAL . 68.9 mt -77.8 15.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.43 -0.35 . . . . 3.7200000000000002 111.405 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -164.44 -34.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 9.25 110.917 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.65 -43.88 21.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 3.1000000000000001 111.398 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.56 -44.08 58.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 4.8899999999999997 110.994 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.6 p -80.93 6.86 12.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 4.2599999999999998 111.34 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.14 -23.99 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 6.1100000000000003 110.995 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -125.0 -27.85 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.337 -0.392 . . . . 3.3300000000000001 111.255 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -71.36 -166.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 4.2699999999999996 110.829 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -50.74 117.75 2.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.9399999999999999 111.135 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.3999999999999999 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.3700000000000001 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 3.27 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.02 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.6400000000000001 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 2.0899999999999999 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.6400000000000001 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.1499999999999999 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.8399999999999999 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.431 HD12 HD23 ' A' ' 216' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 2.3999999999999999 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 150' ' ' LEU . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.95 111.31 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.7 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 4.1100000000000003 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 2.4100000000000001 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 2.02 111.53 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 2.0299999999999998 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 2.5499999999999998 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.9399999999999999 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.427 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 2.3300000000000001 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.73999999999999999 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.542 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 2.6499999999999999 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.542 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 1.1100000000000001 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 2.4500000000000002 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.484 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.9299999999999999 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.9399999999999999 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.6099999999999999 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.9100000000000001 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.48 -161.5 17.99 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 2.1899999999999999 112.531 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.09 162.07 34.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.572 2.181 . . . . 3.46 111.906 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 56.6 18.39 3.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.405 . . . . 4.04 110.381 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.16 -82.45 0.16 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 4.4800000000000004 112.469 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -150.61 -21.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 8.6699999999999999 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -92.84 175.68 37.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.923 -0.656 . . . . 3.4300000000000002 112.749 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -135.54 86.86 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 6.8099999999999996 110.651 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.0 pt -134.58 157.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 3.5899999999999999 110.942 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.64 -4.22 5.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 3.3900000000000001 110.688 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.494 ' HG3' ' H ' ' A' ' 197' ' ' ILE . 50.5 tp60 -60.0 151.07 27.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.978 -0.555 . . . . 6.1100000000000003 110.924 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.9 p -73.06 -14.84 61.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.893 -0.594 . . . . 3.04 111.516 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.494 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 20.2 tt -54.61 -28.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 2.7999999999999998 111.491 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.85 -41.26 68.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.357 . . . . 2.6600000000000001 110.97 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 2.2200000000000002 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.96 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.6699999999999999 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.79 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.483 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 2.3900000000000001 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 2.2599999999999998 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.623 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.8799999999999999 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.623 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79000000000000004 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 2.2999999999999998 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 2.8100000000000001 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 2.0499999999999998 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . 0.465 ' HG2' ' HE2' ' A' ' 15' ' ' MET . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.6800000000000002 110.754 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 3.4100000000000001 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.3799999999999999 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 3.5600000000000001 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.8399999999999999 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 4.1299999999999999 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.431 HD23 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.77 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.9100000000000001 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.7599999999999998 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.5900000000000001 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -19.5 60.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 4.0099999999999998 110.916 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 59.23 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 6.3799999999999999 111.285 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -87.13 179.39 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.486 -0.324 . . . . 6.0700000000000003 110.977 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.65 116.1 16.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 6.6600000000000001 110.931 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -127.67 114.47 17.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 6.9900000000000002 111.031 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.73 129.07 35.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 6.9400000000000004 110.777 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.7 m -118.31 82.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 6.8300000000000001 110.97 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -93.22 112.31 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 11.49 110.962 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.32 -0.847 . . . . 9.4700000000000006 110.995 179.769 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.799 0.333 . . . . 9.0999999999999996 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -101.42 -2.05 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 7.2000000000000002 110.691 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.4 tp -99.07 87.61 3.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 6.7300000000000004 110.553 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -79.94 2.88 21.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.51 . . . . 5.4400000000000004 111.018 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m 59.8 -179.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 4.1299999999999999 110.897 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.438 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp -160.33 -26.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.6000000000000001 110.863 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.8799999999999999 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 2.1699999999999999 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1899999999999999 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.438 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 2.21 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 2.3500000000000001 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.418 HG23 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 1.48 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 1.51 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.82999999999999996 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.9299999999999999 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.8 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.465 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.79 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 1.3700000000000001 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.7599999999999998 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.6899999999999999 111.049 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.97 ' O ' ' OG ' ' B' ' 26' ' ' SER . 3.2 p90 -53.42 -33.16 52.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 5.1500000000000004 111.298 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -104.26 -20.78 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 4.1799999999999997 111.264 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 41.4 t -82.6 -57.33 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.958 0.355 . . . . 2.77 111.958 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.54 -0.45 42.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.372 0.508 . . . . 3.4900000000000002 112.372 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.97 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 37.8 m -55.34 -29.24 57.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.928 -0.709 . . . . 3.0299999999999998 110.739 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -43.99 -24.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.825 0.822 . . . . 6.4500000000000002 109.858 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.81 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.54 -153.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 114.26 -1.337 . . . . 5.3700000000000001 109.237 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.81 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 80.9 Cg_exo -1.91 115.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 124.418 3.412 . . . . 4.2999999999999998 117.292 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . 0.493 ' HD2' ' N ' ' B' ' 30' ' ' ARG . 8.5 mpt_? 42.76 35.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.711 -1.131 . . . . 8.5600000000000005 112.123 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 75.37 -50.68 2.45 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.633 -0.587 . . . . 4.6100000000000003 111.633 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.27 106.27 5.17 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-N 116.678 0.239 . . . . 5.4800000000000004 110.962 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.538 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 96.3 Cg_endo -85.12 116.52 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.19 1.26 . . . . 4.3899999999999997 112.482 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 9.8 tt0 -84.78 -25.55 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.844 0.831 . . . . 4.2999999999999998 109.503 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.485 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.56 -65.65 0.98 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.85 -1.523 . . . . 3.5899999999999999 114.012 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.485 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.5699999999999998 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.8799999999999999 112.191 -178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' B' ' 34' ' ' GLN . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 2.2200000000000002 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 2.5299999999999998 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.8999999999999999 110.803 179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.412 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.6200000000000001 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 2.3199999999999998 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.574 HG21 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 1.3899999999999999 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.80000000000000004 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.412 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 2.2200000000000002 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.521 ' HE1' HG21 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 2.5600000000000001 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.74 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.57999999999999996 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 1.4299999999999999 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 1.23 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.49 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.418 ' HB2' HG23 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.6299999999999999 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 1.1699999999999999 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 1.45 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.537 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 1.3600000000000001 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.463 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 2.02 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.622 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.1 tp60 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.71 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . 0.622 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.618 ' HB2' ' HZ2' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.8900000000000001 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 2.3500000000000001 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.1800000000000002 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.2599999999999998 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.79 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.52 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.6899999999999999 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 2.25 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.3999999999999999 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.567 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.23 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.414 ' CE2' HD12 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.8999999999999999 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.563 ' HA ' HD11 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 1.3100000000000001 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.71 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.471 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 2.6699999999999999 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.563 HD11 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 2.0 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . 0.471 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.6099999999999999 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.443 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.8300000000000001 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.474 ' O ' HD22 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.8899999999999999 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.574 HG23 HG21 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.6000000000000001 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.565 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 2.1200000000000001 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.3100000000000001 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.474 HD22 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 2.0800000000000001 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 2.21 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.568 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 2.3599999999999999 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.425 ' N ' HD13 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 2.5099999999999998 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.405 ' O ' HG22 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.72 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.464 ' HA ' ' HG1' ' B' ' 90' ' ' THR . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.78 111.125 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.73 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.8799999999999999 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.464 ' HG1' ' HA ' ' B' ' 87' ' ' LEU . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 2.1000000000000001 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.5 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 3.1499999999999999 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.444 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 3.1499999999999999 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . 0.444 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 5.0800000000000001 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 3.1899999999999999 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.402 ' HD3' ' HZ3' ' C' ' 96' ' ' LYS . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.6500000000000004 111.271 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.9699999999999998 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.2400000000000002 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 6.25 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.6200000000000001 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 3.0600000000000001 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.6899999999999999 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.53 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 3.6099999999999999 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.6699999999999999 111.084 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.411 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.7999999999999998 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 2.3100000000000001 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.5699999999999998 111.231 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.568 ' HG3' HD22 ' B' ' 84' ' ' LEU . 15.4 mm100 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 3.3799999999999999 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.526 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 2.6200000000000001 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 2.1699999999999999 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.6499999999999999 111.504 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.9500000000000002 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 1.21 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 1.1100000000000001 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.59999999999999998 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.422 HD13 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.98 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.422 HG13 HD13 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 2.0800000000000001 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.3100000000000001 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.71 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' SER . . . . . 0.474 ' HG ' ' HB2' ' B' ' 128' ' ' ARG . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 2.3300000000000001 110.721 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.8900000000000001 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.613 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 3.0800000000000001 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . 0.613 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.9699999999999998 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 2.0 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.474 ' HB2' ' HG ' ' B' ' 122' ' ' SER . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 3.0600000000000001 110.664 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 3.2200000000000002 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.6099999999999999 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.6699999999999999 111.173 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 2.5699999999999998 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 2.27 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.69999999999999996 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 2.0800000000000001 111.27 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 2.6499999999999999 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 1.51 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 2.3999999999999999 111.313 -179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.48 111.444 -179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 2.4500000000000002 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 3.3500000000000001 111.71 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.9299999999999999 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 5.0800000000000001 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.5900000000000001 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.6699999999999999 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 2.1099999999999999 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.521 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 3.0 t-20 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.79 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo -65.7 -4.51 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.3599999999999999 113.087 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.52 7.27 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 3.29 110.77 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -154.39 -32.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 8.9000000000000004 110.835 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.0 -37.76 23.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 2.8399999999999999 111.395 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.25 -51.65 7.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 4.96 110.917 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.581 ' HA ' ' HB2' ' B' ' 157' ' ' GLN . 9.7 t -69.67 -0.73 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 4.1699999999999999 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.42 -37.51 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 5.71 111.01 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 63.8 p -117.84 5.15 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 3.75 111.349 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.581 ' HB2' ' HA ' ' B' ' 154' ' ' THR . 28.7 mm-40 -102.8 -162.66 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.373 -0.376 . . . . 4.6299999999999999 110.913 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 55.2 m -55.91 115.85 2.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.076 -0.511 . . . . 3.1099999999999999 111.244 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m -78.12 -34.39 50.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 2.46 110.883 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 3.02 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 2.1499999999999999 111.691 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 3.25 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.77 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . 0.408 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.52 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.9399999999999999 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.7799999999999998 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.453 HD11 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 2.1499999999999999 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.453 ' N ' HD11 ' B' ' 168' ' ' LEU . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 2.2400000000000002 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.6699999999999999 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 4.1299999999999999 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 2.4700000000000002 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.98 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 2.1000000000000001 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 2.5800000000000001 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . 0.434 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.8700000000000001 110.545 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.499 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 2.0299999999999998 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.467 ' O ' HG23 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 2.5600000000000001 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.455 ' HG2' ' O ' ' B' ' 177' ' ' ILE . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 1.1799999999999999 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.499 HG12 ' O ' ' B' ' 177' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 2.1000000000000001 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.467 HG23 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.6499999999999999 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . 0.46 ' NE1' H163 ' B' ' 301' ' ' RET . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 3.1699999999999999 111.577 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.448 HG21 HG22 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 2.4100000000000001 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.448 HG22 HG21 ' B' ' 184' ' ' ILE . 34.8 pt -117.69 164.21 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 3.1200000000000001 111.4 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.67 -166.81 52.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.9 -0.667 . . . . 2.0600000000000001 112.724 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.93 163.62 27.66 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.692 2.261 . . . . 3.29 111.857 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 93.5 p 47.24 24.74 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 4.5 110.899 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.68 68.54 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.871 -0.68 . . . . 4.7000000000000002 112.446 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 56.7 t80 50.64 88.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.916 0.389 . . . . 8.4800000000000004 111.217 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.31 151.27 6.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.846 -0.693 . . . . 3.9300000000000002 112.222 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -128.51 39.29 3.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 7.3799999999999999 111.062 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.9 pt -96.54 140.01 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 3.6299999999999999 111.253 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -115.86 10.71 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 3.8599999999999999 110.576 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -66.57 138.78 57.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 6.2300000000000004 110.883 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -64.15 -14.92 58.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 2.8799999999999999 111.432 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 10.1 tp -56.41 -31.33 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 2.8300000000000001 111.218 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.4900000000000002 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 2.2799999999999998 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.9199999999999999 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.3500000000000001 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 2.8300000000000001 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.421 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 2.27 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.78 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 2.0600000000000001 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77000000000000002 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 2.4300000000000002 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 2.5899999999999999 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.45 ' HB2' HD12 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.9299999999999999 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.6499999999999999 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 3.1000000000000001 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.3899999999999999 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 3.0600000000000001 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.3500000000000001 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 4.3700000000000001 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 2.0 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 3.0899999999999999 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 4.1600000000000001 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.6699999999999999 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.412 HD23 ' N ' ' B' ' 221' ' ' LEU . 3.6 mm? -83.08 -31.03 27.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.9700000000000002 110.891 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 61.7 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 6.5700000000000003 111.23 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -87.84 154.13 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 5.9100000000000001 110.861 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . 0.426 ' N ' HD22 ' B' ' 224' ' ' LEU . 2.5 mm? -113.74 143.71 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 7.2599999999999998 110.624 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -161.25 132.41 5.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 7.5099999999999998 110.712 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.15 161.25 15.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 8.2100000000000009 110.946 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 83.2 p -153.85 140.99 19.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.493 . . . . 8.0999999999999996 111.127 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.35 -179.09 5.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 14.06 110.91 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.285 -0.864 . . . . 10.4 110.991 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 8.3499999999999996 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -158.21 -7.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 6.8499999999999996 110.817 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.6 3.11 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 6.6799999999999997 111.064 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.92 106.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 4.8200000000000003 111.171 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 47.5 t -66.19 145.52 55.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 3.5299999999999998 110.667 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.38 -1.94 18.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 3.2400000000000002 111.313 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.7599999999999998 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.534 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 2.3399999999999999 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.25 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.46 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.3799999999999999 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.5800000000000001 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 1.46 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 1.04 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.95 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 2.1400000000000001 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 2.3399999999999999 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 1.02 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.51 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.5800000000000001 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . 0.402 ' HE2' HD22 ' C' ' 25' ' ' LEU . 77.4 t60 -55.52 -19.71 10.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.5699999999999998 111.049 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.49 -30.19 69.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.446 . . . . 5.9299999999999997 111.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.457 ' O ' ' OG ' ' C' ' 26' ' ' SER . 88.7 t90 -97.18 -31.49 12.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 5.1600000000000001 111.41 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.5 t -64.89 -50.85 64.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 2.79 111.542 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.402 HD22 ' HE2' ' C' ' 21' ' ' HIS . 29.4 tp -87.89 -0.49 57.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 3.3700000000000001 111.561 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 77.8 p -53.56 -24.98 15.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.743 0.275 . . . . 2.7400000000000002 111.743 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -49.78 -30.24 9.23 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.28 0.562 . . . . 6.2800000000000002 109.881 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.5 p-10 -174.31 132.26 0.52 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 4.79 109.625 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 18.1 Cg_endo -90.79 143.43 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.508 2.138 . . . . 3.9199999999999999 112.487 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.58 22.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 9.3900000000000006 111.511 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' C' ' 29' ' ' PRO . . . 119.81 -4.06 13.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 4.2699999999999996 112.701 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.529 HG13 ' HB3' ' C' ' 36' ' ' GLU . 44.0 t -104.39 110.24 63.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.634 0.254 . . . . 5.5 110.931 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.496 ' HG2' ' HE1' ' C' ' 35' ' ' TYR . 6.5 Cg_exo -79.05 166.56 22.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.37 2.714 . . . . 3.6000000000000001 112.582 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.51 -44.17 2.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.033 0.753 . . . . 4.2699999999999996 113.033 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.496 ' HE1' ' HG2' ' C' ' 33' ' ' PRO . 12.2 p90 -64.79 -49.23 71.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.7799999999999998 112.313 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . 0.529 ' HB3' HG13 ' C' ' 32' ' ' VAL . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.7200000000000002 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . 0.407 ' HB2' HG11 ' C' ' 32' ' ' VAL . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.9800000000000004 110.109 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 2.4100000000000001 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 2.4300000000000002 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.8500000000000001 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.419 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.6299999999999999 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 2.29 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.581 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 1.3799999999999999 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.90000000000000002 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.434 HG21 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 2.27 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . 0.434 ' N ' HG21 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 2.2400000000000002 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.71 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.57999999999999996 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.8200000000000001 110.635 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 1.28 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 2.46 110.901 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.7 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.47 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 1.2 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.4099999999999999 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.534 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 1.3200000000000001 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.47 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.96 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.9399999999999999 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.511 HE21 ' H ' ' C' ' 59' ' ' GLY . 24.8 tp60 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 2.25 110.866 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.511 ' H ' HE21 ' C' ' 58' ' ' GLN . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 3.4300000000000002 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 2.5499999999999998 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.27 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.8500000000000001 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.6200000000000001 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 3.2599999999999998 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 2.2599999999999998 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.51 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . . . . . . . . . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.3999999999999999 110.809 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.8199999999999998 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 1.3899999999999999 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 2.3599999999999999 111.132 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.483 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 2.7000000000000002 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.8200000000000001 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.3300000000000001 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . 0.483 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 2.4100000000000001 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.409 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.9199999999999999 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.451 ' O ' HD21 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.79 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.581 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.97 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.565 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 2.2000000000000002 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.25 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.451 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.8300000000000001 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 2.1400000000000001 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 2.2400000000000002 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.6699999999999999 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.8 110.627 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 2.1200000000000001 110.645 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 2.29 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 4.0300000000000002 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 2.0699999999999998 110.998 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.47 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.8599999999999999 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.6299999999999999 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 5.46 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.8399999999999999 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . 0.402 ' HZ3' ' HD3' ' B' ' 96' ' ' LYS . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.8399999999999999 111.311 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.8600000000000003 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 6.0700000000000003 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.79 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 3.1499999999999999 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.8799999999999999 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.72 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 3.6200000000000001 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.8199999999999998 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.7000000000000002 110.894 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.54 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.569 HG22 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.8799999999999999 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.71 110.287 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.521 HG21 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 2.52 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 2.1699999999999999 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.5900000000000001 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 3.0299999999999998 110.515 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 1.3300000000000001 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 1.3100000000000001 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.65000000000000002 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 2.0299999999999998 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 2.23 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 1.4399999999999999 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.79 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' SER . . . . . 0.564 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.5499999999999998 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -74.47 -24.92 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.3100000000000001 110.965 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.471 ' HB2' HG11 ' C' ' 127' ' ' VAL . 90.7 mtt180 -118.37 135.61 54.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 3.52 110.767 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.12 -10.89 60.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 4.2400000000000002 110.719 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -81.23 -47.7 13.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 5.4500000000000002 110.828 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.471 HG11 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -70.94 -26.59 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.267 -0.424 . . . . 1.73 110.92 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . 0.564 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 3.3799999999999999 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 3.0 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 2.48 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.74 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 2.5699999999999998 110.901 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.7000000000000002 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 2.2000000000000002 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.72999999999999998 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 2.1000000000000001 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.76 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.9399999999999999 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.54 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 2.4700000000000002 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.569 HD13 HG22 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 3.0699999999999998 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.9399999999999999 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 4.5199999999999996 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.6499999999999999 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.9300000000000002 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.8599999999999999 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.549 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 7.1 t30 -89.07 -48.91 0.41 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.7000000000000002 112.402 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 35.2 Cg_endo -64.34 0.97 1.87 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.257 1.971 . . . . 2.46 113.122 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.59 23.13 0.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 3.46 111.576 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -171.93 -32.81 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.658 0.266 . . . . 9.1199999999999992 111.286 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.92 -39.93 23.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.851 0.315 . . . . 2.9700000000000002 111.851 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -83.87 -27.34 28.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.296 . . . . 4.8899999999999997 111.209 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.509 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 62.2 p -98.8 6.69 46.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 4.1500000000000004 111.35 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -53.42 -35.49 60.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 5.5800000000000001 111.562 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -133.13 10.3 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 3.5800000000000001 111.396 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 34.3 tt0 -87.24 -70.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.381 . . . . 4.1799999999999997 110.858 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 68.0 m -149.71 114.13 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 2.6800000000000002 110.669 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p -77.69 -38.59 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 3.1800000000000002 111.112 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.1800000000000002 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.9900000000000002 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 2.2400000000000002 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.3900000000000001 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.6499999999999999 110.888 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.6299999999999999 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . 0.441 ' HA ' ' HG1' ' C' ' 170' ' ' THR . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.9199999999999999 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.8 110.583 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . 0.462 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 170' ' ' THR . . . . . 0.441 ' HG1' ' HA ' ' C' ' 167' ' ' LYS . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 2.0299999999999998 111.031 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.8799999999999999 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . 0.462 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 2.3100000000000001 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 2.0 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 2.4199999999999999 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.7000000000000002 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.1100000000000001 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.442 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 2.3100000000000001 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.71999999999999997 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.583 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 2.71 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 1.0700000000000001 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.429 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 2.0800000000000001 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.427 HG23 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.71 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.8999999999999999 110.778 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 2.2000000000000002 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 3.23 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.27 -159.63 13.79 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.9099999999999999 112.752 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 171.43 18.21 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.622 2.215 . . . . 3.46 111.981 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.5 p 49.1 21.93 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.156 -0.475 . . . . 4.2199999999999998 110.721 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.02 -90.65 0.19 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.729 -0.669 . . . . 4.3499999999999996 112.333 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -135.83 -34.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 8.2400000000000002 110.829 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -79.89 168.43 52.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 3.6699999999999999 112.673 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -131.38 74.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 6.4900000000000002 110.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -128.35 146.56 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 3.1899999999999999 111.095 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -124.95 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 4.3399999999999999 111.238 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . 0.547 ' HG2' ' H ' ' C' ' 197' ' ' ILE . 52.9 tt0 -95.48 146.93 24.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.376 -0.375 . . . . 5.9900000000000002 110.747 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.5 p -65.93 -15.21 62.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.124 -0.489 . . . . 2.7999999999999998 111.751 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.547 ' H ' ' HG2' ' C' ' 195' ' ' GLN . 19.4 tt -57.49 -31.21 38.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 2.8599999999999999 110.76 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.6800000000000002 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 2.54 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.77 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 2.5299999999999998 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.8799999999999999 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.486 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 2.48 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.95 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.637 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.8700000000000001 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76000000000000001 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 2.3599999999999999 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 2.6200000000000001 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.9299999999999999 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.6600000000000001 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 3.1099999999999999 110.439 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.4099999999999999 111.844 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.77 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.8399999999999999 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 4.3399999999999999 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 2.25 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.54 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 4.0099999999999998 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -24.36 47.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.6400000000000001 110.841 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 59.72 -86.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.901 -0.59 . . . . 6.3799999999999999 111.305 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.15 -177.35 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 6.0899999999999999 110.639 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.524 HD23 ' H ' ' C' ' 224' ' ' LEU . 2.6 pt? -133.29 143.58 49.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.425 -0.352 . . . . 7.0099999999999998 111.054 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.14 134.53 17.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 6.7999999999999998 110.897 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.68 155.23 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 7.0499999999999998 110.669 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 63.3 m -151.59 109.2 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 6.8200000000000003 110.965 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -113.42 -179.69 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 10.17 110.65 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.121 -0.942 . . . . 9.4499999999999993 110.985 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.454 ' H10' ' NE1' ' A' ' 76' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.497 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.417 ' C16' ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.84 0.352 . . . . 8.5199999999999996 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -105.82 177.92 4.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 6.0999999999999996 110.773 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -167.7 15.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 6.6900000000000004 110.704 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 60.73 174.69 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.113 -0.494 . . . . 6.5199999999999996 111.013 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -161.48 117.19 2.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 3.77 111.02 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt -82.33 -3.79 56.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 3.8199999999999998 110.678 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 2.46 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.475 ' HE2' ' HG1' ' A' ' 199' ' ' THR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.9299999999999999 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 1.0800000000000001 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 2.4100000000000001 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 2.2599999999999998 109.981 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 1.5800000000000001 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 1.54 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.89000000000000001 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.8200000000000001 110.904 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.8500000000000001 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 2.23 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.95999999999999996 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 1.4099999999999999 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.5699999999999998 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.8799999999999999 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -62.99 -31.9 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.7999999999999998 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.697 ' O ' ' OG ' ' A' ' 26' ' ' SER . 73.5 t90 -64.52 -29.53 70.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 4.7999999999999998 110.264 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -66.57 -52.23 47.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 2.7799999999999998 110.522 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.74 -6.62 57.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 3.27 110.654 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.697 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 89.3 p -59.64 -16.17 24.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 2.52 111.068 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -48.16 -41.15 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.305 0.574 . . . . 6.0099999999999998 109.565 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -175.9 131.18 0.4 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.113 -0.948 . . . . 4.79 110.038 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -100.47 169.24 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.15 2.567 . . . . 3.3900000000000001 112.586 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -149.92 105.95 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 7.4100000000000001 111.154 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.54 -47.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 4.9800000000000004 113.414 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.28 114.44 10.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.827 0.313 . . . . 5.2199999999999998 111.68 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' TYR . 77.0 Cg_exo -51.46 169.82 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.853 2.369 . . . . 4.1299999999999999 112.144 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -37.23 -18.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 4.0199999999999996 112.968 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 3.1600000000000001 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.3900000000000001 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.5 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 2.1099999999999999 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.423 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.8999999999999999 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.48 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.5299999999999998 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 2.0499999999999998 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.472 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.74 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.68999999999999995 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 2.1699999999999999 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.47 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.9199999999999999 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.55000000000000004 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 HD23 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 1.6499999999999999 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 1.1399999999999999 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 2.4199999999999999 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.4099999999999999 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 1.0900000000000001 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 1.47 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 1.23 110.255 178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.8700000000000001 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.492 ' NE2' HG11 ' B' ' 127' ' ' VAL . 85.0 mm-40 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.3399999999999999 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 2.3100000000000001 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 2.48 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.6400000000000001 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 2.1200000000000001 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.54 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.2999999999999998 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 3.4199999999999999 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.8900000000000001 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 1.4299999999999999 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.588 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.1599999999999999 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.7999999999999998 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 1.29 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 3.3999999999999999 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.46 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 2.21 110.496 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.4199999999999999 109.515 178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.73 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.418 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.9399999999999999 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' O ' HD22 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.9099999999999999 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.422 HG22 HG21 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.8200000000000001 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 2.1099999999999999 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.26 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 2.1099999999999999 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.9099999999999999 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 2.2200000000000002 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 2.54 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.8600000000000001 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.9199999999999999 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 2.4700000000000002 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 3.0699999999999998 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 2.0099999999999998 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.7 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 3.0800000000000001 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.98 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 6.0499999999999998 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.4100000000000001 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.7000000000000002 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.9699999999999998 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.9399999999999999 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 6.96 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.7000000000000002 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 3.25 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 3.1099999999999999 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.5900000000000001 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 4.0300000000000002 111.072 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 2.4300000000000002 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.8100000000000001 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.4300000000000002 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.505 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.75 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 3.2200000000000002 111.213 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 2.3799999999999999 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 2.2200000000000002 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 3.2599999999999998 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.466 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 1.28 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 1.0900000000000001 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.488 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 2.1299999999999999 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.488 ' N ' HD11 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.6400000000000001 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.3400000000000001 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.8799999999999999 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 2.0099999999999998 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.6699999999999999 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.4900000000000002 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.6000000000000001 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.607 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 4.79 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.531 HG23 HD13 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.8600000000000001 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 3.23 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.4900000000000002 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.531 HD13 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 2.3700000000000001 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.96 111.041 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 2.6000000000000001 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.5699999999999998 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 2.2599999999999998 111.013 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.77000000000000002 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.6099999999999999 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 2.0699999999999998 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.72 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 4.0099999999999998 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 3.3999999999999999 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 3.0600000000000001 111.413 -179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.505 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.6699999999999999 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.46 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 4.3099999999999996 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.6200000000000001 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 3.1200000000000001 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 3.0499999999999998 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.545 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.3 t-20 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 3.0899999999999999 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo -63.1 -8.33 13.91 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.3599999999999999 112.994 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.58 36.49 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.727 0.299 . . . . 3.7200000000000002 111.183 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -146.55 -62.57 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 9.25 111.406 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.89 -44.82 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 3.1000000000000001 111.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -73.31 0.04 13.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 4.8899999999999997 111.643 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 81.1 p -104.89 -37.62 6.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 4.2599999999999998 111.586 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -69.49 -16.16 63.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 6.1100000000000003 111.171 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 74.4 p -91.02 -34.61 15.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.3300000000000001 111.233 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 -74.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 4.2699999999999996 111.065 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 116.07 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 2.9399999999999999 110.934 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.3999999999999999 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 3.27 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 2.02 111.342 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.6400000000000001 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 2.0899999999999999 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.6400000000000001 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.1499999999999999 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.8399999999999999 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 2.3999999999999999 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.95 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.7 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 4.1100000000000003 110.357 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 2.4100000000000001 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 2.02 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 2.0299999999999998 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 2.5499999999999998 111.149 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.9399999999999999 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 2.3300000000000001 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.417 ' O ' HG23 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.73999999999999999 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.577 ' HB3' H163 ' A' ' 301' ' ' RET . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 2.6499999999999999 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 1.1100000000000001 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.417 HG23 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 2.4500000000000002 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 185' ' ' ILE . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.9299999999999999 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.479 ' HE1' H161 ' A' ' 301' ' ' RET . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.9399999999999999 111.883 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.6099999999999999 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 189' ' ' GLY . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.9100000000000001 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.448 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 159.87 -179.65 35.28 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 2.1899999999999999 112.37 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.45 100.39 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.465 2.11 . . . . 3.46 112.032 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t 51.64 53.04 13.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.135 -0.484 . . . . 4.04 110.374 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.482 ' O ' HG13 ' A' ' 185' ' ' ILE . . . 132.44 -145.1 17.01 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.746 -0.661 . . . . 4.4800000000000004 111.541 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . 0.572 ' HB2' HD12 ' A' ' 193' ' ' ILE . 55.2 m-85 -56.36 169.57 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 8.6699999999999999 110.616 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.448 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -84.36 134.94 13.13 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.711 -0.757 . . . . 3.4300000000000002 112.916 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 55.18 56.58 6.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 6.8099999999999996 111.226 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 190' ' ' PHE . 22.3 pt -127.05 150.85 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 3.5899999999999999 111.091 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.12 -173.83 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 3.3900000000000001 110.924 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.97 -20.6 65.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 6.1100000000000003 110.948 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.1 m -63.37 -60.31 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.084 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.531 ' HB ' ' HB ' ' A' ' 193' ' ' ILE . 50.3 mm -68.82 -27.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 2.7999999999999998 111.126 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -47.27 -60.63 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 2.6600000000000001 111.133 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' THR . . . . . 0.475 ' HG1' ' HE2' ' A' ' 8' ' ' HIS . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 2.2200000000000002 111.217 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.96 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.6699999999999999 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.79 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.455 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 2.3900000000000001 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 2.2599999999999998 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.8799999999999999 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79000000000000004 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 2.2999999999999998 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 2.8100000000000001 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 2.0499999999999998 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.6800000000000002 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 3.4100000000000001 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.3799999999999999 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 3.5600000000000001 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.8399999999999999 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 4.1299999999999999 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.77 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.9100000000000001 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.7599999999999998 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.5900000000000001 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp -55.23 -28.88 56.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 4.0099999999999998 110.88 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -56.22 123.82 15.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 6.3799999999999999 111.123 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -148.98 -11.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 6.0700000000000003 110.388 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.6 mp 60.63 16.44 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.774 -0.648 . . . . 6.6600000000000001 111.329 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -172.46 76.52 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 6.9900000000000002 110.797 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.02 101.33 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.469 . . . . 6.9400000000000004 110.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.0 t -150.05 156.95 42.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 6.8300000000000001 110.903 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -102.43 99.37 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 11.49 110.896 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.253 -0.88 . . . . 9.4700000000000006 111.093 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.834 0.349 . . . . 9.0999999999999996 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -100.96 -175.88 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 7.2000000000000002 110.809 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.454 HD22 ' N ' ' B' ' 3' ' ' LEU . 2.1 pt? -166.15 41.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 6.7300000000000004 111.126 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 58.87 76.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 5.4400000000000004 110.789 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t -68.47 138.91 55.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 4.1299999999999999 111.1 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.401 HD12 HD23 ' B' ' 7' ' ' LEU . 2.2 pp -108.51 -4.87 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 3.6000000000000001 111.325 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.435 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.8799999999999999 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.53 ' HE2' HH22 ' B' ' 72' ' ' ARG . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 2.1699999999999999 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1899999999999999 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 2.21 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 2.3500000000000001 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 1.48 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 1.51 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.82999999999999996 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.9299999999999999 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.8 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.79 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 1.3700000000000001 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.7599999999999998 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.6899999999999999 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 -60.93 -39.06 87.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 5.1500000000000004 110.197 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . 0.651 ' O ' ' OG ' ' B' ' 26' ' ' SER . 85.5 t90 -58.9 -36.33 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 4.1799999999999997 110.436 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.5 t -64.2 -47.56 79.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 2.77 111.295 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.69 -7.23 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 3.4900000000000002 110.953 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.651 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 85.0 p -63.82 -14.24 51.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 3.0299999999999998 111.328 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -43.61 -45.55 6.83 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.415 -0.587 . . . . 6.4500000000000002 109.415 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.3 p30 178.51 129.21 0.21 Allowed Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.377 -0.829 . . . . 5.3700000000000001 110.781 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 71.3 Cg_endo -102.39 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.632 2.888 . . . . 4.2999999999999998 111.526 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -114.21 5.1 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.503 -0.925 . . . . 8.5600000000000005 108.503 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.511 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.73 -51.88 0.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.075 -1.42 . . . . 4.6100000000000003 110.993 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -142.38 107.34 5.62 Favored Pre-proline 0 C--N 1.332 -0.164 0 O-C-N 123.009 -0.112 . . . . 5.4800000000000004 110.901 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.481 ' HB2' ' HB2' ' B' ' 36' ' ' GLU . 85.3 Cg_endo -85.05 114.28 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 120.685 0.923 . . . . 4.3899999999999997 112.817 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -85.73 -31.4 22.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.299 1.047 . . . . 4.2999999999999998 109.033 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.513 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -82.58 -64.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 113.144 -1.844 . . . . 3.5899999999999999 113.185 -177.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.513 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.5699999999999998 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.401 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.8799999999999999 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 2.2200000000000002 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.416 HG11 ' O ' ' B' ' 35' ' ' TYR . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 2.5299999999999998 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.8999999999999999 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.6200000000000001 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 2.3199999999999998 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.678 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 1.3899999999999999 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.678 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.80000000000000004 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 2.2200000000000002 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.55 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 2.5600000000000001 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.74 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.57999999999999996 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.467 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 1.4299999999999999 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 1.23 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.49 111.363 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.467 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.6299999999999999 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 1.1699999999999999 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 1.45 110.23 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 1.3600000000000001 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 2.02 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.434 ' NE2' HG13 ' C' ' 127' ' ' VAL . 84.3 mm-40 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.71 110.904 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.8900000000000001 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 2.3500000000000001 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.1800000000000002 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.2599999999999998 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.79 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.52 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.6899999999999999 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 2.25 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.3999999999999999 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.446 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.23 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . 0.435 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.8999999999999999 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 1.3100000000000001 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.53 HH22 ' HE2' ' B' ' 8' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.71 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.409 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 2.6699999999999999 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.435 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 2.0 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.3100000000000001 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.6099999999999999 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.8300000000000001 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.8899999999999999 112.081 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.433 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.6000000000000001 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.598 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 2.1200000000000001 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.3100000000000001 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.545 ' HB3' HD13 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 2.0800000000000001 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.447 HD23 H203 ' B' ' 301' ' ' RET . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 2.21 110.207 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 2.3599999999999999 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 2.5099999999999998 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.72 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.73 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.8799999999999999 111.324 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 2.1000000000000001 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.5 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 3.1499999999999999 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 3.1499999999999999 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 5.0800000000000001 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 3.1899999999999999 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.6500000000000004 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.9699999999999998 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.2400000000000002 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 6.25 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' THR . . . . . 0.415 ' HG1' ' HG ' ' A' ' 38' ' ' LEU . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.6200000000000001 111.624 -179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 3.0600000000000001 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.6899999999999999 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.53 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 3.6099999999999999 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.6699999999999999 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.7999999999999998 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 2.3100000000000001 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.558 ' HB ' HD11 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.5699999999999998 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 3.3799999999999999 111.274 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 2.6200000000000001 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 2.1699999999999999 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.6499999999999999 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.463 HG21 HD23 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.9500000000000002 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.41 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 1.21 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 1.1100000000000001 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.496 ' HA2' ' H22' ' B' ' 301' ' ' RET . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.59999999999999998 112.701 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.463 HD23 HG21 ' B' ' 113' ' ' ILE . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.98 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.547 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 2.0800000000000001 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.3100000000000001 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.71 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' SER . . . . . 0.516 ' HG ' ' HB2' ' B' ' 128' ' ' ARG . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 2.3300000000000001 110.791 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.8900000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.45 ' HB2' HG13 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 3.0800000000000001 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.9699999999999998 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.492 HG11 ' NE2' ' A' ' 58' ' ' GLN . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 2.0 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.516 ' HB2' ' HG ' ' B' ' 122' ' ' SER . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 3.0600000000000001 110.729 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 3.2200000000000002 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.6099999999999999 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.6699999999999999 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 2.5699999999999998 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 2.27 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.432 ' SG ' HD23 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 2.2999999999999998 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.69999999999999996 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 2.0800000000000001 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 2.6499999999999999 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 1.51 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.3999999999999999 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.48 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 2.4500000000000002 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.558 HD11 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 3.3500000000000001 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.9299999999999999 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 5.0800000000000001 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.5900000000000001 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.6699999999999999 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 2.1099999999999999 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.581 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.4 t-20 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.79 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo -55.49 -24.64 45.06 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.3599999999999999 112.711 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 57.3 mt -96.8 59.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 3.29 110.911 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.443 HH21 ' ND2' ' B' ' 148' ' ' ASN . 38.0 ttp180 -165.85 -68.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.128 -0.487 . . . . 8.9000000000000004 111.093 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.85 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 2.8399999999999999 111.45 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -73.45 -15.61 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 4.96 111.024 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' B' ' 162' ' ' ALA . 74.2 p -96.85 -30.8 12.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 4.1699999999999999 111.0 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -64.63 -23.26 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 5.71 110.776 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.1 t -98.22 -21.96 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.508 . . . . 3.75 111.144 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -91.4 -73.77 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 4.6299999999999999 110.938 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.5 p -148.82 113.54 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 3.1099999999999999 110.881 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -72.09 -26.91 62.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 2.46 111.084 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 164' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 3.02 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . 0.428 ' HB3' ' HB ' ' B' ' 154' ' ' THR . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 2.1499999999999999 111.255 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 3.25 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . 0.41 HD13 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.77 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.52 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.7799999999999998 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 2.1499999999999999 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 2.2400000000000002 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.6699999999999999 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 4.1299999999999999 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 2.4700000000000002 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.98 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 2.1000000000000001 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 2.5800000000000001 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.8700000000000001 111.315 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.519 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 2.0299999999999998 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67000000000000004 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 2.5600000000000001 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 1.1799999999999999 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.519 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 2.1000000000000001 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.474 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.6499999999999999 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . 0.489 ' HE1' H161 ' B' ' 301' ' ' RET . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 3.1699999999999999 111.755 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 2.4100000000000001 111.602 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 2.4 pp -112.26 -172.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 3.1200000000000001 111.421 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.409 ' O ' ' HA3' ' B' ' 191' ' ' GLY . . . 84.15 -120.88 5.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.816 -0.707 . . . . 2.0600000000000001 112.443 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.641 ' HD3' HD12 ' B' ' 193' ' ' ILE . 89.4 Cg_endo -94.63 -174.0 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.916 2.41 . . . . 3.29 111.972 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 51.21 20.52 0.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.129 0.49 . . . . 4.5 110.34 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.05 19.21 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.6 -0.727 . . . . 4.7000000000000002 112.137 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.4 t80 60.19 94.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.951 0.405 . . . . 8.4800000000000004 110.95 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' B' ' 186' ' ' GLY . . . -139.79 -117.3 1.43 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.838 -0.696 . . . . 3.9300000000000002 112.311 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -123.86 14.78 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 7.3799999999999999 110.829 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.641 HD12 ' HD3' ' B' ' 187' ' ' PRO . 95.5 mt -117.66 139.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 3.6299999999999999 110.735 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.77 -174.98 4.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 3.8599999999999999 111.265 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.04 -23.29 64.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 6.2300000000000004 111.248 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 76.2 p -61.82 -65.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 2.8799999999999999 111.466 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . 0.535 ' HB ' HG22 ' B' ' 193' ' ' ILE . 86.2 mt -67.9 -25.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 2.8300000000000001 110.936 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.4900000000000002 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 2.2799999999999998 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.9199999999999999 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 2.3500000000000001 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 2.8300000000000001 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 2.27 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.78 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.567 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 2.0600000000000001 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77000000000000002 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG22 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 2.4300000000000002 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 2.5899999999999999 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.9299999999999999 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.6499999999999999 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . 0.423 HG22 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 3.1000000000000001 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.3899999999999999 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 3.0600000000000001 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.3500000000000001 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 4.3700000000000001 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 2.0 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.2200000000000002 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 3.0899999999999999 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 4.1600000000000001 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.38 -26.62 67.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.9700000000000002 110.817 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -80.14 106.54 12.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 6.5700000000000003 110.997 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -162.19 100.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 5.9100000000000001 110.909 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 81.6 mt 50.73 43.83 27.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 7.2599999999999998 110.911 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.2 t30 66.24 141.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.985 -0.552 . . . . 7.5099999999999998 110.861 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.5 123.36 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 8.2100000000000009 111.212 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 62.8 m -131.74 166.73 20.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 8.0999999999999996 110.755 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -132.56 78.33 1.79 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 14.06 111.057 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.24 -0.886 . . . . 10.4 110.965 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.875 0.369 . . . . 8.3499999999999996 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.18 111.71 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 6.8499999999999996 110.741 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 49.4 tp -78.17 132.97 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 6.6799999999999997 111.041 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.45 128.11 46.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 4.8200000000000003 110.784 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 34.4 t -83.32 152.16 25.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 3.5299999999999998 111.046 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.14 2.65 12.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 3.2400000000000002 111.223 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.7599999999999998 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.55 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 73.5 m-70 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 2.3399999999999999 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.403 ' O ' HG11 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.25 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.46 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 2.3799999999999999 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.403 HG11 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 1.46 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 1.04 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.453 ' HE2' ' HB3' ' C' ' 47' ' ' SER . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.95 110.222 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 2.1400000000000001 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.419 HD12 ' O ' ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 2.3399999999999999 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 1.02 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.51 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.5800000000000001 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -60.61 -43.76 97.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.5699999999999998 110.218 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -61.62 -29.5 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.066 -0.515 . . . . 5.9299999999999997 110.414 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.749 ' O ' ' OG ' ' C' ' 26' ' ' SER . 82.2 t90 -66.42 -31.0 71.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 5.1600000000000001 110.211 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -66.9 -46.84 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 2.79 110.692 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -84.78 -2.76 58.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 3.3700000000000001 110.394 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.749 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 66.8 p -71.19 -14.03 62.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 2.7400000000000002 110.505 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -40.94 -48.26 3.13 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.342 -0.614 . . . . 6.2800000000000002 109.342 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.431 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 2.5 p-10 179.14 128.86 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.28 -0.873 . . . . 4.79 110.736 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' C' ' 31' ' ' GLY . 60.1 Cg_endo -102.82 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.749 2.966 . . . . 3.9199999999999999 111.584 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -120.96 12.03 11.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.924 -0.769 . . . . 9.3900000000000006 108.924 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . 0.492 ' H ' ' HD2' ' C' ' 29' ' ' PRO . . . 119.78 -51.59 0.76 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 114.385 -1.28 . . . . 4.2699999999999996 111.002 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.81 108.1 5.94 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 122.994 -0.121 . . . . 5.5 110.816 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.469 ' HB2' ' HB2' ' C' ' 36' ' ' GLU . 90.9 Cg_endo -83.89 115.96 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 120.822 1.014 . . . . 3.6000000000000001 112.881 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -84.47 -25.79 28.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.215 1.007 . . . . 4.2699999999999996 108.547 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -82.71 -62.16 1.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.255 -1.793 . . . . 3.7799999999999998 112.988 -177.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . 0.469 ' HB2' ' HB2' ' C' ' 33' ' ' PRO . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.7200000000000002 112.679 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.9800000000000004 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 2.4100000000000001 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 2.4300000000000002 113.15 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.8500000000000001 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.6299999999999999 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 2.29 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.633 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 1.3799999999999999 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.90000000000000002 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 2.27 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 2.2400000000000002 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.453 ' HB3' ' HE2' ' C' ' 15' ' ' MET . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.71 111.69 -179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.57999999999999996 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 138' ' ' ALA . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.8200000000000001 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 1.28 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 2.46 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.7 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 1.2 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.4099999999999999 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 1.3200000000000001 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . 0.422 HG23 ' O ' ' C' ' 56' ' ' ILE . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.96 110.81 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 2.25 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 3.4300000000000002 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 2.5499999999999998 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.27 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.8500000000000001 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.6200000000000001 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 3.2599999999999998 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 2.2599999999999998 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.51 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.571 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.3999999999999999 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.8199999999999998 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.406 ' O ' HG21 ' C' ' 74' ' ' ILE . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 1.3899999999999999 112.121 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.571 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 2.3599999999999999 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 2.7000000000000002 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.406 HG21 ' O ' ' C' ' 71' ' ' ALA . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.8200000000000001 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.3300000000000001 109.38 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 2.4100000000000001 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.9199999999999999 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.79 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.97 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 2.2000000000000002 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.25 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.426 HD21 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.8300000000000001 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 2.1400000000000001 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 2.2400000000000002 110.767 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.6699999999999999 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.8 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.597 HD23 HD13 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 2.1200000000000001 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 2.29 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 4.0300000000000002 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 2.0699999999999998 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.47 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' MET . . . . . 0.471 ' HE3' HD13 ' C' ' 102' ' ' ILE . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.8599999999999999 110.907 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.6299999999999999 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 5.46 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.8399999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.8399999999999999 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.8600000000000003 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 6.0700000000000003 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.79 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 3.1499999999999999 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.471 HD13 ' HE3' ' C' ' 92' ' ' MET . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.8799999999999999 110.697 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.72 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 3.6200000000000001 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.8199999999999998 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.7000000000000002 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.54 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.431 ' HB ' HG22 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.8799999999999999 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.461 HE22 ' HE1' ' C' ' 176' ' ' TRP . 14.7 mm100 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.71 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.55 HG23 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 2.52 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 2.1699999999999999 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.5900000000000001 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 3.0299999999999998 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 1.3300000000000001 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 1.3100000000000001 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.65000000000000002 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.467 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 2.0299999999999998 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.436 HG12 HD13 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 2.23 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 1.4399999999999999 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.79 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.5499999999999998 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.91 -30.27 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.3100000000000001 111.038 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.483 ' HB2' HG12 ' C' ' 127' ' ' VAL . 96.3 mtt180 -109.7 141.58 42.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 3.52 110.702 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.22 -10.8 59.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.302 -0.408 . . . . 4.2400000000000002 110.744 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -87.61 -35.53 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 5.4500000000000002 110.674 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.527 ' HA ' HD23 ' C' ' 130' ' ' LEU . 8.5 p -81.17 -23.71 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.531 . . . . 1.73 110.869 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 3.3799999999999999 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 3.0 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.527 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 2.48 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.74 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 2.5699999999999998 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.7000000000000002 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 2.2000000000000002 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.72999999999999998 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 2.1000000000000001 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.76 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.51 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.9399999999999999 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.54 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 2.4700000000000002 111.568 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.431 HG22 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 3.0699999999999998 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.9399999999999999 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 4.5199999999999996 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.6499999999999999 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.9300000000000002 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.8599999999999999 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.551 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 8.0 t30 -53.84 -48.81 92.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.7000000000000002 112.02 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 73.8 Cg_exo -51.22 -39.5 61.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.284 1.99 . . . . 2.46 112.733 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.98 54.51 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 3.46 110.937 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -163.66 -70.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 9.1199999999999992 110.937 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.81 -40.16 20.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 2.9700000000000002 111.384 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . 0.489 ' HD2' ' HA ' ' C' ' 149' ' ' PRO . 67.9 mttm -75.43 -8.66 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 4.8899999999999997 110.985 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.43 ' HB ' ' HB1' ' C' ' 162' ' ' ALA . 39.9 p -105.72 -28.26 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 4.1500000000000004 111.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.96 -18.46 63.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.358 -0.383 . . . . 5.5800000000000001 110.793 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 43.2 p -100.48 -21.52 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 3.5800000000000001 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.06 -70.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 4.1799999999999997 110.937 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 36.5 t -146.43 115.82 7.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 2.6800000000000002 110.842 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m -77.1 -28.88 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.47 . . . . 3.1800000000000002 111.101 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.1800000000000002 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.9900000000000002 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . 0.43 ' HB1' ' HB ' ' C' ' 154' ' ' THR . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 2.2400000000000002 111.193 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.3900000000000001 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.6499999999999999 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.6299999999999999 110.969 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.2599999999999998 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.9199999999999999 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.597 HD13 HD23 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.8 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 2.21 111.336 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 2.0299999999999998 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.8799999999999999 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 2.3100000000000001 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 2.0 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 2.4199999999999999 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.411 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.7000000000000002 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . 0.461 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.1100000000000001 111.457 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 2.3100000000000001 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 113.143 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.53 ' HB3' H162 ' C' ' 301' ' ' RET . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 2.71 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 1.0700000000000001 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.421 ' O ' HG21 ' C' ' 185' ' ' ILE . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 2.0800000000000001 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.447 ' HA ' HG12 ' C' ' 185' ' ' ILE . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.71 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.608 ' HE1' H163 ' C' ' 301' ' ' RET . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.8999999999999999 111.966 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 2.2000000000000002 112.751 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 3.23 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.78 43.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.9099999999999999 112.639 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 95.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.651 2.234 . . . . 3.46 112.35 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 81.1 p 46.79 35.17 2.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.137 -0.483 . . . . 4.2199999999999998 111.038 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.81 -139.34 2.98 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.587 -0.816 . . . . 4.3499999999999996 112.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -78.98 -69.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 8.2400000000000002 111.319 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.45 124.23 0.89 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.969 -0.634 . . . . 3.6699999999999999 112.328 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 56.45 23.38 7.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 6.4900000000000002 110.7 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.473 HG23 HG22 ' C' ' 197' ' ' ILE . 2.0 pp -90.94 167.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 3.1899999999999999 111.097 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -107.9 -166.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 4.3399999999999999 111.178 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -59.44 -30.14 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 5.9900000000000002 111.407 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 97.2 m -58.34 -65.54 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 2.7999999999999998 111.473 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.473 HG22 HG23 ' C' ' 193' ' ' ILE . 3.7 mp -65.51 -25.47 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 2.8599999999999999 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.6800000000000002 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 2.54 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . 0.403 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.77 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 2.5299999999999998 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.8799999999999999 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 2.48 110.407 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.95 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.666 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.8700000000000001 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.666 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76000000000000001 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 2.3599999999999999 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 2.6200000000000001 110.148 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.411 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.9299999999999999 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.6600000000000001 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . 0.41 HG21 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 3.1099999999999999 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.41 ' N ' HG21 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.4099999999999999 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.77 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.8399999999999999 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 4.3399999999999999 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 2.25 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2000000000000002 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.54 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 4.0099999999999998 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.58 -18.09 65.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.6400000000000001 111.247 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -69.28 99.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 6.3799999999999999 111.13 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -126.42 179.13 5.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 6.0899999999999999 110.813 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.18 -60.83 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 7.0099999999999998 110.929 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -143.33 131.19 21.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 6.7999999999999998 110.96 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.63 108.31 20.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 7.0499999999999998 110.704 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -104.71 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 6.8200000000000003 110.906 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -142.24 31.94 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 10.17 110.79 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.377 -0.821 . . . . 9.4499999999999993 110.842 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.577 H163 ' HB3' ' A' ' 179' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.511 ' H8 ' H173 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.608 H163 ' HE1' ' C' ' 183' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.611 0.243 . . . . 8.5199999999999996 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.4 t30 62.39 106.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.134 -0.485 . . . . 6.0999999999999996 111.322 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.2 146.55 23.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 6.6900000000000004 110.839 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -100.43 165.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.505 . . . . 6.5199999999999996 111.0 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -167.19 168.63 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 3.77 110.651 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -133.28 11.84 4.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.357 -0.383 . . . . 3.8199999999999998 111.011 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 2.46 110.778 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.3 m-70 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.9299999999999999 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 1.0800000000000001 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 2.4100000000000001 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 2.2599999999999998 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 1.5800000000000001 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 1.54 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.89000000000000001 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.8200000000000001 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.8500000000000001 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 2.23 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.449 ' N ' HD13 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.95999999999999996 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 1.4099999999999999 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.5699999999999998 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.8799999999999999 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.4 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 -70.07 -31.07 68.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.7999999999999998 111.07 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.579 ' O ' ' OG ' ' A' ' 26' ' ' SER . 82.9 t90 -81.1 -31.67 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 4.7999999999999998 110.94 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m -62.45 -42.05 99.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 2.7799999999999998 110.724 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.2 -1.09 57.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 3.27 111.397 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.579 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 86.3 p -58.86 -20.82 54.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.513 -0.312 . . . . 2.52 111.173 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -49.86 -31.34 11.82 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.29 0.567 . . . . 6.0099999999999998 109.639 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -176.13 132.12 0.4 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.071 -0.968 . . . . 4.79 109.713 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.1 Cg_endo -92.5 122.96 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.652 2.234 . . . . 3.3900000000000001 112.316 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -108.35 101.68 10.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 7.4100000000000001 111.223 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.98 -44.85 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 4.9800000000000004 112.763 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 32' ' ' VAL . 27.7 m -99.19 112.98 64.33 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.987 0.422 . . . . 5.2199999999999998 111.425 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 7.1 Cg_exo -78.53 167.61 22.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.306 2.671 . . . . 4.1299999999999999 112.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 -42.69 -42.24 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.012 0.375 . . . . 4.0199999999999996 112.012 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 3.1600000000000001 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.3900000000000001 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.5 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' B' ' 104' ' ' PHE . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 2.1099999999999999 110.929 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.8999999999999999 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.48 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.5299999999999998 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 2.0499999999999998 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.74 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.68999999999999995 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 2.1699999999999999 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.47 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.9199999999999999 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.55000000000000004 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 1.6499999999999999 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 1.1399999999999999 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 2.4199999999999999 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.4099999999999999 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 1.0900000000000001 110.868 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 1.47 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 1.23 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.8700000000000001 110.698 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.3399999999999999 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.554 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 2.3100000000000001 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 2.48 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.6400000000000001 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 2.1200000000000001 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.54 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.2999999999999998 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.615 HE21 ' H ' ' A' ' 67' ' ' ILE . 25.0 tp60 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 3.4199999999999999 110.996 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.615 ' H ' HE21 ' A' ' 66' ' ' GLN . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.8900000000000001 111.123 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 111.128 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.1599999999999999 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.7999999999999998 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 1.29 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.579 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 3.3999999999999999 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.46 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 2.21 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.4199999999999999 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.419 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.73 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.9399999999999999 111.007 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.415 ' O ' HD21 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.9099999999999999 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.8200000000000001 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.608 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 2.1099999999999999 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.608 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.26 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 2.1099999999999999 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.9099999999999999 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 2.2200000000000002 110.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 2.54 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.8600000000000001 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.9199999999999999 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 2.4700000000000002 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 3.0699999999999998 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 2.0099999999999998 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.465 ' HB1' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.7 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 3.0800000000000001 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.98 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 6.0499999999999998 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.4100000000000001 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.7000000000000002 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.9699999999999998 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.9399999999999999 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 6.96 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.7000000000000002 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 3.25 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 3.1099999999999999 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.5900000000000001 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 4.0300000000000002 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 2.4300000000000002 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . 0.421 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.8100000000000001 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.4300000000000002 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.479 ' HG1' HG23 ' A' ' 142' ' ' ILE . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.75 111.828 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.509 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 3.8 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 3.2200000000000002 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 2.3799999999999999 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 2.2200000000000002 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.6499999999999999 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 3.2599999999999998 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 1.28 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' SER . . . . . 0.481 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 1.0900000000000001 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 2.1299999999999999 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.6400000000000001 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.3400000000000001 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.8799999999999999 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 2.0099999999999998 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.6699999999999999 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.4900000000000002 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG13 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.6000000000000001 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 4.79 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.8600000000000001 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 3.23 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.4900000000000002 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 2.3700000000000001 110.598 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.545 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.96 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 2.6000000000000001 110.701 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.5699999999999998 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 2.2599999999999998 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.77000000000000002 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.6099999999999999 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD13 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 2.0699999999999998 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.72 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.421 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 4.0099999999999998 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 3.3999999999999999 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.443 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 3.0600000000000001 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.479 HG23 ' HG1' ' A' ' 108' ' ' THR . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.6699999999999999 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.46 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 4.3099999999999996 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.6200000000000001 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 3.1200000000000001 111.371 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 3.0499999999999998 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.563 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 3.0 t-20 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 3.0899999999999999 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo -59.04 -1.18 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.3599999999999999 113.327 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 96.1 mt -58.99 89.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.664 0.268 . . . . 3.7200000000000002 111.164 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.405 ' HA ' ' NE ' ' A' ' 151' ' ' ARG . 3.5 mmp_? 52.14 43.96 30.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.236 -0.438 . . . . 9.25 111.143 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.67 -46.6 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 3.1000000000000001 111.427 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.26 -33.0 72.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 4.8899999999999997 111.109 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.631 ' HG1' ' HB3' ' A' ' 157' ' ' GLN . 9.3 t -93.8 6.31 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 4.2599999999999998 111.046 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -63.87 -20.56 65.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 6.1100000000000003 110.968 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.4 p -99.92 -10.85 21.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 3.3300000000000001 111.302 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.631 ' HB3' ' HG1' ' A' ' 154' ' ' THR . 54.1 tt0 -87.32 -51.93 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 4.2699999999999996 110.93 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m -141.31 114.2 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 2.9399999999999999 111.033 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.3999999999999999 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.3700000000000001 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 3.27 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 2.02 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.6400000000000001 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.493 HD11 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 2.0899999999999999 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.493 ' N ' HD11 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.6400000000000001 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.8399999999999999 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.465 HD22 ' HB1' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 2.3999999999999999 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.95 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.7 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.451 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 4.1100000000000003 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 2.4100000000000001 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 2.02 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 2.0299999999999998 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 2.5499999999999998 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.496 ' HA ' H191 ' A' ' 301' ' ' RET . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.9399999999999999 111.538 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 2.3300000000000001 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.456 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.73999999999999999 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.513 ' N ' ' HD2' ' A' ' 180' ' ' PRO . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 2.6499999999999999 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 1.1100000000000001 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.447 HG23 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 2.4500000000000002 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 178' ' ' GLY . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.9299999999999999 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.415 ' N ' HG22 ' A' ' 182' ' ' VAL . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.9399999999999999 112.76 -178.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.6099999999999999 112.148 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.595 HG13 ' HD2' ' A' ' 187' ' ' PRO . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.9100000000000001 112.468 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.633 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . 134.35 -55.35 0.74 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 2.1899999999999999 113.18 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.595 ' HD2' HG13 ' A' ' 185' ' ' ILE . 56.1 Cg_exo -32.83 146.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.496 2.798 . . . . 3.46 112.983 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.6 t 63.97 12.01 6.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.719 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.89 -88.62 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.494 -0.775 . . . . 4.4800000000000004 112.187 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -158.71 85.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 8.6699999999999999 110.818 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.633 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -143.76 -73.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.855 -0.688 . . . . 3.4300000000000002 112.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -145.35 -46.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 6.8099999999999996 110.634 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.15 148.29 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 3.5899999999999999 110.632 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -162.05 16.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.605 0.241 . . . . 3.3900000000000001 111.493 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.79 -165.57 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.579 -0.282 . . . . 6.1100000000000003 111.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.7 t -59.53 -15.27 17.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 3.04 111.074 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.3 mm -58.65 -34.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 2.7999999999999998 111.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.5 -52.45 46.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 2.6600000000000001 110.764 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 2.2200000000000002 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.96 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.6699999999999999 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.79 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 2.3900000000000001 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 2.2599999999999998 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.664 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.8799999999999999 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.664 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79000000000000004 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 2.2999999999999998 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 2.8100000000000001 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 2.0499999999999998 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.6800000000000002 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 3.4100000000000001 111.073 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.3799999999999999 112.196 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 3.5600000000000001 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.8399999999999999 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 4.1299999999999999 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.77 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.4399999999999999 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.9100000000000001 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.7599999999999998 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.5900000000000001 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 4.0099999999999998 111.135 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 52.3 85.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 6.3799999999999999 111.226 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -64.18 162.19 14.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 6.0700000000000003 111.094 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.73 -20.67 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 6.6600000000000001 110.868 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -161.32 150.95 16.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 6.9900000000000002 110.885 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -157.96 -76.81 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 6.9400000000000004 110.995 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t 54.92 82.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 6.8300000000000001 110.893 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -82.32 -66.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 11.49 110.813 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.152 -0.928 . . . . 9.4700000000000006 110.933 -179.849 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.787 0.327 . . . . 9.0999999999999996 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -123.39 115.12 21.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 7.2000000000000002 110.973 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.44 -59.86 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 6.7300000000000004 110.73 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -168.07 120.74 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 5.4400000000000004 110.87 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.476 ' C ' ' H ' ' B' ' 7' ' ' LEU . 50.3 m -91.01 -52.69 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 4.1299999999999999 111.011 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 29.0 tp 72.73 -30.35 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.843 -0.617 . . . . 3.6000000000000001 111.698 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.476 ' H ' ' C ' ' B' ' 5' ' ' SER . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.8799999999999999 110.95 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 2.1699999999999999 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1899999999999999 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 2.21 110.315 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.47 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 2.3500000000000001 110.688 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 1.48 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 1.51 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.82999999999999996 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' MET . . . . . 0.593 ' HA ' ' HE3' ' B' ' 15' ' ' MET . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.9299999999999999 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.8 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.418 HD11 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.418 ' N ' HD11 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 1.3700000000000001 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.7599999999999998 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.6899999999999999 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.814 ' O ' ' OG ' ' B' ' 26' ' ' SER . 0.2 OUTLIER -71.9 -34.13 68.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 5.1500000000000004 110.464 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -70.04 -36.11 74.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 4.1799999999999997 111.033 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -85.62 -38.06 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.622 0.601 . . . . 2.77 112.622 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 tp -85.09 -0.67 55.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.147 0.425 . . . . 3.4900000000000002 112.147 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.814 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 19.0 m -61.38 -28.89 69.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.713 -0.795 . . . . 3.0299999999999998 111.07 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -44.56 -23.91 0.15 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.84 0.829 . . . . 6.4500000000000002 109.829 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.824 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 1.2 m-20 -66.31 -154.03 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 114.094 -1.412 . . . . 5.3700000000000001 108.955 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.824 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 58.6 Cg_exo -2.05 115.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 124.394 3.396 . . . . 4.2999999999999998 117.174 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 42.5 35.29 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.605 -1.18 . . . . 8.5600000000000005 112.076 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 74.97 -50.6 2.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.623 -0.591 . . . . 4.6100000000000003 111.623 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.0 p -143.08 107.27 5.29 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.925 0.362 . . . . 5.4800000000000004 111.186 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.404 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 93.3 Cg_endo -84.5 116.17 1.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 120.969 1.113 . . . . 4.3899999999999997 112.125 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.37 -25.44 29.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.067 0.937 . . . . 4.2999999999999998 109.941 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.637 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER -83.25 -65.79 0.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.829 -1.532 . . . . 3.5899999999999999 114.514 -176.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.547 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.5699999999999998 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.434 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.8799999999999999 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 2.2200000000000002 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 2.5299999999999998 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . 0.434 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.8999999999999999 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.6200000000000001 110.159 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 2.3199999999999998 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.434 HG21 HG22 ' B' ' 79' ' ' THR . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 1.3899999999999999 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.416 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.80000000000000004 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 2.2200000000000002 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 2.5600000000000001 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.4 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.74 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . 0.45 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.57999999999999996 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.413 HD21 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 1.4299999999999999 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 1.23 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.49 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.6299999999999999 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 1.1699999999999999 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 1.45 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 1.3600000000000001 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.523 HG23 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 2.02 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.71 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.8900000000000001 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 2.3500000000000001 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.1800000000000002 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.2599999999999998 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.79 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.52 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.6899999999999999 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 2.25 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.3999999999999999 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.584 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.23 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.8999999999999999 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.454 ' O ' HG21 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 1.3100000000000001 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.584 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.71 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.455 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 2.6699999999999999 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.454 HG21 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 2.0 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.4 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.3100000000000001 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . 0.455 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.6099999999999999 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.467 ' HE3' HG22 ' B' ' 113' ' ' ILE . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.8300000000000001 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.428 ' O ' HD22 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.8899999999999999 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.434 HG22 HG21 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.6000000000000001 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 2.1200000000000001 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.3100000000000001 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.428 HD22 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 2.0800000000000001 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 2.21 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.507 HD11 HD13 ' B' ' 105' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 2.3599999999999999 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.425 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 2.5099999999999998 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.72 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.78 110.276 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.73 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . 0.637 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.8799999999999999 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 2.1000000000000001 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.5 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 3.1499999999999999 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 3.1499999999999999 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 5.0800000000000001 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 3.1899999999999999 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.6500000000000004 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.9699999999999998 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.2400000000000002 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 6.25 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.6200000000000001 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 3.0600000000000001 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.6899999999999999 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.53 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.42 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 3.6099999999999999 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.507 HD13 HD11 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.6699999999999999 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' MET . . . . . 0.42 ' N ' HD11 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.7999999999999998 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 2.3100000000000001 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.424 ' HB ' HD12 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.5699999999999998 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.564 HE21 HD12 ' B' ' 113' ' ' ILE . 57.7 tp60 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 3.3799999999999999 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.41 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 2.6200000000000001 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 2.1699999999999999 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.6499999999999999 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.564 HD12 HE21 ' B' ' 109' ' ' GLN . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.9500000000000002 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 1.21 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 1.1100000000000001 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.59999999999999998 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.49 HD23 HG22 ' B' ' 113' ' ' ILE . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.98 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.547 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 2.0800000000000001 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.3100000000000001 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.547 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.71 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 2.3300000000000001 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.8900000000000001 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.51 ' HB2' HG11 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 3.0800000000000001 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.9699999999999998 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.51 HG11 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 2.0 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 3.0600000000000001 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 3.2200000000000002 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.6099999999999999 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.6699999999999999 110.695 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 2.5699999999999998 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 2.27 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 2.2999999999999998 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.69999999999999996 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 2.0800000000000001 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 2.6499999999999999 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 1.51 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 2.3999999999999999 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.48 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 2.4500000000000002 111.739 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.424 HD12 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 3.3500000000000001 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.9299999999999999 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 5.0800000000000001 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.5900000000000001 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.42 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.6699999999999999 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 2.1099999999999999 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.59 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.79 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo -62.61 0.46 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.3599999999999999 113.303 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.47 HD23 HG23 ' B' ' 169' ' ' VAL . 94.5 mt -58.87 92.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 3.29 111.049 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 52.63 46.28 27.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 8.9000000000000004 111.071 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.42 -51.15 12.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 2.8399999999999999 111.215 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -72.78 -29.69 63.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 4.96 110.781 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 71.6 p -90.65 4.98 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 4.1699999999999999 110.991 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -64.91 -36.34 84.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 5.71 110.696 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 17.52 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 3.75 110.923 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -108.99 -69.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 4.6299999999999999 110.674 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.2 t -130.35 114.55 15.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 3.1099999999999999 110.813 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p -73.1 -30.85 63.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 2.46 110.979 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 3.02 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 2.1499999999999999 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 3.25 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.77 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.52 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.9399999999999999 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.7799999999999998 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.47 HG23 HD23 ' B' ' 150' ' ' LEU . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 2.2400000000000002 111.142 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.6699999999999999 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 4.1299999999999999 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 2.4700000000000002 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.98 111.442 -179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 2.1000000000000001 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 2.5800000000000001 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.8700000000000001 110.761 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.438 ' C ' ' HD2' ' B' ' 180' ' ' PRO . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 2.0299999999999998 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.464 ' O ' HG23 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 2.5600000000000001 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 1.1799999999999999 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.464 HG23 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 2.1000000000000001 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.487 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.6499999999999999 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . 0.487 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 3.1699999999999999 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 2.4100000000000001 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 26.8 pt -61.31 -26.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 3.1200000000000001 111.279 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.4 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . -166.54 -171.56 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.684 -0.77 . . . . 2.0600000000000001 112.537 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.81 83.74 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.517 2.144 . . . . 3.29 112.186 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 55.0 m 55.84 57.39 5.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 4.5 110.969 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . 0.463 ' HA3' HD13 ' B' ' 193' ' ' ILE . . . 158.12 -164.34 33.28 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.585 -0.816 . . . . 4.7000000000000002 112.735 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . 0.581 ' H ' HD13 ' B' ' 193' ' ' ILE . 86.9 m-85 -52.31 -60.71 2.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.68 0.276 . . . . 8.4800000000000004 111.402 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . 0.4 ' HA2' ' HA3' ' B' ' 186' ' ' GLY . . . 167.16 135.19 1.82 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.657 -0.782 . . . . 3.9300000000000002 112.406 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 96.0 m95 58.08 22.79 9.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 7.3799999999999999 111.202 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.581 HD13 ' H ' ' B' ' 190' ' ' PHE . 30.2 pt -115.71 144.77 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 3.6299999999999999 111.322 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -138.62 -139.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 3.8599999999999999 110.642 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 63.96 -163.23 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.537 -0.301 . . . . 6.2300000000000004 111.184 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 6.2 t -63.73 -15.52 58.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 2.8799999999999999 111.61 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . 0.423 HD11 ' N ' ' B' ' 197' ' ' ILE . 3.0 mp -57.92 -29.53 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 2.8300000000000001 111.386 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.4900000000000002 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 2.2799999999999998 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.9199999999999999 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.3500000000000001 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 2.8300000000000001 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.451 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 2.27 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.78 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.525 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 2.0600000000000001 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.525 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77000000000000002 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 2.4300000000000002 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 2.5899999999999999 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.537 ' HG ' ' HD2' ' B' ' 210' ' ' LYS . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.9299999999999999 110.874 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . 0.537 ' HD2' ' HG ' ' B' ' 209' ' ' SER . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.6499999999999999 111.022 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 3.1000000000000001 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.3899999999999999 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 3.0600000000000001 110.796 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.3500000000000001 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 4.3700000000000001 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 2.0 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.2200000000000002 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.436 HD11 ' ND2' ' B' ' 28' ' ' ASN . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 3.0899999999999999 111.369 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 4.1600000000000001 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.6699999999999999 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.79 -58.61 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.9700000000000002 111.085 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 57.02 88.51 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.259 -0.428 . . . . 6.5700000000000003 111.005 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -61.16 139.05 58.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 5.9100000000000001 111.099 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.45 20.8 2.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 7.2599999999999998 110.742 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -128.58 -74.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.959 -0.564 . . . . 7.5099999999999998 110.806 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 56.12 93.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.004 0.43 . . . . 8.2100000000000009 111.144 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -149.11 76.47 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.559 . . . . 8.0999999999999996 110.771 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -62.71 174.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 14.06 111.158 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.172 -0.918 . . . . 10.4 110.99 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.747 0.308 . . . . 8.3499999999999996 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -106.54 159.0 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 6.8499999999999996 111.017 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 66.6 tp -131.8 129.89 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 6.6799999999999997 110.925 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.78 136.15 33.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 4.8200000000000003 111.023 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.469 ' HB2' HD22 ' C' ' 7' ' ' LEU . 81.2 p -141.81 139.83 32.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 3.5299999999999998 110.831 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.25 9.63 33.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.433 . . . . 3.2400000000000002 111.087 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.469 HD22 ' HB2' ' C' ' 5' ' ' SER . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.7599999999999998 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.604 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 2.3399999999999999 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.25 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.46 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 2.3799999999999999 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.5800000000000001 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 1.46 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 1.04 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.95 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 2.1400000000000001 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . 0.48 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 2.3399999999999999 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . 0.48 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 1.02 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.51 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.5800000000000001 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -58.02 -19.34 30.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.5699999999999998 111.372 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -62.25 -30.76 71.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.658 0.266 . . . . 5.9299999999999997 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.58 ' O ' ' OG ' ' C' ' 26' ' ' SER . 42.5 t-105 -89.96 -35.2 15.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.404 -0.362 . . . . 5.1600000000000001 110.906 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 47.7 m -62.21 -47.06 86.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 2.79 110.943 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.463 HD22 ' HH ' ' C' ' 37' ' ' TYR . 28.4 tp -87.6 -1.26 57.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 3.3700000000000001 111.1 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 85.7 p -56.52 -24.11 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7400000000000002 111.537 -179.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.65 -36.03 10.35 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.22 0.533 . . . . 6.2800000000000002 109.777 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.404 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 6.3 p30 -170.92 131.9 0.86 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 4.79 109.969 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 51.1 Cg_endo -94.52 142.53 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.833 2.356 . . . . 3.9199999999999999 112.472 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . 0.418 HH11 ' HB3' ' C' ' 218' ' ' LEU . 95.8 mtt180 -91.31 64.1 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 9.3900000000000006 111.081 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.5 -40.06 2.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.815 -0.707 . . . . 4.2699999999999996 112.971 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.47 ' O ' HG21 ' C' ' 32' ' ' VAL . 27.7 m -79.5 113.14 34.51 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 121.005 0.431 . . . . 5.5 111.364 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' C' ' 32' ' ' VAL . 6.5 Cg_exo -78.76 167.75 21.95 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.406 2.737 . . . . 3.6000000000000001 112.614 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -41.84 -43.54 3.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.216 -0.447 . . . . 4.2699999999999996 112.123 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -56.62 -40.09 74.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.7799999999999998 111.055 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . 0.463 ' HH ' HD22 ' C' ' 25' ' ' LEU . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.9800000000000004 110.533 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 2.4100000000000001 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 2.4300000000000002 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.8500000000000001 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.6299999999999999 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 2.29 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.475 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 1.3799999999999999 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.90000000000000002 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 2.27 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 2.2400000000000002 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.71 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.57999999999999996 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.8200000000000001 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 1.28 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.46 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.7 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 1.2 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.4099999999999999 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 1.3200000000000001 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.96 110.507 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.9399999999999999 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 2.25 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.459 ' HD3' ' N ' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 3.4300000000000002 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 2.5499999999999998 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.27 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.8500000000000001 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.6200000000000001 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 3.2599999999999998 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 2.2599999999999998 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.51 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.544 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.3999999999999999 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . 0.511 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.8199999999999998 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.536 ' HA ' HD13 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 1.3899999999999999 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.544 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 2.3599999999999999 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 2.7000000000000002 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.536 HD13 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.8200000000000001 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.404 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.3300000000000001 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . 0.503 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 2.4100000000000001 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.405 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.9199999999999999 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.79 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.97 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.499 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 2.2000000000000002 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.499 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.25 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.8300000000000001 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 2.1400000000000001 109.449 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 2.2400000000000002 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.6699999999999999 111.019 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.8 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 2.1200000000000001 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 2.29 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 4.0300000000000002 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 2.0699999999999998 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.47 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.8599999999999999 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.6299999999999999 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 5.46 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.8399999999999999 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.8399999999999999 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.8600000000000003 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 6.0700000000000003 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.79 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 3.1499999999999999 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.8799999999999999 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.72 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 3.6200000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.444 ' HB3' HD13 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.8199999999999998 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.7000000000000002 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.54 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.8799999999999999 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.543 ' HB2' HD11 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.71 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 2.52 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 2.1699999999999999 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.5900000000000001 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 3.0299999999999998 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 1.3300000000000001 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 1.3100000000000001 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.65000000000000002 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 2.0299999999999998 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 2.23 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 1.4399999999999999 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.611 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.79 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.5499999999999998 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.93 -19.13 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.3100000000000001 110.758 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.458 ' HB2' HG12 ' C' ' 127' ' ' VAL . 59.9 mtm180 -132.08 149.6 52.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 3.52 110.639 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.72 -9.73 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 4.2400000000000002 110.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -91.09 -28.82 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 5.4500000000000002 111.001 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.458 HG12 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -84.76 -25.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 1.73 111.107 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 3.3799999999999999 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . 0.42 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 3.0 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.523 HD23 HG23 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 2.48 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.74 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 2.5699999999999998 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . 0.42 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.7000000000000002 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . 0.413 ' SG ' HD21 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 2.2000000000000002 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.72999999999999998 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 2.1000000000000001 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.76 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.51 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.9399999999999999 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.54 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 2.4700000000000002 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.408 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 3.0699999999999998 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.9399999999999999 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 4.5199999999999996 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.6499999999999999 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.419 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.9300000000000002 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.8599999999999999 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -92.12 -49.74 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.7000000000000002 112.426 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 32.5 Cg_exo -59.48 0.42 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.379 2.053 . . . . 2.46 113.5 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' C' ' 148' ' ' ASN . 97.7 mt -57.21 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.683 0.278 . . . . 3.46 111.375 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 44.55 36.96 1.89 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.092 -0.504 . . . . 9.1199999999999992 111.687 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.27 56.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 2.9700000000000002 110.934 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.01 -43.1 18.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 4.8899999999999997 110.746 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -88.13 6.83 34.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 4.1500000000000004 111.089 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.37 -30.6 69.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 5.5800000000000001 110.95 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -84.73 -11.06 56.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 3.5800000000000001 111.18 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -91.82 -25.58 18.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 4.1799999999999997 110.642 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.4 t -165.29 113.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 2.6800000000000002 110.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -77.59 -38.17 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 3.1800000000000002 110.73 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . 0.415 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.1800000000000002 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.9900000000000002 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 2.2400000000000002 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.3900000000000001 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.6499999999999999 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.6299999999999999 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.2599999999999998 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.9199999999999999 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.8 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 2.21 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 2.0299999999999998 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . 0.504 ' HH ' ' HA ' ' C' ' 209' ' ' SER . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.8799999999999999 110.5 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 2.3100000000000001 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 2.0 111.506 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 2.4199999999999999 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.7000000000000002 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . 0.465 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.1100000000000001 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.526 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 2.3100000000000001 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.71999999999999997 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.598 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 2.71 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 1.0700000000000001 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.526 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 2.0800000000000001 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.544 HG21 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.71 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.8999999999999999 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.401 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 2.2000000000000002 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 3.23 111.77 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.38 161.35 28.72 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.9099999999999999 112.781 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 95.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.673 2.249 . . . . 3.46 112.382 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 41.9 t 57.56 63.03 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.977 -0.556 . . . . 4.2199999999999998 111.247 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.57 -173.34 21.21 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.632 -0.795 . . . . 4.3499999999999996 112.952 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . 0.546 ' H ' HD12 ' C' ' 193' ' ' ILE . 86.0 m-85 -74.01 96.58 2.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.693 0.282 . . . . 8.2400000000000002 111.196 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 77.51 -158.6 47.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 3.6699999999999999 113.052 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -72.73 79.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 6.4900000000000002 111.377 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.546 HD12 ' H ' ' C' ' 190' ' ' PHE . 46.3 pt -142.6 141.85 27.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.385 -0.37 . . . . 3.1899999999999999 111.12 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -142.95 88.09 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 4.3399999999999999 110.714 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.32 -172.01 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 5.9900000000000002 111.146 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -74.49 -21.48 59.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 2.7999999999999998 111.435 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -56.46 -24.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 2.8599999999999999 111.187 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.6800000000000002 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 2.54 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.77 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 2.5299999999999998 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.8799999999999999 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.47 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 2.48 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.95 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.583 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.8700000000000001 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76000000000000001 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 2.3599999999999999 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 2.6200000000000001 110.808 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.504 ' HA ' ' HH ' ' C' ' 171' ' ' TYR . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.9299999999999999 110.656 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.6600000000000001 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 3.1099999999999999 110.793 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.4099999999999999 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.77 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' SER . . . . . 0.411 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.8399999999999999 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . 0.401 ' HA ' HD13 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 4.3399999999999999 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 2.25 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . 0.418 ' HB3' HH11 ' C' ' 30' ' ' ARG . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.54 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 4.0099999999999998 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.85 -58.96 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.6400000000000001 111.256 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 57.45 93.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.189 -0.46 . . . . 6.3799999999999999 111.048 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -64.59 148.49 50.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 6.0899999999999999 111.13 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.65 -32.99 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.101 -0.5 . . . . 7.0099999999999998 110.903 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -134.7 120.33 19.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 6.7999999999999998 110.879 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.83 105.32 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 7.0499999999999998 110.909 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -142.26 85.51 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 6.8200000000000003 110.925 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -94.57 -71.15 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 10.17 110.956 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.166 -0.921 . . . . 9.4499999999999993 110.819 -179.856 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.496 H191 ' HA ' ' A' ' 176' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.448 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.479 ' H8 ' H163 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.932 0.396 . . . . 8.5199999999999996 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -158.58 -72.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 6.0999999999999996 110.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.5 mt 60.42 104.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.003 -0.544 . . . . 6.6900000000000004 111.37 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.97 -37.48 81.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 6.5199999999999996 110.894 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 t -99.98 137.54 38.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 3.77 110.842 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 10' ' ' ILE . 70.2 mt -135.67 123.29 22.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 3.8199999999999998 111.183 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 2.46 111.135 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.9299999999999999 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 1.0800000000000001 110.262 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 2.4100000000000001 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 2.2599999999999998 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.466 HG12 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 1.5800000000000001 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 1.54 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.89000000000000001 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.8200000000000001 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.8500000000000001 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 2.23 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 1.4099999999999999 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.5699999999999998 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.8799999999999999 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.687 ' O ' ' OG ' ' A' ' 26' ' ' SER . 22.1 t80 -76.17 -28.4 57.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.7999999999999998 110.696 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -60.66 -33.24 72.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 4.7999999999999998 110.626 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.9 m -85.7 -29.01 24.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.089 -0.505 . . . . 2.7799999999999998 111.154 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -86.89 -9.47 55.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 3.27 111.105 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.687 ' OG ' ' O ' ' A' ' 22' ' ' PHE . 2.9 m -67.82 -23.23 65.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 2.52 110.588 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -48.5 -32.71 8.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.213 0.53 . . . . 6.0099999999999998 109.98 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 6.7 p30 -173.0 131.72 0.61 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.384 -0.825 . . . . 4.79 110.355 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 55.2 Cg_endo -96.18 -178.75 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.051 2.501 . . . . 3.3900000000000001 112.197 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -105.34 67.12 0.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.924 0.393 . . . . 7.4100000000000001 111.068 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.87 -38.94 2.54 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.952 -0.642 . . . . 4.9800000000000004 112.716 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.94 127.36 69.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.6 0.2 . . . . 5.2199999999999998 111.167 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HD2' ' HE1' ' A' ' 35' ' ' TYR . 39.4 Cg_exo -59.38 165.54 9.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.637 2.224 . . . . 4.1299999999999999 112.578 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.56 -19.86 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.287 -0.87 . . . . 4.0199999999999996 112.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.431 ' HE1' ' HD2' ' A' ' 33' ' ' PRO . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 3.1600000000000001 111.998 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.3900000000000001 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.5 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 2.1099999999999999 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.8999999999999999 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.48 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.5299999999999998 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.411 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 2.0499999999999998 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.74 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.68999999999999995 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 2.1699999999999999 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.495 ' HE1' HG21 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.47 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.9199999999999999 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.55000000000000004 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 1.6499999999999999 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 1.1399999999999999 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 2.4199999999999999 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.466 ' HG2' HG12 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.4099999999999999 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 1.0900000000000001 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 1.47 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.47 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 1.23 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.8700000000000001 110.745 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.3399999999999999 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 2.3100000000000001 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 2.48 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.6400000000000001 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 2.1200000000000001 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.54 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.2999999999999998 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 3.4199999999999999 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.8900000000000001 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 1.4299999999999999 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.534 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.1599999999999999 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.7999999999999998 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 1.29 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.534 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 3.3999999999999999 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.46 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG21 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 2.21 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG21 ' A' ' 74' ' ' ILE . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.4199999999999999 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.73 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.521 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.9399999999999999 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.404 ' O ' HD21 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.9099999999999999 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.416 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.8200000000000001 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 2.1099999999999999 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.26 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.404 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 2.1099999999999999 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.9099999999999999 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD11 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 2.2200000000000002 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.482 ' N ' HD11 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 2.54 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.8600000000000001 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.519 HD23 HD13 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 2.4700000000000002 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 3.0699999999999998 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 2.0099999999999998 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.7 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 3.0800000000000001 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.98 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 6.0499999999999998 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.4100000000000001 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.493 ' HD3' ' N ' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.7000000000000002 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.9699999999999998 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.9399999999999999 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 6.96 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.7000000000000002 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 3.25 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 3.1099999999999999 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.5900000000000001 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 4.0300000000000002 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 2.4300000000000002 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.8100000000000001 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.4300000000000002 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.518 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.75 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 3.2200000000000002 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 2.3799999999999999 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 2.2200000000000002 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.6499999999999999 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 3.2599999999999998 111.098 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 1.28 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 1.0900000000000001 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 2.1299999999999999 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.6400000000000001 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.3400000000000001 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 2.0099999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.6699999999999999 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.4900000000000002 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.6000000000000001 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 4.79 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.8600000000000001 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 3.23 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.4900000000000002 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 2.3700000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.96 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 2.6000000000000001 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.5699999999999998 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 2.2599999999999998 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.77000000000000002 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.6099999999999999 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 2.0699999999999998 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.72 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 4.0099999999999998 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 3.3999999999999999 110.842 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 3.0600000000000001 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.518 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.6699999999999999 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.46 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 4.3099999999999996 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.6200000000000001 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 3.1200000000000001 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 3.0499999999999998 111.568 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.584 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.2 t-20 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 3.0899999999999999 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo -58.83 -9.43 7.54 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.3599999999999999 112.861 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.74 21.09 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.568 -0.287 . . . . 3.7200000000000002 111.081 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -161.58 -36.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.475 -0.329 . . . . 9.25 111.16 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.68 -33.2 25.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 3.1000000000000001 111.844 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.49 -32.76 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.494 -0.321 . . . . 4.8899999999999997 111.37 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 9.0 t -77.19 2.4 15.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 4.2599999999999998 111.55 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -58.61 -38.24 77.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.458 -0.337 . . . . 6.1100000000000003 110.962 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 82.2 p -115.41 -6.37 12.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 3.3300000000000001 111.1 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.538 ' HB2' ' HA ' ' A' ' 154' ' ' THR . 95.3 mt-30 -93.61 -165.98 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 4.2699999999999996 111.009 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -65.49 116.67 7.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 2.9399999999999999 111.047 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.3999999999999999 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.3700000000000001 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 3.27 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 2.02 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.6400000000000001 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 2.0899999999999999 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.6400000000000001 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.1499999999999999 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.8399999999999999 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.519 HD13 HD23 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 2.3999999999999999 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.95 111.201 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.7 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 4.1100000000000003 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 2.4100000000000001 111.501 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 2.02 111.628 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 2.0299999999999998 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 2.5499999999999998 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.9399999999999999 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.481 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 2.3300000000000001 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 112.876 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.573 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 2.6499999999999999 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 1.1100000000000001 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 2.4500000000000002 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.9299999999999999 111.045 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.9399999999999999 111.955 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.6099999999999999 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.529 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.9100000000000001 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.94 -156.64 40.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 2.1899999999999999 112.854 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.582 ' HG2' ' HB2' ' A' ' 198' ' ' ASP . 27.5 Cg_exo -62.81 154.02 68.89 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.715 2.277 . . . . 3.46 111.964 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 57.51 16.69 3.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 4.04 110.517 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -161.03 35.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.955 -0.64 . . . . 4.4800000000000004 112.576 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 61.6 t80 59.74 91.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 8.6699999999999999 111.028 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.71 -171.53 23.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.641 . . . . 3.4300000000000002 112.355 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -128.87 22.37 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 6.8099999999999996 110.539 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.536 ' HB ' ' HD3' ' A' ' 187' ' ' PRO . 10.2 mt -99.14 160.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.874 -0.603 . . . . 3.5899999999999999 110.643 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -95.92 179.49 5.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.281 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -65.62 -22.59 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 6.1100000000000003 111.059 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 47.8 m -53.18 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 3.04 111.421 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.9 mm -68.16 -31.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.478 -0.328 . . . . 2.7999999999999998 111.321 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.582 ' HB2' ' HG2' ' A' ' 187' ' ' PRO . 25.2 t70 -49.72 -57.86 6.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.334 -0.393 . . . . 2.6600000000000001 110.988 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 2.2200000000000002 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.96 111.345 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.6699999999999999 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.79 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 2.3900000000000001 109.97 178.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 2.2599999999999998 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.519 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.8799999999999999 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.519 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79000000000000004 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 2.2999999999999998 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 2.8100000000000001 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 2.0499999999999998 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.6800000000000002 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 3.4100000000000001 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.3799999999999999 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 3.5600000000000001 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.8399999999999999 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 4.1299999999999999 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.77 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.4399999999999999 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.9100000000000001 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.7599999999999998 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.5900000000000001 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp -52.67 -58.76 5.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 4.0099999999999998 111.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.31 80.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 6.3799999999999999 110.865 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -95.0 121.04 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 6.0700000000000003 111.011 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.94 153.85 40.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 6.6600000000000001 110.576 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -91.96 93.86 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 6.9900000000000002 111.015 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -172.35 97.0 0.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.117 -0.492 . . . . 6.9400000000000004 110.829 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -149.89 -13.48 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 6.8300000000000001 110.978 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 62.45 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.07 -0.514 . . . . 11.49 110.856 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.171 -0.919 . . . . 9.4700000000000006 110.867 179.836 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 9.0999999999999996 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -158.41 140.05 13.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 7.2000000000000002 111.047 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.81 -177.64 3.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 6.7300000000000004 110.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.57 90.7 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 5.4400000000000004 110.702 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.6 p -139.54 149.75 44.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 4.1299999999999999 110.707 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.407 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt -113.08 30.73 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 3.6000000000000001 111.023 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.8799999999999999 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.545 ' HB2' ' HB3' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 2.1699999999999999 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1899999999999999 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 2.21 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.469 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 2.3500000000000001 110.517 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 1.48 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 1.51 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.82999999999999996 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.9299999999999999 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.8 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.402 HD13 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.79 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.402 ' N ' HD13 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . 0.469 ' HB2' ' HE1' ' B' ' 41' ' ' MET . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 1.3700000000000001 111.168 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.7599999999999998 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.6899999999999999 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -73.09 -40.01 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 5.1500000000000004 110.664 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -55.68 -28.51 55.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 4.1799999999999997 110.42 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 43.5 t -84.83 -29.55 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 2.77 111.084 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.25 -19.13 32.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.552 -0.294 . . . . 3.4900000000000002 111.394 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -62.81 -19.28 63.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.903 -0.319 . . . . 3.0299999999999998 110.645 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.448 ' HG2' HD21 ' B' ' 28' ' ' ASN . 55.5 ttp180 -50.51 -32.9 19.59 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.505 -0.554 . . . . 6.4500000000000002 109.505 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.448 HD21 ' HG2' ' B' ' 27' ' ' ARG . 6.7 p30 -173.95 132.78 0.56 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.122 -0.945 . . . . 5.3700000000000001 110.01 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.8 Cg_endo -95.16 -179.61 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.001 2.468 . . . . 4.2999999999999998 112.504 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -111.85 64.01 0.62 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.455 . . . . 8.5600000000000005 110.848 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.04 -36.86 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 4.6100000000000003 112.39 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p -89.99 122.14 68.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.536 0.208 . . . . 5.4800000000000004 110.8 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.05 165.2 5.41 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.284 1.99 . . . . 4.3899999999999997 112.133 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . 0.499 HE21 ' H ' ' B' ' 35' ' ' TYR . 0.5 OUTLIER -62.57 -18.12 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.65 . . . . 4.2999999999999998 112.245 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.499 ' H ' HE21 ' B' ' 34' ' ' GLN . 1.8 p90 -51.34 -33.39 29.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.5899999999999999 111.47 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.5699999999999998 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.8799999999999999 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 2.2200000000000002 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 2.5299999999999998 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.8999999999999999 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' MET . . . . . 0.469 ' HE1' ' HB2' ' B' ' 19' ' ' ALA . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.6200000000000001 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 2.3199999999999998 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG22 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 1.3899999999999999 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.80000000000000004 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 2.2200000000000002 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 2.5600000000000001 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.475 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.74 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.57999999999999996 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 1.4299999999999999 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 1.23 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.49 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.6299999999999999 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . 0.589 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 1.1699999999999999 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 1.45 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.545 ' HB3' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 1.3600000000000001 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 2.02 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.589 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.71 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.8900000000000001 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 2.3500000000000001 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.1800000000000002 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.2599999999999998 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.79 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.52 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.6899999999999999 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 2.25 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.3999999999999999 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.528 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.23 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.8999999999999999 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.528 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.71 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.429 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 2.6699999999999999 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 2.0 110.461 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.475 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.3100000000000001 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.6099999999999999 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.8300000000000001 110.626 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.8899999999999999 111.844 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.529 HG22 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.6000000000000001 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 2.1200000000000001 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.3100000000000001 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 2.0800000000000001 111.102 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 2.21 110.712 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.405 HD13 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 2.3599999999999999 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.405 ' N ' HD13 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 2.5099999999999998 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.72 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.582 HD21 HD13 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.78 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.73 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.8799999999999999 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 2.1000000000000001 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.5 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 3.1499999999999999 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 3.1499999999999999 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 5.0800000000000001 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 3.1899999999999999 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.6500000000000004 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.9699999999999998 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.2400000000000002 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 6.25 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.6200000000000001 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 3.0600000000000001 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.6899999999999999 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.53 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.461 ' HB2' HD13 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 3.6099999999999999 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.6699999999999999 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.7999999999999998 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.411 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 2.3100000000000001 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.429 HG22 HG23 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.5699999999999998 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 3.3799999999999999 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . 0.495 HG21 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 2.6200000000000001 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 2.1699999999999999 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.6499999999999999 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.9500000000000002 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 1.21 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 1.1100000000000001 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.59999999999999998 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.539 HD11 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.98 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.539 ' N ' HD11 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 2.0800000000000001 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.3100000000000001 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.71 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 2.3300000000000001 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.8900000000000001 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 3.0800000000000001 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.9699999999999998 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 2.0 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 3.0600000000000001 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 3.2200000000000002 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.6099999999999999 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.6699999999999999 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 2.5699999999999998 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 2.27 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 2.2999999999999998 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 2.0800000000000001 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 2.6499999999999999 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 1.51 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 2.3999999999999999 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.48 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 2.4500000000000002 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.429 HG23 HG22 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 3.3500000000000001 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.9299999999999999 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 5.0800000000000001 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.5900000000000001 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.6699999999999999 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 2.1099999999999999 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.534 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.79 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo -59.94 -7.55 6.36 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.3599999999999999 112.594 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.63 21.66 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 3.29 111.158 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -169.33 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.517 -0.31 . . . . 8.9000000000000004 111.188 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.77 -54.68 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 2.8399999999999999 111.505 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -71.5 -30.02 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.447 -0.342 . . . . 4.96 110.911 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.417 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 79.7 p -84.93 6.01 26.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 4.1699999999999999 111.224 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -60.16 -34.26 73.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 5.71 110.749 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.7 p -140.23 19.64 2.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 3.75 111.599 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 21.8 tp60 -101.54 -75.55 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 4.6299999999999999 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -144.51 113.37 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 3.1099999999999999 110.583 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p -77.83 -51.32 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 2.46 111.185 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 3.02 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 2.1499999999999999 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 3.25 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.77 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.52 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.9399999999999999 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.7799999999999998 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.582 HD13 HD21 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 2.1499999999999999 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 2.2400000000000002 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.6699999999999999 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . 0.413 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 4.1299999999999999 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 2.4700000000000002 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.98 111.481 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 2.1000000000000001 111.705 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 2.5800000000000001 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.8700000000000001 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.448 ' O ' HG13 ' B' ' 181' ' ' ILE . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 2.0299999999999998 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67000000000000004 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 2.5600000000000001 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 1.1799999999999999 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.448 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 2.1000000000000001 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.463 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.6499999999999999 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 3.1699999999999999 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 2.4100000000000001 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt -92.22 172.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 3.1200000000000001 111.377 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.519 ' HA2' HD11 ' B' ' 193' ' ' ILE . . . 89.67 -165.65 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.726 . . . . 2.0600000000000001 112.29 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . 0.432 ' HG2' ' HB2' ' B' ' 198' ' ' ASP . 28.0 Cg_exo -62.11 154.59 61.48 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 3.29 111.825 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 42.3 t 58.65 13.79 2.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 4.5 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -153.79 39.61 0.68 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.847 -0.615 . . . . 4.7000000000000002 112.315 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 80.5 t80 57.76 85.8 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 8.4800000000000004 110.798 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.95 147.12 10.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.849 -0.691 . . . . 3.9300000000000002 112.285 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -92.38 69.62 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 7.3799999999999999 110.678 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.519 HD11 ' HA2' ' B' ' 186' ' ' GLY . 67.4 mt -136.43 143.03 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 3.6299999999999999 111.021 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.52 165.14 25.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 3.8599999999999999 111.052 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.34 8.85 5.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 6.2300000000000004 111.334 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.9 m -71.88 -64.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 2.8799999999999999 110.786 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.62 -24.8 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 2.8300000000000001 110.972 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . 0.432 ' HB2' ' HG2' ' B' ' 187' ' ' PRO . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.4900000000000002 110.728 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 2.2799999999999998 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.9199999999999999 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 2.3500000000000001 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 2.8300000000000001 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 2.27 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.78 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 2.0600000000000001 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77000000000000002 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 2.4300000000000002 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 2.5899999999999999 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.9299999999999999 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.6499999999999999 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 3.1000000000000001 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.3899999999999999 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 3.0600000000000001 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.3500000000000001 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 4.3700000000000001 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 2.0 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.2200000000000002 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 3.0899999999999999 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 4.1600000000000001 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt -56.54 -58.72 6.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.9700000000000002 110.957 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 50.73 70.46 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 6.5700000000000003 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -91.21 116.7 29.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 5.9100000000000001 111.038 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.55 166.29 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 7.2599999999999998 110.667 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -97.37 94.58 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 7.5099999999999998 111.014 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -173.19 95.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.217 -0.447 . . . . 8.2100000000000009 110.874 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.2 m -149.5 86.19 1.46 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 8.0999999999999996 111.089 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -99.98 85.89 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 14.06 110.828 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.274 -0.87 . . . . 10.4 110.865 179.926 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.754 0.312 . . . . 8.3499999999999996 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.38 91.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 6.8499999999999996 111.178 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.36 105.04 5.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 6.6799999999999997 110.678 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 144.17 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 4.8200000000000003 111.074 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -151.98 -42.56 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 3.5299999999999998 111.066 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt 62.78 3.38 1.16 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.979 -0.555 . . . . 3.2400000000000002 111.492 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.491 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.7599999999999998 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.476 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 2.3399999999999999 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.25 110.8 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.46 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.432 ' HH ' ' HB2' ' C' ' 206' ' ' PRO . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 2.3799999999999999 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.5800000000000001 111.375 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 1.46 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 1.04 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.95 110.831 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 2.1400000000000001 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 2.3399999999999999 110.865 179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 1.02 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.51 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.5800000000000001 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -57.98 -31.81 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.5699999999999998 110.35 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . 0.798 ' O ' ' OG ' ' C' ' 26' ' ' SER . 34.4 t80 -70.18 -35.71 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.922 -0.581 . . . . 5.9299999999999997 110.437 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -61.78 -30.32 70.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 5.1600000000000001 110.604 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -84.79 -32.19 23.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 2.79 111.152 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 -9.3 53.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 3.3700000000000001 111.066 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.798 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -68.28 -19.19 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.866 -0.334 . . . . 2.7400000000000002 110.545 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.35 -35.06 17.47 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.482 -0.562 . . . . 6.2800000000000002 109.482 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -172.65 132.06 0.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 4.79 110.065 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.433 ' HB3' HE22 ' C' ' 34' ' ' GLN . 64.0 Cg_endo -94.89 -179.13 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.081 2.52 . . . . 3.9199999999999999 112.389 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . 0.439 ' HB2' HD11 ' C' ' 221' ' ' LEU . 23.9 mmm180 -97.21 51.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 9.3900000000000006 111.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.87 -45.24 1.99 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.825 -0.702 . . . . 4.2699999999999996 112.721 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 98.3 t -77.41 131.31 72.03 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.502 0.191 . . . . 5.5 111.029 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.439 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 35.6 Cg_exo -58.82 163.82 10.69 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.419 2.079 . . . . 3.6000000000000001 112.263 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . 0.433 HE22 ' HB3' ' C' ' 29' ' ' PRO . 23.7 mm-40 -61.39 -18.44 58.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.794 -0.639 . . . . 4.2699999999999996 112.273 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -51.31 -33.85 30.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.7799999999999998 111.504 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.7200000000000002 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.9800000000000004 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 2.4100000000000001 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 2.4300000000000002 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.8500000000000001 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.413 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.407 ' HA ' HD11 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 2.29 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.528 HG22 HG21 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 1.3799999999999999 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.90000000000000002 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . 0.407 HD11 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 2.27 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 2.2400000000000002 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.71 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.57999999999999996 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.8200000000000001 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 1.28 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 2.46 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.7 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 1.2 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 1.3200000000000001 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.96 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.9399999999999999 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB3' ' HB3' ' C' ' 53' ' ' ALA . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 2.25 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 3.4300000000000002 110.933 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 2.5499999999999998 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.27 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.8500000000000001 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.6200000000000001 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 3.2599999999999998 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 2.2599999999999998 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.51 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.531 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.3999999999999999 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.8199999999999998 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 1.3899999999999999 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 2.3599999999999999 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.441 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 2.7000000000000002 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.8200000000000001 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.3300000000000001 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 2.4100000000000001 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.407 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.9199999999999999 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.79 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.528 HG21 HG22 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.97 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 2.2000000000000002 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.25 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.8300000000000001 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 2.1400000000000001 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 85' ' ' LEU . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 2.2400000000000002 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.463 ' N ' HD13 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.6699999999999999 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.8 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.419 HD22 HD13 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 2.1200000000000001 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' SER . . . . . 0.434 ' HG ' HD13 ' C' ' 102' ' ' ILE . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 2.29 110.772 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 4.0300000000000002 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 2.0699999999999998 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.47 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.8599999999999999 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.6299999999999999 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 5.46 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.8399999999999999 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.8399999999999999 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.8600000000000003 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 6.0700000000000003 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.79 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 3.1499999999999999 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . 0.434 HD13 ' HG ' ' C' ' 88' ' ' SER . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.8799999999999999 110.933 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.72 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 3.6200000000000001 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.8199999999999998 110.74 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.469 ' HE3' ' HB3' ' C' ' 81' ' ' PRO . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.7000000000000002 111.193 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.54 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.411 HG23 HD11 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.8799999999999999 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . 0.529 HE22 ' HE1' ' C' ' 176' ' ' TRP . 6.6 tp-100 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.71 110.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 2.52 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 2.1699999999999999 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.5900000000000001 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 3.0299999999999998 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 1.3300000000000001 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.536 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 1.3100000000000001 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.65000000000000002 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.441 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 2.0299999999999998 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 2.23 111.207 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . 0.478 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 1.4399999999999999 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' C' ' 122' ' ' SER . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.79 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.5499999999999998 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 98.92 -108.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.3100000000000001 109.441 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.888 ' O ' ' N ' ' C' ' 126' ' ' TRP . 0.3 OUTLIER -54.9 -179.52 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 107.3 -1.37 . . . . 3.52 107.3 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 127' ' ' VAL . 19.5 m-20 -4.88 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.834 2.531 . . . . 4.2400000000000002 117.834 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . 0.888 ' N ' ' O ' ' C' ' 124' ' ' ARG . 6.1 p-90 -44.29 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.932 2.197 . . . . 5.4500000000000002 116.932 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' C' ' 125' ' ' ASP . 8.8 m -41.39 -17.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.585 0.63 . . . . 1.73 110.811 176.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . 0.536 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 3.3799999999999999 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 3.0 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 2.48 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . 0.559 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.74 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 2.5699999999999998 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.7000000000000002 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 2.2000000000000002 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 2.1000000000000001 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.76 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.51 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.9399999999999999 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.414 HD11 ' O ' ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.54 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 2.4700000000000002 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.411 HD11 HG23 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 3.0699999999999998 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.9399999999999999 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 4.5199999999999996 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.6499999999999999 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.9300000000000002 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.8599999999999999 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.525 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 35.1 t-20 -95.24 -49.04 0.26 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.7000000000000002 111.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 53.4 Cg_endo -69.2 0.53 5.1 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.135 1.89 . . . . 2.46 112.424 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.16 -26.61 62.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 3.46 111.177 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -139.54 -13.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 9.1199999999999992 110.948 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.19 -41.34 20.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 2.9700000000000002 111.216 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -82.52 -27.84 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 4.8899999999999997 110.702 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.448 ' HA ' ' HB2' ' C' ' 157' ' ' GLN . 67.7 p -83.26 6.86 18.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 4.1500000000000004 111.25 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.69 -22.65 57.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.181 -0.463 . . . . 5.5800000000000001 111.215 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 156' ' ' THR . . . . . 0.501 HG21 HE21 ' C' ' 157' ' ' GLN . 7.5 t -131.93 -12.72 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 3.5800000000000001 111.334 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.501 HE21 HG21 ' C' ' 156' ' ' THR . 29.2 mm-40 -83.45 -167.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.405 . . . . 4.1799999999999997 111.033 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -55.46 120.54 7.32 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.203 -0.453 . . . . 2.6800000000000002 111.014 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -78.29 -38.8 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.556 . . . . 3.1800000000000002 111.071 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.1800000000000002 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.9900000000000002 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 2.2400000000000002 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.3900000000000001 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.6499999999999999 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.6299999999999999 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.2599999999999998 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.9199999999999999 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.419 HD13 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.8 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.21 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 2.0299999999999998 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.8799999999999999 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 2.3100000000000001 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 173' ' ' THR . . . . . 0.447 HG22 HD11 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 2.0 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 2.4199999999999999 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.7000000000000002 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . 0.529 ' HE1' HE22 ' C' ' 109' ' ' GLN . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.1100000000000001 110.796 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.447 HD11 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 2.3100000000000001 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.593 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 2.71 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 1.0700000000000001 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 2.0800000000000001 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.409 HG23 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.8999999999999999 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 2.2000000000000002 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 3.23 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.07 -153.51 38.43 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.9099999999999999 112.547 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.1 162.69 38.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.722 2.281 . . . . 3.46 112.246 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 56.65 15.04 1.96 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.179 -0.464 . . . . 4.2199999999999998 110.69 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.25 -87.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.614 . . . . 4.3499999999999996 112.285 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -159.35 89.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 8.2400000000000002 110.499 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -168.21 158.26 30.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.803 -0.713 . . . . 3.6699999999999999 112.673 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -82.77 -27.72 30.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 6.4900000000000002 110.991 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.545 HD11 HG12 ' C' ' 197' ' ' ILE . 14.5 pt -87.37 139.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 3.1899999999999999 110.865 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -150.74 175.7 11.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.022 0.439 . . . . 4.3399999999999999 111.842 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 60.9 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.45 -0.796 . . . . 5.9900000000000002 112.46 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 39.1 m -49.39 -56.21 10.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 2.7999999999999998 112.047 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.545 HG12 HD11 ' C' ' 193' ' ' ILE . 9.3 tp -71.31 -28.75 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.389 -0.369 . . . . 2.8599999999999999 111.503 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.6800000000000002 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 2.54 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . 0.491 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.77 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 2.5299999999999998 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.8799999999999999 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 2.48 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.95 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.631 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.8700000000000001 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.631 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76000000000000001 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 2.3599999999999999 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 2.6200000000000001 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.9299999999999999 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.6600000000000001 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 3.1099999999999999 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.4099999999999999 112.451 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.77 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.8399999999999999 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 4.3399999999999999 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 2.25 110.7 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2000000000000002 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.54 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 4.0099999999999998 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' C' ' 30' ' ' ARG . 95.6 mt -60.76 -55.22 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.6400000000000001 110.856 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 62.45 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.835 -0.621 . . . . 6.3799999999999999 111.263 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 17.8 m120 64.53 115.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.002 0.429 . . . . 6.0899999999999999 111.315 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 91.0 mt -115.52 155.89 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 7.0099999999999998 110.504 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -83.27 55.46 3.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 6.7999999999999998 111.057 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.34 94.48 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 7.0499999999999998 110.914 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 62.7 m -136.46 -61.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.895 -0.593 . . . . 6.8200000000000003 110.683 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.01 86.94 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.005 -0.543 . . . . 10.17 111.148 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 9.4499999999999993 110.897 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.527 ' H8 ' H172 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.496 H162 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.432 ' C17' ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.829 0.347 . . . . 8.5199999999999996 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -147.82 108.67 4.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 6.0999999999999996 111.055 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -64.18 134.31 54.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.984 -0.553 . . . . 6.6900000000000004 110.957 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.25 19.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 6.5199999999999996 111.09 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -132.04 129.7 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 3.77 110.834 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt -137.2 -5.37 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 3.8199999999999998 110.821 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 2.46 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.518 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.9299999999999999 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 1.0800000000000001 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 2.4100000000000001 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 2.2599999999999998 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 1.5800000000000001 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 1.54 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.89000000000000001 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.527 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.8200000000000001 110.589 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.8500000000000001 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.427 HD13 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 2.23 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.427 ' N ' HD13 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.95999999999999996 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 1.4099999999999999 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.5699999999999998 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.8799999999999999 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -60.64 -32.93 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.7999999999999998 111.0 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -59.07 -30.33 67.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 4.7999999999999998 110.581 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 m -80.91 -31.73 35.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 2.7799999999999998 110.414 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.6 mt -87.33 -0.53 56.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.685 -0.689 . . . . 3.27 110.538 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -49.92 -26.46 4.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.016 -0.538 . . . . 2.52 111.346 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' HG2' ' ND2' ' A' ' 28' ' ' ASN . 70.3 ttt180 -45.89 -41.21 11.07 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.093 -0.706 . . . . 6.0099999999999998 109.093 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 41.2 m-80 -154.36 131.24 5.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.997 -1.001 . . . . 4.79 109.264 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.9 Cg_endo -81.25 166.22 18.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.624 2.216 . . . . 3.3900000000000001 112.277 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 218' ' ' LEU . 98.3 mtt180 -80.16 26.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 7.4100000000000001 111.07 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 29' ' ' PRO . . . 108.46 -30.3 9.01 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.735 -0.745 . . . . 4.9800000000000004 112.527 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG13 HD21 ' A' ' 221' ' ' LEU . 21.1 m -93.22 128.37 43.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.519 0.2 . . . . 5.2199999999999998 111.108 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 167.77 16.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 4.1299999999999999 112.139 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -35.41 -33.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 4.0199999999999996 112.59 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 3.1600000000000001 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.3900000000000001 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.5 110.857 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 2.1099999999999999 110.982 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.8999999999999999 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.424 ' HA ' HD11 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.48 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.542 ' HE1' HD13 ' A' ' 45' ' ' ILE . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.5299999999999998 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.565 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 2.0499999999999998 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.429 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.74 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.429 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.68999999999999995 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.542 HD13 ' HE1' ' A' ' 41' ' ' MET . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 2.1699999999999999 111.733 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.489 ' HE1' ' HG1' ' B' ' 114' ' ' THR . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.47 110.918 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.9199999999999999 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.55000000000000004 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 1.6499999999999999 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 1.1399999999999999 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 2.4199999999999999 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.4099999999999999 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 1.0900000000000001 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 1.47 110.246 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 1.23 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.8700000000000001 110.583 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.3399999999999999 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 2.3100000000000001 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 2.48 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 2.1200000000000001 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.54 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.2999999999999998 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 3.4199999999999999 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.8900000000000001 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 1.4299999999999999 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.447 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.1599999999999999 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.7999999999999998 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' O ' HG21 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 1.29 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.447 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 3.3999999999999999 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.442 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.46 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.413 HG21 ' O ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 2.21 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.4199999999999999 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.73 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.515 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.9399999999999999 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.449 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.9099999999999999 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.4 HG21 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.8200000000000001 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.56 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 2.1099999999999999 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.26 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.575 HD21 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 2.1099999999999999 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.548 ' HG ' H201 ' A' ' 301' ' ' RET . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.9099999999999999 109.147 178.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 2.2200000000000002 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.575 HD12 HD21 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 2.54 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.8600000000000001 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB3' HD23 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 2.4700000000000002 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 3.0699999999999998 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 2.0099999999999998 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.7 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 3.0800000000000001 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.98 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 6.0499999999999998 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.4100000000000001 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.7000000000000002 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.9699999999999998 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 6.96 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.7000000000000002 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 HD23 ' N ' ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 3.25 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 3.1099999999999999 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.5900000000000001 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.407 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 4.0300000000000002 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.433 ' HB3' HD22 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 2.4300000000000002 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.8100000000000001 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.4300000000000002 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 104' ' ' PHE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.75 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.468 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 3.2200000000000002 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 2.3799999999999999 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 2.2200000000000002 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.6499999999999999 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.468 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 3.2599999999999998 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 1.28 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 1.0900000000000001 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.515 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 2.1299999999999999 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.6400000000000001 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.3400000000000001 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 2.0099999999999998 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.6699999999999999 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.4900000000000002 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' HG11 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.6000000000000001 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 4.79 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.8600000000000001 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 3.23 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.4900000000000002 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 2.3700000000000001 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.96 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 2.6000000000000001 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.5699999999999998 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 2.2599999999999998 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.77000000000000002 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.6099999999999999 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 2.0699999999999998 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.72 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 4.0099999999999998 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 3.3999999999999999 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 3.0600000000000001 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.6699999999999999 111.473 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.46 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 4.3099999999999996 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.6200000000000001 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 3.1200000000000001 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 3.0499999999999998 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.551 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 3.0899999999999999 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo -62.31 -7.79 11.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.3599999999999999 113.177 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.34 -0.73 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.732 0.301 . . . . 3.7200000000000002 111.192 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.409 ' O ' HG22 ' A' ' 154' ' ' THR . 82.1 mtp180 -144.18 -28.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 9.25 111.055 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.64 -49.16 9.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 3.1000000000000001 111.826 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -85.75 -0.45 55.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.02 0.378 . . . . 4.8899999999999997 112.02 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.409 HG22 ' O ' ' A' ' 151' ' ' ARG . 14.7 t -80.35 -2.66 46.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 4.2599999999999998 110.846 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -64.92 -48.51 73.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 6.1100000000000003 110.765 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -96.0 -40.56 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 3.3300000000000001 111.095 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -61.7 152.35 31.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 4.2699999999999996 110.822 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -56.92 114.5 2.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 2.9399999999999999 110.983 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.3999999999999999 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.3700000000000001 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 3.27 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 2.02 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.6400000000000001 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 2.0899999999999999 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.445 ' O ' HG21 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.6400000000000001 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.1499999999999999 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.8399999999999999 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.419 HD23 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 2.3999999999999999 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.95 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.7 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 4.1100000000000003 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.433 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 2.4100000000000001 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 2.02 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.43 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 2.0299999999999998 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 2.5499999999999998 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.9399999999999999 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 174' ' ' VAL . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 2.3300000000000001 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.73999999999999999 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.616 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 2.6499999999999999 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.616 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 1.1100000000000001 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 2.4500000000000002 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.9299999999999999 111.421 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.9399999999999999 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.6099999999999999 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.9100000000000001 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.33 21.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 2.1899999999999999 112.772 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.07 162.3 31.9 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 3.46 112.111 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.2 t 56.19 19.06 3.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 4.04 110.226 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -136.31 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.902 -0.666 . . . . 4.4800000000000004 112.609 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -150.9 -38.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.78 0.324 . . . . 8.6699999999999999 110.694 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.0 -166.79 38.65 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.972 -0.632 . . . . 3.4300000000000002 112.472 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -153.59 105.4 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 6.8099999999999996 110.852 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 pt -138.44 -179.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 3.5899999999999999 111.114 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -50.0 123.83 8.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 3.3900000000000001 111.195 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.26 -24.17 66.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 6.1100000000000003 110.769 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -68.87 -35.87 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 3.04 110.95 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.75 -44.0 76.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 2.7999999999999998 111.08 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.88 -56.18 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 2.6600000000000001 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 2.2200000000000002 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.96 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.6699999999999999 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.79 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 2.3900000000000001 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 2.2599999999999998 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.8799999999999999 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79000000000000004 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 2.2999999999999998 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 2.8100000000000001 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.6800000000000002 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 3.4100000000000001 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.3799999999999999 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 3.5600000000000001 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.8399999999999999 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 4.1299999999999999 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.77 110.66 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.4399999999999999 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.116 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.7599999999999998 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.5900000000000001 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.437 HD21 HG13 ' A' ' 32' ' ' VAL . 38.2 tp -84.12 -50.33 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 4.0099999999999998 111.129 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 58.2 90.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.415 . . . . 6.3799999999999999 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -79.07 142.13 36.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 6.0700000000000003 111.034 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.9 tp -140.23 -33.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 6.6600000000000001 110.825 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -112.31 125.58 54.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 6.9900000000000002 110.695 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.82 110.89 22.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 6.9400000000000004 110.878 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.1 m -153.89 165.56 35.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 6.8300000000000001 110.933 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -144.56 -37.19 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 11.49 110.813 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.452 -0.785 . . . . 9.4700000000000006 111.092 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.697 0.284 . . . . 9.0999999999999996 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.73 171.22 9.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 7.2000000000000002 110.899 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.3 mt -132.02 116.8 17.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 6.7300000000000004 110.929 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.29 23.48 13.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 5.4400000000000004 111.087 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -148.03 106.97 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.417 . . . . 4.1299999999999999 111.095 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.74 -8.76 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 3.6000000000000001 110.738 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.406 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.8799999999999999 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 2.1699999999999999 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1899999999999999 110.599 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 2.21 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 2.3500000000000001 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 1.48 111.486 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 1.51 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.82999999999999996 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.9299999999999999 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.8 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.79 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 1.3700000000000001 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.7599999999999998 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.6899999999999999 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.443 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 74.2 m-85 -74.89 -29.18 60.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 5.1500000000000004 110.693 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.92 -45.07 71.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 4.1799999999999997 110.412 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.2 t -84.53 -19.42 33.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.151 0.5 . . . . 2.77 110.561 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.613 HD12 HD11 ' B' ' 218' ' ' LEU . 22.0 tp -81.94 -0.61 44.7 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.784 -0.644 . . . . 3.4900000000000002 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.466 ' C ' ' N ' ' B' ' 28' ' ' ASN . 62.5 m -58.5 -27.54 64.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.719 -0.392 . . . . 3.0299999999999998 111.257 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -47.14 -21.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.022 0.915 . . . . 6.4500000000000002 109.193 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.752 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 6.0 t30 -66.31 -155.39 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.443 0 CA-C-N 113.796 -1.547 . . . . 5.3700000000000001 109.09 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.752 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 71.0 Cg_exo -1.39 113.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 124.654 3.569 . . . . 4.2999999999999998 117.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 43.99 32.11 0.59 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.477 -1.238 . . . . 8.5600000000000005 112.504 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.432 ' H ' ' ND2' ' B' ' 223' ' ' ASN . . . 76.21 -47.57 2.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.48 -0.866 . . . . 4.6100000000000003 111.687 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.88 108.15 7.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.334 0.112 . . . . 5.4800000000000004 110.787 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.595 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 84.6 Cg_endo -83.91 119.58 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.675 1.583 . . . . 4.3899999999999997 112.755 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.88 -23.53 38.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.071 -1.085 . . . . 4.2999999999999998 108.071 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.75 -63.5 1.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.318 -1.765 . . . . 3.5899999999999999 112.119 -179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.5699999999999998 112.103 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.8799999999999999 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 2.2200000000000002 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.436 HG11 ' HG ' ' B' ' 86' ' ' SER . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 2.5299999999999998 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.8999999999999999 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.6200000000000001 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 2.3199999999999998 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.571 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 1.3899999999999999 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.80000000000000004 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 2.2200000000000002 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 2.5600000000000001 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.435 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.74 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.57999999999999996 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . 0.423 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 1.4299999999999999 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 1.23 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.49 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.423 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.6299999999999999 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 1.1699999999999999 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' MET . . . . . 0.426 ' HE3' HH21 ' B' ' 72' ' ' ARG . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 1.45 110.536 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.517 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 1.3600000000000001 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.458 HD12 HG22 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 2.02 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.71 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.8900000000000001 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 2.3500000000000001 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.1800000000000002 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.2599999999999998 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.79 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.52 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.6899999999999999 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.46 HD12 ' N ' ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 2.25 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.3999999999999999 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.562 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.23 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.8999999999999999 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 1.3100000000000001 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.71 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.436 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 2.6699999999999999 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 2.0 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.435 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . 0.436 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.6099999999999999 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.445 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.8300000000000001 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.403 ' O ' HD21 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.8899999999999999 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.571 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.6000000000000001 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 2.1200000000000001 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.3100000000000001 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.403 HD21 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 2.0800000000000001 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 2.21 110.595 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 2.3599999999999999 110.474 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 110.444 179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.436 ' HG ' HG11 ' B' ' 39' ' ' VAL . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.72 110.241 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.78 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.73 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.8799999999999999 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' THR . . . . . 0.592 HG22 HD23 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 2.1000000000000001 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.5 111.36 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 3.1499999999999999 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 3.1499999999999999 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 5.0800000000000001 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 3.1899999999999999 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . 0.553 ' HZ3' ' HB3' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.6500000000000004 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.9699999999999998 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.2400000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 6.25 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.6200000000000001 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 3.0600000000000001 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.51 HD11 ' H ' ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.6899999999999999 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.53 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 3.6099999999999999 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.6699999999999999 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.7999999999999998 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.565 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 2.3100000000000001 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.491 ' HG1' HD12 ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.5699999999999998 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 3.3799999999999999 110.726 179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 2.6200000000000001 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 2.1699999999999999 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.6499999999999999 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.9500000000000002 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.508 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 1.21 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 1.1100000000000001 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.59999999999999998 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.98 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 2.0800000000000001 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.3100000000000001 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.71 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 2.3300000000000001 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.8900000000000001 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.504 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.9699999999999998 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.504 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 2.0 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.458 ' CZ ' ' HA ' ' B' ' 188' ' ' SER . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 3.0600000000000001 110.836 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 3.2200000000000002 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.6099999999999999 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.6699999999999999 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 2.5699999999999998 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 2.27 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 2.2999999999999998 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.69999999999999996 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 2.6499999999999999 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 1.51 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 2.3999999999999999 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.48 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 2.4500000000000002 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.491 HD12 ' HG1' ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 3.3500000000000001 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.9299999999999999 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 5.0800000000000001 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.5900000000000001 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.4 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.6699999999999999 110.992 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 2.1099999999999999 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.79 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo -61.23 -8.36 10.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.3599999999999999 113.024 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 146' ' ' ILE . 81.4 mt -86.06 16.25 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 3.29 111.064 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -155.18 -37.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 8.9000000000000004 110.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.67 -52.67 9.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 2.8399999999999999 111.032 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -76.8 -21.23 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 4.96 110.675 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.49 ' HA ' ' HG2' ' B' ' 157' ' ' GLN . 77.5 m -61.89 -26.69 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 4.1699999999999999 111.148 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -64.29 -17.16 63.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 5.71 111.266 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 65.0 p -113.77 -45.41 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.871 0.323 . . . . 3.75 111.871 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . 0.49 ' HG2' ' HA ' ' B' ' 154' ' ' THR . 3.8 pt20 -74.37 176.69 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.388 . . . . 4.6299999999999999 110.849 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 158' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' B' ' 160' ' ' GLU . 91.7 p -64.37 117.54 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 3.1099999999999999 111.078 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p -67.12 -19.8 65.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 2.46 110.736 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . 0.512 ' HG2' ' HB2' ' B' ' 158' ' ' SER . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 3.02 110.715 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 2.1499999999999999 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.25 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.77 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.52 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.9399999999999999 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.7799999999999998 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.479 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 2.1499999999999999 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . 0.479 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 2.2400000000000002 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.6699999999999999 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 4.1299999999999999 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 2.4700000000000002 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.98 111.643 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . 0.447 HG22 HD23 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 2.1000000000000001 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.447 HD23 HG22 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 2.5800000000000001 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.8700000000000001 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.464 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 2.0299999999999998 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 2.5600000000000001 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 1.1799999999999999 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.464 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 2.1000000000000001 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.6499999999999999 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 3.1699999999999999 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 2.4100000000000001 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt -71.44 169.97 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 3.1200000000000001 111.337 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.508 ' HA2' HG12 ' B' ' 193' ' ' ILE . . . 76.89 -159.63 49.6 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.794 -0.717 . . . . 2.0600000000000001 112.548 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.97 165.89 15.0 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.728 2.285 . . . . 3.29 111.963 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' SER . . . . . 0.458 ' HA ' ' CZ ' ' B' ' 128' ' ' ARG . 68.7 m 55.98 18.14 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 4.5 110.593 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.42 -65.32 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.923 -0.656 . . . . 4.7000000000000002 112.531 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -167.16 -26.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.851 0.358 . . . . 8.4800000000000004 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.09 -163.73 29.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 3.9300000000000002 112.492 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -154.08 95.48 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 7.3799999999999999 110.674 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.508 HG12 ' HA2' ' B' ' 186' ' ' GLY . 28.6 pt -131.96 -179.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 3.6299999999999999 111.378 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -52.41 126.37 19.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 3.8599999999999999 111.233 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.72 -21.68 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 6.2300000000000004 111.301 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -70.12 -33.44 71.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 2.8799999999999999 111.088 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt -75.45 -42.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 2.8300000000000001 111.08 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.4900000000000002 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 199' ' ' THR . . . . . 0.483 HG22 ' HE2' ' B' ' 8' ' ' HIS . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 2.2799999999999998 111.02 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.9199999999999999 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 2.3500000000000001 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 2.8300000000000001 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 2.27 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.78 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.665 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 2.0600000000000001 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.665 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77000000000000002 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 2.4300000000000002 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 2.5899999999999999 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 209' ' ' SER . . . . . 0.412 ' HB2' HD11 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.9299999999999999 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.6499999999999999 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 3.1000000000000001 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.3899999999999999 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 3.0600000000000001 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.3500000000000001 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 4.3700000000000001 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 2.0 110.58 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.2200000000000002 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . 0.613 HD11 HD12 ' B' ' 25' ' ' LEU . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 3.0899999999999999 111.215 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 4.1600000000000001 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.6699999999999999 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.592 HD23 HG22 ' B' ' 90' ' ' THR . 3.3 mm? -84.58 -55.59 4.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.9700000000000002 111.043 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 57.5 84.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 6.5700000000000003 110.426 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' B' ' 31' ' ' GLY . 43.9 t-20 -68.97 135.3 50.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 5.9100000000000001 111.121 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.38 -24.9 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 7.2599999999999998 110.69 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -137.93 146.72 43.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.449 . . . . 7.5099999999999998 110.799 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -131.74 146.46 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 8.2100000000000009 111.043 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 45.5 t -167.48 132.76 1.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.473 . . . . 8.0999999999999996 110.958 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -133.04 24.04 4.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 14.06 110.899 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 10.4 111.003 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.812 0.339 . . . . 8.3499999999999996 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -99.51 169.85 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 6.8499999999999996 111.11 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -149.55 154.11 38.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 6.6799999999999997 110.55 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.72 -25.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.781 0.324 . . . . 4.8200000000000003 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 35.7 t -66.13 117.51 8.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 3.5299999999999998 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt -126.47 -7.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 3.2400000000000002 110.597 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.7599999999999998 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.531 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 2.3399999999999999 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.25 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.46 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 2.3799999999999999 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.5800000000000001 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 1.46 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 1.04 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.512 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.95 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 2.1400000000000001 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 2.3399999999999999 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 1.02 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.51 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.5800000000000001 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' C' ' 24' ' ' SER . 7.9 t60 -52.38 -60.63 3.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.5699999999999998 111.287 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . 0.576 ' HB3' ' HA ' ' C' ' 28' ' ' ASN . 13.1 m-85 -62.35 -41.05 98.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 5.9299999999999997 110.856 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.469 ' HA ' ' C ' ' C' ' 27' ' ' ARG . 57.0 t-105 -57.11 -20.89 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.433 -0.58 . . . . 5.1600000000000001 109.433 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' C' ' 21' ' ' HIS . 38.3 t -86.91 -28.78 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.298 -0.865 . . . . 2.79 112.898 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.76 -66.56 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 118.875 -1.13 . . . . 3.3700000000000001 112.964 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.921 ' OG ' ' OD1' ' C' ' 28' ' ' ASN . 62.1 p -101.92 -31.15 10.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.505 1.145 . . . . 2.7400000000000002 110.269 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . 0.469 ' C ' ' HA ' ' C' ' 23' ' ' TRP . 67.4 ttt180 126.98 0.11 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 100.485 -3.895 . . . . 6.2800000000000002 100.485 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.921 ' OD1' ' OG ' ' C' ' 26' ' ' SER . 5.5 p-10 -168.31 -173.69 0.3 Allowed Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 110.109 -3.223 . . . . 4.79 106.091 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.466 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 31.8 Cg_exo -59.16 -177.87 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 122.39 2.06 . . . . 3.9199999999999999 112.821 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -100.04 83.37 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 9.3900000000000006 110.822 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.66 -37.83 3.31 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.722 -0.751 . . . . 4.2699999999999996 112.513 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' C' ' 29' ' ' PRO . 97.9 t -71.57 130.0 87.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.537 0.208 . . . . 5.5 111.195 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.424 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 32.8 Cg_exo -59.48 165.66 9.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.743 2.295 . . . . 3.6000000000000001 112.628 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -18.45 51.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 4.2699999999999996 111.69 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.427 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 -50.68 -40.4 53.67 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.7799999999999998 111.032 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.9800000000000004 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 2.4100000000000001 110.38 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 2.4300000000000002 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.8500000000000001 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.416 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.6299999999999999 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 2.29 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.432 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 1.3799999999999999 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.90000000000000002 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 2.27 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 2.2400000000000002 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.422 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.71 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.57999999999999996 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.8200000000000001 111.086 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 1.28 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 2.46 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.7 110.51 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 1.2 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.4099999999999999 110.26 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.531 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 1.3200000000000001 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.96 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.9399999999999999 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' C' ' 53' ' ' ALA . 14.8 mm100 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 2.25 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . 0.405 ' HA3' ' HB1' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 3.4300000000000002 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 2.5499999999999998 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.27 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.8500000000000001 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.6200000000000001 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 3.2599999999999998 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 2.2599999999999998 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.51 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.3999999999999999 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . 0.425 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.8199999999999998 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.405 ' HB1' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 1.3899999999999999 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 2.3599999999999999 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 2.7000000000000002 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.425 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.8200000000000001 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' C' ' 47' ' ' SER . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 2.4100000000000001 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.482 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.9199999999999999 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.79 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.408 HG23 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.97 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 2.2000000000000002 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.25 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.8300000000000001 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 2.1400000000000001 110.046 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 2.2400000000000002 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.6699999999999999 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' SER . . . . . 0.431 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.8 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.474 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 2.1200000000000001 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 2.29 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . 0.431 ' HE3' ' HA ' ' C' ' 86' ' ' SER . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 4.0300000000000002 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 2.0699999999999998 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.47 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.8599999999999999 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.6299999999999999 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 5.46 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.8399999999999999 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.8399999999999999 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.8600000000000003 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 6.0700000000000003 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.79 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 3.1499999999999999 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.8799999999999999 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.72 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 3.6200000000000001 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . 0.417 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.8199999999999998 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.7000000000000002 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.54 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.8799999999999999 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.71 111.065 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 2.52 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 2.1699999999999999 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.5900000000000001 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.482 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 3.0299999999999998 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 1.3300000000000001 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.462 ' HB2' ' H22' ' C' ' 301' ' ' RET . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 110.456 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.65000000000000002 112.298 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 2.0299999999999998 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 2.23 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.79 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.5499999999999998 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -91.55 -27.15 18.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.3100000000000001 111.0 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.412 ' HB2' HG11 ' C' ' 127' ' ' VAL . 46.3 mtm180 -131.83 143.98 50.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.952 0.405 . . . . 3.52 110.833 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.23 -9.72 54.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.982 -0.554 . . . . 4.2400000000000002 111.368 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -86.69 -55.11 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 5.4500000000000002 110.958 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.458 HG22 HD12 ' B' ' 56' ' ' ILE . 10.9 p -63.47 -27.13 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 1.73 111.374 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 3.3799999999999999 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 3.0 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 2.48 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.74 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 2.5699999999999998 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.7000000000000002 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 2.2000000000000002 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.72999999999999998 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 2.1000000000000001 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.76 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.51 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.9399999999999999 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.54 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 2.4700000000000002 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 3.0699999999999998 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.9399999999999999 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 4.5199999999999996 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.6499999999999999 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.9300000000000002 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.8599999999999999 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.558 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 63.5 t30 -54.81 -49.81 89.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.7000000000000002 112.342 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 41.9 Cg_exo -57.8 -15.95 23.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.308 2.005 . . . . 2.46 112.956 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.42 3.67 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.63 -0.259 . . . . 3.46 111.277 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -144.37 -32.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 9.1199999999999992 111.291 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.47 -58.34 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 2.9700000000000002 111.642 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.81 -10.05 56.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 4.8899999999999997 111.491 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.9 p -73.42 -4.81 35.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 4.1500000000000004 111.215 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -60.22 -54.04 50.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 5.5800000000000001 110.865 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -96.87 -31.54 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 3.5800000000000001 111.22 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.6 HE21 ' H ' ' C' ' 158' ' ' SER . 23.8 tp60 -67.26 149.57 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 4.1799999999999997 110.545 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 158' ' ' SER . . . . . 0.6 ' H ' HE21 ' C' ' 157' ' ' GLN . 37.5 t -55.58 113.68 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 2.6800000000000002 110.917 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p -62.69 -19.75 64.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 3.1800000000000002 111.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.1800000000000002 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . 0.429 HD22 ' N ' ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.9900000000000002 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 2.2400000000000002 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.3900000000000001 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.6499999999999999 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . 0.427 ' O ' HG21 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.6299999999999999 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.2599999999999998 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.9199999999999999 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.474 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.8 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . 0.427 HG21 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 2.21 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 2.0299999999999998 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.8799999999999999 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . 0.407 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 2.3100000000000001 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 2.0 111.959 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 2.4199999999999999 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.7000000000000002 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . 0.407 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.1100000000000001 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.455 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 2.3100000000000001 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.71999999999999997 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.605 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 2.71 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 1.0700000000000001 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.504 ' O ' HG23 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 2.0800000000000001 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.4 HG21 ' HA ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.71 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.8999999999999999 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.504 HG23 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 2.2000000000000002 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 3.23 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.39 -149.76 18.35 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.9099999999999999 112.438 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.47 168.79 7.24 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.766 2.31 . . . . 3.46 112.17 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 49.6 m 56.38 19.0 3.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.107 0.479 . . . . 4.2199999999999998 110.575 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -152.14 -79.19 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.72 -0.673 . . . . 4.3499999999999996 112.251 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -173.32 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 8.2400000000000002 110.464 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 177.84 -43.78 0.09 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.632 -0.794 . . . . 3.6699999999999999 112.727 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 57.93 84.77 0.1 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.003 0.43 . . . . 6.4900000000000002 111.274 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 46.7 pt -141.69 -179.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 3.1899999999999999 110.792 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -48.13 139.19 8.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.334 -0.394 . . . . 4.3399999999999999 110.973 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -85.76 -27.15 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.051 -0.522 . . . . 5.9900000000000002 111.265 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 36.0 p -59.74 -55.63 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.35 . . . . 2.7999999999999998 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -62.37 -35.03 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 2.8599999999999999 110.91 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 2.54 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.77 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 2.5299999999999998 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.8799999999999999 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.497 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 2.48 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.95 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.624 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.8700000000000001 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76000000000000001 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 2.3599999999999999 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 2.6200000000000001 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.9299999999999999 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . 0.512 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.6600000000000001 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 3.1099999999999999 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.4099999999999999 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.77 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.8399999999999999 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 4.3399999999999999 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 2.25 110.784 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2000000000000002 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.54 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 4.0099999999999998 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp -77.59 -51.77 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.6400000000000001 111.161 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 58.95 92.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.406 . . . . 6.3799999999999999 110.799 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.2 151.49 38.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 6.0899999999999999 110.892 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 37.3 tp -168.3 -19.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 7.0099999999999998 111.064 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.65 -63.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 6.7999999999999998 111.082 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 59.61 86.18 0.09 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.26 -0.427 . . . . 7.0499999999999998 110.921 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -169.92 133.52 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 6.8200000000000003 110.944 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.35 -61.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 10.17 110.789 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.391 -0.814 . . . . 9.4499999999999993 110.953 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.548 H201 ' HG ' ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.494 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.462 ' H22' ' HB2' ' C' ' 115' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.845 0.355 . . . . 8.5199999999999996 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -148.21 114.35 5.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 6.0999999999999996 110.818 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.64 161.71 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 6.6900000000000004 110.892 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -141.11 105.49 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 6.5199999999999996 110.62 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 p -98.61 169.15 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 3.77 111.256 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -143.38 -10.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 3.8199999999999998 110.811 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 2.46 110.952 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.9299999999999999 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 2.4100000000000001 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 2.2599999999999998 110.6 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 1.5800000000000001 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 1.54 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.89000000000000001 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.8200000000000001 110.49 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.8500000000000001 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.425 ' HA ' HD11 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 2.23 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 1.4099999999999999 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.425 HD11 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.5699999999999998 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.8799999999999999 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.1 -30.2 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.7999999999999998 110.611 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -59.43 -39.05 82.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 4.7999999999999998 109.991 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -26.05 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.845 -0.616 . . . . 2.7799999999999998 110.219 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.88 0.47 1.79 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.839 -0.619 . . . . 3.27 111.124 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 28' ' ' ASN . 93.2 p -51.4 -19.67 1.45 Allowed 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.131 0.27 . . . . 2.52 111.491 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -51.18 -22.75 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.628 -1.249 . . . . 6.0099999999999998 107.628 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.757 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 20.3 p-10 -67.05 -158.71 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 113.016 -1.902 . . . . 4.79 107.635 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.757 ' HD2' ' HB2' ' A' ' 28' ' ' ASN . 36.1 Cg_exo -16.16 96.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.333 2.688 . . . . 3.3900000000000001 115.143 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.39 65.94 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.587 -0.733 . . . . 7.4100000000000001 109.27 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.95 7.84 6.43 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.514 -1.034 . . . . 4.9800000000000004 110.514 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 33' ' ' PRO . 0.1 OUTLIER -122.27 160.91 45.81 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 114.652 -0.774 . . . . 5.2199999999999998 110.255 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.543 ' HD2' HG13 ' A' ' 32' ' ' VAL . 44.5 Cg_exo -33.55 134.07 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.561 2.84 . . . . 4.1299999999999999 115.285 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 -77.44 -11.7 59.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.232 -1.349 . . . . 4.0199999999999996 111.036 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.506 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 3.1600000000000001 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.3900000000000001 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.5 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 2.1099999999999999 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.8999999999999999 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.48 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.5299999999999998 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 2.0499999999999998 112.762 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.43 HG22 HG21 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.74 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.68999999999999995 114.136 -178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 2.1699999999999999 112.115 -178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.47 110.707 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.9199999999999999 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.55000000000000004 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 1.6499999999999999 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 1.1399999999999999 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 2.4199999999999999 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.4099999999999999 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.498 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 1.0900000000000001 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 1.47 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.538 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 1.23 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.498 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.8700000000000001 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.3399999999999999 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 2.3100000000000001 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 2.48 111.252 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 2.1200000000000001 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.54 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.2999999999999998 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 3.4199999999999999 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.8900000000000001 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 1.4299999999999999 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.1599999999999999 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.7999999999999998 110.68 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 1.29 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 3.3999999999999999 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.442 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.46 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.418 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 2.21 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.408 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.73 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.459 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.9399999999999999 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.9099999999999999 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG21 HG22 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.8200000000000001 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 2.1099999999999999 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.605 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.26 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 2.1099999999999999 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.9099999999999999 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.502 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 2.2200000000000002 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 2.54 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.8600000000000001 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.9199999999999999 110.788 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 2.4700000000000002 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 3.0699999999999998 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 2.0099999999999998 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.7 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 3.0800000000000001 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.98 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 6.0499999999999998 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.4100000000000001 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.7000000000000002 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.9699999999999998 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.9399999999999999 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 6.96 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.471 ' HA ' HD21 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.7000000000000002 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 3.25 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 3.1099999999999999 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.5900000000000001 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 4.0300000000000002 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 2.4300000000000002 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.8100000000000001 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.4300000000000002 111.307 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.75 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.502 ' HG3' HD22 ' A' ' 84' ' ' LEU . 10.8 mm100 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 3.2200000000000002 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 2.3799999999999999 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 2.2200000000000002 110.671 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.6499999999999999 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 3.2599999999999998 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.423 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 1.28 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 1.0900000000000001 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.518 HD11 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 2.1299999999999999 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.518 ' N ' HD11 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.6400000000000001 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.3400000000000001 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.8799999999999999 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 2.0099999999999998 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.6699999999999999 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.4900000000000002 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.501 ' HB2' HG11 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.6000000000000001 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 4.79 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.504 ' HA ' HD12 ' A' ' 130' ' ' LEU . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.8600000000000001 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 3.23 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.4900000000000002 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 2.3700000000000001 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.96 111.187 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 2.6000000000000001 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.5699999999999998 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.404 ' SG ' HD21 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 2.2599999999999998 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.77000000000000002 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.6099999999999999 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 2.0699999999999998 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.72 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 4.0099999999999998 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 3.3999999999999999 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 3.0600000000000001 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.6699999999999999 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.46 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 4.3099999999999996 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 3.1200000000000001 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 3.0499999999999998 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.547 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 3.0899999999999999 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo -61.15 -9.46 12.56 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.3599999999999999 112.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.466 HD12 ' HA ' ' A' ' 166' ' ' ASP . 30.5 tp -71.38 -6.35 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.398 . . . . 3.7200000000000002 111.23 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.74 -20.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.421 -0.354 . . . . 9.25 111.232 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.93 -44.94 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 3.1000000000000001 111.193 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -86.17 -9.41 56.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 4.8899999999999997 111.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.6 p -71.64 -6.36 40.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 4.2599999999999998 111.017 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -57.3 -53.35 59.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.483 . . . . 6.1100000000000003 110.487 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.7 t -99.57 -30.01 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.235 -0.439 . . . . 3.3300000000000001 111.226 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.609 HE21 ' H ' ' A' ' 158' ' ' SER . 21.8 tp60 -61.36 154.33 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 4.2699999999999996 110.703 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.609 ' H ' HE21 ' A' ' 157' ' ' GLN . 54.3 m -62.0 115.46 4.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 2.9399999999999999 110.865 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.3999999999999999 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 3.27 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 2.02 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.6400000000000001 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 2.0899999999999999 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.6400000000000001 110.715 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.466 ' HA ' HD12 ' A' ' 150' ' ' LEU . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.1499999999999999 110.597 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.8399999999999999 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 2.3999999999999999 111.037 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.489 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.95 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.7 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . 0.5 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 4.1100000000000003 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.489 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 2.4100000000000001 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 2.02 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 2.0299999999999998 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 2.5499999999999998 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.9399999999999999 111.374 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.461 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 2.3300000000000001 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.73999999999999999 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.587 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 2.6499999999999999 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.587 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 1.1100000000000001 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.47 ' O ' HG21 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 2.4500000000000002 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.9299999999999999 111.461 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.9399999999999999 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.47 HG21 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.6099999999999999 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.9100000000000001 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.18 -157.62 21.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 2.1899999999999999 113.06 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.03 165.5 29.66 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.925 2.416 . . . . 3.46 111.89 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.9 t 58.48 14.08 2.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 4.04 110.188 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.56 -82.48 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.62 -0.718 . . . . 4.4800000000000004 112.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -172.42 83.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 8.6699999999999999 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.84 171.87 44.02 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.77 -0.729 . . . . 3.4300000000000002 112.519 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -113.74 26.92 9.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 6.8099999999999996 110.758 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.5 mm -89.33 140.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 3.5899999999999999 111.103 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -147.29 95.7 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 3.3900000000000001 111.13 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . 0.511 ' HB3' HG22 ' A' ' 197' ' ' ILE . 18.2 tt0 -168.1 167.23 12.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 6.1100000000000003 111.042 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.9 m -65.06 -16.42 63.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 3.04 111.192 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 195' ' ' GLN . 17.0 tt -56.44 -26.13 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.431 . . . . 2.7999999999999998 111.247 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -55.37 -56.02 24.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.355 . . . . 2.6600000000000001 111.024 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 2.2200000000000002 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.96 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.6699999999999999 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.79 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.422 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 2.3900000000000001 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 2.2599999999999998 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.489 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.8799999999999999 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79000000000000004 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 2.2999999999999998 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 2.8100000000000001 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 2.0499999999999998 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.6800000000000002 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 3.4100000000000001 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.3799999999999999 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 3.5600000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.8399999999999999 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 4.1299999999999999 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.77 110.483 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.4399999999999999 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.9100000000000001 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.7599999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.5900000000000001 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 224' ' ' LEU . 53.4 tp -70.36 -39.45 74.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 4.0099999999999998 110.972 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 60.59 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 6.3799999999999999 111.217 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -130.23 156.13 45.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 6.0700000000000003 110.867 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.467 HD23 HD23 ' A' ' 221' ' ' LEU . 91.6 mt -94.91 108.5 20.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 6.6600000000000001 111.162 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -136.24 123.37 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.979 -0.555 . . . . 6.9900000000000002 110.497 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -140.52 142.75 35.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 6.9400000000000004 111.349 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 69.1 m -158.22 90.22 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.901 -0.591 . . . . 6.8300000000000001 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 59.42 90.78 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.526 . . . . 11.49 111.135 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 9.4700000000000006 110.758 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.754 0.312 . . . . 9.0999999999999996 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.79 126.21 28.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 7.2000000000000002 110.722 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -130.61 144.32 51.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.364 -0.38 . . . . 6.7300000000000004 111.04 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.15 163.71 12.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 5.4400000000000004 110.699 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t -159.85 130.8 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 4.1299999999999999 110.825 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -105.81 -9.24 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 3.6000000000000001 110.833 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.8799999999999999 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 2.1699999999999999 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1899999999999999 110.662 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 2.21 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.3500000000000001 110.615 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 1.48 111.075 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 1.51 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.82999999999999996 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.9299999999999999 110.837 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.8 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.79 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 1.3700000000000001 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.7599999999999998 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.6899999999999999 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.56 -26.51 61.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 5.1500000000000004 110.49 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -61.66 -45.77 92.6 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.633 -0.506 . . . . 4.1799999999999997 109.633 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -72.91 -19.46 61.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.745 -0.661 . . . . 2.77 109.698 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' B' ' 28' ' ' ASN . 16.9 tp -67.72 1.08 2.7 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.578 -0.737 . . . . 3.4900000000000002 111.034 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.438 ' C ' ' N ' ' B' ' 28' ' ' ASN . 59.1 p -48.04 -19.54 0.27 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 123.077 0.235 . . . . 3.0299999999999998 111.524 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -53.32 -19.88 3.77 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.297 1.046 . . . . 6.4500000000000002 108.323 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.765 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.6 t30 -66.15 -154.5 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 113.351 -1.75 . . . . 5.3700000000000001 107.58 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.765 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 37.4 Cg_exo -5.21 -75.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.149 2.566 . . . . 4.2999999999999998 115.407 -176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 49.46 55.36 9.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.467 0.651 . . . . 8.5600000000000005 109.349 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.06 -3.95 9.06 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.67 -0.972 . . . . 4.6100000000000003 110.67 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.524 HG13 ' HD2' ' B' ' 33' ' ' PRO . 1.2 t -110.32 156.28 40.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.243 -0.479 . . . . 5.4800000000000004 110.001 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.524 ' HD2' HG13 ' B' ' 32' ' ' VAL . 27.3 Cg_exo -35.97 142.28 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.04 2.493 . . . . 4.3899999999999997 114.005 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' B' ' 36' ' ' GLU . 77.0 mt-30 -75.42 -13.8 60.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.032 . . . . 4.2999999999999998 111.529 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.471 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER -38.87 -23.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.5899999999999999 113.348 -178.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.471 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.5699999999999998 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.8799999999999999 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 2.2200000000000002 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 2.5299999999999998 111.698 -179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.8999999999999999 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.6200000000000001 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . 0.512 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 2.3199999999999998 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.431 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 1.3899999999999999 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.80000000000000004 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 2.2200000000000002 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 2.5600000000000001 111.294 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.74 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.57999999999999996 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 1.4299999999999999 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 1.23 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.49 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.6299999999999999 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 1.1699999999999999 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 1.45 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 1.3600000000000001 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 2.02 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.517 HE22 ' HA ' ' C' ' 122' ' ' SER . 13.0 mm100 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.71 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.8900000000000001 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 2.3500000000000001 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.1800000000000002 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.2599999999999998 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.79 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.52 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.6899999999999999 111.014 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 2.25 110.776 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.3999999999999999 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.486 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.23 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.8999999999999999 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 1.3100000000000001 112.115 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.486 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.71 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.41 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 2.6699999999999999 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 2.0 110.852 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.3100000000000001 109.389 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.6099999999999999 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.438 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.8300000000000001 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.8899999999999999 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.6000000000000001 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.579 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 2.1200000000000001 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.579 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.3100000000000001 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 2.0800000000000001 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . 0.515 ' HG ' H201 ' B' ' 301' ' ' RET . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 2.21 110.659 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.528 HD22 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 2.3599999999999999 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.418 ' N ' HD11 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 2.5099999999999998 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.72 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.493 ' HB3' HD12 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.78 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.73 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.8799999999999999 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 2.1000000000000001 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.5 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 3.1499999999999999 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 3.1499999999999999 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 5.0800000000000001 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 3.1899999999999999 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.6500000000000004 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.9699999999999998 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 6.25 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.6200000000000001 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.429 HD21 ' HZ2' ' B' ' 153' ' ' LYS . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 3.0600000000000001 110.917 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.6899999999999999 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.53 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 3.6099999999999999 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.6699999999999999 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.7999999999999998 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 2.3100000000000001 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.5699999999999998 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD22 ' B' ' 84' ' ' LEU . 8.4 tp-100 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 3.3799999999999999 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 2.6200000000000001 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 2.1699999999999999 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.6499999999999999 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.9500000000000002 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 1.1100000000000001 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . 0.447 ' HA3' H172 ' B' ' 301' ' ' RET . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.59999999999999998 112.923 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.41 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.98 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 2.0800000000000001 111.111 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.3100000000000001 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.71 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' SER . . . . . 0.522 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 2.3300000000000001 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.8900000000000001 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 3.0800000000000001 110.925 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.9699999999999998 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 2.0 110.88 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . 0.522 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 3.0600000000000001 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 3.2200000000000002 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.6099999999999999 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.6699999999999999 111.165 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 2.5699999999999998 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 2.27 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 2.2999999999999998 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.69999999999999996 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 2.0800000000000001 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 2.6499999999999999 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 1.51 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 2.3999999999999999 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.48 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 2.4500000000000002 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . . . . . . . . . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 3.3500000000000001 111.09 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.9299999999999999 110.337 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 5.0800000000000001 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.5900000000000001 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.6699999999999999 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 2.1099999999999999 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.578 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.79 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo -56.05 -19.33 26.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.3599999999999999 112.643 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.08 39.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 3.29 110.709 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -166.86 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 8.9000000000000004 110.598 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.32 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 2.8399999999999999 111.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . 0.429 ' HZ2' HD21 ' B' ' 101' ' ' LEU . 88.5 tttt -68.83 -17.7 64.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 4.96 110.787 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 17.4 m -66.13 -14.86 62.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 4.1699999999999999 110.865 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -55.13 -45.4 75.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 5.71 111.195 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 71.3 p -102.23 -36.42 8.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.347 -0.388 . . . . 3.75 111.292 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -62.98 151.41 39.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 4.6299999999999999 110.732 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -57.82 117.84 4.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 3.1099999999999999 111.164 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -66.89 -19.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 2.46 111.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 3.02 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 2.1499999999999999 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 3.25 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.77 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.52 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.9399999999999999 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.7799999999999998 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.493 HD12 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 2.1499999999999999 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 2.2400000000000002 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.6699999999999999 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 4.1299999999999999 110.36 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 2.4700000000000002 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' THR . . . . . 0.421 ' HG1' ' N ' ' B' ' 174' ' ' VAL . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.98 111.674 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . 0.421 ' N ' ' HG1' ' B' ' 173' ' ' THR . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 2.1000000000000001 111.462 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 2.5800000000000001 111.732 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . 0.47 ' HE1' HE22 ' B' ' 109' ' ' GLN . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.8700000000000001 111.476 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.45 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 2.0299999999999998 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67000000000000004 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.618 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 2.5600000000000001 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 1.1799999999999999 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.45 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 2.1000000000000001 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.6499999999999999 111.373 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 3.1699999999999999 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 2.4100000000000001 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt -95.34 129.18 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 3.1200000000000001 111.311 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . 0.52 ' HA2' HD13 ' B' ' 193' ' ' ILE . . . 106.03 -153.61 17.05 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.889 -0.672 . . . . 2.0600000000000001 112.795 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.34 168.64 22.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.764 2.31 . . . . 3.29 112.027 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 49.9 m 57.03 14.94 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.115 0.483 . . . . 4.5 110.146 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.84 26.95 0.29 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.553 -0.749 . . . . 4.7000000000000002 112.25 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 58.22 90.27 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.846 0.355 . . . . 8.4800000000000004 110.976 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.94 -7.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 3.9300000000000002 112.672 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 61.12 31.94 19.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.777 0.322 . . . . 7.3799999999999999 110.983 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.52 HD13 ' HA2' ' B' ' 186' ' ' GLY . 83.9 mt -119.0 139.7 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 3.6299999999999999 111.116 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -141.42 93.65 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 3.8599999999999999 110.458 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . 0.536 HE21 ' HB ' ' B' ' 197' ' ' ILE . 29.1 tt0 -160.84 151.87 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 6.2300000000000004 110.884 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 5.3 t -60.54 -14.78 21.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 2.8799999999999999 111.792 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . 0.536 ' HB ' HE21 ' B' ' 195' ' ' GLN . 17.5 tt -52.05 -29.26 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.461 -0.336 . . . . 2.8300000000000001 111.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.4900000000000002 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 2.2799999999999998 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.9199999999999999 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' B' ' 201' ' ' LEU . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 2.3500000000000001 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 2.8300000000000001 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . 0.418 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 2.27 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.78 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.472 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 2.0600000000000001 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77000000000000002 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 2.4300000000000002 110.194 179.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 2.5899999999999999 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.9299999999999999 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.6499999999999999 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 3.1000000000000001 110.97 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.3899999999999999 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 3.0600000000000001 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.3500000000000001 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 4.3700000000000001 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 2.0 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.2200000000000002 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 3.0899999999999999 110.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 4.1600000000000001 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp -58.32 -42.77 87.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.9700000000000002 110.804 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 60.27 -83.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 6.5700000000000003 111.407 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -128.72 165.07 21.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 5.9100000000000001 110.85 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.9 110.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 7.2599999999999998 110.771 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.12 143.46 34.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 7.5099999999999998 111.148 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.92 139.26 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 8.2100000000000009 110.811 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 79.9 p -113.21 -33.62 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 8.0999999999999996 111.073 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . 0.406 ' HG3' ' HG3' ' B' ' 229' ' ' GLN . 40.5 ptt180 -158.49 -3.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 14.06 111.13 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . 0.406 ' HG3' ' HG3' ' B' ' 228' ' ' ARG . 87.7 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.147 -0.93 . . . . 10.4 110.93 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 8.3499999999999996 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.78 151.97 28.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 6.8499999999999996 110.714 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.14 149.42 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 6.6799999999999997 111.003 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.11 116.59 32.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 4.8200000000000003 111.055 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -100.48 177.89 4.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 3.5299999999999998 110.639 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . 0.412 ' N ' HD21 ' C' ' 6' ' ' LEU . 2.6 pt? -158.6 -8.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 3.2400000000000002 111.109 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.7599999999999998 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.546 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 2.3399999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.424 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.25 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.46 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 2.3799999999999999 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.424 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.5800000000000001 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 1.46 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 1.04 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.95 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 2.1400000000000001 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 2.3399999999999999 110.505 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 1.02 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.51 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.5800000000000001 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.66 -37.5 84.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.5699999999999998 110.581 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . 0.481 ' HA ' ' HB3' ' C' ' 25' ' ' LEU . 72.8 m-85 -68.63 -39.21 80.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 5.9299999999999997 110.662 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -50.63 -42.23 55.99 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.034 0.445 . . . . 5.1600000000000001 110.108 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -85.49 -24.18 27.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.635 . . . . 2.79 110.547 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.517 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 28.5 tp -77.29 -0.95 27.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.961 -0.563 . . . . 3.3700000000000001 110.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.856 ' OG ' ' HA ' ' C' ' 32' ' ' VAL . 34.6 t -63.76 -29.79 70.96 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.747 -0.381 . . . . 2.7400000000000002 111.012 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -42.23 -26.31 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.078 0.942 . . . . 6.2800000000000002 108.702 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.731 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 3.1 t30 -66.66 -157.57 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 113.536 -1.665 . . . . 4.79 108.468 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.731 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 73.1 Cg_exo -9.17 118.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 124.542 3.495 . . . . 3.9199999999999999 117.339 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 45.42 24.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.533 -1.212 . . . . 9.3900000000000006 113.718 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.83 -47.7 1.89 Allowed Glycine 0 C--O 1.23 -0.146 0 C-N-CA 120.195 -1.003 . . . . 4.2699999999999996 111.46 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.856 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 11.6 m -139.21 106.45 7.26 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.452 -0.573 . . . . 5.5 109.452 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.622 ' HD3' ' OG ' ' C' ' 26' ' ' SER . 6.1 Cg_exo -83.71 119.57 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.096 1.864 . . . . 3.6000000000000001 113.278 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -81.19 -24.46 37.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.731 -1.211 . . . . 4.2699999999999996 107.731 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.488 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 -83.19 -61.67 1.79 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.102 -1.863 . . . . 3.7799999999999998 112.373 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . 0.438 ' HB3' ' HB2' ' C' ' 33' ' ' PRO . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.7200000000000002 111.803 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.9800000000000004 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.471 HD21 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 2.4100000000000001 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . 0.417 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 2.4300000000000002 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.8500000000000001 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.6299999999999999 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 2.29 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.417 HG13 ' O ' ' C' ' 39' ' ' VAL . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 1.3799999999999999 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.90000000000000002 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 2.27 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 2.2400000000000002 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.71 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.57999999999999996 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . 0.404 HD21 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.8200000000000001 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 1.28 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 2.46 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.7 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 1.2 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' MET . . . . . 0.4 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.4099999999999999 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.546 ' HB1' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 1.3200000000000001 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.96 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.9399999999999999 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.402 ' HB3' ' HB1' ' C' ' 53' ' ' ALA . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 2.25 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 3.4300000000000002 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 2.5499999999999998 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.27 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.8500000000000001 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.6200000000000001 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 3.2599999999999998 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 2.2599999999999998 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.51 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.535 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.3999999999999999 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.8199999999999998 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . 0.421 ' HA ' ' CG2' ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 1.3899999999999999 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.535 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 2.3599999999999999 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.509 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 2.7000000000000002 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . 0.421 ' CG2' ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.8200000000000001 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.3300000000000001 109.652 179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 2.4100000000000001 111.2 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.9199999999999999 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.79 112.423 -179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.97 112.166 -178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 2.2000000000000002 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.25 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.8300000000000001 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . 0.401 ' O ' ' HG ' ' C' ' 87' ' ' LEU . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 2.1400000000000001 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . 0.417 ' H ' HD21 ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 2.2400000000000002 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.6699999999999999 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.8 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 2.1200000000000001 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 2.29 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 4.0300000000000002 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 2.0699999999999998 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.47 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.8599999999999999 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.6299999999999999 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 5.46 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.8399999999999999 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.8399999999999999 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.8600000000000003 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 6.0700000000000003 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.79 111.174 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 3.1499999999999999 110.875 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.8799999999999999 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.72 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 3.6200000000000001 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.8199999999999998 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.7000000000000002 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.54 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.8799999999999999 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.71 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 2.52 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 2.1699999999999999 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.5900000000000001 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 3.0299999999999998 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 1.3300000000000001 110.735 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 1.3100000000000001 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.65000000000000002 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 2.0299999999999998 111.291 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 2.23 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 1.4399999999999999 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.79 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' SER . . . . . 0.517 ' HA ' HE22 ' B' ' 58' ' ' GLN . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.5499999999999998 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -85.01 -29.81 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.3100000000000001 111.041 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.475 ' HB2' HG13 ' C' ' 127' ' ' VAL . 85.0 mtm180 -123.29 139.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 3.52 110.74 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.43 -11.2 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 4.2400000000000002 111.213 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -87.08 -36.64 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 5.4500000000000002 110.9 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.475 HG13 ' HB2' ' C' ' 124' ' ' ARG . 13.3 p -80.38 -24.1 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 1.73 110.862 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 3.3799999999999999 110.888 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 3.0 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.474 HD13 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 2.48 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.74 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 2.5699999999999998 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.7000000000000002 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 2.2000000000000002 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.72999999999999998 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 2.1000000000000001 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.76 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.9399999999999999 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.54 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 2.4700000000000002 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 3.0699999999999998 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.9399999999999999 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 4.5199999999999996 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.6499999999999999 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.9300000000000002 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.8599999999999999 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.539 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -55.48 -48.41 96.43 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.7000000000000002 112.0 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 28.5 Cg_exo -61.49 -12.46 24.43 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.214 1.942 . . . . 2.46 112.913 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.48 24.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 3.46 111.216 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.4 ' H ' ' C ' ' C' ' 149' ' ' PRO . 13.8 ptm180 -174.44 -28.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 9.1199999999999992 110.93 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.18 -41.26 18.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 2.9700000000000002 111.142 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -86.24 -22.15 27.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 4.8899999999999997 111.018 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 53.0 p -65.28 -13.02 57.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 4.1500000000000004 111.483 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.74 -28.21 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 5.5800000000000001 111.216 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 30.0 m -115.49 -43.01 3.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 3.5800000000000001 111.466 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.42 160.37 16.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.507 -0.315 . . . . 4.1799999999999997 110.976 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -60.13 115.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 2.6800000000000002 111.01 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m -63.99 -18.88 64.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 3.1800000000000002 110.899 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.1800000000000002 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.9900000000000002 110.625 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 2.2400000000000002 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.3900000000000001 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.6499999999999999 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.6299999999999999 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.2599999999999998 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.9199999999999999 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.8 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 2.21 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 2.0299999999999998 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.8799999999999999 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 2.3100000000000001 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 2.0 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 2.4199999999999999 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.7000000000000002 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.1100000000000001 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 2.3100000000000001 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . 0.471 ' O ' HG22 ' C' ' 181' ' ' ILE . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.71999999999999997 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.6 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 2.71 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.606 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 1.0700000000000001 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.471 HG22 ' O ' ' C' ' 178' ' ' GLY . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 2.0800000000000001 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.444 HG23 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.71 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . 0.606 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.8999999999999999 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.477 HG22 HG22 ' C' ' 185' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 2.2000000000000002 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.477 HG22 HG22 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 3.23 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . 0.632 ' H ' ' H ' ' C' ' 191' ' ' GLY . . . 108.77 -168.15 13.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.9099999999999999 112.494 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.1 151.28 9.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.722 2.281 . . . . 3.46 111.89 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m 57.82 15.38 2.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.053 0.454 . . . . 4.2199999999999998 110.465 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -145.61 -93.6 0.15 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.785 -0.643 . . . . 4.3499999999999996 112.18 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -114.11 -68.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.775 0.321 . . . . 8.2400000000000002 110.596 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . 0.632 ' H ' ' H ' ' C' ' 186' ' ' GLY . . . 130.89 105.84 1.09 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.787 -0.721 . . . . 3.6699999999999999 112.436 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -169.62 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.627 0.251 . . . . 6.4900000000000002 111.471 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.418 HD11 HG22 ' C' ' 197' ' ' ILE . 37.6 pt -89.38 -179.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 3.1899999999999999 111.444 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.21 -162.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 4.3399999999999999 111.332 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -100.93 -62.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.9900000000000002 111.149 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.1 t -69.35 -16.68 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.419 . . . . 2.7999999999999998 111.844 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . 0.418 HG22 HD11 ' C' ' 193' ' ' ILE . 9.5 tp -59.28 -29.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 2.8599999999999999 111.205 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.6800000000000002 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 2.54 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.77 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 2.5299999999999998 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.8799999999999999 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.433 ' HG ' HH12 ' C' ' 72' ' ' ARG . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 2.48 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.95 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.685 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.8700000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76000000000000001 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 2.3599999999999999 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 2.6200000000000001 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.9299999999999999 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.6600000000000001 110.867 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 3.1099999999999999 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.4099999999999999 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.77 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.8399999999999999 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 4.3399999999999999 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 2.25 110.381 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . 0.626 ' HA ' HD22 ' C' ' 28' ' ' ASN . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.54 110.5 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 4.0099999999999998 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.541 HD11 ' HD3' ' C' ' 29' ' ' PRO . 58.6 tp -61.61 -28.43 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.6400000000000001 110.877 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 61.52 -82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 6.3799999999999999 110.956 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -149.43 122.77 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 6.0899999999999999 110.523 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 55.3 tp -58.46 136.41 57.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 7.0099999999999998 110.998 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -163.39 109.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 6.7999999999999998 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -115.47 153.81 30.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 7.0499999999999998 110.759 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.7 t -137.6 -57.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 6.8200000000000003 110.942 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -128.97 163.06 26.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 10.17 110.863 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 9.4499999999999993 110.866 179.973 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.487 H162 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.515 H201 ' HG ' ' B' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.486 ' H8 ' H161 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.81 0.338 . . . . 8.5199999999999996 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -71.47 118.65 14.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 6.0999999999999996 110.753 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.38 -70.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 6.6900000000000004 110.997 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.12 169.11 18.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 6.5199999999999996 111.202 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.424 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 40.6 t -126.94 143.14 51.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 3.77 110.516 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp -111.83 -22.57 11.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 3.8199999999999998 110.916 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 2.46 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.572 ' HB2' ' HB3' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.9299999999999999 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 1.0800000000000001 110.95 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 2.4100000000000001 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 2.2599999999999998 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 1.5800000000000001 110.949 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 1.54 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.89000000000000001 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.8200000000000001 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.8500000000000001 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 2.23 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.95999999999999996 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 1.4099999999999999 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.5699999999999998 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.8799999999999999 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 -68.21 -30.63 69.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.7999999999999998 110.466 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -60.41 -33.22 72.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.513 -0.551 . . . . 4.7999999999999998 109.513 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -83.91 -20.38 33.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 2.7799999999999998 109.972 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 22' ' ' PHE . 69.5 mt -77.92 -0.46 27.63 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.769 -0.65 . . . . 3.27 110.995 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.971 ' OG ' ' HA ' ' A' ' 32' ' ' VAL . 33.6 t -56.15 -32.6 64.44 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.527 -0.469 . . . . 2.52 111.353 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -40.14 -29.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.914 0.864 . . . . 6.0099999999999998 109.252 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.799 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 14.8 m-20 -66.48 -155.48 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 113.949 -1.478 . . . . 4.79 108.524 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.799 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 75.5 Cg_exo -7.12 114.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.212 3.274 . . . . 3.3900000000000001 116.819 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 41.92 32.13 0.26 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.494 -1.23 . . . . 7.4100000000000001 113.99 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 74.3 -47.4 1.68 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.535 -0.841 . . . . 4.9800000000000004 112.035 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.971 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 1.8 p -139.36 107.5 7.25 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.927 -0.397 . . . . 5.2199999999999998 109.927 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.566 ' HB3' ' HB2' ' A' ' 29' ' ' PRO . 86.0 Cg_endo -83.78 118.48 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.397 1.398 . . . . 4.1299999999999999 113.106 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -81.55 -25.14 36.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 4.0199999999999996 108.133 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 3.1600000000000001 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.3900000000000001 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.5 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 2.1099999999999999 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.8999999999999999 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.48 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.5299999999999998 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 2.0499999999999998 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.453 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.74 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.68999999999999995 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 2.1699999999999999 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.47 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.416 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.9199999999999999 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.55000000000000004 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.41 HD21 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 1.6499999999999999 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 1.1399999999999999 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 2.4199999999999999 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.4099999999999999 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 1.0900000000000001 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 1.47 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 1.23 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.8700000000000001 110.546 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.3399999999999999 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 2.3100000000000001 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 2.48 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.6400000000000001 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 2.1200000000000001 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.54 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.2999999999999998 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 3.4199999999999999 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.8900000000000001 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 1.4299999999999999 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.1599999999999999 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.429 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.7999999999999998 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 1.29 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.597 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 3.3999999999999999 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.46 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 2.21 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4199999999999999 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.416 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.73 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.9399999999999999 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.424 ' O ' HD21 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.9099999999999999 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.8200000000000001 111.62 -179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 2.1099999999999999 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.601 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.26 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 2.1099999999999999 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.9099999999999999 110.689 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 2.2200000000000002 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 2.54 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.8600000000000001 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.9199999999999999 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 2.4700000000000002 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 3.0699999999999998 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 2.0099999999999998 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.7 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 3.0800000000000001 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.98 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 6.0499999999999998 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.4100000000000001 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.7000000000000002 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.9699999999999998 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.9399999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 6.96 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.7000000000000002 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' N ' HD21 ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 3.25 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 3.1099999999999999 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.463 ' HA3' HD22 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.5900000000000001 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 4.0300000000000002 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 2.4300000000000002 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.8100000000000001 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.4300000000000002 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.456 ' H ' ' HG ' ' A' ' 107' ' ' SER . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.75 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . 0.454 ' HG2' HD23 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 3.2200000000000002 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 2.3799999999999999 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 2.2200000000000002 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.6499999999999999 111.28 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 3.2599999999999998 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 1.28 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 1.0900000000000001 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.425 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 2.1299999999999999 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.6400000000000001 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.3400000000000001 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.8799999999999999 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 2.0099999999999998 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.6699999999999999 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.4900000000000002 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.448 ' HB2' HG13 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.6000000000000001 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 4.79 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.8600000000000001 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.46 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 3.23 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.4900000000000002 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 2.3700000000000001 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.45 ' HA ' ' HG ' ' A' ' 134' ' ' CYS . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.96 111.249 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 2.6000000000000001 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.5699999999999998 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.45 ' HG ' ' HA ' ' A' ' 131' ' ' TRP . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 2.2599999999999998 110.952 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.77000000000000002 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.6099999999999999 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 2.0699999999999998 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.72 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 4.0099999999999998 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 3.3999999999999999 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 3.0600000000000001 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.422 HD12 HG22 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.6699999999999999 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.46 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 4.3099999999999996 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.598 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.6200000000000001 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 3.1200000000000001 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 3.0499999999999998 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.61 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 3.0899999999999999 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo -58.58 -21.06 53.02 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.3599999999999999 112.843 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 tp -75.41 111.17 10.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.7200000000000002 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 56.96 57.93 4.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.988 -0.551 . . . . 9.25 111.193 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.82 -41.9 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 3.1000000000000001 110.755 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -86.25 -6.28 59.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 4.8899999999999997 110.822 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.4 m -89.24 -14.44 35.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 4.2599999999999998 111.096 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -59.93 -25.92 65.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 6.1100000000000003 110.719 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -104.97 -14.88 15.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.146 -0.479 . . . . 3.3300000000000001 111.138 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -80.51 -42.08 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 4.2699999999999996 110.833 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -159.32 113.41 2.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 2.9399999999999999 110.575 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.3999999999999999 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.3700000000000001 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 3.27 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.6400000000000001 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 2.0899999999999999 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.6400000000000001 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.1499999999999999 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.8399999999999999 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 2.3999999999999999 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.95 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.7 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 4.1100000000000003 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 2.4100000000000001 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 2.02 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 2.0299999999999998 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 2.5499999999999998 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.9399999999999999 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.48 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 2.3300000000000001 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.437 ' HA2' HD13 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.73999999999999999 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.537 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 2.6499999999999999 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.537 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 1.1100000000000001 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 2.4500000000000002 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.9299999999999999 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . 0.46 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.9399999999999999 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.6099999999999999 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.522 HD13 ' HG2' ' A' ' 187' ' ' PRO . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.9100000000000001 111.331 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . -58.93 -50.92 62.6 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 2.1899999999999999 113.211 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.625 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 25.3 Cg_exo -35.49 151.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.292 2.661 . . . . 3.46 112.633 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.8 t 64.88 14.03 8.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.917 -0.772 . . . . 4.04 108.917 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.94 51.71 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.015 -0.993 . . . . 4.4800000000000004 112.26 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 60.8 t80 63.39 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.954 0.407 . . . . 8.6699999999999999 110.888 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -158.05 -135.09 1.83 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.904 -0.665 . . . . 3.4300000000000002 112.199 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . 0.625 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 53.8 t-105 -72.6 -38.22 67.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.896 0.379 . . . . 6.8099999999999996 110.717 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.459 ' HB ' HG22 ' A' ' 197' ' ' ILE . 17.7 mt -139.05 148.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.077 -0.51 . . . . 3.5899999999999999 111.107 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.402 HD22 ' H ' ' A' ' 191' ' ' GLY . 41.9 m-80 -141.63 166.4 24.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 3.3900000000000001 111.478 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 64.12 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.677 -0.692 . . . . 6.1100000000000003 112.001 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.7 m -53.38 -61.29 2.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 3.04 111.964 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.459 HG22 ' HB ' ' A' ' 193' ' ' ILE . 17.1 tt -56.36 -31.2 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 2.7999999999999998 111.867 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.85 -45.81 66.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 2.6600000000000001 111.43 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 2.2200000000000002 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.96 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.6699999999999999 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.79 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.407 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 2.3900000000000001 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 2.2599999999999998 111.591 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.537 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.8799999999999999 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.537 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79000000000000004 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 2.2999999999999998 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 2.8100000000000001 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 2.0499999999999998 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 3.4100000000000001 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.3799999999999999 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 3.5600000000000001 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.8399999999999999 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 4.1299999999999999 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.77 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.4399999999999999 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.9100000000000001 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.7599999999999998 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.5900000000000001 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.77 -57.13 3.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 4.0099999999999998 111.107 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 55.03 64.26 1.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.952 0.406 . . . . 6.3799999999999999 110.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -96.6 134.92 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 6.0700000000000003 110.928 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.8 tp -84.16 128.73 34.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 6.6600000000000001 111.029 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -77.1 134.2 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 6.9900000000000002 110.704 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -151.41 128.73 11.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 6.9400000000000004 110.874 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.3 t -120.73 111.53 17.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 6.8300000000000001 110.928 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -99.03 -25.55 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 11.49 110.759 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.214 -0.898 . . . . 9.4700000000000006 110.953 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.699 0.285 . . . . 9.0999999999999996 110.792 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -168.1 148.54 4.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 7.2000000000000002 111.057 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . 0.408 HD13 ' N ' ' B' ' 3' ' ' LEU . 6.8 mp -100.01 138.76 36.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 6.7300000000000004 110.858 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.55 -4.99 57.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 5.4400000000000004 111.0 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -148.03 99.21 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 4.1299999999999999 110.939 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.07 178.36 5.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 3.6000000000000001 110.874 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.8799999999999999 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.436 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 2.1699999999999999 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1899999999999999 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 2.21 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 2.3500000000000001 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 1.48 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 1.51 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.82999999999999996 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.9299999999999999 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.8 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . 0.4 HD13 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.79 110.567 179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.4 ' N ' HD13 ' B' ' 17' ' ' ILE . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 1.3700000000000001 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.7599999999999998 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.6899999999999999 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' B' ' 25' ' ' LEU . 4.0 t80 -69.36 -35.33 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 5.1500000000000004 110.198 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -56.9 -31.91 65.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.427 -0.583 . . . . 4.1799999999999997 109.427 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -85.38 -19.82 30.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.638 -0.71 . . . . 2.77 110.557 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . 0.504 HD12 ' HA ' ' B' ' 22' ' ' PHE . 28.5 mt -65.41 2.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.906 -0.588 . . . . 3.4900000000000002 112.026 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 29.3 t -46.53 -22.64 0.29 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.748 0.277 . . . . 3.0299999999999998 111.748 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -47.98 -29.86 3.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.149 0.975 . . . . 6.4500000000000002 108.639 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.748 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.29 -153.97 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 113.506 -1.679 . . . . 5.3700000000000001 108.451 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.748 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 33.4 Cg_exo -4.17 -77.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.356 2.704 . . . . 4.2999999999999998 115.909 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 53.0 53.7 11.62 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.804 -0.813 . . . . 8.5600000000000005 108.804 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.07 0.2 8.95 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.937 -1.029 . . . . 4.6100000000000003 110.834 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' B' ' 33' ' ' PRO . 1.2 t -112.77 156.07 43.07 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 115.433 -0.383 . . . . 5.4800000000000004 110.301 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' B' ' 32' ' ' VAL . 34.2 Cg_exo -35.9 131.33 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.234 2.623 . . . . 4.3899999999999997 114.03 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 36' ' ' GLU . 4.2 pt20 -76.9 -12.5 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.672 -1.149 . . . . 4.2999999999999998 111.55 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.581 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER -38.36 -22.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.5899999999999999 113.767 -177.883 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . 0.581 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.5699999999999998 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.8799999999999999 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 2.2200000000000002 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . 0.515 HG13 ' HG ' ' B' ' 86' ' ' SER . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 2.5299999999999998 111.581 -179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.8999999999999999 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.6200000000000001 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 2.3199999999999998 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.43 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 1.3899999999999999 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.80000000000000004 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.424 HG22 HG12 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 2.2200000000000002 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . 0.484 ' HE1' HG23 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 2.5600000000000001 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.553 ' HG ' ' HG1' ' B' ' 79' ' ' THR . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.74 111.59 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.57999999999999996 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 1.4299999999999999 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 1.23 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.49 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.6299999999999999 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 1.1699999999999999 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 1.45 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 1.3600000000000001 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . 0.422 HG22 HD13 ' C' ' 130' ' ' LEU . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 2.02 110.268 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.71 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.8900000000000001 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 2.3500000000000001 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.1800000000000002 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.2599999999999998 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.79 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.52 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.6899999999999999 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 2.25 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.3999999999999999 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.414 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.23 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.8999999999999999 111.64 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.465 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 1.3100000000000001 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.453 ' NH2' HG22 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.71 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.467 ' HA ' ' HB2' ' B' ' 76' ' ' TRP . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 2.6699999999999999 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.465 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 2.0 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.3100000000000001 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . 0.467 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.6099999999999999 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.421 ' SD ' HD23 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.8300000000000001 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.8899999999999999 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.553 ' HG1' ' HG ' ' B' ' 47' ' ' SER . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.6000000000000001 111.582 -179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 2.1200000000000001 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.607 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.3100000000000001 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 2.0800000000000001 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 2.21 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 2.3599999999999999 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.461 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 2.5099999999999998 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' SER . . . . . 0.515 ' HG ' HG13 ' B' ' 39' ' ' VAL . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.72 111.053 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . 0.423 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.78 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.73 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . 0.461 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.8799999999999999 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 2.1000000000000001 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.5 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 3.1499999999999999 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 3.1499999999999999 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 5.0800000000000001 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 3.1899999999999999 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.6500000000000004 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.9699999999999998 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.2400000000000002 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . 0.51 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 6.25 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.6200000000000001 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 3.0600000000000001 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . 0.51 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.6899999999999999 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.53 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 3.6099999999999999 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.6699999999999999 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.7999999999999998 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 2.3100000000000001 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.546 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.5699999999999998 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.483 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 3.3799999999999999 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.6200000000000001 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 2.1699999999999999 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . 0.447 HG12 H182 ' B' ' 301' ' ' RET . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.6499999999999999 111.533 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . 0.483 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.9500000000000002 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 1.21 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 1.1100000000000001 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.59999999999999998 112.013 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.421 HD23 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.98 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 2.0800000000000001 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.3100000000000001 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . 0.505 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.71 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 2.3300000000000001 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.8900000000000001 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . 0.511 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 3.0800000000000001 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.9699999999999998 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 2.0 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 3.0600000000000001 110.802 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 3.2200000000000002 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.6099999999999999 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.6699999999999999 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 2.5699999999999998 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 2.27 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . 0.41 ' SG ' HD21 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 2.2999999999999998 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.69999999999999996 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . 0.443 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 2.0800000000000001 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 2.6499999999999999 110.979 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 1.51 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 2.3999999999999999 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.48 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 2.4500000000000002 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.546 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 3.3500000000000001 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.47 HD12 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.9299999999999999 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 5.0800000000000001 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . 0.588 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.5900000000000001 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . 0.484 HG13 HD23 ' B' ' 150' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.6699999999999999 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . 0.47 ' HE1' HD12 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 2.1099999999999999 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.639 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 14.6 m120 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.79 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.639 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo -62.56 -4.05 5.12 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.3599999999999999 112.979 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . 0.519 HD13 ' HG2' ' B' ' 151' ' ' ARG . 1.2 tm? -64.45 -69.04 0.31 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 3.29 110.929 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . 0.519 ' HG2' HD13 ' B' ' 150' ' ' LEU . 16.4 ptm180 -148.11 49.47 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 8.9000000000000004 111.17 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.31 -33.4 75.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.285 -0.416 . . . . 2.8399999999999999 111.094 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -75.81 -36.4 59.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 4.96 110.736 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' B' ' 151' ' ' ARG . 7.0 m -70.72 -9.19 56.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 4.1699999999999999 111.151 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.56 -44.78 85.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 5.71 111.053 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.4 p -79.75 -11.88 59.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 3.75 111.24 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -81.86 -39.06 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 4.6299999999999999 110.764 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -163.46 113.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 3.1099999999999999 110.723 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p -78.14 -17.83 56.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 2.46 111.034 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . 0.421 ' HB2' HH22 ' B' ' 151' ' ' ARG . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 3.02 110.828 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 2.1499999999999999 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 3.25 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.77 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.52 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.9399999999999999 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.7799999999999998 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . 0.423 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 2.1499999999999999 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 2.2400000000000002 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.6699999999999999 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 4.1299999999999999 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 2.4700000000000002 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.98 111.377 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 2.1000000000000001 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 2.5800000000000001 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.8700000000000001 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.501 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 2.0299999999999998 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67000000000000004 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.608 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 2.5600000000000001 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.608 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 1.1799999999999999 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 2.1000000000000001 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.53 HG21 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.6499999999999999 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 3.1699999999999999 112.084 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 2.4100000000000001 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt -61.66 -29.85 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 3.1200000000000001 111.853 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.22 164.74 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.472 -0.87 . . . . 2.0600000000000001 112.92 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 98.37 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.675 2.25 . . . . 3.29 112.594 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 66.1 m 55.47 60.56 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 4.5 111.457 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.28 -165.13 26.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.487 -0.863 . . . . 4.7000000000000002 113.054 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.13 88.38 7.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 8.4800000000000004 111.151 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.15 -134.95 34.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 3.9300000000000002 112.794 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -63.37 88.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.85 0.357 . . . . 7.3799999999999999 110.767 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 43.1 mm -135.15 151.17 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.003 -0.544 . . . . 3.6299999999999999 110.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.12 -75.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 3.8599999999999999 111.474 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -155.97 -29.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.591 -0.277 . . . . 6.2300000000000004 111.393 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 11.3 p -54.36 -62.42 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.49 -0.323 . . . . 2.8799999999999999 111.376 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 2.9 mp -62.53 -30.5 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 2.8300000000000001 110.833 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.4900000000000002 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 199' ' ' THR . . . . . 0.453 HG22 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 2.2799999999999998 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.9199999999999999 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 2.3500000000000001 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 2.8300000000000001 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 2.27 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.78 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.657 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 2.0600000000000001 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.657 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77000000000000002 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 2.4300000000000002 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 2.5899999999999999 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.9299999999999999 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.6499999999999999 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 3.1000000000000001 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.3899999999999999 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 3.0600000000000001 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.3500000000000001 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 4.3700000000000001 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 2.0 110.516 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.2200000000000002 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 3.0899999999999999 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 4.1600000000000001 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.6699999999999999 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.05 -57.55 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.9700000000000002 110.796 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 54.88 62.3 2.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 6.5700000000000003 110.69 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -95.45 138.25 33.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 5.9100000000000001 110.95 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 7.6 mp -109.51 102.33 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 7.2599999999999998 110.843 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -81.93 -77.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 7.5099999999999998 111.046 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.88 78.38 0.11 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.161 -0.472 . . . . 8.2100000000000009 110.802 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.4 m -90.57 167.09 12.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 8.0999999999999996 111.085 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.59 37.45 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 14.06 110.808 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 10.4 110.79 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.9 tpp . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.902 0.382 . . . . 8.3499999999999996 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -121.22 140.57 51.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 6.8499999999999996 110.67 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . 0.494 ' H ' HD21 ' C' ' 3' ' ' LEU . 2.4 pt? -133.86 154.7 50.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 6.6799999999999997 110.877 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.09 110.96 9.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 4.8200000000000003 110.762 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' C' ' 55' ' ' ALA . 66.3 m -64.32 151.5 43.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 3.5299999999999998 110.835 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp -124.02 -23.76 4.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 3.2400000000000002 110.871 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.7599999999999998 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.473 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 2.3399999999999999 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.25 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.46 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . 0.403 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 2.3799999999999999 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.5800000000000001 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 1.46 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 1.04 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.95 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 2.1400000000000001 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 2.3399999999999999 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 1.02 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.51 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.5800000000000001 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -57.21 -42.98 82.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.5699999999999998 110.993 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.86 -28.29 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 5.9299999999999997 110.82 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -57.72 -48.58 79.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 5.1600000000000001 110.286 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -72.38 -19.19 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 2.79 110.622 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 16.0 tp -69.42 0.02 5.76 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.826 -0.625 . . . . 3.3700000000000001 111.781 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.423 ' C ' ' N ' ' C' ' 28' ' ' ASN . 12.6 t -54.79 -22.34 13.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 2.7400000000000002 111.835 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -50.72 -24.48 3.44 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.181 -1.044 . . . . 6.2800000000000002 108.181 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . 0.692 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 0.2 OUTLIER -71.09 -157.45 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 113.508 -1.678 . . . . 4.79 107.8 177.501 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.692 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 32.2 Cg_exo -12.82 105.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.454 2.77 . . . . 3.9199999999999999 115.616 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.07 96.37 5.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 9.3900000000000006 108.795 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.07 -0.26 66.5 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.06 -1.216 . . . . 4.2699999999999996 110.06 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.482 HG12 ' HD2' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -111.42 162.54 20.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.221 -0.99 . . . . 5.5 109.719 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.577 ' HB3' ' CD2' ' C' ' 35' ' ' TYR . 10.4 Cg_exo -33.52 116.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.843 2.362 . . . . 3.6000000000000001 115.108 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -84.33 -20.34 32.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 114.617 -1.174 . . . . 4.2699999999999996 108.257 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -49.52 -23.21 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.329 -1.759 . . . . 3.7799999999999998 112.343 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.7200000000000002 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.9800000000000004 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.463 HD22 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 2.4100000000000001 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 2.4300000000000002 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.8500000000000001 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.6299999999999999 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . 0.504 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 2.29 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.45 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 1.3799999999999999 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.90000000000000002 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 2.27 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 2.2400000000000002 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' SER . . . . . 0.413 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.71 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.57999999999999996 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.8200000000000001 111.212 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 1.28 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 2.46 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.7 110.23 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 1.2 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.4099999999999999 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' C' ' 5' ' ' SER . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 1.3200000000000001 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.96 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . 0.546 ' HA ' ' HZ1' ' C' ' 60' ' ' LYS . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.9399999999999999 111.108 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 2.25 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . 0.546 ' HZ1' ' HA ' ' C' ' 57' ' ' ASP . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 3.4300000000000002 111.225 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 2.5499999999999998 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.27 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.8500000000000001 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.6200000000000001 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 3.2599999999999998 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 2.2599999999999998 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.51 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.431 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.3999999999999999 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.8199999999999998 111.254 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 1.3899999999999999 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 2.3599999999999999 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 2.7000000000000002 111.22 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.8200000000000001 110.175 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . 0.413 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.3300000000000001 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 2.4100000000000001 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.9199999999999999 110.486 179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.79 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.97 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.598 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 2.2000000000000002 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.598 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.25 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.8300000000000001 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 2.1400000000000001 109.947 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 2.2400000000000002 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.6699999999999999 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.8 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . 0.405 ' HB3' HD12 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 2.1200000000000001 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 2.29 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 4.0300000000000002 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 2.0699999999999998 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . 0.439 ' HB2' HD21 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.47 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.8599999999999999 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.6299999999999999 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 5.46 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.8399999999999999 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.8399999999999999 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.8600000000000003 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 6.0700000000000003 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.79 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 3.1499999999999999 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.8799999999999999 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.72 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 3.6200000000000001 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.8199999999999998 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.7000000000000002 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.54 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.8799999999999999 111.511 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.71 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.484 HG23 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 2.52 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . 0.424 HG12 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 2.1699999999999999 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . 0.485 HG11 H183 ' C' ' 301' ' ' RET . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.5900000000000001 111.234 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.477 HG22 HD22 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 3.0299999999999998 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 1.3300000000000001 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' SER . . . . . 0.456 ' HG ' ' HA2' ' C' ' 135' ' ' GLY . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 1.3100000000000001 110.371 179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.65000000000000002 112.594 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.477 HD22 HG22 ' C' ' 113' ' ' ILE . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 2.0299999999999998 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.525 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 2.23 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 1.4399999999999999 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . 0.525 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.79 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.5499999999999998 110.907 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.33 -27.31 21.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.3100000000000001 110.825 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . 0.637 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 38.4 ttm180 -118.59 138.05 52.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 3.52 110.813 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.89 -19.34 61.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 4.2400000000000002 111.238 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . 0.637 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 62.1 t90 -77.07 -50.25 13.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 5.4500000000000002 110.987 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' C' ' 124' ' ' ARG . 14.4 p -66.42 -24.11 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.73 111.061 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 3.3799999999999999 110.622 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 3.0 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . 0.475 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 2.48 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . 0.475 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.74 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 2.5699999999999998 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.7000000000000002 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 2.2000000000000002 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . 0.456 ' HA2' ' HG ' ' C' ' 115' ' ' SER . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.72999999999999998 112.924 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 2.1000000000000001 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.76 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.51 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.9399999999999999 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.54 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . 0.482 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 2.4700000000000002 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.482 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 3.0699999999999998 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.9399999999999999 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 4.5199999999999996 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . 0.478 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.6499999999999999 113.155 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . 0.403 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.9300000000000002 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.8599999999999999 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 18.2 t30 -100.36 -52.68 0.18 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.7000000000000002 112.46 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 31.9 Cg_exo -58.78 -15.37 26.13 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.086 1.857 . . . . 2.46 112.987 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.91 110.35 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 3.46 111.087 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . 0.408 ' HB3' ' HB ' ' C' ' 154' ' ' THR . 98.6 mtt180 58.42 61.08 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 9.1199999999999992 111.19 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.94 -49.72 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.548 . . . . 2.9700000000000002 111.107 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.61 5.09 37.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 4.8899999999999997 110.942 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' C' ' 151' ' ' ARG . 44.4 m -85.29 -25.46 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 4.1500000000000004 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -61.25 -27.95 68.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 5.5800000000000001 110.873 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 24.1 m -81.52 -21.05 38.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 3.5800000000000001 110.824 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.49 -71.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 4.1799999999999997 110.741 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 77.8 p -127.84 118.28 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 2.6800000000000002 110.855 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -21.44 50.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 3.1800000000000002 110.963 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.1800000000000002 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.9900000000000002 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 2.2400000000000002 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.3900000000000001 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.6499999999999999 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.6299999999999999 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.9199999999999999 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.8 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 2.21 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 2.0299999999999998 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . 0.49 ' HH ' ' HA3' ' C' ' 212' ' ' GLY . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.8799999999999999 110.79 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 2.3100000000000001 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 2.0 111.956 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 2.4199999999999999 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.7000000000000002 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.1100000000000001 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.517 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 2.3100000000000001 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . 0.475 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.572 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 2.71 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.572 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 1.0700000000000001 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.517 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 2.0800000000000001 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.463 HG23 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.71 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.8999999999999999 112.147 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 2.2000000000000002 112.232 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' C' ' 182' ' ' VAL . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 3.23 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -170.65 165.75 38.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.9099999999999999 112.391 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.88 97.58 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.152 . . . . 3.46 112.446 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 61.18 45.51 8.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 4.2199999999999998 111.267 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.94 -157.57 27.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.431 -0.89 . . . . 4.3499999999999996 113.028 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . 0.4 ' HA ' ' CD1' ' C' ' 185' ' ' ILE . 71.7 m-85 -55.88 -66.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.607 0.241 . . . . 8.2400000000000002 111.572 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 176.12 131.44 1.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.891 -0.671 . . . . 3.6699999999999999 112.374 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.4 m95 55.64 21.15 4.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.893 0.378 . . . . 6.4900000000000002 110.786 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 2.3 pp -90.45 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 3.1899999999999999 111.104 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -124.08 -168.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 4.3399999999999999 111.145 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -58.26 -30.46 66.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 5.9900000000000002 111.405 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 99.0 m -52.17 -58.41 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 2.7999999999999998 111.246 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.59 -40.18 87.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 2.8599999999999999 111.208 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 2.54 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.77 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 2.5299999999999998 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.8799999999999999 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 2.48 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.95 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.8700000000000001 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76000000000000001 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 2.3599999999999999 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 2.6200000000000001 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.9299999999999999 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.6600000000000001 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 3.1099999999999999 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . 0.49 ' HA3' ' HH ' ' C' ' 171' ' ' TYR . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.4099999999999999 112.376 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.77 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.8399999999999999 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 4.3399999999999999 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 2.25 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2000000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.54 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 4.0099999999999998 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.6 -57.11 4.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.6400000000000001 111.082 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 56.64 60.97 2.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 6.3799999999999999 110.932 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.93 -176.55 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 6.0899999999999999 110.895 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 50.3 tp -127.44 132.69 50.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 7.0099999999999998 110.696 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.34 115.92 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 6.7999999999999998 111.025 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.49 150.94 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 7.0499999999999998 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -132.81 143.54 49.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 6.8200000000000003 111.065 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -130.61 -48.95 1.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 10.17 110.746 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.287 -0.863 . . . . 9.4499999999999993 110.805 179.803 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.474 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.469 ' H8 ' H172 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.485 H183 HG11 ' C' ' 112' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.778 0.323 . . . . 8.5199999999999996 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -91.74 149.16 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 6.0999999999999996 110.786 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.611 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 63.5 tp -148.64 -63.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 6.6900000000000004 110.843 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.611 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 46.3 mt-10 -130.23 -74.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 6.5199999999999996 110.864 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p 49.04 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.003 -0.544 . . . . 3.77 111.271 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 6' ' ' LEU . 1.6 pt? -107.94 5.27 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 3.8199999999999998 111.162 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.417 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 2.46 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.477 ' HB2' ' HB1' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.9299999999999999 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 1.0800000000000001 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 2.4100000000000001 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 2.2599999999999998 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.405 HG13 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 1.5800000000000001 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 1.54 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.89000000000000001 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.8200000000000001 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.8500000000000001 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.507 ' HA ' HD13 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 2.23 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.95999999999999996 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 1.4099999999999999 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD13 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.5699999999999998 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.8799999999999999 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.619 ' O ' ' OG ' ' A' ' 26' ' ' SER . 75.2 m-85 -76.59 -21.06 56.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.7999999999999998 110.522 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.705 ' HA ' ' HG ' ' A' ' 26' ' ' SER . 88.5 t90 -69.9 -31.27 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 4.7999999999999998 110.655 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.0 p -79.3 -44.42 21.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.063 -0.517 . . . . 2.7799999999999998 110.54 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.0 tp -76.17 -3.88 38.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 3.27 109.982 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.705 ' HG ' ' HA ' ' A' ' 23' ' ' TRP . 0.7 OUTLIER -60.33 -22.32 63.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 2.52 110.808 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.429 ' HE ' ' ND2' ' A' ' 28' ' ' ASN . 58.4 ttp180 -46.3 -31.52 2.59 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.269 0.557 . . . . 6.0099999999999998 109.643 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.429 ' ND2' ' HE ' ' A' ' 27' ' ' ARG . 7.9 p30 -176.06 131.96 0.4 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.976 -1.011 . . . . 4.79 109.898 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 60.8 Cg_endo -92.32 -177.83 0.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.747 2.298 . . . . 3.3900000000000001 112.466 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -85.32 38.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 7.4100000000000001 111.119 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.86 -24.58 31.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 4.9800000000000004 112.478 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.87 120.84 83.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.371 0.129 . . . . 5.2199999999999998 110.837 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 43.0 Cg_exo -55.42 165.55 3.15 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.397 2.065 . . . . 4.1299999999999999 112.777 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.08 -18.26 45.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 4.0199999999999996 112.267 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' HD1' ' HB2' ' A' ' 33' ' ' PRO . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 3.1600000000000001 111.209 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.3900000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.5 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.585 HD22 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 2.1099999999999999 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.8999999999999999 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.48 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.5299999999999998 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 2.0499999999999998 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 39' ' ' VAL . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.74 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.68999999999999995 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 2.1699999999999999 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TRP . . . . . 0.431 ' HE1' ' HG1' ' B' ' 114' ' ' THR . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.47 111.37 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.9199999999999999 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.55000000000000004 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 1.1399999999999999 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.42 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 2.4199999999999999 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.405 ' HB2' HG13 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.4099999999999999 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 1.0900000000000001 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.407 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 1.47 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.477 ' HB1' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 1.23 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.8700000000000001 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.3399999999999999 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 2.3100000000000001 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 2.48 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.6400000000000001 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 2.1200000000000001 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.54 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.2999999999999998 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 3.4199999999999999 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.8900000000000001 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 1.4299999999999999 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.432 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.1599999999999999 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.7999999999999998 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 1.29 111.997 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.432 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 3.3999999999999999 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.447 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.46 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 2.21 110.316 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.4199999999999999 109.296 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.73 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' MET . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.9399999999999999 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.9099999999999999 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.405 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.8200000000000001 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.625 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 2.1099999999999999 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.625 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.26 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 2.1099999999999999 110.66 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.458 HD11 H202 ' A' ' 301' ' ' RET . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.9099999999999999 109.5 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.568 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 2.2200000000000002 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 2.54 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.8600000000000001 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.9199999999999999 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 2.4700000000000002 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 3.0699999999999998 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 2.0099999999999998 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.7 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 3.0800000000000001 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.98 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 6.0499999999999998 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.4100000000000001 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.569 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.7000000000000002 111.027 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.9699999999999998 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.9399999999999999 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 6.96 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.7000000000000002 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 3.25 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 3.1099999999999999 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.5900000000000001 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 4.0300000000000002 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.568 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 2.4300000000000002 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.8100000000000001 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.4300000000000002 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.558 HG23 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.75 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 3.2200000000000002 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 2.3799999999999999 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 2.2200000000000002 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.6499999999999999 111.47 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 3.2599999999999998 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 1.28 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 1.0900000000000001 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 2.1299999999999999 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.6400000000000001 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.507 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.3400000000000001 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 2.0099999999999998 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.638 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.6699999999999999 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.406 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.4900000000000002 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.788 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.6000000000000001 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.788 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 4.79 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.442 ' O ' ' N ' ' A' ' 129' ' ' TYR . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.8600000000000001 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.745 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 3.23 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.443 ' N ' ' HD2' ' A' ' 128' ' ' ARG . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.4900000000000002 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.421 HD23 ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 2.3700000000000001 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' TRP . . . . . 0.745 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.96 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 2.6000000000000001 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.5699999999999998 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 2.2599999999999998 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.77000000000000002 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.6099999999999999 111.064 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' CYS . . . . . 0.46 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 2.0699999999999998 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.72 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 4.0099999999999998 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.46 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 3.3999999999999999 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 3.0600000000000001 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.558 HG12 HG23 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.6699999999999999 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.46 110.925 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 4.3099999999999996 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 3.1200000000000001 111.189 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 3.0499999999999998 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASN . . . . . 0.44 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 3.0899999999999999 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo -69.82 0.17 6.09 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.3599999999999999 112.556 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.51 101.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 3.7200000000000002 110.856 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.457 HH11 HG23 ' A' ' 154' ' ' THR . 24.2 mmt180 57.97 27.64 15.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 9.25 111.15 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.68 -55.4 8.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 3.1000000000000001 110.87 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -82.28 -4.13 56.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 4.8899999999999997 110.754 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.457 HG23 HH11 ' A' ' 151' ' ' ARG . 15.4 m -92.56 -15.41 26.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 4.2599999999999998 111.019 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -58.82 -22.8 59.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 6.1100000000000003 110.859 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 p -84.32 -29.86 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 3.3300000000000001 111.047 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -77.37 -53.81 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 4.2699999999999996 110.768 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p -156.71 117.68 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 2.9399999999999999 110.91 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.3999999999999999 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.3700000000000001 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 3.27 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 2.02 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.6400000000000001 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 2.0899999999999999 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' TYR . . . . . 0.417 ' O ' HG21 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.6400000000000001 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.8399999999999999 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 2.3999999999999999 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.95 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.7 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 4.1100000000000003 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 2.4100000000000001 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 2.02 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 2.0299999999999998 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 2.5499999999999998 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.9399999999999999 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 2.3300000000000001 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.73999999999999999 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' TYR . . . . . 0.551 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 2.6499999999999999 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 1.1100000000000001 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 2.4500000000000002 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.9299999999999999 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.9399999999999999 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . 0.477 HG21 HG22 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.6099999999999999 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . 0.477 HG22 HG21 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.9100000000000001 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.62 -152.06 20.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 2.1899999999999999 112.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.503 ' HD3' HD13 ' A' ' 193' ' ' ILE . 88.7 Cg_endo -80.33 167.68 19.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.687 2.258 . . . . 3.46 112.047 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.2 t 57.94 14.0 2.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 4.04 110.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.54 -74.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 4.4800000000000004 112.002 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -175.44 87.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 8.6699999999999999 110.605 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -161.05 -171.9 27.65 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 3.4300000000000002 112.701 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -117.35 36.16 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 6.8099999999999996 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.503 HD13 ' HD3' ' A' ' 187' ' ' PRO . 76.5 mt -103.21 139.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 3.5899999999999999 110.963 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.74 148.42 51.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 3.3900000000000001 110.867 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -64.0 -17.88 63.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.953 -0.567 . . . . 6.1100000000000003 111.655 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 97.6 m -57.49 -50.33 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 3.04 110.886 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.34 -30.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 2.7999999999999998 110.791 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.5 -57.53 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 2.6600000000000001 110.826 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 2.2200000000000002 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.96 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.6699999999999999 110.685 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.79 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.451 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 2.3900000000000001 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 2.2599999999999998 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . 0.655 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.8799999999999999 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.655 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79000000000000004 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 2.2999999999999998 110.296 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' PHE . . . . . 0.401 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 2.8100000000000001 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 2.0499999999999998 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.6800000000000002 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 208' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 3.4100000000000001 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.3799999999999999 112.149 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 3.5600000000000001 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.8399999999999999 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 4.1299999999999999 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.77 110.664 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.4399999999999999 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.9100000000000001 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.7599999999999998 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.5900000000000001 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.0 -6.12 58.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 4.0099999999999998 110.953 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.4 -47.87 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 6.3799999999999999 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -97.62 99.69 11.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 6.0700000000000003 111.349 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.7 mt -145.09 -178.39 6.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 6.6600000000000001 110.581 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -143.68 82.11 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 6.9900000000000002 110.694 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.07 -57.18 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.9400000000000004 110.975 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -161.06 -61.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 6.8300000000000001 111.205 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 55.35 78.84 0.17 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.266 -0.424 . . . . 11.49 110.801 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.181 -0.914 . . . . 9.4700000000000006 111.056 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.848 0.356 . . . . 9.0999999999999996 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -110.99 102.03 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 7.2000000000000002 110.703 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.14 133.56 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.413 . . . . 6.7300000000000004 111.056 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.62 111.21 18.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.604 . . . . 5.4400000000000004 111.154 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 37.8 t -122.82 126.96 48.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 4.1299999999999999 110.722 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -109.7 -9.74 14.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 3.6000000000000001 110.944 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.441 ' N ' HD23 ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.8799999999999999 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' HIS . . . . . 0.502 ' HB2' ' HB1' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 2.1699999999999999 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1899999999999999 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 2.21 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' TYR . . . . . 0.472 ' HH ' ' HB2' ' B' ' 206' ' ' PRO . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 2.3500000000000001 110.485 179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.411 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 1.48 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 1.51 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.82999999999999996 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.9299999999999999 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.8 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.79 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 1.3700000000000001 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.7599999999999998 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' HIS . . . . . 0.514 ' HA ' ' HB2' ' B' ' 24' ' ' SER . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.6899999999999999 109.988 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.596 ' HA ' ' HG3' ' B' ' 27' ' ' ARG . 42.3 t80 -57.84 -31.6 66.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 5.1500000000000004 110.202 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -104.08 3.75 33.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.22 -0.9 . . . . 4.1799999999999997 109.042 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' SER . . . . . 0.514 ' HB2' ' HA ' ' B' ' 21' ' ' HIS . 46.5 t -73.31 -70.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.308 -0.557 . . . . 2.77 111.61 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 tp -101.29 -82.12 0.47 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 116.516 -2.074 . . . . 3.4900000000000002 112.978 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' SER . . . . . 0.552 ' C ' ' N ' ' B' ' 28' ' ' ASN . 5.0 p -115.89 -60.5 1.86 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.297 0.57 . . . . 3.0299999999999998 110.741 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 18.3 mmm180 36.31 28.92 0.01 OUTLIER 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.133 -1.394 . . . . 6.4500000000000002 108.773 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASN . . . . . 0.682 ' HB3' ' CD ' ' B' ' 29' ' ' PRO . 13.3 m120 -137.48 -162.53 0.05 OUTLIER Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 112.785 -2.007 . . . . 5.3700000000000001 106.978 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.682 ' CD ' ' HB3' ' B' ' 28' ' ' ASN . 55.0 Cg_endo -91.43 166.15 3.51 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.555 1.503 . . . . 4.2999999999999998 113.031 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -111.05 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 8.5600000000000005 110.338 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.11 6.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.901 -0.666 . . . . 4.6100000000000003 111.903 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.437 HG11 ' HD2' ' B' ' 33' ' ' PRO . 96.7 t -84.48 138.06 38.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.536 -0.172 . . . . 5.4800000000000004 110.536 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.576 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 82.3 Cg_exo -45.7 164.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.666 2.244 . . . . 4.3899999999999997 113.411 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.41 -16.14 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.075 -0.966 . . . . 4.2999999999999998 113.064 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' TYR . . . . . 0.576 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 6.1 p90 -40.74 -36.19 0.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.5899999999999999 111.951 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.5699999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.8799999999999999 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 2.2200000000000002 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 2.5299999999999998 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.8999999999999999 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.6200000000000001 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 2.3199999999999998 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.51 HG22 HG21 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 1.3899999999999999 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.80000000000000004 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 2.2200000000000002 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 2.5600000000000001 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.412 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.74 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.57999999999999996 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 1.4299999999999999 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 1.23 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.49 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.411 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.6299999999999999 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 1.1699999999999999 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 1.45 110.361 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 1.3600000000000001 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 2.02 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLN . . . . . 0.525 ' HG3' HD11 ' C' ' 118' ' ' ILE . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.71 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.8900000000000001 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 2.3500000000000001 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.1800000000000002 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.2599999999999998 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.79 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.52 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.6899999999999999 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 2.25 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.3999999999999999 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' HIS . . . . . 0.539 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.23 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.8999999999999999 111.203 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' ALA . . . . . 0.402 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 1.3100000000000001 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.71 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' TYR . . . . . 0.445 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 2.6699999999999999 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' ILE . . . . . 0.462 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 2.0 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . 0.462 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.3100000000000001 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.6099999999999999 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.8300000000000001 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.445 HG11 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.8899999999999999 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' THR . . . . . 0.51 HG21 HG22 ' B' ' 43' ' ' ILE . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.6000000000000001 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' THR . . . . . 0.607 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 2.1200000000000001 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' PRO . . . . . 0.607 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.3100000000000001 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' LEU . . . . . 0.496 HD21 HD13 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 2.0800000000000001 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 2.21 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' LEU . . . . . 0.542 HD23 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 2.3599999999999999 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.496 HD13 HD21 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 2.5099999999999998 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.72 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.78 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.73 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.8799999999999999 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 2.1000000000000001 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.5 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 3.1499999999999999 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 3.1499999999999999 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 5.0800000000000001 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 3.1899999999999999 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.6500000000000004 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.9699999999999998 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 6.25 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.6200000000000001 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 3.0600000000000001 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.6899999999999999 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLY . . . . . 0.585 ' HA3' HD22 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.53 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 3.6099999999999999 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' LEU . . . . . 0.542 ' HB3' HD23 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.6699999999999999 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.7999999999999998 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 2.3100000000000001 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.563 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.5699999999999998 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLN . . . . . 0.429 ' NE2' HG23 ' B' ' 80' ' ' THR . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 3.3799999999999999 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 2.6200000000000001 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 2.1699999999999999 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.6499999999999999 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.9500000000000002 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . 0.503 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 1.21 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 1.1100000000000001 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.59999999999999998 112.745 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.98 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 2.0800000000000001 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.3100000000000001 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.71 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 2.3300000000000001 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.8900000000000001 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 3.0800000000000001 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.9699999999999998 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 2.0 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 3.0600000000000001 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 3.2200000000000002 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.6099999999999999 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.6699999999999999 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 2.5699999999999998 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 2.27 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 2.2999999999999998 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.69999999999999996 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 2.0800000000000001 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 2.6499999999999999 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 1.51 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 2.3999999999999999 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.48 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' ILE . . . . . 0.563 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 3.3500000000000001 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.9299999999999999 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 5.0800000000000001 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.5900000000000001 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.6699999999999999 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 2.1099999999999999 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' ASN . . . . . 0.625 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.79 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' PRO . . . . . 0.625 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo -71.78 -0.2 8.02 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.3599999999999999 112.198 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.74 100.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 3.29 111.013 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 54.31 27.87 8.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.51 . . . . 8.9000000000000004 110.978 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -45.82 14.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 2.8399999999999999 111.26 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.55 -37.1 60.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 4.96 111.098 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 72.5 p -74.27 5.04 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 4.1699999999999999 111.462 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.62 -28.18 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.267 -0.424 . . . . 5.71 110.695 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.3 t -83.31 -26.12 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 3.75 111.32 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -72.06 -72.61 0.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 4.6299999999999999 110.958 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 t -139.61 115.13 9.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.545 . . . . 3.1099999999999999 110.85 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m -76.37 -25.41 54.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 2.46 110.861 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 3.02 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 2.1499999999999999 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 3.25 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.77 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.52 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.9399999999999999 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.7799999999999998 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 2.1499999999999999 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 2.2400000000000002 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.6699999999999999 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' TYR . . . . . 0.407 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 4.1299999999999999 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 2.4700000000000002 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.98 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 2.1000000000000001 111.905 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 2.5800000000000001 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' TRP . . . . . 0.408 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.8700000000000001 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 2.0299999999999998 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' GLY . . . . . 0.5 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67000000000000004 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' TYR . . . . . 0.479 ' N ' ' HD2' ' B' ' 180' ' ' PRO . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 2.5600000000000001 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 1.1799999999999999 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' ILE . . . . . 0.5 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 2.1000000000000001 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' VAL . . . . . 0.448 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.6499999999999999 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 3.1699999999999999 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' ILE . . . . . 0.45 HG21 HG21 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 2.4100000000000001 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . 0.45 HG21 HG21 ' B' ' 184' ' ' ILE . 2.3 pp -117.35 -172.27 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 3.1200000000000001 112.219 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.28 167.19 0.61 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.681 -0.69 . . . . 2.0600000000000001 113.146 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.58 77.41 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.502 2.135 . . . . 3.29 111.412 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' SER . . . . . 0.415 ' HB3' ' HE2' ' B' ' 202' ' ' PHE . 24.9 m 62.28 53.38 2.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 4.5 110.482 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' GLY . . . . . 0.571 ' HA3' HD13 ' B' ' 193' ' ' ILE . . . 179.84 -149.41 8.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.524 -0.846 . . . . 4.7000000000000002 113.372 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -91.03 -0.3 57.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 8.4800000000000004 111.406 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 92.15 161.25 36.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.576 -0.821 . . . . 3.9300000000000002 112.781 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 79.1 m95 53.65 41.39 32.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 7.3799999999999999 110.752 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 193' ' ' ILE . . . . . 0.571 HD13 ' HA3' ' B' ' 189' ' ' GLY . 8.0 pt -138.13 139.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 3.6299999999999999 110.784 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 194' ' ' ASN . . . . . 0.509 ' ND2' ' H ' ' B' ' 195' ' ' GLN . 3.1 t-20 -79.04 163.71 24.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 3.8599999999999999 111.089 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 195' ' ' GLN . . . . . 0.509 ' H ' ' ND2' ' B' ' 194' ' ' ASN . 27.0 tt0 -52.48 -35.83 53.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.708 0.29 . . . . 6.2300000000000004 111.184 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -53.43 -44.23 68.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.391 . . . . 2.8799999999999999 110.967 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt -72.82 -37.55 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.941 -0.572 . . . . 2.8300000000000001 111.168 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.4900000000000002 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 199' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' B' ' 200' ' ' PHE . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 2.2799999999999998 111.524 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 200' ' ' PHE . . . . . 0.44 ' H ' ' HG1' ' B' ' 199' ' ' THR . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.9199999999999999 111.248 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 2.3500000000000001 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 202' ' ' PHE . . . . . 0.415 ' HE2' ' HB3' ' B' ' 188' ' ' SER . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 2.8300000000000001 111.085 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 2.27 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.78 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 205' ' ' LEU . . . . . 0.417 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 2.0600000000000001 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 206' ' ' PRO . . . . . 0.472 ' HB2' ' HH ' ' B' ' 11' ' ' TYR . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77000000000000002 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 2.4300000000000002 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 2.5899999999999999 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.9299999999999999 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.6499999999999999 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 3.1000000000000001 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.3899999999999999 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 3.0600000000000001 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.3500000000000001 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 4.3700000000000001 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 2.0 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.2200000000000002 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 3.0899999999999999 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 4.1600000000000001 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.6699999999999999 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 221' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' B' ' 29' ' ' PRO . 75.3 mt -76.34 -14.01 60.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.9700000000000002 110.864 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -66.51 -49.79 65.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 6.5700000000000003 110.768 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.38 75.4 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 5.9100000000000001 110.835 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.3 tp -147.54 140.28 24.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 7.2599999999999998 110.701 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -96.83 121.4 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 7.5099999999999998 110.894 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.07 49.88 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.5 . . . . 8.2100000000000009 111.005 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.5 t 59.51 96.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 8.0999999999999996 111.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -86.48 154.12 21.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 14.06 110.961 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.257 -0.878 . . . . 10.4 110.84 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.738 0.304 . . . . 8.3499999999999996 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 65.29 156.57 0.09 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.921 -0.581 . . . . 6.8499999999999996 111.312 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -157.59 135.62 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 6.6799999999999997 110.703 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.84 94.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 4.8200000000000003 110.662 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.8 m -114.77 122.58 46.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 3.5299999999999998 110.983 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt -104.01 2.59 32.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 3.2400000000000002 110.586 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' LEU . . . . . 0.435 HD12 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.7599999999999998 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 2.3399999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' TRP . . . . . 0.478 ' HB2' ' HB3' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.25 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.46 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 2.3799999999999999 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.5800000000000001 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 1.46 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 1.04 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' MET . . . . . 0.49 ' HE1' ' HB3' ' C' ' 44' ' ' PRO . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.95 111.119 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 2.1400000000000001 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 2.3399999999999999 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 1.02 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.51 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.5800000000000001 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -57.72 -43.4 85.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.5699999999999998 110.293 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.77 -28.76 60.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 5.9299999999999997 110.527 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' TRP . . . . . 0.787 ' O ' ' OG ' ' C' ' 26' ' ' SER . 87.7 t90 -62.92 -23.75 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 5.1600000000000001 110.402 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -84.88 -50.47 7.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 2.79 110.917 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' LEU . . . . . 0.41 ' N ' HD13 ' C' ' 25' ' ' LEU . 7.9 mp -74.05 -1.31 19.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.287 -0.415 . . . . 3.3700000000000001 110.394 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' SER . . . . . 0.787 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.0 OUTLIER -57.97 -23.67 54.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 2.7400000000000002 111.265 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -45.87 -35.1 4.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.299 0.571 . . . . 6.2800000000000002 109.796 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -174.25 131.77 0.51 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.13 -0.941 . . . . 4.79 110.014 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -93.87 176.16 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.901 2.401 . . . . 3.9199999999999999 112.477 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -88.15 62.02 6.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 9.3900000000000006 111.311 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.58 -29.64 3.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.852 -0.689 . . . . 4.2699999999999996 112.88 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' HG ' ' C' ' 221' ' ' LEU . 5.0 p -73.02 115.64 42.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.62 0.248 . . . . 5.5 111.164 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 48.9 Cg_exo -55.83 165.78 3.44 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.562 2.175 . . . . 3.6000000000000001 112.611 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -62.51 -18.61 62.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.277 -0.874 . . . . 4.2699999999999996 112.74 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' TYR . . . . . 0.407 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.5 p90 -51.27 -37.37 46.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.7799999999999998 111.484 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.7200000000000002 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.9800000000000004 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 2.4100000000000001 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 2.4300000000000002 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.8500000000000001 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' MET . . . . . 0.456 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.6299999999999999 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 2.29 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ILE . . . . . 0.599 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 1.3799999999999999 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' PRO . . . . . 0.599 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.90000000000000002 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 2.27 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 2.2400000000000002 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.71 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.57999999999999996 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.8200000000000001 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 1.28 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' TYR . . . . . 0.46 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 2.46 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' MET . . . . . 0.421 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.7 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 1.2 111.028 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.4099999999999999 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' ALA . . . . . 0.478 ' HB3' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 1.3200000000000001 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.96 111.148 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.9399999999999999 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' GLN . . . . . 0.472 ' NE2' ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 2.25 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 3.4300000000000002 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 2.5499999999999998 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.27 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.8500000000000001 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.6200000000000001 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 3.2599999999999998 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 2.2599999999999998 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.51 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' HIS . . . . . 0.616 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.3999999999999999 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' TYR . . . . . 0.42 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.8199999999999998 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 1.3899999999999999 112.345 -178.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' ARG . . . . . 0.616 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 2.3599999999999999 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' TYR . . . . . 0.447 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 2.7000000000000002 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.8200000000000001 110.476 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 2.4100000000000001 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' MET . . . . . 0.504 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.9199999999999999 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.437 ' O ' HD22 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.79 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' THR . . . . . 0.533 HG23 HG21 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.97 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' THR . . . . . 0.529 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 2.2000000000000002 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' PRO . . . . . 0.529 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.25 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' LEU . . . . . 0.465 HD11 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.8300000000000001 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 2.1400000000000001 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . 0.465 HD12 HD11 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.6699999999999999 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.8 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 2.1200000000000001 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 2.29 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 4.0300000000000002 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 2.0699999999999998 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD13 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.47 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.8599999999999999 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.6299999999999999 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 5.46 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.8399999999999999 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.8399999999999999 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.8600000000000003 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' TRP . . . . . 0.441 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 6.0700000000000003 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.79 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 3.1499999999999999 111.521 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.8799999999999999 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.72 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 3.6200000000000001 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.8199999999999998 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' MET . . . . . 0.418 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.7000000000000002 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.54 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' THR . . . . . 0.41 HG21 HG23 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.8799999999999999 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.71 111.667 -179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ILE . . . . . 0.432 ' HA ' HD13 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 2.52 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 2.1699999999999999 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.5900000000000001 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 3.0299999999999998 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 1.3300000000000001 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 1.3100000000000001 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' GLY . . . . . 0.472 ' HA3' H171 ' C' ' 301' ' ' RET . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.65000000000000002 113.325 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' LEU . . . . . 0.495 HD13 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 2.0299999999999998 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' ILE . . . . . 0.525 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 2.23 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 1.4399999999999999 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.79 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' SER . . . . . 0.501 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.5499999999999998 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.89 -20.96 40.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.3100000000000001 110.301 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -131.83 136.27 47.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.606 -0.725 . . . . 3.52 110.478 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.88 -9.25 35.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 4.2400000000000002 111.16 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -82.15 -56.88 3.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 5.4500000000000002 111.211 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.08 -23.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.316 -0.402 . . . . 1.73 111.178 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 3.3799999999999999 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 3.0 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 2.48 110.652 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.74 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 2.5699999999999998 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.7000000000000002 111.035 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 2.2000000000000002 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 2.1000000000000001 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.76 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.51 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.9399999999999999 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.54 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 2.4700000000000002 111.453 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' ILE . . . . . 0.41 HG23 HG21 ' C' ' 108' ' ' THR . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 3.0699999999999998 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.9399999999999999 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 4.5199999999999996 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.6499999999999999 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.9300000000000002 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.8599999999999999 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' ASN . . . . . 0.427 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 6.6 t30 -77.46 -53.93 1.52 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.7000000000000002 112.017 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 58.3 Cg_endo -69.66 -0.55 7.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.952 1.768 . . . . 2.46 112.438 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.39 98.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 3.46 110.706 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 56.25 30.43 16.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 9.1199999999999992 111.009 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.25 -50.49 8.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.274 -0.421 . . . . 2.9700000000000002 111.387 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.79 -2.78 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 4.8899999999999997 111.093 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' THR . . . . . 0.553 ' HA ' HE21 ' C' ' 157' ' ' GLN . 67.2 p -102.16 2.12 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 4.1500000000000004 111.216 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -66.05 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 5.5800000000000001 110.85 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -83.38 -10.95 58.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 3.5800000000000001 110.666 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 157' ' ' GLN . . . . . 0.553 HE21 ' HA ' ' C' ' 154' ' ' THR . 51.0 mt-30 -94.97 -72.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.943 -0.571 . . . . 4.1799999999999997 110.929 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p -142.53 116.07 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 2.6800000000000002 110.981 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p -75.63 -25.17 56.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 3.1800000000000002 110.771 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.1800000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 161' ' ' LEU . . . . . 0.448 HD12 HD13 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.9900000000000002 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 2.2400000000000002 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.3900000000000001 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 164' ' ' LEU . . . . . 0.448 HD13 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.6499999999999999 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.6299999999999999 111.042 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.2599999999999998 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.9199999999999999 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.8 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 2.21 110.975 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 2.0299999999999998 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.8799999999999999 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 2.3100000000000001 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 2.0 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 2.4199999999999999 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 175' ' ' LEU . . . . . 0.488 HD21 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.7000000000000002 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.1100000000000001 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 177' ' ' ILE . . . . . 0.412 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 2.3100000000000001 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 179' ' ' TYR . . . . . 0.528 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 2.71 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 180' ' ' PRO . . . . . 0.528 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 1.0700000000000001 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 181' ' ' ILE . . . . . 0.412 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 2.0800000000000001 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 182' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.71 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.8999999999999999 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 184' ' ' ILE . . . . . 0.544 HG21 HG22 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 2.2000000000000002 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . 0.544 HG22 HG21 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 3.23 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.72 17.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.9099999999999999 112.416 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 187' ' ' PRO . . . . . 0.528 ' HD3' HD13 ' C' ' 193' ' ' ILE . 72.0 Cg_endo -76.96 150.39 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.446 2.097 . . . . 3.46 112.233 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m 56.53 28.12 13.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 4.2199999999999998 110.769 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -157.18 -71.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.701 . . . . 4.3499999999999996 112.345 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -172.39 82.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 8.2400000000000002 110.755 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.23 162.39 35.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.559 -0.829 . . . . 3.6699999999999999 112.829 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -96.02 64.12 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.813 0.34 . . . . 6.4900000000000002 110.74 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 193' ' ' ILE . . . . . 0.528 HD13 ' HD3' ' C' ' 187' ' ' PRO . 75.3 mt -126.32 142.48 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 3.1899999999999999 111.188 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -55.81 147.69 18.47 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.937 -0.574 . . . . 4.3399999999999999 111.338 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.82 -1.41 28.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.948 -0.569 . . . . 5.9900000000000002 110.905 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 84.2 m -74.35 -59.91 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 2.7999999999999998 111.19 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.94 -30.85 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 2.8599999999999999 111.096 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.6800000000000002 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 2.54 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 200' ' ' PHE . . . . . 0.435 ' HB2' HD12 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.77 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 2.5299999999999998 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.8799999999999999 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 2.48 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.95 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.8700000000000001 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76000000000000001 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 2.3599999999999999 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 2.6200000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' SER . . . . . 0.488 ' HB2' HD21 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.9299999999999999 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' LYS . . . . . 0.525 ' HG3' ' H15' ' C' ' 301' ' ' RET . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.6600000000000001 111.606 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 3.1099999999999999 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.4099999999999999 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.77 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.8399999999999999 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 4.3399999999999999 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 2.25 110.596 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2000000000000002 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.54 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 4.0099999999999998 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' LEU . . . . . 0.536 HD13 HD11 ' C' ' 224' ' ' LEU . 4.5 mm? -65.69 -11.79 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.6400000000000001 111.389 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -88.67 32.42 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 6.3799999999999999 111.113 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.72 -0.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 6.0899999999999999 110.812 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' LEU . . . . . 0.536 HD11 HD13 ' C' ' 221' ' ' LEU . 86.1 mt -101.86 166.62 10.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 7.0099999999999998 110.944 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.24 125.28 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 6.7999999999999998 110.98 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 27.39 9.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.496 . . . . 7.0499999999999998 110.947 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.9 t -129.37 127.31 40.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 6.8200000000000003 111.18 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -159.22 110.53 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 10.17 110.75 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.334 -0.841 . . . . 9.4499999999999993 111.075 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' RET . . . . . 0.458 H202 HD11 ' A' ' 83' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' RET . . . . . 0.44 H162 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 301' ' ' RET . . . . . 0.525 ' H15' ' HG3' ' C' ' 210' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.589 0.233 . . . . 3.23 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 1.8799999999999999 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.29 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' VAL . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 0.98999999999999999 110.69 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 1.9199999999999999 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 1.45 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.89000000000000001 111.166 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 0.90000000000000002 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.82999999999999996 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.24 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.29 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 1.71 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.95999999999999996 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 0.98999999999999999 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.23 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.0199999999999996 110.442 179.542 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 3.4100000000000001 113.377 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 2.8100000000000001 112.139 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.3900000000000001 110.62 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.2400000000000002 110.685 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 1.6000000000000001 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.03 111.345 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.0 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.0 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.58999999999999997 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 1.6299999999999999 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.669 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 79' ' ' THR . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.3200000000000001 111.386 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.52000000000000002 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' SG ' ' B' ' 134' ' ' CYS . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 0.97999999999999998 110.953 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.52000000000000002 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 1.6899999999999999 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.1200000000000001 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.59999999999999998 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 0.93999999999999995 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.78000000000000003 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.23 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.1000000000000001 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 1.76 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.8400000000000001 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 1.8400000000000001 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.2400000000000002 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.1600000000000001 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 2.8399999999999999 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.3900000000000001 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.96999999999999997 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.04 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.3799999999999999 110.992 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.76000000000000001 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 2.9300000000000002 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.1299999999999999 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 1.6599999999999999 110.654 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.4199999999999999 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.0899999999999999 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.52 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.3300000000000001 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' HG13 ' A' ' 78' ' ' VAL . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.3899999999999999 112.126 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 1.55 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.01 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.3 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 1.6699999999999999 110.482 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 1.8700000000000001 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.3999999999999999 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 1.9099999999999999 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 2.3300000000000001 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 1.4299999999999999 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.1899999999999999 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 2.5499999999999998 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.3300000000000001 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 5.0999999999999996 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.0699999999999998 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.4100000000000001 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.3099999999999996 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.9399999999999999 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 5.9800000000000004 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.2400000000000002 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 2.6699999999999999 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 2.5899999999999999 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.53 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 3.1400000000000001 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 1.99 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.3599999999999999 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.0499999999999998 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.25 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.8799999999999999 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.6000000000000001 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0900000000000001 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 2.6499999999999999 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.426 HG21 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 0.89000000000000001 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 0.68000000000000005 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 1.5800000000000001 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.04 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.1000000000000001 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.8799999999999999 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.53 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.29 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.4900000000000002 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.1299999999999999 110.838 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 3.9700000000000002 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.22 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 2.8100000000000001 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.25 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 1.8400000000000001 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.54 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 1.79 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.0800000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 1.76 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.76000000000000001 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.0699999999999998 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.3200000000000001 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 3.25 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 2.9199999999999999 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 2.6499999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.614 HD13 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.21 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 146' ' ' ILE . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.0099999999999998 111.091 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 3.6000000000000001 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.6200000000000001 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 143' ' ' LEU . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 2.4700000000000002 111.646 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 2.48 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.624 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 2.6899999999999999 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo . . . . . 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.3599999999999999 112.684 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.878 0.371 . . . . 2.6299999999999999 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.1600000000000001 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 2.8300000000000001 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 1.7 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.1600000000000001 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 1.5900000000000001 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.456 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.3100000000000001 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.1499999999999999 110.899 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.478 ' NZ ' ' HB2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.3900000000000001 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.4199999999999999 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.1200000000000001 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 174' ' ' VAL . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.719 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 1.5800000000000001 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 1.4099999999999999 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 171' ' ' TYR . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 1.4199999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 1.9099999999999999 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.55 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.541 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.8600000000000001 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.73999999999999999 112.958 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.594 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 1.78 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 0.92000000000000004 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 1.77 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 179' ' ' TYR . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.3400000000000001 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.5099999999999998 111.618 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.02 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.483 HG13 HG22 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.4500000000000002 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 1.73 112.819 179.598 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.834 0.35 . . . . 2.6600000000000001 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 1.8100000000000001 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.21 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.1800000000000002 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.0099999999999998 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 1.9299999999999999 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 1.7 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.28 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79000000000000004 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 1.51 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 1.9299999999999999 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 1.71 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.04 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 2.8900000000000001 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.3100000000000001 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 2.8700000000000001 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.3799999999999999 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 3.4199999999999999 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.4399999999999999 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.5099999999999998 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.0099999999999998 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.5900000000000001 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 221' ' ' LEU . 3.3 mm? . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 3.4900000000000002 111.229 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 3.0800000000000001 110.993 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.3500000000000001 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 1.3899999999999999 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.406 ' O ' HG23 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1000000000000001 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 1.71 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 1.48 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 0.94999999999999996 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.96999999999999997 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.80000000000000004 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.29 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.3600000000000001 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.23 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 0.97999999999999998 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.1200000000000001 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.0 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 4.2599999999999998 111.032 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.159 0 N-CA-C 112.011 0.375 . . . . 3.1699999999999999 112.011 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.5699999999999998 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.7400000000000002 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 1.72 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 1.95 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.2 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.457 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.1200000000000001 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 1.49 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 0.77000000000000002 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.68000000000000005 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 1.6299999999999999 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 1.9099999999999999 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.22 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.55000000000000004 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.87 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.55000000000000004 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.0600000000000001 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.1899999999999999 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 0.66000000000000003 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 0.85999999999999999 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 0.83999999999999997 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.507 HG21 HG23 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 1.4399999999999999 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.2400000000000002 110.886 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.3100000000000001 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 1.8100000000000001 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.1800000000000002 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.48 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.3700000000000001 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.2799999999999998 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 1.78 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.05 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.1100000000000001 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.448 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.2999999999999998 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 0.71999999999999997 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.478 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.04 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 1.79 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.448 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 1.4399999999999999 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.57 ' O ' HG22 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.0099999999999998 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.411 ' SD ' HG21 ' B' ' 113' ' ' ILE . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.4299999999999999 110.414 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.21 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.57 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.1799999999999999 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 1.6499999999999999 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.0600000000000001 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 1.5800000000000001 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 1.49 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' B' ' 109' ' ' GLN . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 1.72 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.456 ' N ' HD12 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 1.96 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.24 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.543 HD13 HD21 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.21 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.3200000000000001 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 1.4399999999999999 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 2.6800000000000002 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 2.71 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 4.1900000000000004 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.79 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.2699999999999996 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.5700000000000003 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.2400000000000002 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 5.3899999999999997 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' THR . . . . . 0.474 ' HA ' HD22 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.1600000000000001 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 101' ' ' LEU . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 111.063 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.48 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.47 ' HB2' HD11 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 2.7599999999999998 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.2200000000000002 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.3599999999999999 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 1.9199999999999999 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.555 ' O ' HG23 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.0600000000000001 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.556 ' HG3' HD21 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 2.8700000000000001 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.669 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 111' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 1.6200000000000001 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.04 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' B' ' 77' ' ' MET . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.46 110.64 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.82999999999999996 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.73999999999999999 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.59999999999999998 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.4199999999999999 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 1.51 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.0900000000000001 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.1599999999999999 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 1.76 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.774 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 2.6699999999999999 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.774 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.0700000000000003 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 1.4099999999999999 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 2.4700000000000002 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 2.6099999999999999 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 56' ' ' ILE . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.0699999999999998 111.281 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.3 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' B' ' 137' ' ' CYS . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 1.6699999999999999 111.081 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.405 ' SG ' HD22 ' A' ' 49' ' ' LEU . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 1.54 110.971 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 1.4399999999999999 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 137' ' ' CYS . . . . . 0.424 ' HG ' HG22 ' B' ' 133' ' ' ILE . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 1.8200000000000001 110.709 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.93999999999999995 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 1.6000000000000001 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.0099999999999998 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.445 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 1.96 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.445 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 2.8799999999999999 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.52 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 4.1500000000000004 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.1299999999999999 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 1.78 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.4500000000000002 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.3599999999999999 112.921 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.766 0.317 . . . . 2.3999999999999999 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' B' ' 91' ' ' ALA . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 1.72 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 2.6899999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.1600000000000001 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.491 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.1299999999999999 111.188 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.9399999999999999 110.91 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.3300000000000001 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.543 HD21 HD13 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.5600000000000001 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 165' ' ' TYR . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.5900000000000001 111.008 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.1399999999999999 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 3.8700000000000001 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.6100000000000001 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.3 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 1.53 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 1.99 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.5 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.512 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 1.46 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67000000000000004 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.604 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 1.73 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 0.93000000000000005 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 1.3600000000000001 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.1899999999999999 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 2.73 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.53 HG22 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 1.9299999999999999 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 111.252 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.815 0.341 . . . . 2.2000000000000002 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.4900000000000002 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 1.76 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 200' ' ' PHE . . . . . 0.423 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.1800000000000002 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.78 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 1.98 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 1.6499999999999999 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.1100000000000001 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 1.4299999999999999 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77000000000000002 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 1.6000000000000001 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 1.77 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.428 ' HB3' HD23 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.54 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.0099999999999998 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 2.6499999999999999 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.3300000000000001 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 2.29 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.1200000000000001 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 3.6000000000000001 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.426 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 1.51 110.929 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.2200000000000002 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 2.6899999999999999 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 3.3999999999999999 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.6699999999999999 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.3900000000000001 111.319 -179.541 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.52 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.799 0.333 . . . . 2.79 110.998 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.0800000000000001 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 1.4299999999999999 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.1599999999999999 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.0899999999999999 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 1.5800000000000001 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.95999999999999996 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 0.95999999999999996 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.3 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 1.52 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8999999999999999 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 0.95999999999999996 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.0700000000000001 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.0800000000000001 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.02 110.306 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 p90 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.3700000000000001 111.235 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.7200000000000002 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.6699999999999999 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.9299999999999999 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 1.8799999999999999 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.23 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.0899999999999999 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 1.4099999999999999 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 0.80000000000000004 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.71999999999999997 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 1.6799999999999999 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.426 ' HZ3' HG21 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 1.6799999999999999 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.28 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.51000000000000001 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.3300000000000001 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.56999999999999995 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 1.6699999999999999 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.4199999999999999 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 0.70999999999999996 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.1399999999999999 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 0.88 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.3799999999999999 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.502 ' HB2' HG21 ' A' ' 127' ' ' VAL . 6.3 tp-100 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.8700000000000001 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 2.8599999999999999 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 1.95 111.248 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.1099999999999999 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.54 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.4700000000000002 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 2.8500000000000001 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 1.8700000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.544 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.26 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.0800000000000001 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 0.85999999999999999 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.471 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 1.96 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 1.8 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.1799999999999999 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.3300000000000001 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 1.8500000000000001 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.5600000000000001 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.433 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.1100000000000001 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.49 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.657 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 1.6000000000000001 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.01 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.1799999999999999 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 1.54 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 1.6499999999999999 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.3799999999999999 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' C' ' 168' ' ' LEU . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.481 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 1.8700000000000001 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 3.1000000000000001 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.02 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.3399999999999999 110.689 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.21 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 4.54 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.3399999999999999 110.714 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.4000000000000004 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.54 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 5.21 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.422 ' N ' HD12 ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 2.6400000000000001 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.3799999999999999 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.6200000000000001 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 2.9300000000000002 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.478 HD12 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.1600000000000001 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.491 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.2999999999999998 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.0699999999999998 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.439 ' O ' HG23 ' C' ' 112' ' ' VAL . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 111.596 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 83.2 mm-40 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.48 111.342 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 1.9299999999999999 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 1.6699999999999999 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 108' ' ' THR . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.1100000000000001 111.518 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 2.5899999999999999 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.44 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.90000000000000002 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.92000000000000004 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.55000000000000004 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 1.49 110.582 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.576 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 1.6599999999999999 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.93999999999999995 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.29 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.1499999999999999 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.3100000000000001 110.839 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.507 HG23 HG21 ' B' ' 56' ' ' ILE . 7.1 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.3100000000000001 111.236 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 2.8399999999999999 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 2.7000000000000002 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 1.8799999999999999 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.3799999999999999 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 1.76 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.1499999999999999 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.72999999999999998 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 1.48 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 138' ' ' ALA . . . . . 0.415 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.149 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.0499999999999998 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.0699999999999998 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.9199999999999999 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.415 HG12 ' O ' ' C' ' 138' ' ' ALA . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 2.6400000000000001 111.33 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 143' ' ' LEU . . . . . 0.409 ' O ' HG22 ' C' ' 146' ' ' ILE . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.51 110.742 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 3.5800000000000001 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.409 HG22 ' O ' ' C' ' 143' ' ' LEU . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.46 111.6 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.27 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.3300000000000001 111.959 -179.429 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.831 0.348 . . . . 2.8199999999999998 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.1800000000000002 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.5 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.8100000000000001 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.21 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.3100000000000001 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.2599999999999998 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.756 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' C' ' 87' ' ' LEU . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.916 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 1.73 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.4299999999999999 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.7200000000000002 110.63 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 1.55 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 1.5 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.8400000000000001 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.1200000000000001 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.475 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 1.75 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.71999999999999997 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.642 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 1.8 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 0.88 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 1.52 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.2 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.4700000000000002 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.511 HG22 HG23 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 1.6200000000000001 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.511 HG23 HG22 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 2.6299999999999999 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.77 112.757 179.741 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.797 0.332 . . . . 2.3700000000000001 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6800000000000002 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.95 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.0499999999999998 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.9099999999999999 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.04 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 1.6200000000000001 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.49 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.3200000000000001 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76000000000000001 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 1.8400000000000001 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.6799999999999999 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.04 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 2.6499999999999999 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.3300000000000001 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.02 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.3500000000000001 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 3.6200000000000001 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.415 HD23 ' O ' ' C' ' 216' ' ' LEU . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 1.6399999999999999 110.771 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2000000000000002 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.1099999999999999 111.259 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 3.3700000000000001 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.1099999999999999 111.19 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.642 0.258 . . . . 3.23 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 1.8799999999999999 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.29 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.98999999999999999 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.9199999999999999 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 1.45 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.89000000000000001 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 0.90000000000000002 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.82999999999999996 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.592 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.24 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.29 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 1.71 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.95999999999999996 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.98999999999999999 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.1099999999999999 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.23 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.0199999999999996 110.637 179.447 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.4 0.519 . . . . 3.4100000000000001 112.4 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 2.8100000000000001 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.3900000000000001 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.2400000000000002 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.3300000000000001 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.03 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 1.3100000000000001 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.58999999999999997 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 1.6299999999999999 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.1200000000000001 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.52000000000000002 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 0.97999999999999998 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.52000000000000002 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 1.6899999999999999 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.461 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.1200000000000001 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 0.59999999999999998 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.93999999999999995 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.78000000000000003 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.442 HD13 HD23 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.23 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.53 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.1 tp-100 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.1000000000000001 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 1.76 110.884 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.8400000000000001 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 1.8400000000000001 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.2400000000000002 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.1600000000000001 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 2.8399999999999999 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.3900000000000001 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 0.96999999999999997 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.04 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.3799999999999999 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 0.76000000000000001 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' A' ' 54' ' ' MET . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.1299999999999999 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 1.6599999999999999 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.0899999999999999 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 117' ' ' LEU . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.52 110.412 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.3300000000000001 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.3899999999999999 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.61 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 1.55 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.01 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 1.45 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.3 110.618 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 1.6699999999999999 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 1.8700000000000001 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.3999999999999999 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 1.9099999999999999 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 2.3300000000000001 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 1.4299999999999999 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.1899999999999999 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 2.5499999999999998 110.993 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.3300000000000001 110.866 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 5.0999999999999996 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.0699999999999998 111.464 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.4100000000000001 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.3099999999999996 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.9399999999999999 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 5.9800000000000004 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.2400000000000002 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.6699999999999999 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 2.5899999999999999 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 3.1400000000000001 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 1.99 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.3599999999999999 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.0499999999999998 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 112' ' ' VAL . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.25 111.837 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 2.7200000000000002 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 1.8799999999999999 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 1.6000000000000001 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 108' ' ' THR . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.0900000000000001 111.216 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 2.6499999999999999 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 117' ' ' LEU . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.89000000000000001 110.961 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.68000000000000005 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 1.5800000000000001 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.04 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.1000000000000001 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.8799999999999999 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.29 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.4900000000000002 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.1299999999999999 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 3.9700000000000002 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.22 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 2.8100000000000001 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.25 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 1.8400000000000001 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.54 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 1.79 110.878 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.0800000000000001 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 1.76 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.76000000000000001 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.0699999999999998 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.8500000000000001 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.3200000000000001 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 3.25 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.9199999999999999 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 2.6499999999999999 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.21 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.0099999999999998 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 3.6000000000000001 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.6200000000000001 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.422 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 2.4700000000000002 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 2.48 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 2.6899999999999999 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.3599999999999999 112.384 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.873 0.368 . . . . 2.6299999999999999 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.8300000000000001 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.1600000000000001 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 1.5900000000000001 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.3100000000000001 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.3900000000000001 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 171' ' ' TYR . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.1200000000000001 111.593 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.437 ' N ' HG23 ' A' ' 170' ' ' THR . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 3.8599999999999999 110.206 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 1.5800000000000001 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 1.4099999999999999 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 1.4199999999999999 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 1.9099999999999999 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.55 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 1.8600000000000001 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.73999999999999999 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 1.78 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 0.92000000000000004 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 184' ' ' ILE . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 1.77 111.524 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 183' ' ' TRP . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.621 ' CD2' HG23 ' A' ' 182' ' ' VAL . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.5099999999999998 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 181' ' ' ILE . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.02 111.265 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.4500000000000002 110.676 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 1.73 112.335 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.748 0.309 . . . . 2.6600000000000001 111.019 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 1.8100000000000001 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.21 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 201' ' ' LEU . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.1800000000000002 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.0099999999999998 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 1.9299999999999999 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 1.7 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.468 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.28 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79000000000000004 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 211' ' ' VAL . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.51 110.244 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 1.9299999999999999 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 1.71 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.04 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 207' ' ' PHE . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 2.8900000000000001 110.958 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.3100000000000001 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 2.8700000000000001 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.3799999999999999 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 3.4199999999999999 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.24 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.4399999999999999 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.0099999999999998 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.5900000000000001 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 3.4900000000000002 111.259 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.76 0.314 . . . . 3.0800000000000001 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.3500000000000001 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 61.8 m-70 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 1.3899999999999999 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1000000000000001 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 1.71 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 1.48 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 0.94999999999999996 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.96999999999999997 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.80000000000000004 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.29 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.3600000000000001 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.23 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.97999999999999998 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.1200000000000001 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.0 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 4.2599999999999998 110.589 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.705 0.288 . . . . 3.1699999999999999 111.536 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.5699999999999998 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.7400000000000002 111.299 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 1.72 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.439 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 1.95 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.2 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.434 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.1200000000000001 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 1.49 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 0.77000000000000002 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.68000000000000005 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.434 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 1.6299999999999999 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.9099999999999999 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.55000000000000004 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.87 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.0600000000000001 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.1899999999999999 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' B' ' 58' ' ' GLN . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.66000000000000003 110.891 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.85999999999999999 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.83999999999999997 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 1.4399999999999999 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.539 ' NE2' HG11 ' C' ' 127' ' ' VAL . 89.1 mm-40 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.2400000000000002 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.3100000000000001 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 61' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.8100000000000001 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.1800000000000002 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.0299999999999998 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.48 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.3700000000000001 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.2799999999999998 110.881 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.78 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.05 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.1100000000000001 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.431 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.2999999999999998 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 0.71999999999999997 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.04 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 1.79 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 1.4399999999999999 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.554 ' O ' HG22 ' B' ' 79' ' ' THR . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.3100000000000001 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.0099999999999998 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.4299999999999999 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.421 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.21 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.1799999999999999 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.641 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 1.6499999999999999 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.0600000000000001 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.515 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 1.5800000000000001 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 1.72 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.515 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 1.96 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.24 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.581 HD22 HD11 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.21 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.3200000000000001 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.1499999999999999 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 1.4399999999999999 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.05 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 2.6800000000000002 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 2.71 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 4.1900000000000004 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 2.79 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.2699999999999996 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.5700000000000003 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 5.3899999999999997 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.1600000000000001 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 2.5800000000000001 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.48 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 2.7599999999999998 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.2200000000000002 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.3599999999999999 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 1.9199999999999999 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.0600000000000001 111.528 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 2.8700000000000001 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 1.98 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 1.6200000000000001 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.82999999999999996 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.73999999999999999 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.59999999999999998 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.4199999999999999 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.493 ' N ' HD12 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 1.51 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.0900000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.1599999999999999 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 1.76 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.8900000000000001 110.691 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 2.6699999999999999 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.0700000000000003 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 1.4099999999999999 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 2.4700000000000002 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 2.6099999999999999 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' LEU . . . . . 0.442 HD23 HD13 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.0699999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 1.6699999999999999 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 1.54 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.69999999999999996 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' B' ' 180' ' ' PRO . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 1.4399999999999999 111.584 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 1.8200000000000001 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.93999999999999995 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 1.6000000000000001 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.0099999999999998 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.448 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 1.96 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.448 ' N ' HG13 ' B' ' 141' ' ' ILE . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 2.8799999999999999 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 4.1500000000000004 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.5900000000000001 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.1299999999999999 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 1.78 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.4500000000000002 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.3599999999999999 112.868 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.889 0.376 . . . . 2.3999999999999999 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 2.5699999999999998 110.614 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 1.72 111.257 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.6899999999999999 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.1600000000000001 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.1299999999999999 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.9399999999999999 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.3300000000000001 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.581 HD11 HD22 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 1.5600000000000001 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.5900000000000001 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.1399999999999999 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 3.8700000000000001 110.289 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 1.6100000000000001 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.439 ' O ' HG22 ' B' ' 177' ' ' ILE . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.3 111.524 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 1.53 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 1.99 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.5 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 173' ' ' THR . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 1.46 110.565 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67000000000000004 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.673 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 1.73 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 0.93000000000000005 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 1.3600000000000001 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.585 HG23 ' CD2' ' B' ' 183' ' ' TRP . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.1899999999999999 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' TRP . . . . . 0.585 ' CD2' HG23 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 2.73 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 1.9299999999999999 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 2.6400000000000001 111.071 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 2.2000000000000002 111.247 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.4900000000000002 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 1.76 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.1800000000000002 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 201' ' ' LEU . . . . . 0.481 ' N ' HD22 ' B' ' 201' ' ' LEU . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 1.98 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 1.6499999999999999 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.1100000000000001 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.477 HD12 HG21 ' B' ' 182' ' ' VAL . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 1.4299999999999999 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD2' ' C ' ' B' ' 203' ' ' CYS . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77000000000000002 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.432 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.6000000000000001 110.437 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 1.77 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.418 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.54 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.0099999999999998 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 207' ' ' PHE . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 2.6499999999999999 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.3300000000000001 112.468 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 2.29 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.1200000000000001 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 3.6000000000000001 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 1.51 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.2200000000000002 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 2.6899999999999999 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 3.3999999999999999 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.6699999999999999 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.3900000000000001 111.566 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.75 0.309 . . . . 2.79 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.0800000000000001 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 1.4299999999999999 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.553 ' O ' HG12 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.1599999999999999 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.0899999999999999 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 1.5800000000000001 110.949 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.95999999999999996 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 0.95999999999999996 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.3 110.575 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 1.52 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 0.95999999999999996 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.0700000000000001 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.0800000000000001 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.02 110.425 179.716 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.3700000000000001 111.559 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.7200000000000002 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.6699999999999999 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 1.9299999999999999 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.8799999999999999 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.23 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.434 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.0899999999999999 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 1.4099999999999999 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.62 HG23 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 0.80000000000000004 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.71999999999999997 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 1.6799999999999999 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 1.6799999999999999 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.28 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.51000000000000001 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.3300000000000001 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 1.6699999999999999 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.536 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.4199999999999999 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.70999999999999996 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.1399999999999999 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.88 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.517 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.3799999999999999 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 1.8700000000000001 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.45 ' HZ2' ' HA ' ' C' ' 69' ' ' HIS . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 2.8599999999999999 110.957 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.1099999999999999 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.54 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.4700000000000002 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 2.8500000000000001 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.8700000000000001 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.26 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.476 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.0800000000000001 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 0.85999999999999999 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.454 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 1.96 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 1.8 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.476 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.1799999999999999 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.3300000000000001 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 1.8500000000000001 110.733 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.5600000000000001 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.1100000000000001 111.908 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.62 HG23 HG23 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.49 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 1.6000000000000001 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.01 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.1799999999999999 111.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 1.54 111.286 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.483 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 1.6499999999999999 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD12 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.1000000000000001 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.3799999999999999 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 1.4399999999999999 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.8700000000000001 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 3.1000000000000001 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 1.48 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' ALA . . . . . 0.463 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.02 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.3399999999999999 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.21 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 4.54 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.3399999999999999 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.4000000000000004 110.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.54 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 5.21 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.3799999999999999 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 2.6400000000000001 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.3799999999999999 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.6200000000000001 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 2.9300000000000002 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.1600000000000001 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.449 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.2999999999999998 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.0699999999999998 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' HG23 ' C' ' 112' ' ' VAL . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.2999999999999998 111.517 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.48 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 1.9299999999999999 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 1.6699999999999999 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 108' ' ' THR . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.1100000000000001 111.158 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 2.5899999999999999 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.90000000000000002 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.92000000000000004 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.55000000000000004 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 1.49 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.445 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 1.6599999999999999 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.93999999999999995 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.29 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.1499999999999999 110.982 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.3100000000000001 110.848 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' B' ' 58' ' ' GLN . 14.4 p . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.862 0.363 . . . . 1.3100000000000001 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 2.8399999999999999 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 2.7000000000000002 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 1.8799999999999999 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.3799999999999999 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 1.76 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.1499999999999999 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.5600000000000001 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.72999999999999998 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 1.48 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.51 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.01 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.0499999999999998 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.0699999999999998 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.459 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 1.9199999999999999 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.459 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 2.6400000000000001 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 3.5800000000000001 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.6499999999999999 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.46 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.27 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.3300000000000001 112.019 -179.576 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.78 0.324 . . . . 2.8199999999999998 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.1800000000000002 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 161' ' ' LEU . . . . . 0.416 HD22 ' N ' ' C' ' 161' ' ' LEU . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.5 110.752 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 1.8100000000000001 111.165 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.1299999999999999 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.21 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.3100000000000001 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.2599999999999998 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.5800000000000001 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.3 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 1.73 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.4299999999999999 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 171' ' ' TYR . . . . . 0.419 ' O ' HG22 ' C' ' 174' ' ' VAL . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.7200000000000002 110.887 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 1.55 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.5 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 174' ' ' VAL . . . . . 0.419 HG22 ' O ' ' C' ' 171' ' ' TYR . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 1.8400000000000001 111.88 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.1200000000000001 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 1.75 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 1.8 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 0.88 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.552 ' O ' HG22 ' C' ' 184' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 1.52 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' C' ' 183' ' ' TRP . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.2 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 183' ' ' TRP . . . . . 0.67 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.4700000000000002 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.552 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.6200000000000001 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.943 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.77 112.194 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 2.3700000000000001 111.385 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.6800000000000002 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 1.95 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.0499999999999998 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.9099999999999999 111.651 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 202' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.04 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.6200000000000001 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.49 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.3200000000000001 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76000000000000001 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 1.52 110.256 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 1.8400000000000001 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.6799999999999999 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.04 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 2.6499999999999999 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.3300000000000001 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.02 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.3500000000000001 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 3.6200000000000001 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 1.6399999999999999 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2000000000000002 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.1099999999999999 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 3.3700000000000001 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.1099999999999999 111.759 -179.481 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.755 0.312 . . . . 3.23 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 1.8799999999999999 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.29 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.98999999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.9199999999999999 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.90000000000000002 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.82999999999999996 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.24 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.29 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 1.71 110.622 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.95999999999999996 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 0.98999999999999999 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.1099999999999999 110.535 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.23 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.0199999999999996 111.068 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 113.003 0.742 . . . . 3.4100000000000001 113.003 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 36' ' ' GLU . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 2.8100000000000001 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 35' ' ' TYR . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.3900000000000001 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.2400000000000002 110.157 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 1.6000000000000001 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 43' ' ' ILE . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.3300000000000001 110.52 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.03 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.0 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 1.3100000000000001 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.58999999999999997 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 1.6299999999999999 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.1200000000000001 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.3200000000000001 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.97999999999999998 110.7 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.52000000000000002 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 1.6899999999999999 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.1200000000000001 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 0.59999999999999998 110.72 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.93999999999999995 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' ALA . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.728 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.464 ' NE2' HG11 ' B' ' 127' ' ' VAL . 27.5 mm-40 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.1000000000000001 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.657 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 1.76 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 1.8400000000000001 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.6400000000000001 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 1.8400000000000001 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.2400000000000002 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.1600000000000001 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 2.8399999999999999 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.3900000000000001 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.96999999999999997 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.04 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.3799999999999999 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 0.76000000000000001 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 2.9300000000000002 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.1299999999999999 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 1.6599999999999999 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.4199999999999999 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.0899999999999999 111.499 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.52 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.3300000000000001 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.3899999999999999 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 1.55 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.01 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 1.45 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.3 109.772 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 1.6699999999999999 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 1.8700000000000001 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.4199999999999999 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 168' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.3999999999999999 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 1.9099999999999999 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 2.3300000000000001 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 1.4299999999999999 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 2.5499999999999998 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.3300000000000001 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 5.0999999999999996 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.0699999999999998 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.4100000000000001 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.3099999999999996 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.9399999999999999 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 5.9800000000000004 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.2400000000000002 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.6699999999999999 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 2.5899999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.53 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 3.1400000000000001 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 1.99 110.936 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.3599999999999999 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.0499999999999998 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 112' ' ' VAL . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.25 111.501 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' HD22 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 2.7200000000000002 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 1.8799999999999999 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.6000000000000001 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 108' ' ' THR . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.0900000000000001 111.112 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 2.6499999999999999 110.507 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.89000000000000001 110.47 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.424 ' HA ' HG22 ' A' ' 118' ' ' ILE . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 0.68000000000000005 110.204 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 1.5800000000000001 112.268 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 115' ' ' SER . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.418 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.1000000000000001 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.8799999999999999 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 1.53 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.29 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.4900000000000002 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 3.9700000000000002 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.22 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 2.8100000000000001 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.25 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 1.8400000000000001 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.54 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 1.79 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.0800000000000001 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.409 ' SG ' HD22 ' C' ' 49' ' ' LEU . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 1.76 110.705 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.76000000000000001 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.0699999999999998 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 1.8500000000000001 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.3200000000000001 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 3.25 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 2.9199999999999999 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 141' ' ' ILE . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 2.6499999999999999 111.346 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.21 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.0099999999999998 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 3.6000000000000001 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.6200000000000001 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 2.4700000000000002 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 2.48 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.633 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 2.6899999999999999 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo . . . . . 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.3599999999999999 112.992 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.361 . . . . 2.6299999999999999 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.1600000000000001 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.3700000000000001 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 2.8300000000000001 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 1.7 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.1600000000000001 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 1.5900000000000001 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.1499999999999999 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.3900000000000001 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.51 HD11 HD22 ' A' ' 87' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.79 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.4199999999999999 111.31 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.1200000000000001 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.8599999999999999 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 1.5800000000000001 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 177' ' ' ILE . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 1.4099999999999999 111.53 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 1.4199999999999999 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 1.9099999999999999 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.55 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 1.8600000000000001 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.73999999999999999 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 1.78 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 0.92000000000000004 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 1.77 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.5099999999999998 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.02 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.4500000000000002 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 1.73 112.531 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 2.6600000000000001 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 1.8100000000000001 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.1800000000000002 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.0099999999999998 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.491 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 1.9299999999999999 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 1.7 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.28 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79000000000000004 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 1.51 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 1.9299999999999999 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 1.71 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.754 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 2.8900000000000001 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.3100000000000001 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 2.8700000000000001 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.3799999999999999 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 3.4199999999999999 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.24 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.5099999999999998 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.0099999999999998 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.5900000000000001 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 3.4900000000000002 110.916 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.441 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.797 0.332 . . . . 3.0800000000000001 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.3500000000000001 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1000000000000001 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 1.71 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 1.48 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.94999999999999996 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.96999999999999997 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.80000000000000004 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.29 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.3600000000000001 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.475 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.23 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.97999999999999998 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.1200000000000001 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.0 111.049 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 4.2599999999999998 111.298 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.535 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.012 1.116 . . . . 3.1699999999999999 114.012 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.535 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.5699999999999998 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.7400000000000002 112.191 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 1.72 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 1.95 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.2 110.803 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.441 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.1200000000000001 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 1.49 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.592 HG23 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 0.77000000000000002 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.68000000000000005 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 1.6299999999999999 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.546 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 1.9099999999999999 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.22 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.55000000000000004 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 0.87 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 0.55000000000000004 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.0600000000000001 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.41 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.1899999999999999 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.85999999999999999 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.83999999999999997 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 1.4399999999999999 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.427 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 6.4 tp-100 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.2400000000000002 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.3100000000000001 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 1.8100000000000001 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.1800000000000002 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.0299999999999998 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.48 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.3700000000000001 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.2799999999999998 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.78 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.05 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.1100000000000001 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.2999999999999998 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 0.71999999999999997 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.04 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.479 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 1.79 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 1.4399999999999999 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.479 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.0099999999999998 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.4299999999999999 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.499 ' O ' HD23 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.21 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.592 HG23 HG23 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.1799999999999999 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.581 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 1.6499999999999999 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.0600000000000001 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 1.5800000000000001 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 1.49 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.598 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 1.72 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 1.96 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.24 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.21 111.125 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.3200000000000001 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.1499999999999999 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 86' ' ' SER . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 1.4399999999999999 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 2.6800000000000002 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.452 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 2.71 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 94' ' ' PHE . . . . . 0.452 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 4.1900000000000004 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 2.79 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.2699999999999996 111.271 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.5700000000000003 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.2400000000000002 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 5.3899999999999997 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 2.5800000000000001 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.29 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.48 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 2.7599999999999998 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' B' ' 109' ' ' GLN . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.2200000000000002 111.084 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.428 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.3599999999999999 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 1.9199999999999999 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.4 ' O ' HG23 ' B' ' 112' ' ' VAL . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.0600000000000001 111.231 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.598 ' HG3' HD22 ' B' ' 84' ' ' LEU . 28.6 mm-40 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 2.8700000000000001 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 1.98 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 1.6200000000000001 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 108' ' ' THR . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.04 111.504 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.46 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.82999999999999996 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.73999999999999999 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.59999999999999998 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.474 HD12 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.4199999999999999 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.474 HG13 HD12 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 1.51 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.0900000000000001 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 1.76 110.721 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.8900000000000001 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.676 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.6699999999999999 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' TRP . . . . . 0.676 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.0700000000000003 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.4099999999999999 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 2.4700000000000002 110.664 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 2.6099999999999999 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.0699999999999998 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 131' ' ' TRP . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.3 111.173 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.6699999999999999 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 1.54 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.69999999999999996 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.27 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 1.8200000000000001 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.93999999999999995 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 139' ' ' PHE . . . . . 0.404 ' HA ' HG12 ' B' ' 142' ' ' ILE . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 111.313 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.0099999999999998 111.444 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.96 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' B' ' 139' ' ' PHE . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 2.8799999999999999 111.71 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.52 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 4.1500000000000004 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.5900000000000001 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.1299999999999999 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 1.78 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 45.1 t30 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.4500000000000002 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo . . . . . 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.3599999999999999 113.087 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.968 0.413 . . . . 2.3999999999999999 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 2.5699999999999998 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 1.72 111.691 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.1600000000000001 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 165' ' ' TYR . . . . . 0.477 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.1299999999999999 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.9399999999999999 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.3300000000000001 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 1.5600000000000001 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 165' ' ' TYR . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 1.5900000000000001 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 3.8700000000000001 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.6100000000000001 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.3 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 1.53 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.99 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.5 110.545 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.521 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 1.46 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.551 ' O ' HG22 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 1.73 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 0.93000000000000005 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.546 ' O ' HG22 ' B' ' 184' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 1.3600000000000001 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.1899999999999999 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 2.73 111.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 1.9299999999999999 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 184' ' ' ILE . 34.8 pt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 2.6400000000000001 111.4 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.313 . . . . 2.2000000000000002 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.4900000000000002 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.76 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.1800000000000002 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.78 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 1.98 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 1.6499999999999999 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.1100000000000001 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.699 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 1.4299999999999999 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77000000000000002 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 1.6000000000000001 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 1.77 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.475 ' HB2' HD11 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.54 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.0099999999999998 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 2.6499999999999999 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.3300000000000001 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 2.29 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.1200000000000001 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 3.6000000000000001 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.51 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 2.6899999999999999 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 3.3999999999999999 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.6699999999999999 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 221' ' ' LEU . . . . . 0.416 ' N ' HD22 ' B' ' 221' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.3900000000000001 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.682 0.277 . . . . 2.79 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.0800000000000001 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.1599999999999999 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.0899999999999999 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.95999999999999996 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.95999999999999996 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.3 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 1.52 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 0.95999999999999996 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.0700000000000001 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.0800000000000001 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.02 111.049 179.564 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' C' ' 36' ' ' GLU . 12.2 p90 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.3700000000000001 112.313 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' C' ' 35' ' ' TYR . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.7200000000000002 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.6699999999999999 110.109 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 1.9299999999999999 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 1.8799999999999999 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.23 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.426 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.0899999999999999 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 1.4099999999999999 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.613 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 0.80000000000000004 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.71999999999999997 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.478 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 1.6799999999999999 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' TRP . . . . . 0.478 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 1.6799999999999999 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.28 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.51000000000000001 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.409 HD22 ' SG ' ' A' ' 134' ' ' CYS . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.635 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.56999999999999995 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 1.6699999999999999 110.901 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.4199999999999999 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 0.70999999999999996 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.1399999999999999 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 0.88 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.3799999999999999 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.9399999999999999 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 1.8700000000000001 110.866 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 2.8599999999999999 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 1.95 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.1099999999999999 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.54 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.4700000000000002 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 2.8500000000000001 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 1.8700000000000001 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.1200000000000001 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.26 110.809 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.0800000000000001 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.132 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 1.8 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.1799999999999999 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.3300000000000001 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 76' ' ' TRP . . . . . 0.505 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 1.8500000000000001 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.5600000000000001 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.517 ' O ' HD23 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.1100000000000001 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.613 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.49 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 1.6000000000000001 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.01 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.517 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.1799999999999999 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 1.54 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 1.6499999999999999 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.1000000000000001 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.437 ' O ' HG23 ' C' ' 90' ' ' THR . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.3799999999999999 110.627 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.415 HD22 HD11 ' C' ' 168' ' ' LEU . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.4399999999999999 110.645 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 1.8700000000000001 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 3.1000000000000001 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 ' O ' ' C' ' 86' ' ' SER . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 1.48 110.998 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.02 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.3399999999999999 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 4.54 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.3399999999999999 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.4000000000000004 111.311 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.54 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 5.21 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.3799999999999999 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 2.6400000000000001 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.3799999999999999 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.6200000000000001 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 2.9300000000000002 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.1600000000000001 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.416 ' O ' HG12 ' C' ' 110' ' ' ILE . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 110.894 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.0699999999999998 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.682 HG21 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.2999999999999998 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.411 HE21 HG13 ' C' ' 113' ' ' ILE . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.48 110.287 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 1.9299999999999999 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 1.6699999999999999 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.1100000000000001 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.411 HG13 HE21 ' C' ' 109' ' ' GLN . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 2.5899999999999999 110.515 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 0.92000000000000004 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.55000000000000004 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 1.49 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 1.6599999999999999 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.93999999999999995 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.29 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.611 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.1499999999999999 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.3100000000000001 110.965 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.873 0.368 . . . . 1.3100000000000001 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 128' ' ' ARG . . . . . 0.611 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 2.8399999999999999 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 2.7000000000000002 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 1.8799999999999999 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.3799999999999999 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' TYR . . . . . 0.405 ' HE1' ' HB3' ' C' ' 183' ' ' TRP . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.76 110.901 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.1499999999999999 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.5600000000000001 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.72999999999999998 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 1.48 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.51 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.01 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.0499999999999998 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 1.9199999999999999 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.682 HD13 HG21 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 2.6400000000000001 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.5800000000000001 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.6499999999999999 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.46 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.27 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.3300000000000001 112.402 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.82 0.343 . . . . 2.8199999999999998 111.112 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.1800000000000002 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 1.8100000000000001 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 164' ' ' LEU . . . . . 0.413 ' HA ' ' HE2' ' C' ' 167' ' ' LYS . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.21 110.888 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 167' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' C' ' 164' ' ' LEU . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.5800000000000001 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.415 HD11 HD22 ' C' ' 87' ' ' LEU . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.3 110.583 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 1.73 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 1.4299999999999999 111.031 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.7200000000000002 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 1.55 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 1.5 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 1.8400000000000001 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.1200000000000001 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 1.75 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.71999999999999997 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.625 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 1.8 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 0.88 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 1.52 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.2 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 183' ' ' TRP . . . . . 0.405 ' HB3' ' HE1' ' C' ' 132' ' ' TYR . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.4700000000000002 110.778 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.6200000000000001 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 2.6299999999999999 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.77 112.752 179.755 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.904 0.383 . . . . 2.3700000000000001 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.6800000000000002 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.0499999999999998 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 1.9099999999999999 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.04 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.501 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 1.6200000000000001 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.49 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.3200000000000001 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76000000000000001 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 1.52 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 1.8400000000000001 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.6799999999999999 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.04 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.446 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 2.6499999999999999 110.439 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.446 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.3300000000000001 111.844 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.02 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.3500000000000001 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 3.6200000000000001 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 1.6399999999999999 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.1099999999999999 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 3.3700000000000001 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.1099999999999999 110.841 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.788 0.328 . . . . 3.23 110.678 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 1.8799999999999999 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.29 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.98999999999999999 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 1.9199999999999999 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 15' ' ' MET . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 1.45 109.981 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 0.89000000000000001 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.82999999999999996 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.24 110.904 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.71 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.95999999999999996 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.98999999999999999 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.1099999999999999 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.0199999999999996 110.469 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 3.4100000000000001 112.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HA ' HD23 ' A' ' 38' ' ' LEU . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 2.8100000000000001 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.3900000000000001 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.2400000000000002 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 1.6000000000000001 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.3300000000000001 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.03 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.0 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 1.3100000000000001 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.58999999999999997 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 1.6299999999999999 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.1200000000000001 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.3200000000000001 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.52000000000000002 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.97999999999999998 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.52000000000000002 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 1.6899999999999999 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.1200000000000001 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.93999999999999995 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 0.78000000000000003 110.255 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.23 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.407 ' OE1' HG11 ' B' ' 127' ' ' VAL . 17.6 mm100 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.1000000000000001 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 1.76 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.8400000000000001 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.6400000000000001 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 1.8400000000000001 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.2400000000000002 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.1600000000000001 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 2.8399999999999999 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.3900000000000001 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.96999999999999997 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.04 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.3799999999999999 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.76000000000000001 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 2.9300000000000002 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.1299999999999999 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 75' ' ' ASP . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 1.6599999999999999 110.496 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 74' ' ' ILE . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.4199999999999999 109.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.0899999999999999 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.52 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.3300000000000001 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.3899999999999999 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 1.55 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.01 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.3 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 1.8700000000000001 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.3999999999999999 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 1.9099999999999999 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 2.3300000000000001 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.4299999999999999 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.1899999999999999 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 2.5499999999999998 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.3300000000000001 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 5.0999999999999996 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.0699999999999998 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.4100000000000001 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.3099999999999996 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.9399999999999999 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 5.9800000000000004 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 2.6699999999999999 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 2.5899999999999999 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.53 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 108' ' ' THR . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 3.1400000000000001 111.072 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 1.99 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.3599999999999999 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.25 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 2.7200000000000002 111.213 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 1.8799999999999999 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 1.6000000000000001 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.0900000000000001 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 2.6499999999999999 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 0.89000000000000001 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.68000000000000005 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 1.5800000000000001 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.04 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.1000000000000001 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.8799999999999999 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.29 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.4900000000000002 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.694 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.1299999999999999 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.694 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 3.9700000000000002 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.22 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.8100000000000001 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.25 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 1.8400000000000001 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.54 111.041 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 1.79 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' C' ' 49' ' ' LEU . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 1.76 111.013 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.76000000000000001 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.0699999999999998 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.8500000000000001 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.3200000000000001 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 3.25 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 2.9199999999999999 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 142' ' ' ILE . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 2.6499999999999999 111.413 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.21 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.0099999999999998 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 3.6000000000000001 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.6200000000000001 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 2.4700000000000002 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 2.48 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 64.0 t30 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 2.6899999999999999 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo . . . . . 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.3599999999999999 112.994 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.862 0.363 . . . . 2.6299999999999999 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.1600000000000001 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 1.7 111.342 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.1600000000000001 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 1.5900000000000001 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.3100000000000001 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.1499999999999999 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.3900000000000001 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 1.79 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.1200000000000001 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.439 ' O ' HD13 ' A' ' 175' ' ' LEU . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 3.8599999999999999 110.357 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 1.5800000000000001 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 1.4099999999999999 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 1.4199999999999999 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 171' ' ' TYR . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 1.9099999999999999 111.149 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.55 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 1.8600000000000001 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.73999999999999999 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 182' ' ' VAL . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 1.78 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 0.92000000000000004 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 1.77 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.3400000000000001 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.5099999999999998 111.883 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.02 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 182' ' ' VAL . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.4500000000000002 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 1.73 112.37 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.869 0.366 . . . . 2.6600000000000001 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 111.217 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.21 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.453 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.1800000000000002 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.0099999999999998 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 1.9299999999999999 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 1.7 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.28 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79000000000000004 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 1.51 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 1.9299999999999999 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 1.71 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.04 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 2.8900000000000001 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.3100000000000001 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 2.8700000000000001 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.3799999999999999 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 3.4199999999999999 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.24 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.5099999999999998 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.0099999999999998 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.5900000000000001 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 3.4900000000000002 110.88 179.798 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.46 0.055 0 CA-C-O 120.682 0.277 . . . . 3.0800000000000001 111.325 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.459 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.3500000000000001 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 1.3899999999999999 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1000000000000001 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 1.71 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 1.48 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 0.94999999999999996 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.96999999999999997 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.80000000000000004 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.29 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 0.97999999999999998 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.1200000000000001 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.0 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 4.2599999999999998 110.197 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.55 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 N-CA-C 113.185 0.809 . . . . 3.1699999999999999 113.185 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.55 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.5699999999999998 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.7400000000000002 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 1.72 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.497 HG23 HD13 ' B' ' 43' ' ' ILE . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 1.95 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.1200000000000001 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 1.49 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 0.77000000000000002 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.68000000000000005 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 1.6299999999999999 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.586 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 1.9099999999999999 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.22 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.55000000000000004 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 0.87 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 0.55000000000000004 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HA ' ' SD ' ' B' ' 54' ' ' MET . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 111.363 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.486 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.1899999999999999 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.66000000000000003 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' B' ' 51' ' ' TYR . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 0.85999999999999999 110.23 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 0.83999999999999997 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 1.4399999999999999 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.2400000000000002 110.904 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.3100000000000001 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 1.8100000000000001 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.1800000000000002 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.48 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.3700000000000001 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 1.78 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.05 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.1100000000000001 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.2999999999999998 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 0.71999999999999997 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.46 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.04 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 1.79 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 1.4399999999999999 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.3100000000000001 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.0099999999999998 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.4299999999999999 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.43 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.21 112.081 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.486 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.1799999999999999 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.611 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 1.6499999999999999 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.0600000000000001 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.601 ' HB3' HD11 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 1.5800000000000001 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 1.49 110.207 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 1.96 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.24 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.21 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.3200000000000001 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' B' ' 35' ' ' TYR . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.1499999999999999 111.324 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 1.4399999999999999 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.05 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 2.6800000000000002 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.71 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 4.1900000000000004 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 2.79 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.2699999999999996 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.5700000000000003 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.2400000000000002 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 5.3899999999999997 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.1600000000000001 111.624 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 2.5800000000000001 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.29 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.48 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 2.7599999999999998 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.3599999999999999 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 1.9199999999999999 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.617 ' HB ' HD13 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.0600000000000001 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.435 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 2.8700000000000001 111.274 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 1.98 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 1.6200000000000001 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.04 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.465 HG22 HD21 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.82999999999999996 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 0.73999999999999999 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.59999999999999998 112.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 73' ' ' TYR . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.4199999999999999 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.51 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.0900000000000001 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.1599999999999999 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 1.76 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.8900000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.546 ' HB2' HG12 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 2.6699999999999999 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.0700000000000003 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 1.4099999999999999 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 2.4700000000000002 110.729 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 2.6099999999999999 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.0699999999999998 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.69999999999999996 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 1.4399999999999999 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 1.8200000000000001 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.93999999999999995 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.6000000000000001 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.0099999999999998 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 1.96 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 2.8799999999999999 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.52 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 4.1500000000000004 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.5900000000000001 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.1299999999999999 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.4 t-20 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.4500000000000002 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo . . . . . 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.3599999999999999 112.711 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.848 0.356 . . . . 2.3999999999999999 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 161' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 2.5699999999999998 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.72 111.255 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 164' ' ' LEU . . . . . 0.426 HD12 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.1600000000000001 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.1299999999999999 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.3300000000000001 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 1.5600000000000001 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.5900000000000001 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.1399999999999999 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 3.8700000000000001 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.53 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 1.99 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' TRP . . . . . 0.435 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.5 111.315 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.532 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 1.46 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67000000000000004 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.67 ' O ' HG22 ' B' ' 182' ' ' VAL . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 1.73 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 0.93000000000000005 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.532 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 1.3600000000000001 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.67 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.1899999999999999 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 2.73 111.755 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.405 HG22 HG23 ' B' ' 185' ' ' ILE . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 1.9299999999999999 111.602 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.412 ' H ' HG13 ' B' ' 185' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 2.6400000000000001 111.421 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.349 . . . . 2.2000000000000002 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.4900000000000002 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.76 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.1800000000000002 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 1.98 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 1.6499999999999999 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.1100000000000001 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.576 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 1.4299999999999999 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77000000000000002 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG23 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 1.6000000000000001 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 1.77 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.54 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.0099999999999998 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.6499999999999999 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.3300000000000001 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 2.29 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 3.6000000000000001 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 1.51 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.2200000000000002 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 2.6899999999999999 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 3.3999999999999999 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.3900000000000001 110.817 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.705 0.288 . . . . 2.79 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.0800000000000001 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.4 m80 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 1.4299999999999999 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.468 ' O ' HG12 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.1599999999999999 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.0899999999999999 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 1.5800000000000001 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.468 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 0.95999999999999996 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.95999999999999996 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.3 110.222 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 1.52 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.449 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.8999999999999999 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 0.95999999999999996 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.0700000000000001 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.0800000000000001 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.02 110.218 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.471 ' O ' HG22 ' C' ' 39' ' ' VAL . 1.5 p90 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.988 0.736 . . . . 3.3700000000000001 112.988 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.7200000000000002 112.679 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.6699999999999999 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 1.9299999999999999 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 35' ' ' TYR . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 1.8799999999999999 113.15 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.23 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.0899999999999999 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 1.4099999999999999 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 0.80000000000000004 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.71999999999999997 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 1.6799999999999999 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 1.6799999999999999 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.28 111.69 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.51000000000000001 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.473 HD22 ' SG ' ' A' ' 134' ' ' CYS . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.3300000000000001 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.56999999999999995 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 1.6699999999999999 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.4199999999999999 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 0.70999999999999996 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.1399999999999999 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 0.88 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.3799999999999999 110.81 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8700000000000001 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 2.8599999999999999 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 1.95 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.1099999999999999 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.54 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.4700000000000002 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 2.8500000000000001 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.8700000000000001 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.591 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.26 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.0800000000000001 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 0.85999999999999999 112.121 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 1.96 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 1.8 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.438 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.1799999999999999 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.438 ' N ' HG23 ' C' ' 74' ' ' ILE . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.3300000000000001 109.38 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 1.8500000000000001 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.5600000000000001 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.481 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.1100000000000001 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.49 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 1.6000000000000001 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.01 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.436 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.1799999999999999 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 1.54 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' C' ' 109' ' ' GLN . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 1.6499999999999999 110.767 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.1000000000000001 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.3799999999999999 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.637 HD22 HD11 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 1.4399999999999999 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.8700000000000001 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 3.1000000000000001 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 1.48 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.02 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.3399999999999999 110.907 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 4.54 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.3399999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.4000000000000004 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.54 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 5.21 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.3799999999999999 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 2.6400000000000001 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.3799999999999999 110.697 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.6200000000000001 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 2.9300000000000002 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.1600000000000001 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.2999999999999998 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.0699999999999998 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.512 ' HB ' HG21 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.2999999999999998 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 85.6 mm-40 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.586 HG22 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 1.9299999999999999 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 1.6699999999999999 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.1100000000000001 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 2.5899999999999999 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.92000000000000004 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.55000000000000004 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 1.49 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.433 HG12 HD12 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 1.6599999999999999 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.93999999999999995 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.29 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.1499999999999999 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.3100000000000001 111.038 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' C' ' 130' ' ' LEU . 8.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.849 0.357 . . . . 1.3100000000000001 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 2.8399999999999999 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 2.7000000000000002 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8799999999999999 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.3799999999999999 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.76 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.1499999999999999 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 1.5600000000000001 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.72999999999999998 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 1.48 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.01 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.0699999999999998 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 141' ' ' ILE . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 1.9199999999999999 111.568 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.6400000000000001 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.51 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 3.5800000000000001 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.6499999999999999 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.46 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.27 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.3300000000000001 112.02 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.821 0.343 . . . . 2.8199999999999998 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.1800000000000002 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.5 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 1.8100000000000001 111.193 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.1299999999999999 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.437 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.3100000000000001 110.969 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.2599999999999998 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.5800000000000001 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.637 HD11 HD22 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.3 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 165' ' ' TYR . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 1.73 111.336 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 1.4299999999999999 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.7200000000000002 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 1.55 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 1.5 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 1.8400000000000001 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.43 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.1200000000000001 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.457 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 1.75 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.473 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 113.143 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.591 ' O ' HG22 ' C' ' 182' ' ' VAL . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 1.8 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 0.88 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.447 HG22 ' O ' ' C' ' 178' ' ' GLY . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 1.52 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.2 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.4700000000000002 111.966 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.43 HG22 ' O ' ' C' ' 181' ' ' ILE . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 1.6200000000000001 112.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.457 HG12 ' O ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 2.6299999999999999 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.77 112.639 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 197' ' ' ILE . . . . . 0.487 ' N ' HD12 ' C' ' 197' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.757 0.313 . . . . 2.3700000000000001 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.6800000000000002 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 1.95 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 200' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.0499999999999998 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.9099999999999999 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.04 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 1.6200000000000001 110.407 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.49 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.3200000000000001 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76000000000000001 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 208' ' ' PHE . . . . . 0.429 ' HA ' HG22 ' C' ' 211' ' ' VAL . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 1.8400000000000001 110.148 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.43 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.6799999999999999 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.04 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.457 HG23 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 2.6499999999999999 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.457 ' N ' HG23 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.3300000000000001 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.02 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.3500000000000001 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 3.6200000000000001 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 1.6399999999999999 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2000000000000002 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.1099999999999999 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.1099999999999999 111.247 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.824 0.345 . . . . 3.23 111.011 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.8799999999999999 110.778 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.1 m80 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.29 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 0.98999999999999999 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 1.9199999999999999 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 1.45 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.89000000000000001 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.82999999999999996 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.24 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.29 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 1.71 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.95999999999999996 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 0.98999999999999999 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.1099999999999999 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.23 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.0199999999999996 111.07 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.012 0.375 . . . . 3.4100000000000001 112.012 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 2.8100000000000001 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.3900000000000001 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.2400000000000002 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 1.6000000000000001 110.929 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.03 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.0 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.58999999999999997 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 1.6299999999999999 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.1200000000000001 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.3200000000000001 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.52000000000000002 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 0.97999999999999998 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.52000000000000002 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 1.6899999999999999 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.1200000000000001 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HE1' ' B' ' 131' ' ' TRP . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 0.59999999999999998 110.868 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 0.93999999999999995 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.78000000000000003 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 56' ' ' ILE . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.23 110.698 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.1000000000000001 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 1.76 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.6400000000000001 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 1.8400000000000001 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.2400000000000002 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.1600000000000001 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 2.8399999999999999 110.996 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.3900000000000001 111.123 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.96999999999999997 111.128 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.04 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.3799999999999999 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 0.76000000000000001 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 2.9300000000000002 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.1299999999999999 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 1.6599999999999999 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.4199999999999999 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.43 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.0899999999999999 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.52 111.007 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.3300000000000001 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.3899999999999999 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 1.55 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.01 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 1.45 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.3 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.49 HD22 ' NE2' ' A' ' 109' ' ' GLN . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 1.6699999999999999 110.222 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 1.8700000000000001 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.4199999999999999 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 1.9099999999999999 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 2.3300000000000001 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 1.4299999999999999 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.1899999999999999 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 2.5499999999999998 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.3300000000000001 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 5.0999999999999996 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.0699999999999998 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.4100000000000001 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.3099999999999996 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.9399999999999999 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 5.9800000000000004 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.2400000000000002 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 2.6699999999999999 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 2.5899999999999999 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.53 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 3.1400000000000001 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.99 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . 0.513 ' HA ' HE21 ' A' ' 109' ' ' GLN . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.3599999999999999 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.25 111.828 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 106' ' ' MET . 29.2 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 2.7200000000000002 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 1.8799999999999999 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.6000000000000001 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 2.6499999999999999 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.89000000000000001 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 0.68000000000000005 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 1.5800000000000001 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.04 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.1000000000000001 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.8799999999999999 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.29 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.4900000000000002 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' HG12 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.1299999999999999 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 3.9700000000000002 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.22 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 2.8100000000000001 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.25 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' VAL . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 1.8400000000000001 110.598 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.558 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 184' ' ' ILE . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.79 110.701 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.0800000000000001 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 1.76 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.76000000000000001 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.0699999999999998 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.426 ' HA ' HD12 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 1.8500000000000001 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 3.25 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 2.9199999999999999 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 2.6499999999999999 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 141' ' ' ILE . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.21 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.0099999999999998 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 3.6000000000000001 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.6200000000000001 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 2.4700000000000002 111.371 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 52.1 t30 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 2.6899999999999999 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.3599999999999999 113.327 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.895 0.379 . . . . 2.6299999999999999 111.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.3700000000000001 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.8300000000000001 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.7 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 1.5900000000000001 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.497 ' N ' HD12 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.3100000000000001 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.3900000000000001 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.4199999999999999 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.1200000000000001 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 3.8599999999999999 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 1.5800000000000001 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 1.4099999999999999 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 1.4199999999999999 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 1.9099999999999999 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.55 111.538 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.8600000000000001 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.73999999999999999 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.596 ' O ' HG22 ' A' ' 182' ' ' VAL . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 1.78 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 0.92000000000000004 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 1.77 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.3400000000000001 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.5099999999999998 112.76 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 132' ' ' TYR . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.02 112.148 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.4500000000000002 112.468 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 1.73 113.18 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.755 0.312 . . . . 2.6600000000000001 110.764 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 1.8100000000000001 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.21 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.1800000000000002 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.0099999999999998 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 1.7 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.28 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79000000000000004 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 1.9299999999999999 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 1.71 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.04 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 212' ' ' GLY . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 2.8900000000000001 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 211' ' ' VAL . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.3100000000000001 112.196 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 2.8700000000000001 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.3799999999999999 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 3.4199999999999999 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.24 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.4399999999999999 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.5099999999999998 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.0099999999999998 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.5900000000000001 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 3.4900000000000002 111.135 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 10' ' ' ILE . 29.0 tp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.698 0.259 . . . . 3.0800000000000001 111.698 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.3500000000000001 110.95 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1000000000000001 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 6' ' ' LEU . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 1.71 110.315 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 1.48 110.688 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.94999999999999996 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.80000000000000004 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.472 ' HG3' ' HA2' ' B' ' 48' ' ' GLY . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.29 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.3600000000000001 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.97999999999999998 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.1200000000000001 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 4.2599999999999998 110.464 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 114.514 1.302 . . . . 3.1699999999999999 114.514 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.557 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.5699999999999998 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.7400000000000002 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 1.72 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 1.95 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.2 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.1200000000000001 110.159 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 1.49 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.436 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 0.77000000000000002 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.68000000000000005 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 1.6299999999999999 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 1.9099999999999999 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.22 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLY . . . . . 0.472 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.55000000000000004 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.421 HD22 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.87 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.55000000000000004 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.0600000000000001 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.1899999999999999 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 0.66000000000000003 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.85999999999999999 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 0.83999999999999997 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.497 HG21 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 1.4399999999999999 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.2400000000000002 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.3100000000000001 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 1.8100000000000001 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.1800000000000002 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.0299999999999998 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.48 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.3700000000000001 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.78 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.05 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.623 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.1100000000000001 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.2999999999999998 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.475 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.71999999999999997 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.04 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.463 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 1.79 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.475 HG22 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 1.4399999999999999 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.3100000000000001 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.463 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.0099999999999998 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.512 ' HE2' HD11 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.4299999999999999 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.466 ' O ' HD23 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.21 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.429 HG23 HG23 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.1799999999999999 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.562 HG21 HD11 ' B' ' 113' ' ' ILE . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 1.6499999999999999 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.0600000000000001 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 1.5800000000000001 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.49 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.536 ' H ' HD23 ' B' ' 84' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 1.72 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 1.96 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.24 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.438 HD23 ' HE1' ' B' ' 213' ' ' PHE . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.21 110.276 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.3200000000000001 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' TRP . . . . . 0.689 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.1499999999999999 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 1.4399999999999999 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 2.6800000000000002 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 2.71 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 4.1900000000000004 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 2.79 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.2699999999999996 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.5700000000000003 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.2400000000000002 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 5.3899999999999997 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.1600000000000001 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 2.5800000000000001 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.29 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.48 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.437 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 2.7599999999999998 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.497 HD13 HD12 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.2200000000000002 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' MET . . . . . 0.436 ' N ' HD12 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.3599999999999999 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 1.9199999999999999 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.0600000000000001 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.634 HE22 ' HE1' ' B' ' 176' ' ' TRP . 8.1 tp-100 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 2.8700000000000001 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 1.98 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.6200000000000001 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.04 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.562 HD11 HG21 ' B' ' 80' ' ' THR . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.46 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 0.82999999999999996 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.73999999999999999 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.59999999999999998 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 77' ' ' MET . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.4199999999999999 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 1.51 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.1599999999999999 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 1.76 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.8900000000000001 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 2.6699999999999999 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.0700000000000003 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 1.4099999999999999 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 2.4700000000000002 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 2.6099999999999999 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.0699999999999998 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' TRP . . . . . 0.402 ' HE1' ' HB1' ' A' ' 53' ' ' ALA . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.695 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 1.75 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 1.6699999999999999 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.69999999999999996 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 1.4399999999999999 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 1.8200000000000001 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.93999999999999995 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 1.6000000000000001 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.0099999999999998 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 1.96 111.739 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 2.8799999999999999 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 4.1500000000000004 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.5900000000000001 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 1.78 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.4500000000000002 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.3599999999999999 113.303 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 2.3999999999999999 110.979 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 2.5699999999999998 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 1.72 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 2.6899999999999999 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.1600000000000001 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.1299999999999999 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.9399999999999999 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.3300000000000001 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 1.5600000000000001 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.5900000000000001 111.142 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.1399999999999999 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 3.8700000000000001 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 1.6100000000000001 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.453 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.3 111.442 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 1.53 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 1.99 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' TRP . . . . . 0.634 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.5 110.761 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.453 HG22 ' O ' ' B' ' 173' ' ' THR . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 1.46 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.497 ' O ' HG22 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.707 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 1.73 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 0.93000000000000005 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 1.3600000000000001 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.1899999999999999 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 183' ' ' TRP . . . . . 0.536 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 2.73 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 1.9299999999999999 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.426 HG23 ' O ' ' B' ' 181' ' ' ILE . 26.8 pt . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 2.6400000000000001 111.279 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 197' ' ' ILE . . . . . 0.465 ' N ' HD12 ' B' ' 197' ' ' ILE . 3.0 mp . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.643 0.259 . . . . 2.2000000000000002 111.386 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.4900000000000002 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.1800000000000002 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.78 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 1.98 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.461 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 1.6499999999999999 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.1100000000000001 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 1.4299999999999999 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77000000000000002 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.6000000000000001 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 1.77 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.54 110.874 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.0099999999999998 111.022 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 2.6499999999999999 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.3300000000000001 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 213' ' ' PHE . . . . . 0.438 ' HE1' HD23 ' B' ' 87' ' ' LEU . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 2.29 110.796 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.1200000000000001 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 3.6000000000000001 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 1.51 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.2200000000000002 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.6899999999999999 111.369 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 3.3999999999999999 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.6699999999999999 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.3900000000000001 111.085 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.72 0.295 . . . . 2.79 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.535 HD22 ' H ' ' C' ' 7' ' ' LEU . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.0800000000000001 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 1.4299999999999999 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.1599999999999999 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.0899999999999999 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 1.5800000000000001 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.0 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.95999999999999996 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.3 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 1.52 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 1.8999999999999999 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' GLY . . . . . 0.476 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 0.95999999999999996 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.0700000000000001 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.0800000000000001 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.02 111.372 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.3700000000000001 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.6699999999999999 110.533 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 1.9299999999999999 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 1.8799999999999999 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.23 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 1.4099999999999999 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 0.80000000000000004 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.71999999999999997 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 1.6799999999999999 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 1.6799999999999999 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.51000000000000001 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.3300000000000001 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.56999999999999995 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 1.6699999999999999 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.4199999999999999 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 0.70999999999999996 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.1399999999999999 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.88 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.451 ' O ' HG22 ' C' ' 56' ' ' ILE . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.3799999999999999 110.507 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.9399999999999999 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 1.8700000000000001 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 2.8599999999999999 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 1.95 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.1099999999999999 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.54 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.4700000000000002 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 2.8500000000000001 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 1.8700000000000001 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.1200000000000001 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.26 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.517 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.0800000000000001 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.85999999999999999 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 1.96 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 1.8 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.1799999999999999 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.3300000000000001 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 1.8500000000000001 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.426 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.5600000000000001 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.1100000000000001 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.49 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.523 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 1.6000000000000001 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.01 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.1799999999999999 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 1.54 109.449 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 1.6499999999999999 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.429 HD23 ' O ' ' C' ' 81' ' ' PRO . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.1000000000000001 111.019 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.3799999999999999 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 1.4399999999999999 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 1.8700000000000001 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 3.1000000000000001 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 1.48 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.02 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.3399999999999999 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.21 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 4.54 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.3399999999999999 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.4000000000000004 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.54 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 5.21 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.3799999999999999 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 2.6400000000000001 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.3799999999999999 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.6200000000000001 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 2.9300000000000002 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD11 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.1600000000000001 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.2999999999999998 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.0699999999999998 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.2999999999999998 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.48 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 1.9299999999999999 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.1100000000000001 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 2.5899999999999999 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 0.90000000000000002 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.92000000000000004 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.55000000000000004 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 1.49 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 1.6599999999999999 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.93999999999999995 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.624 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.29 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.1499999999999999 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.3100000000000001 110.758 179.884 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.709 0.29 . . . . 1.3100000000000001 111.107 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 2.8399999999999999 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 129' ' ' TYR . . . . . 0.431 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 2.7000000000000002 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 1.8799999999999999 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.3799999999999999 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.76 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' ILE . . . . . 0.431 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.1499999999999999 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 134' ' ' CYS . . . . . 0.421 ' SG ' HD22 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.5600000000000001 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.72999999999999998 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 1.48 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.51 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.01 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.0499999999999998 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.0699999999999998 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.9199999999999999 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.406 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 2.6400000000000001 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.51 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 3.5800000000000001 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.6499999999999999 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.419 HD13 HD23 ' C' ' 105' ' ' LEU . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.46 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.27 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.3300000000000001 112.426 -178.99 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.762 0.315 . . . . 2.8199999999999998 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 160' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.1800000000000002 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.5 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.8100000000000001 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.1299999999999999 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 164' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.21 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.3100000000000001 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.2599999999999998 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.5800000000000001 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 1.73 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 1.4299999999999999 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.7200000000000002 110.5 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.434 ' O ' HG22 ' C' ' 177' ' ' ILE . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 1.5 111.506 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 1.8400000000000001 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.1200000000000001 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 176' ' ' TRP . . . . . 0.503 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.529 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.71999999999999997 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 1.8 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 0.88 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 1.52 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.2 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.4700000000000002 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 1.6200000000000001 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 2.6299999999999999 111.77 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.77 112.781 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.874 0.369 . . . . 2.3700000000000001 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.6800000000000002 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.95 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.0499999999999998 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 1.9099999999999999 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.04 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.484 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 1.6200000000000001 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.49 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.3200000000000001 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76000000000000001 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 208' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' C' ' 211' ' ' VAL . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 1.8400000000000001 110.808 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 110.656 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.04 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 211' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 208' ' ' PHE . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 2.6499999999999999 110.793 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.3300000000000001 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.02 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 214' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.3500000000000001 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 3.6200000000000001 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' C' ' 214' ' ' SER . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.1099999999999999 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 3.3700000000000001 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.1099999999999999 111.256 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 70.2 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.976 0.417 . . . . 3.23 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HD1' ' A' ' 200' ' ' PHE . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 1.8799999999999999 111.135 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.29 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 0.98999999999999999 110.262 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 1.9199999999999999 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 1.45 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 0.89000000000000001 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 0.90000000000000002 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.82999999999999996 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.24 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.29 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 1.71 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 0.98999999999999999 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.1099999999999999 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.23 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.0199999999999996 110.696 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 N--CA 1.461 0.1 0 N-CA-C 112.53 0.566 . . . . 3.4100000000000001 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 2.8100000000000001 111.998 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.3900000000000001 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.2400000000000002 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 1.6000000000000001 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.3300000000000001 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.03 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.442 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.58999999999999997 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 1.6299999999999999 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.3200000000000001 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.52000000000000002 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.97999999999999998 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.52000000000000002 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 1.6899999999999999 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG2' HG11 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.1200000000000001 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 0.59999999999999998 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.93999999999999995 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 0.78000000000000003 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 56' ' ' ILE . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.23 110.745 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.1000000000000001 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 1.76 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 1.8400000000000001 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.6400000000000001 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 1.8400000000000001 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.2400000000000002 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.1600000000000001 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 2.8399999999999999 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.3900000000000001 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.96999999999999997 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.04 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.3799999999999999 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.76000000000000001 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 2.9300000000000002 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.1299999999999999 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 1.6599999999999999 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 79' ' ' THR . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.4199999999999999 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.0899999999999999 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.3300000000000001 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.3899999999999999 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 1.55 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.01 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 1.45 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.3 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 1.6699999999999999 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 1.8700000000000001 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.4199999999999999 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 1.9099999999999999 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 2.3300000000000001 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.4299999999999999 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.1899999999999999 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 2.5499999999999998 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.3300000000000001 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 5.0999999999999996 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.0699999999999998 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.4100000000000001 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.3099999999999996 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.9399999999999999 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 5.9800000000000004 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.2400000000000002 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 2.6699999999999999 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.53 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.99 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.3599999999999999 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.0499999999999998 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.501 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 2.7200000000000002 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 1.8799999999999999 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 1.6000000000000001 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.0900000000000001 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.4 HD12 ' SD ' ' A' ' 77' ' ' MET . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 2.6499999999999999 111.098 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.89000000000000001 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.68000000000000005 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 1.5800000000000001 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.04 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.1000000000000001 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 1.53 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.4900000000000002 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.1299999999999999 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 3.9700000000000002 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.22 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 2.8100000000000001 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 1.8400000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 1.79 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.0800000000000001 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 1.76 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.76000000000000001 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.0699999999999998 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.8500000000000001 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.3200000000000001 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 3.25 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 2.9199999999999999 110.842 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 2.6499999999999999 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.21 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.0099999999999998 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 3.6000000000000001 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.6200000000000001 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 2.4700000000000002 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.474 ' HE1' HG21 ' A' ' 173' ' ' THR . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 2.48 111.568 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.595 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 49.4 t30 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 2.6899999999999999 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.3599999999999999 112.861 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 2.6299999999999999 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.3700000000000001 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 2.8300000000000001 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.1600000000000001 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 1.5900000000000001 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.3100000000000001 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.1499999999999999 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.3900000000000001 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.575 HD11 HD22 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 1.79 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 111.201 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.8599999999999999 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.5800000000000001 111.501 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.474 HG21 ' HE1' ' A' ' 147' ' ' TRP . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 1.4099999999999999 111.628 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 1.9099999999999999 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.55 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 1.8600000000000001 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 112.876 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 1.78 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 0.92000000000000004 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 184' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 1.77 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.3400000000000001 111.045 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.5099999999999998 111.955 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.02 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.4500000000000002 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 1.73 112.854 179.681 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.8 0.334 . . . . 2.6600000000000001 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.8100000000000001 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PHE . . . . . 0.405 ' HD1' HD13 ' A' ' 7' ' ' LEU . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.21 111.345 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.1800000000000002 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.0099999999999998 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 1.9299999999999999 109.97 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 1.7 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.28 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79000000000000004 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 1.51 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 1.9299999999999999 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 1.71 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 2.8900000000000001 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.3100000000000001 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 2.8700000000000001 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.3799999999999999 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 3.4199999999999999 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.24 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.4399999999999999 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.5099999999999998 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.0099999999999998 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.5900000000000001 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 3.4900000000000002 111.446 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.402 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.75 0.31 . . . . 3.0800000000000001 111.023 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.3500000000000001 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 1.3899999999999999 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1000000000000001 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 1.71 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 1.48 110.517 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.94999999999999996 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.96999999999999997 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.80000000000000004 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.29 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.3600000000000001 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.417 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.23 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.417 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 0.97999999999999998 111.168 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.1200000000000001 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 4.2599999999999998 110.664 179.662 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.1699999999999999 111.47 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.5699999999999998 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.7400000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 1.72 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 1.95 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.2 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' MET . . . . . 0.421 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.1200000000000001 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 1.49 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG23 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 0.77000000000000002 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.68000000000000005 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 1.6299999999999999 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 1.9099999999999999 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.485 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.22 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.55000000000000004 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 0.87 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.55000000000000004 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.0600000000000001 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.1899999999999999 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 0.66000000000000003 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.85999999999999999 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 0.83999999999999997 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 1.4399999999999999 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.591 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.2400000000000002 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.3100000000000001 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.8100000000000001 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.1800000000000002 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.0299999999999998 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.48 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.3700000000000001 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.2799999999999998 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.1100000000000001 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.2999999999999998 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.71999999999999997 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.04 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 1.79 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.441 HG23 ' N ' ' B' ' 75' ' ' ASP . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 1.4399999999999999 110.461 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.3100000000000001 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.0099999999999998 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.4299999999999999 110.626 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' B' ' 82' ' ' LEU . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.21 111.844 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.529 HG23 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 1.6499999999999999 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.0600000000000001 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.5800000000000001 111.102 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 1.49 110.712 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 1.72 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.416 ' N ' HD12 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 1.96 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.3200000000000001 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.1499999999999999 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 1.4399999999999999 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 2.6800000000000002 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 2.71 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 4.1900000000000004 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 2.79 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.2699999999999996 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.5700000000000003 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.2400000000000002 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 5.3899999999999997 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.1600000000000001 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 2.5800000000000001 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.29 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.48 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 2.7599999999999998 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.2200000000000002 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.3599999999999999 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 1.9199999999999999 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.489 HG21 HD13 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.0600000000000001 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 2.8700000000000001 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.98 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 1.6200000000000001 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.04 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.46 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.82999999999999996 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.73999999999999999 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.59999999999999998 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.546 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.4199999999999999 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.546 ' N ' HD12 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 1.51 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.0900000000000001 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 1.76 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.8900000000000001 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 2.6699999999999999 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.0700000000000003 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.4099999999999999 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 2.4700000000000002 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 2.6099999999999999 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.0699999999999998 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.3 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.6699999999999999 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.8200000000000001 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.93999999999999995 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 1.6000000000000001 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.0099999999999998 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 1.96 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.489 HD13 HG21 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 2.8799999999999999 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.52 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 4.1500000000000004 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.5900000000000001 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.1299999999999999 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.3599999999999999 112.594 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 2.3999999999999999 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 2.5699999999999998 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 1.72 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 2.6899999999999999 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.1600000000000001 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.1299999999999999 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.9399999999999999 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.3300000000000001 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.642 HD11 HD22 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 1.5600000000000001 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.5900000000000001 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.1399999999999999 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 171' ' ' TYR . . . . . 0.423 ' O ' HG12 ' B' ' 174' ' ' VAL . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 3.8700000000000001 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 1.6100000000000001 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.3 111.481 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.423 HG12 ' O ' ' B' ' 171' ' ' TYR . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 1.53 111.705 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 1.99 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.5 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.445 HG22 ' O ' ' B' ' 173' ' ' THR . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 1.46 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67000000000000004 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 1.73 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 0.93000000000000005 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 1.3600000000000001 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.1899999999999999 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 2.73 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.413 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 1.9299999999999999 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 2.6400000000000001 111.377 -179.562 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.729 0.299 . . . . 2.2000000000000002 110.972 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.4900000000000002 110.728 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.76 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.1800000000000002 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 1.98 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 1.6499999999999999 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.1100000000000001 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 1.4299999999999999 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77000000000000002 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 1.6000000000000001 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 1.77 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.54 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.0099999999999998 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 2.6499999999999999 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.3300000000000001 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 2.29 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.1200000000000001 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 3.6000000000000001 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 1.51 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.2200000000000002 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 2.6899999999999999 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 3.3999999999999999 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.3900000000000001 110.957 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.61 0.243 . . . . 2.79 111.492 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.0800000000000001 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 1.4299999999999999 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' C' ' 12' ' ' VAL . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.1599999999999999 110.8 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.0899999999999999 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' TYR . . . . . 0.406 ' O ' ' HG2' ' C' ' 15' ' ' MET . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 1.5800000000000001 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.375 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.95999999999999996 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 0.95999999999999996 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 15' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.3 110.831 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.425 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 1.8999999999999999 110.865 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 0.95999999999999996 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.0700000000000001 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.0800000000000001 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.02 110.35 179.621 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.747 0.308 . . . . 3.3700000000000001 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.7200000000000002 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.6699999999999999 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.9299999999999999 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.23 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.417 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.0899999999999999 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 0.80000000000000004 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.71999999999999997 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 1.6799999999999999 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 1.6799999999999999 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.51000000000000001 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.3300000000000001 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 1.6699999999999999 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.4199999999999999 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 0.70999999999999996 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.1399999999999999 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.88 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.3799999999999999 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.9399999999999999 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 1.8700000000000001 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LYS . . . . . 0.4 ' HD3' HH12 ' C' ' 72' ' ' ARG . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 2.8599999999999999 110.933 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.1099999999999999 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.54 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.4700000000000002 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 2.8500000000000001 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.1200000000000001 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.26 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.0800000000000001 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.85999999999999999 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 1.96 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 1.8 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.1799999999999999 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.3300000000000001 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 1.8500000000000001 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.5600000000000001 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.566 HG23 HG23 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.49 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 1.6000000000000001 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.01 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.1799999999999999 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 1.54 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' C' ' 85' ' ' LEU . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 1.6499999999999999 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.1000000000000001 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.446 HD22 HD11 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.4399999999999999 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 1.8700000000000001 110.772 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 3.1000000000000001 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 1.48 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.3399999999999999 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.21 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 4.54 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.3399999999999999 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.4000000000000004 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.54 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 5.21 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.3799999999999999 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 2.6400000000000001 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.3799999999999999 110.933 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.6200000000000001 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 2.9300000000000002 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.414 HD23 HD11 ' C' ' 142' ' ' ILE . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.1600000000000001 110.74 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.2999999999999998 111.193 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.0699999999999998 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.42 HG21 HD12 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.2999999999999998 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.48 110.457 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 1.9299999999999999 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 1.6699999999999999 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.1100000000000001 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 2.5899999999999999 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.90000000000000002 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 115' ' ' SER . . . . . 0.57 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 0.92000000000000004 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.55000000000000004 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 1.49 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 117' ' ' LEU . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 1.6599999999999999 111.207 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 119' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.93999999999999995 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.29 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.1499999999999999 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.3100000000000001 109.441 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' C' ' 129' ' ' TYR . 8.8 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.215 0.531 . . . . 1.3100000000000001 110.811 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 128' ' ' ARG . . . . . 0.567 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 2.8399999999999999 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 2.7000000000000002 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 1.8799999999999999 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 131' ' ' TRP . . . . . 0.578 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.3799999999999999 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 1.76 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.1499999999999999 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.5600000000000001 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 1.48 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.51 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.01 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.453 ' O ' HD13 ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.0699999999999998 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 1.9199999999999999 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.42 HD12 HG21 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 2.6400000000000001 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.51 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 3.5800000000000001 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.6499999999999999 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.46 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.27 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.3300000000000001 111.341 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.857 0.361 . . . . 2.8199999999999998 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.1800000000000002 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.5 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 1.8100000000000001 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.1299999999999999 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.21 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.3100000000000001 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.2599999999999998 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.5800000000000001 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.446 HD11 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.3 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.73 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 1.4299999999999999 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.7200000000000002 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 1.55 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.484 HG22 HD12 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 1.5 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 1.8400000000000001 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.1200000000000001 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.796 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.484 HD12 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 1.75 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 1.8 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 0.88 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 1.52 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.2 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.6200000000000001 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 2.6299999999999999 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.77 112.547 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 2.3700000000000001 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.6800000000000002 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 200' ' ' PHE . . . . . 0.506 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.0499999999999998 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 1.9099999999999999 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.04 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.6200000000000001 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.49 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.3200000000000001 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76000000000000001 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 1.8400000000000001 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.6799999999999999 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 2.6499999999999999 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 212' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' C' ' 216' ' ' LEU . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.3300000000000001 112.451 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.02 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.3500000000000001 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 3.6200000000000001 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 212' ' ' GLY . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 1.6399999999999999 110.7 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2000000000000002 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.1099999999999999 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 3.3700000000000001 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 221' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 95.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.1099999999999999 110.856 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.639 0.257 . . . . 3.23 110.821 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 1.8799999999999999 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.29 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.98999999999999999 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 1.9199999999999999 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 1.45 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.89000000000000001 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.82999999999999996 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.24 110.589 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.29 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.71 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.95999999999999996 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.98999999999999999 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.1099999999999999 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.23 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.0199999999999996 111.0 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.4 pt20 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 3.4100000000000001 112.59 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 2.8100000000000001 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.3900000000000001 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' MET . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.2400000000000002 110.857 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 34' ' ' GLN . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 1.6000000000000001 110.982 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.3300000000000001 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.03 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.0 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 1.3100000000000001 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.58999999999999997 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 1.6299999999999999 111.733 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 110.918 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.3200000000000001 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.52000000000000002 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.97999999999999998 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.52000000000000002 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.6899999999999999 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.1200000000000001 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 0.59999999999999998 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.93999999999999995 110.246 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 0.78000000000000003 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.23 110.583 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.1000000000000001 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 1.76 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 1.8400000000000001 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 1.8400000000000001 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.2400000000000002 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.1600000000000001 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 2.8399999999999999 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.3900000000000001 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 0.96999999999999997 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.04 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.3799999999999999 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.76000000000000001 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 2.9300000000000002 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.1299999999999999 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 1.6599999999999999 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.4199999999999999 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.0899999999999999 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.52 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.3300000000000001 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.3899999999999999 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 1.55 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.01 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 1.45 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.3 109.147 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 1.6699999999999999 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD12 HD23 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 1.8700000000000001 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.4199999999999999 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 1.9099999999999999 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 2.3300000000000001 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 1.4299999999999999 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.1899999999999999 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 2.5499999999999998 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.3300000000000001 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 5.0999999999999996 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.0699999999999998 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.4100000000000001 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.3099999999999996 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 5.9800000000000004 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.2400000000000002 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD22 ' H ' ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 2.6699999999999999 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 2.5899999999999999 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 3.1400000000000001 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.487 ' HB3' HD21 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 1.99 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.3599999999999999 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' HG21 ' A' ' 142' ' ' ILE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.25 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.511 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 2.7200000000000002 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 1.8799999999999999 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 1.6000000000000001 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.0900000000000001 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 2.6499999999999999 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.89000000000000001 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.68000000000000005 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 1.5800000000000001 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.04 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.1000000000000001 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 1.53 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.29 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.4900000000000002 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.1299999999999999 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 3.9700000000000002 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.22 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 2.8100000000000001 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.25 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 1.8400000000000001 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.54 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 1.79 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.0800000000000001 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.76000000000000001 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.0699999999999998 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 1.8500000000000001 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 3.25 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 2.9199999999999999 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 2.6499999999999999 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.432 HG21 ' OG1' ' A' ' 108' ' ' THR . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.21 111.473 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.0099999999999998 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.6200000000000001 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 2.4700000000000002 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 2.48 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.563 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 2.6899999999999999 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo . . . . . 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.3599999999999999 113.177 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.873 0.368 . . . . 2.6299999999999999 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.1600000000000001 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.3700000000000001 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.8300000000000001 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 1.7 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.1600000000000001 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 1.5900000000000001 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.3100000000000001 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.1499999999999999 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.3900000000000001 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.79 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.1200000000000001 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 3.8599999999999999 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 1.5800000000000001 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 1.4099999999999999 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 1.4199999999999999 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 1.9099999999999999 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.55 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 1.8600000000000001 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.73999999999999999 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 1.78 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 0.92000000000000004 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 1.77 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 179' ' ' TYR . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.3400000000000001 111.421 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.5099999999999998 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.02 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.4500000000000002 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 1.73 112.772 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 2.6600000000000001 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 1.8100000000000001 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.21 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.1800000000000002 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.0099999999999998 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 1.9299999999999999 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 1.7 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.28 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79000000000000004 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 1.51 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 1.9299999999999999 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 1.71 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.04 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 2.8900000000000001 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.3100000000000001 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 2.8700000000000001 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.3799999999999999 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 3.4199999999999999 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 216' ' ' LEU . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.24 110.66 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.4399999999999999 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.0099999999999998 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.5900000000000001 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 3.4900000000000002 111.129 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.638 0.256 . . . . 3.0800000000000001 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.473 ' H ' HD22 ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.3500000000000001 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 1.3899999999999999 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG12 ' B' ' 12' ' ' VAL . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1000000000000001 110.599 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 1.71 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 1.48 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 0.94999999999999996 111.486 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 0.96999999999999997 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.29 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.3600000000000001 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ILE . . . . . 0.458 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.23 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.1200000000000001 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 4.2599999999999998 110.693 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.43 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 112.119 0.414 . . . . 3.1699999999999999 112.119 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.43 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.5699999999999998 112.103 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.7400000000000002 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 1.72 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.457 HG12 HD11 ' B' ' 43' ' ' ILE . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 1.95 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.2 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 1.49 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.657 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 0.77000000000000002 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.68000000000000005 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 1.6299999999999999 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 1.9099999999999999 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.438 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.22 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.55000000000000004 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 0.87 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.55000000000000004 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.0600000000000001 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.1899999999999999 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.66000000000000003 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 0.85999999999999999 110.536 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.83999999999999997 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ILE . . . . . 0.472 HD12 HG23 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.4399999999999999 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.2400000000000002 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.3100000000000001 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 1.8100000000000001 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.1800000000000002 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.0299999999999998 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.3700000000000001 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.2799999999999998 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.501 HD12 ' N ' ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 1.78 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.05 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.1100000000000001 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.2999999999999998 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.71999999999999997 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.04 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.446 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 1.79 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.4399999999999999 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.4299999999999999 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.21 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.657 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.1799999999999999 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.542 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 1.6499999999999999 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.0600000000000001 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.425 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 1.5800000000000001 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' B' ' 83' ' ' LEU . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.595 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' B' ' 109' ' ' GLN . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.474 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 1.96 110.444 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.24 110.241 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.21 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.3200000000000001 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.1499999999999999 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' THR . . . . . 0.631 HG23 HD21 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 1.4399999999999999 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.05 111.36 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 2.6800000000000002 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 2.71 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 4.1900000000000004 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 2.79 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.2699999999999996 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.5700000000000003 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.2400000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 5.3899999999999997 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.1600000000000001 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 2.5800000000000001 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.63 ' H ' HD12 ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.29 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.48 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 2.7599999999999998 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.2200000000000002 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.3599999999999999 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 1.9199999999999999 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.416 HG21 ' CB ' ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.0600000000000001 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.424 ' OE1' HD21 ' B' ' 84' ' ' LEU . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 2.8700000000000001 110.726 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 1.98 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 1.6200000000000001 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.04 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.46 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.82999999999999996 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 0.73999999999999999 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.59999999999999998 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.4199999999999999 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 1.51 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.0900000000000001 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.1599999999999999 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.8900000000000001 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 2.6699999999999999 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.0700000000000003 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.4099999999999999 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 2.4700000000000002 110.836 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 2.6099999999999999 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.0699999999999998 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.3 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 1.75 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 1.6699999999999999 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.54 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.69999999999999996 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 1.4399999999999999 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.8200000000000001 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.93999999999999995 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.6000000000000001 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.0099999999999998 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.416 ' CB ' HG21 ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 2.8799999999999999 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.52 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 4.1500000000000004 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.5900000000000001 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.1299999999999999 110.992 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 1.78 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.565 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.4500000000000002 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.3599999999999999 113.024 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.673 0.273 . . . . 2.3999999999999999 110.736 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.404 HD11 ' HB1' ' B' ' 91' ' ' ALA . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 110.715 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 1.72 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 2.6899999999999999 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.1600000000000001 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.1299999999999999 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.9399999999999999 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.3300000000000001 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.5600000000000001 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 169' ' ' VAL . . . . . 0.489 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 1.5900000000000001 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.1399999999999999 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.8700000000000001 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.6100000000000001 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.3 111.643 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.422 HG23 HD22 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 1.53 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.422 HD22 HG23 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 1.99 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 1.46 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.683 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 1.73 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 0.93000000000000005 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 1.3600000000000001 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.1899999999999999 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 2.73 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 1.9299999999999999 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.337 -179.757 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.76 0.314 . . . . 2.2000000000000002 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.4900000000000002 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.02 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.1800000000000002 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.78 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.98 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 1.6499999999999999 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 1.4299999999999999 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77000000000000002 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 1.6000000000000001 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 209' ' ' SER . . . . . 0.419 ' HB2' HD12 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.54 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.0099999999999998 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 2.6499999999999999 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.3300000000000001 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 2.29 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.1200000000000001 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 3.6000000000000001 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.4 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 1.51 110.58 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.2200000000000002 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 2.6899999999999999 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 3.3999999999999999 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.6699999999999999 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 221' ' ' LEU . . . . . 0.631 HD21 HG23 ' B' ' 90' ' ' THR . 3.3 mm? . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.3900000000000001 111.043 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.31 . . . . 2.79 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.0800000000000001 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.0899999999999999 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 1.5800000000000001 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 0.95999999999999996 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 0.95999999999999996 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' MET . . . . . 0.468 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.3 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 1.8999999999999999 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.95999999999999996 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.0700000000000001 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.0800000000000001 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 7.9 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.02 111.287 -179.923 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.3700000000000001 111.032 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.6699999999999999 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' C' ' 38' ' ' LEU . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 1.9299999999999999 110.38 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 1.8799999999999999 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.0899999999999999 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 1.4099999999999999 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.449 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 0.80000000000000004 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.71999999999999997 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 1.6799999999999999 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 1.6799999999999999 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.432 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.28 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.51000000000000001 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' SD ' ' C' ' 52' ' ' MET . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.3300000000000001 111.086 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 1.6699999999999999 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' C' ' 49' ' ' LEU . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.4199999999999999 110.51 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.418 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.1399999999999999 110.26 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.88 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.3799999999999999 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.9399999999999999 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 25.2 mm-40 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 1.8700000000000001 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 59' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 2.8599999999999999 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 1.95 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.1099999999999999 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.54 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.4700000000000002 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 2.8500000000000001 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.26 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.451 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.0800000000000001 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.418 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 0.85999999999999999 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 1.96 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 1.8 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.451 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.1799999999999999 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.551 ' O ' HG22 ' C' ' 79' ' ' THR . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 1.8500000000000001 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.534 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.5600000000000001 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.1100000000000001 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.551 HG22 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.49 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 1.6000000000000001 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.01 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.1799999999999999 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 1.54 110.046 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 1.6499999999999999 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.1000000000000001 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' SER . . . . . 0.435 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.3799999999999999 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 1.4399999999999999 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 1.8700000000000001 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' TRP . . . . . 0.439 ' HB3' ' HE2' ' C' ' 35' ' ' TYR . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 3.1000000000000001 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 1.48 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.02 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.3399999999999999 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.21 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 4.54 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.3399999999999999 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.4000000000000004 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.54 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 5.21 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.3799999999999999 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.3799999999999999 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.6200000000000001 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 2.9300000000000002 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 105' ' ' LEU . . . . . 0.437 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.1600000000000001 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.2999999999999998 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.0699999999999998 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.2999999999999998 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.405 HE21 HG23 ' C' ' 113' ' ' ILE . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.48 111.065 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 1.6699999999999999 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.1100000000000001 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 2.5899999999999999 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.92000000000000004 110.456 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.55000000000000004 112.298 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 1.49 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 1.6599999999999999 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 0.93999999999999995 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.29 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.1499999999999999 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.3100000000000001 111.0 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.472 HG23 HD12 ' B' ' 56' ' ' ILE . 10.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.713 0.292 . . . . 1.3100000000000001 111.374 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 2.8399999999999999 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 2.7000000000000002 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 1.8799999999999999 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.3799999999999999 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 1.76 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.1499999999999999 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 1.5600000000000001 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.72999999999999998 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 136' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 1.48 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.01 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.0499999999999998 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 140' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.0699999999999998 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 1.9199999999999999 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 2.6400000000000001 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.51 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.6499999999999999 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.46 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.27 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.3300000000000001 112.342 -178.844 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.791 0.329 . . . . 2.8199999999999998 111.048 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.1800000000000002 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 161' ' ' LEU . . . . . 0.401 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.5 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 1.8100000000000001 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.1299999999999999 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.21 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.465 ' O ' HG23 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.3100000000000001 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.2599999999999998 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.5800000000000001 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.3 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 1.73 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 1.4299999999999999 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.7200000000000002 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 172' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 177' ' ' ILE . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 1.5 111.959 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 1.8400000000000001 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.1200000000000001 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 176' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.457 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 1.75 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.71999999999999997 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.63 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 1.8 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 0.88 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.514 ' O ' HG22 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.52 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.2 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.4700000000000002 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.514 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 1.6200000000000001 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 2.6299999999999999 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.77 112.438 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.822 0.344 . . . . 2.3700000000000001 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.95 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.0499999999999998 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 1.9099999999999999 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.04 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.505 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 1.6200000000000001 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.49 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.64 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.3200000000000001 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76000000000000001 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 1.52 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 1.8400000000000001 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.6799999999999999 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 210' ' ' LYS . . . . . 0.468 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.04 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 2.6499999999999999 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.3300000000000001 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.02 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.3500000000000001 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 215' ' ' PHE . . . . . 0.482 ' HA ' HD12 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 3.6200000000000001 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.419 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.6399999999999999 110.784 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2000000000000002 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.1099999999999999 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 3.3700000000000001 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.1099999999999999 111.161 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.695 0.283 . . . . 3.23 110.811 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.8799999999999999 110.952 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.29 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 0.98999999999999999 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 1.9199999999999999 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' MET . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.6 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 0.89000000000000001 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.82999999999999996 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.24 110.49 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.29 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 1.71 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.98999999999999999 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.1099999999999999 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.0199999999999996 110.611 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.727 0.298 . . . . 3.4100000000000001 111.036 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 2.8100000000000001 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.3900000000000001 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.2400000000000002 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 1.6000000000000001 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.03 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.0 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HA ' HG22 ' A' ' 45' ' ' ILE . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 1.3100000000000001 112.762 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.58999999999999997 114.136 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' TRP . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 1.6299999999999999 112.115 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TRP . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.1200000000000001 110.707 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.3200000000000001 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.52000000000000002 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 0.97999999999999998 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.52000000000000002 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.6899999999999999 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 0.59999999999999998 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.93999999999999995 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.78000000000000003 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.23 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.1000000000000001 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 1.76 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' HE2' ' A' ' 70' ' ' TYR . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 1.8400000000000001 111.252 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.2400000000000002 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.1600000000000001 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.8399999999999999 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.3900000000000001 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.96999999999999997 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.04 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.44 ' HE2' HG13 ' A' ' 61' ' ' VAL . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.3799999999999999 110.68 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 0.76000000000000001 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 2.9300000000000002 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.1299999999999999 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 1.6599999999999999 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.0899999999999999 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.52 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.3300000000000001 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.3899999999999999 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 1.55 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.01 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 1.45 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.3 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 1.6699999999999999 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.4199999999999999 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 168' ' ' LEU . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.3999999999999999 110.788 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.9099999999999999 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 2.3300000000000001 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 1.4299999999999999 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 2.5499999999999998 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.3300000000000001 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.0999999999999996 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.0699999999999998 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.4100000000000001 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.3099999999999996 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.9399999999999999 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 5.9800000000000004 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.47 ' HA ' HD22 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.2400000000000002 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 2.6699999999999999 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 2.5899999999999999 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.53 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 3.1400000000000001 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 1.99 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.3599999999999999 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 111' ' ' VAL . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.0499999999999998 111.307 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.25 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.583 ' HG3' HD22 ' A' ' 84' ' ' LEU . 22.3 mm-40 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 2.7200000000000002 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 107' ' ' SER . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.6000000000000001 110.671 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.0900000000000001 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 2.6499999999999999 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 0.89000000000000001 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.68000000000000005 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 1.5800000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.04 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.1000000000000001 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.8799999999999999 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.53 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.29 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.4900000000000002 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.1299999999999999 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 3.9700000000000002 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 124' ' ' ARG . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.22 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 2.8100000000000001 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.25 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.8400000000000001 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.402 ' CD1' ' HG2' ' C' ' 58' ' ' GLN . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.54 111.187 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 1.79 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.0800000000000001 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.418 ' SG ' HD22 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 1.76 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.76000000000000001 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.0699999999999998 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 1.8500000000000001 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.3200000000000001 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 3.25 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 2.9199999999999999 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 2.6499999999999999 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.21 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.0099999999999998 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 3.6000000000000001 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 2.4700000000000002 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 2.48 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 2.6899999999999999 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.3599999999999999 112.605 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.874 0.369 . . . . 2.6299999999999999 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.1600000000000001 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 2.8300000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 1.7 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.1600000000000001 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 1.5900000000000001 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.3100000000000001 110.715 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.1499999999999999 110.597 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.3900000000000001 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.414 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 1.79 111.037 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 3.8599999999999999 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.5800000000000001 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 1.4099999999999999 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 1.4199999999999999 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 1.9099999999999999 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.374 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 1.8600000000000001 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.73999999999999999 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 1.78 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 0.92000000000000004 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 1.77 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 179' ' ' TYR . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.3400000000000001 111.461 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.5099999999999998 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.02 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.4500000000000002 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 1.73 113.06 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.725 0.298 . . . . 2.6600000000000001 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.8100000000000001 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.21 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.0099999999999998 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 1.9299999999999999 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 1.7 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.28 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79000000000000004 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 1.51 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 1.9299999999999999 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 2.8900000000000001 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.3100000000000001 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 2.8700000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.3799999999999999 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 3.4199999999999999 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 216' ' ' LEU . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.24 110.483 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.4399999999999999 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.5099999999999998 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.0099999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.5900000000000001 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 3.4900000000000002 110.972 -179.858 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 3.0800000000000001 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.3500000000000001 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 1.3899999999999999 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' TRP . . . . . 0.451 ' O ' HG12 ' B' ' 12' ' ' VAL . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 110.662 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 1.71 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' B' ' 15' ' ' MET . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 1.48 110.615 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.94999999999999996 111.075 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.96999999999999997 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.80000000000000004 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.29 110.837 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.3600000000000001 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.23 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 0.97999999999999998 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.1200000000000001 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 4.2599999999999998 110.49 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.44 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.1699999999999999 113.348 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.5699999999999998 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.7400000000000002 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.72 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 35' ' ' TYR . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 1.95 111.698 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.2 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.1200000000000001 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 1.49 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 0.77000000000000002 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.68000000000000005 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 1.6299999999999999 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.421 ' HZ3' HG21 ' C' ' 114' ' ' THR . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 1.9099999999999999 111.294 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.22 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.55000000000000004 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 0.87 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.55000000000000004 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.0600000000000001 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.1899999999999999 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.66000000000000003 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.83999999999999997 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 1.4399999999999999 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.401 HE22 ' H ' ' C' ' 123' ' ' GLU . 19.6 mm-40 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.2400000000000002 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.3100000000000001 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 1.8100000000000001 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.1800000000000002 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.0299999999999998 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.48 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.3700000000000001 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.2799999999999998 111.014 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 1.78 110.776 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.05 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.524 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.1100000000000001 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.2999999999999998 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 0.71999999999999997 112.115 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.04 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 1.79 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' B' ' 71' ' ' ALA . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 1.4399999999999999 110.852 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.404 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.3100000000000001 109.389 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.4299999999999999 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.21 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.1799999999999999 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 1.6499999999999999 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.0600000000000001 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 1.5800000000000001 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 83' ' ' LEU . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 1.49 110.659 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 1.72 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.408 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 1.96 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.24 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.21 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.3200000000000001 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 1.4399999999999999 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 2.6800000000000002 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 2.71 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 4.1900000000000004 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 2.79 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.2699999999999996 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.5700000000000003 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 5.3899999999999997 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.1600000000000001 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 2.5800000000000001 110.917 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.29 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.48 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 2.7599999999999998 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.2200000000000002 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.3599999999999999 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 1.9199999999999999 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.0600000000000001 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' B' ' 84' ' ' LEU . 61.4 tp60 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 2.8700000000000001 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 1.98 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 1.6200000000000001 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.04 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.46 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.82999999999999996 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 0.73999999999999999 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.59999999999999998 112.923 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.4199999999999999 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.409 HG13 HD12 ' B' ' 117' ' ' LEU . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 1.51 111.111 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' SER . . . . . 0.576 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.76 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.8900000000000001 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HB2' HG12 ' B' ' 127' ' ' VAL . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 2.6699999999999999 110.925 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.0700000000000003 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' B' ' 124' ' ' ARG . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 1.4099999999999999 110.88 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 2.4700000000000002 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 2.6099999999999999 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.0699999999999998 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' TRP . . . . . 0.411 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.3 111.165 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 1.75 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 1.6699999999999999 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.69999999999999996 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 1.4399999999999999 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 1.8200000000000001 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.93999999999999995 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 1.6000000000000001 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.0099999999999998 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 1.96 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.41 HG13 ' N ' ' B' ' 143' ' ' LEU . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 2.8799999999999999 111.09 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.41 ' N ' HG13 ' B' ' 142' ' ' ILE . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.52 110.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 4.1500000000000004 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.5900000000000001 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.589 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.4500000000000002 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo . . . . . 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.3599999999999999 112.643 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.701 0.286 . . . . 2.3999999999999999 111.116 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 2.5699999999999998 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 1.72 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.1299999999999999 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.9399999999999999 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.3300000000000001 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 1.5600000000000001 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.5900000000000001 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.1399999999999999 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 171' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 3.8700000000000001 110.36 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.6100000000000001 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.3 111.674 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 1.53 111.462 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 1.99 111.732 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.5 111.476 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 1.46 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67000000000000004 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 1.73 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 0.93000000000000005 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.524 ' O ' HG22 ' B' ' 184' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 179' ' ' TYR . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 111.373 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 2.73 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.524 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 1.9299999999999999 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 2.6400000000000001 111.311 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.712 0.291 . . . . 2.2000000000000002 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.4900000000000002 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 1.76 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.1800000000000002 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 201' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 182' ' ' VAL . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.78 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 1.98 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 1.6499999999999999 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.1100000000000001 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 1.4299999999999999 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77000000000000002 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 207' ' ' PHE . . . . . 0.424 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 1.6000000000000001 110.194 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.54 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.0099999999999998 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 211' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 207' ' ' PHE . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 2.6499999999999999 110.97 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.3300000000000001 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 2.29 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.1200000000000001 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 3.6000000000000001 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.2200000000000002 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 2.6899999999999999 110.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 3.3999999999999999 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.3900000000000001 110.804 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 6' ' ' LEU . . . . . 0.459 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.738 0.304 . . . . 2.79 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.0800000000000001 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.556 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 1.4299999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.542 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.1599999999999999 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.0899999999999999 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 1.5800000000000001 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.542 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.95999999999999996 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 0.95999999999999996 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.3 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 1.52 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' ILE . . . . . 0.405 HD12 ' O ' ' C' ' 17' ' ' ILE . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 1.8999999999999999 110.505 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 0.95999999999999996 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.0700000000000001 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.02 110.581 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.537 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.373 0.508 . . . . 3.3700000000000001 112.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.7200000000000002 111.803 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.6699999999999999 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 1.9299999999999999 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.8799999999999999 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.23 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.0899999999999999 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 1.4099999999999999 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 0.80000000000000004 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.71999999999999997 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 1.6799999999999999 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 1.6799999999999999 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.28 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.51000000000000001 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.418 HD22 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.3300000000000001 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.56999999999999995 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.6699999999999999 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.4199999999999999 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.70999999999999996 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 54' ' ' MET . . . . . 0.424 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.1399999999999999 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.88 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.3799999999999999 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.9399999999999999 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 1.8700000000000001 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 2.8599999999999999 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.1099999999999999 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.54 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.4700000000000002 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 2.8500000000000001 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.8700000000000001 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.1200000000000001 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 1.96 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.523 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 1.8 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.1799999999999999 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' C' ' 74' ' ' ILE . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.3300000000000001 109.652 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 1.8500000000000001 111.2 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.5600000000000001 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.402 HG23 ' N ' ' C' ' 79' ' ' THR . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.1100000000000001 112.423 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.402 ' N ' HG23 ' C' ' 78' ' ' VAL . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.49 112.166 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 1.6000000000000001 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.01 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.1799999999999999 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 83' ' ' LEU . . . . . 0.438 HD21 ' HE3' ' C' ' 210' ' ' LYS . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 1.54 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 84' ' ' LEU . . . . . 0.475 HD23 ' H ' ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 1.6499999999999999 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.1000000000000001 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.3799999999999999 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 1.4399999999999999 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 1.8700000000000001 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 3.1000000000000001 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.3399999999999999 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 4.54 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.3399999999999999 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.4000000000000004 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.54 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 5.21 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' THR . . . . . 0.412 HG23 ' N ' ' C' ' 101' ' ' LEU . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.3799999999999999 111.174 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.412 ' N ' HG23 ' C' ' 100' ' ' THR . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 2.6400000000000001 110.875 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.3799999999999999 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.6200000000000001 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 2.9300000000000002 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.1600000000000001 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.2999999999999998 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 107' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.0699999999999998 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.2999999999999998 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.48 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 1.9299999999999999 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 1.6699999999999999 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.1100000000000001 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 2.5899999999999999 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 114' ' ' THR . . . . . 0.421 HG21 ' HZ3' ' B' ' 46' ' ' TRP . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.90000000000000002 110.735 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.92000000000000004 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.55000000000000004 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 1.49 111.291 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 1.6599999999999999 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.93999999999999995 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.29 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.1499999999999999 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 123' ' ' GLU . . . . . 0.401 ' H ' HE22 ' B' ' 58' ' ' GLN . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.3100000000000001 111.041 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.494 HG23 HD12 ' C' ' 130' ' ' LEU . 13.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.961 0.41 . . . . 1.3100000000000001 110.862 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 2.8399999999999999 110.888 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 2.7000000000000002 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.494 HD12 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 1.8799999999999999 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.3799999999999999 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 1.76 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.1499999999999999 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 1.5600000000000001 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.72999999999999998 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 1.48 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.51 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.01 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.0699999999999998 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 1.9199999999999999 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 2.6400000000000001 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 3.5800000000000001 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.6499999999999999 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.46 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.27 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.3300000000000001 112.0 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.348 . . . . 2.8199999999999998 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.1800000000000002 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 161' ' ' LEU . . . . . 0.444 ' H ' HD12 ' C' ' 161' ' ' LEU . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.5 110.625 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.8100000000000001 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.1299999999999999 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.3100000000000001 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.2599999999999998 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.5800000000000001 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.3 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 1.73 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.7200000000000002 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 1.55 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 1.5 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 1.8400000000000001 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.1200000000000001 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.501 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.75 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.53 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.71999999999999997 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 1.8 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.676 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 0.88 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.541 ' O ' HG22 ' C' ' 184' ' ' ILE . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 1.52 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.61 HG22 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.2 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 183' ' ' TRP . . . . . 0.676 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.4700000000000002 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.541 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 1.6200000000000001 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.524 HG23 HG23 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 2.6299999999999999 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.77 112.494 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.782 0.325 . . . . 2.3700000000000001 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.6800000000000002 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 1.95 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.0499999999999998 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 1.9099999999999999 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.04 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.6200000000000001 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.49 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.3200000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76000000000000001 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 1.8400000000000001 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.6799999999999999 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 210' ' ' LYS . . . . . 0.438 ' HE3' HD21 ' C' ' 83' ' ' LEU . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.04 110.867 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 2.6499999999999999 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.3300000000000001 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.02 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.3500000000000001 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 3.6200000000000001 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.402 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 1.6399999999999999 110.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.1099999999999999 110.5 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 3.3700000000000001 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.1099999999999999 110.877 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.714 0.292 . . . . 3.23 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 1.8799999999999999 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.29 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' VAL . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 0.98999999999999999 110.95 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 1.9199999999999999 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 1.45 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.89000000000000001 110.949 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.90000000000000002 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.82999999999999996 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.24 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.29 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.95999999999999996 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 0.98999999999999999 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.1099999999999999 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.23 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.0199999999999996 110.466 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.133 -1.062 . . . . 3.4100000000000001 108.133 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.532 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 2.8100000000000001 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.3900000000000001 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.2400000000000002 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.3300000000000001 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.03 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.0 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 1.3100000000000001 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.58999999999999997 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 1.6299999999999999 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.1200000000000001 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.3200000000000001 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.52000000000000002 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 0.97999999999999998 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 0.52000000000000002 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 1.6899999999999999 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.1200000000000001 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.59999999999999998 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.93999999999999995 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 0.78000000000000003 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 56' ' ' ILE . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.546 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.1000000000000001 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 1.76 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 1.8400000000000001 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.6400000000000001 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.2400000000000002 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.1600000000000001 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 2.8399999999999999 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.96999999999999997 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.04 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.3799999999999999 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 0.76000000000000001 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 2.9300000000000002 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.1299999999999999 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 1.6599999999999999 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4199999999999999 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.0899999999999999 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.52 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.3300000000000001 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 83' ' ' LEU . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.3899999999999999 111.62 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.01 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 1.45 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 79' ' ' THR . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.689 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 1.6699999999999999 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 1.8700000000000001 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.4199999999999999 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.3999999999999999 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 2.3300000000000001 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 1.4299999999999999 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.1899999999999999 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 2.5499999999999998 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.3300000000000001 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 5.0999999999999996 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.0699999999999998 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.4100000000000001 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.3099999999999996 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.9399999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 5.9800000000000004 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.2400000000000002 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 2.6699999999999999 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 2.5899999999999999 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.53 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 3.1400000000000001 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 1.99 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.3599999999999999 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.0499999999999998 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 142' ' ' ILE . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.25 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HG2' HD21 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 2.7200000000000002 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.8799999999999999 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.6000000000000001 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 108' ' ' THR . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.28 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 2.6499999999999999 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.89000000000000001 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.04 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.1000000000000001 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.8799999999999999 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 1.53 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.29 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.4900000000000002 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.1299999999999999 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 3.9700000000000002 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.22 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 2.8100000000000001 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.25 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 1.8400000000000001 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.249 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.79 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.0800000000000001 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.76 110.952 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.76000000000000001 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.0699999999999998 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 1.8500000000000001 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.3200000000000001 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 3.25 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 2.9199999999999999 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 2.6499999999999999 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.21 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.0099999999999998 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 3.6000000000000001 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.6200000000000001 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 2.4700000000000002 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 2.48 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 2.6899999999999999 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.3599999999999999 112.843 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.849 0.357 . . . . 2.6299999999999999 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.1600000000000001 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.3700000000000001 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 2.8300000000000001 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.1600000000000001 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 1.5900000000000001 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.3100000000000001 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.1499999999999999 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.3900000000000001 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 1.79 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.4199999999999999 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.1200000000000001 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 3.8599999999999999 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 1.5800000000000001 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 1.4099999999999999 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 1.4199999999999999 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 1.9099999999999999 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.55 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.479 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 1.8600000000000001 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.73999999999999999 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.59 ' O ' HG22 ' A' ' 182' ' ' VAL . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 1.78 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 0.92000000000000004 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 1.77 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.3400000000000001 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' TRP . . . . . 0.476 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.5099999999999998 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.02 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.4500000000000002 111.331 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 1.73 113.211 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.765 0.317 . . . . 2.6600000000000001 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 1.8100000000000001 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.21 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.1800000000000002 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.0099999999999998 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 1.9299999999999999 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 204' ' ' LEU . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 1.7 111.591 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.28 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79000000000000004 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 1.9299999999999999 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 1.71 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.04 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 2.8900000000000001 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.3100000000000001 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 2.8700000000000001 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.3799999999999999 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 3.4199999999999999 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.24 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.4399999999999999 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.0099999999999998 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.5900000000000001 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 3.4900000000000002 111.107 -179.771 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.761 0.315 . . . . 3.0800000000000001 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.3500000000000001 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 1.3899999999999999 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1000000000000001 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 1.71 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 0.94999999999999996 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.96999999999999997 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.80000000000000004 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.29 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.3600000000000001 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.23 110.567 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 0.97999999999999998 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.1200000000000001 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 4.2599999999999998 110.198 179.756 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.1699999999999999 113.767 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLU . . . . . 0.585 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.5699999999999998 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.7400000000000002 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.72 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 1.95 111.581 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.2 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.1200000000000001 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 1.49 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 0.77000000000000002 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.68000000000000005 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.484 HG22 HG11 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 1.6299999999999999 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' TRP . . . . . 0.508 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 1.9099999999999999 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.59 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.55000000000000004 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.87 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 0.55000000000000004 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.0600000000000001 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.1899999999999999 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 0.66000000000000003 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.85999999999999999 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 0.83999999999999997 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 1.4399999999999999 110.268 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.2400000000000002 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.3100000000000001 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 1.8100000000000001 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.1800000000000002 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.0299999999999998 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.48 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.3700000000000001 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.2799999999999998 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.05 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.1100000000000001 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.475 ' HD1' ' HH ' ' B' ' 73' ' ' TYR . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.2999999999999998 111.64 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 0.71999999999999997 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.486 ' NH2' HG23 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.04 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.475 ' HH ' ' HD1' ' B' ' 70' ' ' TYR . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 1.79 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 1.4399999999999999 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.3100000000000001 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.577 ' SD ' HD21 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.4299999999999999 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.21 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.1799999999999999 111.582 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.628 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 1.6499999999999999 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.0600000000000001 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 1.5800000000000001 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 1.49 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 1.72 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 1.96 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.24 111.053 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' LEU . . . . . 0.457 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.3200000000000001 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' TRP . . . . . 0.463 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.1499999999999999 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.4399999999999999 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.05 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 2.6800000000000002 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 2.71 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 4.1900000000000004 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 2.79 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.2699999999999996 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.5700000000000003 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.2400000000000002 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' TRP . . . . . 0.54 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 5.3899999999999997 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.1600000000000001 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 2.5800000000000001 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.29 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.48 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 2.7599999999999998 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.2200000000000002 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.3599999999999999 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.9199999999999999 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.554 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.0600000000000001 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.521 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 2.8700000000000001 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 1.98 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 1.6200000000000001 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 108' ' ' THR . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.04 111.533 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ILE . . . . . 0.521 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.46 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.73999999999999999 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.59999999999999998 112.013 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.577 HD21 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.4199999999999999 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 1.51 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.0900000000000001 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 121' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 1.76 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.8900000000000001 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 2.6699999999999999 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.0700000000000003 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 1.4099999999999999 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 128' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 2.4700000000000002 110.802 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 2.6099999999999999 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.0699999999999998 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.3 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.75 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 1.6699999999999999 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 1.54 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.69999999999999996 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 1.4399999999999999 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD12 ' B' ' 140' ' ' LEU . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 1.8200000000000001 110.979 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.93999999999999995 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 1.6000000000000001 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 140' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.0099999999999998 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 1.96 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.554 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 2.8799999999999999 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 143' ' ' LEU . . . . . 0.472 HD11 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.52 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 4.1500000000000004 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 145' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.5900000000000001 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 146' ' ' ILE . . . . . 0.464 HG22 ' O ' ' B' ' 143' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.1299999999999999 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 147' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 1.78 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.648 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 81.2 m-20 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.4500000000000002 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo . . . . . 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.3599999999999999 112.979 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.654 0.264 . . . . 2.3999999999999999 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 161' ' ' LEU . . . . . 0.4 ' N ' HD12 ' B' ' 161' ' ' LEU . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 2.5699999999999998 110.828 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 2.6899999999999999 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.1600000000000001 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.1299999999999999 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.9399999999999999 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 168' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 1.5600000000000001 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.1399999999999999 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 3.8700000000000001 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 1.6100000000000001 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.3 111.377 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 1.53 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 1.99 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.5 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 1.46 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67000000000000004 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.657 ' O ' HG22 ' B' ' 182' ' ' VAL . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 1.73 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 0.93000000000000005 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.5 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 1.3600000000000001 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.657 HG22 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 2.73 112.084 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 1.9299999999999999 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 2.6400000000000001 111.853 -179.183 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 197' ' ' ILE . . . . . 0.438 ' N ' HD12 ' B' ' 197' ' ' ILE . 2.9 mp . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.873 0.368 . . . . 2.2000000000000002 110.833 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.4900000000000002 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 199' ' ' THR . . . . . 0.486 HG23 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 1.76 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.1800000000000002 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 1.78 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 1.98 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 1.6499999999999999 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.1100000000000001 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 1.4299999999999999 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77000000000000002 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 1.6000000000000001 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 1.77 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.54 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.0099999999999998 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 2.6499999999999999 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.3300000000000001 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 2.29 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.1200000000000001 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 3.6000000000000001 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 216' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 216' ' ' LEU . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.516 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.2200000000000002 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 2.6899999999999999 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 3.3999999999999999 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.6699999999999999 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.3900000000000001 110.796 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.747 0.308 . . . . 2.79 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.0800000000000001 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.4299999999999999 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.1599999999999999 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.0899999999999999 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 1.5800000000000001 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 0.95999999999999996 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 0.95999999999999996 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.3 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 1.52 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 1.8999999999999999 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 0.95999999999999996 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.0700000000000001 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.0800000000000001 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.993 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 35' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 112.343 0.498 . . . . 3.3700000000000001 112.343 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.7200000000000002 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.6699999999999999 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.473 HD21 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 1.9299999999999999 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 1.8799999999999999 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.23 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.0899999999999999 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 42' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 1.4099999999999999 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.80000000000000004 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.71999999999999997 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 1.6799999999999999 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 1.6799999999999999 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.28 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.51000000000000001 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' C' ' 52' ' ' MET . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.3300000000000001 111.212 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 1.6699999999999999 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.427 ' HE2' HD13 ' C' ' 49' ' ' LEU . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.4199999999999999 110.23 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.70999999999999996 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.1399999999999999 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.88 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.3799999999999999 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.9399999999999999 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 1.8700000000000001 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 2.8599999999999999 111.225 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 1.95 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.1099999999999999 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.54 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.4700000000000002 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 2.8500000000000001 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.8700000000000001 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.1200000000000001 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.417 ' O ' HG12 ' C' ' 74' ' ' ILE . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.0800000000000001 111.254 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.85999999999999999 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 1.96 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' C' ' 117' ' ' LEU . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 1.8 111.22 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.417 HG12 ' O ' ' C' ' 70' ' ' TYR . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.1799999999999999 110.175 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.3300000000000001 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.8500000000000001 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.5600000000000001 110.486 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.433 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.1100000000000001 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.49 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 1.6000000000000001 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.01 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.433 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.1799999999999999 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 1.54 109.947 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 1.6499999999999999 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.3799999999999999 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 87' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 1.4399999999999999 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 3.1000000000000001 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.02 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.3399999999999999 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.54 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.3399999999999999 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.4000000000000004 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.54 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 5.21 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.3799999999999999 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 2.6400000000000001 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.3799999999999999 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.6200000000000001 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 2.9300000000000002 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.1600000000000001 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.2999999999999998 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.0699999999999998 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.5 ' O ' HG23 ' C' ' 112' ' ' VAL . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.2999999999999998 111.511 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.48 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.508 HG22 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 1.9299999999999999 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 111' ' ' VAL . . . . . 0.484 HG11 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 1.6699999999999999 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 112' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 108' ' ' THR . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.1100000000000001 111.234 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.455 HG22 HD21 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 2.5899999999999999 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.92000000000000004 110.371 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.55000000000000004 112.594 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 1.49 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.538 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 1.6599999999999999 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 0.93999999999999995 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.29 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.1499999999999999 110.907 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.3100000000000001 110.825 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 127' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' C' ' 130' ' ' LEU . 14.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.92 0.39 . . . . 1.3100000000000001 111.061 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 2.8399999999999999 110.622 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 2.7000000000000002 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.482 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 1.8799999999999999 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 131' ' ' TRP . . . . . 0.482 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.3799999999999999 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 1.5600000000000001 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.72999999999999998 112.924 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 1.48 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.51 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.01 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.0499999999999998 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.0699999999999998 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.504 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 1.9199999999999999 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.504 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 2.6400000000000001 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.6499999999999999 113.155 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 146' ' ' ILE . . . . . 0.408 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.46 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.27 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.3300000000000001 112.46 -179.218 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.713 0.292 . . . . 2.8199999999999998 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.1800000000000002 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.5 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 1.8100000000000001 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.1299999999999999 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.21 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.3100000000000001 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.5800000000000001 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 168' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.3 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 1.73 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 1.4299999999999999 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.7200000000000002 110.79 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 1.55 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 177' ' ' ILE . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 1.5 111.956 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 1.8400000000000001 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.1200000000000001 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.515 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 1.75 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 178' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.718 ' O ' HG22 ' C' ' 182' ' ' VAL . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 1.8 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 0.88 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.515 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 1.52 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.718 HG22 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.2 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.4700000000000002 112.147 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.42 HG22 ' O ' ' C' ' 181' ' ' ILE . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 1.6200000000000001 112.232 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' C' ' 182' ' ' VAL . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 2.6299999999999999 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.77 112.391 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.601 0.239 . . . . 2.3700000000000001 111.208 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 1.95 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.0499999999999998 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 1.9099999999999999 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.04 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 1.6200000000000001 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.49 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.563 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.3200000000000001 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76000000000000001 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 1.52 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 1.8400000000000001 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.6799999999999999 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 2.6499999999999999 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.3300000000000001 112.376 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.02 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.3500000000000001 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 3.6200000000000001 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2000000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.1099999999999999 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 3.3700000000000001 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.1099999999999999 111.082 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.742 0.305 . . . . 3.23 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 1.8799999999999999 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.29 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 0.98999999999999999 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.9199999999999999 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 1.45 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.89000000000000001 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.90000000000000002 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.82999999999999996 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.24 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.29 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.95999999999999996 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.98999999999999999 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.1099999999999999 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.23 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.0199999999999996 110.522 179.787 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.079 0 N-CA-C 112.267 0.469 . . . . 3.4100000000000001 112.267 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 2.8100000000000001 111.209 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.3900000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.2400000000000002 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD21 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 1.6000000000000001 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.3300000000000001 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.03 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.0 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.3100000000000001 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.0 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.58999999999999997 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 1.6299999999999999 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.1200000000000001 111.37 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.52000000000000002 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 0.97999999999999998 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 0.52000000000000002 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 1.6899999999999999 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.1200000000000001 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.59999999999999998 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.93999999999999995 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 0.78000000000000003 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.23 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.1000000000000001 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.76 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 1.8400000000000001 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.6400000000000001 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.8400000000000001 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.2400000000000002 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.1600000000000001 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 2.8399999999999999 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.3900000000000001 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.04 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.3799999999999999 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 111.997 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 2.9300000000000002 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.1299999999999999 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 110.316 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 79' ' ' THR . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.4199999999999999 109.296 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.0899999999999999 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.52 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.3300000000000001 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.543 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.3899999999999999 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 1.55 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.01 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 1.45 110.66 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.3 109.5 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 1.6699999999999999 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 1.8700000000000001 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 1.9099999999999999 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 2.3300000000000001 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 1.4299999999999999 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.1899999999999999 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 2.5499999999999998 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.3300000000000001 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 5.0999999999999996 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.0699999999999998 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.4100000000000001 111.027 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.3099999999999996 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.9399999999999999 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 5.9800000000000004 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.2400000000000002 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.6699999999999999 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 2.5899999999999999 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 3.1400000000000001 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 1.99 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.3599999999999999 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.0499999999999998 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.25 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 2.7200000000000002 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 1.8799999999999999 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 111.47 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 2.6499999999999999 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.89000000000000001 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.68000000000000005 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 1.5800000000000001 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.04 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.1000000000000001 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 1.53 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.29 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.4900000000000002 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.797 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.1299999999999999 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 127' ' ' VAL . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.797 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 3.9700000000000002 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ASP . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.22 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 2.8100000000000001 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 127' ' ' VAL . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.25 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 1.8400000000000001 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' TRP . . . . . 0.795 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.54 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 1.79 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.0800000000000001 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 1.76 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.76000000000000001 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.0699999999999998 111.064 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' CYS . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 1.8500000000000001 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.3200000000000001 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 3.25 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 2.9199999999999999 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 2.6499999999999999 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . 0.611 HG12 HG21 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.21 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 146' ' ' ILE . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.0099999999999998 110.925 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 3.6000000000000001 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' LEU . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.4700000000000002 111.189 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 2.48 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 2.6899999999999999 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.3599999999999999 112.556 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.718 0.294 . . . . 2.6299999999999999 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.1600000000000001 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.3700000000000001 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 2.8300000000000001 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.1600000000000001 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.5900000000000001 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.3100000000000001 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.3900000000000001 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 1.79 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.4199999999999999 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.1200000000000001 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 3.8599999999999999 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 1.5800000000000001 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.4099999999999999 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 1.4199999999999999 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 1.9099999999999999 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.55 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.8600000000000001 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.73999999999999999 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' TYR . . . . . 0.584 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 1.78 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 0.92000000000000004 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 1.77 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.3400000000000001 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.5099999999999998 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.02 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.4500000000000002 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 1.73 112.518 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.8 0.333 . . . . 2.6600000000000001 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.8100000000000001 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.21 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 201' ' ' LEU . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.1800000000000002 110.685 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.0099999999999998 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 1.9299999999999999 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 1.7 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . 0.676 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.28 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79000000000000004 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 211' ' ' VAL . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 1.51 110.296 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.9299999999999999 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.04 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 207' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 2.8900000000000001 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 216' ' ' LEU . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.3100000000000001 112.149 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 2.8700000000000001 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.3799999999999999 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 3.4199999999999999 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 212' ' ' GLY . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.4399999999999999 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.5099999999999998 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.0099999999999998 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.5900000000000001 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 3.4900000000000002 110.953 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.701 0.286 . . . . 3.0800000000000001 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 7' ' ' LEU . . . . . 0.463 ' H ' HD22 ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.3500000000000001 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 1.3899999999999999 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 1.48 110.485 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.94999999999999996 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 0.96999999999999997 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.80000000000000004 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.29 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.3600000000000001 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.97999999999999998 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.1200000000000001 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.0 109.988 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 4.2599999999999998 110.202 179.538 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HE1' ' C' ' 99' ' ' TRP . 6.1 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.1699999999999999 111.951 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.5699999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.7400000000000002 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 1.72 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 1.95 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.2 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.1200000000000001 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.51 HG23 HG23 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 0.77000000000000002 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.68000000000000005 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 1.6299999999999999 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 1.9099999999999999 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.22 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.55000000000000004 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 0.87 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.55000000000000004 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.0600000000000001 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' MET . . . . . 0.402 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.1899999999999999 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 0.66000000000000003 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' MET . . . . . 0.404 ' HB2' ' HB3' ' B' ' 8' ' ' HIS . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.85999999999999999 110.361 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 0.83999999999999997 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 1.4399999999999999 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' C' ' 122' ' ' SER . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.2400000000000002 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.3100000000000001 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 1.8100000000000001 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.1800000000000002 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.0299999999999998 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.48 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.3700000000000001 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.2799999999999998 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 1.78 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.05 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.1100000000000001 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' TYR . . . . . 0.438 ' O ' HG23 ' B' ' 74' ' ' ILE . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.2999999999999998 111.203 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.71999999999999997 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.04 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 1.79 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' ILE . . . . . 0.48 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 1.4399999999999999 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' ASP . . . . . 0.48 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.3100000000000001 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.0099999999999998 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.4299999999999999 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.523 HG13 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.21 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' THR . . . . . 0.523 ' H ' HG13 ' B' ' 78' ' ' VAL . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.1799999999999999 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 1.6499999999999999 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.0600000000000001 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 82' ' ' LEU . . . . . 0.518 HD23 HD12 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 1.5800000000000001 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 1.49 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 84' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 1.72 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.518 HD12 HD23 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 1.96 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.21 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.1499999999999999 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.4399999999999999 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.05 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 2.6800000000000002 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 2.71 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 4.1900000000000004 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.79 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.2699999999999996 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.5700000000000003 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 5.3899999999999997 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.1600000000000001 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 2.5800000000000001 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.29 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' GLY . . . . . 0.69 ' HA3' HD21 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 2.7599999999999998 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' LEU . . . . . 0.58 ' HB3' HD21 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.2200000000000002 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.3599999999999999 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 1.9199999999999999 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' THR . . . . . 0.61 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.0600000000000001 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' GLN . . . . . 0.452 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 2.8700000000000001 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 1.6200000000000001 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.04 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.46 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.82999999999999996 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 0.73999999999999999 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.59999999999999998 112.745 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 1.51 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.0900000000000001 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.1599999999999999 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 1.76 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.8900000000000001 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 2.6699999999999999 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.0700000000000003 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 1.4099999999999999 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 2.4700000000000002 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 2.6099999999999999 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.0699999999999998 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.3 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 1.75 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 1.6699999999999999 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.54 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.69999999999999996 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 1.4399999999999999 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 1.8200000000000001 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.93999999999999995 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 1.6000000000000001 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.0099999999999998 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 142' ' ' ILE . . . . . 0.61 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 2.8799999999999999 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.52 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 4.1500000000000004 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.5900000000000001 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.1299999999999999 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 1.78 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.4500000000000002 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 149' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo . . . . . 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.3599999999999999 112.198 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 2.3999999999999999 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 2.5699999999999998 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 1.72 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 2.6899999999999999 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.1600000000000001 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.1299999999999999 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.9399999999999999 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.3300000000000001 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 1.5600000000000001 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 1.5900000000000001 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.1399999999999999 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 171' ' ' TYR . . . . . 0.496 ' O ' HG22 ' B' ' 174' ' ' VAL . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 3.8700000000000001 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.6100000000000001 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.3 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 171' ' ' TYR . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 1.53 111.905 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 175' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 1.99 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 176' ' ' TRP . . . . . 0.452 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.5 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 1.46 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67000000000000004 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 179' ' ' TYR . . . . . 0.58 ' O ' HG22 ' B' ' 182' ' ' VAL . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 1.73 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 180' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 0.93000000000000005 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 181' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 1.3600000000000001 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' VAL . . . . . 0.58 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.1899999999999999 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 2.73 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' ILE . . . . . 0.464 HG22 HG23 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 1.9299999999999999 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 185' ' ' ILE . . . . . 0.464 HG23 HG22 ' B' ' 184' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 2.6400000000000001 112.219 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.689 0.28 . . . . 2.2000000000000002 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.4900000000000002 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 1.76 111.524 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.1800000000000002 111.248 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 1.78 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 1.98 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 1.6499999999999999 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.1100000000000001 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 205' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 1.4299999999999999 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77000000000000002 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 1.6000000000000001 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 1.77 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.54 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.0099999999999998 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 2.6499999999999999 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.3300000000000001 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 2.29 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.1200000000000001 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 3.6000000000000001 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.2200000000000002 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 2.6899999999999999 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 3.3999999999999999 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.6699999999999999 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.3900000000000001 110.864 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 2.79 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.0800000000000001 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 8' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 1.4299999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.1599999999999999 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.0899999999999999 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 1.5800000000000001 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 12' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.95999999999999996 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 0.95999999999999996 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.3 111.119 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 1.52 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 1.8999999999999999 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.95999999999999996 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.0700000000000001 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.0800000000000001 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.02 110.293 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.3700000000000001 111.484 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.7200000000000002 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.6699999999999999 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 38' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 1.9299999999999999 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' MET . . . . . 0.469 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.0899999999999999 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 1.4099999999999999 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 0.80000000000000004 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.71999999999999997 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 1.6799999999999999 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 1.6799999999999999 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.28 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.51000000000000001 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.3300000000000001 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 0.56999999999999995 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 1.6699999999999999 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' MET . . . . . 0.434 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.4199999999999999 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 0.70999999999999996 111.028 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 0.88 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 56' ' ' ILE . . . . . 0.478 HD11 ' HD1' ' A' ' 131' ' ' TRP . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.3799999999999999 111.148 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.9399999999999999 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 58' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.8700000000000001 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.8599999999999999 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 1.95 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.1099999999999999 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.4700000000000002 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 2.8500000000000001 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.8700000000000001 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.1200000000000001 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.26 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.0800000000000001 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 71' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 0.85999999999999999 112.345 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 1.96 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 73' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 1.8 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.1799999999999999 110.476 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 1.8500000000000001 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 77' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.5600000000000001 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.48 ' O ' HD23 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.49 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 1.6000000000000001 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 81' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.01 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 82' ' ' LEU . . . . . 0.49 HD13 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.1799999999999999 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 1.54 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 1.6499999999999999 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' LEU . . . . . 0.49 HD12 HD13 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.1000000000000001 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.3799999999999999 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 1.4399999999999999 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 1.8700000000000001 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 3.1000000000000001 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.3399999999999999 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.21 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 4.54 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.3399999999999999 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.54 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 5.21 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.3799999999999999 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 101' ' ' LEU . . . . . 0.41 ' N ' HD12 ' C' ' 101' ' ' LEU . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 2.6400000000000001 111.521 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.3799999999999999 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.6200000000000001 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 2.9300000000000002 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.1600000000000001 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' MET . . . . . 0.42 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.2999999999999998 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.0699999999999998 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' THR . . . . . 0.409 HG22 HG21 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.2999999999999998 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 109' ' ' GLN . . . . . 0.433 HE21 HG22 ' C' ' 80' ' ' THR . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.48 111.667 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ILE . . . . . 0.477 ' HA ' HD12 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 1.9299999999999999 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 1.6699999999999999 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.1100000000000001 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 113' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 2.5899999999999999 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.92000000000000004 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.55000000000000004 113.325 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' LEU . . . . . 0.501 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 1.49 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 118' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 1.6599999999999999 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.93999999999999995 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.29 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' SER . . . . . 0.533 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.1499999999999999 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.3100000000000001 110.301 179.475 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.836 0.351 . . . . 1.3100000000000001 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 2.8399999999999999 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.7000000000000002 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' LEU . . . . . 0.417 ' O ' HG22 ' C' ' 133' ' ' ILE . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.8799999999999999 110.652 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.3799999999999999 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.76 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' ILE . . . . . 0.417 HG22 ' O ' ' C' ' 130' ' ' LEU . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.1499999999999999 111.035 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 1.5600000000000001 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 1.48 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.51 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.01 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.0499999999999998 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.0699999999999998 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 141' ' ' ILE . . . . . 0.415 HG13 ' N ' ' C' ' 142' ' ' ILE . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 1.9199999999999999 111.453 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 142' ' ' ILE . . . . . 0.415 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 2.6400000000000001 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.51 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 3.5800000000000001 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.6499999999999999 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.46 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.3300000000000001 112.017 -179.443 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.823 0.344 . . . . 2.8199999999999998 110.771 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.1800000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 161' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.5 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 1.8100000000000001 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.1299999999999999 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 164' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.21 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.3100000000000001 111.042 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.2599999999999998 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.5800000000000001 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.3 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 1.73 110.975 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 1.4299999999999999 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.7200000000000002 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.55 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 1.5 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 1.8400000000000001 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 175' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.1200000000000001 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 177' ' ' ILE . . . . . 0.414 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 1.75 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 179' ' ' TYR . . . . . 0.593 ' O ' HG22 ' C' ' 182' ' ' VAL . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 1.8 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 0.88 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 181' ' ' ILE . . . . . 0.414 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 1.52 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.4700000000000002 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 184' ' ' ILE . . . . . 0.605 HG22 HG23 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 1.6200000000000001 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 185' ' ' ILE . . . . . 0.605 HG23 HG22 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 2.6299999999999999 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.77 112.416 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.779 0.323 . . . . 2.3700000000000001 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.6800000000000002 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 1.95 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 200' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.0499999999999998 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 1.9099999999999999 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.04 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 203' ' ' CYS . . . . . 0.439 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 1.6200000000000001 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.49 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 205' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.3200000000000001 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 206' ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76000000000000001 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 1.52 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 1.8400000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 209' ' ' SER . . . . . 0.501 ' HB2' HD23 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.6799999999999999 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.04 111.606 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 2.6499999999999999 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.3300000000000001 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.02 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.3500000000000001 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 3.6200000000000001 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' LEU . . . . . 0.426 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.6399999999999999 110.596 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2000000000000002 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.1099999999999999 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 3.3700000000000001 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.1099999999999999 111.389 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.851 0.358 . . . . 8.0899999999999999 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.29 -17.83 60.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 5.6799999999999997 110.919 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.47 117.28 17.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 6.2699999999999996 110.993 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -84.92 92.51 8.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 6.5199999999999996 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.5 t -127.85 -80.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 3.5899999999999999 110.959 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt 63.42 2.56 1.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 1.8799999999999999 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.29 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' VAL . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 0.98999999999999999 110.69 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 1.9199999999999999 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 1.45 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.89000000000000001 111.166 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 0.90000000000000002 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.82999999999999996 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.24 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.29 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 1.71 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.95999999999999996 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 0.98999999999999999 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.1099999999999999 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.23 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.73 -33.14 62.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.0199999999999996 110.442 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -54.76 -36.03 64.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.978 -0.555 . . . . 3.96 110.588 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.6 m -84.1 -27.52 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 2.3799999999999999 110.671 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 tp -83.25 -1.6 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 2.77 110.769 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -59.37 -20.88 58.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 2.52 111.021 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -46.77 -32.62 3.77 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.554 0.692 . . . . 5.54 109.445 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.6 p-10 -172.31 131.36 0.68 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.746 -1.115 . . . . 4.4400000000000004 109.309 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.4 Cg_endo -81.64 171.19 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.601 2.201 . . . . 2.8100000000000001 111.907 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -146.52 125.68 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 6.7999999999999998 111.725 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.21 3.04 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.839 -0.619 . . . . 4.9699999999999998 113.193 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.553 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 34.5 m -136.32 149.78 68.84 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.615 0.245 . . . . 4.71 111.659 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HG2' ' HE1' ' A' ' 35' ' ' TYR . 19.5 Cg_exo -67.41 166.41 23.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.996 2.464 . . . . 3.5099999999999998 112.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -44.33 -56.69 3.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 3.4100000000000001 113.377 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HE1' ' HG2' ' A' ' 33' ' ' PRO . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 2.8100000000000001 112.139 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.3900000000000001 110.62 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.2400000000000002 110.685 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 1.6000000000000001 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.3300000000000001 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.03 111.345 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.0 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 1.3100000000000001 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.0 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.58999999999999997 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 1.6299999999999999 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.669 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.1200000000000001 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 79' ' ' THR . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.3200000000000001 111.386 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.52000000000000002 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' SG ' ' B' ' 134' ' ' CYS . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 0.97999999999999998 110.953 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.52000000000000002 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 1.6899999999999999 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.1200000000000001 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.59999999999999998 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 0.93999999999999995 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.78000000000000003 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.23 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.1000000000000001 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 1.76 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.8400000000000001 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.6400000000000001 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 1.8400000000000001 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.2400000000000002 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.1600000000000001 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 2.8399999999999999 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.3900000000000001 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.96999999999999997 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.04 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.3799999999999999 110.992 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.76000000000000001 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 2.9300000000000002 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.1299999999999999 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 1.6599999999999999 110.654 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.4199999999999999 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.0899999999999999 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.52 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.3300000000000001 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' HG13 ' A' ' 78' ' ' VAL . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.3899999999999999 112.126 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 1.55 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.01 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.3 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 1.6699999999999999 110.482 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 1.8700000000000001 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.4199999999999999 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.3999999999999999 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 1.9099999999999999 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 2.3300000000000001 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 1.4299999999999999 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.1899999999999999 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 2.5499999999999998 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 84.5 mm-40 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.3300000000000001 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 5.0999999999999996 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.0699999999999998 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.4100000000000001 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.3099999999999996 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.9399999999999999 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 5.9800000000000004 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.2400000000000002 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 2.6699999999999999 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 2.5899999999999999 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.53 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 3.1400000000000001 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 1.99 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.3599999999999999 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.0499999999999998 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.25 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.8799999999999999 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.6000000000000001 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.0900000000000001 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 2.6499999999999999 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.426 HG21 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 0.89000000000000001 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 0.68000000000000005 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 1.5800000000000001 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.04 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.1000000000000001 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.8799999999999999 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.53 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.29 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.4900000000000002 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.565 HH12 ' HG3' ' C' ' 1' ' ' MET . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.1299999999999999 110.838 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 3.9700000000000002 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.22 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 2.8100000000000001 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.25 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 1.8400000000000001 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.54 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 1.79 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.0800000000000001 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 1.76 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.76000000000000001 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.0699999999999998 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 1.8500000000000001 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.3200000000000001 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 3.25 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 2.9199999999999999 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 2.6499999999999999 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.614 HD13 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.21 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 146' ' ' ILE . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.0099999999999998 111.091 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 3.6000000000000001 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.6200000000000001 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 143' ' ' LEU . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 2.4700000000000002 111.646 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 2.48 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.624 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 2.6899999999999999 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo -65.8 -2.06 5.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.3599999999999999 112.684 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 166' ' ' ASP . 55.5 tp -61.04 -31.82 71.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.312 -0.404 . . . . 3.2999999999999998 111.156 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -135.95 -4.61 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.504 -0.316 . . . . 8.4800000000000004 111.108 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.77 -50.72 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.395 -0.366 . . . . 2.98 111.439 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 153' ' ' LYS . 8.3 mtpm? -75.38 -30.97 60.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 4.5499999999999998 111.174 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.4 p -83.12 5.77 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 4.0 111.312 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -69.73 -24.47 63.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 5.5099999999999998 110.861 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 39.5 m -110.75 -35.83 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 3.2000000000000002 111.135 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -63.48 -67.99 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 3.98 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -156.09 115.05 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.6299999999999999 110.847 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.1600000000000001 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.3700000000000001 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 2.8300000000000001 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 1.7 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.1600000000000001 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 1.5900000000000001 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.456 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.3100000000000001 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.578 ' HA ' HD21 ' A' ' 150' ' ' LEU . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.1499999999999999 110.899 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.478 ' NZ ' ' HB2' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.3900000000000001 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.4199999999999999 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.1200000000000001 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 174' ' ' VAL . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 3.8599999999999999 110.719 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 1.5800000000000001 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 1.4099999999999999 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 171' ' ' TYR . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 1.4199999999999999 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 1.9099999999999999 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.55 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.541 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.8600000000000001 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.73999999999999999 112.958 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.594 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 1.78 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 0.92000000000000004 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 1.77 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 179' ' ' TYR . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.3400000000000001 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.5099999999999998 111.618 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.02 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.483 HG13 HG22 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.4500000000000002 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 64.56 173.01 3.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 1.73 112.819 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.38 74.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.492 2.128 . . . . 3.0499999999999998 111.541 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.1 m 62.25 53.13 2.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.53 . . . . 4.04 110.775 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 182' ' ' VAL . . . -176.09 -143.96 4.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.502 -0.856 . . . . 4.4800000000000004 113.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -95.32 0.71 53.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.673 0.273 . . . . 7.96 111.429 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . 89.17 170.38 45.0 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.578 -0.82 . . . . 3.23 112.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 18.2 m-90 54.79 27.68 9.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 6.0300000000000002 110.813 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' A' ' 189' ' ' GLY . 5.6 pt -123.39 151.98 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 3.1800000000000002 111.05 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.03 -175.07 5.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 3.3900000000000001 111.228 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.44 -35.16 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 5.7599999999999998 110.916 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 36.6 m -61.2 -54.08 48.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 2.5 110.732 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 15.5 tt -64.95 -26.99 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 2.3999999999999999 110.972 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -56.3 -58.76 6.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.388 -0.369 . . . . 2.6600000000000001 110.741 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 1.8100000000000001 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.21 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.1800000000000002 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.0099999999999998 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 1.9299999999999999 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 1.7 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.28 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79000000000000004 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 1.51 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 1.9299999999999999 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 1.71 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.04 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 2.8900000000000001 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.3100000000000001 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 2.8700000000000001 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.3799999999999999 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 3.4199999999999999 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.4399999999999999 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.5099999999999998 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.0099999999999998 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.5900000000000001 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 221' ' ' LEU . 3.3 mm? -82.86 -58.94 2.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 3.4900000000000002 111.229 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 50.74 75.84 0.17 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.395 -0.366 . . . . 5.7400000000000002 110.653 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -115.57 -54.89 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 5.46 111.128 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.8 mt 59.86 80.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 6.1299999999999999 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -104.82 -168.34 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 6.46 110.943 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -165.52 51.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 6.9400000000000004 110.744 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -125.53 136.11 52.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 6.8300000000000001 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.01 -26.47 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 10.77 110.787 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.313 -0.851 . . . . 9.4100000000000001 110.948 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.81 0.338 . . . . 8.9100000000000001 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -105.86 10.04 32.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 6.7599999999999998 110.981 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.438 HD22 ' N ' ' B' ' 3' ' ' LEU . 3.7 mm? 59.22 -170.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.087 -0.506 . . . . 6.25 111.084 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 58.61 34.65 24.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.159 -0.473 . . . . 5.4400000000000004 111.245 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 72.5 p -147.12 70.83 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 3.8399999999999999 110.96 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.1 38.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 3.0800000000000001 110.993 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.3500000000000001 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 1.3899999999999999 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.406 ' O ' HG23 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1000000000000001 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 1.71 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 1.48 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 0.94999999999999996 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.96999999999999997 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.80000000000000004 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.29 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.3600000000000001 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.23 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 0.97999999999999998 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.1200000000000001 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.0 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.646 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 83.7 m-85 -73.91 -28.31 61.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 4.2599999999999998 111.032 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.471 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 t90 -56.08 -49.74 72.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.231 -0.44 . . . . 3.6200000000000001 110.448 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -81.48 -21.21 38.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 2.5499999999999998 110.179 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.646 ' HB3' ' HA ' ' B' ' 22' ' ' PHE . 42.0 tp -77.85 0.1 25.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.492 -0.776 . . . . 3.1099999999999999 110.655 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 3.2 m -52.38 -22.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.915 -0.314 . . . . 3.02 111.154 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -53.61 -19.73 4.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.04 0.924 . . . . 5.8899999999999997 108.906 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 9.0 t30 -66.39 -154.18 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-N 113.835 -1.529 . . . . 5.0199999999999996 108.236 177.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 52.5 Cg_exo -0.35 87.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.433 2.755 . . . . 3.5299999999999998 115.998 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -120.24 69.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.781 -1.1 . . . . 7.8799999999999999 108.676 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 3.53 8.14 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.518 -1.033 . . . . 4.6100000000000003 110.518 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.589 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 28.7 m -130.89 160.69 65.48 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 114.905 -0.647 . . . . 4.7300000000000004 109.91 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' B' ' 32' ' ' VAL . 18.8 Cg_exo -35.56 116.99 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.369 2.046 . . . . 3.75 114.871 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -36.88 22.59 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.09 -0.959 . . . . 3.7599999999999998 108.657 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' B' ' 33' ' ' PRO . 0.4 OUTLIER -51.07 -22.66 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.813 -1.54 . . . . 3.1699999999999999 112.011 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.5699999999999998 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.7400000000000002 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 1.72 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 1.95 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.2 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.457 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.1200000000000001 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 1.49 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 0.77000000000000002 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.68000000000000005 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 1.6299999999999999 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 1.9099999999999999 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.22 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.55000000000000004 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.87 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.55000000000000004 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.0600000000000001 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.1899999999999999 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 0.66000000000000003 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 0.85999999999999999 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 0.83999999999999997 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.507 HG21 HG23 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 1.4399999999999999 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.2400000000000002 110.886 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.3100000000000001 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 1.8100000000000001 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.1800000000000002 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.0299999999999998 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.48 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.3700000000000001 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.2799999999999998 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 1.78 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.05 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.1100000000000001 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.448 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.2999999999999998 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 0.71999999999999997 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.478 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.04 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 1.79 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.448 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 1.4399999999999999 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.57 ' O ' HG22 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.0099999999999998 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.411 ' SD ' HG21 ' B' ' 113' ' ' ILE . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.4299999999999999 110.414 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.21 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.57 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.1799999999999999 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 1.6499999999999999 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.0600000000000001 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 1.5800000000000001 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 1.49 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' B' ' 109' ' ' GLN . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 1.72 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.456 ' N ' HD12 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 1.96 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.24 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.543 HD13 HD21 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.21 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.3200000000000001 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.1499999999999999 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 1.4399999999999999 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 2.6800000000000002 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 2.71 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 4.1900000000000004 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.79 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.2699999999999996 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.5700000000000003 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.2400000000000002 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 5.3899999999999997 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' THR . . . . . 0.474 ' HA ' HD22 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.1600000000000001 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.444 HD12 ' N ' ' B' ' 101' ' ' LEU . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 2.5800000000000001 111.063 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.48 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.47 ' HB2' HD11 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 2.7599999999999998 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.2200000000000002 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.3599999999999999 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 1.9199999999999999 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.555 ' O ' HG23 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.0600000000000001 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.556 ' HG3' HD21 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 2.8700000000000001 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.669 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 1.6200000000000001 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.04 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' B' ' 77' ' ' MET . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.46 110.64 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.82999999999999996 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.73999999999999999 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.59999999999999998 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.4199999999999999 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 1.51 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.0900000000000001 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.1599999999999999 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 1.76 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.8900000000000001 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.774 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 2.6699999999999999 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.774 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.0700000000000003 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 1.4099999999999999 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 2.4700000000000002 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 2.6099999999999999 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 56' ' ' ILE . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.0699999999999998 111.281 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.3 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' B' ' 137' ' ' CYS . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 1.6699999999999999 111.081 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.405 ' SG ' HD22 ' A' ' 49' ' ' LEU . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 1.54 110.971 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.69999999999999996 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 1.4399999999999999 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' CYS . . . . . 0.424 ' HG ' HG22 ' B' ' 133' ' ' ILE . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 1.8200000000000001 110.709 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.93999999999999995 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 1.6000000000000001 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.0099999999999998 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.445 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 1.96 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.445 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 2.8799999999999999 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.52 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 4.1500000000000004 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.5900000000000001 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.1299999999999999 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 1.78 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.4500000000000002 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo -70.14 -1.29 8.53 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.3599999999999999 112.921 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' B' ' 166' ' ' ASP . 57.3 tp -61.23 -21.91 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 2.8799999999999999 110.988 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.16 -14.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 8.0700000000000003 110.835 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -38.47 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 2.7999999999999998 110.975 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.36 -41.99 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 4.5800000000000001 110.742 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 73.4 p -79.4 6.49 10.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 3.8100000000000001 110.858 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -60.52 -25.35 66.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 5.2199999999999998 110.686 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.0 p -115.5 -17.86 11.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 3.4199999999999999 111.022 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.427 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 50.1 tt0 -80.89 -68.55 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 4.2000000000000002 110.94 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 40.6 t -157.53 117.24 3.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 2.75 111.122 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t -73.68 -39.31 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 2.3999999999999999 111.236 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' B' ' 91' ' ' ALA . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 1.72 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 2.6899999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.1600000000000001 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.491 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.1299999999999999 111.188 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 166' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' B' ' 150' ' ' LEU . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.9399999999999999 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.3300000000000001 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.543 HD21 HD13 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.5600000000000001 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 165' ' ' TYR . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.5900000000000001 111.008 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.1399999999999999 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 3.8700000000000001 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.6100000000000001 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.3 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 1.53 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 1.99 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.5 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.512 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 1.46 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67000000000000004 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.604 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 1.73 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 0.93000000000000005 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 1.3600000000000001 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.1899999999999999 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 2.73 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.53 HG22 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 1.9299999999999999 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 184' ' ' ILE . 2.8 pp -118.0 175.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 111.252 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.63 23.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 1.9299999999999999 112.582 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.468 ' HD3' HD12 ' B' ' 193' ' ' ILE . 58.2 Cg_endo -72.05 164.23 36.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.642 2.228 . . . . 2.9700000000000002 111.93 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t 56.71 14.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 4.5 110.336 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.28 -86.13 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.653 -0.703 . . . . 4.5 112.155 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -159.39 84.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 7.8899999999999997 110.645 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.38 177.4 35.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.842 -0.694 . . . . 3.6200000000000001 112.321 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -110.58 24.14 13.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 6.54 110.762 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.468 HD12 ' HD3' ' B' ' 187' ' ' PRO . 59.9 mt -88.56 139.89 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 3.1600000000000001 111.16 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.09 147.02 40.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.154 -0.476 . . . . 3.3900000000000001 110.8 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -62.94 -12.34 24.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.02 -0.536 . . . . 5.5599999999999996 111.65 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 89.4 m -68.73 -53.98 18.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 2.6800000000000002 110.796 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt -64.35 -26.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 2.2000000000000002 110.82 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.4900000000000002 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 1.76 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' PHE . . . . . 0.423 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.1800000000000002 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.78 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 1.98 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 1.6499999999999999 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.1100000000000001 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 1.4299999999999999 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77000000000000002 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 1.6000000000000001 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 1.77 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.428 ' HB3' HD23 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.54 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.0099999999999998 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 2.6499999999999999 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.3300000000000001 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 2.29 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.1200000000000001 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 3.6000000000000001 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.426 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 1.51 110.929 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.2200000000000002 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 2.6899999999999999 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 3.3999999999999999 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.6699999999999999 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp -84.7 -57.95 2.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.3900000000000001 111.319 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 53.93 68.41 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.904 0.383 . . . . 5.9100000000000001 110.918 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.49 143.78 19.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 5.2599999999999998 110.608 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.88 92.12 3.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 6.8099999999999996 110.889 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.44 159.49 14.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 7.0199999999999996 110.726 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -138.46 77.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 8.2100000000000009 110.867 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.3 m -154.22 128.9 9.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.0999999999999996 111.029 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -147.26 -21.04 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 13.279999999999999 110.583 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.279 -0.867 . . . . 10.4 110.89 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.565 ' HG3' HH12 ' A' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.716 0.293 . . . . 8.0999999999999996 111.029 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 56.89 82.72 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.115 -0.493 . . . . 6.2699999999999996 110.78 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.559 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.7 pt? -72.62 149.2 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 6.2000000000000002 111.128 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.51 -38.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 4.8200000000000003 110.8 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 63.1 p -118.76 94.09 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 3.25 110.939 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.52 ' N ' HD12 ' C' ' 6' ' ' LEU . 5.0 mp -94.82 2.62 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 2.79 110.998 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.0800000000000001 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 1.4299999999999999 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.1599999999999999 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.0899999999999999 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 1.5800000000000001 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.95999999999999996 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 0.95999999999999996 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.3 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 1.52 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8999999999999999 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 0.95999999999999996 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.0700000000000001 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.0800000000000001 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -59.67 -33.46 71.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.02 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.07 -17.48 43.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.596 . . . . 4.9800000000000004 110.725 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -64.74 -42.82 94.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 4.29 110.118 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 37.0 t -81.07 -29.51 34.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 2.4700000000000002 110.269 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 tp -77.71 -0.97 28.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 2.8999999999999999 110.534 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.3 m -56.62 -20.92 23.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 2.7400000000000002 111.064 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -52.88 -28.25 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.374 0.607 . . . . 5.8499999999999996 109.434 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -168.36 131.69 1.31 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.045 -0.98 . . . . 4.5199999999999996 109.868 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 7.3 Cg_endo -87.81 -176.27 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.825 2.35 . . . . 3.2200000000000002 112.458 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' C' ' 218' ' ' LEU . 41.1 mmt180 -89.82 28.75 1.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 8.6799999999999997 111.393 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.482 ' HA2' HD23 ' C' ' 224' ' ' LEU . . . 118.32 -46.2 1.17 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.776 . . . . 4.1399999999999997 113.008 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.58 HG12 HD12 ' C' ' 221' ' ' LEU . 20.7 m -73.41 142.62 81.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.51 0.195 . . . . 5.0899999999999999 111.128 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' C' ' 35' ' ' TYR . 23.5 Cg_exo -65.57 166.33 20.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.723 2.282 . . . . 3.1000000000000001 112.653 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -44.37 55.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.669 0.618 . . . . 3.8500000000000001 112.669 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 33' ' ' PRO . 6.6 p90 -54.38 -41.37 69.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.3700000000000001 111.235 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.7200000000000002 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.6699999999999999 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.9299999999999999 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 1.8799999999999999 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.23 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.0899999999999999 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 1.4099999999999999 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 0.80000000000000004 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.71999999999999997 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 1.6799999999999999 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.426 ' HZ3' HG21 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 1.6799999999999999 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.28 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.51000000000000001 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.3300000000000001 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.56999999999999995 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 1.6699999999999999 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.4199999999999999 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 0.70999999999999996 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.1399999999999999 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 0.88 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.3799999999999999 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.9399999999999999 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.502 ' HB2' HG21 ' A' ' 127' ' ' VAL . 6.3 tp-100 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.8700000000000001 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 2.8599999999999999 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 1.95 111.248 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.1099999999999999 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.54 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.4700000000000002 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 2.8500000000000001 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 1.8700000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.544 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.26 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.0800000000000001 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 0.85999999999999999 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.471 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 1.96 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 1.8 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.1799999999999999 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.3300000000000001 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 1.8500000000000001 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.5600000000000001 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.433 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.1100000000000001 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.49 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.657 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 1.6000000000000001 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.01 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.1799999999999999 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 1.54 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 1.6499999999999999 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.1000000000000001 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.3799999999999999 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' C' ' 168' ' ' LEU . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 1.4399999999999999 110.481 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 1.8700000000000001 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 3.1000000000000001 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.02 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.3399999999999999 110.689 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.21 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 4.54 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.3399999999999999 110.714 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.4000000000000004 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.54 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 5.21 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.3799999999999999 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.422 ' N ' HD12 ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 2.6400000000000001 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.3799999999999999 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.6200000000000001 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 2.9300000000000002 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.478 HD12 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.1600000000000001 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.491 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.2999999999999998 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.0699999999999998 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.439 ' O ' HG23 ' C' ' 112' ' ' VAL . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.2999999999999998 111.596 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 83.2 mm-40 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.48 111.342 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 1.9299999999999999 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 1.6699999999999999 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 108' ' ' THR . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.1100000000000001 111.518 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 2.5899999999999999 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.44 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.90000000000000002 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.92000000000000004 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.55000000000000004 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 1.49 110.582 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.576 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 1.6599999999999999 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.93999999999999995 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.29 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.1499999999999999 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.63 -18.75 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.3100000000000001 110.839 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.532 ' HB2' HG12 ' C' ' 127' ' ' VAL . 77.5 mtm180 -126.23 147.18 49.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 3.1600000000000001 111.129 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.18 -11.09 59.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 4.2400000000000002 110.832 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -83.63 -48.25 10.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 4.6500000000000004 110.743 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.1 p -67.5 -34.38 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 2.8399999999999999 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 2.7000000000000002 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 1.8799999999999999 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.3799999999999999 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 1.76 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.1499999999999999 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.5600000000000001 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.72999999999999998 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 1.48 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 138' ' ' ALA . . . . . 0.415 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.149 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.0499999999999998 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.0699999999999998 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.9199999999999999 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.415 HG12 ' O ' ' C' ' 138' ' ' ALA . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 2.6400000000000001 111.33 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 143' ' ' LEU . . . . . 0.409 ' O ' HG22 ' C' ' 146' ' ' ILE . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.51 110.742 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 3.5800000000000001 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.6499999999999999 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.409 HG22 ' O ' ' C' ' 143' ' ' LEU . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.46 111.6 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.27 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 54.9 t30 -60.45 -51.9 76.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.3300000000000001 111.959 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 64.5 Cg_endo -72.64 -7.25 20.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 2.46 112.737 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.67 -21.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 3.0800000000000001 110.707 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -138.71 -22.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.55 . . . . 8.4499999999999993 110.929 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.97 -50.43 19.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 2.8999999999999999 111.353 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -71.28 -35.68 71.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 4.6200000000000001 110.966 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 54.8 p -82.83 2.51 33.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 3.8500000000000001 111.305 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -65.54 -28.89 69.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 5.1200000000000001 110.486 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.6 p -114.29 -20.62 10.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 3.4300000000000002 111.127 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 45.9 tt0 -73.12 -66.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 3.98 110.721 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -156.66 113.47 3.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 2.3999999999999999 110.596 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p -72.7 -39.55 66.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 2.8199999999999998 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.1800000000000002 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.5 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.8100000000000001 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.1299999999999999 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.21 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.3100000000000001 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.2599999999999998 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.756 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' C' ' 87' ' ' LEU . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.916 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 1.73 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.4299999999999999 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.7200000000000002 110.63 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 1.55 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 1.5 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.8400000000000001 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.1200000000000001 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.475 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 1.75 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.71999999999999997 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.642 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 1.8 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 0.88 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 1.52 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.2 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.4700000000000002 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.511 HG22 HG23 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 1.6200000000000001 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.511 HG23 HG22 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 2.6299999999999999 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.15 -154.6 27.81 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.77 112.757 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' C' ' 193' ' ' ILE . 59.3 Cg_endo -72.15 159.17 50.52 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.615 2.21 . . . . 3.0299999999999998 112.116 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 31.8 m 55.56 20.34 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 4.2199999999999998 110.302 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.71 45.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.707 -0.679 . . . . 4.0800000000000001 112.427 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 48.8 t80 61.77 97.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.914 0.387 . . . . 7.54 111.303 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.93 167.18 40.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.008 -0.615 . . . . 3.29 112.192 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -106.12 22.36 15.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 5.6699999999999999 110.939 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.488 ' HB ' ' HD3' ' C' ' 187' ' ' PRO . 48.7 mt -90.47 144.53 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 2.7599999999999998 111.173 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 57.8 m-20 -58.67 152.69 18.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 3.6899999999999999 111.19 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 29.6 pt20 -73.6 -27.54 61.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 5.3399999999999999 110.995 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.2 t -65.77 -30.21 70.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 2.5699999999999998 111.177 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt -77.85 -32.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 2.3700000000000001 110.872 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.6800000000000002 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.95 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.0499999999999998 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.9099999999999999 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.04 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 1.6200000000000001 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.49 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.3200000000000001 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76000000000000001 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 1.8400000000000001 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.6799999999999999 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.04 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 2.6499999999999999 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.3300000000000001 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.02 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.3500000000000001 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 3.6200000000000001 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.415 HD23 ' O ' ' C' ' 216' ' ' LEU . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 1.6399999999999999 110.771 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2000000000000002 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' C' ' 30' ' ' ARG . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.1099999999999999 111.259 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 3.3700000000000001 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.58 HD12 HG12 ' C' ' 32' ' ' VAL . 76.7 mt -84.95 -59.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.1099999999999999 111.19 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 50.75 72.29 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 5.7300000000000004 110.751 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -164.66 148.3 9.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 5.5300000000000002 110.867 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.482 HD23 ' HA2' ' C' ' 31' ' ' GLY . 95.9 mt -123.74 131.21 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 6.5999999999999996 110.749 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -140.24 115.2 9.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.4 . . . . 6.5099999999999998 110.885 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -101.97 109.18 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 7.0499999999999998 110.974 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.1 t -155.2 87.04 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 6.7199999999999998 110.903 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -142.06 -45.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 9.5600000000000005 110.737 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.154 -0.926 . . . . 9.0800000000000001 110.857 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.728 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.743 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.751 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.767 0.317 . . . . 8.0899999999999999 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -95.42 12.91 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 5.6799999999999997 110.929 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.1 mt -97.5 111.29 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 6.2699999999999996 110.473 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.2 142.94 32.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 6.5199999999999996 111.086 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 p -173.22 145.01 1.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 3.5899999999999999 110.913 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.3 pt? -136.63 -29.49 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.285 -0.416 . . . . 3.23 111.255 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 1.8799999999999999 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.29 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.98999999999999999 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.9199999999999999 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 1.45 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.89000000000000001 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 0.90000000000000002 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.82999999999999996 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.592 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.24 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.29 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 1.71 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.95999999999999996 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.98999999999999999 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.1099999999999999 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.23 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 13.8 m-85 -72.98 -39.23 66.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.0199999999999996 110.637 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -53.11 -37.76 62.03 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.453 -0.573 . . . . 3.96 109.453 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.9 p -85.36 -21.35 28.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.64 -0.709 . . . . 2.3799999999999999 110.105 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -77.28 0.36 22.39 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.853 -0.612 . . . . 2.77 110.555 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 28' ' ' ASN . 21.3 p -48.92 -21.84 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 2.52 111.105 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -51.33 -21.3 2.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.107 0.956 . . . . 5.54 108.723 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.744 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 3.5 t-20 -66.47 -156.04 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 113.507 -1.678 . . . . 4.4400000000000004 107.901 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 56.0 Cg_exo -1.79 70.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.599 2.866 . . . . 2.8100000000000001 115.76 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' ASN . 13.9 ptm180 -102.93 54.07 0.77 Allowed 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.342 -0.984 . . . . 6.7999999999999998 108.342 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.36 9.04 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.572 -1.411 . . . . 4.9699999999999998 109.572 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' HD2' ' A' ' 33' ' ' PRO . 96.1 t -111.85 139.11 21.92 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 114.446 -0.877 . . . . 4.71 110.023 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 32' ' ' VAL . 61.0 Cg_exo -38.77 145.86 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.976 2.451 . . . . 3.5099999999999998 114.114 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.32 -16.2 57.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.044 -0.98 . . . . 3.4100000000000001 112.4 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 2.8100000000000001 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.3900000000000001 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.2400000000000002 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.3300000000000001 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.03 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 1.3100000000000001 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.58999999999999997 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 1.6299999999999999 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.1200000000000001 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.3200000000000001 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.52000000000000002 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 0.97999999999999998 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.52000000000000002 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 1.6899999999999999 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.461 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.1200000000000001 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 0.59999999999999998 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.93999999999999995 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.78000000000000003 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.442 HD13 HD23 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.23 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.53 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . 6.1 tp-100 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.1000000000000001 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 1.76 110.884 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.8400000000000001 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.6400000000000001 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 1.8400000000000001 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.2400000000000002 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.1600000000000001 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 2.8399999999999999 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.3900000000000001 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 0.96999999999999997 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.04 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.3799999999999999 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 0.76000000000000001 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' A' ' 54' ' ' MET . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 2.9300000000000002 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.1299999999999999 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 1.6599999999999999 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.0899999999999999 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 117' ' ' LEU . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.52 110.412 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.3300000000000001 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.3899999999999999 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.61 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 1.55 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.01 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 1.45 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.3 110.618 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 1.6699999999999999 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 1.8700000000000001 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.4199999999999999 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.3999999999999999 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 1.9099999999999999 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 2.3300000000000001 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 1.4299999999999999 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.1899999999999999 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 2.5499999999999998 110.993 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.3300000000000001 110.866 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 5.0999999999999996 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.0699999999999998 111.464 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.4100000000000001 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.3099999999999996 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.9399999999999999 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 5.9800000000000004 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.2400000000000002 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.6699999999999999 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 2.5899999999999999 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 3.1400000000000001 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 1.99 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.3599999999999999 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.0499999999999998 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 112' ' ' VAL . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.25 111.837 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 2.7200000000000002 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 1.8799999999999999 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 1.6000000000000001 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 108' ' ' THR . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.0900000000000001 111.216 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 2.6499999999999999 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 117' ' ' LEU . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.89000000000000001 110.961 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.68000000000000005 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 1.5800000000000001 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.04 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.1000000000000001 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.8799999999999999 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.29 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.4900000000000002 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.1299999999999999 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 3.9700000000000002 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.22 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 2.8100000000000001 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.25 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 1.8400000000000001 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.54 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 1.79 110.878 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.0800000000000001 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 1.76 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.76000000000000001 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.0699999999999998 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.8500000000000001 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.3200000000000001 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 3.25 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.9199999999999999 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 2.6499999999999999 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.21 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.0099999999999998 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 3.6000000000000001 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.6200000000000001 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.422 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 2.4700000000000002 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 2.48 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 2.6899999999999999 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo -55.64 -27.78 62.38 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.3599999999999999 112.384 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.27 49.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 3.2999999999999998 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.44 -59.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.126 -0.488 . . . . 8.4800000000000004 110.98 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.8 -36.25 28.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.62 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.52 -17.41 41.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 4.5499999999999998 111.19 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.8 p -96.77 6.72 48.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 4.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -79.27 -25.81 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 5.5099999999999998 111.252 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -105.14 -36.92 7.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.478 -0.328 . . . . 3.2000000000000002 111.491 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -57.29 -76.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.331 -0.395 . . . . 3.98 111.263 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -158.75 118.04 3.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 2.6299999999999999 110.88 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.1600000000000001 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.8300000000000001 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.1600000000000001 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 1.5900000000000001 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.3100000000000001 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.3900000000000001 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.4199999999999999 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 171' ' ' TYR . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.1200000000000001 111.593 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.437 ' N ' HG23 ' A' ' 170' ' ' THR . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 3.8599999999999999 110.206 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 1.5800000000000001 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 1.4099999999999999 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 1.4199999999999999 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 1.9099999999999999 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.55 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 1.8600000000000001 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.73999999999999999 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 1.78 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 0.92000000000000004 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 184' ' ' ILE . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 1.77 111.524 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 183' ' ' TRP . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.3400000000000001 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.621 ' CD2' HG23 ' A' ' 182' ' ' VAL . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.5099999999999998 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 181' ' ' ILE . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.02 111.265 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.695 ' HB ' ' HA2' ' A' ' 189' ' ' GLY . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.4500000000000002 110.676 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -155.54 -99.1 0.16 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 1.73 112.335 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 191' ' ' GLY . 59.5 Cg_endo -73.05 78.62 2.17 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.435 2.09 . . . . 3.0499999999999998 111.745 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 35.6 t 60.42 22.47 12.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.855 -0.611 . . . . 4.04 110.845 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 185' ' ' ILE . . . 74.18 84.68 0.3 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.914 -0.66 . . . . 4.4800000000000004 112.882 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -175.39 -19.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.598 0.199 . . . . 7.96 111.496 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 187' ' ' PRO . . . -155.3 -172.24 22.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.118 -1.039 . . . . 3.23 113.643 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -64.87 158.81 24.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 6.0300000000000002 110.725 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.2 mt -88.01 139.59 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.029 -0.532 . . . . 3.1800000000000002 111.519 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -117.53 -90.08 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.11 -0.496 . . . . 3.3900000000000001 110.807 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -177.49 -76.44 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.454 -0.339 . . . . 5.7599999999999998 110.864 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.9 p -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 2.5 111.261 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.56 -24.12 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 2.3999999999999999 110.848 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -57.81 -59.29 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 2.6600000000000001 111.019 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 1.8100000000000001 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.21 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 201' ' ' LEU . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.1800000000000002 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.0099999999999998 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 1.9299999999999999 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 1.7 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.468 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.28 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79000000000000004 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 211' ' ' VAL . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.51 110.244 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 1.9299999999999999 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 1.71 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.04 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 207' ' ' PHE . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 2.8900000000000001 110.958 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.3100000000000001 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 2.8700000000000001 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.3799999999999999 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 3.4199999999999999 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.24 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.4399999999999999 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.5099999999999998 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.0099999999999998 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.5900000000000001 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -55.81 -33.81 64.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 3.4900000000000002 111.259 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -72.88 92.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 5.7400000000000002 110.723 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -142.96 163.62 32.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 5.46 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.45 107.5 6.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 6.1299999999999999 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -165.29 144.39 6.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.307 -0.406 . . . . 6.46 111.009 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.0 111.87 18.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 6.9400000000000004 110.976 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -80.83 149.33 29.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 6.8300000000000001 111.102 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -158.18 145.84 18.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 10.77 110.952 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.251 -0.88 . . . . 9.4100000000000001 110.904 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.809 0.338 . . . . 8.9100000000000001 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.73 50.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 6.7599999999999998 111.124 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.0 mt -115.52 124.05 50.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 6.25 110.97 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.77 120.39 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 5.4400000000000004 110.753 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 59.7 m -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 3.8399999999999999 111.089 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -134.96 -20.12 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 3.0800000000000001 110.918 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.3500000000000001 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 37.4 m80 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 1.3899999999999999 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1000000000000001 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 1.71 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 1.48 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 0.94999999999999996 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.96999999999999997 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.80000000000000004 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.29 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.3600000000000001 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.23 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.97999999999999998 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.1200000000000001 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.0 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.85 -30.35 61.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 4.2599999999999998 110.589 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -62.3 -42.56 99.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 3.6200000000000001 110.366 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.4 m -78.86 -19.64 51.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 2.5499999999999998 110.755 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.4 tp -85.64 -1.47 57.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.526 . . . . 3.1099999999999999 110.901 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 24.5 t -56.59 -19.76 17.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.26 -0.427 . . . . 3.02 111.243 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 59.2 ttp180 -50.4 -30.83 13.32 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.449 -0.574 . . . . 5.8899999999999997 109.449 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.409 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.3 p-10 -177.21 132.6 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 5.0199999999999996 109.948 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 45.6 Cg_endo -93.19 49.72 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.828 2.352 . . . . 3.5299999999999998 111.939 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.583 ' HG3' HD22 ' B' ' 221' ' ' LEU . 22.0 tpt180 58.92 24.95 13.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 7.8799999999999999 110.947 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.96 -45.44 3.03 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.821 -0.704 . . . . 4.6100000000000003 112.791 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.17 149.1 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.459 0.171 . . . . 4.7300000000000004 110.947 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.435 ' HB2' ' HD1' ' B' ' 35' ' ' TYR . 48.0 Cg_exo -54.68 165.7 2.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.572 2.182 . . . . 3.75 112.549 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -61.7 -18.88 61.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 3.7599999999999998 112.224 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.435 ' HD1' ' HB2' ' B' ' 33' ' ' PRO . 2.1 p90 -52.35 -35.01 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.705 0.288 . . . . 3.1699999999999999 111.536 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.5699999999999998 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.7400000000000002 111.299 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 1.72 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.439 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 1.95 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.2 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.434 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.1200000000000001 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 1.49 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 0.77000000000000002 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.68000000000000005 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.434 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 1.6299999999999999 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.9099999999999999 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.55000000000000004 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.87 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.55000000000000004 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.0600000000000001 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.1899999999999999 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' B' ' 58' ' ' GLN . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.66000000000000003 110.891 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.85999999999999999 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.83999999999999997 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 1.4399999999999999 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.539 ' NE2' HG11 ' C' ' 127' ' ' VAL . 89.1 mm-40 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.2400000000000002 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.3100000000000001 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.8100000000000001 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.1800000000000002 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.0299999999999998 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.48 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.3700000000000001 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.2799999999999998 110.881 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.78 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.05 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.1100000000000001 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.431 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.2999999999999998 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 0.71999999999999997 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.04 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 1.79 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 1.4399999999999999 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.554 ' O ' HG22 ' B' ' 79' ' ' THR . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.3100000000000001 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.0099999999999998 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.4299999999999999 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.421 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.21 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.1799999999999999 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.641 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 1.6499999999999999 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.0600000000000001 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.515 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 1.5800000000000001 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 1.72 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.515 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 1.96 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.24 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.581 HD22 HD11 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.21 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.3200000000000001 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.1499999999999999 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 1.4399999999999999 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.05 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 2.6800000000000002 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 2.71 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 4.1900000000000004 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 2.79 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.2699999999999996 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.5700000000000003 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.2400000000000002 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 5.3899999999999997 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.1600000000000001 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 2.5800000000000001 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.48 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 2.7599999999999998 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.2200000000000002 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.3599999999999999 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 1.9199999999999999 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.0600000000000001 111.528 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 2.8700000000000001 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 1.98 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 1.6200000000000001 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.82999999999999996 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.73999999999999999 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.59999999999999998 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.4199999999999999 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.493 ' N ' HD12 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 1.51 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.0900000000000001 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.1599999999999999 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 1.76 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.8900000000000001 110.691 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 2.6699999999999999 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.0700000000000003 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 1.4099999999999999 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 2.4700000000000002 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 2.6099999999999999 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' LEU . . . . . 0.442 HD23 HD13 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.0699999999999998 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 1.6699999999999999 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 1.54 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.69999999999999996 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' B' ' 180' ' ' PRO . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 1.4399999999999999 111.584 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 1.8200000000000001 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.93999999999999995 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 1.6000000000000001 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.0099999999999998 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.448 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 1.96 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.448 ' N ' HG13 ' B' ' 141' ' ' ILE . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 2.8799999999999999 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 4.1500000000000004 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.5900000000000001 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.1299999999999999 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 1.78 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.4500000000000002 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo -63.56 -7.23 12.08 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.3599999999999999 112.868 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.16 26.49 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.898 0.38 . . . . 2.8799999999999999 111.005 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -145.62 -58.86 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 8.0700000000000003 111.031 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -47.56 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 2.7999999999999998 111.288 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.6 -13.17 61.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 4.5800000000000001 111.355 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' B' ' 162' ' ' ALA . 42.2 p -105.69 5.69 31.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.301 -0.409 . . . . 3.8100000000000001 111.292 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -74.77 -35.34 62.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 5.2199999999999998 110.791 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.6 p -94.85 -22.28 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.4199999999999999 111.337 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.28 -71.9 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 4.2000000000000002 110.815 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' B' ' 161' ' ' LEU . 48.4 t -163.31 114.32 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 2.75 110.876 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 -29.15 66.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 2.3999999999999999 110.908 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' B' ' 158' ' ' SER . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 2.5699999999999998 110.614 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 162' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' B' ' 154' ' ' THR . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 1.72 111.257 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.6899999999999999 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.1600000000000001 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.1299999999999999 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.9399999999999999 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.3300000000000001 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.581 HD11 HD22 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 1.5600000000000001 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.5900000000000001 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.1399999999999999 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 3.8700000000000001 110.289 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 1.6100000000000001 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.439 ' O ' HG22 ' B' ' 177' ' ' ILE . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.3 111.524 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 1.53 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 1.99 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.5 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 173' ' ' THR . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 1.46 110.565 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67000000000000004 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.673 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 1.73 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 0.93000000000000005 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 1.3600000000000001 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.585 HG23 ' CD2' ' B' ' 183' ' ' TRP . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.1899999999999999 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.585 ' CD2' HG23 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 2.73 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 1.9299999999999999 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.42 -83.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 2.6400000000000001 111.071 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.22 -94.43 0.1 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.809 -0.71 . . . . 1.9299999999999999 112.266 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.14 79.86 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.596 2.197 . . . . 2.9700000000000002 111.967 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' B' ' 201' ' ' LEU . 73.9 p 47.26 34.64 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.967 -0.56 . . . . 4.5 111.349 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 189' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 182' ' ' VAL . . . 93.31 137.65 8.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.773 -0.727 . . . . 4.5 112.726 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 59.32 99.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.879 0.371 . . . . 7.8899999999999997 111.017 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.42 29.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.725 -0.75 . . . . 3.6200000000000001 112.718 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -94.05 145.08 24.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 6.54 110.801 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 23.6 mt -88.2 140.21 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 3.1600000000000001 110.99 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -134.66 -87.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.379 . . . . 3.3900000000000001 111.073 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -173.63 -70.53 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.377 -0.374 . . . . 5.5599999999999996 111.029 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.2 m -70.2 -21.17 63.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.6800000000000002 111.427 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.65 -31.17 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 2.2000000000000002 111.247 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.4900000000000002 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 1.76 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.1800000000000002 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 201' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' B' ' 188' ' ' SER . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 1.98 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 1.6499999999999999 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.1100000000000001 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.477 HD12 HG21 ' B' ' 182' ' ' VAL . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 1.4299999999999999 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD2' ' C ' ' B' ' 203' ' ' CYS . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77000000000000002 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.432 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.6000000000000001 110.437 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 1.77 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.418 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.54 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.0099999999999998 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 207' ' ' PHE . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 2.6499999999999999 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.3300000000000001 112.468 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 2.29 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.1200000000000001 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 3.6000000000000001 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 1.51 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.2200000000000002 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 2.6899999999999999 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 3.3999999999999999 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.6699999999999999 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' B' ' 30' ' ' ARG . 58.8 tp -54.48 -29.5 50.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.3900000000000001 111.566 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.61 104.89 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 5.9100000000000001 111.233 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -140.88 -178.55 5.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.04 0.447 . . . . 5.2599999999999998 111.118 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tt -172.46 83.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.71 -0.677 . . . . 6.8099999999999996 110.097 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.5 154.62 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.511 . . . . 7.0199999999999996 111.163 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -112.22 147.03 37.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 8.2100000000000009 110.727 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.3 t -130.59 137.59 49.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.214 -0.448 . . . . 8.0999999999999996 111.201 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -155.69 162.15 40.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 13.279999999999999 110.762 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.185 -0.912 . . . . 10.4 110.905 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.788 0.328 . . . . 8.0999999999999996 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.8 63.66 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 6.2699999999999996 110.787 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -66.06 137.05 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 6.2000000000000002 110.833 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -104.45 179.92 4.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 4.8200000000000003 110.934 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 62.3 m -152.92 128.1 9.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 3.25 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.0 -177.3 3.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 2.79 110.891 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.0800000000000001 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 1.4299999999999999 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.553 ' O ' HG12 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.1599999999999999 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.0899999999999999 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 1.5800000000000001 110.949 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.95999999999999996 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 0.95999999999999996 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.3 110.575 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 1.52 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 1.8999999999999999 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 0.95999999999999996 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.0700000000000001 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.0800000000000001 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' HIS . . . . . 0.409 ' O ' ' HG ' ' C' ' 25' ' ' LEU . 12.7 t-80 -55.6 -26.82 45.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.02 110.425 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -65.65 -41.88 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 4.9800000000000004 110.677 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -59.86 -36.72 77.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 4.29 110.652 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -73.7 -21.22 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 2.4700000000000002 110.928 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 21' ' ' HIS . 95.5 mt -88.55 -0.88 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 2.8999999999999999 111.624 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 64.8 p -57.64 -19.08 23.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.625 0.232 . . . . 2.7400000000000002 111.625 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -51.3 -30.08 17.0 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.306 -0.627 . . . . 5.8499999999999996 109.306 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -176.68 133.0 0.39 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.75 -1.113 . . . . 4.5199999999999996 109.43 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.449 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 35.8 Cg_endo -89.77 39.91 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.345 2.03 . . . . 3.2200000000000002 112.442 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 40.2 mmt180 56.89 33.67 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 8.6799999999999997 111.496 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.87 3.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.756 -0.735 . . . . 4.1399999999999997 112.561 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' C' ' 29' ' ' PRO . 77.0 t -70.86 133.1 86.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.638 -0.134 . . . . 5.0899999999999999 110.638 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.462 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 50.2 Cg_exo -51.96 165.36 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.352 2.035 . . . . 3.1000000000000001 112.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -59.43 -18.39 38.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 3.8500000000000001 112.429 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -52.41 -39.46 60.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.3700000000000001 111.559 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.7200000000000002 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.6699999999999999 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 1.9299999999999999 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.8799999999999999 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.23 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.434 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.0899999999999999 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 1.4099999999999999 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.62 HG23 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 0.80000000000000004 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.71999999999999997 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 1.6799999999999999 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 1.6799999999999999 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.28 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.51000000000000001 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.3300000000000001 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.56999999999999995 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 1.6699999999999999 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.536 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.4199999999999999 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.70999999999999996 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.1399999999999999 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.88 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.517 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.3799999999999999 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.9399999999999999 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 1.8700000000000001 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.45 ' HZ2' ' HA ' ' C' ' 69' ' ' HIS . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 2.8599999999999999 110.957 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.1099999999999999 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.54 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.4700000000000002 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 2.8500000000000001 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.8700000000000001 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.1200000000000001 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.26 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.476 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.0800000000000001 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 0.85999999999999999 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.454 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 1.96 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 1.8 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.476 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.1799999999999999 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.3300000000000001 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 1.8500000000000001 110.733 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.5600000000000001 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.1100000000000001 111.908 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.62 HG23 HG23 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.49 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 1.6000000000000001 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.01 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.1799999999999999 111.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.527 HD22 H201 ' C' ' 301' ' ' RET . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 1.54 111.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.483 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 1.6499999999999999 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD12 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.1000000000000001 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.3799999999999999 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 1.4399999999999999 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.8700000000000001 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 3.1000000000000001 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 1.48 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 91' ' ' ALA . . . . . 0.463 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.02 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.3399999999999999 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.21 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 4.54 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.3399999999999999 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.4000000000000004 110.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.54 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 5.21 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.3799999999999999 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 2.6400000000000001 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.3799999999999999 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.6200000000000001 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 2.9300000000000002 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.1600000000000001 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.449 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.2999999999999998 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.0699999999999998 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' HG23 ' C' ' 112' ' ' VAL . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.2999999999999998 111.517 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.48 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 1.9299999999999999 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 1.6699999999999999 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 108' ' ' THR . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.1100000000000001 111.158 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 2.5899999999999999 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.90000000000000002 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.92000000000000004 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.55000000000000004 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 1.49 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.445 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 1.6599999999999999 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.93999999999999995 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.29 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.1499999999999999 110.982 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.16 -28.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.3100000000000001 110.848 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG12 ' C' ' 127' ' ' VAL . 78.7 mtm180 -126.56 151.18 48.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 3.1600000000000001 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.63 -15.03 55.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.15 -0.477 . . . . 4.2400000000000002 111.277 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -81.25 -40.73 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 4.6500000000000004 110.672 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.539 HG11 ' NE2' ' B' ' 58' ' ' GLN . 14.4 p -77.49 -23.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 1.3100000000000001 110.984 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 2.8399999999999999 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 2.7000000000000002 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 1.8799999999999999 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.3799999999999999 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 1.76 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.1499999999999999 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.5600000000000001 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.72999999999999998 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 1.48 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.51 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.01 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.0499999999999998 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.0699999999999998 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.459 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 1.9199999999999999 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.459 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 2.6400000000000001 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 3.5800000000000001 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.6499999999999999 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.46 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.27 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 54.9 t30 -66.72 -51.49 39.37 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.3300000000000001 112.019 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 19.4 Cg_endo -58.35 -20.77 49.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.123 1.882 . . . . 2.46 112.773 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.33 45.33 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 3.0800000000000001 110.768 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' ARG . . . . . 0.412 ' HA ' ' NE ' ' C' ' 151' ' ' ARG . 8.1 tpm_? -163.24 -58.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 8.4499999999999993 111.044 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -48.37 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.88 0.371 . . . . 2.8999999999999999 111.22 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' C' ' 149' ' ' PRO . 28.0 ttpp -67.24 -26.71 66.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 4.6200000000000001 110.875 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 71.7 p -91.0 5.44 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 3.8500000000000001 111.546 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -82.73 -23.42 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 5.1200000000000001 110.641 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 50.7 p -101.26 -35.69 9.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 3.4300000000000002 111.394 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.14 -76.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.459 -0.337 . . . . 3.98 111.016 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -155.96 115.71 3.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 2.3999999999999999 110.875 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -68.62 -31.44 70.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 2.8199999999999998 111.107 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.1800000000000002 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 161' ' ' LEU . . . . . 0.416 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.5 110.752 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 162' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 1.8100000000000001 111.165 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.1299999999999999 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.21 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.3100000000000001 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.2599999999999998 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.5800000000000001 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.3 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 1.73 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.4299999999999999 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 171' ' ' TYR . . . . . 0.419 ' O ' HG22 ' C' ' 174' ' ' VAL . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.7200000000000002 110.887 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 1.55 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.5 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 174' ' ' VAL . . . . . 0.419 HG22 ' O ' ' C' ' 171' ' ' TYR . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 1.8400000000000001 111.88 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.1200000000000001 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 1.75 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.71999999999999997 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 1.8 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 0.88 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.552 ' O ' HG22 ' C' ' 184' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 1.52 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' C' ' 183' ' ' TRP . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.2 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.67 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.4700000000000002 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.552 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.6200000000000001 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' C' ' 189' ' ' GLY . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 2.6299999999999999 110.943 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 186' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' C' ' 187' ' ' PRO . . . -172.88 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.77 112.194 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 187' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' C' ' 186' ' ' GLY . 9.6 Cg_exo -71.39 79.21 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.523 2.149 . . . . 3.0299999999999998 111.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 188' ' ' SER . . . . . 0.579 ' HA ' ' HB ' ' C' ' 182' ' ' VAL . 97.3 p 47.27 29.41 1.22 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.909 -0.587 . . . . 4.2199999999999998 111.146 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 189' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' C' ' 185' ' ' ILE . . . 132.86 -139.2 10.74 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.676 -0.773 . . . . 4.0800000000000001 112.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -49.24 128.57 16.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.362 . . . . 7.54 111.442 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.92 157.22 7.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.847 -0.692 . . . . 3.29 112.483 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -69.45 152.25 45.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 5.6699999999999999 110.867 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 15.1 mt -88.08 139.43 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 2.7599999999999998 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -131.01 -95.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 3.6899999999999999 110.811 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -177.63 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.845 0.355 . . . . 5.3399999999999999 111.204 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -65.17 -35.61 81.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 2.5699999999999998 111.454 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.91 -31.08 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 2.3700000000000001 111.385 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.6800000000000002 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 1.95 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.0499999999999998 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 201' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' C' ' 188' ' ' SER . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.9099999999999999 111.651 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 202' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.04 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.6200000000000001 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.49 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.3200000000000001 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76000000000000001 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 1.52 110.256 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 1.8400000000000001 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.6799999999999999 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.04 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 2.6499999999999999 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.3300000000000001 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.02 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.3500000000000001 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 3.6200000000000001 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 1.6399999999999999 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2000000000000002 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.1099999999999999 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 3.3700000000000001 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt -44.75 -51.99 8.82 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.1099999999999999 111.759 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -72.47 125.21 26.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 5.7300000000000004 110.987 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -173.71 143.39 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 5.5300000000000002 110.731 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 63.9 tp -109.7 131.55 54.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 6.5999999999999996 110.651 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -157.24 -179.96 8.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 6.5099999999999998 111.122 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -155.99 93.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 7.0499999999999998 110.636 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 77.1 p -102.5 116.81 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 6.7199999999999998 111.136 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -139.42 133.68 31.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 9.5600000000000005 110.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 21.6 tp60 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 9.0800000000000001 110.87 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.729 H161 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.73 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.721 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.838 0.351 . . . . 8.0899999999999999 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.19 17.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 5.6799999999999997 111.078 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 tp -153.72 -61.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 6.2699999999999996 110.737 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.82 75.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 6.5199999999999996 111.043 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -155.5 81.34 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 3.5899999999999999 110.806 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.94 175.05 5.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.254 -0.43 . . . . 3.23 111.09 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 1.8799999999999999 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.29 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.98999999999999999 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.9199999999999999 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 0.89000000000000001 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.90000000000000002 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.82999999999999996 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.24 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.29 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 1.71 110.622 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.95999999999999996 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 0.98999999999999999 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.1099999999999999 110.535 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.23 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -55.47 -36.21 66.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.0199999999999996 111.068 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -93.67 -24.91 17.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 3.96 110.963 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 m -66.55 -46.76 75.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 2.3799999999999999 111.21 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.5 tp -83.61 -0.85 52.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 2.77 111.23 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -51.91 -22.95 4.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.353 -0.385 . . . . 2.52 111.362 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -46.99 -38.59 11.0 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.362 0.601 . . . . 5.54 109.78 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 21.3 p-10 -170.12 132.3 1.01 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.061 -0.972 . . . . 4.4400000000000004 109.698 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 52.7 Cg_endo -93.84 98.78 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.74 2.293 . . . . 2.8100000000000001 112.489 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -117.57 114.87 24.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.595 . . . . 6.7999999999999998 111.033 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.68 -46.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 4.9699999999999998 112.85 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 36' ' ' GLU . 23.8 t -135.26 111.53 10.87 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.609 0.243 . . . . 4.71 111.445 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 5.2 Cg_exo -78.63 166.54 23.69 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.275 2.65 . . . . 3.5099999999999998 112.279 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -41.63 -43.64 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.003 0.742 . . . . 3.4100000000000001 113.003 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 2.8100000000000001 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' HG13 ' A' ' 32' ' ' VAL . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.3900000000000001 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 32' ' ' VAL . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.2400000000000002 110.157 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 1.6000000000000001 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 43' ' ' ILE . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.3300000000000001 110.52 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.03 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.0 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 1.3100000000000001 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.58999999999999997 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 1.6299999999999999 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.1200000000000001 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.3200000000000001 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.52000000000000002 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.97999999999999998 110.7 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.52000000000000002 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 1.6899999999999999 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.1200000000000001 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 0.59999999999999998 110.72 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.93999999999999995 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 0.78000000000000003 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' ALA . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.728 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.464 ' NE2' HG11 ' B' ' 127' ' ' VAL . 27.5 mm-40 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.1000000000000001 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.657 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 1.76 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 1.8400000000000001 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.6400000000000001 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 1.8400000000000001 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.2400000000000002 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.1600000000000001 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 2.8399999999999999 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.3900000000000001 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.96999999999999997 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.04 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.3799999999999999 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 0.76000000000000001 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 2.9300000000000002 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.1299999999999999 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 1.6599999999999999 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.4199999999999999 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.474 ' NE1' ' H10' ' A' ' 301' ' ' RET . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.0899999999999999 111.499 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.52 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.3300000000000001 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.3899999999999999 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 1.55 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.01 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 1.45 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' H201 ' A' ' 301' ' ' RET . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.3 109.772 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 1.6699999999999999 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 1.8700000000000001 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.4199999999999999 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 168' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.3999999999999999 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 1.9099999999999999 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 2.3300000000000001 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 1.4299999999999999 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.1899999999999999 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 2.5499999999999998 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.3300000000000001 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 5.0999999999999996 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.0699999999999998 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.4100000000000001 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.3099999999999996 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.9399999999999999 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 5.9800000000000004 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.2400000000000002 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.6699999999999999 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 2.5899999999999999 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.53 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 3.1400000000000001 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 1.99 110.936 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.3599999999999999 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.0499999999999998 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 112' ' ' VAL . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.25 111.501 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' HD22 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 2.7200000000000002 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 1.8799999999999999 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.6000000000000001 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 108' ' ' THR . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.0900000000000001 111.112 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 2.6499999999999999 110.507 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.89000000000000001 110.47 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.424 ' HA ' HG22 ' A' ' 118' ' ' ILE . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 0.68000000000000005 110.204 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 1.5800000000000001 112.268 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 115' ' ' SER . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.418 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.1000000000000001 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.8799999999999999 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 1.53 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.29 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.4900000000000002 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.1299999999999999 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 3.9700000000000002 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.22 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 2.8100000000000001 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.25 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 1.8400000000000001 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.54 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 1.79 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.0800000000000001 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.409 ' SG ' HD22 ' C' ' 49' ' ' LEU . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 1.76 110.705 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.76000000000000001 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.0699999999999998 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 1.8500000000000001 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.3200000000000001 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 3.25 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 2.9199999999999999 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 141' ' ' ILE . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 2.6499999999999999 111.346 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.21 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.0099999999999998 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 3.6000000000000001 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.6200000000000001 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 2.4700000000000002 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 2.48 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.633 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 2.6899999999999999 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo -66.49 0.22 3.69 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.3599999999999999 112.992 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.8 15.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.43 -0.35 . . . . 3.2999999999999998 111.405 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -164.44 -34.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 8.4800000000000004 110.917 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.65 -43.88 21.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 2.98 111.398 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.56 -44.08 58.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 4.5499999999999998 110.994 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.6 p -80.93 6.86 12.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 4.0 111.34 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.14 -23.99 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 5.5099999999999998 110.995 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -125.0 -27.85 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.337 -0.392 . . . . 3.2000000000000002 111.255 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -71.36 -166.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 3.98 110.829 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -50.74 117.75 2.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.6299999999999999 111.135 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.1600000000000001 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.3700000000000001 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 2.8300000000000001 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 1.7 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.1600000000000001 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 1.5900000000000001 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.3100000000000001 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.1499999999999999 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.3900000000000001 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.51 HD11 HD22 ' A' ' 87' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.79 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.4199999999999999 111.31 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.1200000000000001 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.8599999999999999 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 1.5800000000000001 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 177' ' ' ILE . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 1.4099999999999999 111.53 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 1.4199999999999999 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 1.9099999999999999 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.55 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 1.8600000000000001 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.73999999999999999 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 1.78 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 0.92000000000000004 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 1.77 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.3400000000000001 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.5099999999999998 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.02 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.4500000000000002 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.48 -161.5 17.99 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 1.73 112.531 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.09 162.07 34.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.572 2.181 . . . . 3.0499999999999998 111.906 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 56.6 18.39 3.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.405 . . . . 4.04 110.381 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.16 -82.45 0.16 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 4.4800000000000004 112.469 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -150.61 -21.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 7.96 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -92.84 175.68 37.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.923 -0.656 . . . . 3.23 112.749 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -135.54 86.86 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 6.0300000000000002 110.651 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.0 pt -134.58 157.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 3.1800000000000002 110.942 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.64 -4.22 5.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 3.3900000000000001 110.688 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG3' ' H ' ' A' ' 197' ' ' ILE . 50.5 tp60 -60.0 151.07 27.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.978 -0.555 . . . . 5.7599999999999998 110.924 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.9 p -73.06 -14.84 61.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.893 -0.594 . . . . 2.5 111.516 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 20.2 tt -54.61 -28.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 2.3999999999999999 111.491 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.85 -41.26 68.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.357 . . . . 2.6600000000000001 110.97 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 1.8100000000000001 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.1800000000000002 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.0099999999999998 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.491 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 1.9299999999999999 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 1.7 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.28 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79000000000000004 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 1.51 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 1.9299999999999999 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 1.71 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.754 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 2.8900000000000001 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.3100000000000001 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 2.8700000000000001 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.3799999999999999 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 3.4199999999999999 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.24 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.4399999999999999 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.5099999999999998 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.0099999999999998 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.5900000000000001 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -19.5 60.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 3.4900000000000002 110.916 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 59.23 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 5.7400000000000002 111.285 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -87.13 179.39 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.486 -0.324 . . . . 5.46 110.977 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.65 116.1 16.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 6.1299999999999999 110.931 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -127.67 114.47 17.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 6.46 111.031 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.73 129.07 35.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 6.9400000000000004 110.777 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.7 m -118.31 82.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 6.8300000000000001 110.97 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -93.22 112.31 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 10.77 110.962 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.32 -0.847 . . . . 9.4100000000000001 110.995 179.769 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.799 0.333 . . . . 8.9100000000000001 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -101.42 -2.05 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 6.7599999999999998 110.691 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.4 tp -99.07 87.61 3.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 6.25 110.553 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -79.94 2.88 21.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.51 . . . . 5.4400000000000004 111.018 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m 59.8 -179.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 3.8399999999999999 110.897 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.441 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp -160.33 -26.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.0800000000000001 110.863 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.3500000000000001 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 1.3899999999999999 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1000000000000001 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 1.71 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 1.48 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.94999999999999996 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.96999999999999997 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.80000000000000004 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.29 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.3600000000000001 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.475 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.23 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.97999999999999998 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.1200000000000001 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' B' ' 24' ' ' SER . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.0 111.049 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.97 ' O ' ' OG ' ' B' ' 26' ' ' SER . 3.2 p90 -53.42 -33.16 52.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 4.2599999999999998 111.298 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -104.26 -20.78 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 3.6200000000000001 111.264 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' B' ' 21' ' ' HIS . 41.4 t -82.6 -57.33 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.958 0.355 . . . . 2.5499999999999998 111.958 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.54 -0.45 42.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.372 0.508 . . . . 3.1099999999999999 112.372 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.97 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 37.8 m -55.34 -29.24 57.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.928 -0.709 . . . . 3.02 110.739 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -43.99 -24.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.825 0.822 . . . . 5.8899999999999997 109.858 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.891 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.54 -153.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 114.26 -1.337 . . . . 5.0199999999999996 109.237 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.891 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 80.9 Cg_exo -1.91 115.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 124.418 3.412 . . . . 3.5299999999999998 117.292 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' B' ' 30' ' ' ARG . 8.5 mpt_? 42.76 35.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.711 -1.131 . . . . 7.8799999999999999 112.123 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 75.37 -50.68 2.45 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.633 -0.587 . . . . 4.6100000000000003 111.633 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.27 106.27 5.17 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-N 116.678 0.239 . . . . 4.7300000000000004 110.962 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.569 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 96.3 Cg_endo -85.12 116.52 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.19 1.26 . . . . 3.75 112.482 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 9.8 tt0 -84.78 -25.55 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.844 0.831 . . . . 3.7599999999999998 109.503 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.535 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.56 -65.65 0.98 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.85 -1.523 . . . . 3.1699999999999999 114.012 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.535 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.5699999999999998 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.7400000000000002 112.191 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' B' ' 34' ' ' GLN . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 1.72 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 1.95 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.2 110.803 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.441 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.1200000000000001 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 1.49 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.592 HG23 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 0.77000000000000002 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.68000000000000005 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 1.6299999999999999 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.546 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 1.9099999999999999 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.22 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.55000000000000004 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 0.87 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 0.55000000000000004 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.0600000000000001 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.41 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.1899999999999999 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 0.66000000000000003 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.85999999999999999 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.83999999999999997 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 1.4399999999999999 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.427 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 6.4 tp-100 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.2400000000000002 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.3100000000000001 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 1.8100000000000001 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.1800000000000002 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.0299999999999998 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.48 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.3700000000000001 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.2799999999999998 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.78 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.05 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.1100000000000001 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.2999999999999998 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 0.71999999999999997 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.04 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.479 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 1.79 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 1.4399999999999999 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.3100000000000001 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.479 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.0099999999999998 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.4299999999999999 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.499 ' O ' HD23 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.21 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.592 HG23 HG23 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.1799999999999999 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.581 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 1.6499999999999999 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.0600000000000001 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 1.5800000000000001 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 1.49 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.598 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 1.72 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 1.96 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.24 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.21 111.125 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.3200000000000001 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.1499999999999999 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 86' ' ' SER . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 1.4399999999999999 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 2.6800000000000002 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.452 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 2.71 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' PHE . . . . . 0.452 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 4.1900000000000004 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 2.79 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.2699999999999996 111.271 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.5700000000000003 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.2400000000000002 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 5.3899999999999997 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.1600000000000001 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 2.5800000000000001 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.29 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.48 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 2.7599999999999998 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' B' ' 109' ' ' GLN . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.2200000000000002 111.084 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.428 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.3599999999999999 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 1.9199999999999999 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.4 ' O ' HG23 ' B' ' 112' ' ' VAL . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.0600000000000001 111.231 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.598 ' HG3' HD22 ' B' ' 84' ' ' LEU . 28.6 mm-40 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 2.8700000000000001 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 1.98 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 1.6200000000000001 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 108' ' ' THR . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.04 111.504 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.46 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.82999999999999996 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.73999999999999999 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.59999999999999998 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.474 HD12 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.4199999999999999 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.474 HG13 HD12 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 1.51 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.0900000000000001 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.1599999999999999 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 1.76 110.721 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.8900000000000001 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.676 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.6699999999999999 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' TRP . . . . . 0.676 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.0700000000000003 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.4099999999999999 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 2.4700000000000002 110.664 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 2.6099999999999999 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.0699999999999998 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.3 111.173 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.6699999999999999 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 1.54 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.69999999999999996 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.27 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 1.8200000000000001 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.93999999999999995 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' PHE . . . . . 0.404 ' HA ' HG12 ' B' ' 142' ' ' ILE . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 111.313 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.0099999999999998 111.444 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.96 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' B' ' 139' ' ' PHE . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 2.8799999999999999 111.71 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.52 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 4.1500000000000004 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.5900000000000001 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.1299999999999999 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 1.78 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 45.1 t30 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.4500000000000002 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo -65.7 -4.51 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.3599999999999999 113.087 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.52 7.27 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 2.8799999999999999 110.77 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -154.39 -32.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 8.0700000000000003 110.835 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.0 -37.76 23.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 2.7999999999999998 111.395 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.25 -51.65 7.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 4.5800000000000001 110.917 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' B' ' 157' ' ' GLN . 9.7 t -69.67 -0.73 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 3.8100000000000001 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.42 -37.51 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 5.2199999999999998 111.01 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 63.8 p -117.84 5.15 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 3.4199999999999999 111.349 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.58 ' HB2' ' HA ' ' B' ' 154' ' ' THR . 28.7 mm-40 -102.8 -162.66 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.373 -0.376 . . . . 4.2000000000000002 110.913 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 55.2 m -55.91 115.85 2.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.076 -0.511 . . . . 2.75 111.244 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m -78.12 -34.39 50.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 2.3999999999999999 110.883 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 2.5699999999999998 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 162' ' ' ALA . . . . . 0.419 ' HB2' ' OG1' ' B' ' 154' ' ' THR . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 1.72 111.691 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 2.6899999999999999 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.1600000000000001 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 165' ' ' TYR . . . . . 0.477 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.1299999999999999 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.9399999999999999 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.3300000000000001 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 1.5600000000000001 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 165' ' ' TYR . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 1.5900000000000001 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.1399999999999999 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 3.8700000000000001 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.6100000000000001 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.3 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 1.53 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.99 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.5 110.545 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.521 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 1.46 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67000000000000004 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.551 ' O ' HG22 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 1.73 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 0.93000000000000005 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.546 ' O ' HG22 ' B' ' 184' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 1.3600000000000001 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.1899999999999999 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 2.73 111.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 1.9299999999999999 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 184' ' ' ILE . 34.8 pt -117.69 164.21 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 2.6400000000000001 111.4 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.67 -166.81 52.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.9 -0.667 . . . . 1.9299999999999999 112.724 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.93 163.62 27.66 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.692 2.261 . . . . 2.9700000000000002 111.857 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 93.5 p 47.24 24.74 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 4.5 110.899 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.68 68.54 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.871 -0.68 . . . . 4.5 112.446 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 56.7 t80 50.64 88.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.916 0.389 . . . . 7.8899999999999997 111.217 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.31 151.27 6.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.846 -0.693 . . . . 3.6200000000000001 112.222 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -128.51 39.29 3.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 6.54 111.062 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.9 pt -96.54 140.01 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 3.1600000000000001 111.253 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -115.86 10.71 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 3.3900000000000001 110.576 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 195' ' ' GLN . . . . . 0.416 ' HB2' HG22 ' B' ' 197' ' ' ILE . 88.1 mt-30 -66.57 138.78 57.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 5.5599999999999996 110.883 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -64.15 -14.92 58.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 2.6800000000000002 111.432 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' B' ' 195' ' ' GLN . 10.1 tp -56.41 -31.33 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 2.2000000000000002 111.218 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.4900000000000002 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.76 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.1800000000000002 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.78 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 1.98 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 1.6499999999999999 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.1100000000000001 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.699 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 1.4299999999999999 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77000000000000002 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 1.6000000000000001 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 1.77 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.475 ' HB2' HD11 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.54 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.0099999999999998 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 2.6499999999999999 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.3300000000000001 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 2.29 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.1200000000000001 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 3.6000000000000001 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.51 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 2.6899999999999999 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 3.3999999999999999 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.6699999999999999 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.416 ' N ' HD22 ' B' ' 221' ' ' LEU . 3.6 mm? -83.08 -31.03 27.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.3900000000000001 110.891 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 61.7 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 5.9100000000000001 111.23 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -87.84 154.13 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 5.2599999999999998 110.861 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.513 ' N ' HD22 ' B' ' 224' ' ' LEU . 2.5 mm? -113.74 143.71 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 6.8099999999999996 110.624 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -161.25 132.41 5.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 7.0199999999999996 110.712 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.15 161.25 15.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 8.2100000000000009 110.946 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 83.2 p -153.85 140.99 19.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.493 . . . . 8.0999999999999996 111.127 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.35 -179.09 5.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 13.279999999999999 110.91 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.285 -0.864 . . . . 10.4 110.991 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 8.0999999999999996 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -158.21 -7.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 6.2699999999999996 110.817 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.6 3.11 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 6.2000000000000002 111.064 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.92 106.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 4.8200000000000003 111.171 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 47.5 t -66.19 145.52 55.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 3.25 110.667 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.38 -1.94 18.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 2.79 111.313 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.0800000000000001 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.4299999999999999 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.1599999999999999 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.0899999999999999 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 1.5800000000000001 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.95999999999999996 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.95999999999999996 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.3 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 1.52 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 1.8999999999999999 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 0.95999999999999996 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.0700000000000001 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.0800000000000001 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -55.52 -19.71 10.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.02 111.049 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.49 -30.19 69.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.446 . . . . 4.9800000000000004 111.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -97.18 -31.49 12.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 4.29 111.41 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.5 t -64.89 -50.85 64.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 2.4700000000000002 111.542 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 tp -87.89 -0.49 57.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 2.8999999999999999 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 77.8 p -53.56 -24.98 15.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.743 0.275 . . . . 2.7400000000000002 111.743 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -49.78 -30.24 9.23 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.28 0.562 . . . . 5.8499999999999996 109.881 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.5 p-10 -174.31 132.26 0.52 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 4.5199999999999996 109.625 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 18.1 Cg_endo -90.79 143.43 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.508 2.138 . . . . 3.2200000000000002 112.487 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.58 22.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 8.6799999999999997 111.511 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.81 -4.06 13.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 4.1399999999999997 112.701 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' C' ' 36' ' ' GLU . 44.0 t -104.39 110.24 63.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.634 0.254 . . . . 5.0899999999999999 110.931 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.498 ' HG2' ' HE1' ' C' ' 35' ' ' TYR . 6.5 Cg_exo -79.05 166.56 22.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.37 2.714 . . . . 3.1000000000000001 112.582 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.51 -44.17 2.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.033 0.753 . . . . 3.8500000000000001 113.033 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.498 ' HE1' ' HG2' ' C' ' 33' ' ' PRO . 12.2 p90 -64.79 -49.23 71.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.3700000000000001 112.313 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 36' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' C' ' 32' ' ' VAL . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.7200000000000002 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' C' ' 32' ' ' VAL . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.6699999999999999 110.109 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 1.9299999999999999 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 1.8799999999999999 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.23 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.426 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.0899999999999999 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 1.4099999999999999 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.613 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 0.80000000000000004 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.71999999999999997 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.478 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 1.6799999999999999 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' TRP . . . . . 0.478 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 1.6799999999999999 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.28 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.51000000000000001 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.409 HD22 ' SG ' ' A' ' 134' ' ' CYS . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.3300000000000001 110.635 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.56999999999999995 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 1.6699999999999999 110.901 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.4199999999999999 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 0.70999999999999996 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.1399999999999999 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 0.88 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.3799999999999999 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.9399999999999999 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 1.8700000000000001 110.866 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 2.8599999999999999 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 1.95 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.1099999999999999 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.54 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.4700000000000002 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 2.8500000000000001 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 1.8700000000000001 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.1200000000000001 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.26 110.809 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.0800000000000001 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.132 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 1.8 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.1799999999999999 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.3300000000000001 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.505 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 1.8500000000000001 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.5600000000000001 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.517 ' O ' HD23 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.1100000000000001 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.613 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.49 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 1.6000000000000001 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.01 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.517 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.1799999999999999 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 1.54 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 1.6499999999999999 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.1000000000000001 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.437 ' O ' HG23 ' C' ' 90' ' ' THR . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.3799999999999999 110.627 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.415 HD22 HD11 ' C' ' 168' ' ' LEU . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.4399999999999999 110.645 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 1.8700000000000001 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 3.1000000000000001 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 ' O ' ' C' ' 86' ' ' SER . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 1.48 110.998 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.02 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.3399999999999999 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 4.54 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.3399999999999999 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.4000000000000004 111.311 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.54 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 5.21 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.3799999999999999 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 2.6400000000000001 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.3799999999999999 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.6200000000000001 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 2.9300000000000002 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.1600000000000001 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.416 ' O ' HG12 ' C' ' 110' ' ' ILE . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.2999999999999998 110.894 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.0699999999999998 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.682 HG21 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.2999999999999998 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.411 HE21 HG13 ' C' ' 113' ' ' ILE . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.48 110.287 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 1.9299999999999999 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 1.6699999999999999 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.1100000000000001 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.411 HG13 HE21 ' C' ' 109' ' ' GLN . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 2.5899999999999999 110.515 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 0.92000000000000004 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.55000000000000004 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 1.49 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 1.6599999999999999 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.93999999999999995 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.29 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.611 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.1499999999999999 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -74.47 -24.92 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.3100000000000001 110.965 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.501 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.7 mtt180 -118.37 135.61 54.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 3.1600000000000001 110.767 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.12 -10.89 60.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 4.2400000000000002 110.719 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -81.23 -47.7 13.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 4.6500000000000004 110.828 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -70.94 -26.59 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.267 -0.424 . . . . 1.3100000000000001 110.92 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.611 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 2.8399999999999999 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 2.7000000000000002 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 1.8799999999999999 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.3799999999999999 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' TYR . . . . . 0.405 ' HE1' ' HB3' ' C' ' 183' ' ' TRP . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.76 110.901 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.1499999999999999 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.5600000000000001 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.72999999999999998 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 1.48 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.51 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.01 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.0499999999999998 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.0699999999999998 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 1.9199999999999999 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.682 HD13 HG21 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 2.6400000000000001 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.5800000000000001 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.6499999999999999 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.46 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.27 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.56 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 7.1 t30 -89.07 -48.91 0.41 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.3300000000000001 112.402 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 35.2 Cg_endo -64.34 0.97 1.87 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.257 1.971 . . . . 2.46 113.122 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.59 23.13 0.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 3.0800000000000001 111.576 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -171.93 -32.81 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.658 0.266 . . . . 8.4499999999999993 111.286 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.92 -39.93 23.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.851 0.315 . . . . 2.8999999999999999 111.851 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -83.87 -27.34 28.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.296 . . . . 4.6200000000000001 111.209 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 62.2 p -98.8 6.69 46.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 3.8500000000000001 111.35 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -53.42 -35.49 60.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 5.1200000000000001 111.562 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -133.13 10.3 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 3.4300000000000002 111.396 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 34.3 tt0 -87.24 -70.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.381 . . . . 3.98 110.858 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 68.0 m -149.71 114.13 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 2.3999999999999999 110.669 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p -77.69 -38.59 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 2.8199999999999998 111.112 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.1800000000000002 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 1.8100000000000001 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.1299999999999999 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 164' ' ' LEU . . . . . 0.413 ' HA ' ' HE2' ' C' ' 167' ' ' LYS . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.21 110.888 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.3100000000000001 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.2599999999999998 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 167' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' C' ' 164' ' ' LEU . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.5800000000000001 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.415 HD11 HD22 ' C' ' 87' ' ' LEU . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.3 110.583 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 1.73 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 1.4299999999999999 111.031 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.7200000000000002 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 1.55 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 1.5 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 1.8400000000000001 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.1200000000000001 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 1.75 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.71999999999999997 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.625 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 1.8 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 0.88 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 1.52 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.2 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.405 ' HB3' ' HE1' ' C' ' 132' ' ' TYR . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.4700000000000002 110.778 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.6200000000000001 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 2.6299999999999999 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.27 -159.63 13.79 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.77 112.752 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 171.43 18.21 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.622 2.215 . . . . 3.0299999999999998 111.981 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.5 p 49.1 21.93 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.156 -0.475 . . . . 4.2199999999999998 110.721 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.02 -90.65 0.19 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.729 -0.669 . . . . 4.0800000000000001 112.333 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -135.83 -34.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 7.54 110.829 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -79.89 168.43 52.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 3.29 112.673 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -131.38 74.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 5.6699999999999999 110.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -128.35 146.56 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 2.7599999999999998 111.095 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -124.95 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 3.6899999999999999 111.238 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' H ' ' C' ' 197' ' ' ILE . 52.9 tt0 -95.48 146.93 24.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.376 -0.375 . . . . 5.3399999999999999 110.747 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.5 p -65.93 -15.21 62.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.124 -0.489 . . . . 2.5699999999999998 111.751 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.602 ' H ' ' HG2' ' C' ' 195' ' ' GLN . 19.4 tt -57.49 -31.21 38.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 2.3700000000000001 110.76 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.6800000000000002 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.0499999999999998 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 1.9099999999999999 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.04 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.501 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 1.6200000000000001 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.49 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.3200000000000001 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76000000000000001 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 1.52 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 1.8400000000000001 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.6799999999999999 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.04 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.446 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 2.6499999999999999 110.439 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.446 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.3300000000000001 111.844 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.02 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.3500000000000001 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 3.6200000000000001 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 1.6399999999999999 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2000000000000002 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.1099999999999999 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 3.3700000000000001 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -24.36 47.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.1099999999999999 110.841 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 59.72 -86.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.901 -0.59 . . . . 5.7300000000000004 111.305 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.15 -177.35 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 5.5300000000000002 110.639 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.59 HD23 ' H ' ' C' ' 224' ' ' LEU . 2.6 pt? -133.29 143.58 49.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.425 -0.352 . . . . 6.5999999999999996 111.054 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.14 134.53 17.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 6.5099999999999998 110.897 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.68 155.23 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 7.0499999999999998 110.669 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 63.3 m -151.59 109.2 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 6.7199999999999998 110.965 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -113.42 -179.69 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.5600000000000005 110.65 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.121 -0.942 . . . . 9.0800000000000001 110.985 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.738 H171 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.747 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.738 ' H8 ' H161 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.84 0.352 . . . . 8.0899999999999999 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -105.82 177.92 4.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 5.6799999999999997 110.773 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 3' ' ' LEU . 2.6 pt? -167.7 15.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 6.2699999999999996 110.704 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 60.73 174.69 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.113 -0.494 . . . . 6.5199999999999996 111.013 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -161.48 117.19 2.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 3.5899999999999999 111.02 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt -82.33 -3.79 56.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 3.23 110.678 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 1.8799999999999999 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.29 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.98999999999999999 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 1.9199999999999999 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 15' ' ' MET . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 1.45 109.981 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 0.89000000000000001 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 0.90000000000000002 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.82999999999999996 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.24 110.904 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.71 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.95999999999999996 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.98999999999999999 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.1099999999999999 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -62.99 -31.9 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.0199999999999996 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.697 ' O ' ' OG ' ' A' ' 26' ' ' SER . 73.5 t90 -64.52 -29.53 70.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 3.96 110.264 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -66.57 -52.23 47.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 2.3799999999999999 110.522 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.74 -6.62 57.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 2.77 110.654 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.697 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 89.3 p -59.64 -16.17 24.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 2.52 111.068 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -48.16 -41.15 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.305 0.574 . . . . 5.54 109.565 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.1 p-10 -175.9 131.18 0.4 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.113 -0.948 . . . . 4.4400000000000004 110.038 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 81.1 Cg_endo -100.47 169.24 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.15 2.567 . . . . 2.8100000000000001 112.586 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -149.92 105.95 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 6.7999999999999998 111.154 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.54 -47.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 4.9699999999999998 113.414 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 32' ' ' VAL . 7.1 p -136.28 114.44 10.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.827 0.313 . . . . 4.71 111.68 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' TYR . 77.0 Cg_exo -51.46 169.82 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.853 2.369 . . . . 3.5099999999999998 112.144 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -37.23 -18.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 3.4100000000000001 112.968 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 2.8100000000000001 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.3900000000000001 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.2400000000000002 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 1.6000000000000001 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.3300000000000001 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.03 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.0 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 1.3100000000000001 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.58999999999999997 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 1.6299999999999999 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.1200000000000001 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.3200000000000001 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.52000000000000002 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.97999999999999998 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.52000000000000002 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 1.6899999999999999 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.1200000000000001 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.59999999999999998 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.93999999999999995 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 0.78000000000000003 110.255 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.23 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.407 ' OE1' HG11 ' B' ' 127' ' ' VAL . 17.6 mm100 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.1000000000000001 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 1.76 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.8400000000000001 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.6400000000000001 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 1.8400000000000001 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.2400000000000002 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.1600000000000001 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 2.8399999999999999 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.3900000000000001 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.96999999999999997 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.04 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.3799999999999999 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.76000000000000001 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 2.9300000000000002 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.1299999999999999 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 75' ' ' ASP . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 1.6599999999999999 110.496 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 74' ' ' ILE . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.4199999999999999 109.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.0899999999999999 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.52 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.3300000000000001 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.3899999999999999 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 1.55 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.01 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.3 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 1.6699999999999999 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 1.8700000000000001 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.3999999999999999 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 1.9099999999999999 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 2.3300000000000001 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.4299999999999999 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.1899999999999999 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 2.5499999999999998 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.3300000000000001 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 5.0999999999999996 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.0699999999999998 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.4100000000000001 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.3099999999999996 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.9399999999999999 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 5.9800000000000004 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.2400000000000002 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 2.6699999999999999 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 2.5899999999999999 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.53 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 108' ' ' THR . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 3.1400000000000001 111.072 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 1.99 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.3599999999999999 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.0499999999999998 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.25 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 2.7200000000000002 111.213 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 1.8799999999999999 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 1.6000000000000001 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.0900000000000001 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 2.6499999999999999 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 0.89000000000000001 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.68000000000000005 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 1.5800000000000001 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.04 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.1000000000000001 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.8799999999999999 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.29 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.4900000000000002 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.694 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.1299999999999999 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.694 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 3.9700000000000002 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.22 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.8100000000000001 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.25 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 1.8400000000000001 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.54 111.041 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 1.79 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' C' ' 49' ' ' LEU . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 1.76 111.013 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.76000000000000001 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.0699999999999998 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.8500000000000001 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.3200000000000001 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 3.25 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 2.9199999999999999 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 142' ' ' ILE . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 2.6499999999999999 111.413 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.21 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.0099999999999998 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 3.6000000000000001 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.6200000000000001 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 2.4700000000000002 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 2.48 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 64.0 t30 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 2.6899999999999999 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo -63.1 -8.33 13.91 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.3599999999999999 112.994 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.58 36.49 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.727 0.299 . . . . 3.2999999999999998 111.183 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -146.55 -62.57 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 8.4800000000000004 111.406 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.89 -44.82 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 2.98 111.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -73.31 0.04 13.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 4.5499999999999998 111.643 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 162' ' ' ALA . 81.1 p -104.89 -37.62 6.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 4.0 111.586 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -69.49 -16.16 63.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 5.5099999999999998 111.171 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 74.4 p -91.02 -34.61 15.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.2000000000000002 111.233 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 -74.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 3.98 111.065 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 116.07 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 2.6299999999999999 110.934 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.1600000000000001 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.3700000000000001 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.8300000000000001 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 154' ' ' THR . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 1.7 111.342 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.1600000000000001 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 1.5900000000000001 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.3100000000000001 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.1499999999999999 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.3900000000000001 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 1.79 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.4199999999999999 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.1200000000000001 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' O ' HD13 ' A' ' 175' ' ' LEU . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 3.8599999999999999 110.357 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 1.5800000000000001 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 1.4099999999999999 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 1.4199999999999999 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 171' ' ' TYR . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 1.9099999999999999 111.149 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.55 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 1.8600000000000001 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.73999999999999999 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 182' ' ' VAL . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 1.78 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 0.92000000000000004 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 1.77 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.3400000000000001 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.5099999999999998 111.883 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.02 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 189' ' ' GLY . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.4500000000000002 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 159.87 -179.65 35.28 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 1.73 112.37 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.45 100.39 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.465 2.11 . . . . 3.0499999999999998 112.032 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t 51.64 53.04 13.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.135 -0.484 . . . . 4.04 110.374 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 185' ' ' ILE . . . 132.44 -145.1 17.01 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.746 -0.661 . . . . 4.4800000000000004 111.541 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 193' ' ' ILE . 55.2 m-85 -56.36 169.57 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 7.96 110.616 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.473 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -84.36 134.94 13.13 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.711 -0.757 . . . . 3.23 112.916 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 55.18 56.58 6.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 6.0300000000000002 111.226 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.571 HD13 ' HB2' ' A' ' 190' ' ' PHE . 22.3 pt -127.05 150.85 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 3.1800000000000002 111.091 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.1 m-20 -87.12 -173.83 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 3.3900000000000001 110.924 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.97 -20.6 65.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 5.7599999999999998 110.948 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.1 m -63.37 -60.31 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 2.5 111.084 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 193' ' ' ILE . 50.3 mm -68.82 -27.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 2.3999999999999999 111.126 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -47.27 -60.63 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 2.6600000000000001 111.133 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 1.8100000000000001 111.217 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.21 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.453 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.1800000000000002 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.0099999999999998 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 1.9299999999999999 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 1.7 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.28 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79000000000000004 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 1.51 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 1.9299999999999999 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 1.71 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.04 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 2.8900000000000001 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.3100000000000001 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 2.8700000000000001 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.3799999999999999 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 3.4199999999999999 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.24 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.4399999999999999 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.5099999999999998 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.0099999999999998 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.5900000000000001 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp -55.23 -28.88 56.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 3.4900000000000002 110.88 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -56.22 123.82 15.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 5.7400000000000002 111.123 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -148.98 -11.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 5.46 110.388 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.6 mp 60.63 16.44 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.774 -0.648 . . . . 6.1299999999999999 111.329 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -172.46 76.52 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 6.46 110.797 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.02 101.33 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.469 . . . . 6.9400000000000004 110.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.0 t -150.05 156.95 42.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 6.8300000000000001 110.903 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -102.43 99.37 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 10.77 110.896 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.253 -0.88 . . . . 9.4100000000000001 111.093 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.834 0.349 . . . . 8.9100000000000001 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -100.96 -175.88 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 6.7599999999999998 110.809 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' N ' ' B' ' 3' ' ' LEU . 2.1 pt? -166.15 41.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 6.25 111.126 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 58.87 76.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 5.4400000000000004 110.789 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t -68.47 138.91 55.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 3.8399999999999999 111.1 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.51 -4.87 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 3.0800000000000001 111.325 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.459 ' N ' HD22 ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.3500000000000001 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 1.3899999999999999 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1000000000000001 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 1.71 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 1.48 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 0.94999999999999996 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.96999999999999997 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.80000000000000004 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.29 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.3600000000000001 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 0.97999999999999998 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.1200000000000001 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.0 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 -60.93 -39.06 87.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 4.2599999999999998 110.197 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' TRP . . . . . 0.637 ' O ' ' OG ' ' B' ' 26' ' ' SER . 85.5 t90 -58.9 -36.33 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 3.6200000000000001 110.436 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.5 t -64.2 -47.56 79.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 2.5499999999999998 111.295 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.69 -7.23 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 3.1099999999999999 110.953 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 85.0 p -63.82 -14.24 51.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 3.02 111.328 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -43.61 -45.55 6.83 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.415 -0.587 . . . . 5.8899999999999997 109.415 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.3 p30 178.51 129.21 0.21 Allowed Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.377 -0.829 . . . . 5.0199999999999996 110.781 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 71.3 Cg_endo -102.39 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.632 2.888 . . . . 3.5299999999999998 111.526 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -114.21 5.1 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.503 -0.925 . . . . 7.8799999999999999 108.503 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.573 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.73 -51.88 0.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.075 -1.42 . . . . 4.6100000000000003 110.993 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.427 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.0 p -142.38 107.34 5.62 Favored Pre-proline 0 C--N 1.332 -0.164 0 O-C-N 123.009 -0.112 . . . . 4.7300000000000004 110.901 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 36' ' ' GLU . 85.3 Cg_endo -85.05 114.28 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 120.685 0.923 . . . . 3.75 112.817 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -85.73 -31.4 22.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.299 1.047 . . . . 3.7599999999999998 109.033 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.55 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -82.58 -64.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 113.144 -1.844 . . . . 3.1699999999999999 113.185 -177.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.55 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.5699999999999998 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.7400000000000002 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 1.72 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.497 HG23 HD13 ' B' ' 43' ' ' ILE . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 1.95 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.1200000000000001 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 1.49 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 0.77000000000000002 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.68000000000000005 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 1.6299999999999999 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.586 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 1.9099999999999999 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.22 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.55000000000000004 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 0.87 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 0.55000000000000004 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HA ' ' SD ' ' B' ' 54' ' ' MET . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.0600000000000001 111.363 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.486 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.1899999999999999 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.66000000000000003 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' B' ' 51' ' ' TYR . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 0.85999999999999999 110.23 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 0.83999999999999997 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 1.4399999999999999 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.2400000000000002 110.904 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.3100000000000001 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 1.8100000000000001 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.1800000000000002 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.0299999999999998 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.48 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.3700000000000001 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.2799999999999998 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 1.78 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.05 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.1100000000000001 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.2999999999999998 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 0.71999999999999997 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.46 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.04 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 1.79 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 1.4399999999999999 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.3100000000000001 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.0099999999999998 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.4299999999999999 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.43 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.21 112.081 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.486 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.1799999999999999 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.611 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 1.6499999999999999 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.0600000000000001 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.601 ' HB3' HD11 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 1.5800000000000001 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 1.49 110.207 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 1.96 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.24 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.21 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.3200000000000001 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 89' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' B' ' 35' ' ' TYR . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.1499999999999999 111.324 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 1.4399999999999999 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.05 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 2.6800000000000002 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.71 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 4.1900000000000004 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 2.79 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.2699999999999996 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.5700000000000003 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.2400000000000002 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 5.3899999999999997 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.1600000000000001 111.624 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 2.5800000000000001 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.29 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.48 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 2.7599999999999998 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.2200000000000002 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.3599999999999999 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 1.9199999999999999 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.617 ' HB ' HD13 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.0600000000000001 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.435 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 2.8700000000000001 111.274 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 1.98 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 1.6200000000000001 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.04 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.465 HG22 HD21 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.82999999999999996 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 0.73999999999999999 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.535 ' HA2' ' H21' ' B' ' 301' ' ' RET . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.59999999999999998 112.701 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 73' ' ' TYR . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.4199999999999999 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.51 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.0900000000000001 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.1599999999999999 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 1.76 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.8900000000000001 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.546 ' HB2' HG12 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 2.6699999999999999 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.0700000000000003 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 1.4099999999999999 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 2.4700000000000002 110.729 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 2.6099999999999999 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.0699999999999998 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.69999999999999996 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 1.4399999999999999 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 1.8200000000000001 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.93999999999999995 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.6000000000000001 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.0099999999999998 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 1.96 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 2.8799999999999999 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.52 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 4.1500000000000004 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.5900000000000001 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.1299999999999999 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 5.9 t30 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.4500000000000002 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo -55.49 -24.64 45.06 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.3599999999999999 112.711 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 57.3 mt -96.8 59.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 2.8799999999999999 110.911 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 38.0 ttp180 -165.85 -68.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.128 -0.487 . . . . 8.0700000000000003 111.093 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.85 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 2.7999999999999998 111.45 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -73.45 -15.61 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 4.5800000000000001 111.024 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' B' ' 162' ' ' ALA . 74.2 p -96.85 -30.8 12.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 3.8100000000000001 111.0 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -64.63 -23.26 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 5.2199999999999998 110.776 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.1 t -98.22 -21.96 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.508 . . . . 3.4199999999999999 111.144 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -91.4 -73.77 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 4.2000000000000002 110.938 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.5 p -148.82 113.54 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 2.75 110.881 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -72.09 -26.91 62.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 2.3999999999999999 111.084 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 161' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 2.5699999999999998 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 162' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 154' ' ' THR . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.72 111.255 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.6899999999999999 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 164' ' ' LEU . . . . . 0.426 HD12 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.1600000000000001 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.1299999999999999 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.9399999999999999 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.3300000000000001 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 1.5600000000000001 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.5900000000000001 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.1399999999999999 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 3.8700000000000001 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 1.6100000000000001 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.53 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 1.99 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' TRP . . . . . 0.435 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.5 111.315 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.532 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 1.46 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67000000000000004 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.67 ' O ' HG22 ' B' ' 182' ' ' VAL . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 1.73 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 0.93000000000000005 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.532 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 1.3600000000000001 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.67 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.1899999999999999 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 2.73 111.755 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.405 HG22 HG23 ' B' ' 185' ' ' ILE . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 1.9299999999999999 111.602 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.412 ' H ' HG13 ' B' ' 185' ' ' ILE . 2.4 pp -112.26 -172.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 2.6400000000000001 111.421 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 191' ' ' GLY . . . 84.15 -120.88 5.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.816 -0.707 . . . . 1.9299999999999999 112.443 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.7 ' HD3' HD12 ' B' ' 193' ' ' ILE . 89.4 Cg_endo -94.63 -174.0 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.916 2.41 . . . . 2.9700000000000002 111.972 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 51.21 20.52 0.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.129 0.49 . . . . 4.5 110.34 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.05 19.21 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.6 -0.727 . . . . 4.5 112.137 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.4 t80 60.19 94.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.951 0.405 . . . . 7.8899999999999997 110.95 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 186' ' ' GLY . . . -139.79 -117.3 1.43 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.838 -0.696 . . . . 3.6200000000000001 112.311 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -123.86 14.78 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 6.54 110.829 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.7 HD12 ' HD3' ' B' ' 187' ' ' PRO . 95.5 mt -117.66 139.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 3.1600000000000001 110.735 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.77 -174.98 4.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 3.3900000000000001 111.265 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.04 -23.29 64.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 5.5599999999999996 111.248 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 76.2 p -61.82 -65.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 2.6800000000000002 111.466 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' B' ' 193' ' ' ILE . 86.2 mt -67.9 -25.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 2.2000000000000002 110.936 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.4900000000000002 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.76 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.1800000000000002 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 1.98 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 1.6499999999999999 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.1100000000000001 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.576 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 1.4299999999999999 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77000000000000002 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG23 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 1.6000000000000001 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 1.77 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.54 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.0099999999999998 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.6499999999999999 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.3300000000000001 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 2.29 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.1200000000000001 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 3.6000000000000001 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 1.51 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.2200000000000002 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 2.6899999999999999 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 3.3999999999999999 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.38 -26.62 67.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.3900000000000001 110.817 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -80.14 106.54 12.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 5.9100000000000001 110.997 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -162.19 100.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 5.2599999999999998 110.909 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 81.6 mt 50.73 43.83 27.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 6.8099999999999996 110.911 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.2 t30 66.24 141.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.985 -0.552 . . . . 7.0199999999999996 110.861 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.5 123.36 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 8.2100000000000009 111.212 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 62.8 m -131.74 166.73 20.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 8.0999999999999996 110.755 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -132.56 78.33 1.79 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 13.279999999999999 111.057 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.24 -0.886 . . . . 10.4 110.965 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.875 0.369 . . . . 8.0999999999999996 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -157.18 111.71 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 6.2699999999999996 110.741 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 49.4 tp -78.17 132.97 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 6.2000000000000002 111.041 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.45 128.11 46.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 4.8200000000000003 110.784 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 34.4 t -83.32 152.16 25.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 3.25 111.046 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.14 2.65 12.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 2.79 111.223 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.0800000000000001 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.4 m80 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 1.4299999999999999 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.468 ' O ' HG12 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.1599999999999999 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.0899999999999999 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 1.5800000000000001 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.468 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 0.95999999999999996 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.95999999999999996 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.3 110.222 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 1.52 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.449 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.8999999999999999 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 0.95999999999999996 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.0700000000000001 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.0800000000000001 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -60.61 -43.76 97.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.02 110.218 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -61.62 -29.5 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.066 -0.515 . . . . 4.9800000000000004 110.414 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.746 ' O ' ' OG ' ' C' ' 26' ' ' SER . 82.2 t90 -66.42 -31.0 71.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 4.29 110.211 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -66.9 -46.84 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 2.4700000000000002 110.692 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -84.78 -2.76 58.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 2.8999999999999999 110.394 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.746 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 66.8 p -71.19 -14.03 62.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 2.7400000000000002 110.505 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -40.94 -48.26 3.13 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.342 -0.614 . . . . 5.8499999999999996 109.342 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 2.5 p-10 179.14 128.86 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.28 -0.873 . . . . 4.5199999999999996 110.736 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 31' ' ' GLY . 60.1 Cg_endo -102.82 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.749 2.966 . . . . 3.2200000000000002 111.584 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -120.96 12.03 11.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.924 -0.769 . . . . 8.6799999999999997 108.924 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 31' ' ' GLY . . . . . 0.546 ' H ' ' HD2' ' C' ' 29' ' ' PRO . . . 119.78 -51.59 0.76 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 114.385 -1.28 . . . . 4.1399999999999997 111.002 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.81 108.1 5.94 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 122.994 -0.121 . . . . 5.0899999999999999 110.816 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' C' ' 36' ' ' GLU . 90.9 Cg_endo -83.89 115.96 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 120.822 1.014 . . . . 3.1000000000000001 112.881 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -84.47 -25.79 28.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.215 1.007 . . . . 3.8500000000000001 108.547 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.471 ' O ' HG22 ' C' ' 39' ' ' VAL . 1.5 p90 -82.71 -62.16 1.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.255 -1.793 . . . . 3.3700000000000001 112.988 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' C' ' 33' ' ' PRO . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.7200000000000002 112.679 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.6699999999999999 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 1.9299999999999999 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 35' ' ' TYR . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 1.8799999999999999 113.15 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.23 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.0899999999999999 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 1.4099999999999999 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 0.80000000000000004 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.71999999999999997 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 1.6799999999999999 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 1.6799999999999999 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.28 111.69 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.51000000000000001 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.473 HD22 ' SG ' ' A' ' 134' ' ' CYS . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.3300000000000001 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.56999999999999995 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 1.6699999999999999 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.4199999999999999 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 0.70999999999999996 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.1399999999999999 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 0.88 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.3799999999999999 110.81 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.9399999999999999 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.8700000000000001 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 2.8599999999999999 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 1.95 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.1099999999999999 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.54 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.4700000000000002 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 2.8500000000000001 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.8700000000000001 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.1200000000000001 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.591 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.26 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.0800000000000001 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 0.85999999999999999 112.121 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 1.96 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 1.8 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.438 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.1799999999999999 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.438 ' N ' HG23 ' C' ' 74' ' ' ILE . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.3300000000000001 109.38 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 1.8500000000000001 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.5600000000000001 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.481 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.1100000000000001 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.49 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 1.6000000000000001 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.01 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.436 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.1799999999999999 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 1.54 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' C' ' 109' ' ' GLN . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 1.6499999999999999 110.767 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.1000000000000001 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.3799999999999999 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.637 HD22 HD11 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 1.4399999999999999 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.8700000000000001 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 3.1000000000000001 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 1.48 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.02 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.3399999999999999 110.907 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 4.54 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.3399999999999999 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.4000000000000004 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.54 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 5.21 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.3799999999999999 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 2.6400000000000001 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.3799999999999999 110.697 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.6200000000000001 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 2.9300000000000002 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.1600000000000001 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.2999999999999998 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.0699999999999998 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.512 ' HB ' HG21 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.2999999999999998 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 85.6 mm-40 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.586 HG22 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 1.9299999999999999 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 1.6699999999999999 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.1100000000000001 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 2.5899999999999999 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 0.90000000000000002 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.92000000000000004 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.55000000000000004 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 1.49 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.433 HG12 HD12 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 1.6599999999999999 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.93999999999999995 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.29 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.1499999999999999 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.91 -30.27 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.3100000000000001 111.038 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' C' ' 127' ' ' VAL . 96.3 mtt180 -109.7 141.58 42.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 3.1600000000000001 110.702 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.22 -10.8 59.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.302 -0.408 . . . . 4.2400000000000002 110.744 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -87.61 -35.53 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 4.6500000000000004 110.674 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -81.17 -23.71 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.531 . . . . 1.3100000000000001 110.869 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 2.8399999999999999 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 2.7000000000000002 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.8799999999999999 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.3799999999999999 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.76 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.1499999999999999 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 1.5600000000000001 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.72999999999999998 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 1.48 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.01 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.0499999999999998 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.0699999999999998 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 141' ' ' ILE . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 1.9199999999999999 111.568 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.6400000000000001 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.51 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 3.5800000000000001 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.6499999999999999 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.46 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.27 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 8.0 t30 -53.84 -48.81 92.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.3300000000000001 112.02 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 73.8 Cg_exo -51.22 -39.5 61.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.284 1.99 . . . . 2.46 112.733 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.98 54.51 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 3.0800000000000001 110.937 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -163.66 -70.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 8.4499999999999993 110.937 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.81 -40.16 20.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 2.8999999999999999 111.384 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' C' ' 149' ' ' PRO . 67.9 mttm -75.43 -8.66 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 4.6200000000000001 110.985 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 39.9 p -105.72 -28.26 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 3.8500000000000001 111.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.96 -18.46 63.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.358 -0.383 . . . . 5.1200000000000001 110.793 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 43.2 p -100.48 -21.52 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 3.4300000000000002 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.06 -70.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 3.98 110.937 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 36.5 t -146.43 115.82 7.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 2.3999999999999999 110.842 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m -77.1 -28.88 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.47 . . . . 2.8199999999999998 111.101 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.1800000000000002 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.5 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 162' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 1.8100000000000001 111.193 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.1299999999999999 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.437 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.3100000000000001 110.969 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.2599999999999998 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.5800000000000001 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.637 HD11 HD22 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.3 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 165' ' ' TYR . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 1.73 111.336 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 1.4299999999999999 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.7200000000000002 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 1.55 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 1.5 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 1.8400000000000001 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.43 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.1200000000000001 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.457 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 1.75 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.473 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.71999999999999997 113.143 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.591 ' O ' HG22 ' C' ' 182' ' ' VAL . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 1.8 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 0.88 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.447 HG22 ' O ' ' C' ' 178' ' ' GLY . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 1.52 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.2 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.4700000000000002 111.966 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.43 HG22 ' O ' ' C' ' 181' ' ' ILE . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 1.6200000000000001 112.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.457 HG12 ' O ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 2.6299999999999999 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.78 43.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.77 112.639 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 95.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.651 2.234 . . . . 3.0299999999999998 112.35 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 81.1 p 46.79 35.17 2.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.137 -0.483 . . . . 4.2199999999999998 111.038 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.81 -139.34 2.98 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.587 -0.816 . . . . 4.0800000000000001 112.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 190' ' ' PHE . . . . . 0.413 ' H ' HG12 ' C' ' 193' ' ' ILE . 78.3 t80 -78.98 -69.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 7.54 111.319 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.45 124.23 0.89 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.969 -0.634 . . . . 3.29 112.328 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 56.45 23.38 7.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 5.6699999999999999 110.7 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.539 HG21 HG21 ' C' ' 197' ' ' ILE . 2.0 pp -90.94 167.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 2.7599999999999998 111.097 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -107.9 -166.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 3.6899999999999999 111.178 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -59.44 -30.14 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 5.3399999999999999 111.407 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 97.2 m -58.34 -65.54 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 2.5699999999999998 111.473 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.558 ' H ' HD12 ' C' ' 197' ' ' ILE . 3.7 mp -65.51 -25.47 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 2.3700000000000001 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.6800000000000002 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 1.95 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 200' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.0499999999999998 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.9099999999999999 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.04 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 1.6200000000000001 110.407 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.49 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.3200000000000001 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76000000000000001 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 208' ' ' PHE . . . . . 0.429 ' HA ' HG22 ' C' ' 211' ' ' VAL . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 1.8400000000000001 110.148 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.43 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.6799999999999999 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.04 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.457 HG23 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 2.6499999999999999 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.457 ' N ' HG23 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.3300000000000001 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.02 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.3500000000000001 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 3.6200000000000001 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 1.6399999999999999 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2000000000000002 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.1099999999999999 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 3.3700000000000001 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.58 -18.09 65.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.1099999999999999 111.247 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -69.28 99.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 5.7300000000000004 111.13 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -126.42 179.13 5.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 5.5300000000000002 110.813 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.18 -60.83 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 6.5999999999999996 110.929 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -143.33 131.19 21.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 6.5099999999999998 110.96 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.63 108.31 20.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 7.0499999999999998 110.704 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -104.71 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 6.7199999999999998 110.906 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -142.24 31.94 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 9.5600000000000005 110.79 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.377 -0.821 . . . . 9.0800000000000001 110.842 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.717 H171 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.736 H171 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.745 ' H8 ' H161 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.611 0.243 . . . . 8.0899999999999999 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.4 t30 62.39 106.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.134 -0.485 . . . . 5.6799999999999997 111.322 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.2 146.55 23.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 6.2699999999999996 110.839 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -100.43 165.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.505 . . . . 6.5199999999999996 111.0 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -167.19 168.63 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 3.5899999999999999 110.651 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -133.28 11.84 4.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.357 -0.383 . . . . 3.23 111.011 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 7' ' ' LEU . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.8799999999999999 110.778 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 24.1 m80 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.29 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 0.98999999999999999 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 1.9199999999999999 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 1.45 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.89000000000000001 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 0.90000000000000002 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.82999999999999996 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.24 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.29 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 1.71 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.95999999999999996 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 0.98999999999999999 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.1099999999999999 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.23 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 -70.07 -31.07 68.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.0199999999999996 111.07 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -81.1 -31.67 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 3.96 110.94 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m -62.45 -42.05 99.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 2.3799999999999999 110.724 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.2 -1.09 57.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.397 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -58.86 -20.82 54.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.513 -0.312 . . . . 2.52 111.173 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -49.86 -31.34 11.82 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.29 0.567 . . . . 5.54 109.639 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -176.13 132.12 0.4 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.071 -0.968 . . . . 4.4400000000000004 109.713 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.1 Cg_endo -92.5 122.96 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.652 2.234 . . . . 2.8100000000000001 112.316 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -108.35 101.68 10.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 6.7999999999999998 111.223 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 223' ' ' ASN . . . 82.98 -44.85 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 4.9699999999999998 112.763 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 32' ' ' VAL . 27.7 m -99.19 112.98 64.33 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.987 0.422 . . . . 4.71 111.425 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 7.1 Cg_exo -78.53 167.61 22.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.306 2.671 . . . . 3.5099999999999998 112.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 -42.69 -42.24 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.012 0.375 . . . . 3.4100000000000001 112.012 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 2.8100000000000001 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.3900000000000001 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.2400000000000002 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 1.6000000000000001 110.929 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.3300000000000001 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.03 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 1.3100000000000001 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.0 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.58999999999999997 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 1.6299999999999999 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.1200000000000001 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.3200000000000001 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.52000000000000002 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 0.97999999999999998 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.52000000000000002 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 1.6899999999999999 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.1200000000000001 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HE1' ' B' ' 131' ' ' TRP . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 0.59999999999999998 110.868 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 0.93999999999999995 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.78000000000000003 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 56' ' ' ILE . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.23 110.698 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.1000000000000001 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 1.76 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.8400000000000001 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.6400000000000001 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 1.8400000000000001 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.2400000000000002 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.1600000000000001 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 2.8399999999999999 110.996 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.3900000000000001 111.123 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.96999999999999997 111.128 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.04 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.3799999999999999 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 0.76000000000000001 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 2.9300000000000002 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.1299999999999999 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 1.6599999999999999 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.4199999999999999 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.43 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.0899999999999999 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.52 111.007 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.3300000000000001 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.3899999999999999 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 1.55 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.01 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 1.45 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.3 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.49 HD22 ' NE2' ' A' ' 109' ' ' GLN . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 1.6699999999999999 110.222 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 1.8700000000000001 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.4199999999999999 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.3999999999999999 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 1.9099999999999999 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 2.3300000000000001 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 1.4299999999999999 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.1899999999999999 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 2.5499999999999998 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.3300000000000001 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 5.0999999999999996 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.0699999999999998 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.4100000000000001 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.3099999999999996 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.9399999999999999 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 5.9800000000000004 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.2400000000000002 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 2.6699999999999999 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 2.5899999999999999 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.53 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 3.1400000000000001 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.99 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . 0.513 ' HA ' HE21 ' A' ' 109' ' ' GLN . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.3599999999999999 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.0499999999999998 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.25 111.828 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.513 HE21 ' HA ' ' A' ' 106' ' ' MET . 29.2 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 2.7200000000000002 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 1.8799999999999999 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.6000000000000001 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.0900000000000001 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 2.6499999999999999 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.89000000000000001 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 0.68000000000000005 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 1.5800000000000001 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.04 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.1000000000000001 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.8799999999999999 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.29 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.4900000000000002 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' HG12 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.1299999999999999 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 3.9700000000000002 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.22 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 2.8100000000000001 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.25 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' VAL . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 1.8400000000000001 110.598 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.558 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 184' ' ' ILE . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.79 110.701 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.0800000000000001 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 1.76 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.76000000000000001 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.0699999999999998 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.426 ' HA ' HD12 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 1.8500000000000001 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.3200000000000001 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 3.25 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 2.9199999999999999 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 2.6499999999999999 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 141' ' ' ILE . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.21 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.0099999999999998 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 3.6000000000000001 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.6200000000000001 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 2.4700000000000002 111.371 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 52.1 t30 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 2.6899999999999999 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo -59.04 -1.18 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.3599999999999999 113.327 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 96.1 mt -58.99 89.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.664 0.268 . . . . 3.2999999999999998 111.164 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 151' ' ' ARG . 3.5 mmp_? 52.14 43.96 30.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.236 -0.438 . . . . 8.4800000000000004 111.143 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.67 -46.6 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 2.98 111.427 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.26 -33.0 72.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 4.5499999999999998 111.109 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.3 t -93.8 6.31 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 4.0 111.046 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -63.87 -20.56 65.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 5.5099999999999998 110.968 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.4 p -99.92 -10.85 21.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 3.2000000000000002 111.302 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -87.32 -51.93 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 3.98 110.93 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m -141.31 114.2 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 2.6299999999999999 111.033 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.1600000000000001 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.3700000000000001 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.8300000000000001 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.7 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 48.2 m-80 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.1600000000000001 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 1.5900000000000001 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.497 ' N ' HD12 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.3100000000000001 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.1499999999999999 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.3900000000000001 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.4199999999999999 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.1200000000000001 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 3.8599999999999999 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 1.5800000000000001 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 1.4099999999999999 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 1.4199999999999999 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 1.9099999999999999 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.55 111.538 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.8600000000000001 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.73999999999999999 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.596 ' O ' HG22 ' A' ' 182' ' ' VAL . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 1.78 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 0.92000000000000004 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 1.77 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.3400000000000001 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.5099999999999998 112.76 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 132' ' ' TYR . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.02 112.148 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.609 HG13 ' HD2' ' A' ' 187' ' ' PRO . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.4500000000000002 112.468 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . 134.35 -55.35 0.74 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 1.73 113.18 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.609 ' HD2' HG13 ' A' ' 185' ' ' ILE . 56.1 Cg_exo -32.83 146.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.496 2.798 . . . . 3.0499999999999998 112.983 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.6 t 63.97 12.01 6.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.719 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.89 -88.62 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.494 -0.775 . . . . 4.4800000000000004 112.187 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -158.71 85.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 7.96 110.818 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -143.76 -73.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.855 -0.688 . . . . 3.23 112.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -145.35 -46.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 6.0300000000000002 110.634 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.15 148.29 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 3.1800000000000002 110.632 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -162.05 16.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.605 0.241 . . . . 3.3900000000000001 111.493 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.79 -165.57 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.579 -0.282 . . . . 5.7599999999999998 111.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.7 t -59.53 -15.27 17.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 2.5 111.074 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.3 mm -58.65 -34.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 2.3999999999999999 111.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.5 -52.45 46.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 2.6600000000000001 110.764 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 1.8100000000000001 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.21 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.1800000000000002 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.0099999999999998 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 1.9299999999999999 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 1.7 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.28 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79000000000000004 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 1.9299999999999999 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 1.71 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.04 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 212' ' ' GLY . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 2.8900000000000001 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 211' ' ' VAL . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.3100000000000001 112.196 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 2.8700000000000001 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.3799999999999999 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 3.4199999999999999 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.24 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.4399999999999999 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.5099999999999998 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.0099999999999998 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.5900000000000001 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 3.4900000000000002 111.135 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 52.3 85.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 5.7400000000000002 111.226 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ASN . . . . . 0.421 HD21 ' H ' ' A' ' 31' ' ' GLY . 3.7 m-20 -64.18 162.19 14.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 5.46 111.094 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.73 -20.67 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 6.1299999999999999 110.868 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -161.32 150.95 16.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 6.46 110.885 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -157.96 -76.81 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 6.9400000000000004 110.995 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t 54.92 82.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 6.8300000000000001 110.893 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -82.32 -66.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 10.77 110.813 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 82.7 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.152 -0.928 . . . . 9.4100000000000001 110.933 -179.849 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.787 0.327 . . . . 8.9100000000000001 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -123.39 115.12 21.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 6.7599999999999998 110.973 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.426 HD12 ' N ' ' B' ' 3' ' ' LEU . 7.0 mp -115.44 -59.86 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 6.25 110.73 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -168.07 120.74 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 5.4400000000000004 110.87 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.446 ' C ' ' H ' ' B' ' 7' ' ' LEU . 50.3 m -91.01 -52.69 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 3.8399999999999999 111.011 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 10' ' ' ILE . 29.0 tp 72.73 -30.35 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.843 -0.617 . . . . 3.0800000000000001 111.698 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' B' ' 5' ' ' SER . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.3500000000000001 110.95 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 1.3899999999999999 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1000000000000001 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 6' ' ' LEU . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 1.71 110.315 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 1.48 110.688 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.94999999999999996 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.96999999999999997 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.80000000000000004 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.472 ' HG3' ' HA2' ' B' ' 48' ' ' GLY . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.29 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.3600000000000001 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.97999999999999998 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.1200000000000001 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.814 ' O ' ' OG ' ' B' ' 26' ' ' SER . 0.2 OUTLIER -71.9 -34.13 68.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 4.2599999999999998 110.464 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -70.04 -36.11 74.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 3.6200000000000001 111.033 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -85.62 -38.06 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.622 0.601 . . . . 2.5499999999999998 112.622 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 tp -85.09 -0.67 55.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.147 0.425 . . . . 3.1099999999999999 112.147 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.814 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 19.0 m -61.38 -28.89 69.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.713 -0.795 . . . . 3.02 111.07 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -44.56 -23.91 0.15 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.84 0.829 . . . . 5.8899999999999997 109.829 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.914 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 1.2 m-20 -66.31 -154.03 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 114.094 -1.412 . . . . 5.0199999999999996 108.955 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.914 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 58.6 Cg_exo -2.05 115.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 124.394 3.396 . . . . 3.5299999999999998 117.174 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 42.5 35.29 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.605 -1.18 . . . . 7.8799999999999999 112.076 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 74.97 -50.6 2.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.623 -0.591 . . . . 4.6100000000000003 111.623 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 32' ' ' VAL . 3.0 p -143.08 107.27 5.29 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.925 0.362 . . . . 4.7300000000000004 111.186 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 93.3 Cg_endo -84.5 116.17 1.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 120.969 1.113 . . . . 3.75 112.125 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -84.37 -25.44 29.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.067 0.937 . . . . 3.7599999999999998 109.941 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER -83.25 -65.79 0.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.829 -1.532 . . . . 3.1699999999999999 114.514 -176.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.557 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.5699999999999998 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.7400000000000002 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 1.72 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 1.95 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.2 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.1200000000000001 110.159 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 1.49 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.436 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 0.77000000000000002 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.68000000000000005 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 1.6299999999999999 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 1.9099999999999999 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.22 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . 0.472 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.55000000000000004 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.421 HD22 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.87 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.55000000000000004 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.0600000000000001 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.1899999999999999 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 0.66000000000000003 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.85999999999999999 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 0.83999999999999997 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.497 HG21 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 1.4399999999999999 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.2400000000000002 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.3100000000000001 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 1.8100000000000001 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.1800000000000002 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.0299999999999998 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.48 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.3700000000000001 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.2799999999999998 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.78 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.05 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.623 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.1100000000000001 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.2999999999999998 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.475 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.71999999999999997 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.04 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.463 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 1.79 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.475 HG22 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 1.4399999999999999 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.3100000000000001 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.463 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.0099999999999998 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.512 ' HE2' HD11 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.4299999999999999 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.466 ' O ' HD23 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.21 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.429 HG23 HG23 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.1799999999999999 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.562 HG21 HD11 ' B' ' 113' ' ' ILE . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 1.6499999999999999 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.0600000000000001 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 1.5800000000000001 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.49 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 84' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 1.72 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 1.96 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.24 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.438 HD23 ' HE1' ' B' ' 213' ' ' PHE . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.21 110.276 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.3200000000000001 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' TRP . . . . . 0.689 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.1499999999999999 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 1.4399999999999999 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 2.6800000000000002 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 2.71 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 4.1900000000000004 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 2.79 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.2699999999999996 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.5700000000000003 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.2400000000000002 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 5.3899999999999997 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.1600000000000001 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 2.5800000000000001 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.29 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.48 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.437 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 2.7599999999999998 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.497 HD13 HD12 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.2200000000000002 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' MET . . . . . 0.436 ' N ' HD12 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.3599999999999999 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 1.9199999999999999 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.0600000000000001 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.634 HE22 ' HE1' ' B' ' 176' ' ' TRP . 8.1 tp-100 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 2.8700000000000001 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 1.98 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.6200000000000001 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.04 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.562 HD11 HG21 ' B' ' 80' ' ' THR . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.46 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 0.82999999999999996 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.73999999999999999 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.59999999999999998 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 77' ' ' MET . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.4199999999999999 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 1.51 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.0900000000000001 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.1599999999999999 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 1.76 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.8900000000000001 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 2.6699999999999999 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.0700000000000003 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 1.4099999999999999 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 2.4700000000000002 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 2.6099999999999999 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.0699999999999998 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.402 ' HE1' ' HB1' ' A' ' 53' ' ' ALA . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.695 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 1.75 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 1.6699999999999999 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.69999999999999996 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 1.4399999999999999 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 1.8200000000000001 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.93999999999999995 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 1.6000000000000001 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.0099999999999998 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 1.96 111.739 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 2.8799999999999999 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 4.1500000000000004 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.5900000000000001 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.1299999999999999 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 1.78 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.4500000000000002 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo -62.61 0.46 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.3599999999999999 113.303 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.487 HD22 HG21 ' B' ' 169' ' ' VAL . 94.5 mt -58.87 92.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 2.8799999999999999 111.049 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 52.63 46.28 27.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 8.0700000000000003 111.071 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.42 -51.15 12.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 2.7999999999999998 111.215 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -72.78 -29.69 63.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 4.5800000000000001 110.781 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 71.6 p -90.65 4.98 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 3.8100000000000001 110.991 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -64.91 -36.34 84.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 5.2199999999999998 110.696 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 17.52 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 3.4199999999999999 110.923 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -108.99 -69.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 4.2000000000000002 110.674 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.2 t -130.35 114.55 15.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.75 110.813 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p -73.1 -30.85 63.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 2.3999999999999999 110.979 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 2.5699999999999998 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 1.72 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 2.6899999999999999 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.1600000000000001 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.1299999999999999 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.9399999999999999 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.3300000000000001 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 1.5600000000000001 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.487 HG21 HD22 ' B' ' 150' ' ' LEU . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.5900000000000001 111.142 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.1399999999999999 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 3.8700000000000001 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 1.6100000000000001 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.453 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.3 111.442 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 1.53 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 1.99 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' TRP . . . . . 0.634 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.5 110.761 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.453 HG22 ' O ' ' B' ' 173' ' ' THR . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 1.46 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.497 ' O ' HG22 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67000000000000004 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.707 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 1.73 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 0.93000000000000005 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 1.3600000000000001 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.1899999999999999 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.536 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 2.73 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 1.9299999999999999 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.426 HG23 ' O ' ' B' ' 181' ' ' ILE . 26.8 pt -61.31 -26.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 2.6400000000000001 111.279 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . -166.54 -171.56 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.684 -0.77 . . . . 1.9299999999999999 112.537 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.81 83.74 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.517 2.144 . . . . 2.9700000000000002 112.186 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 55.0 m 55.84 57.39 5.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 4.5 110.969 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 189' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' B' ' 193' ' ' ILE . . . 158.12 -164.34 33.28 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.585 -0.816 . . . . 4.5 112.735 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 190' ' ' PHE . . . . . 0.657 ' H ' HD11 ' B' ' 193' ' ' ILE . 86.9 m-85 -52.31 -60.71 2.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.68 0.276 . . . . 7.8899999999999997 111.402 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 191' ' ' GLY . . . . . 0.431 ' H ' HG12 ' B' ' 193' ' ' ILE . . . 167.16 135.19 1.82 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.657 -0.782 . . . . 3.6200000000000001 112.406 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 96.0 m95 58.08 22.79 9.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 6.54 111.202 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.657 HD11 ' H ' ' B' ' 190' ' ' PHE . 30.2 pt -115.71 144.77 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 3.1600000000000001 111.322 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -138.62 -139.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 3.3900000000000001 110.642 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 63.96 -163.23 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.537 -0.301 . . . . 5.5599999999999996 111.184 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 6.2 t -63.73 -15.52 58.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 2.6800000000000002 111.61 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.502 HD12 ' H ' ' B' ' 197' ' ' ILE . 3.0 mp -57.92 -29.53 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 2.2000000000000002 111.386 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.4900000000000002 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.1800000000000002 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.78 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 1.98 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.461 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 1.6499999999999999 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.1100000000000001 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 1.4299999999999999 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77000000000000002 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.6000000000000001 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 1.77 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.54 110.874 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.0099999999999998 111.022 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 2.6499999999999999 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.3300000000000001 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 213' ' ' PHE . . . . . 0.438 ' HE1' HD23 ' B' ' 87' ' ' LEU . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 2.29 110.796 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.1200000000000001 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 3.6000000000000001 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 1.51 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.2200000000000002 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.435 HD13 ' ND2' ' B' ' 28' ' ' ASN . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.6899999999999999 111.369 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 3.3999999999999999 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.6699999999999999 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.79 -58.61 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.3900000000000001 111.085 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 57.02 88.51 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.259 -0.428 . . . . 5.9100000000000001 111.005 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -61.16 139.05 58.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 5.2599999999999998 111.099 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.45 20.8 2.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 6.8099999999999996 110.742 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -128.58 -74.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.959 -0.564 . . . . 7.0199999999999996 110.806 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 56.12 93.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.004 0.43 . . . . 8.2100000000000009 111.144 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -149.11 76.47 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.559 . . . . 8.0999999999999996 110.771 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -62.71 174.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 13.279999999999999 111.158 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.172 -0.918 . . . . 10.4 110.99 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.747 0.308 . . . . 8.0999999999999996 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -106.54 159.0 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 6.2699999999999996 111.017 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 66.6 tp -131.8 129.89 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 6.2000000000000002 110.925 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.78 136.15 33.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 4.8200000000000003 111.023 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.437 ' HB2' HD23 ' C' ' 7' ' ' LEU . 81.2 p -141.81 139.83 32.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 3.25 110.831 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.25 9.63 33.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.433 . . . . 2.79 111.087 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.535 ' H ' HD22 ' C' ' 7' ' ' LEU . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.0800000000000001 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 1.4299999999999999 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.1599999999999999 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.0899999999999999 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 1.5800000000000001 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.0 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.95999999999999996 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.3 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 1.52 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 1.8999999999999999 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' GLY . . . . . 0.476 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 0.95999999999999996 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.0700000000000001 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.0800000000000001 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -58.02 -19.34 30.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.02 111.372 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -62.25 -30.76 71.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.658 0.266 . . . . 4.9800000000000004 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -89.96 -35.2 15.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.404 -0.362 . . . . 4.29 110.906 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 47.7 m -62.21 -47.06 86.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 2.4700000000000002 110.943 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 28.4 tp -87.6 -1.26 57.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 2.8999999999999999 111.1 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -56.52 -24.11 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 2.7400000000000002 111.537 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.65 -36.03 10.35 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.22 0.533 . . . . 5.8499999999999996 109.777 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 2.5 p-10 -170.92 131.9 0.86 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 4.5199999999999996 109.969 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 51.1 Cg_endo -94.52 142.53 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.833 2.356 . . . . 3.2200000000000002 112.472 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 30' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' C' ' 218' ' ' LEU . 95.8 mtt180 -91.31 64.1 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 8.6799999999999997 111.081 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.5 -40.06 2.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.815 -0.707 . . . . 4.1399999999999997 112.971 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.52 HG23 ' O ' ' C' ' 32' ' ' VAL . 27.7 m -79.5 113.14 34.51 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 121.005 0.431 . . . . 5.0899999999999999 111.364 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' C' ' 32' ' ' VAL . 6.5 Cg_exo -78.76 167.75 21.95 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.406 2.737 . . . . 3.1000000000000001 112.614 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -41.84 -43.54 3.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.216 -0.447 . . . . 3.8500000000000001 112.123 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -56.62 -40.09 74.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.3700000000000001 111.055 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.7200000000000002 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.6699999999999999 110.533 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 1.9299999999999999 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 1.8799999999999999 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.23 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.0899999999999999 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 1.4099999999999999 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 0.80000000000000004 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.71999999999999997 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 1.6799999999999999 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 1.6799999999999999 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.51000000000000001 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.3300000000000001 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.56999999999999995 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 1.6699999999999999 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.4199999999999999 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 0.70999999999999996 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.1399999999999999 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.88 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.451 HG22 ' O ' ' C' ' 56' ' ' ILE . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.3799999999999999 110.507 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.9399999999999999 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 1.8700000000000001 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 2.8599999999999999 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 1.95 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.1099999999999999 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.54 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.4700000000000002 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 2.8500000000000001 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 1.8700000000000001 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.1200000000000001 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.26 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.517 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.0800000000000001 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.85999999999999999 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 1.96 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 1.8 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.1799999999999999 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.3300000000000001 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 1.8500000000000001 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.426 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.5600000000000001 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.1100000000000001 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.49 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.523 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 1.6000000000000001 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.01 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.1799999999999999 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 1.54 109.449 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 1.6499999999999999 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.429 HD23 ' O ' ' C' ' 81' ' ' PRO . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.1000000000000001 111.019 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.3799999999999999 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 1.4399999999999999 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 1.8700000000000001 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 3.1000000000000001 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 1.48 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.02 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.3399999999999999 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.21 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 4.54 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.3399999999999999 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.4000000000000004 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.54 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 5.21 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.3799999999999999 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 2.6400000000000001 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.3799999999999999 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.6200000000000001 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 2.9300000000000002 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD11 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.1600000000000001 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.2999999999999998 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.0699999999999998 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.2999999999999998 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.48 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 1.9299999999999999 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 1.6699999999999999 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.1100000000000001 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 2.5899999999999999 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 0.90000000000000002 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.92000000000000004 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.55000000000000004 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 1.49 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 1.6599999999999999 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.93999999999999995 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.624 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.29 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.1499999999999999 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.93 -19.13 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.3100000000000001 110.758 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.466 ' HB2' HG12 ' C' ' 127' ' ' VAL . 59.9 mtm180 -132.08 149.6 52.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 3.1600000000000001 110.639 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.72 -9.73 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 4.2400000000000002 110.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -91.09 -28.82 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 4.6500000000000004 111.001 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -84.76 -25.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 1.3100000000000001 111.107 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 2.8399999999999999 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 129' ' ' TYR . . . . . 0.431 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 2.7000000000000002 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 1.8799999999999999 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.3799999999999999 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.76 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' ILE . . . . . 0.431 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.1499999999999999 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' CYS . . . . . 0.421 ' SG ' HD22 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.5600000000000001 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.72999999999999998 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 1.48 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.51 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.01 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.0499999999999998 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.0699999999999998 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.9199999999999999 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.406 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 2.6400000000000001 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.51 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 3.5800000000000001 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.6499999999999999 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.46 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.27 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -92.12 -49.74 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.3300000000000001 112.426 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 32.5 Cg_exo -59.48 0.42 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.379 2.053 . . . . 2.46 113.5 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 150' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 146' ' ' ILE . 97.7 mt -57.21 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.683 0.278 . . . . 3.0800000000000001 111.375 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 44.55 36.96 1.89 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.092 -0.504 . . . . 8.4499999999999993 111.687 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.27 56.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 2.8999999999999999 110.934 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.01 -43.1 18.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 4.6200000000000001 110.746 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -88.13 6.83 34.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 3.8500000000000001 111.089 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.37 -30.6 69.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 5.1200000000000001 110.95 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -84.73 -11.06 56.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 3.4300000000000002 111.18 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -91.82 -25.58 18.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 3.98 110.642 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.4 t -165.29 113.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 2.3999999999999999 110.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -77.59 -38.17 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 2.8199999999999998 110.73 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 160' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.1800000000000002 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.5 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.8100000000000001 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.1299999999999999 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 164' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.21 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.3100000000000001 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.2599999999999998 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.5800000000000001 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 1.73 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 1.4299999999999999 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.7200000000000002 110.5 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.434 ' O ' HG22 ' C' ' 177' ' ' ILE . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 1.5 111.506 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 1.8400000000000001 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.1200000000000001 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 176' ' ' TRP . . . . . 0.503 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.529 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.71999999999999997 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 1.8 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 0.88 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 1.52 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.2 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.4700000000000002 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 1.6200000000000001 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' C' ' 190' ' ' PHE . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 2.6299999999999999 111.77 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.38 161.35 28.72 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.77 112.781 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 95.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.673 2.249 . . . . 3.0299999999999998 112.382 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 41.9 t 57.56 63.03 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.977 -0.556 . . . . 4.2199999999999998 111.247 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.57 -173.34 21.21 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.632 -0.795 . . . . 4.0800000000000001 112.952 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 190' ' ' PHE . . . . . 0.576 ' H ' HD11 ' C' ' 193' ' ' ILE . 86.0 m-85 -74.01 96.58 2.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.693 0.282 . . . . 7.54 111.196 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 77.51 -158.6 47.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 3.29 113.052 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -72.73 79.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 5.6699999999999999 111.377 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.576 HD11 ' H ' ' C' ' 190' ' ' PHE . 46.3 pt -142.6 141.85 27.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.385 -0.37 . . . . 2.7599999999999998 111.12 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -142.95 88.09 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 3.6899999999999999 110.714 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.32 -172.01 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 5.3399999999999999 111.146 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -74.49 -21.48 59.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 2.5699999999999998 111.435 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -56.46 -24.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 2.3700000000000001 111.187 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.6800000000000002 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.95 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.0499999999999998 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 1.9099999999999999 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.04 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.484 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 1.6200000000000001 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.49 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.3200000000000001 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76000000000000001 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' C' ' 211' ' ' VAL . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 1.8400000000000001 110.808 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.6799999999999999 110.656 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.04 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 208' ' ' PHE . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 2.6499999999999999 110.793 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.3300000000000001 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.02 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.3500000000000001 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 3.6200000000000001 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 1.6399999999999999 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2000000000000002 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.432 ' HB3' HH11 ' C' ' 30' ' ' ARG . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.1099999999999999 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 3.3700000000000001 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.85 -58.96 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.1099999999999999 111.256 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 57.45 93.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.189 -0.46 . . . . 5.7300000000000004 111.048 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -64.59 148.49 50.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 5.5300000000000002 111.13 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.65 -32.99 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.101 -0.5 . . . . 6.5999999999999996 110.903 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -134.7 120.33 19.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 6.5099999999999998 110.879 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.83 105.32 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 7.0499999999999998 110.909 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -142.26 85.51 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 6.7199999999999998 110.925 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -94.57 -71.15 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 9.5600000000000005 110.956 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.166 -0.921 . . . . 9.0800000000000001 110.819 -179.856 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.768 H161 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.73 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.723 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.932 0.396 . . . . 8.0899999999999999 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -158.58 -72.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 5.6799999999999997 110.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.5 mt 60.42 104.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.003 -0.544 . . . . 6.2699999999999996 111.37 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.97 -37.48 81.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 6.5199999999999996 110.894 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 t -99.98 137.54 38.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 3.5899999999999999 110.842 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 70.2 mt -135.67 123.29 22.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 3.23 111.183 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HD1' ' A' ' 200' ' ' PHE . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 1.8799999999999999 111.135 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.29 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 0.98999999999999999 110.262 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 1.9199999999999999 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 1.45 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 0.89000000000000001 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 0.90000000000000002 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.82999999999999996 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.24 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.29 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 1.71 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.95999999999999996 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 0.98999999999999999 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.1099999999999999 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.23 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.687 ' O ' ' OG ' ' A' ' 26' ' ' SER . 22.1 t80 -76.17 -28.4 57.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.0199999999999996 110.696 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -60.66 -33.24 72.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 3.96 110.626 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.9 m -85.7 -29.01 24.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.089 -0.505 . . . . 2.3799999999999999 111.154 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -86.89 -9.47 55.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 2.77 111.105 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.687 ' OG ' ' O ' ' A' ' 22' ' ' PHE . 2.9 m -67.82 -23.23 65.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 2.52 110.588 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -48.5 -32.71 8.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.213 0.53 . . . . 5.54 109.98 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 6.7 p30 -173.0 131.72 0.61 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.384 -0.825 . . . . 4.4400000000000004 110.355 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 55.2 Cg_endo -96.18 -178.75 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.051 2.501 . . . . 2.8100000000000001 112.197 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -105.34 67.12 0.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.924 0.393 . . . . 6.7999999999999998 111.068 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.87 -38.94 2.54 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.952 -0.642 . . . . 4.9699999999999998 112.716 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.94 127.36 69.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.6 0.2 . . . . 4.71 111.167 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' HE1' ' A' ' 35' ' ' TYR . 39.4 Cg_exo -59.38 165.54 9.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.637 2.224 . . . . 3.5099999999999998 112.578 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.56 -19.86 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.287 -0.87 . . . . 3.4100000000000001 112.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 33' ' ' PRO . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 2.8100000000000001 111.998 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.3900000000000001 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.2400000000000002 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 1.6000000000000001 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.3300000000000001 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.03 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 1.3100000000000001 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.442 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.58999999999999997 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 1.6299999999999999 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.3200000000000001 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.52000000000000002 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.97999999999999998 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.52000000000000002 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 1.6899999999999999 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG2' HG11 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.1200000000000001 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 0.59999999999999998 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.93999999999999995 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 0.78000000000000003 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' O ' HG22 ' A' ' 56' ' ' ILE . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.23 110.745 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.1000000000000001 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 1.76 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 1.8400000000000001 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.6400000000000001 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 1.8400000000000001 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.2400000000000002 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.1600000000000001 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 2.8399999999999999 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.3900000000000001 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.96999999999999997 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.04 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.3799999999999999 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.76000000000000001 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 2.9300000000000002 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.1299999999999999 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 1.6599999999999999 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 79' ' ' THR . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.4199999999999999 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.0899999999999999 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.3300000000000001 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.3899999999999999 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 1.55 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.01 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 1.45 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.3 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 1.6699999999999999 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 1.8700000000000001 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.4199999999999999 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 1.9099999999999999 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 2.3300000000000001 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.4299999999999999 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.1899999999999999 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 2.5499999999999998 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.3300000000000001 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 5.0999999999999996 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.0699999999999998 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.4100000000000001 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.3099999999999996 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.9399999999999999 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 5.9800000000000004 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.2400000000000002 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 2.6699999999999999 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 2.5899999999999999 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.53 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 3.1400000000000001 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.99 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.3599999999999999 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.0499999999999998 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.501 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 2.7200000000000002 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 1.8799999999999999 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 1.6000000000000001 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.0900000000000001 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.4 HD12 ' SD ' ' A' ' 77' ' ' MET . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 2.6499999999999999 111.098 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.89000000000000001 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.68000000000000005 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 1.5800000000000001 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.04 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.1000000000000001 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.8799999999999999 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 1.53 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.4900000000000002 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.1299999999999999 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 3.9700000000000002 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.22 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 2.8100000000000001 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 1.8400000000000001 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 1.79 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.0800000000000001 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 1.76 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.76000000000000001 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.0699999999999998 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.8500000000000001 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.3200000000000001 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 3.25 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 2.9199999999999999 110.842 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 2.6499999999999999 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.21 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.0099999999999998 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 3.6000000000000001 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.6200000000000001 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 2.4700000000000002 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.474 ' HE1' HG21 ' A' ' 173' ' ' THR . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 2.48 111.568 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.595 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 49.4 t30 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 2.6899999999999999 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo -58.83 -9.43 7.54 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.3599999999999999 112.861 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.74 21.09 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.568 -0.287 . . . . 3.2999999999999998 111.081 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -161.58 -36.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.475 -0.329 . . . . 8.4800000000000004 111.16 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.68 -33.2 25.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 2.98 111.844 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.49 -32.76 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.494 -0.321 . . . . 4.5499999999999998 111.37 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 9.0 t -77.19 2.4 15.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 4.0 111.55 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -58.61 -38.24 77.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.458 -0.337 . . . . 5.5099999999999998 110.962 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 82.2 p -115.41 -6.37 12.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 3.2000000000000002 111.1 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 154' ' ' THR . 95.3 mt-30 -93.61 -165.98 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 3.98 111.009 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -65.49 116.67 7.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 2.6299999999999999 111.047 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.1600000000000001 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.3700000000000001 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 2.8300000000000001 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.1600000000000001 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 1.5900000000000001 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.3100000000000001 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.1499999999999999 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.3900000000000001 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.575 HD11 HD22 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 1.79 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.4199999999999999 111.201 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.1200000000000001 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.8599999999999999 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.5800000000000001 111.501 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.474 HG21 ' HE1' ' A' ' 147' ' ' TRP . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 1.4099999999999999 111.628 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.4199999999999999 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 1.9099999999999999 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.55 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 1.8600000000000001 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.73999999999999999 112.876 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 1.78 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 0.92000000000000004 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 184' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 1.77 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.3400000000000001 111.045 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.412 ' O ' ' HA3' ' A' ' 189' ' ' GLY . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.5099999999999998 111.955 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.02 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.4500000000000002 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.94 -156.64 40.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 1.73 112.854 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 198' ' ' ASP . 27.5 Cg_exo -62.81 154.02 68.89 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.715 2.277 . . . . 3.0499999999999998 111.964 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 57.51 16.69 3.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 4.04 110.517 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 183' ' ' TRP . . . -161.03 35.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.955 -0.64 . . . . 4.4800000000000004 112.576 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 61.6 t80 59.74 91.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 7.96 111.028 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.71 -171.53 23.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.641 . . . . 3.23 112.355 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -128.87 22.37 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 6.0300000000000002 110.539 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 187' ' ' PRO . 10.2 mt -99.14 160.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.874 -0.603 . . . . 3.1800000000000002 110.643 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.413 ' N ' HG22 ' A' ' 193' ' ' ILE . 87.8 m-20 -95.92 179.49 5.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.862 0.363 . . . . 3.3900000000000001 111.281 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -65.62 -22.59 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 5.7599999999999998 111.059 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 47.8 m -53.18 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 2.5 111.421 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 193' ' ' ILE . 49.9 mm -68.16 -31.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.478 -0.328 . . . . 2.3999999999999999 111.321 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.583 ' HB2' ' HG2' ' A' ' 187' ' ' PRO . 25.2 t70 -49.72 -57.86 6.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.334 -0.393 . . . . 2.6600000000000001 110.988 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.8100000000000001 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PHE . . . . . 0.405 ' HD1' HD13 ' A' ' 7' ' ' LEU . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.21 111.345 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.1800000000000002 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.0099999999999998 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 1.9299999999999999 109.97 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 1.7 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.28 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79000000000000004 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 1.51 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 1.9299999999999999 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 1.71 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 2.8900000000000001 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.3100000000000001 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 2.8700000000000001 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.3799999999999999 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 3.4199999999999999 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.24 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.4399999999999999 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.5099999999999998 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.0099999999999998 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.5900000000000001 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp -52.67 -58.76 5.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 3.4900000000000002 111.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.31 80.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 5.7400000000000002 110.865 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -95.0 121.04 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 5.46 111.011 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.94 153.85 40.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 6.1299999999999999 110.576 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -91.96 93.86 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 6.46 111.015 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -172.35 97.0 0.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.117 -0.492 . . . . 6.9400000000000004 110.829 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -149.89 -13.48 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 6.8300000000000001 110.978 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 62.45 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.07 -0.514 . . . . 10.77 110.856 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.171 -0.919 . . . . 9.4100000000000001 110.867 179.836 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 8.9100000000000001 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -158.41 140.05 13.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 6.7599999999999998 111.047 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.81 -177.64 3.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 6.25 110.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.57 90.7 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 5.4400000000000004 110.702 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.6 p -139.54 149.75 44.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 3.8399999999999999 110.707 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.402 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt -113.08 30.73 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 3.0800000000000001 111.023 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.3500000000000001 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 1.3899999999999999 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1000000000000001 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 1.71 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 1.48 110.517 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.94999999999999996 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.96999999999999997 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.80000000000000004 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.29 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.3600000000000001 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.417 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.23 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.417 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 0.97999999999999998 111.168 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.1200000000000001 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -73.09 -40.01 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 4.2599999999999998 110.664 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -55.68 -28.51 55.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 3.6200000000000001 110.42 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 43.5 t -84.83 -29.55 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 2.5499999999999998 111.084 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.25 -19.13 32.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.552 -0.294 . . . . 3.1099999999999999 111.394 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -62.81 -19.28 63.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.903 -0.319 . . . . 3.02 110.645 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 55.5 ttp180 -50.51 -32.9 19.59 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.505 -0.554 . . . . 5.8899999999999997 109.505 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 3.0 p-10 -173.95 132.78 0.56 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.122 -0.945 . . . . 5.0199999999999996 110.01 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.8 Cg_endo -95.16 -179.61 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.001 2.468 . . . . 3.5299999999999998 112.504 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -111.85 64.01 0.62 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.455 . . . . 7.8799999999999999 110.848 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.04 -36.86 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 4.6100000000000003 112.39 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p -89.99 122.14 68.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.536 0.208 . . . . 4.7300000000000004 110.8 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.05 165.2 5.41 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.284 1.99 . . . . 3.75 112.133 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.57 -18.12 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.65 . . . . 3.7599999999999998 112.245 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -51.34 -33.39 29.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.1699999999999999 111.47 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.5699999999999998 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.7400000000000002 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 1.72 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 1.95 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.2 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' MET . . . . . 0.421 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.1200000000000001 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 1.49 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG23 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 0.77000000000000002 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.68000000000000005 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 1.6299999999999999 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 1.9099999999999999 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.485 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.22 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.55000000000000004 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 0.87 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.55000000000000004 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.0600000000000001 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.1899999999999999 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 0.66000000000000003 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.85999999999999999 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 0.83999999999999997 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 1.4399999999999999 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.591 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.2400000000000002 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.3100000000000001 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.8100000000000001 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.1800000000000002 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.0299999999999998 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.48 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.3700000000000001 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.2799999999999998 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.1100000000000001 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.2999999999999998 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.71999999999999997 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.04 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 1.79 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.441 HG23 ' N ' ' B' ' 75' ' ' ASP . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 1.4399999999999999 110.461 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.3100000000000001 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.0099999999999998 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.4299999999999999 110.626 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' B' ' 82' ' ' LEU . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.21 111.844 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.529 HG23 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.1799999999999999 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 1.6499999999999999 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.0600000000000001 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.5800000000000001 111.102 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.45 HD22 H201 ' B' ' 301' ' ' RET . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 1.49 110.712 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 1.72 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.416 ' N ' HD12 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 1.96 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.3200000000000001 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.1499999999999999 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 1.4399999999999999 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 2.6800000000000002 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 2.71 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 4.1900000000000004 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 2.79 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.2699999999999996 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.5700000000000003 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.2400000000000002 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 5.3899999999999997 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.1600000000000001 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 2.5800000000000001 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.29 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.48 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 2.7599999999999998 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.2200000000000002 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.3599999999999999 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 1.9199999999999999 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.489 HG21 HD13 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.0600000000000001 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 2.8700000000000001 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.98 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 1.6200000000000001 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.04 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.46 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.82999999999999996 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.73999999999999999 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.59999999999999998 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.546 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.4199999999999999 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.546 ' N ' HD12 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 1.51 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.0900000000000001 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.1599999999999999 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 1.76 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.8900000000000001 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 2.6699999999999999 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.0700000000000003 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.4099999999999999 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 2.4700000000000002 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 2.6099999999999999 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.0699999999999998 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.3 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.6699999999999999 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 1.4399999999999999 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.8200000000000001 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.93999999999999995 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 1.6000000000000001 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.0099999999999998 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 1.96 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.489 HD13 HG21 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 2.8799999999999999 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.52 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 4.1500000000000004 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.5900000000000001 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.1299999999999999 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.4500000000000002 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo -59.94 -7.55 6.36 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.3599999999999999 112.594 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.63 21.66 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 2.8799999999999999 111.158 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -169.33 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.517 -0.31 . . . . 8.0700000000000003 111.188 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.77 -54.68 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 2.7999999999999998 111.505 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -71.5 -30.02 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.447 -0.342 . . . . 4.5800000000000001 110.911 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.448 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 79.7 p -84.93 6.01 26.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 3.8100000000000001 111.224 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -60.16 -34.26 73.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 5.2199999999999998 110.749 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.7 p -140.23 19.64 2.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 3.4199999999999999 111.599 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 21.8 tp60 -101.54 -75.55 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 4.2000000000000002 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -144.51 113.37 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 2.75 110.583 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p -77.83 -51.32 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 2.3999999999999999 111.185 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 2.5699999999999998 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 1.72 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 2.6899999999999999 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.1600000000000001 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.1299999999999999 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.9399999999999999 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.3300000000000001 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.642 HD11 HD22 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 1.5600000000000001 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.5900000000000001 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.1399999999999999 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' TYR . . . . . 0.423 ' O ' HG12 ' B' ' 174' ' ' VAL . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 3.8700000000000001 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 1.6100000000000001 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.3 111.481 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.423 HG12 ' O ' ' B' ' 171' ' ' TYR . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 1.53 111.705 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 1.99 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.5 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.445 HG22 ' O ' ' B' ' 173' ' ' THR . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 1.46 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67000000000000004 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 1.73 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 0.93000000000000005 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 1.3600000000000001 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.1899999999999999 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 2.73 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.413 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 1.9299999999999999 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt -92.22 172.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 2.6400000000000001 111.377 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.563 ' HA2' HD12 ' B' ' 193' ' ' ILE . . . 89.67 -165.65 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.726 . . . . 1.9299999999999999 112.29 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 187' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' B' ' 198' ' ' ASP . 28.0 Cg_exo -62.11 154.59 61.48 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 2.9700000000000002 111.825 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 42.3 t 58.65 13.79 2.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 4.5 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -153.79 39.61 0.68 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.847 -0.615 . . . . 4.5 112.315 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 80.5 t80 57.76 85.8 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 7.8899999999999997 110.798 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.95 147.12 10.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.849 -0.691 . . . . 3.6200000000000001 112.285 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -92.38 69.62 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 6.54 110.678 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.563 HD12 ' HA2' ' B' ' 186' ' ' GLY . 67.4 mt -136.43 143.03 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 3.1600000000000001 111.021 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.52 165.14 25.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 3.3900000000000001 111.052 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.34 8.85 5.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 5.5599999999999996 111.334 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.9 m -71.88 -64.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 2.6800000000000002 110.786 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.62 -24.8 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 2.2000000000000002 110.972 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 198' ' ' ASP . . . . . 0.442 ' HB2' ' HG2' ' B' ' 187' ' ' PRO . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.4900000000000002 110.728 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.76 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.1800000000000002 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 1.98 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 1.6499999999999999 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.1100000000000001 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 1.4299999999999999 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77000000000000002 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 1.6000000000000001 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 1.77 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.54 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.0099999999999998 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 2.6499999999999999 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.3300000000000001 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 2.29 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.1200000000000001 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 3.6000000000000001 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 1.51 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.2200000000000002 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 2.6899999999999999 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 3.3999999999999999 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.6699999999999999 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt -56.54 -58.72 6.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.3900000000000001 110.957 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 50.73 70.46 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 5.9100000000000001 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -91.21 116.7 29.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 5.2599999999999998 111.038 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 224' ' ' LEU . 7.4 mp -109.55 166.29 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 6.8099999999999996 110.667 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -97.37 94.58 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 7.0199999999999996 111.014 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -173.19 95.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.217 -0.447 . . . . 8.2100000000000009 110.874 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.2 m -149.5 86.19 1.46 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 8.0999999999999996 111.089 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -99.98 85.89 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 13.279999999999999 110.828 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.274 -0.87 . . . . 10.4 110.865 179.926 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.754 0.312 . . . . 8.0999999999999996 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.38 91.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 6.2699999999999996 111.178 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.36 105.04 5.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 6.2000000000000002 110.678 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 144.17 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 4.8200000000000003 111.074 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -151.98 -42.56 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 3.25 111.066 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt 62.78 3.38 1.16 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.979 -0.555 . . . . 2.79 111.492 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.0800000000000001 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 1.4299999999999999 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' C' ' 12' ' ' VAL . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.1599999999999999 110.8 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.0899999999999999 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' TYR . . . . . 0.406 ' O ' ' HG2' ' C' ' 15' ' ' MET . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 1.5800000000000001 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.375 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.95999999999999996 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 0.95999999999999996 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 15' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.3 110.831 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.425 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 1.8999999999999999 110.865 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 0.95999999999999996 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.0700000000000001 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.0800000000000001 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -57.98 -31.81 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.02 110.35 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 22' ' ' PHE . . . . . 0.798 ' O ' ' OG ' ' C' ' 26' ' ' SER . 34.4 t80 -70.18 -35.71 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.922 -0.581 . . . . 4.9800000000000004 110.437 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -61.78 -30.32 70.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.29 110.604 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -84.79 -32.19 23.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 111.152 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 -9.3 53.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 2.8999999999999999 111.066 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.798 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -68.28 -19.19 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.866 -0.334 . . . . 2.7400000000000002 110.545 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.35 -35.06 17.47 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.482 -0.562 . . . . 5.8499999999999996 109.482 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.5 p-10 -172.65 132.06 0.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 4.5199999999999996 110.065 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.485 ' HB3' HE22 ' C' ' 34' ' ' GLN . 64.0 Cg_endo -94.89 -179.13 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.081 2.52 . . . . 3.2200000000000002 112.389 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' ARG . . . . . 0.43 ' HB2' HD13 ' C' ' 221' ' ' LEU . 23.9 mmm180 -97.21 51.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 8.6799999999999997 111.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.87 -45.24 1.99 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.825 -0.702 . . . . 4.1399999999999997 112.721 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 98.3 t -77.41 131.31 72.03 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.502 0.191 . . . . 5.0899999999999999 111.029 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.428 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 35.6 Cg_exo -58.82 163.82 10.69 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.419 2.079 . . . . 3.1000000000000001 112.263 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 34' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' C' ' 29' ' ' PRO . 23.7 mm-40 -61.39 -18.44 58.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.794 -0.639 . . . . 3.8500000000000001 112.273 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.428 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -51.31 -33.85 30.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.3700000000000001 111.504 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.7200000000000002 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.6699999999999999 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.9299999999999999 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 1.8799999999999999 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.23 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.417 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.0899999999999999 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 0.80000000000000004 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.71999999999999997 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 1.6799999999999999 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 1.6799999999999999 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.51000000000000001 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.3300000000000001 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.56999999999999995 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 1.6699999999999999 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.4199999999999999 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 0.70999999999999996 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.1399999999999999 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.88 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.3799999999999999 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.9399999999999999 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 1.8700000000000001 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LYS . . . . . 0.4 ' HD3' HH12 ' C' ' 72' ' ' ARG . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 2.8599999999999999 110.933 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.1099999999999999 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.54 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.4700000000000002 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.2 tp60 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 2.8500000000000001 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 1.8700000000000001 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.1200000000000001 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.26 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.0800000000000001 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.85999999999999999 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 1.96 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 1.8 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.1799999999999999 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.3300000000000001 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 1.8500000000000001 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.5600000000000001 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.1100000000000001 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.566 HG23 HG23 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.49 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 1.6000000000000001 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.01 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.1799999999999999 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 1.54 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.469 HD12 ' N ' ' C' ' 85' ' ' LEU . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 1.6499999999999999 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.1000000000000001 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.3799999999999999 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.446 HD22 HD11 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.4399999999999999 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 1.8700000000000001 110.772 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 3.1000000000000001 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 1.48 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.3399999999999999 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.21 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 4.54 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.3399999999999999 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.4000000000000004 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.54 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 5.21 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.3799999999999999 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 2.6400000000000001 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.3799999999999999 110.933 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.6200000000000001 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 2.9300000000000002 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.414 HD23 HD11 ' C' ' 142' ' ' ILE . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.1600000000000001 110.74 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.2999999999999998 111.193 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.0699999999999998 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.42 HG21 HD12 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.2999999999999998 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.48 110.457 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 1.9299999999999999 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 1.6699999999999999 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.1100000000000001 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 2.5899999999999999 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.90000000000000002 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.57 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 0.92000000000000004 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.55000000000000004 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 1.49 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 117' ' ' LEU . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 1.6599999999999999 111.207 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 119' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.93999999999999995 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.29 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.1499999999999999 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 98.92 -108.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.3100000000000001 109.441 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.887 ' O ' ' N ' ' C' ' 126' ' ' TRP . 0.3 OUTLIER -54.9 -179.52 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 107.3 -1.37 . . . . 3.1600000000000001 107.3 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 125' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 127' ' ' VAL . 19.5 m-20 -4.88 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.834 2.531 . . . . 4.2400000000000002 117.834 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 126' ' ' TRP . . . . . 0.887 ' N ' ' O ' ' C' ' 124' ' ' ARG . 6.1 p-90 -44.29 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.932 2.197 . . . . 4.6500000000000004 116.932 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' C' ' 125' ' ' ASP . 8.8 m -41.39 -17.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.585 0.63 . . . . 1.3100000000000001 110.811 176.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.567 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 2.8399999999999999 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 2.7000000000000002 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 1.8799999999999999 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 131' ' ' TRP . . . . . 0.578 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.3799999999999999 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 1.76 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.1499999999999999 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.5600000000000001 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.72999999999999998 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 1.48 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.51 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.01 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.0499999999999998 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.453 ' O ' HD13 ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.0699999999999998 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 1.9199999999999999 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.42 HD12 HG21 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 2.6400000000000001 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.51 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 3.5800000000000001 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.6499999999999999 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.46 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.27 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.58 ' H ' ' HD2' ' C' ' 149' ' ' PRO . 35.1 t-20 -95.24 -49.04 0.26 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.3300000000000001 111.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' C' ' 148' ' ' ASN . 53.4 Cg_endo -69.2 0.53 5.1 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.135 1.89 . . . . 2.46 112.424 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.16 -26.61 62.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 3.0800000000000001 111.177 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -139.54 -13.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 8.4499999999999993 110.948 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.19 -41.34 20.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 2.8999999999999999 111.216 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -82.52 -27.84 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 4.6200000000000001 110.702 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 157' ' ' GLN . 67.7 p -83.26 6.86 18.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 3.8500000000000001 111.25 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.69 -22.65 57.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.181 -0.463 . . . . 5.1200000000000001 111.215 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 7.5 t -131.93 -12.72 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 3.4300000000000002 111.334 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 157' ' ' GLN . . . . . 0.454 ' HB2' ' HA ' ' C' ' 154' ' ' THR . 15.0 mm100 -83.45 -167.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.405 . . . . 3.98 111.033 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -55.46 120.54 7.32 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.203 -0.453 . . . . 2.3999999999999999 111.014 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -78.29 -38.8 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.556 . . . . 2.8199999999999998 111.071 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.1800000000000002 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.5 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 1.8100000000000001 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.1299999999999999 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.21 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.3100000000000001 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.2599999999999998 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.5800000000000001 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.446 HD11 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.3 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.73 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 1.4299999999999999 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.7200000000000002 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 1.55 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.484 HG22 HD12 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 1.5 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 1.8400000000000001 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.1200000000000001 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.796 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.484 HD12 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 1.75 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 1.8 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 0.88 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 1.52 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.2 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.4700000000000002 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.6200000000000001 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 2.6299999999999999 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.07 -153.51 38.43 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.77 112.547 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.1 162.69 38.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.722 2.281 . . . . 3.0299999999999998 112.246 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 56.65 15.04 1.96 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.179 -0.464 . . . . 4.2199999999999998 110.69 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.25 -87.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.614 . . . . 4.0800000000000001 112.285 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -159.35 89.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 7.54 110.499 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -168.21 158.26 30.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.803 -0.713 . . . . 3.29 112.673 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -82.77 -27.72 30.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 5.6699999999999999 110.991 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.608 HD12 HG12 ' C' ' 197' ' ' ILE . 14.5 pt -87.37 139.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 2.7599999999999998 110.865 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -150.74 175.7 11.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.022 0.439 . . . . 3.6899999999999999 111.842 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 60.9 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.45 -0.796 . . . . 5.3399999999999999 112.46 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 39.1 m -49.39 -56.21 10.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 2.5699999999999998 112.047 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.608 HG12 HD12 ' C' ' 193' ' ' ILE . 9.3 tp -71.31 -28.75 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.389 -0.369 . . . . 2.3700000000000001 111.503 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.6800000000000002 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 200' ' ' PHE . . . . . 0.506 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.0499999999999998 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 1.9099999999999999 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.04 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.6200000000000001 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.49 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.3200000000000001 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76000000000000001 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 1.8400000000000001 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.6799999999999999 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 2.6499999999999999 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' C' ' 216' ' ' LEU . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.3300000000000001 112.451 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.02 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.3500000000000001 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 3.6200000000000001 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 212' ' ' GLY . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 1.6399999999999999 110.7 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2000000000000002 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.1099999999999999 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 3.3700000000000001 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' C' ' 30' ' ' ARG . 95.6 mt -60.76 -55.22 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.1099999999999999 110.856 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 62.45 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.835 -0.621 . . . . 5.7300000000000004 111.263 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 17.8 m120 64.53 115.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.002 0.429 . . . . 5.5300000000000002 111.315 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 91.0 mt -115.52 155.89 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 6.5999999999999996 110.504 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -83.27 55.46 3.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 6.5099999999999998 111.057 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.34 94.48 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 7.0499999999999998 110.914 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 62.7 m -136.46 -61.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.895 -0.593 . . . . 6.7199999999999998 110.683 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.01 86.94 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.005 -0.543 . . . . 9.5600000000000005 111.148 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 9.0800000000000001 110.897 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.743 H171 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.755 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.742 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.829 0.347 . . . . 8.0899999999999999 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -147.82 108.67 4.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 5.6799999999999997 111.055 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -64.18 134.31 54.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.984 -0.553 . . . . 6.2699999999999996 110.957 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.25 19.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 6.5199999999999996 111.09 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -132.04 129.7 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 3.5899999999999999 110.834 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt -137.2 -5.37 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 3.23 110.821 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 1.8799999999999999 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.29 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.98999999999999999 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 1.9199999999999999 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 1.45 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.89000000000000001 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 0.90000000000000002 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.82999999999999996 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.24 110.589 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.29 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.71 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.95999999999999996 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.98999999999999999 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.1099999999999999 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.23 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -60.64 -32.93 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.0199999999999996 111.0 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -59.07 -30.33 67.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 3.96 110.581 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 m -80.91 -31.73 35.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 2.3799999999999999 110.414 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.6 mt -87.33 -0.53 56.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.685 -0.689 . . . . 2.77 110.538 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -49.92 -26.46 4.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.016 -0.538 . . . . 2.52 111.346 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -45.89 -41.21 11.07 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.093 -0.706 . . . . 5.54 109.093 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 19.4 m120 -154.36 131.24 5.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.997 -1.001 . . . . 4.4400000000000004 109.264 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.9 Cg_endo -81.25 166.22 18.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.624 2.216 . . . . 2.8100000000000001 112.277 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 218' ' ' LEU . 98.3 mtt180 -80.16 26.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 6.7999999999999998 111.07 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.46 -30.3 9.01 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.735 -0.745 . . . . 4.9699999999999998 112.527 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 221' ' ' LEU . 21.1 m -93.22 128.37 43.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.519 0.2 . . . . 4.71 111.108 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 167.77 16.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 3.5099999999999998 112.139 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.4 pt20 -35.41 -33.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 3.4100000000000001 112.59 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 2.8100000000000001 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.3900000000000001 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' MET . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.2400000000000002 110.857 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 34' ' ' GLN . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 1.6000000000000001 110.982 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.3300000000000001 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.03 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.0 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 1.3100000000000001 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.58999999999999997 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 1.6299999999999999 111.733 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.1200000000000001 110.918 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.3200000000000001 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.52000000000000002 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.97999999999999998 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.52000000000000002 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.6899999999999999 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.1200000000000001 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 0.59999999999999998 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.93999999999999995 110.246 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 0.78000000000000003 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.23 110.583 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.1000000000000001 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 1.76 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 1.8400000000000001 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.6400000000000001 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 1.8400000000000001 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.2400000000000002 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.1600000000000001 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 2.8399999999999999 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.3900000000000001 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 0.96999999999999997 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.04 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.3799999999999999 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.76000000000000001 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 2.9300000000000002 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.1299999999999999 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 1.6599999999999999 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.4199999999999999 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.0899999999999999 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.52 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.3300000000000001 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.3899999999999999 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 1.55 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.01 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 1.45 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.3 109.147 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 1.6699999999999999 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD12 HD23 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 1.8700000000000001 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.4199999999999999 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 1.9099999999999999 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 2.3300000000000001 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 1.4299999999999999 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.1899999999999999 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 2.5499999999999998 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.3300000000000001 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 5.0999999999999996 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.0699999999999998 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.4100000000000001 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.3099999999999996 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.9399999999999999 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 5.9800000000000004 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.2400000000000002 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.478 HD22 ' H ' ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 2.6699999999999999 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 2.5899999999999999 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 3.1400000000000001 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.487 ' HB3' HD21 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 1.99 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.3599999999999999 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.0499999999999998 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' HG21 ' A' ' 142' ' ' ILE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.25 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.511 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 2.7200000000000002 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 1.8799999999999999 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 1.6000000000000001 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.0900000000000001 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 2.6499999999999999 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.89000000000000001 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.68000000000000005 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.6 ' HA3' H172 ' A' ' 301' ' ' RET . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 1.5800000000000001 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.04 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.1000000000000001 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.8799999999999999 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 1.53 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.29 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.4900000000000002 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.1299999999999999 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 3.9700000000000002 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.22 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 2.8100000000000001 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.25 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 1.8400000000000001 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.54 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 1.79 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.0800000000000001 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.76000000000000001 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.0699999999999998 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 1.8500000000000001 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.3200000000000001 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 3.25 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 2.9199999999999999 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 2.6499999999999999 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.432 HG21 ' OG1' ' A' ' 108' ' ' THR . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.21 111.473 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.0099999999999998 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 3.6000000000000001 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.6200000000000001 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 2.4700000000000002 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 2.48 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.563 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 2.6899999999999999 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo -62.31 -7.79 11.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.3599999999999999 113.177 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.34 -0.73 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.732 0.301 . . . . 3.2999999999999998 111.192 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.427 ' O ' HG22 ' A' ' 154' ' ' THR . 82.1 mtp180 -144.18 -28.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 8.4800000000000004 111.055 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.64 -49.16 9.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 2.98 111.826 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -85.75 -0.45 55.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.02 0.378 . . . . 4.5499999999999998 112.02 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 151' ' ' ARG . 14.7 t -80.35 -2.66 46.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 4.0 110.846 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -64.92 -48.51 73.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 5.5099999999999998 110.765 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -96.0 -40.56 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 3.2000000000000002 111.095 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -61.7 152.35 31.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 3.98 110.822 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -56.92 114.5 2.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 2.6299999999999999 110.983 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.1600000000000001 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.3700000000000001 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.8300000000000001 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 1.7 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.1600000000000001 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 1.5900000000000001 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.3100000000000001 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.1499999999999999 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.3900000000000001 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.79 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.4199999999999999 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.1200000000000001 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 3.8599999999999999 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 1.5800000000000001 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 1.4099999999999999 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 1.4199999999999999 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 1.9099999999999999 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.55 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 1.8600000000000001 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.73999999999999999 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 1.78 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 0.92000000000000004 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 1.77 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 179' ' ' TYR . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.3400000000000001 111.421 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.5099999999999998 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.02 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.4500000000000002 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.33 21.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 1.73 112.772 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.07 162.3 31.9 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 3.0499999999999998 112.111 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.2 t 56.19 19.06 3.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 4.04 110.226 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -136.31 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.902 -0.666 . . . . 4.4800000000000004 112.609 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -150.9 -38.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.78 0.324 . . . . 7.96 110.694 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.0 -166.79 38.65 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.972 -0.632 . . . . 3.23 112.472 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -153.59 105.4 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 6.0300000000000002 110.852 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 pt -138.44 -179.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 3.1800000000000002 111.114 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -50.0 123.83 8.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 3.3900000000000001 111.195 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -61.26 -24.17 66.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 5.7599999999999998 110.769 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -68.87 -35.87 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 2.5 110.95 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.75 -44.0 76.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 2.3999999999999999 111.08 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.88 -56.18 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 2.6600000000000001 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 1.8100000000000001 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.21 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.1800000000000002 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.0099999999999998 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 1.9299999999999999 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 1.7 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.28 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79000000000000004 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 1.51 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 1.9299999999999999 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 1.71 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.04 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 2.8900000000000001 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.3100000000000001 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 2.8700000000000001 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.3799999999999999 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 3.4199999999999999 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 216' ' ' LEU . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.24 110.66 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.4399999999999999 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.116 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.0099999999999998 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.5900000000000001 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 32' ' ' VAL . 38.2 tp -84.12 -50.33 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 3.4900000000000002 111.129 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 58.2 90.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.415 . . . . 5.7400000000000002 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -79.07 142.13 36.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 5.46 111.034 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.9 tp -140.23 -33.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 6.1299999999999999 110.825 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -112.31 125.58 54.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 6.46 110.695 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.82 110.89 22.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 6.9400000000000004 110.878 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.1 m -153.89 165.56 35.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 6.8300000000000001 110.933 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -144.56 -37.19 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 10.77 110.813 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.452 -0.785 . . . . 9.4100000000000001 111.092 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.697 0.284 . . . . 8.9100000000000001 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.73 171.22 9.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 6.7599999999999998 110.899 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.3 mt -132.02 116.8 17.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 6.25 110.929 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.29 23.48 13.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 5.4400000000000004 111.087 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -148.03 106.97 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.417 . . . . 3.8399999999999999 111.095 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.74 -8.76 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 3.0800000000000001 110.738 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.473 ' H ' HD22 ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.3500000000000001 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 1.3899999999999999 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG12 ' B' ' 12' ' ' VAL . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1000000000000001 110.599 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 1.71 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 1.48 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 0.94999999999999996 111.486 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 0.96999999999999997 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.29 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.3600000000000001 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ILE . . . . . 0.458 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.23 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.97999999999999998 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.1200000000000001 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.467 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 74.2 m-85 -74.89 -29.18 60.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 4.2599999999999998 110.693 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.92 -45.07 71.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 3.6200000000000001 110.412 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.2 t -84.53 -19.42 33.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.151 0.5 . . . . 2.5499999999999998 110.561 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.703 HD11 HD13 ' B' ' 218' ' ' LEU . 22.0 tp -81.94 -0.61 44.7 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.784 -0.644 . . . . 3.1099999999999999 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 33' ' ' PRO . 62.5 m -58.5 -27.54 64.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.719 -0.392 . . . . 3.02 111.257 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -47.14 -21.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.022 0.915 . . . . 5.8899999999999997 109.193 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.769 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 0.2 OUTLIER -66.31 -155.39 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.443 0 CA-C-N 113.796 -1.547 . . . . 5.0199999999999996 109.09 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 71.0 Cg_exo -1.39 113.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 124.654 3.569 . . . . 3.5299999999999998 117.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 43.99 32.11 0.59 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.477 -1.238 . . . . 7.8799999999999999 112.504 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.495 ' H ' ' ND2' ' B' ' 223' ' ' ASN . . . 76.21 -47.57 2.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.48 -0.866 . . . . 4.6100000000000003 111.687 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.88 108.15 7.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.334 0.112 . . . . 4.7300000000000004 110.787 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 84.6 Cg_endo -83.91 119.58 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.675 1.583 . . . . 3.75 112.755 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.88 -23.53 38.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.071 -1.085 . . . . 3.7599999999999998 108.071 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.43 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -82.75 -63.5 1.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.318 -1.765 . . . . 3.1699999999999999 112.119 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.43 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.5699999999999998 112.103 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.7400000000000002 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 1.72 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.457 HG12 HD11 ' B' ' 43' ' ' ILE . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 1.95 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.2 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.1200000000000001 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 1.49 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.657 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 0.77000000000000002 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.68000000000000005 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 1.6299999999999999 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 1.9099999999999999 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.438 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.22 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.55000000000000004 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 0.87 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.55000000000000004 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.0600000000000001 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.1899999999999999 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.66000000000000003 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 0.85999999999999999 110.536 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.83999999999999997 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ILE . . . . . 0.472 HD12 HG23 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.4399999999999999 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.2400000000000002 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.3100000000000001 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 1.8100000000000001 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.1800000000000002 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.0299999999999998 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.3700000000000001 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.2799999999999998 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.501 HD12 ' N ' ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 1.78 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.05 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.1100000000000001 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.2999999999999998 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.71999999999999997 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.04 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.446 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 1.79 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.4399999999999999 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.3100000000000001 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.0099999999999998 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.4299999999999999 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.21 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.657 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.1799999999999999 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.542 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 1.6499999999999999 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.0600000000000001 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.425 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 1.5800000000000001 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' B' ' 83' ' ' LEU . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.595 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' B' ' 109' ' ' GLN . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.474 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 1.96 110.444 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.24 110.241 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.21 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.3200000000000001 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.1499999999999999 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' THR . . . . . 0.631 HG23 HD21 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 1.4399999999999999 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.05 111.36 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 2.6800000000000002 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 2.71 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 4.1900000000000004 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 2.79 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.2699999999999996 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.5700000000000003 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.2400000000000002 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 5.3899999999999997 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.1600000000000001 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 2.5800000000000001 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.63 ' H ' HD12 ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.29 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.48 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 2.7599999999999998 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.2200000000000002 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.3599999999999999 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 1.9199999999999999 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.416 HG21 ' CB ' ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.0600000000000001 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.424 ' OE1' HD21 ' B' ' 84' ' ' LEU . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 2.8700000000000001 110.726 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 1.98 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 1.6200000000000001 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.04 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.46 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.82999999999999996 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 0.73999999999999999 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.59999999999999998 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.4199999999999999 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 1.51 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.0900000000000001 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.1599999999999999 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.8900000000000001 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 2.6699999999999999 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.0700000000000003 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.4099999999999999 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.47 ' CZ ' ' HA ' ' B' ' 188' ' ' SER . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 2.4700000000000002 110.836 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 2.6099999999999999 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.0699999999999998 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.3 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 1.75 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 1.6699999999999999 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.54 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.69999999999999996 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 1.4399999999999999 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.8200000000000001 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.93999999999999995 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.6000000000000001 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.0099999999999998 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.416 ' CB ' HG21 ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 2.8799999999999999 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.52 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 4.1500000000000004 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.5900000000000001 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.1299999999999999 110.992 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 1.78 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.565 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.4500000000000002 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo -61.23 -8.36 10.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.3599999999999999 113.024 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 146' ' ' ILE . 81.4 mt -86.06 16.25 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 2.8799999999999999 111.064 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -155.18 -37.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 8.0700000000000003 110.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.67 -52.67 9.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 2.7999999999999998 111.032 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -76.8 -21.23 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 4.5800000000000001 110.675 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.531 ' HA ' ' HG2' ' B' ' 157' ' ' GLN . 77.5 m -61.89 -26.69 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 3.8100000000000001 111.148 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -64.29 -17.16 63.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 5.2199999999999998 111.266 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 65.0 p -113.77 -45.41 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.871 0.323 . . . . 3.4199999999999999 111.871 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 157' ' ' GLN . . . . . 0.531 ' HG2' ' HA ' ' B' ' 154' ' ' THR . 13.7 pt20 -74.37 176.69 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.388 . . . . 4.2000000000000002 110.849 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 158' ' ' SER . . . . . 0.531 ' HB2' ' HG2' ' B' ' 160' ' ' GLU . 91.7 p -64.37 117.54 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 2.75 111.078 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p -67.12 -19.8 65.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 2.3999999999999999 110.736 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 160' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 158' ' ' SER . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.404 HD11 ' HB1' ' B' ' 91' ' ' ALA . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 2.5699999999999998 110.715 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 1.72 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 2.6899999999999999 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.1600000000000001 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.1299999999999999 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.9399999999999999 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.3300000000000001 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.5600000000000001 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 169' ' ' VAL . . . . . 0.489 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 1.5900000000000001 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.1399999999999999 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.8700000000000001 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.6100000000000001 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.3 111.643 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.422 HG23 HD22 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 1.53 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.422 HD22 HG23 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 1.99 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 1.46 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67000000000000004 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.683 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 1.73 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 0.93000000000000005 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 1.3600000000000001 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.1899999999999999 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 2.73 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 1.9299999999999999 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt -71.44 169.97 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 2.6400000000000001 111.337 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.515 ' HA2' HG12 ' B' ' 193' ' ' ILE . . . 76.89 -159.63 49.6 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.794 -0.717 . . . . 1.9299999999999999 112.548 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.97 165.89 15.0 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.728 2.285 . . . . 2.9700000000000002 111.963 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' SER . . . . . 0.47 ' HA ' ' CZ ' ' B' ' 128' ' ' ARG . 68.7 m 55.98 18.14 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 4.5 110.593 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.42 -65.32 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.923 -0.656 . . . . 4.5 112.531 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -167.16 -26.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.851 0.358 . . . . 7.8899999999999997 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.09 -163.73 29.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 3.6200000000000001 112.492 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -154.08 95.48 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 6.54 110.674 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.515 HG12 ' HA2' ' B' ' 186' ' ' GLY . 28.6 pt -131.96 -179.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 3.1600000000000001 111.378 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -52.41 126.37 19.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 3.3900000000000001 111.233 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.72 -21.68 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 5.5599999999999996 111.301 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -70.12 -33.44 71.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 2.6800000000000002 111.088 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt -75.45 -42.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 2.2000000000000002 111.08 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.4900000000000002 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.02 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.1800000000000002 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.78 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.98 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 1.6499999999999999 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.1100000000000001 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 1.4299999999999999 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77000000000000002 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 1.6000000000000001 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 209' ' ' SER . . . . . 0.419 ' HB2' HD12 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.54 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.0099999999999998 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 2.6499999999999999 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.3300000000000001 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 2.29 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.1200000000000001 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 3.6000000000000001 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.4 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 1.51 110.58 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.2200000000000002 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.703 HD13 HD11 ' B' ' 25' ' ' LEU . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 2.6899999999999999 111.215 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 3.3999999999999999 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.6699999999999999 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.631 HD21 HG23 ' B' ' 90' ' ' THR . 3.3 mm? -84.58 -55.59 4.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.3900000000000001 111.043 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 57.5 84.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 5.9100000000000001 110.426 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 223' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' B' ' 31' ' ' GLY . 43.9 t-20 -68.97 135.3 50.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 5.2599999999999998 111.121 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.38 -24.9 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 6.8099999999999996 110.69 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -137.93 146.72 43.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.449 . . . . 7.0199999999999996 110.799 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -131.74 146.46 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 8.2100000000000009 111.043 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 45.5 t -167.48 132.76 1.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.473 . . . . 8.0999999999999996 110.958 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -133.04 24.04 4.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 13.279999999999999 110.899 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 10.4 111.003 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.812 0.339 . . . . 8.0999999999999996 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -99.51 169.85 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 6.2699999999999996 111.11 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.406 HD23 ' N ' ' C' ' 3' ' ' LEU . 2.7 pt? -149.55 154.11 38.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 6.2000000000000002 110.55 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.72 -25.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.781 0.324 . . . . 4.8200000000000003 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 35.7 t -66.13 117.51 8.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 3.25 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt -126.47 -7.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 2.79 110.597 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.0800000000000001 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 1.4299999999999999 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.0899999999999999 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 1.5800000000000001 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 0.95999999999999996 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 0.95999999999999996 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' MET . . . . . 0.468 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.3 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 1.8999999999999999 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.95999999999999996 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.0700000000000001 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.0800000000000001 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 21' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' C' ' 24' ' ' SER . 7.9 t60 -52.38 -60.63 3.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.02 111.287 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' C' ' 28' ' ' ASN . 13.1 m-85 -62.35 -41.05 98.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 4.9800000000000004 110.856 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.471 ' HA ' ' C ' ' C' ' 27' ' ' ARG . 57.0 t-105 -57.11 -20.89 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.433 -0.58 . . . . 4.29 109.433 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 24' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' C' ' 21' ' ' HIS . 38.3 t -86.91 -28.78 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.298 -0.865 . . . . 2.4700000000000002 112.898 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.76 -66.56 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 118.875 -1.13 . . . . 2.8999999999999999 112.964 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.921 ' OG ' ' OD1' ' C' ' 28' ' ' ASN . 62.1 p -101.92 -31.15 10.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.505 1.145 . . . . 2.7400000000000002 110.269 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ARG . . . . . 0.471 ' C ' ' HA ' ' C' ' 23' ' ' TRP . 67.4 ttt180 126.98 0.11 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 100.485 -3.895 . . . . 5.8499999999999996 100.485 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.921 ' OD1' ' OG ' ' C' ' 26' ' ' SER . 5.5 p-10 -168.31 -173.69 0.3 Allowed Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 110.109 -3.223 . . . . 4.5199999999999996 106.091 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.495 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 31.8 Cg_exo -59.16 -177.87 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 122.39 2.06 . . . . 3.2200000000000002 112.821 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -100.04 83.37 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 8.6799999999999997 110.822 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.66 -37.83 3.31 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.722 -0.751 . . . . 4.1399999999999997 112.513 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' C' ' 29' ' ' PRO . 97.9 t -71.57 130.0 87.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.537 0.208 . . . . 5.0899999999999999 111.195 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 32' ' ' VAL . 32.8 Cg_exo -59.48 165.66 9.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.743 2.295 . . . . 3.1000000000000001 112.628 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -18.45 51.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 3.8500000000000001 111.69 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 -50.68 -40.4 53.67 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.3700000000000001 111.032 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.7200000000000002 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.6699999999999999 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' C' ' 38' ' ' LEU . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 1.9299999999999999 110.38 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 1.8799999999999999 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.0899999999999999 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 1.4099999999999999 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.449 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 0.80000000000000004 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.71999999999999997 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 1.6799999999999999 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 1.6799999999999999 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.432 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.28 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.51000000000000001 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' SD ' ' C' ' 52' ' ' MET . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.3300000000000001 111.086 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.56999999999999995 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 1.6699999999999999 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' C' ' 49' ' ' LEU . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.4199999999999999 110.51 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.70999999999999996 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.418 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.1399999999999999 110.26 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.88 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.3799999999999999 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.9399999999999999 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 25.2 mm-40 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 1.8700000000000001 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 59' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 2.8599999999999999 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 1.95 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.1099999999999999 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.54 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.4700000000000002 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 2.8500000000000001 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.1200000000000001 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.26 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.451 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.0800000000000001 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.418 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 0.85999999999999999 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 1.96 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 1.8 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.451 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.1799999999999999 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.551 ' O ' HG22 ' C' ' 79' ' ' THR . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.3300000000000001 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 1.8500000000000001 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.534 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.5600000000000001 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.1100000000000001 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.551 HG22 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.49 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 1.6000000000000001 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.01 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.1799999999999999 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.4 ' CD1' H201 ' C' ' 301' ' ' RET . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 1.54 110.046 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 1.6499999999999999 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.1000000000000001 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' SER . . . . . 0.435 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.3799999999999999 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 1.4399999999999999 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 1.8700000000000001 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' TRP . . . . . 0.439 ' HB3' ' HE2' ' C' ' 35' ' ' TYR . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 3.1000000000000001 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 1.48 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.02 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.3399999999999999 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.21 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 4.54 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.3399999999999999 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.4000000000000004 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.54 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 5.21 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.3799999999999999 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 2.6400000000000001 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.3799999999999999 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.6200000000000001 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 2.9300000000000002 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 105' ' ' LEU . . . . . 0.437 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.1600000000000001 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.2999999999999998 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.0699999999999998 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.2999999999999998 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.405 HE21 HG23 ' C' ' 113' ' ' ILE . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.48 111.065 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.9299999999999999 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 1.6699999999999999 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.1100000000000001 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 2.5899999999999999 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.90000000000000002 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 115' ' ' SER . . . . . 0.492 ' HB2' ' H21' ' C' ' 301' ' ' RET . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.92000000000000004 110.456 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.44 ' HA3' H172 ' C' ' 301' ' ' RET . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.55000000000000004 112.298 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 1.49 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 1.6599999999999999 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 0.93999999999999995 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.29 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.1499999999999999 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -91.55 -27.15 18.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.3100000000000001 111.0 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.42 ' HB2' HG12 ' C' ' 127' ' ' VAL . 46.3 mtm180 -131.83 143.98 50.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.952 0.405 . . . . 3.1600000000000001 110.833 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.23 -9.72 54.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.982 -0.554 . . . . 4.2400000000000002 111.368 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -86.69 -55.11 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 4.6500000000000004 110.958 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.472 HG23 HD12 ' B' ' 56' ' ' ILE . 10.9 p -63.47 -27.13 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 1.3100000000000001 111.374 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 2.8399999999999999 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 2.7000000000000002 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 1.8799999999999999 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.3799999999999999 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 1.76 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.1499999999999999 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 1.5600000000000001 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.72999999999999998 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 1.48 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.01 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.0499999999999998 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.0699999999999998 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 1.9199999999999999 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 2.6400000000000001 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.51 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 3.5800000000000001 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.6499999999999999 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.46 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.27 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 63.5 t30 -54.81 -49.81 89.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.3300000000000001 112.342 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 41.9 Cg_exo -57.8 -15.95 23.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.308 2.005 . . . . 2.46 112.956 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.42 3.67 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.63 -0.259 . . . . 3.0800000000000001 111.277 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -144.37 -32.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 8.4499999999999993 111.291 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.47 -58.34 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 2.8999999999999999 111.642 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.81 -10.05 56.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 4.6200000000000001 111.491 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.9 p -73.42 -4.81 35.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 3.8500000000000001 111.215 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -60.22 -54.04 50.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 5.1200000000000001 110.865 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -96.87 -31.54 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 3.4300000000000002 111.22 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -67.26 149.57 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 3.98 110.545 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 37.5 t -55.58 113.68 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 2.3999999999999999 110.917 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p -62.69 -19.75 64.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 2.8199999999999998 111.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.1800000000000002 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 161' ' ' LEU . . . . . 0.401 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.5 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 1.8100000000000001 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.1299999999999999 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.21 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.465 ' O ' HG23 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.3100000000000001 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.2599999999999998 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.5800000000000001 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.3 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 1.73 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 1.4299999999999999 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.7200000000000002 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 172' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 177' ' ' ILE . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 1.5 111.959 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 1.8400000000000001 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.1200000000000001 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 176' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.457 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 1.75 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.71999999999999997 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.63 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 1.8 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 0.88 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.514 ' O ' HG22 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.52 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.2 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.4700000000000002 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.514 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 1.6200000000000001 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 2.6299999999999999 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.39 -149.76 18.35 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.77 112.438 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.47 168.79 7.24 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.766 2.31 . . . . 3.0299999999999998 112.17 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 49.6 m 56.38 19.0 3.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.107 0.479 . . . . 4.2199999999999998 110.575 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -152.14 -79.19 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.72 -0.673 . . . . 4.0800000000000001 112.251 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -173.32 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 7.54 110.464 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 177.84 -43.78 0.09 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.632 -0.794 . . . . 3.29 112.727 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 57.93 84.77 0.1 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.003 0.43 . . . . 5.6699999999999999 111.274 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 46.7 pt -141.69 -179.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.7599999999999998 110.792 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -48.13 139.19 8.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.334 -0.394 . . . . 3.6899999999999999 110.973 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -85.76 -27.15 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.051 -0.522 . . . . 5.3399999999999999 111.265 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 36.0 p -59.74 -55.63 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.35 . . . . 2.5699999999999998 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -62.37 -35.03 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 2.3700000000000001 110.91 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.6800000000000002 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.95 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.0499999999999998 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 1.9099999999999999 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.04 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.505 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 1.6200000000000001 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.49 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.64 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.3200000000000001 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76000000000000001 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 1.52 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 1.8400000000000001 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.6799999999999999 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 210' ' ' LYS . . . . . 0.468 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.04 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 2.6499999999999999 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.3300000000000001 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.02 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.3500000000000001 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' PHE . . . . . 0.482 ' HA ' HD12 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 3.6200000000000001 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.419 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.6399999999999999 110.784 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2000000000000002 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.1099999999999999 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 3.3700000000000001 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp -77.59 -51.77 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.1099999999999999 111.161 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 58.95 92.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.406 . . . . 5.7300000000000004 110.799 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.2 151.49 38.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 5.5300000000000002 110.892 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 37.3 tp -168.3 -19.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 6.5999999999999996 111.064 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.65 -63.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 6.5099999999999998 111.082 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 59.61 86.18 0.09 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.26 -0.427 . . . . 7.0499999999999998 110.921 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -169.92 133.52 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 6.7199999999999998 110.944 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.35 -61.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 9.5600000000000005 110.789 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.391 -0.814 . . . . 9.0800000000000001 110.953 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.744 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.754 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.714 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.845 0.355 . . . . 8.0899999999999999 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -148.21 114.35 5.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 5.6799999999999997 110.818 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.64 161.71 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 6.2699999999999996 110.892 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -141.11 105.49 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 6.5199999999999996 110.62 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 p -98.61 169.15 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 3.5899999999999999 111.256 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -143.38 -10.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.811 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.8799999999999999 110.952 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.29 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 0.98999999999999999 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 1.9199999999999999 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' MET . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.6 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 0.89000000000000001 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.90000000000000002 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.82999999999999996 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.24 110.49 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.29 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 1.71 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.95999999999999996 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.98999999999999999 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.1099999999999999 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.1 -30.2 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.0199999999999996 110.611 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -59.43 -39.05 82.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 3.96 109.991 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -26.05 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.845 -0.616 . . . . 2.3799999999999999 110.219 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.88 0.47 1.79 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.839 -0.619 . . . . 2.77 111.124 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 28' ' ' ASN . 93.2 p -51.4 -19.67 1.45 Allowed 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.131 0.27 . . . . 2.52 111.491 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -51.18 -22.75 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.628 -1.249 . . . . 5.54 107.628 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.778 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 20.3 p-10 -67.05 -158.71 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 113.016 -1.902 . . . . 4.4400000000000004 107.635 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HD2' ' HB2' ' A' ' 28' ' ' ASN . 36.1 Cg_exo -16.16 96.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.333 2.688 . . . . 2.8100000000000001 115.143 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.39 65.94 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.587 -0.733 . . . . 6.7999999999999998 109.27 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.95 7.84 6.43 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.514 -1.034 . . . . 4.9699999999999998 110.514 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -122.27 160.91 45.81 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 114.652 -0.774 . . . . 4.71 110.255 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' HG12 ' A' ' 32' ' ' VAL . 44.5 Cg_exo -33.55 134.07 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.561 2.84 . . . . 3.5099999999999998 115.285 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 -77.44 -11.7 59.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.232 -1.349 . . . . 3.4100000000000001 111.036 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 2.8100000000000001 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.3900000000000001 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.2400000000000002 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 1.6000000000000001 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.3300000000000001 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.03 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.0 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HA ' HG22 ' A' ' 45' ' ' ILE . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 1.3100000000000001 112.762 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.58999999999999997 114.136 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' TRP . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 1.6299999999999999 112.115 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TRP . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.1200000000000001 110.707 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.3200000000000001 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.52000000000000002 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 0.97999999999999998 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.52000000000000002 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.6899999999999999 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.1200000000000001 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 0.59999999999999998 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.93999999999999995 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.78000000000000003 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.23 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.1000000000000001 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 1.76 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' HE2' ' A' ' 70' ' ' TYR . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 1.8400000000000001 111.252 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.6400000000000001 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.2400000000000002 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.1600000000000001 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.8399999999999999 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.3900000000000001 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.96999999999999997 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.04 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.44 ' HE2' HG13 ' A' ' 61' ' ' VAL . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.3799999999999999 110.68 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 0.76000000000000001 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 2.9300000000000002 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.1299999999999999 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 1.6599999999999999 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.4199999999999999 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.0899999999999999 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.52 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.3300000000000001 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.3899999999999999 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 1.55 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.01 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 1.45 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.3 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 1.6699999999999999 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.4199999999999999 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 168' ' ' LEU . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.3999999999999999 110.788 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.9099999999999999 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 2.3300000000000001 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 1.4299999999999999 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.1899999999999999 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 2.5499999999999998 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.3300000000000001 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.0999999999999996 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.0699999999999998 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.4100000000000001 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.3099999999999996 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.9399999999999999 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 5.9800000000000004 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.47 ' HA ' HD22 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.2400000000000002 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 2.6699999999999999 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 2.5899999999999999 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.53 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 3.1400000000000001 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 1.99 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.3599999999999999 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 111' ' ' VAL . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.0499999999999998 111.307 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.25 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.583 ' HG3' HD22 ' A' ' 84' ' ' LEU . 22.3 mm-40 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 2.7200000000000002 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.8799999999999999 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 107' ' ' SER . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.6000000000000001 110.671 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.0900000000000001 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 2.6499999999999999 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 0.89000000000000001 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.68000000000000005 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 1.5800000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.04 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.1000000000000001 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.8799999999999999 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.53 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.29 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.4900000000000002 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.1299999999999999 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 3.9700000000000002 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 124' ' ' ARG . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.22 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 2.8100000000000001 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.25 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.8400000000000001 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.402 ' CD1' ' HG2' ' C' ' 58' ' ' GLN . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.54 111.187 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 1.79 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.0800000000000001 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.418 ' SG ' HD22 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 1.76 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.76000000000000001 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.0699999999999998 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 1.8500000000000001 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.3200000000000001 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 3.25 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 2.9199999999999999 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 2.6499999999999999 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.21 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.0099999999999998 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 3.6000000000000001 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.6200000000000001 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 2.4700000000000002 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 2.48 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 2.6899999999999999 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo -61.15 -9.46 12.56 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.3599999999999999 112.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 166' ' ' ASP . 30.5 tp -71.38 -6.35 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.398 . . . . 3.2999999999999998 111.23 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.74 -20.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.421 -0.354 . . . . 8.4800000000000004 111.232 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.93 -44.94 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 2.98 111.193 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -86.17 -9.41 56.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 4.5499999999999998 111.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.6 p -71.64 -6.36 40.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.017 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -57.3 -53.35 59.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.483 . . . . 5.5099999999999998 110.487 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.7 t -99.57 -30.01 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.235 -0.439 . . . . 3.2000000000000002 111.226 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -61.36 154.33 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 3.98 110.703 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.3 m -62.0 115.46 4.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 2.6299999999999999 110.865 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.1600000000000001 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.3700000000000001 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 2.8300000000000001 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 1.7 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.1600000000000001 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 1.5900000000000001 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.3100000000000001 110.715 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 150' ' ' LEU . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.1499999999999999 110.597 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.3900000000000001 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.414 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 1.79 111.037 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.4199999999999999 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.1200000000000001 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 3.8599999999999999 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.5800000000000001 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 1.4099999999999999 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 1.4199999999999999 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 1.9099999999999999 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.404 ' HA ' H193 ' A' ' 301' ' ' RET . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.374 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 1.8600000000000001 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.73999999999999999 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 1.78 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 0.92000000000000004 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 1.77 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 179' ' ' TYR . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.3400000000000001 111.461 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.5099999999999998 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.02 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.4500000000000002 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.18 -157.62 21.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 1.73 113.06 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.03 165.5 29.66 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.925 2.416 . . . . 3.0499999999999998 111.89 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.9 t 58.48 14.08 2.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 4.04 110.188 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.56 -82.48 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.62 -0.718 . . . . 4.4800000000000004 112.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -172.42 83.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 7.96 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.84 171.87 44.02 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.77 -0.729 . . . . 3.23 112.519 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -113.74 26.92 9.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 6.0300000000000002 110.758 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.5 mm -89.33 140.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 3.1800000000000002 111.103 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -147.29 95.7 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 3.3900000000000001 111.13 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLN . . . . . 0.562 ' HB3' HG22 ' A' ' 197' ' ' ILE . 33.2 tt0 -168.1 167.23 12.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 5.7599999999999998 111.042 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.9 m -65.06 -16.42 63.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 2.5 111.192 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' A' ' 195' ' ' GLN . 17.0 tt -56.44 -26.13 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.431 . . . . 2.3999999999999999 111.247 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -55.37 -56.02 24.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.355 . . . . 2.6600000000000001 111.024 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.8100000000000001 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.21 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.1800000000000002 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.0099999999999998 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 1.9299999999999999 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 1.7 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.28 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79000000000000004 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 1.51 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 1.9299999999999999 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 2.8900000000000001 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.3100000000000001 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 2.8700000000000001 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.3799999999999999 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 3.4199999999999999 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.424 HD23 ' O ' ' A' ' 216' ' ' LEU . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.24 110.483 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.4399999999999999 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.5099999999999998 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.0099999999999998 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.5900000000000001 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . 0.54 HD21 HD21 ' A' ' 224' ' ' LEU . 53.4 tp -70.36 -39.45 74.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 3.4900000000000002 110.972 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 60.59 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 5.7400000000000002 111.217 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -130.23 156.13 45.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 5.46 110.867 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.54 HD21 HD21 ' A' ' 221' ' ' LEU . 91.6 mt -94.91 108.5 20.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 6.1299999999999999 111.162 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -136.24 123.37 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.979 -0.555 . . . . 6.46 110.497 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -140.52 142.75 35.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 6.9400000000000004 111.349 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 69.1 m -158.22 90.22 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.901 -0.591 . . . . 6.8300000000000001 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 59.42 90.78 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.526 . . . . 10.77 111.135 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 9.4100000000000001 110.758 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.754 0.312 . . . . 8.9100000000000001 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.79 126.21 28.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 6.7599999999999998 110.722 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -130.61 144.32 51.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.364 -0.38 . . . . 6.25 111.04 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.15 163.71 12.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 5.4400000000000004 110.699 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t -159.85 130.8 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 3.8399999999999999 110.825 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -105.81 -9.24 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 3.0800000000000001 110.833 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.3500000000000001 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 1.3899999999999999 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' TRP . . . . . 0.451 ' O ' HG12 ' B' ' 12' ' ' VAL . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1000000000000001 110.662 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 1.71 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' B' ' 15' ' ' MET . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 1.48 110.615 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.94999999999999996 111.075 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.96999999999999997 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.80000000000000004 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.29 110.837 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.3600000000000001 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.23 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 0.97999999999999998 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.1200000000000001 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.56 -26.51 61.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 4.2599999999999998 110.49 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -61.66 -45.77 92.6 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.633 -0.506 . . . . 3.6200000000000001 109.633 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -72.91 -19.46 61.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.745 -0.661 . . . . 2.5499999999999998 109.698 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' B' ' 28' ' ' ASN . 16.9 tp -67.72 1.08 2.7 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.578 -0.737 . . . . 3.1099999999999999 111.034 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.438 ' C ' ' N ' ' B' ' 28' ' ' ASN . 59.1 p -48.04 -19.54 0.27 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 123.077 0.235 . . . . 3.02 111.524 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -53.32 -19.88 3.77 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.297 1.046 . . . . 5.8899999999999997 108.323 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.768 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.6 t30 -66.15 -154.5 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 113.351 -1.75 . . . . 5.0199999999999996 107.58 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 37.4 Cg_exo -5.21 -75.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.149 2.566 . . . . 3.5299999999999998 115.407 -176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 49.46 55.36 9.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.467 0.651 . . . . 7.8799999999999999 109.349 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.06 -3.95 9.06 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.67 -0.972 . . . . 4.6100000000000003 110.67 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' B' ' 29' ' ' PRO . 1.2 t -110.32 156.28 40.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.243 -0.479 . . . . 4.7300000000000004 110.001 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' B' ' 32' ' ' VAL . 27.3 Cg_exo -35.97 142.28 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.04 2.493 . . . . 3.75 114.005 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' B' ' 36' ' ' GLU . 77.0 mt-30 -75.42 -13.8 60.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.032 . . . . 3.7599999999999998 111.529 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -38.87 -23.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.1699999999999999 113.348 -178.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.5699999999999998 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.7400000000000002 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.72 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 35' ' ' TYR . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 1.95 111.698 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.2 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.1200000000000001 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 1.49 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 0.77000000000000002 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.68000000000000005 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 1.6299999999999999 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.421 ' HZ3' HG21 ' C' ' 114' ' ' THR . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 1.9099999999999999 111.294 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.22 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.55000000000000004 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 0.87 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.55000000000000004 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.0600000000000001 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.1899999999999999 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.66000000000000003 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.85999999999999999 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.83999999999999997 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 1.4399999999999999 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.401 HE22 ' H ' ' C' ' 123' ' ' GLU . 19.6 mm-40 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.2400000000000002 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.3100000000000001 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 1.8100000000000001 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.1800000000000002 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.0299999999999998 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.48 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.3700000000000001 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.2799999999999998 111.014 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 1.78 110.776 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.05 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.524 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.1100000000000001 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.2999999999999998 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 0.71999999999999997 112.115 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.04 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 1.79 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' B' ' 71' ' ' ALA . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 1.4399999999999999 110.852 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.404 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.3100000000000001 109.389 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.0099999999999998 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.4299999999999999 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.21 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.1799999999999999 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 1.6499999999999999 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.0600000000000001 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 1.5800000000000001 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 83' ' ' LEU . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 1.49 110.659 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 1.72 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.408 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 1.96 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.24 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.21 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.3200000000000001 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.1499999999999999 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 1.4399999999999999 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 2.6800000000000002 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 2.71 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 4.1900000000000004 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 2.79 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.2699999999999996 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.5700000000000003 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.2400000000000002 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 5.3899999999999997 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.1600000000000001 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.419 HD21 ' NZ ' ' B' ' 153' ' ' LYS . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 2.5800000000000001 110.917 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.29 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.48 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 2.7599999999999998 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.2200000000000002 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.3599999999999999 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 1.9199999999999999 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.0600000000000001 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' B' ' 84' ' ' LEU . 61.4 tp60 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 2.8700000000000001 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 1.98 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 1.6200000000000001 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.04 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.46 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.82999999999999996 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 0.73999999999999999 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.59999999999999998 112.923 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.4199999999999999 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.409 HG13 HD12 ' B' ' 117' ' ' LEU . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 1.51 111.111 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.0900000000000001 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' SER . . . . . 0.576 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.76 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.8900000000000001 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HB2' HG12 ' B' ' 127' ' ' VAL . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 2.6699999999999999 110.925 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.0700000000000003 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' B' ' 124' ' ' ARG . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 1.4099999999999999 110.88 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 2.4700000000000002 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 2.6099999999999999 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.0699999999999998 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' TRP . . . . . 0.411 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.3 111.165 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 1.75 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 1.6699999999999999 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.69999999999999996 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 1.4399999999999999 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 1.8200000000000001 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.93999999999999995 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 1.6000000000000001 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.0099999999999998 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 1.96 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.41 HG13 ' N ' ' B' ' 143' ' ' LEU . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 2.8799999999999999 111.09 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.41 ' N ' HG13 ' B' ' 142' ' ' ILE . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.52 110.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 4.1500000000000004 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.5900000000000001 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.1299999999999999 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.589 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.4500000000000002 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo -56.05 -19.33 26.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.3599999999999999 112.643 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.08 39.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 2.8799999999999999 110.709 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -166.86 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 8.0700000000000003 110.598 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.32 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 2.7999999999999998 111.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' LYS . . . . . 0.419 ' NZ ' HD21 ' B' ' 101' ' ' LEU . 88.5 tttt -68.83 -17.7 64.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 4.5800000000000001 110.787 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 17.4 m -66.13 -14.86 62.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 3.8100000000000001 110.865 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -55.13 -45.4 75.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 5.2199999999999998 111.195 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 71.3 p -102.23 -36.42 8.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.347 -0.388 . . . . 3.4199999999999999 111.292 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -62.98 151.41 39.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 4.2000000000000002 110.732 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -57.82 117.84 4.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 2.75 111.164 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -66.89 -19.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 2.3999999999999999 111.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 2.5699999999999998 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 1.72 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 2.6899999999999999 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.1600000000000001 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.1299999999999999 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.9399999999999999 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.3300000000000001 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 1.5600000000000001 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.5900000000000001 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.1399999999999999 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 3.8700000000000001 110.36 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.6100000000000001 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.3 111.674 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 1.53 111.462 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 1.99 111.732 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.5 111.476 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 1.46 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67000000000000004 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 1.73 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 0.93000000000000005 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.524 ' O ' HG22 ' B' ' 184' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 179' ' ' TYR . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.1899999999999999 111.373 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 2.73 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.524 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 1.9299999999999999 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt -95.34 129.18 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 2.6400000000000001 111.311 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' B' ' 193' ' ' ILE . . . 106.03 -153.61 17.05 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.889 -0.672 . . . . 1.9299999999999999 112.795 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.34 168.64 22.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.764 2.31 . . . . 2.9700000000000002 112.027 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 188' ' ' SER . . . . . 0.426 ' HA ' HH11 ' B' ' 128' ' ' ARG . 49.9 m 57.03 14.94 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.115 0.483 . . . . 4.5 110.146 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.84 26.95 0.29 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.553 -0.749 . . . . 4.5 112.25 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 58.22 90.27 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.846 0.355 . . . . 7.8899999999999997 110.976 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.94 -7.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 3.6200000000000001 112.672 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 61.12 31.94 19.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.777 0.322 . . . . 6.54 110.983 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.544 HD12 ' HA2' ' B' ' 186' ' ' GLY . 83.9 mt -119.0 139.7 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 3.1600000000000001 111.116 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -141.42 93.65 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 3.3900000000000001 110.458 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 195' ' ' GLN . . . . . 0.558 ' HG2' ' H ' ' B' ' 197' ' ' ILE . 33.0 tt0 -160.84 151.87 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 5.5599999999999996 110.884 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 5.3 t -60.54 -14.78 21.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 2.6800000000000002 111.792 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.558 ' H ' ' HG2' ' B' ' 195' ' ' GLN . 17.5 tt -52.05 -29.26 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.461 -0.336 . . . . 2.2000000000000002 111.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.4900000000000002 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 1.76 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.1800000000000002 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 201' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 182' ' ' VAL . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.78 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 1.98 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 1.6499999999999999 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.1100000000000001 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 1.4299999999999999 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77000000000000002 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 207' ' ' PHE . . . . . 0.424 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 1.6000000000000001 110.194 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.54 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.0099999999999998 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 211' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 207' ' ' PHE . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 2.6499999999999999 110.97 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.3300000000000001 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 2.29 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.1200000000000001 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 3.6000000000000001 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.2200000000000002 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD21 HD11 ' B' ' 25' ' ' LEU . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 2.6899999999999999 110.955 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 3.3999999999999999 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.6699999999999999 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp -58.32 -42.77 87.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.3900000000000001 110.804 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 60.27 -83.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 5.9100000000000001 111.407 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -128.72 165.07 21.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 5.2599999999999998 110.85 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.9 110.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 6.8099999999999996 110.771 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.12 143.46 34.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 7.0199999999999996 111.148 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.92 139.26 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 8.2100000000000009 110.811 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 79.9 p -113.21 -33.62 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 8.0999999999999996 111.073 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 228' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' B' ' 229' ' ' GLN . 40.5 ptt180 -158.49 -3.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 13.279999999999999 111.13 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 229' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 228' ' ' ARG . 87.7 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.147 -0.93 . . . . 10.4 110.93 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 8.0999999999999996 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.78 151.97 28.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 6.2699999999999996 110.714 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.14 149.42 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 6.2000000000000002 111.003 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.11 116.59 32.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 4.8200000000000003 111.055 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -100.48 177.89 4.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 3.25 110.639 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' LEU . . . . . 0.459 ' N ' HD23 ' C' ' 6' ' ' LEU . 2.6 pt? -158.6 -8.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 2.79 111.109 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.0800000000000001 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.556 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 1.4299999999999999 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.542 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.1599999999999999 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.0899999999999999 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 1.5800000000000001 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.542 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.95999999999999996 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 0.95999999999999996 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.3 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 1.52 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' ILE . . . . . 0.405 HD12 ' O ' ' C' ' 17' ' ' ILE . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 1.8999999999999999 110.505 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 0.95999999999999996 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.0700000000000001 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.0800000000000001 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.66 -37.5 84.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.02 110.581 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 22' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' C' ' 25' ' ' LEU . 72.8 m-85 -68.63 -39.21 80.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 4.9800000000000004 110.662 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -50.63 -42.23 55.99 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.034 0.445 . . . . 4.29 110.108 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -85.49 -24.18 27.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.635 . . . . 2.4700000000000002 110.547 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 28.5 tp -77.29 -0.95 27.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.961 -0.563 . . . . 2.8999999999999999 110.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.866 ' OG ' ' HA ' ' C' ' 32' ' ' VAL . 34.6 t -63.76 -29.79 70.96 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.747 -0.381 . . . . 2.7400000000000002 111.012 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -42.23 -26.31 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.078 0.942 . . . . 5.8499999999999996 108.702 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.759 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 0.2 OUTLIER -66.66 -157.57 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 113.536 -1.665 . . . . 4.5199999999999996 108.468 177.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.759 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 73.1 Cg_exo -9.17 118.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 124.542 3.495 . . . . 3.2200000000000002 117.339 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 45.42 24.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.533 -1.212 . . . . 8.6799999999999997 113.718 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.83 -47.7 1.89 Allowed Glycine 0 C--O 1.23 -0.146 0 C-N-CA 120.195 -1.003 . . . . 4.1399999999999997 111.46 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.866 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 11.6 m -139.21 106.45 7.26 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.452 -0.573 . . . . 5.0899999999999999 109.452 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.66 ' HD3' ' OG ' ' C' ' 26' ' ' SER . 6.1 Cg_exo -83.71 119.57 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.096 1.864 . . . . 3.1000000000000001 113.278 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.19 -24.46 37.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.731 -1.211 . . . . 3.8500000000000001 107.731 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.537 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 -83.19 -61.67 1.79 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.102 -1.863 . . . . 3.3700000000000001 112.373 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 36' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' C' ' 33' ' ' PRO . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.7200000000000002 111.803 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.6699999999999999 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 1.9299999999999999 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.8799999999999999 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.23 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.0899999999999999 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 1.4099999999999999 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 0.80000000000000004 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.71999999999999997 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 1.6799999999999999 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 1.6799999999999999 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.28 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.51000000000000001 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.418 HD22 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.3300000000000001 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.56999999999999995 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.6699999999999999 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.4199999999999999 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.70999999999999996 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 54' ' ' MET . . . . . 0.424 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.1399999999999999 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.88 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.3799999999999999 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.9399999999999999 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 1.8700000000000001 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 2.8599999999999999 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.1099999999999999 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.54 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.4700000000000002 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 2.8500000000000001 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.8700000000000001 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.1200000000000001 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.0800000000000001 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.85999999999999999 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 1.96 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.523 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 1.8 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.1799999999999999 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' C' ' 74' ' ' ILE . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.3300000000000001 109.652 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 1.8500000000000001 111.2 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.5600000000000001 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.402 HG23 ' N ' ' C' ' 79' ' ' THR . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.1100000000000001 112.423 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.402 ' N ' HG23 ' C' ' 78' ' ' VAL . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.49 112.166 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 1.6000000000000001 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.01 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.1799999999999999 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.438 HD21 ' HE3' ' C' ' 210' ' ' LYS . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 1.54 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 84' ' ' LEU . . . . . 0.475 HD23 ' H ' ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 1.6499999999999999 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.1000000000000001 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.3799999999999999 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 1.4399999999999999 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 1.8700000000000001 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 3.1000000000000001 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.3399999999999999 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 4.54 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.3399999999999999 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.4000000000000004 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.54 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 5.21 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' THR . . . . . 0.412 HG23 ' N ' ' C' ' 101' ' ' LEU . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.3799999999999999 111.174 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.412 ' N ' HG23 ' C' ' 100' ' ' THR . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 2.6400000000000001 110.875 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.3799999999999999 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.6200000000000001 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 2.9300000000000002 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.1600000000000001 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.2999999999999998 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 107' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.0699999999999998 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.2999999999999998 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.48 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 1.9299999999999999 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 1.6699999999999999 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.1100000000000001 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 2.5899999999999999 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 114' ' ' THR . . . . . 0.421 HG21 ' HZ3' ' B' ' 46' ' ' TRP . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.90000000000000002 110.735 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.92000000000000004 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.55000000000000004 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 1.49 111.291 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 1.6599999999999999 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.93999999999999995 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.29 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.419 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.1499999999999999 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 123' ' ' GLU . . . . . 0.401 ' H ' HE22 ' B' ' 58' ' ' GLN . 46.5 mt-10 -85.01 -29.81 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.3100000000000001 111.041 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG12 ' C' ' 127' ' ' VAL . 85.0 mtm180 -123.29 139.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 3.1600000000000001 110.74 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.43 -11.2 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 4.2400000000000002 111.213 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -87.08 -36.64 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 4.6500000000000004 110.9 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' C' ' 124' ' ' ARG . 13.3 p -80.38 -24.1 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 1.3100000000000001 110.862 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 2.8399999999999999 110.888 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 2.7000000000000002 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.494 HD12 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 1.8799999999999999 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.3799999999999999 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 1.76 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.1499999999999999 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 1.5600000000000001 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.72999999999999998 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 1.48 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.51 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.01 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.0499999999999998 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.0699999999999998 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 1.9199999999999999 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 2.6400000000000001 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 3.5800000000000001 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.6499999999999999 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.46 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.27 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -55.48 -48.41 96.43 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.3300000000000001 112.0 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 28.5 Cg_exo -61.49 -12.46 24.43 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.214 1.942 . . . . 2.46 112.913 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.48 24.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 3.0800000000000001 111.216 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -174.44 -28.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 8.4499999999999993 110.93 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.18 -41.26 18.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 2.8999999999999999 111.142 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -86.24 -22.15 27.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 4.6200000000000001 111.018 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 53.0 p -65.28 -13.02 57.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 3.8500000000000001 111.483 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.74 -28.21 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 5.1200000000000001 111.216 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 30.0 m -115.49 -43.01 3.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 3.4300000000000002 111.466 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -63.42 160.37 16.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.507 -0.315 . . . . 3.98 110.976 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -60.13 115.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 2.3999999999999999 111.01 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m -63.99 -18.88 64.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.8199999999999998 110.899 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.1800000000000002 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 161' ' ' LEU . . . . . 0.444 ' H ' HD12 ' C' ' 161' ' ' LEU . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.5 110.625 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.8100000000000001 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.1299999999999999 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.3100000000000001 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.2599999999999998 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.5800000000000001 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.3 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 1.73 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 1.4299999999999999 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.7200000000000002 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 1.55 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 1.5 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 1.8400000000000001 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.1200000000000001 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.501 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.75 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.53 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.71999999999999997 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 1.8 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.676 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 0.88 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.541 ' O ' HG22 ' C' ' 184' ' ' ILE . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 1.52 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.61 HG22 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.2 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.676 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.4700000000000002 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.541 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 1.6200000000000001 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.524 HG23 HG23 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 2.6299999999999999 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 186' ' ' GLY . . . . . 0.764 ' H ' ' H ' ' C' ' 191' ' ' GLY . . . 108.77 -168.15 13.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.77 112.494 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.1 151.28 9.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.722 2.281 . . . . 3.0299999999999998 111.89 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m 57.82 15.38 2.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.053 0.454 . . . . 4.2199999999999998 110.465 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -145.61 -93.6 0.15 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.785 -0.643 . . . . 4.0800000000000001 112.18 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -114.11 -68.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.775 0.321 . . . . 7.54 110.596 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 191' ' ' GLY . . . . . 0.764 ' H ' ' H ' ' C' ' 186' ' ' GLY . . . 130.89 105.84 1.09 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.787 -0.721 . . . . 3.29 112.436 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -169.62 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.627 0.251 . . . . 5.6699999999999999 111.471 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.443 HD12 HG23 ' C' ' 197' ' ' ILE . 37.6 pt -89.38 -179.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 2.7599999999999998 111.444 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.21 -162.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 3.6899999999999999 111.332 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -100.93 -62.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.3399999999999999 111.149 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.1 t -69.35 -16.68 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.419 . . . . 2.5699999999999998 111.844 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 197' ' ' ILE . . . . . 0.443 HG23 HD12 ' C' ' 193' ' ' ILE . 9.5 tp -59.28 -29.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 2.3700000000000001 111.205 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.6800000000000002 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 1.95 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.0499999999999998 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 1.9099999999999999 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.04 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.6200000000000001 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.49 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.3200000000000001 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76000000000000001 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 1.8400000000000001 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.6799999999999999 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 210' ' ' LYS . . . . . 0.438 ' HE3' HD21 ' C' ' 83' ' ' LEU . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.04 110.867 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 2.6499999999999999 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.3300000000000001 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.02 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.3500000000000001 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 3.6200000000000001 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.402 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 1.6399999999999999 110.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2000000000000002 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.1099999999999999 110.5 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 3.3700000000000001 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.529 HD13 ' HD3' ' C' ' 29' ' ' PRO . 58.6 tp -61.61 -28.43 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.1099999999999999 110.877 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 61.52 -82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 5.7300000000000004 110.956 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -149.43 122.77 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 5.5300000000000002 110.523 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 55.3 tp -58.46 136.41 57.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 6.5999999999999996 110.998 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -163.39 109.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 6.5099999999999998 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -115.47 153.81 30.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 7.0499999999999998 110.759 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.7 t -137.6 -57.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 6.7199999999999998 110.942 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -128.97 163.06 26.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 9.5600000000000005 110.863 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 9.0800000000000001 110.866 179.973 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.766 H161 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.731 H171 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.765 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.81 0.338 . . . . 8.0899999999999999 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -71.47 118.65 14.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 5.6799999999999997 110.753 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.38 -70.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 6.2699999999999996 110.997 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.12 169.11 18.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 6.5199999999999996 111.202 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 40.6 t -126.94 143.14 51.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 3.5899999999999999 110.516 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp -111.83 -22.57 11.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 3.23 110.916 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 1.8799999999999999 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.29 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' VAL . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 0.98999999999999999 110.95 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 1.9199999999999999 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 1.45 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.89000000000000001 110.949 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.90000000000000002 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.82999999999999996 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.24 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.29 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.95999999999999996 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 0.98999999999999999 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.1099999999999999 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.23 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 -68.21 -30.63 69.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.0199999999999996 110.466 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -60.41 -33.22 72.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.513 -0.551 . . . . 3.96 109.513 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -83.91 -20.38 33.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 2.3799999999999999 109.972 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 22' ' ' PHE . 69.5 mt -77.92 -0.46 27.63 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.769 -0.65 . . . . 2.77 110.995 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.979 ' OG ' ' HA ' ' A' ' 32' ' ' VAL . 33.6 t -56.15 -32.6 64.44 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.527 -0.469 . . . . 2.52 111.353 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -40.14 -29.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.914 0.864 . . . . 5.54 109.252 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.88 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 4.5 m120 -66.48 -155.48 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 113.949 -1.478 . . . . 4.4400000000000004 108.524 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 75.5 Cg_exo -7.12 114.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.212 3.274 . . . . 2.8100000000000001 116.819 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 41.92 32.13 0.26 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.494 -1.23 . . . . 6.7999999999999998 113.99 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 74.3 -47.4 1.68 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.535 -0.841 . . . . 4.9699999999999998 112.035 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.979 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 1.8 p -139.36 107.5 7.25 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.927 -0.397 . . . . 4.71 109.927 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 29' ' ' PRO . 86.0 Cg_endo -83.78 118.48 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.397 1.398 . . . . 3.5099999999999998 113.106 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -81.55 -25.14 36.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 3.4100000000000001 108.133 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.532 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 2.8100000000000001 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.3900000000000001 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.2400000000000002 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 1.6000000000000001 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.3300000000000001 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.03 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.0 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 1.3100000000000001 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.58999999999999997 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 1.6299999999999999 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.1200000000000001 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.3200000000000001 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.52000000000000002 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 0.97999999999999998 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 0.52000000000000002 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 1.6899999999999999 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.1200000000000001 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.59999999999999998 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.93999999999999995 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 0.78000000000000003 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 56' ' ' ILE . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.546 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.1000000000000001 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 1.76 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 1.8400000000000001 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.6400000000000001 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.8400000000000001 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.2400000000000002 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.1600000000000001 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 2.8399999999999999 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.3900000000000001 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.96999999999999997 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.04 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.3799999999999999 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 0.76000000000000001 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 2.9300000000000002 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.1299999999999999 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 1.6599999999999999 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.4199999999999999 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.0899999999999999 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.52 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.3300000000000001 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 83' ' ' LEU . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.3899999999999999 111.62 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.01 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 1.45 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 79' ' ' THR . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.689 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 1.6699999999999999 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 1.8700000000000001 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.4199999999999999 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.3999999999999999 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 1.9099999999999999 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 2.3300000000000001 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 1.4299999999999999 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.1899999999999999 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 2.5499999999999998 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.3300000000000001 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 5.0999999999999996 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.0699999999999998 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.4100000000000001 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.3099999999999996 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.9399999999999999 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 5.9800000000000004 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.2400000000000002 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 2.6699999999999999 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 2.5899999999999999 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.53 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 3.1400000000000001 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 1.99 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.3599999999999999 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.0499999999999998 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 142' ' ' ILE . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.25 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HG2' HD21 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 2.7200000000000002 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.8799999999999999 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.6000000000000001 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 108' ' ' THR . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.28 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 2.6499999999999999 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.89000000000000001 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.68000000000000005 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 1.5800000000000001 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.04 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.1000000000000001 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.8799999999999999 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 1.53 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.29 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.4900000000000002 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.1299999999999999 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 3.9700000000000002 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.22 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 2.8100000000000001 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.25 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 1.8400000000000001 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.249 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.79 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.0800000000000001 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.76 110.952 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.76000000000000001 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.0699999999999998 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 1.8500000000000001 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.3200000000000001 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 3.25 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 2.9199999999999999 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 2.6499999999999999 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.21 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.0099999999999998 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 3.6000000000000001 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.6200000000000001 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 2.4700000000000002 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 2.48 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 2.6899999999999999 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo -58.58 -21.06 53.02 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.3599999999999999 112.843 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 tp -75.41 111.17 10.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.2999999999999998 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 40.9 mmt180 56.96 57.93 4.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.988 -0.551 . . . . 8.4800000000000004 111.193 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.82 -41.9 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 2.98 110.755 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -86.25 -6.28 59.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 4.5499999999999998 110.822 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 151' ' ' ARG . 8.4 m -89.24 -14.44 35.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 4.0 111.096 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -59.93 -25.92 65.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 5.5099999999999998 110.719 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -104.97 -14.88 15.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.146 -0.479 . . . . 3.2000000000000002 111.138 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -80.51 -42.08 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 3.98 110.833 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -159.32 113.41 2.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 2.6299999999999999 110.575 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.1600000000000001 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.3700000000000001 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 2.8300000000000001 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.1600000000000001 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 1.5900000000000001 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.3100000000000001 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.1499999999999999 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.3900000000000001 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 1.79 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.4199999999999999 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.1200000000000001 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 3.8599999999999999 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 1.5800000000000001 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 1.4099999999999999 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 1.4199999999999999 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 1.9099999999999999 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.55 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.479 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 1.8600000000000001 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.73999999999999999 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.59 ' O ' HG22 ' A' ' 182' ' ' VAL . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 1.78 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 0.92000000000000004 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 1.77 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.3400000000000001 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' TRP . . . . . 0.476 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.5099999999999998 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.02 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 187' ' ' PRO . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.4500000000000002 111.331 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . -58.93 -50.92 62.6 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 1.73 113.211 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.614 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 25.3 Cg_exo -35.49 151.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.292 2.661 . . . . 3.0499999999999998 112.633 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.8 t 64.88 14.03 8.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.917 -0.772 . . . . 4.04 108.917 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.94 51.71 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.015 -0.993 . . . . 4.4800000000000004 112.26 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 60.8 t80 63.39 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.954 0.407 . . . . 7.96 110.888 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -158.05 -135.09 1.83 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.904 -0.665 . . . . 3.23 112.199 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' TRP . . . . . 0.614 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 53.8 t-105 -72.6 -38.22 67.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.896 0.379 . . . . 6.0300000000000002 110.717 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 197' ' ' ILE . 17.7 mt -139.05 148.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.077 -0.51 . . . . 3.1800000000000002 111.107 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.451 HD21 ' H ' ' A' ' 191' ' ' GLY . 41.9 m-80 -141.63 166.4 24.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 3.3900000000000001 111.478 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 64.12 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.677 -0.692 . . . . 5.7599999999999998 112.001 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.7 m -53.38 -61.29 2.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 2.5 111.964 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 193' ' ' ILE . 17.1 tt -56.36 -31.2 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 2.3999999999999999 111.867 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.85 -45.81 66.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 2.6600000000000001 111.43 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 1.8100000000000001 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.21 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.1800000000000002 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.0099999999999998 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 1.9299999999999999 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 1.7 111.591 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.28 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79000000000000004 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 1.9299999999999999 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 1.71 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.04 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 2.8900000000000001 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.3100000000000001 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 2.8700000000000001 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.3799999999999999 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 3.4199999999999999 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.24 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.4399999999999999 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.5099999999999998 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.0099999999999998 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.5900000000000001 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.77 -57.13 3.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 3.4900000000000002 111.107 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 55.03 64.26 1.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.952 0.406 . . . . 5.7400000000000002 110.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -96.6 134.92 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 5.46 110.928 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.8 tp -84.16 128.73 34.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 6.1299999999999999 111.029 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -77.1 134.2 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 6.46 110.704 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -151.41 128.73 11.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 6.9400000000000004 110.874 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.3 t -120.73 111.53 17.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 6.8300000000000001 110.928 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -99.03 -25.55 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 10.77 110.759 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.214 -0.898 . . . . 9.4100000000000001 110.953 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.699 0.285 . . . . 8.9100000000000001 110.792 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -168.1 148.54 4.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 6.7599999999999998 111.057 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LEU . . . . . 0.456 HD12 ' N ' ' B' ' 3' ' ' LEU . 6.8 mp -100.01 138.76 36.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 6.25 110.858 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.55 -4.99 57.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 5.4400000000000004 111.0 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -148.03 99.21 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 3.8399999999999999 110.939 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.07 178.36 5.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 3.0800000000000001 110.874 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.3500000000000001 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 1.3899999999999999 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1000000000000001 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 1.71 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 0.94999999999999996 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.96999999999999997 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.80000000000000004 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.29 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.3600000000000001 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.23 110.567 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 0.97999999999999998 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.1200000000000001 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' B' ' 25' ' ' LEU . 4.0 t80 -69.36 -35.33 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 4.2599999999999998 110.198 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -56.9 -31.91 65.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.427 -0.583 . . . . 3.6200000000000001 109.427 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -85.38 -19.82 30.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.638 -0.71 . . . . 2.5499999999999998 110.557 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' B' ' 22' ' ' PHE . 28.5 mt -65.41 2.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.906 -0.588 . . . . 3.1099999999999999 112.026 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 29.3 t -46.53 -22.64 0.29 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.748 0.277 . . . . 3.02 111.748 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -47.98 -29.86 3.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.149 0.975 . . . . 5.8899999999999997 108.639 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.29 -153.97 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 113.506 -1.679 . . . . 5.0199999999999996 108.451 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 33.4 Cg_exo -4.17 -77.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.356 2.704 . . . . 3.5299999999999998 115.909 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 53.0 53.7 11.62 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.804 -0.813 . . . . 7.8799999999999999 108.804 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.07 0.2 8.95 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.937 -1.029 . . . . 4.6100000000000003 110.834 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' B' ' 33' ' ' PRO . 1.2 t -112.77 156.07 43.07 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 115.433 -0.383 . . . . 4.7300000000000004 110.301 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' B' ' 32' ' ' VAL . 34.2 Cg_exo -35.9 131.33 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.234 2.623 . . . . 3.75 114.03 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 36' ' ' GLU . 30.0 pt20 -76.9 -12.5 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.672 -1.149 . . . . 3.7599999999999998 111.55 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER -38.36 -22.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.1699999999999999 113.767 -177.883 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLU . . . . . 0.585 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.5699999999999998 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.7400000000000002 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.72 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 1.95 111.581 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.2 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.1200000000000001 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 1.49 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 0.77000000000000002 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.68000000000000005 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.484 HG22 HG11 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 1.6299999999999999 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' TRP . . . . . 0.508 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 1.9099999999999999 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.59 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.55000000000000004 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.87 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 0.55000000000000004 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.0600000000000001 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.1899999999999999 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 0.66000000000000003 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.85999999999999999 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 0.83999999999999997 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 1.4399999999999999 110.268 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.2400000000000002 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.3100000000000001 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 1.8100000000000001 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.1800000000000002 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.0299999999999998 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.48 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.3700000000000001 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.2799999999999998 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.05 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.1100000000000001 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.475 ' HD1' ' HH ' ' B' ' 73' ' ' TYR . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.2999999999999998 111.64 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 0.71999999999999997 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.486 ' NH2' HG23 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.04 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.475 ' HH ' ' HD1' ' B' ' 70' ' ' TYR . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 1.79 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 1.4399999999999999 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.3100000000000001 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.577 ' SD ' HD21 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.4299999999999999 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.21 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.1799999999999999 111.582 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.628 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 1.6499999999999999 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.0600000000000001 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 1.5800000000000001 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 1.49 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 1.72 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 1.96 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.24 111.053 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' LEU . . . . . 0.457 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.3200000000000001 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' TRP . . . . . 0.463 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.1499999999999999 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.4399999999999999 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.05 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 2.6800000000000002 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 2.71 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 4.1900000000000004 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 2.79 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.2699999999999996 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.5700000000000003 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.2400000000000002 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 99' ' ' TRP . . . . . 0.54 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 5.3899999999999997 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.1600000000000001 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 2.5800000000000001 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.29 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.48 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 2.7599999999999998 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.2200000000000002 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.3599999999999999 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.9199999999999999 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.554 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.0600000000000001 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.521 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 2.8700000000000001 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 1.98 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 1.6200000000000001 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 108' ' ' THR . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.04 111.533 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ILE . . . . . 0.521 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.46 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.82999999999999996 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.73999999999999999 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.684 ' HA2' H173 ' B' ' 301' ' ' RET . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.59999999999999998 112.013 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.577 HD21 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.4199999999999999 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 1.51 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.0900000000000001 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.1599999999999999 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 1.76 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.8900000000000001 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 2.6699999999999999 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.0700000000000003 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 1.4099999999999999 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 128' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 2.4700000000000002 110.802 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 2.6099999999999999 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.0699999999999998 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.3 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.75 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 1.6699999999999999 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 1.54 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.69999999999999996 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 1.4399999999999999 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD12 ' B' ' 140' ' ' LEU . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 1.8200000000000001 110.979 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.93999999999999995 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 1.6000000000000001 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.0099999999999998 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 1.96 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.554 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 2.8799999999999999 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.472 HD11 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.52 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 4.1500000000000004 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.5900000000000001 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 146' ' ' ILE . . . . . 0.605 HG13 HD23 ' B' ' 150' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.1299999999999999 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 1.78 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.648 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 81.2 m-20 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.4500000000000002 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo -62.56 -4.05 5.12 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.3599999999999999 112.979 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' LEU . . . . . 0.605 HD23 HG13 ' B' ' 146' ' ' ILE . 1.2 tm? -64.45 -69.04 0.31 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 2.8799999999999999 110.929 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' ARG . . . . . 0.507 ' HG2' HD12 ' B' ' 150' ' ' LEU . 16.4 ptm180 -148.11 49.47 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 8.0700000000000003 111.17 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.31 -33.4 75.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.285 -0.416 . . . . 2.7999999999999998 111.094 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -75.81 -36.4 59.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 4.5800000000000001 110.736 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' B' ' 151' ' ' ARG . 7.0 m -70.72 -9.19 56.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 3.8100000000000001 111.151 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.56 -44.78 85.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 5.2199999999999998 111.053 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.4 p -79.75 -11.88 59.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 3.4199999999999999 111.24 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -81.86 -39.06 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 4.2000000000000002 110.764 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -163.46 113.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 2.75 110.723 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p -78.14 -17.83 56.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 2.3999999999999999 111.034 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 161' ' ' LEU . . . . . 0.452 ' HB2' HH22 ' B' ' 151' ' ' ARG . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 2.5699999999999998 110.828 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 2.6899999999999999 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.1600000000000001 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.1299999999999999 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.9399999999999999 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.3300000000000001 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 1.5600000000000001 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 1.5900000000000001 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.1399999999999999 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 3.8700000000000001 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 1.6100000000000001 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.3 111.377 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 1.53 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 1.99 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.5 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 1.46 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67000000000000004 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.657 ' O ' HG22 ' B' ' 182' ' ' VAL . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 1.73 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 0.93000000000000005 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.5 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 1.3600000000000001 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.657 HG22 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.1899999999999999 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' TRP . . . . . 0.699 ' HE1' H163 ' B' ' 301' ' ' RET . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 2.73 112.084 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 1.9299999999999999 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt -61.66 -29.85 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 2.6400000000000001 111.853 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.22 164.74 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.472 -0.87 . . . . 1.9299999999999999 112.92 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 98.37 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.675 2.25 . . . . 2.9700000000000002 112.594 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 66.1 m 55.47 60.56 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 4.5 111.457 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.28 -165.13 26.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.487 -0.863 . . . . 4.5 113.054 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.13 88.38 7.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 7.8899999999999997 111.151 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.15 -134.95 34.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 3.6200000000000001 112.794 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -63.37 88.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.85 0.357 . . . . 6.54 110.767 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 43.1 mm -135.15 151.17 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.003 -0.544 . . . . 3.1600000000000001 110.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.12 -75.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 3.3900000000000001 111.474 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -155.97 -29.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.591 -0.277 . . . . 5.5599999999999996 111.393 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 11.3 p -54.36 -62.42 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.49 -0.323 . . . . 2.6800000000000002 111.376 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 197' ' ' ILE . . . . . 0.438 HD12 ' N ' ' B' ' 197' ' ' ILE . 2.9 mp -62.53 -30.5 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 2.2000000000000002 110.833 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.4900000000000002 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 199' ' ' THR . . . . . 0.486 HG23 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 1.76 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.1800000000000002 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 1.78 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 1.98 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 1.6499999999999999 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.1100000000000001 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 1.4299999999999999 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77000000000000002 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 1.6000000000000001 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 1.77 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.54 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.0099999999999998 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 2.6499999999999999 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.3300000000000001 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 2.29 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.1200000000000001 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 3.6000000000000001 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.417 ' O ' HD13 ' B' ' 216' ' ' LEU . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.516 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.2200000000000002 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 2.6899999999999999 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 3.3999999999999999 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.6699999999999999 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.05 -57.55 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.3900000000000001 110.796 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 54.88 62.3 2.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 5.9100000000000001 110.69 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -95.45 138.25 33.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 5.2599999999999998 110.95 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 224' ' ' LEU . . . . . 0.442 ' N ' HD12 ' B' ' 224' ' ' LEU . 7.6 mp -109.51 102.33 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 6.8099999999999996 110.843 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -81.93 -77.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 7.0199999999999996 111.046 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.88 78.38 0.11 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.161 -0.472 . . . . 8.2100000000000009 110.802 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.4 m -90.57 167.09 12.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 8.0999999999999996 111.085 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.59 37.45 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 13.279999999999999 110.808 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 10.4 110.79 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.9 tpp . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.902 0.382 . . . . 8.0999999999999996 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -121.22 140.57 51.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 6.2699999999999996 110.67 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' LEU . . . . . 0.553 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.4 pt? -133.86 154.7 50.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 6.2000000000000002 110.877 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.09 110.96 9.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 4.8200000000000003 110.762 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' SER . . . . . 0.572 ' HB2' ' HA ' ' C' ' 55' ' ' ALA . 66.3 m -64.32 151.5 43.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 3.25 110.835 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp -124.02 -23.76 4.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 2.79 110.871 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.0800000000000001 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.4299999999999999 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.1599999999999999 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.0899999999999999 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 1.5800000000000001 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 0.95999999999999996 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 0.95999999999999996 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.3 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 1.52 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 1.8999999999999999 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 0.95999999999999996 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.0700000000000001 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.0800000000000001 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -57.21 -42.98 82.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.993 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.86 -28.29 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 4.9800000000000004 110.82 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -57.72 -48.58 79.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 4.29 110.286 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -72.38 -19.19 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 2.4700000000000002 110.622 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 16.0 tp -69.42 0.02 5.76 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.826 -0.625 . . . . 2.8999999999999999 111.781 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.423 ' C ' ' N ' ' C' ' 28' ' ' ASN . 12.6 t -54.79 -22.34 13.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 2.7400000000000002 111.835 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -50.72 -24.48 3.44 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.181 -1.044 . . . . 5.8499999999999996 108.181 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ASN . . . . . 0.713 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 3.4 t30 -71.09 -157.45 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 113.508 -1.678 . . . . 4.5199999999999996 107.8 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.713 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 32.2 Cg_exo -12.82 105.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.454 2.77 . . . . 3.2200000000000002 115.616 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.07 96.37 5.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 8.6799999999999997 108.795 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.07 -0.26 66.5 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.06 -1.216 . . . . 4.1399999999999997 110.06 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -111.42 162.54 20.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.221 -0.99 . . . . 5.0899999999999999 109.719 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.574 ' HB3' ' CD2' ' C' ' 35' ' ' TYR . 10.4 Cg_exo -33.52 116.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.843 2.362 . . . . 3.1000000000000001 115.108 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -84.33 -20.34 32.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 114.617 -1.174 . . . . 3.8500000000000001 108.257 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -49.52 -23.21 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.329 -1.759 . . . . 3.3700000000000001 112.343 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.7200000000000002 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.6699999999999999 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.473 HD21 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 1.9299999999999999 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 1.8799999999999999 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.23 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.0899999999999999 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 42' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 1.4099999999999999 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.80000000000000004 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.71999999999999997 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 1.6799999999999999 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 1.6799999999999999 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.28 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.51000000000000001 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' C' ' 52' ' ' MET . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.3300000000000001 111.212 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.56999999999999995 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 1.6699999999999999 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.427 ' HE2' HD13 ' C' ' 49' ' ' LEU . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.4199999999999999 110.23 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.70999999999999996 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.1399999999999999 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.572 ' HA ' ' HB2' ' C' ' 5' ' ' SER . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.88 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.3799999999999999 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.9399999999999999 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 1.8700000000000001 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 2.8599999999999999 111.225 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 1.95 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.1099999999999999 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.54 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.4700000000000002 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 2.8500000000000001 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.8700000000000001 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.1200000000000001 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.417 ' O ' HG12 ' C' ' 74' ' ' ILE . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.0800000000000001 111.254 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.85999999999999999 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 1.96 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' C' ' 117' ' ' LEU . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 1.8 111.22 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.417 HG12 ' O ' ' C' ' 70' ' ' TYR . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.1799999999999999 110.175 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.3300000000000001 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.8500000000000001 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.5600000000000001 110.486 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.433 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.1100000000000001 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.49 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 1.6000000000000001 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.01 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.433 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.1799999999999999 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 83' ' ' LEU . . . . . 0.647 HD22 H201 ' C' ' 301' ' ' RET . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 1.54 109.947 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 1.6499999999999999 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.1000000000000001 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.3799999999999999 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 87' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 1.4399999999999999 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.8700000000000001 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 3.1000000000000001 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.02 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.3399999999999999 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.54 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.3399999999999999 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.4000000000000004 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.54 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 5.21 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.3799999999999999 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 2.6400000000000001 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.3799999999999999 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.6200000000000001 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 2.9300000000000002 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.1600000000000001 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.2999999999999998 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.0699999999999998 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.5 ' O ' HG23 ' C' ' 112' ' ' VAL . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.2999999999999998 111.511 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.48 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.508 HG22 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 1.9299999999999999 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 111' ' ' VAL . . . . . 0.484 HG11 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 1.6699999999999999 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 112' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 108' ' ' THR . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.1100000000000001 111.234 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.455 HG22 HD21 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 2.5899999999999999 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.90000000000000002 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.92000000000000004 110.371 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.589 ' HA2' H173 ' C' ' 301' ' ' RET . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.55000000000000004 112.594 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 1.49 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.538 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 1.6599999999999999 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 0.93999999999999995 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.29 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.1499999999999999 110.907 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.33 -27.31 21.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.3100000000000001 110.825 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' ARG . . . . . 0.712 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 38.4 ttm180 -118.59 138.05 52.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 3.1600000000000001 110.813 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.89 -19.34 61.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 4.2400000000000002 111.238 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' TRP . . . . . 0.712 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 62.1 t90 -77.07 -50.25 13.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 4.6500000000000004 110.987 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 127' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' C' ' 124' ' ' ARG . 14.4 p -66.42 -24.11 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.3100000000000001 111.061 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 2.8399999999999999 110.622 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 2.7000000000000002 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.482 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 1.8799999999999999 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 131' ' ' TRP . . . . . 0.482 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.3799999999999999 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.1499999999999999 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 1.5600000000000001 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.72999999999999998 112.924 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 1.48 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.51 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.01 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.0499999999999998 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.0699999999999998 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.504 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 1.9199999999999999 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.504 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 2.6400000000000001 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.5800000000000001 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.6499999999999999 113.155 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 146' ' ' ILE . . . . . 0.408 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.46 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.27 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.61 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 18.2 t30 -100.36 -52.68 0.18 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.3300000000000001 112.46 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 31.9 Cg_exo -58.78 -15.37 26.13 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.086 1.857 . . . . 2.46 112.987 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.91 110.35 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 3.0800000000000001 111.087 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 151' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' C' ' 154' ' ' THR . 98.6 mtt180 58.42 61.08 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 8.4499999999999993 111.19 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.94 -49.72 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.548 . . . . 2.8999999999999999 111.107 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.61 5.09 37.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 4.6200000000000001 110.942 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' C' ' 151' ' ' ARG . 44.4 m -85.29 -25.46 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 3.8500000000000001 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -61.25 -27.95 68.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 5.1200000000000001 110.873 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 24.1 m -81.52 -21.05 38.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 3.4300000000000002 110.824 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.49 -71.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 3.98 110.741 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 77.8 p -127.84 118.28 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 2.3999999999999999 110.855 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -21.44 50.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 2.8199999999999998 110.963 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.1800000000000002 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.5 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 1.8100000000000001 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.1299999999999999 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.21 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.3100000000000001 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.2599999999999998 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.5800000000000001 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 168' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.3 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 1.73 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 1.4299999999999999 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.7200000000000002 110.79 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 1.55 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 177' ' ' ILE . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 1.5 111.956 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 1.8400000000000001 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.1200000000000001 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.515 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 1.75 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 178' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.718 ' O ' HG22 ' C' ' 182' ' ' VAL . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 1.8 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 0.88 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.515 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 1.52 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.718 HG22 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.2 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 183' ' ' TRP . . . . . 0.648 ' HE1' H163 ' C' ' 301' ' ' RET . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.4700000000000002 112.147 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.42 HG22 ' O ' ' C' ' 181' ' ' ILE . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 1.6200000000000001 112.232 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' C' ' 190' ' ' PHE . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 2.6299999999999999 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 186' ' ' GLY . . . . . 0.422 ' HA3' ' HA2' ' C' ' 191' ' ' GLY . . . -170.65 165.75 38.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.77 112.391 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.88 97.58 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.152 . . . . 3.0299999999999998 112.446 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 61.18 45.51 8.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 4.2199999999999998 111.267 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.94 -157.57 27.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.431 -0.89 . . . . 4.0800000000000001 113.028 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 190' ' ' PHE . . . . . 0.415 ' HA ' ' CD1' ' C' ' 185' ' ' ILE . 71.7 m-85 -55.88 -66.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.607 0.241 . . . . 7.54 111.572 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 191' ' ' GLY . . . . . 0.422 ' HA2' ' HA3' ' C' ' 186' ' ' GLY . . . 176.12 131.44 1.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.891 -0.671 . . . . 3.29 112.374 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.4 m95 55.64 21.15 4.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.893 0.378 . . . . 5.6699999999999999 110.786 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 2.3 pp -90.45 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 2.7599999999999998 111.104 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -124.08 -168.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 3.6899999999999999 111.145 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -58.26 -30.46 66.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 5.3399999999999999 111.405 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 99.0 m -52.17 -58.41 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 2.5699999999999998 111.246 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.59 -40.18 87.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 2.3700000000000001 111.208 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.6800000000000002 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 1.95 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.0499999999999998 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 1.9099999999999999 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.04 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 1.6200000000000001 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.49 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.563 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.3200000000000001 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76000000000000001 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 1.52 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 1.8400000000000001 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.6799999999999999 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 2.6499999999999999 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.3300000000000001 112.376 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.02 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.3500000000000001 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 3.6200000000000001 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 1.6399999999999999 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2000000000000002 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.1099999999999999 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 3.3700000000000001 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.6 -57.11 4.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.1099999999999999 111.082 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 56.64 60.97 2.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 5.7300000000000004 110.932 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.93 -176.55 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 5.5300000000000002 110.895 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 50.3 tp -127.44 132.69 50.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 6.5999999999999996 110.696 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.34 115.92 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 6.5099999999999998 111.025 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.49 150.94 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 7.0499999999999998 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -132.81 143.54 49.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 6.7199999999999998 111.065 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -130.61 -48.95 1.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 9.5600000000000005 110.746 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.287 -0.863 . . . . 9.0800000000000001 110.805 179.803 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.699 H161 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.715 H171 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.753 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.778 0.323 . . . . 8.0899999999999999 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -91.74 149.16 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 5.6799999999999997 110.786 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 63.5 tp -148.64 -63.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 6.2699999999999996 110.843 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.631 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 46.3 mt-10 -130.23 -74.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 6.5199999999999996 110.864 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p 49.04 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.003 -0.544 . . . . 3.5899999999999999 111.271 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD23 ' H ' ' A' ' 6' ' ' LEU . 1.6 pt? -107.94 5.27 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 3.23 111.162 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 1.8799999999999999 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.29 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 0.98999999999999999 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.9199999999999999 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 1.45 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.89000000000000001 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.90000000000000002 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.82999999999999996 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.24 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.29 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.95999999999999996 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.98999999999999999 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.1099999999999999 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.23 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' O ' ' OG ' ' A' ' 26' ' ' SER . 75.2 m-85 -76.59 -21.06 56.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.0199999999999996 110.522 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 88.5 t90 -69.9 -31.27 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 3.96 110.655 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.0 p -79.3 -44.42 21.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.063 -0.517 . . . . 2.3799999999999999 110.54 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.0 tp -76.17 -3.88 38.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 2.77 109.982 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.577 ' OG ' ' O ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -60.33 -22.32 63.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 2.52 110.808 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -46.3 -31.52 2.59 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.269 0.557 . . . . 5.54 109.643 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.1 p-10 -176.06 131.96 0.4 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.976 -1.011 . . . . 4.4400000000000004 109.898 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 60.8 Cg_endo -92.32 -177.83 0.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.747 2.298 . . . . 2.8100000000000001 112.466 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -85.32 38.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 6.7999999999999998 111.119 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.86 -24.58 31.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 4.9699999999999998 112.478 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.87 120.84 83.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.371 0.129 . . . . 4.71 110.837 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 43.0 Cg_exo -55.42 165.55 3.15 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.397 2.065 . . . . 3.5099999999999998 112.777 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -18.26 45.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 3.4100000000000001 112.267 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.404 ' HD1' ' HB2' ' A' ' 33' ' ' PRO . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 2.8100000000000001 111.209 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.3900000000000001 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.2400000000000002 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD21 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 1.6000000000000001 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.3300000000000001 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.03 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.0 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.3100000000000001 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.0 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.58999999999999997 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 1.6299999999999999 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.1200000000000001 111.37 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.3200000000000001 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.52000000000000002 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 0.97999999999999998 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 0.52000000000000002 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 1.6899999999999999 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.1200000000000001 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.59999999999999998 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.93999999999999995 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 0.78000000000000003 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.23 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.1000000000000001 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.76 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 1.8400000000000001 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.6400000000000001 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.8400000000000001 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.2400000000000002 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.1600000000000001 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 2.8399999999999999 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.3900000000000001 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.96999999999999997 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.04 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.3799999999999999 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 0.76000000000000001 111.997 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 2.9300000000000002 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.1299999999999999 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 1.6599999999999999 110.316 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 79' ' ' THR . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.4199999999999999 109.296 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.0899999999999999 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.52 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.3300000000000001 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.543 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.3899999999999999 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 1.55 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.01 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 1.45 110.66 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.3 109.5 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 1.6699999999999999 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 1.8700000000000001 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.4199999999999999 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.3999999999999999 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 1.9099999999999999 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 2.3300000000000001 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 1.4299999999999999 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.1899999999999999 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 2.5499999999999998 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.3300000000000001 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 5.0999999999999996 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.0699999999999998 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.4100000000000001 111.027 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.3099999999999996 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.9399999999999999 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 5.9800000000000004 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.2400000000000002 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.6699999999999999 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 2.5899999999999999 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 3.1400000000000001 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 1.99 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.3599999999999999 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.0499999999999998 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.25 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 2.7200000000000002 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 1.8799999999999999 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 1.6000000000000001 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.452 HG12 H173 ' A' ' 301' ' ' RET . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.0900000000000001 111.47 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 2.6499999999999999 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.89000000000000001 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.68000000000000005 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 1.5800000000000001 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.04 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.1000000000000001 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.8799999999999999 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 1.53 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.29 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.4900000000000002 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.797 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.1299999999999999 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 127' ' ' VAL . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.797 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 3.9700000000000002 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ASP . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.22 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 2.8100000000000001 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 127' ' ' VAL . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.25 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 1.8400000000000001 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' TRP . . . . . 0.795 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.54 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 1.79 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.0800000000000001 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 1.76 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.76000000000000001 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.0699999999999998 111.064 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' CYS . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 1.8500000000000001 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.3200000000000001 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 3.25 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 2.9199999999999999 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 2.6499999999999999 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.611 HG12 HG21 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.21 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 146' ' ' ILE . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.0099999999999998 110.925 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 3.6000000000000001 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.6200000000000001 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' LEU . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.4700000000000002 111.189 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 2.48 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 2.6899999999999999 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo -69.82 0.17 6.09 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.3599999999999999 112.556 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.51 101.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 3.2999999999999998 110.856 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.493 HH11 HG21 ' A' ' 154' ' ' THR . 24.2 mmt180 57.97 27.64 15.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 8.4800000000000004 111.15 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.68 -55.4 8.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 2.98 110.87 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -82.28 -4.13 56.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 4.5499999999999998 110.754 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.493 HG21 HH11 ' A' ' 151' ' ' ARG . 15.4 m -92.56 -15.41 26.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 4.0 111.019 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -58.82 -22.8 59.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 5.5099999999999998 110.859 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 p -84.32 -29.86 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 3.2000000000000002 111.047 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -77.37 -53.81 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 3.98 110.768 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p -156.71 117.68 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 2.6299999999999999 110.91 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.1600000000000001 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.3700000000000001 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 2.8300000000000001 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.1600000000000001 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.5900000000000001 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.3100000000000001 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.1499999999999999 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.3900000000000001 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 1.79 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.4199999999999999 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.1200000000000001 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 3.8599999999999999 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 1.5800000000000001 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.4099999999999999 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 1.4199999999999999 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 1.9099999999999999 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.55 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.8600000000000001 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.73999999999999999 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' TYR . . . . . 0.584 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 1.78 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . 0.847 ' HG3' H183 ' A' ' 301' ' ' RET . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 0.92000000000000004 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 1.77 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.3400000000000001 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.5099999999999998 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.02 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.4500000000000002 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.62 -152.06 20.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 1.73 112.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.574 ' HD3' HD12 ' A' ' 193' ' ' ILE . 88.7 Cg_endo -80.33 167.68 19.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.687 2.258 . . . . 3.0499999999999998 112.047 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.2 t 57.94 14.0 2.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 4.04 110.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.54 -74.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 4.4800000000000004 112.002 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -175.44 87.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 7.96 110.605 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -161.05 -171.9 27.65 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 3.23 112.701 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -117.35 36.16 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 6.0300000000000002 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' A' ' 187' ' ' PRO . 76.5 mt -103.21 139.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 3.1800000000000002 110.963 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.74 148.42 51.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 3.3900000000000001 110.867 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -64.0 -17.88 63.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.953 -0.567 . . . . 5.7599999999999998 111.655 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 97.6 m -57.49 -50.33 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 2.5 110.886 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.34 -30.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 2.3999999999999999 110.791 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.5 -57.53 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 2.6600000000000001 110.826 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.8100000000000001 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.21 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 201' ' ' LEU . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.1800000000000002 110.685 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.0099999999999998 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 1.9299999999999999 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 1.7 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . 0.676 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.28 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79000000000000004 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 211' ' ' VAL . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 1.51 110.296 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.9299999999999999 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.04 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 207' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 2.8900000000000001 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 216' ' ' LEU . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.3100000000000001 112.149 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 2.8700000000000001 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.3799999999999999 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 3.4199999999999999 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 212' ' ' GLY . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.4399999999999999 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.5099999999999998 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.0099999999999998 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.5900000000000001 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.0 -6.12 58.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 3.4900000000000002 110.953 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.4 -47.87 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 5.7400000000000002 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -97.62 99.69 11.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 5.46 111.349 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.7 mt -145.09 -178.39 6.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 6.1299999999999999 110.581 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -143.68 82.11 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 6.46 110.694 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.07 -57.18 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.9400000000000004 110.975 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -161.06 -61.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 6.8300000000000001 111.205 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 55.35 78.84 0.17 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.266 -0.424 . . . . 10.77 110.801 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.181 -0.914 . . . . 9.4100000000000001 111.056 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.848 0.356 . . . . 8.9100000000000001 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -110.99 102.03 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 6.7599999999999998 110.703 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.14 133.56 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.413 . . . . 6.25 111.056 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.62 111.21 18.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.604 . . . . 5.4400000000000004 111.154 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 37.8 t -122.82 126.96 48.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 3.8399999999999999 110.722 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -109.7 -9.74 14.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 3.0800000000000001 110.944 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.463 ' H ' HD22 ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.3500000000000001 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 1.3899999999999999 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1000000000000001 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 1.48 110.485 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.94999999999999996 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 0.96999999999999997 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.80000000000000004 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.29 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.3600000000000001 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.97999999999999998 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.1200000000000001 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' HIS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 24' ' ' SER . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.0 109.988 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.596 ' HA ' ' HG3' ' B' ' 27' ' ' ARG . 42.3 t80 -57.84 -31.6 66.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 4.2599999999999998 110.202 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -104.08 3.75 33.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.22 -0.9 . . . . 3.6200000000000001 109.042 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 24' ' ' SER . . . . . 0.547 ' HB2' ' HA ' ' B' ' 21' ' ' HIS . 46.5 t -73.31 -70.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.308 -0.557 . . . . 2.5499999999999998 111.61 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 tp -101.29 -82.12 0.47 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 116.516 -2.074 . . . . 3.1099999999999999 112.978 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' SER . . . . . 0.552 ' C ' ' N ' ' B' ' 28' ' ' ASN . 5.0 p -115.89 -60.5 1.86 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.297 0.57 . . . . 3.02 110.741 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 18.3 mmm180 36.31 28.92 0.01 OUTLIER 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.133 -1.394 . . . . 5.8899999999999997 108.773 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASN . . . . . 0.71 ' HB3' ' CD ' ' B' ' 29' ' ' PRO . 76.3 m-20 -137.48 -162.53 0.05 OUTLIER Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 112.785 -2.007 . . . . 5.0199999999999996 106.978 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.71 ' CD ' ' HB3' ' B' ' 28' ' ' ASN . 55.0 Cg_endo -91.43 166.15 3.51 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.555 1.503 . . . . 3.5299999999999998 113.031 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -111.05 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 7.8799999999999999 110.338 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.11 6.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.901 -0.666 . . . . 4.6100000000000003 111.903 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' B' ' 33' ' ' PRO . 96.7 t -84.48 138.06 38.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.536 -0.172 . . . . 4.7300000000000004 110.536 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.592 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 82.3 Cg_exo -45.7 164.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.666 2.244 . . . . 3.75 113.411 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.41 -16.14 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.075 -0.966 . . . . 3.7599999999999998 113.064 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 6.1 p90 -40.74 -36.19 0.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.1699999999999999 111.951 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.5699999999999998 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.7400000000000002 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 1.72 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 1.95 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.2 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.1200000000000001 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.51 HG23 HG23 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 0.77000000000000002 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.68000000000000005 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 1.6299999999999999 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 1.9099999999999999 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.22 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.55000000000000004 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 0.87 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.55000000000000004 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.0600000000000001 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' MET . . . . . 0.402 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.1899999999999999 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 0.66000000000000003 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' MET . . . . . 0.404 ' HB2' ' HB3' ' B' ' 8' ' ' HIS . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.85999999999999999 110.361 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 0.83999999999999997 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 1.4399999999999999 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' C' ' 122' ' ' SER . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.2400000000000002 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.3100000000000001 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 1.8100000000000001 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.1800000000000002 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.0299999999999998 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.48 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.3700000000000001 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.2799999999999998 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 1.78 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.05 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.1100000000000001 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' TYR . . . . . 0.438 ' O ' HG23 ' B' ' 74' ' ' ILE . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.2999999999999998 111.203 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.71999999999999997 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.04 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 1.79 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' ILE . . . . . 0.48 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 1.4399999999999999 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASP . . . . . 0.48 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.3100000000000001 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.0099999999999998 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.4299999999999999 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.523 HG13 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.21 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' THR . . . . . 0.523 ' H ' HG13 ' B' ' 78' ' ' VAL . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.1799999999999999 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 1.6499999999999999 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.0600000000000001 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 82' ' ' LEU . . . . . 0.518 HD23 HD12 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 1.5800000000000001 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 1.49 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 84' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 1.72 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.518 HD12 HD23 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 1.96 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.21 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.3200000000000001 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.1499999999999999 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.4399999999999999 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.05 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 2.6800000000000002 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 2.71 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 4.1900000000000004 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.79 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.2699999999999996 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.5700000000000003 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.2400000000000002 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 5.3899999999999997 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.1600000000000001 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 2.5800000000000001 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.29 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLY . . . . . 0.69 ' HA3' HD21 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 2.7599999999999998 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' LEU . . . . . 0.58 ' HB3' HD21 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.2200000000000002 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.3599999999999999 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 1.9199999999999999 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.61 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.0600000000000001 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLN . . . . . 0.452 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 2.8700000000000001 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 1.6200000000000001 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.04 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.46 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.82999999999999996 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 0.73999999999999999 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . 0.4 ' HA3' H172 ' B' ' 301' ' ' RET . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.59999999999999998 112.745 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.4199999999999999 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 1.51 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.0900000000000001 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.1599999999999999 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 1.76 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.8900000000000001 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 2.6699999999999999 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.0700000000000003 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 1.4099999999999999 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 2.4700000000000002 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 2.6099999999999999 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.0699999999999998 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.3 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 1.75 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 1.6699999999999999 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.54 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.69999999999999996 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 1.4399999999999999 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 1.8200000000000001 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.93999999999999995 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 1.6000000000000001 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.0099999999999998 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' ILE . . . . . 0.61 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 2.8799999999999999 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.52 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 4.1500000000000004 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.5900000000000001 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.1299999999999999 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 1.78 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.4500000000000002 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 149' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo -71.78 -0.2 8.02 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.3599999999999999 112.198 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.74 100.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 2.8799999999999999 111.013 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 54.31 27.87 8.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.51 . . . . 8.0700000000000003 110.978 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -45.82 14.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 2.7999999999999998 111.26 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.55 -37.1 60.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 4.5800000000000001 111.098 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 72.5 p -74.27 5.04 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 3.8100000000000001 111.462 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.62 -28.18 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.267 -0.424 . . . . 5.2199999999999998 110.695 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.3 t -83.31 -26.12 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 3.4199999999999999 111.32 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -72.06 -72.61 0.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 4.2000000000000002 110.958 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 t -139.61 115.13 9.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.545 . . . . 2.75 110.85 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m -76.37 -25.41 54.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 2.3999999999999999 110.861 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 2.5699999999999998 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 1.72 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 2.6899999999999999 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.1600000000000001 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.1299999999999999 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.9399999999999999 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.3300000000000001 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 1.5600000000000001 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 1.5900000000000001 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.1399999999999999 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' TYR . . . . . 0.496 ' O ' HG22 ' B' ' 174' ' ' VAL . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 3.8700000000000001 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.6100000000000001 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.3 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 171' ' ' TYR . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 1.53 111.905 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 175' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 1.99 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 176' ' ' TRP . . . . . 0.452 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.5 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 1.46 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67000000000000004 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 179' ' ' TYR . . . . . 0.58 ' O ' HG22 ' B' ' 182' ' ' VAL . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 1.73 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 180' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 0.93000000000000005 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 181' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 1.3600000000000001 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' VAL . . . . . 0.58 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.1899999999999999 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 2.73 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' ILE . . . . . 0.464 HG22 HG23 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 1.9299999999999999 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.464 HG23 HG22 ' B' ' 184' ' ' ILE . 2.3 pp -117.35 -172.27 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 2.6400000000000001 112.219 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.28 167.19 0.61 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.681 -0.69 . . . . 1.9299999999999999 113.146 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.58 77.41 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.502 2.135 . . . . 2.9700000000000002 111.412 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' B' ' 202' ' ' PHE . 24.9 m 62.28 53.38 2.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 4.5 110.482 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' B' ' 193' ' ' ILE . . . 179.84 -149.41 8.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.524 -0.846 . . . . 4.5 113.372 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -91.03 -0.3 57.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 7.8899999999999997 111.406 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 92.15 161.25 36.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.576 -0.821 . . . . 3.6200000000000001 112.781 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 79.1 m95 53.65 41.39 32.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 6.54 110.752 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 193' ' ' ILE . . . . . 0.575 HD11 ' HA3' ' B' ' 189' ' ' GLY . 8.0 pt -138.13 139.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 3.1600000000000001 110.784 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -79.04 163.71 24.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 3.3900000000000001 111.089 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -52.48 -35.83 53.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.708 0.29 . . . . 5.5599999999999996 111.184 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -53.43 -44.23 68.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.391 . . . . 2.6800000000000002 110.967 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt -72.82 -37.55 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.941 -0.572 . . . . 2.2000000000000002 111.168 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.4900000000000002 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 1.76 111.524 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.1800000000000002 111.248 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 1.78 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 202' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' B' ' 188' ' ' SER . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 1.98 111.085 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 1.6499999999999999 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.1100000000000001 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 205' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 1.4299999999999999 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77000000000000002 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 1.6000000000000001 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 1.77 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.54 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.0099999999999998 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 2.6499999999999999 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.3300000000000001 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 2.29 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.1200000000000001 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 3.6000000000000001 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.2200000000000002 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 2.6899999999999999 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 3.3999999999999999 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.6699999999999999 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 221' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' B' ' 29' ' ' PRO . 75.3 mt -76.34 -14.01 60.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.3900000000000001 110.864 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -66.51 -49.79 65.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 5.9100000000000001 110.768 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.38 75.4 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 5.2599999999999998 110.835 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.3 tp -147.54 140.28 24.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 6.8099999999999996 110.701 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -96.83 121.4 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 7.0199999999999996 110.894 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.07 49.88 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.5 . . . . 8.2100000000000009 111.005 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.5 t 59.51 96.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 8.0999999999999996 111.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -86.48 154.12 21.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 13.279999999999999 110.961 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.257 -0.878 . . . . 10.4 110.84 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.738 0.304 . . . . 8.0999999999999996 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 65.29 156.57 0.09 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.921 -0.581 . . . . 6.2699999999999996 111.312 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -157.59 135.62 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 6.2000000000000002 110.703 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.84 94.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 4.8200000000000003 110.662 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.8 m -114.77 122.58 46.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 3.25 110.983 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt -104.01 2.59 32.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 2.79 110.586 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.0800000000000001 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 1.4299999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.1599999999999999 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.0899999999999999 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 1.5800000000000001 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 12' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.95999999999999996 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 0.95999999999999996 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.3 111.119 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 1.52 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 1.8999999999999999 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.95999999999999996 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.0700000000000001 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.0800000000000001 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -57.72 -43.4 85.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.02 110.293 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.77 -28.76 60.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 4.9800000000000004 110.527 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' TRP . . . . . 0.787 ' O ' ' OG ' ' C' ' 26' ' ' SER . 87.7 t90 -62.92 -23.75 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 4.29 110.402 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -84.88 -50.47 7.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 2.4700000000000002 110.917 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.05 -1.31 19.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.287 -0.415 . . . . 2.8999999999999999 110.394 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' SER . . . . . 0.787 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.0 OUTLIER -57.97 -23.67 54.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 2.7400000000000002 111.265 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -45.87 -35.1 4.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.299 0.571 . . . . 5.8499999999999996 109.796 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -174.25 131.77 0.51 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.13 -0.941 . . . . 4.5199999999999996 110.014 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -93.87 176.16 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.901 2.401 . . . . 3.2200000000000002 112.477 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -88.15 62.02 6.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 8.6799999999999997 111.311 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.58 -29.64 3.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.852 -0.689 . . . . 4.1399999999999997 112.88 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' VAL . . . . . 0.541 ' HB ' ' HG ' ' C' ' 221' ' ' LEU . 5.0 p -73.02 115.64 42.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.62 0.248 . . . . 5.0899999999999999 111.164 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 33' ' ' PRO . . . . . 0.402 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 48.9 Cg_exo -55.83 165.78 3.44 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.562 2.175 . . . . 3.1000000000000001 112.611 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -62.51 -18.61 62.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.277 -0.874 . . . . 3.8500000000000001 112.74 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 35' ' ' TYR . . . . . 0.402 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.5 p90 -51.27 -37.37 46.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.3700000000000001 111.484 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.7200000000000002 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.6699999999999999 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 38' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 1.9299999999999999 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 1.8799999999999999 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' MET . . . . . 0.469 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.0899999999999999 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 1.4099999999999999 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 0.80000000000000004 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.71999999999999997 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 1.6799999999999999 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 1.6799999999999999 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.28 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.51000000000000001 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.3300000000000001 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 0.56999999999999995 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 51' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 1.6699999999999999 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' MET . . . . . 0.434 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.4199999999999999 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 0.70999999999999996 111.028 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 0.88 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 56' ' ' ILE . . . . . 0.478 HD11 ' HD1' ' A' ' 131' ' ' TRP . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.3799999999999999 111.148 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.9399999999999999 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 58' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.8700000000000001 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.8599999999999999 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 1.95 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.1099999999999999 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.4700000000000002 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 2.8500000000000001 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.8700000000000001 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.1200000000000001 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.26 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.0800000000000001 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 71' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 0.85999999999999999 112.345 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 1.96 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 73' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 1.8 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.1799999999999999 110.476 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.3300000000000001 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 1.8500000000000001 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 77' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.5600000000000001 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.48 ' O ' HD23 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.1100000000000001 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.49 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 1.6000000000000001 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 81' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.01 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 82' ' ' LEU . . . . . 0.49 HD13 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.1799999999999999 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 1.54 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 1.6499999999999999 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' LEU . . . . . 0.49 HD12 HD13 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.1000000000000001 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.3799999999999999 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 1.4399999999999999 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 1.8700000000000001 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 3.1000000000000001 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.3399999999999999 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.21 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 4.54 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.3399999999999999 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.4000000000000004 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.54 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 99' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 5.21 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.3799999999999999 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 101' ' ' LEU . . . . . 0.41 ' N ' HD12 ' C' ' 101' ' ' LEU . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 2.6400000000000001 111.521 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.3799999999999999 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.6200000000000001 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 2.9300000000000002 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.1600000000000001 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' MET . . . . . 0.42 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.2999999999999998 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.0699999999999998 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' THR . . . . . 0.409 HG22 HG21 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.2999999999999998 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 109' ' ' GLN . . . . . 0.433 HE21 HG22 ' C' ' 80' ' ' THR . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.48 111.667 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ILE . . . . . 0.477 ' HA ' HD12 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 1.9299999999999999 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 1.6699999999999999 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.1100000000000001 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 113' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 2.5899999999999999 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.90000000000000002 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.92000000000000004 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' GLY . . . . . 0.583 ' HA3' H172 ' C' ' 301' ' ' RET . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.55000000000000004 113.325 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 117' ' ' LEU . . . . . 0.501 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 1.49 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 118' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 1.6599999999999999 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.93999999999999995 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.29 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' SER . . . . . 0.533 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.1499999999999999 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.89 -20.96 40.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.3100000000000001 110.301 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -131.83 136.27 47.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.606 -0.725 . . . . 3.1600000000000001 110.478 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.88 -9.25 35.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 4.2400000000000002 111.16 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -82.15 -56.88 3.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 4.6500000000000004 111.211 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.08 -23.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.316 -0.402 . . . . 1.3100000000000001 111.178 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 2.8399999999999999 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.7000000000000002 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 130' ' ' LEU . . . . . 0.417 ' O ' HG22 ' C' ' 133' ' ' ILE . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.8799999999999999 110.652 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.3799999999999999 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.76 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 133' ' ' ILE . . . . . 0.417 HG22 ' O ' ' C' ' 130' ' ' LEU . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.1499999999999999 111.035 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 1.5600000000000001 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 1.48 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.51 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.01 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.0499999999999998 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.0699999999999998 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.415 HG13 ' N ' ' C' ' 142' ' ' ILE . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 1.9199999999999999 111.453 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 142' ' ' ILE . . . . . 0.415 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 2.6400000000000001 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.51 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 3.5800000000000001 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.6499999999999999 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.46 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 148' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 6.6 t30 -77.46 -53.93 1.52 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.3300000000000001 112.017 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 149' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 58.3 Cg_endo -69.66 -0.55 7.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.952 1.768 . . . . 2.46 112.438 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.39 98.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 3.0800000000000001 110.706 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' C' ' 155' ' ' ARG . 39.9 mmt180 56.25 30.43 16.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 8.4499999999999993 111.009 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.25 -50.49 8.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.274 -0.421 . . . . 2.8999999999999999 111.387 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.79 -2.78 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 4.6200000000000001 111.093 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 67.2 p -102.16 2.12 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 3.8500000000000001 111.216 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' C' ' 151' ' ' ARG . 97.2 mtt180 -66.05 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 5.1200000000000001 110.85 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -83.38 -10.95 58.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 3.4300000000000002 110.666 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -94.97 -72.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.943 -0.571 . . . . 3.98 110.929 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p -142.53 116.07 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 2.3999999999999999 110.981 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p -75.63 -25.17 56.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 2.8199999999999998 110.771 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.1800000000000002 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 161' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.5 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 1.8100000000000001 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.1299999999999999 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 164' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.21 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.3100000000000001 111.042 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.2599999999999998 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.5800000000000001 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.3 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 1.73 110.975 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 1.4299999999999999 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.7200000000000002 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.55 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 1.5 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 1.8400000000000001 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 175' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.1200000000000001 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 177' ' ' ILE . . . . . 0.414 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 1.75 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.71999999999999997 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 179' ' ' TYR . . . . . 0.593 ' O ' HG22 ' C' ' 182' ' ' VAL . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 1.8 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 0.88 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 181' ' ' ILE . . . . . 0.414 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 1.52 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.4700000000000002 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 184' ' ' ILE . . . . . 0.605 HG22 HG23 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 1.6200000000000001 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.605 HG23 HG22 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 2.6299999999999999 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.72 17.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.77 112.416 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 187' ' ' PRO . . . . . 0.623 ' HD3' HD12 ' C' ' 193' ' ' ILE . 72.0 Cg_endo -76.96 150.39 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.446 2.097 . . . . 3.0299999999999998 112.233 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m 56.53 28.12 13.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 4.2199999999999998 110.769 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -157.18 -71.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.701 . . . . 4.0800000000000001 112.345 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -172.39 82.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 7.54 110.755 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.23 162.39 35.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.559 -0.829 . . . . 3.29 112.829 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -96.02 64.12 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.813 0.34 . . . . 5.6699999999999999 110.74 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 193' ' ' ILE . . . . . 0.623 HD12 ' HD3' ' C' ' 187' ' ' PRO . 75.3 mt -126.32 142.48 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 2.7599999999999998 111.188 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -55.81 147.69 18.47 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.937 -0.574 . . . . 3.6899999999999999 111.338 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.82 -1.41 28.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.948 -0.569 . . . . 5.3399999999999999 110.905 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 84.2 m -74.35 -59.91 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 2.5699999999999998 111.19 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.94 -30.85 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 2.3700000000000001 111.096 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.6800000000000002 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 1.95 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 200' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.0499999999999998 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 1.9099999999999999 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.04 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 203' ' ' CYS . . . . . 0.439 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 1.6200000000000001 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.49 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 205' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.3200000000000001 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 206' ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76000000000000001 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 1.52 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 1.8400000000000001 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 209' ' ' SER . . . . . 0.501 ' HB2' HD23 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.6799999999999999 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.04 111.606 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 2.6499999999999999 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.3300000000000001 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.02 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.3500000000000001 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 3.6200000000000001 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.426 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.6399999999999999 110.596 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2000000000000002 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.1099999999999999 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 3.3700000000000001 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 221' ' ' LEU . . . . . 0.558 HD13 HD12 ' C' ' 224' ' ' LEU . 4.5 mm? -65.69 -11.79 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.1099999999999999 111.389 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -88.67 32.42 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 5.7300000000000004 111.113 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.72 -0.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 5.5300000000000002 110.812 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 224' ' ' LEU . . . . . 0.558 HD12 HD13 ' C' ' 221' ' ' LEU . 86.1 mt -101.86 166.62 10.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 6.5999999999999996 110.944 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.24 125.28 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 6.5099999999999998 110.98 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 27.39 9.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.496 . . . . 7.0499999999999998 110.947 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.9 t -129.37 127.31 40.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 6.7199999999999998 111.18 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -159.22 110.53 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 9.5600000000000005 110.75 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.334 -0.841 . . . . 9.0800000000000001 111.075 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 301' ' ' RET . . . . . 0.847 H183 ' HG3' ' A' ' 180' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 301' ' ' RET . . . . . 0.752 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 301' ' ' RET . . . . . 0.742 H171 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.464 0.242 0 CA-C-O 120.589 0.233 . . . . 3.23 111.479 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 1.88 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.29 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' VAL . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 0.99 110.69 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 1.92 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 1.45 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.89 111.166 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 0.9 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.83 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.24 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.29 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 1.71 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.96 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 0.99 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.11 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.23 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.02 110.442 179.542 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 3.41 113.377 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 2.81 112.139 -178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.39 110.62 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.24 110.685 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 1.6 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.33 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.03 111.345 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.0 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 1.31 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.0 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.59 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 1.63 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.669 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.12 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 79' ' ' THR . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.32 111.386 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.52 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' SG ' ' B' ' 134' ' ' CYS . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 0.98 110.953 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.52 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 1.69 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.12 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 0.94 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.78 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.23 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.1 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 1.76 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.84 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.64 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 1.84 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.24 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.16 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 2.84 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.39 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.97 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.04 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.38 110.992 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.76 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 2.93 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.13 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 1.66 110.654 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.42 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.09 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.52 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.33 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' HG13 ' A' ' 78' ' ' VAL . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.39 112.126 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 1.55 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.01 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.3 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 1.67 110.482 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.42 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.4 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 1.91 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 2.33 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 1.43 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.19 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 2.55 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.33 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 5.1 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.07 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.41 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.31 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.94 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 5.98 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.24 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 2.67 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 2.59 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.53 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 3.14 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 1.99 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.36 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.05 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.25 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.88 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.6 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.09 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 2.65 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.426 HG21 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 0.89 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 0.68 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 1.58 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.04 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.1 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.88 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.53 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.29 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.49 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.13 110.838 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 3.97 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.22 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 2.81 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.25 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 1.84 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.54 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 1.79 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.08 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 1.76 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.76 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.07 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 1.85 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.32 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 3.25 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 2.92 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 2.65 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.614 HD13 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.21 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 146' ' ' ILE . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.01 111.091 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 3.6 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.62 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 143' ' ' LEU . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 2.47 111.646 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 2.48 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.624 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 2.69 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo . . . . . 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.36 112.684 -179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.878 0.371 . . . . 2.63 110.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.16 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.37 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 2.83 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 1.7 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.16 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 1.59 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.456 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.31 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.15 110.899 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.478 ' HB2' ' NZ ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.39 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.42 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.12 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 174' ' ' VAL . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 3.86 110.719 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 1.58 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 1.41 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 171' ' ' TYR . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 1.42 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 1.91 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.55 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.541 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.86 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.74 112.958 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.594 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 1.78 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 0.92 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 1.77 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 179' ' ' TYR . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.34 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.51 111.618 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.02 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.483 HG13 HG22 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.45 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 1.73 112.819 179.598 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 . . . . . 0 CA--C 1.523 -0.066 0 CA-C-O 120.834 0.35 . . . . 2.66 110.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 1.81 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.21 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.18 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.01 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 1.93 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 1.7 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.28 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 1.51 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 1.93 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 1.71 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.04 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 2.89 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.31 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 2.87 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.38 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 3.42 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.44 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.51 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.01 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.59 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 221' ' ' LEU . 3.3 mm? . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 3.49 111.229 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.838 0.351 . . . . 3.08 110.993 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.35 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 1.39 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.406 ' O ' HG23 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 1.71 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 1.48 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 0.95 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.97 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.29 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.36 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.23 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 0.98 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.12 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.0 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 4.26 111.032 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.159 0 N-CA-C 112.011 0.375 . . . . 3.17 112.011 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.57 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.74 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 1.72 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 1.95 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.2 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.457 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.12 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 1.49 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 0.77 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.68 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 1.63 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 1.91 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.22 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.55 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.87 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.55 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.06 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.19 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 0.66 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 0.86 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 0.84 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.507 HG21 HG23 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 1.44 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.31 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 1.81 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.18 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.03 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.48 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.37 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.28 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 1.78 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.05 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.11 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.448 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.3 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 0.72 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.478 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.04 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 1.79 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.448 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 1.44 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.57 ' O ' HG22 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.31 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.411 ' SD ' HG21 ' B' ' 113' ' ' ILE . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.43 110.414 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.21 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.57 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.18 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 1.65 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.06 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 1.58 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 1.49 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' B' ' 109' ' ' GLN . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 1.72 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.456 ' N ' HD12 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 1.96 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.24 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.543 HD13 HD21 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.21 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.32 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.15 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 1.44 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 2.68 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 2.71 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 4.19 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.79 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.27 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.57 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.24 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 5.39 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . 0.474 ' HA ' HD22 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.16 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.444 ' N ' HD12 ' B' ' 101' ' ' LEU . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 2.58 111.063 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.48 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.47 ' HB2' HD11 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 2.76 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.22 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 1.92 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.555 ' O ' HG23 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.06 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.556 ' HG3' HD21 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 2.87 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.669 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 1.62 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.04 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' B' ' 77' ' ' MET . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.46 110.64 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.83 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.74 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.6 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.42 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 1.51 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.09 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.16 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 1.76 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.89 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.774 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 2.67 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.774 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.07 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 1.41 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 2.47 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 2.61 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 56' ' ' ILE . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.07 111.281 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.3 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' B' ' 137' ' ' CYS . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 1.67 111.081 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.405 ' SG ' HD22 ' A' ' 49' ' ' LEU . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 1.54 110.971 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 1.44 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . 0.424 ' HG ' HG22 ' B' ' 133' ' ' ILE . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 1.82 110.709 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.94 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 1.6 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.445 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 1.96 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.445 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 2.88 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.52 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 4.15 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.59 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.13 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 1.78 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.45 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.36 112.921 -179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.766 0.317 . . . . 2.4 111.236 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' B' ' 91' ' ' ALA . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 2.57 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 1.72 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 2.69 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.16 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.491 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.13 111.188 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.94 110.91 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.33 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.543 HD21 HD13 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 165' ' ' TYR . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.59 111.008 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.14 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 3.87 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.61 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.3 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 1.53 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 1.99 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.5 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.512 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 1.46 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.604 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 1.73 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 0.93 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 1.36 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.19 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 2.73 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.53 HG22 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 1.93 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 184' ' ' ILE . 2.8 pp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.64 111.252 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.815 0.341 . . . . 2.2 110.82 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.49 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 1.76 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . 0.423 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.18 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.78 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 1.98 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 1.65 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.11 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 1.43 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 1.6 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 1.77 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.428 ' HB3' HD23 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.54 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.01 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 2.65 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 2.29 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.12 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 3.6 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.426 ' C ' HD23 ' B' ' 216' ' ' LEU . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 1.51 110.929 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.22 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 2.69 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 3.4 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.67 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.39 111.319 -179.541 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.52 HD12 ' N ' ' C' ' 6' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.799 0.333 . . . . 2.79 110.998 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.08 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 1.43 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.16 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.09 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 1.58 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.96 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 0.96 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.3 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 1.52 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.9 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 0.96 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.07 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.08 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.02 110.306 179.672 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 6.6 p90 . . . . . 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.37 111.235 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.72 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.67 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.93 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 1.88 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.23 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.09 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 1.41 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 0.8 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.72 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 1.68 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.426 ' HZ3' HG21 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 1.68 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.28 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.51 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.33 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.57 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 1.67 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.42 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 0.71 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.14 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 0.88 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.38 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.94 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.502 ' HB2' HG21 ' A' ' 127' ' ' VAL . 18.6 tp60 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.87 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 2.86 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 1.95 111.248 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.11 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.54 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.47 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 2.85 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 1.87 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.544 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.26 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.08 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 0.86 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.471 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 1.96 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 1.8 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.18 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.33 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 1.85 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.56 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.433 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.11 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.49 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.657 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 1.6 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.01 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.18 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 1.54 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 1.65 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.1 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.38 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' C' ' 168' ' ' LEU . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.481 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 1.87 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 3.1 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.02 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.34 110.689 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.21 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 4.54 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.34 110.714 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.4 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.54 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 5.21 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.38 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.422 HD12 ' N ' ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 2.64 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.38 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.62 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 2.93 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.478 HD12 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.16 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.491 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.3 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.07 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.439 ' O ' HG23 ' C' ' 112' ' ' VAL . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.3 111.596 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 13.9 mm100 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.48 111.342 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 1.93 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 1.67 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 108' ' ' THR . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.11 111.518 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 2.59 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.44 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.9 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.92 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.55 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 1.49 110.582 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.576 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 1.66 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.94 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.29 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.15 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.31 110.839 -179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.507 HG23 HG21 ' B' ' 56' ' ' ILE . 7.1 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.808 0.337 . . . . 1.31 111.236 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 2.84 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 2.7 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.38 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 1.76 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.15 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.56 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.73 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 1.48 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . 0.415 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.149 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.05 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.07 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.92 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.415 HG12 ' O ' ' C' ' 138' ' ' ALA . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 2.64 111.33 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . 0.409 ' O ' HG22 ' C' ' 146' ' ' ILE . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.51 110.742 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 3.58 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.65 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.409 HG22 ' O ' ' C' ' 143' ' ' LEU . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.46 111.6 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.27 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 54.9 t30 . . . . . 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.33 111.959 -179.429 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 C--O 1.23 0.034 0 CA-C-O 120.831 0.348 . . . . 2.82 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.18 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.5 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.81 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.13 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.21 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.31 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.26 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.756 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' C' ' 87' ' ' LEU . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.916 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 1.73 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.43 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.72 110.63 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 1.55 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 1.5 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.84 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.12 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.475 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 1.75 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.72 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.642 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 1.8 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 0.88 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 1.52 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.2 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.47 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.511 HG22 HG23 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 1.62 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.511 HG23 HG22 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 2.63 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.77 112.757 179.741 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.797 0.332 . . . . 2.37 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.68 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.95 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.05 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.91 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.04 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 1.62 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.49 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.32 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 1.84 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.68 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.04 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 2.65 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.33 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.02 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.35 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 3.62 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.415 ' O ' HD23 ' C' ' 216' ' ' LEU . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 1.64 110.771 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.11 111.259 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 3.37 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 76.7 mt . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.11 111.19 -179.746 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.3 pt? . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.642 0.258 . . . . 3.23 111.255 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 1.88 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.29 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.99 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.92 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 1.45 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.89 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 0.9 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.83 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.592 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.24 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.29 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 1.71 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.96 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.99 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.11 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.23 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 . . . . . 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.02 110.637 179.447 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 112.4 0.519 . . . . 3.41 112.4 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 2.81 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.593 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.39 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.24 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 1.6 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.33 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.03 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 1.31 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.59 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 1.63 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.12 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.32 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.52 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 0.98 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.52 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 1.69 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.461 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.12 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 0.6 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.94 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.78 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.442 HD13 HD23 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.23 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.61 HE21 ' H ' ' A' ' 59' ' ' GLY . 22.6 tp60 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.1 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.61 ' H ' HE21 ' A' ' 58' ' ' GLN . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 1.76 110.884 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.84 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 1.84 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.24 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.16 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 2.84 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.39 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 0.97 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.04 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.38 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 0.76 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' A' ' 54' ' ' MET . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 2.93 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.13 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 1.66 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.09 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 117' ' ' LEU . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.52 110.412 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.33 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.39 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.61 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 1.55 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.01 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 1.45 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.412 ' O ' HD13 ' A' ' 83' ' ' LEU . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.3 110.618 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 1.67 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 1.87 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.42 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.4 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 1.91 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 2.33 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 1.43 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.19 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 2.55 110.993 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.33 110.866 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 5.1 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.07 111.464 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.41 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.31 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.94 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 5.98 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.24 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.67 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 2.59 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 3.14 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 1.99 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.36 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.05 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 112' ' ' VAL . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.25 111.837 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 2.72 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 1.88 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 1.6 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 108' ' ' THR . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.09 111.216 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 2.65 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 117' ' ' LEU . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.89 110.961 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 1.58 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.04 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.1 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.88 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.29 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.49 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.13 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 3.97 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.22 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 2.81 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.25 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 1.84 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.54 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 1.79 110.878 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.08 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 1.76 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.76 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.07 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.85 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.32 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 3.25 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.92 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 2.65 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.21 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.01 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 3.6 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.62 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.422 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 2.47 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 2.48 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 2.69 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo . . . . . 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.36 112.384 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.873 0.368 . . . . 2.63 110.88 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.16 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.37 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.83 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.16 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 1.59 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.31 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.15 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.39 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.42 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 171' ' ' TYR . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.12 111.593 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.437 ' N ' HG23 ' A' ' 170' ' ' THR . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 3.86 110.206 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 1.58 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 1.41 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 1.42 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 1.91 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.55 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 1.86 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.74 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 1.78 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 0.92 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 184' ' ' ILE . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 1.77 111.524 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 183' ' ' TRP . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.34 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.621 ' CD2' HG23 ' A' ' 182' ' ' VAL . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.51 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 181' ' ' ILE . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.02 111.265 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.45 110.676 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 1.73 112.335 179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.748 0.309 . . . . 2.66 111.019 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 1.81 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.21 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 201' ' ' LEU . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.18 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.01 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 1.93 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 1.7 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.468 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.28 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 211' ' ' VAL . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.51 110.244 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 1.93 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 1.71 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.04 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 207' ' ' PHE . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 2.89 110.958 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.31 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 2.87 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.38 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 3.42 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.24 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.44 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.51 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.01 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.59 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 3.49 111.259 179.984 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.76 0.314 . . . . 3.08 110.918 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.35 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 61.8 m-70 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 1.39 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 1.71 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 1.48 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 0.95 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.97 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.8 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.29 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.36 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.23 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.98 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.12 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.0 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 4.26 110.589 179.752 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 2.1 p90 . . . . . 0 N--CA 1.464 0.231 0 CA-C-O 120.705 0.288 . . . . 3.17 111.536 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.57 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.74 111.299 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 1.72 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.439 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 1.95 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.2 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.434 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.12 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 1.49 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 0.77 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.68 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.434 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 1.63 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.91 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.87 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.55 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.06 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.19 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' B' ' 58' ' ' GLN . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.66 110.891 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.86 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.84 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 1.44 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' C' ' 122' ' ' SER . 17.3 mm100 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.24 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.31 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.81 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.18 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.03 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.48 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.37 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.549 HE22 ' HA ' ' B' ' 123' ' ' GLU . 10.0 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.28 110.881 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.78 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.05 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.11 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.431 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.3 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 0.72 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.04 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 1.79 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 1.44 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.554 ' O ' HG22 ' B' ' 79' ' ' THR . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.31 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.01 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.43 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.421 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.21 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.18 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.641 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 1.65 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.06 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.515 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 1.58 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 1.72 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.515 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 1.96 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.24 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.581 HD22 HD11 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.21 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.32 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.15 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.05 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 2.68 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 2.71 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 4.19 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 2.79 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.27 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.57 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.24 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 5.39 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.16 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 2.58 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.48 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 2.76 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.22 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.36 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 1.92 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.06 111.528 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 2.87 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 1.98 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 1.62 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.83 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.74 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.6 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.42 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.493 ' N ' HD12 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 1.51 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.09 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.16 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 1.76 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . 0.549 ' HA ' HE22 ' B' ' 66' ' ' GLN . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.89 110.691 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 2.67 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.07 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 1.41 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 2.47 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 2.61 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . 0.442 HD23 HD13 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.07 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 1.67 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 1.54 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.7 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' B' ' 180' ' ' PRO . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 1.44 111.584 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 1.82 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.94 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 1.6 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.448 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 1.96 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.448 ' N ' HG13 ' B' ' 141' ' ' ILE . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 2.88 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 4.15 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.59 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.13 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 1.78 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.45 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.36 112.868 -179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.889 0.376 . . . . 2.4 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 2.57 110.614 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 1.72 111.257 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.69 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.16 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.13 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.94 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.33 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.581 HD11 HD22 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 1.56 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.59 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.14 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 3.87 110.289 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 1.61 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.439 ' O ' HG22 ' B' ' 177' ' ' ILE . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.3 111.524 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 1.53 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 1.99 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.5 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 173' ' ' THR . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 1.46 110.565 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.673 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 1.73 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 0.93 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 1.36 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.585 HG23 ' CD2' ' B' ' 183' ' ' TRP . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.19 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . 0.585 ' CD2' HG23 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 2.73 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 1.93 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 2.64 111.071 -179.909 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.821 0.343 . . . . 2.2 111.247 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.49 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 1.76 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.18 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . 0.481 HD22 ' N ' ' B' ' 201' ' ' LEU . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 1.98 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 1.65 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.11 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.477 HD12 HG21 ' B' ' 182' ' ' VAL . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 1.43 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD2' ' C ' ' B' ' 203' ' ' CYS . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.432 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.6 110.437 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 1.77 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.418 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.54 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.01 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 207' ' ' PHE . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 2.65 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.33 112.468 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 2.29 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.12 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 3.6 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 1.51 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.22 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 2.69 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 3.4 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.67 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 58.8 tp . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.39 111.566 -179.846 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.75 0.309 . . . . 2.79 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.08 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 1.43 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.553 ' O ' HG12 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.16 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.09 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 1.58 110.949 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.96 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 0.96 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.3 110.575 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 1.52 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 1.9 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 0.96 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.07 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.08 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.02 110.425 179.716 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.37 111.559 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.72 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.67 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 1.93 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.88 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.23 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.434 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.09 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 1.41 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.62 HG23 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 0.8 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.72 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 1.68 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 1.68 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.28 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.51 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.33 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.57 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 1.67 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.536 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.42 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.71 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.14 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.88 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.517 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.38 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.94 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 1.87 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.45 ' HZ2' ' HA ' ' C' ' 69' ' ' HIS . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 2.86 110.957 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.11 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.54 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.47 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 2.85 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.87 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.12 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.26 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.476 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.08 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 0.86 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.454 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 1.96 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 1.8 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.476 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.18 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.33 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 1.85 110.733 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.56 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.11 111.908 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.62 HG23 HG23 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.49 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 1.6 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.01 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.18 111.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 1.54 111.286 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.483 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 1.65 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD12 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.1 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.38 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 1.44 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.87 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 3.1 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 1.48 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . 0.463 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.02 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.34 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.21 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 4.54 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.34 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.4 110.978 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.54 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 5.21 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.38 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 2.64 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.38 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.62 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 2.93 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.16 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.449 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.3 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.07 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' HG23 ' C' ' 112' ' ' VAL . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.3 111.517 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.48 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 1.93 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 1.67 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 108' ' ' THR . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.11 111.158 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 2.59 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.9 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.92 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.55 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 1.49 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.445 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 1.66 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.94 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.29 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.503 ' HA ' HE22 ' B' ' 58' ' ' GLN . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.15 110.982 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.31 110.848 179.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 N--CA 1.456 -0.168 0 CA-C-O 120.862 0.363 . . . . 1.31 110.984 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 2.84 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 2.7 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 1.88 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.38 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 1.76 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.15 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.56 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.73 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 1.48 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.51 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.01 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.05 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.07 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.459 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 1.92 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.459 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 2.64 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 3.58 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.65 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.46 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.27 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.33 112.019 -179.576 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.78 0.324 . . . . 2.82 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.18 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . 0.416 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.5 110.752 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 1.81 111.165 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.13 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.21 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.31 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.26 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.58 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.3 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 1.73 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.43 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . 0.419 ' O ' HG22 ' C' ' 174' ' ' VAL . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.72 110.887 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 1.55 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.5 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . 0.419 HG22 ' O ' ' C' ' 171' ' ' TYR . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 1.84 111.88 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.12 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 1.75 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.72 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 1.8 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 0.88 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.552 ' O ' HG22 ' C' ' 184' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 1.52 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' C' ' 183' ' ' TRP . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.2 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . 0.67 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.47 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.552 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.62 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 2.63 110.943 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.77 112.194 -179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.694 0.283 . . . . 2.37 111.385 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.68 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 1.95 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.05 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.91 111.651 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.04 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.62 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.49 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.32 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 1.52 110.256 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 1.84 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.68 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.04 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 2.65 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.33 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.02 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.35 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 3.62 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 1.64 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.11 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 3.37 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.11 111.759 -179.481 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.755 0.312 . . . . 3.23 111.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 1.88 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.29 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.99 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.92 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 0.89 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.9 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.83 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.24 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.29 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 1.71 110.622 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.96 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 0.99 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.11 110.535 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.23 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.02 111.068 179.722 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 . . . . . 0 CA--C 1.533 0.301 0 N-CA-C 113.003 0.742 . . . . 3.41 113.003 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' A' ' 36' ' ' GLU . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 2.81 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' N ' ' CG ' ' A' ' 35' ' ' TYR . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.39 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.24 110.157 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 1.6 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 43' ' ' ILE . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.33 110.52 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.03 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.0 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 1.31 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.59 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 1.63 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.12 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.32 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.52 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.98 110.7 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.52 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 1.69 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.12 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 0.6 110.72 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.94 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 0.78 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' ALA . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.728 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.499 HE22 ' HA ' ' B' ' 122' ' ' SER . 15.9 mm100 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.657 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 1.76 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 1.84 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.64 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 1.84 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.24 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.16 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 2.84 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.39 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.97 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.04 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.38 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 0.76 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 2.93 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.13 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 1.66 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.42 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.09 111.499 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.52 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.33 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.39 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 1.55 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.01 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 1.45 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.3 109.772 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 1.67 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 1.87 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.42 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 168' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.4 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 1.91 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 2.33 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 1.43 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.33 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 5.1 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.07 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.41 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.31 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.94 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 5.98 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.24 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.67 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 2.59 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.53 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 3.14 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 1.99 110.936 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.36 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.05 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 112' ' ' VAL . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.25 111.501 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' HD22 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 2.72 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 1.88 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.6 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 108' ' ' THR . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.09 111.112 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 2.65 110.507 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.89 110.47 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.424 ' HA ' HG22 ' A' ' 118' ' ' ILE . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 0.68 110.204 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 1.58 112.268 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 115' ' ' SER . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.418 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.1 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.88 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 1.53 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.29 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.49 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.13 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 3.97 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.22 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 2.81 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.25 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 1.84 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.54 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 1.79 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.08 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.409 ' SG ' HD22 ' C' ' 49' ' ' LEU . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 1.76 110.705 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.76 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.07 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 1.85 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.32 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 3.25 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 2.92 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 141' ' ' ILE . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 2.65 111.346 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.21 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.01 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 3.6 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.62 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 2.47 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 2.48 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.633 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 2.69 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo . . . . . 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.36 112.992 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.859 0.361 . . . . 2.63 111.135 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.16 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.37 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 2.83 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 1.7 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.16 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 1.59 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.31 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.15 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.39 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.51 HD11 HD22 ' A' ' 87' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.79 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.42 111.31 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.12 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.86 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 1.58 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 177' ' ' ILE . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 1.41 111.53 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 1.42 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 1.91 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.55 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 1.86 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.74 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 1.78 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 0.92 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 1.77 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.34 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.51 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.02 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.45 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 1.73 112.531 179.862 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.851 0.357 . . . . 2.66 110.97 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 1.81 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.18 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.01 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.491 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 1.93 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 1.7 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.28 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 1.51 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 1.93 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 1.71 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.754 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 2.89 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.31 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 2.87 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.38 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 3.42 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.24 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.44 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.51 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.01 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.59 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt . . . . . 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 3.49 110.916 -179.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.441 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp . . . . . 0 N--CA 1.457 -0.088 0 CA-C-O 120.797 0.332 . . . . 3.08 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.35 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 1.39 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 1.71 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 1.48 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.95 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.97 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.8 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.29 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.36 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.475 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.23 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.98 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.12 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.0 111.049 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 3.2 p90 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 4.26 111.298 -179.584 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.535 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 114.012 1.116 . . . . 3.17 114.012 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.535 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.57 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.74 112.191 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' B' ' 35' ' ' TYR . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 1.72 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 1.95 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.2 110.803 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.441 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.12 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 1.49 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.592 HG23 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 0.77 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.68 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 1.63 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.546 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 1.91 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.22 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.55 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 0.87 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 0.55 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.06 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.41 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.19 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 0.66 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.86 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.84 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 1.44 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.664 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.1 tp60 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.24 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . 0.664 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.31 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 1.81 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.18 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.03 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.48 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.37 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.28 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.78 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.05 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.11 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.3 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 0.72 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.04 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.479 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 1.79 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 1.44 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.31 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.479 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.01 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.43 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.499 ' O ' HD23 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.21 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.592 HG23 HG23 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.18 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.581 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 1.65 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.06 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 1.58 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 1.49 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.598 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 1.72 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 1.96 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.24 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.21 111.125 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.32 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.15 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 86' ' ' SER . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 1.44 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 2.68 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.452 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 2.71 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . 0.452 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 4.19 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 2.79 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.27 111.271 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.57 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.24 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 5.39 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.16 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 2.58 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.29 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.48 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 2.76 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' B' ' 109' ' ' GLN . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.22 111.084 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.428 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.36 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 1.92 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.4 ' O ' HG23 ' B' ' 112' ' ' VAL . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.06 111.231 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.598 ' HG3' HD22 ' B' ' 84' ' ' LEU . 15.4 mm100 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 2.87 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 1.98 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 1.62 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 108' ' ' THR . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.04 111.504 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.46 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.83 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.74 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.6 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.474 HD12 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.42 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.474 HG13 HD12 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 1.51 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.09 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.16 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.499 ' HA ' HE22 ' A' ' 58' ' ' GLN . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 1.76 110.721 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.89 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.676 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.67 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . 0.676 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.07 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.41 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 2.47 110.664 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 2.61 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.07 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.3 111.173 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.67 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 1.54 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.7 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.44 111.27 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.94 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . 0.404 ' HA ' HG12 ' B' ' 142' ' ' ILE . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.6 111.313 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.01 111.444 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.96 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' B' ' 139' ' ' PHE . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 2.88 111.71 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.52 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 4.15 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.59 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.13 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 1.78 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 3.0 t-20 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.45 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo . . . . . 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.36 113.087 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 C--O 1.233 0.191 0 CA-C-O 120.968 0.413 . . . . 2.4 110.883 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 2.57 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 1.72 111.691 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 2.69 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.16 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . 0.477 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.13 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.94 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.33 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 1.56 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 165' ' ' TYR . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 1.59 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.14 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 3.87 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.61 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.3 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 1.53 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.99 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . 0.485 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.5 110.545 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.521 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 1.46 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.551 ' O ' HG22 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 1.73 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 0.93 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.546 ' O ' HG22 ' B' ' 184' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 1.36 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.19 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 2.73 111.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 1.93 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 184' ' ' ILE . 34.8 pt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 2.64 111.4 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.758 0.313 . . . . 2.2 111.218 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.49 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.76 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.18 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.78 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 1.98 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 1.65 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.11 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.699 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 1.43 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 1.6 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 1.77 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.475 ' HB2' HD11 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.54 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.01 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 2.65 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.33 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 2.29 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.12 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 3.6 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.51 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.22 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 2.69 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 3.4 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.67 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . 0.416 HD22 ' N ' ' B' ' 221' ' ' LEU . 3.6 mm? . . . . . 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.39 110.891 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.682 0.277 . . . . 2.79 111.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.08 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.43 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.16 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.09 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 1.58 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.96 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.96 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.3 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 1.52 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 1.9 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 0.96 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.07 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.08 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 77.4 t60 . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.02 111.049 179.564 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.423 ' CG ' ' N ' ' C' ' 36' ' ' GLU . 12.2 p90 . . . . . 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.37 112.313 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . 0.423 ' N ' ' CG ' ' C' ' 35' ' ' TYR . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.72 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.67 110.109 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 1.93 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 1.88 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.23 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.426 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.09 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 1.41 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.613 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 0.8 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.72 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.478 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 1.68 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . 0.478 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 1.68 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.28 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.51 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.409 HD22 ' SG ' ' A' ' 134' ' ' CYS . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.33 110.635 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.57 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 1.67 110.901 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.42 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 0.71 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.14 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 0.88 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.38 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.94 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.554 HE21 ' H ' ' C' ' 59' ' ' GLY . 24.8 tp60 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 1.87 110.866 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.554 ' H ' HE21 ' C' ' 58' ' ' GLN . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 2.86 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 1.95 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.11 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.54 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.47 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 2.85 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 1.87 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.12 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.26 110.809 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.08 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.86 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.132 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 1.8 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.18 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.33 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . 0.505 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 1.85 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.56 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.517 ' O ' HD23 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.11 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.613 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.49 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 1.6 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.01 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.517 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.18 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 1.54 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 1.65 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.1 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.437 ' O ' HG23 ' C' ' 90' ' ' THR . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.38 110.627 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.415 HD22 HD11 ' C' ' 168' ' ' LEU . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.44 110.645 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 1.87 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 3.1 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 ' O ' ' C' ' 86' ' ' SER . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 1.48 110.998 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.02 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.34 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 4.54 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.34 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.4 111.311 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.54 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 5.21 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.38 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 2.64 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.38 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.62 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 2.93 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.16 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.416 ' O ' HG12 ' C' ' 110' ' ' ILE . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.3 110.894 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.07 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.682 HG21 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.3 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.411 HE21 HG13 ' C' ' 113' ' ' ILE . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.48 110.287 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 1.93 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 1.67 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.11 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.411 HG13 HE21 ' C' ' 109' ' ' GLN . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 2.59 110.515 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 0.92 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.55 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 1.49 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 1.66 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.94 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.29 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.611 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.31 110.965 -179.952 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 CA--C 1.527 0.09 0 CA-C-O 120.873 0.368 . . . . 1.31 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . 0.611 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 2.84 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 2.7 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 1.88 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.38 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . 0.405 ' HE1' ' HB3' ' C' ' 183' ' ' TRP . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.76 110.901 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.15 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.73 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 1.48 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.51 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.01 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.05 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.07 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 1.92 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.682 HD13 HG21 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 2.64 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.58 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.65 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.46 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.27 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 7.1 t30 . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.33 112.402 -179.453 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.82 0.343 . . . . 2.82 111.112 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.18 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 1.81 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.13 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . 0.413 ' HA ' ' HE2' ' C' ' 167' ' ' LYS . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.21 110.888 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.31 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.26 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' C' ' 164' ' ' LEU . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.58 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.415 HD11 HD22 ' C' ' 87' ' ' LEU . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.3 110.583 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 1.73 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 1.43 111.031 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.72 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 1.55 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 1.5 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 1.84 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.12 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 1.75 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.72 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.625 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 1.8 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 0.88 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 1.52 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.2 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . 0.405 ' HB3' ' HE1' ' C' ' 132' ' ' TYR . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.47 110.778 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.62 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 2.63 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.77 112.752 179.755 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.4 tt . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.904 0.383 . . . . 2.37 110.76 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.68 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.05 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 1.91 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.04 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.501 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 1.62 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.49 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.32 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 1.52 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 1.84 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.68 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.04 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.446 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 2.65 110.439 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.446 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.33 111.844 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.02 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.35 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 3.62 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 1.64 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.11 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 3.37 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.11 110.841 179.875 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.788 0.328 . . . . 3.23 110.678 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 1.88 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.29 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.99 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 1.92 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 15' ' ' MET . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 1.45 109.981 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 0.89 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 0.9 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.83 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.24 110.904 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.71 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.96 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.99 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.11 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.02 110.469 179.64 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 . . . . . 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 3.41 112.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.517 ' HA ' HD23 ' A' ' 38' ' ' LEU . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 2.81 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.39 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.24 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 1.6 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.33 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.03 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.0 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 1.31 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.59 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 1.63 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.12 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.32 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.52 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.98 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.52 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 1.69 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.12 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.6 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 0.78 110.255 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.23 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.557 ' NE2' HG11 ' B' ' 127' ' ' VAL . 85.0 mm-40 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.1 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 1.76 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.84 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.64 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 1.84 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.24 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.16 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 2.84 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.39 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.97 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.04 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.38 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.76 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 2.93 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.13 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 75' ' ' ASP . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 1.66 110.496 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 74' ' ' ILE . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.42 109.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.09 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.52 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.33 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.39 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 1.55 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.01 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.3 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 1.67 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 1.87 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.42 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.4 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 1.91 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 2.33 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.43 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.19 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 2.55 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.33 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 5.1 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.07 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.41 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.31 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.94 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 5.98 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.24 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 2.67 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 2.59 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.53 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 108' ' ' THR . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 3.14 111.072 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 1.99 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.36 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.05 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.25 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 2.72 111.213 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 1.88 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 1.6 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.09 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 2.65 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 0.89 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.68 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 1.58 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.04 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.1 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.88 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.29 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.49 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.694 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.13 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.694 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 3.97 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.22 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.81 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.25 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 1.84 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.54 111.041 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 1.79 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.08 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' C' ' 49' ' ' LEU . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 1.76 111.013 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.76 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.07 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.85 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.32 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 3.25 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 2.92 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 142' ' ' ILE . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 2.65 111.413 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.21 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.01 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 3.6 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.62 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 2.47 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 2.48 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.3 t-20 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 2.69 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo . . . . . 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.36 112.994 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.862 0.363 . . . . 2.63 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.16 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.37 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.83 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 1.7 111.342 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.16 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 1.59 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.31 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.15 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.39 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 1.79 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.42 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.12 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.439 ' O ' HD13 ' A' ' 175' ' ' LEU . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 3.86 110.357 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 1.58 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 1.41 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 1.42 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 171' ' ' TYR . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 1.91 111.149 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.55 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 1.86 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.74 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 182' ' ' VAL . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 1.78 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 0.92 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 1.77 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.34 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.51 111.883 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.02 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 182' ' ' VAL . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.45 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 1.73 112.37 179.837 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 . . . . . 0 C--O 1.233 0.212 0 CA-C-O 120.869 0.366 . . . . 2.66 111.133 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 1.81 111.217 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.21 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.453 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.18 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.01 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 1.93 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 1.7 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.28 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 1.51 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 1.93 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 1.71 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.04 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 2.89 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.31 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 2.87 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.38 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 3.42 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.24 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.44 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.51 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.01 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.59 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 3.49 110.88 179.798 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pp . . . . . 0 N--CA 1.46 0.055 0 CA-C-O 120.682 0.277 . . . . 3.08 111.325 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.459 HD22 ' N ' ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.35 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 1.39 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 1.71 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 1.48 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 0.95 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.97 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.8 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.29 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.36 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 0.98 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.12 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.0 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 . . . . . 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 4.26 110.197 179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.55 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.125 0 N-CA-C 113.185 0.809 . . . . 3.17 113.185 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.55 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.57 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.74 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 1.72 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.497 HG23 HD13 ' B' ' 43' ' ' ILE . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 1.95 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.12 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 1.49 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 0.77 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.68 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 1.63 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.586 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 1.91 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.22 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 0.87 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 0.55 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HA ' ' SD ' ' B' ' 54' ' ' MET . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.06 111.363 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.486 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.19 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' B' ' 51' ' ' TYR . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 0.86 110.23 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 0.84 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 1.44 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.456 ' NE2' HG11 ' C' ' 127' ' ' VAL . 84.3 mm-40 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.24 110.904 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.31 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 1.81 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.18 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.03 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.48 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.37 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.28 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 1.78 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.05 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.11 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.3 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 0.72 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.46 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.04 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 1.79 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 1.44 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.31 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.01 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.43 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.43 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.21 112.081 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.486 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.18 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.611 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 1.65 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.06 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.601 ' HB3' HD11 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 1.58 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 1.49 110.207 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 1.96 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.24 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.21 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.32 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' B' ' 35' ' ' TYR . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.15 111.324 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 1.44 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.05 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 2.68 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.71 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 4.19 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 2.79 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.27 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.57 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.24 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 5.39 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.16 111.624 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 2.58 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.29 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.48 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 2.76 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.22 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.36 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 1.92 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.617 ' HB ' HD13 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.06 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.435 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 2.87 111.274 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 1.98 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 1.62 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.04 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.465 HG22 HD21 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.83 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 0.74 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.6 112.701 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 73' ' ' TYR . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.42 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.51 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.09 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.16 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 1.76 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.89 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.546 ' HB2' HG12 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 2.67 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.07 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 58' ' ' GLN . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 1.41 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 2.47 110.729 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 2.61 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.07 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 1.67 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 1.44 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 1.82 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.94 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.6 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.01 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 1.96 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 2.88 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.52 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 4.15 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.59 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.13 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.4 t-20 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.45 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo . . . . . 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.36 112.711 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.848 0.356 . . . . 2.4 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 161' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 2.57 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.72 111.255 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.69 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . 0.426 HD12 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.16 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.13 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.94 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.33 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 1.56 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.59 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.14 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 3.87 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 1.61 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.53 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 1.99 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . 0.435 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.5 111.315 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.532 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 1.46 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.67 ' O ' HG22 ' B' ' 182' ' ' VAL . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 1.73 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 0.93 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.532 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 1.36 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.67 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.19 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 2.73 111.755 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.405 HG22 HG23 ' B' ' 185' ' ' ILE . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 1.93 111.602 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.412 ' H ' HG13 ' B' ' 185' ' ' ILE . 2.4 pp . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 2.64 111.421 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.832 0.349 . . . . 2.2 110.936 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.49 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.76 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.18 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 1.98 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 1.65 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.11 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.576 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 1.43 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG23 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 1.6 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 1.77 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.54 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.01 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.65 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.33 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 2.29 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.12 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 3.6 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 1.51 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.22 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 2.69 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 3.4 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.67 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.39 110.817 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.705 0.288 . . . . 2.79 111.223 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.08 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 73.5 m-70 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 1.43 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.468 ' O ' HG12 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.16 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.09 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 1.58 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.468 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 0.96 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.96 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.3 110.222 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 1.52 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.449 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.9 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 0.96 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.07 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.08 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.02 110.218 179.568 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.471 ' O ' HG22 ' C' ' 39' ' ' VAL . 1.5 p90 . . . . . 0 CA--C 1.53 0.208 0 N-CA-C 112.988 0.736 . . . . 3.37 112.988 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.72 112.679 -177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.67 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 1.93 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 35' ' ' TYR . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 1.88 113.15 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.23 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.09 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 1.41 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 0.8 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.72 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 1.68 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 1.68 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.28 111.69 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.51 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.473 HD22 ' SG ' ' A' ' 134' ' ' CYS . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.33 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.57 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 1.67 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.42 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 0.71 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.14 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 0.88 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.38 110.81 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.94 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.87 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 2.86 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 1.95 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.11 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.54 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.47 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 2.85 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.87 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.12 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.591 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.26 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.08 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 0.86 112.121 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 1.96 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 1.8 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.438 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.18 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.438 ' N ' HG23 ' C' ' 74' ' ' ILE . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.33 109.38 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 1.85 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.56 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.481 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.11 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.49 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 1.6 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.01 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.436 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.18 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 1.54 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' C' ' 109' ' ' GLN . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 1.65 110.767 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.1 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.38 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.637 HD22 HD11 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 1.44 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 3.1 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 1.48 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.02 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.34 110.907 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 4.54 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.34 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.4 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.54 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 5.21 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.38 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 2.64 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.38 110.697 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.62 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 2.93 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.16 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.3 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.07 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.512 ' HB ' HG21 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.3 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.532 HE22 ' HE1' ' C' ' 176' ' ' TRP . 14.7 mm100 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.586 HG22 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 1.93 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 1.67 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.11 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 2.59 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 0.9 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.92 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.55 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 1.49 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.433 HG12 HD12 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 1.66 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.94 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.29 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.15 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.31 111.038 -179.832 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.547 ' HA ' HD23 ' C' ' 130' ' ' LEU . 8.5 p . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.849 0.357 . . . . 1.31 110.869 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 2.84 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 2.7 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.88 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.38 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.76 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.15 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 1.56 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.73 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 1.48 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.01 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.05 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.07 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 141' ' ' ILE . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 1.92 111.568 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.64 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.51 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 3.58 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.65 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.46 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.27 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 8.0 t30 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.33 112.02 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.821 0.343 . . . . 2.82 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.18 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.5 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 1.81 111.193 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.13 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.437 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.969 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.26 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.58 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.637 HD11 HD22 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.3 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 165' ' ' TYR . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 1.73 111.336 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 1.43 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.72 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 1.55 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 1.5 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 1.84 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.43 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.12 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . 0.532 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.457 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 1.75 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.473 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.72 113.143 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.591 ' O ' HG22 ' C' ' 182' ' ' VAL . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 1.8 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 0.88 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.447 HG22 ' O ' ' C' ' 178' ' ' GLY . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 1.52 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.2 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.47 111.966 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.43 HG22 ' O ' ' C' ' 181' ' ' ILE . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 1.62 112.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.457 HG12 ' O ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 2.63 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.77 112.639 -179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . 0.487 ' N ' HD12 ' C' ' 197' ' ' ILE . 3.7 mp . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.757 0.313 . . . . 2.37 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.68 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 1.95 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.05 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.91 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.04 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 1.62 110.407 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.49 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.32 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . 0.429 ' HA ' HG22 ' C' ' 211' ' ' VAL . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 1.84 110.148 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.43 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.68 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.04 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.457 HG23 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 2.65 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.457 ' N ' HG23 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.33 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.02 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.35 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 3.62 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 1.64 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.11 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 3.37 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.11 111.247 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.824 0.345 . . . . 3.23 111.011 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 7' ' ' LEU . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.778 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.3 m-70 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.29 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 0.99 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 1.92 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 1.45 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.89 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 0.9 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.83 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.24 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.29 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 1.71 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.96 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 0.99 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.11 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.23 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.02 111.07 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 . . . . . 0 N--CA 1.463 0.224 0 N-CA-C 112.012 0.375 . . . . 3.41 112.012 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 2.81 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.39 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.24 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 1.6 110.929 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.33 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.03 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 1.31 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.0 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.59 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 1.63 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.12 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.32 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.52 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 0.98 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.52 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 1.69 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.12 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HE1' ' B' ' 131' ' ' TRP . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 0.6 110.868 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 0.94 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.78 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 56' ' ' ILE . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.23 110.698 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.1 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 1.76 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.84 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.64 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 1.84 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.24 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.16 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.65 HE21 ' H ' ' A' ' 67' ' ' ILE . 25.0 tp60 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 2.84 110.996 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.65 ' H ' HE21 ' A' ' 66' ' ' GLN . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.39 111.123 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.97 111.128 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.04 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.38 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 0.76 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 2.93 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.13 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.42 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.43 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.09 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.52 111.007 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.33 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.39 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 1.55 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.01 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 1.45 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.3 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 1.67 110.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 1.87 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.42 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.4 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 1.91 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.19 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 2.55 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.33 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 5.1 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.07 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.41 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.31 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.94 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 5.98 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.24 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 2.67 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 2.59 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.53 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 3.14 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.99 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.36 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.05 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.25 111.828 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.532 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 3.8 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 2.72 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 1.88 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.6 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.09 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 2.65 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.89 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 0.68 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 1.58 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.04 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.1 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.88 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.29 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.49 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' HG12 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.13 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 3.97 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.22 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 2.81 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.25 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' VAL . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 1.84 110.598 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.558 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 184' ' ' ILE . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.79 110.701 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.08 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 1.76 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.76 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.07 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.426 ' HA ' HD12 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 1.85 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.32 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 3.25 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 2.92 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 2.65 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 141' ' ' ILE . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.21 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.01 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 3.6 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.62 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 2.47 111.371 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 3.0 t-20 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 2.69 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.36 113.327 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.895 0.379 . . . . 2.63 111.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.16 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.37 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.83 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.7 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.16 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 1.59 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.497 ' N ' HD12 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.31 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.15 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.39 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.42 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.12 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 3.86 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 1.58 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 1.41 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 1.42 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 1.91 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.55 111.538 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.86 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.74 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.596 ' O ' HG22 ' A' ' 182' ' ' VAL . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 1.78 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 0.92 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 1.77 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.34 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.51 112.76 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 132' ' ' TYR . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.02 112.148 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.45 112.468 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 1.73 113.18 179.886 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.755 0.312 . . . . 2.66 110.764 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 1.81 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.21 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.18 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.01 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 1.93 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 1.7 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.28 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 1.93 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 1.71 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.04 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 212' ' ' GLY . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 2.89 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 211' ' ' VAL . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.31 112.196 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 2.87 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.38 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 3.42 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.24 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.44 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.51 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.01 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.59 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 3.49 111.135 -179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 10' ' ' ILE . 29.0 tp . . . . . 0 N--CA 1.466 0.362 0 N-CA-C 111.698 0.259 . . . . 3.08 111.698 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.35 110.95 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 1.39 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 6' ' ' LEU . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 1.71 110.315 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 1.48 110.688 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.95 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.97 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.8 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.472 ' HG3' ' HA2' ' B' ' 48' ' ' GLY . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.29 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.36 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.98 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.12 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 4.26 110.464 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER . . . . . 0 C--O 1.236 0.353 0 N-CA-C 114.514 1.302 . . . . 3.17 114.514 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.557 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.57 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.74 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 1.72 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 1.95 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.2 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.12 110.159 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 1.49 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.436 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 0.77 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.68 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 1.63 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 1.91 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.22 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . 0.472 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.55 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.421 HD22 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.87 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.55 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.06 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.19 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 0.66 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.86 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 0.84 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.497 HG21 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.24 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.31 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 1.81 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.18 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.03 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.48 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.37 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.28 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.78 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.05 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.623 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.11 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.3 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.475 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.72 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.04 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.463 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 1.79 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.475 HG22 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 1.44 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.31 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.463 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.01 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.512 ' HE2' HD11 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.43 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.466 ' O ' HD23 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.21 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.429 HG23 HG23 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.18 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.562 HG21 HD11 ' B' ' 113' ' ' ILE . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 1.65 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.06 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 1.58 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.49 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.536 ' H ' HD23 ' B' ' 84' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 1.72 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 1.96 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.24 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.438 HD23 ' HE1' ' B' ' 213' ' ' PHE . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.21 110.276 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.32 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . 0.689 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.15 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 1.44 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 2.68 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 2.71 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 4.19 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 2.79 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.27 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.57 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.24 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 5.39 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.16 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 2.58 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.29 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.48 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.437 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 2.76 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.497 HD13 HD12 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.22 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . 0.436 ' N ' HD12 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.36 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 1.92 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.06 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.587 HE21 HD11 ' B' ' 113' ' ' ILE . 57.7 tp60 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 2.87 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 1.98 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.62 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.04 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.587 HD11 HE21 ' B' ' 109' ' ' GLN . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.46 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 0.83 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.6 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 77' ' ' MET . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.42 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 1.51 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.09 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.16 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 1.76 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.89 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 2.67 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.07 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 1.41 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 2.47 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 2.61 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.07 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . 0.402 ' HE1' ' HB1' ' A' ' 53' ' ' ALA . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.695 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 1.75 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 1.67 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.7 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 1.44 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 1.82 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.94 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 1.6 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.01 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 1.96 111.739 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 2.88 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 4.15 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.59 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.13 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 1.78 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.45 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.36 113.303 -179.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.7 0.286 . . . . 2.4 110.979 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 2.57 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 1.72 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 2.69 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.16 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.13 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.94 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.33 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 1.56 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.59 111.142 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.14 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 3.87 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 1.61 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.453 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.3 111.442 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 1.53 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 1.99 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.5 110.761 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.453 HG22 ' O ' ' B' ' 173' ' ' THR . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 1.46 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.497 ' O ' HG22 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.707 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 1.73 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 0.93 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 1.36 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.19 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . 0.536 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 2.73 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 1.93 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.426 HG23 ' O ' ' B' ' 181' ' ' ILE . 26.8 pt . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 2.64 111.279 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . 0.465 ' N ' HD12 ' B' ' 197' ' ' ILE . 3.0 mp . . . . . 0 C--O 1.233 0.199 0 CA-C-O 120.643 0.259 . . . . 2.2 111.386 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.49 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.18 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.78 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 1.98 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.461 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 1.65 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.11 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 1.43 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.6 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 1.77 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.54 110.874 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.01 111.022 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 2.65 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.33 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . 0.438 ' HE1' HD23 ' B' ' 87' ' ' LEU . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 2.29 110.796 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.12 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 3.6 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 1.51 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.22 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.69 111.369 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 3.4 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.67 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.39 111.085 -179.707 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.72 0.295 . . . . 2.79 111.087 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.535 ' H ' HD22 ' C' ' 7' ' ' LEU . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.08 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 1.43 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.16 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.09 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 1.58 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.0 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.96 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 0.96 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.3 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 1.52 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 1.9 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . 0.476 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 0.96 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.07 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.08 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.02 111.372 -179.871 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 . . . . . 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.37 111.055 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.72 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.67 110.533 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 1.93 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 1.88 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.23 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.09 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 1.41 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 0.8 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.72 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 1.68 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 1.68 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.51 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.33 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.57 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 1.67 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.42 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 0.71 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.14 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.88 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.451 HG22 ' O ' ' C' ' 56' ' ' ILE . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.38 110.507 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.94 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 1.87 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 2.86 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 1.95 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.11 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.54 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.47 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 2.85 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 1.87 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.12 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.26 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.517 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.08 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.86 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 1.96 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 1.8 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.18 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.33 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 1.85 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.426 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.56 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.11 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.49 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.523 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 1.6 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.01 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.18 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 1.54 109.449 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 1.65 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.429 HD23 ' O ' ' C' ' 81' ' ' PRO . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.1 111.019 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.38 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 1.44 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 1.87 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 3.1 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 1.48 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.02 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.34 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.21 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 4.54 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.34 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.4 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.54 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 5.21 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.38 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 2.64 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.38 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.62 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 2.93 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD11 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.16 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.3 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.07 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.3 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.48 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 1.93 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 1.67 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.11 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 2.59 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 0.9 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.92 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.55 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 1.49 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 1.66 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.94 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.624 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.29 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.15 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.31 110.758 179.884 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.709 0.29 . . . . 1.31 111.107 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 2.84 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . 0.431 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 2.7 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 1.88 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.38 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.76 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . 0.431 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.15 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . 0.421 ' SG ' HD22 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.56 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.73 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 1.48 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.51 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.01 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.05 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.07 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.92 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.406 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 2.64 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.51 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 3.58 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.65 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.419 HD13 HD23 ' C' ' 105' ' ' LEU . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.46 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.27 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.33 112.426 -178.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.762 0.315 . . . . 2.82 110.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.18 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.5 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.81 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.13 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.21 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.31 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.26 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.58 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 1.73 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 1.43 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.72 110.5 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.434 ' O ' HG22 ' C' ' 177' ' ' ILE . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 1.5 111.506 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 1.84 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.12 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . 0.503 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.529 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.72 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 1.8 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 0.88 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 1.52 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.2 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.47 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 1.62 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 2.63 111.77 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.77 112.781 -179.983 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt . . . . . 0 CA--C 1.528 0.117 0 CA-C-O 120.874 0.369 . . . . 2.37 111.187 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.68 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.95 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.05 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 1.91 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.04 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.484 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 1.62 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.49 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.32 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' C' ' 211' ' ' VAL . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 1.84 110.808 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.68 110.656 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.04 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 208' ' ' PHE . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 2.65 110.793 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.33 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.02 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.35 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 3.62 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 1.64 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' C' ' 214' ' ' SER . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.11 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 3.37 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.11 111.256 -179.436 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 70.2 mt . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.976 0.417 . . . . 3.23 111.183 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HD1' ' A' ' 200' ' ' PHE . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 1.88 111.135 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.29 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 0.99 110.262 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 1.92 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 1.45 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 0.89 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 0.9 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.83 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.24 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.29 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 1.71 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.96 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 0.99 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.11 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.23 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.1 t80 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.02 110.696 179.732 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 . . . . . 0 N--CA 1.461 0.1 0 N-CA-C 112.53 0.566 . . . . 3.41 112.53 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 2.81 111.998 -178.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.39 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.24 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 1.6 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.33 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.03 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 1.31 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.442 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.59 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 1.63 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.12 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.32 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.52 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.98 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.52 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 1.69 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG2' HG11 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.12 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 0.6 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.94 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 0.78 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' ILE . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.23 110.745 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.1 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 1.76 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 1.84 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.64 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 1.84 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.24 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.16 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 2.84 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.39 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.97 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.04 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.38 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.76 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 2.93 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.13 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 1.66 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 79' ' ' THR . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.42 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.09 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.33 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.39 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 1.55 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.01 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 1.45 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.3 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 1.67 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 1.87 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.42 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 1.91 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 2.33 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.43 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.19 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 2.55 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.33 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 5.1 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.07 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.41 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.31 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.94 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 5.98 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.24 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 2.67 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 2.59 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.53 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 3.14 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.99 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.36 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.05 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.501 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 2.72 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 1.88 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 1.6 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.09 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.4 HD12 ' SD ' ' A' ' 77' ' ' MET . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 2.65 111.098 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.89 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.68 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 1.58 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.04 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.1 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.88 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 1.53 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.49 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.13 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 3.97 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.22 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 2.81 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 1.84 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 1.79 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.08 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 1.76 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.76 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.07 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.85 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.32 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 3.25 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 2.92 110.842 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 2.65 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.21 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.01 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 3.6 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.62 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 2.47 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.474 ' HE1' HG21 ' A' ' 173' ' ' THR . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 2.48 111.568 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.595 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.2 t-20 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 2.69 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo . . . . . 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.36 112.861 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.782 0.325 . . . . 2.63 111.047 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.16 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.37 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 2.83 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.16 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 1.59 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.31 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.15 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.39 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.575 HD11 HD22 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 1.79 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.42 111.201 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.12 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.86 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.58 111.501 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.474 HG21 ' HE1' ' A' ' 147' ' ' TRP . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 1.41 111.628 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.42 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 1.91 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.55 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 1.86 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.428 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.74 112.876 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 1.78 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 0.92 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 184' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 1.77 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.34 111.045 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.51 111.955 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.02 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.45 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 1.73 112.854 179.681 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.2 t70 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.8 0.334 . . . . 2.66 110.988 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.81 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . 0.405 ' HD1' HD13 ' A' ' 7' ' ' LEU . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.21 111.345 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.18 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.01 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 1.93 109.97 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 1.7 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.28 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 1.51 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 1.93 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 1.71 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 2.89 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.31 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 2.87 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.38 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 3.42 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.24 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.44 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.51 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.01 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.59 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp . . . . . 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 3.49 111.446 -179.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.402 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt . . . . . 0 C--O 1.23 0.037 0 CA-C-O 120.75 0.31 . . . . 3.08 111.023 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.35 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 1.39 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 1.71 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 1.48 110.517 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.95 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.97 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.8 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.29 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.36 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.417 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.23 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.417 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 0.98 111.168 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.12 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 4.26 110.664 179.662 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . . . . . . . . . 1.8 p90 . . . . . 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.17 111.47 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.57 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.74 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 1.72 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 1.95 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.2 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . 0.421 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.12 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 1.49 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG23 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 0.77 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.68 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 1.63 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 1.91 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.485 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.22 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.55 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 0.87 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.55 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.06 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.19 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 0.66 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.86 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 0.84 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 1.44 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.591 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.24 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.31 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.81 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.18 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.03 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.48 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.37 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.28 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.11 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.3 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.72 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.04 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 1.79 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.441 HG23 ' N ' ' B' ' 75' ' ' ASP . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 1.44 110.461 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.31 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.01 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.43 110.626 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' B' ' 82' ' ' LEU . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.21 111.844 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.529 HG23 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.18 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 1.65 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.06 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.58 111.102 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 1.49 110.712 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 1.72 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.416 ' N ' HD12 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 1.96 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.32 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.15 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 1.44 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 2.68 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 2.71 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 4.19 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 2.79 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.27 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.57 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.24 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 5.39 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.16 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 2.58 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.29 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.48 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 2.76 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.22 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.36 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 1.92 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.489 HG21 HD13 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.06 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 2.87 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.98 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 1.62 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.04 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.46 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.83 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.74 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.6 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.546 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.42 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.546 ' N ' HD12 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 1.51 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.09 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.16 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 1.76 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.89 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 2.67 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.07 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.41 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 2.47 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 2.61 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.07 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.3 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.67 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.7 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 1.44 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.82 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.94 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 1.6 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.01 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 1.96 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.489 HD13 HG21 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 2.88 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.52 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 4.15 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.59 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.13 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.45 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo . . . . . 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.36 112.594 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.828 0.347 . . . . 2.4 111.185 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 2.57 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 1.72 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 2.69 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.16 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.13 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.94 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.33 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.642 HD11 HD22 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 1.56 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.59 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.14 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . 0.423 ' O ' HG12 ' B' ' 174' ' ' VAL . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 3.87 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 1.61 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.3 111.481 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.423 HG12 ' O ' ' B' ' 171' ' ' TYR . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 1.53 111.705 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 1.99 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.5 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.445 HG22 ' O ' ' B' ' 173' ' ' THR . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 1.46 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 1.73 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 0.93 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 1.36 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.19 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 2.73 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.413 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 1.93 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 2.64 111.377 -179.562 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.729 0.299 . . . . 2.2 110.972 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.49 110.728 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.76 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.18 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 1.98 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 1.65 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.11 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 1.43 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 1.6 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 1.77 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.54 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.01 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 2.65 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.33 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 2.29 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.12 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 3.6 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 1.51 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.22 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 2.69 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 3.4 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.67 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.39 110.957 -179.967 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.61 0.243 . . . . 2.79 111.492 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.08 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 1.43 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' C' ' 12' ' ' VAL . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.16 110.8 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.09 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . 0.406 ' O ' ' HG2' ' C' ' 15' ' ' MET . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 1.58 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.375 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.96 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 0.96 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.3 110.831 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.425 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 1.9 110.865 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 0.96 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.07 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.08 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.02 110.35 179.621 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 p90 . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.747 0.308 . . . . 3.37 111.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.72 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.67 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.93 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 1.88 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.23 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.417 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.09 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 1.41 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 0.8 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.72 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 1.68 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 1.68 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.51 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.33 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.57 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 1.67 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.42 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 0.71 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.14 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.88 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.94 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 1.87 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . 0.4 ' HD3' HH12 ' C' ' 72' ' ' ARG . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 2.86 110.933 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.11 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.54 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.47 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 2.85 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 1.87 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.12 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.26 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.08 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 1.96 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 1.8 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.18 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.33 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 1.85 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.56 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.11 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.566 HG23 HG23 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.49 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 1.6 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.01 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.18 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 1.54 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.481 HD23 HE21 ' C' ' 109' ' ' GLN . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 1.65 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.1 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.446 HD22 HD11 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.44 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 1.87 110.772 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 3.1 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 1.48 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.34 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.21 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 4.54 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.34 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.4 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.54 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 5.21 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.38 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 2.64 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.38 110.933 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.62 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 2.93 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.414 HD23 HD11 ' C' ' 142' ' ' ILE . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.16 110.74 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.3 111.193 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.07 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.42 HG21 HD12 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.3 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.59 HE22 ' HE1' ' C' ' 176' ' ' TRP . 6.6 tp-100 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.48 110.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 1.93 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 1.67 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.11 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 2.59 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.9 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . 0.57 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 0.92 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.55 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 1.49 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 117' ' ' LEU . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 1.66 111.207 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.94 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.29 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.15 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.31 109.441 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.431 ' C ' ' N ' ' C' ' 129' ' ' TYR . 8.8 m . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 121.215 0.531 . . . . 1.31 110.811 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . 0.567 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 2.84 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 2.7 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 1.88 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . 0.578 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.38 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 1.76 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.15 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 1.48 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.51 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.01 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.05 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.453 HD13 ' O ' ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.07 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 1.92 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.42 HD12 HG21 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 2.64 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.51 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 3.58 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.65 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.46 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.27 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 35.1 t-20 . . . . . 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.33 111.341 179.99 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.857 0.361 . . . . 2.82 111.071 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.18 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.5 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 1.81 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.13 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.21 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.31 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.26 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.58 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.446 HD11 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.3 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.73 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 1.43 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.72 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 1.55 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.484 HG22 HD12 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 1.5 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 1.84 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.12 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . 0.59 ' HE1' HE22 ' C' ' 109' ' ' GLN . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.796 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.484 HD12 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 1.75 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.72 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 1.8 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 0.88 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 1.52 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.2 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.47 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.62 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 2.63 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.77 112.547 179.76 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.3 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.866 0.365 . . . . 2.37 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.68 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . 0.506 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.05 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 1.91 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.04 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.62 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.49 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.32 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 1.84 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.68 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 2.65 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' C' ' 216' ' ' LEU . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.33 112.451 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.02 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.35 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 3.62 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 212' ' ' GLY . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 1.64 110.7 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.11 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 3.37 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' C' ' 217' ' ' ASP . 95.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.11 110.856 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.639 0.257 . . . . 3.23 110.821 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 1.88 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.29 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.99 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 1.92 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 1.45 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.89 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 0.9 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.83 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.24 110.589 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.29 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.71 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.96 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.99 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.11 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.23 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.02 111.0 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.4 pt20 . . . . . 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 3.41 112.59 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 2.81 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.39 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' MET . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.24 110.857 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 34' ' ' GLN . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 1.6 110.982 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.33 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.03 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.0 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 1.31 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.59 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 1.63 111.733 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.12 110.918 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.32 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.52 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.98 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.52 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.69 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.12 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 0.6 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.94 110.246 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 0.78 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.23 110.583 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.1 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 1.76 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 1.84 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.64 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 1.84 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.24 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.16 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 2.84 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.39 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 0.97 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.04 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.38 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.76 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 2.93 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.13 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 1.66 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.42 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.09 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.52 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.33 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.39 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 1.55 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.01 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 1.45 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.3 109.147 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 1.67 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.642 HD12 HD23 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 1.87 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.42 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 1.91 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 2.33 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 1.43 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.19 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 2.55 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.33 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 5.1 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.07 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.41 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.31 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.94 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 5.98 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.24 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.478 HD22 ' H ' ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 2.67 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 2.59 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 3.14 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.487 ' HB3' HD21 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 1.99 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.36 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.05 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' HG21 ' A' ' 142' ' ' ILE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.25 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.511 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 2.72 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 1.88 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 1.6 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.09 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.511 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 2.65 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.89 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.68 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 1.58 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.04 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.1 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.88 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 1.53 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.29 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.49 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.13 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 3.97 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.22 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 2.81 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.25 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 1.84 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.54 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 1.79 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.08 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.76 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.07 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 1.85 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.32 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 3.25 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 2.92 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 2.65 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.432 HG21 ' OG1' ' A' ' 108' ' ' THR . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.21 111.473 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.01 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 3.6 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.62 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 2.47 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 2.48 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.563 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 2.69 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo . . . . . 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.36 113.177 -179.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.873 0.368 . . . . 2.63 110.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.16 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.37 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.83 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 1.7 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.16 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 1.59 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.31 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.15 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.39 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.79 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.42 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.12 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 3.86 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 1.58 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 1.41 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 1.42 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 1.91 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.55 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 1.86 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.74 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 1.78 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 0.92 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 1.77 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 179' ' ' TYR . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.34 111.421 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.51 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.02 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.45 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 1.73 112.772 179.842 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.79 0.329 . . . . 2.66 110.921 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 1.81 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.21 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.18 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.01 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 1.93 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 1.7 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.28 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 1.51 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 1.93 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 1.71 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.04 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 2.89 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.31 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 2.87 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.38 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 3.42 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 216' ' ' LEU . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.24 110.66 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.44 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.116 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.01 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.59 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 38.2 tp . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 3.49 111.129 -179.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.638 0.256 . . . . 3.08 110.738 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.473 HD22 ' H ' ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.35 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 1.39 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG12 ' B' ' 12' ' ' VAL . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1 110.599 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 1.71 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 1.48 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 0.95 111.486 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 0.97 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.8 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.29 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.36 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . 0.458 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.23 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.98 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.12 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 4.26 110.693 179.679 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.43 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 112.119 0.414 . . . . 3.17 112.119 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.43 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.57 112.103 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.74 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 1.72 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.457 HG12 HD11 ' B' ' 43' ' ' ILE . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 1.95 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.2 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.12 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 1.49 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.657 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 0.77 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.68 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 1.63 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 1.91 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.438 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.22 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.55 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 0.87 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.55 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.06 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.19 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.66 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 0.86 110.536 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.84 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . 0.472 HD12 HG23 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.44 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.24 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.31 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.18 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.03 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.37 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.28 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.501 ' N ' HD12 ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 1.78 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.05 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.11 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.3 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.72 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.04 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.446 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 1.79 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.44 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.31 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.01 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.43 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.21 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.657 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.18 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.542 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 1.65 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.06 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.425 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 1.58 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' B' ' 83' ' ' LEU . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.595 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' B' ' 109' ' ' GLN . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.474 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 1.96 110.444 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.24 110.241 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.21 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.32 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.15 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . 0.631 HG23 HD21 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 1.44 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.05 111.36 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 2.68 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 2.71 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 4.19 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 2.79 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.27 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.57 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.24 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 5.39 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.16 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 2.58 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.63 ' H ' HD12 ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.29 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.48 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 2.76 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.22 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.36 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 1.92 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.416 HG21 ' CB ' ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.06 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.424 ' OE1' HD21 ' B' ' 84' ' ' LEU . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 2.87 110.726 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 1.98 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 1.62 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.04 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.46 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.83 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 0.74 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.6 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.42 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 1.51 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.09 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.16 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.89 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 2.67 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.07 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.41 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 2.47 110.836 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 2.61 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.07 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.3 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 1.75 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 1.67 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.54 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.7 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 1.44 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.82 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.94 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.6 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.01 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.416 ' CB ' HG21 ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 2.88 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.52 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 4.15 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.59 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.13 110.992 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 1.78 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.565 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.45 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo . . . . . 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.36 113.024 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.673 0.273 . . . . 2.4 110.736 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.404 HD11 ' HB1' ' B' ' 91' ' ' ALA . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 2.57 110.715 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 1.72 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 2.69 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.16 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.13 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.94 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.33 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.56 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . 0.489 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 1.59 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.14 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.87 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.61 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.3 111.643 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.422 HG23 HD22 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 1.53 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.422 HD22 HG23 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 1.99 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 1.46 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.683 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 1.73 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 0.93 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 1.36 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.19 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 2.73 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 1.93 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 2.64 111.337 -179.757 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.76 0.314 . . . . 2.2 111.08 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.49 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.02 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.18 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.78 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.98 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 1.65 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.11 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 1.43 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 1.6 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . 0.419 ' HB2' HD12 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.54 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.01 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 2.65 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.33 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 2.29 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.12 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 3.6 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.4 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 1.51 110.58 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.22 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 2.69 111.215 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 3.4 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.67 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . 0.631 HD21 HG23 ' B' ' 90' ' ' THR . 3.3 mm? . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.39 111.043 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.75 0.31 . . . . 2.79 110.597 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.08 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 1.43 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.16 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.09 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 1.58 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 0.96 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 0.96 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . 0.468 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.3 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 1.9 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.96 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.07 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.08 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 7.9 t60 . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.02 111.287 -179.923 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 . . . . . 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.37 111.032 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.67 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' C' ' 38' ' ' LEU . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 1.93 110.38 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.09 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 1.41 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.449 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 0.8 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.72 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 1.68 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 1.68 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.432 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.28 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.51 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' SD ' ' C' ' 52' ' ' MET . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.33 111.086 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.57 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 1.67 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' C' ' 49' ' ' LEU . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.42 110.51 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.71 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.418 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.14 110.26 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.88 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.38 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.94 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 14.8 mm100 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 1.87 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 2.86 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 1.95 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.11 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.54 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.47 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 2.85 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 1.87 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.26 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.451 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.08 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.418 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 0.86 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 1.96 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 1.8 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.451 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.18 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.551 ' O ' HG22 ' C' ' 79' ' ' THR . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.33 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 1.85 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.534 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.56 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.11 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.551 HG22 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.49 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 1.6 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.01 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.18 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 1.54 110.046 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 1.65 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.1 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . 0.435 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.38 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 1.44 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 1.87 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . 0.439 ' HB3' ' HE2' ' C' ' 35' ' ' TYR . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 3.1 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 1.48 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.02 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.34 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.21 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 4.54 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.34 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.4 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.54 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 5.21 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.38 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 2.64 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.38 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.62 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 2.93 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . 0.437 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.16 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.3 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.07 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.3 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.405 HE21 HG23 ' C' ' 113' ' ' ILE . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.48 111.065 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.93 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 1.67 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.11 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 2.59 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.9 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.456 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.55 112.298 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 1.49 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 1.66 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 0.94 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.29 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.15 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.31 111.0 -179.848 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.472 HG23 HD12 ' B' ' 56' ' ' ILE . 10.9 p . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.713 0.292 . . . . 1.31 111.374 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 2.84 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 2.7 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 1.88 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.38 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 1.76 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.15 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 1.56 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.73 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 1.48 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.01 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.05 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.07 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 1.92 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 2.64 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.51 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 3.58 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.65 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.46 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.27 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 63.5 t30 . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.33 112.342 -178.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.791 0.329 . . . . 2.82 111.048 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.18 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . 0.401 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.5 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 1.81 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.13 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.21 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.465 ' O ' HG23 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.31 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.26 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.58 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.3 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 1.73 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 1.43 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.72 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 177' ' ' ILE . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 1.5 111.959 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 1.84 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.12 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.457 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 1.75 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.72 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.63 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 1.8 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 0.88 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.514 ' O ' HG22 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.52 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.2 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.47 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.514 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 1.62 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 2.63 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.77 112.438 179.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.822 0.344 . . . . 2.37 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.68 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.95 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.05 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 1.91 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.04 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.505 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 1.62 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.49 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.64 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.32 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 1.52 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 1.84 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.68 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . 0.468 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.04 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 2.65 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.33 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.02 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.35 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . 0.482 ' HA ' HD12 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 3.62 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.419 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.64 110.784 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.11 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp . . . . . 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.11 111.161 -179.531 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.695 0.283 . . . . 3.23 110.811 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.88 110.952 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.29 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 0.99 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 1.92 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' MET . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.6 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 0.89 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.9 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.83 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.24 110.49 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.29 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 1.71 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.96 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.99 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.11 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.02 110.611 -179.842 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 . . . . . 0 N--CA 1.462 0.149 0 CA-C-O 120.727 0.298 . . . . 3.41 111.036 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 2.81 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.39 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.24 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 1.6 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.33 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.03 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.0 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HA ' HG22 ' A' ' 45' ' ' ILE . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 1.31 112.762 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.59 114.136 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' TRP . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 1.63 112.115 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.12 110.707 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.32 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.52 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 0.98 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.52 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.69 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.12 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 0.6 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.94 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.23 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.1 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 1.76 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' HE2' ' A' ' 70' ' ' TYR . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 1.84 111.252 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.64 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.84 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.24 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.16 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.84 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.39 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.97 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.04 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.44 ' HE2' HG13 ' A' ' 61' ' ' VAL . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.38 110.68 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 0.76 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 2.93 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.13 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 1.66 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.42 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.09 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.52 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.33 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.39 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 1.55 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.01 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 1.45 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.3 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 1.67 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.42 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 168' ' ' LEU . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.4 110.788 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.91 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 2.33 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 1.43 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.19 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 2.55 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.33 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.1 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.07 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.41 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.31 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.94 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 5.98 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.47 ' HA ' HD22 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.24 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 2.67 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 2.59 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.53 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 3.14 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 1.99 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.36 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 111' ' ' VAL . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.05 111.307 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.25 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.583 ' HG3' HD22 ' A' ' 84' ' ' LEU . 10.8 mm100 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 2.72 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.88 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 107' ' ' SER . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.6 110.671 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.09 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 2.65 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 0.89 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.68 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 1.58 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.04 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.1 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.88 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.53 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.29 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.49 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.13 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 3.97 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 124' ' ' ARG . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.22 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 2.81 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.25 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.84 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.402 ' CD1' ' HG2' ' C' ' 58' ' ' GLN . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.54 111.187 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 1.79 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.08 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.418 ' SG ' HD22 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 1.76 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.76 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.07 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 1.85 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.32 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 3.25 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 2.92 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 2.65 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.21 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.01 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 3.6 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.62 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 2.47 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 2.48 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 2.69 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.36 112.605 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.874 0.369 . . . . 2.63 110.865 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.16 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.37 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 2.83 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 1.7 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.16 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 1.59 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.31 110.715 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.15 110.597 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.39 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.414 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 1.79 111.037 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.42 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.12 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 3.86 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.58 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 1.41 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 1.42 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 1.91 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.374 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 1.86 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.74 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 1.78 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 0.92 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 1.77 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 179' ' ' TYR . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.34 111.461 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.51 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.02 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.45 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 1.73 113.06 179.655 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.725 0.298 . . . . 2.66 111.024 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.81 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.21 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.18 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 1.93 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 1.7 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.28 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 1.51 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 1.93 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 2.89 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.31 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 2.87 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.38 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 3.42 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 216' ' ' LEU . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.24 110.483 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.44 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.51 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.01 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.59 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 53.4 tp . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 3.49 110.972 -179.858 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.751 0.31 . . . . 3.08 110.833 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.35 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 1.39 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . 0.451 ' O ' HG12 ' B' ' 12' ' ' VAL . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1 110.662 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 1.71 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' B' ' 15' ' ' MET . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 1.48 110.615 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.95 111.075 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.97 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.8 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.29 110.837 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.36 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.23 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 0.98 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.12 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 4.26 110.49 -179.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.44 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.17 113.348 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.57 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.74 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.72 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 35' ' ' TYR . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 1.95 111.698 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.2 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.12 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 1.49 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 0.77 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.68 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 1.63 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.421 ' HZ3' HG21 ' C' ' 114' ' ' THR . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 1.91 111.294 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.22 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.55 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 0.87 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.55 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.06 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.19 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.66 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.86 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 1.44 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' C' ' 122' ' ' SER . 13.0 mm100 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.24 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.31 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 1.81 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.18 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.03 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.48 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.37 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . 0.408 HE21 ' H ' ' B' ' 67' ' ' ILE . 25.6 tp60 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.28 111.014 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.408 ' H ' HE21 ' B' ' 66' ' ' GLN . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 1.78 110.776 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.05 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.524 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.11 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.3 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 0.72 112.115 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.04 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 1.79 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' B' ' 71' ' ' ALA . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 1.44 110.852 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.404 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.31 109.389 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.01 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.43 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.21 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.18 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 1.65 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.06 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 1.58 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 83' ' ' LEU . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 1.49 110.659 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 1.72 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.408 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 1.96 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.24 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.21 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.32 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.15 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 2.68 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 2.71 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 4.19 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 2.79 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.27 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.57 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.24 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 5.39 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.16 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 2.58 110.917 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.29 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.48 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 2.76 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.22 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.36 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 1.92 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.06 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' B' ' 84' ' ' LEU . 8.4 tp-100 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 2.87 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 1.98 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 1.62 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.04 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.46 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.83 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 0.74 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.6 112.923 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.42 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.409 HG13 HD12 ' B' ' 117' ' ' LEU . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 1.51 111.111 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.09 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.16 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.576 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.76 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.89 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HB2' HG12 ' B' ' 127' ' ' VAL . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 2.67 110.925 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.07 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' B' ' 124' ' ' ARG . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 1.41 110.88 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 2.47 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 2.61 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.07 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . 0.411 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.3 111.165 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 1.75 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 1.67 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.7 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 1.44 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 1.82 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.94 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 1.6 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.01 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 1.96 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.41 HG13 ' N ' ' B' ' 143' ' ' LEU . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 2.88 111.09 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.41 ' N ' HG13 ' B' ' 142' ' ' ILE . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.52 110.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 4.15 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.59 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.13 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.589 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.45 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo . . . . . 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.36 112.643 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.701 0.286 . . . . 2.4 111.116 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 2.57 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 1.72 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 2.69 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.16 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.13 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.94 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.33 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 1.56 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.59 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.14 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 3.87 110.36 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.61 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.3 111.674 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 1.53 111.462 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 1.99 111.732 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . 0.521 ' HE1' HE22 ' B' ' 109' ' ' GLN . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.5 111.476 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 1.46 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 1.73 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 0.93 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.524 ' O ' HG22 ' B' ' 184' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.36 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 179' ' ' TYR . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.19 111.373 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 2.73 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.524 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 1.93 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt . . . . . 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 2.64 111.311 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 17.5 tt . . . . . 0 C--O 1.232 0.169 0 CA-C-O 120.712 0.291 . . . . 2.2 111.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.49 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 1.76 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.18 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 182' ' ' VAL . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.78 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 1.98 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 1.65 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.11 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 1.43 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . 0.424 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 1.6 110.194 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.54 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.01 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 207' ' ' PHE . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 2.65 110.97 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.33 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 2.29 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.12 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 3.6 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.22 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 2.69 110.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 3.4 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.67 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.39 110.804 -179.788 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . 0.459 HD23 ' N ' ' C' ' 6' ' ' LEU . 2.6 pt? . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.738 0.304 . . . . 2.79 111.109 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.08 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.556 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 1.43 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.542 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.16 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.09 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 1.58 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.542 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.96 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 0.96 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.3 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 1.52 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . 0.405 HD12 ' O ' ' C' ' 17' ' ' ILE . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 1.9 110.505 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 0.96 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.07 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.08 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.02 110.581 179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.537 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.373 0.508 . . . . 3.37 112.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.72 111.803 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.67 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 1.93 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.88 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.23 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.09 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 1.41 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 0.8 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.72 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 1.68 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 1.68 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.28 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.51 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.418 HD22 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.33 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.57 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.67 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.42 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.71 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . 0.424 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.14 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.88 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.38 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.94 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 1.87 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 2.86 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.11 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.54 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.47 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 2.85 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.87 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.12 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.08 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.86 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 1.96 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.523 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 1.8 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.18 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' C' ' 74' ' ' ILE . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.33 109.652 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 1.85 111.2 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.56 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.402 HG23 ' N ' ' C' ' 79' ' ' THR . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.11 112.423 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.402 ' N ' HG23 ' C' ' 78' ' ' VAL . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.49 112.166 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 1.6 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.01 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.18 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . 0.438 HD21 ' HE3' ' C' ' 210' ' ' LYS . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 1.54 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . 0.475 ' H ' HD23 ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 1.65 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.1 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.38 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 1.44 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 1.87 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 3.1 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.34 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 4.54 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.34 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.4 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.54 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 5.21 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . 0.412 HG23 ' N ' ' C' ' 101' ' ' LEU . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.38 111.174 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.412 ' N ' HG23 ' C' ' 100' ' ' THR . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 2.64 110.875 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.38 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.62 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 2.93 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.16 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.3 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.07 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.3 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.48 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 1.93 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 1.67 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.11 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 2.59 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . 0.421 HG21 ' HZ3' ' B' ' 46' ' ' TRP . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.735 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.92 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.55 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 1.49 111.291 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 1.66 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.94 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.29 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.562 ' HA ' HE22 ' B' ' 58' ' ' GLN . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.15 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.31 111.041 -179.82 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.494 HG23 HD12 ' C' ' 130' ' ' LEU . 13.3 p . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.961 0.41 . . . . 1.31 110.862 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 2.84 110.888 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 2.7 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.494 HD12 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 1.88 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.38 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 1.76 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.15 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 1.56 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.73 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 1.48 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.51 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.01 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.05 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.07 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 1.92 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 2.64 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 3.58 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.65 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.46 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.27 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.33 112.0 -179.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.832 0.348 . . . . 2.82 110.899 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.18 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . 0.444 HD12 ' H ' ' C' ' 161' ' ' LEU . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.5 110.625 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.81 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.13 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.31 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.26 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.58 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.3 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 1.73 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 1.43 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.72 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 1.55 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 1.5 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 1.84 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.12 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.501 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.75 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.53 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.72 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 1.8 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.676 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 0.88 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.541 ' O ' HG22 ' C' ' 184' ' ' ILE . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 1.52 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.61 HG22 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.2 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . 0.676 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.47 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.541 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 1.62 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.524 HG23 HG23 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 2.63 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.77 112.494 -179.986 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.782 0.325 . . . . 2.37 111.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.68 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 1.95 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.05 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 1.91 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.04 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.62 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.49 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.32 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 1.84 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.68 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . 0.438 ' HE3' HD21 ' C' ' 83' ' ' LEU . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.04 110.867 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 2.65 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.33 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.02 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.35 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 3.62 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.402 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 1.64 110.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.11 110.5 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 3.37 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 58.6 tp . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.11 110.877 179.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.714 0.292 . . . . 3.23 110.916 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 1.88 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.29 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' VAL . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 0.99 110.95 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 1.92 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 1.45 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.89 110.949 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.83 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.24 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.29 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.96 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 0.99 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.11 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.23 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.02 110.466 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 108.133 -1.062 . . . . 3.41 108.133 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.532 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 2.81 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.39 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.24 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 1.6 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.33 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.03 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.0 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 1.31 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.59 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 1.63 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.12 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.32 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.52 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 0.98 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 0.52 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.12 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.6 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.94 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 0.78 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 56' ' ' ILE . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.546 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.1 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 1.76 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 1.84 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.64 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.84 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.24 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.16 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 2.84 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.39 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.97 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.04 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.38 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 0.76 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 2.93 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.13 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 1.66 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.42 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.09 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.52 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.33 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 83' ' ' LEU . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.39 111.62 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.01 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 1.45 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 79' ' ' THR . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.689 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 1.67 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.42 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.4 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 1.91 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 2.33 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 1.43 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.19 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 2.55 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.33 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 5.1 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.07 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.41 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.31 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.94 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 5.98 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.24 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 2.67 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 2.59 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.53 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 3.14 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 1.99 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.36 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.05 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 142' ' ' ILE . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.25 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HG2' HD21 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 2.72 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.88 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 108' ' ' THR . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.28 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 2.65 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.89 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.68 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 1.58 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.04 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.1 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.88 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 1.53 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.29 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.49 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.13 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 3.97 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.22 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 2.81 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.25 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 1.84 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.249 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.79 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.08 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.76 110.952 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.76 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.07 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 1.85 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.32 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 3.25 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 2.92 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 2.65 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.21 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.01 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 3.6 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.62 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 2.47 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 2.48 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 2.69 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.36 112.843 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.849 0.357 . . . . 2.63 110.575 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.16 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.37 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 2.83 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.16 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 1.59 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.31 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.15 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.39 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 1.79 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.42 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.12 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 3.86 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 1.58 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 1.41 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 1.42 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 1.91 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.55 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.479 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 1.86 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.74 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.59 ' O ' HG22 ' A' ' 182' ' ' VAL . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 1.78 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 0.92 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 1.77 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.34 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . 0.476 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.51 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.02 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.45 111.331 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 1.73 113.211 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.765 0.317 . . . . 2.66 111.43 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 1.81 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.21 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.18 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.01 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 1.93 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 204' ' ' LEU . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 1.7 111.591 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.28 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 1.93 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 1.71 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.04 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 2.89 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.31 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 2.87 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.38 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 3.42 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.24 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.44 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.01 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.59 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 3.49 111.107 -179.771 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.761 0.315 . . . . 3.08 110.874 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.35 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 1.39 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 1.71 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 0.95 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.97 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.8 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.29 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.36 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.23 110.567 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 0.98 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.12 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 4.0 t80 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 4.26 110.198 179.756 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.17 113.767 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . 0.585 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.57 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.74 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.72 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 1.95 111.581 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.2 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.12 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 1.49 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 0.77 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.68 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.484 HG22 HG11 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 1.63 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . 0.508 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 1.91 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.59 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.55 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.87 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 0.55 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.06 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.19 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 0.66 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.86 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 0.84 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 1.44 110.268 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.24 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.31 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 1.81 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.18 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.03 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.48 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.37 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.28 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.05 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.11 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.475 ' HD1' ' HH ' ' B' ' 73' ' ' TYR . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.3 111.64 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 0.72 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.486 ' NH2' HG23 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.04 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.475 ' HH ' ' HD1' ' B' ' 70' ' ' TYR . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 1.79 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 1.44 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.31 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.01 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.577 ' SD ' HD21 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.43 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.21 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.18 111.582 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.628 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 1.65 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.06 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 1.58 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 1.49 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 1.72 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 1.96 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.24 111.053 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . 0.457 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.32 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . 0.463 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.15 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.44 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.05 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 2.68 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 2.71 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 4.19 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 2.79 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.27 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.57 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.24 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . 0.54 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 5.39 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.16 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 2.58 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.29 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.48 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 2.76 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.22 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.36 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.92 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.554 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.06 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.521 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 2.87 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 1.98 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 1.62 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 108' ' ' THR . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.04 111.533 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . 0.521 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.46 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.83 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.74 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.6 112.013 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.577 HD21 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.42 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 1.51 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.09 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.16 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 1.76 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.89 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 2.67 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.07 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 1.41 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 2.47 110.802 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 2.61 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.07 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.3 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.75 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 1.67 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 1.54 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.7 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 1.44 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD12 ' B' ' 140' ' ' LEU . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 1.82 110.979 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.94 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 1.6 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.01 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 1.96 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.554 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 2.88 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . 0.472 HD11 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.52 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 4.15 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.59 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . 0.464 HG22 ' O ' ' B' ' 143' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.13 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 1.78 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.648 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 14.6 m120 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.45 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo . . . . . 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.36 112.979 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.654 0.264 . . . . 2.4 111.034 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . 0.4 ' N ' HD12 ' B' ' 161' ' ' LEU . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 2.57 110.828 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 2.69 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.16 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.13 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.94 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.33 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 1.56 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 1.59 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.14 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 3.87 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 1.61 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.3 111.377 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 1.53 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 1.99 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.5 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 1.46 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.657 ' O ' HG22 ' B' ' 182' ' ' VAL . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 1.73 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 0.93 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.5 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 1.36 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.657 HG22 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.19 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 2.73 112.084 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 1.93 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 2.64 111.853 -179.183 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . 0.438 ' N ' HD12 ' B' ' 197' ' ' ILE . 2.9 mp . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.873 0.368 . . . . 2.2 110.833 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.49 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . 0.486 HG23 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 1.76 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.18 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 1.78 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 1.98 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 1.65 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.11 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 1.43 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 1.6 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 1.77 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.54 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.01 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 2.65 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.33 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 2.29 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.12 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 3.6 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . 0.417 HD13 ' O ' ' B' ' 216' ' ' LEU . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.516 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.22 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 2.69 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 3.4 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.67 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.39 110.796 179.924 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.747 0.308 . . . . 2.79 110.871 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.08 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.43 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.09 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 1.58 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 0.96 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 0.96 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.3 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 1.52 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 1.9 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 0.96 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.07 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.08 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.993 -179.78 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' C' ' 38' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.118 0 N-CA-C 112.343 0.498 . . . . 3.37 112.343 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.72 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.67 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.473 HD21 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 1.93 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 1.88 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.23 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.09 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 1.41 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.8 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.72 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 1.68 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 1.68 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.28 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.51 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' C' ' 52' ' ' MET . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.33 111.212 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.57 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 1.67 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.427 ' HE2' HD13 ' C' ' 49' ' ' LEU . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.42 110.23 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.71 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.88 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.38 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.94 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 2.86 111.225 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 1.95 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.11 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.54 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.47 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 2.85 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.87 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.12 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.417 ' O ' HG12 ' C' ' 74' ' ' ILE . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.08 111.254 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.86 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 1.96 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' C' ' 117' ' ' LEU . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 1.8 111.22 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.417 HG12 ' O ' ' C' ' 70' ' ' TYR . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.18 110.175 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.33 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.85 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.56 110.486 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.433 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.11 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.49 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 1.6 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.01 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.433 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.18 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 1.54 109.947 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 1.65 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.1 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.38 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 1.44 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.87 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 3.1 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.02 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.54 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.34 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.4 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.54 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 5.21 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.38 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 2.64 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.62 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 2.93 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.16 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.3 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.07 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.5 ' O ' HG23 ' C' ' 112' ' ' VAL . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.3 111.511 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.48 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.508 HG22 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 1.93 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . 0.484 HG11 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 108' ' ' THR . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.11 111.234 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.455 HG22 HD21 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 2.59 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.9 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.92 110.371 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.55 112.594 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 1.49 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.538 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 1.66 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 0.94 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.29 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.15 110.907 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.31 110.825 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . 0.432 ' O ' ' HG ' ' C' ' 130' ' ' LEU . 14.4 p . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.92 0.39 . . . . 1.31 111.061 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 2.84 110.622 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 2.7 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.482 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 1.88 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . 0.482 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.38 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.15 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 1.56 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.73 112.924 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 1.48 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.51 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.01 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.05 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.07 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.504 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 1.92 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.504 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 2.64 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.65 113.155 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . 0.408 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.46 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.27 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 18.2 t30 . . . . . 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.33 112.46 -179.218 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.713 0.292 . . . . 2.82 110.963 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.18 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.5 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 1.81 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.13 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.21 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.31 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.58 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.3 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 1.73 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 1.43 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.72 110.79 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 1.55 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 177' ' ' ILE . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 1.5 111.956 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 1.84 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.12 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.515 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 1.75 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.72 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.718 ' O ' HG22 ' C' ' 182' ' ' VAL . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 1.8 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 0.88 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.515 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 1.52 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.718 HG22 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.2 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.47 112.147 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.42 HG22 ' O ' ' C' ' 181' ' ' ILE . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 1.62 112.232 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' C' ' 182' ' ' VAL . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 2.63 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.77 112.391 179.965 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.601 0.239 . . . . 2.37 111.208 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.68 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 1.95 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.05 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 1.91 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.04 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 1.62 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.49 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.563 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.32 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 1.52 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 1.84 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.68 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 2.65 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.33 112.376 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.02 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.35 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 3.62 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 1.64 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.11 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 3.37 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.11 111.082 -179.647 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pt? . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.742 0.305 . . . . 3.23 111.162 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 1.88 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.29 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 0.99 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.92 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 1.45 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.89 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.9 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.83 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.24 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.29 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.96 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.99 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.11 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.23 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.02 110.522 179.787 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.412 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.079 0 N-CA-C 112.267 0.469 . . . . 3.41 112.267 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.412 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 2.81 111.209 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.39 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.24 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.69 HD21 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 1.6 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.33 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.03 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.0 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.31 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.0 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.59 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 1.63 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.12 111.37 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.32 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.52 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 0.98 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 0.52 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 1.69 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.12 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.6 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.94 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 0.78 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.23 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.1 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.76 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 1.84 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.64 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.84 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.24 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.16 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 2.84 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.39 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.97 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.04 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.38 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 0.76 111.997 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 2.93 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.13 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 1.66 110.316 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 79' ' ' THR . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.42 109.296 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.09 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.52 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.543 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.33 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.543 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.39 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 1.55 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.01 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 1.45 110.66 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.3 109.5 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 1.67 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 1.87 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 1.91 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 2.33 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 1.43 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.19 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 2.55 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.33 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 5.1 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.07 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.41 111.027 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.31 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.94 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 5.98 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.24 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.67 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 2.59 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 3.14 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 1.99 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.36 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.05 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.25 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 2.72 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 1.88 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 1.6 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.09 111.47 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 2.65 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.89 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.68 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 1.58 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.04 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.1 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.88 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 1.53 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.29 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.49 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.797 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.13 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 127' ' ' VAL . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.797 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 3.97 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ASP . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.22 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 2.81 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 127' ' ' VAL . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.25 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.452 HD22 ' N ' ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 1.84 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' TRP . . . . . 0.795 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.54 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 1.79 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.08 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 1.76 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.76 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.07 111.064 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' CYS . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 1.85 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.32 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 3.25 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 2.92 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 2.65 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . 0.611 HG12 HG21 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.21 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 146' ' ' ILE . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.01 110.925 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 3.6 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.62 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' LEU . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.47 111.189 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 2.48 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 2.69 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo . . . . . 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.36 112.556 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.718 0.294 . . . . 2.63 110.91 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.16 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.37 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 2.83 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.16 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.59 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.31 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.15 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.39 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 1.79 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.42 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.12 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 3.86 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 1.58 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.41 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 1.42 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 1.91 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.55 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.86 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.74 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' TYR . . . . . 0.584 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 1.78 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 0.92 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 1.77 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.34 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.51 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.02 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.45 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 1.73 112.518 -179.999 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.8 0.333 . . . . 2.66 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.81 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.21 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 201' ' ' LEU . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.18 110.685 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.01 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 1.93 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 1.7 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . 0.676 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.28 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 211' ' ' VAL . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 1.51 110.296 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.93 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.04 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 207' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 2.89 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 216' ' ' LEU . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.31 112.149 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 2.87 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.38 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 3.42 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 212' ' ' GLY . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.44 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.51 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.01 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.59 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 3.49 110.953 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.701 0.286 . . . . 3.08 110.944 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' LEU . . . . . 0.463 HD22 ' H ' ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.35 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 1.39 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 1.48 110.485 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.95 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 0.97 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.8 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.29 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.36 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.98 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.12 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.0 109.988 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 4.26 110.202 179.538 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' TYR . . . . . 0.5 ' HB2' ' HE1' ' C' ' 99' ' ' TRP . 6.1 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.17 111.951 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.57 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.74 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 1.72 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 1.95 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.2 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.12 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.51 HG23 HG23 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 0.77 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.68 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 1.63 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 1.91 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.22 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.55 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 0.87 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.55 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.06 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' MET . . . . . 0.402 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.19 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 0.66 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' MET . . . . . 0.404 ' HB2' ' HB3' ' B' ' 8' ' ' HIS . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.86 110.361 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 0.84 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' C' ' 122' ' ' SER . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.24 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.31 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 1.81 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.18 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.03 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.48 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.37 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.28 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 1.78 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.05 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.11 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' TYR . . . . . 0.438 ' O ' HG23 ' B' ' 74' ' ' ILE . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.3 111.203 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.72 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.04 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 1.79 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' ILE . . . . . 0.48 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 1.44 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' ASP . . . . . 0.48 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.31 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.01 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.43 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.523 HG13 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.21 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' THR . . . . . 0.523 ' H ' HG13 ' B' ' 78' ' ' VAL . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.18 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 1.65 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.06 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' LEU . . . . . 0.518 HD23 HD12 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 1.58 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 1.49 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 1.72 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.518 HD12 HD23 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 1.96 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.21 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.32 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.15 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.44 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.05 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 2.68 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 2.71 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 4.19 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.79 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.27 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.57 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.24 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 5.39 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.16 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 2.58 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.29 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' GLY . . . . . 0.69 ' HA3' HD21 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 2.76 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' LEU . . . . . 0.58 ' HB3' HD21 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.22 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.36 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 1.92 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' THR . . . . . 0.61 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.06 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' GLN . . . . . 0.452 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 2.87 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 1.62 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.04 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.46 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.83 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 0.74 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.6 112.745 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.42 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 1.51 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.09 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.16 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 1.76 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.89 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 2.67 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.07 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 1.41 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 2.47 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 2.61 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.07 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.3 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 1.75 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 1.67 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.54 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.7 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 1.44 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 1.82 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.94 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 1.6 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.01 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 142' ' ' ILE . . . . . 0.61 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 2.88 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.52 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 4.15 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.59 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.13 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 1.78 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.45 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo . . . . . 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.36 112.198 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.815 0.341 . . . . 2.4 110.861 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 2.57 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 1.72 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 2.69 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.16 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.13 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.94 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.33 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 1.56 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 1.59 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.14 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 171' ' ' TYR . . . . . 0.496 ' O ' HG22 ' B' ' 174' ' ' VAL . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 3.87 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.3 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 171' ' ' TYR . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 1.53 111.905 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 1.99 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' TRP . . . . . 0.452 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.5 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 1.46 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' TYR . . . . . 0.58 ' O ' HG22 ' B' ' 182' ' ' VAL . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 1.73 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 0.93 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 1.36 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' VAL . . . . . 0.58 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.19 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 2.73 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' ILE . . . . . 0.464 HG22 HG23 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 1.93 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' ILE . . . . . 0.464 HG23 HG22 ' B' ' 184' ' ' ILE . 2.3 pp . . . . . 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 2.64 112.219 -178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.689 0.28 . . . . 2.2 111.168 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.49 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 1.76 111.524 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.18 111.248 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 1.78 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 1.98 111.085 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 1.65 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.11 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 205' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 1.43 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 1.6 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 1.77 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.54 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.01 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 2.65 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.33 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 2.29 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.12 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 3.6 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.22 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 2.69 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 3.4 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.67 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 75.3 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.39 110.864 -179.997 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.89 0.376 . . . . 2.79 110.586 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.08 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 8' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 1.43 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.16 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.09 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 1.58 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.96 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 0.96 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.3 111.119 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 1.52 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 1.9 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.96 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.07 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.08 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.02 110.293 179.627 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 2.5 p90 . . . . . 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.37 111.484 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.72 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.67 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 1.93 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 1.88 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' MET . . . . . 0.469 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.09 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 1.41 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 0.8 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.72 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 1.68 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 1.68 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.28 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.51 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.33 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 0.57 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 1.67 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' MET . . . . . 0.434 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.42 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 0.71 111.028 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.14 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 0.88 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' ILE . . . . . 0.478 HD11 ' HD1' ' A' ' 131' ' ' TRP . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.148 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.94 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.87 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.86 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 1.95 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.11 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.47 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 2.85 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.87 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.12 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.26 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.08 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 0.86 112.345 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 1.96 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 1.8 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.18 110.476 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.33 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 1.85 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.56 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.48 ' O ' HD23 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.11 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.49 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 1.6 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.01 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' LEU . . . . . 0.49 HD13 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.18 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 1.54 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 1.65 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' LEU . . . . . 0.49 HD12 HD13 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.1 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.38 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 1.44 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 1.87 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 3.1 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.34 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.21 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 4.54 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.34 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.4 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.54 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 5.21 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.38 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' LEU . . . . . 0.41 HD12 ' N ' ' C' ' 101' ' ' LEU . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 2.64 111.521 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.38 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.62 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 2.93 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.16 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' MET . . . . . 0.42 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.3 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.07 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' THR . . . . . 0.409 HG22 HG21 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.3 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' GLN . . . . . 0.433 HE21 HG22 ' C' ' 80' ' ' THR . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.48 111.667 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ILE . . . . . 0.477 ' HA ' HD12 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 1.93 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 1.67 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.11 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 2.59 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.9 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.92 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.55 113.325 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' LEU . . . . . 0.501 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 1.49 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 1.66 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.94 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.29 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' SER . . . . . 0.533 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.15 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.31 110.301 179.475 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 CA--C 1.528 0.112 0 CA-C-O 120.836 0.351 . . . . 1.31 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 2.84 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.7 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' LEU . . . . . 0.417 ' O ' HG22 ' C' ' 133' ' ' ILE . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.88 110.652 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.38 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.76 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' ILE . . . . . 0.417 HG22 ' O ' ' C' ' 130' ' ' LEU . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.15 111.035 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 1.56 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.73 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 1.48 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.51 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.01 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.05 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.07 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 141' ' ' ILE . . . . . 0.415 HG13 ' N ' ' C' ' 142' ' ' ILE . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 1.92 111.453 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 142' ' ' ILE . . . . . 0.415 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 2.64 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.51 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 3.58 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.65 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.46 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 148' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.33 112.017 -179.443 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.823 0.344 . . . . 2.82 110.771 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.18 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 161' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.5 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 1.81 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.13 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 164' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.21 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.31 111.042 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.26 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.58 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.3 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 1.73 110.975 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 1.43 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.72 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.55 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 1.5 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 1.84 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 175' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.12 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 177' ' ' ILE . . . . . 0.414 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 1.75 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.72 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 179' ' ' TYR . . . . . 0.593 ' O ' HG22 ' C' ' 182' ' ' VAL . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 1.8 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 0.88 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 181' ' ' ILE . . . . . 0.414 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 1.52 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.47 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 184' ' ' ILE . . . . . 0.605 HG22 HG23 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 1.62 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 185' ' ' ILE . . . . . 0.605 HG23 HG22 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 2.63 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.77 112.416 -179.905 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.779 0.323 . . . . 2.37 111.096 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.68 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 1.95 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 200' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.05 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 1.91 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.04 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 203' ' ' CYS . . . . . 0.439 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 1.62 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.49 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 205' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.32 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 206' ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 1.52 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 1.84 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 209' ' ' SER . . . . . 0.501 ' HB2' HD23 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.68 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.04 111.606 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 2.65 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.33 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.02 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.35 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 3.62 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' LEU . . . . . 0.426 HD13 ' C ' ' C' ' 216' ' ' LEU . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.64 110.596 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.11 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 3.37 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.11 111.389 -179.984 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.485 1.275 0 CA-C-O 120.851 0.358 . . . . 8.09 110.899 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -75.29 -17.83 60.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.094 -0.503 . . . . 5.68 110.919 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.47 117.28 17.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 6.27 110.993 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -84.92 92.51 8.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.081 -0.509 . . . . 6.52 110.797 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.5 t -127.85 -80.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.098 -0.501 . . . . 3.59 110.959 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt 63.42 2.56 1.2 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.337 -0.392 . . . . 3.23 111.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.8 mt -81.2 -49.73 10.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.974 0.416 . . . . 1.88 110.804 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 35.0 m80 -64.73 -24.01 67.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.907 -0.588 . . . . 1.29 110.497 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' O ' HG12 ' A' ' 12' ' ' VAL . 52.9 t-105 -73.75 -44.58 55.77 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.975 -0.557 . . . . 0.99 110.69 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.9 mt -69.21 -21.73 25.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.931 0.396 . . . . 1.92 110.59 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -68.2 -52.53 33.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 1.45 110.933 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' TRP . 9.0 p -61.59 -32.07 52.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.525 -0.307 . . . . 0.89 111.166 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.22 -56.77 17.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.905 0.384 . . . . 0.9 111.271 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.84 -19.81 65.81 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.784 -0.722 . . . . 0.83 112.414 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 43.8 tpp -75.2 -40.12 59.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 1.24 111.067 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.6 p -61.42 -51.64 67.91 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 1.29 110.918 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.06 -23.4 33.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.083 -0.508 . . . . 1.71 111.002 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.95 -48.05 86.03 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.771 -0.728 . . . . 0.96 112.345 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.51 -27.14 61.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.773 0.321 . . . . 0.99 111.08 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -71.19 -27.79 63.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 2.11 110.775 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 62.5 t60 -57.89 -35.19 70.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.132 -0.485 . . . . 2.23 110.409 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -74.73 -33.14 62.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.043 -0.526 . . . . 4.02 110.442 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -54.76 -36.03 64.39 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.978 -0.555 . . . . 3.96 110.588 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 64.6 m -84.1 -27.52 28.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.009 -0.541 . . . . 2.38 110.671 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 34.1 tp -83.25 -1.6 53.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.088 -0.506 . . . . 2.77 110.769 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 31.1 t -59.37 -20.88 58.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 2.52 111.021 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -46.77 -32.62 3.77 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 121.554 0.692 . . . . 5.54 109.445 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.6 p-10 -172.31 131.36 0.68 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 114.746 -1.115 . . . . 4.44 109.309 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.4 Cg_endo -81.64 171.19 13.58 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.601 2.201 . . . . 2.81 111.907 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -146.52 125.68 12.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.014 0.435 . . . . 6.8 111.725 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.47 -47.21 3.04 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.839 -0.619 . . . . 4.97 113.193 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.553 ' HB ' ' HG3' ' A' ' 36' ' ' GLU . 34.5 m -136.32 149.78 68.84 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.615 0.245 . . . . 4.71 111.659 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.405 ' HG2' ' HE1' ' A' ' 35' ' ' TYR . 19.5 Cg_exo -67.41 166.41 23.75 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.996 2.464 . . . . 3.51 112.757 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -44.33 -56.69 3.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.377 0.88 . . . . 3.41 113.377 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.405 ' HE1' ' HG2' ' A' ' 33' ' ' PRO . 20.5 p90 -47.26 -37.36 10.49 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.139 0.422 . . . . 2.81 112.139 -178.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.553 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 mm-40 -62.32 -42.19 99.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.876 0.37 . . . . 3.39 110.62 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -70.15 -26.83 64.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.505 . . . . 5.24 110.685 179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' B' ' 100' ' ' THR . 48.4 tp -56.4 -59.12 5.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 1.6 110.772 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.9 t -63.6 -40.31 88.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 1.33 110.936 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.416 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -68.62 -9.39 49.51 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 1.03 111.345 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.6 ttt -88.91 -39.37 13.83 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.102 -0.499 . . . . 2.0 111.261 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -71.62 -31.41 66.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 1.31 111.688 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 88.1 mt -55.08 -53.76 57.86 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 111.989 0.366 . . . . 1.0 111.989 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 55.5 Cg_endo -70.01 -39.26 6.23 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.177 1.918 . . . . 0.59 113.072 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 96.8 mt -54.51 -61.44 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 111.783 0.29 . . . . 1.63 111.783 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.669 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -57.99 -53.62 56.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.909 0.385 . . . . 1.12 111.054 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' HG21 ' A' ' 79' ' ' THR . 90.6 p -57.16 -21.76 35.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.047 -0.524 . . . . 1.32 111.386 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.89 -57.57 6.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.746 -0.74 . . . . 0.52 112.755 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 ' SG ' ' B' ' 134' ' ' CYS . 46.2 mt -59.59 -26.16 65.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.878 0.37 . . . . 0.98 110.953 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.44 -55.47 33.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.52 111.107 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.4 m-85 -60.65 -37.3 81.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.246 -0.434 . . . . 1.69 110.941 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.2 ttp -52.46 -34.93 51.12 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.153 0.501 . . . . 1.12 110.217 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.01 -41.67 74.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.6 110.609 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.43 ' SD ' ' HA ' ' A' ' 51' ' ' TYR . 41.7 mtt -53.84 -25.19 18.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.892 -0.595 . . . . 0.94 110.34 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.527 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.57 -48.41 19.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.818 -0.628 . . . . 0.78 110.678 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.421 HG12 ' HA ' ' A' ' 53' ' ' ALA . 22.9 pt -78.85 8.83 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.481 . . . . 1.23 111.242 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 61.37 28.14 17.64 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.128 -0.487 . . . . 2.02 111.318 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -96.43 94.19 7.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.383 . . . . 2.1 110.684 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 145.62 30.58 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.844 -0.693 . . . . 1.27 112.168 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -141.91 125.68 17.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.662 0.268 . . . . 1.76 110.874 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -118.71 136.07 57.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.346 -0.388 . . . . 1.84 111.067 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -95.38 117.54 30.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.64 110.875 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -131.7 120.25 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 1.84 111.146 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.09 19.9 10.4 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.018 -0.537 . . . . 2.24 111.427 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.07 -9.61 74.87 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.799 -0.715 . . . . 2.16 112.707 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -100.03 127.72 46.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.824 0.345 . . . . 2.84 110.887 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 71.7 mt -83.43 138.62 18.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.26 -0.427 . . . . 2.39 110.947 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 139.29 45.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.97 111.322 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 28.0 m-70 -106.11 57.89 0.66 Allowed 'General case' 0 C--O 1.235 0.332 0 CA-C-N 116.044 -0.525 . . . . 1.04 110.934 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -65.77 -26.76 67.86 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.0 -0.545 . . . . 3.38 110.992 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -26.08 60.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.952 0.406 . . . . 0.76 110.764 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -69.47 -51.67 33.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.952 -0.567 . . . . 2.93 111.643 -179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' HA ' ' CE3' ' A' ' 76' ' ' TRP . 1.9 p90 -67.01 -31.2 71.59 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.661 -0.416 . . . . 3.13 110.762 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 30.6 mt -54.74 -47.75 73.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 116.387 -0.37 . . . . 1.66 110.654 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -63.43 -27.75 69.5 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.02 0.438 . . . . 1.42 109.858 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.412 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 12.8 m0 -92.74 7.64 42.72 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 115.74 -0.663 . . . . 2.09 110.41 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . . . . . . . . . 54.1 tpp -104.49 -13.16 16.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.733 -0.667 . . . . 1.52 109.935 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.455 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.4 p -111.2 -50.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.708 -0.678 . . . . 1.33 112.097 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.425 ' N ' HG13 ' A' ' 78' ' ' VAL . 66.8 p -67.85 -49.49 61.83 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.126 0.417 . . . . 1.39 112.126 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.495 HG22 ' NE2' ' A' ' 109' ' ' GLN . 57.5 m -51.14 -54.28 39.61 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 112.98 0.733 . . . . 1.55 112.98 -178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 80' ' ' THR . 17.7 Cg_endo -57.84 -31.92 93.65 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 121.61 1.54 . . . . 1.01 112.003 -179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.455 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -83.3 -19.42 36.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 1.45 110.758 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.23 -31.63 58.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.217 0.532 . . . . 1.3 109.816 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 tt -84.71 -27.36 27.07 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.366 -0.833 . . . . 1.67 110.482 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 68.8 mt -82.69 -37.3 24.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.007 -0.542 . . . . 1.87 111.211 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 75.2 p -57.76 -47.57 82.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.125 -0.489 . . . . 1.42 110.799 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 61.7 mt -63.32 -31.82 73.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 1.4 110.614 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.3 m -63.15 -43.32 98.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.038 -0.528 . . . . 1.91 110.519 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -75.28 -17.16 60.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 2.33 110.738 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.3 m -68.95 -39.19 79.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.329 -0.396 . . . . 1.43 110.998 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -90.1 -34.08 16.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.1 -0.5 . . . . 1.19 111.333 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 80.2 mtp -95.26 108.47 20.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.32 -0.4 . . . . 2.55 110.98 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -81.19 -51.36 8.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.464 . . . . 3.33 111.004 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -120.72 149.54 42.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.977 0.418 . . . . 5.1 111.024 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 15.5 tt -140.72 143.19 29.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.034 -0.53 . . . . 3.07 111.013 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -142.75 -70.59 0.33 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.235 -0.439 . . . . 4.41 111.011 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.54 13.48 14.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.754 0.311 . . . . 5.31 111.086 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -109.25 99.01 8.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.38 -0.373 . . . . 3.94 110.804 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 58.6 p-90 -136.63 2.17 2.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.356 -0.384 . . . . 5.98 111.305 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.4 p -67.35 -31.15 71.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.449 -0.342 . . . . 2.24 111.517 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.3 mt -75.33 -44.74 43.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.405 -0.362 . . . . 2.67 111.492 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 40.6 pt -72.62 -30.78 34.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.522 -0.308 . . . . 2.59 111.484 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.06 -29.76 66.37 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.68 -0.772 . . . . 1.53 112.514 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -78.19 -33.61 49.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.707 0.289 . . . . 3.14 111.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.1 mt -77.71 -36.29 51.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 1.99 111.089 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -68.54 -39.2 81.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 2.36 111.023 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 76.7 p -62.29 -54.42 40.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 2.05 111.082 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.614 HG21 HD13 ' A' ' 142' ' ' ILE . 74.0 p -60.92 -24.47 66.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.307 -0.406 . . . . 2.25 111.222 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' NE2' HG22 ' A' ' 80' ' ' THR . 7.2 tp60 -67.97 -45.85 73.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.919 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 90.2 mt -57.5 -37.14 56.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 1.88 110.736 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.6 t -63.16 -43.32 98.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 1.6 111.396 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.6 -49.22 79.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 1.09 111.561 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 63.4 mt -58.18 -39.63 74.05 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 2.65 110.88 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.426 HG21 ' HZ3' ' C' ' 46' ' ' TRP . 46.5 m -57.64 -37.43 73.32 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.973 -0.558 . . . . 0.89 110.706 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 20.2 m -58.11 -56.37 22.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.87 -0.604 . . . . 0.68 110.48 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.38 -19.3 68.46 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.785 -0.722 . . . . 0.63 112.294 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 tt -60.98 -56.11 24.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.919 0.39 . . . . 1.58 110.311 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 65.5 mt -84.31 -24.19 7.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.98 -0.554 . . . . 2.04 111.288 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.13 44.99 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.375 -0.375 . . . . 1.1 111.069 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -89.63 -27.98 19.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.958 -0.564 . . . . 1.88 110.609 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.2 mt -86.68 34.21 0.65 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 1.53 111.121 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.1 m -93.43 132.54 37.58 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.287 -0.415 . . . . 2.29 110.699 179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -90.07 -31.58 17.09 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.195 -0.457 . . . . 3.49 110.965 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.565 HH12 ' HG3' ' C' ' 1' ' ' MET . 78.9 mtm180 -115.53 142.4 46.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.998 0.428 . . . . 3.13 110.838 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -75.09 -9.59 58.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.966 -0.561 . . . . 3.71 111.062 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -85.56 -46.32 10.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.318 -0.401 . . . . 3.97 110.823 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.502 HG21 ' HB2' ' C' ' 58' ' ' GLN . 13.0 p -69.09 -26.54 32.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.313 -0.403 . . . . 1.22 111.132 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -65.38 -30.81 71.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.483 . . . . 2.81 110.986 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -66.78 -32.24 73.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 4.25 110.752 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.53 -50.39 15.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 1.84 111.201 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -61.6 -28.2 69.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.272 -0.422 . . . . 1.54 111.45 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 31.5 t80 -63.52 -52.94 59.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.318 -0.401 . . . . 1.79 110.879 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 42.9 mm -55.61 -32.74 31.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.24 -0.436 . . . . 2.08 110.869 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.456 ' SG ' HD22 ' C' ' 49' ' ' LEU . 19.3 t -62.05 -38.85 90.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 1.76 111.08 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.04 -53.54 22.09 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.802 -0.713 . . . . 0.76 112.834 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.441 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 27.3 m -62.83 -31.22 51.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.799 0.333 . . . . 2.07 111.217 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 45.4 t -55.49 -59.18 5.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 1.85 111.024 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.16 -26.02 68.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 1.32 111.284 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -74.27 -28.94 61.44 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.106 -0.497 . . . . 3.25 110.954 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 136' ' ' VAL . 92.2 mt -78.35 -27.9 47.11 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.41 -0.359 . . . . 2.92 111.57 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 28.0 mm -77.37 -41.54 30.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.444 -0.344 . . . . 2.65 111.166 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.614 HD13 HG21 ' A' ' 108' ' ' THR . 6.7 tp -73.76 -33.98 39.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.056 -0.52 . . . . 3.21 111.343 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 146' ' ' ILE . 39.9 tp -63.76 -56.18 17.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.305 -0.407 . . . . 2.01 111.091 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -65.2 -22.32 66.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.003 0.43 . . . . 3.6 110.43 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -16.97 67.03 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.902 -0.59 . . . . 1.62 113.063 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 143' ' ' LEU . 19.8 tt -105.16 -13.63 9.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.807 0.337 . . . . 2.47 111.646 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -69.38 -45.73 68.62 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.21 0.448 . . . . 2.48 112.21 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.624 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 49.7 t30 -71.07 -51.32 10.68 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 112.367 0.506 . . . . 2.69 112.367 -178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 22.6 Cg_exo -65.8 -2.06 5.95 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.259 1.973 . . . . 2.36 112.684 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.578 HD21 ' HA ' ' A' ' 166' ' ' ASP . 55.5 tp -61.04 -31.82 71.46 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.312 -0.404 . . . . 3.3 111.156 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 71.7 mtp180 -135.95 -4.61 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.504 -0.316 . . . . 8.48 111.108 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.77 -50.72 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.395 -0.366 . . . . 2.98 111.439 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.504 ' NZ ' ' HB3' ' A' ' 153' ' ' LYS . 8.3 mtpm? -75.38 -30.97 60.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 4.55 111.174 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.4 p -83.12 5.77 21.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.253 -0.43 . . . . 4.0 111.312 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 75.1 ttt180 -69.73 -24.47 63.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.22 -0.446 . . . . 5.51 110.861 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 39.5 m -110.75 -35.83 5.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.104 -0.498 . . . . 3.2 111.135 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -63.48 -67.99 0.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 3.98 110.917 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.1 t -156.09 115.05 3.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 2.63 110.847 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 80.8 p -73.79 -34.3 64.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.158 -0.473 . . . . 2.16 111.022 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -67.02 -47.27 71.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 3.37 110.704 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -66.51 -22.48 66.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 2.83 110.582 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.52 -47.88 74.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.057 -0.519 . . . . 1.7 111.036 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -60.66 -43.47 97.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.011 -0.54 . . . . 2.16 110.758 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 168' ' ' LEU . 76.4 mt -57.15 -52.41 65.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.141 -0.482 . . . . 1.59 110.602 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.456 ' HA ' HD12 ' A' ' 168' ' ' LEU . 0.6 OUTLIER -60.27 -36.34 77.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.779 -0.646 . . . . 2.31 111.313 -179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.578 ' HA ' HD21 ' A' ' 150' ' ' LEU . 25.5 t70 -56.75 -33.86 66.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.338 -0.392 . . . . 2.15 110.899 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.478 ' HB2' ' NZ ' ' A' ' 167' ' ' LYS . 0.1 OUTLIER -81.99 -25.89 34.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.418 . . . . 2.39 110.728 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 164' ' ' LEU . 77.7 mt -71.42 -57.61 4.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.095 -0.502 . . . . 1.79 110.971 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.1 t -56.94 -23.81 18.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.871 -0.604 . . . . 1.42 111.482 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 26.6 m -58.65 -58.59 7.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.819 0.342 . . . . 1.12 111.34 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.429 ' HA ' HG12 ' A' ' 174' ' ' VAL . 91.9 m-85 -73.22 -22.44 60.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 3.86 110.719 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -70.82 -31.83 68.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 1.58 111.126 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 33.5 p -79.57 -45.88 18.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.273 -0.421 . . . . 1.41 111.88 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 171' ' ' TYR . 14.0 p -59.24 -30.73 44.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 N-CA-C 111.845 0.313 . . . . 1.42 111.845 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.422 HD12 HG13 ' A' ' 174' ' ' VAL . 7.8 mp -80.86 -51.79 8.2 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.881 0.372 . . . . 1.91 110.781 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.29 -28.94 63.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.904 -0.589 . . . . 1.55 110.855 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.541 ' O ' HG12 ' A' ' 181' ' ' ILE . 11.0 tp -87.48 -22.34 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.86 110.707 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' O ' ' HB ' ' A' ' 181' ' ' ILE . . . -60.64 -44.93 97.29 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.935 -0.65 . . . . 0.74 112.958 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.594 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.7 m-85 -60.17 -54.29 56.65 Favored Pre-proline 0 CA--C 1.533 0.318 0 N-CA-C 112.035 0.383 . . . . 1.78 112.035 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 10.8 Cg_endo -56.17 -23.89 47.34 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 121.447 1.431 . . . . 0.92 112.397 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.541 HG12 ' O ' ' A' ' 177' ' ' ILE . 27.0 mm -63.67 -56.58 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 121.159 0.504 . . . . 1.77 109.929 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.594 HG22 ' O ' ' A' ' 179' ' ' TYR . 15.5 m -64.06 -22.76 31.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.701 -0.681 . . . . 1.34 109.717 178.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -74.7 -12.62 60.47 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.195 -0.911 . . . . 2.51 111.618 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.483 HG22 HG13 ' A' ' 185' ' ' ILE . 32.3 mm -55.74 -81.12 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 112.125 0.417 . . . . 2.02 112.125 -179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.483 HG13 HG22 ' A' ' 184' ' ' ILE . 1.7 pp -120.13 -173.47 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 N-CA-C 112.433 0.531 . . . . 2.45 112.433 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.476 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 64.56 173.01 3.19 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-N 115.675 -0.693 . . . . 1.73 112.819 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.38 74.27 1.58 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.492 2.128 . . . . 3.05 111.541 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.1 m 62.25 53.13 2.93 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.033 -0.53 . . . . 4.04 110.775 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 182' ' ' VAL . . . -176.09 -143.96 4.91 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.502 -0.856 . . . . 4.48 113.038 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -95.32 0.71 53.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.673 0.273 . . . . 7.96 111.429 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.476 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . 89.17 170.38 45.0 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.578 -0.82 . . . . 3.23 112.589 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 18.2 m-90 54.79 27.68 9.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 6.03 110.813 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.405 HD11 ' HA3' ' A' ' 189' ' ' GLY . 5.6 pt -123.39 151.98 28.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.937 -0.574 . . . . 3.18 111.05 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.03 -175.07 5.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 3.39 111.228 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -79.44 -35.16 40.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 5.76 110.916 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 36.6 m -61.2 -54.08 48.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.217 -0.447 . . . . 2.5 110.732 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 15.5 tt -64.95 -26.99 41.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 2.4 110.972 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -56.3 -58.76 6.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.388 -0.369 . . . . 2.66 110.741 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 81.5 p -62.94 -24.24 67.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 1.81 110.653 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -71.67 -37.63 70.75 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.996 -0.547 . . . . 2.21 111.077 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 62.4 tp -70.75 -43.96 67.75 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.293 -0.412 . . . . 2.18 110.891 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -74.45 0.85 13.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 2.01 110.726 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 53.3 t -96.2 -46.22 6.54 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.342 0.591 . . . . 1.93 110.225 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.7 tp -74.03 -33.64 63.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.458 -0.792 . . . . 1.7 111.693 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.679 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 49.9 tp -57.8 -53.82 61.72 Favored Pre-proline 0 CA--C 1.532 0.283 0 C-N-CA 121.176 -0.209 . . . . 1.28 111.213 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.679 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 39.8 Cg_exo -58.78 -42.33 54.26 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.949 1.766 . . . . 0.79 111.299 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -60.51 -32.43 71.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.114 -0.493 . . . . 1.51 109.999 178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -81.91 -22.66 36.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.74 -0.663 . . . . 1.93 110.098 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.4 t -81.23 -35.61 31.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.709 -0.678 . . . . 1.71 110.564 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.4 -46.65 31.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.018 -0.537 . . . . 2.04 111.257 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 13.8 p -63.74 -36.83 77.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.466 -0.334 . . . . 2.89 111.304 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.08 -49.7 75.7 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.699 -0.762 . . . . 1.31 112.861 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -66.57 -32.32 73.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.573 0.225 . . . . 2.87 111.563 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 38.0 t -55.14 -57.65 10.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.93 0.395 . . . . 2.38 110.991 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -71.86 -19.77 61.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.122 -0.49 . . . . 3.42 110.677 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.15 -49.76 58.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.803 -0.635 . . . . 1.24 110.965 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -62.63 -41.59 99.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.27 -0.423 . . . . 2.44 111.101 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.4 mt -60.28 -46.47 89.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 2.51 111.198 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -74.99 -20.63 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 3.01 110.851 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.74 -54.16 40.22 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 121.073 -0.584 . . . . 1.59 113.172 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.453 HD22 ' N ' ' A' ' 221' ' ' LEU . 3.3 mm? -82.86 -58.94 2.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.59 0.233 . . . . 3.49 111.229 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.2 tpt180 50.74 75.84 0.17 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.395 -0.366 . . . . 5.74 110.653 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.493 HD21 ' HB3' ' A' ' 225' ' ' ASN . 7.2 t30 -115.57 -54.89 2.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 5.46 111.128 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 55.8 mt 59.86 80.94 0.19 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.236 -0.438 . . . . 6.13 110.876 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . 0.493 ' HB3' HD21 ' A' ' 223' ' ' ASN . 3.3 p-10 -104.82 -168.34 1.46 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.984 -0.553 . . . . 6.46 110.943 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -165.52 51.72 0.1 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 6.94 110.744 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 77.6 p -125.53 136.11 52.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.103 -0.499 . . . . 6.83 110.886 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -145.01 -26.47 0.48 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.065 -0.516 . . . . 10.77 110.787 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.313 -0.851 . . . . 9.41 110.948 -179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.81 0.338 . . . . 8.91 110.938 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -105.86 10.04 32.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.13 -0.486 . . . . 6.76 110.981 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.438 HD22 ' N ' ' B' ' 3' ' ' LEU . 3.7 mm? 59.22 -170.82 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.087 -0.506 . . . . 6.25 111.084 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 58.61 34.65 24.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.159 -0.473 . . . . 5.44 111.245 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 72.5 p -147.12 70.83 1.2 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.307 -0.406 . . . . 3.84 110.96 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 95.2 mt -97.1 38.11 1.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.071 -0.513 . . . . 3.08 110.993 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' B' ' 200' ' ' PHE . 61.8 tp -80.95 -52.61 7.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 2.35 110.89 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.567 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 29.7 m80 -71.9 -23.93 61.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.141 -0.481 . . . . 1.39 110.623 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.406 ' O ' HG23 ' B' ' 12' ' ' VAL . 72.6 t-105 -69.91 -53.5 17.65 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.022 -0.535 . . . . 1.1 111.255 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 46.0 pt -58.79 -31.5 44.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-O 120.96 0.409 . . . . 1.71 110.079 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.425 ' O ' ' HG2' ' B' ' 15' ' ' MET . 10.4 t80 -58.33 -41.55 84.81 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.77 -0.65 . . . . 1.48 109.523 178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.406 HG23 ' O ' ' B' ' 9' ' ' TRP . 2.3 t -58.1 -51.87 65.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.352 -0.84 . . . . 0.95 111.103 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.62 -32.91 65.75 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.204 -0.453 . . . . 0.97 111.222 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.02 -42.12 85.77 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.701 -0.761 . . . . 0.8 112.534 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 75.0 mmm -71.64 -35.35 70.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.798 0.332 . . . . 1.29 111.061 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -57.95 -59.65 4.93 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.182 -0.463 . . . . 1.36 111.262 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.34 -22.74 31.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.453 . . . . 1.23 111.306 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.44 -48.84 84.03 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.796 -0.716 . . . . 0.88 112.69 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.35 -37.13 71.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.733 0.302 . . . . 0.98 111.212 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.3 tp -59.16 -29.16 67.23 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.298 -0.41 . . . . 2.12 110.614 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -57.94 -37.19 73.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.08 -0.509 . . . . 2.0 110.395 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.646 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 83.7 m-85 -73.91 -28.31 61.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.946 -0.57 . . . . 4.26 111.032 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.471 ' O ' ' OG ' ' B' ' 26' ' ' SER . 80.8 t90 -56.08 -49.74 72.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.231 -0.44 . . . . 3.62 110.448 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 46.7 t -81.48 -21.21 38.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.084 -0.507 . . . . 2.55 110.179 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.646 ' HB3' ' HA ' ' B' ' 22' ' ' PHE . 42.0 tp -77.85 0.1 25.22 Favored 'General case' 0 C--O 1.22 -0.456 0 CA-C-N 115.492 -0.776 . . . . 3.11 110.655 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 3.2 m -52.38 -22.34 4.53 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.915 -0.314 . . . . 3.02 111.154 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.1 mtp180 -53.61 -19.73 4.29 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 122.04 0.924 . . . . 5.89 108.906 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.746 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 0.4 OUTLIER -66.39 -154.18 0.0 OUTLIER Pre-proline 0 CA--C 1.556 1.192 0 CA-C-N 113.835 -1.529 . . . . 5.02 108.236 177.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 52.5 Cg_exo -0.35 87.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 123.433 2.755 . . . . 3.53 115.998 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -120.24 69.19 0.85 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 114.781 -1.1 . . . . 7.88 108.676 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.1 3.53 8.14 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.518 -1.033 . . . . 4.61 110.518 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.589 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 28.7 m -130.89 160.69 65.48 Favored Pre-proline 0 CA--C 1.518 -0.265 0 CA-C-N 114.905 -0.647 . . . . 4.73 109.91 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' B' ' 32' ' ' VAL . 18.8 Cg_exo -35.56 116.99 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.369 2.046 . . . . 3.75 114.871 -177.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.14 -36.88 22.59 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.09 -0.959 . . . . 3.76 108.657 176.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.521 ' CE2' ' HB3' ' B' ' 33' ' ' PRO . 0.4 OUTLIER -51.07 -22.66 2.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 113.813 -1.54 . . . . 3.17 112.011 -179.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -53.54 -60.29 3.49 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.711 0.291 . . . . 2.57 111.271 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -75.06 -19.09 60.16 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.524 -0.307 . . . . 5.74 111.07 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 46.2 tp -58.16 -60.36 3.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.936 0.398 . . . . 1.72 110.61 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 9.3 p -65.94 -32.9 60.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.023 -0.535 . . . . 1.95 110.77 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.69 -11.95 60.83 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.082 -0.508 . . . . 1.2 111.017 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.457 ' O ' HG12 ' B' ' 45' ' ' ILE . 58.9 ttp -88.71 -35.72 16.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.469 . . . . 2.12 110.879 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -72.62 -29.14 63.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.106 -0.497 . . . . 1.49 111.42 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 97.2 mt -57.33 -54.09 58.53 Favored Pre-proline 0 CA--C 1.536 0.411 0 N-CA-C 111.866 0.321 . . . . 0.77 111.866 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 59.5 Cg_endo -71.15 -32.33 13.25 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.274 1.983 . . . . 0.68 113.088 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.457 HG12 ' O ' ' B' ' 41' ' ' MET . 23.2 mm -57.25 -62.54 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.655 0.264 . . . . 1.63 111.502 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.481 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.1 t90 -57.39 -51.45 69.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.972 0.415 . . . . 1.91 110.762 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 52.7 m -59.12 -21.19 58.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.822 -0.626 . . . . 1.22 111.433 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.44 -52.61 12.31 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.55 112.481 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.461 HD22 ' SG ' ' C' ' 134' ' ' CYS . 40.9 mt -63.15 -26.15 68.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.991 0.424 . . . . 0.87 110.79 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.25 -55.57 33.13 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.114 -0.494 . . . . 0.55 111.002 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 29.8 m-85 -62.34 -27.26 68.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.199 -0.455 . . . . 1.06 110.815 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 54.0 ttp -57.97 -36.55 72.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.223 0.535 . . . . 1.19 109.94 178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -41.61 71.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.529 -0.759 . . . . 0.66 110.869 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 53.0 mtt -55.29 -23.94 25.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.015 -0.539 . . . . 0.86 110.551 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.567 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -79.02 -46.34 18.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.005 -0.543 . . . . 0.84 110.984 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.507 HG21 HG23 ' C' ' 127' ' ' VAL . 8.1 mt -80.13 5.63 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.05 -0.523 . . . . 1.44 110.951 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.86 32.98 22.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 1.55 111.099 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 56.1 tp60 -105.1 91.99 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 2.24 110.886 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 158.76 -12.05 0.21 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.616 -0.802 . . . . 1.26 112.81 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -99.22 147.98 24.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.842 0.353 . . . . 2.31 111.124 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -132.25 139.45 50.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.075 -0.511 . . . . 1.81 110.859 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -86.31 115.65 23.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.226 -0.443 . . . . 3.18 110.858 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.9 111.15 10.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 2.03 111.162 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.84 28.52 17.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.994 -0.548 . . . . 2.48 111.451 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.23 -5.06 74.0 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.747 -0.739 . . . . 2.37 112.508 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -102.32 125.13 48.94 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.683 0.277 . . . . 2.28 110.804 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.7 mt -76.99 124.64 35.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.262 -0.426 . . . . 1.78 110.752 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.17 128.33 40.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 1.05 111.139 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.478 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 20.6 m-70 -88.65 64.15 7.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.992 -0.549 . . . . 1.11 110.998 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.448 ' O ' HG12 ' B' ' 74' ' ' ILE . 67.3 t80 -61.03 -57.08 14.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.692 -0.685 . . . . 2.3 111.438 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.27 -22.01 64.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.3 -0.409 . . . . 0.72 112.082 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.478 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 17.1 tpp180 -67.13 -52.1 45.8 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.157 0.429 . . . . 3.04 112.157 -178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -74.75 -28.81 60.92 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.788 -0.365 . . . . 1.79 110.684 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.448 HG12 ' O ' ' B' ' 70' ' ' TYR . 16.8 mm -52.3 -49.33 42.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.393 -0.367 . . . . 1.44 110.456 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.57 ' O ' HG22 ' B' ' 79' ' ' THR . 17.1 t70 -62.18 -29.62 70.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.063 -0.517 . . . . 1.31 109.719 179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -86.0 7.51 24.18 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.849 -0.614 . . . . 2.01 111.162 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.411 ' SD ' HG21 ' B' ' 113' ' ' ILE . 50.6 tpp -105.18 -14.47 15.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.751 -0.659 . . . . 1.43 110.414 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 23.6 m -114.15 -42.54 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 113.062 0.764 . . . . 1.21 113.062 -178.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.57 HG22 ' O ' ' B' ' 75' ' ' ASP . 12.1 t -76.16 -41.08 50.94 Favored 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 112.617 0.599 . . . . 1.18 112.617 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.56 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 33.4 m -61.4 -51.58 76.55 Favored Pre-proline 0 C--N 1.327 -0.383 0 N-CA-C 112.377 0.51 . . . . 1.65 112.377 -178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' B' ' 80' ' ' THR . 19.6 Cg_endo -57.82 -34.66 98.56 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 121.891 1.728 . . . . 1.06 112.096 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 8.4 mp -84.86 -17.37 38.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.232 -0.44 . . . . 1.58 111.476 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 13.1 tp -75.83 -37.53 58.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.844 0.354 . . . . 1.49 110.82 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.556 HD21 ' HG3' ' B' ' 109' ' ' GLN . 1.6 pp -83.61 -26.89 29.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.056 0.455 . . . . 1.72 110.335 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.456 ' N ' HD12 ' B' ' 84' ' ' LEU . 11.3 tp -75.9 -31.85 59.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.702 -0.681 . . . . 1.96 110.323 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 93.7 p -61.71 -26.27 67.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.888 -0.596 . . . . 1.24 110.466 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.543 HD13 HD21 ' B' ' 168' ' ' LEU . 94.3 mt -75.89 -32.49 59.68 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 1.21 110.76 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 59.0 m -62.46 -41.02 98.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 1.32 110.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 97.1 m95 -72.68 -35.2 67.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 2.15 111.098 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 85.8 m -56.44 -49.11 75.52 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.067 -0.515 . . . . 1.44 111.351 -179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.4 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -77.99 -48.82 15.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 1.05 111.39 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 62.1 mtt -86.63 95.29 9.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 2.68 111.34 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -76.16 -14.63 60.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.16 -0.473 . . . . 2.71 110.511 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -154.37 133.91 12.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.985 -0.552 . . . . 4.19 110.553 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.33 147.53 28.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.244 -0.435 . . . . 2.79 111.572 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 53.1 tptt -162.01 -16.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.01 -0.541 . . . . 5.27 110.496 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -76.59 -169.15 1.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.007 -0.542 . . . . 5.57 111.211 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -71.43 165.9 22.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.031 -0.532 . . . . 4.24 110.99 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 79.4 m95 -99.37 81.5 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.177 -0.465 . . . . 5.39 110.857 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . 0.474 ' HA ' HD22 ' A' ' 38' ' ' LEU . 31.6 m -104.66 -45.91 4.48 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 2.16 111.248 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.444 ' N ' HD12 ' B' ' 101' ' ' LEU . 7.1 mp -76.83 -60.4 2.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.203 -0.453 . . . . 2.58 111.063 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -59.74 -31.86 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.326 -0.397 . . . . 2.29 110.834 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.31 -52.88 24.39 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.767 -0.73 . . . . 1.48 112.305 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.47 ' HB2' HD11 ' A' ' 38' ' ' LEU . 78.5 t80 -59.31 -26.42 64.99 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.965 0.412 . . . . 2.76 110.643 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 56.7 tp -76.89 -41.7 42.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.891 -0.595 . . . . 2.22 110.735 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 49.0 ttp -70.12 -32.46 70.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.664 -0.698 . . . . 2.36 111.518 -179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 75.1 p -66.84 -59.59 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 1.92 110.918 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.555 ' O ' HG23 ' B' ' 112' ' ' VAL . 17.4 m -59.78 -18.95 47.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.061 -0.518 . . . . 2.06 110.475 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.556 ' HG3' HD21 ' B' ' 84' ' ' LEU . 0.5 OUTLIER -69.95 -41.48 74.49 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.102 -0.499 . . . . 2.87 110.709 179.478 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.669 HG22 ' HE1' ' A' ' 46' ' ' TRP . 54.1 mt -63.87 -44.5 98.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.094 -0.503 . . . . 1.98 111.651 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . 0.48 HG22 ' O ' ' B' ' 108' ' ' THR . 25.6 m -62.71 -34.64 66.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.725 0.298 . . . . 1.62 111.1 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.555 HG23 ' O ' ' B' ' 108' ' ' THR . 65.4 t -68.21 -53.89 25.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.326 -0.397 . . . . 1.04 111.136 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.411 HG21 ' SD ' ' B' ' 77' ' ' MET . 49.6 mm -55.7 -34.97 37.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.896 0.379 . . . . 2.46 110.64 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 65.3 m -59.92 -39.22 84.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.937 -0.574 . . . . 0.83 110.477 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -57.97 -56.94 15.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.911 -0.586 . . . . 0.74 110.461 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.82 -21.29 67.31 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.888 -0.672 . . . . 0.6 112.35 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 3.3 tt -61.16 -54.11 48.59 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.813 0.339 . . . . 1.42 110.474 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.442 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 49.3 mt -84.0 -24.57 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.129 -0.487 . . . . 1.51 111.306 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.74 61.36 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.275 -0.42 . . . . 1.09 110.976 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.432 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 7.8 m-20 -85.74 -24.23 26.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.953 -0.567 . . . . 2.25 110.552 179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 98.2 mt -89.87 25.69 2.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.108 -0.496 . . . . 1.16 110.718 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 90.3 p -88.42 130.1 35.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.15 -0.477 . . . . 1.76 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.72 -33.47 17.51 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.11 -0.495 . . . . 2.89 110.733 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.774 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 40.5 ttp180 -110.51 143.61 40.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.196 -0.456 . . . . 2.67 110.726 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -78.32 -14.36 59.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.216 -0.447 . . . . 3.25 111.289 -179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.774 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 49.7 t-105 -80.64 -42.71 21.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.352 -0.385 . . . . 4.07 110.878 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' B' ' 124' ' ' ARG . 12.8 p -73.59 -27.0 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 1.41 111.158 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -71.52 -27.43 63.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 2.47 111.055 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -66.5 -27.36 67.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.339 -0.391 . . . . 2.61 111.154 -179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 56' ' ' ILE . 54.1 tp -83.03 -46.96 12.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 2.07 111.281 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 6.5 m95 -60.83 -33.19 72.65 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.526 -0.306 . . . . 1.3 111.147 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -58.73 -51.56 69.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.27 -0.423 . . . . 1.75 110.857 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . 0.424 HG22 ' HG ' ' B' ' 137' ' ' CYS . 34.3 mt -61.91 -32.36 53.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 1.67 111.081 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.405 ' SG ' HD22 ' A' ' 49' ' ' LEU . 41.3 t -61.97 -31.58 71.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 1.54 110.971 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.37 -45.26 30.85 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.798 -0.715 . . . . 0.7 112.729 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 23.9 m -69.69 -28.51 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.598 0.237 . . . . 1.44 111.587 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . 0.424 ' HG ' HG22 ' B' ' 133' ' ' ILE . 86.6 m -65.37 -47.83 75.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.519 -0.31 . . . . 1.82 110.709 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.0 -36.12 78.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.132 -0.485 . . . . 0.94 110.853 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -76.43 -20.2 57.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.984 -0.553 . . . . 1.6 110.654 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.21 -44.06 60.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.083 -0.508 . . . . 2.01 111.328 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.445 HG13 ' N ' ' B' ' 142' ' ' ILE . 26.5 pt -70.31 -44.57 77.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 112.108 0.41 . . . . 1.96 112.108 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.445 ' N ' HG13 ' B' ' 141' ' ' ILE . 14.9 tt -67.23 -35.04 72.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.677 0.275 . . . . 2.88 111.538 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.6 tp -61.51 -48.65 80.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.441 -0.345 . . . . 1.52 110.833 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -71.5 -24.64 62.01 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.984 0.421 . . . . 4.15 110.464 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -79.73 -16.94 76.4 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.856 -0.611 . . . . 1.59 112.777 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.6 tt -104.72 -16.21 7.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 2.13 111.326 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -65.3 -49.83 67.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 1.78 111.741 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.468 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.3 t30 -63.26 -52.17 63.45 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.067 0.395 . . . . 2.45 112.067 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 56.0 Cg_endo -70.14 -1.29 8.53 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.123 1.882 . . . . 2.36 112.921 -179.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' B' ' 166' ' ' ASP . 57.3 tp -61.23 -21.91 64.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.883 0.373 . . . . 2.88 110.988 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -147.16 -14.12 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 8.07 110.835 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -38.47 27.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.037 -0.529 . . . . 2.8 110.975 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -75.36 -41.99 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 4.58 110.742 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 73.4 p -79.4 6.49 10.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 3.81 110.858 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 58.2 ttp180 -60.52 -25.35 66.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.474 . . . . 5.22 110.686 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.0 p -115.5 -17.86 11.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.017 -0.538 . . . . 3.42 111.022 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.427 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 8.5 tt0 -80.89 -68.55 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.198 -0.455 . . . . 4.2 110.94 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 40.6 t -157.53 117.24 3.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 2.75 111.122 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 40.2 t -73.68 -39.31 64.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.028 -0.533 . . . . 2.4 111.236 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.34 -45.26 94.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.382 -0.372 . . . . 3.46 111.053 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.4 HD11 ' HB1' ' B' ' 91' ' ' ALA . 49.3 tp -65.19 -25.51 67.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.267 -0.424 . . . . 2.57 110.681 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -64.75 -43.22 94.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.107 -0.497 . . . . 1.72 111.067 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 -64.91 -43.78 91.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.072 -0.513 . . . . 2.69 111.116 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 47.4 mt -60.91 -46.65 89.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.097 -0.501 . . . . 2.16 110.908 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.491 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.9 OUTLIER -71.95 -22.68 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.969 -0.559 . . . . 2.13 111.188 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' B' ' 150' ' ' LEU . 27.9 t70 -60.67 -51.43 69.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.289 -0.414 . . . . 1.94 110.91 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -76.4 -23.29 54.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 3.33 110.854 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.543 HD21 HD13 ' B' ' 87' ' ' LEU . 10.1 tt -65.39 -46.31 80.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 1.56 110.749 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 165' ' ' TYR . 43.0 t -71.0 -23.4 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 1.59 111.008 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.1 m -55.4 -58.89 5.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 1.14 111.144 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -65.04 -39.45 93.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 3.87 110.862 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -57.25 -28.63 63.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.12 -0.491 . . . . 1.61 111.154 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 32.4 m -79.64 -35.18 39.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.294 -0.412 . . . . 1.3 111.65 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 42.3 t -69.79 -37.52 73.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 112.077 0.399 . . . . 1.53 112.077 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' B' ' 209' ' ' SER . 10.7 mp -75.79 -51.3 12.92 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.851 0.357 . . . . 1.99 111.392 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.9 -30.33 63.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 1.5 111.18 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.512 ' O ' HG12 ' B' ' 181' ' ' ILE . 10.1 tp -87.86 -19.53 7.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.815 0.341 . . . . 1.46 110.347 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.08 -53.62 44.87 Favored Glycine 0 C--N 1.332 0.334 0 CA-C-N 115.897 -0.592 . . . . 0.67 112.842 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.604 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 63.9 m-85 -54.46 -56.68 24.12 Favored Pre-proline 0 CA--C 1.532 0.25 0 C-N-CA 120.856 -0.338 . . . . 1.73 110.971 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 80.2 Cg_exo -44.73 -33.89 7.6 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.0 1.8 . . . . 0.93 112.734 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.512 HG12 ' O ' ' B' ' 177' ' ' ILE . 42.4 mm -61.91 -58.81 5.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.355 -0.384 . . . . 1.36 111.372 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.5 m -60.23 -26.37 36.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.265 -0.425 . . . . 1.19 111.557 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -70.86 -24.22 62.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.722 0.296 . . . . 2.73 111.085 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.53 HG22 HG23 ' B' ' 185' ' ' ILE . 85.5 mt -55.65 -67.85 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.35 -0.386 . . . . 1.93 111.417 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.53 HG23 HG22 ' B' ' 184' ' ' ILE . 2.8 pp -118.0 175.89 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.193 -0.458 . . . . 2.64 111.252 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 93.92 -158.63 23.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.739 -0.743 . . . . 1.93 112.582 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.468 ' HD3' HD12 ' B' ' 193' ' ' ILE . 58.2 Cg_endo -72.05 164.23 36.3 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.642 2.228 . . . . 2.97 111.93 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 33.5 t 56.71 14.99 1.97 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 4.5 110.336 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -151.28 -86.13 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.653 -0.703 . . . . 4.5 112.155 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -159.39 84.39 0.78 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.91 0.386 . . . . 7.89 110.645 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -159.38 177.4 35.93 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.842 -0.694 . . . . 3.62 112.321 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 28.1 p-90 -110.58 24.14 13.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.938 0.399 . . . . 6.54 110.762 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.468 HD12 ' HD3' ' B' ' 187' ' ' PRO . 59.9 mt -88.56 139.89 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.037 -0.529 . . . . 3.16 111.16 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -60.09 147.02 40.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.154 -0.476 . . . . 3.39 110.8 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -62.94 -12.34 24.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.02 -0.536 . . . . 5.56 111.65 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 89.4 m -68.73 -53.98 18.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 2.68 110.796 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 75.0 mt -64.35 -26.72 41.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 2.2 110.82 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -48.53 -61.19 2.15 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 2.49 111.08 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 70.3 p -65.7 -36.14 82.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 1.76 110.815 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . 0.423 ' HA ' HD21 ' B' ' 7' ' ' LEU . 90.8 t80 -57.43 -29.34 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.18 111.096 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 58.6 tp -83.9 -46.91 11.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 1.78 111.39 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -71.18 0.47 7.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.484 -0.326 . . . . 1.98 111.57 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 55.0 m -96.7 -45.37 6.71 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.122 0.486 . . . . 1.65 110.602 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 39.0 tp -71.45 -32.4 68.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.788 -0.642 . . . . 1.11 111.966 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.557 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 1.7 tt -62.24 -54.79 46.26 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 121.07 -0.252 . . . . 1.43 111.299 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.557 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.8 Cg_exo -54.88 -46.07 36.1 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.948 1.765 . . . . 0.77 111.508 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -59.8 -36.36 76.59 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.45 . . . . 1.6 109.883 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -76.54 -16.35 59.64 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.904 -0.589 . . . . 1.77 110.336 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.428 ' HB3' HD23 ' B' ' 175' ' ' LEU . 49.6 m -91.41 -26.67 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.817 -0.628 . . . . 1.54 110.744 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.5 mptt -79.48 -51.2 9.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.276 -0.42 . . . . 2.01 110.839 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 79.8 t -57.46 -55.01 23.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.141 -0.482 . . . . 2.65 111.249 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -56.38 -35.89 67.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.698 -0.763 . . . . 1.33 112.488 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -68.56 -35.38 77.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.832 0.349 . . . . 2.29 110.869 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 66.1 m -63.17 -52.89 60.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 2.12 111.229 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -61.19 -26.05 67.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.316 -0.402 . . . . 3.6 110.921 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.426 ' C ' HD23 ' B' ' 216' ' ' LEU . 8.2 tt -64.18 -49.48 71.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 1.51 110.929 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.35 -39.25 86.48 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.355 -0.384 . . . . 2.22 111.195 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 61.4 mt -67.15 -29.73 69.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.101 -0.499 . . . . 2.69 111.004 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -87.88 -20.58 25.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 3.4 111.126 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.04 -49.33 67.9 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.858 -0.687 . . . . 1.67 112.902 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 39.3 tp -84.7 -57.95 2.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.57 0.224 . . . . 3.39 111.319 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 82.3 mtm180 53.93 68.41 0.85 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.904 0.383 . . . . 5.91 110.918 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.49 143.78 19.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.008 -0.542 . . . . 5.26 110.608 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 88.1 mt -131.88 92.12 3.08 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.337 -0.392 . . . . 6.81 110.889 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -95.44 159.49 14.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.09 -0.505 . . . . 7.02 110.726 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -138.46 77.54 1.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.496 . . . . 8.21 110.867 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 66.3 m -154.22 128.9 9.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 8.1 111.029 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -147.26 -21.04 0.39 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.033 -0.53 . . . . 13.28 110.583 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.279 -0.867 . . . . 10.4 110.89 -179.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.565 ' HG3' HH12 ' A' ' 124' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.716 0.293 . . . . 8.1 111.029 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 56.89 82.72 0.11 Allowed 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.115 -0.493 . . . . 6.27 110.78 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.559 ' H ' HD23 ' C' ' 3' ' ' LEU . 2.7 pt? -72.62 149.2 44.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.132 -0.485 . . . . 6.2 111.128 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -161.51 -38.94 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.981 -0.554 . . . . 4.82 110.8 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 63.1 p -118.76 94.09 4.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.086 -0.506 . . . . 3.25 110.939 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.52 HD12 ' N ' ' C' ' 6' ' ' LEU . 5.0 mp -94.82 2.62 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.055 -0.52 . . . . 2.79 110.998 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.9 tp -58.5 -42.12 86.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 2.08 111.237 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.608 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.2 m-70 -66.94 -27.55 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 1.43 111.113 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 66.5 t-105 -73.75 -39.63 64.09 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.913 0.387 . . . . 1.16 110.611 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.21 -20.86 14.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.136 -0.483 . . . . 2.09 110.498 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -66.88 -47.67 71.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.808 -0.633 . . . . 1.58 110.559 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.0 p -69.27 -33.84 59.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 1.0 111.107 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.84 -57.49 12.23 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.267 -0.424 . . . . 0.96 111.245 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.9 -19.2 67.38 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.884 -0.674 . . . . 0.96 112.574 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 45.6 tpp -76.91 -35.84 57.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.78 0.324 . . . . 1.3 110.718 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 35.5 m -64.74 -53.63 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.103 -0.499 . . . . 1.52 110.777 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.71 -23.4 33.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.9 111.108 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -61.75 -49.91 71.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.687 -0.768 . . . . 0.96 112.224 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.78 -24.0 61.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.853 0.359 . . . . 1.07 111.063 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.58 -29.75 59.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.073 -0.512 . . . . 2.08 110.928 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 62.8 t60 -59.67 -33.46 71.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.095 -0.502 . . . . 2.02 110.306 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -83.07 -17.48 43.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.89 -0.596 . . . . 4.98 110.725 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 73.7 t-105 -64.74 -42.82 94.9 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.106 -0.497 . . . . 4.29 110.118 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 37.0 t -81.07 -29.51 34.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.928 -0.578 . . . . 2.47 110.269 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 34.0 tp -77.71 -0.97 28.9 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.935 -0.575 . . . . 2.9 110.534 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 6.3 m -56.62 -20.92 23.61 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.268 -0.424 . . . . 2.74 111.064 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 40.6 ttm180 -52.88 -28.25 22.29 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 121.374 0.607 . . . . 5.85 109.434 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 8.4 p30 -168.36 131.69 1.31 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.045 -0.98 . . . . 4.52 109.868 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 7.3 Cg_endo -87.81 -176.27 1.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.825 2.35 . . . . 3.22 112.458 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . 0.497 ' HB2' HD22 ' C' ' 218' ' ' LEU . 41.1 mmt180 -89.82 28.75 1.28 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 8.68 111.393 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.482 ' HA2' HD23 ' C' ' 224' ' ' LEU . . . 118.32 -46.2 1.17 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.671 -0.776 . . . . 4.14 113.008 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.58 HG12 HD12 ' C' ' 221' ' ' LEU . 20.7 m -73.41 142.62 81.69 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.51 0.195 . . . . 5.09 111.128 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.412 ' HB2' ' CD2' ' C' ' 35' ' ' TYR . 23.5 Cg_exo -65.57 166.33 20.16 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.723 2.282 . . . . 3.1 112.653 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -44.37 55.65 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.669 0.618 . . . . 3.85 112.669 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.412 ' CD2' ' HB2' ' C' ' 33' ' ' PRO . 6.6 p90 -54.38 -41.37 69.13 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.591 0.234 . . . . 3.37 111.235 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.17 -36.26 74.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.057 0.456 . . . . 2.72 110.159 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -76.24 -26.0 55.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.732 -0.667 . . . . 5.67 110.786 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 60.2 tp -56.83 -60.84 2.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 1.93 110.832 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 58.8 t -63.37 -36.27 75.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.969 0.414 . . . . 1.88 110.748 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.06 -8.56 55.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.994 -0.548 . . . . 1.23 111.153 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.11 -37.03 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 2.09 111.186 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -73.55 -30.3 62.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.246 -0.433 . . . . 1.41 111.934 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.465 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 76.7 mt -58.13 -52.13 76.77 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 112.216 0.45 . . . . 0.8 112.216 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 53.3 Cg_endo -70.24 -46.03 1.15 Allowed 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.125 1.883 . . . . 0.72 112.808 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 35.6 mm -50.95 -61.32 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.442 -0.344 . . . . 1.68 111.636 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.426 ' HZ3' HG21 ' A' ' 114' ' ' THR . 5.1 t-105 -54.5 -58.3 8.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.35 -0.386 . . . . 1.68 111.301 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 94.1 p -51.98 -27.52 13.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 1.28 111.611 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.66 -52.14 45.5 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.599 -0.81 . . . . 0.51 112.606 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.456 HD22 ' SG ' ' A' ' 134' ' ' CYS . 67.9 mt -63.27 -28.6 70.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.691 0.281 . . . . 1.33 111.355 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.27 -59.58 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.401 -0.363 . . . . 0.57 111.196 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 21.2 m-85 -59.74 -35.75 75.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 1.67 110.928 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 56.8 ttp -52.02 -36.08 48.97 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.067 0.461 . . . . 1.42 110.348 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.68 -41.45 72.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.812 -0.631 . . . . 0.71 110.591 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 47.4 mtt -53.24 -29.24 31.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.956 -0.566 . . . . 1.14 110.371 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.608 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -75.02 -42.6 56.98 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.021 -0.536 . . . . 0.88 110.834 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 4.8 mt -80.29 5.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.116 -0.493 . . . . 1.38 110.885 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 59.19 37.55 23.84 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.058 -0.519 . . . . 1.94 111.287 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.502 ' HB2' HG21 ' A' ' 127' ' ' VAL . 18.6 tp60 -114.89 102.36 9.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 1.87 110.781 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 152.0 -14.5 0.77 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 1.27 112.275 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -105.55 145.31 31.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.682 0.277 . . . . 2.86 110.74 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.4 p -123.01 138.2 53.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 1.95 111.248 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -90.62 104.91 17.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.098 -0.501 . . . . 3.04 110.728 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -132.78 125.14 29.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 2.11 111.065 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 31.03 20.81 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.282 -0.417 . . . . 2.54 111.174 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 73.07 -0.36 47.05 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.889 -0.672 . . . . 2.47 112.751 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -104.08 141.84 35.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.897 0.38 . . . . 2.85 111.089 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.8 mt -92.58 130.64 41.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.977 -0.556 . . . . 1.87 110.899 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -100.47 133.79 44.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.544 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.471 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 41.1 m-70 -94.07 58.95 2.62 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.318 0.58 . . . . 1.26 110.316 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.471 ' O ' HG12 ' C' ' 74' ' ' ILE . 41.5 t80 -56.28 -58.46 7.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.436 -0.802 . . . . 2.08 111.887 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.55 -24.52 66.7 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.268 0.47 . . . . 0.86 112.268 -178.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.471 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 20.3 tpp180 -61.2 -51.89 67.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.0 0.37 . . . . 1.96 112.0 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 77' ' ' MET . 19.6 p90 -78.38 -25.84 46.35 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.696 -0.402 . . . . 1.8 111.391 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.471 HG12 ' O ' ' C' ' 70' ' ' TYR . 16.8 mm -50.72 -50.9 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.652 0.263 . . . . 1.18 110.758 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.94 -24.6 67.95 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.232 -0.44 . . . . 1.33 110.198 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 35.9 m0 -85.81 7.7 22.88 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 116.069 -0.514 . . . . 1.85 111.38 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 73' ' ' TYR . 29.5 mtp -104.71 -23.36 13.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.039 -0.528 . . . . 1.56 110.396 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.433 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 1.4 p -113.95 -43.9 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.897 -0.592 . . . . 1.11 111.927 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 16.8 m -68.12 -53.42 25.48 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.018 0.377 . . . . 1.49 112.018 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.657 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.4 m -49.81 -53.52 41.39 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 112.031 0.382 . . . . 1.6 112.031 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.657 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 53.0 Cg_exo -55.05 -30.63 71.02 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 121.802 1.668 . . . . 1.01 112.141 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 92.2 mt -84.43 -25.1 29.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 1.18 111.274 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -40.66 97.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.943 0.401 . . . . 1.54 110.45 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.27 -38.7 20.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.899 -0.592 . . . . 1.65 110.797 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' C' ' 81' ' ' PRO . 14.4 tp -58.1 -43.77 87.3 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.643 -0.708 . . . . 2.1 111.148 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 47.0 t -57.1 -33.69 67.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.284 -0.416 . . . . 1.38 110.614 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.415 ' HB3' HD21 ' C' ' 168' ' ' LEU . 56.7 mt -74.89 -30.83 61.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.997 -0.547 . . . . 1.44 110.481 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 47.8 t -64.02 -41.97 97.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 1.87 110.775 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -71.16 -32.76 69.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 3.1 110.798 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 58.7 m -60.0 -36.55 77.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.047 -0.524 . . . . 1.48 111.163 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.19 -44.1 11.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.208 -0.451 . . . . 1.02 110.993 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -93.58 97.48 10.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.072 -0.513 . . . . 2.34 110.689 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 -69.72 -58.36 4.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.079 -0.509 . . . . 3.21 110.977 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -113.73 144.74 42.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.329 -0.396 . . . . 4.54 111.179 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 50.8 mt -136.21 146.01 29.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.087 -0.506 . . . . 2.34 110.714 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -142.69 -71.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.358 -0.383 . . . . 4.4 110.942 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.3 pttm -127.91 94.29 3.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 5.54 111.071 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -147.11 -83.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.005 -0.543 . . . . 3.54 110.824 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 94.5 m95 49.17 36.9 9.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 5.21 111.095 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 89.2 m -112.97 -59.39 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 2.38 111.008 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.422 HD12 ' N ' ' C' ' 101' ' ' LEU . 7.4 mp -68.62 -50.88 48.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.275 -0.42 . . . . 2.64 110.872 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.43 -52.89 55.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.095 -0.502 . . . . 2.38 111.126 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.65 -25.48 51.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.915 -0.659 . . . . 1.62 112.946 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -74.42 -58.85 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.617 0.246 . . . . 2.93 111.387 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.478 HD12 ' N ' ' C' ' 106' ' ' MET . 4.0 pp -60.49 -32.81 71.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.466 -0.333 . . . . 2.16 111.429 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.491 ' O ' HG12 ' C' ' 110' ' ' ILE . 89.2 mtp -62.68 -47.47 83.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.622 -0.263 . . . . 2.3 111.143 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 92.9 p -63.41 -45.78 89.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.951 0.405 . . . . 2.07 111.476 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.439 ' O ' HG23 ' C' ' 112' ' ' VAL . 59.4 p -60.41 -29.8 69.21 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 2.3 111.596 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' C' ' 105' ' ' LEU . 13.9 mm100 -77.48 -24.41 50.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.331 -0.395 . . . . 2.48 111.342 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.491 HG12 ' O ' ' C' ' 106' ' ' MET . 48.1 mm -69.13 -41.04 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.722 0.296 . . . . 1.93 110.882 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 34.0 m -72.02 -31.85 41.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.883 0.373 . . . . 1.67 111.047 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.439 HG23 ' O ' ' C' ' 108' ' ' THR . 44.6 t -64.93 -57.69 10.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.222 -0.445 . . . . 1.11 111.518 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.44 HG13 ' N ' ' C' ' 114' ' ' THR . 44.8 pt -55.87 -35.9 41.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.618 -0.265 . . . . 2.59 110.99 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.44 ' N ' HG13 ' C' ' 113' ' ' ILE . 65.5 m -51.71 -54.17 31.31 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.399 -0.364 . . . . 0.9 111.009 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.9 m -59.98 -31.1 69.59 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.251 -0.431 . . . . 0.92 110.356 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -67.24 -27.66 73.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.023 -0.608 . . . . 0.55 112.501 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.404 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.9 mt -71.68 -59.05 2.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 1.49 110.582 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.576 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 25.3 mm -61.19 -29.92 46.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.747 -0.66 . . . . 1.66 111.204 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.33 -43.81 64.77 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.305 -0.407 . . . . 0.94 110.969 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -91.23 -17.66 25.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 1.79 110.67 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 95.9 mt -90.46 4.54 50.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 1.29 110.876 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 72.9 m -69.61 140.86 53.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.32 -0.4 . . . . 2.15 110.891 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -98.63 -18.75 17.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 3.31 110.839 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.532 ' HB2' HG12 ' C' ' 127' ' ' VAL . 77.5 mtm180 -126.23 147.18 49.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.238 -0.437 . . . . 3.16 111.129 -179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -77.18 -11.09 59.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.884 -0.598 . . . . 4.24 110.832 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 75.5 t90 -83.63 -48.25 10.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 4.65 110.743 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.532 HG12 ' HB2' ' C' ' 124' ' ' ARG . 7.1 p -67.5 -34.38 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.01 -0.541 . . . . 1.31 111.236 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -65.09 -20.17 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 2.84 110.791 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -74.28 -30.31 62.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.147 -0.479 . . . . 2.7 110.905 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 90.9 mt -83.56 -43.93 15.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.251 -0.431 . . . . 1.88 110.986 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 6.7 m95 -58.97 -37.84 77.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.017 -0.538 . . . . 1.38 111.077 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -61.31 -49.78 75.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 1.76 110.795 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 73.4 mt -53.55 -34.39 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 2.15 111.057 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . 0.461 ' SG ' HD22 ' B' ' 49' ' ' LEU . 37.5 t -65.29 -38.12 89.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 1.56 110.96 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.88 -47.4 66.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.781 -0.723 . . . . 0.73 112.63 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 33.7 m -71.36 -27.43 28.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.736 0.303 . . . . 1.48 111.296 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.53 -46.52 82.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 1.51 111.037 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . 0.415 ' O ' HG12 ' C' ' 142' ' ' ILE . . . -71.91 -25.32 61.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.381 -0.372 . . . . 1.01 111.149 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -70.97 -34.34 71.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 2.05 111.221 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 94.1 mt -73.68 -44.41 56.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.471 -0.332 . . . . 2.07 111.642 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 53.3 mt -58.85 -45.29 91.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.623 0.249 . . . . 1.92 111.429 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.415 HG12 ' O ' ' C' ' 138' ' ' ALA . 40.3 mm -73.73 -32.34 34.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.499 -0.319 . . . . 2.64 111.33 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . 0.409 ' O ' HG22 ' C' ' 146' ' ' ILE . 55.4 tp -62.6 -50.2 72.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.465 -0.334 . . . . 1.51 110.742 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 56.8 t-105 -68.22 -23.09 64.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.937 0.398 . . . . 3.58 110.24 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -80.0 -16.94 75.78 Favored Glycine 0 N--CA 1.45 -0.372 0 CA-C-N 115.796 -0.638 . . . . 1.65 112.959 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.409 HG22 ' O ' ' C' ' 143' ' ' LEU . 17.7 tt -105.32 -19.53 6.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.716 0.293 . . . . 2.46 111.6 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 16.3 m95 -66.12 -50.05 65.35 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.323 -0.399 . . . . 2.27 111.591 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.45 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 54.9 t30 -60.45 -51.9 76.73 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.352 -0.385 . . . . 2.33 111.959 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 64.5 Cg_endo -72.64 -7.25 20.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.138 1.892 . . . . 2.46 112.737 -179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 54.0 tp -59.67 -21.09 60.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.818 0.342 . . . . 3.08 110.707 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 80.2 mtp180 -138.71 -22.09 0.98 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.989 -0.55 . . . . 8.45 110.929 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -73.97 -50.43 19.98 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.173 -0.467 . . . . 2.9 111.353 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -71.28 -35.68 71.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 4.62 110.966 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.507 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 54.8 p -82.83 2.51 33.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 3.85 111.305 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -65.54 -28.89 69.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.26 -0.427 . . . . 5.12 110.486 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 77.6 p -114.29 -20.62 10.8 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.997 -0.547 . . . . 3.43 111.127 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 7.6 tt0 -73.12 -66.91 0.62 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 3.98 110.721 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.0 m -156.66 113.47 3.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 2.4 110.596 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 80.1 p -72.7 -39.55 66.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.22 -0.445 . . . . 2.82 110.851 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -63.38 -49.83 72.29 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.072 -0.513 . . . . 3.18 110.646 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 48.7 tp -66.17 -28.83 69.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.034 -0.53 . . . . 2.5 110.741 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -60.29 -43.47 96.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 1.81 111.104 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -66.6 -40.67 88.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 2.13 110.847 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 57.6 mt -61.61 -41.64 97.74 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.155 -0.475 . . . . 2.21 110.749 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -24.12 55.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 1.31 110.935 -179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -63.43 -41.45 98.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.258 -0.428 . . . . 2.26 110.894 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -83.56 -22.32 32.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.756 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.415 HD21 ' HB3' ' C' ' 87' ' ' LEU . 49.1 tp -67.91 -47.73 67.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.979 -0.555 . . . . 1.3 110.916 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.8 -24.71 29.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 1.73 111.345 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 46.9 m -55.65 -59.23 5.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.402 -0.363 . . . . 1.43 111.497 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -69.39 -30.82 68.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.248 -0.433 . . . . 3.72 110.63 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -65.62 -29.31 69.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.922 -0.581 . . . . 1.55 111.005 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 61.5 m -79.55 -38.39 34.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.48 . . . . 1.5 111.75 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 96.8 t -60.82 -49.15 85.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.476 -0.329 . . . . 1.84 111.654 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.86 -50.38 64.74 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.439 -0.346 . . . . 2.12 111.441 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -31.86 53.55 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.232 -0.44 . . . . 1.0 110.851 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.475 ' O ' HG13 ' C' ' 181' ' ' ILE . 81.4 mt -87.62 -22.45 6.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.07 -0.514 . . . . 1.75 110.404 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.37 -56.35 22.21 Favored Glycine 0 CA--C 1.517 0.216 0 CA-C-N 115.753 -0.658 . . . . 0.72 113.253 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.642 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 93.7 m-85 -54.89 -56.21 30.17 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.821 0.31 . . . . 1.8 111.208 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.642 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 87.3 Cg_exo -43.91 -37.52 9.17 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.003 1.802 . . . . 0.88 112.4 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.475 HG13 ' O ' ' C' ' 177' ' ' ILE . 98.0 mt -58.67 -59.79 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 1.52 111.17 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.2 m -60.6 -24.82 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.439 . . . . 1.2 111.504 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 47.8 m95 -72.02 -25.38 61.79 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.516 -0.311 . . . . 2.47 111.397 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.511 HG22 HG23 ' C' ' 185' ' ' ILE . 50.7 mm -54.13 -72.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.823 0.344 . . . . 1.62 111.182 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.511 HG23 HG22 ' C' ' 184' ' ' ILE . 38.2 pt -111.22 -174.55 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.312 -0.404 . . . . 2.63 111.088 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 86.15 -154.6 27.81 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 120.836 -0.697 . . . . 1.77 112.757 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . 0.488 ' HD3' ' HB ' ' C' ' 193' ' ' ILE . 59.3 Cg_endo -72.15 159.17 50.52 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.615 2.21 . . . . 3.03 112.116 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 31.8 m 55.56 20.34 3.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.009 0.433 . . . . 4.22 110.302 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -171.71 45.56 0.18 Allowed Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.707 -0.679 . . . . 4.08 112.427 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 48.8 t80 61.77 97.97 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.914 0.387 . . . . 7.54 111.303 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.93 167.18 40.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 121.008 -0.615 . . . . 3.29 112.192 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 41.2 p90 -106.12 22.36 15.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.745 0.307 . . . . 5.67 110.939 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.488 ' HB ' ' HD3' ' C' ' 187' ' ' PRO . 48.7 mt -90.47 144.53 8.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 2.76 111.173 -179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -58.67 152.69 18.12 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.904 -0.589 . . . . 3.69 111.19 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -73.6 -27.54 61.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.867 -0.606 . . . . 5.34 110.995 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.2 t -65.77 -30.21 70.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.426 . . . . 2.57 111.177 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 91.1 mt -77.85 -32.14 17.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.001 -0.545 . . . . 2.37 110.872 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -52.5 -53.83 40.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.68 111.064 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 6.1 t -69.31 -38.11 78.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.114 -0.494 . . . . 1.95 111.258 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -58.92 -32.19 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 2.05 111.036 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.0 tp -84.28 -45.18 13.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.287 -0.415 . . . . 1.91 111.605 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.17 -4.96 19.58 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 111.941 0.348 . . . . 2.04 111.941 -179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 64.3 m -96.22 -38.57 10.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.069 0.462 . . . . 1.62 110.723 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 41.0 tp -74.83 -26.02 59.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.656 -0.702 . . . . 1.49 111.7 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -67.14 -54.46 19.77 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 120.883 -0.327 . . . . 1.32 110.877 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.5 Cg_exo -55.86 -44.12 50.57 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 121.897 1.732 . . . . 0.76 111.266 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -60.91 -31.99 71.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.899 -0.591 . . . . 1.52 109.958 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -78.19 -25.57 47.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.939 -0.573 . . . . 1.84 109.741 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 47.0 t -79.61 -51.07 9.74 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.717 -0.674 . . . . 1.68 110.619 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -55.09 -57.63 10.95 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 116.112 -0.494 . . . . 2.04 111.139 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.37 -36.71 59.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.529 . . . . 2.65 111.367 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -64.28 -47.53 83.85 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.746 -0.74 . . . . 1.33 112.977 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -71.66 -27.85 63.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.619 0.247 . . . . 3.02 111.5 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 66.2 m -58.84 -51.49 69.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.03 0.443 . . . . 2.35 110.619 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -69.19 -26.15 64.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.887 -0.597 . . . . 3.62 110.509 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.415 ' O ' HD23 ' C' ' 216' ' ' LEU . 2.4 tt -67.22 -46.26 74.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.951 -0.568 . . . . 1.64 110.771 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -59.53 -40.53 87.46 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.104 -0.498 . . . . 2.2 110.986 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' C' ' 30' ' ' ARG . 67.6 mt -71.81 -29.97 65.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.252 -0.431 . . . . 3.11 111.259 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -83.49 -20.67 33.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.38 -0.373 . . . . 3.37 111.061 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.12 -51.49 56.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.88 -0.676 . . . . 1.55 112.951 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.58 HD12 HG12 ' C' ' 32' ' ' VAL . 76.7 mt -84.95 -59.04 2.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 3.11 111.19 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 68.2 ttt180 50.75 72.29 0.36 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 5.73 110.751 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -164.66 148.3 9.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.072 -0.513 . . . . 5.53 110.867 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.482 HD23 ' HA2' ' C' ' 31' ' ' GLY . 95.9 mt -123.74 131.21 53.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.478 . . . . 6.6 110.749 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -140.24 115.2 9.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.319 -0.4 . . . . 6.51 110.885 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -101.97 109.18 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.245 -0.434 . . . . 7.05 110.974 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 48.1 t -155.2 87.04 1.11 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.146 -0.479 . . . . 6.72 110.903 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 63.4 mtm180 -142.06 -45.74 0.34 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.27 -0.423 . . . . 9.56 110.737 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.154 -0.926 . . . . 9.08 110.857 179.835 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.728 H161 ' H8 ' ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.743 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.751 ' H8 ' H171 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ptt? . . . . . 0 N--CA 1.485 1.301 0 CA-C-O 120.767 0.317 . . . . 8.09 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 -95.42 12.91 27.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.302 -0.408 . . . . 5.68 110.929 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 44.1 mt -97.5 111.29 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.925 -0.58 . . . . 6.27 110.473 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -142.2 142.94 32.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.42 -0.354 . . . . 6.52 111.086 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 73.9 p -173.22 145.01 1.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.25 -0.432 . . . . 3.59 110.913 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.441 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.3 pt? -136.63 -29.49 0.94 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.285 -0.416 . . . . 3.23 111.255 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 57.2 tp -58.65 -41.25 85.63 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.466 -0.334 . . . . 1.88 111.255 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 43.1 m80 -61.84 -30.16 70.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.912 0.386 . . . . 1.29 110.704 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 76.0 t-105 -74.63 -41.87 59.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.141 -0.481 . . . . 0.99 110.473 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.5 mt -70.26 -20.6 22.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 1.92 110.162 179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -67.23 -57.53 6.53 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.817 -0.629 . . . . 1.45 110.451 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' A' ' 52' ' ' MET . 7.2 p -56.1 -33.1 35.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 0.89 110.993 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.8 -48.05 82.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.273 -0.422 . . . . 0.9 110.915 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.92 -17.54 71.64 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.822 -0.704 . . . . 0.83 112.267 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.592 ' HG3' ' HA2' ' A' ' 48' ' ' GLY . 31.5 mmt -77.81 -38.66 45.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.839 0.352 . . . . 1.24 110.707 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 65.6 p -62.18 -51.65 66.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 1.29 110.539 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.35 -26.95 42.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.113 -0.494 . . . . 1.71 110.351 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.01 -28.62 73.36 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.001 -0.619 . . . . 0.96 112.043 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.98 -44.67 63.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.813 0.34 . . . . 0.99 110.344 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.8 mt -61.74 -28.26 69.3 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.098 -0.501 . . . . 2.11 110.17 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -56.59 -26.4 55.32 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.773 -0.648 . . . . 2.23 110.389 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.549 ' HA ' ' HB2' ' A' ' 25' ' ' LEU . 13.8 m-85 -72.98 -39.23 66.27 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.966 -0.561 . . . . 4.02 110.637 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 29.1 m95 -53.11 -37.76 62.03 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.453 -0.573 . . . . 3.96 109.453 178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 86.9 p -85.36 -21.35 28.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.64 -0.709 . . . . 2.38 110.105 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 0.2 OUTLIER -77.28 0.36 22.39 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.853 -0.612 . . . . 2.77 110.555 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 28' ' ' ASN . 21.3 p -48.92 -21.84 0.73 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.644 -0.253 . . . . 2.52 111.105 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 37.0 ptt180 -51.33 -21.3 2.12 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 122.107 0.956 . . . . 5.54 108.723 178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.744 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 3.5 t-20 -66.47 -156.04 0.0 OUTLIER Pre-proline 0 CA--C 1.554 1.111 0 CA-C-N 113.507 -1.678 . . . . 4.44 107.901 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.744 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 56.0 Cg_exo -1.79 70.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.892 0 C-N-CA 123.599 2.866 . . . . 2.81 115.76 -176.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 28' ' ' ASN . 13.9 ptm180 -102.93 54.07 0.77 Allowed 'General case' 0 CA--C 1.521 -0.165 0 N-CA-C 108.342 -0.984 . . . . 6.8 108.342 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.14 -1.36 9.04 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 109.572 -1.411 . . . . 4.97 109.572 -177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.478 HG13 ' HD2' ' A' ' 33' ' ' PRO . 96.1 t -111.85 139.11 21.92 Favored Pre-proline 0 CA--C 1.529 0.146 0 CA-C-N 114.446 -0.877 . . . . 4.71 110.023 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.478 ' HD2' HG13 ' A' ' 32' ' ' VAL . 61.0 Cg_exo -38.77 145.86 0.17 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.976 2.451 . . . . 3.51 114.114 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -78.32 -16.2 57.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.044 -0.98 . . . . 3.41 112.4 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.593 ' HD1' ' N ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -43.03 -27.76 0.22 Allowed 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.974 0.731 . . . . 2.81 112.974 -177.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.593 ' N ' ' HD1' ' A' ' 35' ' ' TYR . 12.7 pt-20 -80.2 -37.98 32.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.04 0.448 . . . . 3.39 110.84 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -68.95 -41.96 77.32 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.668 -0.696 . . . . 5.24 111.661 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -66.44 -61.64 1.89 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.307 -0.406 . . . . 1.6 112.022 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 98.7 t -53.32 -42.28 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.36 -0.382 . . . . 1.33 111.826 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.35 -21.42 65.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.389 -0.369 . . . . 1.03 111.476 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.404 ' C ' ' HD2' ' A' ' 44' ' ' PRO . 27.1 ttt -88.2 -27.12 22.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.353 -0.385 . . . . 2.0 111.377 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 48.6 t80 -73.26 -31.01 63.84 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.516 -0.311 . . . . 1.31 111.646 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.494 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 81.7 mt -60.31 -51.51 79.67 Favored Pre-proline 0 CA--C 1.536 0.438 0 N-CA-C 112.27 0.47 . . . . 1.0 112.27 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -68.52 -41.27 6.56 Favored 'Trans proline' 0 C--N 1.352 0.752 0 C-N-CA 122.211 1.941 . . . . 0.59 113.555 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.4 mm -56.41 -62.36 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 N-CA-C 111.934 0.346 . . . . 1.63 111.934 -179.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.494 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.9 t90 -56.87 -52.71 64.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.722 0.296 . . . . 1.12 111.148 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 50.2 m -57.41 -24.59 56.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 1.32 111.297 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.592 ' HA2' ' HG3' ' A' ' 15' ' ' MET . . . -64.61 -63.74 4.05 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.744 -0.741 . . . . 0.52 112.898 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 81.0 mt -58.48 -26.33 63.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.582 0.23 . . . . 0.98 111.547 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.94 -59.37 5.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.52 111.314 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' HA ' ' SD ' ' A' ' 54' ' ' MET . 27.7 m-85 -64.32 -28.15 69.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.262 -0.427 . . . . 1.69 111.265 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.461 ' HB2' HG21 ' A' ' 12' ' ' VAL . 58.4 ttp -55.37 -38.54 68.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.187 0.518 . . . . 1.12 109.899 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 58' ' ' GLN . . . -72.54 -38.29 68.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.578 -0.737 . . . . 0.6 110.696 179.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.462 ' HB2' ' HB3' ' A' ' 8' ' ' HIS . 57.3 mtt -54.91 -25.04 26.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.94 110.656 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.479 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -80.98 -52.24 7.65 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.131 -0.486 . . . . 0.78 111.086 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.442 HD13 HD23 ' B' ' 130' ' ' LEU . 18.6 pt -77.22 7.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.491 . . . . 1.23 111.356 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 57.78 66.28 1.16 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.857 -0.611 . . . . 2.02 111.148 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.61 HE21 ' H ' ' A' ' 59' ' ' GLY . 22.6 tp60 -131.36 140.73 49.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 2.1 110.841 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.61 ' H ' HE21 ' A' ' 58' ' ' GLN . . . 99.35 26.39 8.77 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.868 -0.682 . . . . 1.27 112.16 -179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 8.6 ptpp? -141.02 153.4 45.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.704 0.287 . . . . 1.76 110.884 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -122.3 149.41 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 1.84 111.38 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -113.38 88.71 2.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 2.64 110.949 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -106.87 130.6 54.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.194 -0.457 . . . . 1.84 111.119 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 63.41 13.03 6.77 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.06 -0.518 . . . . 2.24 111.487 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 95.52 -3.81 66.1 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.645 -0.788 . . . . 2.16 112.891 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -98.52 150.12 22.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.968 0.413 . . . . 2.84 111.06 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.5 mm -102.51 130.54 52.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.873 -0.603 . . . . 2.39 110.932 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.62 137.68 39.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.422 . . . . 0.97 111.385 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.433 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 16.4 m-70 -98.8 51.32 0.97 Allowed 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.006 -0.543 . . . . 1.04 110.947 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.501 ' O ' HG12 ' A' ' 74' ' ' ILE . 88.8 t80 -58.69 -58.47 8.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.854 -0.612 . . . . 3.38 111.53 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.97 -22.24 66.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.494 -0.321 . . . . 0.76 111.644 -179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' A' ' 54' ' ' MET . 16.0 tpp180 -60.48 -51.82 67.85 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.991 0.367 . . . . 2.93 111.991 -179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 18.4 p90 -78.07 -25.81 47.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 120.807 -0.357 . . . . 3.13 111.552 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 70' ' ' TYR . 27.7 mm -53.23 -47.58 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 120.791 0.329 . . . . 1.66 110.886 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -65.03 -21.72 66.88 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.126 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 37.6 m0 -93.39 0.67 56.94 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.933 -0.576 . . . . 2.09 111.016 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.41 ' HE1' HD21 ' A' ' 117' ' ' LEU . 55.9 ttm -104.73 -13.7 15.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.962 -0.563 . . . . 1.52 110.412 179.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 29.8 m -113.74 -30.95 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.115 -0.493 . . . . 1.33 111.786 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.454 HG23 HG23 ' A' ' 43' ' ' ILE . 45.6 m -86.01 -40.49 15.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.288 -0.415 . . . . 1.39 112.04 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.61 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 78.5 m -61.48 -51.56 76.39 Favored Pre-proline 0 C--N 1.329 -0.316 0 N-CA-C 112.166 0.432 . . . . 1.55 112.166 -179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.61 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 46.2 Cg_exo -56.23 -45.67 36.23 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 121.921 1.748 . . . . 1.01 112.018 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' HA ' HD12 ' A' ' 85' ' ' LEU . 4.5 mm? -69.45 -15.78 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.942 -0.572 . . . . 1.45 111.02 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 83' ' ' LEU . 0.5 OUTLIER -71.81 -45.53 61.2 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.332 -0.395 . . . . 1.3 110.618 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD21 ' HA ' ' A' ' 81' ' ' PRO . 0.6 OUTLIER -84.2 -18.97 34.85 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.358 -0.383 . . . . 1.67 111.065 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 82' ' ' LEU . 27.5 mt -68.97 -42.75 76.19 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.203 -0.453 . . . . 1.87 111.201 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.7 t -62.61 -28.68 70.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.354 -0.385 . . . . 1.42 111.059 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 92.7 mt -71.28 -22.09 62.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.29 -0.414 . . . . 1.4 110.71 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 44.7 t -78.65 -38.57 39.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.116 -0.493 . . . . 1.91 111.041 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.37 -36.63 71.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.168 -0.469 . . . . 2.33 111.014 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 31.0 p -67.95 -36.95 80.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.3 -0.409 . . . . 1.43 111.113 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.464 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -78.59 -27.46 45.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 1.19 111.127 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 88.8 mtp -138.47 100.33 4.07 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.192 -0.458 . . . . 2.55 110.993 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -60.89 -49.76 76.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 3.33 110.866 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -128.55 138.2 52.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.072 -0.513 . . . . 5.1 110.455 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 74.1 mt -114.89 142.26 28.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 3.07 111.464 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -95.53 -43.68 7.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.98 -0.555 . . . . 4.41 110.428 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -143.3 -92.07 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.984 -0.553 . . . . 5.31 110.542 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 43.68 86.02 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.343 -0.389 . . . . 3.94 111.738 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 37.5 t90 -122.22 -29.95 4.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 5.98 110.738 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 63.9 p -79.08 -37.68 38.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.058 -0.519 . . . . 2.24 111.09 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 53.8 tp -67.14 -58.88 4.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 2.67 111.015 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 pt -62.35 -22.86 30.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 2.59 111.166 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.11 -42.11 78.02 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.326 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -74.67 -34.36 62.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.713 0.292 . . . . 3.14 110.779 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.0 mt -67.47 -56.92 7.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.202 -0.454 . . . . 1.99 110.797 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.477 ' O ' HG12 ' A' ' 110' ' ' ILE . 46.3 tpp -48.67 -52.39 23.58 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.91 -0.587 . . . . 2.36 110.997 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.0 m -51.82 -40.94 61.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.524 . . . . 2.05 111.594 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.449 ' O ' HG23 ' A' ' 112' ' ' VAL . 92.7 m -53.77 -49.78 67.47 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.38 -0.373 . . . . 2.25 111.837 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 14.0 mp0 -70.2 -27.86 64.84 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.269 0.47 . . . . 2.72 112.269 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 106' ' ' MET . 48.0 mm -61.46 -50.28 81.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.636 0.255 . . . . 1.88 111.681 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.34 -36.81 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 111.826 0.306 . . . . 1.6 111.826 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 108' ' ' THR . 97.4 t -62.86 -49.86 81.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.601 -0.272 . . . . 1.09 111.216 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 31.6 mm -51.99 -45.25 40.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.483 -0.326 . . . . 2.65 110.899 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.415 ' HA ' HD13 ' A' ' 117' ' ' LEU . 86.9 m -50.64 -48.12 58.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.226 -0.443 . . . . 0.89 110.961 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 40.4 m -54.05 -35.1 61.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.003 -0.544 . . . . 0.68 110.299 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.08 -35.2 91.5 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.957 -0.639 . . . . 0.63 112.317 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.419 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 10.1 mp -57.62 -61.12 2.73 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.148 0.499 . . . . 1.58 110.725 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.507 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 7.3 tp -67.02 -29.18 45.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.152 0 CA-C-N 115.467 -0.788 . . . . 2.04 111.934 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -48.82 -40.58 29.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.819 0.343 . . . . 1.1 111.146 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -92.43 -21.42 20.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.037 -0.529 . . . . 1.88 110.805 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.507 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 95.6 mt -87.54 33.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 1.53 111.38 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 54.6 m -81.06 133.72 35.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.779 0.323 . . . . 2.29 110.73 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.77 -24.24 26.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.19 -0.459 . . . . 3.49 111.264 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.488 ' HB2' HG12 ' A' ' 127' ' ' VAL . 88.5 mtt180 -134.67 158.55 43.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.266 -0.424 . . . . 3.13 110.96 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -82.64 -12.98 57.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.955 -0.566 . . . . 3.71 110.907 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -87.41 -37.08 17.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.225 -0.443 . . . . 3.97 110.574 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG12 ' HB2' ' A' ' 124' ' ' ARG . 14.9 p -78.4 -25.39 13.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.915 -0.584 . . . . 1.22 110.733 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -62.5 -26.63 68.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.862 -0.608 . . . . 2.81 110.54 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -76.14 -19.2 58.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.823 -0.626 . . . . 4.25 110.97 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 82.6 mt -80.1 -55.63 4.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 1.84 111.094 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -64.01 -29.43 70.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 1.54 111.209 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -58.62 -42.53 88.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 1.79 110.878 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.6 mt -72.55 -31.82 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 2.08 110.941 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.3 m -62.94 -34.61 77.82 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 1.76 111.211 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -72.53 -52.57 9.93 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.73 -0.747 . . . . 0.76 112.811 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -64.59 -33.62 64.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.718 0.294 . . . . 2.07 111.665 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -71.68 -30.36 65.61 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.851 0.358 . . . . 1.85 110.863 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.98 -46.28 75.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.486 . . . . 1.32 111.084 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 73.9 t80 -73.1 -21.29 60.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.033 -0.53 . . . . 3.25 111.073 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.86 -60.98 2.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.351 -0.386 . . . . 2.92 110.867 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 142' ' ' ILE . 16.9 pt -57.68 -45.26 86.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.042 -0.526 . . . . 2.65 111.614 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.457 HG13 HG13 ' A' ' 141' ' ' ILE . 46.8 mt -67.59 -27.57 38.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.366 -0.379 . . . . 3.21 111.393 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 59.7 tp -57.22 -55.47 34.32 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.763 0.316 . . . . 2.01 110.612 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 72.3 t-105 -64.82 -25.79 68.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.279 -0.419 . . . . 3.6 110.466 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -72.86 -17.05 78.18 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.951 -0.642 . . . . 1.62 112.712 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.422 ' C ' ' HD2' ' A' ' 149' ' ' PRO . 81.4 mt -102.87 -23.52 4.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.92 0.39 . . . . 2.47 111.292 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -74.56 -46.42 39.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.376 -0.375 . . . . 2.48 111.735 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.642 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 7.1 t30 -54.71 -52.1 73.13 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.419 -0.355 . . . . 2.69 111.866 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 52.9 Cg_exo -55.64 -27.78 62.38 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 122.071 1.848 . . . . 2.36 112.384 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.3 mt -83.27 49.92 1.65 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 3.3 110.898 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 32.3 tpt180 -170.44 -59.43 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.126 -0.488 . . . . 8.48 110.98 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.8 -36.25 28.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.089 -0.505 . . . . 2.98 111.62 -179.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -83.52 -17.41 41.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.409 . . . . 4.55 111.19 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 71.8 p -96.77 6.72 48.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.248 -0.433 . . . . 4.0 111.011 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 41.2 ttm180 -79.27 -25.81 42.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.038 -0.528 . . . . 5.51 111.252 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -105.14 -36.92 7.1 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.478 -0.328 . . . . 3.2 111.491 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -57.29 -76.12 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.331 -0.395 . . . . 3.98 111.263 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 40.8 t -158.75 118.04 3.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.265 -0.425 . . . . 2.63 110.88 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 89.7 p -72.58 -25.27 61.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.129 -0.487 . . . . 2.16 110.869 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -68.62 -62.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 3.37 111.03 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.445 HD13 HD12 ' A' ' 164' ' ' LEU . 4.3 mm? -61.9 -25.99 67.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.83 111.137 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.23 -56.82 14.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.7 111.253 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -53.44 -42.41 67.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.489 . . . . 2.16 110.96 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.445 HD12 HD13 ' A' ' 161' ' ' LEU . 73.4 mt -60.78 -37.82 83.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.052 -0.522 . . . . 1.59 110.9 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.08 -30.96 71.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 2.31 111.231 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -65.1 -42.24 94.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.849 0.357 . . . . 2.15 110.993 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -75.76 -20.28 58.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.119 -0.491 . . . . 2.39 110.931 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 91' ' ' ALA . 49.1 tp -81.51 -62.73 1.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.979 -0.555 . . . . 1.79 111.74 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 t -58.37 -30.87 41.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 112.87 0.693 . . . . 1.42 112.87 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 171' ' ' TYR . 9.8 t -53.94 -46.88 71.7 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 121.046 -0.261 . . . . 1.12 111.593 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.437 ' N ' HG23 ' A' ' 170' ' ' THR . 42.4 t80 -70.62 -38.15 73.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.129 0.49 . . . . 3.86 110.206 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -63.84 -21.56 66.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.602 -0.726 . . . . 1.58 110.43 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 177' ' ' ILE . 65.0 m -77.1 -47.65 19.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.883 -0.599 . . . . 1.41 111.497 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 89.0 t -58.92 -30.4 42.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.407 -0.361 . . . . 1.42 111.48 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 90.8 mt -74.29 -58.24 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.725 0.298 . . . . 1.91 111.385 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -58.88 -30.38 67.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 1.55 111.259 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 173' ' ' THR . 49.5 mt -87.57 -19.91 7.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.148 0.499 . . . . 1.86 110.166 178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.47 -52.23 53.84 Favored Glycine 0 N--CA 1.452 -0.293 0 CA-C-N 115.708 -0.678 . . . . 0.74 113.246 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.691 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 61.2 m-85 -58.22 -55.48 45.07 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.792 0.296 . . . . 1.78 111.763 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.691 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.5 Cg_exo -48.03 -34.33 22.88 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.1 1.867 . . . . 0.92 113.524 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.497 ' O ' HG22 ' A' ' 184' ' ' ILE . 85.1 mt -73.4 -57.93 5.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.872 0.368 . . . . 1.77 111.524 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.621 HG23 ' CD2' ' A' ' 183' ' ' TRP . 20.1 m -56.33 -27.34 24.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.13 -0.486 . . . . 1.34 111.543 -179.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.621 ' CD2' HG23 ' A' ' 182' ' ' VAL . 4.5 m95 -91.89 -12.62 33.02 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.872 -0.331 . . . . 2.51 111.419 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.497 HG22 ' O ' ' A' ' 181' ' ' ILE . 6.9 tt -57.61 -19.55 11.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-O 120.749 0.309 . . . . 2.02 111.265 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.695 ' HB ' ' HA2' ' A' ' 189' ' ' GLY . 33.8 mm -111.99 -88.36 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.104 0 CA-C-N 116.402 -0.363 . . . . 2.45 110.676 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -155.54 -99.1 0.16 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.807 -0.711 . . . . 1.73 112.335 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' A' ' 191' ' ' GLY . 59.5 Cg_endo -73.05 78.62 2.17 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.435 2.09 . . . . 3.05 111.745 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.527 ' HA ' ' HB ' ' A' ' 182' ' ' VAL . 35.6 t 60.42 22.47 12.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.855 -0.611 . . . . 4.04 110.845 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.695 ' HA2' ' HB ' ' A' ' 185' ' ' ILE . . . 74.18 84.68 0.3 Allowed Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.914 -0.66 . . . . 4.48 112.882 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -175.39 -19.87 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.137 0 CA-C-N 116.598 0.199 . . . . 7.96 111.496 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.405 ' O ' ' HD2' ' A' ' 187' ' ' PRO . . . -155.3 -172.24 22.73 Favored Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.118 -1.039 . . . . 3.23 113.643 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 21.6 m-90 -64.87 158.81 24.17 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.825 0.345 . . . . 6.03 110.725 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 7.2 mt -88.01 139.59 17.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.029 -0.532 . . . . 3.18 111.519 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -117.53 -90.08 0.57 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.11 -0.496 . . . . 3.39 110.807 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -177.49 -76.44 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.454 -0.339 . . . . 5.76 110.864 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 62.9 p -63.78 -27.44 69.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 2.5 111.261 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.56 -24.12 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 2.4 110.848 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -57.81 -59.29 5.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.064 -0.516 . . . . 2.66 111.019 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 22.6 m -63.05 -26.15 68.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 1.81 111.225 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -58.66 -50.63 73.15 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.328 -0.396 . . . . 2.21 111.287 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 201' ' ' LEU . 3.3 mm? -83.14 -24.06 32.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 2.18 111.183 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.28 -11.61 51.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.527 -0.306 . . . . 2.01 111.023 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.423 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 72.0 m -96.17 -36.18 11.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.981 0.42 . . . . 1.93 110.995 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.9 tp -68.51 -33.9 74.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.96 -0.564 . . . . 1.7 112.09 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.468 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.2 OUTLIER -65.14 -54.56 32.46 Favored Pre-proline 0 CA--C 1.534 0.35 0 C-N-CA 120.998 -0.281 . . . . 1.28 111.339 -179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.468 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 72.3 Cg_exo -50.43 -44.66 38.3 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.105 1.87 . . . . 0.79 111.87 179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 211' ' ' VAL . 85.0 t80 -57.53 -38.47 74.75 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.51 110.244 179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -69.24 -23.25 63.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.108 -0.496 . . . . 1.93 110.484 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 40.2 t -84.13 -39.82 19.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.784 -0.644 . . . . 1.71 111.078 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -65.45 -37.6 87.38 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.317 -0.401 . . . . 2.04 111.25 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 207' ' ' PHE . 69.6 t -63.62 -51.84 65.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.726 0.298 . . . . 2.89 110.958 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.77 -26.29 62.52 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 1.31 112.664 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -63.54 -44.55 93.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.905 0.383 . . . . 2.87 110.989 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 59.6 m -60.03 -52.76 63.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.548 . . . . 2.38 110.937 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -59.33 -31.7 69.41 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.182 -0.463 . . . . 3.42 110.53 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 8.0 tt -64.29 -44.93 90.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.056 -0.52 . . . . 1.24 110.652 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -57.4 -48.65 78.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.054 -0.521 . . . . 2.44 111.143 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 93.2 mt -52.14 -45.02 64.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.146 -0.479 . . . . 2.51 111.353 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -71.11 -24.48 62.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.901 0.382 . . . . 3.01 110.813 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.18 -21.85 75.85 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.863 -0.684 . . . . 1.59 112.653 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.0 mp -55.81 -33.81 64.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.774 0.321 . . . . 3.49 111.259 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -72.88 92.87 1.65 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.381 -0.372 . . . . 5.74 110.723 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 28.4 p30 -142.96 163.62 32.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.159 -0.473 . . . . 5.46 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.9 mt -137.45 107.5 6.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.133 -0.485 . . . . 6.13 110.929 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -165.29 144.39 6.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.307 -0.406 . . . . 6.46 111.009 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.0 111.87 18.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 6.94 110.976 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.6 t -80.83 149.33 29.6 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.03 -0.532 . . . . 6.83 111.102 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -158.18 145.84 18.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.16 -0.473 . . . . 10.77 110.952 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.251 -0.88 . . . . 9.41 110.904 -179.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.809 0.338 . . . . 8.91 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -104.73 50.29 0.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 6.76 111.124 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.0 mt -115.52 124.05 50.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.284 -0.417 . . . . 6.25 110.97 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -162.77 120.39 2.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 5.44 110.753 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 59.7 m -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.274 -0.421 . . . . 3.84 111.089 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 63.7 mt -134.96 -20.12 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.156 -0.475 . . . . 3.08 110.918 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 41.9 tp -61.91 -44.53 96.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 2.35 111.175 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.583 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 61.8 m-70 -67.17 -25.51 66.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 1.39 110.914 -179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 72.5 t-105 -76.17 -44.56 37.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 1.1 110.479 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 50.2 mm -69.41 -22.17 25.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.057 -0.52 . . . . 1.71 110.489 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.409 ' O ' ' HG2' ' B' ' 15' ' ' MET . 24.7 t80 -66.46 -60.37 2.8 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.787 -0.642 . . . . 1.48 110.729 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -52.62 -35.81 21.52 Favored 'Isoleucine or valine' 0 C--O 1.231 0.121 0 CA-C-N 116.283 -0.417 . . . . 0.95 110.982 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.57 94.38 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.413 -0.358 . . . . 0.97 110.952 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.81 -29.12 71.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.897 -0.668 . . . . 0.8 112.448 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.409 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 74.3 mmm -72.15 -32.77 67.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.877 0.37 . . . . 1.29 110.543 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 61.5 m -63.39 -58.78 5.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.094 -0.503 . . . . 1.36 111.148 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -59.66 -25.77 32.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.259 -0.428 . . . . 1.23 111.059 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.76 -38.72 96.59 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.751 -0.738 . . . . 0.88 112.333 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.78 -36.17 72.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.98 110.903 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.75 -22.1 66.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.317 -0.402 . . . . 2.12 110.897 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -58.21 -27.76 64.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.174 -0.467 . . . . 2.0 110.365 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -74.85 -30.35 61.33 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.879 -0.601 . . . . 4.26 110.589 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 89.6 t90 -62.3 -42.56 99.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 3.62 110.366 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 49.4 m -78.86 -19.64 51.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 2.55 110.755 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 28.4 tp -85.64 -1.47 57.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.044 -0.526 . . . . 3.11 110.901 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 24.5 t -56.59 -19.76 17.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.26 -0.427 . . . . 3.02 111.243 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' B' ' 28' ' ' ASN . 59.2 ttp180 -50.4 -30.83 13.32 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 109.449 -0.574 . . . . 5.89 109.449 179.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.467 HD22 ' HG2' ' B' ' 27' ' ' ARG . 7.6 p30 -177.21 132.6 0.36 Allowed Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 115.027 -0.988 . . . . 5.02 109.948 178.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 45.6 Cg_endo -93.19 49.72 0.39 Allowed 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.828 2.352 . . . . 3.53 111.939 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.583 ' HG3' HD22 ' B' ' 221' ' ' LEU . 22.0 tpt180 58.92 24.95 13.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.88 -0.6 . . . . 7.88 110.947 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 89.96 -45.44 3.03 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.821 -0.704 . . . . 4.61 112.791 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.17 149.1 96.08 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.459 0.171 . . . . 4.73 110.947 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.435 ' HB2' ' HD1' ' B' ' 35' ' ' TYR . 48.0 Cg_exo -54.68 165.7 2.35 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.572 2.182 . . . . 3.75 112.549 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -61.7 -18.88 61.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.713 -0.676 . . . . 3.76 112.224 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.435 ' HD1' ' HB2' ' B' ' 33' ' ' PRO . 2.1 p90 -52.35 -35.01 50.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.705 0.288 . . . . 3.17 111.536 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -64.83 -57.68 8.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.998 0.428 . . . . 2.57 111.058 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -70.24 -18.36 63.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.968 -0.56 . . . . 5.74 111.299 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 57.0 tp -59.92 -55.5 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.019 0.438 . . . . 1.72 110.393 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.439 ' O ' HG13 ' B' ' 43' ' ' ILE . 35.5 t -67.52 -38.4 80.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.05 -0.523 . . . . 1.95 110.619 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.26 -12.75 61.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 1.2 111.223 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.434 ' O ' HG12 ' B' ' 45' ' ' ILE . 26.1 ttt -87.74 -34.1 18.47 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.97 0.414 . . . . 2.12 110.743 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -72.33 -27.39 62.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.022 -0.536 . . . . 1.49 111.14 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.479 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 68.6 mt -57.59 -54.2 57.58 Favored Pre-proline 0 CA--C 1.536 0.422 0 N-CA-C 111.983 0.364 . . . . 0.77 111.983 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.479 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 55.5 Cg_endo -70.48 -38.46 6.2 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.168 1.912 . . . . 0.68 113.149 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.434 HG12 ' O ' ' B' ' 41' ' ' MET . 36.6 mm -53.39 -62.6 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.648 0.261 . . . . 1.63 111.666 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.8 t90 -59.6 -49.31 78.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.369 -0.378 . . . . 1.91 110.85 -179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.479 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 97.0 p -67.26 1.06 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.276 -0.42 . . . . 1.22 111.399 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.9 -53.54 2.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.67 -0.776 . . . . 0.55 112.432 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 94.2 mt -65.14 -26.37 68.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.87 111.151 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.81 -57.59 12.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.351 -0.386 . . . . 0.55 111.318 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 26.9 m-85 -60.44 -35.23 75.33 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.274 -0.421 . . . . 1.06 111.082 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.2 tmm? -51.69 -38.1 53.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.962 0.41 . . . . 1.19 110.093 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' B' ' 58' ' ' GLN . . . -70.19 -41.16 74.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.66 110.891 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.6 mtt -54.14 -24.88 19.54 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.875 -0.602 . . . . 0.86 110.844 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.38 -47.51 13.16 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.236 -0.438 . . . . 0.84 111.354 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 35.3 pt -81.99 8.85 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.888 0.375 . . . . 1.44 111.179 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 60.07 63.91 1.35 Allowed 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 115.818 -0.628 . . . . 1.55 111.297 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' C' ' 122' ' ' SER . 17.3 mm100 -132.85 150.45 52.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.158 -0.474 . . . . 2.24 110.83 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 92.2 6.26 64.94 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.747 -0.74 . . . . 1.26 112.096 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -110.5 173.41 6.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.859 0.362 . . . . 2.31 110.825 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . 0.467 HG12 ' HB3' ' B' ' 68' ' ' ALA . 13.1 p -144.53 144.48 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.151 -0.477 . . . . 1.81 110.991 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . 0.53 ' HB2' ' HB2' ' C' ' 64' ' ' ALA . 11.9 mm-40 -94.14 96.39 9.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.021 -0.536 . . . . 3.18 111.024 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -117.06 120.68 39.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 2.03 111.16 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.38 32.61 21.95 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.093 -0.503 . . . . 2.48 111.203 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.88 -7.76 33.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.869 -0.681 . . . . 2.37 112.496 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.549 HE22 ' HA ' ' B' ' 123' ' ' GLU . 10.0 tt0 -98.52 155.04 17.47 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.857 0.361 . . . . 2.28 110.881 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 57.5 mt -100.63 126.95 54.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.084 -0.507 . . . . 1.78 111.17 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . 0.467 ' HB3' HG12 ' B' ' 61' ' ' VAL . . . -97.96 127.61 44.02 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.309 -0.405 . . . . 1.05 111.24 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.607 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 98.3 m-70 -84.56 61.03 6.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.148 0.499 . . . . 1.11 110.905 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.431 ' O ' HG12 ' B' ' 74' ' ' ILE . 76.8 t80 -62.79 -56.99 12.47 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.595 -0.729 . . . . 2.3 111.303 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -63.27 -22.45 66.88 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.277 0.473 . . . . 0.72 112.277 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.607 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 11.0 mpt_? -66.0 -52.38 49.93 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.054 0.39 . . . . 3.04 112.054 -178.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.426 ' CG ' ' HB3' ' B' ' 117' ' ' LEU . 7.0 p90 -72.36 -33.12 67.03 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.682 -0.407 . . . . 1.79 110.659 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.431 HG12 ' O ' ' B' ' 70' ' ' TYR . 22.3 mm -52.53 -46.57 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.168 0 CA-C-O 121.076 0.465 . . . . 1.44 110.013 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.554 ' O ' HG22 ' B' ' 79' ' ' THR . 17.8 t70 -64.41 -24.41 67.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.49 -0.777 . . . . 1.31 110.236 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -94.86 2.25 55.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 116.088 -0.505 . . . . 2.01 111.138 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 50.3 ttm -104.66 -4.88 21.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.012 -0.54 . . . . 1.43 110.137 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.421 ' C ' ' HD2' ' B' ' 81' ' ' PRO . 1.9 p -113.72 -49.67 5.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 CA-C-N 115.828 -0.624 . . . . 1.21 112.015 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.554 HG22 ' O ' ' B' ' 75' ' ' ASP . 14.8 t -72.93 -38.83 66.68 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.029 0.381 . . . . 1.18 112.029 -178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.641 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 87.2 m -59.77 -53.0 69.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 111.857 0.317 . . . . 1.65 111.857 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.641 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 50.5 Cg_exo -53.81 -45.37 41.54 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.659 1.572 . . . . 1.06 111.439 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.515 HD23 HD12 ' B' ' 85' ' ' LEU . 86.1 mt -68.01 -27.68 66.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.813 -0.63 . . . . 1.58 110.575 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.06 -33.23 73.24 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.35 -0.611 . . . . 1.49 109.35 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 8.4 tt -84.18 -22.42 30.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.24 -0.891 . . . . 1.72 109.95 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.515 HD12 HD23 ' B' ' 82' ' ' LEU . 63.6 mt -82.63 -31.4 28.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.721 -0.672 . . . . 1.96 110.874 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 70.2 m -63.35 -34.93 78.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.047 -0.524 . . . . 1.24 110.986 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.581 HD22 HD11 ' B' ' 168' ' ' LEU . 72.6 mt -71.45 -22.33 61.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 1.21 110.911 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.6 m -76.41 -35.21 58.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.086 -0.506 . . . . 1.32 110.959 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -77.21 -39.78 47.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.281 -0.418 . . . . 2.15 111.016 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 23.4 p -64.51 -32.96 74.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 1.44 111.201 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.74 -28.92 25.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 1.05 111.013 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 83.5 mtp -135.86 112.82 10.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.051 -0.522 . . . . 2.68 110.816 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -84.69 -17.05 39.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 2.71 111.069 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -147.64 152.32 37.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.321 -0.4 . . . . 4.19 110.874 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 16.2 tt -137.2 144.76 31.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.082 -0.508 . . . . 2.79 111.02 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -105.25 -55.76 2.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.058 -0.519 . . . . 5.27 110.98 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -171.31 103.73 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.234 -0.439 . . . . 5.57 110.949 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -161.58 123.56 2.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.119 -0.491 . . . . 4.24 110.983 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -141.1 30.15 1.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.209 -0.45 . . . . 5.39 110.976 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 72.7 p -104.81 -57.57 2.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.323 -0.399 . . . . 2.16 111.425 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 48.1 tp -63.74 -57.68 9.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.309 -0.405 . . . . 2.58 111.097 -179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 83.8 mt -57.38 -32.88 42.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.168 -0.469 . . . . 2.29 111.13 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.55 -29.63 75.61 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.815 -0.707 . . . . 1.48 112.589 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -86.04 -29.2 23.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.785 0.326 . . . . 2.76 110.951 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -75.68 -40.23 56.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 2.22 110.919 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 93.5 mmm -73.14 -40.17 65.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.228 -0.442 . . . . 2.36 110.886 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 58.7 p -53.71 -58.43 7.23 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.103 -0.498 . . . . 1.92 111.196 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.5 t -59.1 -33.31 70.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 2.06 111.528 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -59.97 -48.14 82.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.51 -0.313 . . . . 2.87 111.026 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.494 HG22 ' HE1' ' A' ' 46' ' ' TRP . 57.5 mt -58.67 -34.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 1.98 111.251 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 41.0 t -68.58 -40.62 82.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.148 -0.478 . . . . 1.62 111.11 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 99.7 t -66.07 -45.3 90.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 1.04 111.167 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 71.4 mt -57.49 -36.73 54.58 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 116.35 -0.386 . . . . 2.46 110.874 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.42 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.4 m -58.78 -48.39 81.41 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.187 -0.461 . . . . 0.83 110.827 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.9 m -60.11 -24.99 65.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.145 -0.48 . . . . 0.74 110.501 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.17 -58.11 10.31 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.945 -0.645 . . . . 0.6 112.854 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.493 HD12 ' N ' ' B' ' 118' ' ' ILE . 2.0 pp -61.36 -38.13 85.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.617 0.246 . . . . 1.42 111.202 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.493 ' N ' HD12 ' B' ' 117' ' ' LEU . 46.3 mm -63.13 -40.56 89.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.724 0.297 . . . . 1.51 111.15 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.59 -38.8 67.15 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 1.09 111.444 -179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 69' ' ' HIS . 12.0 m-20 -82.24 -21.32 36.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.31 -0.405 . . . . 2.25 110.871 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 93.8 mt -86.59 10.6 14.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.014 -0.539 . . . . 1.16 111.305 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 52.8 m -68.45 126.39 29.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.381 -0.372 . . . . 1.76 110.87 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . 0.549 ' HA ' HE22 ' B' ' 66' ' ' GLN . 37.5 tt0 -89.67 -27.81 19.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.311 -0.404 . . . . 2.89 110.691 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -125.6 138.49 53.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.945 -0.57 . . . . 2.67 110.683 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.47 -10.84 60.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.114 -0.494 . . . . 3.25 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -81.37 -52.78 6.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.333 -0.394 . . . . 4.07 110.648 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.2 p -71.12 -24.02 23.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 1.41 110.812 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -62.91 -32.52 73.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 2.47 110.761 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -65.66 -21.8 66.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.877 -0.601 . . . . 2.61 110.938 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . 0.442 HD23 HD13 ' A' ' 56' ' ' ILE . 60.5 tp -79.19 -57.64 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.15 -0.477 . . . . 2.07 111.068 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 7.0 m95 -58.54 -29.19 66.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.235 -0.439 . . . . 1.3 111.218 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -62.75 -50.47 70.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.327 -0.397 . . . . 1.75 110.592 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 70.8 mt -67.33 -23.97 31.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.064 -0.516 . . . . 1.67 110.672 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 34.7 t -69.38 -40.32 77.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.113 -0.494 . . . . 1.54 110.979 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.31 -42.6 90.14 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.847 -0.692 . . . . 0.7 112.89 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.417 HG12 ' HB3' ' B' ' 180' ' ' PRO . 30.8 m -72.0 -37.93 62.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.677 0.275 . . . . 1.44 111.584 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 96.7 m -69.84 -33.26 72.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.821 0.343 . . . . 1.82 110.893 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.6 -42.15 91.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.94 110.79 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -77.16 -13.88 59.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.949 -0.568 . . . . 1.6 110.867 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 2.9 tt -77.55 -57.44 3.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.511 . . . . 2.01 110.718 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.448 HG13 ' N ' ' B' ' 142' ' ' ILE . 37.1 pt -58.4 -39.79 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.096 -0.502 . . . . 1.96 111.327 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.448 ' N ' HG13 ' B' ' 141' ' ' ILE . 47.2 mm -69.6 -33.79 58.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.402 -0.363 . . . . 2.88 110.914 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 30.0 tp -52.01 -55.96 17.27 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.529 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -65.42 -26.24 67.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.074 -0.512 . . . . 4.15 110.371 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.54 -16.69 79.98 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.041 -0.6 . . . . 1.59 112.414 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 94.2 mt -99.83 -28.07 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.784 0.326 . . . . 2.13 111.086 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -68.34 -50.47 53.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.303 -0.408 . . . . 1.78 111.81 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.497 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 6.0 t30 -52.91 -52.82 61.48 Favored Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.61 0.596 . . . . 2.45 112.61 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 31.0 Cg_endo -63.56 -7.23 12.08 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.024 1.816 . . . . 2.36 112.868 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 96.4 mt -100.16 26.49 6.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.898 0.38 . . . . 2.88 111.005 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -145.62 -58.86 0.33 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.297 -0.41 . . . . 8.07 111.031 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.07 -47.56 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.219 -0.446 . . . . 2.8 111.288 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -71.6 -13.17 61.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.261 -0.427 . . . . 4.58 111.355 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' B' ' 162' ' ' ALA . 42.2 p -105.69 5.69 31.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.301 -0.409 . . . . 3.81 111.292 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 61.6 ttp180 -74.77 -35.34 62.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.32 -0.4 . . . . 5.22 110.791 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 72.6 p -94.85 -22.28 18.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 3.42 111.337 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -71.28 -71.9 0.24 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 4.2 110.815 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.418 ' HB3' ' HB3' ' B' ' 161' ' ' LEU . 48.4 t -163.31 114.32 1.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.268 -0.423 . . . . 2.75 110.876 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 43.3 t -69.34 -29.15 66.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 2.4 110.908 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -75.83 -39.88 55.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 3.46 110.632 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.418 ' HB3' ' HB3' ' B' ' 158' ' ' SER . 51.7 tp -70.19 -35.28 73.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.014 -0.539 . . . . 2.57 110.614 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . 0.421 ' HB2' ' HB ' ' B' ' 154' ' ' THR . . . -69.01 -42.07 76.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.987 -0.552 . . . . 1.72 111.257 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -55.14 -60.53 3.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 2.69 111.349 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 3.8 pp -59.01 -24.43 62.8 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 2.16 111.272 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -79.19 -30.57 43.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.399 -0.364 . . . . 2.13 110.694 179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -62.74 -41.17 99.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.353 -0.385 . . . . 1.94 110.454 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -77.02 -27.25 54.5 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 3.33 110.686 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.581 HD11 HD22 ' B' ' 87' ' ' LEU . 58.9 tp -67.97 -47.0 69.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.052 -0.522 . . . . 1.56 111.103 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 53.6 t -70.75 -24.96 25.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 1.59 111.135 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 64.6 m -57.15 -59.0 5.74 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.38 -0.373 . . . . 1.14 111.404 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -61.99 -39.3 91.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.062 0.458 . . . . 3.87 110.289 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -58.16 -28.16 64.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.677 -0.692 . . . . 1.61 110.57 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.439 ' O ' HG22 ' B' ' 177' ' ' ILE . 85.8 m -79.28 -37.38 37.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.96 -0.564 . . . . 1.3 111.524 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 59.7 t -55.9 -44.12 76.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.37 -0.377 . . . . 1.53 111.953 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.418 HD12 ' HB2' ' B' ' 209' ' ' SER . 4.1 mm? -76.14 -53.25 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.351 -0.386 . . . . 1.99 111.867 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -54.85 -31.49 59.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.436 -0.347 . . . . 1.5 111.665 -179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.439 HG22 ' O ' ' B' ' 173' ' ' THR . 10.1 tp -87.72 -19.25 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 1.46 110.565 179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -61.5 -53.29 45.13 Favored Glycine 0 N--CA 1.45 -0.381 0 CA-C-N 115.936 -0.575 . . . . 0.67 113.215 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.673 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 45.6 m-85 -57.03 -55.11 47.38 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.855 0.328 . . . . 1.73 111.49 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.673 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.8 Cg_exo -46.19 -48.21 13.45 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.05 1.834 . . . . 0.93 113.057 -179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.87 -57.31 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.359 0.503 . . . . 1.36 112.359 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.585 HG23 ' CD2' ' B' ' 183' ' ' TRP . 33.0 m -56.05 -25.13 18.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.076 -0.511 . . . . 1.19 112.271 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.585 ' CD2' HG23 ' B' ' 182' ' ' VAL . 3.3 m95 -89.99 -14.1 34.71 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.619 -0.433 . . . . 2.73 112.062 -179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.501 HG13 ' O ' ' B' ' 180' ' ' PRO . 55.2 mt -51.12 -40.4 21.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.741 0.305 . . . . 1.93 110.973 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 16.3 mm -93.42 -83.71 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 2.64 111.071 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.22 -94.43 0.1 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 120.809 -0.71 . . . . 1.93 112.266 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.14 79.86 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.596 2.197 . . . . 2.97 111.967 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . 0.579 ' HB3' ' HB3' ' B' ' 201' ' ' LEU . 73.9 p 47.26 34.64 3.22 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.967 -0.56 . . . . 4.5 111.349 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' B' ' 182' ' ' VAL . . . 93.31 137.65 8.44 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.773 -0.727 . . . . 4.5 112.726 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.7 t80 59.32 99.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.879 0.371 . . . . 7.89 111.017 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 153.19 -179.42 29.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.725 -0.75 . . . . 3.62 112.718 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 21.5 m-90 -94.05 145.08 24.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.894 0.378 . . . . 6.54 110.801 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 23.6 mt -88.2 140.21 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.034 -0.53 . . . . 3.16 110.99 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -134.66 -87.36 0.38 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.379 . . . . 3.39 111.073 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -173.63 -70.53 0.01 OUTLIER 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.377 -0.374 . . . . 5.56 111.029 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 24.2 m -70.2 -21.17 63.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 2.68 111.427 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 8.9 tp -58.65 -31.17 43.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 2.2 111.247 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -60.82 -56.13 24.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 2.49 111.407 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.8 p -60.09 -23.15 63.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.401 -0.363 . . . . 1.76 111.618 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -65.94 -51.52 57.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.849 0.357 . . . . 2.18 111.245 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . 0.579 ' HB3' ' HB3' ' B' ' 188' ' ' SER . 3.1 mm? -82.5 -21.59 35.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.347 -0.388 . . . . 1.78 111.43 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -67.95 -12.53 60.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.576 -0.284 . . . . 1.98 111.271 -179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.432 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 74.4 m -96.37 -40.1 9.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.005 0.431 . . . . 1.65 111.266 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 65.5 tp -63.65 -39.75 95.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 1.11 112.449 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.477 HD12 HG21 ' B' ' 182' ' ' VAL . 0.8 OUTLIER -63.06 -54.51 45.55 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 112.049 0.389 . . . . 1.43 112.049 -178.852 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD2' ' C ' ' B' ' 203' ' ' CYS . 85.3 Cg_exo -48.95 -42.33 38.18 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.022 1.815 . . . . 0.77 112.091 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.432 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.0 t80 -57.69 -42.22 83.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.212 -0.449 . . . . 1.6 110.437 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -65.47 -19.74 66.06 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.991 -0.55 . . . . 1.77 110.722 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.418 ' HB2' HD12 ' B' ' 175' ' ' LEU . 48.2 t -87.16 -36.18 18.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 1.54 110.858 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -70.01 -31.96 69.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.084 -0.507 . . . . 2.01 111.367 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.432 HG23 ' O ' ' B' ' 207' ' ' PHE . 92.6 t -71.57 -52.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.823 0.344 . . . . 2.65 111.076 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.34 -23.71 58.17 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 1.33 112.468 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -63.9 -48.56 76.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.702 0.286 . . . . 2.29 110.852 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 97.6 p -58.55 -41.52 85.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.249 -0.432 . . . . 2.12 110.653 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -66.26 -29.77 70.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 3.6 110.389 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 4.4 tt -64.98 -53.16 50.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.976 -0.556 . . . . 1.51 110.597 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -58.43 -27.11 64.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.196 -0.456 . . . . 2.22 110.748 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.76 -47.42 85.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.002 -0.545 . . . . 2.69 110.554 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -81.89 -21.78 37.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.02 -0.536 . . . . 3.4 110.983 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -62.64 -18.62 59.35 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.889 -0.672 . . . . 1.67 112.817 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' B' ' 30' ' ' ARG . 58.8 tp -54.48 -29.5 50.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.636 0.255 . . . . 3.39 111.566 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -71.61 104.89 3.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.508 -0.315 . . . . 5.91 111.233 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -140.88 -178.55 5.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.04 0.447 . . . . 5.26 111.118 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 4.1 tt -172.46 83.11 0.06 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.71 -0.677 . . . . 6.81 110.097 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -142.5 154.62 44.67 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.077 -0.511 . . . . 7.02 111.163 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -112.22 147.03 37.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.242 -0.436 . . . . 8.21 110.727 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 46.3 t -130.59 137.59 49.73 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.214 -0.448 . . . . 8.1 111.201 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -155.69 162.15 40.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 13.28 110.762 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.185 -0.912 . . . . 10.4 110.905 -179.951 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.788 0.328 . . . . 8.1 110.762 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.8 63.66 6.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 6.27 110.787 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 33.7 tp -66.06 137.05 56.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.516 . . . . 6.2 110.833 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' C' ' 4' ' ' GLU . 0.0 OUTLIER -104.45 179.92 4.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.269 -0.423 . . . . 4.82 110.934 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 62.3 m -152.92 128.1 9.78 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.111 -0.495 . . . . 3.25 110.92 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 76.4 mt -106.0 -177.3 3.32 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 2.79 110.891 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 58.5 tp -64.96 -56.78 11.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.308 -0.405 . . . . 2.08 111.118 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.5 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 20.6 m170 -58.24 -24.37 59.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.089 -0.505 . . . . 1.43 111.257 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.553 ' O ' HG12 ' C' ' 12' ' ' VAL . 63.3 t-105 -74.5 -61.94 1.7 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.886 0.374 . . . . 1.16 110.456 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 47.3 mt -57.0 -19.4 9.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 121.345 0.593 . . . . 2.09 109.877 179.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.32 -62.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.269 -0.878 . . . . 1.58 110.949 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.553 HG12 ' O ' ' C' ' 9' ' ' TRP . 14.5 p -54.21 -30.14 20.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.173 -0.467 . . . . 1.0 111.039 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.8 -48.54 81.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.169 -0.469 . . . . 0.96 110.892 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.59 -23.86 75.34 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.747 -0.74 . . . . 0.96 112.286 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 30.8 mmt -73.16 -34.72 66.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.868 0.366 . . . . 1.3 110.575 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 90.7 m -63.84 -57.66 9.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 1.52 110.937 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.52 -22.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.113 -0.494 . . . . 1.9 111.063 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -65.27 -41.95 96.47 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.726 . . . . 0.96 112.258 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.2 -28.31 63.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.712 0.292 . . . . 1.07 110.965 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 86.0 mt -66.31 -31.66 72.59 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.97 0.414 . . . . 2.08 110.898 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . 0.409 ' O ' ' HG ' ' C' ' 25' ' ' LEU . 12.7 t-80 -55.6 -26.82 45.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.001 -0.545 . . . . 2.02 110.425 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -65.65 -41.88 92.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.846 -0.615 . . . . 4.98 110.677 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 37.8 t90 -59.86 -36.72 77.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.23 -0.441 . . . . 4.29 110.652 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 32.2 t -73.7 -21.22 60.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.936 -0.575 . . . . 2.47 110.928 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 21' ' ' HIS . 95.5 mt -88.55 -0.88 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 2.9 111.624 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 64.8 p -57.64 -19.08 23.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.625 0.232 . . . . 2.74 111.625 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -51.3 -30.08 17.0 Favored 'General case' 0 C--O 1.232 0.133 0 N-CA-C 109.306 -0.627 . . . . 5.85 109.306 178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.436 HD22 ' H ' ' C' ' 30' ' ' ARG . 3.5 p-10 -176.68 133.0 0.39 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.75 -1.113 . . . . 4.52 109.43 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.449 ' HB2' ' O ' ' C' ' 32' ' ' VAL . 35.8 Cg_endo -89.77 39.91 0.43 Allowed 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.345 2.03 . . . . 3.22 112.442 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . 0.436 ' H ' HD22 ' C' ' 28' ' ' ASN . 40.2 mmt180 56.89 33.67 23.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.829 -0.623 . . . . 8.68 111.496 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 82.48 -44.87 3.27 Favored Glycine 0 C--N 1.329 0.18 0 C-N-CA 120.756 -0.735 . . . . 4.14 112.561 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' C' ' 29' ' ' PRO . 77.0 t -70.86 133.1 86.43 Favored Pre-proline 0 C--N 1.329 -0.294 0 N-CA-C 110.638 -0.134 . . . . 5.09 110.638 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.462 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 50.2 Cg_exo -51.96 165.36 0.86 Allowed 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.352 2.035 . . . . 3.1 112.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -59.43 -18.39 38.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.642 -0.708 . . . . 3.85 112.429 -178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -52.41 -39.46 60.94 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.582 0.23 . . . . 3.37 111.559 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -63.23 -62.01 1.98 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.831 0.348 . . . . 2.72 111.054 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -64.65 -18.4 64.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.084 -0.507 . . . . 5.67 111.219 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 62.5 tp -58.82 -60.91 3.1 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.841 0.353 . . . . 1.93 110.183 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.55 -36.35 77.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.086 -0.506 . . . . 1.88 110.528 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.52 -17.51 64.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.99 -0.55 . . . . 1.23 111.154 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.434 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 55.6 ttp -88.18 -27.05 22.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.226 -0.443 . . . . 2.09 110.465 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -74.55 -27.63 60.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.924 -0.58 . . . . 1.41 111.197 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.62 HG23 HG23 ' C' ' 79' ' ' THR . 28.1 mm -60.79 -51.92 76.14 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 112.093 0.405 . . . . 0.8 112.093 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 58.5 Cg_endo -71.11 -37.33 6.18 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.341 2.027 . . . . 0.72 113.074 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 95.3 mt -58.41 -62.13 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.647 0.261 . . . . 1.68 111.606 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.7 t90 -58.08 -50.3 73.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.471 -0.331 . . . . 1.68 111.089 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.451 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 88.6 p -51.83 -47.38 64.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 1.28 111.347 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -51.51 -48.14 49.74 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.935 -0.65 . . . . 0.51 112.973 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 72.2 mt -57.17 -36.55 70.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.007 0.432 . . . . 1.33 110.904 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . 0.497 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -69.28 -36.75 77.39 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.093 -0.503 . . . . 0.57 111.219 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 55.6 m-85 -67.92 -52.86 31.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.322 -0.399 . . . . 1.67 111.493 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.536 ' HB3' HG11 ' C' ' 12' ' ' VAL . 26.0 ptm -51.49 -32.01 25.81 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.96 0.409 . . . . 1.42 110.355 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.61 -43.2 73.23 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.71 111.127 179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' C' ' 50' ' ' ALA . 57.0 mtt -54.68 -39.09 67.76 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.374 -0.376 . . . . 1.14 110.61 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.5 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -63.12 -44.15 96.43 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.0 -0.545 . . . . 0.88 110.926 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.517 ' HB ' ' HG2' ' C' ' 58' ' ' GLN . 7.7 mt -85.17 4.16 3.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 1.38 110.961 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 58.82 26.34 14.67 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.02 -0.536 . . . . 1.94 111.252 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.517 ' HG2' ' HB ' ' C' ' 56' ' ' ILE . 15.5 mm100 -82.82 135.89 34.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 1.87 111.042 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.35 20.61 10.82 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.902 -0.666 . . . . 1.27 112.496 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.45 ' HZ2' ' HA ' ' C' ' 69' ' ' HIS . 66.9 mttm -123.17 160.73 25.9 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.765 0.316 . . . . 2.86 110.957 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 20.2 m -131.87 140.45 48.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 1.95 111.084 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -91.88 89.13 6.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.901 0.381 . . . . 3.04 111.041 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.36 54.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.057 -0.52 . . . . 2.11 111.071 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . 0.53 ' HB2' ' HB2' ' B' ' 62' ' ' GLU . . . 60.31 31.45 20.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.949 -0.569 . . . . 2.54 111.278 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.57 67.61 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.946 -0.645 . . . . 2.47 112.74 179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -114.67 161.15 18.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.922 0.391 . . . . 2.85 111.0 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 46.6 pt -111.27 139.42 35.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.0 -0.545 . . . . 1.87 111.478 -179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.63 135.76 47.59 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.183 -0.462 . . . . 1.12 111.278 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' CB ' ' C' ' 72' ' ' ARG . 62.6 m-70 -88.18 57.02 4.08 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 121.327 0.584 . . . . 1.26 110.689 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.476 ' O ' HG12 ' C' ' 74' ' ' ILE . 59.5 t80 -58.29 -58.07 10.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.454 -0.794 . . . . 2.08 111.635 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -60.8 -21.99 63.68 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 111.871 0.323 . . . . 0.86 111.871 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.454 ' CB ' ' HB3' ' C' ' 69' ' ' HIS . 6.1 tpp180 -62.8 -52.15 64.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.379 -0.373 . . . . 1.96 111.814 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.424 ' CG ' ' HB3' ' C' ' 117' ' ' LEU . 4.4 p90 -74.39 -28.15 60.97 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 120.815 -0.354 . . . . 1.8 111.179 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.476 HG12 ' O ' ' C' ' 70' ' ' TYR . 31.1 mm -53.11 -44.11 50.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.807 0.337 . . . . 1.18 110.929 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.451 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 37.2 t70 -62.68 -29.41 70.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 1.33 109.983 179.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 17.3 m0 -89.57 1.8 55.49 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 116.02 -0.537 . . . . 1.85 110.733 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . . . . . . . . . 55.9 tpp -100.06 -16.35 17.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.665 -0.698 . . . . 1.56 109.877 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.422 ' O ' HD23 ' C' ' 82' ' ' LEU . 26.9 m -114.2 -37.93 2.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.685 -0.688 . . . . 1.11 111.908 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.62 HG23 HG23 ' C' ' 43' ' ' ILE . 94.1 m -77.66 -52.76 8.47 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.058 0.392 . . . . 1.49 112.058 -178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.517 ' N ' ' HD2' ' C' ' 81' ' ' PRO . 60.1 m -50.8 -52.43 57.14 Favored Pre-proline 0 C--N 1.329 -0.314 0 N-CA-C 112.496 0.554 . . . . 1.6 112.496 -178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' C' ' 80' ' ' THR . 19.3 Cg_endo -58.54 -32.43 96.54 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 121.704 1.603 . . . . 1.01 111.751 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.422 HD23 ' O ' ' C' ' 78' ' ' VAL . 3.3 mm? -80.48 -21.58 41.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.894 -0.594 . . . . 1.18 111.208 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.527 HD22 H201 ' C' ' 301' ' ' RET . 8.0 tp -70.57 -40.46 73.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.478 -0.328 . . . . 1.54 111.286 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.483 HD12 ' N ' ' C' ' 85' ' ' LEU . 3.5 pp -77.91 -31.62 51.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.369 -0.378 . . . . 1.65 110.498 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.483 ' N ' HD12 ' C' ' 84' ' ' LEU . 69.9 mt -66.73 -30.09 70.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 2.1 110.784 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 67.1 m -64.31 -32.65 74.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 1.38 110.993 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 49.9 mt -76.76 -23.53 52.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 1.44 110.862 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 52.5 m -69.88 -40.76 75.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 1.87 111.054 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 6.5 m0 -77.56 -29.31 52.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.265 -0.425 . . . . 3.1 111.139 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.5 m -70.57 -29.18 65.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.342 -0.39 . . . . 1.48 110.885 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . 0.463 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -94.5 -26.54 16.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 1.02 111.106 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 55.8 mtm -134.09 108.42 8.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 2.34 110.937 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -77.55 -30.67 52.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.431 -0.349 . . . . 3.21 110.932 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -141.04 142.75 34.16 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.264 -0.425 . . . . 4.54 110.953 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 37.8 pt -124.31 154.39 31.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.061 -0.518 . . . . 2.34 110.968 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . 0.497 ' HD3' HE22 ' C' ' 229' ' ' GLN . 28.2 tptp -118.97 -42.0 2.73 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.238 -0.437 . . . . 4.4 110.978 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -168.33 35.03 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.378 -0.374 . . . . 5.54 111.148 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -89.06 91.26 8.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.326 -0.397 . . . . 3.54 110.975 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 81.5 m95 -131.05 40.58 3.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 5.21 110.796 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 62.0 m -113.34 -61.86 1.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.18 -0.464 . . . . 2.38 111.382 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 58.1 tp -66.66 -39.9 88.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.334 -0.394 . . . . 2.64 110.817 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 10.0 tp -72.36 -24.63 22.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 2.38 111.039 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -67.91 -62.45 4.25 Favored Glycine 0 C--N 1.332 0.321 0 C-N-CA 120.876 -0.678 . . . . 1.62 112.594 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -59.75 -30.86 69.14 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.665 0.269 . . . . 2.93 110.885 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 45.1 tp -64.7 -54.46 31.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.286 -0.415 . . . . 2.16 111.043 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.449 ' O ' HG13 ' C' ' 110' ' ' ILE . 49.7 ttm -62.72 -25.92 68.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.011 -0.541 . . . . 2.3 111.138 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 64.7 m -68.78 -59.52 3.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.425 . . . . 2.07 111.417 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.44 ' O ' HG23 ' C' ' 112' ' ' VAL . 5.2 t -56.08 -29.81 61.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.301 -0.409 . . . . 2.3 111.517 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.469 ' HG2' HD21 ' C' ' 84' ' ' LEU . 24.9 tp60 -63.67 -48.48 77.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.438 -0.346 . . . . 2.48 110.81 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' B' ' 46' ' ' TRP . 69.7 mt -53.57 -35.84 26.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 1.93 110.923 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.7 t -70.52 -39.73 76.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 1.67 111.129 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.44 HG23 ' O ' ' C' ' 108' ' ' THR . 97.3 t -65.6 -48.94 80.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.253 -0.43 . . . . 1.11 111.158 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 63.6 mt -55.91 -36.93 45.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 2.59 110.782 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 61.0 m -57.78 -48.69 78.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.48 . . . . 0.9 110.896 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.6 m -61.39 -23.11 65.56 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.099 -0.5 . . . . 0.92 110.281 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.8 -49.0 45.41 Favored Glycine 0 C--N 1.33 0.236 0 C-N-CA 121.008 -0.615 . . . . 0.55 112.757 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.4 pp -71.02 -29.18 65.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.564 0.221 . . . . 1.49 111.205 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.445 ' N ' HD12 ' C' ' 117' ' ' LEU . 80.1 mt -74.31 -36.03 41.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.735 0.302 . . . . 1.66 111.077 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.17 -38.32 70.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.94 110.894 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -81.78 -23.19 36.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.169 -0.469 . . . . 1.79 110.67 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -89.03 32.43 0.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 1.29 111.001 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.503 ' HA ' HE22 ' B' ' 58' ' ' GLN . 72.0 p -85.23 121.71 28.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.264 -0.425 . . . . 2.15 110.982 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -76.16 -28.8 57.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.092 -0.504 . . . . 3.31 110.848 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.529 ' HB2' HG12 ' C' ' 127' ' ' VAL . 78.7 mtm180 -126.56 151.18 48.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.963 -0.562 . . . . 3.16 110.614 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.63 -15.03 55.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.15 -0.477 . . . . 4.24 111.277 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 91.1 t90 -81.25 -40.73 23.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.317 -0.401 . . . . 4.65 110.672 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' C' ' 124' ' ' ARG . 14.4 p -77.49 -23.19 14.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.866 -0.606 . . . . 1.31 110.984 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -55.7 -30.78 61.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.063 -0.517 . . . . 2.84 110.924 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -74.07 -26.11 60.2 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.371 -0.377 . . . . 2.7 111.13 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 66.4 tp -67.71 -52.97 31.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.368 -0.378 . . . . 1.88 111.09 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.4 m95 -67.09 -30.23 70.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.349 -0.387 . . . . 1.38 111.171 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -58.48 -40.84 83.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.312 -0.403 . . . . 1.76 110.797 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.2 mt -73.9 -32.55 34.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 2.15 110.785 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -64.0 -32.46 74.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 1.56 111.008 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.88 -50.94 8.26 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.714 -0.755 . . . . 0.73 112.622 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.424 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 30.5 m -64.04 -40.24 88.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.686 0.279 . . . . 1.48 111.532 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 42.3 t -60.8 -44.15 97.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.448 -0.342 . . . . 1.51 111.211 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.11 79.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.051 -0.522 . . . . 1.01 111.41 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -72.65 -24.56 61.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.01 -0.541 . . . . 2.05 111.363 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 87.4 mt -73.33 -57.82 3.74 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.879 0.325 . . . . 2.07 111.879 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.459 HG13 ' N ' ' C' ' 142' ' ' ILE . 49.4 pt -56.46 -39.41 61.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.503 -0.317 . . . . 1.92 111.81 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.459 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.5 pp -74.34 -26.74 20.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.724 0.297 . . . . 2.64 111.429 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.1 tp -57.16 -53.75 54.6 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.371 -0.377 . . . . 1.51 110.565 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -63.37 -37.32 86.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.068 -0.515 . . . . 3.58 110.598 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -63.62 -17.02 59.61 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.895 -0.669 . . . . 1.65 112.839 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 74.0 mt -106.3 -26.91 3.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.75 0.309 . . . . 2.46 111.414 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -74.32 -34.99 63.62 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.451 -0.34 . . . . 2.27 111.611 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.561 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 2.9 t-20 -66.72 -51.49 39.37 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 112.019 0.377 . . . . 2.33 112.019 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 19.4 Cg_endo -58.35 -20.77 49.75 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.123 1.882 . . . . 2.46 112.773 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 95.4 mt -85.33 45.33 1.17 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.844 0.354 . . . . 3.08 110.768 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . 0.412 ' NE ' ' HA ' ' C' ' 151' ' ' ARG . 8.1 tpm_? -163.24 -58.38 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.203 -0.453 . . . . 8.45 111.044 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -48.37 11.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.88 0.371 . . . . 2.9 111.22 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' C' ' 149' ' ' PRO . 28.0 ttpp -67.24 -26.71 66.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 4.62 110.875 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 71.7 p -91.0 5.44 48.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.291 -0.413 . . . . 3.85 111.546 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -82.73 -23.42 34.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.269 -0.423 . . . . 5.12 110.641 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 50.7 p -101.26 -35.69 9.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 3.43 111.394 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -64.14 -76.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.459 -0.337 . . . . 3.98 111.016 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -155.96 115.71 3.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.293 -0.412 . . . . 2.4 110.875 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -68.62 -31.44 70.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.026 -0.534 . . . . 2.82 111.107 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -66.91 -55.67 13.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 3.18 110.966 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . 0.416 HD22 ' N ' ' C' ' 161' ' ' LEU . 3.8 mm? -66.34 -19.65 65.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.313 -0.403 . . . . 2.5 110.752 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . 0.424 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -71.75 -46.46 58.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 1.81 111.165 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -62.92 -44.11 96.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.131 -0.486 . . . . 2.13 111.04 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 45.7 mt -60.38 -35.76 76.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 2.21 110.803 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -74.27 -22.62 59.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.889 -0.596 . . . . 1.31 111.055 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -68.32 -48.7 64.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.3 -0.409 . . . . 2.26 110.971 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -71.45 -23.83 61.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.445 . . . . 3.58 110.926 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.463 HD22 ' HB2' ' C' ' 91' ' ' ALA . 35.3 tp -73.18 -55.89 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 1.3 111.337 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.42 -23.09 24.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 1.73 111.188 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 64.0 m -57.02 -58.97 5.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 1.43 111.347 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . 0.419 ' O ' HG22 ' C' ' 174' ' ' VAL . 63.7 m-85 -61.46 -35.03 76.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.319 -0.4 . . . . 3.72 110.887 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -66.89 -27.43 67.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.364 -0.38 . . . . 1.55 111.048 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 89.8 m -75.87 -47.76 24.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 1.5 111.473 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . 0.419 HG22 ' O ' ' C' ' 171' ' ' TYR . 35.1 m -61.13 -25.01 34.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 111.88 0.326 . . . . 1.84 111.88 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 74.0 mt -80.0 -58.07 3.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.973 0.416 . . . . 2.12 110.978 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -58.19 -27.28 63.73 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.852 -0.613 . . . . 1.0 111.265 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 13.9 tt -87.74 -22.73 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 1.75 110.335 179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.5 -50.44 66.92 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 115.627 -0.715 . . . . 0.72 113.206 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.687 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 58.3 m-85 -58.75 -55.97 40.69 Favored Pre-proline 0 CA--C 1.536 0.428 0 CA-C-N 116.87 0.335 . . . . 1.8 111.715 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.687 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 76.0 Cg_exo -48.16 -34.02 22.86 Favored 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.05 1.833 . . . . 0.88 113.395 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.552 ' O ' HG22 ' C' ' 184' ' ' ILE . 49.7 mm -73.71 -58.72 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.811 0.339 . . . . 1.52 111.686 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' C' ' 183' ' ' TRP . 19.2 m -54.58 -26.71 16.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.296 -0.411 . . . . 1.2 111.749 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.67 ' CD2' HG23 ' C' ' 182' ' ' VAL . 4.4 m95 -93.61 -12.94 28.31 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 121.029 -0.269 . . . . 2.47 111.597 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.552 HG22 ' O ' ' C' ' 181' ' ' ILE . 8.7 tt -57.83 -17.64 8.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.62 111.371 -179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.418 ' HB ' ' O ' ' C' ' 189' ' ' GLY . 36.2 mm -114.7 -77.02 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.369 -0.378 . . . . 2.63 110.943 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' C' ' 187' ' ' PRO . . . -172.88 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.072 -0.585 . . . . 1.77 112.194 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' C' ' 186' ' ' GLY . 9.6 Cg_exo -71.39 79.21 1.49 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.523 2.149 . . . . 3.03 111.749 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . 0.579 ' HA ' ' HB ' ' C' ' 182' ' ' VAL . 97.3 p 47.27 29.41 1.22 Allowed 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.909 -0.587 . . . . 4.22 111.146 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . 0.418 ' O ' ' HB ' ' C' ' 185' ' ' ILE . . . 132.86 -139.2 10.74 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.676 -0.773 . . . . 4.08 112.337 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 70.4 t80 -49.24 128.57 16.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.861 0.362 . . . . 7.54 111.442 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 141.92 157.22 7.08 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.847 -0.692 . . . . 3.29 112.483 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -69.45 152.25 45.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 5.67 110.867 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 15.1 mt -88.08 139.43 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.16 -0.473 . . . . 2.76 110.859 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -131.01 -95.45 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.264 -0.426 . . . . 3.69 110.811 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -177.63 -65.99 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.845 0.355 . . . . 5.34 111.204 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 25.4 m -65.17 -35.61 81.62 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.241 -0.436 . . . . 2.57 111.454 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 48.0 mm -56.91 -31.08 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.28 -0.418 . . . . 2.37 111.385 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -54.41 -60.68 3.02 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.282 -0.417 . . . . 2.68 111.498 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 82.6 p -60.4 -27.1 67.18 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.421 -0.354 . . . . 1.95 111.826 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.69 -52.7 64.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 2.05 110.942 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' C' ' 188' ' ' SER . 5.1 mt -84.3 -20.63 31.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 1.91 111.651 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . 0.454 ' HA ' ' CZ2' ' C' ' 183' ' ' TRP . 0.5 OUTLIER -65.95 -16.03 63.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.714 0.292 . . . . 2.04 110.575 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.49 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 71.2 m -95.91 -29.29 14.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.5 . . . . 1.62 110.614 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 27.0 tp -68.48 -41.19 80.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.844 -0.616 . . . . 1.49 111.345 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 0.2 OUTLIER -58.51 -54.41 56.3 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.461 -0.336 . . . . 1.32 111.211 -179.487 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 78.7 Cg_exo -49.46 -44.65 33.97 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 122.096 1.864 . . . . 0.76 111.812 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -55.31 -38.35 68.57 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.997 0.427 . . . . 1.52 110.256 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.979 -0.555 . . . . 1.84 110.353 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 41.9 t -86.35 -26.7 24.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.041 -0.527 . . . . 1.68 110.819 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.1 mptt -78.7 -27.87 45.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.306 -0.407 . . . . 2.04 110.654 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.91 -41.06 19.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.407 -0.36 . . . . 2.65 110.848 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -67.69 -17.68 69.36 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.739 -0.743 . . . . 1.33 111.846 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -74.22 -40.94 62.11 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.352 . . . . 3.02 110.755 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 44.8 t -63.22 -51.21 67.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.13 -0.487 . . . . 2.35 110.714 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -63.28 -27.1 69.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.096 -0.502 . . . . 3.62 110.589 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.8 tt -65.39 -52.56 52.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.024 -0.534 . . . . 1.64 110.691 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -57.98 -33.25 68.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.263 -0.426 . . . . 2.2 110.789 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 27.3 tp -62.69 -34.79 77.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.083 -0.508 . . . . 3.11 110.422 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -84.11 -22.26 31.18 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.864 -0.607 . . . . 3.37 110.741 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.37 -18.05 79.49 Favored Glycine 0 CA--C 1.517 0.185 0 CA-C-N 115.97 -0.559 . . . . 1.55 112.669 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 87.6 mt -44.75 -51.99 8.82 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 111.759 0.281 . . . . 3.11 111.759 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -72.47 125.21 26.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.006 0.431 . . . . 5.73 110.987 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . 0.479 HD22 HD22 ' C' ' 225' ' ' ASN . 3.0 p-10 -173.71 143.39 1.0 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.987 -0.551 . . . . 5.53 110.731 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 63.9 tp -109.7 131.55 54.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.157 -0.474 . . . . 6.6 110.651 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . 0.479 HD22 HD22 ' C' ' 223' ' ' ASN . 8.9 p30 -157.24 -179.96 8.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.152 -0.476 . . . . 6.51 111.122 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -155.99 93.96 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 7.05 110.636 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 77.1 p -102.5 116.81 33.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.974 -0.557 . . . . 6.72 111.136 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.6 ttp180 -139.42 133.68 31.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.055 -0.521 . . . . 9.56 110.721 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . 0.497 HE22 ' HD3' ' C' ' 96' ' ' LYS . 6.6 tp-100 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.231 -0.89 . . . . 9.08 110.87 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.729 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.73 ' H8 ' H161 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.721 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 N--CA 1.487 1.402 0 CA-C-O 120.838 0.351 . . . . 8.09 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.19 17.23 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.143 -0.48 . . . . 5.68 111.078 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 50.5 tp -153.72 -61.87 0.14 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.123 -0.489 . . . . 6.27 110.737 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 56.82 75.83 0.34 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.067 -0.515 . . . . 6.52 111.043 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 47.9 t -155.5 81.34 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 3.59 110.806 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.1 mt -103.94 175.05 5.61 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.254 -0.43 . . . . 3.23 111.09 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 64.1 mt -55.32 -59.8 4.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 1.88 111.186 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.654 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.1 m80 -57.37 -23.52 49.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.065 -0.516 . . . . 1.29 111.185 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.4 t-105 -74.67 -36.39 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.276 -0.42 . . . . 0.99 111.014 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.0 mt -69.78 -33.78 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 1.92 110.877 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' O ' ' HG2' ' A' ' 15' ' ' MET . 58.9 t80 -62.0 -58.87 6.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.067 -0.515 . . . . 1.45 110.821 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.1 p -53.29 -31.38 18.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-N 116.32 -0.4 . . . . 0.89 111.034 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.6 -46.46 88.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.9 110.991 179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -25.49 75.17 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.958 -0.639 . . . . 0.83 112.669 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 79.5 mmm -74.74 -35.87 62.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.866 0.365 . . . . 1.24 110.74 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.3 m -61.19 -53.89 51.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 1.29 110.909 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.439 ' HA ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -57.73 -34.16 47.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.237 -0.438 . . . . 1.71 110.622 179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.98 -36.97 83.45 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.886 -0.673 . . . . 0.96 112.204 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.84 -30.64 56.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.63 0.252 . . . . 0.99 110.912 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 17' ' ' ILE . 81.8 mt -65.28 -21.95 66.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.026 0.441 . . . . 2.11 110.535 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -59.77 -19.65 51.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.812 -0.631 . . . . 2.23 110.273 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -55.47 -36.21 66.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.643 -0.708 . . . . 4.02 111.068 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 49.4 t-105 -93.67 -24.91 17.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.465 . . . . 3.96 110.963 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 45.0 m -66.55 -46.76 75.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.288 -0.414 . . . . 2.38 111.21 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 33.5 tp -83.61 -0.85 52.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.086 -0.506 . . . . 2.77 111.23 -179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.3 p -51.91 -22.95 4.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.353 -0.385 . . . . 2.52 111.362 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 69.0 mtp180 -46.99 -38.59 11.0 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 121.362 0.601 . . . . 5.54 109.78 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 21.3 p-10 -170.12 132.3 1.01 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.061 -0.972 . . . . 4.44 109.698 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 52.7 Cg_endo -93.84 98.78 0.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.74 2.293 . . . . 2.81 112.489 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -117.57 114.87 24.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.89 -0.595 . . . . 6.8 111.033 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 106.68 -46.31 1.18 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.838 -0.696 . . . . 4.97 112.85 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.649 HG13 ' HB3' ' A' ' 36' ' ' GLU . 23.8 t -135.26 111.53 10.87 Favored Pre-proline 0 CA--C 1.531 0.224 0 CA-C-O 120.609 0.243 . . . . 4.71 111.445 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HG2' ' HE2' ' A' ' 35' ' ' TYR . 5.2 Cg_exo -78.63 166.54 23.69 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.275 2.65 . . . . 3.51 112.279 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -41.63 -43.64 2.84 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 113.003 0.742 . . . . 3.41 113.003 -179.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.453 ' HE2' ' HG2' ' A' ' 33' ' ' PRO . 5.2 p90 -62.97 -51.07 68.31 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 112.13 0.418 . . . . 2.81 112.13 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.649 ' HB3' HG13 ' A' ' 32' ' ' VAL . 9.2 tp10 -65.53 -34.55 78.51 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.873 0.368 . . . . 3.39 110.993 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.447 ' HB2' HG12 ' A' ' 32' ' ' VAL . 4.3 t80 -78.72 -22.15 47.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.257 -0.429 . . . . 5.24 110.157 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 51.9 tp -60.44 -60.26 4.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.904 -0.589 . . . . 1.6 110.546 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 43' ' ' ILE . 59.8 t -63.23 -35.79 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 1.33 110.52 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.07 -11.42 60.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.134 -0.484 . . . . 1.03 111.057 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.442 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 ttt -89.02 -35.62 16.27 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.154 -0.475 . . . . 2.0 110.643 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -71.64 -27.42 63.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.182 -0.463 . . . . 1.31 111.106 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.491 HG23 HG23 ' A' ' 79' ' ' THR . 84.0 mt -60.8 -54.41 54.8 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 111.936 0.347 . . . . 1.0 111.936 -179.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.457 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 56.5 Cg_endo -69.34 -30.08 24.83 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.302 2.001 . . . . 0.59 112.766 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 41' ' ' MET . 28.9 mm -63.32 -60.9 2.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.697 -0.228 . . . . 1.63 111.368 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.558 ' HE1' HG22 ' B' ' 110' ' ' ILE . 0.9 OUTLIER -59.06 -55.58 33.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.819 0.343 . . . . 1.12 110.711 -179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -58.18 -23.57 55.9 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.174 -0.466 . . . . 1.32 111.223 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -64.51 -61.9 5.55 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.677 -0.773 . . . . 0.52 112.298 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.439 HD22 ' N ' ' A' ' 49' ' ' LEU . 3.3 mm? -60.0 -21.75 61.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.889 0.376 . . . . 0.98 110.7 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.19 -57.06 13.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.068 -0.515 . . . . 0.52 111.129 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 21.5 m-85 -62.84 -43.31 99.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.018 -0.537 . . . . 1.69 111.21 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 57.3 ttp -50.23 -30.64 12.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.263 0.554 . . . . 1.12 110.167 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -73.17 -39.98 65.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.47 -0.786 . . . . 0.6 110.72 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 51.3 mtt -54.34 -28.15 40.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.83 -0.623 . . . . 0.94 110.508 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.654 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.2 -52.31 10.3 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.955 -0.566 . . . . 0.78 111.052 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 HG12 ' HA ' ' A' ' 53' ' ' ALA . 25.7 pt -73.41 5.74 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.728 -179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 59.3 69.07 0.74 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.254 -0.43 . . . . 2.02 111.158 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.499 HE22 ' HA ' ' B' ' 122' ' ' SER . 15.9 mm100 -131.1 157.94 41.76 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.254 -0.43 . . . . 2.1 111.113 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.657 ' HA3' ' HB2' ' A' ' 71' ' ' ALA . . . 80.38 27.25 52.55 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.871 -0.68 . . . . 1.27 112.523 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -123.5 167.15 14.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.639 0.257 . . . . 1.76 110.43 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.9 p -148.0 140.82 18.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.429 -0.351 . . . . 1.84 111.358 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -92.57 99.1 11.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.184 -0.462 . . . . 2.64 110.774 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -111.36 113.29 25.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 1.84 111.311 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.22 19.63 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.073 -0.512 . . . . 2.24 111.424 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.64 -7.22 74.41 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.764 -0.731 . . . . 2.16 112.837 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -99.57 124.7 45.01 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.746 0.308 . . . . 2.84 110.796 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.459 HD12 ' N ' ' A' ' 67' ' ' ILE . 4.1 mp -84.46 132.07 32.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.331 -0.395 . . . . 2.39 110.914 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.14 131.84 55.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.97 111.186 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 30.7 m-70 -87.15 55.83 3.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.018 -0.537 . . . . 1.04 110.766 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -54.05 -46.93 72.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.929 -0.578 . . . . 3.38 111.036 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.657 ' HB2' ' HA3' ' A' ' 59' ' ' GLY . . . -59.83 -34.19 72.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.32 0.581 . . . . 0.76 110.673 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 3.7 tpp180 -60.56 -28.23 68.29 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.828 -0.624 . . . . 2.93 110.419 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.446 ' O ' ' HG3' ' A' ' 77' ' ' MET . 0.7 OUTLIER -103.27 -17.67 15.21 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 112.856 0.688 . . . . 3.13 112.856 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 71' ' ' ALA . 9.7 tp -62.4 -34.75 66.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 120.18 -0.608 . . . . 1.66 109.705 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -69.85 -17.72 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.743 -0.662 . . . . 1.42 110.118 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.474 ' NE1' ' H10' ' A' ' 301' ' ' RET . 1.2 m-90 -87.41 -14.02 41.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.686 -0.688 . . . . 2.09 111.499 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.446 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 47.4 mtp -104.22 -7.83 19.8 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.293 -0.412 . . . . 1.52 111.234 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 17.2 m -114.75 -29.1 2.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.334 -0.394 . . . . 1.33 111.748 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.491 HG23 HG23 ' A' ' 43' ' ' ILE . 74.6 m -94.11 -51.06 5.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.322 -0.399 . . . . 1.39 111.804 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.538 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 22.6 m -49.99 -48.91 77.51 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.004 0.372 . . . . 1.55 112.004 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.538 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 50.9 Cg_exo -54.83 -33.39 81.24 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.934 1.756 . . . . 1.01 112.549 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -83.4 -28.22 29.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.511 -0.313 . . . . 1.45 110.602 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.412 ' HG ' H201 ' A' ' 301' ' ' RET . 0.2 OUTLIER -63.35 -38.27 90.5 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.772 -0.455 . . . . 1.3 109.772 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.495 HD22 ' HG3' ' A' ' 109' ' ' GLN . 2.9 pp -84.5 -22.29 30.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.794 -0.639 . . . . 1.67 110.233 179.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -44.46 76.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.627 -0.715 . . . . 1.87 110.671 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.0 t -60.71 -30.56 70.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.42 110.566 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.51 HD22 HD11 ' A' ' 168' ' ' LEU . 72.5 mt -66.66 -42.37 86.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.477 . . . . 1.4 110.504 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.4 t -73.27 -22.58 60.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.983 -0.553 . . . . 1.91 110.854 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -82.6 -30.53 29.44 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.174 -0.466 . . . . 2.33 110.859 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 39.2 m -74.75 -29.45 61.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.45 . . . . 1.43 111.062 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.23 -44.31 16.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 1.19 111.195 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 64.6 mtt -132.54 123.1 25.88 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 2.55 110.965 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -75.31 -29.66 60.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.07 -0.514 . . . . 3.33 110.926 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -156.13 140.92 17.1 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.375 -0.375 . . . . 5.1 110.96 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 14.4 tt -136.07 145.9 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 3.07 111.011 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -160.22 25.98 0.17 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.135 -0.484 . . . . 4.41 110.695 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -74.95 -75.58 0.16 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.51 . . . . 5.31 111.121 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -140.29 -9.92 1.11 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.353 -0.385 . . . . 3.94 111.119 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 14.1 t90 57.92 33.6 23.38 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.972 -0.558 . . . . 5.98 110.718 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.5 p -90.74 -41.94 10.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.042 -0.526 . . . . 2.24 111.156 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 86.1 mt -69.41 -44.92 70.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 2.67 111.004 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 27.3 mm -66.57 -35.35 74.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 2.59 111.02 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.31 -28.06 58.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.914 -0.66 . . . . 1.53 112.575 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -74.9 -41.76 59.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.745 0.307 . . . . 3.14 111.104 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.408 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 96.3 mt -66.58 -39.16 88.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.472 -0.331 . . . . 1.99 110.936 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.463 ' O ' HG12 ' A' ' 110' ' ' ILE . 63.5 mtt -70.39 -44.22 68.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.405 . . . . 2.36 111.308 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 88.1 p -55.0 -45.7 75.11 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.28 -0.418 . . . . 2.05 111.431 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 112' ' ' VAL . 82.4 p -63.93 -35.98 82.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.23 -0.441 . . . . 2.25 111.501 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.495 ' HG3' HD22 ' A' ' 84' ' ' LEU . 81.2 mm-40 -71.95 -22.8 61.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.323 -0.399 . . . . 2.72 111.411 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 106' ' ' MET . 36.8 mm -71.66 -46.44 62.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.757 0.313 . . . . 1.88 111.249 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 27.3 m -67.1 -30.77 50.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.396 -0.365 . . . . 1.6 111.367 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 108' ' ' THR . 56.1 t -66.04 -60.48 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.473 -0.33 . . . . 1.09 111.112 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.419 ' O ' HD12 ' A' ' 117' ' ' LEU . 42.5 pt -54.61 -30.08 21.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.51 -0.314 . . . . 2.65 110.507 179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.409 ' O ' HD13 ' A' ' 117' ' ' LEU . 18.5 m -57.98 -43.68 86.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.986 -0.552 . . . . 0.89 110.47 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.424 ' HA ' HG22 ' A' ' 118' ' ' ILE . 40.1 m -69.86 -20.07 63.42 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.818 -0.628 . . . . 0.68 110.204 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.99 -62.64 3.47 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.908 -0.663 . . . . 0.63 114.09 -179.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' C ' HD22 ' A' ' 117' ' ' LEU . 0.0 OUTLIER -69.05 -21.26 64.1 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.268 0.469 . . . . 1.58 112.268 -178.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.424 HG22 ' HA ' ' A' ' 115' ' ' SER . 10.6 tp -83.18 -29.24 7.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 C-N-CA 120.861 -0.336 . . . . 2.04 111.418 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -65.88 -37.61 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.981 0.419 . . . . 1.1 110.797 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -76.15 -27.57 57.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.956 -0.566 . . . . 1.88 111.09 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 90.3 mt -84.44 34.8 0.53 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.327 -0.397 . . . . 1.53 111.021 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.9 m -93.92 122.16 36.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.292 -0.413 . . . . 2.29 110.948 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.25 -13.15 60.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.145 -0.48 . . . . 3.49 110.865 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.499 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.0 mtp180 -133.64 134.21 42.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 3.13 110.654 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -72.66 -11.86 60.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 3.71 111.189 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -83.63 -40.21 19.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.383 -0.371 . . . . 3.97 111.105 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.499 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.1 p -77.06 -26.76 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.834 0.349 . . . . 1.22 110.697 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -61.87 -31.44 71.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.59 . . . . 2.81 110.873 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -64.45 -27.4 68.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.042 -0.526 . . . . 4.25 110.867 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 97.0 mt -77.13 -38.9 51.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 1.84 111.086 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.8 m95 -72.62 -26.82 61.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 1.54 111.226 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.41 -45.06 81.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.989 0.423 . . . . 1.79 110.437 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.5 mm -66.73 -36.38 77.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.529 . . . . 2.08 110.575 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.409 ' SG ' HD22 ' C' ' 49' ' ' LEU . 20.4 t -63.94 -32.73 74.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.921 -0.581 . . . . 1.76 110.705 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.6 -55.57 22.07 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.72 -0.752 . . . . 0.76 112.396 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.3 m -67.08 -27.13 38.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.743 0.306 . . . . 2.07 111.11 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 42.4 t -55.81 -54.95 38.29 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.217 -0.447 . . . . 1.85 110.83 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.61 -28.75 69.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 1.32 110.809 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -68.02 -31.7 71.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 3.25 110.922 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 97.2 mt -70.07 -44.21 69.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 2.92 111.239 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 141' ' ' ILE . 12.5 mt -65.35 -45.53 93.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.472 -0.331 . . . . 2.65 111.346 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 35.2 pt -70.74 -29.94 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 3.21 111.468 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 47.5 tp -60.29 -51.31 70.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 2.01 111.059 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 70.1 t-105 -66.03 -29.94 70.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.303 -0.408 . . . . 3.6 111.008 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.52 -17.95 79.91 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.694 -0.765 . . . . 1.62 112.553 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.6 mt -108.36 -14.39 9.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.937 0.399 . . . . 2.47 110.886 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 45.9 t-105 -99.78 0.27 41.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.199 -0.455 . . . . 2.48 111.155 -179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.633 ' H ' ' HD2' ' A' ' 149' ' ' PRO . 22.5 t-20 -98.79 -50.33 0.21 Allowed Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 112.312 0.486 . . . . 2.69 112.312 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.633 ' HD2' ' H ' ' A' ' 148' ' ' ASN . 49.8 Cg_endo -66.49 0.22 3.69 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.242 1.961 . . . . 2.36 112.992 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 68.9 mt -77.8 15.77 0.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.43 -0.35 . . . . 3.3 111.405 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 24.2 tpp180 -164.44 -34.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.706 0.289 . . . . 8.48 110.917 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -79.65 -43.88 21.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 2.98 111.398 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -73.56 -44.08 58.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.461 . . . . 4.55 110.994 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 69.6 p -80.93 6.86 12.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.428 . . . . 4.0 111.34 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -61.14 -23.99 65.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 5.51 110.995 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -125.0 -27.85 3.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.337 -0.392 . . . . 3.2 111.255 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -71.36 -166.17 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 3.98 110.829 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 45.3 t -50.74 117.75 2.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 2.63 111.135 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 54.9 m -78.37 -36.36 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 2.16 111.054 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -64.43 -39.78 94.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 3.37 111.107 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.77 -23.55 62.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.369 -0.378 . . . . 2.83 110.851 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.0 -42.95 75.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 1.7 110.985 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -69.87 -32.98 71.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.058 -0.519 . . . . 2.16 110.901 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 96.5 mt -69.31 -43.96 72.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.991 0.424 . . . . 1.59 110.837 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.89 -23.44 59.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.954 -0.566 . . . . 2.31 111.01 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.5 -46.57 75.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 2.15 110.873 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -74.85 -23.64 58.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.065 -0.516 . . . . 2.39 111.209 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.51 HD11 HD22 ' A' ' 87' ' ' LEU . 51.0 tp -72.75 -50.69 22.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 1.79 110.94 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.5 p -68.94 -17.93 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.009 -0.542 . . . . 1.42 111.31 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 53.8 m -54.8 -59.06 5.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.306 -0.407 . . . . 1.12 110.919 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -67.08 -35.58 80.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.014 -0.539 . . . . 3.86 110.145 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -60.89 -24.96 66.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.669 . . . . 1.58 111.133 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.403 ' O ' HG22 ' A' ' 177' ' ' ILE . 86.0 m -78.82 -51.08 10.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.334 -0.394 . . . . 1.41 111.53 -179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 45.4 t -62.68 -31.85 53.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 CA-C-N 116.311 -0.404 . . . . 1.42 111.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 65.8 tp -75.82 -57.76 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.412 -0.358 . . . . 1.91 111.933 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -30.8 54.14 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.257 -0.429 . . . . 1.55 111.596 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 17.6 tt -87.68 -21.21 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.957 0.408 . . . . 1.86 110.982 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.58 -50.96 62.05 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.922 -0.656 . . . . 0.74 112.992 -179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.595 ' O ' HG22 ' A' ' 182' ' ' VAL . 49.0 m-85 -56.37 -55.36 43.26 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 111.726 0.269 . . . . 1.78 111.726 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.578 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 87.9 Cg_exo -45.88 -37.21 16.5 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.163 1.909 . . . . 0.92 112.843 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.73 -60.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.768 0.318 . . . . 1.77 111.728 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' A' ' 179' ' ' TYR . 11.2 m -55.45 -24.45 15.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 1.34 111.683 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -69.25 -41.57 76.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.544 -0.298 . . . . 2.51 111.222 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 60.1 mt -56.65 -33.23 39.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.397 -0.365 . . . . 2.02 111.018 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 10.9 tt -101.16 138.93 23.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 2.45 111.014 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.48 -161.5 17.99 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.628 -0.796 . . . . 1.73 112.531 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.09 162.07 34.78 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.572 2.181 . . . . 3.05 111.906 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 56.6 18.39 3.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.31 -0.405 . . . . 4.04 110.381 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -135.16 -82.45 0.16 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.021 -0.609 . . . . 4.48 112.469 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -150.61 -21.39 0.23 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 7.96 110.786 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -92.84 175.68 37.12 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.923 -0.656 . . . . 3.23 112.749 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 25.2 m-90 -135.54 86.86 2.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.359 . . . . 6.03 110.651 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.0 pt -134.58 157.96 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 3.18 110.942 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -127.64 -4.22 5.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 3.39 110.688 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.546 ' HG3' ' H ' ' A' ' 197' ' ' ILE . 50.5 tp60 -60.0 151.07 27.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.978 -0.555 . . . . 5.76 110.924 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 71.9 p -73.06 -14.84 61.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.893 -0.594 . . . . 2.5 111.516 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.546 ' H ' ' HG3' ' A' ' 195' ' ' GLN . 20.2 tt -54.61 -28.83 19.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.284 -0.416 . . . . 2.4 111.491 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -71.85 -41.26 68.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.851 0.357 . . . . 2.66 110.97 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 85.5 m -70.54 -35.43 73.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.038 -0.528 . . . . 1.81 111.223 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -66.83 -34.13 77.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.317 -0.401 . . . . 2.21 111.256 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.12 -35.16 66.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.36 -0.382 . . . . 2.18 110.738 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.7 -12.94 60.04 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.129 -0.487 . . . . 2.01 110.646 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.491 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.3 t -95.64 -38.32 10.43 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.975 -0.557 . . . . 1.93 110.637 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.37 -42.3 75.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.649 -0.705 . . . . 1.7 111.69 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.642 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 64.2 tp -52.37 -53.76 49.43 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 121.276 -0.17 . . . . 1.28 111.068 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.642 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 77.5 Cg_exo -51.6 -47.47 26.08 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 121.946 1.764 . . . . 0.79 111.596 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -56.37 -41.22 75.84 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.121 -0.491 . . . . 1.51 110.356 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -70.38 -25.75 63.39 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 1.93 110.34 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 28.5 t -78.0 -23.76 48.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.793 -0.64 . . . . 1.71 110.719 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.09 -43.96 14.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 2.04 110.754 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 87.0 t -63.03 -53.08 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.287 -0.415 . . . . 2.89 110.889 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.42 -27.02 62.7 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.761 -0.733 . . . . 1.31 112.241 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -67.35 -35.55 79.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.372 . . . . 2.87 110.815 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 49.1 m -63.69 -52.93 58.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 2.38 110.723 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -65.53 -22.46 66.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.1 -0.5 . . . . 3.42 110.841 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.447 HD21 HD12 ' A' ' 168' ' ' LEU . 9.4 tt -65.09 -58.99 4.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 1.24 110.932 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -60.24 -25.37 65.61 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.292 -0.413 . . . . 2.44 111.073 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 40.9 tp -63.13 -51.81 65.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 2.51 110.893 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 42.7 m80 -82.56 -20.27 36.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.15 -0.477 . . . . 3.01 111.146 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.62 -50.44 67.14 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.795 -0.717 . . . . 1.59 112.803 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 83.9 mt -74.86 -19.5 60.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 3.49 110.916 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 mtm180 59.23 -87.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.027 -0.533 . . . . 5.74 111.285 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -87.13 179.39 6.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.486 -0.324 . . . . 5.46 110.977 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.1 mt -132.65 116.1 16.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.221 -0.445 . . . . 6.13 110.931 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -127.67 114.47 17.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 6.46 111.031 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.73 129.07 35.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 6.94 110.777 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 50.7 m -118.31 82.33 1.83 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.122 -0.49 . . . . 6.83 110.97 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 25.1 tpp180 -93.22 112.31 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 10.77 110.962 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.32 -0.847 . . . . 9.41 110.995 179.769 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 120.799 0.333 . . . . 8.91 110.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 30.2 p-10 -101.42 -2.05 31.77 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 6.76 110.691 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 30.4 tp -99.07 87.61 3.73 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.17 -0.468 . . . . 6.25 110.553 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -79.94 2.88 21.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.079 -0.51 . . . . 5.44 111.018 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 24.5 m 59.8 -179.61 0.09 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.087 -0.506 . . . . 3.84 110.897 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.441 ' O ' HG13 ' B' ' 10' ' ' ILE . 33.7 tp -160.33 -26.78 0.06 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.185 -0.461 . . . . 3.08 110.863 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 44.3 mt -57.52 -62.16 1.98 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.092 -0.504 . . . . 2.35 110.996 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.571 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 37.8 m80 -62.41 -23.85 67.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.982 -0.554 . . . . 1.39 110.839 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 67.3 t-105 -68.23 -41.55 81.04 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.998 -0.547 . . . . 1.1 111.027 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.441 HG13 ' O ' ' B' ' 6' ' ' LEU . 82.0 mt -67.21 -31.6 53.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.964 0.412 . . . . 1.71 110.74 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -57.96 -62.1 2.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.979 -0.555 . . . . 1.48 110.906 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.4 p -54.0 -35.1 27.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 0.95 111.472 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.97 -49.68 76.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.927 0.394 . . . . 0.97 111.054 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.39 -24.33 65.56 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.848 -0.691 . . . . 0.8 112.302 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 24.9 mmt -80.21 -31.43 38.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.776 0.322 . . . . 1.29 110.909 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 89.8 m -59.98 -56.26 23.93 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.286 -0.415 . . . . 1.36 110.735 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.475 HD13 ' O ' ' B' ' 17' ' ' ILE . 0.0 OUTLIER -60.35 -38.41 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 CA-C-N 115.987 -0.552 . . . . 1.23 110.094 179.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.83 -22.15 53.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.862 -0.685 . . . . 0.88 112.066 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.5 -38.32 34.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.98 110.372 179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.91 -26.98 66.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.965 -0.562 . . . . 2.12 110.626 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' B' ' 24' ' ' SER . 35.5 m170 -55.48 -19.36 9.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.083 -0.508 . . . . 2.0 111.049 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.97 ' O ' ' OG ' ' B' ' 26' ' ' SER . 3.2 p90 -53.42 -33.16 52.86 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.47 -0.332 . . . . 4.26 111.298 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 73.3 t90 -104.26 -20.78 13.67 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.391 -0.368 . . . . 3.62 111.264 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.42 ' HB3' ' HA ' ' B' ' 21' ' ' HIS . 41.4 t -82.6 -57.33 3.38 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.958 0.355 . . . . 2.55 111.958 -179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.54 -0.45 42.12 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.372 0.508 . . . . 3.11 112.372 -179.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.97 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 37.8 m -55.34 -29.24 57.98 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 119.928 -0.709 . . . . 3.02 110.739 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.5 mmt180 -43.99 -24.98 0.17 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.825 0.822 . . . . 5.89 109.858 179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.891 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.54 -153.8 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.413 0 CA-C-N 114.26 -1.337 . . . . 5.02 109.237 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.891 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 80.9 Cg_exo -1.91 115.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 124.418 3.412 . . . . 3.53 117.292 -175.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . 0.505 ' HD2' ' N ' ' B' ' 30' ' ' ARG . 8.5 mpt_? 42.76 35.41 0.7 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 114.711 -1.131 . . . . 7.88 112.123 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 75.37 -50.68 2.45 Favored Glycine 0 C--O 1.226 -0.401 0 N-CA-C 111.633 -0.587 . . . . 4.61 111.633 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 p -143.27 106.27 5.17 Favored Pre-proline 0 N--CA 1.455 -0.183 0 CA-C-N 116.678 0.239 . . . . 4.73 110.962 176.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.569 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 96.3 Cg_endo -85.12 116.52 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.19 1.26 . . . . 3.75 112.482 178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' B' ' 38' ' ' LEU . 9.8 tt0 -84.78 -25.55 28.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.844 0.831 . . . . 3.76 109.503 177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.535 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -83.56 -65.65 0.98 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 113.85 -1.523 . . . . 3.17 114.012 -177.306 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.535 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.2 tp10 -57.29 -62.39 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.574 0.583 . . . . 2.57 112.574 -177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.441 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.4 m-30 -58.49 -18.48 29.36 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.191 0.441 . . . . 5.74 112.191 -178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' B' ' 34' ' ' GLN . 48.3 tp -63.89 -61.37 2.33 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.81 -0.441 . . . . 1.72 109.81 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 13.0 m -67.08 -34.94 72.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.019 -0.537 . . . . 1.95 110.586 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.441 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -68.7 -9.91 53.24 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.143 -0.48 . . . . 1.2 110.803 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.441 ' O ' HG12 ' B' ' 45' ' ' ILE . 14.9 tpt -89.06 -42.8 11.52 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.025 -0.534 . . . . 2.12 110.934 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -72.57 -36.78 68.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 1.49 112.132 -179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.592 HG23 HG23 ' B' ' 79' ' ' THR . 92.0 mt -51.35 -52.62 57.68 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.132 0.419 . . . . 0.77 112.132 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 62.4 Cg_endo -72.0 -37.56 4.76 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.393 2.062 . . . . 0.68 113.284 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.441 HG12 ' O ' ' B' ' 41' ' ' MET . 26.6 mm -55.13 -60.78 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 111.771 0.285 . . . . 1.63 111.771 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.546 ' HE1' HG22 ' C' ' 110' ' ' ILE . 0.8 OUTLIER -60.44 -55.15 37.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.889 0.376 . . . . 1.91 110.85 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 41.0 t -52.15 -26.29 11.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.882 -0.599 . . . . 1.22 111.573 -179.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.69 -52.03 22.37 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.84 -0.695 . . . . 0.55 112.959 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 69.2 mt -58.89 -28.72 66.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.655 0.264 . . . . 0.87 111.453 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.89 -59.15 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.405 -0.361 . . . . 0.55 111.434 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.444 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 32.6 m-85 -64.44 -35.83 82.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 1.06 111.295 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.41 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.6 ttp -52.96 -34.95 58.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.207 0.527 . . . . 1.19 110.288 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' B' ' 56' ' ' ILE . . . -73.16 -39.39 65.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.655 -0.702 . . . . 0.66 110.9 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -55.75 -24.56 36.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.95 -0.568 . . . . 0.86 110.399 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.571 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -78.08 -49.26 14.3 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.012 -0.54 . . . . 0.84 110.466 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.484 HG12 ' HA ' ' B' ' 53' ' ' ALA . 31.8 pt -79.22 10.54 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.04 -0.527 . . . . 1.44 111.023 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 58.65 65.9 1.16 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.862 -0.608 . . . . 1.55 111.147 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.664 HE21 ' H ' ' B' ' 59' ' ' GLY . 26.1 tp60 -140.47 139.33 35.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.06 -0.518 . . . . 2.24 110.578 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . 0.664 ' H ' HE21 ' B' ' 58' ' ' GLN . . . 106.41 -2.01 37.14 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.746 -0.74 . . . . 1.26 112.086 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.467 ' HB2' ' NZ ' ' B' ' 60' ' ' LYS . 9.8 mtmp? -112.1 151.02 29.91 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.746 0.307 . . . . 2.31 110.732 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -124.26 139.15 51.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.24 -0.436 . . . . 1.81 111.137 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -87.51 89.72 8.1 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.116 -0.493 . . . . 3.18 110.929 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.75 121.17 40.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.288 -0.414 . . . . 2.03 111.202 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.56 27.3 16.47 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.001 -0.545 . . . . 2.48 111.445 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.28 -9.06 65.17 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.827 -0.701 . . . . 2.37 112.691 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -98.4 144.16 28.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.362 . . . . 2.28 110.923 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 32.2 mt -81.82 133.21 29.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.187 -0.461 . . . . 1.78 110.921 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.29 142.51 34.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.294 -0.412 . . . . 1.05 111.22 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.585 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 91.2 m-70 -97.29 51.19 1.09 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.319 0.581 . . . . 1.11 110.764 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' B' ' 74' ' ' ILE . 76.1 t80 -60.91 -52.46 64.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.344 -0.844 . . . . 2.3 111.384 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' B' ' 74' ' ' ILE . . . -67.26 -22.72 65.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.503 -0.317 . . . . 0.72 111.723 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.585 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 62.1 mmt-85 -61.84 -52.79 62.73 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 112.111 0.412 . . . . 3.04 112.111 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.479 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 5.2 p90 -70.18 -29.58 66.49 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.653 -0.419 . . . . 1.79 110.756 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.564 HD12 ' HA ' ' B' ' 71' ' ' ALA . 36.2 mt -50.61 -49.18 25.89 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.178 0 CA-C-O 120.815 0.34 . . . . 1.44 110.991 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -61.19 -31.67 71.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 1.31 109.899 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.479 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 7.7 m0 -90.89 3.89 53.34 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.773 -0.649 . . . . 2.01 110.564 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 34.9 tpp -105.28 -17.0 14.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.372 -0.831 . . . . 1.43 109.836 178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.499 ' O ' HD23 ' B' ' 82' ' ' LEU . 27.1 m -113.86 -34.74 2.15 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 CA-C-N 115.843 -0.617 . . . . 1.21 111.847 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.592 HG23 HG23 ' B' ' 43' ' ' ILE . 45.4 m -84.15 -44.15 14.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.44 -0.346 . . . . 1.18 111.809 -178.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.581 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 37.7 m -57.61 -49.51 93.38 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 112.313 0.486 . . . . 1.65 112.313 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.7 Cg_endo -58.96 -34.31 99.08 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.043 1.828 . . . . 1.06 112.3 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.499 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.6 mm? -84.4 -16.31 43.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.438 . . . . 1.58 110.836 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.71 -34.94 60.41 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.233 -0.44 . . . . 1.49 110.139 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.598 HD22 ' HG3' ' B' ' 109' ' ' GLN . 3.5 pp -84.55 -29.77 25.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.796 -0.638 . . . . 1.72 111.054 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.428 ' N ' HD12 ' B' ' 84' ' ' LEU . 12.8 tp -69.93 -33.33 72.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.851 -0.613 . . . . 1.96 111.166 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . 0.457 ' O ' HG23 ' B' ' 90' ' ' THR . 66.5 m -65.65 -40.39 92.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.446 -0.343 . . . . 1.24 110.77 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 97.1 mt -59.23 -25.87 64.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.181 -0.463 . . . . 1.21 111.125 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -77.07 -37.25 54.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 1.32 110.861 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 7.5 m0 -75.6 -30.65 59.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.446 -0.343 . . . . 2.15 111.105 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.457 HG23 ' O ' ' B' ' 86' ' ' SER . 70.1 p -66.13 -41.65 90.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.405 -0.361 . . . . 1.44 111.045 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -81.32 -33.88 32.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 1.05 110.902 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 63.7 mtt -136.1 104.65 5.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.096 -0.502 . . . . 2.68 110.819 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.452 ' HG3' ' HD2' ' B' ' 94' ' ' PHE . 10.9 pt20 -71.48 -29.11 64.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.248 -0.433 . . . . 2.71 110.926 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . 0.452 ' HD2' ' HG3' ' B' ' 93' ' ' GLN . 45.1 p90 -142.57 145.7 33.84 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.371 -0.377 . . . . 4.19 110.738 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.2 tp -154.93 141.66 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.301 -0.409 . . . . 2.79 111.01 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 mtmm -149.64 -6.55 0.34 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.342 -0.39 . . . . 5.27 111.271 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -78.06 -83.72 0.08 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.674 0.273 . . . . 5.57 111.486 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -107.19 152.57 23.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 4.24 111.194 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 45.7 p90 -145.6 3.58 0.99 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.93 -0.577 . . . . 5.39 110.725 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 3.3 t -66.61 -29.63 69.72 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.102 -0.499 . . . . 2.16 111.324 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 63.5 tp -69.48 -45.89 67.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.316 -0.402 . . . . 2.58 110.957 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 86.2 mt -58.24 -33.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 2.29 111.194 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.42 -41.93 65.97 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.85 -0.69 . . . . 1.48 112.604 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -65.59 -29.5 70.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.835 0.35 . . . . 2.76 111.113 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' B' ' 109' ' ' GLN . 96.3 mt -76.72 -58.27 3.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.374 -0.376 . . . . 2.22 111.084 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.428 ' O ' HG12 ' B' ' 110' ' ' ILE . 27.7 ttt -56.19 -36.54 68.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 2.36 111.587 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 80.5 p -61.81 -52.89 62.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.834 0.349 . . . . 1.92 111.151 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.4 ' O ' HG23 ' B' ' 112' ' ' VAL . 69.0 p -58.25 -29.95 66.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 2.06 111.231 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.598 ' HG3' HD22 ' B' ' 84' ' ' LEU . 15.4 mm100 -69.51 -39.6 77.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 2.87 111.027 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.558 HG22 ' HE1' ' A' ' 46' ' ' TRP . 47.8 mm -57.25 -41.98 79.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 1.98 110.841 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.77 -40.17 88.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.079 -0.51 . . . . 1.62 111.363 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.4 HG23 ' O ' ' B' ' 108' ' ' THR . 87.0 t -62.06 -61.8 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 1.04 111.504 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 31.2 mt -52.54 -31.5 15.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.327 -0.397 . . . . 2.46 111.34 -179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 36.3 m -57.74 -50.16 74.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.842 0.353 . . . . 0.83 110.855 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 50.2 m -63.98 -25.08 67.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.163 -0.471 . . . . 0.74 110.825 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -73.97 -40.11 44.5 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.914 -0.66 . . . . 0.6 112.864 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.474 HD12 HG13 ' B' ' 118' ' ' ILE . 3.6 pp -79.72 -22.88 42.8 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.591 0.234 . . . . 1.42 111.507 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.474 HG13 HD12 ' B' ' 117' ' ' LEU . 78.2 mt -82.87 -36.13 12.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.491 -0.322 . . . . 1.51 111.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.82 -38.9 61.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 1.09 111.321 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -78.99 -26.91 43.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.337 -0.392 . . . . 2.25 110.939 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -81.58 5.49 17.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.104 -0.498 . . . . 1.16 111.079 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.499 ' HA ' HE22 ' A' ' 58' ' ' GLN . 84.2 p -63.73 125.37 24.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.092 -0.504 . . . . 1.76 110.721 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -77.44 -34.19 54.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.999 -0.546 . . . . 2.89 110.972 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.676 ' HG2' ' H ' ' B' ' 126' ' ' TRP . 35.7 ttm180 -112.8 141.83 46.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 2.67 110.633 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -73.33 -9.27 58.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 3.25 111.428 -179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . 0.676 ' H ' ' HG2' ' B' ' 124' ' ' ARG . 51.6 t-105 -89.64 -43.64 10.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.282 -0.417 . . . . 4.07 110.857 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' B' ' 124' ' ' ARG . 13.4 p -68.88 -26.65 33.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 1.41 111.315 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 44.2 ttp180 -61.99 -25.72 67.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.328 -0.396 . . . . 2.47 110.664 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.65 -18.17 60.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.036 -0.529 . . . . 2.61 110.66 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 mt -82.82 -48.86 10.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.104 -0.498 . . . . 2.07 110.851 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 7.9 m95 -62.52 -35.85 80.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.072 -0.513 . . . . 1.3 111.173 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 76.5 t80 -58.28 -43.5 88.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 1.75 110.689 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 60.4 mt -68.12 -37.34 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.331 -0.395 . . . . 1.67 110.84 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 63.6 m -66.71 -27.57 67.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 1.54 110.81 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.45 -54.72 14.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.749 -0.738 . . . . 0.7 112.44 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.408 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 4.9 p -63.34 -37.18 78.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.734 0.302 . . . . 1.44 111.27 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.8 t -51.33 -55.01 20.72 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.256 -0.429 . . . . 1.82 110.774 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.48 69.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.998 -0.546 . . . . 0.94 111.132 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . 0.404 ' HA ' HG12 ' B' ' 142' ' ' ILE . 83.7 t80 -71.42 -25.84 62.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.37 -0.377 . . . . 1.6 111.313 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.7 mt -69.05 -53.02 22.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.844 0.355 . . . . 2.01 111.444 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 22.5 mm -60.54 -45.01 97.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.96 111.961 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' B' ' 139' ' ' PHE . 35.2 pt -69.55 -24.05 26.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.503 -0.317 . . . . 2.88 111.71 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.1 tp -67.98 -42.09 81.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.745 0.307 . . . . 1.52 111.044 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -74.75 -28.92 60.96 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.375 -0.375 . . . . 4.15 110.551 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -75.41 -16.84 80.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.942 -0.647 . . . . 1.59 112.867 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 18.4 tt -102.68 -18.34 6.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.692 0.282 . . . . 2.13 111.706 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 7.6 m95 -96.79 -34.52 11.28 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.932 0.345 . . . . 1.78 111.932 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.538 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 3.0 t-20 -61.48 -49.84 85.43 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 112.177 0.436 . . . . 2.45 112.177 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.538 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 39.4 Cg_endo -65.7 -4.51 9.94 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 122.106 1.871 . . . . 2.36 113.087 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 91.2 mt -77.52 7.27 5.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 2.88 110.77 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 76.0 ttt180 -154.39 -32.1 0.11 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.05 -0.523 . . . . 8.07 110.835 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.0 -37.76 23.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 2.8 111.395 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -82.25 -51.65 7.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 4.58 110.917 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.58 ' HA ' ' HB2' ' B' ' 157' ' ' GLN . 9.7 t -69.67 -0.73 7.38 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 3.81 111.168 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.42 -37.51 65.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.083 -0.508 . . . . 5.22 111.01 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 63.8 p -117.84 5.15 12.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.294 -0.412 . . . . 3.42 111.349 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.58 ' HB2' ' HA ' ' B' ' 154' ' ' THR . 28.7 mm-40 -102.8 -162.66 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.373 -0.376 . . . . 4.2 110.913 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 55.2 m -55.91 115.85 2.63 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.076 -0.511 . . . . 2.75 111.244 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 52.4 m -78.12 -34.39 50.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 2.4 110.883 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -62.98 -51.01 68.53 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.062 -0.517 . . . . 3.46 111.125 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -63.39 -19.83 65.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.134 -0.484 . . . . 2.57 111.199 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . 0.419 ' HB2' ' OG1' ' B' ' 154' ' ' THR . . . -69.75 -46.71 65.24 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.33 -0.395 . . . . 1.72 111.691 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -63.31 -47.69 81.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 2.69 111.195 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 60.7 mt -56.32 -46.65 79.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 2.16 111.187 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . 0.477 ' O ' HG23 ' B' ' 169' ' ' VAL . 0.7 OUTLIER -64.84 -47.86 76.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.945 -0.571 . . . . 2.13 111.368 -179.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -57.09 -19.2 18.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 1.94 111.413 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -84.13 -47.68 10.63 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 3.33 111.759 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.464 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.1 pp -72.35 -31.45 65.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.971 0.36 . . . . 1.56 111.971 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 165' ' ' TYR . 88.3 t -68.28 -23.64 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.906 0.384 . . . . 1.59 111.183 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 32.3 m -54.1 -58.82 5.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.172 -0.467 . . . . 1.14 111.48 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -69.6 -28.92 66.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.106 -0.497 . . . . 3.87 110.912 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.97 -25.72 66.46 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.288 -0.415 . . . . 1.61 111.114 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 72.9 m -78.84 -60.82 2.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 1.3 111.357 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 11.8 p -56.75 -24.9 20.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.232 -0.44 . . . . 1.53 111.687 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.475 HD11 ' HB2' ' B' ' 209' ' ' SER . 48.7 tp -78.28 -58.04 3.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.854 0.359 . . . . 1.99 111.202 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . 0.485 ' HE1' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -56.02 -27.29 52.5 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.107 -0.497 . . . . 1.5 110.545 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.521 ' O ' HG12 ' B' ' 181' ' ' ILE . 83.0 mt -87.8 -26.96 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.032 -0.531 . . . . 1.46 110.5 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.09 -43.23 83.37 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.906 -0.664 . . . . 0.67 112.886 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.551 ' O ' HG22 ' B' ' 182' ' ' VAL . 83.4 m-85 -64.28 -57.06 19.14 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.127 0.417 . . . . 1.73 112.127 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 3.8 Cg_endo -49.76 -23.75 8.88 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 121.936 1.757 . . . . 0.93 112.39 -179.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.546 ' O ' HG22 ' B' ' 184' ' ' ILE . 41.2 mm -71.33 -60.2 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.44 -0.346 . . . . 1.36 111.168 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.551 HG22 ' O ' ' B' ' 179' ' ' TYR . 13.8 m -55.34 -24.69 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.495 . . . . 1.19 111.985 -179.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -67.76 -33.58 75.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.632 -0.258 . . . . 2.73 111.577 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 185' ' ' ILE . 10.7 tt -57.15 -20.29 12.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 N-CA-C 112.182 0.438 . . . . 1.93 112.182 -178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.574 HG23 HG23 ' B' ' 184' ' ' ILE . 34.8 pt -117.69 164.21 14.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.873 0.368 . . . . 2.64 111.4 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 78.67 -166.81 52.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.9 -0.667 . . . . 1.93 112.724 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -64.93 163.62 27.66 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.692 2.261 . . . . 2.97 111.857 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 93.5 p 47.24 24.74 0.46 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 4.5 110.899 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -175.68 68.54 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.871 -0.68 . . . . 4.5 112.446 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 56.7 t80 50.64 88.96 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.916 0.389 . . . . 7.89 111.217 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.31 151.27 6.02 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.846 -0.693 . . . . 3.62 112.222 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 20.2 m-90 -128.51 39.29 3.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.803 0.335 . . . . 6.54 111.062 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 41.9 pt -96.54 140.01 18.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.937 0.399 . . . . 3.16 111.253 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -115.86 10.71 15.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 3.39 110.576 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.416 ' HB2' HG22 ' B' ' 197' ' ' ILE . 20.7 mt-30 -66.57 138.78 57.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.893 -0.594 . . . . 5.56 110.883 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 63.2 p -64.15 -14.92 58.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.933 -0.576 . . . . 2.68 111.432 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.416 HG22 ' HB2' ' B' ' 195' ' ' GLN . 10.1 tp -56.41 -31.33 33.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.425 -0.352 . . . . 2.2 111.218 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -69.48 -55.83 9.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 2.49 110.834 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 62.4 p -63.5 -21.94 66.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.485 . . . . 1.76 111.231 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -79.03 -30.65 44.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.118 -0.492 . . . . 2.18 110.822 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 59.8 tp -80.12 -32.89 38.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 1.78 111.153 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -74.39 -14.64 60.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.869 0.366 . . . . 1.98 110.617 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 84.0 m -95.24 -33.47 12.57 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.062 0.458 . . . . 1.65 110.076 178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 31.8 tp -72.46 -24.36 61.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.794 -0.639 . . . . 1.11 111.019 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.699 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 65.6 tp -69.92 -54.74 9.55 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 121.184 -0.206 . . . . 1.43 111.03 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.699 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 53.6 Cg_exo -55.58 -37.46 95.13 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.908 1.739 . . . . 0.77 111.383 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -63.19 -43.23 98.79 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.219 -0.446 . . . . 1.6 109.81 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -67.46 -26.53 66.44 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.906 -0.588 . . . . 1.77 110.353 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.475 ' HB2' HD11 ' B' ' 175' ' ' LEU . 30.4 t -71.93 -43.93 64.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 1.54 110.528 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -66.74 -44.86 80.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.479 . . . . 2.01 110.734 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 73.7 t -58.45 -53.4 47.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.234 -0.439 . . . . 2.65 110.635 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.82 -27.28 70.92 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.621 -0.799 . . . . 1.33 111.972 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -66.39 -29.23 69.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.943 0.401 . . . . 2.29 110.656 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 47.4 t -72.1 -50.7 26.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.058 -0.519 . . . . 2.12 110.781 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -66.96 -24.07 66.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 3.6 110.754 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.85 -53.64 25.23 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.114 -0.494 . . . . 1.51 110.819 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -59.99 -28.6 67.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.227 -0.442 . . . . 2.22 110.888 -179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 37.0 tp -61.15 -50.34 73.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.07 -0.513 . . . . 2.69 110.981 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 51.5 m80 -81.31 -20.34 40.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.272 -0.422 . . . . 3.4 110.942 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.34 -45.63 92.64 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.972 -0.632 . . . . 1.67 112.907 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.416 HD22 ' N ' ' B' ' 221' ' ' LEU . 3.6 mm? -83.08 -31.03 27.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.657 0.265 . . . . 3.39 110.891 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 61.7 -83.37 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.089 -0.505 . . . . 5.91 111.23 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -87.84 154.13 20.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 5.26 110.861 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.513 HD22 ' N ' ' B' ' 224' ' ' LEU . 2.5 mm? -113.74 143.71 44.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.073 -0.512 . . . . 6.81 110.624 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -161.25 132.41 5.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.369 -0.378 . . . . 7.02 110.712 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -91.15 161.25 15.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.235 -0.439 . . . . 8.21 110.946 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 83.2 p -153.85 140.99 19.44 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.114 -0.493 . . . . 8.1 111.127 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -132.35 -179.09 5.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.435 . . . . 13.28 110.91 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.285 -0.864 . . . . 10.4 110.991 -179.982 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.485 1.3 0 CA-C-O 120.841 0.353 . . . . 8.1 111.059 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -158.21 -7.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 6.27 110.817 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 68.2 mt -78.6 3.11 17.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 6.2 111.064 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -60.92 106.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 4.82 111.171 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 47.5 t -66.19 145.52 55.7 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.313 -0.403 . . . . 3.25 110.667 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 94.9 mt -109.38 -1.94 18.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.417 -0.356 . . . . 2.79 111.313 -179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 62.6 tp -70.81 -58.52 3.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.424 -0.353 . . . . 2.08 110.67 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.553 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 81.0 m-70 -60.41 -23.81 64.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 1.43 110.645 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -65.75 -43.22 89.6 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.183 -0.462 . . . . 1.16 110.52 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 64.1 mt -69.01 -23.24 26.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.086 0.47 . . . . 2.09 110.215 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -63.46 -56.43 16.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 1.58 110.99 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 9.0 p -60.54 -31.82 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.358 -0.383 . . . . 1.0 111.198 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -55.34 -58.85 6.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.356 -0.384 . . . . 0.96 111.274 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.54 -19.09 62.11 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.751 -0.737 . . . . 0.96 112.525 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 49.1 tpp -77.73 -38.66 46.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.713 0.292 . . . . 1.3 111.066 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 60.5 p -62.32 -48.2 80.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.462 -0.336 . . . . 1.52 111.298 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -62.18 -34.92 66.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 121.002 0.43 . . . . 1.9 110.437 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.47 -33.89 73.29 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.827 -0.702 . . . . 0.96 112.272 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.02 -36.55 61.91 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.502 0.191 . . . . 1.07 110.858 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 93.9 mt -61.58 -21.21 64.12 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-O 120.961 0.41 . . . . 2.08 110.74 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -55.52 -19.71 10.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.709 -0.678 . . . . 2.02 111.049 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -60.49 -30.19 69.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.22 -0.446 . . . . 4.98 111.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 88.7 t90 -97.18 -31.49 12.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.367 -0.379 . . . . 4.29 111.41 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.5 t -64.89 -50.85 64.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.366 -0.379 . . . . 2.47 111.542 -179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 29.4 tp -87.89 -0.49 57.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.439 -0.346 . . . . 2.9 111.561 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 77.8 p -53.56 -24.98 15.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.743 0.275 . . . . 2.74 111.743 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -49.78 -30.24 9.23 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-O 121.28 0.562 . . . . 5.85 109.881 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.5 p-10 -174.31 132.26 0.52 Allowed Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.103 -0.953 . . . . 4.52 109.625 178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 18.1 Cg_endo -90.79 143.43 3.45 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.508 2.138 . . . . 3.22 112.487 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -76.58 22.72 0.17 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.954 -0.566 . . . . 8.68 111.511 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.81 -4.06 13.07 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.654 -0.784 . . . . 4.14 112.701 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.534 HG13 ' HB3' ' C' ' 36' ' ' GLU . 44.0 t -104.39 110.24 63.92 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 120.634 0.254 . . . . 5.09 110.931 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.498 ' HG2' ' HE1' ' C' ' 35' ' ' TYR . 6.5 Cg_exo -79.05 166.56 22.9 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.37 2.714 . . . . 3.1 112.582 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -41.51 -44.17 2.88 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.033 0.753 . . . . 3.85 113.033 -178.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.498 ' HE1' ' HG2' ' C' ' 33' ' ' PRO . 12.2 p90 -64.79 -49.23 71.54 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.313 0.486 . . . . 3.37 112.313 -178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . 0.534 ' HB3' HG13 ' C' ' 32' ' ' VAL . 11.2 tp10 -64.14 -37.65 88.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 2.72 110.841 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . 0.417 ' HB2' HG12 ' C' ' 32' ' ' VAL . 5.0 t80 -76.69 -20.8 56.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.11 -0.495 . . . . 5.67 110.109 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.36 -59.76 4.9 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.061 -0.518 . . . . 1.93 110.216 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 43.0 t -62.55 -36.57 75.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.966 0.412 . . . . 1.88 110.066 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.38 -12.44 60.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.742 -0.663 . . . . 1.23 110.802 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.426 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 51.9 ttm -89.04 -33.26 17.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.426 . . . . 2.09 111.159 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -73.53 -27.56 61.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.42 . . . . 1.41 111.586 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.613 HG23 HG23 ' C' ' 79' ' ' THR . 76.5 mt -63.62 -51.21 67.94 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.375 0.509 . . . . 0.8 112.375 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 60.1 Cg_endo -71.5 -39.44 3.67 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.406 2.071 . . . . 0.72 113.637 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.478 HG23 ' N ' ' C' ' 46' ' ' TRP . 9.3 tp -59.9 -46.99 93.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 112.188 0.44 . . . . 1.68 112.188 -178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . 0.478 ' N ' HG23 ' C' ' 45' ' ' ILE . 0.8 OUTLIER -69.84 -58.19 4.18 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.827 0.346 . . . . 1.68 111.171 -179.441 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 87.7 p -54.55 -31.65 56.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.28 110.868 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.08 -52.28 53.78 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.94 -0.648 . . . . 0.51 112.502 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.409 HD22 ' SG ' ' A' ' 134' ' ' CYS . 31.9 mt -63.96 -26.69 68.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.869 0.366 . . . . 1.33 110.635 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.6 58.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.999 -0.546 . . . . 0.57 111.433 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 35.0 m-85 -65.63 -40.69 92.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.453 -0.339 . . . . 1.67 110.901 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.1 ttp -54.29 -30.98 52.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.002 0.43 . . . . 1.42 110.208 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' C' ' 56' ' ' ILE . . . -73.19 -38.32 66.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.785 -0.643 . . . . 0.71 110.843 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.3 mtt -58.62 -24.59 61.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.941 -0.572 . . . . 1.14 110.391 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.553 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.32 -45.83 18.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.915 -0.584 . . . . 0.88 111.117 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.493 HG12 ' HA ' ' C' ' 53' ' ' ALA . 43.1 pt -79.34 3.66 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 1.38 111.123 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 60.42 65.72 1.03 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.727 -0.67 . . . . 1.94 111.122 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.554 HE21 ' H ' ' C' ' 59' ' ' GLY . 24.8 tp60 -140.63 145.01 36.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.095 -0.502 . . . . 1.87 110.866 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.554 ' H ' HE21 ' C' ' 58' ' ' GLN . . . 106.83 -3.75 36.17 Favored Glycine 0 C--N 1.33 0.246 0 C-N-CA 120.776 -0.726 . . . . 1.27 112.627 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 7.5 ptpp? -113.24 155.4 25.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.633 0.254 . . . . 2.86 110.908 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 14.3 p -123.33 147.4 27.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.411 -0.358 . . . . 1.95 111.468 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -97.29 88.91 4.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 3.04 110.614 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.39 116.6 29.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.152 -0.476 . . . . 2.11 111.306 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.02 31.61 20.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.077 -0.51 . . . . 2.54 111.468 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.58 -6.11 70.85 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.695 -0.764 . . . . 2.47 112.654 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 -98.67 143.21 29.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 2.85 111.108 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 70.5 mt -90.06 124.14 42.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.832 -0.622 . . . . 1.87 110.938 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -98.82 137.83 36.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 1.12 111.166 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.418 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 48.2 m-70 -91.58 56.01 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.063 -0.517 . . . . 1.26 110.809 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -62.26 -57.58 10.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.9 -0.591 . . . . 2.08 111.144 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.02 -22.6 60.94 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 0.86 111.604 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 14.6 tpp180 -65.57 -50.32 65.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.132 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.505 ' HA ' ' CE2' ' C' ' 76' ' ' TRP . 0.1 OUTLIER -67.86 -37.22 81.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.702 0.287 . . . . 1.8 110.597 -179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 33.3 mm -48.56 -45.39 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.214 -0.448 . . . . 1.18 111.037 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -58.18 -36.87 73.69 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.917 -0.583 . . . . 1.33 110.903 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.505 ' CE2' ' HA ' ' C' ' 73' ' ' TYR . 0.9 OUTLIER -91.98 9.04 34.81 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 119.975 -0.69 . . . . 1.85 111.433 179.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.428 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 43.1 tpp -104.48 -16.36 15.09 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.677 -0.86 . . . . 1.56 108.677 177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.517 ' O ' HD23 ' C' ' 82' ' ' LEU . 33.6 m -114.57 -28.55 2.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 115.123 -0.944 . . . . 1.11 111.894 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.613 HG23 HG23 ' C' ' 43' ' ' ILE . 89.1 m -95.24 -41.86 8.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.239 0.459 . . . . 1.49 112.239 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.583 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 59.7 m -60.17 -50.42 86.2 Favored Pre-proline 0 C--N 1.327 -0.413 0 N-CA-C 111.698 0.258 . . . . 1.6 111.698 -179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.583 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.3 Cg_exo -55.91 -34.49 91.93 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.99 1.793 . . . . 1.01 112.011 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.517 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.2 mm? -79.97 -29.02 39.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 1.18 110.53 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.17 -29.49 69.19 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.273 0.558 . . . . 1.54 109.555 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 8.1 tt -84.36 -48.01 10.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.305 -0.861 . . . . 1.65 110.239 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 21.4 tp -53.63 -35.79 61.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.357 -0.838 . . . . 2.1 111.021 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.437 ' O ' HG23 ' C' ' 90' ' ' THR . 78.1 p -65.63 -36.89 85.0 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.263 -0.426 . . . . 1.38 110.627 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.415 HD22 HD11 ' C' ' 168' ' ' LEU . 76.3 mt -62.71 -35.35 79.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.232 -0.44 . . . . 1.44 110.645 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 64.6 m -78.86 -22.1 46.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.028 -0.533 . . . . 1.87 110.766 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 31.7 t-105 -84.34 -27.76 27.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 3.1 110.95 -179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . 0.437 HG23 ' O ' ' C' ' 86' ' ' SER . 46.8 p -76.21 -42.79 45.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 1.48 110.998 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.1 -47.82 41.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 1.02 110.944 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 79.7 mtp -126.41 101.56 6.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.013 -0.54 . . . . 2.34 110.677 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -68.39 -31.92 71.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.143 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -132.46 148.74 52.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.928 0.394 . . . . 4.54 111.049 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 40.5 pt -141.76 166.63 16.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.95 -0.568 . . . . 2.34 110.698 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -162.9 -78.24 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.375 -0.375 . . . . 4.4 111.311 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -80.35 -25.46 39.22 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.135 -0.484 . . . . 5.54 111.058 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -104.27 118.59 37.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.341 -0.39 . . . . 3.54 111.023 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -164.89 26.95 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.073 -0.512 . . . . 5.21 110.783 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 5.7 t -88.41 -34.66 17.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.001 -0.545 . . . . 2.38 111.297 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.3 -57.49 5.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 2.64 110.864 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 17.0 tt -56.91 -28.9 29.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 2.38 111.045 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.52 -52.46 8.44 Favored Glycine 0 C--N 1.33 0.207 0 C-N-CA 120.783 -0.723 . . . . 1.62 112.428 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -61.26 -29.24 69.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.941 0.4 . . . . 2.93 110.453 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 23.2 tp -73.66 -45.33 53.26 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.86 -0.609 . . . . 2.16 110.6 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.416 ' O ' HG12 ' C' ' 110' ' ' ILE . 13.7 tpt -65.22 -24.78 67.44 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.719 -0.673 . . . . 2.3 110.894 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 73.3 m -73.68 -58.24 3.44 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.276 -0.42 . . . . 2.07 110.927 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.682 HG21 HD13 ' C' ' 142' ' ' ILE . 18.3 p -59.74 -24.81 64.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 2.3 111.128 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.411 HE21 HG13 ' C' ' 113' ' ' ILE . 22.8 tp60 -64.69 -52.29 57.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.977 0.418 . . . . 2.48 110.287 179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.546 HG22 ' HE1' ' B' ' 46' ' ' TRP . 50.8 mm -54.01 -34.94 27.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.868 -0.605 . . . . 1.93 110.921 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.35 -41.47 92.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.267 -0.424 . . . . 1.67 110.878 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 84.6 t -66.36 -52.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.047 -0.524 . . . . 1.11 111.124 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.411 HG13 HE21 ' C' ' 109' ' ' GLN . 20.1 mt -54.98 -31.77 25.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.195 -0.457 . . . . 2.59 110.515 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 63.8 m -64.39 -38.05 89.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.269 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 48.6 m -55.63 -59.89 4.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.981 -0.554 . . . . 0.92 110.235 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -64.78 -20.01 65.89 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.806 -0.712 . . . . 0.55 112.333 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 6.0 tt -64.3 -59.23 4.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.872 0.368 . . . . 1.49 111.012 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 55.3 mt -83.67 -21.48 8.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 1.66 112.038 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.52 -41.25 63.29 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.76 0.314 . . . . 0.94 111.229 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -85.06 -16.84 39.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 1.79 110.702 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 94.4 mt -91.58 22.46 4.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 1.29 111.076 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.611 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 45.1 m -87.72 123.51 32.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.417 -0.356 . . . . 2.15 110.791 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -74.47 -24.92 59.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.094 -0.503 . . . . 3.31 110.965 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.501 ' HB2' HG12 ' C' ' 127' ' ' VAL . 90.7 mtt180 -118.37 135.61 54.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 3.16 110.767 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.12 -10.89 60.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.267 -0.424 . . . . 4.24 110.719 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 57.7 t-105 -81.23 -47.7 13.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 4.65 110.828 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.501 HG12 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -70.94 -26.59 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.267 -0.424 . . . . 1.31 110.92 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.611 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.0 ttm180 -60.26 -20.83 60.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.994 -0.548 . . . . 2.84 110.856 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -74.08 -40.59 62.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 2.7 111.041 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.92 -45.61 91.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.2 -0.455 . . . . 1.88 111.081 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 5.1 m95 -70.48 -27.23 64.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 1.38 110.907 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . 0.405 ' HE1' ' HB3' ' C' ' 183' ' ' TRP . 77.4 t80 -66.68 -53.5 33.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 1.76 110.901 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 49.3 pt -64.59 -24.08 34.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 2.15 111.401 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 53.8 t -75.04 -33.9 61.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 1.56 110.952 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.7 -51.85 33.22 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.73 112.617 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -62.74 -40.07 87.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.708 0.289 . . . . 1.48 111.311 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.0 t -55.8 -46.65 77.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 1.51 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.71 76.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.311 -0.404 . . . . 1.01 111.027 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 92.6 t80 -67.75 -26.81 66.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.49 . . . . 2.05 110.952 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.37 -45.91 65.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.243 -0.435 . . . . 2.07 111.084 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -62.51 -50.34 80.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.399 -0.364 . . . . 1.92 111.552 -179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.682 HD13 HG21 ' C' ' 108' ' ' THR . 6.0 tp -64.66 -35.62 75.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.381 -0.372 . . . . 2.64 111.605 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 37.6 tp -55.73 -49.59 72.64 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.444 -0.344 . . . . 1.51 110.925 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 77.9 t90 -66.78 -27.77 67.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.58 110.662 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.06 -18.78 76.11 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.806 -0.711 . . . . 1.65 112.758 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 46.3 pt -108.69 -9.93 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.838 0.351 . . . . 2.46 111.179 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -100.28 -13.56 18.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.27 111.454 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.56 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 7.1 t30 -89.07 -48.91 0.41 Allowed Pre-proline 0 CA--C 1.536 0.439 0 N-CA-C 112.402 0.519 . . . . 2.33 112.402 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 35.2 Cg_endo -64.34 0.97 1.87 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.257 1.971 . . . . 2.46 113.122 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 91.0 mt -78.59 23.13 0.33 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.579 -0.282 . . . . 3.08 111.576 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -171.93 -32.81 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.658 0.266 . . . . 8.45 111.286 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.92 -39.93 23.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.851 0.315 . . . . 2.9 111.851 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -83.87 -27.34 28.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.55 -0.296 . . . . 4.62 111.209 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.531 ' HA ' ' HB3' ' C' ' 157' ' ' GLN . 62.2 p -98.8 6.69 46.73 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.347 -0.388 . . . . 3.85 111.35 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -53.42 -35.49 60.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.257 -0.429 . . . . 5.12 111.562 -179.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 9.5 t -133.13 10.3 4.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.784 0.326 . . . . 3.43 111.396 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' C' ' 154' ' ' THR . 34.3 tt0 -87.24 -70.87 0.59 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.361 -0.381 . . . . 3.98 110.858 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 68.0 m -149.71 114.13 5.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.086 -0.506 . . . . 2.4 110.669 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 83.3 p -77.69 -38.59 47.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 2.82 111.112 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -65.86 -44.88 84.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.425 . . . . 3.18 110.786 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.34 -29.09 67.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.014 -0.539 . . . . 2.5 110.812 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.15 -32.67 73.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.105 -0.498 . . . . 1.81 110.984 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -71.77 -43.0 66.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.17 -0.468 . . . . 2.13 110.763 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . 0.413 ' HA ' ' HE2' ' C' ' 167' ' ' LYS . 63.9 mt -65.39 -42.35 92.75 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.163 -0.471 . . . . 2.21 110.888 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -70.13 -22.94 62.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.01 -0.541 . . . . 1.31 110.956 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -68.38 -53.02 26.7 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 2.26 110.87 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' C' ' 164' ' ' LEU . 58.9 pttt -69.9 -24.08 63.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 3.58 111.02 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.415 HD11 HD22 ' C' ' 87' ' ' LEU . 49.0 tp -70.9 -55.84 7.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.205 0.526 . . . . 1.3 110.583 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.485 ' HA ' ' HB3' ' C' ' 172' ' ' PHE . 10.8 p -64.57 -16.46 19.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.762 -0.654 . . . . 1.73 111.413 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 24.6 m -58.04 -58.65 7.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.897 0.379 . . . . 1.43 111.031 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -71.8 -22.8 61.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.204 -0.453 . . . . 3.72 110.673 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.485 ' HB3' ' HA ' ' C' ' 169' ' ' VAL . 88.2 t80 -71.46 -41.02 69.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.989 -0.55 . . . . 1.55 112.19 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 9.8 t -73.89 -36.65 64.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.248 0.462 . . . . 1.5 112.248 -178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 27.7 m -71.93 -29.6 33.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 112.066 0.395 . . . . 1.84 112.066 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -82.41 -49.39 10.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.733 0.302 . . . . 2.12 111.068 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.26 -30.48 62.47 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.136 -0.483 . . . . 1.0 111.06 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.448 ' O ' HG12 ' C' ' 181' ' ' ILE . 16.7 tt -87.58 -24.1 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.024 0.44 . . . . 1.75 110.411 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -54.83 -51.53 52.47 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.665 -0.698 . . . . 0.72 113.054 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.625 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.2 m-85 -57.17 -56.57 32.33 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 116.875 0.337 . . . . 1.8 111.56 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 90.4 Cg_exo -44.22 -32.66 5.22 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 122.262 1.975 . . . . 0.88 113.13 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.448 HG12 ' O ' ' C' ' 177' ' ' ILE . 49.4 mm -68.81 -61.12 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.475 -0.33 . . . . 1.52 111.725 -179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.532 HG22 ' O ' ' C' ' 179' ' ' TYR . 16.3 m -54.13 -24.73 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.334 -0.393 . . . . 1.2 111.611 -179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.405 ' HB3' ' HE1' ' C' ' 132' ' ' TYR . 47.9 m95 -66.97 -43.03 84.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.418 -0.356 . . . . 2.47 110.778 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 48.6 mt -55.43 -38.38 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.62 111.274 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 16.1 tt -97.87 130.31 46.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 2.63 111.661 -179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 110.27 -159.63 13.79 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.703 -0.761 . . . . 1.77 112.752 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.77 171.43 18.21 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.622 2.215 . . . . 3.03 111.981 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 94.5 p 49.1 21.93 0.55 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.156 -0.475 . . . . 4.22 110.721 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -140.02 -90.65 0.19 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.729 -0.669 . . . . 4.08 112.333 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -135.83 -34.85 0.8 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.838 0.352 . . . . 7.54 110.829 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -79.89 168.43 52.28 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.851 -0.69 . . . . 3.29 112.673 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 54.5 t-105 -131.38 74.83 1.61 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.859 0.361 . . . . 5.67 110.708 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 38.9 pt -128.35 146.56 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 2.76 111.095 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -124.95 39.56 3.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 3.69 111.238 -179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . 0.602 ' HG2' ' H ' ' C' ' 197' ' ' ILE . 52.9 tt0 -95.48 146.93 24.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.376 -0.375 . . . . 5.34 110.747 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 77.5 p -65.93 -15.21 62.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.124 -0.489 . . . . 2.57 111.751 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.602 ' H ' ' HG2' ' C' ' 195' ' ' GLN . 19.4 tt -57.49 -31.21 38.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.904 0.383 . . . . 2.37 110.76 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.1 -54.53 24.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.127 -0.488 . . . . 2.68 110.885 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 65.9 p -59.75 -21.53 60.85 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.217 -0.447 . . . . 1.95 110.869 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 70.0 t80 -73.45 -35.11 65.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 2.05 111.006 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 66.1 tp -80.47 -49.02 11.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.435 . . . . 1.91 111.387 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -59.75 -20.65 57.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.353 -0.385 . . . . 2.04 111.22 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.501 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 98.4 m -95.46 -30.13 14.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.917 0.389 . . . . 1.62 110.606 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 29.3 tp -71.9 -31.48 66.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.104 -0.498 . . . . 1.49 111.427 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.653 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 35.2 tp -63.66 -53.54 49.98 Favored Pre-proline 0 CA--C 1.532 0.287 0 C-N-CA 121.1 -0.24 . . . . 1.32 110.992 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.653 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.3 Cg_exo -53.57 -41.55 72.78 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.896 1.731 . . . . 0.76 111.514 178.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -67.71 -32.16 72.61 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.052 0.453 . . . . 1.52 110.133 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -78.35 -21.42 49.53 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.702 -0.681 . . . . 1.84 110.471 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 79.6 p -84.64 -34.92 22.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.05 -0.523 . . . . 1.68 110.154 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -70.17 -44.08 69.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.993 -0.549 . . . . 2.04 110.373 179.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.446 HG13 ' N ' ' C' ' 212' ' ' GLY . 7.5 p -64.03 -45.6 96.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.171 -0.468 . . . . 2.65 110.439 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.446 ' N ' HG13 ' C' ' 211' ' ' VAL . . . -65.21 -22.76 69.36 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.655 -0.783 . . . . 1.33 111.844 179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -71.74 -36.87 70.57 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.922 0.391 . . . . 3.02 110.404 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.6 m -62.16 -51.04 69.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.969 -0.559 . . . . 2.35 110.44 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -69.59 -20.42 63.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.158 -0.474 . . . . 3.62 110.532 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 8.5 tt -69.73 -52.04 28.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 1.64 110.655 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -65.19 -24.44 67.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.228 -0.442 . . . . 2.2 110.599 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.3 tp -61.36 -58.74 7.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 3.11 110.802 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 44.5 m-70 -77.97 -22.34 49.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.051 -0.522 . . . . 3.37 110.975 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -57.49 -44.67 93.64 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.843 -0.694 . . . . 1.55 112.638 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 3.9 pp -78.22 -24.36 47.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.705 0.288 . . . . 3.11 110.841 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 21.3 tpp180 59.72 -86.57 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.901 -0.59 . . . . 5.73 111.305 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -94.15 -177.35 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.394 . . . . 5.53 110.639 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.59 ' H ' HD23 ' C' ' 224' ' ' LEU . 2.6 pt? -133.29 143.58 49.15 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.425 -0.352 . . . . 6.6 111.054 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.14 134.53 17.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 6.51 110.897 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -93.68 155.23 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 7.05 110.669 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 63.3 m -151.59 109.2 3.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 6.72 110.965 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 ptp180 -113.42 -179.69 3.71 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.042 -0.526 . . . . 9.56 110.65 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.121 -0.942 . . . . 9.08 110.985 179.986 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.738 ' H8 ' H171 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.747 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.738 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mtm . . . . . 0 N--CA 1.485 1.314 0 CA-C-O 120.84 0.352 . . . . 8.09 110.798 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -105.82 177.92 4.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 5.68 110.773 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.455 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.6 pt? -167.7 15.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.054 -0.521 . . . . 6.27 110.704 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 60.73 174.69 0.1 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.113 -0.494 . . . . 6.52 111.013 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 78.5 p -161.48 117.19 2.1 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.261 -0.427 . . . . 3.59 111.02 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.0 mt -82.33 -3.79 56.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.505 . . . . 3.23 110.678 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.8 mt -59.66 -63.79 1.18 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.214 -0.448 . . . . 1.88 110.861 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 41.1 m80 -63.57 -24.24 67.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.348 -0.387 . . . . 1.29 110.987 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 60.3 t-105 -64.99 -58.32 6.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.201 -0.454 . . . . 0.99 110.975 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -53.76 -33.19 22.65 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 CA-C-N 116.131 -0.486 . . . . 1.92 110.23 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.404 ' O ' ' HG2' ' A' ' 15' ' ' MET . 2.9 t80 -58.02 -41.57 83.42 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.718 -0.674 . . . . 1.45 109.981 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 8' ' ' HIS . 9.3 t -57.15 -44.66 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.464 -0.789 . . . . 0.89 110.551 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.56 -38.02 85.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.798 -0.637 . . . . 0.9 111.056 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.11 -24.11 71.66 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.815 -0.707 . . . . 0.83 112.527 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.404 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 87.3 mmm -74.86 -40.17 61.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.772 0.32 . . . . 1.24 110.904 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.3 m -58.84 -56.0 27.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.102 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.6 pp -60.11 -29.16 43.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 1.71 110.83 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.3 -33.26 85.54 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.734 -0.746 . . . . 0.96 112.09 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.17 -27.66 48.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.87 0.367 . . . . 0.99 110.825 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.62 -28.16 68.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 2.11 110.677 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 36.0 t60 -55.71 -40.58 72.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 2.23 110.649 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -62.99 -31.9 73.12 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 4.02 110.469 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.697 ' O ' ' OG ' ' A' ' 26' ' ' SER . 73.5 t90 -64.52 -29.53 70.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 3.96 110.264 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -66.57 -52.23 47.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.918 -0.583 . . . . 2.38 110.522 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 50.2 tp -79.74 -6.62 57.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.131 -0.486 . . . . 2.77 110.654 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.697 ' OG ' ' O ' ' A' ' 23' ' ' TRP . 89.3 p -59.64 -16.17 24.26 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.102 -0.499 . . . . 2.52 111.068 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.42 ' HG2' HD22 ' A' ' 28' ' ' ASN . 32.6 ttm180 -48.16 -41.15 26.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.305 0.574 . . . . 5.54 109.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.42 HD22 ' HG2' ' A' ' 27' ' ' ARG . 7.7 p30 -175.9 131.18 0.4 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.113 -0.948 . . . . 4.44 110.038 178.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 81.1 Cg_endo -100.47 169.24 0.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 123.15 2.567 . . . . 2.81 112.586 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -149.92 105.95 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.057 -0.519 . . . . 6.8 111.154 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.54 -47.39 1.02 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 4.97 113.414 179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.1 p -136.28 114.44 10.63 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.827 0.313 . . . . 4.71 111.68 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 35' ' ' TYR . 77.0 Cg_exo -51.46 169.82 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.853 2.369 . . . . 3.51 112.144 179.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -37.23 -18.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.968 0.729 . . . . 3.41 112.968 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.54 ' N ' ' O ' ' A' ' 33' ' ' PRO . 3.0 m-30 -42.0 -40.46 2.23 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.806 0.336 . . . . 2.81 111.21 179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -61.01 -40.91 95.36 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.269 -0.423 . . . . 3.39 111.257 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -57.67 -36.76 72.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 5.24 111.305 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.517 HD23 ' HA ' ' A' ' 35' ' ' TYR . 3.6 mm? -60.31 -54.13 49.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.912 0.387 . . . . 1.6 110.368 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 86' ' ' SER . 53.7 t -63.89 -36.03 75.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.33 110.717 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -78.05 -3.73 43.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.749 -0.66 . . . . 1.03 111.272 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 15.8 tpt -89.69 -40.4 12.56 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.272 -0.422 . . . . 2.0 110.969 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -75.97 -31.52 59.06 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 1.31 112.385 -179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.496 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.7 mt -61.25 -53.02 66.9 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.198 0.814 . . . . 1.0 113.198 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 85.4 Cg_endo -79.01 -43.52 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.319 2.012 . . . . 0.59 113.682 -178.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 36.9 mm -58.36 -53.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 111.983 0.364 . . . . 1.63 111.983 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -64.07 -56.85 12.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.657 0.265 . . . . 1.12 111.57 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 66.4 m -51.88 -45.0 63.96 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 1.32 111.118 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -49.47 -54.06 17.99 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 121.177 -0.535 . . . . 0.52 113.191 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.453 HD22 ' SG ' ' B' ' 134' ' ' CYS . 26.4 mt -56.56 -35.56 68.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.754 0.312 . . . . 0.98 110.888 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -65.63 -36.58 84.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.082 -0.508 . . . . 0.52 110.824 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 70.8 m-85 -70.87 -40.7 72.14 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.4 -0.364 . . . . 1.69 110.822 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 16.6 tmm? -58.31 -29.32 65.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.175 0.512 . . . . 1.12 109.946 179.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.77 -54.66 10.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.661 -0.7 . . . . 0.6 111.346 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 77.3 mtm -56.78 -19.52 17.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.627 179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.421 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.24 -38.6 56.11 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.022 -0.535 . . . . 0.78 110.255 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 25.0 pt -96.67 12.39 4.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.703 -0.681 . . . . 1.23 110.882 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 61.99 59.53 1.68 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.758 -0.655 . . . . 2.02 111.358 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.557 ' NE2' HG11 ' B' ' 127' ' ' VAL . 85.0 mm-40 -133.25 157.39 45.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.297 -0.41 . . . . 2.1 110.983 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 93.54 -3.11 71.31 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.78 -0.724 . . . . 1.27 112.157 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -112.9 158.44 20.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.761 0.315 . . . . 1.76 110.918 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.1 p -127.9 145.05 35.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 1.84 111.122 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -103.67 95.05 5.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 2.64 110.842 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.01 117.07 33.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 1.84 111.226 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.39 20.78 9.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.068 -0.514 . . . . 2.24 111.606 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.37 -3.76 72.68 Favored Glycine 0 CA--C 1.518 0.28 0 C-N-CA 120.799 -0.715 . . . . 2.16 113.086 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -98.48 133.68 42.52 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.826 0.346 . . . . 2.84 111.016 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.9 mt -93.03 133.18 35.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 2.39 110.955 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.91 143.71 42.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.273 -0.421 . . . . 0.97 111.124 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.606 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 76.1 m-70 -88.59 61.85 6.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.035 0.445 . . . . 1.04 110.692 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -64.93 -35.42 81.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.754 -0.657 . . . . 3.38 111.469 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.09 -24.48 55.02 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.386 -0.37 . . . . 0.76 111.683 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 2.3 mmp_? -70.62 -52.35 21.94 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.452 0.538 . . . . 2.93 112.452 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.9 p90 -73.22 -36.63 66.51 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.09 0.404 . . . . 3.13 112.09 -178.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG23 ' N ' ' A' ' 75' ' ' ASP . 10.3 tp -56.42 -42.17 74.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 C-N-CA 120.92 -0.312 . . . . 1.66 110.496 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' N ' HG23 ' A' ' 74' ' ' ILE . 33.9 t70 -70.49 -17.99 62.97 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 109.515 -0.55 . . . . 1.42 109.515 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -95.36 -0.14 52.97 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.726 -0.67 . . . . 2.09 110.941 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.437 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 58.8 ttm -104.47 -13.93 15.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.466 . . . . 1.52 110.484 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.507 ' O ' HD23 ' A' ' 82' ' ' LEU . 35.2 m -114.31 -32.92 2.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.004 -0.544 . . . . 1.33 111.768 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.431 HG23 HG23 ' A' ' 43' ' ' ILE . 60.2 m -87.91 -47.33 8.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.367 -0.379 . . . . 1.39 111.989 -178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 7.3 m -54.85 -49.69 90.35 Favored Pre-proline 0 CA--C 1.533 0.304 0 N-CA-C 111.984 0.364 . . . . 1.55 111.984 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 49.6 Cg_exo -55.45 -42.97 62.8 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 121.789 1.659 . . . . 1.01 111.429 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.507 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.1 mm? -68.31 -30.12 69.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.383 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.92 -29.32 68.38 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.215 0.531 . . . . 1.3 109.669 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.5 tt -84.07 -28.1 27.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.451 -0.795 . . . . 1.67 110.406 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 87.2 mt -76.99 -37.75 54.51 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.08 -0.509 . . . . 1.87 111.155 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.419 ' HB2' HG11 ' A' ' 39' ' ' VAL . 41.6 t -58.18 -20.74 43.53 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.348 -0.387 . . . . 1.42 110.952 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 34.4 mt -73.68 -32.21 63.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 1.4 110.931 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 97.9 p -79.14 -23.6 43.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.296 -0.411 . . . . 1.91 110.824 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -81.38 -39.78 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 2.33 111.052 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.8 t -72.08 -31.28 65.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.228 -0.442 . . . . 1.43 111.318 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.43 -50.37 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.3 -0.409 . . . . 1.19 111.046 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 62.4 mtt -100.26 118.12 35.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 2.55 110.637 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -83.97 -18.74 36.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.167 -0.47 . . . . 3.33 111.068 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -155.79 147.91 23.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 5.1 111.086 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 46.5 mm -113.54 142.44 26.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.145 -0.479 . . . . 3.07 110.907 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -128.28 -75.98 0.56 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.355 -0.384 . . . . 4.41 111.114 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -130.2 83.26 2.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.113 -0.494 . . . . 5.31 111.032 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -171.22 64.37 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.202 -0.454 . . . . 3.94 111.03 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -93.57 6.68 47.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.254 -0.43 . . . . 5.98 110.727 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 44.2 m -95.81 -40.27 9.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 2.24 111.196 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 39.7 tp -63.31 -50.88 68.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 2.67 110.59 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 9.7 tt -62.92 -41.0 91.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.004 -0.544 . . . . 2.59 111.036 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.84 -15.24 75.94 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.716 -0.754 . . . . 1.53 112.403 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.412 ' O ' HG23 ' A' ' 108' ' ' THR . 62.6 t80 -84.35 -45.35 12.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.839 0.352 . . . . 3.14 111.072 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.0 mt -67.83 -29.21 68.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 1.99 111.009 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 91.2 mtp -76.65 -42.19 42.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 2.36 111.662 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.5 m -60.42 -48.28 82.45 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 120.967 0.413 . . . . 2.05 111.093 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.536 ' HB ' HG21 ' A' ' 142' ' ' ILE . 47.5 p -60.95 -38.43 85.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.971 -0.558 . . . . 2.25 111.442 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.412 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 64.3 tt0 -60.69 -48.77 80.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 2.72 111.213 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 75.6 mt -50.76 -39.53 18.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.391 -0.368 . . . . 1.88 110.993 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.4 t -59.28 -49.36 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 1.6 111.243 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.45 -39.16 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.238 -0.437 . . . . 1.09 111.454 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.8 mm -54.79 -42.95 65.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.484 -0.325 . . . . 2.65 111.216 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.473 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 55.1 m -61.36 -46.09 91.66 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.302 -0.408 . . . . 0.89 111.081 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 55.1 m -59.08 -20.33 52.4 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.389 -0.369 . . . . 0.68 110.683 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.15 -45.79 7.36 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.883 -0.675 . . . . 0.63 113.295 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.9 pp -67.5 -28.82 68.16 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.786 0.291 . . . . 1.58 111.786 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.498 ' N ' HD12 ' A' ' 117' ' ' LEU . 9.1 tp -83.5 -31.18 8.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.695 0.283 . . . . 2.04 111.349 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.65 80.35 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.911 0.386 . . . . 1.1 110.904 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -83.09 -26.47 31.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.044 -0.526 . . . . 1.88 110.525 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 67.2 mt -84.28 34.57 0.52 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 1.53 110.778 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 86.5 p -86.37 130.51 34.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.11 -0.496 . . . . 2.29 110.973 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -89.19 -20.7 23.88 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 3.49 110.842 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.694 ' HG2' ' H ' ' A' ' 126' ' ' TRP . 57.2 ttp180 -135.42 133.1 38.29 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 3.13 110.561 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -69.86 -14.01 62.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 3.71 111.386 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.694 ' H ' ' HG2' ' A' ' 124' ' ' ARG . 60.8 t-105 -78.76 -44.9 22.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.844 0.354 . . . . 3.97 110.758 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.545 HG23 HD12 ' A' ' 130' ' ' LEU . 9.2 p -75.66 -23.67 16.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.146 -0.479 . . . . 1.22 111.314 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 51.8 ttp180 -54.68 -38.45 66.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 2.81 111.31 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -61.63 -24.67 66.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 4.25 111.283 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.545 HD12 HG23 ' A' ' 127' ' ' VAL . 95.2 mt -75.92 -55.05 5.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.404 -0.362 . . . . 1.84 111.39 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.402 ' O ' ' HB3' ' A' ' 134' ' ' CYS . 0.1 OUTLIER -58.2 -34.2 70.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.393 -0.367 . . . . 1.54 111.041 -179.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -56.69 -50.29 72.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 1.79 110.285 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 50.0 mm -57.56 -30.46 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.057 -0.52 . . . . 2.08 110.722 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.473 ' SG ' HD22 ' C' ' 49' ' ' LEU . 35.6 t -69.46 -40.22 77.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.013 -0.539 . . . . 1.76 111.013 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.03 -47.25 60.8 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.765 -0.731 . . . . 0.76 112.653 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -67.76 -34.06 65.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.698 0.285 . . . . 2.07 111.258 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 53.1 t -57.22 -44.0 83.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 1.85 110.693 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.438 ' HB2' HD11 ' C' ' 49' ' ' LEU . . . -67.31 -39.57 85.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.063 -0.517 . . . . 1.32 110.955 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -64.54 -26.76 68.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.112 -0.495 . . . . 3.25 111.074 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 75.3 mt -70.18 -62.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.368 -0.378 . . . . 2.92 111.482 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 142' ' ' ILE . 19.8 pt -53.43 -42.38 48.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.486 -0.324 . . . . 2.65 111.413 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.536 HG21 ' HB ' ' A' ' 108' ' ' THR . 42.9 mm -67.35 -34.53 69.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.31 -0.405 . . . . 3.21 111.079 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 44.9 tp -55.06 -56.15 23.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.459 -0.337 . . . . 2.01 110.761 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -66.82 -18.24 65.28 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.917 0.389 . . . . 3.6 110.351 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.29 -17.14 67.42 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.967 -0.635 . . . . 1.62 112.544 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 46.2 pt -106.17 -7.46 10.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.745 0.307 . . . . 2.47 111.325 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 28.1 m95 -89.2 -49.3 6.82 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 2.48 111.363 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.3 t-20 -54.27 -48.72 93.68 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.877 -0.601 . . . . 2.69 112.264 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.3 Cg_endo -63.1 -8.33 13.91 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.03 1.82 . . . . 2.36 112.994 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 96.9 mt -105.58 36.49 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.727 0.299 . . . . 3.3 111.183 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 60.7 mtm180 -146.55 -62.57 0.3 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.893 0.377 . . . . 8.48 111.406 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.89 -44.82 16.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.191 -0.459 . . . . 2.98 111.662 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -73.31 0.04 13.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.267 -0.424 . . . . 4.55 111.643 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 162' ' ' ALA . 81.1 p -104.89 -37.62 6.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.415 -0.357 . . . . 4.0 111.586 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -69.49 -16.16 63.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.379 -0.373 . . . . 5.51 111.171 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 74.4 p -91.02 -34.61 15.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.389 -0.369 . . . . 3.2 111.233 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -89.69 -74.82 0.47 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 3.98 111.065 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.7 m -139.54 116.07 10.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 2.63 110.934 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 83.1 p -76.66 -26.75 55.16 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.178 -0.465 . . . . 2.16 111.042 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.3 -60.53 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.171 -0.468 . . . . 3.37 110.738 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 79.9 mt -62.59 -19.71 63.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 2.83 110.867 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.519 ' HB2' ' HB ' ' A' ' 154' ' ' THR . . . -63.39 -52.77 60.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.08 -0.509 . . . . 1.7 111.342 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -62.75 -39.98 95.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 2.16 110.938 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -60.67 -43.79 97.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.127 -0.488 . . . . 1.59 111.007 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -76.05 -24.68 55.17 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.815 -0.63 . . . . 2.31 111.352 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -68.34 -44.41 75.35 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.849 0.356 . . . . 2.15 110.783 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -79.51 -24.82 42.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.171 -0.468 . . . . 2.39 110.818 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.56 -44.92 56.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.895 -0.593 . . . . 1.79 111.087 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 12.7 p -67.57 -24.74 31.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 1.42 110.778 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -56.37 -58.28 8.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.093 -0.503 . . . . 1.12 111.056 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.439 ' O ' HD13 ' A' ' 175' ' ' LEU . 81.9 t80 -63.71 -30.85 71.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.042 -0.526 . . . . 3.86 110.357 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -59.8 -46.85 87.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 1.58 111.143 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 82.6 p -62.61 -40.02 95.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.273 -0.421 . . . . 1.41 111.635 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.81 -41.2 47.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.479 -0.328 . . . . 1.42 111.385 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 171' ' ' TYR . 9.0 mp -69.96 -56.55 6.71 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.301 -0.409 . . . . 1.91 111.149 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -54.25 -26.49 29.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.897 -0.592 . . . . 1.55 111.297 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 97.2 mt -88.79 -23.99 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.998 0.428 . . . . 1.86 110.971 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.455 ' O ' HG22 ' A' ' 181' ' ' ILE . . . -62.46 -35.43 91.71 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.963 -0.562 . . . . 0.74 113.625 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.602 ' O ' HG22 ' A' ' 182' ' ' VAL . 48.5 m-85 -74.36 -50.75 4.7 Favored Pre-proline 0 C--N 1.326 -0.425 0 N-CA-C 112.222 0.452 . . . . 1.78 112.222 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 21.2 Cg_endo -62.25 -28.13 78.85 Favored 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 121.945 1.763 . . . . 0.92 112.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.455 HG22 ' O ' ' A' ' 178' ' ' GLY . 10.1 tp -73.44 -39.92 55.38 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 C-N-CA 121.064 -0.254 . . . . 1.77 111.463 -179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.602 HG22 ' O ' ' A' ' 179' ' ' TYR . 31.1 m -69.84 -23.61 25.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.042 0.449 . . . . 1.34 110.655 179.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -64.05 -15.46 59.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 2.51 111.883 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 22.1 pt -115.74 -7.72 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.198 0 N-CA-C 112.95 0.722 . . . . 2.02 112.95 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 189' ' ' GLY . 23.2 pt -74.47 4.16 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 C-N-CA 120.713 -0.395 . . . . 2.45 110.859 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.473 ' HA3' ' HA2' ' A' ' 191' ' ' GLY . . . 159.87 -179.65 35.28 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.069 -0.586 . . . . 1.73 112.37 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -63.45 100.39 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.465 2.11 . . . . 3.05 112.032 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.6 t 51.64 53.04 13.42 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.135 -0.484 . . . . 4.04 110.374 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.497 ' O ' HG13 ' A' ' 185' ' ' ILE . . . 132.44 -145.1 17.01 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.746 -0.661 . . . . 4.48 111.541 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . 0.571 ' HB2' HD13 ' A' ' 193' ' ' ILE . 55.2 m-85 -56.36 169.57 0.42 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.766 0.317 . . . . 7.96 110.616 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.473 ' HA2' ' HA3' ' A' ' 186' ' ' GLY . . . -84.36 134.94 13.13 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.711 -0.757 . . . . 3.23 112.916 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 55.18 56.58 6.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.871 0.367 . . . . 6.03 111.226 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.571 HD13 ' HB2' ' A' ' 190' ' ' PHE . 22.3 pt -127.05 150.85 33.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.245 -0.434 . . . . 3.18 111.091 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -87.12 -173.83 4.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 3.39 110.924 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -62.97 -20.6 65.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.831 0.348 . . . . 5.76 110.948 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 24.1 m -63.37 -60.31 3.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 2.5 111.084 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.559 ' HB ' ' HB ' ' A' ' 193' ' ' ILE . 50.3 mm -68.82 -27.28 35.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.256 -0.429 . . . . 2.4 111.126 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -47.27 -60.63 2.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.201 -0.454 . . . . 2.66 111.133 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 7.3 t -71.34 -31.85 67.86 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.197 -0.456 . . . . 1.81 111.217 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -54.86 -32.2 60.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 2.21 111.475 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.453 HD21 ' HB ' ' A' ' 182' ' ' VAL . 45.8 tp -84.02 -50.74 7.71 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.869 0.322 . . . . 2.18 111.869 -179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 38.0 m-85 -66.99 -7.36 21.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.609 -0.268 . . . . 2.01 111.491 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 57.9 m -96.55 -45.77 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.134 0.493 . . . . 1.93 110.839 178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -70.31 -32.69 70.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.569 . . . . 1.7 111.769 -179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 38.1 tp -60.77 -53.99 58.88 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 121.062 -0.255 . . . . 1.28 111.247 -179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.7 Cg_exo -55.09 -44.59 48.0 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.052 1.835 . . . . 0.79 111.987 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -62.88 -33.47 75.36 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.379 -0.373 . . . . 1.51 110.595 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -80.06 -18.92 48.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 1.93 110.279 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 97.3 p -94.76 -12.82 26.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.88 -0.6 . . . . 1.71 110.752 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 41.3 mttp -93.15 -43.84 8.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.131 -0.486 . . . . 2.04 111.044 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 17.4 m -61.21 -43.25 96.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.35 -0.386 . . . . 2.89 111.1 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.48 -28.49 67.53 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 1.31 112.334 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -64.2 -40.1 95.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.628 0.252 . . . . 2.87 110.806 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 68.7 m -62.12 -56.56 17.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 2.38 110.725 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -58.97 -23.34 61.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 3.42 110.725 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.2 tt -71.53 -48.78 46.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.132 -0.486 . . . . 1.24 110.415 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -56.88 -26.73 59.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.126 0.489 . . . . 2.44 110.495 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 62.4 tp -69.63 -47.01 64.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.676 . . . . 2.51 110.648 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 53.2 m80 -73.17 -22.66 60.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 3.01 110.964 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.71 -19.01 62.38 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.794 -0.717 . . . . 1.59 112.512 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 60.4 tp -55.23 -28.88 56.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.768 0.318 . . . . 3.49 110.88 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -56.22 123.82 15.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.169 -0.469 . . . . 5.74 111.123 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -148.98 -11.19 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.0 -0.545 . . . . 5.46 110.388 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 9.6 mp 60.63 16.44 6.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.774 -0.648 . . . . 6.13 111.329 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -172.46 76.52 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.431 . . . . 6.46 110.797 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -83.02 101.33 11.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.167 -0.469 . . . . 6.94 110.703 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 46.0 t -150.05 156.95 42.59 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.213 -0.449 . . . . 6.83 110.903 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -102.43 99.37 9.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 10.77 110.896 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.253 -0.88 . . . . 9.41 111.093 179.83 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.834 0.349 . . . . 8.91 110.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -100.96 -175.88 3.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 6.76 110.809 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.474 HD23 ' N ' ' B' ' 3' ' ' LEU . 2.1 pt? -166.15 41.1 0.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 6.25 111.126 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 58.87 76.29 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.142 -0.481 . . . . 5.44 110.789 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 36.5 t -68.47 138.91 55.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 3.84 111.1 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 2.2 pp -108.51 -4.87 16.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 3.08 111.325 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.459 HD22 ' N ' ' B' ' 7' ' ' LEU . 3.3 mm? -61.56 -57.59 11.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.32 -0.4 . . . . 2.35 110.88 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 58.6 m80 -60.82 -23.81 65.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.036 -0.529 . . . . 1.39 110.993 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -68.48 -35.0 76.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.133 -0.485 . . . . 1.1 110.188 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 65.5 mt -72.51 -28.97 29.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.14 -0.482 . . . . 1.71 110.446 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -63.77 -56.4 15.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.997 -0.547 . . . . 1.48 110.789 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -54.18 -35.18 28.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.282 -0.417 . . . . 0.95 111.016 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.84 -41.74 99.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.017 0.437 . . . . 0.97 110.57 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -69.94 -17.54 73.6 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.757 -0.735 . . . . 0.8 112.116 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 83.9 mmm -75.2 -39.92 59.69 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.772 0.32 . . . . 1.29 110.629 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 76.6 p -62.12 -50.97 69.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.205 -0.452 . . . . 1.36 110.553 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.8 pp -63.99 -22.51 31.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.088 -0.506 . . . . 1.23 110.537 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -62.64 -51.6 54.85 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.787 -0.721 . . . . 0.88 112.098 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -62.9 -30.03 71.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.915 0.388 . . . . 0.98 110.388 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 46.9 tp -61.23 -38.88 88.23 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.912 -0.586 . . . . 2.12 110.297 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 22.4 t-80 -58.47 -35.8 72.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.953 -0.567 . . . . 2.0 110.31 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.412 ' HB3' ' O ' ' B' ' 19' ' ' ALA . 9.9 t80 -60.93 -39.06 87.96 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.171 -0.468 . . . . 4.26 110.197 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . 0.637 ' O ' ' OG ' ' B' ' 26' ' ' SER . 85.5 t90 -58.9 -36.33 74.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 3.62 110.436 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 40.5 t -64.2 -47.56 79.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.975 -0.557 . . . . 2.55 111.295 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 40.7 tp -84.69 -7.23 59.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.91 0.386 . . . . 3.11 110.953 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.637 ' OG ' ' O ' ' B' ' 23' ' ' TRP . 85.0 p -63.82 -14.24 51.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.472 . . . . 3.02 111.328 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -43.61 -45.55 6.83 Favored 'General case' 0 C--O 1.231 0.119 0 N-CA-C 109.415 -0.587 . . . . 5.89 109.415 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.446 ' HA ' ' HD3' ' B' ' 29' ' ' PRO . 6.3 p30 178.51 129.21 0.21 Allowed Pre-proline 0 C--O 1.233 0.189 0 CA-C-N 115.377 -0.829 . . . . 5.02 110.781 177.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.573 ' HD2' ' H ' ' B' ' 31' ' ' GLY . 71.3 Cg_endo -102.39 -84.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 123.632 2.888 . . . . 3.53 111.526 178.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 -114.21 5.1 15.75 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.503 -0.925 . . . . 7.88 108.503 178.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.573 ' H ' ' HD2' ' B' ' 29' ' ' PRO . . . 123.73 -51.88 0.8 Allowed Glycine 0 N--CA 1.45 -0.418 0 CA-C-N 114.075 -1.42 . . . . 4.61 110.993 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.427 ' O ' HG13 ' B' ' 32' ' ' VAL . 3.0 p -142.38 107.34 5.62 Favored Pre-proline 0 C--N 1.332 -0.164 0 O-C-N 123.009 -0.112 . . . . 4.73 110.901 177.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.516 ' HB2' ' HB2' ' B' ' 36' ' ' GLU . 85.3 Cg_endo -85.05 114.28 1.59 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 120.685 0.923 . . . . 3.75 112.817 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -85.73 -31.4 22.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.299 1.047 . . . . 3.76 109.033 176.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.55 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -82.58 -64.62 1.14 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 113.144 -1.844 . . . . 3.17 113.185 -177.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.55 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 48.7 mt-10 -41.11 -32.66 0.27 Allowed 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.662 0.616 . . . . 2.57 112.662 -178.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.417 ' O ' ' HG2' ' B' ' 41' ' ' MET . 32.7 t80 -68.39 -59.22 3.34 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.967 0.413 . . . . 5.74 110.93 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.63 -55.27 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.584 0.587 . . . . 1.72 112.584 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.497 HG23 HD13 ' B' ' 43' ' ' ILE . 14.2 p -56.84 -42.58 78.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 112.957 0.725 . . . . 1.95 112.957 -178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' B' ' 44' ' ' PRO . . . -70.64 -18.5 62.85 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 112.114 0.413 . . . . 1.2 112.114 -178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.417 ' HG2' ' O ' ' B' ' 37' ' ' TYR . 90.5 mmm -89.06 -54.42 4.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.091 0.404 . . . . 2.12 112.091 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -70.01 -62.79 1.25 Allowed 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 113.788 1.032 . . . . 1.49 113.788 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.695 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 2.9 mp -51.14 -59.03 8.5 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 113.604 0.965 . . . . 0.77 113.604 -177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.695 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 31.6 Cg_exo -61.52 -50.78 5.02 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 122.225 1.95 . . . . 0.68 113.939 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -60.81 -59.41 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 112.168 0.433 . . . . 1.63 112.168 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.586 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.4 t90 -52.17 -58.0 7.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.64 0.257 . . . . 1.91 111.415 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 60.3 m -54.25 -32.19 55.46 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.381 -0.372 . . . . 1.22 111.604 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -57.8 -59.55 10.62 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.687 -0.768 . . . . 0.55 112.891 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.486 ' HA ' ' HE2' ' B' ' 52' ' ' MET . 44.3 mt -59.46 -34.76 72.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.605 0.241 . . . . 0.87 111.439 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -55.99 -59.21 5.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.455 -0.338 . . . . 0.55 111.301 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.403 ' HA ' ' SD ' ' B' ' 54' ' ' MET . 42.9 m-85 -64.44 -35.42 80.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.06 111.363 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.486 ' HE2' ' HA ' ' B' ' 49' ' ' LEU . 55.0 ttp -53.66 -34.44 58.64 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.232 0.539 . . . . 1.19 110.229 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.68 -41.13 65.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.731 -0.668 . . . . 0.66 110.682 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . 0.403 ' SD ' ' HA ' ' B' ' 51' ' ' TYR . 43.9 mtt -55.39 -23.83 26.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.992 -0.549 . . . . 0.86 110.23 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -77.08 -50.51 12.89 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.817 -0.628 . . . . 0.84 110.888 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 32.1 pt -77.25 7.47 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 1.44 111.036 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 59.79 57.54 3.12 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.842 -0.617 . . . . 1.55 111.333 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.456 ' NE2' HG11 ' C' ' 127' ' ' VAL . 84.3 mm-40 -135.38 141.16 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 2.24 110.904 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 114.75 -17.15 18.26 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.722 -0.751 . . . . 1.26 112.569 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -99.37 143.41 29.65 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.907 0.384 . . . . 2.31 111.012 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.1 p -113.38 139.08 40.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.153 -0.476 . . . . 1.81 110.994 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -90.71 106.25 18.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.306 -0.406 . . . . 3.18 110.756 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -113.73 124.85 53.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 2.03 111.092 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.86 28.77 18.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.208 -0.451 . . . . 2.48 111.23 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.03 -8.43 63.43 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.829 -0.7 . . . . 2.37 112.921 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -98.61 151.88 20.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.988 0.423 . . . . 2.28 110.967 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 51.1 mt -95.87 130.13 45.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.029 -0.532 . . . . 1.78 111.328 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -102.72 141.19 35.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 1.05 110.86 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' CB ' ' B' ' 72' ' ' ARG . 87.0 m-70 -91.18 61.8 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.326 0.584 . . . . 1.11 110.955 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.458 ' O ' HG12 ' B' ' 74' ' ' ILE . 87.5 t80 -59.49 -58.58 7.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.532 -0.758 . . . . 2.3 111.667 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.82 -22.29 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.255 0.465 . . . . 0.72 112.255 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.46 ' CB ' ' HB3' ' B' ' 69' ' ' HIS . 8.7 tpp180 -63.95 -51.63 63.49 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.039 0.385 . . . . 3.04 112.039 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.579 ' CD1' HD22 ' B' ' 117' ' ' LEU . 17.7 p90 -83.55 -27.28 29.4 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.827 -0.349 . . . . 1.79 111.55 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.458 HG12 ' O ' ' B' ' 70' ' ' TYR . 13.0 mm -52.35 -49.97 40.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 1.44 110.613 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.9 -22.68 65.95 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.77 -0.455 . . . . 1.31 109.77 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 46.3 m0 -87.12 3.81 44.76 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.848 -0.615 . . . . 2.01 111.176 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . . . . . . . . . 56.6 ttm -105.39 -18.0 14.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 1.43 110.944 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.43 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.8 m -113.77 -30.47 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 N-CA-C 112.081 0.401 . . . . 1.21 112.081 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.486 HG23 HG23 ' B' ' 43' ' ' ILE . 85.8 m -77.33 -49.76 14.28 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.128 0.418 . . . . 1.18 112.128 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.611 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.4 p -58.32 -44.76 99.51 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 113.213 0.82 . . . . 1.65 113.213 -178.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' B' ' 80' ' ' THR . 14.5 Cg_endo -57.2 -49.88 12.77 Favored 'Trans proline' 0 C--N 1.354 0.856 0 C-N-CA 121.539 1.492 . . . . 1.06 111.969 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.601 ' HB3' HD11 ' B' ' 43' ' ' ILE . 4.4 mm? -67.74 -26.02 65.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.139 -0.482 . . . . 1.58 110.653 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 14.8 tp -69.87 -33.75 72.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.312 -0.404 . . . . 1.49 110.207 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 tt -79.14 -34.9 42.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.903 -0.59 . . . . 1.72 110.174 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -65.97 -41.44 91.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.779 -0.646 . . . . 1.96 110.475 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 74.0 m -53.78 -25.38 18.85 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.07 -0.514 . . . . 1.24 111.059 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.41 -42.81 74.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.277 -0.42 . . . . 1.21 110.791 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -68.41 -23.18 64.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.998 -0.546 . . . . 1.32 111.0 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . 0.408 ' HB3' ' HD2' ' B' ' 35' ' ' TYR . 63.7 m95 -84.3 -47.24 10.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 2.15 111.324 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 9.2 t -64.47 -21.38 66.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.526 -0.306 . . . . 1.44 111.35 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -96.52 -48.74 5.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.382 -0.372 . . . . 1.05 111.005 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 85.0 mtp -102.79 118.87 37.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.485 . . . . 2.68 110.914 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -87.53 -5.93 58.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.21 -0.45 . . . . 2.71 111.048 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -162.41 149.4 13.49 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.263 -0.426 . . . . 4.19 110.806 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 15.4 tt -117.34 143.48 27.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.181 -0.463 . . . . 2.79 111.326 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -115.52 -155.94 0.59 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.955 -0.566 . . . . 5.27 110.796 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -67.09 85.03 0.13 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.342 -0.39 . . . . 5.57 111.085 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -172.6 116.51 0.32 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.185 -0.461 . . . . 4.24 110.969 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 17.3 m-90 -131.63 27.52 4.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 5.39 110.728 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 4.9 t -109.99 -30.09 7.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 2.16 111.624 -179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 86.9 mt -72.39 -54.99 7.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.313 -0.403 . . . . 2.58 111.074 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 19.7 tt -66.31 -26.81 38.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.297 -0.41 . . . . 2.29 110.875 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.02 -29.17 61.1 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.826 -0.702 . . . . 1.48 112.572 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -73.1 -49.01 30.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.764 0.316 . . . . 2.76 110.753 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.74 -31.25 71.41 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.227 -0.442 . . . . 2.22 110.808 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 37.1 ttp -77.45 -26.98 51.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.866 -0.607 . . . . 2.36 111.026 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 31.4 t -74.23 -51.67 14.67 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.068 0.461 . . . . 1.92 110.79 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.617 ' HB ' HD13 ' B' ' 142' ' ' ILE . 70.9 p -59.53 -33.96 72.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.768 -0.651 . . . . 2.06 111.126 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.435 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.4 tp60 -61.07 -51.55 68.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.069 -0.514 . . . . 2.87 111.274 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 83.1 mt -53.08 -39.99 35.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.328 -0.396 . . . . 1.98 111.387 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.55 -43.39 96.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.436 -0.347 . . . . 1.62 111.41 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 83.5 t -64.67 -48.02 86.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.278 -0.419 . . . . 1.04 111.508 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.465 HG22 HD21 ' B' ' 117' ' ' LEU . 87.1 mt -54.7 -41.08 54.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.502 -0.317 . . . . 2.46 111.05 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.425 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 99.7 m -54.76 -51.8 64.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.149 -0.478 . . . . 0.83 111.482 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 14.9 m -56.55 -32.68 65.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 0.74 110.539 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.535 ' HA2' ' H21' ' B' ' 301' ' ' RET . . . -66.0 -33.0 84.24 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.89 -0.672 . . . . 0.6 112.701 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.579 HD22 ' CD1' ' B' ' 73' ' ' TYR . 1.0 OUTLIER -67.7 -61.37 1.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.879 0.371 . . . . 1.42 110.72 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.56 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 30.8 mm -59.3 -30.36 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.036 -0.529 . . . . 1.51 111.601 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.62 -44.6 62.94 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.892 0.377 . . . . 1.09 111.331 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -91.45 -13.24 32.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 2.25 110.805 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.56 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.9 mt -90.41 25.69 2.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 1.16 111.106 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 47.1 t -84.5 142.29 30.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.36 -0.382 . . . . 1.76 110.791 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.33 -26.17 14.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.082 -0.508 . . . . 2.89 110.873 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.546 ' HB2' HG12 ' B' ' 127' ' ' VAL . 83.4 mtm180 -121.78 133.6 54.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 2.67 110.64 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -70.26 -14.82 62.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.98 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 43.1 t-105 -78.81 -47.84 15.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 4.07 110.936 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.557 HG11 ' NE2' ' A' ' 58' ' ' GLN . 14.9 p -73.2 -24.14 20.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.125 -0.488 . . . . 1.41 111.315 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -58.34 -28.26 64.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 2.47 110.729 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -67.16 -29.78 69.58 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.024 -0.534 . . . . 2.61 110.79 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 75.8 mt -74.62 -55.41 5.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.992 -0.549 . . . . 2.07 111.182 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -55.86 -30.76 62.01 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.205 -0.452 . . . . 1.3 111.163 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -59.28 -47.1 86.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 1.75 110.426 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 42.2 mm -61.62 -30.98 49.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.069 -0.514 . . . . 1.67 111.113 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.453 ' SG ' HD22 ' A' ' 49' ' ' LEU . 43.2 t -65.0 -38.21 90.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 1.54 111.225 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.53 -49.32 61.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.821 -0.704 . . . . 0.7 112.585 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 32.9 m -67.62 -28.57 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.901 0.381 . . . . 1.44 111.217 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 48.9 t -62.29 -46.99 86.28 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 1.82 110.718 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.67 -49.21 76.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.004 -0.544 . . . . 0.94 111.116 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.68 -21.98 66.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.6 110.937 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -65.27 -62.87 1.28 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.292 -0.413 . . . . 2.01 110.728 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 25.4 mt -60.51 -45.77 96.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.241 -0.436 . . . . 1.96 110.996 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.617 HD13 ' HB ' ' B' ' 108' ' ' THR . 88.3 mt -53.24 -42.22 46.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.05 -0.523 . . . . 2.88 111.12 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 42.1 tp -54.91 -52.1 63.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 1.52 110.759 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -66.67 -22.47 66.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 4.15 110.505 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.64 -17.54 65.8 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 1.59 113.057 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 50.8 pt -104.16 -6.03 9.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.913 0.357 . . . . 2.13 111.552 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -90.67 -52.39 4.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.349 -0.387 . . . . 1.78 111.625 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.589 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.4 t-20 -51.42 -49.86 79.81 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.034 -0.53 . . . . 2.45 111.881 -179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 50.6 Cg_exo -55.49 -24.64 45.06 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.241 1.961 . . . . 2.36 112.711 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 57.3 mt -96.8 59.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 2.88 110.911 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.458 HH21 ' ND2' ' B' ' 148' ' ' ASN . 38.0 ttp180 -165.85 -68.8 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.128 -0.487 . . . . 8.07 111.093 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.55 -40.85 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 2.8 111.45 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -73.45 -15.61 61.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.34 -0.391 . . . . 4.58 111.024 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' B' ' 162' ' ' ALA . 74.2 p -96.85 -30.8 12.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.093 -0.503 . . . . 3.81 111.0 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 32.7 tpt180 -64.63 -23.26 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.028 -0.533 . . . . 5.22 110.776 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.1 t -98.22 -21.96 16.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.081 -0.508 . . . . 3.42 111.144 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -91.4 -73.77 0.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 4.2 110.938 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 78.5 p -148.82 113.54 5.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 2.75 110.881 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 47.7 t -72.09 -26.91 62.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 2.4 111.084 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -63.72 -58.34 7.19 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.163 -0.471 . . . . 3.46 111.005 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.43 HD22 ' N ' ' B' ' 161' ' ' LEU . 3.8 mm? -65.84 -19.51 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.28 -0.418 . . . . 2.57 110.85 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . 0.494 ' HB2' ' HB ' ' B' ' 154' ' ' THR . . . -67.18 -38.91 86.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.168 -0.469 . . . . 1.72 111.255 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -73.95 -41.34 62.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 2.69 110.975 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . 0.426 HD12 HD13 ' B' ' 161' ' ' LEU . 83.7 mt -63.06 -40.16 96.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 2.16 111.138 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -30.36 60.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 2.13 111.44 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.73 -46.14 90.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.37 -0.377 . . . . 1.94 111.131 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -78.4 -27.58 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 3.33 111.019 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 64.4 tp -64.3 -54.37 34.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.354 -0.384 . . . . 1.56 110.95 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.32 -28.56 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.287 -0.415 . . . . 1.59 111.334 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -55.51 -58.55 7.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 1.14 111.235 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -61.23 -44.23 97.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.011 -0.54 . . . . 3.87 110.67 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -56.47 -32.85 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.082 -0.508 . . . . 1.61 110.773 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.3 m -67.41 -42.22 83.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 1.3 111.004 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 39.9 t -57.48 -34.36 46.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.53 111.577 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 57.5 mt -76.65 -57.41 3.87 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.926 0.393 . . . . 1.99 111.417 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . 0.435 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.14 -29.15 63.34 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 1.5 111.315 -179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.532 ' O ' HG12 ' B' ' 181' ' ' ILE . 13.5 tt -87.73 -20.83 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.814 0.34 . . . . 1.46 110.299 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.67 -53.43 46.19 Favored Glycine 0 CA--C 1.519 0.323 0 CA-C-N 115.799 -0.637 . . . . 0.67 113.015 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.67 ' O ' HG22 ' B' ' 182' ' ' VAL . 89.7 m-85 -54.31 -54.06 52.31 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 116.828 0.314 . . . . 1.73 111.28 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.612 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 83.0 Cg_exo -46.33 -33.45 12.36 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.102 1.868 . . . . 0.93 112.277 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.532 HG12 ' O ' ' B' ' 177' ' ' ILE . 49.1 mm -62.05 -58.25 8.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.176 -0.465 . . . . 1.36 111.54 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.67 HG22 ' O ' ' B' ' 179' ' ' TYR . 12.9 m -56.58 -24.64 19.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 1.19 111.562 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 39.4 m95 -70.11 -25.27 63.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.308 -0.406 . . . . 2.73 111.755 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.405 HG22 HG23 ' B' ' 185' ' ' ILE . 82.1 mt -51.15 -82.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-O 120.721 0.296 . . . . 1.93 111.602 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.412 ' H ' HG13 ' B' ' 185' ' ' ILE . 2.4 pp -112.26 -172.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.827 0.346 . . . . 2.64 111.421 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.406 ' O ' ' HA3' ' B' ' 191' ' ' GLY . . . 84.15 -120.88 5.36 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.816 -0.707 . . . . 1.93 112.443 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.7 ' HD3' HD12 ' B' ' 193' ' ' ILE . 89.4 Cg_endo -94.63 -174.0 0.33 Allowed 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 122.916 2.41 . . . . 2.97 111.972 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 71.0 m 51.21 20.52 0.91 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.129 0.49 . . . . 4.5 110.34 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -167.05 19.21 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 115.6 -0.727 . . . . 4.5 112.137 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 74.4 t80 60.19 94.01 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.951 0.405 . . . . 7.89 110.95 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' B' ' 186' ' ' GLY . . . -139.79 -117.3 1.43 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.838 -0.696 . . . . 3.62 112.311 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -123.86 14.78 9.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 6.54 110.829 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.7 HD12 ' HD3' ' B' ' 187' ' ' PRO . 95.5 mt -117.66 139.92 42.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.927 -0.579 . . . . 3.16 110.735 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -88.77 -174.98 4.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.465 . . . . 3.39 111.265 -179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -69.04 -23.29 64.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.024 -0.534 . . . . 5.56 111.248 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 76.2 p -61.82 -65.47 0.69 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.352 -0.386 . . . . 2.68 111.466 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.556 ' HB ' HG23 ' B' ' 193' ' ' ILE . 86.2 mt -67.9 -25.37 32.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.31 -0.405 . . . . 2.2 110.936 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -49.96 -55.34 14.94 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.516 . . . . 2.49 110.998 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.9 p -70.59 -38.03 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.468 . . . . 1.76 111.079 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -57.02 -26.41 60.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 2.18 111.121 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 97.3 mt -83.29 -50.33 8.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.469 -0.332 . . . . 1.78 111.009 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -68.84 -10.23 55.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.367 -0.379 . . . . 1.98 111.381 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 96.5 m -96.42 -39.88 9.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.112 0.482 . . . . 1.65 110.709 178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 53.2 tp -68.8 -34.8 76.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.751 -0.659 . . . . 1.11 111.684 -179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.576 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -62.17 -54.75 46.9 Favored Pre-proline 0 CA--C 1.533 0.327 0 C-N-CA 121.073 -0.251 . . . . 1.43 111.262 -179.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 72.6 Cg_exo -51.64 -42.61 55.51 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.893 1.729 . . . . 0.77 111.684 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.423 ' O ' HG23 ' B' ' 211' ' ' VAL . 65.3 t80 -61.88 -45.57 93.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.045 -0.525 . . . . 1.6 110.186 179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -71.0 -16.87 62.65 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.994 -0.548 . . . . 1.77 110.422 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 40.1 t -93.0 -18.58 22.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.857 -0.611 . . . . 1.54 110.588 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -88.6 -44.27 10.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.027 -0.533 . . . . 2.01 110.955 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.423 HG23 ' O ' ' B' ' 207' ' ' PHE . 67.5 t -61.42 -46.57 96.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.401 . . . . 2.65 110.813 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -58.28 -27.93 61.07 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.646 -0.788 . . . . 1.33 112.402 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -68.61 -33.4 73.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 2.29 110.897 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 48.1 t -64.11 -54.8 28.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 2.12 110.581 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -61.33 -26.64 67.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.963 -0.562 . . . . 3.6 111.019 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.9 tt -64.82 -51.85 59.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 1.51 110.467 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.76 -26.5 65.75 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.093 -0.503 . . . . 2.22 110.884 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 49.7 tp -70.82 -50.25 37.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 2.69 110.845 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 32.6 m80 -68.44 -23.03 64.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.126 -0.488 . . . . 3.4 110.644 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.31 -18.99 65.94 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.893 -0.67 . . . . 1.67 112.465 179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.38 -26.62 67.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.763 0.316 . . . . 3.39 110.817 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -80.14 106.54 12.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 5.91 110.997 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -162.19 100.94 1.09 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.078 -0.51 . . . . 5.26 110.909 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 81.6 mt 50.73 43.83 27.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.193 -0.458 . . . . 6.81 110.911 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.2 t30 66.24 141.74 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.985 -0.552 . . . . 7.02 110.861 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -74.5 123.36 24.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 8.21 111.212 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 62.8 m -131.74 166.73 20.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.997 -0.547 . . . . 8.1 110.755 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -132.56 78.33 1.79 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.31 -0.405 . . . . 13.28 111.057 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.24 -0.886 . . . . 10.4 110.965 179.948 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.875 0.369 . . . . 8.1 110.84 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -157.18 111.71 2.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 6.27 110.741 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 49.4 tp -78.17 132.97 37.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.147 -0.479 . . . . 6.2 111.041 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -100.45 128.11 46.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.106 -0.497 . . . . 4.82 110.784 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 34.4 t -83.32 152.16 25.23 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 3.25 111.046 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.14 2.65 12.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.123 -0.489 . . . . 2.79 111.223 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 64.9 tp -61.73 -55.65 27.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.302 -0.408 . . . . 2.08 110.825 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 73.5 m-70 -62.91 -23.84 67.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 1.43 110.617 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.468 ' O ' HG12 ' C' ' 12' ' ' VAL . 36.7 t-105 -66.67 -38.92 87.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.148 0.499 . . . . 1.16 110.356 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 70.8 mt -72.19 -23.56 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 2.09 109.951 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -69.46 -52.2 28.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.756 -0.656 . . . . 1.58 110.803 179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.468 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.3 p -56.17 -35.26 41.56 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 CA-C-N 116.441 -0.345 . . . . 1.0 110.761 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.19 -43.07 96.21 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.261 -0.427 . . . . 0.96 110.413 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -68.81 -21.56 75.11 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.826 -0.625 . . . . 0.96 112.243 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 87.4 mmm -69.7 -37.04 76.44 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.9 0.381 . . . . 1.3 110.222 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 24.0 m -64.73 -56.31 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.938 -0.574 . . . . 1.52 110.524 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.449 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.25 -30.8 36.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.08 -0.509 . . . . 1.9 110.443 179.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -57.93 -45.58 93.52 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.965 -0.636 . . . . 0.96 112.161 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.32 -39.73 88.09 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.935 0.397 . . . . 1.07 110.552 179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -61.26 -32.16 71.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.013 -0.54 . . . . 2.08 110.642 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -60.61 -43.76 97.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.332 -0.395 . . . . 2.02 110.218 179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -61.62 -29.5 70.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.066 -0.515 . . . . 4.98 110.414 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.746 ' O ' ' OG ' ' C' ' 26' ' ' SER . 82.2 t90 -66.42 -31.0 71.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.048 -0.524 . . . . 4.29 110.211 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 49.8 m -66.9 -46.84 73.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.961 -0.563 . . . . 2.47 110.692 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 26.8 tp -84.78 -2.76 58.1 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.285 -0.416 . . . . 2.9 110.394 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.746 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 66.8 p -71.19 -14.03 62.12 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.994 -0.548 . . . . 2.74 110.505 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -40.94 -48.26 3.13 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.342 -0.614 . . . . 5.85 109.342 179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.445 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 2.5 p-10 179.14 128.86 0.22 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.28 -0.873 . . . . 4.52 110.736 178.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' C' ' 31' ' ' GLY . 60.1 Cg_endo -102.82 -77.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 123.749 2.966 . . . . 3.22 111.584 178.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -120.96 12.03 11.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 108.924 -0.769 . . . . 8.68 108.924 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . 0.546 ' H ' ' HD2' ' C' ' 29' ' ' PRO . . . 119.78 -51.59 0.76 Allowed Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 114.385 -1.28 . . . . 4.14 111.002 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 2.5 p -141.81 108.1 5.94 Favored Pre-proline 0 C--N 1.331 -0.222 0 O-C-N 122.994 -0.121 . . . . 5.09 110.816 177.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.483 ' HB2' ' HB2' ' C' ' 36' ' ' GLU . 90.9 Cg_endo -83.89 115.96 2.12 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 120.822 1.014 . . . . 3.1 112.881 178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -84.47 -25.79 28.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 122.215 1.007 . . . . 3.85 108.547 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.471 ' O ' HG22 ' C' ' 39' ' ' VAL . 1.5 p90 -82.71 -62.16 1.68 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.255 -1.793 . . . . 3.37 112.988 -177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . 0.483 ' HB2' ' HB2' ' C' ' 33' ' ' PRO . 19.6 mm-40 -38.14 -54.5 1.36 Allowed 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.679 0.622 . . . . 2.72 112.679 -177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -54.28 -59.99 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 5.67 111.897 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 44.3 tp -62.54 -61.37 2.48 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.737 0.643 . . . . 1.93 112.737 -178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.471 HG22 ' O ' ' C' ' 35' ' ' TYR . 5.4 m -54.23 -44.66 65.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 113.15 0.796 . . . . 1.88 113.15 -178.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.553 ' O ' ' HG2' ' C' ' 44' ' ' PRO . . . -72.69 -11.83 60.79 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 111.824 0.305 . . . . 1.23 111.824 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 11.2 tpt -89.2 -58.58 2.49 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.812 -0.355 . . . . 2.09 111.785 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -74.87 -58.98 2.94 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 113.625 0.972 . . . . 1.41 113.625 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.623 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 58.4 mt -42.83 -54.36 8.79 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.126 0.788 . . . . 0.8 113.126 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 17.4 Cg_exo -69.94 -52.36 0.32 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.282 1.988 . . . . 0.72 113.576 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 77.5 mt -55.19 -60.35 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 N-CA-C 111.834 0.309 . . . . 1.68 111.834 -179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 9.5 t-105 -50.05 -58.34 5.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.763 0.316 . . . . 1.68 111.665 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 40.0 t -53.77 -35.37 61.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.153 -0.476 . . . . 1.28 111.69 -179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.59 -64.09 4.72 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.752 . . . . 0.51 113.083 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.473 HD22 ' SG ' ' A' ' 134' ' ' CYS . 42.1 mt -56.95 -32.37 65.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.691 0.282 . . . . 1.33 111.514 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.15 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.315 -0.402 . . . . 0.57 111.384 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -63.27 -37.1 85.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 1.67 111.656 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.6 ttp -53.76 -35.98 61.87 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.128 0.489 . . . . 1.42 110.275 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.445 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -68.55 -42.22 78.71 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.658 -0.701 . . . . 0.71 110.564 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -52.58 -29.48 25.9 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.002 -0.545 . . . . 1.14 110.193 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.86 -48.18 55.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.878 -0.601 . . . . 0.88 110.556 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.9 mt -77.71 5.92 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.038 -0.528 . . . . 1.38 110.81 179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 63.07 46.02 4.93 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.016 -0.538 . . . . 1.94 110.947 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.445 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 31.4 mm-40 -112.62 166.9 10.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.975 -0.557 . . . . 1.87 110.901 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.35 41.76 84.53 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.433 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -141.48 139.42 33.31 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.903 0.382 . . . . 2.86 110.799 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -113.23 152.73 14.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.982 -0.553 . . . . 1.95 111.012 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -123.63 87.43 2.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.285 -0.416 . . . . 3.04 110.87 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.53 130.95 46.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.236 -0.438 . . . . 2.11 111.178 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.5 27.67 17.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.039 -0.528 . . . . 2.54 111.212 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 75.85 6.41 81.93 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.861 -0.685 . . . . 2.47 112.66 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -105.15 132.78 50.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.634 0.254 . . . . 2.85 111.021 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 78.3 mt -84.03 125.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.316 -0.402 . . . . 1.87 110.873 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.03 133.54 53.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.182 -0.463 . . . . 1.12 111.247 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.591 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 82.5 m-70 -80.38 72.49 7.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.166 0.507 . . . . 1.26 110.556 179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -64.77 -34.16 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.51 -0.768 . . . . 2.08 111.738 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.08 -25.48 40.02 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.121 0.415 . . . . 0.86 112.121 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.591 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 33.0 mmt180 -68.12 -52.07 39.05 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.264 0.468 . . . . 1.96 112.264 -178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.488 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 5.2 p90 -76.63 -36.41 57.43 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.707 -0.397 . . . . 1.8 112.027 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.438 HG23 ' N ' ' C' ' 75' ' ' ASP . 10.8 tp -52.86 -44.75 49.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 C-N-CA 121.067 -0.253 . . . . 1.18 111.015 -179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.438 ' N ' HG23 ' C' ' 74' ' ' ILE . 11.7 t70 -68.72 -24.79 64.52 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.38 -0.6 . . . . 1.33 109.38 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -87.11 6.24 33.7 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 115.612 -0.722 . . . . 1.85 111.206 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 96.4 mmm -105.07 -23.48 12.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.946 -0.57 . . . . 1.56 110.716 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.481 ' C ' ' HD2' ' C' ' 81' ' ' PRO . 30.5 m -114.15 -27.77 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.829 -0.623 . . . . 1.11 112.511 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 28.3 m -82.39 -45.8 14.37 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 112.232 0.456 . . . . 1.49 112.232 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' C' ' 81' ' ' PRO . 69.2 p -59.14 -40.97 85.34 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 112.83 0.678 . . . . 1.6 112.83 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.556 ' HD3' ' OG1' ' C' ' 80' ' ' THR . 25.0 Cg_exo -63.91 -31.09 67.52 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 121.811 1.674 . . . . 1.01 111.842 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.436 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.5 mm? -84.02 -29.43 26.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.098 -0.501 . . . . 1.18 110.723 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -39.92 96.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 1.54 110.531 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.42 HD22 ' HG3' ' C' ' 109' ' ' GLN . 2.6 pp -78.75 -32.93 46.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.575 . . . . 1.65 110.767 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -68.33 -29.51 68.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.862 0.363 . . . . 2.1 110.35 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 43.9 m -62.31 -40.04 94.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.882 -0.599 . . . . 1.38 110.307 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.637 HD22 HD11 ' C' ' 168' ' ' LEU . 77.2 mt -68.6 -28.04 66.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.661 -0.699 . . . . 1.44 110.709 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 50.8 m -73.02 -32.67 65.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 1.87 110.718 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -83.19 -27.59 29.92 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.421 . . . . 3.1 110.718 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 90.5 m -72.72 -26.74 61.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 1.48 110.865 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.96 -33.89 16.22 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.491 . . . . 1.02 111.241 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 68.9 mtm -113.05 123.3 49.98 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.337 -0.392 . . . . 2.34 110.907 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -87.78 -17.38 31.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.225 -0.443 . . . . 3.21 111.054 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 47.0 p90 -155.09 167.05 31.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.944 0.402 . . . . 4.54 111.176 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -132.05 144.1 38.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.942 -0.572 . . . . 2.34 110.842 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -151.07 -31.78 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.43 . . . . 4.4 110.903 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 47.2 mmtm -86.0 -174.38 5.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.163 -0.471 . . . . 5.54 110.958 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -65.34 176.39 1.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.98 -0.555 . . . . 3.54 110.874 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 9.0 p90 -134.57 57.13 1.82 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.114 -0.494 . . . . 5.21 110.89 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 81.4 p -89.69 -24.11 21.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.047 -0.524 . . . . 2.38 111.033 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 95.7 mt -78.0 -44.58 26.22 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.206 -0.452 . . . . 2.64 110.948 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 61.2 mt -63.59 -32.55 57.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.268 -0.424 . . . . 2.38 110.697 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.79 -39.59 65.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 1.62 112.165 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -59.44 -45.95 90.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.815 0.341 . . . . 2.93 110.577 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.452 ' O ' ' HG2' ' C' ' 109' ' ' GLN . 43.3 mt -58.9 -58.27 9.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 2.16 110.733 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 53.4 ttm -49.85 -38.51 35.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.7 -0.682 . . . . 2.3 111.622 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 56.5 m -62.18 -54.3 42.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.023 0.44 . . . . 2.07 110.75 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.512 ' HB ' HG21 ' C' ' 142' ' ' ILE . 49.3 p -60.55 -28.06 68.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.877 -0.601 . . . . 2.3 111.386 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.532 HE22 ' HE1' ' C' ' 176' ' ' TRP . 14.7 mm100 -69.7 -43.53 72.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.378 . . . . 2.48 111.156 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.586 HG22 ' HE1' ' B' ' 46' ' ' TRP . 84.5 mt -59.73 -31.95 48.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.868 0.365 . . . . 1.93 110.806 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 37.1 t -68.62 -39.68 80.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 1.67 110.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 83.2 t -66.93 -56.47 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 1.11 111.396 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 37.6 pt -52.72 -27.56 12.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.391 -0.368 . . . . 2.59 111.171 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 42.6 m -64.19 -51.21 64.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.953 0.406 . . . . 0.9 110.467 179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 36.9 m -60.97 -23.29 65.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.92 110.497 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -70.1 -53.2 15.18 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 121.053 -0.594 . . . . 0.55 112.888 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.488 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.2 pp -65.54 -21.45 66.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.652 0.263 . . . . 1.49 111.385 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.433 HG12 HD12 ' C' ' 117' ' ' LEU . 39.9 mm -82.16 -40.87 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.142 0 CA-C-N 116.405 -0.362 . . . . 1.66 111.028 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.29 -36.75 61.54 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.14 -0.482 . . . . 0.94 111.332 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.36 -30.43 37.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 1.79 110.967 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 66.8 mt -75.87 -0.07 20.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.371 -0.377 . . . . 1.29 111.095 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 57.5 m -62.93 121.52 13.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.322 -0.399 . . . . 2.15 110.769 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -83.91 -30.27 26.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 3.31 111.038 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.551 ' HB2' HG12 ' C' ' 127' ' ' VAL . 96.3 mtt180 -109.7 141.58 42.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 3.16 110.702 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -81.22 -10.8 59.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.302 -0.408 . . . . 4.24 110.744 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 80.1 t90 -87.61 -35.53 18.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.076 -0.511 . . . . 4.65 110.674 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.551 HG12 ' HB2' ' C' ' 124' ' ' ARG . 8.5 p -81.17 -23.71 10.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.031 -0.531 . . . . 1.31 110.869 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 62.7 ttp180 -59.24 -30.77 68.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.091 -0.504 . . . . 2.84 110.904 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -68.65 -20.68 64.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 2.7 110.893 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.547 HD23 ' HA ' ' C' ' 127' ' ' VAL . 3.9 mm? -79.84 -60.39 2.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.34 -0.391 . . . . 1.88 110.99 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -56.99 -29.96 63.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.434 . . . . 1.38 110.858 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -57.79 -50.36 73.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 1.76 110.596 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 48.5 mm -63.88 -29.81 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.236 -0.438 . . . . 2.15 110.595 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 61.4 m -66.02 -32.77 74.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.943 -0.571 . . . . 1.56 110.911 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.62 -56.21 8.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.734 -0.746 . . . . 0.73 112.328 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 3.5 p -60.71 -34.34 58.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.767 0.318 . . . . 1.48 111.015 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 41.7 t -53.73 -54.57 36.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.825 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.89 -34.41 73.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.989 -0.55 . . . . 1.01 111.162 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -68.1 -22.32 64.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.136 -0.484 . . . . 2.05 110.902 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -74.44 -57.29 4.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 2.07 111.118 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.401 ' H ' HG13 ' C' ' 141' ' ' ILE . 34.5 mt -56.17 -48.24 79.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.384 -0.371 . . . . 1.92 111.568 -179.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.512 HG21 ' HB ' ' C' ' 108' ' ' THR . 33.4 pt -63.59 -30.23 49.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 2.64 111.478 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 38.0 tp -59.78 -55.33 35.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 1.51 110.664 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 48.1 t-105 -65.38 -19.88 66.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 3.58 110.054 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.31 -16.7 68.44 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.637 -0.711 . . . . 1.65 112.799 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 47.3 pt -108.39 -3.65 10.32 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 120.654 0.264 . . . . 2.46 111.33 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 12.5 m95 -94.04 -50.26 5.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 2.27 111.048 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.564 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 8.0 t30 -53.84 -48.81 92.42 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 2.33 112.02 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.564 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 73.8 Cg_exo -51.22 -39.5 61.82 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.284 1.99 . . . . 2.46 112.733 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -82.98 54.51 2.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.33 -0.395 . . . . 3.08 110.937 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -163.66 -70.57 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 8.45 110.937 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.81 -40.16 20.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 2.9 111.384 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' C' ' 149' ' ' PRO . 67.9 mttm -75.43 -8.66 57.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.384 -0.371 . . . . 4.62 110.985 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' C' ' 162' ' ' ALA . 39.9 p -105.72 -28.26 10.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.418 -0.355 . . . . 3.85 111.501 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.96 -18.46 63.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.358 -0.383 . . . . 5.12 110.793 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 43.2 p -100.48 -21.52 15.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.239 -0.437 . . . . 3.43 111.545 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -97.06 -70.94 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 3.98 110.937 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 36.5 t -146.43 115.82 7.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.169 -0.469 . . . . 2.4 110.842 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 65.5 m -77.1 -28.88 54.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.165 -0.47 . . . . 2.82 111.101 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.01 -53.72 28.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.291 -0.413 . . . . 3.18 110.742 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 63.5 mt -65.38 -20.11 66.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.048 -0.524 . . . . 2.5 110.533 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . 0.467 ' HB2' ' HB ' ' C' ' 154' ' ' THR . . . -66.76 -62.66 1.33 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 1.81 111.193 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 53.5 t30 -57.31 -24.11 52.91 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.09 0.472 . . . . 2.13 110.478 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 27.2 tp -69.93 -50.91 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.762 -0.654 . . . . 2.21 111.025 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.437 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.9 OUTLIER -74.99 -22.67 58.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 1.31 110.969 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -61.18 -53.39 57.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 2.26 111.057 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -75.25 -21.46 58.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.107 -0.497 . . . . 3.58 111.045 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.637 HD11 HD22 ' C' ' 87' ' ' LEU . 58.5 tp -68.82 -49.77 55.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.239 -0.437 . . . . 1.3 111.164 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.437 HG23 ' O ' ' C' ' 165' ' ' TYR . 63.0 t -63.95 -29.02 46.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.148 -0.478 . . . . 1.73 111.336 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.1 m -50.19 -58.57 5.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 1.43 111.722 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -63.65 -42.07 98.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 3.72 110.724 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -59.09 -24.95 63.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.009 -0.541 . . . . 1.55 111.118 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 32.5 m -76.24 -41.14 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.286 -0.415 . . . . 1.5 110.968 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 53.6 t -57.64 -36.25 53.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.226 -0.443 . . . . 1.84 111.646 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.43 HD13 ' OG ' ' C' ' 209' ' ' SER . 32.6 mt -76.04 -57.28 3.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.002 0.43 . . . . 2.12 111.095 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . 0.532 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -55.97 -29.15 59.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.966 -0.561 . . . . 1.0 111.457 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . . . . . . . . . 9.2 tp -88.48 -18.9 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 121.073 0.463 . . . . 1.75 110.733 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.473 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -66.44 -32.7 82.59 Favored Glycine 0 C--N 1.332 0.324 0 CA-C-N 115.79 -0.641 . . . . 0.72 113.143 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.591 ' O ' HG22 ' C' ' 182' ' ' VAL . 88.6 m-85 -73.52 -51.18 5.64 Favored Pre-proline 0 CA--C 1.537 0.467 0 O-C-N 122.576 -0.367 . . . . 1.8 111.812 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' C' ' 179' ' ' TYR . 27.6 Cg_endo -62.61 -21.59 73.06 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.09 1.86 . . . . 0.88 113.146 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.447 HG22 ' O ' ' C' ' 178' ' ' GLY . 20.5 tt -82.61 -36.26 13.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.816 -0.353 . . . . 1.52 111.527 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.591 HG22 ' O ' ' C' ' 179' ' ' TYR . 33.0 m -71.25 -23.69 23.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.004 0.43 . . . . 1.2 110.73 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -66.91 -17.54 64.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.067 -0.515 . . . . 2.47 111.966 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.43 HG22 ' O ' ' C' ' 181' ' ' ILE . 20.7 tt -109.59 -23.32 4.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 112.751 0.648 . . . . 1.62 112.751 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.457 HG12 ' O ' ' C' ' 182' ' ' VAL . 45.0 pt -60.66 -26.47 38.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 C-N-CA 120.801 -0.359 . . . . 2.63 111.372 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.43 173.78 43.16 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.539 -0.839 . . . . 1.77 112.639 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.03 95.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.651 2.234 . . . . 3.03 112.35 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 81.1 p 46.79 35.17 2.97 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.137 -0.483 . . . . 4.22 111.038 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -174.81 -139.34 2.98 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.587 -0.816 . . . . 4.08 112.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . 0.413 ' H ' HG12 ' C' ' 193' ' ' ILE . 78.3 t80 -78.98 -69.91 0.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 7.54 111.319 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -179.45 124.23 0.89 Allowed Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.969 -0.634 . . . . 3.29 112.328 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 56.45 23.38 7.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.945 0.402 . . . . 5.67 110.7 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.539 HG21 HG21 ' C' ' 197' ' ' ILE . 2.0 pp -90.94 167.0 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.009 -0.541 . . . . 2.76 111.097 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 30.0 p-10 -107.9 -166.97 1.19 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 3.69 111.178 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 82.2 mm-40 -59.44 -30.14 68.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.059 -0.519 . . . . 5.34 111.407 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 97.2 m -58.34 -65.54 0.63 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.802 0.334 . . . . 2.57 111.473 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.558 ' H ' HD12 ' C' ' 197' ' ' ILE . 3.7 mp -65.51 -25.47 36.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 2.37 110.925 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.1 -60.86 2.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 2.68 111.351 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 69.3 p -74.26 -25.66 59.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 1.95 111.328 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' C' ' 197' ' ' ILE . 80.6 t80 -66.9 -26.23 66.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.211 -0.45 . . . . 2.05 111.085 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 35.5 tp -83.9 -55.26 4.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 1.91 111.665 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -68.02 -1.81 6.51 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.979 0.363 . . . . 2.04 111.979 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.411 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 44.9 t -95.99 -43.79 7.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.375 0.607 . . . . 1.62 110.407 178.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 51.8 tp -71.22 -36.74 71.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.413 -0.812 . . . . 1.49 111.912 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.683 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 60.3 tp -58.05 -54.55 54.45 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 120.865 -0.334 . . . . 1.32 111.432 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.683 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.9 Cg_exo -55.57 -39.31 91.78 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.767 1.645 . . . . 0.76 111.366 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -61.69 -42.71 99.3 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.218 -0.446 . . . . 1.52 110.208 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . 0.429 ' HA ' HG22 ' C' ' 211' ' ' VAL . 53.9 t80 -75.31 -18.59 59.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.049 -0.523 . . . . 1.84 110.148 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.43 ' OG ' HD13 ' C' ' 175' ' ' LEU . 31.0 t -88.63 -14.13 38.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.616 -0.72 . . . . 1.68 110.429 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 41.5 mttp -96.75 -36.23 10.72 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.895 -0.593 . . . . 2.04 110.907 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.457 HG23 ' N ' ' C' ' 212' ' ' GLY . 18.8 m -65.68 -46.55 88.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.246 -0.434 . . . . 2.65 111.023 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.457 ' N ' HG23 ' C' ' 211' ' ' VAL . . . -62.08 -23.41 63.89 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.804 -0.713 . . . . 1.33 112.074 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -64.28 -45.79 86.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 3.02 110.697 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 91.2 p -62.5 -47.12 85.34 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.168 -0.469 . . . . 2.35 110.9 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -65.88 -26.17 67.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 3.62 110.529 179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -70.22 -42.21 72.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.978 -0.555 . . . . 1.64 110.405 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -67.49 -28.32 67.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.09 -0.504 . . . . 2.2 110.345 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 39.4 tp -68.49 -46.46 69.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.924 -0.58 . . . . 3.11 110.504 179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -76.02 -23.69 55.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.792 -0.64 . . . . 3.37 110.75 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.23 -21.35 66.12 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.816 -0.707 . . . . 1.55 112.644 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 88.4 mt -65.58 -18.09 65.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.741 0.305 . . . . 3.11 111.247 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 52.8 mtp180 -69.28 99.36 1.17 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.343 -0.39 . . . . 5.73 111.13 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -126.42 179.13 5.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 5.53 110.813 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 95.8 mt -62.18 -60.83 3.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 6.6 110.929 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -143.33 131.19 21.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 6.51 110.96 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -93.63 108.31 20.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.19 -0.459 . . . . 7.05 110.704 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 35.3 t -104.71 175.39 5.51 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.135 -0.484 . . . . 6.72 110.906 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 38.1 ptt180 -142.24 31.94 1.54 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.016 -0.538 . . . . 9.56 110.79 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 24.7 tp60 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.377 -0.821 . . . . 9.08 110.842 179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.717 ' H8 ' H171 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.736 ' H8 ' H171 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.745 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.8 mtm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.611 0.243 . . . . 8.09 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 32.4 t30 62.39 106.76 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.134 -0.485 . . . . 5.68 111.322 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.0 mp -91.2 146.55 23.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 6.27 110.839 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -100.43 165.77 11.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.088 -0.505 . . . . 6.52 111.0 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 83.3 p -167.19 168.63 13.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.008 -0.542 . . . . 3.59 110.651 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 6' ' ' LEU . 2.6 pt? -133.28 11.84 4.18 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.357 -0.383 . . . . 3.23 111.011 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 7' ' ' LEU . 8.0 mp -64.43 -55.24 22.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.164 -0.471 . . . . 1.88 110.778 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 44.3 m-70 -63.27 -23.89 67.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.966 -0.561 . . . . 1.29 110.651 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 55.6 t-105 -67.81 -36.6 80.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.562 . . . . 0.99 110.854 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.67 -27.81 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.969 0.414 . . . . 1.92 110.707 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 38.8 t80 -63.08 -54.73 33.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.964 -0.562 . . . . 1.45 110.701 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.11 -37.91 64.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.145 -0.48 . . . . 0.89 111.193 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.02 87.24 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.988 0.423 . . . . 0.9 110.891 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.76 -25.07 67.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.766 -0.731 . . . . 0.83 112.078 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 22.5 mmt -79.99 -27.47 39.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.864 0.364 . . . . 1.24 110.547 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.9 m -61.33 -54.12 47.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.068 -0.515 . . . . 1.29 110.433 179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.447 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.7 pp -68.04 -28.93 42.93 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-N 115.964 -0.562 . . . . 1.71 110.901 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.447 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -63.99 -25.0 69.02 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.822 -0.704 . . . . 0.96 112.191 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.84 -45.49 16.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.711 0.291 . . . . 0.99 110.599 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.17 -19.58 46.34 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.1 -0.5 . . . . 2.11 111.032 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -52.55 -20.87 3.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.07 -0.513 . . . . 2.23 111.651 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.413 ' HB2' ' HB3' ' A' ' 37' ' ' TYR . 1.8 p90 -70.07 -31.07 68.48 Favored 'General case' 0 CA--C 1.528 0.127 0 CA-C-O 120.842 0.353 . . . . 4.02 111.07 -179.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -81.1 -31.67 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 3.96 110.94 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.7 m -62.45 -42.05 99.18 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.33 -0.396 . . . . 2.38 110.724 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -88.2 -1.09 57.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.277 -0.42 . . . . 2.77 111.397 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 86.3 p -58.86 -20.82 54.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.513 -0.312 . . . . 2.52 111.173 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -49.86 -31.34 11.82 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-O 121.29 0.567 . . . . 5.54 109.639 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.6 p-10 -176.13 132.12 0.4 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.071 -0.968 . . . . 4.44 109.713 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 39.1 Cg_endo -92.5 122.96 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.652 2.234 . . . . 2.81 112.316 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -108.35 101.68 10.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.974 -0.557 . . . . 6.8 111.223 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.421 ' H ' HD21 ' A' ' 223' ' ' ASN . . . 82.98 -44.85 3.33 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.784 -0.722 . . . . 4.97 112.763 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' HG23 ' A' ' 32' ' ' VAL . 27.7 m -99.19 112.98 64.33 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-O 120.987 0.422 . . . . 4.71 111.425 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 32' ' ' VAL . 7.1 Cg_exo -78.53 167.61 22.49 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 123.306 2.671 . . . . 3.51 112.3 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG3' ' N ' ' A' ' 35' ' ' TYR . 10.6 pt20 -42.69 -42.24 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.012 0.375 . . . . 3.41 112.012 -179.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.5 p90 -58.94 -37.04 75.8 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.663 0.268 . . . . 2.81 111.093 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -64.28 -39.43 93.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.408 -0.36 . . . . 3.39 110.205 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.413 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 74.4 m-85 -66.32 -31.58 72.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.193 -0.458 . . . . 5.24 110.606 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 47.0 tp -57.64 -61.07 2.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.989 -0.55 . . . . 1.6 110.929 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 41.7 t -62.04 -32.72 55.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.27 -0.423 . . . . 1.33 110.726 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.48 -20.3 63.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.897 -0.592 . . . . 1.03 110.931 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 ttp -88.51 -24.54 22.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 2.0 110.834 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -76.67 -28.84 56.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.022 -0.535 . . . . 1.31 111.639 -179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.461 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 69.2 mt -63.91 -50.31 70.82 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 112.459 0.54 . . . . 1.0 112.459 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 68.9 Cg_endo -74.27 -40.99 1.01 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.289 1.993 . . . . 0.59 113.766 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.7 tp -58.81 -40.14 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 N-CA-C 112.049 0.388 . . . . 1.63 112.049 -178.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -76.34 -51.77 11.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.878 0.371 . . . . 1.12 110.59 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.8 m -64.16 -10.22 21.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 1.32 111.183 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.32 -60.51 1.91 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.637 -0.792 . . . . 0.52 112.481 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 27.0 mt -56.03 -32.31 63.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.713 0.292 . . . . 0.98 111.071 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.37 -58.68 7.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.304 -0.407 . . . . 0.52 111.242 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.33 -40.94 96.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.152 -0.477 . . . . 1.69 111.152 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.1 ttp -50.59 -32.88 19.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.103 0.478 . . . . 1.12 110.468 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.402 ' HB1' ' HE1' ' B' ' 131' ' ' TRP . . . -72.79 -39.05 67.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.779 -0.646 . . . . 0.6 110.868 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 55.9 mtt -53.49 -28.82 32.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.964 -0.562 . . . . 0.94 110.34 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -79.58 -39.98 30.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 0.78 110.638 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 56' ' ' ILE . 33.5 mt -73.54 -4.56 5.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.888 -0.597 . . . . 1.23 110.698 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.8 t70 65.11 62.77 0.7 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.652 -0.704 . . . . 2.02 110.863 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 20.6 tp60 -148.2 94.09 2.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.222 -0.444 . . . . 2.1 110.751 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.08 11.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.803 -0.713 . . . . 1.27 112.369 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.574 ' HG2' ' HA ' ' A' ' 69' ' ' HIS . 37.0 mtmm -131.95 134.39 45.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.741 0.305 . . . . 1.76 111.018 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.0 m -123.27 141.58 43.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.216 -0.447 . . . . 1.84 111.052 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -81.66 92.97 6.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 2.64 110.846 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.33 117.04 33.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 1.84 111.109 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.85 29.95 19.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.1 -0.5 . . . . 2.24 111.178 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.82 -13.91 54.5 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.85 -0.691 . . . . 2.16 112.847 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.65 HE21 ' H ' ' A' ' 67' ' ' ILE . 25.0 tp60 -98.76 139.07 34.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.859 0.362 . . . . 2.84 110.996 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.65 ' H ' HE21 ' A' ' 66' ' ' GLN . 71.5 mt -89.97 129.91 40.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.092 -0.504 . . . . 2.39 111.123 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.402 ' HB1' HD23 ' A' ' 121' ' ' LEU . . . -112.95 130.75 56.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.136 -0.484 . . . . 0.97 111.128 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 47.7 m-70 -87.85 76.03 8.78 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.23 0.538 . . . . 1.04 110.462 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.477 ' O ' HG12 ' A' ' 74' ' ' ILE . 74.1 t80 -57.02 -58.86 6.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.371 -0.832 . . . . 3.38 111.963 -179.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.36 -22.78 65.26 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.419 0.525 . . . . 0.76 112.419 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.624 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 7.0 tpp180 -63.93 -51.73 63.09 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.197 0.443 . . . . 2.93 112.197 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.43 ' HA ' ' HE3' ' A' ' 76' ' ' TRP . 31.2 p90 -87.54 -24.57 24.01 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.612 -0.435 . . . . 3.13 111.847 -179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 70' ' ' TYR . 13.7 mm -54.11 -43.04 58.24 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.228 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' O ' HG22 ' A' ' 79' ' ' THR . 21.6 t70 -65.12 -28.33 69.36 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.699 -0.682 . . . . 1.42 109.411 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.43 ' HE3' ' HA ' ' A' ' 73' ' ' TYR . 7.2 m0 -81.22 6.13 14.94 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-N 115.804 -0.635 . . . . 2.09 111.431 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 31.5 mtp -105.09 -19.81 13.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.462 . . . . 1.52 111.007 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.429 ' O ' HD23 ' A' ' 82' ' ' LEU . 27.5 m -113.94 -35.22 2.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 112.371 0.508 . . . . 1.33 112.371 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.6 t -79.64 -32.44 41.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 111.891 0.33 . . . . 1.39 111.891 -178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.632 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 29.8 m -66.34 -51.61 42.31 Favored Pre-proline 0 CA--C 1.531 0.234 0 N-CA-C 111.738 0.273 . . . . 1.55 111.738 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.632 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -55.0 -35.92 91.31 Favored 'Trans proline' 0 C--N 1.353 0.811 0 C-N-CA 122.073 1.848 . . . . 1.01 111.812 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.6 mm? -80.94 -25.6 37.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.822 -0.626 . . . . 1.45 110.827 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -29.93 67.33 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.618 -0.512 . . . . 1.3 109.618 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.5 tt -84.42 -41.86 16.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.576 -0.738 . . . . 1.67 110.222 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -64.15 -37.65 88.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.899 -0.591 . . . . 1.87 111.041 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 84.9 p -59.52 -23.73 63.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 1.42 110.822 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 56.4 mt -77.73 -29.95 51.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 1.4 110.837 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 45.8 t -81.19 -30.88 34.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.517 . . . . 1.91 110.97 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -74.22 -31.14 62.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 2.33 111.273 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 8.9 t -81.62 -33.0 31.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.491 -0.322 . . . . 1.43 111.579 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.462 ' HB2' HD22 ' A' ' 168' ' ' LEU . . . -91.27 -1.12 57.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.825 0.345 . . . . 1.19 111.294 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 53.6 ttm -155.15 112.8 3.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 2.55 110.73 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -71.49 -55.64 7.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.983 -0.553 . . . . 3.33 111.042 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -113.69 142.83 45.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 5.1 111.173 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 tp -111.91 142.1 25.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 3.07 110.914 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -89.46 -171.15 3.11 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.122 -0.49 . . . . 4.41 110.989 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -82.33 41.22 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 5.31 111.205 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -121.21 107.65 12.82 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.307 -0.406 . . . . 3.94 110.845 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -103.23 25.18 9.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.436 . . . . 5.98 111.092 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.5 p -82.49 -50.05 9.26 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.232 -0.44 . . . . 2.24 111.044 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 46.0 tp -73.66 -57.44 3.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.1 -0.5 . . . . 2.67 110.93 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 46.7 mm -56.92 -33.59 42.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.108 -0.496 . . . . 2.59 111.247 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.99 -20.01 71.32 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.825 -0.702 . . . . 1.53 112.728 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -75.35 -54.99 6.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.821 0.343 . . . . 3.14 110.914 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.8 mp -60.16 -40.74 90.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.055 -0.52 . . . . 1.99 111.286 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . 0.417 ' O ' HG13 ' A' ' 110' ' ' ILE . 24.7 ttt -62.53 -42.56 99.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.747 -0.66 . . . . 2.36 111.377 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 87.7 p -69.12 -36.73 77.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 2.05 111.002 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 68.9 m -62.33 -53.77 50.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.983 -0.553 . . . . 2.25 111.828 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.532 ' NE2' ' HA ' ' A' ' 81' ' ' PRO . 3.8 pt20 -57.65 -38.41 75.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.419 -0.355 . . . . 2.72 111.852 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 106' ' ' MET . 88.1 mt -55.69 -45.63 79.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.634 0.254 . . . . 1.88 111.298 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.23 -39.28 80.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 1.6 111.061 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 95.2 t -68.7 -46.51 79.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.127 -0.488 . . . . 1.09 111.259 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 90.0 mt -55.62 -39.89 56.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.473 -0.331 . . . . 2.65 110.485 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 61.0 m -55.76 -50.7 69.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.09 -0.504 . . . . 0.89 110.603 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . 0.514 ' HA ' ' HE1' ' A' ' 131' ' ' TRP . 57.7 m -59.72 -26.96 66.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.742 -0.663 . . . . 0.68 110.675 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.3 -28.0 70.67 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.622 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.8 mt -71.84 -61.11 1.9 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.042 0.449 . . . . 1.58 110.299 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.572 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 34.7 mm -58.44 -31.1 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.594 -0.73 . . . . 2.04 111.208 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.76 -47.0 67.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.329 -0.396 . . . . 1.1 110.85 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -85.95 -17.66 34.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.024 -0.535 . . . . 1.88 110.618 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.2 mt -90.21 8.66 31.93 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.138 -0.483 . . . . 1.53 110.967 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 84.2 p -64.86 131.92 48.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 2.29 110.942 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -81.24 -28.82 34.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.059 -0.519 . . . . 3.49 110.938 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.497 ' HB2' HG12 ' A' ' 127' ' ' VAL . 73.4 mtm180 -115.87 143.45 45.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 3.13 110.977 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -74.61 -13.02 60.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.036 -0.529 . . . . 3.71 110.82 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 60.6 t90 -91.49 -37.78 12.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 3.97 111.125 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 124' ' ' ARG . 10.9 p -70.02 -26.42 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.492 -0.322 . . . . 1.22 111.039 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -59.15 -37.3 76.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.368 -0.378 . . . . 2.81 110.575 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -67.52 -26.26 66.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 4.25 110.25 179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.403 HD12 ' HA ' ' A' ' 127' ' ' VAL . 55.1 mt -77.82 -50.15 12.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.601 . . . . 1.84 110.598 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.558 ' NE1' ' HB ' ' A' ' 118' ' ' ILE . 53.1 t-105 -60.21 -39.41 86.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.109 -0.496 . . . . 1.54 110.663 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.417 ' CE2' HD13 ' A' ' 184' ' ' ILE . 30.7 t80 -53.59 -43.36 68.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.019 -0.537 . . . . 1.79 110.701 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.3 mt -58.69 -41.69 83.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.066 -0.515 . . . . 2.08 110.597 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.21 -36.74 84.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 1.76 111.19 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.99 -56.74 11.31 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.774 -0.727 . . . . 0.76 112.737 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.4 m -61.11 -44.11 97.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 111.883 0.327 . . . . 2.07 111.883 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.426 ' HA ' HD12 ' A' ' 140' ' ' LEU . 55.1 m -53.93 -35.59 61.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.716 0.293 . . . . 1.85 111.267 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.82 -44.24 77.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.317 -0.401 . . . . 1.32 111.316 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 143' ' ' LEU . 71.5 t80 -74.22 -21.93 59.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.481 . . . . 3.25 111.419 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.426 HD12 ' HA ' ' A' ' 137' ' ' CYS . 60.9 mt -69.63 -59.32 3.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.725 0.298 . . . . 2.92 111.536 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' N ' ' A' ' 142' ' ' ILE . 29.6 pt -56.15 -43.5 76.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.281 -0.418 . . . . 2.65 111.658 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.461 ' N ' HG13 ' A' ' 141' ' ' ILE . 69.7 mt -69.06 -34.19 62.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.534 -0.303 . . . . 3.21 111.415 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 44.2 tp -58.26 -51.81 68.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.874 0.369 . . . . 2.01 110.93 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.4 t-105 -66.97 -22.1 65.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 3.6 110.6 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.62 -18.17 64.47 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.894 -0.669 . . . . 1.62 112.636 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 150' ' ' LEU . 49.9 pt -107.35 -0.46 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.645 0.26 . . . . 2.47 111.371 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -77.0 -17.06 59.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.319 -0.4 . . . . 2.48 111.404 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 3.0 t-20 -98.74 -49.48 0.21 Allowed Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.43 -0.35 . . . . 2.69 111.831 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 31.7 Cg_exo -59.04 -1.18 0.74 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 122.248 1.966 . . . . 2.36 113.327 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 146' ' ' ILE . 96.1 mt -58.99 89.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.664 0.268 . . . . 3.3 111.164 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.401 ' HA ' ' NE ' ' A' ' 151' ' ' ARG . 3.5 mmp_? 52.14 43.96 30.07 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.236 -0.438 . . . . 8.48 111.143 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -78.67 -46.6 18.77 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 2.98 111.427 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -69.26 -33.0 72.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.359 -0.382 . . . . 4.55 111.109 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 9.3 t -93.8 6.31 48.82 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.328 -0.396 . . . . 4.0 111.046 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.2 ttt180 -63.87 -20.56 65.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 5.51 110.968 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 68.4 p -99.92 -10.85 21.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 3.2 111.302 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -87.32 -51.93 5.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 3.98 110.93 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 53.3 m -141.31 114.2 8.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 2.63 111.033 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 57.8 m -74.66 -40.68 61.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 2.16 110.939 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -55.13 -46.59 75.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.31 -0.404 . . . . 3.37 111.304 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.68 -33.09 75.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 2.83 111.152 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.52 -22.72 63.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.7 111.581 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -81.09 -49.39 10.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 2.16 111.557 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 165' ' ' TYR . 3.7 pp -60.79 -26.21 67.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.403 -0.362 . . . . 1.59 111.722 -179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.497 ' N ' HD12 ' A' ' 164' ' ' LEU . 1.4 t80 -81.63 -37.34 27.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.791 0.329 . . . . 2.31 110.831 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -61.17 -35.24 76.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.052 -0.522 . . . . 2.15 110.848 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -84.05 -28.68 27.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.993 -0.549 . . . . 2.39 111.116 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.462 HD22 ' HB2' ' A' ' 91' ' ' ALA . 50.1 tp -65.4 -56.92 9.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 1.79 111.074 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 56.1 t -53.71 -30.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.035 -0.53 . . . . 1.42 111.444 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 93.9 m -54.34 -58.57 6.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.312 -0.404 . . . . 1.12 111.911 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 30.1 t80 -60.66 -29.88 69.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.901 0.381 . . . . 3.86 110.918 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.38 -34.37 74.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.234 -0.439 . . . . 1.58 111.667 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 74.2 p -72.89 -44.62 61.07 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.067 0.395 . . . . 1.41 112.067 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 34.5 m -61.58 -29.5 46.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 111.625 0.231 . . . . 1.42 111.625 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 91.5 mt -74.15 -57.9 3.65 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.916 0.389 . . . . 1.91 111.356 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -56.23 -29.78 61.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.887 -0.597 . . . . 1.55 111.538 -179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.7 tp -88.23 -19.48 7.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.86 110.963 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 182' ' ' VAL . . . -63.33 -51.34 55.5 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 121.067 -0.587 . . . . 0.74 113.424 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.596 ' O ' HG22 ' A' ' 182' ' ' VAL . 42.7 m-85 -58.91 -53.07 70.08 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.107 0.41 . . . . 1.78 112.107 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 179' ' ' TYR . 24.3 Cg_endo -61.44 -26.55 81.33 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 121.851 1.701 . . . . 0.92 113.514 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.551 HG22 ' O ' ' A' ' 178' ' ' GLY . 9.8 tp -88.2 -20.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 113.168 0.803 . . . . 1.77 113.168 -178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.4 m -79.58 -40.57 21.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 113.406 0.891 . . . . 1.34 113.406 -178.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 30.2 p-90 -93.37 -12.48 29.83 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.76 0.652 . . . . 2.51 112.76 -178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.417 HD13 ' CE2' ' A' ' 132' ' ' TYR . 6.4 tp -66.58 -33.78 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 N-CA-C 112.148 0.425 . . . . 2.02 112.148 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.609 HG13 ' HD2' ' A' ' 187' ' ' PRO . 3.2 pt -63.18 -4.11 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.468 0.544 . . . . 2.45 112.468 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . 134.35 -55.35 0.74 Allowed Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.161 -1.018 . . . . 1.73 113.18 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.609 ' HD2' HG13 ' A' ' 185' ' ' ILE . 56.1 Cg_exo -32.83 146.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.496 2.798 . . . . 3.05 112.983 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.6 t 63.97 12.01 6.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.88 -0.6 . . . . 4.04 109.719 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.89 -88.62 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.494 -0.775 . . . . 4.48 112.187 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -158.71 85.53 0.84 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 7.96 110.818 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.658 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -143.76 -73.19 0.03 OUTLIER Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.855 -0.688 . . . . 3.23 112.295 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 67.5 t-105 -145.35 -46.3 0.22 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.952 0.406 . . . . 6.03 110.634 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 55.3 mt -96.15 148.29 5.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.981 -0.554 . . . . 3.18 110.632 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -162.05 16.27 0.09 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.605 0.241 . . . . 3.39 111.493 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -100.79 -165.57 1.22 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.579 -0.282 . . . . 5.76 111.039 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 7.7 t -59.53 -15.27 17.01 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.396 -0.365 . . . . 2.5 111.074 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 49.3 mm -58.65 -34.39 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.209 -0.45 . . . . 2.4 111.083 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -51.5 -52.45 46.59 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.353 -0.385 . . . . 2.66 110.764 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 79.9 p -66.26 -31.42 72.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 1.81 110.789 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -61.38 -32.05 71.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.017 -0.538 . . . . 2.21 110.757 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -81.02 -40.84 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 2.18 111.088 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -70.25 -19.05 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 2.01 111.34 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 78.7 m -96.43 -41.74 8.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.915 0.388 . . . . 1.93 111.32 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.8 tp -69.07 -32.42 71.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.092 -0.503 . . . . 1.7 111.848 -179.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.677 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 42.6 tp -63.19 -54.49 44.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 121.032 -0.267 . . . . 1.28 111.527 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.3 Cg_exo -54.23 -42.97 62.73 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.872 1.714 . . . . 0.79 111.633 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -61.3 -35.86 78.52 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.177 -0.465 . . . . 1.51 110.341 179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -74.45 -19.48 60.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.913 -0.585 . . . . 1.93 110.346 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 37.7 t -86.6 -27.4 23.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.77 -0.65 . . . . 1.71 110.992 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -81.9 -40.16 22.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.351 -0.386 . . . . 2.04 110.989 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.434 HG23 ' N ' ' A' ' 212' ' ' GLY . 31.2 m -67.43 -44.4 86.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.369 -0.378 . . . . 2.89 111.073 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 211' ' ' VAL . . . -62.81 -26.6 68.92 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.619 -0.8 . . . . 1.31 112.196 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -64.81 -43.16 94.04 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.619 0.247 . . . . 2.87 111.064 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.3 p -61.27 -50.35 73.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.359 -0.382 . . . . 2.38 110.972 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -66.15 -20.08 66.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.946 0.403 . . . . 3.42 110.488 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 10.2 tt -77.37 -40.33 44.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 1.24 110.908 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -69.82 -25.97 64.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.286 -0.416 . . . . 2.44 111.341 -179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 92.2 mt -72.38 -57.43 4.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.451 -0.34 . . . . 2.51 111.246 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -75.52 -20.4 58.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 3.01 111.08 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -65.22 -59.11 8.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.948 -0.644 . . . . 1.59 113.201 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.47 -59.4 2.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.701 0.251 . . . . 3.49 111.135 -179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 31.7 ttm180 52.3 85.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 5.74 111.226 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . 0.421 HD21 ' H ' ' A' ' 31' ' ' GLY . 3.7 m-20 -64.18 162.19 14.96 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 5.46 111.094 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 tp -136.73 -20.67 1.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.014 -0.539 . . . . 6.13 110.868 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 19.9 p30 -161.32 150.95 16.78 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.11 -0.496 . . . . 6.46 110.885 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -157.96 -76.81 0.08 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 6.94 110.995 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.3 t 54.92 82.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.229 -0.441 . . . . 6.83 110.893 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -82.32 -66.79 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 10.77 110.813 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.152 -0.928 . . . . 9.41 110.933 -179.849 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 83.2 mtp . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 120.787 0.327 . . . . 8.91 111.019 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -123.39 115.12 21.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.114 -0.494 . . . . 6.76 110.973 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.426 ' N ' HD12 ' B' ' 3' ' ' LEU . 7.0 mp -115.44 -59.86 1.95 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.127 -0.488 . . . . 6.25 110.73 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -168.07 120.74 0.87 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.243 -0.435 . . . . 5.44 110.87 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.446 ' C ' ' H ' ' B' ' 7' ' ' LEU . 50.3 m -91.01 -52.69 4.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 3.84 111.011 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.4 ' O ' HG12 ' B' ' 10' ' ' ILE . 29.0 tp 72.73 -30.35 0.21 Allowed 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.843 -0.617 . . . . 3.08 111.698 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.446 ' H ' ' C ' ' B' ' 5' ' ' SER . 76.3 mt -58.0 -54.87 42.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.886 0.374 . . . . 2.35 110.95 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.621 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 43.5 m80 -62.46 -23.79 67.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.085 -0.507 . . . . 1.39 110.769 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 53.0 t-105 -75.16 -31.96 61.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.049 -0.523 . . . . 1.1 110.83 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.4 HG12 ' O ' ' B' ' 6' ' ' LEU . 45.8 mm -74.45 -30.05 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.004 0.431 . . . . 1.71 110.315 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -63.58 -53.24 54.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.829 -0.623 . . . . 1.48 110.688 179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.7 p -59.13 -35.53 57.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.353 -0.385 . . . . 0.95 110.987 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.18 -47.98 83.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.97 110.859 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.29 -17.57 66.29 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.78 -0.724 . . . . 0.8 112.328 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.472 ' HG3' ' HA2' ' B' ' 48' ' ' GLY . 25.8 mmt -78.49 -38.73 40.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.74 0.305 . . . . 1.29 110.771 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 51.3 p -60.43 -51.05 71.13 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.313 -0.403 . . . . 1.36 110.753 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -62.43 -31.93 53.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.095 -0.502 . . . . 1.23 110.574 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.424 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -71.04 -16.72 75.08 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.823 -0.703 . . . . 0.88 111.806 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -76.17 -56.14 4.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.743 0.306 . . . . 0.98 110.436 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.04 -20.63 64.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.096 0.474 . . . . 2.12 110.29 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -58.34 -19.78 38.08 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.677 -0.692 . . . . 2.0 110.696 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.814 ' O ' ' OG ' ' B' ' 26' ' ' SER . 0.2 OUTLIER -71.9 -34.13 68.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.975 0.417 . . . . 4.26 110.464 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 18.2 t-105 -70.04 -36.11 74.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.853 -0.612 . . . . 3.62 111.033 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 78.2 p -85.62 -38.06 18.83 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.622 0.601 . . . . 2.55 112.622 -179.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.6 tp -85.09 -0.67 55.25 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.147 0.425 . . . . 3.11 112.147 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.814 ' OG ' ' O ' ' B' ' 22' ' ' PHE . 19.0 m -61.38 -28.89 69.56 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 119.713 -0.795 . . . . 3.02 111.07 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -44.56 -23.91 0.15 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.84 0.829 . . . . 5.89 109.829 179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.914 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 1.2 m-20 -66.31 -154.03 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.434 0 CA-C-N 114.094 -1.412 . . . . 5.02 108.955 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.914 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 58.6 Cg_exo -2.05 115.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.065 0 C-N-CA 124.394 3.396 . . . . 3.53 117.174 -175.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 42.5 35.29 0.63 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.605 -1.18 . . . . 7.88 112.076 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' B' ' 26' ' ' SER . . . 74.97 -50.6 2.29 Favored Glycine 0 N--CA 1.45 -0.384 0 N-CA-C 111.623 -0.591 . . . . 4.61 111.623 -179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.42 HG13 ' O ' ' B' ' 32' ' ' VAL . 3.0 p -143.08 107.27 5.29 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.925 0.362 . . . . 4.73 111.186 176.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 93.3 Cg_endo -84.5 116.17 1.95 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 120.969 1.113 . . . . 3.75 112.125 178.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -84.37 -25.44 29.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.067 0.937 . . . . 3.76 109.941 177.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.689 ' HB2' ' HE1' ' B' ' 89' ' ' TRP . 0.1 OUTLIER -83.25 -65.79 0.97 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 113.829 -1.532 . . . . 3.17 114.514 -176.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.557 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 37.5 tt0 -59.55 -63.01 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.483 0.92 . . . . 2.57 113.483 -176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.465 ' HA ' ' HB3' ' B' ' 40' ' ' ALA . 3.1 m-85 -55.25 -19.52 8.53 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.542 0.571 . . . . 5.74 112.542 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 59.5 tp -66.96 -65.15 0.72 Allowed 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.216 0.531 . . . . 1.72 109.596 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.9 t -66.79 -29.13 45.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.748 -0.66 . . . . 1.95 110.431 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' B' ' 37' ' ' TYR . . . -72.69 -13.07 61.26 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.756 -0.656 . . . . 1.2 111.004 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.4 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 56.2 ttp -87.25 -33.53 19.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 2.12 110.159 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -70.34 -30.85 67.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.903 -0.59 . . . . 1.49 111.367 179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.436 ' HB ' ' HD3' ' B' ' 44' ' ' PRO . 96.5 mt -56.46 -54.94 47.94 Favored Pre-proline 0 CA--C 1.538 0.484 0 N-CA-C 112.614 0.598 . . . . 0.77 112.614 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.436 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 58.2 Cg_endo -70.35 -42.06 3.07 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.354 2.036 . . . . 0.68 113.259 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 88.3 mt -50.85 -57.7 2.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.415 -0.357 . . . . 1.63 111.573 -179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -63.65 -48.18 78.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.379 -0.373 . . . . 1.91 111.178 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.402 ' HA ' ' OD1' ' B' ' 75' ' ' ASP . 95.9 p -65.77 -3.9 5.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.065 -0.516 . . . . 1.22 111.651 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . 0.472 ' HA2' ' HG3' ' B' ' 15' ' ' MET . . . -94.14 -60.82 1.1 Allowed Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.608 -0.806 . . . . 0.55 112.5 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.421 HD22 ' SG ' ' C' ' 134' ' ' CYS . 85.9 mt -57.94 -27.53 63.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.816 0.341 . . . . 0.87 111.061 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.18 -55.94 18.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.216 -0.447 . . . . 0.55 111.126 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 15.8 m-85 -60.98 -39.28 89.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.19 -0.459 . . . . 1.06 110.978 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.3 ttp -51.21 -37.8 48.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.187 0.518 . . . . 1.19 110.084 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.61 -40.26 88.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.562 -0.745 . . . . 0.66 111.002 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 54.6 mtt -51.9 -32.89 34.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.072 -0.513 . . . . 0.86 110.381 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.621 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -72.99 -39.59 65.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.507 . . . . 0.84 110.391 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.497 HG21 HD23 ' C' ' 130' ' ' LEU . 13.9 mt -75.9 -0.33 2.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.894 -0.594 . . . . 1.44 110.656 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.99 54.76 1.66 Allowed 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.628 -0.715 . . . . 1.55 111.308 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -134.2 112.84 11.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 2.24 110.602 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.36 15.9 0.65 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.875 -0.679 . . . . 1.26 112.41 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -145.29 129.27 17.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.906 0.384 . . . . 2.31 110.993 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 19.2 m -118.74 143.73 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.049 -0.523 . . . . 1.81 110.907 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -85.52 87.1 7.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 3.18 110.749 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.81 127.89 44.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 2.03 111.06 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.18 23.98 12.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.064 -0.516 . . . . 2.48 111.556 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.44 -15.48 58.52 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.712 -0.756 . . . . 2.37 112.695 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -99.57 142.79 30.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.821 0.343 . . . . 2.28 110.935 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -93.58 131.94 39.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 1.78 111.144 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.09 132.77 53.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 1.05 111.02 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.623 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 48.2 m-70 -92.32 70.79 5.21 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 121.227 0.536 . . . . 1.11 111.092 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -56.63 -57.03 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.528 -0.76 . . . . 2.3 111.604 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.475 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -60.01 -24.54 64.56 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 116.171 -0.468 . . . . 0.72 112.25 -179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.623 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 18.4 tpp180 -63.49 -52.08 62.8 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.175 0.435 . . . . 3.04 112.175 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.463 ' HA ' ' HE3' ' B' ' 76' ' ' TRP . 29.5 p90 -88.67 -20.88 24.32 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.633 -0.427 . . . . 1.79 112.073 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.475 HG22 ' O ' ' B' ' 71' ' ' ALA . 7.5 tp -58.4 -37.89 66.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 C-N-CA 120.376 -0.529 . . . . 1.44 109.683 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.402 ' OD1' ' HA ' ' B' ' 47' ' ' SER . 31.7 t70 -68.88 -24.93 64.39 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.077 -0.712 . . . . 1.31 109.077 178.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.463 ' HE3' ' HA ' ' B' ' 73' ' ' TYR . 8.3 m0 -85.08 8.2 18.85 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-N 115.538 -0.756 . . . . 2.01 110.679 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.512 ' HE2' HD11 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -105.5 -23.86 12.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.602 -0.726 . . . . 1.43 110.893 179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.466 ' O ' HD23 ' B' ' 82' ' ' LEU . 23.9 m -114.53 -30.28 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.163 -0.471 . . . . 1.21 112.232 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.429 HG23 HG23 ' B' ' 43' ' ' ILE . 58.6 m -86.82 -43.33 12.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.853 0.316 . . . . 1.18 111.853 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.562 HG21 HD11 ' B' ' 113' ' ' ILE . 22.8 m -58.93 -50.0 90.34 Favored Pre-proline 0 C--N 1.327 -0.395 0 N-CA-C 112.004 0.372 . . . . 1.65 112.004 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 48.5 Cg_exo -56.14 -43.03 60.24 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.075 1.85 . . . . 1.06 112.161 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.466 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.4 mm? -77.62 -9.3 58.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 1.58 110.852 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.56 -44.59 42.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.285 -0.416 . . . . 1.49 110.322 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.536 HD23 ' H ' ' B' ' 84' ' ' LEU . 0.9 OUTLIER -79.78 -36.57 36.9 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.308 -0.405 . . . . 1.72 110.677 179.645 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.442 ' N ' ' HG ' ' B' ' 84' ' ' LEU . 78.4 mt -61.72 -29.63 70.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 1.96 110.43 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 35.6 t -68.55 -32.95 73.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.028 -0.533 . . . . 1.24 110.115 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.438 HD23 ' HE1' ' B' ' 213' ' ' PHE . 53.4 mt -66.0 -46.67 77.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.815 -0.629 . . . . 1.21 110.276 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 53.0 m -66.49 -38.73 87.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 1.32 110.762 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . 0.689 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 61.3 t-105 -63.0 -28.9 70.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.075 -0.512 . . . . 2.15 110.793 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 44.0 m -78.15 -32.6 50.37 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.176 -0.466 . . . . 1.44 110.977 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -70.31 -43.27 70.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.994 -0.548 . . . . 1.05 111.23 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 21.0 ptp -113.44 123.15 49.38 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.253 -0.431 . . . . 2.68 110.81 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -87.69 -15.97 35.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 2.71 110.906 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -137.28 173.62 11.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 4.19 110.71 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 8.5 tp -153.99 146.49 14.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 2.79 111.14 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -122.14 -71.46 0.73 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 5.27 111.063 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -145.19 -168.48 2.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.239 -0.437 . . . . 5.57 110.829 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 20.0 t70 65.41 144.17 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.916 -0.584 . . . . 4.24 111.591 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -153.4 33.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.89 -0.595 . . . . 5.39 110.779 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 m -77.0 -51.18 11.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.152 -0.476 . . . . 2.16 111.01 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.34 -34.71 78.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 2.58 110.797 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 46.0 mm -74.15 -49.11 34.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 2.29 111.038 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.41 -17.18 70.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.725 -0.75 . . . . 1.48 112.605 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.437 ' HE2' ' HB ' ' B' ' 146' ' ' ILE . 63.0 t80 -74.91 -57.67 3.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.719 0.295 . . . . 2.76 110.846 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.497 HD13 HD12 ' B' ' 84' ' ' LEU . 3.1 pp -66.72 -21.05 66.08 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.409 -0.36 . . . . 2.22 111.162 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . 0.436 ' N ' HD12 ' B' ' 105' ' ' LEU . 72.3 mtp -77.95 -52.47 8.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.292 -0.413 . . . . 2.36 111.073 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.0 m -58.32 -46.83 85.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.35 -0.387 . . . . 1.92 110.749 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.418 ' HB ' HD13 ' B' ' 142' ' ' ILE . 80.8 p -62.1 -37.23 84.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.858 -0.61 . . . . 2.06 111.388 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.587 HE21 HD11 ' B' ' 113' ' ' ILE . 57.7 tp60 -63.2 -43.31 98.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.118 -0.492 . . . . 2.87 111.25 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.414 HG13 ' O ' ' B' ' 106' ' ' MET . 70.8 mt -55.29 -43.8 72.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.29 -0.414 . . . . 1.98 111.109 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.2 t -61.28 -39.11 81.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.018 -0.537 . . . . 1.62 111.351 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 98.8 t -66.59 -40.18 85.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 1.04 111.292 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.587 HD11 HE21 ' B' ' 109' ' ' GLN . 46.6 mm -67.06 -36.68 77.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.799 0.333 . . . . 2.46 110.642 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 54.3 m -53.71 -51.7 62.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.103 -0.499 . . . . 0.83 110.863 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 83.8 p -62.42 -28.99 70.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.03 -0.532 . . . . 0.74 110.336 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -65.37 -32.97 85.3 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.881 -0.676 . . . . 0.6 112.292 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.512 HD11 ' HE2' ' B' ' 77' ' ' MET . 2.0 mt -69.49 -61.28 1.85 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.057 0.456 . . . . 1.42 110.262 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.561 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 50.4 mt -58.39 -25.46 27.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.541 -0.754 . . . . 1.51 111.392 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.41 -44.97 69.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 1.09 110.851 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -90.93 -17.99 25.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 2.25 110.751 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 94.0 mt -86.83 22.45 1.97 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.316 -0.402 . . . . 1.16 110.835 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 35.5 t -81.1 126.85 31.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.47 . . . . 1.76 111.118 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -76.89 -37.8 54.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.947 -0.569 . . . . 2.89 110.867 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 73.8 mtp180 -107.66 146.25 32.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.119 -0.491 . . . . 2.67 110.775 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -80.31 -9.93 59.74 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.916 -0.583 . . . . 3.25 111.178 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 91.8 t90 -92.79 -29.59 15.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.432 -0.349 . . . . 4.07 111.459 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.4 p -82.38 -27.48 8.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.473 -0.33 . . . . 1.41 111.805 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -57.38 -27.28 62.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.55 -0.296 . . . . 2.47 111.15 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -69.92 -35.81 74.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 2.61 111.086 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.86 -52.24 57.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.371 -0.377 . . . . 2.07 110.654 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.402 ' HE1' ' HB1' ' A' ' 53' ' ' ALA . 2.6 m95 -63.93 -30.49 71.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 1.3 110.695 179.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -57.96 -45.14 87.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.963 -0.562 . . . . 1.75 110.56 179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 50.1 mm -72.01 -34.11 49.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.052 -0.522 . . . . 1.67 110.909 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 40.5 t -63.55 -34.51 77.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 1.54 110.835 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.38 -53.63 20.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.7 112.475 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 33.1 m -67.29 -25.43 33.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.675 0.274 . . . . 1.44 111.236 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -60.93 -51.39 69.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 1.82 110.88 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.69 -36.04 81.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.277 -0.42 . . . . 0.94 110.924 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 91.1 t80 -70.91 -23.94 62.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 1.6 111.02 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 35.5 mt -73.06 -62.61 1.4 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.506 -0.315 . . . . 2.01 111.64 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.413 HG13 ' N ' ' B' ' 142' ' ' ILE . 27.3 pt -54.1 -38.9 39.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.436 -0.347 . . . . 1.96 111.739 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.418 HD13 ' HB ' ' B' ' 108' ' ' THR . 93.7 mt -70.85 -34.77 57.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.27 -0.423 . . . . 2.88 111.214 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 44.8 tp -60.81 -45.82 92.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.296 -0.411 . . . . 1.52 111.247 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 72.9 t-105 -71.08 -25.91 62.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.933 0.397 . . . . 4.15 110.878 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.06 -16.76 68.86 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.908 -0.663 . . . . 1.59 112.779 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.437 ' HB ' ' HE2' ' B' ' 104' ' ' PHE . 20.2 tt -103.93 -13.1 8.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.752 0.31 . . . . 2.13 111.615 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 4.6 m95 -72.92 -12.42 60.95 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 111.973 0.361 . . . . 1.78 111.973 -179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.593 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 36.6 t30 -100.05 -49.68 0.2 Allowed Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 112.069 0.396 . . . . 2.45 112.069 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 37.7 Cg_exo -62.61 0.46 1.46 Allowed 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.393 2.062 . . . . 2.36 113.303 -179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.487 HD22 HG21 ' B' ' 169' ' ' VAL . 94.5 mt -58.87 92.61 0.02 OUTLIER 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.741 0.305 . . . . 2.88 111.049 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 52.63 46.28 27.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.114 -0.493 . . . . 8.07 111.071 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.42 -51.15 12.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.202 -0.454 . . . . 2.8 111.215 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -72.78 -29.69 63.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.425 -0.352 . . . . 4.58 110.781 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 71.6 p -90.65 4.98 49.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 3.81 110.991 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.7 ttm180 -64.91 -36.34 84.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.269 -0.423 . . . . 5.22 110.696 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 8.8 t -87.73 17.52 4.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.039 -0.528 . . . . 3.42 110.923 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -108.99 -69.57 0.85 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.968 -0.56 . . . . 4.2 110.674 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 48.2 t -130.35 114.55 15.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.172 -0.467 . . . . 2.75 110.813 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 81.1 p -73.1 -30.85 63.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 2.4 110.979 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -62.92 -53.55 52.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 3.46 110.853 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 39.2 tp -60.85 -33.05 72.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.144 -0.48 . . . . 2.57 111.11 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.82 -34.08 76.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.074 -0.512 . . . . 1.72 111.277 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -74.11 -41.4 61.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 2.69 110.986 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 36.9 mt -60.03 -41.14 91.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 2.16 110.975 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -78.49 -31.33 47.72 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.003 -0.544 . . . . 2.13 111.112 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.55 -43.05 93.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.943 0.402 . . . . 1.94 110.693 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -84.0 -22.04 31.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.046 -0.525 . . . . 3.33 110.931 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 55.4 tp -67.17 -54.25 22.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.327 -0.397 . . . . 1.56 111.065 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.487 HG21 HD22 ' B' ' 150' ' ' LEU . 48.0 t -58.76 -27.2 34.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.291 -0.413 . . . . 1.59 111.142 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 66.7 m -57.41 -58.22 9.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 1.14 111.261 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -60.92 -26.44 67.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.265 -0.425 . . . . 3.87 110.712 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -71.75 -33.12 68.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.457 . . . . 1.61 111.47 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.453 ' O ' HG22 ' B' ' 177' ' ' ILE . 66.6 p -78.3 -45.64 22.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.582 -0.281 . . . . 1.3 111.442 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.94 -29.2 42.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.451 -0.341 . . . . 1.53 111.502 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 60.7 tp -78.52 -54.8 5.77 Favored 'General case' 0 C--O 1.236 0.395 0 CA-C-O 120.901 0.381 . . . . 1.99 111.011 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -55.05 -34.34 63.47 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.034 -0.53 . . . . 1.5 110.761 179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.453 HG22 ' O ' ' B' ' 173' ' ' THR . 15.7 tt -88.02 -18.46 8.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.191 0.519 . . . . 1.46 109.944 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.497 ' O ' HG22 ' B' ' 181' ' ' ILE . . . -55.66 -43.82 86.3 Favored Glycine 0 C--N 1.334 0.436 0 CA-C-N 115.343 -0.844 . . . . 0.67 113.188 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.707 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 74.0 m-85 -73.49 -54.82 3.82 Favored Pre-proline 0 CA--C 1.535 0.38 0 CA-C-N 117.14 0.47 . . . . 1.73 111.25 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.707 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 38.5 Cg_exo -57.19 -19.77 35.49 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.123 1.882 . . . . 0.93 113.564 -179.224 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.497 HG22 ' O ' ' B' ' 178' ' ' GLY . 16.2 tt -87.17 -34.66 7.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.724 -0.391 . . . . 1.36 111.436 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.536 HG23 ' CD2' ' B' ' 183' ' ' TRP . 35.3 m -79.93 -24.84 11.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.651 0.263 . . . . 1.19 111.555 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.536 ' CD2' HG23 ' B' ' 182' ' ' VAL . 6.6 m95 -89.47 -13.58 37.23 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.636 -0.256 . . . . 2.73 111.552 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 20.3 tt -91.62 -30.31 4.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.656 0.265 . . . . 1.93 111.533 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.426 HG23 ' O ' ' B' ' 181' ' ' ILE . 26.8 pt -61.31 -26.88 40.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.797 0.332 . . . . 2.64 111.279 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.427 ' HA3' ' HA2' ' B' ' 191' ' ' GLY . . . -166.54 -171.56 32.82 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.684 -0.77 . . . . 1.93 112.537 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.81 83.74 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.517 2.144 . . . . 2.97 112.186 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 55.0 m 55.84 57.39 5.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.084 -0.507 . . . . 4.5 110.969 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . 0.403 ' HA3' HD11 ' B' ' 193' ' ' ILE . . . 158.12 -164.34 33.28 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.585 -0.816 . . . . 4.5 112.735 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . 0.657 ' H ' HD11 ' B' ' 193' ' ' ILE . 86.9 m-85 -52.31 -60.71 2.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.68 0.276 . . . . 7.89 111.402 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . 0.431 ' H ' HG12 ' B' ' 193' ' ' ILE . . . 167.16 135.19 1.82 Allowed Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.657 -0.782 . . . . 3.62 112.406 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 96.0 m95 58.08 22.79 9.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.761 0.315 . . . . 6.54 111.202 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.657 HD11 ' H ' ' B' ' 190' ' ' PHE . 30.2 pt -115.71 144.77 22.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.934 0.397 . . . . 3.16 111.322 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 24.5 p-10 -138.62 -139.4 0.14 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.851 -0.613 . . . . 3.39 110.642 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 63.96 -163.23 0.27 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.537 -0.301 . . . . 5.56 111.184 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 6.2 t -63.73 -15.52 58.74 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.867 0.365 . . . . 2.68 111.61 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.502 HD12 ' H ' ' B' ' 197' ' ' ILE . 3.0 mp -57.92 -29.53 36.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.193 -0.458 . . . . 2.2 111.386 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 46.8 m-20 -57.87 -60.9 3.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.962 0.41 . . . . 2.49 110.817 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 81.4 p -71.49 -16.25 62.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.076 -0.511 . . . . 1.76 111.146 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -63.83 -40.13 95.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 2.18 110.973 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 51.5 tp -84.24 -29.11 26.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.78 111.127 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.22 -25.13 66.77 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.427 -0.351 . . . . 1.98 111.287 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.461 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 26.6 p -95.82 -33.34 12.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.966 0.412 . . . . 1.65 111.133 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 64.5 tp -69.26 -34.36 74.65 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.115 -0.493 . . . . 1.11 111.974 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.534 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -63.79 -54.31 42.77 Favored Pre-proline 0 CA--C 1.533 0.31 0 C-N-CA 121.093 -0.243 . . . . 1.43 111.213 -179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.534 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 75.8 Cg_exo -51.45 -47.09 27.76 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.036 1.824 . . . . 0.77 112.329 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -60.6 -28.5 68.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.811 0.338 . . . . 1.6 110.903 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -79.27 -19.52 50.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.125 -0.489 . . . . 1.77 110.973 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 79.1 p -86.12 -32.63 21.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.501 -0.318 . . . . 1.54 110.874 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -72.53 -47.7 46.32 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.381 -0.372 . . . . 2.01 111.022 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 7.5 p -60.47 -41.09 86.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.208 -0.451 . . . . 2.65 110.929 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.93 -28.8 73.94 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.671 -0.776 . . . . 1.33 112.166 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . 0.438 ' HE1' HD23 ' B' ' 87' ' ' LEU . 65.1 t80 -64.83 -42.69 94.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.769 0.319 . . . . 2.29 110.796 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 36.0 t -58.1 -58.06 10.12 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 2.12 110.786 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -62.47 -19.84 63.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.141 -0.481 . . . . 3.6 111.08 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 9.8 tt -73.91 -44.81 54.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.327 -0.397 . . . . 1.51 111.133 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -66.78 -25.91 66.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.839 0.352 . . . . 2.22 110.948 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.435 HD13 ' ND2' ' B' ' 28' ' ' ASN . 64.2 tp -68.2 -59.25 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 2.69 111.369 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 38.4 t60 -75.59 -22.9 56.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.462 -0.335 . . . . 3.4 111.176 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -61.92 -57.11 18.88 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.882 -0.675 . . . . 1.67 113.006 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 50.9 tp -82.79 -58.61 2.81 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.701 0.286 . . . . 3.39 111.085 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 57.02 88.51 0.05 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.259 -0.428 . . . . 5.91 111.005 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -61.16 139.05 58.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.089 -0.505 . . . . 5.26 111.099 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 1.9 pp -142.45 20.8 2.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.097 -0.501 . . . . 6.81 110.742 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -128.58 -74.74 0.57 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.959 -0.564 . . . . 7.02 110.806 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 56.12 93.82 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.004 0.43 . . . . 8.21 111.144 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 48.9 m -149.11 76.47 1.33 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.969 -0.559 . . . . 8.1 110.771 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -62.71 174.59 0.99 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 13.28 111.158 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.172 -0.918 . . . . 10.4 110.99 -179.907 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.747 0.308 . . . . 8.1 111.137 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -106.54 159.0 16.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 6.27 111.017 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 66.6 tp -131.8 129.89 41.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.053 -0.522 . . . . 6.2 110.925 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.78 136.15 33.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 4.82 111.023 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.437 ' HB2' HD23 ' C' ' 7' ' ' LEU . 81.2 p -141.81 139.83 32.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 3.25 110.831 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 96.1 mt -105.25 9.63 33.91 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.246 -0.433 . . . . 2.79 111.087 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.535 ' H ' HD22 ' C' ' 7' ' ' LEU . 2.4 mm? -71.28 -39.49 71.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.066 0.46 . . . . 2.08 110.23 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.633 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 41.5 m80 -74.85 -23.65 58.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.015 -0.539 . . . . 1.43 110.207 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -75.11 -42.27 56.8 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.896 -0.593 . . . . 1.16 110.963 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 17.0 tt -70.62 -22.98 23.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.162 0.506 . . . . 2.09 110.288 179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -67.82 -54.42 19.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.69 -0.686 . . . . 1.58 110.79 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.1 p -59.27 -31.26 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.246 -0.433 . . . . 1.0 111.067 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.2 -53.82 49.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.279 -0.419 . . . . 0.96 111.008 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.02 -21.21 58.83 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.847 -0.692 . . . . 0.96 112.531 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 22.1 mmt -79.32 -28.99 42.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.744 0.307 . . . . 1.3 110.99 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 52.7 m -67.15 -52.18 44.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 1.52 110.713 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.476 HD12 ' N ' ' C' ' 18' ' ' GLY . 2.6 pp -62.6 -32.1 54.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.186 -0.461 . . . . 1.9 110.916 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . 0.476 ' N ' HD12 ' C' ' 17' ' ' ILE . . . -62.28 -37.42 94.54 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.724 -0.751 . . . . 0.96 112.038 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.92 -27.61 61.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.732 0.301 . . . . 1.07 110.706 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 29.4 tp -71.3 -21.49 62.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.101 -0.5 . . . . 2.08 110.79 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -58.02 -19.34 30.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.846 -0.616 . . . . 2.02 111.372 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -62.25 -30.76 71.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.658 0.266 . . . . 4.98 111.062 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 42.5 t-105 -89.96 -35.2 15.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.404 -0.362 . . . . 4.29 110.906 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 47.7 m -62.21 -47.06 86.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.341 -0.39 . . . . 2.47 110.943 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 28.4 tp -87.6 -1.26 57.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 2.9 111.1 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . . . . . . . . . 85.7 p -56.52 -24.11 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.354 -0.385 . . . . 2.74 111.537 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -47.65 -36.03 10.35 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 121.22 0.533 . . . . 5.85 109.777 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 6.3 p30 -170.92 131.9 0.86 Allowed Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.214 -0.903 . . . . 4.52 109.969 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' C' ' 28' ' ' ASN . 51.1 Cg_endo -94.52 142.53 1.48 Allowed 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.833 2.356 . . . . 3.22 112.472 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . 0.432 HH11 ' HB3' ' C' ' 218' ' ' LEU . 95.8 mtt180 -91.31 64.1 5.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 8.68 111.081 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.5 -40.06 2.67 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.815 -0.707 . . . . 4.14 112.971 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.52 ' O ' HG23 ' C' ' 32' ' ' VAL . 27.7 m -79.5 113.14 34.51 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-O 121.005 0.431 . . . . 5.09 111.364 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' C' ' 32' ' ' VAL . 6.5 Cg_exo -78.76 167.75 21.95 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.406 2.737 . . . . 3.1 112.614 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -41.84 -43.54 3.03 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.216 -0.447 . . . . 3.85 112.123 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -56.62 -40.09 74.75 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.709 0.29 . . . . 3.37 111.055 -179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -66.7 -37.54 84.93 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.357 -0.383 . . . . 2.72 110.306 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -65.32 -32.81 74.65 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.022 -0.535 . . . . 5.67 110.533 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 58.9 tp -59.19 -64.36 0.97 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.964 -0.562 . . . . 1.93 111.441 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 42.6 t -57.21 -43.13 81.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.241 -0.436 . . . . 1.88 111.157 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.12 -17.1 64.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 1.23 111.168 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.401 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.8 ttt -89.02 -28.2 20.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.92 0.391 . . . . 2.09 110.925 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -72.92 -27.63 61.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.927 -0.579 . . . . 1.41 111.273 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.489 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 54.3 mt -65.36 -52.33 46.67 Favored Pre-proline 0 CA--C 1.537 0.472 0 N-CA-C 112.375 0.509 . . . . 0.8 112.375 -179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 43.1 Cg_endo -66.93 -44.34 5.51 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.409 2.073 . . . . 0.72 113.497 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 14.5 tt -57.96 -40.06 74.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 111.895 0.331 . . . . 1.68 111.895 -179.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -73.92 -57.21 4.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.785 0.326 . . . . 1.68 110.887 -179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 77.6 p -60.52 -14.82 21.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.192 -0.458 . . . . 1.28 111.126 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.9 -55.08 3.92 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.673 -0.775 . . . . 0.51 112.668 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 64.3 mt -59.42 -35.36 73.84 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.661 0.267 . . . . 1.33 111.133 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.97 -58.08 9.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.394 -0.366 . . . . 0.57 111.384 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.498 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 14.7 m-85 -59.62 -43.49 93.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 1.67 111.275 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 54.7 ttp -49.96 -30.66 10.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.078 0.466 . . . . 1.42 110.484 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.76 -44.64 61.35 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.797 -0.638 . . . . 0.71 111.086 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 3.0 mpp? -55.34 -27.13 45.13 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-N 116.317 -0.401 . . . . 1.14 110.265 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.633 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.88 -45.0 62.81 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.107 -0.497 . . . . 0.88 110.208 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.451 HG22 ' O ' ' C' ' 56' ' ' ILE . 16.8 mt -80.2 5.35 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 115.878 -0.601 . . . . 1.38 110.507 179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 62.88 63.3 0.97 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.724 -0.671 . . . . 1.94 111.256 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -144.29 85.31 1.79 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.08 -0.509 . . . . 1.87 110.818 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.41 31.03 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.079 -0.582 . . . . 1.27 112.139 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' C' ' 60' ' ' LYS . 0.3 OUTLIER -145.61 147.48 32.09 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.747 0.308 . . . . 2.86 110.837 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 22.8 m -140.54 151.1 20.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.262 -0.426 . . . . 1.95 111.137 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -93.96 101.97 14.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 3.04 110.784 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -115.33 120.97 41.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.138 -0.483 . . . . 2.11 111.036 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.81 23.32 12.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.154 -0.475 . . . . 2.54 111.159 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 90.11 -13.22 65.43 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.902 -0.666 . . . . 2.47 112.789 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -98.34 143.52 28.72 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.997 0.427 . . . . 2.85 111.059 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.7 mt -84.49 106.79 15.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.614 . . . . 1.87 111.113 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -95.76 106.9 19.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 1.12 111.256 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.582 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 48.3 m-70 -83.73 74.0 10.21 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.094 -0.503 . . . . 1.26 110.762 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.517 ' O ' HG13 ' C' ' 74' ' ' ILE . 22.9 p90 -56.36 -55.07 38.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.99 -0.55 . . . . 2.08 111.094 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.527 ' HA ' HD12 ' C' ' 74' ' ' ILE . . . -53.43 -34.56 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.86 111.555 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.582 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 18.8 tpp180 -54.21 -51.48 64.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 1.96 111.22 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.529 ' O ' ' HB2' ' C' ' 76' ' ' TRP . 9.8 p90 -90.6 -5.94 55.26 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.557 -0.457 . . . . 1.8 111.63 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' C' ' 71' ' ' ALA . 10.2 mt -61.69 -40.19 85.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 109.26 -0.644 . . . . 1.18 109.26 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.405 ' O ' ' HB ' ' C' ' 79' ' ' THR . 15.4 t70 -64.63 -18.07 64.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.417 -0.81 . . . . 1.33 110.073 178.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.529 ' HB2' ' O ' ' C' ' 73' ' ' TYR . 0.7 OUTLIER -76.86 -25.1 52.74 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.071 -0.513 . . . . 1.85 111.619 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.426 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 40.8 mtp -85.22 -15.7 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 112.107 0.41 . . . . 1.56 112.107 -178.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 19.3 m -114.65 -43.86 4.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 112.816 0.673 . . . . 1.11 112.816 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' C' ' 75' ' ' ASP . 52.9 m -75.96 -50.76 14.0 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.537 0.569 . . . . 1.49 112.537 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.523 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 4.1 m -53.43 -50.65 81.73 Favored Pre-proline 0 C--N 1.327 -0.38 0 N-CA-C 112.705 0.632 . . . . 1.6 112.705 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.523 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 48.8 Cg_exo -54.93 -54.89 3.75 Favored 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 121.857 1.704 . . . . 1.01 111.76 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -62.42 -26.91 68.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.903 -0.59 . . . . 1.18 110.803 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' C' ' 83' ' ' LEU . 0.4 OUTLIER -65.7 -47.62 74.79 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 109.449 -0.575 . . . . 1.54 109.449 179.303 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.561 HD13 ' HB2' ' C' ' 109' ' ' GLN . 6.2 tt -65.41 -24.86 67.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.49 -0.777 . . . . 1.65 110.406 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.429 HD23 ' O ' ' C' ' 81' ' ' PRO . 3.9 mm? -82.85 -27.63 30.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.968 -0.56 . . . . 2.1 111.019 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 68.1 m -64.43 -38.24 90.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.32 -0.4 . . . . 1.38 110.865 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.89 -38.9 92.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.11 -0.495 . . . . 1.44 111.054 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 -35.2 73.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.487 -0.324 . . . . 1.87 110.961 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 55.7 m95 -76.39 -18.73 58.71 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.338 -0.392 . . . . 3.1 111.029 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 97.9 m -75.26 -47.07 29.74 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.418 . . . . 1.48 111.112 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.85 -50.32 12.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.206 -0.452 . . . . 1.02 111.05 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 52.8 ttm -96.49 110.03 22.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.185 -0.461 . . . . 2.34 110.727 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -79.76 -53.8 6.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.469 . . . . 3.21 111.428 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -110.51 145.59 37.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.43 -0.35 . . . . 4.54 111.357 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 8.9 tp -117.49 143.26 28.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.973 -0.558 . . . . 2.34 110.697 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -144.73 75.23 1.44 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.488 -0.323 . . . . 4.4 111.295 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm 58.79 101.2 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.145 -0.479 . . . . 5.54 111.447 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -169.14 -82.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.302 -0.408 . . . . 3.54 111.045 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 76.2 m95 51.02 62.17 2.86 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.295 -0.411 . . . . 5.21 111.036 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 59.1 m -110.59 -62.1 1.58 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.38 111.326 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 79.6 mt -73.52 -39.64 64.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.245 -0.434 . . . . 2.64 110.785 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 55.2 mt -64.52 -55.56 20.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.15 -0.477 . . . . 2.38 111.117 -179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -56.8 -34.76 65.55 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.986 -0.625 . . . . 1.62 112.674 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -66.79 -39.05 87.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.005 0.431 . . . . 2.93 110.477 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.466 ' HB3' HD11 ' C' ' 84' ' ' LEU . 78.6 mt -76.58 -24.48 53.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.843 -0.617 . . . . 2.16 110.936 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 88.0 mtp -69.45 -48.13 61.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 2.3 111.599 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 60.2 m -64.77 -56.22 14.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.962 0.41 . . . . 2.07 111.184 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 66.5 p -55.45 -25.44 36.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.995 -0.548 . . . . 2.3 111.513 -179.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.561 ' HB2' HD13 ' C' ' 84' ' ' LEU . 8.4 tp-100 -71.24 -46.41 61.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.381 -0.372 . . . . 2.48 110.972 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 46.3 mm -53.49 -35.01 24.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 1.93 110.859 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 25.8 t -67.17 -46.49 84.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.069 -0.514 . . . . 1.67 111.394 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 89.7 t -62.37 -51.71 68.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.311 -0.404 . . . . 1.11 111.747 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 65.5 mt -53.27 -40.33 38.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.571 -0.286 . . . . 2.59 111.093 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 57.2 m -54.07 -49.26 69.42 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.341 -0.39 . . . . 0.9 110.78 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 49.0 m -58.12 -33.3 68.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.048 -0.524 . . . . 0.92 110.478 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.02 -31.17 78.62 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.807 -0.711 . . . . 0.55 112.492 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.7 mt -71.51 -59.19 2.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.972 0.415 . . . . 1.49 110.424 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 6.9 tp -60.75 -28.39 42.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.845 -0.616 . . . . 1.66 111.441 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.79 -43.81 58.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.899 0.38 . . . . 0.94 110.886 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -91.79 -19.11 22.91 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.02 -0.536 . . . . 1.79 110.824 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.624 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 94.5 mt -82.69 11.09 6.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.293 -0.412 . . . . 1.29 110.822 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 81.1 p -66.74 135.41 53.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.091 -0.504 . . . . 2.15 110.874 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -84.93 -19.13 32.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.081 -0.509 . . . . 3.31 110.758 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.466 ' HB2' HG12 ' C' ' 127' ' ' VAL . 59.9 mtm180 -132.08 149.6 52.37 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.027 -0.533 . . . . 3.16 110.639 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -80.72 -9.73 59.78 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 4.24 110.89 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -91.09 -28.82 17.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 4.65 111.001 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' C' ' 124' ' ' ARG . 15.0 p -84.76 -25.52 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.362 -0.381 . . . . 1.31 111.107 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -56.18 -37.54 69.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.314 -0.403 . . . . 2.84 110.656 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . 0.431 ' O ' HG12 ' C' ' 133' ' ' ILE . 91.6 t80 -65.19 -34.7 79.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 2.7 110.66 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 56' ' ' ILE . 32.1 tp -68.17 -54.09 20.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 1.88 110.63 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.65 -28.45 65.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.327 -0.397 . . . . 1.38 110.426 179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -62.14 -46.56 88.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.988 -0.551 . . . . 1.76 110.433 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . 0.431 HG12 ' O ' ' C' ' 129' ' ' TYR . 28.4 mm -60.76 -30.29 46.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.089 -0.505 . . . . 2.15 110.848 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . 0.421 ' SG ' HD22 ' B' ' 49' ' ' LEU . 42.5 t -65.8 -49.06 69.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.067 -0.515 . . . . 1.56 111.236 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -60.23 -49.91 73.47 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.036 -0.602 . . . . 0.73 113.192 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 4.9 p -63.58 -42.11 94.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 111.829 0.307 . . . . 1.48 111.829 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 52.9 t -56.91 -37.94 72.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 1.51 111.067 -179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.85 -47.82 76.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.275 -0.42 . . . . 1.01 111.385 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -73.24 -18.27 61.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.201 -0.454 . . . . 2.05 111.416 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.83 -62.84 1.24 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 2.07 111.085 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 25.6 pt -59.2 -37.77 70.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 1.92 111.656 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.406 ' O ' HG13 ' C' ' 146' ' ' ILE . 37.8 mm -69.11 -35.61 69.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.339 -0.391 . . . . 2.64 111.251 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 62.2 tp -55.84 -54.26 46.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.433 -0.349 . . . . 1.51 111.215 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 62.1 t-105 -60.71 -31.24 70.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.365 -0.38 . . . . 3.58 110.794 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.18 -17.1 78.59 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.916 -0.659 . . . . 1.65 113.188 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' C' ' 149' ' ' PRO . 61.2 mt -105.94 -12.47 9.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.879 0.371 . . . . 2.46 111.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -65.92 -26.39 67.58 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.143 0.423 . . . . 2.27 112.143 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.604 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -92.12 -49.74 0.3 Allowed Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.426 0.528 . . . . 2.33 112.426 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 32.5 Cg_exo -59.48 0.42 0.54 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.379 2.053 . . . . 2.46 113.5 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' C' ' 146' ' ' ILE . 97.7 mt -57.21 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 120.683 0.278 . . . . 3.08 111.375 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 44.55 36.96 1.89 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.092 -0.504 . . . . 8.45 111.687 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -75.43 -23.27 56.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 2.9 110.934 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -82.01 -43.1 18.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.154 -0.475 . . . . 4.62 110.746 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 9.2 t -88.13 6.83 34.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 3.85 111.089 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -60.37 -30.6 69.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.177 -0.465 . . . . 5.12 110.95 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 73.7 p -84.73 -11.06 56.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.377 -0.374 . . . . 3.43 111.18 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -91.82 -25.58 18.92 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 3.98 110.642 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 47.4 t -165.29 113.68 1.01 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.018 -0.537 . . . . 2.4 110.95 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 42.3 t -77.59 -38.17 48.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.018 -0.537 . . . . 2.82 110.73 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . 0.427 ' O ' ' HG ' ' C' ' 164' ' ' LEU . 12.0 pt-20 -61.25 -43.32 99.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.241 -0.436 . . . . 3.18 110.833 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 39.7 tp -64.75 -34.53 78.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 2.5 110.699 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.98 -30.23 68.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.039 -0.528 . . . . 1.81 111.345 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -75.95 -32.06 59.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 2.13 110.978 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . 0.427 ' HG ' ' O ' ' C' ' 160' ' ' GLU . 85.5 mt -63.8 -50.65 68.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.272 -0.422 . . . . 2.21 110.905 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -70.38 -23.88 62.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.869 -0.605 . . . . 1.31 111.162 -179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -61.48 -51.58 68.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 2.26 111.113 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 60.2 tttp -83.65 -22.53 32.14 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.261 -0.427 . . . . 3.58 111.234 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 35.5 tp -63.0 -54.11 43.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.476 -0.329 . . . . 1.3 110.965 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.6 -30.11 47.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.15 -0.477 . . . . 1.73 111.429 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 81.9 m -53.32 -58.4 7.21 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.81 0.338 . . . . 1.43 111.278 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -59.8 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 3.72 110.5 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -66.94 -25.28 66.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.983 -0.553 . . . . 1.55 110.782 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.434 ' O ' HG22 ' C' ' 177' ' ' ILE . 33.1 m -79.53 -54.49 5.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.106 -0.497 . . . . 1.5 111.506 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 33.9 m -55.76 -25.16 18.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.507 -0.315 . . . . 1.84 111.529 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 67.4 tp -77.63 -57.08 4.01 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 120.96 0.41 . . . . 2.12 110.827 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . 0.503 ' HE1' HE22 ' C' ' 109' ' ' GLN . 0.9 OUTLIER -54.59 -35.48 63.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.881 -0.599 . . . . 1.0 111.179 179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.529 ' O ' HG13 ' C' ' 181' ' ' ILE . 17.6 tt -87.09 -19.49 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.75 110.302 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.88 -56.51 23.56 Favored Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.72 113.052 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.648 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 79.7 m-85 -55.31 -55.56 38.33 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.793 0.297 . . . . 1.8 111.342 -179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 82.4 Cg_exo -44.13 -40.01 12.03 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.929 1.752 . . . . 0.88 112.619 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.529 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.5 mt -57.93 -57.84 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.364 -0.38 . . . . 1.52 111.529 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.584 HG22 ' O ' ' C' ' 179' ' ' TYR . 1.4 m -51.14 -23.63 2.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.116 -0.493 . . . . 1.2 111.372 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -84.55 -51.66 6.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 2.47 111.949 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.421 HG22 ' HA ' ' C' ' 181' ' ' ILE . 18.2 tt -63.39 -33.09 59.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 112.581 0.586 . . . . 1.62 112.581 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' C' ' 190' ' ' PHE . 42.3 pt -56.65 -30.06 31.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 111.77 0.285 . . . . 2.63 111.77 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . -177.38 161.35 28.72 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.466 -0.873 . . . . 1.77 112.781 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.13 95.09 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.673 2.249 . . . . 3.03 112.382 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 41.9 t 57.56 63.03 1.95 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.977 -0.556 . . . . 4.22 111.247 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 133.57 -173.34 21.21 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.632 -0.795 . . . . 4.08 112.952 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . 0.576 ' H ' HD11 ' C' ' 193' ' ' ILE . 86.0 m-85 -74.01 96.58 2.69 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.693 0.282 . . . . 7.54 111.196 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 77.51 -158.6 47.45 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.76 -0.733 . . . . 3.29 113.052 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.5 m95 -72.73 79.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.673 0.273 . . . . 5.67 111.377 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.576 HD11 ' H ' ' C' ' 190' ' ' PHE . 46.3 pt -142.6 141.85 27.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.385 -0.37 . . . . 2.76 111.12 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -142.95 88.09 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.11 -0.495 . . . . 3.69 110.714 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.32 -172.01 3.33 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.252 -0.431 . . . . 5.34 111.146 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 7.5 t -74.49 -21.48 59.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 2.57 111.435 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 19.2 tt -56.46 -24.39 18.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.141 -0.481 . . . . 2.37 111.187 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.13 -56.12 25.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.125 -0.489 . . . . 2.68 110.965 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 63.4 m -59.28 -30.97 68.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.21 -0.45 . . . . 1.95 111.015 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 92.0 t80 -57.78 -46.95 83.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 2.05 111.011 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 59.1 tp -82.23 -26.42 33.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.464 -0.334 . . . . 1.91 111.235 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -69.67 -28.03 65.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.847 0.356 . . . . 2.04 110.475 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.484 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 69.2 m -95.52 -22.21 17.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.904 -0.589 . . . . 1.62 110.43 179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 63.7 tp -75.11 -39.22 60.77 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.768 -0.651 . . . . 1.49 111.574 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.601 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 21.8 tp -58.42 -51.3 82.82 Favored Pre-proline 0 CA--C 1.531 0.244 0 C-N-CA 121.034 -0.267 . . . . 1.32 110.85 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.601 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 50.3 Cg_exo -54.28 -49.58 16.49 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.936 1.757 . . . . 0.76 111.327 178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -55.52 -30.83 61.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.256 -0.429 . . . . 1.52 110.227 179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . 0.415 ' HA ' HG12 ' C' ' 211' ' ' VAL . 87.5 t80 -79.47 -28.22 41.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.973 -0.558 . . . . 1.84 110.808 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 56.5 p -78.57 -22.18 47.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 1.68 110.656 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -85.11 -44.76 12.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.194 -0.457 . . . . 2.04 110.672 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . 0.415 HG12 ' HA ' ' C' ' 208' ' ' PHE . 8.5 p -66.6 -39.8 84.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.263 -0.426 . . . . 2.65 110.793 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -68.94 -27.72 73.66 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.779 -0.724 . . . . 1.33 112.034 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -64.69 -39.14 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.901 0.381 . . . . 3.02 110.712 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' C' ' 218' ' ' LEU . 48.4 t -64.09 -56.59 13.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.958 -0.564 . . . . 2.35 110.764 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' C' ' 218' ' ' LEU . 64.2 t80 -60.33 -20.51 59.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.028 -0.533 . . . . 3.62 110.51 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 10.4 tt -78.03 -41.69 34.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.928 -0.578 . . . . 1.64 110.896 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -71.16 -20.67 62.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.064 -0.516 . . . . 2.2 111.128 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.432 ' HB3' HH11 ' C' ' 30' ' ' ARG . 94.2 mt -75.46 -53.05 9.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.274 -0.421 . . . . 3.11 111.054 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 38.2 t60 -78.21 -25.34 46.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 3.37 111.04 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -60.37 -59.12 10.88 Favored Glycine 0 CA--C 1.518 0.248 0 C-N-CA 120.84 -0.695 . . . . 1.55 113.097 -179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 77.0 mt -77.85 -58.96 2.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.703 0.287 . . . . 3.11 111.256 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 57.45 93.1 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.189 -0.46 . . . . 5.73 111.048 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -64.59 148.49 50.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.195 -0.457 . . . . 5.53 111.13 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 54.7 tp -135.65 -32.99 0.88 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.101 -0.5 . . . . 6.6 110.903 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -134.7 120.33 19.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.475 . . . . 6.51 110.879 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -131.83 105.32 7.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 7.05 110.909 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 38.8 t -142.26 85.51 1.92 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 6.72 110.925 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -94.57 -71.15 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 9.56 110.956 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.166 -0.921 . . . . 9.08 110.819 -179.856 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.768 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.73 ' H8 ' H161 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.723 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.8 mtp . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.932 0.396 . . . . 8.09 110.865 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -158.58 -72.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.078 -0.51 . . . . 5.68 110.896 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 89.5 mt 60.42 104.81 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.003 -0.544 . . . . 6.27 111.37 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -67.97 -37.48 81.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.045 -0.525 . . . . 6.52 110.894 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.7 t -99.98 137.54 38.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.129 -0.487 . . . . 3.59 110.842 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' TRP . 70.2 mt -135.67 123.29 22.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.249 -0.432 . . . . 3.23 111.183 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.405 HD13 ' HD1' ' A' ' 200' ' ' PHE . 58.6 mt -62.69 -45.68 91.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.767 -0.651 . . . . 1.88 111.135 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.515 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.6 m80 -64.09 -24.25 67.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.495 . . . . 1.29 110.584 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 6' ' ' LEU . 39.3 t-105 -74.91 -30.74 61.36 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.966 -0.561 . . . . 0.99 110.262 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 6' ' ' LEU . 57.4 mt -73.53 -24.99 20.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.942 -0.572 . . . . 1.92 110.283 179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -69.02 -53.91 17.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.688 -0.687 . . . . 1.45 110.982 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.494 HG11 ' HG2' ' A' ' 52' ' ' MET . 7.4 p -58.87 -37.0 64.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.345 -0.389 . . . . 0.89 111.583 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.22 94.93 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.411 -0.359 . . . . 0.9 111.132 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.26 -28.81 73.52 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.876 -0.678 . . . . 0.83 112.663 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.9 mmt -78.48 -33.32 48.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.723 0.297 . . . . 1.24 111.332 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 84.0 m -58.54 -55.53 33.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 1.29 110.859 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 1.3 tp -58.17 -44.07 86.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.052 -0.522 . . . . 1.71 110.932 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.09 -39.65 9.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.685 -0.769 . . . . 0.96 112.279 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.53 70.51 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.651 0.262 . . . . 0.99 111.19 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -58.61 -23.33 58.64 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 2.11 110.927 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -59.0 -37.54 77.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.307 -0.406 . . . . 2.23 110.558 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.687 ' O ' ' OG ' ' A' ' 26' ' ' SER . 22.1 t80 -76.17 -28.4 57.32 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.123 -0.489 . . . . 4.02 110.696 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 46.9 t-105 -60.66 -33.24 72.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.164 -0.471 . . . . 3.96 110.626 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 65.9 m -85.7 -29.01 24.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.089 -0.505 . . . . 2.38 111.154 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.7 tp -86.89 -9.47 55.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.281 -0.418 . . . . 2.77 111.105 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.687 ' OG ' ' O ' ' A' ' 22' ' ' PHE . 2.9 m -67.82 -23.23 65.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.49 -0.323 . . . . 2.52 110.588 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.9 mmm180 -48.5 -32.71 8.3 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.213 0.53 . . . . 5.54 109.98 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.473 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 6.7 p30 -173.0 131.72 0.61 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.384 -0.825 . . . . 4.44 110.355 178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 55.2 Cg_endo -96.18 -178.75 0.44 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 123.051 2.501 . . . . 2.81 112.197 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 17.8 tpp180 -105.34 67.12 0.76 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.924 0.393 . . . . 6.8 111.068 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.87 -38.94 2.54 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.952 -0.642 . . . . 4.97 112.716 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 77.5 t -82.94 127.36 69.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.6 0.2 . . . . 4.71 111.167 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' HE1' ' A' ' 35' ' ' TYR . 39.4 Cg_exo -59.38 165.54 9.08 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.637 2.224 . . . . 3.51 112.578 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.56 -19.86 51.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.287 -0.87 . . . . 3.41 112.53 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.429 ' HE1' ' HD2' ' A' ' 33' ' ' PRO . 2.0 p90 -53.11 -35.97 60.23 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 111.998 0.37 . . . . 2.81 111.998 -178.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -65.38 -62.5 1.5 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.771 0.32 . . . . 3.39 111.608 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -65.56 -18.8 65.6 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 5.24 111.049 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' B' ' 104' ' ' PHE . 42.5 tp -58.05 -57.65 11.89 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.034 0.445 . . . . 1.6 110.156 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 49.9 t -64.67 -32.24 57.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.837 -0.62 . . . . 1.33 110.84 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.47 61.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 1.03 111.52 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.2 ttt -88.25 -39.12 14.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.02 0.438 . . . . 2.0 111.042 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' B' ' 107' ' ' SER . 52.7 t80 -69.34 -29.49 67.32 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.063 -0.517 . . . . 1.31 111.559 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.442 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 97.1 mt -55.92 -55.37 41.96 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 112.015 0.376 . . . . 1.0 112.015 -179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 50.4 Cg_endo -67.72 -34.12 25.67 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 122.181 1.921 . . . . 0.59 113.253 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 93.1 mt -56.84 -62.21 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 111.736 0.273 . . . . 1.63 111.736 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.583 ' HE1' HG22 ' B' ' 110' ' ' ILE . 1.1 t90 -56.55 -53.68 54.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.911 0.386 . . . . 1.12 110.895 -179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.418 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 88.3 p -63.3 -9.0 9.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 1.32 111.361 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.61 -55.38 2.72 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.719 -0.753 . . . . 0.52 112.629 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -28.72 69.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.678 0.275 . . . . 0.98 111.301 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.39 -58.22 9.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.357 -0.383 . . . . 0.52 110.579 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 22.9 m-85 -61.86 -30.93 71.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.057 -0.52 . . . . 1.69 110.684 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.494 ' HG2' HG11 ' A' ' 12' ' ' VAL . 13.3 tmm? -54.84 -36.76 65.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.185 0.517 . . . . 1.12 109.746 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.56 71.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.476 -0.784 . . . . 0.6 110.658 179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 57.5 mtt -53.89 -25.93 22.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.993 -0.549 . . . . 0.94 110.388 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.515 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.62 -47.63 21.71 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.964 -0.562 . . . . 0.78 110.42 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 HG22 ' O ' ' A' ' 56' ' ' ILE . 9.9 mt -79.18 6.71 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.879 -0.6 . . . . 1.23 110.745 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.0 t70 61.37 65.62 0.95 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 115.845 -0.616 . . . . 2.02 110.958 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -142.6 141.0 31.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 2.1 110.944 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.75 -3.56 34.16 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.846 -0.692 . . . . 1.27 112.51 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -111.61 148.69 32.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 1.76 110.84 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -124.65 146.94 29.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.249 -0.432 . . . . 1.84 111.057 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -97.81 98.5 9.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.228 -0.442 . . . . 2.64 111.26 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -101.46 110.45 22.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.212 -0.449 . . . . 1.84 110.99 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.57 29.64 19.16 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.154 -0.476 . . . . 2.24 111.281 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.52 8.47 83.1 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.867 -0.683 . . . . 2.16 112.802 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -116.48 124.52 50.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 2.84 110.974 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.5 mt -78.26 138.67 19.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.14 -0.482 . . . . 2.39 111.191 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.01 133.72 54.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.065 -0.516 . . . . 0.97 110.916 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.55 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 43.3 m-70 -81.46 63.85 5.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.118 0.485 . . . . 1.04 111.074 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -64.64 -42.97 95.1 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.687 -0.688 . . . . 3.38 111.07 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.24 65.24 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.162 -0.472 . . . . 0.76 112.111 -179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.55 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 27.6 mmt180 -68.65 -52.72 28.2 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.472 0.545 . . . . 2.93 112.472 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.535 ' O ' ' HG2' ' A' ' 77' ' ' MET . 4.1 p90 -74.22 -40.3 62.52 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.096 0.406 . . . . 3.13 112.096 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.477 HG23 ' N ' ' A' ' 75' ' ' ASP . 20.8 tt -50.46 -44.9 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 C-N-CA 121.01 -0.276 . . . . 1.66 110.773 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.53 ' O ' HG22 ' A' ' 79' ' ' THR . 24.4 t70 -65.52 -30.74 71.53 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.417 -0.586 . . . . 1.42 109.417 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 30.7 m0 -82.75 7.24 15.55 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.698 -0.683 . . . . 2.09 111.319 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' A' ' 73' ' ' TYR . 91.8 mmm -104.76 -19.12 14.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 1.52 110.607 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' HD23 ' A' ' 82' ' ' LEU . 23.8 m -114.24 -40.23 3.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.711 0.634 . . . . 1.33 112.711 -178.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.53 HG22 ' O ' ' A' ' 75' ' ' ASP . 2.8 t -78.18 -29.44 48.5 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.979 0.363 . . . . 1.39 111.979 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.564 ' N ' ' HD2' ' A' ' 81' ' ' PRO . 25.7 m -70.48 -50.65 14.01 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 112.126 0.417 . . . . 1.55 112.126 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 80' ' ' THR . 18.3 Cg_endo -59.77 -33.67 96.16 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 121.936 1.757 . . . . 1.01 112.043 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.5 mm? -79.93 -21.48 43.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 1.45 110.841 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -48.16 73.63 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.123 -0.489 . . . . 1.3 110.492 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 85' ' ' LEU . 3.4 pp -74.84 -30.8 61.48 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.999 -0.546 . . . . 1.67 110.981 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.498 ' N ' HD12 ' A' ' 84' ' ' LEU . 11.5 tp -65.29 -34.47 78.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.903 -0.589 . . . . 1.87 110.871 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 35.1 t -65.0 -30.25 71.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.031 -0.531 . . . . 1.42 110.383 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD22 HD11 ' A' ' 168' ' ' LEU . 81.6 mt -69.52 -24.74 63.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.507 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 54.7 m -74.79 -36.66 62.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.808 -0.633 . . . . 1.91 110.791 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -77.68 -27.05 50.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 2.33 110.827 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 76.9 m -78.16 -40.68 37.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 1.43 111.093 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.07 -22.91 36.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.176 -0.465 . . . . 1.19 110.851 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.5 mtp -136.6 93.16 2.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 2.55 110.637 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -62.98 -24.24 67.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 3.33 110.795 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -143.63 136.89 27.88 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.11 -0.496 . . . . 5.1 110.807 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 71.0 mt -109.5 142.11 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 3.07 111.219 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 96' ' ' LYS . 3.8 mppt? -106.03 55.3 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 4.41 110.569 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.3 tptm 58.35 78.65 0.24 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.916 -0.584 . . . . 5.31 110.756 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -144.15 110.69 5.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.203 -0.453 . . . . 3.94 110.78 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 83.1 m95 -124.82 32.19 5.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 5.98 110.982 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 p -101.65 -53.99 2.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.484 . . . . 2.24 111.341 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 37.6 tp -68.19 -61.97 1.61 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.177 -0.465 . . . . 2.67 110.996 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 55.8 mt -64.21 -28.29 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.119 -0.491 . . . . 2.59 111.036 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.96 -52.22 43.86 Favored Glycine 0 C--N 1.33 0.227 0 C-N-CA 120.734 -0.746 . . . . 1.53 112.596 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -68.21 -17.82 64.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.891 0.377 . . . . 3.14 110.966 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.6 tp -77.87 -49.16 14.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.263 -0.426 . . . . 1.99 110.785 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 66.0 mtm -63.24 -30.98 72.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.116 -0.493 . . . . 2.36 110.965 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -67.49 -44.48 78.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.332 -0.394 . . . . 2.05 110.858 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.501 HG21 HG21 ' A' ' 142' ' ' ILE . 27.8 m -57.18 -36.54 70.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 2.25 110.857 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -63.61 -44.12 94.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.134 -0.485 . . . . 2.72 110.895 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.2 mt -53.33 -38.29 31.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.282 -0.417 . . . . 1.88 111.007 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 41.2 t -68.54 -36.68 75.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.241 -0.436 . . . . 1.6 111.022 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 91.9 t -66.57 -57.11 11.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.088 -0.505 . . . . 1.09 111.167 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.4 HD12 ' SD ' ' A' ' 77' ' ' MET . 23.3 pt -56.32 -29.12 27.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.309 -0.405 . . . . 2.65 111.098 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.411 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 16.9 m -62.53 -42.88 99.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.013 0.435 . . . . 0.89 110.508 179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 39.3 m -69.37 -28.26 66.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.964 -0.562 . . . . 0.68 110.61 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.09 -47.23 38.78 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.034 -0.603 . . . . 0.63 112.932 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.5 pp -64.88 -33.05 75.1 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.616 0.228 . . . . 1.58 111.616 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' N ' HD12 ' A' ' 117' ' ' LEU . 21.2 tt -83.53 -28.83 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.667 0.27 . . . . 2.04 111.44 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -56.99 -46.49 82.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.85 0.357 . . . . 1.1 110.875 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -76.02 -22.63 55.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.098 -0.501 . . . . 1.88 111.004 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.5 31.01 1.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.922 0.391 . . . . 1.53 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 80.8 p -93.49 118.29 31.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 2.29 110.961 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -58.76 -18.84 35.21 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.956 -0.565 . . . . 3.49 110.623 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -137.47 136.09 37.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.858 -0.61 . . . . 3.13 110.78 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -68.41 -9.46 48.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 3.71 110.913 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -78.25 -49.33 13.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.079 -0.51 . . . . 3.97 111.193 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 13.7 p -68.97 -24.35 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.321 -0.399 . . . . 1.22 111.089 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -60.6 -34.33 74.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 2.81 110.916 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -66.7 -43.58 84.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 4.25 111.131 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.87 -39.96 87.0 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.965 0.412 . . . . 1.84 110.477 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 2.6 m95 -76.53 -29.51 56.75 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 1.54 110.647 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -61.81 -54.15 46.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.023 -0.535 . . . . 1.79 110.476 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.9 pt -60.92 -33.2 54.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.247 -0.433 . . . . 2.08 110.808 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 41.6 t -61.83 -39.4 91.69 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.022 0.439 . . . . 1.76 110.485 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.28 -55.87 18.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.879 -0.677 . . . . 0.76 112.557 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.3 m -62.16 -26.18 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.743 0.306 . . . . 2.07 111.06 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 43.2 t -64.26 -37.68 88.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.054 -0.521 . . . . 1.85 110.71 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.94 62.16 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.269 -0.423 . . . . 1.32 110.893 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -76.01 -28.33 57.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.07 -0.514 . . . . 3.25 110.766 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.408 HD22 ' HA ' ' A' ' 140' ' ' LEU . 0.4 OUTLIER -69.54 -49.57 53.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.298 -0.41 . . . . 2.92 110.842 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.1 mt -56.92 -51.94 61.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.251 -0.431 . . . . 2.65 111.211 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.501 HG21 HG21 ' A' ' 108' ' ' THR . 9.0 tp -63.32 -31.53 53.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 3.21 111.286 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 25.6 tp -62.89 -56.04 20.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.286 -0.415 . . . . 2.01 111.077 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 53.8 t90 -65.19 -23.4 67.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.174 -0.466 . . . . 3.6 110.769 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.15 -16.78 68.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.956 -0.64 . . . . 1.62 112.7 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -106.55 -21.0 5.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.716 0.293 . . . . 2.47 111.561 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.474 ' HE1' HG21 ' A' ' 173' ' ' THR . 10.1 m95 -80.06 -27.47 39.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.432 -0.349 . . . . 2.48 111.568 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.595 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 3.2 t-20 -73.87 -49.75 5.85 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 116.386 -0.37 . . . . 2.69 111.963 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 17.9 Cg_endo -58.83 -9.43 7.54 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.221 1.947 . . . . 2.36 112.861 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 95.7 mt -81.74 21.09 0.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.568 -0.287 . . . . 3.3 111.081 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -161.58 -36.13 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.475 -0.329 . . . . 8.48 111.16 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.68 -33.2 25.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 2.98 111.844 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -86.49 -32.76 20.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.494 -0.321 . . . . 4.55 111.37 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.556 ' HA ' ' HB2' ' A' ' 157' ' ' GLN . 9.0 t -77.19 2.4 15.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.417 -0.356 . . . . 4.0 111.55 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.1 mmm180 -58.61 -38.24 77.57 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.458 -0.337 . . . . 5.51 110.962 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 82.2 p -115.41 -6.37 12.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 3.2 111.1 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.556 ' HB2' ' HA ' ' A' ' 154' ' ' THR . 95.3 mt-30 -93.61 -165.98 1.43 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.26 -0.427 . . . . 3.98 111.009 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.5 m -65.49 116.67 7.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.228 -0.442 . . . . 2.63 111.047 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 47.6 t -77.43 -34.71 54.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.476 . . . . 2.16 110.877 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -63.31 -43.41 97.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 3.37 110.793 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 64.6 tp -66.52 -25.8 66.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.118 -0.492 . . . . 2.83 110.529 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.56 -38.98 77.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 1.7 110.938 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -67.73 -46.51 71.97 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.069 -0.514 . . . . 2.16 110.679 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.89 -45.32 82.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.061 0.458 . . . . 1.59 110.721 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -22.48 61.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 2.31 111.019 -179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -68.22 -40.94 81.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.3 -0.409 . . . . 2.15 110.756 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.99 -22.73 31.28 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.198 -0.455 . . . . 2.39 110.768 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.575 HD11 HD22 ' A' ' 87' ' ' LEU . 55.8 tp -71.46 -58.72 3.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.129 -0.487 . . . . 1.79 110.939 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.408 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 61.6 t -58.0 -23.4 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.038 -0.528 . . . . 1.42 111.201 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 42.9 m -51.23 -59.15 4.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.911 0.386 . . . . 1.12 111.297 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -70.96 -23.95 62.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 3.86 110.343 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.408 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 78.8 t80 -68.64 -30.35 69.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 1.58 111.501 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.474 HG21 ' HE1' ' A' ' 147' ' ' TRP . 54.9 p -77.84 -50.3 12.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.617 -0.265 . . . . 1.41 111.628 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.54 -29.09 28.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.348 -0.387 . . . . 1.42 111.816 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 6.7 mp -77.96 -57.55 3.74 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.841 0.353 . . . . 1.91 111.286 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.17 -30.87 64.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 1.55 111.15 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 181' ' ' ILE . 15.6 tt -87.46 -19.11 8.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.364 -0.38 . . . . 1.86 110.137 179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.428 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -58.12 -52.84 50.1 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.792 -0.64 . . . . 0.74 112.876 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.609 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 89.1 m-85 -56.92 -54.16 57.27 Favored Pre-proline 0 CA--C 1.533 0.3 0 C-N-CA 120.965 -0.294 . . . . 1.78 111.082 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 81.9 Cg_exo -46.09 -32.75 10.44 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.102 1.868 . . . . 0.92 112.413 179.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.516 ' O ' HG22 ' A' ' 184' ' ' ILE . 96.1 mt -62.83 -60.39 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.438 . . . . 1.77 111.163 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 179' ' ' TYR . 22.6 m -61.56 -24.2 33.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.192 -0.458 . . . . 1.34 111.045 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.412 ' O ' ' HA3' ' A' ' 189' ' ' GLY . 30.3 m95 -67.87 -46.53 71.42 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.206 -0.452 . . . . 2.51 111.955 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 185' ' ' ILE . 17.6 tt -69.66 -1.39 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 111.888 0.329 . . . . 2.02 111.888 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.522 HG23 HG23 ' A' ' 184' ' ' ILE . 46.5 pt -131.2 170.32 19.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.826 0.346 . . . . 2.45 111.083 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.94 -156.64 40.38 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.837 -0.697 . . . . 1.73 112.854 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.583 ' HG2' ' HB2' ' A' ' 198' ' ' ASP . 27.5 Cg_exo -62.81 154.02 68.89 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.715 2.277 . . . . 3.05 111.964 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 48.8 m 57.51 16.69 3.44 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.289 -0.414 . . . . 4.04 110.517 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.412 ' HA3' ' O ' ' A' ' 183' ' ' TRP . . . -161.03 35.99 0.41 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.955 -0.64 . . . . 4.48 112.576 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 61.6 t80 59.74 91.07 0.05 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.898 0.38 . . . . 7.96 111.028 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -157.71 -171.53 23.79 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.953 -0.641 . . . . 3.23 112.355 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 41.6 t-105 -128.87 22.37 5.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.142 0.496 . . . . 6.03 110.539 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.552 ' HB ' ' HD3' ' A' ' 187' ' ' PRO . 10.2 mt -99.14 160.86 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.874 -0.603 . . . . 3.18 110.643 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.413 ' N ' HG22 ' A' ' 193' ' ' ILE . 15.7 m120 -95.92 179.49 5.07 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.862 0.363 . . . . 3.39 111.281 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -65.62 -22.59 66.68 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.095 -0.502 . . . . 5.76 111.059 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 47.8 m -53.18 -63.39 1.16 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 2.5 111.421 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.428 ' HB ' HG21 ' A' ' 193' ' ' ILE . 49.9 mm -68.16 -31.86 53.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.478 -0.328 . . . . 2.4 111.321 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.583 ' HB2' ' HG2' ' A' ' 187' ' ' PRO . 25.2 t70 -49.72 -57.86 6.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.334 -0.393 . . . . 2.66 110.988 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.6 p -66.35 -34.64 78.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 1.81 111.236 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . 0.405 ' HD1' HD13 ' A' ' 7' ' ' LEU . 75.5 t80 -65.06 -23.7 67.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 2.21 111.345 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 81.1 mt -83.26 -48.1 10.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.485 -0.325 . . . . 2.18 111.37 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -74.83 -6.24 47.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.777 0.322 . . . . 2.01 110.987 -179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.402 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 49.8 t -96.91 -40.81 8.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.287 0.565 . . . . 1.93 109.97 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.2 tp -73.51 -37.97 65.48 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.409 -0.814 . . . . 1.7 111.589 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -57.31 -54.51 54.08 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.751 -0.204 . . . . 1.28 111.214 -179.398 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 51.5 Cg_exo -55.76 -46.83 28.8 Favored 'Trans proline' 0 C--N 1.353 0.816 0 C-N-CA 121.941 1.76 . . . . 0.79 111.668 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -59.69 -28.68 67.5 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.104 0.478 . . . . 1.51 110.052 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.35 -24.49 32.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.664 -0.698 . . . . 1.93 110.471 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 49.4 m -90.32 -12.73 36.87 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.925 -0.58 . . . . 1.71 110.704 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.5 mptt -91.67 -51.11 5.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.561 . . . . 2.04 111.184 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.7 t -61.43 -53.42 48.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.501 -0.318 . . . . 2.89 110.977 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.01 -26.85 56.35 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.755 -0.736 . . . . 1.31 112.173 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -68.55 -38.88 81.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.816 0.341 . . . . 2.87 110.825 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 45.9 t -62.49 -53.92 47.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 2.38 111.033 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -65.22 -20.4 66.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.288 -0.415 . . . . 3.42 110.993 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 5.8 tt -68.94 -53.78 19.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.202 -0.453 . . . . 1.24 110.855 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -59.11 -33.0 70.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.273 -0.421 . . . . 2.44 111.182 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 46.2 tp -61.77 -60.23 3.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 2.51 110.876 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -69.79 -20.57 63.46 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.127 -0.488 . . . . 3.01 111.099 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -75.26 -19.02 79.89 Favored Glycine 0 N--CA 1.453 -0.177 0 C-N-CA 120.69 -0.767 . . . . 1.59 112.794 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 31.1 tp -52.67 -58.76 5.78 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.666 0.27 . . . . 3.49 111.446 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.31 80.47 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.324 -0.398 . . . . 5.74 110.865 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -95.0 121.04 36.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 5.46 111.011 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 51.9 tp -123.94 153.85 40.61 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 6.13 110.576 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -91.96 93.86 9.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.36 -0.382 . . . . 6.46 111.015 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -172.35 97.0 0.15 Allowed 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.117 -0.492 . . . . 6.94 110.829 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -149.89 -13.48 0.27 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.347 -0.388 . . . . 6.83 110.978 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 17.8 tpt180 62.45 -84.51 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.07 -0.514 . . . . 10.77 110.856 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.171 -0.919 . . . . 9.41 110.867 179.836 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 40.3 mtm . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.888 0.375 . . . . 8.91 110.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -158.41 140.05 13.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.031 -0.531 . . . . 6.76 111.047 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.81 -177.64 3.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.458 . . . . 6.25 110.967 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -127.57 90.7 3.16 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.095 -0.502 . . . . 5.44 110.702 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 79.6 p -139.54 149.75 44.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.028 -0.533 . . . . 3.84 110.707 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.402 ' O ' HG13 ' B' ' 10' ' ' ILE . 80.4 mt -113.08 30.73 6.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.369 -0.378 . . . . 3.08 111.023 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.9 -56.99 6.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.263 -0.426 . . . . 2.35 111.274 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.576 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 72.9 m-70 -64.71 -23.96 67.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.318 -0.401 . . . . 1.39 111.144 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 47.6 t-105 -70.23 -35.6 73.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 1.1 110.923 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . 0.402 HG13 ' O ' ' B' ' 6' ' ' LEU . 94.0 mt -72.77 -30.04 31.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.0 0.429 . . . . 1.71 110.533 179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.09 -54.35 48.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.579 . . . . 1.48 110.517 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -62.3 -31.19 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.267 -0.424 . . . . 0.95 111.032 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.32 -53.63 52.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.492 . . . . 0.97 111.312 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -62.35 -25.37 66.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.958 -0.639 . . . . 0.8 113.162 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 23.9 mmt -77.45 -34.42 54.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.704 0.252 . . . . 1.29 111.526 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 33.7 m -63.89 -50.21 69.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.797 0.332 . . . . 1.36 110.917 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.417 HD12 ' N ' ' B' ' 18' ' ' GLY . 2.7 pp -64.83 -29.49 47.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 1.23 111.195 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.417 ' N ' HD12 ' B' ' 17' ' ' ILE . . . -61.24 -39.73 97.61 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.765 -0.731 . . . . 0.88 112.386 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.34 -40.73 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.738 0.304 . . . . 0.98 111.168 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 93.2 mt -58.86 -32.88 69.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 2.12 110.938 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -55.86 -31.27 62.63 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.075 -0.511 . . . . 2.0 110.791 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -73.09 -40.01 65.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.495 . . . . 4.26 110.664 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -55.68 -28.51 55.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 3.62 110.42 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 43.5 t -84.83 -29.55 25.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.113 -0.494 . . . . 2.55 111.084 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 83.9 mt -85.25 -19.13 32.09 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.552 -0.294 . . . . 3.11 111.394 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -62.81 -19.28 63.91 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.903 -0.319 . . . . 3.02 110.645 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.491 ' HG2' HD22 ' B' ' 28' ' ' ASN . 55.5 ttp180 -50.51 -32.9 19.59 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 109.505 -0.554 . . . . 5.89 109.505 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.491 HD22 ' HG2' ' B' ' 27' ' ' ARG . 6.7 p30 -173.95 132.78 0.56 Allowed Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 115.122 -0.945 . . . . 5.02 110.01 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' B' ' 28' ' ' ASN . 55.8 Cg_endo -95.16 -179.61 0.6 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 123.001 2.468 . . . . 3.53 112.504 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -111.85 64.01 0.62 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.2 -0.455 . . . . 7.88 110.848 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.04 -36.86 3.01 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 4.61 112.39 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.0 p -89.99 122.14 68.09 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.536 0.208 . . . . 4.73 110.8 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_exo -57.05 165.2 5.41 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.284 1.99 . . . . 3.75 112.133 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.547 HE21 ' H ' ' B' ' 35' ' ' TYR . 0.5 OUTLIER -62.57 -18.12 61.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.771 -0.65 . . . . 3.76 112.245 -179.114 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.547 ' H ' HE21 ' B' ' 34' ' ' GLN . 1.8 p90 -51.34 -33.39 29.17 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.601 0.239 . . . . 3.17 111.47 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -68.17 -55.75 11.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.472 -0.331 . . . . 2.57 110.801 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -69.3 -18.51 63.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 5.74 110.832 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 30.7 tp -61.44 -58.97 6.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 1.72 110.687 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 7.3 p -62.96 -34.42 66.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.451 . . . . 1.95 110.432 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -72.09 -12.2 61.1 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.964 -0.562 . . . . 1.2 110.764 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . 0.421 ' C ' ' HD2' ' B' ' 44' ' ' PRO . 26.8 ttt -87.88 -32.85 18.76 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 2.12 110.684 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -73.67 -30.19 62.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.059 -0.519 . . . . 1.49 111.337 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.529 HG23 HG23 ' B' ' 79' ' ' THR . 99.4 mt -55.22 -53.33 63.0 Favored Pre-proline 0 CA--C 1.536 0.434 0 CA-C-N 116.409 -0.36 . . . . 0.77 111.804 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 64.3 Cg_endo -72.39 -35.3 6.61 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 122.222 1.948 . . . . 0.68 113.166 -179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 86.0 mt -54.29 -62.05 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.718 0.294 . . . . 1.63 111.327 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t-105 -59.87 -54.88 40.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.441 -0.345 . . . . 1.91 111.153 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.485 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 59.0 m -52.27 -28.09 17.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.032 -0.531 . . . . 1.22 111.476 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.44 -56.9 8.96 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.6 -0.81 . . . . 0.55 112.238 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 81.6 mt -56.12 -34.66 66.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.594 0.235 . . . . 0.87 111.071 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.37 -59.61 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.299 -0.41 . . . . 0.55 111.307 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.464 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 23.2 m-85 -63.59 -32.46 73.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 1.06 111.166 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 56.7 ttp -53.1 -34.83 58.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.127 0.489 . . . . 1.19 109.994 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . 0.591 ' HB1' ' HB3' ' B' ' 58' ' ' GLN . . . -73.75 -40.72 63.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.61 -0.723 . . . . 0.66 110.444 179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 48.1 mtt -56.43 -21.39 24.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.875 -0.602 . . . . 0.86 110.371 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.576 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -80.2 -49.36 11.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.898 -0.592 . . . . 0.84 110.652 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 36.6 pt -79.66 10.63 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.074 -0.512 . . . . 1.44 111.113 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 63.56 68.83 0.58 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.954 -0.566 . . . . 1.55 110.885 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.591 ' HB3' ' HB1' ' B' ' 53' ' ' ALA . 7.9 tt0 -145.38 145.64 31.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.099 -0.5 . . . . 2.24 110.752 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.01 12.25 52.87 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.744 -0.741 . . . . 1.26 112.525 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -125.51 147.63 49.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.821 0.343 . . . . 2.31 110.793 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.9 p -115.98 142.67 28.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.238 -0.437 . . . . 1.81 111.118 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -102.42 85.67 2.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 3.18 110.541 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -95.76 107.92 20.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.058 -0.519 . . . . 2.03 111.476 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.88 38.77 27.14 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.954 -0.566 . . . . 2.48 111.642 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.06 7.35 87.62 Favored Glycine 0 N--CA 1.453 -0.191 0 C-N-CA 120.788 -0.72 . . . . 2.37 112.786 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -111.28 137.74 48.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.893 0.378 . . . . 2.28 110.693 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 63.1 mt -99.71 136.98 28.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.147 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.31 135.44 51.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.235 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.547 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 79.4 m-70 -82.9 64.74 7.67 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.13 0.49 . . . . 1.11 110.709 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.22 -44.86 71.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.733 -0.667 . . . . 2.3 111.395 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.86 -22.59 63.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.983 -0.553 . . . . 0.72 112.114 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.547 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 7.8 mpt_? -72.72 -52.66 14.23 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.25 0.463 . . . . 3.04 112.25 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.45 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.8 p90 -71.58 -38.23 70.94 Favored 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 111.814 0.301 . . . . 1.79 111.814 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.441 HG23 ' N ' ' B' ' 75' ' ' ASP . 19.9 tt -55.56 -42.92 70.7 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.239 0 CA-C-O 120.827 0.346 . . . . 1.44 110.461 -179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.485 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 13.3 t70 -68.5 -23.06 64.51 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.321 -0.622 . . . . 1.31 109.321 178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 34.3 m0 -91.04 3.0 55.89 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.582 -0.735 . . . . 2.01 110.874 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 48.4 ttm -104.81 -17.97 14.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.002 -0.544 . . . . 1.43 110.626 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.402 ' O ' HD23 ' B' ' 82' ' ' LEU . 17.8 m -113.9 -36.53 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.056 -0.52 . . . . 1.21 111.844 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.529 HG23 HG23 ' B' ' 43' ' ' ILE . 49.1 m -75.36 -54.7 6.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.348 -0.387 . . . . 1.18 111.683 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.528 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 24.5 m -49.33 -51.37 58.25 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 112.56 0.578 . . . . 1.65 112.56 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' B' ' 80' ' ' THR . 18.8 Cg_endo -58.18 -27.68 81.21 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.664 1.576 . . . . 1.06 111.656 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.402 HD23 ' O ' ' B' ' 78' ' ' VAL . 3.9 mm? -84.57 -25.04 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.841 -0.618 . . . . 1.58 111.102 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.45 HD22 H201 ' B' ' 301' ' ' RET . 25.7 tp -71.04 -40.39 71.72 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.791 0.329 . . . . 1.49 110.712 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.416 HD12 ' N ' ' B' ' 85' ' ' LEU . 3.7 pp -75.8 -34.43 60.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.17 0.51 . . . . 1.72 110.595 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.416 ' N ' HD12 ' B' ' 84' ' ' LEU . 15.4 tp -65.42 -32.16 73.63 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.489 -0.778 . . . . 1.96 110.947 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 58.6 m -58.54 -33.88 70.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 1.24 111.009 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.642 HD22 HD11 ' B' ' 168' ' ' LEU . 87.5 mt -73.48 -30.72 63.33 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.102 -0.499 . . . . 1.21 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 47.6 t -62.89 -37.19 85.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 1.32 110.954 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -82.72 -20.87 35.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.077 -0.51 . . . . 2.15 110.812 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 86.5 m -75.42 -45.78 36.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.192 -0.458 . . . . 1.44 111.126 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -73.66 -41.78 62.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.128 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 76.4 mtp -117.62 125.07 50.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.23 -0.441 . . . . 2.68 110.947 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -85.79 -45.76 11.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 2.71 110.729 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -121.7 137.42 54.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 4.19 110.692 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 36.8 mm -99.34 143.0 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.189 -0.459 . . . . 2.79 111.299 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -112.56 48.71 0.98 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.081 -0.509 . . . . 5.27 110.483 179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt 62.35 73.59 0.46 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 115.883 -0.599 . . . . 5.57 110.909 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.87 122.24 7.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.14 -0.482 . . . . 4.24 110.708 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -141.05 32.91 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.433 -0.348 . . . . 5.39 111.149 -179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 44.8 p -89.12 -60.58 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.388 -0.369 . . . . 2.16 111.21 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 90.5 mt -58.5 -56.54 20.81 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.245 -0.434 . . . . 2.58 111.058 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.8 tt -61.39 -35.32 65.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.439 . . . . 2.29 111.469 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.25 -60.04 9.29 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.832 -0.699 . . . . 1.48 113.079 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 38' ' ' LEU . 79.3 t80 -53.43 -36.27 61.37 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.662 0.268 . . . . 2.76 111.441 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 96.6 mt -64.34 -61.16 2.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.332 -0.394 . . . . 2.22 111.454 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 52.3 ttm -55.71 -28.85 57.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 2.36 111.409 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.432 ' HB3' ' CD1' ' A' ' 42' ' ' PHE . 50.0 m -64.15 -56.8 12.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.97 0.414 . . . . 1.92 110.906 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.489 HG21 HD13 ' B' ' 142' ' ' ILE . 27.2 m -56.41 -30.05 62.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 2.06 110.752 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -58.19 -43.27 87.47 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 109.883 -0.414 . . . . 2.87 109.883 179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . 0.583 HG22 ' HE1' ' A' ' 46' ' ' TRP . 33.4 mm -58.31 -39.51 74.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-N 116.005 -0.543 . . . . 1.98 110.103 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 56.8 t -61.19 -42.45 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.775 -0.648 . . . . 1.62 110.932 179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.26 -56.87 14.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.047 -0.524 . . . . 1.04 111.557 -179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 42.4 mm -52.34 -33.34 17.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.46 -0.336 . . . . 2.46 111.106 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 53.2 m -59.6 -47.22 86.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.83 110.926 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 10.4 m -63.66 -27.89 69.53 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.74 110.672 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -72.81 -49.9 15.93 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.943 -0.646 . . . . 0.6 113.188 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.546 HD12 ' N ' ' B' ' 118' ' ' ILE . 3.8 pp -62.36 -31.83 72.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.627 0.251 . . . . 1.42 111.598 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.546 ' N ' HD12 ' B' ' 117' ' ' LEU . 9.2 tp -83.59 -32.0 8.7 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 CA-C-N 116.68 -0.236 . . . . 1.51 111.356 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.47 -46.06 73.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.372 . . . . 1.09 111.035 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -80.29 -16.46 54.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 2.25 111.019 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 45.3 mt -97.06 24.99 5.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.159 -0.473 . . . . 1.16 111.079 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 50.9 m -92.98 118.42 31.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.21 -0.45 . . . . 1.76 110.8 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -57.82 -21.23 41.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.998 -0.546 . . . . 2.89 110.684 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 46.9 mtm180 -137.02 137.98 39.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.923 -0.58 . . . . 2.67 110.619 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -67.36 -19.74 65.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 3.25 110.948 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 63.3 t-105 -66.06 -57.46 7.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.328 -0.396 . . . . 4.07 110.765 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 8.8 p -65.26 -23.75 33.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.118 -0.492 . . . . 1.41 110.4 179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -65.65 -43.09 90.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.621 -0.718 . . . . 2.47 110.829 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -60.24 -41.0 92.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.939 -0.573 . . . . 2.61 111.219 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 96.4 mt -60.66 -43.36 97.73 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.425 -0.352 . . . . 2.07 110.585 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -68.05 -32.88 73.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 1.3 110.647 179.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -59.81 -48.17 82.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.929 -0.578 . . . . 1.75 110.847 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.33 -42.91 88.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 1.67 111.247 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 77.4 m -59.25 -33.89 71.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.242 -0.435 . . . . 1.54 111.264 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.11 -59.24 5.56 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.857 -0.687 . . . . 0.7 112.713 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -58.1 -29.51 36.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.734 0.302 . . . . 1.44 111.269 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 39.7 t -63.41 -48.46 77.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.14 -0.482 . . . . 1.82 110.842 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -58.61 -32.38 68.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.051 -0.522 . . . . 0.94 111.267 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -70.75 -39.71 73.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.2 -0.455 . . . . 1.6 111.283 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 96.8 mt -64.43 -40.52 95.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.446 -0.343 . . . . 2.01 111.429 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 51.2 mm -58.44 -59.74 3.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.319 -0.4 . . . . 1.96 111.515 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.489 HD13 HG21 ' B' ' 108' ' ' THR . 48.0 pt -62.35 -31.86 53.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.369 -0.378 . . . . 2.88 111.716 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 33.3 tp -57.03 -55.72 31.02 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.832 0.348 . . . . 1.52 111.157 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -64.28 -22.08 66.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 4.15 110.693 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.53 -18.32 64.32 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.892 -0.67 . . . . 1.59 112.722 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 47.4 pt -107.9 -1.09 9.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.821 0.343 . . . . 2.13 111.253 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 5.4 m95 -97.32 -28.41 14.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.329 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.544 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 26.9 t-20 -73.64 -47.61 7.03 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.258 -0.428 . . . . 2.45 111.943 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 31.7 Cg_exo -59.94 -7.55 6.36 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.267 1.978 . . . . 2.36 112.594 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 68.7 mt -78.63 21.66 0.38 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.326 -0.397 . . . . 2.88 111.158 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -169.33 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.517 -0.31 . . . . 8.07 111.188 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -74.77 -54.68 6.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.353 -0.385 . . . . 2.8 111.505 -179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -71.5 -30.02 65.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.447 -0.342 . . . . 4.58 110.911 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.448 ' HA ' ' HB3' ' B' ' 157' ' ' GLN . 79.7 p -84.93 6.01 26.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.43 . . . . 3.81 111.224 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 30.0 ttm180 -60.16 -34.26 73.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.28 -0.418 . . . . 5.22 110.749 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 76.7 p -140.23 19.64 2.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.22 -0.445 . . . . 3.42 111.599 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.448 ' HB3' ' HA ' ' B' ' 154' ' ' THR . 21.8 tp60 -101.54 -75.55 0.59 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 4.2 110.945 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 49.3 m -144.51 113.37 6.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 2.75 110.583 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 84.4 p -77.83 -51.32 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 2.4 111.185 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.78 -48.47 81.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.177 -0.465 . . . . 3.46 111.164 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 40.6 tp -63.44 -30.86 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.208 -0.451 . . . . 2.57 111.105 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.0 -37.41 75.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 1.72 111.431 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -65.71 -48.17 72.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 2.69 111.035 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 30.4 mt -61.81 -37.54 84.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 2.16 110.971 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -78.1 -22.76 48.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 2.13 111.1 -179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -62.78 -51.52 66.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.259 -0.428 . . . . 1.94 111.077 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 32.2 mtmm -78.21 -21.98 49.22 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.15 -0.477 . . . . 3.33 111.207 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.642 HD11 HD22 ' B' ' 87' ' ' LEU . 25.3 tp -65.52 -57.0 9.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 1.56 111.016 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 43.2 t -63.67 -23.46 33.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 1.59 111.187 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 53.3 m -55.78 -58.79 6.35 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.359 -0.382 . . . . 1.14 111.158 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . 0.423 ' O ' HG12 ' B' ' 174' ' ' VAL . 19.0 t80 -65.66 -27.96 68.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 3.87 110.096 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -68.76 -25.26 64.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.93 -0.577 . . . . 1.61 110.442 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 89.5 m -76.43 -50.85 13.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.962 -0.563 . . . . 1.3 111.481 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.423 HG12 ' O ' ' B' ' 171' ' ' TYR . 11.2 p -56.2 -30.58 30.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.415 -0.357 . . . . 1.53 111.705 -179.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 75.4 mt -75.92 -57.78 3.67 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.014 0.435 . . . . 1.99 111.213 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.95 -29.88 65.53 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.792 -0.64 . . . . 1.5 111.205 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.445 HG22 ' O ' ' B' ' 173' ' ' THR . 14.2 tt -88.11 -19.97 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.014 0.435 . . . . 1.46 110.448 178.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.62 -52.84 50.62 Favored Glycine 0 C--N 1.333 0.377 0 CA-C-N 115.746 -0.661 . . . . 0.67 113.014 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 78.8 m-85 -56.69 -55.07 47.05 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.685 0.243 . . . . 1.73 111.266 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 81.7 Cg_exo -45.68 -36.06 13.94 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 121.953 1.769 . . . . 0.93 112.5 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.444 HG13 ' O ' ' B' ' 177' ' ' ILE . 95.6 mt -60.42 -60.5 2.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.377 -0.374 . . . . 1.36 111.261 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.595 HG22 ' O ' ' B' ' 179' ' ' TYR . 17.6 m -58.35 -24.34 24.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.219 -0.446 . . . . 1.19 111.045 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 30.4 m95 -71.21 -31.54 67.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.888 -0.597 . . . . 2.73 111.034 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.413 HG13 ' O ' ' B' ' 180' ' ' PRO . 90.3 mt -54.07 -73.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.323 -0.398 . . . . 1.93 111.443 -179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 38.8 pt -92.22 172.42 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 2.64 111.377 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.563 ' HA2' HD12 ' B' ' 193' ' ' ILE . . . 89.67 -165.65 32.35 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.776 -0.726 . . . . 1.93 112.29 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . 0.442 ' HG2' ' HB2' ' B' ' 198' ' ' ASP . 28.0 Cg_exo -62.11 154.59 61.48 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.658 2.239 . . . . 2.97 111.825 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 42.3 t 58.65 13.79 2.79 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.241 -0.436 . . . . 4.5 110.463 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -153.79 39.61 0.68 Allowed Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.847 -0.615 . . . . 4.5 112.315 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 80.5 t80 57.76 85.8 0.08 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.946 0.403 . . . . 7.89 110.798 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -169.95 147.12 10.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.849 -0.691 . . . . 3.62 112.285 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 54.1 t-105 -92.38 69.62 5.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.923 0.392 . . . . 6.54 110.678 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.563 HD12 ' HA2' ' B' ' 186' ' ' GLY . 67.4 mt -136.43 143.03 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.955 -0.566 . . . . 3.16 111.021 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -73.52 165.14 25.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.104 -0.498 . . . . 3.39 111.052 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -79.34 8.85 5.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 5.56 111.334 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 88.9 m -71.88 -64.88 0.85 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.892 0.377 . . . . 2.68 110.786 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 19.1 tt -67.62 -24.8 31.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 2.2 110.972 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . 0.442 ' HB2' ' HG2' ' B' ' 187' ' ' PRO . 19.9 t70 -52.95 -55.56 22.52 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.229 -0.441 . . . . 2.49 110.728 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 73.2 p -66.22 -34.54 78.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.226 -0.443 . . . . 1.76 110.463 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -61.96 -28.43 69.54 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.882 -0.599 . . . . 2.18 111.088 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.87 -47.38 11.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.354 -0.385 . . . . 1.78 111.262 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -71.08 -8.51 53.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.676 0.274 . . . . 1.98 110.886 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 45.6 t -96.81 -45.0 6.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.309 0.575 . . . . 1.65 110.301 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 48.9 tp -71.61 -35.71 70.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.426 -0.806 . . . . 1.11 112.041 -178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.678 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 42.7 tp -61.12 -54.65 51.76 Favored Pre-proline 0 CA--C 1.533 0.297 0 C-N-CA 121.031 -0.268 . . . . 1.43 111.604 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.678 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.0 Cg_exo -56.73 -39.08 93.87 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 121.655 1.57 . . . . 0.77 111.434 179.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -62.1 -33.79 75.1 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.191 -0.459 . . . . 1.6 110.433 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -80.01 -29.91 39.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.999 -0.546 . . . . 1.77 110.535 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.863 -0.608 . . . . 1.54 110.466 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -91.44 -46.02 8.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.939 -0.573 . . . . 2.01 110.729 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 69.1 t -65.25 -52.44 52.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.235 -0.439 . . . . 2.65 111.129 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.14 -26.67 66.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.796 -0.716 . . . . 1.33 112.557 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -69.53 -30.95 68.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.663 0.268 . . . . 2.29 111.0 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 46.0 t -69.21 -56.0 8.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.298 -0.41 . . . . 2.12 110.744 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -60.86 -24.69 66.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.22 -0.445 . . . . 3.6 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 5.5 tt -67.42 -50.79 57.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 1.51 110.727 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.39 -34.92 67.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.138 -0.483 . . . . 2.22 111.127 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 81.3 mt -60.5 -56.77 17.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.484 -0.326 . . . . 2.69 111.04 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -67.47 -20.35 65.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.353 -0.385 . . . . 3.4 111.164 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -72.2 -18.95 78.35 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.736 -0.745 . . . . 1.67 112.893 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 86.7 mt -56.54 -58.72 6.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.692 0.282 . . . . 3.39 110.957 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 50.73 70.46 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.166 -0.47 . . . . 5.91 110.678 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -91.21 116.7 29.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.026 -0.534 . . . . 5.26 111.038 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.403 HD12 ' N ' ' B' ' 224' ' ' LEU . 7.4 mp -109.55 166.29 11.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.099 -0.501 . . . . 6.81 110.667 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -97.37 94.58 7.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 7.02 111.014 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -173.19 95.71 0.11 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.217 -0.447 . . . . 8.21 110.874 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.2 m -149.5 86.19 1.46 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.283 -0.417 . . . . 8.1 111.089 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 93.4 mtt180 -99.98 85.89 3.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 13.28 110.828 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.274 -0.87 . . . . 10.4 110.865 179.926 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 21.0 ptm . . . . . 0 N--CA 1.485 1.284 0 CA-C-O 120.754 0.312 . . . . 8.1 111.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 57.38 91.6 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 6.27 111.178 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 84.8 mt -137.36 105.04 5.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.093 -0.503 . . . . 6.2 110.678 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -58.12 144.17 41.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.028 -0.533 . . . . 4.82 111.074 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.7 m -151.98 -42.56 0.11 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.348 -0.387 . . . . 3.25 111.066 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 mt 62.78 3.38 1.16 Allowed 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 115.979 -0.555 . . . . 2.79 111.492 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.506 HD21 ' HA ' ' C' ' 200' ' ' PHE . 60.1 tp -69.09 -50.78 45.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 2.08 110.63 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.506 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 36.5 m80 -69.75 -24.17 63.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.772 -0.649 . . . . 1.43 110.544 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.48 ' O ' HG12 ' C' ' 12' ' ' VAL . 56.3 t-105 -70.89 -53.73 14.05 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.022 -0.536 . . . . 1.16 110.8 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.1 pt -61.23 -22.49 27.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.95 0.405 . . . . 2.09 110.56 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . 0.406 ' O ' ' HG2' ' C' ' 15' ' ' MET . 17.4 t80 -62.51 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.926 -0.579 . . . . 1.58 110.721 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.48 HG12 ' O ' ' C' ' 9' ' ' TRP . 7.9 p -54.51 -29.78 20.81 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-N 116.267 -0.424 . . . . 1.0 111.375 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.83 -40.54 83.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.96 111.209 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.92 -29.82 66.57 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.853 -0.689 . . . . 0.96 112.817 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . 0.406 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 73.4 mmm -74.56 -30.09 61.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.807 0.337 . . . . 1.3 110.831 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -65.97 -56.45 11.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 1.52 111.102 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.425 ' O ' HD13 ' C' ' 17' ' ' ILE . 0.0 OUTLIER -57.68 -32.51 42.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.262 -0.427 . . . . 1.9 110.865 179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.15 -47.91 86.37 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.784 -0.722 . . . . 0.96 112.747 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.37 -28.57 69.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.783 0.325 . . . . 1.07 111.236 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 87.0 mt -68.2 -28.11 66.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.306 -0.407 . . . . 2.08 110.791 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -57.98 -31.81 67.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.275 -0.421 . . . . 2.02 110.35 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . 0.798 ' O ' ' OG ' ' C' ' 26' ' ' SER . 34.4 t80 -70.18 -35.71 74.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.922 -0.581 . . . . 4.98 110.437 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 55.0 t-105 -61.78 -30.32 70.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.943 -0.571 . . . . 4.29 110.604 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -84.79 -32.19 23.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 2.47 111.152 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 43.6 tp -88.15 -9.3 53.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.305 -0.407 . . . . 2.9 111.066 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.798 ' OG ' ' O ' ' C' ' 22' ' ' PHE . 1.4 m -68.28 -19.19 64.68 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.866 -0.334 . . . . 2.74 110.545 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -49.35 -35.06 17.47 Favored 'General case' 0 C--N 1.333 -0.124 0 N-CA-C 109.482 -0.562 . . . . 5.85 109.482 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.411 ' HA ' ' HD3' ' C' ' 29' ' ' PRO . 3.5 p-10 -172.65 132.06 0.66 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.182 -0.917 . . . . 4.52 110.065 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.485 ' HB3' HE22 ' C' ' 34' ' ' GLN . 64.0 Cg_endo -94.89 -179.13 0.59 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 123.081 2.52 . . . . 3.22 112.389 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . 0.43 ' HB2' HD13 ' C' ' 221' ' ' LEU . 23.9 mmm180 -97.21 51.69 1.11 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.299 -0.409 . . . . 8.68 111.276 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.87 -45.24 1.99 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.825 -0.702 . . . . 4.14 112.721 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' C' ' 33' ' ' PRO . 98.3 t -77.41 131.31 72.03 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.502 0.191 . . . . 5.09 111.029 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.428 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 35.6 Cg_exo -58.82 163.82 10.69 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.419 2.079 . . . . 3.1 112.263 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . 0.485 HE22 ' HB3' ' C' ' 29' ' ' PRO . 23.7 mm-40 -61.39 -18.44 58.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.794 -0.639 . . . . 3.85 112.273 -179.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.428 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.4 p90 -51.31 -33.85 30.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.747 0.308 . . . . 3.37 111.504 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -65.25 -62.08 1.75 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 2.72 110.748 -179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -66.41 -18.29 65.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 5.67 110.955 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . . . . . . . . . 51.0 tp -58.06 -61.59 2.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 1.93 110.57 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 11.1 p -63.04 -34.17 64.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 1.88 110.493 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . 0.443 ' HA ' HD12 ' C' ' 43' ' ' ILE . . . -70.38 -11.99 61.28 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.601 . . . . 1.23 110.843 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.417 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 23.9 ttt -88.22 -33.75 18.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.061 -0.518 . . . . 2.09 110.56 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' C' ' 45' ' ' ILE . 31.0 t80 -71.33 -28.73 64.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.907 -0.588 . . . . 1.41 110.908 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.566 HG23 HG23 ' C' ' 79' ' ' THR . 96.0 mt -55.48 -55.57 38.64 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.382 -0.372 . . . . 0.8 111.842 -179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.478 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 56.9 Cg_endo -70.75 -32.48 14.39 Favored 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.155 1.903 . . . . 0.72 112.982 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' C' ' 42' ' ' PHE . 92.5 mt -55.29 -61.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.664 -0.244 . . . . 1.68 111.599 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -62.02 -50.53 71.67 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.733 0.301 . . . . 1.68 111.151 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 99.0 p -67.23 -0.87 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.28 111.532 -179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -91.62 -51.29 2.54 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.74 -0.743 . . . . 0.51 112.653 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 88.0 mt -65.69 -29.14 69.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.73 0.3 . . . . 1.33 111.141 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.66 -54.69 44.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.298 -0.41 . . . . 0.57 111.202 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 23.7 m-85 -60.91 -35.25 76.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.185 -0.461 . . . . 1.67 111.018 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 53.5 ttp -52.51 -37.99 58.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.027 0.441 . . . . 1.42 110.298 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.425 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -68.8 -41.22 78.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.707 -0.679 . . . . 0.71 110.792 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 50.6 mtt -54.57 -24.75 22.36 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.866 -0.606 . . . . 1.14 110.622 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.506 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -79.79 -41.57 26.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.88 110.558 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 7.1 mt -83.28 9.44 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.977 -0.556 . . . . 1.38 110.655 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 61.71 54.64 2.9 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 115.846 -0.615 . . . . 1.94 110.626 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.439 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.6 tp60 -133.68 145.3 49.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.925 -0.579 . . . . 1.87 110.807 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 109.12 -30.17 8.92 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.813 -0.708 . . . . 1.27 112.552 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . 0.4 ' HD3' HH12 ' C' ' 72' ' ' ARG . 60.9 pttt -105.35 141.88 36.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.779 0.324 . . . . 2.86 110.933 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -114.04 142.09 27.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 1.95 110.952 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -87.69 91.6 8.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 3.04 111.074 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -105.69 134.14 49.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 2.11 110.942 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.71 22.19 12.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.112 -0.495 . . . . 2.54 110.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.56 -8.55 71.42 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.894 -0.67 . . . . 2.47 112.705 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -112.77 145.0 41.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 2.85 110.808 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 39.4 pt -87.01 139.27 17.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.214 -0.448 . . . . 1.87 111.373 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -106.15 138.13 42.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.045 -0.525 . . . . 1.12 111.063 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.548 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 92.9 m-70 -82.46 63.61 6.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.058 0.456 . . . . 1.26 110.702 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -71.65 -32.08 67.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.796 -0.638 . . . . 2.08 111.077 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -79.84 -22.86 42.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.86 111.928 -179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 9.1 mpt_? -73.85 -52.19 13.83 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.366 -0.379 . . . . 1.96 111.977 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.463 ' CD1' ' HB3' ' C' ' 117' ' ' LEU . 2.4 p90 -69.06 -38.36 79.04 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.883 -0.327 . . . . 1.8 111.479 -178.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . . . . . . . . . 9.8 tp -56.35 -41.53 71.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 120.91 -0.316 . . . . 1.18 110.407 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.26 -25.99 64.55 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.191 -0.67 . . . . 1.33 109.191 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 27.2 m0 -87.28 6.92 30.95 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 115.631 -0.713 . . . . 1.85 110.438 179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.424 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.0 tpp -104.56 -20.93 13.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.567 -0.742 . . . . 1.56 110.578 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.12 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.157 -0.474 . . . . 1.11 112.125 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.566 HG23 HG23 ' C' ' 43' ' ' ILE . 33.3 m -76.07 -59.98 2.52 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.404 0.52 . . . . 1.49 112.404 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.606 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 88.2 m -48.2 -51.7 47.5 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.741 0.645 . . . . 1.6 112.741 -178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 46.4 Cg_exo -55.56 -38.62 93.92 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 121.865 1.71 . . . . 1.01 112.072 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -77.86 -16.0 58.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.964 -0.562 . . . . 1.18 111.459 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 29.5 tp -74.51 -39.95 62.08 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.863 -0.335 . . . . 1.54 111.008 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.481 HD23 HE21 ' C' ' 109' ' ' GLN . 4.3 pp -77.27 -31.04 54.63 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.75 0.309 . . . . 1.65 110.649 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.469 ' N ' HD12 ' C' ' 84' ' ' LEU . 78.8 mt -65.76 -32.56 74.16 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.003 0.43 . . . . 2.1 110.487 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 46.1 t -60.76 -30.31 69.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.918 -0.583 . . . . 1.38 110.634 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.446 HD22 HD11 ' C' ' 168' ' ' LEU . 84.3 mt -72.08 -31.5 66.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.094 -0.503 . . . . 1.44 110.683 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 42.6 t -63.37 -38.93 93.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.048 -0.524 . . . . 1.87 110.772 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 65.9 m95 -73.18 -40.73 64.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.479 . . . . 3.1 111.01 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 71.3 p -68.26 -29.89 68.79 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.3 -0.409 . . . . 1.48 111.298 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.95 -37.21 24.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.27 -0.423 . . . . 1.02 111.253 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 82.6 mtp -133.96 115.22 14.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.369 -0.378 . . . . 2.34 111.21 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -80.37 -12.19 59.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.419 . . . . 3.21 110.587 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -143.08 140.53 30.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.084 -0.507 . . . . 4.54 110.925 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 16.1 tt -109.32 144.89 16.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 2.34 110.895 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -114.79 53.57 0.8 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 4.4 110.895 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 35.5 mmtp 56.95 48.92 14.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.055 -0.52 . . . . 5.54 111.047 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -118.82 121.58 40.37 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.3 -0.409 . . . . 3.54 111.042 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 13.6 m-90 -139.24 22.15 2.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.182 -0.463 . . . . 5.21 110.958 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 3.9 t -87.58 -47.21 8.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.337 -0.392 . . . . 2.38 111.46 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 66.8 mt -74.4 -53.1 10.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.859 0.361 . . . . 2.64 110.795 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 51.9 mt -67.28 -28.47 42.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.999 -0.546 . . . . 2.38 110.933 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.06 -36.23 80.29 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.825 -0.703 . . . . 1.62 112.748 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -76.78 -32.23 57.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.896 0.379 . . . . 2.93 110.908 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.414 HD23 HD11 ' C' ' 142' ' ' ILE . 98.2 mt -69.53 -48.47 60.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.161 0.505 . . . . 2.16 110.74 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 15.3 tpt -62.3 -33.04 73.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.57 -0.741 . . . . 2.3 111.193 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 91.7 p -70.35 -52.64 21.14 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.987 0.422 . . . . 2.07 110.868 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.42 HG21 HD12 ' C' ' 142' ' ' ILE . 39.5 p -55.22 -31.42 61.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.028 -0.533 . . . . 2.3 111.071 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.59 HE22 ' HE1' ' C' ' 176' ' ' TRP . 6.6 tp-100 -65.07 -42.43 94.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 2.48 110.457 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 68.8 mt -54.78 -35.94 35.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.133 -0.485 . . . . 1.93 110.687 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 99.2 t -63.65 -50.83 76.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.087 -0.506 . . . . 1.67 111.385 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 58.5 t -58.06 -51.19 73.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 1.11 111.707 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 73.8 mt -50.19 -41.67 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.335 -0.393 . . . . 2.59 111.411 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' C' ' 117' ' ' LEU . 70.3 m -61.14 -43.88 98.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.996 0.427 . . . . 0.9 110.823 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.57 ' HA ' ' HE1' ' C' ' 131' ' ' TRP . 50.4 m -57.85 -23.66 53.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.119 -0.491 . . . . 0.92 110.598 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -77.03 -58.8 3.32 Favored Glycine 0 C--N 1.33 0.204 0 C-N-CA 120.923 -0.656 . . . . 0.55 112.965 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.463 ' HB3' ' CD1' ' C' ' 73' ' ' TYR . 3.8 pp -55.78 -35.58 66.42 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.69 0.256 . . . . 1.49 111.69 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.413 ' N ' HD12 ' C' ' 117' ' ' LEU . 60.3 mt -73.14 -44.83 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.788 0.328 . . . . 1.66 111.207 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . 0.484 ' HA ' ' HB2' ' C' ' 128' ' ' ARG . . . -62.05 -28.64 69.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.208 -0.451 . . . . 0.94 111.432 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -73.58 -9.3 58.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.47 -0.332 . . . . 1.79 111.315 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 34.6 mt -80.45 35.47 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.915 0.388 . . . . 1.29 110.655 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.442 ' O ' ' CB ' ' C' ' 123' ' ' GLU . 80.8 p -56.7 177.87 0.07 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 115.856 -0.611 . . . . 2.15 112.358 -179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . 0.442 ' CB ' ' O ' ' C' ' 122' ' ' SER . 11.0 tp10 98.92 -108.17 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.566 1.146 . . . . 3.31 109.441 -179.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.887 ' O ' ' N ' ' C' ' 126' ' ' TRP . 0.3 OUTLIER -54.9 -179.52 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 107.3 -1.37 . . . . 3.16 107.3 177.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . 0.527 ' O ' ' N ' ' C' ' 127' ' ' VAL . 19.5 m-20 -4.88 20.34 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 117.834 2.531 . . . . 4.24 117.834 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . 0.887 ' N ' ' O ' ' C' ' 124' ' ' ARG . 6.1 p-90 -44.29 23.8 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 116.932 2.197 . . . . 4.65 116.932 -176.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.527 ' N ' ' O ' ' C' ' 125' ' ' ASP . 8.8 m -41.39 -17.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 118.585 0.63 . . . . 1.31 110.811 176.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.567 ' HA ' ' HB3' ' C' ' 131' ' ' TRP . 6.4 ppt_? -40.6 -19.79 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.924 -0.58 . . . . 2.84 111.916 178.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . 0.431 ' N ' ' C ' ' C' ' 127' ' ' VAL . 88.7 t80 -47.1 -41.04 16.56 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.898 -0.779 . . . . 2.7 108.898 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 97.2 mt -83.7 -33.87 25.06 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.208 -0.906 . . . . 1.88 109.555 177.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . 0.578 ' HB2' HE22 ' B' ' 58' ' ' GLN . 53.1 t-105 -55.96 -24.11 36.36 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.056 -0.52 . . . . 1.38 110.084 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -67.34 -42.11 84.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.711 -0.677 . . . . 1.76 110.396 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 51.0 mt -62.97 -30.13 48.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.853 -0.612 . . . . 2.15 110.629 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 60.5 m -66.9 -37.81 85.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.867 -0.606 . . . . 1.56 110.584 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.5 -52.76 32.68 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.835 -0.698 . . . . 0.73 112.429 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -62.13 -27.54 42.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.808 0.337 . . . . 1.48 111.108 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -62.74 -44.19 96.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.255 -0.43 . . . . 1.51 110.813 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -38.91 91.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.252 -0.431 . . . . 1.01 110.843 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -72.53 -26.52 61.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.99 -0.55 . . . . 2.05 110.757 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.453 HD13 ' O ' ' C' ' 140' ' ' LEU . 0.7 OUTLIER -69.06 -43.36 74.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.288 -0.415 . . . . 2.07 110.669 -179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 64.9 mt -65.27 -52.89 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 1.92 111.47 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.42 HD12 HG21 ' C' ' 108' ' ' THR . 15.7 tt -63.97 -35.2 72.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.227 -0.442 . . . . 2.64 111.824 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 42.7 tp -55.18 -55.94 25.57 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.677 0.275 . . . . 1.51 110.974 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 88.0 t90 -62.39 -25.84 68.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.345 -0.389 . . . . 3.58 110.821 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -78.96 -19.49 72.6 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.831 -0.7 . . . . 1.65 112.716 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 45.9 pt -108.56 -11.02 11.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.86 0.362 . . . . 2.46 111.304 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 11.6 t-105 -97.26 -6.03 35.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.118 -0.492 . . . . 2.27 110.936 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.58 ' H ' ' HD2' ' C' ' 149' ' ' PRO . 35.1 t-20 -95.24 -49.04 0.26 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.093 -0.503 . . . . 2.33 111.341 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.58 ' HD2' ' H ' ' C' ' 148' ' ' ASN . 53.4 Cg_endo -69.2 0.53 5.1 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.135 1.89 . . . . 2.46 112.424 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.16 -26.61 62.94 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.218 -0.446 . . . . 3.08 111.177 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -139.54 -13.75 1.12 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.43 . . . . 8.45 110.948 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.19 -41.34 20.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 2.9 111.216 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -82.52 -27.84 31.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 4.62 110.702 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' C' ' 157' ' ' GLN . 67.7 p -83.26 6.86 18.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 3.85 111.25 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -58.69 -22.65 57.72 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.181 -0.463 . . . . 5.12 111.215 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . 0.543 HG23 HE21 ' C' ' 157' ' ' GLN . 7.5 t -131.93 -12.72 3.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.34 -0.391 . . . . 3.43 111.334 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.543 HE21 HG23 ' C' ' 156' ' ' THR . 29.2 mm-40 -83.45 -167.19 1.6 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.308 -0.405 . . . . 3.98 111.033 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 49.1 m -55.46 120.54 7.32 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.203 -0.453 . . . . 2.4 111.014 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 47.2 t -78.29 -38.8 41.69 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.976 -0.556 . . . . 2.82 111.071 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -66.63 -51.62 54.2 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.073 -0.512 . . . . 3.18 111.149 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 50.2 tp -58.38 -29.98 66.45 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.359 -0.382 . . . . 2.5 110.763 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -34.75 77.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.139 -0.482 . . . . 1.81 111.024 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -70.93 -42.85 69.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.077 -0.511 . . . . 2.13 111.119 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.45 -39.49 92.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 2.21 110.765 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -72.13 -23.26 61.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.966 -0.561 . . . . 1.31 110.945 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -64.64 -57.49 8.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.246 -0.434 . . . . 2.26 110.691 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -71.56 -20.86 61.96 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.053 -0.522 . . . . 3.58 111.451 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.446 HD11 HD22 ' C' ' 87' ' ' LEU . 58.8 tp -69.28 -61.4 1.81 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.487 -0.324 . . . . 1.3 111.18 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 33.0 t -61.33 -20.37 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.455 -0.339 . . . . 1.73 111.118 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 54.4 m -51.52 -58.93 4.93 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.717 0.294 . . . . 1.43 111.062 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -66.27 -38.02 86.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 3.72 110.102 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -58.58 -22.35 55.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.749 -0.659 . . . . 1.55 110.504 179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.484 HG22 HD12 ' C' ' 177' ' ' ILE . 73.0 m -79.68 -46.29 17.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 1.5 111.092 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.76 -29.74 48.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.37 -0.377 . . . . 1.84 111.49 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 86.8 mt -76.49 -57.81 3.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.82 0.343 . . . . 2.12 111.425 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . 0.59 ' HE1' HE22 ' C' ' 109' ' ' GLN . 1.0 OUTLIER -57.46 -29.7 64.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.171 -0.468 . . . . 1.0 110.796 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.484 HD12 HG22 ' C' ' 173' ' ' THR . 66.3 mt -87.75 -22.51 6.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 1.75 109.96 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.67 -54.09 37.18 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 115.715 -0.675 . . . . 0.72 113.055 -179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.633 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 84.7 m-85 -56.67 -54.47 53.41 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 116.892 0.346 . . . . 1.8 111.221 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.633 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 81.8 Cg_exo -46.13 -31.0 8.19 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.006 1.804 . . . . 0.88 112.517 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.441 HG13 ' O ' ' C' ' 177' ' ' ILE . 97.1 mt -65.73 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.874 0.369 . . . . 1.52 111.147 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.501 HG22 ' O ' ' C' ' 179' ' ' TYR . 23.2 m -58.38 -24.67 25.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.08 -0.509 . . . . 1.2 111.232 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -67.36 -49.68 62.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.164 -0.471 . . . . 2.47 111.253 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . . . . . . . . . 94.9 mt -52.91 -57.51 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.424 . . . . 1.62 111.239 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 36.2 pt -89.16 -172.62 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 2.63 111.486 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 61.07 -153.51 38.43 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.904 -0.665 . . . . 1.77 112.547 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -74.1 162.69 38.34 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.722 2.281 . . . . 3.03 112.246 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 56.65 15.04 1.96 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.179 -0.464 . . . . 4.22 110.69 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -150.25 -87.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.614 . . . . 4.08 112.285 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -159.35 89.88 0.93 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 7.54 110.499 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -168.21 158.26 30.91 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 120.803 -0.713 . . . . 3.29 112.673 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 64.4 t-105 -82.77 -27.72 30.82 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.83 0.348 . . . . 5.67 110.991 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.608 HD12 HG12 ' C' ' 197' ' ' ILE . 14.5 pt -87.37 139.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 2.76 110.865 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -150.74 175.7 11.73 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.022 0.439 . . . . 3.69 111.842 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 60.9 -87.47 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.45 -0.796 . . . . 5.34 112.46 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 39.1 m -49.39 -56.21 10.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.304 -0.407 . . . . 2.57 112.047 -179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.608 HG12 HD12 ' C' ' 193' ' ' ILE . 9.3 tp -71.31 -28.75 33.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.389 -0.369 . . . . 2.37 111.503 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -51.86 -59.98 3.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.209 -0.45 . . . . 2.68 111.619 -179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 76.3 p -70.17 -42.34 72.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.655 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . 0.506 ' HA ' HD21 ' C' ' 7' ' ' LEU . 52.4 t80 -52.62 -29.64 27.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.208 -0.451 . . . . 2.05 111.887 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 79.0 mt -83.84 -54.11 5.12 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.812 0.301 . . . . 1.91 111.812 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -65.58 -9.57 27.82 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.693 0.257 . . . . 2.04 111.693 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.433 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 95.5 m -96.58 -43.56 7.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.62 110.826 178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.7 tp -68.31 -41.87 80.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 1.49 112.165 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.644 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 30.3 tp -56.88 -53.55 63.75 Favored Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 111.694 0.257 . . . . 1.32 111.694 -178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 53.1 Cg_exo -53.45 -45.93 37.5 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 121.836 1.69 . . . . 0.76 111.717 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -57.88 -32.37 67.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.135 -0.484 . . . . 1.52 110.186 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -78.79 -30.01 45.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 1.84 110.511 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 28.8 t -79.98 -20.72 44.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.089 -0.505 . . . . 1.68 110.712 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -86.04 -50.89 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 2.04 110.835 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 90.8 t -60.23 -53.89 42.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.287 -0.415 . . . . 2.65 110.854 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . 0.409 ' O ' ' HB2' ' C' ' 216' ' ' LEU . . . -58.17 -29.06 62.22 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.85 -0.691 . . . . 1.33 112.451 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -69.28 -37.51 77.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.656 0.265 . . . . 3.02 111.131 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -62.13 -52.49 63.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.397 -0.365 . . . . 2.35 111.038 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -68.57 -20.32 64.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.243 -0.435 . . . . 3.62 111.053 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' C' ' 212' ' ' GLY . 4.9 tt -68.89 -55.65 10.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.375 -0.375 . . . . 1.64 110.7 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' C' ' 221' ' ' LEU . 2.5 p30 -59.24 -29.04 67.24 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.221 -0.445 . . . . 2.2 110.527 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.53 -52.62 62.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.077 -0.51 . . . . 3.11 110.619 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -72.96 -24.0 60.74 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.204 -0.453 . . . . 3.37 110.499 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.4 -22.69 73.18 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.839 -0.696 . . . . 1.55 112.533 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.43 HD13 ' HB2' ' C' ' 30' ' ' ARG . 95.6 mt -60.76 -55.22 35.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.753 0.311 . . . . 3.11 110.856 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 62.45 -78.98 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.835 -0.621 . . . . 5.73 111.263 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 17.8 m120 64.53 115.04 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.002 0.429 . . . . 5.53 111.315 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 91.0 mt -115.52 155.89 26.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.888 -0.596 . . . . 6.6 110.504 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -83.27 55.46 3.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.139 -0.482 . . . . 6.51 111.057 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -137.34 94.48 2.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.069 -0.514 . . . . 7.05 110.914 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 62.7 m -136.46 -61.1 0.7 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.895 -0.593 . . . . 6.72 110.683 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 24.3 mmm180 56.01 86.94 0.06 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.005 -0.543 . . . . 9.56 111.148 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.234 -0.889 . . . . 9.08 110.897 -179.902 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.743 ' H8 ' H171 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.755 H161 ' H8 ' ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.742 ' H8 ' H171 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.3 ttp . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.829 0.347 . . . . 8.09 110.867 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -147.82 108.67 4.2 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.312 -0.404 . . . . 5.68 111.055 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 40.8 tp -64.18 134.31 54.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.984 -0.553 . . . . 6.27 110.957 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -162.25 19.81 0.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.346 -0.388 . . . . 6.52 111.09 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.4 t -132.04 129.7 40.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.321 -0.399 . . . . 3.59 110.834 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 10' ' ' ILE . 65.3 mt -137.2 -5.37 1.85 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.102 -0.499 . . . . 3.23 110.821 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.43 -62.13 2.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.098 0.475 . . . . 1.88 110.706 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.542 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 26.3 m80 -59.09 -23.55 62.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 1.29 110.706 179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 36.4 t-105 -68.58 -30.76 69.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.99 110.983 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 6' ' ' LEU . 69.9 mt -74.98 -34.79 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.035 0.445 . . . . 1.92 110.451 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -60.2 -51.57 69.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.751 -0.659 . . . . 1.45 110.99 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.2 p -59.26 -39.71 79.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.418 -0.355 . . . . 0.89 111.348 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.01 -40.02 94.25 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.373 -0.376 . . . . 0.9 111.191 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.88 -24.63 74.33 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.738 -0.744 . . . . 0.83 112.362 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 11.4 mmt -72.44 -35.66 68.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.964 0.411 . . . . 1.24 110.589 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 68.6 m -62.56 -56.27 19.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 1.29 111.156 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 18' ' ' GLY . 2.8 pp -61.4 -25.42 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.324 -0.398 . . . . 1.71 111.188 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.423 ' N ' HD12 ' A' ' 17' ' ' ILE . . . -61.17 -46.38 94.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.846 -0.693 . . . . 0.96 112.291 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -27.12 62.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.99 111.135 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 29.1 tp -67.05 -24.3 65.97 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.166 -0.47 . . . . 2.11 110.74 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -55.9 -55.89 27.22 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.24 -0.436 . . . . 2.23 110.809 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -60.64 -32.93 72.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 4.02 111.0 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.8 t-105 -59.07 -30.33 67.99 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.266 -0.425 . . . . 3.96 110.581 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 60.9 m -80.91 -31.73 35.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.04 -0.527 . . . . 2.38 110.414 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 87.6 mt -87.33 -0.53 56.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.685 -0.689 . . . . 2.77 110.538 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -49.92 -26.46 4.16 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.016 -0.538 . . . . 2.52 111.346 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' ND2' ' A' ' 28' ' ' ASN . 70.3 ttt180 -45.89 -41.21 11.07 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.093 -0.706 . . . . 5.54 109.093 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.456 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 41.2 m-80 -154.36 131.24 5.9 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 114.997 -1.001 . . . . 4.44 109.264 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 2.9 Cg_endo -81.25 166.22 18.47 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.624 2.216 . . . . 2.81 112.277 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.502 ' HD3' ' HA ' ' A' ' 218' ' ' LEU . 98.3 mtt180 -80.16 26.36 0.36 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.009 -0.541 . . . . 6.8 111.07 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 108.46 -30.3 9.01 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.735 -0.745 . . . . 4.97 112.527 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG13 HD22 ' A' ' 221' ' ' LEU . 21.1 m -93.22 128.37 43.19 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 120.519 0.2 . . . . 4.71 111.108 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.87 167.77 16.88 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.53 2.153 . . . . 3.51 112.139 179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.413 ' O ' HD13 ' A' ' 38' ' ' LEU . 11.4 pt20 -35.41 -33.07 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.59 0.589 . . . . 3.41 112.59 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -41.53 -42.19 2.33 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.786 0.291 . . . . 2.81 111.786 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -70.89 -41.43 71.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.704 0.288 . . . . 3.39 110.798 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.415 ' O ' ' HB2' ' A' ' 41' ' ' MET . 91.4 t80 -61.97 -35.29 78.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 5.24 110.857 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 34' ' ' GLN . 10.9 mp -60.33 -55.26 35.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.526 -0.307 . . . . 1.6 110.982 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.86 -41.62 93.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.329 -0.396 . . . . 1.33 110.974 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' HA ' HD12 ' A' ' 43' ' ' ILE . . . -73.61 -6.13 44.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.155 -0.475 . . . . 1.03 111.29 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 37' ' ' TYR . 14.0 tpt -88.57 -38.51 14.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.863 0.363 . . . . 2.0 110.869 179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB2' ' HB3' ' B' ' 107' ' ' SER . 74.9 t80 -75.25 -28.52 59.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.083 -0.508 . . . . 1.31 111.567 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.453 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 97.0 mt -56.34 -52.39 73.49 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 111.999 0.37 . . . . 1.0 111.999 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.453 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -75.57 -35.11 2.92 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 122.272 1.981 . . . . 0.59 113.299 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 80.5 mt -56.86 -62.54 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 111.733 0.272 . . . . 1.63 111.733 -179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.0 t90 -59.57 -48.4 81.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.858 0.361 . . . . 1.12 110.918 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 44.5 t -62.98 -14.29 45.68 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.953 -0.567 . . . . 1.32 111.238 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.18 -47.56 6.44 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.693 -0.765 . . . . 0.52 112.527 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -67.01 -29.85 69.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 0.98 110.82 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.44 -58.2 7.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.088 -0.505 . . . . 0.52 111.379 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 19.7 m-85 -62.68 -47.89 81.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.147 -0.479 . . . . 1.69 111.262 -179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 49.0 ttp -49.87 -33.61 17.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.203 0.525 . . . . 1.12 110.523 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.08 -40.32 75.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.703 -0.68 . . . . 0.6 110.897 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.405 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 49.6 mtt -51.81 -33.9 37.76 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.004 -0.544 . . . . 0.94 110.246 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.542 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -70.29 -43.95 69.36 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.644 -0.707 . . . . 0.78 110.226 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 56' ' ' ILE . 10.6 mt -76.78 4.93 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.991 -0.55 . . . . 1.23 110.583 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 63.38 46.07 4.58 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.777 -0.647 . . . . 2.02 111.035 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -117.23 148.7 41.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.044 -0.525 . . . . 2.1 110.851 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.93 13.42 53.12 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.736 -0.745 . . . . 1.27 112.156 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -123.42 139.51 53.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 1.76 110.768 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -117.87 141.48 36.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.18 -0.464 . . . . 1.84 111.143 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -94.57 92.15 6.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.167 -0.47 . . . . 2.64 110.899 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.24 108.25 20.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.108 -0.497 . . . . 1.84 111.104 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.41 31.64 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.035 -0.53 . . . . 2.24 111.499 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.55 1.83 85.34 Favored Glycine 0 C--N 1.329 0.139 0 C-N-CA 120.681 -0.771 . . . . 2.16 112.733 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -104.67 150.39 24.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 2.84 111.143 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 72.7 mt -109.03 131.4 59.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 2.39 111.111 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.45 140.68 40.02 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.221 -0.445 . . . . 0.97 111.45 -179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.464 ' HB3' ' CB ' ' A' ' 72' ' ' ARG . 50.5 m-70 -89.18 56.62 3.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.325 0.584 . . . . 1.04 110.858 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -55.5 -43.54 75.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 3.38 111.29 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.445 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -70.1 -22.76 62.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 0.76 112.138 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.464 ' CB ' ' HB3' ' A' ' 69' ' ' HIS . 23.4 tpp180 -65.86 -51.75 56.15 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.323 0.49 . . . . 2.93 112.323 -178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' O ' ' HG2' ' A' ' 77' ' ' MET . 21.8 p90 -87.41 -25.01 24.01 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.573 -0.451 . . . . 3.13 112.012 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 71' ' ' ALA . 8.3 tp -56.27 -42.31 73.34 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 120.512 -0.475 . . . . 1.66 110.026 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -69.56 -23.94 63.63 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.137 -0.69 . . . . 1.42 109.137 178.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 46.4 m0 -87.74 6.16 36.37 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.352 -0.84 . . . . 2.09 110.859 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.532 ' SD ' HD23 ' A' ' 117' ' ' LEU . 93.9 mmm -105.07 -21.92 13.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.693 -0.685 . . . . 1.52 110.653 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.448 ' O ' ' HG ' ' A' ' 82' ' ' LEU . 23.0 m -114.14 -28.42 2.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.862 -0.608 . . . . 1.33 111.968 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 43' ' ' ILE . 31.3 m -89.99 -46.49 8.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.059 0.392 . . . . 1.39 112.059 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.581 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.6 m -55.96 -49.73 91.31 Favored Pre-proline 0 CA--C 1.531 0.24 0 N-CA-C 111.816 0.302 . . . . 1.55 111.816 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 52.3 Cg_exo -54.9 -47.24 27.71 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 121.883 1.722 . . . . 1.01 111.613 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.642 HD23 HD12 ' A' ' 85' ' ' LEU . 47.1 mt -67.04 -26.18 66.64 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.163 -0.471 . . . . 1.45 110.324 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -33.16 73.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.147 -0.686 . . . . 1.3 109.147 178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.487 HD21 ' HB3' ' A' ' 105' ' ' LEU . 4.8 tt -84.99 -21.16 29.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.142 -0.936 . . . . 1.67 110.169 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.642 HD12 HD23 ' A' ' 82' ' ' LEU . 67.5 mt -81.84 -37.99 26.15 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.73 -0.668 . . . . 1.87 111.168 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 64.4 m -58.54 -36.22 73.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.254 -0.43 . . . . 1.42 110.915 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.461 ' HB3' HD21 ' A' ' 168' ' ' LEU . 26.1 mt -58.7 -35.01 71.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.657 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 48.5 t -67.44 -48.73 66.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.878 -0.601 . . . . 1.91 110.91 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -58.24 -32.53 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.459 . . . . 2.33 111.236 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 58.5 m -69.99 -32.2 70.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 1.43 111.268 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.42 -50.76 9.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 1.19 111.516 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 21.1 ptp -105.07 124.78 50.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 2.55 110.884 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -80.85 -13.68 58.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.978 -0.556 . . . . 3.33 110.656 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -157.25 179.36 9.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.936 -0.575 . . . . 5.1 110.761 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 20.1 tt -149.91 146.95 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.313 -0.403 . . . . 3.07 111.019 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.8 pttm -141.82 -41.55 0.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 4.41 111.012 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -157.82 71.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 5.31 110.55 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -142.72 52.45 1.41 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 3.94 111.032 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 6.8 m-90 -86.84 11.79 12.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.875 0.369 . . . . 5.98 110.736 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -99.64 -57.25 2.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 2.24 111.343 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.478 ' H ' HD22 ' A' ' 101' ' ' LEU . 3.2 mm? -60.01 -46.97 87.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.363 -0.381 . . . . 2.67 110.831 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 43.3 mm -60.77 -32.23 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.311 -0.404 . . . . 2.59 110.899 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -66.21 -31.98 80.8 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.848 -0.691 . . . . 1.53 112.508 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.423 ' O ' HG22 ' A' ' 108' ' ' THR . 91.3 t80 -67.53 -55.89 11.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 3.14 110.946 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.487 ' HB3' HD21 ' A' ' 84' ' ' LEU . 52.6 mt -58.26 -36.49 73.32 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.984 -0.553 . . . . 1.99 111.265 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 24.5 ttt -70.15 -44.11 69.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.745 -0.661 . . . . 2.36 111.654 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.1 m -60.03 -56.9 15.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.287 -0.415 . . . . 2.05 111.758 -179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.432 ' OG1' HG21 ' A' ' 142' ' ' ILE . 3.7 t -54.36 -37.4 64.9 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.387 -0.369 . . . . 2.25 111.722 -179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.511 HE21 HG23 ' A' ' 113' ' ' ILE . 22.0 tp60 -58.25 -50.39 73.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.32 -0.4 . . . . 2.72 111.606 -179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 54.0 mt -57.08 -34.39 45.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.417 -0.356 . . . . 1.88 111.515 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.1 t -71.3 -42.98 74.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.46 -0.337 . . . . 1.6 111.476 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.86 -49.48 81.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.442 -0.345 . . . . 1.09 111.849 -179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.511 HG23 HE21 ' A' ' 109' ' ' GLN . 31.2 pt -60.49 -29.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.469 -0.332 . . . . 2.65 111.752 -179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.427 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 73.6 m -64.38 -54.28 35.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.868 0.366 . . . . 0.89 111.271 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 69.0 m -58.89 -23.57 61.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.68 110.968 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.6 ' HA3' H172 ' A' ' 301' ' ' RET . . . -73.9 -44.77 29.53 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.873 -0.679 . . . . 0.63 113.131 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.532 HD23 ' SD ' ' A' ' 77' ' ' MET . 3.8 pp -75.89 -22.76 55.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.53 0.205 . . . . 1.58 111.536 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.0 mm -80.95 -36.99 15.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.658 0.266 . . . . 2.04 111.331 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.73 -40.05 62.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 1.1 111.597 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -77.6 -23.31 49.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.237 -0.438 . . . . 1.88 111.122 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.6 mt -86.38 31.59 0.66 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.822 0.344 . . . . 1.53 111.089 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 47.6 t -92.45 120.61 33.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.288 -0.414 . . . . 2.29 110.967 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -83.67 -31.21 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 3.49 111.145 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.457 ' HB2' HG12 ' A' ' 127' ' ' VAL . 85.8 mtm180 -110.51 145.76 37.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.377 . . . . 3.13 111.109 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -77.06 -10.23 59.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.997 -0.547 . . . . 3.71 110.909 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 32.8 t-105 -88.54 -42.75 11.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 3.97 110.945 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.457 HG12 ' HB2' ' A' ' 124' ' ' ARG . 12.2 p -70.09 -24.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.456 . . . . 1.22 111.17 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -63.55 -35.82 81.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 2.81 110.979 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -70.34 -27.98 64.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.379 -0.373 . . . . 4.25 110.867 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.53 -52.83 8.42 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.191 -0.459 . . . . 1.84 111.02 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -63.53 -24.08 67.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 1.54 110.935 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -68.31 -42.62 79.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.283 -0.417 . . . . 1.79 111.027 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.4 mt -64.67 -33.4 62.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.347 -0.388 . . . . 2.08 110.699 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 78.2 m -66.49 -33.13 75.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.038 -0.528 . . . . 1.76 110.902 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.5 -47.92 47.34 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.814 -0.708 . . . . 0.76 112.345 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.82 -31.6 48.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 2.07 110.755 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 54.1 t -63.9 -36.21 83.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.0 -0.546 . . . . 1.85 110.417 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -71.29 -32.09 68.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.924 -0.58 . . . . 1.32 110.602 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -75.63 -17.7 59.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.973 -0.558 . . . . 3.25 110.354 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.42 -51.57 9.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 2.92 111.083 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 44.5 pt -62.1 -35.03 66.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.356 -0.384 . . . . 2.65 111.812 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.432 HG21 ' OG1' ' A' ' 108' ' ' THR . 41.0 pt -76.45 -31.08 20.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.547 -0.297 . . . . 3.21 111.473 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 24.1 tp -62.9 -36.53 83.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.341 -0.39 . . . . 2.01 110.584 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 88.3 t90 -80.72 -24.48 38.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 3.6 110.329 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -81.44 -16.59 73.32 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.863 -0.608 . . . . 1.62 112.493 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 14.9 tt -103.17 -26.09 3.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.719 0.295 . . . . 2.47 111.352 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 24.1 m95 -84.47 -41.16 16.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.313 -0.403 . . . . 2.48 111.377 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.563 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 44.7 t30 -55.98 -49.28 93.95 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 112.401 0.519 . . . . 2.69 112.401 -179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 29.2 Cg_endo -62.31 -7.79 11.08 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.161 1.907 . . . . 2.36 113.177 -179.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.34 -0.73 47.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.732 0.301 . . . . 3.3 111.192 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.427 ' O ' HG22 ' A' ' 154' ' ' THR . 82.1 mtp180 -144.18 -28.44 0.5 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.296 -0.411 . . . . 8.48 111.055 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.64 -49.16 9.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.326 -0.397 . . . . 2.98 111.826 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -85.75 -0.45 55.27 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.02 0.378 . . . . 4.55 112.02 -178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.427 HG22 ' O ' ' A' ' 151' ' ' ARG . 14.7 t -80.35 -2.66 46.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.743 0.306 . . . . 4.0 110.846 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -64.92 -48.51 73.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 5.51 110.765 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 79.4 p -96.0 -40.56 9.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 3.2 111.095 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -61.7 152.35 31.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 3.98 110.822 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.9 m -56.92 114.5 2.13 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.116 -0.493 . . . . 2.63 110.983 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.4 t -59.95 -25.63 65.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.026 -0.534 . . . . 2.16 111.152 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -65.96 -56.0 13.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.329 -0.396 . . . . 3.37 110.948 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.4 tp -65.73 -29.8 70.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 2.83 110.783 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.65 -40.0 88.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 1.7 111.275 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -64.21 -40.8 96.81 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.204 -0.453 . . . . 2.16 110.978 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 58.5 mt -59.94 -44.08 94.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.49 . . . . 1.59 110.815 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.487 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -71.12 -31.18 67.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.646 -0.706 . . . . 2.31 111.097 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -57.39 -39.37 75.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.371 -0.377 . . . . 2.15 111.299 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -82.19 -24.78 34.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.954 0.407 . . . . 2.39 110.598 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.461 HD21 ' HB3' ' A' ' 87' ' ' LEU . 58.1 tp -70.93 -33.31 70.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.996 -0.547 . . . . 1.79 110.995 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 165' ' ' TYR . 81.3 t -72.96 -23.54 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 1.42 110.834 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 49.2 m -55.39 -59.31 4.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.266 -0.425 . . . . 1.12 111.016 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -66.63 -37.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.067 0.461 . . . . 3.86 110.259 179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.446 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 40.3 t80 -57.53 -30.52 65.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.643 -0.708 . . . . 1.58 110.762 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 85.2 m -79.24 -51.29 9.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.167 -0.47 . . . . 1.41 111.546 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 177' ' ' ILE . 47.0 t -51.82 -48.87 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 112.901 0.704 . . . . 1.42 112.901 -178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.16 -56.77 5.0 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.138 0.422 . . . . 1.91 112.138 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 27.3 m95 -60.13 -22.43 62.81 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.209 0.448 . . . . 1.55 112.209 -178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.432 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 13.3 tt -88.15 -21.16 7.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 109.563 -0.532 . . . . 1.86 109.563 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -63.66 -45.43 94.55 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.537 -0.756 . . . . 0.74 112.442 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.665 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 58.8 m-85 -55.76 -57.63 20.36 Favored Pre-proline 0 CA--C 1.533 0.291 0 C-N-CA 120.921 -0.312 . . . . 1.78 110.653 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.665 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 77.1 Cg_exo -48.47 -33.45 23.22 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.021 1.814 . . . . 0.92 112.691 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 177' ' ' ILE . 86.2 mt -72.19 -61.22 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.703 0.287 . . . . 1.77 111.57 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.445 HG22 ' O ' ' A' ' 179' ' ' TYR . 25.8 m -52.91 -25.31 8.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 1.34 111.421 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -64.43 -41.42 96.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.712 0.291 . . . . 2.51 110.752 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 80.0 mt -58.07 -51.0 76.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.184 -0.462 . . . . 2.02 111.217 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.54 138.95 19.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 2.45 111.18 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.28 -161.33 21.49 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 1.73 112.772 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -77.07 162.3 31.9 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.695 2.263 . . . . 3.05 112.111 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.2 t 56.19 19.06 3.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.933 0.397 . . . . 4.04 110.226 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -136.31 -75.63 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.902 -0.666 . . . . 4.48 112.609 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -150.9 -38.05 0.13 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.78 0.324 . . . . 7.96 110.694 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -93.0 -166.79 38.65 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.972 -0.632 . . . . 3.23 112.472 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 80.4 t90 -153.59 105.4 2.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.84 0.352 . . . . 6.03 110.852 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 25.7 pt -138.44 -179.12 2.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.986 -0.552 . . . . 3.18 111.114 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -50.0 123.83 8.92 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.107 -0.497 . . . . 3.39 111.195 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -61.26 -24.17 66.19 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.011 -0.54 . . . . 5.76 110.769 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 89.6 m -68.87 -35.87 77.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.133 -0.485 . . . . 2.5 110.95 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 80.4 mt -70.75 -44.0 76.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 2.4 111.08 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -53.88 -56.18 20.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.213 -0.448 . . . . 2.66 110.921 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 68.4 p -58.59 -31.53 68.13 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.134 -0.485 . . . . 1.81 111.254 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -70.65 -37.23 73.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.132 -0.485 . . . . 2.21 111.259 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 46.7 tp -68.76 -32.0 71.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.516 -0.311 . . . . 2.18 111.004 -179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -81.53 4.16 22.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.302 -0.408 . . . . 2.01 111.335 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.434 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 50.2 t -95.98 -44.16 7.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.292 0.568 . . . . 1.93 110.146 178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 72.2 mt -74.0 -34.78 64.29 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.582 -0.736 . . . . 1.7 111.535 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.674 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 32.6 tp -56.8 -53.63 62.8 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 121.097 -0.241 . . . . 1.28 111.145 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.674 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 40.9 Cg_exo -58.32 -42.05 60.0 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 121.792 1.662 . . . . 0.79 111.296 178.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -61.39 -33.34 73.52 Favored 'General case' 0 N--CA 1.456 -0.129 0 CA-C-N 116.125 -0.488 . . . . 1.51 110.183 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -76.83 -21.51 54.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.791 -0.64 . . . . 1.93 110.469 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.1 t -89.04 -19.08 26.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.973 -0.558 . . . . 1.71 110.778 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -85.94 -42.34 14.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.186 -0.461 . . . . 2.04 110.929 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.52 -39.28 75.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.445 . . . . 2.89 111.413 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -63.88 -21.77 65.8 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.543 -0.837 . . . . 1.31 112.222 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -77.75 -33.96 52.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.647 0.261 . . . . 2.87 111.118 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 89.4 p -64.29 -51.45 63.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 2.38 110.954 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -67.84 -26.25 65.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.341 -0.391 . . . . 3.42 111.091 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.429 ' C ' HD13 ' A' ' 216' ' ' LEU . 2.9 tm? -69.36 -44.7 71.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.273 -0.421 . . . . 1.24 110.66 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.91 -26.86 67.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.367 -0.378 . . . . 2.44 110.878 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 30' ' ' ARG . 45.2 tp -63.01 -60.3 3.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.116 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -78.26 -20.27 51.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.253 -0.43 . . . . 3.01 111.054 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -58.92 -59.13 11.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.917 -0.659 . . . . 1.59 113.032 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.472 HD22 HG13 ' A' ' 32' ' ' VAL . 38.2 tp -84.12 -50.33 8.04 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.587 0.232 . . . . 3.49 111.129 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 58.2 90.93 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.286 -0.415 . . . . 5.74 110.897 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -79.07 142.13 36.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 5.46 111.034 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.9 tp -140.23 -33.46 0.57 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.119 -0.491 . . . . 6.13 110.825 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -112.31 125.58 54.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 6.46 110.695 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -109.82 110.89 22.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 6.94 110.878 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 71.1 m -153.89 165.56 35.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.096 -0.502 . . . . 6.83 110.933 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 29.9 tpt180 -144.56 -37.19 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 10.77 110.813 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.452 -0.785 . . . . 9.41 111.092 179.904 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.697 0.284 . . . . 8.91 110.716 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -90.73 171.22 9.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 6.76 110.899 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 98.3 mt -132.02 116.8 17.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 6.25 110.929 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -104.29 23.48 13.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.151 -0.477 . . . . 5.44 111.087 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.2 t -148.03 106.97 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.284 -0.417 . . . . 3.84 111.095 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 7.0 mp -115.74 -8.76 12.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.041 -0.527 . . . . 3.08 110.738 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.473 HD22 ' H ' ' B' ' 7' ' ' LEU . 3.1 mm? -63.46 -53.84 45.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.38 -0.373 . . . . 2.35 110.622 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.566 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 36.8 m80 -60.04 -24.09 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.04 -0.527 . . . . 1.39 110.539 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.413 ' O ' HG12 ' B' ' 12' ' ' VAL . 39.5 t-105 -71.01 -43.82 67.16 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.217 -0.447 . . . . 1.1 110.599 179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.74 -24.27 35.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.128 0.489 . . . . 1.71 110.192 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -63.77 -62.71 1.48 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.674 -0.694 . . . . 1.48 110.861 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.413 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -50.73 -33.76 12.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.166 -0.47 . . . . 0.95 111.486 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.24 -52.27 66.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.021 0.438 . . . . 0.97 110.904 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -64.33 -18.05 62.57 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.859 -0.686 . . . . 0.8 112.388 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 85.2 mmm -73.35 -35.23 65.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 1.29 110.442 179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.7 m -65.53 -54.37 29.11 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.935 -0.575 . . . . 1.36 110.395 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . 0.458 ' HA ' HD12 ' B' ' 20' ' ' LEU . 2.7 pp -63.31 -21.73 29.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.905 -0.589 . . . . 1.23 110.725 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -63.63 -48.65 75.56 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.986 -0.626 . . . . 0.88 112.205 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.6 -37.98 88.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.877 0.37 . . . . 0.98 110.597 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' B' ' 17' ' ' ILE . 86.1 mt -59.25 -32.83 70.36 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.057 -0.519 . . . . 2.12 110.556 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -60.69 -40.25 91.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.918 -0.583 . . . . 2.0 110.907 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.467 ' HA ' ' HB3' ' B' ' 25' ' ' LEU . 74.2 m-85 -74.89 -29.18 60.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.216 -0.447 . . . . 4.26 110.693 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 90.0 t90 -53.92 -45.07 71.07 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 3.62 110.412 179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 48.2 t -84.53 -19.42 33.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.151 0.5 . . . . 2.55 110.561 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.703 HD11 HD13 ' B' ' 218' ' ' LEU . 22.0 tp -81.94 -0.61 44.7 Favored 'General case' 0 C--O 1.223 -0.31 0 CA-C-N 115.784 -0.644 . . . . 3.11 110.878 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.476 ' HB3' ' HD2' ' B' ' 33' ' ' PRO . 62.5 m -58.5 -27.54 64.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.719 -0.392 . . . . 3.02 111.257 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -47.14 -21.65 0.28 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 122.022 0.915 . . . . 5.89 109.193 178.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.769 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 6.0 t30 -66.31 -155.39 0.0 OUTLIER Pre-proline 0 CA--C 1.563 1.443 0 CA-C-N 113.796 -1.547 . . . . 5.02 109.09 177.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 71.0 Cg_exo -1.39 113.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 124.654 3.569 . . . . 3.53 117.109 -176.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 63.9 mtp180 43.99 32.11 0.59 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 114.477 -1.238 . . . . 7.88 112.504 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.495 ' H ' ' ND2' ' B' ' 223' ' ' ASN . . . 76.21 -47.57 2.33 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.48 -0.866 . . . . 4.61 111.687 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 p -138.88 108.15 7.61 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 120.334 0.112 . . . . 4.73 110.787 178.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' B' ' 29' ' ' PRO . 84.6 Cg_endo -83.91 119.58 2.54 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 121.675 1.583 . . . . 3.75 112.755 178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -80.88 -23.53 38.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.071 -1.085 . . . . 3.76 108.071 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.43 ' HD1' ' H ' ' B' ' 36' ' ' GLU . 0.1 OUTLIER -82.75 -63.5 1.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 113.318 -1.765 . . . . 3.17 112.119 -179.048 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.43 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 10.6 tp10 -50.51 -61.3 2.27 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.937 -0.574 . . . . 2.57 112.103 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -48.52 -42.2 32.44 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.789 0.292 . . . . 5.74 111.789 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 44.9 tp -58.43 -65.08 0.71 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.842 0.353 . . . . 1.72 111.578 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.457 HG12 HD11 ' B' ' 43' ' ' ILE . 18.2 t -61.3 -54.89 28.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 1.95 111.887 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.06 -16.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.24 -0.436 . . . . 1.2 112.104 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 28.0 ttt -88.94 -38.36 14.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 2.12 111.167 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -76.79 -30.62 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 1.49 112.057 -179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.657 HG23 HG23 ' B' ' 79' ' ' THR . 86.4 mt -58.44 -51.17 83.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 N-CA-C 112.203 0.446 . . . . 0.77 112.203 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.454 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 73.9 Cg_endo -74.82 -39.5 1.28 Allowed 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.332 2.021 . . . . 0.68 113.215 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 23.9 mm -55.3 -59.73 2.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.649 0.261 . . . . 1.63 111.342 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -58.75 -53.67 55.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 1.91 110.997 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.438 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 90.9 p -54.28 -31.33 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 1.22 111.413 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -63.09 -44.92 96.52 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.74 -0.743 . . . . 0.55 112.643 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . 0.436 ' HA ' ' SD ' ' B' ' 52' ' ' MET . 97.0 mt -63.88 -32.66 74.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.885 0.374 . . . . 0.87 111.361 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -55.53 14.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.55 112.079 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.446 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 42.4 m-85 -64.85 -49.19 71.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.315 . . . . 1.06 111.841 -179.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.436 ' SD ' ' HA ' ' B' ' 49' ' ' LEU . 26.0 ptm -51.57 -31.44 24.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.876 0.369 . . . . 1.19 110.818 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.48 -41.73 79.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.149 -0.478 . . . . 0.66 110.856 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 44.0 mtt -55.44 -29.85 59.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.895 -0.593 . . . . 0.86 110.536 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.566 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -46.68 61.42 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.004 -0.544 . . . . 0.84 110.882 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . 0.472 HD12 HG23 ' C' ' 127' ' ' VAL . 21.5 pt -82.1 8.69 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.256 -0.429 . . . . 1.44 111.047 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 63.17 66.89 0.7 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.796 -0.638 . . . . 1.55 111.128 179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -144.3 139.59 28.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.077 -0.51 . . . . 2.24 110.769 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 107.24 16.81 12.5 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.738 -0.744 . . . . 1.26 112.267 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 18.0 ptpt -136.94 142.16 42.66 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.709 0.29 . . . . 2.31 110.896 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -119.0 136.44 56.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.294 -0.412 . . . . 1.81 110.913 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -94.78 98.4 10.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.275 -0.421 . . . . 3.18 111.007 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -102.82 115.56 30.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.094 -0.503 . . . . 2.03 111.108 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.54 27.71 17.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 2.48 111.344 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.14 83.91 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.707 -0.759 . . . . 2.37 112.668 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 70.4 mm-40 -100.87 142.02 32.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.91 0.386 . . . . 2.28 111.148 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.501 HD12 ' N ' ' B' ' 67' ' ' ILE . 4.3 mp -94.46 134.75 30.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 1.78 110.604 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.97 129.94 55.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.869 0.366 . . . . 1.05 111.5 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.578 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 80.0 m-70 -86.19 55.29 3.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.329 0.585 . . . . 1.11 110.678 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -58.34 -56.01 27.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.425 -0.807 . . . . 2.3 111.151 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . . . . . . . . . . . -59.96 -22.79 62.94 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.072 -0.513 . . . . 0.72 112.062 -179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.578 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 0.6 OUTLIER -66.07 -52.11 51.92 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.974 0.361 . . . . 3.04 111.974 -179.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.446 ' HA ' ' CE3' ' B' ' 76' ' ' TRP . 3.3 p90 -74.77 -32.58 62.09 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.774 -0.371 . . . . 1.79 111.103 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . . . . . . . . . 21.8 mm -53.3 -47.8 56.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.905 0.383 . . . . 1.44 110.597 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.438 ' OD2' ' HA ' ' B' ' 47' ' ' SER . 12.6 t70 -64.61 -20.38 66.23 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.874 -0.603 . . . . 1.31 110.315 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.446 ' CE3' ' HA ' ' B' ' 73' ' ' TYR . 23.9 m0 -93.1 -4.7 51.85 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.971 -0.559 . . . . 2.01 111.425 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.475 ' O ' ' HG3' ' B' ' 81' ' ' PRO . 58.0 ttm -104.95 -11.3 16.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.897 0.379 . . . . 1.43 110.494 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.425 ' O ' HD23 ' B' ' 82' ' ' LEU . 34.4 m -114.49 -31.25 2.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 116.25 -0.432 . . . . 1.21 112.014 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.657 HG23 HG23 ' B' ' 43' ' ' ILE . 43.0 m -92.69 -55.51 3.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 1.18 111.949 -178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.542 ' N ' ' HD2' ' B' ' 81' ' ' PRO . 40.6 m -49.41 -51.4 58.43 Favored Pre-proline 0 CA--C 1.532 0.282 0 N-CA-C 112.428 0.529 . . . . 1.65 112.428 -179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' B' ' 80' ' ' THR . 15.4 Cg_endo -57.83 -33.45 96.96 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 121.72 1.613 . . . . 1.06 111.753 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.425 HD23 ' O ' ' B' ' 78' ' ' VAL . 4.5 mm? -79.48 -19.86 48.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.976 -0.556 . . . . 1.58 110.709 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' B' ' 83' ' ' LEU . 11.8 tp -76.62 -33.54 58.38 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.238 -0.437 . . . . 1.49 110.595 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.424 HD21 ' OE1' ' B' ' 109' ' ' GLN . 3.6 pp -84.16 -22.72 30.89 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.302 -0.408 . . . . 1.72 110.474 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' B' ' 81' ' ' PRO . 33.2 mt -76.09 -32.41 59.2 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.146 -0.479 . . . . 1.96 110.444 179.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 55.5 m -59.26 -36.51 75.64 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.003 -0.544 . . . . 1.24 110.241 179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 40.6 mt -62.01 -36.4 81.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 1.21 110.744 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 65.2 m -62.44 -40.82 97.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.181 -0.463 . . . . 1.32 110.635 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 99.2 m95 -77.35 -19.87 55.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 2.15 110.433 179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . 0.631 HG23 HD21 ' B' ' 221' ' ' LEU . 61.3 m -79.31 -25.92 42.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.84 -0.618 . . . . 1.44 110.739 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . 0.404 ' HB1' HD11 ' B' ' 161' ' ' LEU . . . -95.24 -33.07 12.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.029 -0.532 . . . . 1.05 111.36 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 60.8 mtm -118.53 111.1 18.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.158 -0.474 . . . . 2.68 110.871 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -66.01 -25.75 67.22 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 2.71 110.876 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -160.45 148.94 16.67 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 4.19 110.477 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 28.4 pt -124.08 142.09 42.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.367 -0.378 . . . . 2.79 111.358 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' B' ' 96' ' ' LYS . 0.1 OUTLIER -138.24 -19.34 1.11 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.121 -0.49 . . . . 5.27 110.795 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -82.46 -170.77 3.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.077 -0.51 . . . . 5.57 111.131 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -73.38 -171.17 0.92 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.057 -0.52 . . . . 4.24 110.84 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 22.9 m-90 -122.84 96.85 5.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 5.39 110.847 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 52.9 p -118.02 -61.63 1.65 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 2.16 111.332 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.93 -52.77 56.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.355 . . . . 2.58 111.084 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.63 HD12 ' H ' ' B' ' 102' ' ' ILE . 4.2 mp -65.83 -31.06 52.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 2.29 111.049 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -60.0 -37.49 92.79 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.841 -0.695 . . . . 1.48 112.893 -179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -78.68 -32.37 47.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.788 0.327 . . . . 2.76 110.952 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 86.5 mt -67.83 -37.26 81.69 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.235 -0.438 . . . . 2.22 110.901 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 69.8 mtm -75.94 -29.09 58.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.123 -0.49 . . . . 2.36 111.224 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.564 ' HB3' ' HB2' ' A' ' 42' ' ' PHE . 67.8 m -64.61 -59.74 3.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.444 -0.343 . . . . 1.92 110.988 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.416 HG21 ' CB ' ' B' ' 142' ' ' ILE . 86.2 m -56.07 -34.39 65.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.333 -0.394 . . . . 2.06 110.523 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.424 ' OE1' HD21 ' B' ' 84' ' ' LEU . 7.7 tt0 -53.39 -52.45 59.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.863 -0.608 . . . . 2.87 110.726 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 45.2 mm -54.64 -40.51 51.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.135 -0.484 . . . . 1.98 111.13 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 58.2 t -64.77 -46.49 91.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 1.62 111.487 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 95.7 t -61.14 -44.06 97.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 1.04 112.047 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 59.0 mt -65.21 -29.18 46.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.589 0.233 . . . . 2.46 111.383 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.517 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 68.0 m -64.91 -51.1 63.71 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.777 0.322 . . . . 0.83 111.404 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 49.3 m -62.17 -25.08 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.895 0.378 . . . . 0.74 110.725 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -75.68 -38.81 36.14 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.858 -0.687 . . . . 0.6 113.021 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.7 pp -78.52 -27.21 45.97 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.574 0.226 . . . . 1.42 111.41 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 59.9 mt -83.51 -32.38 9.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.815 0.34 . . . . 1.51 110.961 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.74 -40.55 63.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.082 -0.508 . . . . 1.09 111.265 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -82.6 -21.49 35.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 2.25 111.016 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 95.3 mt -92.23 30.45 1.46 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 1.16 110.979 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 77.8 p -70.12 132.64 46.14 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.241 -0.436 . . . . 1.76 111.023 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -86.91 -23.39 25.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.183 -0.462 . . . . 2.89 110.929 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.547 ' HB2' HG13 ' B' ' 127' ' ' VAL . 29.0 mmm180 -137.36 166.48 23.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 2.67 110.766 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -83.59 -18.62 37.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.073 -0.512 . . . . 3.25 110.915 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 71.9 t-105 -92.47 -35.45 13.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 4.07 110.973 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.547 HG13 ' HB2' ' B' ' 124' ' ' ARG . 22.1 m -66.56 -30.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.098 -0.501 . . . . 1.41 111.128 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.47 ' CZ ' ' HA ' ' B' ' 188' ' ' SER . 43.9 ttp180 -72.02 -26.94 62.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.894 -0.594 . . . . 2.47 110.836 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -61.65 -32.06 72.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.979 -0.555 . . . . 2.61 110.943 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 77.1 mt -83.6 -44.18 14.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 2.07 111.127 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -61.82 -29.61 70.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 1.3 111.334 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -70.34 -39.41 74.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.792 0.33 . . . . 1.75 111.068 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.5 mm -71.31 -25.76 25.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.385 -0.37 . . . . 1.67 110.739 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 71.8 m -72.79 -37.43 67.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.1 -0.5 . . . . 1.54 110.965 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.03 -52.77 41.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.896 -0.669 . . . . 0.7 112.434 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.5 p -61.84 -36.1 71.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.652 0.263 . . . . 1.44 111.225 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 46.9 t -53.82 -51.6 63.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 1.82 110.769 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.14 -29.88 70.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 0.94 111.23 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 70.7 t80 -72.92 -21.59 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.153 -0.476 . . . . 1.6 111.05 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 91.5 mt -81.46 -46.72 14.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.354 -0.385 . . . . 2.01 111.271 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 48.4 mt -60.09 -40.05 82.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.422 -0.354 . . . . 1.96 111.342 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.416 ' CB ' HG21 ' B' ' 108' ' ' THR . 7.2 tp -71.89 -35.52 54.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.408 -0.36 . . . . 2.88 111.439 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 39.3 tp -53.87 -47.22 71.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 1.52 110.686 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 46.6 t-105 -73.22 -24.81 60.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 4.15 110.365 179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -77.51 -16.82 79.88 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.043 -0.598 . . . . 1.59 112.608 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.403 ' O ' ' HG ' ' B' ' 150' ' ' LEU . 79.7 mt -103.59 -29.35 2.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.753 0.311 . . . . 2.13 110.992 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 33.2 m95 -79.15 -47.84 15.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 1.78 111.796 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.565 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 38.8 t30 -52.9 -49.74 85.34 Favored Pre-proline 0 CA--C 1.537 0.46 0 N-CA-C 112.673 0.62 . . . . 2.45 112.673 -179.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 23.9 Cg_endo -61.23 -8.36 10.13 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.158 1.905 . . . . 2.36 113.024 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 146' ' ' ILE . 81.4 mt -86.06 16.25 4.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.793 0.33 . . . . 2.88 111.064 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -155.18 -37.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 8.07 110.989 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -76.67 -52.67 9.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.233 -0.44 . . . . 2.8 111.032 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -76.8 -21.23 55.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.086 -0.506 . . . . 4.58 110.675 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.531 ' HA ' ' HG2' ' B' ' 157' ' ' GLN . 77.5 m -61.89 -26.69 68.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.111 -0.495 . . . . 3.81 111.148 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 19.8 tpp180 -64.29 -17.16 63.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.169 -0.468 . . . . 5.22 111.266 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 65.0 p -113.77 -45.41 3.1 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 111.871 0.323 . . . . 3.42 111.871 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . 0.531 ' HG2' ' HA ' ' B' ' 154' ' ' THR . 3.8 pt20 -74.37 176.69 6.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.914 0.388 . . . . 4.2 110.849 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . 0.531 ' HB2' ' HG2' ' B' ' 160' ' ' GLU . 91.7 p -64.37 117.54 7.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 2.75 111.078 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 75.2 p -67.12 -19.8 65.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.014 -0.539 . . . . 2.4 110.736 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . 0.531 ' HG2' ' HB2' ' B' ' 158' ' ' SER . 10.2 pt-20 -68.35 -50.88 50.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 3.46 110.987 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.404 HD11 ' HB1' ' B' ' 91' ' ' ALA . 41.4 tp -68.12 -23.28 64.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 2.57 110.715 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.03 -42.87 79.96 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.007 -0.542 . . . . 1.72 111.041 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -65.2 -38.76 91.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 2.69 110.775 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.9 mt -63.83 -42.53 97.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.14 -0.482 . . . . 2.16 111.006 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -74.55 -27.39 60.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.955 -0.566 . . . . 2.13 111.278 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -74.01 -21.02 60.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 1.94 110.894 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -84.5 -42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.128 -0.487 . . . . 3.33 111.241 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.489 HD12 ' N ' ' B' ' 169' ' ' VAL . 3.4 pp -77.38 -24.67 50.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.108 -0.496 . . . . 1.56 111.991 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . 0.489 ' N ' HD12 ' B' ' 168' ' ' LEU . 11.0 p -70.04 -22.37 24.44 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.788 0.328 . . . . 1.59 111.255 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 50.5 m -61.4 -59.02 5.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 1.14 111.235 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -66.36 -25.16 66.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 3.87 110.765 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -73.37 -26.36 60.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.108 -0.496 . . . . 1.61 110.843 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.449 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.4 m -80.19 -46.88 15.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.12 -0.491 . . . . 1.3 111.643 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.422 HG23 HD22 ' B' ' 175' ' ' LEU . 15.9 m -59.78 -35.76 62.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 112.326 0.491 . . . . 1.53 112.326 -179.04 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.422 HD22 HG23 ' B' ' 174' ' ' VAL . 3.9 mm? -76.72 -52.42 9.63 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.745 0.307 . . . . 1.99 111.173 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -56.23 -30.72 62.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 1.5 111.168 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.46 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.7 tt -87.72 -18.99 8.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.882 0.372 . . . . 1.46 110.162 178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.71 -49.62 75.66 Favored Glycine 0 N--CA 1.451 -0.361 0 CA-C-N 115.774 -0.648 . . . . 0.67 112.768 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.683 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 76.3 m-85 -58.4 -55.93 40.57 Favored Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.9 0.35 . . . . 1.73 111.188 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.3 Cg_exo -47.72 -29.46 11.08 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 121.945 1.763 . . . . 0.93 112.659 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.46 HG13 ' O ' ' B' ' 177' ' ' ILE . 96.5 mt -70.39 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.364 -0.38 . . . . 1.36 111.365 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . . . . . . . . . 4.2 p -56.53 -34.68 42.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.476 . . . . 1.19 111.657 -179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 43.7 m95 -54.23 -33.77 59.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.707 0.289 . . . . 2.73 110.765 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 64.1 mt -57.1 -66.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.171 -0.468 . . . . 1.93 111.2 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 25.2 pt -71.44 169.97 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 2.64 111.337 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.515 ' HA2' HG12 ' B' ' 193' ' ' ILE . . . 76.89 -159.63 49.6 Favored Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.794 -0.717 . . . . 1.93 112.548 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.97 165.89 15.0 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.728 2.285 . . . . 2.97 111.963 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . 0.47 ' HA ' ' CZ ' ' B' ' 128' ' ' ARG . 68.7 m 55.98 18.14 2.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.334 -0.394 . . . . 4.5 110.593 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -132.42 -65.32 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.923 -0.656 . . . . 4.5 112.531 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -167.16 -26.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.851 0.358 . . . . 7.89 110.923 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -99.09 -163.73 29.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.733 -0.746 . . . . 3.62 112.492 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 58.6 t-105 -154.08 95.48 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.894 0.378 . . . . 6.54 110.674 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.515 HG12 ' HA2' ' B' ' 186' ' ' GLY . 28.6 pt -131.96 -179.16 3.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.047 -0.524 . . . . 3.16 111.378 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -52.41 126.37 19.04 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.01 -0.541 . . . . 3.39 111.233 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -70.72 -21.68 62.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.061 -0.518 . . . . 5.56 111.301 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 4.9 t -70.12 -33.44 71.84 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 2.68 111.088 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 91.6 mt -75.45 -42.38 42.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.172 -0.467 . . . . 2.2 111.08 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -54.22 -49.91 68.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 2.49 110.797 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 91.8 m -62.99 -42.01 99.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 1.76 111.02 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -63.05 -25.1 68.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 2.18 111.002 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.3 tp -84.0 -39.69 19.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 1.78 111.422 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -72.23 -6.22 41.42 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.735 0.302 . . . . 1.98 111.134 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.457 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 87.5 m -96.71 -41.68 8.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.109 0.48 . . . . 1.65 110.428 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 58.2 tp -69.48 -27.35 65.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.722 -0.672 . . . . 1.11 111.437 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.687 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 58.1 tp -68.06 -54.28 16.62 Favored Pre-proline 0 CA--C 1.535 0.38 0 C-N-CA 121.161 -0.216 . . . . 1.43 111.513 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.687 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 50.6 Cg_exo -54.55 -40.05 85.56 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 121.895 1.73 . . . . 0.77 111.565 178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -59.19 -41.07 87.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.228 -0.442 . . . . 1.6 110.019 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -66.43 -29.68 69.87 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.89 -0.595 . . . . 1.77 110.031 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . 0.419 ' HB2' HD12 ' B' ' 175' ' ' LEU . 43.9 t -73.78 -47.14 41.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.753 -0.658 . . . . 1.54 110.573 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -56.24 -53.98 50.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.082 -0.508 . . . . 2.01 110.993 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 61.1 t -61.31 -30.54 48.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.038 -0.528 . . . . 2.65 111.243 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -62.42 -51.25 57.65 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.753 -0.737 . . . . 1.33 112.672 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -64.92 -23.09 67.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.714 0.292 . . . . 2.29 111.109 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 37.9 m -60.23 -62.34 1.94 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.834 0.35 . . . . 2.12 110.572 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -68.05 -22.76 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 3.6 110.783 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.4 HD23 ' C ' ' B' ' 216' ' ' LEU . 8.6 tt -65.55 -47.89 74.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 1.51 110.58 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.03 -36.52 81.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 2.22 110.816 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.703 HD13 HD11 ' B' ' 25' ' ' LEU . 50.7 tp -56.97 -54.19 49.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.106 -0.497 . . . . 2.69 111.215 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -76.87 -20.55 56.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.416 -0.356 . . . . 3.4 111.2 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.45 -52.54 34.49 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.807 -0.711 . . . . 1.67 112.562 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.631 HD21 HG23 ' B' ' 90' ' ' THR . 3.3 mm? -84.58 -55.59 4.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.721 0.296 . . . . 3.39 111.043 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 57.5 84.63 0.09 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.112 -0.494 . . . . 5.91 110.426 -179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . 0.495 ' ND2' ' H ' ' B' ' 31' ' ' GLY . 43.9 t-20 -68.97 135.3 50.73 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.875 -0.602 . . . . 5.26 111.121 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 98.1 mt -139.38 -24.9 0.86 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.939 -0.573 . . . . 6.81 110.69 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -137.93 146.72 43.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.211 -0.449 . . . . 7.02 110.799 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -131.74 146.46 52.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.276 -0.42 . . . . 8.21 111.043 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 45.5 t -167.48 132.76 1.99 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.158 -0.473 . . . . 8.1 110.958 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 16.2 ptp180 -133.04 24.04 4.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.305 -0.407 . . . . 13.28 110.899 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.177 -0.916 . . . . 10.4 111.003 -179.927 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.812 0.339 . . . . 8.1 110.931 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -99.51 169.85 9.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 6.27 111.11 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.406 ' N ' HD23 ' C' ' 3' ' ' LEU . 2.7 pt? -149.55 154.11 38.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 6.2 110.55 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.72 -25.48 0.07 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.781 0.324 . . . . 4.82 111.177 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 35.7 t -66.13 117.51 8.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.305 -0.407 . . . . 3.25 110.963 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 84.0 mt -126.47 -7.86 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.501 . . . . 2.79 110.597 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 42.0 mt -62.18 -53.81 49.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 2.08 110.729 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.56 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 39.1 m80 -62.28 -25.72 68.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.077 -0.511 . . . . 1.43 110.816 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 40.7 t-105 -67.02 -33.84 76.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.119 0.485 . . . . 1.16 110.158 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 74.0 mt -71.67 -31.6 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.775 -0.648 . . . . 2.09 110.453 179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.81 -60.93 2.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.837 -0.62 . . . . 1.58 110.834 179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 p -53.67 -39.55 38.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.114 -0.493 . . . . 1.0 111.43 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.75 -41.25 81.53 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.856 0.36 . . . . 0.96 110.998 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.64 -23.28 78.23 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.943 -0.646 . . . . 0.96 112.624 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . 0.468 ' HE1' ' HG2' ' C' ' 210' ' ' LYS . 78.1 mmm -73.5 -41.75 62.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.844 0.354 . . . . 1.3 110.932 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 82.8 p -60.88 -51.21 70.27 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 1.52 111.393 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.83 -28.02 43.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 120.914 0.388 . . . . 1.9 110.942 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -56.44 -57.49 19.1 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.911 -0.661 . . . . 0.96 112.415 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.91 -23.45 65.99 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.655 0.264 . . . . 1.07 111.296 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.7 tp -70.29 -20.51 63.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.391 -0.368 . . . . 2.08 111.239 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' C' ' 24' ' ' SER . 7.9 t60 -52.38 -60.63 3.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.357 -0.383 . . . . 2.02 111.287 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . 0.601 ' HB3' ' HA ' ' C' ' 28' ' ' ASN . 13.1 m-85 -62.35 -41.05 98.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.72 0.295 . . . . 4.98 110.856 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.471 ' HA ' ' C ' ' C' ' 27' ' ' ARG . 57.0 t-105 -57.11 -20.89 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.433 -0.58 . . . . 4.29 109.433 178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' C' ' 21' ' ' HIS . 38.3 t -86.91 -28.78 22.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.298 -0.865 . . . . 2.47 112.898 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 10.9 mp -84.76 -66.56 0.88 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 118.875 -1.13 . . . . 2.9 112.964 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.921 ' OG ' ' OD1' ' C' ' 28' ' ' ASN . 62.1 p -101.92 -31.15 10.83 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.505 1.145 . . . . 2.74 110.269 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . 0.471 ' C ' ' HA ' ' C' ' 23' ' ' TRP . 67.4 ttt180 126.98 0.11 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 100.485 -3.895 . . . . 5.85 100.485 -172.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.921 ' OD1' ' OG ' ' C' ' 26' ' ' SER . 5.5 p-10 -168.31 -173.69 0.3 Allowed Pre-proline 0 N--CA 1.437 -1.075 0 CA-C-N 110.109 -3.223 . . . . 4.52 106.091 179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.495 ' HB2' ' HB ' ' C' ' 32' ' ' VAL . 31.8 Cg_exo -59.16 -177.87 0.13 Allowed 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 122.39 2.06 . . . . 3.22 112.821 179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 19.1 tpp180 -100.04 83.37 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.014 -0.539 . . . . 8.68 110.822 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.66 -37.83 3.31 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.722 -0.751 . . . . 4.14 112.513 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.495 ' HB ' ' HB2' ' C' ' 29' ' ' PRO . 97.9 t -71.57 130.0 87.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 120.537 0.208 . . . . 5.09 111.195 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' C' ' 32' ' ' VAL . 32.8 Cg_exo -59.48 165.66 9.08 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.743 2.295 . . . . 3.1 112.628 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.5 -18.45 51.88 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.741 -0.663 . . . . 3.85 111.69 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.439 ' HE2' ' HB3' ' C' ' 89' ' ' TRP . 2.4 p90 -50.68 -40.4 53.67 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.838 0.352 . . . . 3.37 111.032 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.94 -44.79 65.38 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.251 -0.431 . . . . 2.72 110.242 179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -63.98 -23.27 67.27 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.886 -0.597 . . . . 5.67 110.426 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' C' ' 38' ' ' LEU . 1.1 tm? -65.88 -60.24 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.07 -0.514 . . . . 1.93 110.38 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 18.9 m -69.22 -31.81 51.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 1.88 110.968 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.64 -17.08 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 1.23 111.185 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.422 ' C ' ' HD2' ' C' ' 44' ' ' PRO . 27.9 ttt -89.72 -35.82 15.54 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.385 -0.37 . . . . 2.09 111.076 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -74.37 -33.19 63.01 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 1.41 112.007 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.449 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 87.5 mt -59.25 -50.85 85.42 Favored Pre-proline 0 CA--C 1.538 0.493 0 N-CA-C 112.56 0.578 . . . . 0.8 112.56 -179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 73.0 Cg_endo -74.57 -35.35 3.67 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.451 2.101 . . . . 0.72 113.544 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 27.1 mm -60.15 -59.25 4.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.575 0.226 . . . . 1.68 111.499 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -57.73 -53.94 52.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.708 0.289 . . . . 1.68 110.966 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.432 ' HA ' ' OD2' ' C' ' 75' ' ' ASP . 60.7 m -55.82 -33.21 64.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.077 -0.511 . . . . 1.28 111.06 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.37 -35.56 91.58 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.766 -0.731 . . . . 0.51 112.678 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.402 ' HA ' ' SD ' ' C' ' 52' ' ' MET . 74.3 mt -72.75 -32.83 65.95 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 1.33 111.086 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.71 -55.02 14.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.146 -0.479 . . . . 0.57 111.747 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 39.9 m-85 -65.41 -49.96 67.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.365 . . . . 1.67 111.661 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.402 ' SD ' ' HA ' ' C' ' 49' ' ' LEU . 26.2 ptm -50.02 -33.27 17.58 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.896 0.379 . . . . 1.42 110.51 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.549 ' HB1' ' HB2' ' C' ' 58' ' ' GLN . . . -66.63 -43.35 84.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.01 -0.541 . . . . 0.71 110.841 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.418 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 45.6 mtt -52.78 -32.56 44.34 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.881 -0.6 . . . . 1.14 110.26 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.56 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -70.33 -40.09 74.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.8 -0.636 . . . . 0.88 110.512 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 8.4 mt -83.39 6.86 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.019 -0.537 . . . . 1.38 110.462 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 67.13 68.06 0.4 Allowed 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.569 -0.741 . . . . 1.94 111.201 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.549 ' HB2' ' HB1' ' C' ' 53' ' ' ALA . 14.8 mm100 -137.39 178.46 7.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.977 -0.556 . . . . 1.87 110.898 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . 0.418 ' HA3' ' HB2' ' C' ' 71' ' ' ALA . . . 59.82 25.14 61.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.817 -0.706 . . . . 1.27 112.193 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -145.23 134.53 22.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 2.86 110.929 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 29.6 m -116.54 150.95 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 1.95 111.195 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -106.69 86.39 2.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.201 -0.454 . . . . 3.04 110.773 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.18 108.04 19.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.312 -0.404 . . . . 2.11 111.172 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.88 38.46 17.75 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.509 . . . . 2.54 111.203 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.27 1.6 81.39 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.798 -0.715 . . . . 2.47 112.557 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 -98.68 136.6 38.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.731 0.301 . . . . 2.85 110.808 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 73.3 mt -95.05 125.51 47.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 1.87 110.769 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -97.47 131.25 44.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 1.12 111.455 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.455 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 45.4 m-70 -91.35 50.88 1.81 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.248 0.547 . . . . 1.26 110.749 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.451 ' O ' HG12 ' C' ' 74' ' ' ILE . 88.9 t80 -58.0 -58.31 8.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.52 -0.763 . . . . 2.08 111.458 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.418 ' HB2' ' HA3' ' C' ' 59' ' ' GLY . . . -63.67 -22.28 66.82 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.29 -0.413 . . . . 0.86 111.761 -179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 18.1 tpp180 -60.9 -51.54 68.87 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.452 -0.34 . . . . 1.96 111.744 -179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -83.89 -31.67 25.58 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 120.762 -0.375 . . . . 1.8 111.501 -179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.451 HG12 ' O ' ' C' ' 70' ' ' TYR . 19.6 mm -51.89 -47.7 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.199 0 CA-C-O 120.978 0.418 . . . . 1.18 110.404 179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.551 ' O ' HG22 ' C' ' 79' ' ' THR . 5.5 t70 -62.36 -26.69 68.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.845 -0.616 . . . . 1.33 109.817 179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 46.9 m0 -88.21 -1.39 57.99 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.782 -0.645 . . . . 1.85 111.994 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.534 ' HG3' HD12 ' C' ' 113' ' ' ILE . 53.3 ttm -104.95 -7.11 19.52 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.793 0.33 . . . . 1.56 110.89 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 21.9 m -113.97 -37.29 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 112.34 0.496 . . . . 1.11 112.34 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.551 HG22 ' O ' ' C' ' 75' ' ' ASP . 6.1 t -89.77 -30.9 17.68 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.342 0.497 . . . . 1.49 112.342 -178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.612 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 89.6 m -68.24 -52.13 23.06 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 121.023 -0.271 . . . . 1.6 111.572 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.612 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 36.6 Cg_exo -57.05 -30.27 86.16 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.617 1.545 . . . . 1.01 111.158 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -79.32 -32.49 43.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.516 -0.766 . . . . 1.18 110.706 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.4 ' CD1' H201 ' C' ' 301' ' ' RET . 0.8 OUTLIER -68.13 -27.88 66.83 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-O 121.141 0.496 . . . . 1.54 110.046 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.437 HD21 ' HB3' ' C' ' 105' ' ' LEU . 7.1 tt -83.93 -26.86 28.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.655 -0.702 . . . . 1.65 110.163 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 61.0 mt -77.84 -31.95 51.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.994 -0.548 . . . . 2.1 110.576 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . 0.435 ' HA ' ' HE3' ' C' ' 89' ' ' TRP . 42.3 t -64.83 -19.01 65.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 1.38 110.555 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' C' ' 168' ' ' LEU . 41.4 mt -75.2 -28.07 59.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 1.44 110.74 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -78.72 -38.86 37.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.055 -0.52 . . . . 1.87 111.501 -179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . 0.439 ' HB3' ' HE2' ' C' ' 35' ' ' TYR . 5.8 m0 -69.87 -39.18 76.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.424 -0.353 . . . . 3.1 111.242 -179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 9.0 t -69.73 -32.57 71.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.459 -0.337 . . . . 1.48 111.272 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.14 -24.1 32.69 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.225 -0.443 . . . . 1.02 111.252 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 58.6 mtt -131.84 107.8 8.98 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.354 -0.384 . . . . 2.34 110.775 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.47 -29.53 66.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.908 -0.587 . . . . 3.21 111.473 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -157.08 148.91 22.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 4.54 111.206 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 39.5 mm -111.88 143.23 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.012 -0.54 . . . . 2.34 110.777 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -130.52 -39.34 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 4.4 110.986 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -150.9 10.94 0.63 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.282 -0.417 . . . . 5.54 111.106 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -92.11 92.52 8.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.407 -0.36 . . . . 3.54 110.752 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -133.29 25.32 4.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 5.21 110.881 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 52.2 m -107.6 -56.3 2.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 2.38 111.485 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 57.8 tp -53.81 -53.63 49.64 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.193 -0.458 . . . . 2.64 111.33 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 46.9 pt -59.29 -25.48 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 2.38 111.322 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.0 -36.7 81.91 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.84 -0.695 . . . . 1.62 112.571 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -71.48 -41.06 69.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.916 0.388 . . . . 2.93 110.637 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . 0.437 ' HB3' HD21 ' C' ' 84' ' ' LEU . 67.0 mt -66.93 -37.02 83.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.945 -0.57 . . . . 2.16 110.96 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 25.0 ttt -66.3 -42.88 87.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.633 -0.712 . . . . 2.3 111.581 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 75.0 m -64.04 -54.1 39.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.472 -0.331 . . . . 2.07 111.751 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 70.6 p -55.18 -29.64 58.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.273 -0.421 . . . . 2.3 111.537 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.405 HE21 HG23 ' C' ' 113' ' ' ILE . 27.3 tp60 -65.96 -45.58 81.19 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.29 -0.413 . . . . 2.48 111.065 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 48.1 mt -58.56 -33.68 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 1.93 111.292 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.45 -41.15 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 1.67 111.542 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 70.8 t -64.5 -50.61 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 1.11 111.575 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.534 HD12 ' HG3' ' C' ' 77' ' ' MET . 45.6 pt -59.56 -30.37 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 2.59 110.904 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 32.3 m -63.58 -38.0 89.46 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.9 110.686 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . 0.492 ' HB2' ' H21' ' C' ' 301' ' ' RET . 21.1 m -60.41 -58.88 6.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.174 -0.466 . . . . 0.92 110.456 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.44 ' HA3' H172 ' C' ' 301' ' ' RET . . . -62.97 -13.53 48.43 Favored Glycine 0 C--N 1.331 0.285 0 C-N-CA 120.843 -0.694 . . . . 0.55 112.298 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . . . . . . . . . 2.5 tt -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.961 0.41 . . . . 1.49 110.585 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 mm -83.88 -22.79 8.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.954 -0.566 . . . . 1.66 111.795 -179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -50.63 -44.83 57.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.734 0.302 . . . . 0.94 111.279 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.08 -20.73 48.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.251 -0.431 . . . . 1.79 110.807 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 81.2 mt -91.36 30.5 1.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 1.29 111.115 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . . . . . . . . . 80.5 p -69.54 128.02 35.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.334 -0.393 . . . . 2.15 110.649 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -91.55 -27.15 18.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 3.31 111.0 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.42 ' HB2' HG12 ' C' ' 127' ' ' VAL . 46.3 mtm180 -131.83 143.98 50.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.952 0.405 . . . . 3.16 110.833 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -69.23 -9.72 54.37 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.982 -0.554 . . . . 4.24 111.368 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 76.9 t-105 -86.69 -55.11 4.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.808 0.337 . . . . 4.65 110.958 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.472 HG23 HD12 ' B' ' 56' ' ' ILE . 10.9 p -63.47 -27.13 42.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 1.31 111.374 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.4 ttp180 -59.15 -33.8 71.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 2.84 111.193 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -71.65 -25.99 62.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 2.7 111.338 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.13 -53.56 6.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.445 -0.343 . . . . 1.88 111.227 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 1.3 m95 -58.72 -30.2 67.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.255 -0.43 . . . . 1.38 111.362 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -62.86 -48.23 79.95 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.357 -0.383 . . . . 1.76 110.717 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 70.7 mt -62.35 -32.06 53.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 2.15 111.161 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 83.8 m -67.91 -35.07 77.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.925 0.393 . . . . 1.56 110.704 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.14 -47.97 42.05 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.915 -0.659 . . . . 0.73 112.636 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . 0.42 ' O ' ' HG ' ' C' ' 140' ' ' LEU . 35.1 m -65.45 -32.92 60.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.761 0.315 . . . . 1.48 111.091 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.4 t -60.54 -42.97 97.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.791 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -64.21 -35.94 82.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.006 -0.543 . . . . 1.01 111.094 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -69.28 -21.14 63.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 2.05 111.07 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' C' ' 136' ' ' VAL . 95.6 mt -78.77 -55.2 5.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 2.07 111.465 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 41.5 mm -56.77 -39.29 63.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.193 -0.458 . . . . 1.92 111.737 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 42.2 pt -72.38 -31.81 39.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.535 -0.302 . . . . 2.64 111.278 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 30.2 tp -56.62 -53.44 57.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.428 -0.351 . . . . 1.51 110.772 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 92.4 t90 -67.0 -27.02 67.08 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 3.58 110.616 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.79 -17.05 79.15 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.033 -0.603 . . . . 1.65 112.614 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 77.7 mt -106.17 -25.45 3.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.722 0.296 . . . . 2.46 111.207 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 38.4 m95 -81.88 -46.38 14.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 2.27 112.049 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.57 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 63.5 t30 -54.81 -49.81 89.55 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 112.342 0.497 . . . . 2.33 112.342 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 41.9 Cg_exo -57.8 -15.95 23.5 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 122.308 2.005 . . . . 2.46 112.956 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.42 3.67 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.63 -0.259 . . . . 3.08 111.277 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -144.37 -32.16 0.43 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.444 -0.343 . . . . 8.45 111.291 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.47 -58.34 2.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.408 -0.36 . . . . 2.9 111.642 -179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -69.81 -10.05 56.99 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 4.62 111.491 -179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 75.9 p -73.42 -4.81 35.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 3.85 111.215 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 73.8 ttt180 -60.22 -54.04 50.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 5.12 110.865 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 72.7 p -96.87 -31.54 12.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.172 -0.467 . . . . 3.43 111.22 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.632 HE21 ' H ' ' C' ' 158' ' ' SER . 23.8 tp60 -67.26 149.57 50.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.426 . . . . 3.98 110.545 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . 0.632 ' H ' HE21 ' C' ' 157' ' ' GLN . 37.5 t -55.58 113.68 1.55 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.229 -0.441 . . . . 2.4 110.917 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 74.6 p -62.69 -19.75 64.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.479 . . . . 2.82 111.048 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.69 -57.88 5.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.042 0.449 . . . . 3.18 110.734 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . 0.401 ' N ' HD22 ' C' ' 161' ' ' LEU . 3.8 mm? -66.48 -19.88 65.9 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.044 -0.525 . . . . 2.5 110.803 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.55 -55.55 7.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.499 . . . . 1.81 110.833 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -56.87 -26.09 57.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 2.13 110.062 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.99 -44.54 80.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.523 -0.762 . . . . 2.21 110.599 179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.465 ' O ' HG23 ' C' ' 169' ' ' VAL . 1.6 t80 -71.89 -35.51 69.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.845 -0.616 . . . . 1.31 110.944 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.2 -48.81 67.78 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.369 -0.378 . . . . 2.26 110.751 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -66.65 -31.62 72.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 3.58 110.606 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' C' ' 87' ' ' LEU . 48.2 tp -69.38 -32.47 71.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 1.3 111.257 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.465 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.2 t -73.45 -21.81 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.358 -0.383 . . . . 1.73 111.441 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 40.2 m -55.78 -59.14 5.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.402 -0.363 . . . . 1.43 111.376 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -71.96 -32.67 67.51 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.013 0.435 . . . . 3.72 110.781 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' C' ' 176' ' ' TRP . 87.1 t80 -60.19 -36.08 76.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.001 -0.545 . . . . 1.55 111.652 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.421 ' O ' HG22 ' C' ' 177' ' ' ILE . 28.5 p -76.37 -41.5 47.82 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 111.959 0.355 . . . . 1.5 111.959 -179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 85.0 t -54.18 -43.94 62.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 112.087 0.403 . . . . 1.84 112.087 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -78.63 -48.92 14.13 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.934 0.346 . . . . 2.12 111.934 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . 0.409 ' HB2' ' O ' ' C' ' 172' ' ' PHE . 0.9 OUTLIER -55.92 -33.84 65.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.561 -0.29 . . . . 1.0 111.271 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.457 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 14.5 tt -87.26 -19.01 8.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.015 0.436 . . . . 1.75 110.276 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -58.05 -54.28 38.81 Favored Glycine 0 N--CA 1.451 -0.308 0 CA-C-N 115.736 -0.666 . . . . 0.72 113.022 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.63 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 91.3 m-85 -55.75 -53.82 58.53 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.78 0.29 . . . . 1.8 111.163 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.63 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.1 Cg_exo -46.64 -32.1 11.29 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.058 1.838 . . . . 0.88 112.457 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.514 ' O ' HG22 ' C' ' 184' ' ' ILE . 85.1 mt -73.58 -60.96 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.52 111.306 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.477 HG22 ' O ' ' C' ' 179' ' ' TYR . 21.0 m -53.31 -23.69 7.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 1.2 111.551 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 19.1 m95 -63.21 -53.37 54.25 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.257 0.465 . . . . 2.47 112.257 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.514 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.2 tt -60.12 -31.98 49.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 N-CA-C 111.782 0.29 . . . . 1.62 111.782 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 13.0 tt -89.86 131.24 37.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.921 0.391 . . . . 2.63 110.896 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 101.39 -149.76 18.35 Favored Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.696 -0.764 . . . . 1.77 112.438 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -87.47 168.79 7.24 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.766 2.31 . . . . 3.03 112.17 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 49.6 m 56.38 19.0 3.73 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.107 0.479 . . . . 4.22 110.575 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -152.14 -79.19 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.72 -0.673 . . . . 4.08 112.251 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -173.32 87.21 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 7.54 110.464 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . 177.84 -43.78 0.09 OUTLIER Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.632 -0.794 . . . . 3.29 112.727 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 27.9 m-90 57.93 84.77 0.1 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.003 0.43 . . . . 5.67 111.274 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 46.7 pt -141.69 -179.47 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.923 -0.58 . . . . 2.76 110.792 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -48.13 139.19 8.56 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.334 -0.394 . . . . 3.69 110.973 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -85.76 -27.15 25.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.051 -0.522 . . . . 5.34 111.265 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 36.0 p -59.74 -55.63 31.95 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.834 0.35 . . . . 2.57 111.108 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -62.37 -35.03 67.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.159 -0.473 . . . . 2.37 110.91 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.11 -44.85 92.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.14 -0.482 . . . . 2.68 110.957 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 26.4 m -66.54 -26.49 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.159 -0.473 . . . . 1.95 110.822 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -72.45 -24.26 61.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 2.05 111.058 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 94.1 mt -81.55 -48.0 12.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.434 -0.348 . . . . 1.91 111.538 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -62.68 -18.49 62.49 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.885 0.328 . . . . 2.04 111.885 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.505 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 22.8 p -96.46 -35.72 11.05 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.068 0.461 . . . . 1.62 110.991 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 52.1 tp -64.47 -45.17 88.51 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.932 -0.576 . . . . 1.49 111.845 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.64 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 26.5 tp -57.1 -53.62 63.37 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 111.857 0.318 . . . . 1.32 111.857 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 73.4 Cg_exo -48.91 -44.35 32.4 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.108 1.872 . . . . 0.76 112.296 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -56.87 -46.88 81.54 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.4 -0.364 . . . . 1.52 110.639 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -67.61 -22.81 65.33 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.321 -0.399 . . . . 1.84 110.455 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 37.4 t -80.19 -30.63 38.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.996 -0.547 . . . . 1.68 110.532 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . 0.468 ' HG2' ' HE1' ' C' ' 15' ' ' MET . 13.3 mptt -77.36 -45.35 26.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.918 -0.583 . . . . 2.04 110.991 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 53.7 t -66.24 -46.25 87.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.181 -0.463 . . . . 2.65 111.233 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.57 -29.65 61.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.858 -0.687 . . . . 1.33 112.336 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -71.28 -31.37 67.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.773 0.321 . . . . 3.02 111.006 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 46.5 t -63.61 -58.69 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.328 -0.396 . . . . 2.35 110.872 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . 0.482 ' HA ' HD12 ' C' ' 218' ' ' LEU . 96.4 m-85 -61.77 -25.86 67.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.081 -0.509 . . . . 3.62 111.029 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.419 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -70.54 -41.15 72.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 1.64 110.784 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -69.04 -25.12 64.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 2.2 111.211 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' C' ' 215' ' ' PHE . 90.2 mt -71.59 -40.96 69.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.288 -0.414 . . . . 3.11 111.057 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 28.5 t60 -86.8 -24.13 25.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 3.37 110.941 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -63.69 -59.02 9.28 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.903 -0.665 . . . . 1.55 113.065 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 37.9 tp -77.59 -51.77 10.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.614 0.245 . . . . 3.11 111.161 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 25.4 tpt180 58.95 92.29 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.308 -0.406 . . . . 5.73 110.799 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -75.2 151.49 38.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.05 -0.523 . . . . 5.53 110.892 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 37.3 tp -168.3 -19.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.314 -0.403 . . . . 6.6 111.064 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -76.65 -63.52 1.33 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.094 -0.503 . . . . 6.51 111.082 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 59.61 86.18 0.09 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.26 -0.427 . . . . 7.05 110.921 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 43.6 t -169.92 133.52 1.21 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 6.72 110.944 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -102.35 -61.37 1.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.066 -0.516 . . . . 9.56 110.789 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.391 -0.814 . . . . 9.08 110.953 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.744 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.754 ' H8 ' H161 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.714 ' H8 ' H171 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.845 0.355 . . . . 8.09 110.96 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -148.21 114.35 5.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.118 -0.492 . . . . 5.68 110.818 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.2 mp -76.64 161.71 28.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.97 -0.559 . . . . 6.27 110.892 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -141.11 105.49 4.85 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.136 -0.483 . . . . 6.52 110.62 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.0 p -98.61 169.15 9.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 3.59 111.256 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 91.0 mt -143.38 -10.27 0.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.914 -0.585 . . . . 3.23 110.811 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.403 HD22 ' N ' ' A' ' 7' ' ' LEU . 3.9 mm? -61.95 -55.25 31.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 1.88 110.952 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 34.6 m80 -60.39 -23.81 64.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 1.29 110.808 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 62.7 t-105 -70.49 -35.65 73.37 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.19 -0.459 . . . . 0.99 110.32 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 49.3 mm -73.71 -24.95 20.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.018 -0.537 . . . . 1.92 110.218 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.405 ' O ' ' HG2' ' A' ' 15' ' ' MET . 18.9 t80 -64.14 -55.64 20.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.6 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -58.0 -36.56 56.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.264 -0.425 . . . . 0.89 110.76 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.93 -33.8 76.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.9 110.703 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.49 -27.05 70.31 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.83 112.415 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.405 ' HG2' ' O ' ' A' ' 11' ' ' TYR . 76.4 mmm -74.66 -29.29 61.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.939 0.4 . . . . 1.24 110.49 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.0 m -65.71 -58.08 6.53 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.991 -0.55 . . . . 1.29 110.563 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.4 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -59.79 -24.5 29.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.859 -0.61 . . . . 1.71 110.651 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.03 -41.07 95.39 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.847 -0.692 . . . . 0.96 111.923 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.84 -37.13 86.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.903 0.382 . . . . 0.99 110.733 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 17' ' ' ILE . 76.7 mt -60.93 -39.48 89.57 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.971 -0.559 . . . . 2.11 110.601 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 40.2 t60 -57.71 -41.29 81.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.939 -0.573 . . . . 2.23 110.832 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -66.1 -30.2 70.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 4.02 110.611 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 60.5 t-105 -59.43 -39.05 82.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.02 0.438 . . . . 3.96 109.991 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -26.05 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.845 -0.616 . . . . 2.38 110.219 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.88 0.47 1.79 Allowed 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 115.839 -0.619 . . . . 2.77 111.124 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.444 ' C ' ' N ' ' A' ' 28' ' ' ASN . 93.2 p -51.4 -19.67 1.45 Allowed 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.131 0.27 . . . . 2.52 111.491 -179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -51.18 -22.75 2.78 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 107.628 -1.249 . . . . 5.54 107.628 177.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.778 ' HB2' ' HD2' ' A' ' 29' ' ' PRO . 20.3 p-10 -67.05 -158.71 0.0 OUTLIER Pre-proline 0 CA--C 1.547 0.861 0 CA-C-N 113.016 -1.902 . . . . 4.44 107.635 176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HD2' ' HB2' ' A' ' 28' ' ' ASN . 36.1 Cg_exo -16.16 96.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.367 1.519 0 C-N-CA 123.333 2.688 . . . . 2.81 115.143 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -107.39 65.94 0.66 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.587 -0.733 . . . . 6.8 109.27 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.95 7.84 6.43 Favored Glycine 0 N--CA 1.45 -0.369 0 N-CA-C 110.514 -1.034 . . . . 4.97 110.514 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.646 HG23 ' HA ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -122.27 160.91 45.81 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 114.652 -0.774 . . . . 4.71 110.255 -179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.587 ' HD2' HG12 ' A' ' 32' ' ' VAL . 44.5 Cg_exo -33.55 134.07 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 123.561 2.84 . . . . 3.51 115.285 -178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' O ' ' N ' ' A' ' 36' ' ' GLU . 19.0 pt20 -77.44 -11.7 59.87 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 114.232 -1.349 . . . . 3.41 111.036 179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.0 OUTLIER -36.89 -22.66 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 114.038 1.125 . . . . 2.81 114.038 -177.481 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.494 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 17.4 mm-40 -63.79 -54.51 34.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 3.39 110.712 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -76.03 -25.07 55.32 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.095 -0.502 . . . . 5.24 111.197 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 62.4 tp -56.55 -64.95 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.416 -0.357 . . . . 1.6 111.214 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 51.1 t -62.99 -36.41 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.933 0.397 . . . . 1.33 111.2 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -71.96 -8.56 55.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.254 -0.43 . . . . 1.03 111.53 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 14.1 tpt -89.77 -42.07 11.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.511 -0.313 . . . . 2.0 111.795 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.413 ' HA ' HG22 ' A' ' 45' ' ' ILE . 61.0 t80 -74.6 -38.64 62.56 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.762 0.653 . . . . 1.31 112.762 -178.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 79' ' ' THR . 94.1 mt -54.7 -50.19 87.14 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.871 0.693 . . . . 1.0 112.871 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 94.4 Cg_endo -77.11 -45.22 0.17 Allowed 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.323 2.015 . . . . 0.59 114.136 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.457 HG23 ' N ' ' A' ' 46' ' ' TRP . 10.1 tp -54.21 -45.61 67.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 112.115 0.413 . . . . 1.63 112.115 -178.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . 0.457 ' N ' HG23 ' A' ' 45' ' ' ILE . 1.3 t90 -74.68 -52.26 12.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.351 . . . . 1.12 110.707 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 42.6 t -58.66 -14.44 8.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.143 -0.48 . . . . 1.32 111.196 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.94 -54.75 3.31 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.701 -0.761 . . . . 0.52 112.365 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 46.4 mt -56.96 -33.19 66.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.673 0.273 . . . . 0.98 111.222 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.55 -59.03 6.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.52 110.989 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.428 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 18.3 m-85 -59.53 -38.37 80.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.071 -0.513 . . . . 1.69 111.167 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 61.9 ttp -51.41 -34.46 34.86 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.071 0.462 . . . . 1.12 110.012 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 56' ' ' ILE . . . -70.58 -40.14 73.47 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.748 -0.66 . . . . 0.6 110.678 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 49.5 mtt -54.92 -27.12 40.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.849 -0.614 . . . . 0.94 110.375 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -76.67 -45.5 29.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.939 -0.573 . . . . 0.78 110.908 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.516 HG12 ' HA ' ' A' ' 53' ' ' ALA . 27.3 pt -82.65 8.39 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.062 -0.517 . . . . 1.23 111.254 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 60.76 60.16 1.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.896 -0.593 . . . . 2.02 111.392 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -132.66 110.04 10.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.42 . . . . 2.1 110.919 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 138.82 23.3 0.37 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.805 -0.712 . . . . 1.27 112.543 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -131.39 141.5 49.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.646 0.26 . . . . 1.76 110.879 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 HG13 ' HE2' ' A' ' 70' ' ' TYR . 16.6 m -136.19 140.19 44.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.322 -0.399 . . . . 1.84 111.252 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -93.14 94.87 9.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.034 -0.53 . . . . 2.64 110.974 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -99.26 106.8 18.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.104 -0.498 . . . . 1.84 111.079 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.07 28.46 18.02 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.097 -0.501 . . . . 2.24 110.991 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.71 10.03 73.7 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.85 -0.691 . . . . 2.16 112.571 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -115.19 117.72 31.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 2.84 110.708 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.7 mm -79.36 122.73 35.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 2.39 111.06 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -110.76 137.66 48.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.46 . . . . 0.97 111.093 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -99.68 69.75 1.62 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.472 . . . . 1.04 111.175 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.44 ' HE2' HG13 ' A' ' 61' ' ' VAL . 52.1 p90 -68.92 -16.16 63.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.932 0.396 . . . . 3.38 110.68 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.403 ' O ' HG22 ' A' ' 74' ' ' ILE . . . -82.83 -28.06 30.43 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.909 -0.587 . . . . 0.76 110.866 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mmt180 -70.9 -51.62 25.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.891 -0.595 . . . . 2.93 111.378 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.462 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 1.3 p90 -70.88 -39.1 73.05 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.845 0.313 . . . . 3.13 111.845 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 71' ' ' ALA . 10.7 tp -55.36 -40.29 56.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 121.108 -0.237 . . . . 1.66 110.919 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 21.1 t70 -66.7 -26.74 67.16 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.359 -0.608 . . . . 1.42 109.359 178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.6 m0 -92.33 7.49 42.6 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.535 -0.757 . . . . 2.09 110.138 178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.476 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.9 tpp -105.01 -16.79 14.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.474 -0.785 . . . . 1.52 109.871 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 m -114.45 -33.08 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.452 -0.795 . . . . 1.33 111.306 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.436 HG23 HG23 ' A' ' 43' ' ' ILE . 34.5 m -88.17 -47.13 8.7 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.314 0.487 . . . . 1.39 112.314 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 25.4 m -56.97 -51.44 81.57 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.18 0.437 . . . . 1.55 112.18 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 41.7 Cg_exo -57.13 -35.21 98.85 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.087 1.858 . . . . 1.01 112.388 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -84.18 -16.38 43.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.277 -0.419 . . . . 1.45 110.934 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -37.35 57.04 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.075 0.464 . . . . 1.3 110.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' A' ' 109' ' ' GLN . 1.6 pp -84.15 -31.19 25.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.76 -0.655 . . . . 1.67 110.25 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.76 -32.76 63.97 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.871 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 61.5 p -65.79 -28.56 69.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.115 -0.493 . . . . 1.42 110.73 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD22 HD11 ' A' ' 168' ' ' LEU . 92.8 mt -69.88 -39.69 76.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.069 -0.514 . . . . 1.4 110.788 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.4 m -77.88 -21.44 51.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 1.91 110.666 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 23.3 t-105 -74.69 -33.46 62.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.913 -0.585 . . . . 2.33 110.779 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 35.3 m -83.55 -25.27 31.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.073 -0.512 . . . . 1.43 111.026 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.35 -38.99 21.3 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.095 -0.502 . . . . 1.19 111.151 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 85.6 mtp -101.95 107.33 18.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.051 -0.522 . . . . 2.55 110.77 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -77.63 -18.24 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 3.33 110.736 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -124.05 143.34 50.5 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.096 -0.502 . . . . 5.1 111.341 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 83.3 mt -108.1 141.84 22.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.55 . . . . 3.07 110.691 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -101.33 148.12 25.51 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.16 -0.473 . . . . 4.41 110.913 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -91.18 47.45 1.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.235 -0.439 . . . . 5.31 110.962 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -131.08 -37.49 1.27 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.05 -0.523 . . . . 3.94 110.711 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 74.5 m95 51.95 78.0 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.272 -0.422 . . . . 5.98 111.266 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.47 ' HA ' HD22 ' C' ' 38' ' ' LEU . 71.8 p -120.85 -57.39 1.89 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.095 -0.502 . . . . 2.24 111.124 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.4 mt -73.77 -42.8 60.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.969 -0.56 . . . . 2.67 111.016 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 76.7 mt -59.31 -31.48 46.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.293 -0.412 . . . . 2.59 110.842 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.01 -38.37 48.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.89 -0.671 . . . . 1.53 112.64 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -58.98 -37.91 77.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.747 0.308 . . . . 3.14 111.033 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 109' ' ' GLN . 80.2 mt -70.61 -60.11 2.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.171 -0.468 . . . . 1.99 111.102 -179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 50.8 ttm -53.65 -28.4 32.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.035 -0.53 . . . . 2.36 111.622 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.46 ' O ' HG23 ' A' ' 111' ' ' VAL . 73.0 m -70.63 -42.93 70.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.443 -0.344 . . . . 2.05 111.307 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 79.8 p -70.36 -28.14 64.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.004 0.43 . . . . 2.25 111.313 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.583 ' HG3' HD22 ' A' ' 84' ' ' LEU . 10.8 mm100 -76.67 -48.63 18.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.103 -0.498 . . . . 2.72 111.439 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 16.3 tt -56.54 -32.73 37.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.862 0.363 . . . . 1.88 110.993 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 107' ' ' SER . 63.5 t -66.83 -46.36 85.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 1.6 110.671 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.0 t -60.96 -46.41 96.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 1.09 111.332 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 72.1 mt -55.95 -34.84 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.797 0.332 . . . . 2.65 110.838 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 15.3 m -61.55 -40.41 94.6 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.165 -0.47 . . . . 0.89 110.591 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 31.8 m -68.61 -24.45 64.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.897 -0.592 . . . . 0.68 110.418 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.16 -49.52 12.4 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.99 -0.624 . . . . 0.63 112.963 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.534 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.2 pp -62.23 -38.52 89.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.64 0.257 . . . . 1.58 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' N ' HD12 ' A' ' 117' ' ' LEU . 8.7 tp -75.39 -32.09 24.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.623 -0.262 . . . . 2.04 111.304 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.0 -40.03 60.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.256 -0.429 . . . . 1.1 110.914 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -88.15 -23.01 23.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.012 -0.54 . . . . 1.88 110.798 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD23 ' O ' ' A' ' 117' ' ' LEU . 3.8 mm? -86.68 32.64 0.65 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.228 -0.442 . . . . 1.53 110.91 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 49.2 m -96.52 121.39 38.28 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.476 . . . . 2.29 110.938 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -74.63 -41.23 60.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.108 -0.496 . . . . 3.49 110.937 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 127' ' ' VAL . 89.2 mtt180 -99.77 140.34 34.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 3.13 110.714 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.24 -24.16 43.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 3.71 110.838 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 55.5 t-105 -71.09 -46.61 61.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 3.97 110.865 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 124' ' ' ARG . 8.2 p -69.67 -23.73 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 1.22 110.94 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 57.2 ttp180 -57.72 -32.2 67.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.055 -0.52 . . . . 2.81 111.145 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -71.58 -22.35 61.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.434 -0.348 . . . . 4.25 110.957 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 127' ' ' VAL . 8.9 mp -80.35 -48.75 12.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 1.84 111.152 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.402 ' CD1' ' HG2' ' C' ' 58' ' ' GLN . 2.4 m95 -68.79 -25.92 64.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.635 -0.257 . . . . 1.54 111.187 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -65.11 -47.03 78.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 1.79 110.476 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.13 -23.73 27.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.014 -0.539 . . . . 2.08 110.637 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.418 ' SG ' HD22 ' C' ' 49' ' ' LEU . 26.9 t -67.69 -43.65 79.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.035 -0.529 . . . . 1.76 110.807 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.64 -46.53 91.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.76 112.716 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.3 m -69.23 -33.29 57.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.687 0.28 . . . . 2.07 111.301 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.7 -46.43 88.18 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.401 -0.363 . . . . 1.85 110.775 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -67.37 -24.02 65.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.068 -0.514 . . . . 1.32 110.733 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -76.21 -21.56 56.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.961 -0.563 . . . . 3.25 110.638 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 91.8 mt -78.34 -48.47 15.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 2.92 111.311 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.4 pt -61.27 -37.63 78.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 2.65 111.464 -179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 43.8 pt -77.08 -31.22 18.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.52 -0.309 . . . . 3.21 111.282 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 39.5 tp -60.51 -47.24 87.01 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.41 -0.359 . . . . 2.01 110.811 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 69.5 t90 -70.79 -28.61 64.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 3.6 110.434 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.38 80.13 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.863 -0.684 . . . . 1.62 112.567 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.5 pt -106.13 -5.92 10.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.752 0.31 . . . . 2.47 111.15 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 9.2 m95 -99.08 -33.58 10.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 2.48 111.344 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.556 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 26.1 t-20 -63.87 -48.79 78.18 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.307 -0.406 . . . . 2.69 111.761 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 33.7 Cg_exo -61.15 -9.46 12.56 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.22 1.946 . . . . 2.36 112.605 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.457 HD11 ' HA ' ' A' ' 166' ' ' ASP . 30.5 tp -71.38 -6.35 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.323 -0.398 . . . . 3.3 111.23 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -151.74 -20.8 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.421 -0.354 . . . . 8.48 111.232 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -81.93 -44.94 16.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 2.98 111.193 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -86.17 -9.41 56.64 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 4.55 111.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 70.6 p -71.64 -6.36 40.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.445 . . . . 4.0 111.017 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -57.3 -53.35 59.06 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.136 -0.483 . . . . 5.51 110.487 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 3.7 t -99.57 -30.01 12.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.235 -0.439 . . . . 3.2 111.226 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.643 HE21 ' H ' ' A' ' 158' ' ' SER . 21.8 tp60 -61.36 154.33 24.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.28 -0.418 . . . . 3.98 110.703 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.643 ' H ' HE21 ' A' ' 157' ' ' GLN . 54.3 m -62.0 115.46 4.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 2.63 110.865 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 51.3 m -64.5 -18.03 64.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.018 -0.537 . . . . 2.16 111.119 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -67.32 -62.14 1.57 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.36 -0.382 . . . . 3.37 110.782 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.52 -31.68 72.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 2.83 110.882 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.0 -30.87 71.24 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.273 -0.421 . . . . 1.7 110.864 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -71.15 -48.89 49.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 2.16 110.537 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 59.4 mt -59.85 -33.0 71.21 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.045 -0.525 . . . . 1.59 110.393 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.4 ' O ' HG23 ' A' ' 169' ' ' VAL . 0.5 OUTLIER -76.94 -24.95 52.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.62 -0.718 . . . . 2.31 110.715 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.457 ' HA ' HD11 ' A' ' 150' ' ' LEU . 15.3 t70 -64.55 -41.85 96.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 2.15 110.597 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -81.93 -20.84 37.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.012 -0.54 . . . . 2.39 110.581 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.414 HD11 HD22 ' A' ' 87' ' ' LEU . 37.7 tp -71.78 -47.57 52.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.017 -0.538 . . . . 1.79 111.037 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.505 ' HA ' ' HB3' ' A' ' 172' ' ' PHE . 50.2 t -69.48 -18.84 22.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.446 . . . . 1.42 110.945 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 173' ' ' THR . 26.3 m -57.3 -58.71 7.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.217 -0.447 . . . . 1.12 111.524 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . 0.51 ' O ' ' HG ' ' A' ' 175' ' ' LEU . 97.7 m-85 -75.08 -23.35 57.99 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.189 -0.46 . . . . 3.86 110.702 -179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.505 ' HB3' ' HA ' ' A' ' 169' ' ' VAL . 42.6 t80 -72.0 -33.67 68.27 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.278 -0.419 . . . . 1.58 111.791 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 170' ' ' THR . 9.1 t -78.47 -38.07 41.88 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 111.837 0.31 . . . . 1.41 111.837 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -64.83 -32.32 57.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.744 0.307 . . . . 1.42 111.596 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 171' ' ' TYR . 53.6 mt -71.66 -55.43 7.73 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.879 0.371 . . . . 1.91 111.094 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.404 ' HA ' H193 ' A' ' 301' ' ' RET . 1.2 m-90 -57.65 -25.73 60.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.984 -0.553 . . . . 1.55 111.374 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.484 ' O ' HG12 ' A' ' 181' ' ' ILE . 96.7 mt -87.78 -22.97 6.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 121.048 0.451 . . . . 1.86 110.084 178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -59.4 -50.9 62.8 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.751 -0.659 . . . . 0.74 113.084 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.626 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 81.1 m-85 -57.31 -54.54 53.72 Favored Pre-proline 0 CA--C 1.533 0.308 0 CA-C-N 116.9 0.35 . . . . 1.78 111.573 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.626 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 89.3 Cg_exo -47.5 -32.64 15.97 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.107 1.871 . . . . 0.92 112.729 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 184' ' ' ILE . 36.3 mm -64.66 -61.01 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.961 0.41 . . . . 1.77 111.357 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 179' ' ' TYR . 30.6 m -61.21 -24.01 31.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.163 -0.471 . . . . 1.34 111.461 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 23.6 m95 -65.76 -53.4 41.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.088 0.403 . . . . 2.51 112.088 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 181' ' ' ILE . 20.5 tt -59.11 -29.69 42.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 111.88 0.326 . . . . 2.02 111.88 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 47.4 pt -92.14 134.47 30.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.782 0.325 . . . . 2.45 111.074 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 96.18 -157.62 21.56 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 120.579 -0.82 . . . . 1.73 113.06 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.03 165.5 29.66 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 122.925 2.416 . . . . 3.05 111.89 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.9 t 58.48 14.08 2.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.184 0.516 . . . . 4.04 110.188 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.56 -82.48 0.04 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.62 -0.718 . . . . 4.48 112.204 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -172.42 83.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 7.96 110.536 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.84 171.87 44.02 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.77 -0.729 . . . . 3.23 112.519 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 43.7 p90 -113.74 26.92 9.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.949 0.404 . . . . 6.03 110.758 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 42.5 mm -89.33 140.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.992 -0.549 . . . . 3.18 111.103 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 -147.29 95.7 2.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 3.39 111.13 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . 0.562 ' HB3' HG22 ' A' ' 197' ' ' ILE . 18.2 tt0 -168.1 167.23 12.61 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 5.76 111.042 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 40.9 m -65.06 -16.42 63.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 2.5 111.192 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.562 HG22 ' HB3' ' A' ' 195' ' ' GLN . 17.0 tt -56.44 -26.13 22.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.251 -0.431 . . . . 2.4 111.247 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 51.6 m-20 -55.37 -56.02 24.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.42 -0.355 . . . . 2.66 111.024 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 72.2 p -63.62 -27.7 69.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.261 -0.427 . . . . 1.81 110.911 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -68.02 -26.63 65.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.987 -0.552 . . . . 2.21 111.007 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 89.1 mt -75.81 -49.9 16.72 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.871 0.367 . . . . 2.18 110.786 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -70.34 -8.63 52.04 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.206 -0.452 . . . . 2.01 110.692 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.435 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 41.9 t -96.02 -40.9 9.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.297 0.57 . . . . 1.93 110.519 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 35.0 tp -70.78 -33.79 71.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.505 -0.77 . . . . 1.7 111.598 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 0.1 OUTLIER -60.31 -54.87 50.83 Favored Pre-proline 0 CA--C 1.531 0.219 0 C-N-CA 121.124 -0.23 . . . . 1.28 111.111 -179.531 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.505 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 54.4 Cg_exo -52.38 -46.27 34.1 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.735 1.623 . . . . 0.79 111.365 178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -57.76 -33.81 68.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.087 -0.506 . . . . 1.51 110.359 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -76.18 -27.98 57.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.938 -0.573 . . . . 1.93 110.519 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 35.2 t -82.19 -17.12 47.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 1.71 110.598 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -87.41 -46.48 9.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.067 -0.515 . . . . 2.04 110.842 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 14.8 m -60.43 -43.52 94.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.903 0.382 . . . . 2.89 111.027 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -61.92 -34.69 89.7 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.762 -0.732 . . . . 1.31 112.348 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -63.94 -30.07 71.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 2.87 110.439 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 46.2 t -65.35 -60.22 3.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.936 -0.574 . . . . 2.38 110.779 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -59.7 -27.25 66.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 3.42 110.714 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.424 ' O ' HD23 ' A' ' 216' ' ' LEU . 3.4 tt -68.57 -45.09 73.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.06 -0.518 . . . . 1.24 110.483 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -59.05 -30.43 68.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.016 -0.538 . . . . 2.44 110.86 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.58 -52.66 50.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.02 -0.536 . . . . 2.51 110.946 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -68.56 -25.05 64.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 3.01 110.886 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -64.25 -19.87 64.57 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.836 -0.697 . . . . 1.59 112.703 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . 0.54 HD21 HD21 ' A' ' 224' ' ' LEU . 53.4 tp -70.36 -39.45 74.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.695 0.283 . . . . 3.49 110.972 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 79.2 mtp180 60.59 -87.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.078 -0.51 . . . . 5.74 111.217 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -130.23 156.13 45.13 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 5.46 110.867 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.54 HD21 HD21 ' A' ' 221' ' ' LEU . 91.6 mt -94.91 108.5 20.54 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 6.13 111.162 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -136.24 123.37 21.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.979 -0.555 . . . . 6.46 110.497 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -140.52 142.75 35.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.899 0.38 . . . . 6.94 111.349 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 69.1 m -158.22 90.22 1.03 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.901 -0.591 . . . . 6.83 110.695 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 59.42 90.78 0.05 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.042 -0.526 . . . . 10.77 111.135 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.248 -0.882 . . . . 9.41 110.758 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.754 0.312 . . . . 8.91 110.856 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -67.79 126.21 28.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.184 -0.462 . . . . 6.76 110.722 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 90.6 mt -130.61 144.32 51.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.364 -0.38 . . . . 6.25 111.04 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -103.15 163.71 12.07 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.076 -0.511 . . . . 5.44 110.699 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 46.8 t -159.85 130.8 5.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 3.84 110.825 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 77.7 mt -105.81 -9.24 17.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 3.08 110.833 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 48.7 mt -62.45 -49.37 75.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.35 110.948 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.512 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 95.7 m-70 -63.45 -24.32 67.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.26 -0.427 . . . . 1.39 110.672 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . 0.451 ' O ' HG12 ' B' ' 12' ' ' VAL . 42.7 t-105 -71.27 -41.73 69.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 1.1 110.662 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 39.0 mm -68.81 -20.83 25.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.058 0.456 . . . . 1.71 110.24 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . 0.402 ' O ' ' HG2' ' B' ' 15' ' ' MET . 15.0 t80 -66.28 -56.97 8.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.726 -0.67 . . . . 1.48 110.615 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.451 HG12 ' O ' ' B' ' 9' ' ' TRP . 7.3 p -56.43 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.258 -0.428 . . . . 0.95 111.075 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.17 -38.19 85.61 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.283 -0.417 . . . . 0.97 110.745 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.25 -22.0 79.05 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.8 112.198 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' B' ' 11' ' ' TYR . 76.0 mmm -73.9 -31.64 63.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.75 0.31 . . . . 1.29 110.837 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 59.7 p -70.98 -53.92 13.15 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.305 -0.407 . . . . 1.36 110.903 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -58.46 -26.31 30.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 1.23 110.989 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.34 -45.91 75.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.853 -0.689 . . . . 0.88 112.483 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.78 -38.65 75.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.844 0.354 . . . . 0.98 111.084 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 75.4 mt -60.86 -41.06 95.18 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.196 -0.457 . . . . 2.12 110.901 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -58.57 -32.78 69.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.056 -0.52 . . . . 2.0 110.762 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -72.56 -26.51 61.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 4.26 110.49 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 51.0 t90 -61.66 -45.77 92.6 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.633 -0.506 . . . . 3.62 109.633 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 38.4 t -72.91 -19.46 61.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.745 -0.661 . . . . 2.55 109.698 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' B' ' 28' ' ' ASN . 16.9 tp -67.72 1.08 2.7 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 115.578 -0.737 . . . . 3.11 111.034 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.438 ' C ' ' N ' ' B' ' 28' ' ' ASN . 59.1 p -48.04 -19.54 0.27 Allowed 'General case' 0 CA--C 1.531 0.232 0 O-C-N 123.077 0.235 . . . . 3.02 111.524 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -53.32 -19.88 3.77 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 122.297 1.046 . . . . 5.89 108.323 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.768 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.6 t30 -66.15 -154.5 0.0 OUTLIER Pre-proline 0 CA--C 1.551 1.017 0 CA-C-N 113.351 -1.75 . . . . 5.02 107.58 177.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.768 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 37.4 Cg_exo -5.21 -75.0 0.0 OUTLIER 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.149 2.566 . . . . 3.53 115.407 -176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 28.6 tpt180 49.46 55.36 9.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.467 0.651 . . . . 7.88 109.349 -179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.06 -3.95 9.06 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 110.67 -0.972 . . . . 4.61 110.67 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' B' ' 29' ' ' PRO . 1.2 t -110.32 156.28 40.54 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.243 -0.479 . . . . 4.73 110.001 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.526 ' HD2' HG13 ' B' ' 32' ' ' VAL . 27.3 Cg_exo -35.97 142.28 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.04 2.493 . . . . 3.75 114.005 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.425 ' O ' ' N ' ' B' ' 36' ' ' GLU . 77.0 mt-30 -75.42 -13.8 60.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 114.931 -1.032 . . . . 3.76 111.529 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -38.87 -23.31 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.348 0.87 . . . . 3.17 113.348 -178.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.44 ' H ' ' HD1' ' B' ' 35' ' ' TYR . 9.1 tp10 -76.65 -53.21 8.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.78 0.324 . . . . 2.57 110.692 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -71.36 -31.57 67.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.009 -0.542 . . . . 5.74 110.76 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 67.1 tp -58.65 -62.48 1.83 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.72 111.394 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . 0.427 HG22 ' O ' ' B' ' 35' ' ' TYR . 34.0 m -63.83 -38.98 83.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.332 -0.395 . . . . 1.95 111.698 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.19 -11.11 56.49 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.469 -0.332 . . . . 1.2 111.744 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 34.8 tpp -90.02 -43.07 10.77 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.904 0.335 . . . . 2.12 111.904 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' C' ' 107' ' ' SER . 70.7 t80 -76.3 -29.51 57.39 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 112.486 0.55 . . . . 1.49 112.486 -178.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.447 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 92.9 mt -62.16 -50.67 79.06 Favored Pre-proline 0 CA--C 1.538 0.501 0 N-CA-C 112.404 0.52 . . . . 0.77 112.404 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 72.6 Cg_endo -75.44 -48.54 0.16 Allowed 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.458 2.105 . . . . 0.68 113.716 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 36.7 mm -50.27 -58.62 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.617 0.246 . . . . 1.63 111.619 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.421 ' HZ3' HG21 ' C' ' 114' ' ' THR . 4.2 t-105 -56.61 -57.73 11.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.464 -0.335 . . . . 1.91 111.294 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 92.6 p -57.38 -15.76 7.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 1.22 111.596 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.15 -59.63 4.17 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.527 -0.844 . . . . 0.55 112.428 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 59.1 mt -60.95 -23.3 65.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.636 0.255 . . . . 0.87 111.317 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.12 -57.88 8.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.55 111.236 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.456 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 25.0 m-85 -63.01 -41.1 99.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.231 -0.44 . . . . 1.06 111.13 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 50.6 ttp -50.89 -33.55 24.54 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.052 0.453 . . . . 1.19 110.316 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.14 72.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.75 -0.659 . . . . 0.66 110.748 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 47.3 mtt -53.18 -30.53 37.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.902 -0.59 . . . . 0.86 110.394 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -71.08 -50.68 31.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.889 -0.596 . . . . 0.84 110.57 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 26.4 pt -80.05 11.59 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.967 -0.56 . . . . 1.44 111.366 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 60.76 67.95 0.78 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-N 115.962 -0.563 . . . . 1.55 110.908 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.562 HE22 ' HA ' ' C' ' 122' ' ' SER . 13.0 mm100 -143.18 99.21 3.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.945 -0.57 . . . . 2.24 110.779 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 150.01 1.91 0.32 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.784 -0.722 . . . . 1.26 112.405 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -126.96 134.52 50.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 2.31 110.966 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.19 147.21 26.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.167 -0.47 . . . . 1.81 111.069 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.7 88.22 7.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.285 -0.416 . . . . 3.18 110.827 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -100.67 111.43 23.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.089 -0.505 . . . . 2.03 110.919 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.33 32.58 20.74 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.078 -0.51 . . . . 2.48 110.871 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.9 1.39 78.59 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.945 -0.645 . . . . 2.37 112.429 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . 0.408 HE21 ' H ' ' B' ' 67' ' ' ILE . 25.6 tp60 -107.43 126.65 52.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.796 0.331 . . . . 2.28 111.014 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.408 ' H ' HE21 ' B' ' 66' ' ' GLN . 49.6 mm -79.17 112.08 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 1.78 110.776 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -99.78 123.8 44.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.253 -0.431 . . . . 1.05 110.91 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.524 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 41.6 m-70 -77.95 76.35 4.47 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.136 0.493 . . . . 1.11 110.803 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -61.02 -29.7 69.87 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.652 -0.703 . . . . 2.3 111.245 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.457 ' HA ' HG22 ' B' ' 74' ' ' ILE . . . -82.26 -24.08 34.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.115 0.413 . . . . 0.72 112.115 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.524 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 21.1 tpp180 -68.35 -51.39 44.95 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.256 0.465 . . . . 3.04 112.256 -178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.428 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 6.6 p90 -79.82 -34.37 39.53 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.13 0.419 . . . . 1.79 112.13 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.457 HG22 ' HA ' ' B' ' 71' ' ' ALA . 16.5 tt -54.88 -42.38 62.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 C-N-CA 120.869 -0.332 . . . . 1.44 110.852 -179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.404 ' N ' HG23 ' B' ' 74' ' ' ILE . 11.8 t70 -67.14 -23.95 65.86 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.389 -0.597 . . . . 1.31 109.389 178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 49.2 m0 -87.02 7.62 26.89 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.544 -0.753 . . . . 2.01 110.881 179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.463 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 57.0 tpp -104.01 -23.0 13.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.91 -0.586 . . . . 1.43 110.322 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 16.9 m -114.78 -39.02 2.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.018 -0.537 . . . . 1.21 111.995 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -74.3 -58.51 3.25 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.003 0.372 . . . . 1.18 112.003 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.596 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 30.7 m -46.94 -50.86 43.11 Favored Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 112.282 0.475 . . . . 1.65 112.282 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.596 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 46.9 Cg_exo -56.73 -33.77 94.67 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.046 1.831 . . . . 1.06 112.302 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.27 -20.36 32.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 1.58 111.248 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . 0.421 HD22 ' HA ' ' B' ' 83' ' ' LEU . 0.2 OUTLIER -71.14 -38.14 72.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.393 -0.367 . . . . 1.49 110.659 -179.615 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.528 HD21 ' HG2' ' B' ' 109' ' ' GLN . 3.9 pp -84.71 -36.48 21.82 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 1.72 111.059 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.408 ' N ' HD12 ' B' ' 84' ' ' LEU . 14.4 tp -66.48 -44.6 82.21 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.894 -0.594 . . . . 1.96 111.32 -179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 80.6 p -55.75 -23.05 27.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.845 0.355 . . . . 1.24 110.957 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 168' ' ' LEU . 53.3 mt -72.59 -36.4 68.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.033 -0.53 . . . . 1.21 110.832 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 88.7 p -76.25 -36.24 58.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.201 -0.454 . . . . 1.32 111.09 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -58.31 -49.68 76.32 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.849 0.357 . . . . 2.15 110.543 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 55.8 m -69.15 -25.19 64.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.037 -0.529 . . . . 1.44 110.66 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.73 -21.56 47.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.965 -0.561 . . . . 1.05 110.941 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.4 mtm -124.0 101.91 7.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.241 -0.436 . . . . 2.68 110.991 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -64.36 -20.28 66.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 2.71 110.904 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -123.28 160.86 25.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.179 -0.464 . . . . 4.19 111.124 -179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 38.5 mm -120.77 143.26 33.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.997 -0.547 . . . . 2.79 110.902 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -133.65 141.08 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.286 -0.415 . . . . 5.27 110.929 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -79.22 107.42 11.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.283 -0.417 . . . . 5.57 110.96 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -165.14 -45.49 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 4.24 110.916 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 77.0 m95 52.91 69.4 0.7 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.175 -0.466 . . . . 5.39 111.092 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 33.8 p -120.78 -60.41 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.028 -0.533 . . . . 2.16 111.271 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.419 HD21 ' NZ ' ' B' ' 153' ' ' LYS . 4.0 mm? -73.29 -54.77 7.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.209 -0.451 . . . . 2.58 110.917 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 36.1 pt -58.01 -26.59 29.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.354 -0.384 . . . . 2.29 111.072 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -79.67 -30.13 45.39 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.842 -0.694 . . . . 1.48 112.195 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -66.79 -39.65 87.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.037 0.446 . . . . 2.76 110.67 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 76.8 mt -74.96 -44.26 49.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 2.22 110.688 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 46.1 tpp -60.74 -38.98 86.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.56 -0.746 . . . . 2.36 111.394 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 69.3 m -62.89 -57.66 10.03 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.925 0.393 . . . . 1.92 110.744 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 81.5 p -58.62 -21.48 53.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 2.06 110.964 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.528 ' HG2' HD21 ' B' ' 84' ' ' LEU . 8.4 tp-100 -72.77 -54.9 7.65 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.299 -0.41 . . . . 2.87 110.804 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 47.2 mm -50.53 -32.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.235 -0.439 . . . . 1.98 110.909 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 48.9 t -68.24 -48.16 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.976 -0.556 . . . . 1.62 111.215 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 92.6 t -63.33 -42.95 98.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.277 -0.42 . . . . 1.04 111.214 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 68.8 mt -57.78 -37.45 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.15 0 CA-C-N 116.359 -0.382 . . . . 2.46 110.966 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 40.6 m -61.77 -42.27 98.77 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.83 111.079 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 69.6 m -64.18 -24.83 67.82 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.195 -0.457 . . . . 0.74 110.605 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . -74.17 -53.0 7.22 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.928 -0.653 . . . . 0.6 112.923 -179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.428 ' HB3' ' CD1' ' B' ' 73' ' ' TYR . 3.2 pp -62.51 -28.68 70.01 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.639 0.257 . . . . 1.42 111.572 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.409 HG13 HD12 ' B' ' 117' ' ' LEU . 81.6 mt -79.08 -35.34 17.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.601 -0.272 . . . . 1.51 111.111 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.08 -38.22 62.34 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 1.09 111.26 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -85.55 -26.01 26.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 2.25 110.756 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 78.4 mt -84.34 25.18 0.89 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.281 -0.418 . . . . 1.16 111.165 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.576 ' HB3' ' HE ' ' B' ' 128' ' ' ARG . 38.5 t -89.92 127.08 35.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 1.76 110.52 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -82.96 -29.56 28.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.195 -0.457 . . . . 2.89 111.227 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.43 ' HB2' HG12 ' B' ' 127' ' ' VAL . 88.6 mtm180 -116.47 140.72 49.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.312 -0.404 . . . . 2.67 110.925 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -81.34 -9.67 59.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 3.25 110.94 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 77.3 t90 -82.31 -36.77 26.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.241 -0.436 . . . . 4.07 110.581 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.43 HG12 ' HB2' ' B' ' 124' ' ' ARG . 13.4 p -84.29 -25.45 7.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.025 -0.534 . . . . 1.41 110.88 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.576 ' HE ' ' HB3' ' B' ' 122' ' ' SER . 40.9 ttm180 -61.45 -27.0 68.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 2.47 110.64 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -68.55 -28.37 66.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.897 -0.592 . . . . 2.61 110.97 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 66.9 tp -82.16 -37.46 26.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 2.07 111.089 -179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . 0.411 ' HZ2' ' HB2' ' A' ' 53' ' ' ALA . 4.1 m95 -69.98 -34.71 73.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.385 -0.371 . . . . 1.3 111.165 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -60.12 -49.56 77.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.913 0.387 . . . . 1.75 110.634 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 65.3 mt -60.43 -33.83 55.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 1.67 110.942 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 43.8 t -62.49 -32.76 73.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.187 -0.46 . . . . 1.54 111.115 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.27 -54.32 17.34 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.784 -0.722 . . . . 0.7 112.43 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.38 -27.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.664 0.269 . . . . 1.44 111.198 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 53.5 t -63.56 -53.93 44.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 1.82 110.506 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.48 66.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.94 110.47 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -75.89 -20.34 58.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.869 -0.605 . . . . 1.6 110.368 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.8 -48.05 13.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.962 -0.563 . . . . 2.01 110.754 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 42.8 pt -62.26 -35.39 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.423 -0.353 . . . . 1.96 111.46 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.41 HG13 ' N ' ' B' ' 143' ' ' LEU . 49.4 pt -77.28 -33.57 20.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.578 -0.283 . . . . 2.88 111.09 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.41 ' N ' HG13 ' B' ' 142' ' ' ILE . 53.4 tp -55.77 -47.71 76.56 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.366 -0.379 . . . . 1.52 110.337 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -72.46 -29.1 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.029 -0.532 . . . . 4.15 110.317 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -73.4 -16.8 78.79 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.59 112.53 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 84.6 mt -103.46 -24.64 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.871 0.367 . . . . 2.13 110.999 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -81.45 -48.8 11.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 1.78 111.5 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.589 ' N ' ' HD2' ' B' ' 149' ' ' PRO . 55.8 t30 -52.63 -49.83 83.99 Favored Pre-proline 0 CA--C 1.537 0.447 0 CA-C-N 115.932 -0.576 . . . . 2.45 112.426 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' B' ' 148' ' ' ASN . 13.9 Cg_endo -56.05 -19.33 26.11 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.254 1.97 . . . . 2.36 112.643 -179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 88.5 mt -84.08 39.57 0.71 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.96 0.41 . . . . 2.88 110.709 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 39.7 ttm180 -166.86 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.9 -0.591 . . . . 8.07 110.598 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -80.97 -57.32 3.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 2.8 111.063 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . 0.419 ' NZ ' HD21 ' B' ' 101' ' ' LEU . 88.5 tttt -68.83 -17.7 64.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 4.58 110.787 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 17.4 m -66.13 -14.86 62.52 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.142 -0.481 . . . . 3.81 110.865 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 7.4 tpm_? -55.13 -45.4 75.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 5.22 111.195 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 71.3 p -102.23 -36.42 8.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.347 -0.388 . . . . 3.42 111.292 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -62.98 151.41 39.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.327 -0.397 . . . . 4.2 110.732 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 73.0 p -57.82 117.84 4.69 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.171 -0.468 . . . . 2.75 111.164 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 56.5 m -66.89 -19.32 65.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.962 -0.563 . . . . 2.4 111.116 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -72.0 -45.44 60.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.358 -0.383 . . . . 3.46 110.795 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -38.86 80.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 2.57 110.107 179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.83 -30.97 71.29 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.911 -0.586 . . . . 1.72 111.25 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -64.42 -48.48 75.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 2.69 110.828 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 65.2 mt -59.81 -35.86 75.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.122 -0.49 . . . . 2.16 110.779 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -75.48 -26.85 58.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.916 -0.584 . . . . 2.13 110.897 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -61.25 -39.77 91.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 1.94 110.453 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -83.25 -20.88 33.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.063 -0.517 . . . . 3.33 110.685 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 87' ' ' LEU . 52.8 tp -69.82 -52.87 21.38 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 1.56 110.967 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 47.6 t -60.25 -21.42 22.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.177 -0.465 . . . . 1.59 111.282 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 54.6 m -55.55 -58.93 5.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 1.14 111.201 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . 0.402 ' O ' ' HG ' ' B' ' 175' ' ' LEU . 70.5 m-85 -65.51 -33.85 76.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.273 -0.421 . . . . 3.87 110.36 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -57.56 -53.95 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 1.61 111.471 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 65.4 p -55.01 -46.34 75.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.289 -0.414 . . . . 1.3 111.674 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 73.2 t -55.62 -34.37 35.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.392 -0.367 . . . . 1.53 111.462 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 82.4 mt -78.26 -58.25 3.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.283 -0.417 . . . . 1.99 111.732 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . 0.521 ' HE1' HE22 ' B' ' 109' ' ' GLN . 1.2 m-90 -59.35 -25.77 64.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.285 -0.416 . . . . 1.5 111.476 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.472 ' O ' HG12 ' B' ' 181' ' ' ILE . 79.6 mt -88.14 -24.16 6.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.939 0.399 . . . . 1.46 110.305 179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.01 -52.45 52.76 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.916 -0.583 . . . . 0.67 113.231 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.655 ' HB2' ' HD3' ' B' ' 180' ' ' PRO . 91.2 m-85 -55.69 -54.95 45.96 Favored Pre-proline 0 CA--C 1.533 0.316 0 CA-C-N 116.823 0.311 . . . . 1.73 111.776 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 79.1 Cg_exo -47.44 -36.82 24.52 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 121.985 1.79 . . . . 0.93 112.75 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.524 ' O ' HG22 ' B' ' 184' ' ' ILE . 42.2 mm -62.51 -61.16 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.905 0.383 . . . . 1.36 111.335 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.441 HG22 ' O ' ' B' ' 179' ' ' TYR . 27.7 m -60.03 -23.98 28.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.115 -0.493 . . . . 1.19 111.373 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 17.4 m95 -66.2 -53.5 36.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.286 -0.415 . . . . 2.73 112.065 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.524 HG22 ' O ' ' B' ' 181' ' ' ILE . 19.2 tt -60.35 -31.56 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 N-CA-C 112.055 0.391 . . . . 1.93 112.055 -178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 11.2 tt -95.34 129.18 45.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.878 0.371 . . . . 2.64 111.311 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . 0.544 ' HA2' HD12 ' B' ' 193' ' ' ILE . . . 106.03 -153.61 17.05 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.889 -0.672 . . . . 1.93 112.795 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -77.34 168.64 22.6 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.764 2.31 . . . . 2.97 112.027 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . 0.426 ' HA ' HH11 ' B' ' 128' ' ' ARG . 49.9 m 57.03 14.94 2.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.115 0.483 . . . . 4.5 110.146 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . -160.84 26.95 0.29 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.553 -0.749 . . . . 4.5 112.25 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 58.22 90.27 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.846 0.355 . . . . 7.89 110.976 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . -146.94 -7.0 0.29 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 3.62 112.672 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 8.1 m-90 61.12 31.94 19.67 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.777 0.322 . . . . 6.54 110.983 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.544 HD12 ' HA2' ' B' ' 186' ' ' GLY . 83.9 mt -119.0 139.7 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-N 116.149 -0.478 . . . . 3.16 111.116 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -141.42 93.65 2.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 3.39 110.458 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.577 HE21 ' HB ' ' B' ' 197' ' ' ILE . 29.1 tt0 -160.84 151.87 18.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.014 -0.539 . . . . 5.56 110.884 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 5.3 t -60.54 -14.78 21.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.88 -0.6 . . . . 2.68 111.792 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.577 ' HB ' HE21 ' B' ' 195' ' ' GLN . 17.5 tt -52.05 -29.26 11.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.461 -0.336 . . . . 2.2 111.212 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -58.36 -48.54 80.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.344 -0.389 . . . . 2.49 110.649 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 20.2 m -66.27 -28.68 68.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.227 -0.442 . . . . 1.76 110.777 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -77.09 -25.82 52.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.045 -0.525 . . . . 2.18 110.704 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . 0.4 HD11 HG11 ' B' ' 182' ' ' VAL . 0.3 OUTLIER -73.89 -49.42 24.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.159 -0.473 . . . . 1.78 110.64 179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -72.94 1.02 9.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.031 -0.531 . . . . 1.98 111.024 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . 0.429 ' C ' ' HD2' ' B' ' 206' ' ' PRO . 41.9 t -96.42 -44.56 7.15 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.353 0.597 . . . . 1.65 110.287 178.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 51.1 tp -72.63 -31.48 65.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.432 -0.803 . . . . 1.11 111.508 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.481 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.2 OUTLIER -60.5 -54.68 52.53 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 121.201 -0.2 . . . . 1.43 110.952 -179.563 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.481 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 51.7 Cg_exo -55.49 -44.39 48.93 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 121.944 1.763 . . . . 0.77 111.477 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . 0.424 ' O ' HG23 ' B' ' 211' ' ' VAL . 75.8 t80 -61.77 -31.07 71.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.016 0.436 . . . . 1.6 110.194 179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -74.12 -26.0 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.792 -0.64 . . . . 1.77 110.601 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 11.5 t -82.32 -16.14 50.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.001 -0.545 . . . . 1.54 111.078 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.0 mptt -89.47 -41.12 12.24 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.388 -0.369 . . . . 2.01 111.028 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . 0.424 HG23 ' O ' ' B' ' 207' ' ' PHE . 86.1 t -59.4 -49.12 84.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 2.65 110.97 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.9 -28.59 68.8 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.768 -0.729 . . . . 1.33 112.602 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -67.01 -39.23 87.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 2.29 110.895 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 62.3 m -60.37 -57.03 14.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 2.12 111.06 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -58.97 -26.19 64.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 3.6 110.935 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 6.0 tt -69.13 -49.11 59.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 1.51 110.949 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -55.74 -35.08 65.76 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.785 0.326 . . . . 2.22 111.026 -179.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . 0.413 HD21 HD11 ' B' ' 25' ' ' LEU . 61.7 mt -64.68 -41.95 95.68 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.292 -0.413 . . . . 2.69 110.955 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -79.05 -20.36 49.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.5 . . . . 3.4 110.891 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.72 -25.38 75.17 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.893 -0.67 . . . . 1.67 112.913 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 51.4 tp -58.32 -42.77 87.49 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.619 0.247 . . . . 3.39 110.804 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 46.3 ttp180 60.27 -83.79 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.983 -0.553 . . . . 5.91 111.407 179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 71.9 m-20 -128.72 165.07 21.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.314 -0.403 . . . . 5.26 110.85 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 57.0 tp -111.9 110.51 20.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.131 -0.486 . . . . 6.81 110.771 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -141.12 143.46 34.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.288 -0.415 . . . . 7.02 111.148 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -148.92 139.26 22.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 8.21 110.811 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 79.9 p -113.21 -33.62 5.92 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.248 -0.433 . . . . 8.1 111.073 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . 0.457 ' HG3' ' HG3' ' B' ' 229' ' ' GLN . 40.5 ptt180 -158.49 -3.65 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 13.28 111.13 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . 0.457 ' HG3' ' HG3' ' B' ' 228' ' ' ARG . 87.7 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.147 -0.93 . . . . 10.4 110.93 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 94.3 mmm . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.799 0.333 . . . . 8.1 110.942 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -80.78 151.97 28.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.153 -0.476 . . . . 6.27 110.714 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 29.5 tp -111.14 149.42 30.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 6.2 111.003 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -109.11 116.59 32.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 4.82 111.055 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 49.1 m -100.48 177.89 4.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 3.25 110.639 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . 0.459 ' N ' HD23 ' C' ' 6' ' ' LEU . 2.6 pt? -158.6 -8.75 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.511 -0.313 . . . . 2.79 111.109 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 60.0 tp -62.64 -60.71 3.13 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 2.08 110.943 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.556 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 35.3 m80 -61.31 -23.38 65.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.834 -0.621 . . . . 1.43 111.097 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.542 ' O ' HG12 ' C' ' 12' ' ' VAL . 58.3 t-105 -65.04 -56.51 12.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 1.16 110.677 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 41.7 mm -58.89 -22.73 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.039 0.447 . . . . 2.09 110.286 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -61.18 -61.44 2.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.729 -0.669 . . . . 1.58 111.074 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.542 HG12 ' O ' ' C' ' 9' ' ' TRP . 9.6 p -53.35 -34.1 22.18 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 CA-C-N 116.507 -0.315 . . . . 1.0 111.14 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.23 -42.93 99.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.121 0.486 . . . . 0.96 110.365 179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -67.0 -17.33 67.59 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.788 -0.72 . . . . 0.96 111.89 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 80.3 mmm -78.81 -34.61 45.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.923 0.392 . . . . 1.3 110.176 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -61.45 -54.05 48.55 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.875 -0.602 . . . . 1.52 110.392 179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . 0.405 HD12 ' O ' ' C' ' 17' ' ' ILE . 1.2 tp -56.74 -39.51 64.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.009 -0.541 . . . . 1.9 110.505 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.16 -51.99 13.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 0.96 112.293 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.38 81.27 Favored 'General case' 0 CA--C 1.521 -0.146 0 CA-C-O 120.854 0.359 . . . . 1.07 110.735 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.52 -35.15 71.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.057 -0.52 . . . . 2.08 110.541 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -61.66 -37.5 84.27 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.87 -0.604 . . . . 2.02 110.581 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . 0.507 ' HA ' ' HB3' ' C' ' 25' ' ' LEU . 72.8 m-85 -68.63 -39.21 80.86 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 4.98 110.662 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 91.5 t90 -50.63 -42.23 55.99 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-O 121.034 0.445 . . . . 4.29 110.108 179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 48.4 t -85.49 -24.18 27.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.804 -0.635 . . . . 2.47 110.547 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 28.5 tp -77.29 -0.95 27.38 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.961 -0.563 . . . . 2.9 110.634 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.866 ' OG ' ' HA ' ' C' ' 32' ' ' VAL . 34.6 t -63.76 -29.79 70.96 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 120.747 -0.381 . . . . 2.74 111.012 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -42.23 -26.31 0.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.078 0.942 . . . . 5.85 108.702 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.759 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 3.1 t30 -66.66 -157.57 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.343 0 CA-C-N 113.536 -1.665 . . . . 4.52 108.468 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.759 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 73.1 Cg_exo -9.17 118.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.371 1.724 0 C-N-CA 124.542 3.495 . . . . 3.22 117.339 -177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 65.6 ttt180 45.42 24.12 0.16 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.533 -1.212 . . . . 8.68 113.718 177.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 74.83 -47.7 1.89 Allowed Glycine 0 C--O 1.23 -0.146 0 C-N-CA 120.195 -1.003 . . . . 4.14 111.46 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.866 ' HA ' ' OG ' ' C' ' 26' ' ' SER . 11.6 m -139.21 106.45 7.26 Favored Pre-proline 0 N--CA 1.448 -0.525 0 N-CA-C 109.452 -0.573 . . . . 5.09 109.452 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.66 ' HD3' ' OG ' ' C' ' 26' ' ' SER . 6.1 Cg_exo -83.71 119.57 2.61 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.096 1.864 . . . . 3.1 113.278 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -81.19 -24.46 37.47 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 107.731 -1.211 . . . . 3.85 107.731 176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.537 ' HB2' ' HE1' ' C' ' 89' ' ' TRP . 2.7 p90 -83.19 -61.67 1.79 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 113.102 -1.863 . . . . 3.37 112.373 -178.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' C' ' 33' ' ' PRO . 10.5 tp10 -58.55 -52.1 67.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.407 -0.36 . . . . 2.72 111.803 -178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -54.7 -31.9 58.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.54 -0.3 . . . . 5.67 111.149 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 100' ' ' THR . 66.4 tp -62.27 -65.24 0.72 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.305 -0.407 . . . . 1.93 111.687 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . 0.412 ' O ' HG13 ' C' ' 43' ' ' ILE . 17.3 m -64.47 -43.62 96.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.441 . . . . 1.88 111.828 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -62.77 -15.35 53.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.386 -0.37 . . . . 1.23 111.791 -179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 17.5 tpt -89.01 -46.11 9.12 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.861 0.319 . . . . 2.09 111.861 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -71.77 -30.19 65.31 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.736 0.643 . . . . 1.41 112.736 -178.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.422 ' N ' ' HD2' ' C' ' 44' ' ' PRO . 96.1 mt -60.36 -52.72 71.05 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.751 0.649 . . . . 0.8 112.751 -178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' C' ' 43' ' ' ILE . 77.8 Cg_endo -74.66 -35.69 3.35 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.516 2.144 . . . . 0.72 113.791 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 28.8 mm -59.35 -60.64 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 111.905 0.335 . . . . 1.68 111.905 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -58.87 -54.06 51.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.787 0.327 . . . . 1.68 111.397 -179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 89.7 p -51.58 -46.38 63.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 1.28 111.346 -179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -53.83 -44.36 70.79 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.053 -0.594 . . . . 0.51 113.237 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.418 HD22 ' SG ' ' A' ' 134' ' ' CYS . 95.4 mt -57.89 -42.02 83.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.853 0.359 . . . . 1.33 111.254 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' C' ' 54' ' ' MET . . . -61.56 -35.88 79.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.01 -0.541 . . . . 0.57 111.383 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -69.72 -51.43 34.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.275 -0.42 . . . . 1.67 111.396 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . . . . . . . . . 58.8 ttp -50.06 -29.32 8.61 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.039 0.447 . . . . 1.42 110.469 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . 0.409 ' HB1' ' HB3' ' C' ' 58' ' ' GLN . . . -73.17 -44.02 60.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.834 -0.621 . . . . 0.71 111.045 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . 0.424 ' HB2' ' CG ' ' C' ' 8' ' ' HIS . 52.4 mtt -54.11 -31.11 51.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.439 . . . . 1.14 110.606 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.556 ' HB2' ' HB2' ' C' ' 8' ' ' HIS . . . -71.75 -46.43 58.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.88 111.006 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 31.2 pt -84.03 9.69 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 1.38 111.247 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 58.46 68.51 0.82 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.751 -0.659 . . . . 1.94 111.617 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.423 ' HG3' HD11 ' A' ' 118' ' ' ILE . 7.5 tp60 -133.85 114.28 13.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.327 -0.397 . . . . 1.87 110.753 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 126.49 38.84 0.43 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.942 -0.647 . . . . 1.27 112.351 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -129.75 139.39 51.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.791 0.329 . . . . 2.86 110.888 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 m -137.76 132.58 44.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 1.95 111.023 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -89.13 89.83 8.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 3.04 111.001 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.23 108.76 20.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 2.11 110.888 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 61.65 21.99 12.59 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.22 -0.446 . . . . 2.54 111.094 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 92.9 10.11 60.29 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.753 -0.737 . . . . 2.47 112.558 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -113.54 118.68 35.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 2.85 110.802 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 57.0 mt -77.32 117.9 23.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 1.87 110.951 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -109.91 128.53 55.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 1.12 111.135 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.577 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 61.5 m-70 -79.75 80.81 6.1 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.108 -0.496 . . . . 1.26 110.684 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -58.25 -34.25 70.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.583 -0.735 . . . . 2.08 111.38 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.492 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -77.52 -23.76 50.13 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.86 112.05 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.577 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 13.2 tpp180 -66.98 -51.49 54.51 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.201 -0.454 . . . . 1.96 112.17 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.523 ' O ' ' HG2' ' C' ' 77' ' ' MET . 11.4 p90 -82.78 -33.28 27.36 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 120.791 -0.363 . . . . 1.8 111.972 -178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.492 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.4 tp -53.3 -42.12 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.973 -0.291 . . . . 1.18 111.036 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.414 ' N ' HG23 ' C' ' 74' ' ' ILE . 24.3 t70 -64.7 -25.22 67.85 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.652 -0.499 . . . . 1.33 109.652 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . 0.402 ' CE3' ' HA ' ' C' ' 73' ' ' TYR . 29.4 m0 -87.79 9.84 20.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.547 -0.751 . . . . 1.85 111.2 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' C' ' 73' ' ' TYR . 86.1 mmm -104.57 -17.13 14.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.026 -0.534 . . . . 1.56 110.26 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.402 HG23 ' N ' ' C' ' 79' ' ' THR . 27.1 m -114.43 -41.3 3.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.98 -0.555 . . . . 1.11 112.423 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.402 ' N ' HG23 ' C' ' 78' ' ' VAL . 74.2 p -76.15 -57.01 4.12 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.166 0.432 . . . . 1.49 112.166 -178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 9.1 m -46.28 -50.56 38.24 Favored Pre-proline 0 CA--C 1.533 0.321 0 N-CA-C 112.26 0.467 . . . . 1.6 112.26 -178.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 45.1 Cg_exo -56.64 -51.42 9.15 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.036 1.824 . . . . 1.01 112.094 179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -69.65 -12.6 61.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.307 -0.406 . . . . 1.18 111.051 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.438 HD21 ' HE3' ' C' ' 210' ' ' LYS . 0.6 OUTLIER -74.47 -55.75 5.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.311 -0.404 . . . . 1.54 110.975 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . 0.475 HD23 ' H ' ' C' ' 84' ' ' LEU . 1.4 pt? -72.08 -17.24 62.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 1.65 110.459 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 75.2 mt -85.18 -28.76 25.25 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.956 -0.565 . . . . 2.1 110.72 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 32.6 t -73.9 -28.18 61.42 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.185 -0.461 . . . . 1.38 110.451 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' C' ' 83' ' ' LEU . 72.9 mt -71.91 -33.6 68.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.93 -0.577 . . . . 1.44 110.403 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 79.4 p -80.16 -27.55 38.97 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.089 -0.505 . . . . 1.87 110.6 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' C' ' 35' ' ' TYR . 29.1 t-105 -69.37 -35.89 76.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.969 -0.56 . . . . 3.1 110.526 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 55.3 p -80.68 -26.75 37.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.064 -0.516 . . . . 1.48 110.883 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.71 -12.37 59.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.064 -0.516 . . . . 1.02 110.992 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 65.5 mtt -130.39 108.72 10.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.034 -0.53 . . . . 2.34 111.054 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -76.21 -17.95 59.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.264 -0.426 . . . . 3.21 110.572 179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -132.37 133.73 44.32 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.927 -0.578 . . . . 4.54 110.77 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 20.7 mm -101.46 143.94 13.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.279 -0.419 . . . . 2.34 110.924 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -105.24 162.22 13.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 4.4 110.776 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.42 38.58 0.98 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.119 -0.491 . . . . 5.54 110.903 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -115.87 -53.04 2.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.069 -0.514 . . . . 3.54 110.825 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 72.4 m95 55.21 69.07 0.77 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.992 -0.549 . . . . 5.21 110.955 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . 0.412 HG23 ' N ' ' C' ' 101' ' ' LEU . 2.7 t -111.35 -48.22 3.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 2.38 111.174 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.412 ' N ' HG23 ' C' ' 100' ' ' THR . 78.2 mt -71.35 -49.94 37.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.267 -0.424 . . . . 2.64 110.875 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 45.7 mt -58.96 -39.04 77.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.049 -0.523 . . . . 2.38 110.769 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -64.47 -33.15 86.47 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.858 -0.687 . . . . 1.62 112.596 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -68.06 -36.43 79.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.803 0.335 . . . . 2.93 110.724 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 63.5 mt -79.76 -28.29 40.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 2.16 110.889 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 92.7 mtp -75.63 -33.27 60.48 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.225 -0.443 . . . . 2.3 111.143 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' B' ' 42' ' ' PHE . 80.6 p -69.45 -54.19 15.52 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.914 0.387 . . . . 2.07 111.099 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . . . . . . . . . 10.2 t -61.14 -27.94 68.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.085 -0.507 . . . . 2.3 111.263 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 56.6 tp60 -68.87 -53.68 19.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 2.48 111.273 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . . . . . . . . . 99.3 mt -49.06 -36.97 9.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.156 0 CA-C-N 116.258 -0.428 . . . . 1.93 111.199 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 45.1 t -64.73 -47.26 89.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.369 -0.378 . . . . 1.67 111.17 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 60.2 t -62.24 -47.68 91.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.395 -0.366 . . . . 1.11 111.358 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 55.5 mt -52.62 -35.19 20.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.368 -0.378 . . . . 2.59 111.003 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . 0.421 HG21 ' HZ3' ' B' ' 46' ' ' TRP . 99.6 m -62.97 -46.28 88.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.297 -0.411 . . . . 0.9 110.735 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.3 m -55.97 -26.46 48.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.92 110.481 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . . . . . . . . . . . -71.59 -52.4 12.72 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.953 -0.641 . . . . 0.55 112.944 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.401 ' HG ' ' O ' ' C' ' 114' ' ' THR . 3.7 pp -70.23 -29.93 66.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.652 0.263 . . . . 1.49 111.291 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . . . . . . . . . 39.3 mm -74.88 -40.72 46.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.367 . . . . 1.66 111.031 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -52.84 -38.59 61.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.94 110.982 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -81.79 -23.85 36.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.087 -0.506 . . . . 1.79 110.908 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 83.2 mt -87.17 27.59 1.03 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.376 -0.375 . . . . 1.29 111.128 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.562 ' HA ' HE22 ' B' ' 58' ' ' GLN . 66.7 m -78.74 130.38 35.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 2.15 110.838 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -85.01 -29.81 24.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.003 -0.544 . . . . 3.31 111.041 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.518 ' HB2' HG12 ' C' ' 127' ' ' VAL . 85.0 mtm180 -123.29 139.23 54.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 3.16 110.74 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -74.43 -11.2 60.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.999 -0.546 . . . . 4.24 111.213 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 77.2 t90 -87.08 -36.64 18.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.207 -0.452 . . . . 4.65 110.9 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.518 HG12 ' HB2' ' C' ' 124' ' ' ARG . 13.3 p -80.38 -24.1 11.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.12 -0.491 . . . . 1.31 110.862 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.419 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 39.5 ttm180 -58.05 -32.96 68.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.835 -0.62 . . . . 2.84 110.888 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -65.8 -24.9 67.02 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 2.7 110.694 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.494 HD12 HG23 ' C' ' 127' ' ' VAL . 61.3 mt -77.98 -52.97 7.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 1.88 110.87 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 4.2 m95 -59.88 -29.92 68.65 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.23 -0.441 . . . . 1.38 111.403 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -59.07 -55.29 36.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.811 0.338 . . . . 1.76 110.653 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 39.1 mt -61.07 -25.53 36.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 2.15 111.307 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 73.8 m -67.17 -36.87 82.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.207 -0.451 . . . . 1.56 111.008 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.45 -45.16 61.33 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.751 -0.738 . . . . 0.73 112.537 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.21 -34.02 52.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 111.525 0.194 . . . . 1.48 111.525 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 49.7 t -62.61 -42.85 99.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.576 -0.284 . . . . 1.51 111.095 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.93 -26.5 63.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.371 -0.377 . . . . 1.01 110.798 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -75.63 -20.98 58.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.985 -0.552 . . . . 2.05 110.682 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 87.2 mt -78.69 -46.23 19.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.357 -0.383 . . . . 2.07 111.227 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 32.8 pt -62.8 -37.32 78.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.479 -0.328 . . . . 1.92 111.432 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . . . . . . . . . 7.4 tp -76.12 -33.51 24.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.526 -0.306 . . . . 2.64 111.002 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 58.2 tp -59.43 -39.64 84.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.287 -0.415 . . . . 1.51 110.737 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 69.6 t-105 -78.36 -24.96 46.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.086 -0.506 . . . . 3.58 110.495 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -82.83 -16.83 69.25 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.953 -0.641 . . . . 1.65 112.632 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 17.7 tt -99.36 -21.08 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.748 0.308 . . . . 2.46 111.367 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -87.86 -38.88 15.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.37 -0.377 . . . . 2.27 111.83 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.548 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 52.2 t30 -55.48 -48.41 96.43 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.312 -0.404 . . . . 2.33 112.0 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 28.5 Cg_exo -61.49 -12.46 24.43 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.214 1.942 . . . . 2.46 112.913 -179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 86.7 mt -80.48 24.7 0.44 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.684 0.278 . . . . 3.08 111.216 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -174.44 -28.26 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.355 -0.384 . . . . 8.45 110.93 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -83.18 -41.26 18.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.179 -0.464 . . . . 2.9 111.142 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 41.9 ttmt -86.24 -22.15 27.02 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 4.62 111.018 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . . . . . . . . . 53.0 p -65.28 -13.02 57.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.007 -0.542 . . . . 3.85 111.483 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -59.74 -28.21 67.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.319 -0.4 . . . . 5.12 111.216 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 30.0 m -115.49 -43.01 3.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.36 -0.382 . . . . 3.43 111.466 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -63.42 160.37 16.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.507 -0.315 . . . . 3.98 110.976 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 66.7 m -60.13 115.6 3.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.239 -0.437 . . . . 2.4 111.01 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 56.3 m -63.99 -18.88 64.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.089 -0.505 . . . . 2.82 110.899 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -64.43 -61.49 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.198 -0.456 . . . . 3.18 110.879 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . 0.444 HD12 ' H ' ' C' ' 161' ' ' LEU . 6.8 mp -61.18 -31.49 71.24 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.004 -0.543 . . . . 2.5 110.625 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -63.48 -44.33 94.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 1.81 111.034 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -56.7 -41.45 77.39 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 2.13 110.623 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 93.8 mt -64.38 -34.78 78.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 2.21 110.613 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.85 -22.7 49.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.901 -0.59 . . . . 1.31 111.246 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -67.82 -44.54 77.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.452 -0.34 . . . . 2.26 111.186 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -80.07 -21.95 42.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.246 -0.434 . . . . 3.58 110.944 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 54.4 tp -73.48 -56.3 5.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 1.3 111.025 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 13.5 p -57.6 -22.05 17.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 1.73 111.457 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.1 m -53.81 -58.92 5.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.917 0.389 . . . . 1.43 111.135 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 44.3 m-85 -66.12 -30.73 71.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.478 . . . . 3.72 110.7 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -68.06 -25.88 65.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 1.55 111.24 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 38.1 m -79.24 -48.19 14.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.356 -0.384 . . . . 1.5 111.505 -179.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 34.2 m -62.71 -26.8 41.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.278 -0.419 . . . . 1.84 112.025 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 68.9 tp -78.88 -55.21 5.33 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.919 0.39 . . . . 2.12 111.315 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -57.47 -27.95 62.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.022 -0.535 . . . . 1.0 111.436 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.501 ' C ' ' HD2' ' C' ' 180' ' ' PRO . 11.3 tp -87.73 -20.74 7.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.051 0.453 . . . . 1.75 110.591 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.53 ' O ' HG13 ' C' ' 182' ' ' VAL . . . -61.77 -49.23 78.21 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.819 -0.628 . . . . 0.72 113.184 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.641 ' HB2' ' HD3' ' C' ' 180' ' ' PRO . 80.4 m-85 -58.38 -52.63 73.18 Favored Pre-proline 0 CA--C 1.537 0.445 0 N-CA-C 112.008 0.373 . . . . 1.8 112.008 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.676 ' HA ' ' HE1' ' C' ' 183' ' ' TRP . 58.8 Cg_exo -53.27 -31.99 58.76 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.423 2.082 . . . . 0.88 113.953 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.541 ' O ' HG22 ' C' ' 184' ' ' ILE . 8.3 tp -88.01 -20.35 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 113.702 1.001 . . . . 1.52 113.702 -178.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.61 HG22 ' O ' ' C' ' 179' ' ' TYR . 35.1 m -80.31 -35.78 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 N-CA-C 113.351 0.871 . . . . 1.2 113.351 -178.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.676 ' HE1' ' HA ' ' C' ' 180' ' ' PRO . 0.4 OUTLIER -93.61 -12.56 29.17 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.299 0.481 . . . . 2.47 112.299 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.541 HG22 ' O ' ' C' ' 181' ' ' ILE . 18.4 tt -54.63 -24.88 13.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.005 0.431 . . . . 1.62 110.718 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.524 HG23 HG23 ' C' ' 184' ' ' ILE . 15.8 pt -114.18 127.98 71.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.821 -0.627 . . . . 2.63 111.14 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . 0.764 ' H ' ' H ' ' C' ' 191' ' ' GLY . . . 108.77 -168.15 13.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.813 -0.708 . . . . 1.77 112.494 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.1 151.28 9.18 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.722 2.281 . . . . 3.03 111.89 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 70.1 m 57.82 15.38 2.98 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.053 0.454 . . . . 4.22 110.465 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -145.61 -93.6 0.15 Allowed Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.785 -0.643 . . . . 4.08 112.18 -179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -114.11 -68.93 0.89 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.775 0.321 . . . . 7.54 110.596 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . 0.764 ' H ' ' H ' ' C' ' 186' ' ' GLY . . . 130.89 105.84 1.09 Allowed Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.787 -0.721 . . . . 3.29 112.436 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 65.0 t-105 -169.62 -38.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.627 0.251 . . . . 5.67 111.471 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.443 HD12 HG23 ' C' ' 197' ' ' ILE . 37.6 pt -89.38 -179.56 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.859 0.361 . . . . 2.76 111.444 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -67.21 -162.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.067 -0.515 . . . . 3.69 111.332 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -100.93 -62.28 1.26 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 5.34 111.149 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 5.1 t -69.35 -16.68 63.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.277 -0.419 . . . . 2.57 111.844 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . 0.443 HG23 HD12 ' C' ' 193' ' ' ILE . 9.5 tp -59.28 -29.37 41.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 2.37 111.205 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -61.66 -49.24 77.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.217 -0.447 . . . . 2.68 111.086 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 53.8 p -69.55 -16.93 63.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.312 -0.403 . . . . 1.95 111.416 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -81.83 -38.92 24.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.298 -0.41 . . . . 2.05 111.367 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 84.4 mt -83.31 -35.85 24.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.478 -0.328 . . . . 1.91 111.633 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.28 -9.85 20.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.543 -0.298 . . . . 2.04 111.473 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.437 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 87.7 m -96.38 -37.3 10.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.982 0.42 . . . . 1.62 110.975 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 94.4 mt -69.4 -32.83 72.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.847 -0.615 . . . . 1.49 111.937 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.696 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 23.4 tp -64.32 -54.57 37.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 C-N-CA 120.973 -0.291 . . . . 1.32 111.276 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.696 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 52.4 Cg_exo -56.37 -33.61 92.14 Favored 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.915 1.744 . . . . 0.76 111.871 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 91.9 t80 -68.79 -36.06 77.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.252 -0.431 . . . . 1.52 110.267 179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -69.9 -28.45 65.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.991 -0.55 . . . . 1.84 110.846 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 76.1 p -72.63 -38.36 67.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.412 -0.358 . . . . 1.68 110.623 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . 0.438 ' HE3' HD21 ' C' ' 83' ' ' LEU . 11.6 mptt -67.86 -51.33 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.042 -0.526 . . . . 2.04 110.867 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 12.5 p -59.36 -33.53 51.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.936 0.398 . . . . 2.65 110.656 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -70.62 -32.83 67.23 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.837 -0.696 . . . . 1.33 111.939 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 61.2 t80 -70.81 -34.88 72.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.723 0.297 . . . . 3.02 110.928 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 35.2 t -60.04 -55.69 30.85 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.302 -0.408 . . . . 2.35 110.531 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -64.81 -27.86 69.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.943 -0.571 . . . . 3.62 110.201 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.402 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -65.9 -49.2 68.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.036 -0.529 . . . . 1.64 110.381 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -61.95 -29.07 69.99 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 2.2 110.582 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.671 ' HA ' HD21 ' C' ' 28' ' ' ASN . 60.4 tp -64.63 -37.96 89.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.092 -0.504 . . . . 3.11 110.5 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -88.11 -21.19 24.81 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.972 -0.558 . . . . 3.37 110.84 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.84 -19.26 69.38 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.942 -0.647 . . . . 1.55 112.906 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.529 HD13 ' HD3' ' C' ' 29' ' ' PRO . 58.6 tp -61.61 -28.43 69.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.634 0.254 . . . . 3.11 110.877 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 61.52 -82.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.937 -0.574 . . . . 5.73 110.956 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -149.43 122.77 9.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.25 -0.432 . . . . 5.53 110.523 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 55.3 tp -58.46 136.41 57.49 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.039 -0.528 . . . . 6.6 110.998 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -163.39 109.44 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 6.51 110.876 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -115.47 153.81 30.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 7.05 110.759 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 33.7 t -137.6 -57.0 0.69 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 6.72 110.942 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 20.7 mmt180 -128.97 163.06 26.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.106 -0.497 . . . . 9.56 110.863 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.237 -0.887 . . . . 9.08 110.866 179.973 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.766 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.731 ' H8 ' H171 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.765 H161 ' H8 ' ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.4 mtm . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.81 0.338 . . . . 8.09 111.007 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -71.47 118.65 14.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.157 -0.474 . . . . 5.68 110.753 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 56.4 tp -99.38 -70.78 0.72 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 6.27 110.997 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -164.12 169.11 18.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.966 0.412 . . . . 6.52 111.202 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' A' ' 55' ' ' ALA . 40.6 t -126.94 143.14 51.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.939 -0.573 . . . . 3.59 110.516 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.9 tp -111.83 -22.57 11.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.164 -0.471 . . . . 3.23 110.916 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.26 -47.59 81.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.253 -0.43 . . . . 1.88 111.247 -179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.4 m80 -70.05 -25.14 63.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.894 0.378 . . . . 1.29 110.807 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.423 ' O ' HG12 ' A' ' 12' ' ' VAL . 64.0 t-105 -70.38 -49.36 49.88 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.083 -0.508 . . . . 0.99 110.95 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.1 pt -67.5 -19.69 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.9 0.381 . . . . 1.92 110.566 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -63.42 -59.24 4.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.946 -0.57 . . . . 1.45 110.458 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.423 HG12 ' O ' ' A' ' 9' ' ' TRP . 7.3 p -57.09 -34.72 45.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.89 110.949 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -42.92 96.24 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.136 -0.484 . . . . 0.9 110.868 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.39 -18.17 67.22 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.669 -0.777 . . . . 0.83 111.935 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 18.4 mmt -78.76 -35.59 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.606 0.241 . . . . 1.24 111.147 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 61.1 p -63.15 -50.81 68.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.198 0.523 . . . . 1.29 110.3 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.13 -24.2 33.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.786 -0.643 . . . . 1.71 110.432 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.64 -33.1 79.9 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.8 -0.714 . . . . 0.96 112.028 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.06 -47.41 65.37 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.859 0.362 . . . . 0.99 110.424 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.65 -37.51 84.31 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.023 -0.535 . . . . 2.11 110.124 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 32.5 t-80 -59.49 -37.77 79.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.875 -0.602 . . . . 2.23 110.499 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.451 ' HZ ' ' HB3' ' A' ' 36' ' ' GLU . 36.1 t80 -68.21 -30.63 69.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.107 -0.497 . . . . 4.02 110.466 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 59.4 t90 -60.41 -33.22 72.19 Favored 'General case' 0 CA--C 1.52 -0.181 0 N-CA-C 109.513 -0.551 . . . . 3.96 109.513 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 49.1 m -83.91 -20.38 33.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.591 -0.731 . . . . 2.38 109.972 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 22' ' ' PHE . 69.5 mt -77.92 -0.46 27.63 Favored 'General case' 0 C--O 1.226 -0.157 0 CA-C-N 115.769 -0.65 . . . . 2.77 110.995 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.979 ' OG ' ' HA ' ' A' ' 32' ' ' VAL . 33.6 t -56.15 -32.6 64.44 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.527 -0.469 . . . . 2.52 111.353 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 27.3 tpt180 -40.14 -29.12 0.07 Allowed 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.914 0.864 . . . . 5.54 109.252 178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.88 ' HB3' ' HD2' ' A' ' 29' ' ' PRO . 14.8 m-20 -66.48 -155.48 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.425 0 CA-C-N 113.949 -1.478 . . . . 4.44 108.524 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.88 ' HD2' ' HB3' ' A' ' 28' ' ' ASN . 75.5 Cg_exo -7.12 114.8 0.0 OUTLIER 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 124.212 3.274 . . . . 2.81 116.819 -176.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 38.5 mmt180 41.92 32.13 0.26 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 114.494 -1.23 . . . . 6.8 113.99 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 26' ' ' SER . . . 74.3 -47.4 1.68 Allowed Glycine 0 C--O 1.229 -0.204 0 C-N-CA 120.535 -0.841 . . . . 4.97 112.035 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.979 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 1.8 p -139.36 107.5 7.25 Favored Pre-proline 0 N--CA 1.45 -0.448 0 N-CA-C 109.927 -0.397 . . . . 4.71 109.927 177.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.596 ' HB3' ' HB2' ' A' ' 29' ' ' PRO . 86.0 Cg_endo -83.78 118.48 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 121.397 1.398 . . . . 3.51 113.106 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -81.55 -25.14 36.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.133 -1.062 . . . . 3.41 108.133 176.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.532 ' HD1' ' H ' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -82.96 -64.28 1.2 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.262 -1.79 . . . . 2.81 112.413 -178.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.532 ' H ' ' HD1' ' A' ' 35' ' ' TYR . 11.0 mm-40 -52.78 -39.2 62.09 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.06 -0.518 . . . . 3.39 111.78 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -57.92 -36.89 73.11 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.854 0.359 . . . . 5.24 110.876 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.13 -63.87 1.04 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.307 -0.406 . . . . 1.6 111.283 -179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.96 -40.76 86.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.431 . . . . 1.33 112.122 -178.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.2 -12.62 61.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.611 -0.268 . . . . 1.03 111.67 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.1 ttt -89.18 -41.5 12.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.618 -0.265 . . . . 2.0 111.491 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -72.83 -41.07 65.25 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.86 0.689 . . . . 1.31 112.86 -178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 44' ' ' PRO . 92.1 mt -53.6 -49.96 85.89 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 113.027 0.751 . . . . 1.0 113.027 -178.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 43' ' ' ILE . 73.4 Cg_endo -72.92 -46.18 0.42 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.382 2.055 . . . . 0.59 113.661 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 38.6 mm -52.5 -57.63 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.119 0.414 . . . . 1.63 112.119 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -60.28 -55.28 35.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.745 0.307 . . . . 1.12 111.217 -179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 99.6 p -54.57 -26.17 30.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.223 -0.444 . . . . 1.32 111.472 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.48 -60.82 5.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.806 -0.712 . . . . 0.52 112.819 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.484 HD22 ' SG ' ' B' ' 134' ' ' CYS . 67.2 mt -56.4 -26.06 52.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.715 0.293 . . . . 0.98 111.325 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.27 -58.13 7.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.908 0.385 . . . . 0.52 110.926 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 32.2 m-85 -61.86 -39.15 90.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.175 -0.466 . . . . 1.69 110.767 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 59.1 ttp -52.89 -35.54 58.17 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.971 0.415 . . . . 1.12 110.085 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.3 -41.22 85.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.776 -0.647 . . . . 0.6 110.732 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 47.2 mtt -55.85 -26.19 45.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.94 110.206 179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.616 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -75.17 -41.98 56.93 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.819 -0.628 . . . . 0.78 110.396 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 56' ' ' ILE . 19.0 mt -77.58 -0.93 3.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.891 -0.595 . . . . 1.23 110.546 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 60.96 28.39 18.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.766 -0.652 . . . . 2.02 110.915 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -107.28 149.17 28.08 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.019 -0.537 . . . . 2.1 110.802 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 100.71 13.72 33.99 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.694 -0.765 . . . . 1.27 112.457 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -122.51 157.79 31.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 1.76 110.615 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.5 m -117.57 144.63 24.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.315 -0.402 . . . . 1.84 111.17 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -107.32 121.75 45.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.218 -0.446 . . . . 2.64 111.132 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -142.26 120.5 12.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.104 -0.498 . . . . 1.84 111.029 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.36 39.09 22.65 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.128 -0.487 . . . . 2.24 111.166 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.41 22.9 73.32 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.905 -0.664 . . . . 2.16 112.927 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -127.02 145.79 50.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.905 0.383 . . . . 2.84 110.982 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.5 pt -108.37 139.09 32.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.078 -0.51 . . . . 2.39 111.36 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -104.3 143.56 32.8 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.118 -0.492 . . . . 0.97 111.19 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.617 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 87.1 m-70 -85.43 60.71 6.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.3 0.572 . . . . 1.04 110.808 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' O ' HG12 ' A' ' 74' ' ' ILE . 55.9 t80 -60.69 -54.96 39.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.314 -0.857 . . . . 3.38 111.265 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.49 -22.55 65.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.227 -0.442 . . . . 0.76 112.175 -179.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.617 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 0.1 OUTLIER -66.62 -51.62 54.2 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.085 0.402 . . . . 2.93 112.085 -179.009 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.435 ' CD1' ' HG ' ' A' ' 117' ' ' LEU . 8.8 p90 -76.02 -30.35 58.44 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.759 -0.377 . . . . 3.13 111.627 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 70' ' ' TYR . 24.5 mm -53.8 -49.34 58.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.758 0.314 . . . . 1.66 110.673 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' A' ' 47' ' ' SER . 34.2 t70 -64.32 -19.19 65.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.474 . . . . 1.42 110.278 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.426 ' CE3' ' HA ' ' A' ' 73' ' ' TYR . 22.4 m0 -90.1 5.45 46.72 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 116.084 -0.507 . . . . 2.09 111.613 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' A' ' 73' ' ' TYR . 35.1 mtp -105.18 -18.58 14.09 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.883 0.373 . . . . 1.52 110.661 179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' O ' HD23 ' A' ' 82' ' ' LEU . 26.9 m -113.84 -33.08 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.96 -0.564 . . . . 1.33 111.872 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 83' ' ' LEU . 75.1 m -84.71 -36.82 21.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.51 -0.314 . . . . 1.39 111.62 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.623 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 49.5 m -62.64 -51.37 72.84 Favored Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.366 -0.379 . . . . 1.55 111.984 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 31.7 Cg_exo -59.29 -41.81 55.56 Favored 'Trans proline' 0 C--N 1.351 0.681 0 C-N-CA 122.085 1.856 . . . . 1.01 112.137 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -76.12 -11.5 59.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.48 . . . . 1.45 110.784 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 79' ' ' THR . 0.1 OUTLIER -75.41 -38.93 59.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.222 -0.445 . . . . 1.3 110.689 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.489 HD12 ' N ' ' A' ' 85' ' ' LEU . 4.0 pp -84.27 -24.15 30.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.211 -0.449 . . . . 1.67 110.882 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.489 ' N ' HD12 ' A' ' 84' ' ' LEU . 58.1 mt -70.44 -32.14 69.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.202 -0.454 . . . . 1.87 110.851 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -69.91 -34.61 73.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.07 -0.514 . . . . 1.42 110.347 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 74.8 mt -69.02 -45.14 71.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.963 -0.562 . . . . 1.4 110.366 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 55.0 m -63.38 -24.57 67.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.939 -0.573 . . . . 1.91 110.605 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -84.56 -32.36 23.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.048 -0.524 . . . . 2.33 110.655 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 59.8 m -63.04 -44.25 96.4 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 1.43 111.003 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.12 -32.54 50.5 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.084 -0.507 . . . . 1.19 111.119 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 84.2 mtp -103.76 90.4 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 2.55 111.295 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -69.56 -10.7 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.198 -0.455 . . . . 3.33 110.891 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -139.7 142.63 36.89 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.196 -0.456 . . . . 5.1 110.841 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 49.0 mm -105.36 142.5 18.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 3.07 111.005 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -109.19 168.83 9.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 4.41 110.931 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -84.25 54.49 2.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.058 -0.519 . . . . 5.31 111.019 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -167.45 81.4 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.209 -0.45 . . . . 3.94 110.91 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 10.0 m-90 -80.25 87.26 5.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.025 -0.534 . . . . 5.98 110.617 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.3 m -108.31 -56.33 2.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.299 -0.409 . . . . 2.24 111.398 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 101' ' ' LEU . 3.5 mm? -58.1 -41.86 84.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.239 -0.437 . . . . 2.67 110.97 -179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.6 -25.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.098 -0.501 . . . . 2.59 111.252 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.473 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -69.26 -46.92 55.37 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.625 -0.798 . . . . 1.53 112.822 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -63.36 -32.39 73.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.756 0.312 . . . . 3.14 111.412 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.8 mt -76.93 -44.68 30.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.961 0.41 . . . . 1.99 110.933 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 40.8 tpp -64.47 -36.54 84.51 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.876 -0.602 . . . . 2.36 111.36 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.517 ' HB2' ' HB2' ' C' ' 42' ' ' PHE . 73.6 p -63.86 -59.46 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.051 0.453 . . . . 2.05 110.927 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.481 HG21 HD13 ' A' ' 142' ' ' ILE . 57.0 p -56.88 -30.86 64.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.002 -0.544 . . . . 2.25 111.117 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . 0.464 ' HG2' HD21 ' A' ' 84' ' ' LEU . 7.6 tp-100 -60.4 -49.34 77.98 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.296 -0.411 . . . . 2.72 110.789 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.4 mm -55.05 -36.39 38.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 1.88 110.957 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.0 t -71.31 -38.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.122 -0.49 . . . . 1.6 111.015 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 108' ' ' THR . 87.2 t -68.22 -44.0 84.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.063 -0.517 . . . . 1.09 111.28 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.9 mt -58.77 -50.96 77.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.321 -0.4 . . . . 2.65 110.633 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 99.6 m -49.18 -43.15 41.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.165 -0.471 . . . . 0.89 110.948 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 49.1 m -55.9 -42.39 75.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.68 110.42 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -66.2 -33.61 85.72 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.921 -0.657 . . . . 0.63 112.618 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.435 ' HG ' ' CD1' ' A' ' 73' ' ' TYR . 11.0 mp -54.27 -61.39 2.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.801 0.334 . . . . 1.58 110.914 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' HA ' ' HB2' ' A' ' 121' ' ' LEU . 39.1 mm -70.91 -27.48 30.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.019 -0.537 . . . . 2.04 111.368 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -51.51 -41.15 60.79 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.959 0.409 . . . . 1.1 110.581 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -94.2 -24.77 17.36 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 1.88 110.406 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' HB2' ' HA ' ' A' ' 118' ' ' ILE . 94.7 mt -88.28 26.91 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 1.53 111.025 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 78.3 p -92.51 118.72 31.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.15 -0.477 . . . . 2.29 110.546 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -72.88 -54.44 8.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 3.49 110.964 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.519 ' HB2' HG12 ' A' ' 127' ' ' VAL . 71.1 mtp180 -79.02 139.44 38.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.395 . . . . 3.13 110.872 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -82.33 -13.24 57.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.189 -0.46 . . . . 3.71 111.027 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . . . . . . . . . 47.0 t-105 -79.27 -47.59 15.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 3.97 111.03 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.519 HG12 ' HB2' ' A' ' 124' ' ' ARG . 13.4 p -67.85 -24.34 30.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 1.22 111.377 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.476 ' HD3' ' HZ3' ' A' ' 183' ' ' TRP . 30.3 ttm180 -55.82 -32.94 64.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.128 -0.487 . . . . 2.81 111.223 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -69.95 -26.68 64.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.382 -0.372 . . . . 4.25 111.082 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 88.0 mt -81.25 -46.22 15.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 1.84 111.13 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -61.14 -39.62 90.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 1.54 111.249 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -56.42 -38.98 72.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.256 -0.429 . . . . 1.79 111.039 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -71.79 -27.74 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.331 -0.395 . . . . 2.08 111.142 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 77.7 m -66.13 -45.79 79.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.76 110.952 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.07 -53.09 39.28 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.963 -0.637 . . . . 0.76 112.811 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -58.43 -29.49 38.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.677 0.275 . . . . 2.07 111.525 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . . . . . . . . . 50.2 t -61.62 -51.39 68.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.442 -0.344 . . . . 1.85 111.025 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -59.62 -32.34 70.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.214 -0.448 . . . . 1.32 111.135 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -71.62 -30.13 65.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.052 -0.522 . . . . 3.25 111.016 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.09 -48.76 64.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.253 -0.431 . . . . 2.92 111.418 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 20.6 mt -56.16 -56.91 10.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.913 0.387 . . . . 2.65 111.197 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.481 HD13 HG21 ' A' ' 108' ' ' THR . 7.6 tp -59.54 -31.31 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.049 -0.523 . . . . 3.21 111.46 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 32.9 tp -54.59 -56.84 14.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.909 0.385 . . . . 2.01 110.88 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -62.74 -23.24 67.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.243 -0.435 . . . . 3.6 110.637 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.614 ' HA2' ' HG2' ' A' ' 149' ' ' PRO . . . -83.61 -18.91 62.89 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.924 -0.655 . . . . 1.62 113.026 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.1 pt -104.72 0.59 10.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.744 0.272 . . . . 2.47 111.41 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -93.92 -53.23 4.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 2.48 111.458 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 149' ' ' PRO . 5.7 t30 -99.94 -53.95 0.17 Allowed Pre-proline 0 CA--C 1.536 0.441 0 N-CA-C 112.214 0.45 . . . . 2.69 112.214 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.618 ' HD3' ' HB3' ' A' ' 148' ' ' ASN . 34.1 Cg_exo -58.58 -21.06 53.02 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 121.987 1.791 . . . . 2.36 112.843 -179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 45.8 tp -75.41 111.17 10.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.3 110.915 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.404 ' HB3' ' HB ' ' A' ' 154' ' ' THR . 40.9 mmt180 56.96 57.93 4.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.988 -0.551 . . . . 8.48 111.193 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.82 -41.9 18.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.299 -0.41 . . . . 2.98 110.755 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -86.25 -6.28 59.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.934 -0.575 . . . . 4.55 110.822 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 151' ' ' ARG . 8.4 m -89.24 -14.44 35.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.067 -0.515 . . . . 4.0 111.096 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 76.7 mtp180 -59.93 -25.92 65.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.343 -0.389 . . . . 5.51 110.719 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 6.1 t -104.97 -14.88 15.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.146 -0.479 . . . . 3.2 111.138 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -80.51 -42.08 23.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 3.98 110.833 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -159.32 113.41 2.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.034 -0.53 . . . . 2.63 110.575 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 -20.68 54.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.148 -0.478 . . . . 2.16 111.163 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -63.44 -62.32 1.75 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 3.37 111.125 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 tp -59.72 -38.41 81.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 2.83 111.394 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -62.88 -39.74 95.38 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 1.7 111.652 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -70.05 -40.18 75.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.426 . . . . 2.16 111.313 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 94.2 mt -64.12 -56.42 14.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 1.59 111.194 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.08 -27.83 47.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 2.31 111.289 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -64.37 -48.64 74.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.456 -0.338 . . . . 2.15 110.994 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -71.77 -29.16 64.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.282 -0.417 . . . . 2.39 111.282 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -67.97 -63.79 0.99 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.966 0.413 . . . . 1.79 111.379 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 9.2 p -53.48 -20.6 3.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 1.42 111.84 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 52.3 m -59.51 -58.9 6.56 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.721 0.296 . . . . 1.12 111.238 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -62.23 -31.87 72.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 3.86 110.775 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -70.01 -26.43 64.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 1.58 110.838 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 96.9 m -79.5 -46.67 16.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 1.41 111.355 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 13.2 p -66.07 -28.66 44.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.333 -0.394 . . . . 1.42 111.565 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 58.1 tp -74.27 -56.52 4.79 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.434 -0.348 . . . . 1.91 111.12 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -28.02 58.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.272 -0.422 . . . . 1.55 110.814 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.479 ' C ' ' HD2' ' A' ' 180' ' ' PRO . 98.1 mt -87.56 -22.54 6.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.262 -0.427 . . . . 1.86 110.263 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.442 ' HA2' HD12 ' A' ' 181' ' ' ILE . . . -57.4 -52.04 54.09 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.059 -0.591 . . . . 0.74 112.714 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.59 ' O ' HG22 ' A' ' 182' ' ' VAL . 68.4 m-85 -54.03 -55.79 32.57 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 121.01 -0.276 . . . . 1.78 110.959 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.585 ' HD3' ' HB2' ' A' ' 179' ' ' TYR . 88.6 Cg_exo -45.98 -38.39 18.56 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 121.955 1.77 . . . . 0.92 112.371 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 177' ' ' ILE . 96.2 mt -54.5 -52.91 35.68 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.233 0 CA-C-O 120.967 0.413 . . . . 1.77 111.216 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 179' ' ' TYR . 1.3 m -58.16 -25.02 25.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.981 -0.554 . . . . 1.34 111.132 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . 0.476 ' HZ3' ' HD3' ' A' ' 128' ' ' ARG . 83.1 m95 -80.82 -21.38 40.9 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.296 -0.411 . . . . 2.51 111.305 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 42.9 mm -53.49 -54.66 17.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.347 -0.388 . . . . 2.02 111.541 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 187' ' ' PRO . 17.8 pt -69.22 174.83 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.954 0.407 . . . . 2.45 111.331 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 191' ' ' GLY . . . -58.93 -50.92 62.6 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.974 -0.632 . . . . 1.73 113.211 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.614 ' HD3' ' H ' ' A' ' 192' ' ' TRP . 25.3 Cg_exo -35.49 151.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 123.292 2.661 . . . . 3.05 112.633 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.8 t 64.88 14.03 8.95 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 108.917 -0.772 . . . . 4.04 108.917 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 176.94 51.71 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 115.015 -0.993 . . . . 4.48 112.26 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 60.8 t80 63.39 95.65 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.954 0.407 . . . . 7.96 110.888 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 186' ' ' GLY . . . -158.05 -135.09 1.83 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.904 -0.665 . . . . 3.23 112.199 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . 0.614 ' H ' ' HD3' ' A' ' 187' ' ' PRO . 53.8 t-105 -72.6 -38.22 67.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.896 0.379 . . . . 6.03 110.717 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 197' ' ' ILE . 17.7 mt -139.05 148.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.077 -0.51 . . . . 3.18 111.107 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.451 HD21 ' H ' ' A' ' 191' ' ' GLY . 41.9 m-80 -141.63 166.4 24.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.304 -0.407 . . . . 3.39 111.478 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 22.0 mt-30 64.12 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.677 -0.692 . . . . 5.76 112.001 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 85.7 m -53.38 -61.29 2.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.327 -0.397 . . . . 2.5 111.964 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.477 HD12 HD12 ' A' ' 193' ' ' ILE . 17.1 tt -56.36 -31.2 32.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 2.4 111.867 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -69.85 -45.81 66.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.475 -0.33 . . . . 2.66 111.43 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 66.5 p -79.32 -21.99 45.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.418 -0.356 . . . . 1.81 111.934 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -83.56 -57.39 3.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.762 0.315 . . . . 2.21 111.779 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.1 -46.32 90.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 2.18 111.94 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -69.57 -4.14 17.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.726 0.298 . . . . 2.01 111.54 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 206' ' ' PRO . 47.4 t -96.18 -48.91 5.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.198 0.523 . . . . 1.93 110.485 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.456 ' O ' HD13 ' A' ' 204' ' ' LEU . 0.5 OUTLIER -70.33 -41.68 72.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.589 -0.732 . . . . 1.7 111.591 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.55 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 1.0 OUTLIER -51.3 -55.04 32.06 Favored Pre-proline 0 CA--C 1.533 0.327 0 CA-C-N 116.738 -0.21 . . . . 1.28 111.44 -179.19 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 52.9 Cg_exo -56.29 -44.54 45.36 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 121.704 1.603 . . . . 0.79 111.339 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -60.54 -24.46 65.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 1.51 110.031 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -82.2 -28.34 32.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.961 -0.563 . . . . 1.93 110.45 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 99.5 p -79.14 -37.06 39.46 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.002 -0.544 . . . . 1.71 110.788 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -67.65 -51.62 47.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.299 -0.41 . . . . 2.04 110.826 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 84.1 t -63.8 -30.95 51.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.191 -0.459 . . . . 2.89 110.807 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.73 -36.58 92.02 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.679 -0.772 . . . . 1.31 112.085 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.22 -40.88 91.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.712 0.292 . . . . 2.87 110.666 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 43.6 t -56.87 -56.45 21.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 2.38 110.81 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -65.16 -20.72 66.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.058 -0.519 . . . . 3.42 110.288 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 tt -77.73 -33.9 52.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.729 -0.669 . . . . 1.24 110.769 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -73.51 -24.89 60.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.308 -0.405 . . . . 2.44 110.937 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.51 -59.19 2.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 2.51 111.147 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -78.4 -21.19 49.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.263 -0.426 . . . . 3.01 111.634 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -69.06 -59.55 5.81 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.564 -0.827 . . . . 1.59 112.846 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 92.3 mt -78.77 -57.13 3.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.598 0.237 . . . . 3.49 111.107 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 55.03 64.26 1.86 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.952 0.406 . . . . 5.74 110.561 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -96.6 134.92 39.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.022 -0.536 . . . . 5.46 110.928 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.8 tp -84.16 128.73 34.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.086 -0.506 . . . . 6.13 111.029 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -77.1 134.2 38.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 6.46 110.704 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -151.41 128.73 11.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 6.94 110.874 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 44.3 t -120.73 111.53 17.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.186 -0.461 . . . . 6.83 110.928 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -99.03 -25.55 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 10.77 110.759 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.214 -0.898 . . . . 9.41 110.953 179.901 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.699 0.285 . . . . 8.91 110.792 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -168.1 148.54 4.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 6.76 111.057 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . 0.456 ' N ' HD12 ' B' ' 3' ' ' LEU . 6.8 mp -100.01 138.76 36.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.238 -0.437 . . . . 6.25 110.858 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -81.55 -4.99 57.53 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.153 -0.476 . . . . 5.44 111.0 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -148.03 99.21 3.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.437 . . . . 3.84 110.939 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 79.7 mt -93.07 178.36 5.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.111 -0.495 . . . . 3.08 110.874 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . . . . . . . . . 72.4 mt -60.82 -40.5 93.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 2.35 110.587 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.453 ' HB3' ' O ' ' B' ' 51' ' ' TYR . 36.0 m80 -70.15 -23.73 63.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 1.39 110.763 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -73.43 -38.84 65.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.101 0.476 . . . . 1.1 110.333 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 53.6 mt -75.4 -21.45 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.747 -0.66 . . . . 1.71 110.414 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -66.04 -55.24 17.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.705 -0.68 . . . . 1.48 110.472 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.3 p -60.7 -35.45 64.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.068 -0.514 . . . . 0.95 110.845 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.18 -35.17 80.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.97 111.042 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -73.11 -24.39 75.81 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.834 -0.698 . . . . 0.8 112.247 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.76 -29.88 56.3 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.706 0.289 . . . . 1.29 111.217 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 82.3 p -72.17 -55.92 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.906 0.384 . . . . 1.36 110.733 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -59.6 -23.81 26.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.11 -0.495 . . . . 1.23 110.567 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.97 -43.34 82.72 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.804 -0.712 . . . . 0.88 112.178 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.98 -37.46 79.7 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.811 0.338 . . . . 0.98 110.617 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -62.46 -41.72 98.97 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.05 -0.523 . . . . 2.12 110.499 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -54.11 -30.87 50.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.936 -0.574 . . . . 2.0 110.122 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' B' ' 25' ' ' LEU . 4.0 t80 -69.36 -35.33 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.926 -0.579 . . . . 4.26 110.198 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 58.3 t90 -56.9 -31.91 65.37 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.427 -0.583 . . . . 3.62 109.427 178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . . . . . . . . . 50.7 m -85.38 -19.82 30.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.638 -0.71 . . . . 2.55 110.557 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' B' ' 22' ' ' PHE . 28.5 mt -65.41 2.51 0.87 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.906 -0.588 . . . . 3.11 112.026 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . . . . . . . . . 29.3 t -46.53 -22.64 0.29 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 111.748 0.277 . . . . 3.02 111.748 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -47.98 -29.86 3.8 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 122.149 0.975 . . . . 5.89 108.639 178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.829 ' HB3' ' HD2' ' B' ' 29' ' ' PRO . 7.7 m120 -66.29 -153.97 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.142 0 CA-C-N 113.506 -1.679 . . . . 5.02 108.451 177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.829 ' HD2' ' HB3' ' B' ' 28' ' ' ASN . 33.4 Cg_exo -4.17 -77.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.376 1.986 0 C-N-CA 123.356 2.704 . . . . 3.53 115.909 -176.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 73.2 ttt180 53.0 53.7 11.62 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 108.804 -0.813 . . . . 7.88 108.804 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.07 0.2 8.95 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 114.937 -1.029 . . . . 4.61 110.834 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.519 HG13 ' HD2' ' B' ' 33' ' ' PRO . 1.2 t -112.77 156.07 43.07 Favored Pre-proline 0 CA--C 1.53 0.176 0 CA-C-N 115.433 -0.383 . . . . 4.73 110.301 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' HG13 ' B' ' 32' ' ' VAL . 34.2 Cg_exo -35.9 131.33 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.234 2.623 . . . . 3.75 114.03 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . 0.447 ' O ' ' N ' ' B' ' 36' ' ' GLU . 4.2 pt20 -76.9 -12.5 59.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.672 -1.149 . . . . 3.76 111.55 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.585 ' HD1' ' N ' ' B' ' 36' ' ' GLU . 0.0 OUTLIER -38.36 -22.69 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.767 1.025 . . . . 3.17 113.767 -177.883 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . 0.585 ' N ' ' HD1' ' B' ' 35' ' ' TYR . 10.4 tp10 -68.88 -49.31 59.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.765 0.316 . . . . 2.57 110.602 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -65.61 -35.06 79.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.138 -0.483 . . . . 5.74 111.174 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 41.1 tp -53.26 -65.44 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 1.72 111.626 -179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 t -66.28 -42.09 90.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.371 -0.377 . . . . 1.95 111.581 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -65.19 -11.23 38.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.475 -0.33 . . . . 1.2 111.863 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.97 -41.68 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.787 0.327 . . . . 2.12 111.357 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 55.9 t80 -72.38 -27.64 62.5 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.512 0.56 . . . . 1.49 112.512 -178.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.445 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 85.2 mt -61.87 -52.91 64.86 Favored Pre-proline 0 CA--C 1.536 0.435 0 N-CA-C 112.432 0.53 . . . . 0.77 112.432 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' B' ' 43' ' ' ILE . 60.1 Cg_endo -72.15 -39.22 3.18 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 122.252 1.968 . . . . 0.68 113.746 -179.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.484 HG22 HG11 ' C' ' 111' ' ' VAL . 91.3 mt -56.84 -62.87 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.15 0.426 . . . . 1.63 112.15 -179.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . 0.508 ' HE1' HG22 ' C' ' 110' ' ' ILE . 1.6 t90 -57.42 -53.55 56.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.79 0.328 . . . . 1.91 110.931 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 50.7 m -54.79 -23.75 19.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.59 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.18 -41.85 45.38 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.572 -0.823 . . . . 0.55 112.748 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 85.8 mt -66.75 -32.31 73.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.687 0.279 . . . . 0.87 111.333 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.24 -59.51 4.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.414 -0.357 . . . . 0.55 111.388 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . 0.453 ' O ' ' HB3' ' B' ' 8' ' ' HIS . 31.5 m-85 -60.79 -44.94 96.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.386 -0.37 . . . . 1.06 111.27 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 59.5 ttp -48.18 -38.87 19.19 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.141 0.496 . . . . 1.19 110.167 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.73 -44.08 94.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.702 -0.681 . . . . 0.66 111.034 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . . . . . . . . . 52.1 mtt -50.61 -35.62 31.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.988 -0.551 . . . . 0.86 110.319 179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -65.69 -41.13 92.77 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.909 -0.587 . . . . 0.84 110.36 179.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 7.2 mm -78.98 0.29 3.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.999 -0.546 . . . . 1.44 110.268 179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.53 39.88 14.28 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 115.644 -0.707 . . . . 1.55 111.067 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -119.77 163.31 17.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 2.24 111.041 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 89.88 14.92 58.72 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.831 -0.7 . . . . 1.26 112.456 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 8.3 ptpp? -129.59 152.24 49.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.766 0.317 . . . . 2.31 110.917 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 11.9 p -117.45 143.43 27.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.347 -0.388 . . . . 1.81 111.305 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -102.44 143.58 31.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.091 -0.504 . . . . 3.18 110.807 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -156.32 111.63 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.315 -0.402 . . . . 2.03 111.259 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 21.92 10.2 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.022 -0.535 . . . . 2.48 111.52 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.24 22.07 39.24 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.679 -0.772 . . . . 2.37 112.712 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -120.17 126.11 49.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.848 0.356 . . . . 2.28 110.838 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 36.3 mt -89.25 134.93 27.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 1.78 110.964 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.08 140.99 39.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 1.05 111.215 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' B' ' 72' ' ' ARG . 45.7 m-70 -88.73 60.14 5.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 1.11 110.852 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.475 ' HD1' ' HH ' ' B' ' 73' ' ' TYR . 69.1 t80 -63.03 -39.08 93.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.603 -0.726 . . . . 2.3 111.64 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.473 ' O ' HG22 ' B' ' 74' ' ' ILE . . . -76.6 -22.25 54.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.016 0.376 . . . . 0.72 112.016 -179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.486 ' NH2' HG23 ' B' ' 199' ' ' THR . 14.2 tpp180 -67.8 -51.15 52.06 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.061 0.393 . . . . 3.04 112.061 -178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.475 ' HH ' ' HD1' ' B' ' 70' ' ' TYR . 9.2 p90 -83.1 -23.94 32.84 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 112.485 0.55 . . . . 1.79 112.485 -178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.473 HG22 ' O ' ' B' ' 71' ' ' ALA . 17.9 tt -60.25 -41.32 86.51 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 C-N-CA 120.198 -0.601 . . . . 1.44 109.42 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -72.95 -14.4 61.44 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.024 -0.732 . . . . 1.31 109.024 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' B' ' 73' ' ' TYR . 42.0 m0 -89.77 2.05 55.36 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.357 -0.838 . . . . 2.01 111.235 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.577 ' SD ' HD21 ' B' ' 117' ' ' LEU . 97.3 mmm -104.78 -20.05 13.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.002 -0.545 . . . . 1.43 111.185 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 27.3 m -113.64 -31.86 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.931 -0.577 . . . . 1.21 111.967 -178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . . . . . . . . . 61.0 m -84.58 -35.3 22.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.39 -0.368 . . . . 1.18 111.582 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.628 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 86.9 m -64.36 -52.1 56.11 Favored Pre-proline 0 CA--C 1.532 0.264 0 N-CA-C 111.717 0.266 . . . . 1.65 111.717 -179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 32.3 Cg_exo -58.42 -30.24 90.82 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 121.818 1.679 . . . . 1.06 111.66 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -84.11 -23.3 30.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.955 -0.566 . . . . 1.58 110.665 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.38 -29.83 61.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.204 0.526 . . . . 1.49 109.98 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . . . . . . . . . 3.8 tt -84.13 -36.93 22.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 1.72 110.318 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.463 ' HG ' ' NE1' ' B' ' 89' ' ' TRP . 20.5 tp -66.67 -40.84 88.77 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.403 -0.817 . . . . 1.96 111.441 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 65.8 m -55.46 -38.25 68.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.454 -0.339 . . . . 1.24 111.053 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . 0.457 ' HB3' HD21 ' B' ' 168' ' ' LEU . 41.8 mt -63.04 -32.44 73.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.109 -0.496 . . . . 1.21 110.844 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.5 m -71.72 -45.36 62.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 1.32 111.178 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . 0.463 ' NE1' ' HG ' ' B' ' 85' ' ' LEU . 93.8 m95 -63.58 -28.68 70.09 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.294 -0.412 . . . . 2.15 111.094 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 46.8 m -72.17 -36.88 69.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.116 -0.493 . . . . 1.44 111.401 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.3 -17.79 31.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.335 -0.393 . . . . 1.05 111.615 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 66.1 mtm -125.41 103.16 7.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.803 0.335 . . . . 2.68 111.015 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.9 pt20 -77.25 -12.69 59.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.14 -0.482 . . . . 2.71 110.804 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -137.63 147.44 44.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.115 -0.493 . . . . 4.19 110.703 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 19.6 tt -115.72 145.15 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.2 -0.455 . . . . 2.79 111.109 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 52.1 mttp -104.07 -169.68 1.66 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.147 -0.479 . . . . 5.27 111.144 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -74.43 -58.62 3.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.072 -0.513 . . . . 5.57 111.006 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -52.96 132.9 38.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.027 -0.533 . . . . 4.24 111.437 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . 0.54 ' HB2' HD11 ' B' ' 102' ' ' ILE . 28.4 p-90 -120.74 21.6 11.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.029 -0.532 . . . . 5.39 110.656 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 80.5 p -66.5 -36.33 82.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.077 -0.51 . . . . 2.16 111.156 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 75.7 mt -62.19 -55.6 27.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.031 -0.532 . . . . 2.58 110.865 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' B' ' 99' ' ' TRP . 46.8 pt -66.62 -27.74 41.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.262 -0.426 . . . . 2.29 111.107 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . . . . . . . . . . . -68.4 -22.74 74.95 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.684 -0.769 . . . . 1.48 112.104 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -82.04 -40.09 22.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.915 0.388 . . . . 2.76 110.699 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . . . . . . . . . 65.1 mt -75.27 -36.98 61.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.941 -0.572 . . . . 2.22 111.207 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 59.2 mtt -72.0 -41.05 68.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 2.36 110.911 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.9 p -54.28 -56.21 20.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 1.92 110.683 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.554 HG21 HG12 ' B' ' 142' ' ' ILE . 38.5 m -60.54 -35.69 76.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.053 -0.521 . . . . 2.06 111.065 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.521 HE21 HG23 ' B' ' 113' ' ' ILE . 23.6 tp60 -58.19 -39.69 79.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.234 -0.439 . . . . 2.87 111.028 -179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 81.3 mt -64.47 -40.04 87.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.347 -0.388 . . . . 1.98 111.209 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 29.8 t -68.97 -34.59 64.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 1.62 111.216 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . 0.419 HG23 ' O ' ' B' ' 108' ' ' THR . 74.9 t -69.26 -52.93 28.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 1.04 111.533 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . 0.521 HG23 HE21 ' B' ' 109' ' ' GLN . 36.2 pt -58.54 -29.78 39.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.422 -0.353 . . . . 2.46 111.145 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -60.91 -54.41 45.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.837 0.351 . . . . 0.83 110.628 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 51.8 m -56.34 -31.57 63.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.079 -0.51 . . . . 0.74 110.41 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.684 ' HA2' H173 ' B' ' 301' ' ' RET . . . -65.3 -32.08 82.57 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.873 -0.68 . . . . 0.6 112.013 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.577 HD21 ' SD ' ' B' ' 77' ' ' MET . 34.7 mt -64.3 -57.31 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.045 0.45 . . . . 1.42 110.558 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' HB2' ' B' ' 121' ' ' LEU . 23.6 mm -66.6 -31.18 52.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.529 -0.759 . . . . 1.51 111.591 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -54.36 -42.78 70.68 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.96 0.41 . . . . 1.09 111.073 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -87.59 -25.12 23.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.116 -0.493 . . . . 2.25 110.826 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . 0.524 ' HB2' ' HA ' ' B' ' 118' ' ' ILE . 53.2 mt -75.63 -9.87 58.96 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.281 -0.418 . . . . 1.16 111.03 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 42.2 t -60.48 120.07 9.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 1.76 110.946 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -84.28 -34.06 23.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.055 -0.52 . . . . 2.89 111.163 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . 0.552 ' HB2' HG12 ' B' ' 127' ' ' VAL . 49.4 mtm180 -102.59 132.0 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 2.67 110.938 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.54 -14.32 62.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.011 -0.541 . . . . 3.25 111.178 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 68.2 t-105 -79.47 -42.77 24.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.398 -0.365 . . . . 4.07 111.024 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . 0.552 HG12 ' HB2' ' B' ' 124' ' ' ARG . 14.0 p -76.93 -26.75 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.895 0.379 . . . . 1.41 110.958 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' B' ' 128' ' ' ARG . 44.6 ttp180 -61.91 -29.76 70.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 2.47 110.802 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -64.16 -31.6 72.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 2.61 110.593 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 65.2 tp -79.69 -48.36 13.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.984 -0.553 . . . . 2.07 111.251 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 4.1 m95 -58.24 -33.18 69.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.811 0.338 . . . . 1.3 110.774 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -59.16 -37.3 76.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.095 -0.502 . . . . 1.75 110.501 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 44.2 mm -68.55 -35.45 70.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.173 -0.467 . . . . 1.67 110.977 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . 0.484 ' SG ' HD22 ' A' ' 49' ' ' LEU . 21.1 t -64.03 -44.78 91.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 1.54 111.116 -179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.66 -58.84 12.49 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.782 -0.723 . . . . 0.7 112.714 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . 0.459 ' O ' ' HG ' ' B' ' 140' ' ' LEU . 6.3 p -59.75 -36.96 69.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.612 0.244 . . . . 1.44 111.345 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . 0.407 ' HA ' HD12 ' B' ' 140' ' ' LEU . 42.3 t -50.22 -51.43 44.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.314 -0.403 . . . . 1.82 110.979 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.04 74.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.909 0.385 . . . . 0.94 111.018 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -73.76 -19.79 60.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 1.6 110.899 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 136' ' ' VAL . 97.5 mt -75.09 -52.95 9.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.417 . . . . 2.01 111.305 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 24.8 pt -59.1 -40.66 81.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.358 -0.383 . . . . 1.96 111.727 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.554 HG12 HG21 ' B' ' 108' ' ' THR . 9.0 tp -71.71 -25.95 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.566 -0.288 . . . . 2.88 111.149 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.472 HD11 ' HE1' ' B' ' 147' ' ' TRP . 58.3 tp -61.86 -57.33 12.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.291 -0.413 . . . . 1.52 110.899 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -63.61 -26.7 68.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.332 -0.395 . . . . 4.15 110.86 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . 0.596 ' HA2' ' HG2' ' B' ' 149' ' ' PRO . . . -83.63 -17.03 66.92 Favored Glycine 0 CA--C 1.518 0.258 0 C-N-CA 121.017 -0.611 . . . . 1.59 113.021 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . 0.605 HG13 HD23 ' B' ' 150' ' ' LEU . 14.5 tt -101.86 -4.35 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.727 0.299 . . . . 2.13 111.437 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . 0.472 ' HE1' HD11 ' B' ' 143' ' ' LEU . 20.2 m95 -89.27 -54.68 3.99 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 111.891 0.33 . . . . 1.78 111.891 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.648 ' HB2' ' HD3' ' B' ' 149' ' ' PRO . 14.6 m120 -101.48 -52.74 0.16 Allowed Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.492 0.553 . . . . 2.45 112.492 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.648 ' HD3' ' HB2' ' B' ' 148' ' ' ASN . 29.4 Cg_exo -62.56 -4.05 5.12 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.282 1.988 . . . . 2.36 112.979 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . 0.605 HD23 HG13 ' B' ' 146' ' ' ILE . 1.2 tm? -64.45 -69.04 0.31 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.803 0.335 . . . . 2.88 110.929 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . 0.507 ' HG2' HD12 ' B' ' 150' ' ' LEU . 16.4 ptm180 -148.11 49.47 1.04 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 8.07 111.17 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.31 -33.4 75.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.285 -0.416 . . . . 2.8 111.094 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -75.81 -36.4 59.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 4.58 110.736 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' B' ' 151' ' ' ARG . 7.0 m -70.72 -9.19 56.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 3.81 111.151 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 -57.56 -44.78 85.5 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 5.22 111.053 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 69.4 p -79.75 -11.88 59.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.1 -0.5 . . . . 3.42 111.24 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -81.86 -39.06 24.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.099 -0.501 . . . . 4.2 110.764 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 46.9 t -163.46 113.1 1.3 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.124 -0.489 . . . . 2.75 110.723 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 89.6 p -78.14 -17.83 56.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.107 -0.497 . . . . 2.4 111.034 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.69 -60.96 2.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.402 -0.363 . . . . 3.46 111.063 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . 0.452 ' HB2' HH22 ' B' ' 151' ' ' ARG . 7.7 mp -60.89 -22.45 64.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.333 -0.394 . . . . 2.57 110.828 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.11 -61.47 1.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.061 -0.518 . . . . 1.72 110.981 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -56.8 -21.86 31.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.251 0.548 . . . . 2.69 110.132 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 52.4 tp -73.14 -48.29 36.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.327 -0.851 . . . . 2.16 111.064 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -77.79 -22.46 50.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 2.13 111.316 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -72.63 -33.82 66.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 1.94 110.746 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -84.29 -24.49 29.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.987 -0.551 . . . . 3.33 110.592 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' B' ' 87' ' ' LEU . 33.5 tp -71.92 -50.84 25.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.951 -0.568 . . . . 1.56 110.922 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 14.7 p -60.71 -24.17 31.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.464 . . . . 1.59 111.239 -179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 69.6 m -55.74 -58.98 5.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.288 -0.414 . . . . 1.14 111.454 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -61.07 -40.11 92.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.289 -0.414 . . . . 3.87 110.535 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -61.16 -29.51 69.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.876 -0.602 . . . . 1.61 110.916 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . 0.445 ' O ' HG22 ' B' ' 177' ' ' ILE . 90.2 m -73.07 -52.14 15.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 1.3 111.377 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . . . . . . . . . 66.6 t -55.19 -31.57 26.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.362 -0.381 . . . . 1.53 111.514 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . . . . . . . . . 69.2 mt -75.25 -58.06 3.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.311 -0.404 . . . . 1.99 111.683 -179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -58.58 -30.1 66.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.387 . . . . 1.5 111.443 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.5 ' O ' HG13 ' B' ' 181' ' ' ILE . 15.1 tt -87.73 -20.34 7.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.042 0.449 . . . . 1.46 110.345 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . . . . . . . . . . . -60.35 -53.81 42.42 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.658 -0.701 . . . . 0.67 112.987 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.657 ' O ' HG22 ' B' ' 182' ' ' VAL . 88.9 m-85 -54.43 -54.18 51.28 Favored Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.681 0.241 . . . . 1.73 111.174 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.635 ' HD3' ' HB2' ' B' ' 179' ' ' TYR . 87.7 Cg_exo -46.2 -35.07 14.63 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.011 1.807 . . . . 0.93 112.564 179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.5 HG13 ' O ' ' B' ' 177' ' ' ILE . 83.5 mt -62.63 -54.69 30.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.302 -0.408 . . . . 1.36 111.559 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.657 HG22 ' O ' ' B' ' 179' ' ' TYR . 2.3 m -53.59 -23.87 8.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.102 -0.499 . . . . 1.19 111.38 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . 0.699 ' HE1' H163 ' B' ' 301' ' ' RET . 78.3 m95 -79.78 -45.45 18.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 2.73 112.084 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . . . . . . . . . 16.0 tt -72.87 -32.32 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 112.603 0.594 . . . . 1.93 112.603 -178.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 46.7 pt -61.66 -29.85 47.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.853 0.316 . . . . 2.64 111.853 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.22 164.74 37.77 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.472 -0.87 . . . . 1.93 112.92 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.01 98.37 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.675 2.25 . . . . 2.97 112.594 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . . . . . . . . . 66.1 m 55.47 60.56 3.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.007 -0.542 . . . . 4.5 111.457 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . . . . . . . . . . . 141.28 -165.13 26.42 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.487 -0.863 . . . . 4.5 113.054 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -85.13 88.38 7.46 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 7.89 111.151 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 66.15 -134.95 34.2 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.78 -0.724 . . . . 3.62 112.794 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -63.37 88.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.85 0.357 . . . . 6.54 110.767 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . . . . . . . . . 43.1 mm -135.15 151.17 30.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.003 -0.544 . . . . 3.16 110.639 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -101.12 -75.04 0.6 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.329 -0.396 . . . . 3.39 111.474 -179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -155.97 -29.11 0.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.591 -0.277 . . . . 5.56 111.393 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 11.3 p -54.36 -62.42 1.67 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.49 -0.323 . . . . 2.68 111.376 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . 0.438 ' N ' HD12 ' B' ' 197' ' ' ILE . 2.9 mp -62.53 -30.5 49.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.873 0.368 . . . . 2.2 110.833 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -57.66 -58.67 7.3 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.16 -0.473 . . . . 2.49 111.134 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . 0.486 HG23 ' NH2' ' B' ' 72' ' ' ARG . 29.9 m -58.24 -27.31 63.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.118 -0.492 . . . . 1.76 111.496 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -82.17 -25.18 34.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.402 -0.363 . . . . 2.18 111.668 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 29.8 tp -82.77 -50.23 8.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.745 0.307 . . . . 1.78 111.265 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -70.18 -1.57 10.57 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.435 . . . . 1.98 111.438 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 41.3 t -96.38 -45.95 6.58 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.236 0.541 . . . . 1.65 110.699 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 59.6 tp -73.02 -35.92 66.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.485 -0.779 . . . . 1.11 112.412 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.667 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 39.7 tp -60.1 -54.3 56.67 Favored Pre-proline 0 CA--C 1.531 0.24 0 C-N-CA 120.806 -0.358 . . . . 1.43 111.685 -179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.667 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 39.9 Cg_exo -58.08 -39.02 89.14 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 121.653 1.568 . . . . 0.77 111.283 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -60.13 -30.67 69.45 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.069 -0.514 . . . . 1.6 110.31 179.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -77.42 -25.95 51.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.866 -0.606 . . . . 1.77 110.596 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 29.4 t -76.24 -37.46 57.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.93 -0.577 . . . . 1.54 110.64 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -70.17 -53.96 14.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.177 -0.465 . . . . 2.01 110.953 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 70.0 t -60.16 -38.56 77.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-N 116.313 -0.403 . . . . 2.65 110.981 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -60.56 -30.9 73.07 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.746 -0.74 . . . . 1.33 112.241 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -66.56 -30.94 71.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 2.29 110.414 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 43.1 t -64.31 -59.19 4.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.021 -0.536 . . . . 2.12 110.691 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -63.22 -25.37 68.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.269 -0.423 . . . . 3.6 110.886 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.417 ' O ' HD13 ' B' ' 216' ' ' LEU . 3.0 tm? -71.18 -32.56 69.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.15 -0.477 . . . . 1.51 110.516 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -74.54 -26.49 60.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 2.22 110.774 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 85.2 mt -76.47 -57.77 3.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.923 -0.58 . . . . 2.69 111.299 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 27.8 t60 -75.77 -22.35 56.53 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.229 -0.441 . . . . 3.4 111.153 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -71.32 -59.13 5.11 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.69 -0.767 . . . . 1.67 112.41 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . . . . . . . . . 91.9 mt -76.05 -57.55 3.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.717 0.294 . . . . 3.39 110.796 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 54.88 62.3 2.59 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 5.91 110.69 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -95.45 138.25 33.39 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.083 -0.508 . . . . 5.26 110.95 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . 0.442 HD12 ' N ' ' B' ' 224' ' ' LEU . 7.6 mp -109.51 102.33 11.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 6.81 110.843 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -81.93 -77.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.259 -0.428 . . . . 7.02 111.046 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 26.0 t70 50.88 78.38 0.11 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.161 -0.472 . . . . 8.21 110.802 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 50.4 m -90.57 167.09 12.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 8.1 111.085 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 18.8 mmm180 -141.59 37.45 1.66 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 13.28 110.808 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.208 -0.901 . . . . 10.4 110.79 179.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 56.9 tpp . . . . . 0 N--CA 1.484 1.254 0 CA-C-O 120.902 0.382 . . . . 8.1 110.942 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 -121.22 140.57 51.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.06 -0.518 . . . . 6.27 110.67 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . 0.553 HD23 ' H ' ' C' ' 3' ' ' LEU . 2.4 pt? -133.86 154.7 50.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 6.2 110.877 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -134.09 110.96 9.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.026 -0.534 . . . . 4.82 110.762 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . 0.572 ' HB2' ' HA ' ' C' ' 55' ' ' ALA . 66.3 m -64.32 151.5 43.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.31 -0.405 . . . . 3.25 110.835 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 44.5 tp -124.02 -23.76 4.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.116 -0.493 . . . . 2.79 110.871 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.68 -39.15 90.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.231 -0.441 . . . . 2.08 111.079 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.522 ' HB2' ' HB2' ' C' ' 55' ' ' ALA . 94.1 m-70 -70.32 -25.32 63.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.439 . . . . 1.43 110.771 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . . . . . . . . . 64.0 t-105 -72.5 -44.42 62.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.025 -0.534 . . . . 1.16 110.409 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 43.4 mt -68.87 -20.1 24.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.065 -0.516 . . . . 2.09 110.303 179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . 0.412 ' O ' ' HG2' ' C' ' 15' ' ' MET . 4.8 t80 -66.56 -60.14 2.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.921 -0.581 . . . . 1.58 110.713 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -53.39 -37.58 29.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.244 -0.434 . . . . 1.0 111.07 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.59 98.53 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.049 0.452 . . . . 0.96 110.916 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.47 -18.65 67.96 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.892 -0.67 . . . . 0.96 112.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . 0.412 ' HG2' ' O ' ' C' ' 11' ' ' TYR . 86.9 mmm -76.85 -40.59 47.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.799 0.333 . . . . 1.3 110.931 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 70.7 p -60.85 -52.11 66.44 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.245 -0.434 . . . . 1.52 111.114 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -34.49 53.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.272 -0.422 . . . . 1.9 110.655 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.88 -31.08 74.8 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.897 -0.668 . . . . 0.96 112.275 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.11 -39.12 72.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.712 0.292 . . . . 1.07 111.232 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 58.5 mt -63.12 -29.73 71.03 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.933 0.396 . . . . 2.08 111.018 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -57.21 -42.98 82.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.147 -0.479 . . . . 2.02 110.993 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -65.86 -28.29 68.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.408 -0.36 . . . . 4.98 110.82 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . . . . . . . . . 60.6 t-105 -57.72 -48.58 79.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.947 0.403 . . . . 4.29 110.286 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 80.5 p -72.38 -19.19 61.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.004 -0.544 . . . . 2.47 110.622 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' C' ' 28' ' ' ASN . 16.0 tp -69.42 0.02 5.76 Favored 'General case' 0 C--O 1.223 -0.29 0 CA-C-N 115.826 -0.625 . . . . 2.9 111.781 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.423 ' C ' ' N ' ' C' ' 28' ' ' ASN . 12.6 t -54.79 -22.34 13.99 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.813 -0.355 . . . . 2.74 111.835 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -50.72 -24.48 3.44 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 108.181 -1.044 . . . . 5.85 108.181 177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . 0.713 ' CB ' ' HD2' ' C' ' 29' ' ' PRO . 0.2 OUTLIER -71.09 -157.45 0.0 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 CA-C-N 113.508 -1.678 . . . . 4.52 107.8 177.501 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.713 ' HD2' ' CB ' ' C' ' 28' ' ' ASN . 32.2 Cg_exo -12.82 105.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.374 1.899 0 C-N-CA 123.454 2.77 . . . . 3.22 115.616 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -117.07 96.37 5.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.27 -0.877 . . . . 8.68 108.795 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 94.07 -0.26 66.5 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 110.06 -1.216 . . . . 4.14 110.06 -177.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.516 HG12 ' HD2' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -111.42 162.54 20.53 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.221 -0.99 . . . . 5.09 109.719 179.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.574 ' HB3' ' CD2' ' C' ' 35' ' ' TYR . 10.4 Cg_exo -33.52 116.59 0.09 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.843 2.362 . . . . 3.1 115.108 -177.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -84.33 -20.34 32.22 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 114.617 -1.174 . . . . 3.85 108.257 176.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.574 ' CD2' ' HB3' ' C' ' 33' ' ' PRO . 0.1 OUTLIER -49.52 -23.21 1.5 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 113.329 -1.759 . . . . 3.37 112.343 -178.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -56.05 -35.27 66.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 2.72 110.567 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -76.35 -30.39 57.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.869 -0.605 . . . . 5.67 111.037 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.473 HD21 ' HA3' ' A' ' 103' ' ' GLY . 20.9 tp -53.6 -58.74 6.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 1.93 110.965 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 45.5 t -62.05 -44.54 99.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.433 . . . . 1.88 111.314 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -68.64 -7.18 30.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.428 -0.351 . . . . 1.23 111.792 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . . . . . . . . . 27.0 ttt -89.26 -39.26 13.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.434 -0.348 . . . . 2.09 111.495 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . 0.517 ' HB2' ' HB2' ' A' ' 107' ' ' SER . 74.3 t80 -74.69 -30.73 61.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.453 . . . . 1.41 112.161 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.466 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 75.4 mt -58.1 -51.25 83.13 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.277 0.473 . . . . 0.8 112.277 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 71.3 Cg_endo -73.9 -42.27 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.377 2.051 . . . . 0.72 113.471 -179.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 79.6 mt -52.43 -62.95 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.012 0.375 . . . . 1.68 112.012 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.6 t90 -58.46 -50.03 75.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 1.68 111.164 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . 0.42 ' HA ' ' OD1' ' C' ' 75' ' ' ASP . 47.9 t -56.4 -23.61 39.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.005 -0.543 . . . . 1.28 111.397 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.07 -51.03 9.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.686 -0.769 . . . . 0.51 112.692 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . 0.427 HD13 ' HE2' ' C' ' 52' ' ' MET . 4.0 mm? -58.78 -28.35 65.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.793 0.33 . . . . 1.33 111.212 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.99 -59.36 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.57 111.965 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.489 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 37.4 m-85 -58.77 -42.01 87.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.599 -0.273 . . . . 1.67 111.601 -179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.427 ' HE2' HD13 ' C' ' 49' ' ' LEU . 54.8 ttp -51.71 -40.86 60.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 1.42 110.23 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.68 -40.7 95.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.759 -0.655 . . . . 0.71 110.834 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 57.3 mtt -54.48 -34.13 61.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.986 -0.552 . . . . 1.14 110.226 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.572 ' HA ' ' HB2' ' C' ' 5' ' ' SER . . . -68.14 -36.06 79.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.883 -0.599 . . . . 0.88 110.356 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . . . . . . . . . 6.6 mm -85.22 2.26 4.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.617 -0.719 . . . . 1.38 110.951 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 60.37 43.38 13.48 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.891 -0.595 . . . . 1.94 111.108 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -115.96 169.0 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.122 -0.49 . . . . 1.87 111.04 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.18 -3.98 64.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.897 -0.668 . . . . 1.27 112.551 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -113.71 141.27 47.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.887 0.375 . . . . 2.86 111.225 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.6 m -113.03 149.61 15.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 1.95 110.937 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -99.06 141.55 31.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 3.04 110.959 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -146.8 110.99 5.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.102 -0.499 . . . . 2.11 111.113 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 57.7 29.34 17.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 2.54 111.271 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.82 26.0 47.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.748 -0.739 . . . . 2.47 112.543 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 57.9 tp60 -133.61 119.81 19.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.762 0.315 . . . . 2.85 111.044 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 34.5 pt -77.56 136.77 23.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 1.87 111.094 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.68 144.01 30.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.105 -0.498 . . . . 1.12 111.243 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.465 ' HB3' ' HB3' ' C' ' 72' ' ' ARG . 19.9 m-70 -86.61 53.73 2.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.97 -0.559 . . . . 1.26 110.723 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.417 ' O ' HG12 ' C' ' 74' ' ' ILE . 78.5 t80 -60.27 -58.39 8.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.722 -0.672 . . . . 2.08 111.254 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . . . . . . . . . . . -61.09 -22.4 64.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.86 111.582 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.465 ' HB3' ' HB3' ' C' ' 69' ' ' HIS . 6.0 tpp180 -63.8 -51.69 63.62 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.088 0.403 . . . . 1.96 112.088 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' C' ' 117' ' ' LEU . 17.0 p90 -77.88 -28.3 49.92 Favored 'General case' 0 N--CA 1.463 0.185 0 C-N-CA 120.822 -0.351 . . . . 1.8 111.22 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.417 HG12 ' O ' ' C' ' 70' ' ' TYR . 23.0 mm -54.37 -47.99 68.89 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.972 0.415 . . . . 1.18 110.175 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . 0.42 ' OD1' ' HA ' ' C' ' 47' ' ' SER . 16.3 t70 -66.68 -20.57 66.01 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.904 -0.589 . . . . 1.33 109.889 179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 40.0 m0 -89.66 3.9 51.2 Favored 'General case' 0 CA--C 1.512 -0.514 0 CA-C-N 115.704 -0.68 . . . . 1.85 111.313 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.401 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 53.3 ttm -104.11 -17.12 15.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.066 -0.515 . . . . 1.56 110.486 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.433 ' O ' HD23 ' C' ' 82' ' ' LEU . 16.8 m -114.09 -39.95 3.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.194 -0.457 . . . . 1.11 111.731 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . . . . . . . . . 95.8 m -74.66 -45.36 45.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.381 -0.372 . . . . 1.49 111.829 -179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.616 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 86.6 m -57.0 -52.0 77.38 Favored Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 112.173 0.434 . . . . 1.6 112.173 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.616 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 51.7 Cg_exo -52.26 -49.6 16.85 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 121.824 1.682 . . . . 1.01 111.768 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.433 HD23 ' O ' ' C' ' 78' ' ' VAL . 4.6 mm? -65.59 -24.8 67.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.855 -0.611 . . . . 1.18 110.763 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . 0.647 HD22 H201 ' C' ' 301' ' ' RET . 7.1 tp -73.31 -29.15 62.5 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.08 0.467 . . . . 1.54 109.947 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.2 tt -84.52 -29.16 26.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.593 -0.731 . . . . 1.65 110.239 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -77.8 -27.33 50.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.892 -0.595 . . . . 2.1 111.019 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 80.9 p -67.79 -41.15 83.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 1.38 110.82 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . 0.404 ' HB3' HD11 ' C' ' 168' ' ' LEU . 81.2 mt -61.96 -41.11 97.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.102 -0.499 . . . . 1.44 110.887 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 62.6 m -67.74 -28.81 67.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 1.87 110.909 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 33.3 t-105 -76.88 -32.24 57.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 3.1 110.617 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 56.6 m -67.97 -45.04 75.29 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.014 -0.539 . . . . 1.48 111.154 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' C' ' 168' ' ' LEU . . . -73.38 -40.65 64.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 1.02 111.13 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 96.1 mmm -103.37 103.12 13.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.237 -0.438 . . . . 2.34 110.989 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -74.23 -35.14 63.84 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.241 -0.436 . . . . 3.21 111.075 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -123.08 141.14 52.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.206 -0.452 . . . . 4.54 110.769 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 17.0 tt -117.51 145.05 23.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.206 -0.452 . . . . 2.34 111.284 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -117.39 -164.66 1.01 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.103 -0.499 . . . . 4.4 110.818 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp -60.52 -26.32 66.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.431 -0.349 . . . . 5.54 111.147 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -55.59 123.1 12.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.224 -0.444 . . . . 3.54 110.842 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -133.91 -0.37 3.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.125 -0.489 . . . . 5.21 110.657 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 36.7 p -65.64 -47.64 74.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 2.38 111.38 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . . . . . . . . . 97.8 mt -52.2 -63.68 1.06 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.257 -0.429 . . . . 2.64 111.197 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 9.5 tp -54.8 -25.19 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.322 -0.399 . . . . 2.38 110.889 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -65.69 -43.57 94.02 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.674 -0.774 . . . . 1.62 112.219 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -63.56 -33.99 76.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.791 0.329 . . . . 2.93 110.763 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.08 -38.69 61.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 2.16 111.274 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . . . . . . . . . 49.9 mtt -66.63 -43.63 84.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.3 -0.409 . . . . 2.3 111.152 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 50.1 m -58.06 -56.43 22.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.181 -0.463 . . . . 2.07 111.235 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.5 ' O ' HG23 ' C' ' 112' ' ' VAL . 10.0 t -61.66 -18.82 61.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 2.3 111.511 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -76.9 -43.35 36.05 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.519 -0.31 . . . . 2.48 111.17 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.508 HG22 ' HE1' ' B' ' 46' ' ' TRP . 42.0 mm -61.0 -41.43 89.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.336 -0.393 . . . . 1.93 111.761 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . 0.484 HG11 HG22 ' B' ' 45' ' ' ILE . 20.2 m -67.69 -38.16 79.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.56 -0.291 . . . . 1.67 111.516 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . 0.5 HG23 ' O ' ' C' ' 108' ' ' THR . 53.2 t -66.63 -47.18 84.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.676 0.274 . . . . 1.11 111.234 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.455 HG22 HD21 ' C' ' 117' ' ' LEU . 90.6 mt -59.73 -43.33 91.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.383 -0.371 . . . . 2.59 110.976 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 51.5 m -53.96 -47.95 70.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.9 111.126 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 50.6 m -61.05 -27.06 68.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.147 -0.479 . . . . 0.92 110.371 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.589 ' HA2' H173 ' C' ' 301' ' ' RET . . . -73.68 -24.24 74.98 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.952 -0.642 . . . . 0.55 112.594 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.492 HD22 ' CD1' ' C' ' 73' ' ' TYR . 2.3 mt -73.21 -59.66 2.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.795 0.331 . . . . 1.49 110.529 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.538 ' HA ' ' HB2' ' C' ' 121' ' ' LEU . 43.4 mm -62.05 -30.87 49.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.016 -0.538 . . . . 1.66 111.134 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -53.9 -44.41 70.49 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.777 0.322 . . . . 0.94 110.678 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -88.27 -20.46 25.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.022 -0.535 . . . . 1.79 110.9 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . 0.538 ' HB2' ' HA ' ' C' ' 118' ' ' ILE . 89.0 mt -85.32 6.1 27.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.247 -0.433 . . . . 1.29 110.837 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.444 ' HB2' ' HE ' ' C' ' 128' ' ' ARG . 60.8 m -62.59 129.48 40.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.05 -0.523 . . . . 2.15 110.907 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.33 -27.31 21.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.193 -0.458 . . . . 3.31 110.825 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . 0.712 ' HG2' ' H ' ' C' ' 126' ' ' TRP . 38.4 ttm180 -118.59 138.05 52.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 3.16 110.813 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -71.89 -19.34 61.95 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.144 -0.48 . . . . 4.24 111.238 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . 0.712 ' H ' ' HG2' ' C' ' 124' ' ' ARG . 62.1 t90 -77.07 -50.25 13.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 4.65 110.987 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . 0.609 HG12 ' HB3' ' C' ' 124' ' ' ARG . 14.4 p -66.42 -24.11 32.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.169 -0.469 . . . . 1.31 111.061 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . 0.444 ' HE ' ' HB2' ' C' ' 122' ' ' SER . 44.1 ttm180 -62.5 -21.0 65.18 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.45 . . . . 2.84 110.622 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -67.3 -55.69 12.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.024 -0.535 . . . . 2.7 111.185 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.482 HD12 ' N ' ' C' ' 131' ' ' TRP . 4.2 pp -65.6 -31.3 72.26 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.511 -0.313 . . . . 1.88 111.15 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . 0.482 ' N ' HD12 ' C' ' 130' ' ' LEU . 7.2 m95 -65.61 -40.78 93.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.349 . . . . 1.38 110.443 179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -62.15 -31.18 71.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.934 -0.575 . . . . 1.76 110.471 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.58 -33.85 27.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.124 -0.489 . . . . 2.15 111.067 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 86.1 m -63.06 -50.18 71.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.198 -0.455 . . . . 1.56 110.982 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -59.98 -56.13 26.45 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.79 -0.719 . . . . 0.73 112.924 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 34.5 m -57.29 -32.72 41.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.624 0.249 . . . . 1.48 111.655 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 51.1 t -57.91 -44.99 87.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.491 -0.322 . . . . 1.51 110.888 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.35 -31.31 72.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 1.01 111.091 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -74.12 -20.27 60.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 2.05 111.074 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 98.7 mt -80.56 -48.22 13.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.359 -0.382 . . . . 2.07 111.231 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.504 HG13 ' N ' ' C' ' 142' ' ' ILE . 48.3 pt -61.57 -40.77 87.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.878 0.371 . . . . 1.92 111.33 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.504 ' N ' HG13 ' C' ' 141' ' ' ILE . 8.5 tp -69.31 -34.81 64.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.279 -0.419 . . . . 2.64 111.249 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 51.0 tp -55.68 -57.05 13.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 1.51 111.035 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -61.67 -25.53 67.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 3.58 110.956 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . 0.497 ' HA2' ' HG2' ' C' ' 149' ' ' PRO . . . -83.53 -17.5 66.12 Favored Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.918 -0.658 . . . . 1.65 113.155 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . 0.408 HG12 ' O ' ' C' ' 142' ' ' ILE . 46.2 pt -104.33 -0.87 10.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.894 0.347 . . . . 2.46 111.314 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 18.6 m95 -87.91 -53.26 4.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.282 -0.417 . . . . 2.27 111.463 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.61 ' HB3' ' HD3' ' C' ' 149' ' ' PRO . 18.2 t30 -100.36 -52.68 0.18 Allowed Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 112.46 0.541 . . . . 2.33 112.46 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' C' ' 148' ' ' ASN . 31.9 Cg_exo -58.78 -15.37 26.13 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.086 1.857 . . . . 2.46 112.987 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 61.3 tp -88.91 110.35 21.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.49 -0.323 . . . . 3.08 111.087 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . 0.413 ' HB3' ' HB ' ' C' ' 154' ' ' THR . 98.6 mtt180 58.42 61.08 2.37 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.004 -0.544 . . . . 8.45 111.19 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.94 -49.72 9.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.993 -0.548 . . . . 2.9 111.107 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -86.61 5.09 37.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.255 -0.429 . . . . 4.62 110.942 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' C' ' 151' ' ' ARG . 44.4 m -85.29 -25.46 27.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 3.85 110.963 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . . . . . . . . . 23.7 tpp180 -61.25 -27.95 68.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.046 -0.524 . . . . 5.12 110.873 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 24.1 m -81.52 -21.05 38.85 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 3.43 110.824 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -82.49 -71.55 0.48 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 3.98 110.741 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 77.8 p -127.84 118.28 23.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.027 -0.533 . . . . 2.4 110.855 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 78.0 p -78.04 -21.44 50.68 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.126 -0.488 . . . . 2.82 110.963 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -70.8 -60.42 2.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.332 -0.394 . . . . 3.18 110.864 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . . . . . . . . . 29.6 tp -60.02 -29.33 68.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 2.5 110.862 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.42 -62.74 1.27 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 1.81 111.459 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -57.88 -21.91 45.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.264 -0.425 . . . . 2.13 110.69 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.33 -48.55 69.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.836 -0.62 . . . . 2.21 110.939 179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -68.85 -24.88 64.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.021 -0.536 . . . . 1.31 110.958 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -65.74 -38.61 89.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 2.26 110.843 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -77.68 -23.71 49.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 3.58 110.708 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' C' ' 91' ' ' ALA . 49.9 tp -71.87 -60.89 2.0 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.086 -0.506 . . . . 1.3 111.406 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . . . . . . . . . 42.7 t -53.56 -23.67 8.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.179 -0.464 . . . . 1.73 111.66 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 53.4 m -54.28 -58.73 6.27 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 1.43 111.397 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -65.55 -32.9 74.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.122 -0.49 . . . . 3.72 110.79 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -64.96 -30.81 71.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.077 -0.51 . . . . 1.55 111.296 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . 0.407 ' O ' HG22 ' C' ' 177' ' ' ILE . 91.0 m -79.41 -49.48 12.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.397 -0.365 . . . . 1.5 111.956 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 13.8 p -57.52 -28.14 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.146 0.425 . . . . 1.84 112.146 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . . . . . . . . . 61.5 tp -81.02 -57.05 3.71 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.763 0.316 . . . . 2.12 111.455 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -55.29 -27.83 49.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 1.0 111.093 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.515 ' O ' HG13 ' C' ' 181' ' ' ILE . 19.0 tt -87.76 -22.87 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.831 0.348 . . . . 1.75 110.378 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . 0.473 ' HA2' HD12 ' C' ' 181' ' ' ILE . . . -56.68 -53.87 40.57 Favored Glycine 0 N--CA 1.452 -0.27 0 CA-C-N 115.856 -0.611 . . . . 0.72 113.002 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.718 ' O ' HG22 ' C' ' 182' ' ' VAL . 87.3 m-85 -55.85 -54.74 48.61 Favored Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.769 0.284 . . . . 1.8 111.164 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.622 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 86.8 Cg_exo -46.79 -31.57 10.95 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.765 1.643 . . . . 0.88 112.54 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.515 HG13 ' O ' ' C' ' 177' ' ' ILE . 94.4 mt -64.61 -57.3 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 116.401 -0.363 . . . . 1.52 111.433 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.718 HG22 ' O ' ' C' ' 179' ' ' TYR . 6.2 m -52.51 -23.91 5.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.144 -0.48 . . . . 1.2 111.528 -179.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . 0.648 ' HE1' H163 ' C' ' 301' ' ' RET . 74.1 m95 -77.13 -36.37 55.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 2.47 112.147 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.42 HG22 ' O ' ' C' ' 181' ' ' ILE . 16.9 tt -85.08 -34.11 8.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 N-CA-C 112.232 0.456 . . . . 1.62 112.232 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.415 ' CD1' ' HA ' ' C' ' 190' ' ' PHE . 48.9 pt -58.86 -25.24 28.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.706 0.288 . . . . 2.63 111.31 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . 0.422 ' HA3' ' HA2' ' C' ' 191' ' ' GLY . . . -170.65 165.75 38.97 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.878 -0.677 . . . . 1.77 112.391 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.88 97.58 0.4 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.529 2.152 . . . . 3.03 112.446 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 50.5 m 61.18 45.51 8.91 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.128 -0.487 . . . . 4.22 111.267 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . 152.94 -157.57 27.39 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.431 -0.89 . . . . 4.08 113.028 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . 0.415 ' HA ' ' CD1' ' C' ' 185' ' ' ILE . 71.7 m-85 -55.88 -66.73 0.37 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.607 0.241 . . . . 7.54 111.572 -179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . 0.422 ' HA2' ' HA3' ' C' ' 186' ' ' GLY . . . 176.12 131.44 1.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.891 -0.671 . . . . 3.29 112.374 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 97.4 m95 55.64 21.15 4.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.893 0.378 . . . . 5.67 110.786 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . . . . . . . . . 2.3 pp -90.45 179.36 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 2.76 111.104 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 28.6 p-10 -124.08 -168.2 1.76 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.451 -0.341 . . . . 3.69 111.145 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -58.26 -30.46 66.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 5.34 111.405 -179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 99.0 m -52.17 -58.41 6.68 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.326 -0.397 . . . . 2.57 111.246 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 47.2 mm -65.59 -40.18 87.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.439 . . . . 2.37 111.208 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -52.73 -29.07 24.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.299 -0.41 . . . . 2.68 111.446 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 88.6 m -80.28 -65.28 1.03 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.485 -0.325 . . . . 1.95 111.489 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -55.7 -22.0 21.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 2.05 112.027 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 54.4 tp -83.84 -58.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.782 0.29 . . . . 1.91 111.782 -179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -66.69 -1.97 4.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.527 -0.306 . . . . 2.04 111.825 -179.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . . . . . . . . . 68.2 m -95.87 -40.58 9.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.199 0.523 . . . . 1.62 110.306 178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 47.9 tp -74.04 -37.06 64.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.472 -0.786 . . . . 1.49 111.756 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.563 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 1.8 tt -56.63 -54.39 54.22 Favored Pre-proline 0 CA--C 1.532 0.272 0 C-N-CA 121.148 -0.221 . . . . 1.32 111.274 -179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.563 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 48.0 Cg_exo -57.11 -44.86 39.99 Favored 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 121.776 1.651 . . . . 0.76 111.355 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -59.05 -24.99 63.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.132 -0.486 . . . . 1.52 110.111 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -81.44 -27.4 34.67 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.912 -0.585 . . . . 1.84 110.576 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . . . . . . . . . 92.0 p -81.94 -36.68 27.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.977 -0.556 . . . . 1.68 110.621 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -67.11 -45.84 75.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.159 -0.473 . . . . 2.04 110.887 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 11.7 p -67.37 -39.72 83.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-O 120.91 0.386 . . . . 2.65 110.914 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -59.25 -22.83 56.73 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.877 -0.678 . . . . 1.33 112.376 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -67.48 -46.13 73.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.738 0.304 . . . . 3.02 110.961 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 43.4 t -57.45 -52.95 63.28 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 2.35 110.737 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -63.53 -20.4 65.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 3.62 110.713 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 6.5 tt -74.19 -44.94 51.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.458 . . . . 1.64 110.824 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -66.59 -22.57 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.502 -0.317 . . . . 2.2 111.136 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 32.4 tp -72.91 -59.9 2.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 3.11 111.228 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -76.06 -20.41 57.77 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.415 -0.357 . . . . 3.37 111.595 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -76.64 -55.93 4.39 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.679 -0.772 . . . . 1.55 112.715 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . . . . . . . . . 95.9 mt -76.6 -57.11 4.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.588 0.232 . . . . 3.11 111.082 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 56.64 60.97 2.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.444 -0.344 . . . . 5.73 110.932 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -73.93 -176.55 2.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 5.53 110.895 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . . . . . . . . . 50.3 tp -127.44 132.69 50.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.451 . . . . 6.6 110.696 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -88.34 115.92 26.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.294 -0.412 . . . . 6.51 111.025 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -169.49 150.94 4.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.25 -0.432 . . . . 7.05 110.925 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -132.81 143.54 49.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 6.72 111.065 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -130.61 -48.95 1.06 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.302 -0.408 . . . . 9.56 110.746 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.287 -0.863 . . . . 9.08 110.805 179.803 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.699 ' H8 ' H161 ' A' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.715 ' H8 ' H171 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.753 ' H8 ' H171 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.8 mtp . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.778 0.323 . . . . 8.09 110.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -91.74 149.16 21.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 5.68 110.786 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.631 ' HG ' ' HG3' ' A' ' 4' ' ' GLU . 63.5 tp -148.64 -63.03 0.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.271 -0.422 . . . . 6.27 110.843 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.631 ' HG3' ' HG ' ' A' ' 3' ' ' LEU . 46.3 mt-10 -130.23 -74.95 0.54 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 6.52 110.864 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.8 p 49.04 88.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.003 -0.544 . . . . 3.59 111.271 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.671 HD23 ' H ' ' A' ' 6' ' ' LEU . 1.6 pt? -107.94 5.27 26.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.165 -0.471 . . . . 3.23 111.162 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 7' ' ' LEU . 3.7 mm? -67.88 -40.93 83.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.303 -0.408 . . . . 1.88 110.491 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' HB2' ' HB2' ' A' ' 55' ' ' ALA . 38.0 m80 -75.42 -23.72 57.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.026 -0.533 . . . . 1.29 110.627 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 71.1 t-105 -68.93 -49.58 56.81 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.294 -0.412 . . . . 0.99 110.386 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 pt -68.03 -22.83 28.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 1.92 110.232 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -60.94 -60.23 4.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.619 -0.718 . . . . 1.45 110.771 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.428 HG11 ' HB2' ' A' ' 52' ' ' MET . 11.9 p -58.74 -31.11 43.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.067 -0.515 . . . . 0.89 111.255 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.15 -53.01 63.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 0.9 110.882 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -65.91 -21.64 69.71 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.78 -0.724 . . . . 0.83 112.321 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -35.14 63.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.918 0.39 . . . . 1.24 110.506 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.2 m -64.29 -51.6 62.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.92 -0.582 . . . . 1.29 110.916 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 20' ' ' LEU . 2.7 pp -62.76 -26.54 41.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.316 -0.402 . . . . 1.71 111.165 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -59.77 -56.92 22.14 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.743 -0.741 . . . . 0.96 112.526 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.58 -29.59 70.83 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.99 110.834 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 17' ' ' ILE . 84.4 mt -64.41 -33.08 75.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 2.11 110.884 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -59.6 -43.41 93.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.953 0.406 . . . . 2.23 110.49 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.577 ' O ' ' OG ' ' A' ' 26' ' ' SER . 75.2 m-85 -76.59 -21.06 56.11 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.962 -0.563 . . . . 4.02 110.522 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.554 ' HA ' ' OG ' ' A' ' 26' ' ' SER . 88.5 t90 -69.9 -31.27 68.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 3.96 110.655 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 97.0 p -79.3 -44.42 21.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.063 -0.517 . . . . 2.38 110.54 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.0 tp -76.17 -3.88 38.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.129 -0.487 . . . . 2.77 109.982 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.577 ' OG ' ' O ' ' A' ' 22' ' ' PHE . 0.7 OUTLIER -60.33 -22.32 63.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.826 -0.624 . . . . 2.52 110.808 -179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.463 ' HE ' ' ND2' ' A' ' 28' ' ' ASN . 58.4 ttp180 -46.3 -31.52 2.59 Favored 'General case' 0 CA--C 1.521 -0.136 0 CA-C-O 121.269 0.557 . . . . 5.54 109.643 179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' ND2' ' HE ' ' A' ' 27' ' ' ARG . 7.9 p30 -176.06 131.96 0.4 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 114.976 -1.011 . . . . 4.44 109.898 178.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' ASN . 60.8 Cg_endo -92.32 -177.83 0.89 Allowed 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.747 2.298 . . . . 2.81 112.466 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -85.32 38.86 0.75 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.024 -0.535 . . . . 6.8 111.119 -179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.86 -24.58 31.46 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.867 -0.682 . . . . 4.97 112.478 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.6 p -75.87 120.84 83.48 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-O 120.371 0.129 . . . . 4.71 110.837 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.404 ' HB2' ' HD1' ' A' ' 35' ' ' TYR . 43.0 Cg_exo -55.42 165.55 3.15 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.397 2.065 . . . . 3.51 112.777 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.412 HE21 ' H ' ' A' ' 35' ' ' TYR . 0.5 OUTLIER -60.08 -18.26 45.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.563 -0.744 . . . . 3.41 112.267 -179.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.412 ' H ' HE21 ' A' ' 34' ' ' GLN . 2.9 p90 -50.65 -30.42 13.51 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.861 0.362 . . . . 2.81 111.209 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.71 -49.7 20.18 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.247 -0.433 . . . . 3.39 110.582 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -60.98 -29.7 69.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.259 -0.428 . . . . 5.24 110.595 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.69 HD21 ' HA3' ' B' ' 103' ' ' GLY . 59.6 tp -60.42 -63.19 1.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.007 -0.542 . . . . 1.6 110.812 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 43' ' ' ILE . 34.9 t -63.71 -35.24 72.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.873 -0.603 . . . . 1.33 111.431 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.88 -10.52 59.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.371 -0.377 . . . . 1.03 111.611 -179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.5 ttp -89.18 -36.8 15.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.673 0.273 . . . . 2.0 111.134 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -74.48 -30.97 62.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 1.31 112.083 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.434 ' HB ' ' HD3' ' A' ' 44' ' ' PRO . 96.3 mt -59.03 -52.36 75.3 Favored Pre-proline 0 CA--C 1.538 0.498 0 N-CA-C 112.299 0.481 . . . . 1.0 112.299 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' A' ' 43' ' ' ILE . 83.7 Cg_endo -76.22 -35.99 2.07 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 122.318 2.012 . . . . 0.59 113.889 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -58.49 -62.86 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 112.124 0.416 . . . . 1.63 112.124 -178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TRP . . . . . . . . . . . . . 2.3 t90 -58.06 -57.49 12.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.8 0.333 . . . . 1.12 111.37 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 38.3 m -52.4 -39.95 61.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.32 111.363 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -56.95 -58.25 15.51 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.12 -0.562 . . . . 0.52 113.276 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.1 mt -51.06 -33.43 25.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.637 0.256 . . . . 0.98 111.63 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.53 89.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.477 -0.329 . . . . 0.52 111.504 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 85.7 m-85 -66.02 -49.17 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.39 -0.368 . . . . 1.69 111.113 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.428 ' HB2' HG11 ' A' ' 12' ' ' VAL . 55.3 ttp -48.83 -31.84 7.78 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.245 -0.434 . . . . 1.12 110.71 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB1' ' HB2' ' A' ' 58' ' ' GLN . . . -72.15 -45.12 61.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.914 -0.585 . . . . 0.6 111.192 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.43 ' HB2' ' CG ' ' A' ' 8' ' ' HIS . 46.7 mtt -52.53 -35.14 52.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.052 -0.522 . . . . 0.94 110.415 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 8' ' ' HIS . . . -67.05 -47.42 71.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.826 -0.624 . . . . 0.78 111.16 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.5 mt -83.39 9.97 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.096 -0.502 . . . . 1.23 110.957 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 23.3 t70 59.51 65.92 1.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.792 -0.64 . . . . 2.02 110.783 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.412 ' HB2' ' HB1' ' A' ' 53' ' ' ALA . 83.8 mm-40 -136.67 143.97 43.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.052 -0.522 . . . . 2.1 110.741 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 102.13 5.23 50.13 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.907 -0.663 . . . . 1.27 112.359 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -115.46 161.93 17.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.798 0.332 . . . . 1.76 110.862 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 35.3 m -132.6 151.6 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.044 -0.526 . . . . 1.84 111.071 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -114.84 100.48 8.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.35 -0.386 . . . . 2.64 110.792 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -110.05 108.92 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 1.84 111.269 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 59.3 27.77 16.92 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.083 -0.508 . . . . 2.24 111.276 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.59 18.94 59.26 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.694 -0.765 . . . . 2.16 112.511 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.94 116.92 31.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.81 0.338 . . . . 2.84 110.429 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.1 mt -87.08 106.75 16.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.271 -0.422 . . . . 2.39 111.121 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -94.76 138.13 32.96 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.97 111.159 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.454 ' HB3' ' HB2' ' A' ' 72' ' ' ARG . 66.7 m-70 -87.61 62.15 6.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.132 0.491 . . . . 1.04 110.954 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -61.37 -37.22 82.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.759 -0.655 . . . . 3.38 111.139 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' A' ' 74' ' ' ILE . . . -74.38 -22.45 59.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.154 -0.475 . . . . 0.76 111.997 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.454 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 13.3 tpp180 -70.46 -51.37 29.65 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.018 0.377 . . . . 2.93 112.018 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' CD1' ' HB3' ' A' ' 117' ' ' LEU . 3.6 p90 -74.68 -36.85 62.78 Favored 'General case' 0 N--CA 1.463 0.181 0 N-CA-C 111.968 0.358 . . . . 3.13 111.968 -178.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.447 HG22 ' HA ' ' A' ' 71' ' ' ALA . 10.5 tp -56.36 -39.54 61.35 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.18 0 CA-C-O 120.967 0.413 . . . . 1.66 110.316 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.508 ' O ' HG22 ' A' ' 79' ' ' THR . 8.7 t70 -66.86 -22.1 66.0 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.296 -0.631 . . . . 1.42 109.296 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 51.1 m0 -94.25 0.63 55.79 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.465 -0.789 . . . . 2.09 111.594 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 57.1 ttm -104.34 -4.46 22.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.09 0.471 . . . . 1.52 110.556 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.543 HG13 ' H ' ' A' ' 79' ' ' THR . 2.1 p -114.09 -55.65 4.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.978 -0.555 . . . . 1.33 112.229 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.543 ' H ' HG13 ' A' ' 78' ' ' VAL . 7.5 t -71.45 -35.09 70.77 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.488 0.551 . . . . 1.39 112.488 -178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.646 ' HB ' ' HD3' ' A' ' 81' ' ' PRO . 23.4 m -64.75 -53.03 46.77 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 111.968 0.359 . . . . 1.55 111.968 -178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.646 ' HD3' ' HB ' ' A' ' 80' ' ' THR . 48.0 Cg_exo -55.9 -35.61 94.33 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 121.838 1.692 . . . . 1.01 111.709 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 78' ' ' VAL . 4.4 mm? -77.19 -31.38 55.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.782 -0.645 . . . . 1.45 110.66 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.1 tt -64.12 -48.16 77.19 Favored 'General case' 0 CA--C 1.518 -0.253 0 N-CA-C 109.5 -0.555 . . . . 1.3 109.5 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 105' ' ' LEU . 7.0 tt -61.62 -32.68 72.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.568 -0.742 . . . . 1.67 110.138 179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 20.1 tp -74.26 -31.51 62.58 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.498 -0.774 . . . . 1.87 110.71 -179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 t -58.97 -41.22 86.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 1.42 110.741 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -56.65 -37.31 70.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.993 -0.549 . . . . 1.4 110.746 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 38.3 t -67.3 -43.98 80.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.964 -0.562 . . . . 1.91 110.926 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -71.58 -16.63 62.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.255 -0.43 . . . . 2.33 111.002 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 38.4 m -72.01 -47.63 50.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.422 . . . . 1.43 111.192 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.98 -50.53 6.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.351 -0.386 . . . . 1.19 111.313 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' MET . . . . . . . . . . . . . 95.6 mmm -76.51 117.38 18.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.122 -0.49 . . . . 2.55 111.017 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -86.14 -43.01 13.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 3.33 111.075 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 49.7 t80 -138.53 140.13 38.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.242 -0.435 . . . . 5.1 110.971 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 8.8 tp -113.36 143.72 22.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 3.07 111.239 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -131.54 -67.03 0.7 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.229 -0.442 . . . . 4.41 111.027 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 41.7 ttmt -139.19 77.57 1.63 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.368 -0.378 . . . . 5.31 110.934 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -168.79 138.16 2.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.072 -0.513 . . . . 3.94 110.58 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 57.9 p-90 -166.05 15.84 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 5.98 111.091 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 t -76.16 -33.25 59.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.327 -0.397 . . . . 2.24 111.292 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.3 tp -75.41 -53.66 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 2.67 111.21 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 35.9 pt -64.26 -22.64 31.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.376 -0.374 . . . . 2.59 111.318 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.469 ' HA3' HD21 ' C' ' 38' ' ' LEU . . . -76.05 -39.52 32.34 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.786 -0.721 . . . . 1.53 112.915 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -64.4 -43.18 95.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.81 0.338 . . . . 3.14 111.149 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.592 ' HB3' HD11 ' A' ' 84' ' ' LEU . 95.5 mt -70.49 -50.58 36.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 1.99 111.547 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 26.4 ttt -56.68 -47.5 79.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 2.36 111.484 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 m -57.36 -58.12 9.65 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-O 120.855 0.359 . . . . 2.05 111.066 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.611 HG21 HG12 ' A' ' 142' ' ' ILE . 90.1 m -55.83 -33.05 64.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.455 . . . . 2.25 111.279 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -63.42 -48.08 79.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 2.72 111.264 -179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 50.6 mm -53.26 -39.89 36.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.915 0.388 . . . . 1.88 111.076 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 39.0 t -65.66 -45.36 92.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.04 -0.527 . . . . 1.6 111.25 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.452 HG12 H173 ' A' ' 301' ' ' RET . 90.9 t -61.27 -43.74 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.178 -0.464 . . . . 1.09 111.47 -179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.8 mt -52.81 -45.73 50.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.792 0.329 . . . . 2.65 111.193 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 99.9 m -56.08 -42.57 76.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.171 -0.468 . . . . 0.89 110.986 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 14.6 m -56.81 -32.96 66.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.057 -0.519 . . . . 0.68 110.913 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -68.63 -61.39 4.74 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 0.63 113.365 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 118' ' ' ILE . 3.3 pp -53.6 -45.42 70.03 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.649 0.24 . . . . 1.58 111.649 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.525 ' N ' HD12 ' A' ' 117' ' ' LEU . 15.3 tt -65.5 -31.66 54.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.79 0.329 . . . . 2.04 111.145 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.521 ' HA ' ' HB2' ' A' ' 128' ' ' ARG . . . -80.66 -21.82 41.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.436 . . . . 1.1 110.763 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -73.25 -9.5 58.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 1.88 110.766 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mt -80.02 36.32 0.34 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.903 -0.59 . . . . 1.53 110.853 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.678 ' HA ' ' HB2' ' A' ' 126' ' ' TRP . 86.1 p -59.24 176.91 0.2 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.251 0.834 . . . . 2.29 113.251 -178.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 122' ' ' SER . 34.2 tt0 85.07 -85.75 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.059 0.944 . . . . 3.49 111.228 -179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.797 ' C ' ' H ' ' A' ' 126' ' ' TRP . 0.0 OUTLIER -52.93 -170.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.76 0.824 . . . . 3.13 110.766 177.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 127' ' ' VAL . 10.8 m-20 -28.15 1.5 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.255 1.576 . . . . 3.71 115.255 175.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.797 ' H ' ' C ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -35.06 30.37 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 119.343 3.09 . . . . 3.97 119.343 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 125' ' ' ASP . 24.9 m -40.59 -14.7 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 CA-C-N 119.525 1.057 . . . . 1.22 110.156 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.795 ' HA ' ' HB2' ' A' ' 131' ' ' TRP . 6.4 ppt_? -39.21 -20.04 0.01 OUTLIER 'General case' 0 C--N 1.34 0.176 0 CA-C-N 115.801 -0.636 . . . . 2.81 112.0 178.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.442 ' N ' ' O ' ' A' ' 127' ' ' VAL . 70.5 t80 -46.64 -40.54 13.24 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.687 -0.857 . . . . 4.25 108.687 178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 130' ' ' LEU . 3.3 mm? -84.47 -35.12 23.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.077 -0.965 . . . . 1.84 109.573 177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' TRP . . . . . 0.795 ' HB2' ' HA ' ' A' ' 128' ' ' ARG . 0.1 OUTLIER -56.43 -25.54 50.65 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.093 -0.503 . . . . 1.54 110.412 179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -64.45 -46.53 82.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.9 -0.591 . . . . 1.79 110.541 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 49.6 mm -55.47 -34.02 33.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.159 -0.473 . . . . 2.08 110.263 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 85.3 m -64.07 -42.79 96.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.748 -0.66 . . . . 1.76 111.096 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -58.8 -59.49 10.67 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.887 -0.673 . . . . 0.76 112.828 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.402 ' O ' ' HG ' ' A' ' 140' ' ' LEU . 5.8 p -59.23 -37.16 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.641 0.258 . . . . 2.07 111.064 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' CYS . . . . . 0.495 ' HA ' HD12 ' A' ' 140' ' ' LEU . 49.5 t -50.67 -37.9 43.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.292 -0.413 . . . . 1.85 110.838 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -70.86 -43.88 67.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.093 -0.503 . . . . 1.32 111.077 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -67.76 -17.94 64.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.382 -0.372 . . . . 3.25 111.17 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.495 HD12 ' HA ' ' A' ' 137' ' ' CYS . 89.1 mt -77.62 -58.24 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.348 -0.387 . . . . 2.92 111.813 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -52.86 -42.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 2.65 111.755 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.611 HG12 HG21 ' A' ' 108' ' ' THR . 2.6 pp -70.75 -31.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.423 -0.353 . . . . 3.21 111.533 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.41 ' O ' HG22 ' A' ' 146' ' ' ILE . 43.5 tp -62.84 -58.11 8.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.306 -0.406 . . . . 2.01 110.925 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -63.96 -22.63 67.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.964 0.411 . . . . 3.6 110.607 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.63 -16.76 67.58 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.937 -0.649 . . . . 1.62 112.801 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 143' ' ' LEU . 18.9 tt -106.46 -9.9 10.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.913 0.387 . . . . 2.47 111.189 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -67.71 -33.05 74.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.2 -0.454 . . . . 2.48 111.374 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASN . . . . . 0.456 ' N ' ' HD2' ' A' ' 149' ' ' PRO . 5.8 t30 -80.05 -53.39 0.95 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.386 -0.37 . . . . 2.69 111.952 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 148' ' ' ASN . 56.1 Cg_endo -69.82 0.17 6.09 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.001 1.801 . . . . 2.36 112.556 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 52.4 tp -59.51 101.89 0.12 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.403 -0.362 . . . . 3.3 110.856 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.493 HH11 HG21 ' A' ' 154' ' ' THR . 24.2 mmt180 57.97 27.64 15.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.087 -0.506 . . . . 8.48 111.15 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -70.68 -55.4 8.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.305 -0.407 . . . . 2.98 110.87 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -82.28 -4.13 56.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 4.55 110.754 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.493 HG21 HH11 ' A' ' 151' ' ' ARG . 15.4 m -92.56 -15.41 26.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.047 -0.524 . . . . 4.0 111.019 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -58.82 -22.8 59.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 5.51 110.859 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 56.1 p -84.32 -29.86 25.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.102 -0.499 . . . . 3.2 111.047 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -77.37 -53.81 7.21 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.148 -0.478 . . . . 3.98 110.768 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 72.8 p -156.71 117.68 3.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.28 -0.418 . . . . 2.63 110.91 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 93.1 p -75.99 -27.28 57.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.224 -0.444 . . . . 2.16 110.904 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -62.46 -57.82 9.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 3.37 110.848 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 85.2 mt -59.34 -31.36 69.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 2.83 110.773 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -66.82 -26.53 66.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 1.7 111.067 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -83.76 -37.15 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.373 -0.376 . . . . 2.16 110.605 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 69.6 mt -61.84 -46.58 88.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 1.59 110.726 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' TYR . . . . . 0.462 ' O ' HG23 ' A' ' 169' ' ' VAL . 1.1 t80 -73.83 -27.34 61.06 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.937 -0.574 . . . . 2.31 110.998 -179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.07 -56.02 21.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.327 -0.397 . . . . 2.15 111.263 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -78.19 -21.07 50.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.308 -0.406 . . . . 2.39 111.199 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 49.4 tp -65.45 -31.24 72.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.128 -0.487 . . . . 1.79 111.188 -179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 165' ' ' TYR . 87.5 t -75.97 -28.02 18.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 1.42 111.018 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 63.5 m -58.45 -58.79 6.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.282 -0.417 . . . . 1.12 111.528 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -62.75 -40.1 96.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 3.86 110.785 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -60.61 -25.51 66.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.268 -0.424 . . . . 1.58 110.799 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . . . . . . . . . 78.2 m -76.84 -44.57 31.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.132 -0.485 . . . . 1.41 111.431 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 48.7 t -56.71 -33.51 40.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.335 -0.393 . . . . 1.42 111.699 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 63.2 mt -75.15 -58.18 3.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.365 . . . . 1.91 111.519 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -59.8 -27.32 66.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.026 -0.533 . . . . 1.55 111.414 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.488 ' O ' HG12 ' A' ' 181' ' ' ILE . 12.9 tt -87.57 -19.31 7.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 121.001 0.429 . . . . 1.86 110.111 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -62.05 -51.78 54.55 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.646 -0.706 . . . . 0.74 112.957 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' TYR . . . . . 0.584 ' HB2' ' HD3' ' A' ' 180' ' ' PRO . 60.1 m-85 -54.15 -54.16 50.7 Favored Pre-proline 0 N--CA 1.463 0.181 0 CA-C-N 116.831 0.316 . . . . 1.78 111.028 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . 0.847 ' HG3' H183 ' A' ' 301' ' ' RET . 81.1 Cg_exo -44.48 -41.39 13.97 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 121.951 1.767 . . . . 0.92 112.146 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 177' ' ' ILE . 48.4 mm -54.48 -61.21 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.04 -0.527 . . . . 1.77 111.523 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 2.6 p -59.4 -33.37 51.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.387 -0.37 . . . . 1.34 111.187 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -60.76 -27.26 67.83 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.515 -0.311 . . . . 2.51 111.064 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . 0.521 HG22 HG23 ' A' ' 185' ' ' ILE . 64.7 mt -58.83 -81.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.549 -0.296 . . . . 2.02 111.505 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.521 HG23 HG22 ' A' ' 184' ' ' ILE . 2.8 pp -104.53 174.14 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.902 0.382 . . . . 2.45 111.481 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . 94.62 -152.06 20.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.796 -0.716 . . . . 1.73 112.518 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.574 ' HD3' HD12 ' A' ' 193' ' ' ILE . 88.7 Cg_endo -80.33 167.68 19.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.687 2.258 . . . . 3.05 112.047 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 34.2 t 57.94 14.0 2.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.047 0.451 . . . . 4.04 110.349 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -148.54 -74.2 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.671 -0.695 . . . . 4.48 112.002 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PHE . . . . . . . . . . . . . 53.5 t80 -175.44 87.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.747 0.308 . . . . 7.96 110.605 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -161.05 -171.9 27.65 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.729 -0.748 . . . . 3.23 112.701 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -117.35 36.16 4.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 6.03 110.855 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' A' ' 187' ' ' PRO . 76.5 mt -103.21 139.8 23.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.015 -0.539 . . . . 3.18 110.963 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -64.74 148.42 51.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.994 -0.548 . . . . 3.39 110.867 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -64.0 -17.88 63.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.953 -0.567 . . . . 5.76 111.655 -179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' THR . . . . . . . . . . . . . 97.6 m -57.49 -50.33 73.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.785 0.326 . . . . 2.5 110.886 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 47.7 mm -73.34 -30.64 31.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 2.4 110.791 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -52.5 -57.53 9.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.039 -0.528 . . . . 2.66 110.826 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' THR . . . . . . . . . . . . . 20.7 m -60.9 -47.97 83.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.81 111.124 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -58.48 -22.14 53.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.077 -0.511 . . . . 2.21 111.054 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 201' ' ' LEU . 1.5 tm? -79.67 -55.2 5.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 2.18 110.685 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -68.31 -3.72 11.92 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 2.01 111.188 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 82.1 m -96.73 -49.68 4.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.295 0.569 . . . . 1.93 110.388 178.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.8 tp -67.26 -29.92 69.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.492 -0.777 . . . . 1.7 111.811 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . 0.676 ' HB3' ' HD3' ' A' ' 206' ' ' PRO . 40.2 tp -64.85 -54.91 31.65 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 120.841 -0.344 . . . . 1.28 111.518 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.676 ' HD3' ' HB3' ' A' ' 205' ' ' LEU . 53.5 Cg_exo -53.46 -39.03 83.45 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 121.727 1.618 . . . . 0.79 111.145 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 211' ' ' VAL . 92.1 t80 -61.75 -46.63 88.79 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.898 -0.592 . . . . 1.51 110.296 179.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' PHE . . . . . 0.47 ' HA ' HG22 ' A' ' 211' ' ' VAL . 59.7 t80 -74.18 -18.52 60.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.035 -0.53 . . . . 1.93 111.073 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 39.9 t -89.79 -12.39 39.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.08 -0.509 . . . . 1.71 111.234 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -107.76 -27.14 10.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 2.04 111.586 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.48 HG13 ' O ' ' A' ' 207' ' ' PHE . 31.0 m -75.97 -36.83 32.89 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.797 0.332 . . . . 2.89 111.167 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 216' ' ' LEU . . . -65.96 -33.21 84.93 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.676 -0.773 . . . . 1.31 112.149 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -74.82 -29.44 61.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.833 0.349 . . . . 2.87 110.621 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' SER . . . . . . . . . . . . . 47.9 t -60.43 -56.57 19.82 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.025 -0.534 . . . . 2.38 110.96 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -70.82 -20.31 62.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 3.42 110.839 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HB2' ' O ' ' A' ' 212' ' ' GLY . 7.5 tt -69.53 -53.65 18.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 1.24 110.664 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -61.63 -31.81 71.92 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.917 0.389 . . . . 2.44 110.439 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.0 tp -63.56 -34.09 77.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.911 -0.586 . . . . 2.51 110.686 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 48.8 t60 -88.23 -21.57 24.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.974 -0.557 . . . . 3.01 110.952 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -74.3 -19.96 79.72 Favored Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.904 -0.665 . . . . 1.59 112.671 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 71.2 mt -82.0 -6.12 58.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.359 . . . . 3.49 110.953 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -59.4 -47.87 83.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.018 -0.537 . . . . 5.74 111.11 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -97.62 99.69 11.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.252 -0.431 . . . . 5.46 111.349 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 95.7 mt -145.09 -178.39 6.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.913 -0.585 . . . . 6.13 110.581 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -143.68 82.11 1.72 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.339 -0.391 . . . . 6.46 110.694 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -76.07 -57.18 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.116 -0.493 . . . . 6.94 110.975 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . . . . . . . . . 47.2 t -161.06 -61.6 0.06 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.274 -0.421 . . . . 6.83 111.205 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 55.35 78.84 0.17 Allowed 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 116.266 -0.424 . . . . 10.77 110.801 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.181 -0.914 . . . . 9.41 111.056 -179.808 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 85.3 mtp . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.848 0.356 . . . . 8.91 110.973 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -110.99 102.03 10.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 6.76 110.703 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LEU . . . . . . . . . . . . . 92.3 mt -86.14 133.56 33.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.29 -0.413 . . . . 6.25 111.056 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -82.62 111.21 18.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.872 -0.604 . . . . 5.44 111.154 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 37.8 t -122.82 126.96 48.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 3.84 110.722 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 67.8 mt -109.7 -9.74 14.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 3.08 110.944 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.463 HD22 ' H ' ' B' ' 7' ' ' LEU . 3.1 mm? -61.84 -39.77 92.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.261 -0.427 . . . . 2.35 110.72 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' HIS . . . . . 0.532 ' HB2' ' HB2' ' B' ' 55' ' ' ALA . 28.3 m80 -70.96 -24.19 62.37 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.185 -0.461 . . . . 1.39 110.679 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' TRP . . . . . . . . . . . . . 66.3 t-105 -75.2 -32.47 61.22 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.869 -0.605 . . . . 1.1 110.574 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ILE . . . . . . . . . . . . . 68.8 mt -75.09 -29.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 1.71 110.148 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' TYR . . . . . . . . . . . . . 18.9 t80 -61.17 -56.98 14.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.636 -0.711 . . . . 1.48 110.485 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' B' ' 52' ' ' MET . 7.5 p -58.02 -36.96 58.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.203 -0.453 . . . . 0.95 111.125 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.1 -37.09 83.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.286 -0.415 . . . . 0.97 110.899 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -72.1 -30.07 65.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.879 -0.677 . . . . 0.8 112.3 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' MET . . . . . . . . . . . . . 25.3 mmt -77.72 -26.42 50.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.918 0.39 . . . . 1.29 110.684 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' THR . . . . . . . . . . . . . 56.1 m -69.27 -54.4 14.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.004 -0.543 . . . . 1.36 110.591 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -64.72 -23.82 34.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.989 -0.551 . . . . 1.23 110.861 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.52 -52.02 46.96 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.735 -0.745 . . . . 0.88 112.225 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.81 67.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.705 0.288 . . . . 0.98 110.939 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' LEU . . . . . . . . . . . . . 54.3 tp -59.44 -60.66 3.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.247 -0.433 . . . . 2.12 110.864 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' HIS . . . . . 0.547 ' HA ' ' HB2' ' B' ' 24' ' ' SER . 10.0 t-80 -67.74 -37.41 82.14 Favored 'General case' 0 C--O 1.249 1.041 0 CA-C-O 121.23 0.538 . . . . 2.0 109.988 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.596 ' HA ' ' HG3' ' B' ' 27' ' ' ARG . 42.3 t80 -57.84 -31.6 66.8 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 114.776 -1.102 . . . . 4.26 110.202 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' TRP . . . . . . . . . . . . . 32.0 t90 -104.08 3.75 33.53 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.22 -0.9 . . . . 3.62 109.042 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' SER . . . . . 0.547 ' HB2' ' HA ' ' B' ' 21' ' ' HIS . 46.5 t -73.31 -70.4 0.37 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.308 -0.557 . . . . 2.55 111.61 -178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LEU . . . . . . . . . . . . . 14.9 tp -101.29 -82.12 0.47 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 116.516 -2.074 . . . . 3.11 112.978 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' SER . . . . . 0.552 ' C ' ' N ' ' B' ' 28' ' ' ASN . 5.0 p -115.89 -60.5 1.86 Allowed 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.297 0.57 . . . . 3.02 110.741 175.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 18.3 mmm180 36.31 28.92 0.01 OUTLIER 'General case' 0 C--N 1.345 0.388 0 CA-C-N 114.133 -1.394 . . . . 5.89 108.773 -175.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASN . . . . . 0.71 ' HB3' ' CD ' ' B' ' 29' ' ' PRO . 13.3 m120 -137.48 -162.53 0.05 OUTLIER Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 112.785 -2.007 . . . . 5.02 106.978 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.71 ' CD ' ' HB3' ' B' ' 28' ' ' ASN . 55.0 Cg_endo -91.43 166.15 3.51 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 121.555 1.503 . . . . 3.53 113.031 -179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -111.05 86.41 2.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.068 -0.515 . . . . 7.88 110.338 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.34 -28.11 6.13 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.901 -0.666 . . . . 4.61 111.903 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.448 HG13 ' HD2' ' B' ' 33' ' ' PRO . 96.7 t -84.48 138.06 38.78 Favored Pre-proline 0 C--N 1.328 -0.334 0 N-CA-C 110.536 -0.172 . . . . 4.73 110.536 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.592 ' HB2' ' HD2' ' B' ' 35' ' ' TYR . 82.3 Cg_exo -45.7 164.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.666 2.244 . . . . 3.75 113.411 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.41 -16.14 63.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.075 -0.966 . . . . 3.76 113.064 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' TYR . . . . . 0.592 ' HD2' ' HB2' ' B' ' 33' ' ' PRO . 6.1 p90 -40.74 -36.19 0.58 Allowed 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 111.951 0.352 . . . . 3.17 111.951 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -63.75 -48.81 75.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.856 0.36 . . . . 2.57 110.884 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -58.08 -40.77 81.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.017 -0.538 . . . . 5.74 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' LEU . . . . . . . . . . . . . 61.2 tp -50.66 -57.92 7.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 1.72 111.819 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 21.4 t -63.99 -47.79 88.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.312 -0.404 . . . . 1.95 111.907 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.77 -11.08 53.5 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.211 0.448 . . . . 1.2 112.211 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.81 -39.47 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.759 0.314 . . . . 2.12 111.545 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -71.97 -27.5 62.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.223 -0.444 . . . . 1.49 111.943 -179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.51 HG23 HG23 ' B' ' 79' ' ' THR . 98.1 mt -59.3 -54.16 58.98 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 112.351 0.5 . . . . 0.77 112.351 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.434 ' HD3' ' HB ' ' B' ' 43' ' ' ILE . 60.6 Cg_endo -72.04 -36.05 6.37 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 122.22 1.947 . . . . 0.68 113.415 -179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 37.2 mm -59.76 -62.48 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 111.997 0.369 . . . . 1.63 111.997 -179.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -59.2 -55.98 27.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.482 -0.326 . . . . 1.91 111.692 -178.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.419 ' HA ' ' OD2' ' B' ' 75' ' ' ASP . 92.1 p -56.18 -20.53 18.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.418 -0.356 . . . . 1.22 111.728 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.07 -60.74 4.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.555 -0.831 . . . . 0.55 112.804 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 72.5 mt -58.87 -27.69 65.41 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.583 0.216 . . . . 0.87 111.583 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.09 -59.77 4.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.776 0.322 . . . . 0.55 111.499 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -63.39 -29.74 70.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.289 -0.414 . . . . 1.06 110.8 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . 0.402 ' HB2' HG21 ' B' ' 12' ' ' VAL . 57.4 ttp -54.58 -36.34 64.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.128 0.49 . . . . 1.19 109.877 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.2 -41.39 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.68 -0.691 . . . . 0.66 110.657 179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' MET . . . . . 0.404 ' HB2' ' HB3' ' B' ' 8' ' ' HIS . 53.1 mtt -53.34 -23.83 10.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.86 110.361 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.532 ' HB2' ' HB2' ' B' ' 8' ' ' HIS . . . -81.09 -45.19 16.86 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.921 -0.581 . . . . 0.84 110.763 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ILE . . . . . . . . . . . . . 5.8 mt -81.07 7.66 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.111 -0.495 . . . . 1.44 110.917 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.08 58.78 1.78 Allowed 'General case' 0 C--O 1.231 0.099 0 CA-C-N 115.94 -0.573 . . . . 1.55 111.066 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLN . . . . . 0.533 HE22 ' HA ' ' C' ' 122' ' ' SER . 6.3 tp-100 -138.83 141.17 38.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.283 -0.417 . . . . 2.24 111.032 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLY . . . . . . . . . . . . . . . 106.86 10.99 27.37 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.786 -0.721 . . . . 1.26 112.653 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -125.22 150.12 47.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.788 0.328 . . . . 2.31 110.746 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' VAL . . . . . . . . . . . . . 34.5 m -118.14 145.55 23.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 1.81 111.282 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -110.68 93.29 4.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.173 -0.467 . . . . 3.18 110.576 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . . . . . . . . . . . -94.93 121.48 36.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 2.03 111.418 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' ALA . . . . . . . . . . . . . . . 56.05 29.11 13.88 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.979 -0.555 . . . . 2.48 111.367 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.6 23.96 54.84 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 2.37 112.528 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -128.07 117.63 22.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.716 0.293 . . . . 2.28 110.754 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.2 pt -80.58 132.76 30.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.908 0.385 . . . . 1.78 111.155 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.04 144.89 40.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.885 -0.598 . . . . 1.05 111.016 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' HIS . . . . . 0.554 ' HB3' ' HB2' ' B' ' 72' ' ' ARG . 70.1 m-70 -83.28 60.49 5.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.08 0.467 . . . . 1.11 110.952 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' TYR . . . . . 0.438 ' O ' HG23 ' B' ' 74' ' ' ILE . 64.8 t80 -63.49 -39.79 95.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.748 -0.66 . . . . 2.3 111.203 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' ALA . . . . . 0.425 ' HA ' HG12 ' B' ' 74' ' ' ILE . . . -71.49 -25.62 62.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.266 -0.425 . . . . 0.72 112.095 -179.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ARG . . . . . 0.554 ' HB2' ' HB3' ' B' ' 69' ' ' HIS . 26.7 mmt180 -68.88 -51.96 34.73 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.714 0.635 . . . . 3.04 112.714 -178.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' B' ' 117' ' ' LEU . 3.4 p90 -72.65 -38.56 67.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.419 0.525 . . . . 1.79 112.419 -178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' ILE . . . . . 0.48 HG13 ' N ' ' B' ' 75' ' ' ASP . 41.4 pt -55.84 -40.01 59.54 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 120.49 -0.484 . . . . 1.44 110.506 -179.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . 0.48 ' N ' HG13 ' B' ' 74' ' ' ILE . 16.7 t70 -66.06 -27.83 68.39 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 109.175 -0.676 . . . . 1.31 109.175 178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' TRP . . . . . . . . . . . . . 24.2 m0 -91.08 2.72 56.11 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.45 -0.795 . . . . 2.01 110.318 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' MET . . . . . 0.482 ' O ' ' HG2' ' B' ' 81' ' ' PRO . 53.1 tpp -101.03 -16.13 17.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.607 -0.724 . . . . 1.43 109.74 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.523 HG13 ' H ' ' B' ' 79' ' ' THR . 2.4 p -114.59 -54.3 4.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.705 -0.679 . . . . 1.21 111.643 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' THR . . . . . 0.523 ' H ' HG13 ' B' ' 78' ' ' VAL . 93.4 m -68.24 -61.2 1.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.017 -0.538 . . . . 1.18 112.421 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' B' ' 81' ' ' PRO . 27.0 m -45.73 -52.09 26.22 Favored Pre-proline 0 N--CA 1.465 0.319 0 N-CA-C 112.303 0.483 . . . . 1.65 112.303 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' B' ' 80' ' ' THR . 51.4 Cg_exo -55.05 -33.65 84.25 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 121.836 1.691 . . . . 1.06 111.896 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' LEU . . . . . 0.518 HD23 HD12 ' B' ' 85' ' ' LEU . 75.0 mt -80.92 -28.9 35.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.967 -0.561 . . . . 1.58 110.771 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' LEU . . . . . . . . . . . . . 22.0 tp -66.85 -27.7 67.75 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.39 -0.596 . . . . 1.49 109.39 179.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' LEU . . . . . 0.58 HD21 ' HB3' ' B' ' 105' ' ' LEU . 7.8 tt -84.55 -30.83 24.75 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.206 -0.906 . . . . 1.72 109.945 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.518 HD12 HD23 ' B' ' 82' ' ' LEU . 51.2 mt -73.52 -33.37 64.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.756 -0.656 . . . . 1.96 110.941 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' SER . . . . . . . . . . . . . 84.7 p -57.43 -31.33 65.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 1.24 110.692 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' LEU . . . . . . . . . . . . . 58.1 mt -59.23 -44.28 92.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.967 -0.56 . . . . 1.21 110.721 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' SER . . . . . . . . . . . . . 50.1 m -67.45 -30.06 69.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 1.32 110.959 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -80.74 -16.22 54.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 2.15 111.09 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' THR . . . . . . . . . . . . . 40.3 m -81.43 -40.19 23.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.351 -0.386 . . . . 1.44 111.391 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.56 -47.53 8.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.332 -0.395 . . . . 1.05 111.254 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' MET . . . . . . . . . . . . . 81.1 mtp -81.39 116.74 21.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 2.68 110.798 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -87.14 -27.29 23.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 2.71 110.954 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -145.08 150.45 36.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.166 -0.47 . . . . 4.19 111.02 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ILE . . . . . . . . . . . . . 7.6 tp -113.4 145.6 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.121 -0.49 . . . . 2.79 110.777 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -144.9 -61.91 0.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.292 -0.413 . . . . 5.27 110.933 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -152.22 37.73 0.55 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 5.57 111.063 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -120.49 84.83 2.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 4.24 110.847 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -117.98 3.74 12.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.281 -0.418 . . . . 5.39 111.348 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' THR . . . . . . . . . . . . . 6.3 t -73.94 -41.87 61.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.851 0.358 . . . . 2.16 111.244 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 82.6 mt -64.27 -58.53 6.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.198 -0.455 . . . . 2.58 111.296 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 43.8 pt -58.83 -22.16 20.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.059 -0.519 . . . . 2.29 111.567 -179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLY . . . . . 0.69 ' HA3' HD21 ' A' ' 38' ' ' LEU . . . -70.24 -46.75 48.29 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.705 -0.76 . . . . 1.48 112.755 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -60.48 -39.67 88.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.799 0.333 . . . . 2.76 111.07 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' LEU . . . . . 0.58 ' HB3' HD21 ' B' ' 84' ' ' LEU . 68.0 mt -69.41 -53.2 20.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.133 -0.485 . . . . 2.22 111.594 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' MET . . . . . . . . . . . . . 90.8 mtp -59.0 -48.93 79.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.482 -0.326 . . . . 2.36 111.619 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 78.5 p -53.58 -59.17 4.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 1.92 111.192 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.61 HG21 HG12 ' B' ' 142' ' ' ILE . 50.9 p -60.49 -30.98 70.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.311 -0.404 . . . . 2.06 111.467 -179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLN . . . . . 0.452 HE22 ' HZ2' ' B' ' 176' ' ' TRP . 7.3 tp60 -63.35 -50.62 69.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.402 -0.363 . . . . 2.87 111.075 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ILE . . . . . . . . . . . . . 84.8 mt -54.93 -36.95 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 1.98 111.119 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' VAL . . . . . . . . . . . . . 33.3 t -66.39 -42.77 91.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 1.62 111.506 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' VAL . . . . . . . . . . . . . 86.8 t -64.55 -54.67 27.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 1.04 111.768 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 47.6 mm -52.69 -32.92 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.404 -0.362 . . . . 2.46 111.283 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.509 ' O ' ' HG ' ' B' ' 117' ' ' LEU . 52.3 m -61.1 -47.71 85.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.955 0.407 . . . . 0.83 110.594 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 29.6 m -60.89 -21.92 63.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.068 -0.515 . . . . 0.74 110.431 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . 0.4 ' HA3' H172 ' B' ' 301' ' ' RET . . . -75.45 -47.9 11.7 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.956 -0.64 . . . . 0.6 112.745 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' B' ' 114' ' ' THR . 3.9 pp -68.72 -30.18 68.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.745 0.307 . . . . 1.42 111.013 -179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' ILE . . . . . . . . . . . . . 70.5 mt -75.56 -33.84 27.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-N 116.397 -0.365 . . . . 1.51 110.821 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ALA . . . . . . . . . . . . . . . -55.71 -46.6 77.67 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.093 -0.503 . . . . 1.09 111.492 -179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -74.69 -18.43 60.52 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.354 -0.385 . . . . 2.25 111.13 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' LEU . . . . . . . . . . . . . 94.2 mt -90.39 25.99 2.08 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 1.16 110.993 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.7 p -91.38 123.02 34.49 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.001 -0.545 . . . . 1.76 110.978 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -57.64 -23.14 49.59 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.162 -0.472 . . . . 2.89 110.329 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -137.62 139.57 40.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 2.67 110.489 179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -64.69 -9.36 19.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 3.25 111.169 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' TRP . . . . . . . . . . . . . 50.2 t-105 -75.43 -57.2 4.03 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 4.07 111.4 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' VAL . . . . . . . . . . . . . 11.6 p -60.56 -25.79 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.352 -0.385 . . . . 1.41 111.613 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' ARG . . . . . . . . . . . . . 38.9 ttm180 -54.95 -46.92 75.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.815 0.341 . . . . 2.47 110.748 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -60.39 -34.73 74.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.963 -0.562 . . . . 2.61 111.106 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 60.3 tp -66.5 -57.34 7.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.41 -0.359 . . . . 2.07 110.873 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.99 -28.82 64.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 1.3 110.783 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -59.72 -51.49 69.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.498 . . . . 1.75 110.478 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ILE . . . . . . . . . . . . . 83.1 mt -54.14 -40.04 44.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.962 -0.563 . . . . 1.67 111.013 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' CYS . . . . . . . . . . . . . 67.2 m -60.69 -39.74 89.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.226 -0.443 . . . . 1.54 110.897 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' GLY . . . . . . . . . . . . . . . -65.81 -59.5 7.52 Favored Glycine 0 C--N 1.33 0.23 0 C-N-CA 120.845 -0.693 . . . . 0.7 112.666 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' VAL . . . . . . . . . . . . . 4.8 p -57.83 -32.95 44.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.652 0.263 . . . . 1.44 111.118 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' CYS . . . . . . . . . . . . . 45.5 t -55.87 -46.45 78.27 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 1.82 110.774 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' ALA . . . . . . . . . . . . . . . -61.46 -41.62 97.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.039 -0.528 . . . . 0.94 111.368 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -73.81 -19.95 60.6 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.321 -0.4 . . . . 1.6 110.902 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.56 -48.92 20.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 2.01 110.781 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 72.9 mt -58.6 -48.19 86.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.258 -0.428 . . . . 1.96 111.435 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' ILE . . . . . 0.61 HG12 HG21 ' B' ' 108' ' ' THR . 7.9 tp -66.49 -36.54 77.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.341 -0.39 . . . . 2.88 111.601 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 52.9 tp -54.43 -57.39 11.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.825 0.345 . . . . 1.52 111.031 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' TRP . . . . . . . . . . . . . 76.6 t90 -60.85 -25.62 66.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 4.15 110.853 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.41 -17.22 66.98 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.918 -0.658 . . . . 1.59 113.242 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 49.2 pt -105.57 -4.15 9.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 117.062 0.431 . . . . 2.13 111.636 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' TRP . . . . . . . . . . . . . 10.5 m95 -74.01 -39.91 63.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.546 -0.297 . . . . 1.78 111.168 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' ASN . . . . . 0.627 ' HB3' ' HD3' ' B' ' 149' ' ' PRO . 27.2 t-20 -74.29 -51.04 4.68 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.572 -0.285 . . . . 2.45 111.725 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' PRO . . . . . 0.627 ' HD3' ' HB3' ' B' ' 148' ' ' ASN . 11.0 Cg_exo -71.78 -0.2 8.02 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 122.371 2.047 . . . . 2.36 112.198 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' LEU . . . . . . . . . . . . . 61.8 tp -59.74 100.21 0.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.074 -0.512 . . . . 2.88 111.013 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 54.31 27.87 8.58 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.079 -0.51 . . . . 8.07 110.978 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.59 -45.82 14.1 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.074 -0.512 . . . . 2.8 111.26 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -75.55 -37.1 60.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 4.58 111.098 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' THR . . . . . . . . . . . . . 72.5 p -74.27 5.04 4.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.242 -0.435 . . . . 3.81 111.462 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -58.62 -28.18 65.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.267 -0.424 . . . . 5.22 110.695 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' THR . . . . . . . . . . . . . 5.3 t -83.31 -26.12 30.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.084 -0.507 . . . . 3.42 111.32 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -72.06 -72.61 0.22 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.209 -0.45 . . . . 4.2 110.958 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 158' ' ' SER . . . . . . . . . . . . . 42.0 t -139.61 115.13 9.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.545 . . . . 2.75 110.85 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 159' ' ' SER . . . . . . . . . . . . . 60.9 m -76.37 -25.41 54.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 2.4 110.861 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 160' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -68.27 -53.48 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.019 -0.537 . . . . 3.46 110.656 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 161' ' ' LEU . . . . . . . . . . . . . 69.5 mt -64.06 -29.59 70.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.024 -0.534 . . . . 2.57 110.865 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.19 -31.52 71.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.094 -0.503 . . . . 1.72 111.042 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 163' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -77.83 -31.19 51.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 2.69 110.918 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 164' ' ' LEU . . . . . . . . . . . . . 88.9 mt -62.85 -47.28 84.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.043 0.449 . . . . 2.16 110.741 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 165' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -74.83 -23.19 58.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.846 -0.616 . . . . 2.13 111.051 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.21 -46.16 89.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.223 -0.444 . . . . 1.94 110.803 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -84.17 -21.17 31.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 3.33 111.033 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 56.1 tp -65.81 -47.59 74.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.258 -0.428 . . . . 1.56 111.352 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' VAL . . . . . . . . . . . . . 10.6 p -58.13 -31.29 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.381 -0.372 . . . . 1.59 111.338 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' THR . . . . . . . . . . . . . 55.6 m -55.28 -58.63 6.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.467 -0.333 . . . . 1.14 111.326 -179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' TYR . . . . . 0.496 ' O ' HG22 ' B' ' 174' ' ' VAL . 72.3 m-85 -63.69 -38.25 90.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.018 0.437 . . . . 3.87 110.681 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -63.55 -23.37 67.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 1.61 111.051 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' THR . . . . . . . . . . . . . 88.2 m -79.5 -50.39 10.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 1.3 111.814 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' VAL . . . . . 0.496 HG22 ' O ' ' B' ' 171' ' ' TYR . 33.0 m -56.26 -27.73 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.157 0 N-CA-C 111.905 0.335 . . . . 1.53 111.905 -179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' LEU . . . . . 0.417 ' HG ' ' O ' ' B' ' 171' ' ' TYR . 47.5 mt -79.92 -57.59 3.57 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 121.004 0.431 . . . . 1.99 110.944 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' TRP . . . . . 0.452 ' HZ2' HE22 ' B' ' 109' ' ' GLN . 0.9 OUTLIER -57.49 -28.22 63.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.84 -0.618 . . . . 1.5 111.096 -179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' B' ' 180' ' ' PRO . 9.7 tp -87.82 -20.51 7.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.996 0.427 . . . . 1.46 110.585 179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' GLY . . . . . 0.539 ' HA2' HD12 ' B' ' 181' ' ' ILE . . . -61.18 -46.86 93.63 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.888 -0.672 . . . . 0.67 112.745 -179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' TYR . . . . . 0.58 ' O ' HG22 ' B' ' 182' ' ' VAL . 66.1 m-85 -59.75 -54.79 52.18 Favored Pre-proline 0 CA--C 1.536 0.425 0 N-CA-C 111.843 0.312 . . . . 1.73 111.843 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' B' ' 179' ' ' TYR . 6.5 Cg_endo -52.13 -28.42 33.14 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 121.621 1.548 . . . . 0.93 112.359 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' ILE . . . . . 0.539 HD12 ' HA2' ' B' ' 178' ' ' GLY . 92.5 mt -62.69 -54.42 34.07 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.144 0 CA-C-O 120.93 0.395 . . . . 1.36 110.857 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' VAL . . . . . 0.58 HG22 ' O ' ' B' ' 179' ' ' TYR . 18.4 m -66.62 -24.05 32.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.01 -0.541 . . . . 1.19 111.172 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' TRP . . . . . . . . . . . . . 9.0 m95 -75.01 -12.71 60.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.346 -0.388 . . . . 2.73 111.601 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' ILE . . . . . 0.464 HG22 HG23 ' B' ' 185' ' ' ILE . 98.3 mt -56.62 -76.9 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 112.228 0.455 . . . . 1.93 112.228 -179.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.464 HG23 HG22 ' B' ' 184' ' ' ILE . 2.3 pp -117.35 -172.27 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 112.219 0.451 . . . . 2.64 112.219 -178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . 62.28 167.19 0.61 Allowed Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.681 -0.69 . . . . 1.93 113.146 179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.58 77.41 1.37 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.502 2.135 . . . . 2.97 111.412 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' SER . . . . . 0.439 ' HB3' ' HE2' ' B' ' 202' ' ' PHE . 24.9 m 62.28 53.38 2.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 4.5 110.482 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' B' ' 193' ' ' ILE . . . 179.84 -149.41 8.57 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.524 -0.846 . . . . 4.5 113.372 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -91.03 -0.3 57.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.753 0.311 . . . . 7.89 111.406 -179.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' GLY . . . . . . . . . . . . . . . 92.15 161.25 36.59 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.576 -0.821 . . . . 3.62 112.781 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' TRP . . . . . . . . . . . . . 79.1 m95 53.65 41.39 32.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.103 0.478 . . . . 6.54 110.752 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 193' ' ' ILE . . . . . 0.575 HD11 ' HA3' ' B' ' 189' ' ' GLY . 8.0 pt -138.13 139.81 41.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.774 -0.648 . . . . 3.16 110.784 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 194' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' B' ' 195' ' ' GLN . 3.1 t-20 -79.04 163.71 24.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.272 -0.422 . . . . 3.39 111.089 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 195' ' ' GLN . . . . . 0.493 ' H ' ' ND2' ' B' ' 194' ' ' ASN . 27.0 tt0 -52.48 -35.83 53.6 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.708 0.29 . . . . 5.56 111.184 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 196' ' ' THR . . . . . . . . . . . . . 60.7 p -53.43 -44.23 68.65 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.341 -0.391 . . . . 2.68 110.967 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 197' ' ' ILE . . . . . . . . . . . . . 68.2 mt -72.82 -37.55 55.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.941 -0.572 . . . . 2.2 111.168 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 198' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -49.5 -54.22 19.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.088 -0.506 . . . . 2.49 111.193 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 199' ' ' THR . . . . . . . . . . . . . 68.5 p -62.87 -46.52 87.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.141 -0.482 . . . . 1.76 111.524 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 200' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -59.11 -24.65 63.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.393 . . . . 2.18 111.248 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 201' ' ' LEU . . . . . . . . . . . . . 32.7 tp -77.91 -53.96 6.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.559 -0.291 . . . . 1.78 111.374 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 202' ' ' PHE . . . . . 0.439 ' HE2' ' HB3' ' B' ' 188' ' ' SER . 59.1 m-85 -71.77 -2.34 17.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 1.98 111.085 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 203' ' ' CYS . . . . . . . . . . . . . 49.3 t -96.41 -46.73 6.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.535 0.683 . . . . 1.65 109.577 178.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 204' ' ' LEU . . . . . . . . . . . . . 34.9 tp -74.57 -26.97 60.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.277 -0.874 . . . . 1.11 111.536 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 205' ' ' LEU . . . . . 0.432 ' HB3' ' HD3' ' B' ' 206' ' ' PRO . 0.1 OUTLIER -64.46 -54.88 34.09 Favored Pre-proline 0 CA--C 1.531 0.245 0 C-N-CA 120.891 -0.323 . . . . 1.43 111.028 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 206' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' B' ' 205' ' ' LEU . 52.7 Cg_exo -56.69 -43.88 50.61 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 121.85 1.7 . . . . 0.77 111.072 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 207' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.1 -29.13 70.56 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.943 -0.572 . . . . 1.6 110.014 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 208' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -84.55 -19.39 33.21 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.891 -0.595 . . . . 1.77 110.537 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 209' ' ' SER . . . . . . . . . . . . . 47.7 t -86.77 -37.86 17.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.985 -0.552 . . . . 1.54 110.997 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 210' ' ' LYS . . . . . . . . . . . . . 1.3 mppt? -74.65 -36.66 62.86 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.275 -0.42 . . . . 2.01 111.149 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 211' ' ' VAL . . . . . . . . . . . . . 8.6 p -64.36 -41.85 93.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.255 -0.429 . . . . 2.65 111.207 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 212' ' ' GLY . . . . . . . . . . . . . . . -57.92 -45.09 94.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.693 -0.765 . . . . 1.33 112.548 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 213' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -74.49 -25.14 59.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.71 0.29 . . . . 2.29 111.153 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 214' ' ' SER . . . . . . . . . . . . . 40.6 t -56.71 -62.07 1.99 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 2.12 110.804 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 215' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -66.66 -28.82 68.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.356 -0.384 . . . . 3.6 110.832 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.63 -43.15 97.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 1.51 110.575 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 217' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -64.49 -41.67 96.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 2.22 110.717 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 218' ' ' LEU . . . . . . . . . . . . . 15.8 tp -63.76 -32.0 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.476 . . . . 2.69 110.88 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 219' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -80.14 -34.04 38.04 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.286 -0.416 . . . . 3.4 111.087 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 220' ' ' GLY . . . . . . . . . . . . . . . -67.95 -25.96 74.11 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 1.67 112.411 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 221' ' ' LEU . . . . . 0.501 HD13 ' HA ' ' B' ' 29' ' ' PRO . 75.3 mt -76.34 -14.01 60.11 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.701 0.286 . . . . 3.39 110.864 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 222' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -66.51 -49.79 65.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 5.91 110.768 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 223' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.38 75.4 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.461 . . . . 5.26 110.835 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 224' ' ' LEU . . . . . . . . . . . . . 51.3 tp -147.54 140.28 24.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.058 -0.519 . . . . 6.81 110.701 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 225' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -96.83 121.4 38.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.189 -0.46 . . . . 7.02 110.894 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 226' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -116.07 49.88 1.08 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.5 . . . . 8.21 111.005 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 227' ' ' SER . . . . . . . . . . . . . 47.5 t 59.51 96.46 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.103 -0.499 . . . . 8.1 111.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 228' ' ' ARG . . . . . . . . . . . . . 76.5 ttt180 -86.48 154.12 21.35 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.045 -0.525 . . . . 13.28 110.961 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 229' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.257 -0.878 . . . . 10.4 110.84 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.738 0.304 . . . . 8.1 110.992 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' ASN . . . . . . . . . . . . . 16.7 m120 65.29 156.57 0.09 Allowed 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 115.921 -0.581 . . . . 6.27 111.312 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' LEU . . . . . . . . . . . . . 60.2 tp -157.59 135.62 10.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.952 -0.567 . . . . 6.2 110.703 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.84 94.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 4.82 110.662 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' SER . . . . . . . . . . . . . 43.8 m -114.77 122.58 46.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.018 -0.537 . . . . 3.25 110.983 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' LEU . . . . . . . . . . . . . 90.9 mt -104.01 2.59 32.42 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.171 -0.468 . . . . 2.79 110.586 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' LEU . . . . . 0.425 HD13 ' HB2' ' C' ' 200' ' ' PHE . 53.9 mt -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.972 -0.558 . . . . 2.08 110.782 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' HIS . . . . . 0.488 ' HB3' ' O ' ' C' ' 51' ' ' TYR . 30.0 m80 -64.6 -24.7 67.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.031 -0.531 . . . . 1.43 110.825 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' TRP . . . . . 0.492 ' HB2' ' HB1' ' C' ' 55' ' ' ALA . 64.6 t-105 -68.95 -47.93 64.44 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.273 -0.421 . . . . 1.16 110.866 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' ILE . . . . . . . . . . . . . 69.0 mt -58.12 -35.74 54.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.197 -0.456 . . . . 2.09 110.271 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' TYR . . . . . . . . . . . . . 15.8 t80 -57.13 -43.3 82.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.711 -0.677 . . . . 1.58 109.7 179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' VAL . . . . . 0.434 HG21 ' HA ' ' C' ' 52' ' ' MET . 2.1 t -57.18 -54.65 27.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.373 -0.83 . . . . 1.0 111.107 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.63 -28.58 60.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.113 -0.494 . . . . 0.96 111.268 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLY . . . . . . . . . . . . . . . -71.26 -38.81 62.82 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.584 -0.817 . . . . 0.96 112.165 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' MET . . . . . . . . . . . . . 71.9 mmm -71.99 -39.92 68.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.682 0.277 . . . . 1.3 111.119 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' THR . . . . . . . . . . . . . 49.9 p -54.52 -59.62 4.44 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.32 -0.4 . . . . 1.52 111.427 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.41 -22.48 30.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.327 -0.397 . . . . 1.9 111.088 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' GLY . . . . . . . . . . . . . . . -58.08 -59.82 10.11 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.801 -0.714 . . . . 0.96 112.481 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.56 -24.13 64.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.838 0.351 . . . . 1.07 110.599 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' LEU . . . . . . . . . . . . . 49.4 tp -63.98 -33.34 75.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.069 -0.514 . . . . 2.08 110.738 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -57.72 -43.4 85.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.153 -0.476 . . . . 2.02 110.293 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -74.77 -28.76 60.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.764 -0.653 . . . . 4.98 110.527 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' TRP . . . . . 0.787 ' O ' ' OG ' ' C' ' 26' ' ' SER . 87.7 t90 -62.92 -23.75 67.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.934 -0.576 . . . . 4.29 110.402 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' SER . . . . . . . . . . . . . 46.9 m -84.88 -50.47 7.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.05 -0.523 . . . . 2.47 110.917 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.05 -1.31 19.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.287 -0.415 . . . . 2.9 110.394 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' SER . . . . . 0.787 ' OG ' ' O ' ' C' ' 23' ' ' TRP . 0.0 OUTLIER -57.97 -23.67 54.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.919 -0.582 . . . . 2.74 111.265 -179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -45.87 -35.1 4.27 Favored 'General case' 0 CA--C 1.522 -0.118 0 CA-C-O 121.299 0.571 . . . . 5.85 109.796 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -174.25 131.77 0.51 Allowed Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.13 -0.941 . . . . 4.52 110.014 178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -93.87 176.16 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.901 2.401 . . . . 3.22 112.477 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 30.1 mmt180 -88.15 62.02 6.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.205 -0.452 . . . . 8.68 111.311 -179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.58 -29.64 3.61 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.852 -0.689 . . . . 4.14 112.88 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . 0.541 ' HB ' ' HG ' ' C' ' 221' ' ' LEU . 5.0 p -73.02 115.64 42.46 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 120.62 0.248 . . . . 5.09 111.164 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' PRO . . . . . 0.402 ' HB2' ' HD1' ' C' ' 35' ' ' TYR . 48.9 Cg_exo -55.83 165.78 3.44 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.562 2.175 . . . . 3.1 112.611 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' GLN . . . . . . . . . . . . . 24.5 pt20 -62.51 -18.61 62.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.277 -0.874 . . . . 3.85 112.74 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' TYR . . . . . 0.402 ' HD1' ' HB2' ' C' ' 33' ' ' PRO . 2.5 p90 -51.27 -37.37 46.83 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.67 0.271 . . . . 3.37 111.484 -179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -70.73 -42.8 70.06 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.87 0.367 . . . . 2.72 110.719 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -61.79 -30.57 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.018 -0.537 . . . . 5.67 110.808 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' LEU . . . . . 0.469 HD21 ' HA3' ' A' ' 103' ' ' GLY . 58.7 tp -63.17 -62.58 1.6 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 1.93 111.173 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' VAL . . . . . . . . . . . . . 59.6 t -60.58 -42.91 93.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.083 -0.508 . . . . 1.88 111.687 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' ALA . . . . . . . . . . . . . . . -66.71 -13.9 61.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.345 -0.389 . . . . 1.23 111.682 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' MET . . . . . 0.469 ' O ' ' HD2' ' C' ' 44' ' ' PRO . 60.8 ttp -88.6 -30.93 18.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.701 0.286 . . . . 2.09 111.673 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -75.04 -31.31 61.29 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.978 0.362 . . . . 1.41 111.978 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' C' ' 44' ' ' PRO . 70.5 mt -59.52 -51.73 79.11 Favored Pre-proline 0 CA--C 1.538 0.485 0 N-CA-C 112.718 0.636 . . . . 0.8 112.718 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' PRO . . . . . 0.595 ' HD3' ' HB ' ' C' ' 43' ' ' ILE . 7.2 Cg_exo -73.41 -44.04 0.59 Allowed 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.472 2.115 . . . . 0.72 113.675 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ILE . . . . . . . . . . . . . 81.1 mt -50.27 -62.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 N-CA-C 112.18 0.437 . . . . 1.68 112.18 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -57.92 -49.96 74.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.731 0.3 . . . . 1.68 111.237 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' SER . . . . . . . . . . . . . 45.1 t -63.61 -8.64 10.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 1.28 111.768 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.51 -52.01 3.69 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.613 -0.803 . . . . 0.51 112.772 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 76.9 mt -62.2 -35.55 79.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.577 0.227 . . . . 1.33 111.395 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' ALA . . . . . . . . . . . . . . . -56.19 -57.05 13.83 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.811 0.338 . . . . 0.57 111.082 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' C' ' 8' ' ' HIS . 28.4 m-85 -63.44 -26.58 68.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.203 -0.453 . . . . 1.67 110.622 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' MET . . . . . 0.434 ' HA ' HG21 ' C' ' 12' ' ' VAL . 53.3 ttp -62.98 -30.15 71.37 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.134 0.492 . . . . 1.42 110.058 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.94 -54.26 11.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.572 -0.74 . . . . 0.71 111.028 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' MET . . . . . . . . . . . . . 72.4 mtm -54.71 -19.51 6.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.841 -0.618 . . . . 1.14 110.795 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' ALA . . . . . 0.492 ' HB1' ' HB2' ' C' ' 9' ' ' TRP . . . -79.26 -42.27 26.27 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.156 -0.475 . . . . 0.88 110.909 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' ILE . . . . . 0.478 HD11 ' HD1' ' A' ' 131' ' ' TRP . 40.0 pt -97.81 19.28 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 1.38 111.148 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 62.03 66.85 0.78 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.93 -0.577 . . . . 1.94 111.01 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' GLN . . . . . 0.495 HE21 ' HB3' ' A' ' 128' ' ' ARG . 7.0 tp60 -148.81 158.56 44.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.035 -0.53 . . . . 1.87 110.653 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' GLY . . . . . . . . . . . . . . . 79.48 14.67 81.07 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.741 -0.742 . . . . 1.27 111.938 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -123.34 143.87 49.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.789 0.328 . . . . 2.86 110.807 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' VAL . . . . . . . . . . . . . 27.1 m -113.56 152.67 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.26 -0.427 . . . . 1.95 111.134 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -120.5 88.7 2.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.12 -0.491 . . . . 3.04 110.612 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.68 132.86 50.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.517 . . . . 2.11 110.997 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' ALA . . . . . . . . . . . . . . . 60.23 24.79 14.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.107 -0.497 . . . . 2.54 111.055 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.7 -9.22 65.98 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.941 -0.647 . . . . 2.47 112.798 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -99.41 153.51 18.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.883 0.373 . . . . 2.85 111.197 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' ILE . . . . . . . . . . . . . 62.6 mt -106.65 126.06 62.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.87 111.086 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' ALA . . . . . . . . . . . . . . . -101.55 144.5 30.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 1.12 111.098 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' HIS . . . . . 0.634 ' HB3' ' HB2' ' C' ' 72' ' ' ARG . 67.4 m-70 -81.95 67.69 8.04 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.08 -0.509 . . . . 1.26 110.878 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' TYR . . . . . 0.436 ' HA ' ' CE2' ' C' ' 73' ' ' TYR . 68.1 t80 -63.89 -42.31 97.5 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.777 -0.647 . . . . 2.08 111.492 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' ALA . . . . . 0.437 ' HA ' HG22 ' C' ' 74' ' ' ILE . . . -71.45 -24.23 61.98 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.345 0.498 . . . . 0.86 112.345 -178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' ARG . . . . . 0.634 ' HB2' ' HB3' ' C' ' 69' ' ' HIS . 31.5 mmt180 -70.28 -52.73 20.73 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.923 0.712 . . . . 1.96 112.923 -178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' TYR . . . . . 0.47 ' O ' ' HG3' ' C' ' 77' ' ' MET . 13.3 p90 -78.17 -34.9 49.41 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.54 -0.464 . . . . 1.8 111.869 -178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' ILE . . . . . 0.437 HG22 ' HA ' ' C' ' 71' ' ' ALA . 10.8 tp -56.01 -41.22 67.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 C-N-CA 120.807 -0.357 . . . . 1.18 110.476 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -71.32 -20.31 62.2 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.436 -0.579 . . . . 1.33 109.436 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' TRP . . . . . . . . . . . . . 29.8 m0 -89.18 4.05 49.89 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-N 115.45 -0.795 . . . . 1.85 111.394 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' MET . . . . . 0.527 ' O ' ' HG2' ' C' ' 81' ' ' PRO . 23.3 mtp -105.26 -18.59 14.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 1.56 110.744 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.48 ' O ' HD23 ' C' ' 82' ' ' LEU . 34.8 m -114.66 -33.95 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.042 -0.526 . . . . 1.11 112.334 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' THR . . . . . 0.565 HG23 HG23 ' C' ' 43' ' ' ILE . 88.7 m -81.95 -56.49 3.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.348 0.499 . . . . 1.49 112.348 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HD3' ' C' ' 81' ' ' PRO . 13.1 m -51.14 -50.01 77.94 Favored Pre-proline 0 CA--C 1.534 0.345 0 N-CA-C 112.26 0.467 . . . . 1.6 112.26 -178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' PRO . . . . . 0.548 ' HD3' ' HB ' ' C' ' 80' ' ' THR . 52.4 Cg_exo -52.62 -48.06 23.92 Favored 'Trans proline' 0 C--N 1.352 0.715 0 C-N-CA 121.828 1.686 . . . . 1.01 111.798 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' LEU . . . . . 0.49 HD13 HD12 ' C' ' 85' ' ' LEU . 4.6 mm? -66.57 -29.17 69.17 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.92 -0.582 . . . . 1.18 110.692 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' LEU . . . . . . . . . . . . . 39.0 tp -67.15 -31.18 71.43 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.165 0.507 . . . . 1.54 109.984 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' LEU . . . . . . . . . . . . . 7.0 tt -83.96 -23.04 31.26 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.51 -0.768 . . . . 1.65 110.456 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . 0.49 HD12 HD13 ' C' ' 82' ' ' LEU . 90.5 mt -78.82 -32.7 46.34 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.09 -0.504 . . . . 2.1 110.625 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' SER . . . . . . . . . . . . . 69.7 m -57.45 -27.61 62.6 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.136 -0.484 . . . . 1.38 110.534 179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' LEU . . . . . . . . . . . . . 43.2 mt -62.36 -35.95 80.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.865 -0.607 . . . . 1.44 110.998 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' SER . . . . . . . . . . . . . 38.8 t -76.67 -34.45 58.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.47 . . . . 1.87 111.232 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' TRP . . . . . . . . . . . . . 83.7 m95 -74.87 -16.95 60.66 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.415 -0.357 . . . . 3.1 111.167 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' THR . . . . . . . . . . . . . 74.8 m -81.36 -46.89 14.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 1.48 111.131 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' ALA . . . . . 0.466 ' HB1' HD11 ' C' ' 161' ' ' LEU . . . -82.28 -46.02 14.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 1.02 111.322 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' MET . . . . . . . . . . . . . 72.7 mtp -88.59 114.71 25.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 2.34 111.095 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -81.26 -51.26 8.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 3.21 110.761 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -124.16 146.89 48.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.022 -0.535 . . . . 4.54 110.806 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ILE . . . . . . . . . . . . . 32.7 mt -116.9 143.63 26.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.134 -0.485 . . . . 2.34 110.999 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -133.77 -68.28 0.57 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 4.4 110.745 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -144.39 48.2 1.37 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.18 -0.463 . . . . 5.54 110.722 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -139.87 128.27 22.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 3.54 111.273 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' TRP . . . . . 0.5 ' HE1' ' HB2' ' B' ' 35' ' ' TYR . 48.8 p90 -160.94 29.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.039 -0.528 . . . . 5.21 110.51 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' THR . . . . . . . . . . . . . 33.9 m -71.67 -61.58 1.73 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.905 -0.589 . . . . 2.38 111.511 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' LEU . . . . . 0.41 ' N ' HD12 ' C' ' 101' ' ' LEU . 7.2 mp -60.23 -54.68 42.85 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.109 -0.496 . . . . 2.64 111.521 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.55 -27.95 35.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.868 0.366 . . . . 2.38 111.155 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.57 -52.49 8.35 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.857 -0.687 . . . . 1.62 112.903 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.27 -30.94 68.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.785 0.326 . . . . 2.93 111.299 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' LEU . . . . . . . . . . . . . 93.5 mt -75.33 -37.43 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.345 -0.389 . . . . 2.16 111.579 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' MET . . . . . 0.42 ' O ' HG13 ' C' ' 110' ' ' ILE . 87.5 mtp -66.89 -41.96 86.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 2.3 111.7 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' SER . . . . . . . . . . . . . 77.6 p -62.45 -55.76 24.56 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.673 -0.24 . . . . 2.07 111.594 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' THR . . . . . 0.409 HG22 HG21 ' C' ' 142' ' ' ILE . 73.1 p -56.5 -33.24 65.82 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.069 0.396 . . . . 2.3 112.069 -179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' GLN . . . . . 0.433 HE21 HG22 ' C' ' 80' ' ' THR . 62.4 tt0 -65.75 -52.15 53.39 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.611 -0.268 . . . . 2.48 111.667 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ILE . . . . . 0.477 ' HA ' HD12 ' C' ' 113' ' ' ILE . 68.2 mt -50.26 -41.56 19.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.571 -0.286 . . . . 1.93 111.569 -179.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.2 -49.44 84.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.831 0.348 . . . . 1.67 111.088 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' VAL . . . . . . . . . . . . . 65.7 t -60.5 -39.06 80.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 1.11 111.27 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . 0.477 HD12 ' HA ' ' C' ' 110' ' ' ILE . 92.8 mt -56.9 -34.36 43.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 2.59 110.871 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' THR . . . . . . . . . . . . . 52.8 m -65.92 -46.21 79.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.9 111.0 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' SER . . . . . . . . . . . . . 53.3 m -60.16 -22.14 62.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.983 -0.553 . . . . 0.92 110.997 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' GLY . . . . . 0.583 ' HA3' H172 ' C' ' 301' ' ' RET . . . -82.23 -38.94 11.88 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.93 -0.652 . . . . 0.55 113.325 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' LEU . . . . . 0.501 HD12 ' N ' ' C' ' 118' ' ' ILE . 3.5 pp -78.8 -26.38 44.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.588 0.218 . . . . 1.49 111.588 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' ILE . . . . . 0.532 HD11 ' HG3' ' B' ' 58' ' ' GLN . 20.9 tt -83.73 -29.46 7.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 1.66 111.399 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' ALA . . . . . . . . . . . . . . . -59.19 -38.65 80.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.94 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -76.33 -22.66 54.65 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.173 -0.467 . . . . 1.79 111.262 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' LEU . . . . . . . . . . . . . 67.7 mt -86.58 24.04 1.52 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.424 -0.353 . . . . 1.29 111.158 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' SER . . . . . 0.533 ' HA ' HE22 ' B' ' 58' ' ' GLN . 61.3 m -89.68 118.64 29.44 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.218 -0.446 . . . . 2.15 110.994 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -57.89 -20.96 40.67 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.118 -0.492 . . . . 3.31 110.301 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -131.83 136.27 47.36 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.606 -0.725 . . . . 3.16 110.478 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.88 -9.25 35.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.107 -0.497 . . . . 4.24 111.16 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' TRP . . . . . . . . . . . . . 73.2 t-105 -82.15 -56.88 3.65 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.309 -0.405 . . . . 4.65 111.211 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' VAL . . . . . . . . . . . . . 11.5 p -57.08 -23.63 18.88 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.316 -0.402 . . . . 1.31 111.178 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' ARG . . . . . . . . . . . . . 54.0 ttp180 -62.88 -39.56 94.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 2.84 111.1 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -63.79 -37.49 87.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.232 -0.44 . . . . 2.7 111.023 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' LEU . . . . . 0.417 ' O ' HG22 ' C' ' 133' ' ' ILE . 50.0 tp -62.86 -50.14 72.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.056 0.455 . . . . 1.88 110.652 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -67.32 -24.06 65.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.085 -0.507 . . . . 1.38 110.687 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -63.15 -60.17 3.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 1.76 110.926 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' ILE . . . . . 0.417 HG22 ' O ' ' C' ' 130' ' ' LEU . 8.6 tp -54.73 -31.32 23.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.319 -0.401 . . . . 2.15 111.035 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' CYS . . . . . . . . . . . . . 91.2 m -61.91 -43.57 98.58 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.435 -0.348 . . . . 1.56 110.778 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' GLY . . . . . . . . . . . . . . . -61.39 -58.89 11.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.968 -0.634 . . . . 0.73 112.729 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' VAL . . . . . . . . . . . . . 5.2 p -58.12 -33.63 47.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.721 0.296 . . . . 1.48 111.184 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' CYS . . . . . . . . . . . . . 46.2 t -52.74 -45.74 67.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 1.51 110.762 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' ALA . . . . . . . . . . . . . . . -66.64 -36.71 83.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.139 -0.482 . . . . 1.01 111.369 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -75.06 -16.96 60.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.193 -0.458 . . . . 2.05 111.06 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.92 -50.92 9.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.386 -0.37 . . . . 2.07 110.948 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.415 HG13 ' N ' ' C' ' 142' ' ' ILE . 35.2 pt -57.97 -38.97 69.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.31 -0.405 . . . . 1.92 111.453 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' ILE . . . . . 0.415 ' N ' HG13 ' C' ' 141' ' ' ILE . 2.7 pp -74.41 -29.17 23.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.548 -0.297 . . . . 2.64 110.949 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' LEU . . . . . . . . . . . . . 60.6 tp -63.68 -53.93 43.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.399 . . . . 1.51 110.722 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' TRP . . . . . . . . . . . . . 40.6 t-105 -66.32 -23.0 66.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.995 0.426 . . . . 3.58 110.526 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' GLY . . . . . . . . . . . . . . . -83.1 -17.44 67.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.962 -0.637 . . . . 1.65 112.815 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' ILE . . . . . . . . . . . . . 19.0 tt -104.85 -12.94 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-O 120.815 0.341 . . . . 2.46 111.388 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -64.51 -36.09 83.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.327 -0.397 . . . . 2.27 111.584 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' ASN . . . . . 0.445 ' N ' ' HD2' ' C' ' 149' ' ' PRO . 6.6 t30 -77.46 -53.93 1.52 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 112.017 0.377 . . . . 2.33 112.017 -179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' C' ' 148' ' ' ASN . 58.3 Cg_endo -69.66 -0.55 7.0 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 121.952 1.768 . . . . 2.46 112.438 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' LEU . . . . . . . . . . . . . 25.9 tp -57.39 98.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 3.08 110.706 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' ARG . . . . . 0.405 ' O ' ' HG3' ' C' ' 155' ' ' ARG . 39.9 mmt180 56.25 30.43 16.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.208 -0.451 . . . . 8.45 111.009 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' ALA . . . . . . . . . . . . . . . -82.25 -50.49 8.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.274 -0.421 . . . . 2.9 111.387 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -80.79 -2.78 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 4.62 111.093 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' THR . . . . . 0.597 ' HA ' HE21 ' C' ' 157' ' ' GLN . 67.2 p -102.16 2.12 36.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 3.85 111.216 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' C' ' 151' ' ' ARG . 97.2 mtt180 -66.05 -21.2 66.37 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.276 -0.42 . . . . 5.12 110.85 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 156' ' ' THR . . . . . . . . . . . . . 71.0 p -83.38 -10.95 58.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.085 -0.507 . . . . 3.43 110.666 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 157' ' ' GLN . . . . . 0.597 HE21 ' HA ' ' C' ' 154' ' ' THR . 51.0 mt-30 -94.97 -72.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.943 -0.571 . . . . 3.98 110.929 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 158' ' ' SER . . . . . . . . . . . . . 79.4 p -142.53 116.07 9.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.037 -0.529 . . . . 2.4 110.981 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 159' ' ' SER . . . . . . . . . . . . . 86.4 p -75.63 -25.17 56.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.083 -0.508 . . . . 2.82 110.771 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 160' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -64.25 -51.75 62.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 3.18 110.825 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 161' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 164' ' ' LEU . 31.0 tp -65.55 -19.74 66.05 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.265 -0.425 . . . . 2.5 110.511 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 162' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.84 59.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.053 -0.521 . . . . 1.81 110.779 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 163' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -77.66 -35.02 52.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.002 -0.545 . . . . 2.13 110.719 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 164' ' ' LEU . . . . . 0.514 HD12 HD12 ' C' ' 161' ' ' LEU . 86.8 mt -62.67 -52.38 63.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.028 -0.533 . . . . 2.21 110.966 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 165' ' ' TYR . . . . . 0.421 ' O ' HG23 ' C' ' 169' ' ' VAL . 0.7 OUTLIER -67.53 -27.95 67.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.857 -0.611 . . . . 1.31 111.042 -179.647 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 166' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -56.45 -52.96 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 2.26 111.008 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 167' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -79.19 -21.28 46.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.281 -0.418 . . . . 3.58 110.99 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 47.5 tp -65.12 -41.43 94.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.172 -0.467 . . . . 1.3 111.098 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 169' ' ' VAL . . . . . 0.421 HG23 ' O ' ' C' ' 165' ' ' TYR . 99.8 t -66.54 -36.74 78.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.355 -0.384 . . . . 1.73 110.975 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 170' ' ' THR . . . . . . . . . . . . . 66.4 m -51.95 -58.71 5.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.374 -0.376 . . . . 1.43 111.326 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 171' ' ' TYR . . . . . . . . . . . . . 88.6 t80 -63.13 -32.75 74.21 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.027 0.441 . . . . 3.72 110.377 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 172' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -62.74 -33.6 75.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.825 -0.625 . . . . 1.55 111.437 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 173' ' ' THR . . . . . . . . . . . . . 69.9 p -79.09 -34.99 43.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.533 -0.303 . . . . 1.5 111.81 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 174' ' ' VAL . . . . . . . . . . . . . 88.1 t -58.23 -37.91 65.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.731 0.301 . . . . 1.84 111.551 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 175' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' C' ' 209' ' ' SER . 8.7 mp -79.9 -52.07 8.32 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.08 0.467 . . . . 2.12 111.188 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 176' ' ' TRP . . . . . . . . . . . . . 1.1 m-90 -57.45 -27.5 62.5 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.817 -0.629 . . . . 1.0 111.119 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 177' ' ' ILE . . . . . 0.414 ' O ' HG13 ' C' ' 181' ' ' ILE . 9.3 tp -87.91 -23.21 6.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.892 0.377 . . . . 1.75 110.329 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 178' ' ' GLY . . . . . . . . . . . . . . . -55.94 -55.14 30.61 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 115.856 -0.611 . . . . 0.72 112.78 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 179' ' ' TYR . . . . . 0.593 ' O ' HG22 ' C' ' 182' ' ' VAL . 65.5 m-85 -53.49 -56.83 20.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 C-N-CA 120.742 -0.383 . . . . 1.8 110.677 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 180' ' ' PRO . . . . . 0.583 ' HD3' ' HB2' ' C' ' 179' ' ' TYR . 95.6 Cg_exo -42.18 -39.4 6.01 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 122.287 1.991 . . . . 0.88 112.373 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 181' ' ' ILE . . . . . 0.414 HG13 ' O ' ' C' ' 177' ' ' ILE . 90.0 mt -56.62 -59.02 3.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.371 -0.377 . . . . 1.52 111.4 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 182' ' ' VAL . . . . . 0.593 HG22 ' O ' ' C' ' 179' ' ' TYR . 10.9 m -62.42 -25.32 37.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.214 -0.448 . . . . 1.2 111.395 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 183' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -71.97 -21.24 61.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.404 -0.362 . . . . 2.47 110.977 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 184' ' ' ILE . . . . . 0.605 HG22 HG23 ' C' ' 185' ' ' ILE . 85.4 mt -57.51 -75.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.434 -0.348 . . . . 1.62 111.013 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.605 HG23 HG22 ' C' ' 184' ' ' ILE . 2.7 pp -124.95 175.55 7.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.245 -0.434 . . . . 2.63 111.08 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 186' ' ' GLY . . . . . . . . . . . . . . . 97.84 -144.72 17.45 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.773 -0.727 . . . . 1.77 112.416 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 187' ' ' PRO . . . . . 0.623 ' HD3' HD12 ' C' ' 193' ' ' ILE . 72.0 Cg_endo -76.96 150.39 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.446 2.097 . . . . 3.03 112.233 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 188' ' ' SER . . . . . . . . . . . . . 68.9 m 56.53 28.12 13.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.187 -0.461 . . . . 4.22 110.769 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 189' ' ' GLY . . . . . . . . . . . . . . . -157.18 -71.98 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.829 -0.701 . . . . 4.08 112.345 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 190' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -172.39 82.2 0.06 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 7.54 110.755 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 191' ' ' GLY . . . . . . . . . . . . . . . -170.23 162.39 35.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.559 -0.829 . . . . 3.29 112.829 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 192' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -96.02 64.12 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.813 0.34 . . . . 5.67 110.74 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 193' ' ' ILE . . . . . 0.623 HD12 ' HD3' ' C' ' 187' ' ' PRO . 75.3 mt -126.32 142.48 42.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 2.76 111.188 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 194' ' ' ASN . . . . . . . . . . . . . 32.9 m-80 -55.81 147.69 18.47 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.937 -0.574 . . . . 3.69 111.338 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 195' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -76.82 -1.41 28.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.948 -0.569 . . . . 5.34 110.905 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 196' ' ' THR . . . . . . . . . . . . . 84.2 m -74.35 -59.91 2.51 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.266 -0.424 . . . . 2.57 111.19 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 197' ' ' ILE . . . . . . . . . . . . . 14.2 tt -57.94 -30.85 39.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 2.37 111.096 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 198' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -56.29 -49.69 73.52 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.264 -0.425 . . . . 2.68 110.932 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 199' ' ' THR . . . . . . . . . . . . . 81.7 p -66.92 -25.17 66.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 1.95 110.946 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 200' ' ' PHE . . . . . 0.425 ' HB2' HD13 ' C' ' 7' ' ' LEU . 86.6 t80 -80.83 -22.57 39.83 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 2.05 110.706 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' LEU . . . . . . . . . . . . . 41.4 tp -84.84 -45.74 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.284 -0.416 . . . . 1.91 111.242 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -71.64 -6.93 44.61 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.44 -0.346 . . . . 2.04 111.625 -179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' CYS . . . . . 0.439 ' C ' ' HD2' ' C' ' 206' ' ' PRO . 17.3 p -96.68 -43.18 7.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.224 0.535 . . . . 1.62 110.501 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' LEU . . . . . . . . . . . . . 49.6 tp -74.72 -28.7 60.91 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.884 -0.598 . . . . 1.49 111.598 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' LEU . . . . . 0.69 ' HB3' ' HD3' ' C' ' 206' ' ' PRO . 19.5 tp -62.91 -53.71 53.29 Favored Pre-proline 0 CA--C 1.533 0.289 0 C-N-CA 120.918 -0.313 . . . . 1.32 110.771 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' PRO . . . . . 0.69 ' HD3' ' HB3' ' C' ' 205' ' ' LEU . 51.3 Cg_exo -56.57 -40.79 82.01 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.894 1.73 . . . . 0.76 111.508 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -66.26 -32.2 73.48 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.024 -0.534 . . . . 1.52 110.431 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -84.86 -16.33 41.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.991 -0.549 . . . . 1.84 111.108 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' SER . . . . . 0.501 ' HB2' HD23 ' C' ' 175' ' ' LEU . 95.9 p -91.2 -30.12 16.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.42 -0.355 . . . . 1.68 111.424 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' LYS . . . . . . . . . . . . . 19.0 mtmm -94.48 -4.66 47.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.539 -0.3 . . . . 2.04 111.606 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' VAL . . . . . . . . . . . . . 14.7 p -88.85 -38.59 11.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.898 0.38 . . . . 2.65 111.015 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' GLY . . . . . . . . . . . . . . . -66.57 -37.25 92.42 Favored Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.76 -0.733 . . . . 1.33 112.377 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -70.76 -29.18 65.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 3.02 110.679 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' SER . . . . . . . . . . . . . 67.9 m -60.04 -59.37 5.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.278 -0.419 . . . . 2.35 110.794 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -64.67 -22.43 66.98 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.167 -0.47 . . . . 3.62 110.569 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.426 ' C ' HD13 ' C' ' 216' ' ' LEU . 3.2 tm? -68.61 -51.43 42.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.941 -0.572 . . . . 1.64 110.596 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.58 -28.4 68.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.302 -0.408 . . . . 2.2 110.895 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.1 tp -69.31 -35.2 75.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 3.11 110.846 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' HIS . . . . . . . . . . . . . 60.7 t60 -86.3 -21.88 27.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.985 -0.552 . . . . 3.37 111.228 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' GLY . . . . . . . . . . . . . . . -66.32 -46.61 77.35 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.766 -0.731 . . . . 1.55 112.579 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' LEU . . . . . 0.558 HD13 HD12 ' C' ' 224' ' ' LEU . 4.5 mm? -65.69 -11.79 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.785 0.326 . . . . 3.11 111.389 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 -88.67 32.42 0.8 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.342 -0.39 . . . . 5.73 111.113 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -150.72 -0.43 0.4 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.151 -0.477 . . . . 5.53 110.812 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' LEU . . . . . 0.558 HD12 HD13 ' C' ' 221' ' ' LEU . 86.1 mt -101.86 166.62 10.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.476 . . . . 6.6 110.944 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -130.24 125.28 34.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 6.51 110.98 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -114.21 27.39 9.52 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.108 -0.496 . . . . 7.05 110.947 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' SER . . . . . . . . . . . . . 46.9 t -129.37 127.31 40.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.334 -0.394 . . . . 6.72 111.18 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -159.22 110.53 2.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.996 -0.547 . . . . 9.56 110.75 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.334 -0.841 . . . . 9.08 111.075 -179.872 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' RET . . . . . 0.847 H183 ' HG3' ' A' ' 180' ' ' PRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' RET . . . . . 0.752 ' H8 ' H161 ' B' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 301' ' ' RET . . . . . 0.742 ' H8 ' H171 ' C' ' 301' ' ' RET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_